data_2k4w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k4w _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 119.544 -0.265 . . . . 2.1200000000000001 110.756 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.78 152.62 35.5 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.763 -1.211 . . . . 1.47 113.228 -164.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -147.59 130.96 16.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.138 1.775 . . . . 2.2200000000000002 109.599 174.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.44 96.66 10.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 5.9900000000000002 111.117 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 t -90.15 112.32 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 120.597 -1.314 . . . . 1.6200000000000001 109.147 -169.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.28 109.55 2.81 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.781 1.181 . . . . 0.95999999999999996 110.363 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.2 mtp -96.52 131.12 43.45 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.453 0.701 . . . . 2.2000000000000002 111.486 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -105.06 155.61 18.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.465 1.126 . . . . 2.6699999999999999 110.534 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.84 145.29 54.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.412 1.485 . . . . 1.49 109.451 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.4 m -140.07 140.46 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.507 0.723 . . . . 1.3300000000000001 111.085 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.08 57.9 0.1 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.788 0.662 . . . . 2.3500000000000001 112.788 -167.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 77.34 -21.48 0.33 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.949 2.1 . . . . 1.54 114.073 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -19.99 28.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.251 1.02 . . . . 3.1499999999999999 112.858 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.57 -147.93 16.32 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 125.411 1.482 . . . . 1.0800000000000001 111.327 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.05 123.2 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.169 1.788 . . . . 1.3899999999999999 111.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.32 -137.8 9.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.748 1.642 . . . . 1.5700000000000001 112.021 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -90.31 170.11 10.53 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.258 -0.554 . . . . 2.23 110.049 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 t -105.95 157.66 17.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.991 0.9 . . . . 2.1899999999999999 112.201 162.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.95 0.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.715 2.806 . . . . 3.7000000000000002 112.822 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 147.25 6.21 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.571 2.034 . . . . 0.91000000000000003 111.914 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.436 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 4.9 p -88.08 -177.44 5.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.297 -1.001 . . . . 1.02 108.297 159.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.3 134.28 65.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.554 -1.276 . . . . 0.56999999999999995 107.554 149.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.2 p -82.95 127.09 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.596 -0.52 . . . . 1.4099999999999999 109.596 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.8 mt -103.88 130.64 54.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.219 -1.03 . . . . 1.74 108.219 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.41 112.12 8.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.656 1.182 . . . . 2.1499999999999999 109.131 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -77.77 144.49 37.11 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.773 -0.579 . . . . 3.3199999999999998 111.157 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 t -148.24 178.13 8.83 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.356 -0.979 . . . . 1.97 108.356 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -70.36 -14.95 62.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.162 0.585 . . . . 3.3900000000000001 112.176 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.41 12.9 67.47 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.22 1.391 . . . . 1.1000000000000001 114.845 163.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.98 -155.89 22.15 Favored Glycine 0 N--CA 1.467 0.741 0 C-N-CA 127.492 2.473 . . . . 0.81000000000000005 117.224 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -71.63 101.99 2.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.664 0.785 . . . . 0.78000000000000003 111.87 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -71.29 117.3 12.65 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.841 1.256 . . . . 2.7400000000000002 109.163 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.48 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -95.88 127.52 41.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.027 1.731 . . . . 0.95999999999999996 108.162 174.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.412 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 19.9 m -129.62 105.03 17.27 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 119.916 1.235 . . . . 1.45 107.972 167.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.75 164.87 29.58 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.112 2.541 . . . . 0.67000000000000004 110.066 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.436 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 1.3 p80 -155.42 43.66 0.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 122.356 1.074 . . . . 1.54 109.251 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.15 134.83 44.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.891 1.276 . . . . 2.25 112.089 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.492 ' HE3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -104.63 164.47 11.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.962 2.505 . . . . 3.2599999999999998 109.056 168.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.57 16.06 0.38 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.778 2.431 . . . . 1.79 114.195 163.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.36 160.5 36.93 Favored Pre-proline 0 CA--C 1.511 -0.545 0 O-C-N 121.871 -0.518 . . . . 3.0 110.42 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.8 128.45 23.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 O-C-N 123.451 1.237 . . . . 1.1699999999999999 110.307 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -85.8 31.31 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 125.101 3.867 . . . . 1.3100000000000001 113.471 -147.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.08 -122.18 4.29 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 126.399 1.952 . . . . 1.1799999999999999 113.124 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.84 138.21 35.57 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.095 2.158 . . . . 2.5099999999999998 108.386 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -137.88 123.0 19.19 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 123.683 0.793 . . . . 1.55 112.942 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.15 149.26 7.56 Favored Glycine 0 CA--C 1.54 1.656 0 O-C-N 121.336 -0.852 . . . . 0.69999999999999996 112.307 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.7 t80 -124.96 115.4 20.51 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.802 1.301 . . . . 3.3300000000000001 107.5 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -115.03 162.31 17.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.724 1.379 . . . . 1.1799999999999999 114.724 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.2 mt -107.75 143.6 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.765 2.026 . . . . 0.79000000000000004 107.388 155.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -118.41 161.09 20.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.504 1.122 . . . . 1.1100000000000001 112.03 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.62 73.22 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.558 1.318 . . . . 0.85999999999999999 114.558 -163.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -101.92 177.77 4.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.69 1.196 . . . . 2.0099999999999998 111.61 164.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.49 90.2 0.55 Allowed Glycine 0 N--CA 1.469 0.856 0 C-N-CA 124.621 1.105 . . . . 0.91000000000000003 112.003 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -166.4 99.03 0.6 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.356 1.078 . . . . 2.54 113.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.7 m -71.48 45.52 0.11 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.942 2.097 . . . . 1.6399999999999999 113.802 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.55 148.41 42.85 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.172 -1.58 . . . . 3.6099999999999999 111.452 -171.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.51 165.02 9.37 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.473 3.449 . . . . 1.8100000000000001 112.139 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.65 148.96 40.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.425 1.09 . . . . 2.1699999999999999 110.013 166.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.45 134.43 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.323 1.449 . . . . 2.52 108.091 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -162.9 143.6 9.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.305 1.442 . . . . 6.3899999999999997 109.21 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t0 53.21 41.38 32.14 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.358 0.981 . . . . 4.0199999999999996 113.471 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 14.45 73.14 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.936 -0.925 . . . . 2.8799999999999999 115.086 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.38 156.79 44.39 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.446 1.623 . . . . 3.8300000000000001 111.717 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.09 138.98 44.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.377 0.88 . . . . 1.97 113.377 -170.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.83 134.06 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.265 1.426 . . . . 3.2799999999999998 109.037 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.52 -48.47 10.19 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.263 1.579 . . . . 2.6499999999999999 115.263 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.61 122.45 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 130.578 3.551 . . . . 2.71 107.412 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -154.45 -8.31 0.14 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.43 1.092 . . . . 6.79 113.849 -164.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.53 62.47 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 121.088 1.767 . . . . 1.75 113.048 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.0 -8.36 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.167 1.787 . . . . 1.25 114.708 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.4 -165.3 38.93 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 121.344 1.884 . . . . 2.5800000000000001 113.035 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.69 179.35 53.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.27 0.938 . . . . 1.6399999999999999 112.358 165.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . 0.291 0.2 OUTLIER -77.57 54.03 1.14 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.335 1.054 . . . . 3.8399999999999999 113.655 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.9 tp 54.87 69.19 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.921 2.488 . . . . 2.5499999999999998 111.484 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.45 65.52 11.76 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 129.0 2.92 . . . . 4.5899999999999999 113.009 -162.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.88 -58.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.382 2.721 . . . . 2.4900000000000002 113.436 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -137.7 125.96 23.15 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.29 1.036 . . . . 4.7599999999999998 109.51 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -174.89 -95.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.553 1.541 . . . . 6.0300000000000002 112.096 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 t 171.19 -23.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 128.713 2.805 . . . . 3.9399999999999999 112.604 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.78 -34.17 4.47 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 125.892 1.71 . . . . 3.4399999999999999 111.646 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -52.25 144.64 12.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.409 1.1 . . . . 7.8399999999999999 111.912 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -96.26 147.86 23.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.371 1.868 . . . . 2.3500000000000001 111.326 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.1 131.6 45.72 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.529 -0.915 . . . . 4.3899999999999997 108.529 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.19 -145.38 5.2 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.548 -1.14 . . . . 2.9700000000000002 114.108 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.47 -18.89 22.46 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.302 2.668 . . . . 3.23 114.265 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -165.29 146.81 7.52 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.863 1.265 . . . . 5.5099999999999998 110.834 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.88 -135.79 13.13 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.262 0.934 . . . . 5.1399999999999997 111.917 -171.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -165.71 157.89 14.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.435 1.494 . . . . 7.0700000000000003 109.451 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.18 -126.61 0.83 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.199 0.839 . . . . 2.6600000000000001 115.199 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 145.4 25.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.47 1.508 . . . . 4.9100000000000001 111.985 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.58 -11.31 57.5 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.16 1.17 . . . . 2.9100000000000001 114.16 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.01 32.2 4.72 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.216 1.389 . . . . 1.1599999999999999 114.858 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.97 131.64 56.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.008 1.323 . . . . 1.6699999999999999 111.16 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mp -142.32 159.46 58.12 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 125.646 1.579 . . . . 2.98 111.079 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.11 152.0 56.08 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.942 2.428 . . . . 1.05 113.083 -169.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.32 130.95 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.343 1.457 . . . . 3.3100000000000001 112.758 -162.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.33 88.43 2.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.019 2.928 . . . . 2.6600000000000001 109.87 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.67 136.06 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.03 0.932 . . . . 0.90000000000000002 110.587 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.87 138.99 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 127.418 2.287 . . . . 2.4700000000000002 106.295 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.19 161.28 30.12 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.263 -0.898 . . . . 2.3500000000000001 111.276 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -19.2 0.85 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.731 2.123 . . . . 2.6299999999999999 116.731 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.84 1.89 55.4 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.487 2.315 . . . . 2.73 112.812 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.15 23.21 41.75 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 125.258 1.408 . . . . 1.01 114.462 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -123.49 131.8 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.334 1.054 . . . . 1.6399999999999999 111.044 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.02 140.17 44.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.009 1.724 . . . . 1.1299999999999999 111.604 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -140.91 -2.9 1.28 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.745 1.757 . . . . 2.23 115.745 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.3 111.85 3.71 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 114.791 1.404 . . . . 3.2799999999999998 114.791 -165.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.23 101.89 1.18 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.014 2.476 . . . . 2.48 110.079 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.0 178.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.145 1.778 . . . . 2.6400000000000001 110.203 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.0 m -146.92 142.48 27.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.675 0.79 . . . . 1.49 110.621 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.88 106.97 56.45 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.494 1.118 . . . . 0.93999999999999995 110.422 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.61 7.44 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.663 2.909 . . . . 1.04 113.218 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -17.98 63.32 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.229 1.412 . . . . 6.4800000000000004 113.425 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mp -152.82 155.77 37.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.862 3.265 . . . . 3.5299999999999998 108.09 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.304 0.0 OUTLIER -147.94 43.35 1.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.545 2.054 . . . . 5.9800000000000004 116.545 -173.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -175.99 147.36 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.638 1.975 . . . . 2.75 110.161 167.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.75 -28.42 68.69 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 2.3100000000000001 111.717 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.16 -19.23 19.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.123 1.369 . . . . 3.3599999999999999 114.301 173.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.72 -7.94 59.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.565 1.146 . . . . 2.71 112.496 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.27 0.78 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 114.912 1.449 . . . . 1.4199999999999999 114.912 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -72.23 20.22 0.07 Allowed 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.682 2.105 . . . . 4.2800000000000002 116.682 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -142.47 15.8 2.01 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.454 1.901 . . . . 3.0099999999999998 111.322 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -128.91 175.84 8.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.581 1.552 . . . . 3.3300000000000001 112.748 -164.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.15 149.11 39.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.563 1.145 . . . . 0.76000000000000001 112.04 166.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.2 mt -82.22 155.35 24.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.303 1.441 . . . . 2.8500000000000001 109.056 158.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.4 ttm -149.45 122.88 9.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.395 . . . . 2.5299999999999998 111.97 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -94.32 109.25 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.779 1.232 . . . . 0.85999999999999999 108.658 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.4 147.9 22.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.415 2.286 . . . . 3.4399999999999999 113.218 -167.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 t -67.88 -38.54 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.049 -1.032 . . . . 2.0699999999999998 112.332 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.51 155.92 17.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.632 0.634 . . . . 1.48 111.619 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.71 165.6 28.69 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.374 0.988 . . . . 1.3899999999999999 111.758 157.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -122.65 23.5 9.51 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.189 1.181 . . . . 2.6400000000000001 114.189 -136.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -93.72 4.25 54.22 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 116.397 1.999 . . . . 3.04 116.397 -167.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -131.88 151.27 51.81 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.677 1.732 . . . . 4.0999999999999996 115.677 -168.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.0 p -140.27 11.12 2.35 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.666 2.386 . . . . 3.54 112.89 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -118.65 14.7 13.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.219 1.408 . . . . 4.7699999999999996 112.436 -145.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -121.31 163.17 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.758 2.823 . . . . 3.2799999999999998 107.969 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.02 -10.12 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.828 2.352 . . . . 2.6200000000000001 114.441 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.13 133.03 22.58 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.321 1.449 . . . . 6.7199999999999998 109.757 165.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 165.9 31.35 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.64 2.893 . . . . 4.3600000000000003 113.175 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.92 25.48 14.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.293 1.837 . . . . 6.0999999999999996 111.647 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.59 13.72 59.14 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.989 -1.069 . . . . 3.3900000000000001 114.04 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 106.14 -7.7 41.05 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.619 1.58 . . . . 2.0 113.984 -168.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.19 22.08 0.63 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 126.303 1.906 . . . . 1.5600000000000001 115.887 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.86 74.68 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.364 1.459 . . . . 1.98 114.294 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.2 p -73.24 163.31 28.29 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.5 1.52 . . . . 2.0299999999999998 110.921 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 145.02 30.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.768 1.227 . . . . 6.29 111.555 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -92.16 -34.02 14.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.996 0.919 . . . . 4.0999999999999996 112.436 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.83 154.57 42.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.956 0.902 . . . . 0.59999999999999998 113.116 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.3 t -138.9 153.71 48.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.405 2.282 . . . . 1.4299999999999999 109.769 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.99 114.64 0.62 Allowed Glycine 0 N--CA 1.467 0.706 0 C-N-CA 124.088 0.851 . . . . 0.88 113.051 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.88 130.75 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.915 1.286 . . . . 2.54 110.514 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mp -76.4 132.81 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 2.23 109.54 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 118.492 -0.766 . . . . 5.3700000000000001 112.954 -176.339 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 119.479 -0.296 . . . . 2.7599999999999998 110.414 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -131.79 140.34 49.17 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.603 1.705 . . . . 2.2400000000000002 115.603 -137.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.89 136.87 34.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.144 0.973 . . . . 2.5600000000000001 111.569 161.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 98.16 11.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.624 1.17 . . . . 5.7300000000000004 111.36 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.03 118.55 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 120.8 -1.188 . . . . 1.53 109.614 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.42 111.31 3.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.478 1.513 . . . . 1.26 112.013 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 mmt -84.24 124.52 31.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.772 1.229 . . . . 2.3799999999999999 112.518 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -113.03 149.29 33.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.487 0.661 . . . . 2.3500000000000001 111.008 164.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -56.99 140.13 49.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.431 1.092 . . . . 1.3 109.635 171.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.36 147.28 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.43 0.559 . . . . 1.96 111.479 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -167.97 49.51 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.822 0.849 . . . . 2.5699999999999998 112.67 -168.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.42 -31.75 0.23 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.046 2.138 . . . . 1.8500000000000001 114.316 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -2.37 10.74 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.34 0.973 . . . . 2.9500000000000002 111.619 160.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.93 -140.01 16.71 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.671 1.129 . . . . 1.8400000000000001 111.03 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.05 122.34 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.723 1.609 . . . . 1.52 111.165 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.57 -134.99 8.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 126.176 1.846 . . . . 1.74 113.25 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.84 146.24 35.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.16 1.384 . . . . 3.4399999999999999 110.984 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 t -83.89 142.9 30.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 2.1000000000000001 110.878 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.8 -0.24 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.617 1.34 . . . . 4.3300000000000001 114.617 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.21 167.49 14.4 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.673 1.13 . . . . 0.82999999999999996 111.843 -171.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 p -103.3 176.14 5.25 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.569 -0.9 . . . . 1.22 108.569 161.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -119.19 131.36 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.718 -1.586 . . . . 0.75 106.718 148.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -84.88 123.97 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.921 -0.4 . . . . 1.52 109.921 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -98.32 117.91 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.177 -1.046 . . . . 1.8799999999999999 108.177 173.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -119.43 107.96 13.97 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.514 1.526 . . . . 1.9299999999999999 109.717 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.65 147.7 31.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.578 0.955 . . . . 3.9300000000000002 113.578 -172.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -179.58 7.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.719 0.808 . . . . 1.8400000000000001 110.96 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.16 -28.2 69.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.302 1.041 . . . . 3.7799999999999998 111.842 174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.9 10.34 60.48 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.448 1.023 . . . . 1.2 114.657 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.7 -145.74 23.97 Favored Glycine 0 N--CA 1.461 0.342 0 C-N-CA 129.15 3.262 . . . . 0.84999999999999998 114.895 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.6 95.19 7.09 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.916 0.886 . . . . 0.83999999999999997 110.488 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -71.66 107.18 4.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.108 0.963 . . . . 3.0800000000000001 109.856 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 t80 -99.9 105.46 17.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 117.254 -1.355 . . . . 0.65000000000000002 108.716 -167.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.4 m -116.05 109.07 45.21 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.789 1.632 . . . . 1.3 109.216 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.63 151.76 17.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.888 3.059 . . . . 0.71999999999999997 111.654 -176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -141.53 23.68 2.12 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.555 0.693 . . . . 1.75 112.599 171.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -80.11 157.7 26.58 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 126.644 1.978 . . . . 1.02 113.872 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.29 170.31 16.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.661 -1.609 . . . . 3.1899999999999999 109.831 165.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.81 22.93 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.607 2.763 . . . . 1.6599999999999999 112.92 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.85 160.82 26.25 Favored Pre-proline 0 CA--C 1.51 -0.591 0 C-N-CA 123.472 0.709 . . . . 2.8700000000000001 111.56 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.15 127.44 20.22 Favored 'Trans proline' 0 N--CA 1.426 -2.456 0 O-C-N 123.531 1.28 . . . . 1.0 110.482 168.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -88.8 31.78 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.51 3.474 . . . . 1.4399999999999999 112.654 -144.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.37 -120.94 4.84 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 126.22 1.866 . . . . 1.8700000000000001 113.405 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.32 145.07 48.26 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.971 2.108 . . . . 2.54 109.643 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.58 144.01 41.8 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.052 0.941 . . . . 1.04 111.409 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.95 165.57 37.86 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.136 -0.978 . . . . 0.92000000000000004 111.215 168.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -146.55 126.9 13.97 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.358 -1.349 . . . . 3.4700000000000002 107.358 169.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -122.81 167.23 13.78 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.466 1.284 . . . . 1.3500000000000001 114.466 163.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.7 mt -85.24 148.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.132 0.973 . . . . 1.02 108.836 151.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.38 153.74 41.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.822 2.049 . . . . 1.1899999999999999 108.318 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.72 72.67 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.97 1.841 . . . . 1.23 115.97 -159.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.23 -179.59 5.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.43 1.892 . . . . 1.8899999999999999 112.035 -170.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.41 125.78 7.13 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.548 -1.14 . . . . 2.0899999999999999 111.497 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 m 142.73 101.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 130.569 3.548 . . . . 2.6800000000000002 112.526 164.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 61.1 m -63.82 23.18 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 127.56 2.344 . . . . 1.3 115.709 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.08 130.18 33.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.528 -1.982 . . . . 3.27 110.737 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.29 157.9 14.88 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.225 3.283 . . . . 1.1100000000000001 111.544 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.57 174.49 7.73 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 1.8700000000000001 111.399 159.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.72 138.43 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.134 1.374 . . . . 2.7799999999999998 107.967 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.29 -124.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.182 0.593 . . . . 7.8300000000000001 111.378 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.87 -31.32 66.59 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.901 1.68 . . . . 5.0599999999999996 115.353 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 44.17 0.02 OUTLIER Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.135 0.874 . . . . 3.2799999999999998 112.164 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 172.71 158.41 0.11 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.306 2.642 . . . . 4.3099999999999996 109.281 -164.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.6 141.89 47.17 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.131 1.16 . . . . 1.8400000000000001 114.131 -161.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.18 61.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.58 1.552 . . . . 2.1800000000000002 111.651 -167.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.99 -72.2 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 127.431 2.292 . . . . 2.1200000000000001 115.498 166.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.93 106.6 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 1 C-N-CA 132.906 4.482 . . . . 1.6899999999999999 105.575 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -115.54 -46.49 2.86 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.378 1.071 . . . . 3.96 113.62 -155.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.62 -13.51 62.14 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.2 1.185 . . . . 1.51 114.2 -171.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -12.74 61.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.729 2.012 . . . . 1.4299999999999999 113.664 167.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.33 169.4 44.23 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.789 -1.194 . . . . 2.9500000000000002 112.638 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.69 -161.93 8.84 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.941 -0.864 . . . . 1.9199999999999999 110.941 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -42.81 141.33 1.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.601 -0.518 . . . . 2.4700000000000002 109.601 160.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.11 74.61 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.546 1.538 . . . . 4.5999999999999996 112.529 -170.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -132.73 58.81 38.66 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 126.717 2.007 . . . . 4.0599999999999996 112.681 -160.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.51 -37.56 29.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.062 1.841 . . . . 3.27 110.411 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -149.0 146.93 28.01 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.62 2.768 . . . . 4.29 105.805 162.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 p30 166.34 -47.42 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.115 2.166 . . . . 4.9299999999999997 114.327 168.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 t 172.74 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.428 2.691 . . . . 3.3199999999999998 111.425 -167.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.47 22.19 51.74 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 123.782 0.706 . . . . 2.4100000000000001 114.135 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -160.29 -116.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.963 1.305 . . . . 5.0 113.438 -167.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.468 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 2.8 t60 -160.05 145.24 15.09 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 119.833 -1.792 . . . . 2.1699999999999999 114.988 -170.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.65 -129.83 0.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.555 1.542 . . . . 4.29 111.164 170.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.55 -88.75 0.4 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.627 1.584 . . . . 3.1400000000000001 110.964 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -33.56 6.47 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.186 2.591 . . . . 4.4500000000000002 112.636 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.23 129.48 31.64 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.284 1.434 . . . . 5.5599999999999996 107.95 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.41 64.04 2.91 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 125.249 1.404 . . . . 3.8900000000000001 115.641 -158.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.09 98.71 11.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.996 0.918 . . . . 4.8799999999999999 112.92 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.99 -72.3 2.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 116.025 1.17 . . . . 4.8799999999999999 116.025 155.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.955 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 13.5 t-160 -75.09 93.24 2.73 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.314 1.057 . . . . 5.9299999999999997 113.132 -164.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.78 64.03 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.926 1.454 . . . . 4.5300000000000002 114.926 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.7 -0.13 89.85 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.965 1.269 . . . . 1.6899999999999999 114.644 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.955 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 37.7 m-20 -67.03 134.25 51.54 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 118.297 1.048 . . . . 2.8100000000000001 108.651 161.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.28 168.25 11.66 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.096 0.958 . . . . 3.04 111.515 -149.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.12 165.23 28.39 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.279 2.653 . . . . 1.4199999999999999 112.682 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -85.63 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 122.824 1.297 . . . . 2.5499999999999998 112.983 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.59 97.3 2.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.309 3.444 . . . . 2.7000000000000002 109.832 172.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.36 139.15 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.333 1.053 . . . . 1.75 111.37 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.44 140.86 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.039 2.135 . . . . 2.5099999999999998 107.453 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.93 160.94 21.98 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.364 -0.835 . . . . 2.9100000000000001 112.024 174.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -20.38 4.44 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 115.539 1.681 . . . . 2.9199999999999999 115.539 -174.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -85.25 4.48 34.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.361 1.864 . . . . 3.3399999999999999 113.528 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.85 56.69 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 124.588 1.09 . . . . 0.90000000000000002 114.19 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.57 135.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.288 1.835 . . . . 1.8100000000000001 109.513 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 149.58 24.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.698 1.199 . . . . 0.98999999999999999 110.953 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.8 t -159.55 -34.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.672 0.989 . . . . 1.74 113.672 -166.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.69 122.33 85.46 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.111 1.364 . . . . 3.77 111.64 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.18 136.72 16.43 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.91 2.406 . . . . 1.6399999999999999 111.441 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.27 74.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 122.976 1.37 . . . . 2.29 112.096 -167.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.2 m -57.07 137.67 55.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.538 2.335 . . . . 2.2400000000000002 113.022 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.56 98.04 22.36 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.757 1.223 . . . . 0.81000000000000005 111.34 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.63 3.68 5.21 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.29 3.326 . . . . 1.24 113.938 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -76.99 -16.27 59.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.287 1.435 . . . . 4.7800000000000002 112.383 -176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.46 -179.52 4.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.985 2.114 . . . . 3.5099999999999998 107.704 166.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -53.77 2.68 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.32 -0.862 . . . . 4.6699999999999999 111.673 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -127.37 163.44 24.0 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.175 1.546 . . . . 2.3500000000000001 115.175 -149.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tp -74.22 -34.99 63.85 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.595 -1.316 . . . . 2.8799999999999999 111.977 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.42 -35.86 65.85 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.123 1.369 . . . . 3.4100000000000001 113.698 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.33 -3.13 38.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.405 1.261 . . . . 2.1000000000000001 114.405 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.48 7.94 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.483 1.038 . . . . 1.01 113.447 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.07 -10.67 4.56 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.278 1.955 . . . . 3.75 116.278 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -147.03 18.9 1.25 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.614 1.965 . . . . 3.52 111.537 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -101.45 -160.36 0.79 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.405 1.482 . . . . 2.4300000000000002 112.274 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.47 160.71 39.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.081 1.352 . . . . 1.2 112.332 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 19.8 mt -113.62 149.69 34.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.3 2.64 . . . . 2.5600000000000001 108.093 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.5 mtt -137.59 128.13 26.67 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.524 1.056 . . . . 1.8 111.264 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.82 108.53 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.794 -1.187 . . . . 0.88 107.794 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -86.93 144.21 27.05 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.881 1.672 . . . . 3.3100000000000001 113.142 -165.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.57 -43.6 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.099 -1.0 . . . . 1.72 112.035 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.38 172.0 25.98 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.914 -0.874 . . . . 1.3200000000000001 110.914 162.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.53 160.85 6.13 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.063 1.316 . . . . 1.4199999999999999 112.587 165.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -40.38 94.98 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.76 1.224 . . . . 3.46 114.14 -169.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.27 36.96 0.16 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 117.586 2.439 . . . . 2.8500000000000001 117.586 -151.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -108.46 148.19 30.56 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.562 1.545 . . . . 3.8799999999999999 112.372 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -149.48 -141.01 0.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.115 0.966 . . . . 3.5499999999999998 111.125 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.36 111.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.677 2.391 . . . . 5.5599999999999996 114.954 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -154.3 160.99 30.35 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.706 2.002 . . . . 3.9199999999999999 109.461 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.78 12.51 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 124.522 3.482 . . . . 4.0800000000000001 114.747 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -132.36 140.81 39.11 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.519 1.528 . . . . 6.1100000000000003 110.151 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.47 151.61 82.0 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.983 3.122 . . . . 6.3700000000000001 112.955 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.63 21.19 6.97 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.956 1.702 . . . . 6.1600000000000001 113.415 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.93 80.81 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.531 1.062 . . . . 4.3300000000000001 113.62 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.97 -48.66 3.05 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.454 1.502 . . . . 2.25 113.029 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.37 18.84 5.12 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.189 1.852 . . . . 1.8500000000000001 114.956 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.28 -19.82 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.995 1.283 . . . . 1.98 114.098 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.7 p -66.31 145.41 55.76 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.683 1.593 . . . . 1.75 111.714 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.17 136.81 48.62 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.309 1.444 . . . . 5.5800000000000001 110.276 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -75.63 -37.06 60.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 3.3199999999999998 110.411 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.31 152.21 41.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.497 1.119 . . . . 0.73999999999999999 112.861 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 52.1 t -121.42 147.79 45.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.792 2.037 . . . . 1.6299999999999999 109.866 171.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -138.93 91.38 0.2 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.01 1.767 . . . . 1.0700000000000001 111.704 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.29 135.13 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.918 1.287 . . . . 4.1399999999999997 111.587 166.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mt -97.03 151.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 1.6200000000000001 109.93 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? . . . . . 0 N--CA 1.471 0.581 0 O-C-N 121.382 -0.824 . . . . 5.7000000000000002 110.708 177.358 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.138 -0.69 . . . . 2.2599999999999998 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 m -114.79 131.02 56.94 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.221 1.373 . . . . 1.6200000000000001 112.897 -153.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.76 141.53 48.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.624 2.37 . . . . 2.96 107.191 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -120.47 86.3 2.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.937 -1.102 . . . . 4.3600000000000003 110.82 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.11 118.68 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 121.6 -0.687 . . . . 1.49 109.672 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.92 104.01 1.02 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.142 1.354 . . . . 0.79000000000000004 109.953 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 mtp -97.84 137.92 35.97 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.154 0.982 . . . . 1.9099999999999999 110.735 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -129.38 147.35 51.19 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.922 0.889 . . . . 3.02 112.092 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.14 142.93 56.35 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.127 1.371 . . . . 1.48 109.58 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 m -142.13 161.44 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.316 1.046 . . . . 1.6399999999999999 112.851 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t 155.65 124.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.756 2.822 . . . . 3.1499999999999999 111.423 144.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.57 -37.69 0.38 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.439 2.696 . . . . 2.4900000000000002 115.516 164.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -7.87 56.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.585 1.554 . . . . 4.2999999999999998 111.367 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -149.48 18.1 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 125.478 1.513 . . . . 1.6000000000000001 112.386 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.05 130.79 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.65 1.58 . . . . 1.8799999999999999 110.558 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.8 -134.48 8.54 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 125.68 1.609 . . . . 2.3300000000000001 113.351 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.83 153.49 24.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.162 2.185 . . . . 4.2699999999999996 112.153 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -94.49 139.01 31.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.419 0.628 . . . . 2.0499999999999998 112.02 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.7 10.63 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.764 1.626 . . . . 3.6400000000000001 112.385 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 154.18 146.69 4.46 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.722 1.63 . . . . 0.67000000000000004 111.265 -166.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.5 p -88.87 174.52 7.9 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.184 -1.043 . . . . 1.1699999999999999 108.184 158.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.42 129.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.622 -1.251 . . . . 0.81000000000000005 107.622 165.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.4 p -82.83 129.25 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.534 0.683 . . . . 2.1400000000000001 109.824 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.46 109.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.501 -1.666 . . . . 1.96 106.501 169.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -116.0 108.28 16.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 123.098 1.427 . . . . 2.5299999999999998 110.741 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.06 142.83 56.36 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 127.476 2.31 . . . . 4.1399999999999997 111.707 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -154.7 177.01 11.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.535 1.16 . . . . 1.5 111.392 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.55 -25.24 66.01 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.991 0.916 . . . . 4.25 110.661 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.18 14.89 61.04 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.426 1.489 . . . . 1.0900000000000001 115.949 166.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.03 -164.39 51.46 Favored Glycine 0 N--CA 1.47 0.929 0 C-N-CA 129.74 3.543 . . . . 0.89000000000000001 115.095 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.35 104.56 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.445 1.498 . . . . 1.1200000000000001 112.145 -168.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -82.37 104.16 12.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.159 0.983 . . . . 2.27 109.805 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -91.8 110.02 21.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.017 2.127 . . . . 0.89000000000000001 109.567 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 12.0 m -122.32 115.04 30.21 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.836 1.198 . . . . 1.1699999999999999 108.563 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.93 164.44 27.5 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.101 2.534 . . . . 0.65000000000000002 110.867 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -160.03 51.39 0.32 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.316 1.055 . . . . 2.6800000000000002 111.288 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 150.86 32.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.069 1.348 . . . . 0.92000000000000004 112.013 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.27 38.39 3.13 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.221 1.934 . . . . 2.1099999999999999 116.221 -160.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.76 12.0 0.59 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.483 2.031 . . . . 1.6000000000000001 116.483 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.94 160.71 25.37 Favored Pre-proline 0 N--CA 1.477 0.896 0 N-CA-C 114.186 1.18 . . . . 2.2799999999999998 114.186 -169.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.93 130.87 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.328 1.352 . . . . 0.90000000000000002 112.708 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.66 48.08 2.07 Favored 'Trans proline' 0 C--N 1.35 0.653 1 C-N-CA 126.957 5.105 . . . . 1.04 112.755 -158.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.94 -140.09 7.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.414 1.563 . . . . 1.23 113.287 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.04 134.51 53.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.821 1.648 . . . . 2.8399999999999999 108.534 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -139.88 125.21 18.94 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 125.157 1.383 . . . . 1.5900000000000001 111.017 -162.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.79 154.78 9.11 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.642 -1.286 . . . . 0.60999999999999999 112.457 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.38 127.51 29.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.958 1.303 . . . . 3.29 107.719 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 50.3 m170 -121.92 169.77 10.47 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 117.027 2.232 . . . . 1.23 117.027 168.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.16 138.79 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.508 1.923 . . . . 0.89000000000000001 109.254 152.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.14 164.94 16.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.217 2.607 . . . . 1.21 110.602 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.86 -62.79 1.42 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.697 1.369 . . . . 1.47 114.697 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 -97.6 146.93 24.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.652 0.612 . . . . 1.9199999999999999 112.652 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.74 62.83 2.38 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.634 1.111 . . . . 1.23 112.322 168.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -149.73 77.73 1.34 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.72 1.208 . . . . 3.3100000000000001 112.589 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.0 m -64.16 9.42 0.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 116.331 1.974 . . . . 1.3200000000000001 116.331 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -72.44 151.71 91.87 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 119.743 -1.848 . . . . 3.6899999999999999 112.53 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.0 152.15 67.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.257 2.638 . . . . 1.77 111.316 171.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.68 147.79 22.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.546 0.738 . . . . 3.6899999999999999 110.914 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mm -86.45 104.64 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.528 -0.916 . . . . 5.4699999999999998 108.528 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -162.34 138.96 7.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.265 1.026 . . . . 8.5500000000000007 109.909 -157.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t0 51.27 35.79 14.48 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 6.4500000000000002 113.85 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.61 11.0 85.88 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.527 -1.151 . . . . 4.6200000000000001 115.323 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -150.31 169.3 21.71 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.07 1.935 . . . . 3.3399999999999999 113.24 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.77 94.95 8.81 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.838 0.855 . . . . 2.7799999999999998 109.873 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.54 88.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.746 0.818 . . . . 3.4700000000000002 111.593 -170.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 55.69 -86.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.245 2.618 . . . . 2.1400000000000001 115.025 159.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.73 99.04 0.31 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.748 2.819 . . . . 2.7200000000000002 107.253 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -149.34 -17.46 0.28 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.284 1.216 . . . . 7.0199999999999996 114.284 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.04 -9.22 4.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.661 1.184 . . . . 2.0499999999999998 113.55 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 2.65 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.185 2.194 . . . . 1.1000000000000001 113.671 164.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 16.29 26.93 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.563 1.554 . . . . 3.04 114.255 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -114.6 4.86 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.248 -1.541 . . . . 3.23 109.248 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -97.35 -101.67 0.19 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.983 1.313 . . . . 3.8599999999999999 107.652 158.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.9 tp -160.95 79.45 0.61 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.228 2.211 . . . . 2.79 106.759 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.74 68.97 63.07 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.772 -1.104 . . . . 4.9800000000000004 111.111 -152.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.04 -44.93 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.821 2.347 . . . . 2.4900000000000002 113.6 -168.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -154.87 -151.71 0.37 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.287 1.835 . . . . 5.6100000000000003 108.916 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 75.23 -60.82 0.5 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.551 2.74 . . . . 4.4299999999999997 112.84 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 177.29 -19.45 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.927 2.491 . . . . 3.3500000000000001 113.328 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.73 49.17 76.46 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.039 1.29 . . . . 2.8799999999999999 114.896 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -143.96 18.29 1.78 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.662 1.727 . . . . 5.7699999999999996 115.662 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.8 t60 90.05 173.24 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.52 2.328 . . . . 2.8100000000000001 112.871 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -162.1 51.91 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.897 1.279 . . . . 4.8799999999999999 110.136 -161.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.01 -47.95 1.29 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-O 117.973 -1.459 . . . . 2.9900000000000002 114.997 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -103.43 -23.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.179 3.253 . . . . 4.79 113.831 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.97 172.99 1.57 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.793 2.437 . . . . 5.75 108.758 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.19 -159.05 32.13 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.064 0.84 . . . . 4.9500000000000002 113.516 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -153.52 28.71 0.49 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 6.8600000000000003 112.245 -168.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.18 16.65 60.87 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.105 -2.497 . . . . 3.5299999999999998 117.698 -165.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.708 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 2.6 t-160 170.06 99.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 128.396 2.678 . . . . 6.5099999999999998 111.059 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.49 2.79 2.78 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.578 1.696 . . . . 2.9900000000000002 115.578 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -102.42 3.97 50.83 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.322 1.439 . . . . 1.02 113.459 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.708 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 64.3 m-20 -71.93 137.09 47.12 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.525 1.162 . . . . 1.6599999999999999 109.619 165.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.86 169.04 11.06 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.762 1.225 . . . . 2.6400000000000001 109.915 -144.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.52 157.8 55.36 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.714 2.276 . . . . 1.28 111.866 -172.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.8 125.23 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.227 1.011 . . . . 3.46 109.85 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.39 114.34 3.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 128.365 2.666 . . . . 3.9300000000000002 109.872 168.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.87 143.32 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 120.966 -1.083 . . . . 1.1000000000000001 108.628 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -123.2 124.61 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 106.261 -1.755 . . . . 2.6699999999999999 106.261 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.7 152.91 41.21 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.06 0.845 . . . . 1.8899999999999999 111.933 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -4.24 0.05 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 117.539 2.422 . . . . 2.23 117.539 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.06 4.42 10.89 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.793 1.637 . . . . 3.0299999999999998 114.016 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.52 16.51 17.68 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 116.226 1.25 . . . . 0.92000000000000004 116.226 166.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.65 134.08 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.128 1.371 . . . . 1.53 107.932 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.22 120.68 40.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.331 0.652 . . . . 0.82999999999999996 109.352 168.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -132.21 2.81 3.94 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.135 1.774 . . . . 1.6599999999999999 112.745 172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -82.89 117.76 69.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.687 1.995 . . . . 5.0999999999999996 111.983 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.33 147.27 18.05 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.475 2.783 . . . . 1.25 113.473 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.29 176.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.515 1.926 . . . . 1.5600000000000001 109.83 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.8 m -139.73 140.83 36.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.069 0.947 . . . . 0.91000000000000003 110.142 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.72 91.48 6.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.24 1.016 . . . . 0.82999999999999996 110.56 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.29 -8.92 24.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.818 3.012 . . . . 1.46 115.006 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -58.96 -29.17 66.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.178 1.391 . . . . 4.8700000000000001 113.751 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.52 164.98 11.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.131 1.772 . . . . 3.2999999999999998 110.389 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.95 24.6 0.5 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.596 1.558 . . . . 4.79 114.109 -170.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -178.57 148.5 0.45 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.441 2.296 . . . . 2.2000000000000002 112.507 170.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.75 -27.5 69.32 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.53 -1.356 . . . . 2.1699999999999999 111.269 166.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.44 -16.14 0.32 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.299 2.24 . . . . 2.8199999999999998 114.062 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -9.24 40.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.366 1.466 . . . . 2.4900000000000002 113.733 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.5 m -130.19 11.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.552 1.541 . . . . 1.2 113.134 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -62.59 -3.36 1.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.494 2.405 . . . . 3.46 117.494 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.27 29.93 0.78 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.358 1.863 . . . . 2.9700000000000002 110.726 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -121.82 175.02 6.5 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.825 1.65 . . . . 2.48 113.038 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.01 149.2 43.03 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.501 1.12 . . . . 0.68999999999999995 111.782 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.43 170.42 16.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.041 1.336 . . . . 3.02 109.241 158.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 44.9 ttm -151.19 124.96 9.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.37 -0.831 . . . . 3.1299999999999999 111.454 163.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.5 120.98 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.164 -1.05 . . . . 1.1200000000000001 108.164 167.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -105.13 148.49 26.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.869 2.068 . . . . 2.8900000000000001 112.007 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.35 -25.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.718 -1.239 . . . . 1.6599999999999999 113.209 -162.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -129.28 162.55 22.64 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.135 0.874 . . . . 1.29 111.55 168.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.82 144.94 47.56 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.357 0.98 . . . . 1.5800000000000001 113.081 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 37.6 t70 -97.95 -8.86 27.19 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.992 1.849 . . . . 2.6600000000000001 115.992 -147.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -59.96 -25.61 65.34 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.939 1.296 . . . . 4.9199999999999999 113.407 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 76.4 mtm -82.11 61.64 5.47 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 3.3900000000000001 113.899 -167.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.6 p -91.82 -147.47 0.22 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.655 -1.278 . . . . 3.7000000000000002 110.846 156.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t0 58.35 42.25 21.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.456 1.502 . . . . 4.5599999999999996 112.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.92 156.51 5.96 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.509 1.924 . . . . 4.0099999999999998 109.64 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.25 -19.2 22.73 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.116 2.544 . . . . 2.7799999999999998 114.327 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.59 119.91 76.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.216 1.371 . . . . 8.8800000000000008 109.903 167.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.85 118.8 5.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.504 2.136 . . . . 5.1399999999999997 110.179 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 56.64 27.12 12.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.182 1.393 . . . . 4.9500000000000002 112.186 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.07 17.52 63.56 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 121.042 -1.036 . . . . 3.6000000000000001 113.333 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.07 3.78 75.7 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.6 1.571 . . . . 3.1400000000000001 114.367 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.28 -5.91 75.35 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.252 1.526 . . . . 2.1800000000000002 114.845 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.43 -12.0 80.04 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.235 1.398 . . . . 2.02 115.326 -170.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.67 161.6 5.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.069 1.348 . . . . 1.9199999999999999 110.152 164.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 136.15 40.31 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 5.3700000000000001 112.65 -169.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -101.04 -25.63 13.99 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.261 1.424 . . . . 3.8399999999999999 113.294 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.73 144.09 22.31 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.466 2.024 . . . . 0.70999999999999996 116.466 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.76 170.29 14.92 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.209 3.403 . . . . 2.8799999999999999 112.186 165.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 179.94 83.15 0.06 OUTLIER Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.884 1.706 . . . . 1.46 112.41 166.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.94 130.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 118.026 0.913 . . . . 2.1899999999999999 110.704 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 27.3 mt -102.9 140.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.52 1.528 . . . . 1.6399999999999999 111.377 -169.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 mptt . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 124.774 1.23 . . . . 4.3499999999999996 108.733 161.581 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 119.424 -0.322 . . . . 2.73 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.73 154.39 33.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 118.984 -2.323 . . . . 1.7 116.995 -141.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.07 138.97 18.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.68 -1.6 . . . . 3.4300000000000002 111.328 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.81 113.82 27.08 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.803 -1.186 . . . . 5.7000000000000002 112.03 176.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.8 t -88.63 118.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.551 -0.537 . . . . 1.5800000000000001 109.551 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.34 103.09 2.36 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.152 1.358 . . . . 1.1100000000000001 110.323 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 41.8 mtt -81.85 148.83 28.62 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.439 0.904 . . . . 1.98 113.439 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -114.23 151.52 32.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 2.4700000000000002 110.134 167.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 mt -64.49 144.44 57.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.853 0.861 . . . . 1.1699999999999999 109.112 171.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 m -133.69 149.32 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.2 0.6 . . . . 1.53 111.36 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -174.55 53.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.143 0.977 . . . . 2.3700000000000001 112.53 -168.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.49 -14.21 0.42 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.051 1.74 . . . . 1.55 115.094 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.15 -9.9 58.97 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.363 -0.836 . . . . 3.2999999999999998 110.994 160.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -129.69 9.39 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.517 -1.433 . . . . 1.3 109.517 -163.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.7 t -74.33 126.9 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.925 1.69 . . . . 1.24 111.299 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.34 -135.53 8.93 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.066 1.793 . . . . 1.45 112.554 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.93 164.11 12.86 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.983 -0.716 . . . . 2.0600000000000001 111.784 173.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.0 t -100.1 152.0 20.74 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.309 1.044 . . . . 1.8200000000000001 112.757 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.435 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 1.4 pp -144.21 4.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 128.178 2.591 . . . . 3.6600000000000001 113.495 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.53 170.69 27.71 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.205 1.383 . . . . 0.72999999999999998 114.266 172.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.471 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 1.5 p -109.74 177.66 4.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.989 1.316 . . . . 1.1200000000000001 109.889 172.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.83 131.84 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.736 -1.209 . . . . 0.5 107.736 158.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 9.0 p -85.89 123.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 123.579 0.549 . . . . 1.48 110.377 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mt -105.38 126.08 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 125.858 1.663 . . . . 2.1299999999999999 107.884 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -135.5 107.62 7.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.413 1.085 . . . . 2.0800000000000001 109.958 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -74.07 144.08 45.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.613 0.765 . . . . 3.6000000000000001 112.043 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -159.94 -174.58 4.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.708 1.203 . . . . 1.72 109.751 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.34 -26.51 65.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.627 1.571 . . . . 3.1699999999999999 112.75 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.94 13.86 65.81 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 124.851 1.215 . . . . 0.97999999999999998 114.754 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.95 -147.02 32.94 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 127.396 2.427 . . . . 0.80000000000000004 114.399 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.4 mt -76.26 99.46 4.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.986 0.915 . . . . 0.80000000000000004 112.017 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -77.69 114.16 16.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.13 1.372 . . . . 2.6699999999999999 110.397 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.73 116.79 32.63 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.485 2.314 . . . . 0.85999999999999999 109.896 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.433 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.9 m -122.49 115.17 29.93 Favored Pre-proline 0 N--CA 1.477 0.875 0 CA-C-O 118.278 -0.868 . . . . 0.92000000000000004 108.755 176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.22 162.86 4.67 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.91 3.073 . . . . 0.46999999999999997 112.007 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.471 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.3 p80 -151.32 33.31 0.57 Allowed 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.12 0.962 . . . . 1.73 112.606 173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -95.75 150.05 20.82 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.911 1.684 . . . . 0.82999999999999996 113.903 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.5 162.37 24.13 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.516 1.526 . . . . 3.0899999999999999 109.217 174.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.28 21.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.933 2.893 . . . . 1.97 113.789 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.57 155.87 38.1 Favored Pre-proline 0 CA--C 1.51 -0.576 0 C-N-CA 123.857 0.863 . . . . 3.5499999999999998 112.442 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.56 140.36 47.28 Favored 'Trans proline' 0 N--CA 1.427 -2.385 0 O-C-N 123.269 1.142 . . . . 1.22 111.625 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -88.26 32.01 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.839 2.359 . . . . 1.52 114.568 -148.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.89 -147.35 14.02 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.532 1.073 . . . . 1.1899999999999999 113.912 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -81.57 131.51 35.28 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.964 -1.315 . . . . 2.6800000000000002 110.592 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -102.66 135.53 44.14 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.243 -1.021 . . . . 2.2400000000000002 108.243 164.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.55 161.7 21.58 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.852 -0.899 . . . . 1.02 110.852 166.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -146.84 122.34 10.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.915 -1.143 . . . . 3.3599999999999999 107.915 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -126.8 167.65 15.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.207 1.188 . . . . 1.0600000000000001 114.207 159.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.32 145.66 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.08 1.352 . . . . 2.02 107.721 152.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -123.92 158.64 31.51 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.202 1.401 . . . . 1.0900000000000001 110.969 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.42 69.03 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.465 1.654 . . . . 0.68000000000000005 115.465 -163.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -126.48 -174.58 3.16 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.357 1.463 . . . . 1.3600000000000001 112.195 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.97 30.52 5.03 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 117.776 1.87 . . . . 1.4299999999999999 117.776 -156.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.6 m -159.06 114.4 2.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 121.692 2.746 . . . . 3.2799999999999998 115.0 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.3 m -68.83 76.93 0.31 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.385 1.564 . . . . 2.7400000000000002 112.644 167.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -116.56 134.38 22.89 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 124.981 1.312 . . . . 3.8199999999999998 109.134 167.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.11 144.63 21.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.293 2.662 . . . . 1.3500000000000001 110.18 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.91 131.51 42.31 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.08 -0.711 . . . . 1.76 109.08 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.4 mm -99.15 110.0 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.952 -1.129 . . . . 3.9399999999999999 107.952 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -166.81 154.51 9.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 7.3499999999999996 111.003 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t70 41.31 54.86 3.45 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.527 1.531 . . . . 4.2000000000000002 114.853 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.11 87.75 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.722 -1.599 . . . . 2.9199999999999999 115.653 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -153.67 171.89 18.12 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.462 2.131 . . . . 3.1099999999999999 114.161 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 114.59 26.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.215 1.406 . . . . 3.6699999999999999 109.565 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.33 74.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.482 1.113 . . . . 2.2799999999999998 111.02 -172.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.7 -73.51 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.257 2.623 . . . . 2.1699999999999999 116.328 161.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.78 69.23 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 130.801 3.64 . . . . 2.1200000000000001 107.308 -165.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.26 -42.51 14.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.302 1.441 . . . . 4.5 112.236 -165.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.17 5.99 1.46 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.866 1.432 . . . . 1.3300000000000001 114.866 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.74 66.1 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.362 1.065 . . . . 1.2 112.526 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.23 -175.42 51.28 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 119.497 1.044 . . . . 2.3599999999999999 113.066 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.2 170.43 37.95 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.805 1.193 . . . . 1.74 113.298 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.465 ' CD2' ' H ' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -78.22 38.67 0.29 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.036 2.134 . . . . 4.4000000000000004 112.385 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.4 tp 56.73 72.59 0.5 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.132 2.573 . . . . 2.48 110.213 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -153.14 5.95 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 118.17 2.656 . . . . 4.54 118.17 -140.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.39 -26.72 24.3 Favored 'Trans proline' 0 C--N 1.358 1.063 0 CA-C-N 123.906 2.431 . . . . 3.8199999999999998 116.151 -162.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.67 138.14 19.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.4 1.454 . . . . 3.4700000000000002 111.043 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 p30 161.61 -159.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 129.676 3.19 . . . . 5.0700000000000003 109.381 -161.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 t -72.74 -14.12 61.48 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.625 1.342 . . . . 5.0199999999999996 114.625 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.83 -58.38 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.946 1.26 . . . . 4.3300000000000001 113.124 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttt -69.32 163.89 24.09 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.963 1.381 . . . . 7.0599999999999996 113.754 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.34 137.31 55.94 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.201 -0.937 . . . . 2.4399999999999999 111.252 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -76.17 156.04 34.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.153 0.581 . . . . 3.5 112.064 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.2 -157.15 27.13 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.178 1.371 . . . . 3.5899999999999999 112.149 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.14 -23.8 28.67 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.169 2.58 . . . . 4.7400000000000002 111.938 172.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -153.59 176.43 12.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.873 2.069 . . . . 7.9100000000000001 108.626 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.43 -126.63 7.97 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.074 -1.21 . . . . 4.7000000000000002 110.074 -165.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.448 ' NE2' ' H ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -165.95 157.16 13.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.006 0.903 . . . . 5.3200000000000003 110.133 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.448 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . 166.31 -137.13 4.49 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.833 2.635 . . . . 2.6899999999999999 110.669 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -90.9 136.03 33.34 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.781 -0.835 . . . . 5.5199999999999996 112.378 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.53 -33.25 75.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.44 -0.788 . . . . 2.7799999999999998 113.064 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.52 6.13 83.02 Favored Glycine 0 N--CA 1.474 1.18 0 N-CA-C 115.717 1.047 . . . . 0.91000000000000003 115.717 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -67.98 130.18 42.17 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 118.772 1.286 . . . . 1.8 109.075 161.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.82 161.93 40.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.477 1.511 . . . . 2.6099999999999999 110.327 -151.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.31 144.86 20.92 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.427 2.751 . . . . 1.1699999999999999 111.63 -168.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.18 132.45 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.612 1.196 . . . . 2.1299999999999999 113.533 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.87 81.76 1.65 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.807 2.443 . . . . 2.5699999999999998 109.37 169.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.87 131.78 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.421 -0.799 . . . . 1.3400000000000001 109.657 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.51 153.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.253 1.021 . . . . 3.1200000000000001 108.48 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.04 159.36 33.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.732 -0.605 . . . . 2.4700000000000002 111.93 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -49.09 -19.32 0.41 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.173 2.189 . . . . 4.3399999999999999 115.865 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.12 8.1 32.02 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 127.83 2.452 . . . . 4.5800000000000001 112.117 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.48 23.81 15.51 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 117.582 1.793 . . . . 1.25 117.582 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -139.55 134.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.961 1.305 . . . . 1.75 111.29 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.85 118.65 26.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.306 2.242 . . . . 1.01 110.786 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 t -146.94 -3.88 0.57 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.266 1.209 . . . . 2.2999999999999998 114.266 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.73 118.61 72.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.335 1.454 . . . . 3.29 112.219 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.79 125.82 11.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.262 3.308 . . . . 1.1100000000000001 110.227 170.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 175.11 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.581 1.552 . . . . 1.6100000000000001 109.946 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 m -148.4 140.04 23.65 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.303 0.956 . . . . 0.89000000000000001 110.049 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.23 96.12 29.09 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.55 1.14 . . . . 0.80000000000000004 111.636 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.32 7.87 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.254 3.303 . . . . 1.1499999999999999 114.391 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -81.72 -23.65 36.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.32 1.448 . . . . 4.7400000000000002 111.6 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.81 139.32 48.85 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.881 1.673 . . . . 3.71 107.863 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -107.1 -21.29 13.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 115.204 1.557 . . . . 4.5999999999999996 115.204 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.5 t -152.96 155.07 36.27 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.942 1.246 . . . . 2.6099999999999999 114.005 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -57.39 -32.3 66.68 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.131 0.572 . . . . 2.1400000000000001 112.433 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -64.08 -14.66 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.03 1.493 . . . . 3.2599999999999998 115.03 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -72.49 -20.28 61.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.217 0.917 . . . . 2.6200000000000001 112.252 167.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.43 10.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.223 1.409 . . . . 0.91000000000000003 113.96 -163.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -46.39 -20.84 0.13 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.02 2.928 . . . . 5.1399999999999997 116.578 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -117.92 9.11 12.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.201 2.6 . . . . 4.5800000000000001 113.221 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.5 168.14 12.97 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.493 1.294 . . . . 2.1099999999999999 114.493 -160.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.82 158.31 24.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.997 1.319 . . . . 1.1899999999999999 111.565 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.08 150.86 39.29 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.664 1.586 . . . . 2.2599999999999998 108.967 172.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.28 139.64 50.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.063 0.764 . . . . 3.2799999999999998 113.063 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.75 104.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.936 -1.505 . . . . 1.05 106.936 159.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.93 150.05 34.1 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.929 2.091 . . . . 2.8799999999999999 111.65 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.67 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.859 -1.151 . . . . 1.97 112.648 -163.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.7 170.97 14.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.119 1.342 . . . . 1.9199999999999999 111.187 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.49 151.03 50.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.576 1.084 . . . . 1.79 113.072 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.16 -21.43 11.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.094 1.516 . . . . 3.2000000000000002 115.094 -152.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -75.44 8.52 2.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.468 1.655 . . . . 3.2999999999999998 115.468 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -81.22 55.54 2.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.976 1.311 . . . . 3.3799999999999999 111.197 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -81.79 33.98 0.39 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.962 2.505 . . . . 4.3799999999999999 115.211 -163.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.19 19.37 7.61 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.665 1.586 . . . . 5.9100000000000001 113.033 -163.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -147.47 154.61 45.29 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.927 1.691 . . . . 3.9500000000000002 110.525 -167.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.09 7.29 2.14 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.046 3.164 . . . . 2.9100000000000001 114.241 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -107.12 99.77 28.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.021 1.328 . . . . 6.5700000000000003 108.666 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.92 166.69 26.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.234 2.623 . . . . 3.4900000000000002 111.949 -170.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt 64.83 27.18 12.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.269 1.428 . . . . 4.4800000000000004 111.878 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.7 1.62 31.91 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.741 1.639 . . . . 3.7599999999999998 114.7 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.49 -15.18 60.76 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.778 1.18 . . . . 2.3500000000000001 113.063 -162.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.96 24.8 3.23 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.198 1.856 . . . . 2.0499999999999998 113.678 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.62 -15.98 73.69 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.116 1.341 . . . . 1.72 115.246 -169.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 p -69.01 147.39 51.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.554 1.177 . . . . 1.99 110.035 167.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 131.93 47.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 5.2300000000000004 109.818 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -81.94 -44.13 17.17 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.214 0.605 . . . . 3.54 109.554 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.29 155.76 45.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.294 1.038 . . . . 0.73999999999999999 112.717 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 41.0 t -143.52 151.23 40.01 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.136 2.175 . . . . 1.29 111.331 -174.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.68 149.59 18.31 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.739 1.161 . . . . 1.47 113.842 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.98 149.09 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.1 1.76 . . . . 3.5600000000000001 112.36 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.33 147.11 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.492 1.917 . . . . 1.1000000000000001 111.923 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.744 0 C-N-CA 126.455 1.902 . . . . 5.0599999999999996 109.683 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 109.115 -0.698 . . . . 2.3599999999999999 109.115 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -122.38 143.21 49.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.593 1.542 . . . . 1.9299999999999999 114.454 -148.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -154.76 147.55 24.4 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.493 . . . . 3.04 109.584 168.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.43 77.16 1.77 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.679 1.592 . . . . 5.9199999999999999 112.671 -160.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.17 112.19 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 120.55 -1.344 . . . . 1.5800000000000001 111.377 -162.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.32 101.58 0.52 Allowed Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.878 2.18 . . . . 0.78000000000000003 111.476 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.2 mmm -79.93 126.15 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.833 1.253 . . . . 2.8599999999999999 111.133 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -105.56 149.26 26.42 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.786 1.279 . . . . 2.6000000000000001 112.973 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.71 65.66 1.37 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.371 2.268 . . . . 1.3799999999999999 111.619 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -73.12 141.82 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.767 0.827 . . . . 1.6699999999999999 111.005 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -148.72 -159.57 1.05 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.889 -1.05 . . . . 2.6800000000000002 109.049 171.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.06 -3.0 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.491 1.516 . . . . 2.0600000000000001 112.382 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 8.92 44.07 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.965 1.706 . . . . 3.3900000000000001 111.633 171.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 -164.69 26.73 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 125.047 1.308 . . . . 1.75 112.835 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.94 126.51 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.629 1.171 . . . . 2.52 110.774 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.87 -137.23 9.45 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 125.577 1.56 . . . . 1.8300000000000001 113.355 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.32 150.91 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.685 1.594 . . . . 3.7400000000000002 112.546 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -79.45 145.76 33.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.469 0.708 . . . . 2.2400000000000002 110.222 161.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.37 3.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.313 1.845 . . . . 4.0 114.091 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.77 163.85 14.66 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.808 1.671 . . . . 0.71999999999999997 112.717 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -96.24 158.87 15.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.142 -0.688 . . . . 1.5800000000000001 109.142 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.4 t -105.15 132.46 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.352 -1.351 . . . . 0.66000000000000003 107.352 152.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 12.2 p -87.3 128.22 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.311 0.577 . . . . 2.0299999999999998 110.536 172.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 126.46 1.904 . . . . 2.27 107.714 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -131.83 112.57 12.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.048 0.928 . . . . 1.9099999999999999 111.198 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 137.49 57.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 128.25 2.62 . . . . 4.1900000000000004 112.463 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.312 14.8 t -151.2 161.84 41.98 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 124.543 2.116 . . . . 1.6000000000000001 111.064 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -21.23 -41.19 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.573 -2.558 . . . . 3.8100000000000001 115.266 146.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.5 12.05 59.76 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 126.035 1.779 . . . . 0.90000000000000002 117.012 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.36 -152.0 23.94 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 130.225 3.774 . . . . 0.80000000000000004 114.708 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.51 102.59 4.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.281 -1.129 . . . . 0.82999999999999996 111.45 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -76.43 115.96 16.66 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.313 -0.867 . . . . 2.1899999999999999 109.882 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -105.69 110.54 22.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.477 2.311 . . . . 0.60999999999999999 109.623 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.401 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 11.8 m -114.47 110.27 47.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 119.79 1.177 . . . . 0.95999999999999996 108.095 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.61 152.68 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.382 2.722 . . . . 0.69999999999999996 110.89 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 40.4 0.77 Allowed 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.168 1.461 . . . . 2.8500000000000001 111.231 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mp -103.54 141.7 35.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.539 1.936 . . . . 1.22 112.977 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.33 160.08 15.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.451 -1.249 . . . . 3.3500000000000001 109.805 170.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 97.69 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.521 2.728 . . . . 1.53 115.099 160.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 156.24 35.81 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 118.886 0.766 . . . . 2.4500000000000002 111.86 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.82 136.45 57.53 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.915 1.744 . . . . 1.0700000000000001 110.589 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -86.97 34.58 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.564 2.843 . . . . 1.26 114.736 -151.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.62 -140.84 11.62 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.729 1.157 . . . . 1.25 114.072 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -120.3 153.93 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.795 -0.826 . . . . 3.3100000000000001 110.414 165.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -138.23 133.69 33.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.615 0.766 . . . . 1.02 110.203 -163.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 163.44 23.77 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 111.015 -0.834 . . . . 0.71999999999999997 111.015 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -135.95 132.25 36.17 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 106.086 -1.82 . . . . 3.2000000000000002 106.086 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -137.85 158.24 44.76 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.149 -0.97 . . . . 1.02 112.815 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.54 142.85 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 127.42 2.288 . . . . 1.1000000000000001 108.006 163.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -123.28 156.38 35.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.077 1.351 . . . . 1.0700000000000001 110.663 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.75 78.73 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.974 1.842 . . . . 0.68999999999999995 115.974 -159.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -116.33 -177.66 3.23 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.576 1.55 . . . . 1.3 111.483 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.81 97.49 0.31 Allowed Glycine 0 N--CA 1.47 0.902 0 O-C-N 120.769 -1.207 . . . . 0.93000000000000005 113.441 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 t 173.87 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.605 2.362 . . . . 2.5699999999999998 109.638 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.5 m -70.11 31.15 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 115.976 1.843 . . . . 1.3100000000000001 115.976 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -84.54 124.91 72.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 119.724 -1.86 . . . . 4.1299999999999999 111.158 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.07 144.27 13.29 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.307 2.671 . . . . 1.1699999999999999 111.253 173.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.2 153.75 29.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.997 0.519 . . . . 1.75 110.583 164.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.03 132.25 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.984 -1.072 . . . . 2.5 111.07 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.21 172.95 11.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.275 2.63 . . . . 5.6600000000000001 110.055 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -47.4 114.06 0.81 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.663 1.185 . . . . 5.1500000000000004 112.406 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.13 6.47 53.38 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.986 -1.452 . . . . 4.3700000000000001 115.715 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.93 129.14 10.48 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.809 2.304 . . . . 3.6299999999999999 114.378 -167.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.86 117.56 30.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.984 0.914 . . . . 1.77 108.826 165.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.37 74.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.224 1.81 . . . . 2.4300000000000002 111.172 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.43 -73.58 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.863 2.865 . . . . 2.9300000000000002 115.864 164.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.48 38.09 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 130.023 3.329 . . . . 2.46 109.332 -166.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.6 -25.49 62.69 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.293 1.22 . . . . 4.0999999999999996 114.293 -167.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -13.09 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.034 1.288 . . . . 1.3500000000000001 113.908 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.82 -4.24 57.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.63 1.572 . . . . 1.4199999999999999 113.02 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 -179.98 53.11 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.787 -1.196 . . . . 2.5699999999999998 114.22 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.89 -179.3 48.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.99 0.805 . . . . 1.54 111.631 166.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.402 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 24.1 m170 -53.67 137.79 36.47 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 118.585 -0.721 . . . . 2.1899999999999999 109.812 172.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.76 116.46 4.08 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.818 0.736 . . . . 2.4300000000000002 111.642 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -149.32 101.79 3.33 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.81 2.044 . . . . 4.1100000000000003 109.207 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.36 -46.43 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.639 1.559 . . . . 3.8799999999999999 111.111 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -164.16 13.91 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.794 2.038 . . . . 3.9199999999999999 113.083 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -56.87 -39.62 74.67 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.2 -1.562 . . . . 3.3300000000000001 113.543 -170.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t 146.11 -28.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 1 C-N-CA 132.069 4.148 . . . . 3.1600000000000001 111.201 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.73 58.14 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 117.016 1.566 . . . . 2.46 117.016 162.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.85 -67.31 0.79 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.536 1.668 . . . . 8.6999999999999993 112.449 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 t60 171.69 157.54 0.09 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.811 2.844 . . . . 1.6799999999999999 111.549 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.65 133.28 32.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.743 1.217 . . . . 4.2300000000000004 108.69 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.51 -95.29 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 109.404 -1.478 . . . . 2.9300000000000002 109.404 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.76 29.46 0.41 Allowed 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 124.589 3.526 . . . . 3.5899999999999999 112.631 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -146.23 -179.63 6.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.433 1.893 . . . . 5.5499999999999998 109.457 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.15 107.21 0.7 Allowed Glycine 0 N--CA 1.472 1.061 0 N-CA-C 109.095 -1.602 . . . . 4.6200000000000001 109.095 164.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -168.84 -5.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.059 1.503 . . . . 6.6799999999999997 115.059 -149.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -34.98 0.02 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 118.105 2.002 . . . . 3.1299999999999999 118.105 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.49 115.22 3.39 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.201 2.0 . . . . 4.6600000000000001 110.831 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.02 -11.35 7.95 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.479 1.659 . . . . 2.9399999999999999 115.479 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.01 -0.16 89.23 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.963 -1.465 . . . . 0.93999999999999995 116.094 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.402 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 67.7 m-20 -85.09 134.86 34.18 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 120.5 2.15 . . . . 1.5 112.673 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 mt -123.95 160.78 50.27 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.596 1.558 . . . . 4.0800000000000001 112.065 -164.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.06 162.23 43.37 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.749 2.966 . . . . 1.22 112.247 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.08 127.88 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 123.355 1.55 . . . . 2.0600000000000001 114.56 -162.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.07 82.25 5.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.87 2.868 . . . . 2.8399999999999999 109.492 174.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.26 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.071 -1.018 . . . . 1.5900000000000001 109.29 171.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.89 157.96 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.347 1.059 . . . . 3.0299999999999998 110.077 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.16 159.46 27.41 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.895 1.072 . . . . 2.75 113.895 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -49.67 -20.57 0.83 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 127.502 2.321 . . . . 5.3799999999999999 117.148 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.13 0.92 27.89 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.211 1.559 . . . . 3.9700000000000002 115.211 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.99 42.25 2.67 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 116.0 1.16 . . . . 1.2 116.0 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.89 135.46 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.878 1.271 . . . . 1.46 109.522 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.32 118.1 31.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.572 1.949 . . . . 0.89000000000000001 109.238 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -156.54 21.61 0.34 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.737 1.384 . . . . 1.96 114.737 -167.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -134.83 143.48 46.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.149 1.779 . . . . 4.3700000000000001 108.785 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -85.13 162.48 11.54 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.191 3.261 . . . . 1.47 114.362 -170.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.45 172.17 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 126.315 1.846 . . . . 1.6399999999999999 109.722 166.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -141.39 146.5 36.68 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 119.925 1.239 . . . . 0.95999999999999996 111.097 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.72 87.06 3.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.832 1.253 . . . . 1.1699999999999999 113.961 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.5 2.1 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.481 2.787 . . . . 1.3999999999999999 114.732 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -76.86 -11.27 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.695 1.134 . . . . 6.0199999999999996 111.673 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.31 164.87 13.88 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.005 2.122 . . . . 3.3799999999999999 110.711 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -152.08 11.09 0.54 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.528 1.931 . . . . 4.8600000000000003 114.187 173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -159.18 149.3 19.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.324 -1.485 . . . . 2.4900000000000002 113.716 163.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -57.49 -24.53 56.39 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.084 -1.01 . . . . 2.3300000000000001 111.38 162.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -52.03 -31.74 31.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.212 1.005 . . . . 3.0099999999999998 112.768 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.032 1.333 . . . . 2.7799999999999998 112.399 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.04 11.27 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.086 1.354 . . . . 1.04 113.539 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.3 pttt -61.54 7.14 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.984 2.587 . . . . 3.6699999999999999 117.984 -171.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -156.33 22.19 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.48 1.912 . . . . 3.5 111.748 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -113.34 170.53 8.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.846 1.259 . . . . 2.1200000000000001 114.31 -169.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.08 150.3 23.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.609 1.164 . . . . 0.64000000000000001 112.372 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.4 145.27 40.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.864 2.066 . . . . 2.0699999999999998 107.585 165.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -130.65 136.56 48.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.824 0.738 . . . . 2.3199999999999998 112.179 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 88.3 mt -94.26 124.37 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.518 -1.29 . . . . 1.0700000000000001 107.518 167.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -120.29 143.1 48.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.319 1.048 . . . . 2.7999999999999998 112.485 -156.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.25 -37.59 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.898 -1.126 . . . . 1.6299999999999999 112.983 -153.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.9 141.06 16.63 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.78 0.705 . . . . 1.3 112.141 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -47.43 134.45 14.05 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 126.01 1.767 . . . . 2.1499999999999999 112.109 164.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -76.11 1.72 14.88 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.22 1.408 . . . . 2.8999999999999999 113.001 -167.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -66.29 -1.47 3.41 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 119.727 -1.858 . . . . 5.4400000000000004 114.24 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 ptp -93.07 10.35 31.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.288 1.835 . . . . 4.5899999999999999 114.149 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.4 p -47.83 -21.96 0.49 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.812 2.152 . . . . 5.0999999999999996 116.812 -171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.44 -10.42 59.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.089 2.956 . . . . 7.9900000000000002 115.618 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -53.01 148.64 13.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 114.276 1.213 . . . . 4.8399999999999999 114.276 -166.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.36 30.59 0.34 Allowed 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.361 3.374 . . . . 3.6699999999999999 112.234 170.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 140.32 35.26 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.544 1.538 . . . . 5.3700000000000001 109.19 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.71 162.26 32.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.416 2.744 . . . . 3.8700000000000001 112.965 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 71.6 mt 64.39 16.08 9.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.778 1.631 . . . . 5.5999999999999996 114.033 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.03 12.08 58.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.065 1.317 . . . . 5.2699999999999996 114.955 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.33 -64.35 3.79 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.889 1.345 . . . . 3.4900000000000002 112.992 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.17 0.45 31.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.906 1.241 . . . . 2.25 114.949 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.1 9.44 12.37 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.703 2.097 . . . . 2.6499999999999999 116.071 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.0 p -69.04 146.95 52.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.744 1.772 . . . . 2.3599999999999999 108.996 161.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 143.18 27.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.036 -1.04 . . . . 6.2000000000000002 112.942 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -102.2 -26.54 13.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.196 0.598 . . . . 3.3700000000000001 111.849 158.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.96 149.18 28.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.653 -0.654 . . . . 0.52000000000000002 112.664 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.2 t -120.32 144.07 48.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.097 2.159 . . . . 1.46 109.714 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -139.43 104.51 0.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 126.341 1.924 . . . . 0.94999999999999996 111.18 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -83.0 130.37 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.339 1.069 . . . . 2.4500000000000002 110.334 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.74 133.45 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.144 1.378 . . . . 1.1200000000000001 110.677 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 125.863 1.665 . . . . 5.2400000000000002 108.576 176.466 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.187 -0.301 . . . . 2.79 110.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.78 159.63 40.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.786 1.773 . . . . 1.6699999999999999 115.786 -151.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -148.37 136.95 21.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.476 1.511 . . . . 2.9500000000000002 109.459 159.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -83.41 103.63 12.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.429 1.092 . . . . 4.4000000000000004 112.031 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.8 t -79.02 114.36 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.253 -0.904 . . . . 1.49 109.079 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.44 105.57 1.81 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.25 1.405 . . . . 0.87 111.425 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.7 mmm -84.13 122.42 28.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.712 1.205 . . . . 3.1600000000000001 111.365 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.16 151.79 23.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.756 0.789 . . . . 2.4399999999999999 111.185 166.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.52 136.31 57.97 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.083 0.953 . . . . 1.3400000000000001 109.706 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.53 140.59 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.393 -0.965 . . . . 1.47 108.393 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 t -151.44 17.61 0.72 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.597 0.759 . . . . 2.7599999999999998 111.85 -165.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . 69.61 -21.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.538 2.335 . . . . 1.6299999999999999 113.371 -171.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -71.8 28.18 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 119.879 1.218 . . . . 4.0099999999999998 111.985 163.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 12' ' ' ALA . . . 83.08 -174.78 52.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.562 2.029 . . . . 1.6000000000000001 113.201 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.67 119.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.178 0.991 . . . . 1.77 108.608 153.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.04 -69.37 1.02 Allowed Glycine 0 N--CA 1.466 0.638 0 CA-C-O 122.159 0.866 . . . . 1.53 114.129 -170.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 153.88 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.106 1.363 . . . . 2.54 109.537 -165.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -89.59 152.61 21.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.271 1.428 . . . . 1.9199999999999999 112.983 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.42 -2.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 115.196 1.554 . . . . 4.4299999999999997 115.196 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.77 175.05 20.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.561 2.029 . . . . 0.77000000000000002 111.792 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.421 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 3.7 p -104.71 175.21 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.583 -0.951 . . . . 1.04 109.378 167.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.74 131.25 73.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.663 -1.606 . . . . 0.56000000000000005 106.663 152.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.4 p -80.89 122.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.667 -0.494 . . . . 2.1499999999999999 109.667 172.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.4 mt -94.48 127.31 46.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 107.374 -1.343 . . . . 1.9199999999999999 107.374 165.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.38 123.56 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.17 1.388 . . . . 1.98 108.701 171.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 151.0 33.17 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 121.026 -0.269 . . . . 3.23 111.049 172.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -161.29 -173.82 4.01 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.405 0.682 . . . . 1.8300000000000001 109.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -59.73 -25.64 65.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.857 1.263 . . . . 5.5800000000000001 113.353 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.36 16.45 61.04 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.558 1.075 . . . . 1.1399999999999999 114.66 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.7 -140.44 24.23 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 125.334 1.445 . . . . 0.73999999999999999 114.002 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.19 98.38 4.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.194 0.998 . . . . 0.96999999999999997 112.105 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.95 111.22 14.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.2 1.4 . . . . 2.8599999999999999 110.785 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.71 117.58 29.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.255 2.222 . . . . 0.68999999999999995 108.835 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.8 m -123.95 110.69 29.27 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-N 119.796 1.18 . . . . 1.0800000000000001 108.986 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.74 158.34 10.47 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.974 3.116 . . . . 0.46999999999999997 111.341 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.3 p80 -149.06 29.32 0.81 Allowed 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.794 0.807 . . . . 1.5 113.058 174.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.77 148.77 21.94 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.542 1.537 . . . . 1.0900000000000001 111.915 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.52 23.38 6.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.853 2.168 . . . . 1.96 116.853 -164.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.73 69.2 0.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.888 0.875 . . . . 1.6599999999999999 111.351 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.13 160.94 66.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.88 0.872 . . . . 2.2799999999999998 112.007 170.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.28 127.68 18.79 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.052 1.168 . . . . 1.02 110.343 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -83.58 33.39 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.901 1 C-N-CA 126.053 4.502 . . . . 1.24 113.152 -159.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.72 -131.6 4.46 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 123.411 1.562 . . . . 1.1799999999999999 112.131 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.0 147.27 52.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.667 1.587 . . . . 3.8900000000000001 109.548 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.7 122.64 15.52 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.72 0.808 . . . . 1.54 112.25 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.73 155.05 1.67 Allowed Glycine 0 CA--C 1.543 1.794 0 C-N-CA 123.936 0.779 . . . . 1.03 113.057 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.93 112.5 11.31 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.206 -1.405 . . . . 3.2400000000000002 107.206 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -116.33 158.79 22.89 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.249 1.203 . . . . 0.95999999999999996 114.249 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -99.23 151.27 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.236 1.414 . . . . 0.81999999999999995 107.88 154.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.23 153.45 47.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.174 1.79 . . . . 1.1100000000000001 107.648 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.83 71.68 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.909 1.448 . . . . 1.0 114.909 -163.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -119.22 161.21 20.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.19 1.796 . . . . 1.97 112.371 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.13 86.02 0.56 Allowed Glycine 0 N--CA 1.467 0.715 0 C-N-CA 124.682 1.134 . . . . 1.0700000000000001 112.773 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 t -171.11 94.15 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.718 1.207 . . . . 2.3799999999999999 113.011 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 68.3 m -65.92 14.55 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 117.097 2.258 . . . . 1.3600000000000001 117.097 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -101.96 147.85 34.49 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 119.787 -1.821 . . . . 3.8300000000000001 113.965 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.37 161.42 11.19 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.723 3.615 . . . . 1.1499999999999999 112.602 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.31 14.13 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.605 0.762 . . . . 2.21 111.213 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.23 115.34 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.345 1.058 . . . . 3.71 109.643 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -146.34 147.06 30.94 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.85 1.66 . . . . 6.3799999999999999 110.704 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t0 53.13 32.18 12.68 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.617 1.34 . . . . 4.4500000000000002 114.617 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.1 6.48 87.54 Favored Glycine 0 CA--C 1.535 1.343 0 O-C-N 121.105 -0.997 . . . . 4.0300000000000002 114.771 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -141.58 -161.79 1.28 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.57 1.548 . . . . 4.4400000000000004 110.509 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.14 138.64 49.56 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.919 -1.113 . . . . 2.0099999999999998 113.027 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 t -82.24 60.75 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.838 1.655 . . . . 2.6600000000000001 111.029 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 47.17 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.154 2.582 . . . . 2.0 115.874 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.93 84.38 0.81 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.411 2.684 . . . . 1.47 107.556 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -84.72 -46.71 11.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.237 1.415 . . . . 3.98 112.03 -167.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -12.34 57.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.321 1.23 . . . . 1.28 114.321 -164.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.74 -22.82 59.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.562 1.545 . . . . 0.89000000000000001 113.897 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.55 -174.97 17.77 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 120.398 1.454 . . . . 2.3900000000000001 114.278 -176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 -155.57 22.44 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.129 1.347 . . . . 1.8300000000000001 110.832 164.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -71.36 34.41 0.05 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 118.957 1.379 . . . . 2.4100000000000001 113.783 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.11 46.04 3.85 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.452 1.501 . . . . 4.0899999999999999 109.536 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -128.32 44.95 1.47 Allowed Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 116.3 1.963 . . . . 4.4000000000000004 116.3 -148.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.39 -20.81 31.38 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.834 2.356 . . . . 3.6600000000000001 113.722 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -166.65 143.32 4.77 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.82 1.648 . . . . 4.2999999999999998 110.5 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 164.75 -23.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 129.501 3.12 . . . . 3.8399999999999999 113.435 170.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 t 139.18 -2.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 1 C-N-CA 131.829 4.052 . . . . 3.5299999999999998 112.855 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.26 2.73 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.549 1.38 . . . . 2.8100000000000001 116.549 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -86.71 172.5 10.14 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.43 1.615 . . . . 5.6200000000000001 113.73 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -107.68 143.92 35.51 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.068 1.347 . . . . 1.99 112.921 -173.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -152.86 -173.19 4.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.222 1.409 . . . . 3.8300000000000001 109.967 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.38 -52.1 0.01 OUTLIER Glycine 0 CA--C 1.544 1.854 0 CA-C-O 116.977 -2.013 . . . . 4.1500000000000004 115.022 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -105.0 -20.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.875 2.383 . . . . 5.5 116.939 -164.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 177.27 17.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.44 1.496 . . . . 8.0500000000000007 114.369 -165.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.83 -150.05 21.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.494 1.521 . . . . 3.9100000000000001 112.25 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -135.92 135.9 40.03 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.741 -1.207 . . . . 6.5599999999999996 107.741 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.75 -157.72 30.02 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.419 0.554 . . . . 2.9500000000000002 114.434 -173.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 136.75 58.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.286 0.634 . . . . 4.8300000000000001 112.665 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -11.9 60.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.681 0.993 . . . . 3.6899999999999999 113.681 169.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.08 14.77 36.75 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.794 -1.559 . . . . 1.29 115.439 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -106.99 131.93 53.5 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 119.614 1.707 . . . . 1.5700000000000001 112.267 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -131.37 170.51 11.1 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.067 2.147 . . . . 3.0099999999999998 110.418 -168.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.22 152.9 21.29 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.403 2.068 . . . . 1.03 111.868 -172.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.85 128.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.795 1.238 . . . . 3.1899999999999999 112.95 -168.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.38 82.17 1.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.151 2.18 . . . . 2.6200000000000001 108.894 168.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.49 141.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.51 1.124 . . . . 1.5 109.161 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.93 150.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.419 1.888 . . . . 2.8300000000000001 108.866 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 143.49 26.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.057 0.844 . . . . 1.8799999999999999 112.683 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -19.83 -45.19 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.353 4.661 . . . . 4.2699999999999996 117.463 174.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.23 -29.37 65.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.943 1.297 . . . . 3.7000000000000002 112.633 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.11 20.72 6.2 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.807 1.67 . . . . 0.95999999999999996 113.463 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.6 mt -121.71 133.99 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 1.4099999999999999 109.888 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.63 131.01 49.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.615 1.166 . . . . 0.73999999999999999 110.322 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 t -152.37 4.18 0.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.427 2.01 . . . . 1.3700000000000001 116.427 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -100.98 136.96 19.64 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.877 1.217 . . . . 3.8500000000000001 111.334 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.14 146.8 47.08 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.526 3.484 . . . . 1.05 112.178 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.11 161.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.448 1.499 . . . . 1.54 109.442 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -139.25 134.87 33.25 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.341 0.973 . . . . 1.4199999999999999 110.747 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.8 105.32 49.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.957 0.903 . . . . 1.1200000000000001 112.609 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.84 13.05 0.63 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.372 3.382 . . . . 1.4099999999999999 113.299 167.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -64.27 -41.26 97.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.096 1.758 . . . . 5.1100000000000003 110.737 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -111.41 151.73 28.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 3.6699999999999999 107.258 166.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -97.04 -22.07 17.02 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.586 0.958 . . . . 5.4800000000000004 113.586 -174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.16 160.86 43.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.039 1.745 . . . . 2.7000000000000002 115.344 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.43 -30.68 68.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.457 1.503 . . . . 2.5800000000000001 111.889 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -67.27 -2.75 6.42 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.807 2.043 . . . . 2.7599999999999998 113.313 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -96.86 -13.13 22.72 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.195 1.798 . . . . 2.46 113.277 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.18 7.83 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.631 1.105 . . . . 1.26 113.898 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -60.38 -12.6 9.76 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.854 2.168 . . . . 3.6600000000000001 116.854 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.39 16.75 13.87 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.55 1.94 . . . . 4.5800000000000001 114.08 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -121.2 -173.91 2.72 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.956 1.465 . . . . 2.3100000000000001 114.956 -165.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.5 156.56 47.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.508 1.523 . . . . 0.72999999999999998 111.555 169.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mp -118.3 130.0 55.78 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.525 1.93 . . . . 2.1299999999999999 108.489 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.2 mtt -116.98 128.72 55.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.46 0.573 . . . . 1.77 111.772 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.02 103.51 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.61 -1.256 . . . . 0.92000000000000004 107.61 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -87.02 146.1 26.24 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.187 1.795 . . . . 3.4199999999999999 113.034 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.2 t -64.65 -30.32 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.983 -1.073 . . . . 2.0899999999999999 113.409 -164.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.14 149.66 18.07 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.316 0.96 . . . . 1.3899999999999999 112.63 172.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.27 150.48 11.1 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.104 1.811 . . . . 1.5900000000000001 112.952 162.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.01 0.55 38.32 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.2 1.185 . . . . 2.4900000000000002 114.2 -141.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -81.55 -7.27 59.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.356 1.613 . . . . 3.0299999999999998 115.356 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 65.9 mtm -84.45 109.75 18.12 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.74 1.216 . . . . 2.98 110.486 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -137.01 -45.35 0.57 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.17 0.988 . . . . 3.1000000000000001 112.759 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.41 80.64 8.53 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.123 -0.986 . . . . 3.8599999999999999 110.715 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 175.88 147.49 0.26 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 128.491 2.716 . . . . 3.8799999999999999 110.272 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.33 -27.59 47.66 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 2.1299999999999999 114.029 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -109.91 87.75 6.07 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.802 0.841 . . . . 7.8399999999999999 109.125 165.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.67 169.16 16.54 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.914 2.41 . . . . 5.1299999999999999 111.307 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt 66.3 6.04 4.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.523 1.929 . . . . 5.6100000000000003 113.416 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.2 26.92 74.23 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 119.154 0.888 . . . . 4.4199999999999999 113.2 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.57 -9.35 77.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.778 1.18 . . . . 2.7599999999999998 113.186 -166.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 22.43 0.57 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.884 2.183 . . . . 1.8899999999999999 115.851 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.75 75.35 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 118.455 1.128 . . . . 2.1000000000000001 112.337 166.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.7 p -65.21 156.86 30.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.454 1.502 . . . . 2.0299999999999998 110.896 162.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.25 137.67 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.761 1.224 . . . . 5.8799999999999999 110.582 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -82.37 -37.47 25.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.185 0.994 . . . . 3.5699999999999998 111.697 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.1 149.38 32.93 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.038 0.935 . . . . 0.56999999999999995 111.814 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.27 146.71 50.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.975 1.71 . . . . 1.5700000000000001 110.783 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -131.66 90.43 0.28 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.463 2.459 . . . . 1.0 111.352 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.28 140.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.589 1.156 . . . . 3.8799999999999999 112.47 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.72 151.45 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.728 1.611 . . . . 1.3700000000000001 111.246 -170.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 O-C-N 120.912 -1.117 . . . . 5.0300000000000002 112.43 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 109.437 -0.579 . . . . 2.27 109.437 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.55 154.11 26.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.732 1.213 . . . . 1.6299999999999999 109.859 -172.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -149.17 125.77 11.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.921 1.343 . . . . 2.9300000000000002 110.27 170.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -83.83 109.89 17.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.064 1.746 . . . . 3.9399999999999999 110.528 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.66 124.47 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 120.089 1.313 . . . . 1.6399999999999999 110.482 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.25 110.95 3.17 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 125.669 1.604 . . . . 0.81000000000000005 110.752 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.5 mtp -96.74 131.7 43.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.253 1.021 . . . . 2.04 111.121 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.65 142.91 45.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.066 1.346 . . . . 2.6899999999999999 111.524 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.7 mt -65.68 137.65 57.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.858 0.863 . . . . 1.3400000000000001 108.862 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.33 144.44 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.688 0.795 . . . . 1.3799999999999999 111.432 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.1 t -163.79 72.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.677 0.791 . . . . 2.2400000000000002 112.473 -169.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 72.0 -33.47 0.27 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.029 2.531 . . . . 1.71 115.44 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -33.78 68.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.353 1.461 . . . . 3.4700000000000002 110.082 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.39 -158.67 24.53 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 125.909 1.718 . . . . 1.54 112.023 -169.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.84 126.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.391 1.476 . . . . 1.46 110.899 171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.91 -136.78 9.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.492 1.52 . . . . 1.99 111.504 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.34 165.64 12.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.411 -1.052 . . . . 1.97 112.555 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -104.06 162.18 13.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.863 1.315 . . . . 2.3799999999999999 114.443 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pp -147.48 4.53 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 130.431 3.492 . . . . 3.6699999999999999 113.262 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.49 148.09 5.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.959 1.742 . . . . 0.91000000000000003 112.856 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 p -99.46 -179.9 4.36 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.184 -1.043 . . . . 1.1100000000000001 108.184 163.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.2 134.52 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.211 -1.033 . . . . 0.68000000000000005 108.211 163.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.5 p -81.54 122.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.49 -0.559 . . . . 2.1600000000000001 109.49 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -107.42 133.14 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.557 -0.905 . . . . 2.8500000000000001 108.557 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.22 124.91 18.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.547 1.539 . . . . 2.1600000000000001 107.498 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.34 128.66 47.4 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.515 0.726 . . . . 3.5600000000000001 109.703 -168.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -151.5 -174.53 4.86 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.633 0.235 . . . . 1.52 111.633 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.17 -24.97 68.13 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.933 -1.105 . . . . 4.25 112.619 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.99 9.95 64.55 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 124.834 1.207 . . . . 1.1200000000000001 114.609 167.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.29 -140.19 23.43 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 126.668 2.08 . . . . 0.70999999999999996 112.988 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.87 93.47 5.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.9 0.88 . . . . 0.81000000000000005 110.49 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -72.69 131.57 42.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.483 1.913 . . . . 3.7400000000000002 109.22 166.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -127.93 106.72 9.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.99 2.116 . . . . 0.79000000000000004 108.176 -168.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 25.4 m -105.4 107.1 58.36 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.834 1.197 . . . . 2.1600000000000001 108.027 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.05 156.11 30.09 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.028 2.486 . . . . 0.80000000000000004 110.496 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.0 39.65 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.687 1.232 . . . . 2.9100000000000001 110.359 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.54 150.02 20.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 126.794 2.038 . . . . 1.1399999999999999 111.733 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.5 162.34 31.45 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.339 -1.301 . . . . 3.1299999999999999 109.494 170.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.21 23.64 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.484 3.114 . . . . 1.79 112.66 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.517 HD11 ' HH ' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.18 152.51 57.19 Favored Pre-proline 0 CA--C 1.487 -1.46 0 C-N-CA 125.249 1.42 . . . . 3.3399999999999999 112.56 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -76.0 142.7 25.2 Favored 'Trans proline' 0 N--CA 1.413 -3.218 0 C-N-CA 116.599 -1.801 . . . . 1.6599999999999999 111.286 -165.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -80.97 31.3 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.626 1 C-N-CA 127.89 5.727 . . . . 1.5700000000000001 114.127 -155.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.86 -127.98 6.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 123.567 1.648 . . . . 1.6899999999999999 110.958 174.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -120.51 145.93 46.79 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 127.567 2.347 . . . . 3.0699999999999998 110.383 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -139.9 125.11 18.8 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 124.158 0.983 . . . . 1.27 112.404 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.31 149.79 9.41 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.607 -0.683 . . . . 0.66000000000000003 111.778 169.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -135.97 127.52 28.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.951 1.7 . . . . 3.2000000000000002 106.503 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -130.06 167.85 17.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.4 2.37 . . . . 1.1599999999999999 117.4 166.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.0 mt -101.0 146.43 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.637 1.975 . . . . 0.92000000000000004 108.929 155.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -124.08 155.72 37.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.179 1.792 . . . . 1.8700000000000001 110.541 -170.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.91 -37.91 70.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.948 1.462 . . . . 0.77000000000000002 114.948 -162.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -116.64 -179.34 3.65 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.335 1.454 . . . . 1.26 111.033 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.98 51.05 0.86 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 116.646 1.419 . . . . 1.05 116.646 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -153.22 123.93 7.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.661 1.731 . . . . 2.6499999999999999 112.45 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.1 m -68.77 -2.88 10.42 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.603 1.705 . . . . 2.0299999999999998 115.603 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.8 136.6 38.85 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 120.25 -1.531 . . . . 3.3700000000000001 112.02 -162.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -96.88 160.81 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.184 3.256 . . . . 1.73 113.384 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.76 177.3 4.88 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.103 1.361 . . . . 2.6899999999999999 110.915 156.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.25 124.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.579 1.152 . . . . 3.0 108.773 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -104.54 -178.86 3.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.579 1.952 . . . . 5.1399999999999997 109.911 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.33 104.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.529 0.937 . . . . 4.5599999999999996 113.529 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.06 18.03 70.45 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.262 -1.299 . . . . 4.1399999999999997 115.367 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -158.15 134.49 9.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.377 2.089 . . . . 5.0499999999999998 114.818 -169.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.6 130.33 35.01 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.107 -0.996 . . . . 2.04 110.312 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -81.36 49.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.396 . . . . 3.2599999999999998 111.675 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.57 -57.47 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 130.608 3.563 . . . . 2.8799999999999999 117.817 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 163.38 85.35 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 1 C-N-CA 134.228 5.011 . . . . 1.6200000000000001 105.17 -167.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.85 -50.53 7.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.103 0.961 . . . . 5.2599999999999998 111.91 -155.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.56 15.02 0.11 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.12 1.156 . . . . 1.8600000000000001 114.12 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.65 -15.04 35.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.431 1.892 . . . . 0.91000000000000003 112.7 165.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.08 9.68 85.38 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.737 1.455 . . . . 2.7799999999999998 116.737 168.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.04 -166.37 52.8 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.133 1.466 . . . . 2.6499999999999999 112.277 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.603 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 39.4 m170 -61.97 149.87 39.47 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.707 0.753 . . . . 2.5699999999999998 111.22 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 tp -67.98 110.18 3.79 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.904 -0.497 . . . . 2.6800000000000002 111.122 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.81 159.93 2.42 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 130.46 3.504 . . . . 3.4300000000000002 109.006 164.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -90.09 -18.6 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.328 2.019 . . . . 2.8399999999999999 115.712 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 178.55 -3.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.613 2.079 . . . . 4.9800000000000004 116.613 -163.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -58.92 -48.53 81.13 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.096 1.517 . . . . 3.73 115.096 -147.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 161.61 170.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.952 3.301 . . . . 3.6800000000000002 109.467 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.93 -15.62 78.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.318 0.961 . . . . 4.8799999999999999 113.779 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.92 145.38 55.99 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.104 1.452 . . . . 5.1600000000000001 110.348 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -117.46 143.87 45.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.234 1.013 . . . . 2.6000000000000001 112.299 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.74 117.56 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 3.7599999999999998 111.852 -161.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.05 171.53 35.7 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.004 1.288 . . . . 3.0 111.958 171.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.74 -3.33 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.907 3.738 . . . . 4.71 115.876 -168.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -160.69 29.22 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.584 2.354 . . . . 8.0600000000000005 110.675 171.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.76 -141.15 7.76 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.098 2.285 . . . . 4.0099999999999998 112.224 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -151.97 148.07 27.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.336 1.068 . . . . 5.71 112.055 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.12 -91.59 0.08 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.433 1.968 . . . . 2.23 112.524 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -134.76 134.25 40.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.136 1.375 . . . . 4.9400000000000004 110.285 -169.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -67.06 -21.63 65.89 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.63 1.344 . . . . 2.9300000000000002 114.63 -170.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.68 -2.65 76.64 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.707 1.146 . . . . 1.04 115.128 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.603 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 71.8 m-20 -72.71 133.58 44.64 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.796 1.298 . . . . 1.5700000000000001 109.949 169.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.92 163.9 26.35 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.993 1.317 . . . . 2.5299999999999998 110.645 -150.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.3 145.79 34.87 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.514 2.809 . . . . 1.1200000000000001 111.899 -167.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.16 130.35 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.587 1.184 . . . . 3.77 110.446 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 125.31 31.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 131.128 3.771 . . . . 3.77 110.446 -172.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -97.06 140.18 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.336 1.055 . . . . 1.3899999999999999 111.88 -172.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.16 141.07 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.539 1.936 . . . . 2.5299999999999998 108.248 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -103.47 157.5 17.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.693 1.197 . . . . 3.0099999999999998 112.53 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.74 50.08 0.43 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.673 2.389 . . . . 3.0499999999999998 115.649 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -128.34 1.49 5.7 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.402 -1.726 . . . . 3.7200000000000002 111.221 150.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.29 27.47 13.33 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.441 1.972 . . . . 0.84999999999999998 113.883 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.29 138.53 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.533 1.533 . . . . 1.6699999999999999 110.255 -165.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.15 127.72 53.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.354 0.979 . . . . 1.3600000000000001 109.925 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 t -149.03 9.18 0.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.845 1.424 . . . . 1.3799999999999999 114.845 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -100.73 130.77 24.68 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.922 1.289 . . . . 3.5699999999999998 110.306 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.14 140.56 17.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.078 2.519 . . . . 1.0700000000000001 112.252 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.63 160.64 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.04 1.736 . . . . 1.5600000000000001 109.499 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.0 m -144.73 132.55 21.23 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.384 0.993 . . . . 1.1499999999999999 111.423 -167.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.84 97.25 27.94 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.744 1.218 . . . . 0.77000000000000002 112.916 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.0 -2.52 12.77 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.582 3.521 . . . . 1.1799999999999999 115.905 -177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -88.15 -2.44 58.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.548 1.139 . . . . 4.4400000000000004 113.361 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.55 169.72 9.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.976 2.51 . . . . 3.3300000000000001 107.834 164.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -152.67 5.74 0.39 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 117.038 2.236 . . . . 4.71 117.038 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 m -158.1 167.95 28.42 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.987 1.267 . . . . 2.4100000000000001 113.291 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.81 -20.06 63.46 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.957 -1.09 . . . . 2.1400000000000001 111.863 163.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.52 -35.86 78.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.587 1.155 . . . . 3.54 113.657 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -68.51 -13.11 62.1 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.366 1.247 . . . . 3.1800000000000002 114.366 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.16 17.58 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.747 1.219 . . . . 1.0800000000000001 113.539 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -67.44 19.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 128.308 2.643 . . . . 3.0499999999999998 116.977 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -165.96 26.28 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.788 2.435 . . . . 2.9500000000000002 110.94 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -134.6 170.64 15.49 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.952 -1.092 . . . . 2.0800000000000001 113.629 -167.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.5 157.09 25.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.03 1.332 . . . . 0.83999999999999997 112.543 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.35 135.04 51.06 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.871 2.068 . . . . 2.1800000000000002 107.294 168.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.09 138.19 54.3 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.383 0.673 . . . . 2.9900000000000002 111.444 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.33 133.48 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.443 1.116 . . . . 2.0800000000000001 110.278 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.22 135.5 51.67 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.324 1.85 . . . . 3.04 110.828 -155.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -73.53 -15.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.791 1.404 . . . . 3.6899999999999999 114.791 -151.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.03 169.53 24.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.401 1.477 . . . . 1.95 109.891 162.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.2 147.84 34.16 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 117.88 0.84 . . . . 1.8400000000000001 111.786 165.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.64 -22.04 0.89 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.352 1.242 . . . . 3.7599999999999998 114.352 -138.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.6 47.43 0.17 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.85 2.46 . . . . 4.1699999999999999 115.422 -172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 41.4 mtm -105.99 133.32 50.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.918 1.687 . . . . 2.77 112.493 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.9 p -99.18 -36.19 9.74 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.129 1.772 . . . . 4.0700000000000003 114.768 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.39 2.9 54.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.538 1.31 . . . . 4.1500000000000004 114.538 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.62 144.09 32.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.887 0.875 . . . . 3.9700000000000002 110.669 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -41.47 9.06 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.311 2.674 . . . . 2.3399999999999999 112.59 -173.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -83.15 136.94 43.13 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.729 -0.653 . . . . 5.5999999999999996 109.943 158.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.88 167.37 26.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.171 2.581 . . . . 3.48 111.034 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt 66.33 31.11 8.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.971 1.308 . . . . 4.5899999999999999 110.953 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.22 11.2 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.059 1.314 . . . . 3.0 114.223 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.6 -20.76 29.5 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.098 1.808 . . . . 2.8900000000000001 114.392 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.42 -3.31 47.35 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.387 1.47 . . . . 4.3099999999999996 114.617 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.9 46.77 1.8 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.587 1.565 . . . . 4.3600000000000003 115.59 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.2 m -58.79 158.03 8.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.382 1.873 . . . . 2.9100000000000001 110.338 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.45 150.5 28.29 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.281 -1.512 . . . . 6.6500000000000004 113.042 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.517 ' HH ' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -100.73 -32.83 10.52 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 118.817 -0.611 . . . . 8.5800000000000001 111.251 153.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.29 152.47 37.17 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 116.482 2.03 . . . . 0.84999999999999998 116.482 -172.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.0 t -99.2 -177.69 3.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 129.26 3.024 . . . . 1.5900000000000001 110.368 164.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 176.09 91.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 127.427 2.442 . . . . 1.3400000000000001 111.456 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.07 133.62 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 2.1499999999999999 110.024 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.16 128.1 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.468 1.107 . . . . 1.1100000000000001 110.962 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 82.9 mttt . . . . . 0 N--CA 1.472 0.662 0 C-N-CA 123.992 0.917 . . . . 4.79 111.214 -173.063 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 108.99 -0.744 . . . . 2.5899999999999999 108.99 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.7 148.06 23.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.228 1.011 . . . . 3.3300000000000001 113.568 -167.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -153.23 116.99 4.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 2.6000000000000001 109.248 165.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -97.35 108.36 21.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.747 -1.22 . . . . 4.4199999999999999 109.439 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.61 125.92 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.386 0.539 . . . . 1.49 109.886 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.0 114.17 4.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.958 1.266 . . . . 0.73999999999999999 110.171 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.4 mtt -98.09 129.78 44.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.963 0.905 . . . . 2.2000000000000002 111.726 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -107.44 147.83 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.135 1.374 . . . . 2.6400000000000001 110.717 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.5 mt -65.28 139.96 58.66 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.19 1.396 . . . . 1.1599999999999999 109.382 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.0 m -135.27 155.6 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 119.233 0.924 . . . . 1.5700000000000001 111.683 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.1 55.74 0.1 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.127 0.788 . . . . 2.3399999999999999 113.127 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.86 -36.72 0.37 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 127.196 2.199 . . . . 2.29 113.849 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -22.01 57.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 4.6100000000000003 112.283 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.63 -159.81 24.61 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 124.933 1.254 . . . . 1.1299999999999999 112.91 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 t -80.71 130.08 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.512 1.925 . . . . 1.5900000000000001 110.996 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.22 -135.33 8.07 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.4 1.476 . . . . 1.8600000000000001 112.49 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -104.86 172.29 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.942 0.897 . . . . 2.7400000000000002 111.315 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -109.43 141.13 42.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.77 0.828 . . . . 2.1099999999999999 112.473 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mm -118.73 23.85 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 127.068 2.147 . . . . 7.1299999999999999 110.937 164.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.2 173.04 33.37 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.32 -0.863 . . . . 0.90000000000000002 114.83 160.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.514 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.0 p -102.06 -179.49 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.28 1.032 . . . . 1.1299999999999999 109.542 170.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -132.55 135.27 57.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.769 -1.197 . . . . 0.68999999999999995 107.769 160.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.33 128.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.065 0.228 . . . . 1.47 110.626 174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.54 133.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.824 -0.806 . . . . 2.1600000000000001 108.824 161.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.21 128.16 53.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.547 0.739 . . . . 1.96 110.417 156.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 122.27 17.97 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.831 0.852 . . . . 4.0499999999999998 109.25 164.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -135.96 -178.51 5.17 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.33 -0.248 . . . . 1.8600000000000001 110.33 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -54.3 -46.34 72.77 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.866 -1.147 . . . . 5.3600000000000003 110.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.6 17.85 9.93 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.092 1.33 . . . . 1.3100000000000001 115.774 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.84 -144.08 20.13 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 126.698 2.094 . . . . 0.93000000000000005 114.071 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.72 99.52 5.89 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.996 0.903 . . . . 0.76000000000000001 111.224 -170.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 108.16 5.11 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.195 1.798 . . . . 6.0899999999999999 110.177 169.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.402 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 4.4 t80 -101.33 107.42 18.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.353 1.861 . . . . 0.67000000000000004 109.888 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.3 m -117.14 111.58 40.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 119.247 0.93 . . . . 1.7 109.064 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -84.01 166.37 12.98 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.032 3.155 . . . . 0.76000000000000001 111.415 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.514 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 3.2 p80 -150.2 18.71 0.86 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.761 1.393 . . . . 2.0800000000000001 114.761 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.58 140.89 35.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.208 1.003 . . . . 1.1499999999999999 111.857 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -116.52 35.92 4.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.731 1.752 . . . . 2.46 115.731 -166.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.77 49.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.651 0.78 . . . . 1.26 112.165 -165.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 157.54 70.86 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 2.29 112.578 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.0 141.64 40.62 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 O-C-N 122.985 0.992 . . . . 1.22 111.233 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.92 39.59 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 125.282 3.988 . . . . 1.3500000000000001 113.647 -156.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.83 -159.94 12.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.921 1.248 . . . . 1.1399999999999999 114.056 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -89.22 137.46 32.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.662 1.985 . . . . 2.8900000000000001 111.391 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -140.43 143.18 35.46 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.978 0.911 . . . . 1.6200000000000001 109.62 -173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.06 161.97 46.82 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 119.029 0.831 . . . . 0.63 112.112 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.402 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.9 t80 -144.51 124.86 13.83 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.326 -1.731 . . . . 3.23 106.326 166.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.57 166.01 24.21 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.962 1.467 . . . . 1.4199999999999999 114.962 165.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 mt -91.06 148.4 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.922 1.689 . . . . 0.84999999999999998 109.341 159.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -126.42 160.49 30.32 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.355 1.462 . . . . 1.0900000000000001 109.872 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.3 -20.2 65.58 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 116.609 2.077 . . . . 0.79000000000000004 116.609 -162.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -134.9 166.54 22.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.061 1.744 . . . . 1.3799999999999999 112.883 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 83.91 0.34 Allowed Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.151 1.358 . . . . 1.04 112.433 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.8 m -171.5 90.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.595 1.558 . . . . 2.9900000000000002 110.202 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 59.0 m -64.86 45.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 127.0 2.12 . . . . 1.3600000000000001 114.98 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -118.59 136.69 24.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 119.579 -1.95 . . . . 3.6699999999999999 110.786 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.61 168.74 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.185 3.256 . . . . 1.1799999999999999 111.686 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.18 144.98 25.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.016 -0.538 . . . . 1.78 109.772 155.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -109.92 117.35 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.118 1.367 . . . . 3.1299999999999999 108.34 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -166.41 146.4 6.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.962 1.305 . . . . 5.1299999999999999 110.6 -163.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 63.22 18.39 10.94 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.085 -1.009 . . . . 3.27 113.686 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.8 13.46 81.33 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.595 -1.315 . . . . 2.7599999999999998 114.217 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.82 174.54 10.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.643 1.577 . . . . 3.1000000000000001 110.793 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.6 151.04 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.371 -0.831 . . . . 1.6399999999999999 111.89 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.23 95.26 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.148 1.379 . . . . 2.2400000000000002 109.977 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 15.41 -85.41 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 129.396 3.079 . . . . 2.3599999999999999 116.091 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 130.62 12.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.619 1.968 . . . . 1.79 106.818 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -116.66 -46.0 2.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.512 1.925 . . . . 4.0 110.864 -165.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.5 -9.85 38.69 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.896 1.073 . . . . 1.29 113.896 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.48 59.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.683 1.593 . . . . 0.91000000000000003 113.185 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.1 173.5 48.7 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 119.487 1.039 . . . . 2.4100000000000001 112.948 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.56 -177.89 42.15 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.78 0.705 . . . . 1.75 112.444 165.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -49.01 140.15 9.44 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.252 0.526 . . . . 2.1699999999999999 110.306 168.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.93 101.73 0.88 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.416 0.895 . . . . 4.5300000000000002 113.416 -170.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -150.45 130.33 6.71 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 128.009 2.524 . . . . 5.2999999999999998 108.547 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.14 -39.35 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.337 2.025 . . . . 3.0099999999999998 113.918 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.67 31.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.463 1.905 . . . . 5.4299999999999997 114.548 -169.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -73.25 -44.15 59.89 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.115 -1.616 . . . . 4.3799999999999999 110.855 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.6 t 177.07 -37.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.277 1.831 . . . . 3.6099999999999999 113.378 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 5.91 79.13 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 117.853 -1.526 . . . . 2.52 116.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.255 19.2 ptmt -102.39 17.71 22.86 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 117.712 2.486 . . . . 5.54 117.712 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 t60 83.54 168.85 0.1 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 127.126 2.17 . . . . 2.3199999999999998 114.753 164.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -25.04 0.1 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.671 2.1 . . . . 5.1299999999999999 116.671 -154.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.6 -46.14 7.13 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 118.334 2.093 . . . . 2.73 118.334 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -90.02 -12.63 2.77 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.192 2.496 . . . . 4.2199999999999998 113.859 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -147.29 -104.17 0.09 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 6.0499999999999998 108.817 -161.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.68 98.73 0.14 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 119.17 0.896 . . . . 3.3900000000000001 114.23 170.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -159.79 44.76 0.23 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.578 1.151 . . . . 5.3499999999999996 109.741 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.43 -129.68 1.14 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 115.868 1.107 . . . . 2.6600000000000001 115.868 -166.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -95.36 146.2 24.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.236 1.014 . . . . 4.1900000000000004 113.663 -154.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -24.61 33.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.683 0.994 . . . . 4.1900000000000004 113.683 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.27 11.28 69.16 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.347 0.975 . . . . 1.48 114.91 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.8 149.79 32.5 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 117.95 0.875 . . . . 2.46 110.716 163.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.85 166.35 16.53 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.233 1.013 . . . . 2.7000000000000002 110.256 -141.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.37 157.01 50.13 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.605 2.87 . . . . 1.4199999999999999 111.654 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -73.21 128.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.647 1.213 . . . . 2.0299999999999998 112.34 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.09 63.37 5.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.773 2.829 . . . . 4.3600000000000003 110.792 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.87 144.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.088 -1.007 . . . . 1.6499999999999999 110.748 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 135.39 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.684 -0.858 . . . . 4.3499999999999996 108.684 162.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 159.34 25.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.131 1.772 . . . . 3.71 112.52 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.79 -8.68 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 119.867 3.284 . . . . 2.6299999999999999 119.867 -161.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -95.94 -36.3 11.12 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.883 1.673 . . . . 2.8500000000000001 114.589 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 115.01 14.39 8.53 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.922 1.529 . . . . 1.3100000000000001 116.922 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.9 mt -105.82 116.99 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.937 1.369 . . . . 2.2599999999999998 109.883 165.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.09 122.58 21.2 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.921 0.489 . . . . 0.79000000000000004 109.951 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -149.23 17.5 0.95 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.351 . . . . 1.6699999999999999 112.733 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -87.29 112.19 46.3 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.134 1.374 . . . . 3.0 111.526 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.9 107.09 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.89 2.393 . . . . 1.1599999999999999 109.973 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.67 145.93 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.501 1.12 . . . . 1.71 109.582 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -127.36 131.97 50.28 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.016 0.825 . . . . 1.8500000000000001 111.014 -168.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.23 96.67 40.11 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.976 0.91 . . . . 0.80000000000000004 112.326 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.12 6.66 1.35 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.93 3.086 . . . . 1.01 113.293 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.08 -29.01 67.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.041 1.337 . . . . 6.2400000000000002 112.965 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.6 153.84 32.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.033 2.133 . . . . 2.98 108.118 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 10.71 6.75 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.805 1.242 . . . . 6.4400000000000004 112.581 -174.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -167.13 150.72 6.58 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.974 -1.079 . . . . 2.29 112.99 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -71.52 -33.6 69.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.561 0.744 . . . . 2.7799999999999998 110.655 162.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.405 ' CG ' ' HZ1' ' A' ' 121' ' ' LYS . 10.4 t70 -61.02 -26.57 67.71 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.278 1.214 . . . . 3.3399999999999999 114.278 -173.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -84.58 -0.57 53.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.075 1.35 . . . . 2.2799999999999998 113.395 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.81 12.96 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.581 1.152 . . . . 0.95999999999999996 113.922 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.405 ' HZ1' ' CG ' ' A' ' 118' ' ' ASP . 48.8 pttt -69.93 17.45 0.05 Allowed 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 116.719 2.118 . . . . 3.23 116.719 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -156.18 29.7 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.534 1.933 . . . . 2.8399999999999999 110.624 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -139.62 157.74 45.28 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.168 1.387 . . . . 2.5299999999999998 114.12 -167.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.96 149.09 22.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.99 1.316 . . . . 0.64000000000000001 112.998 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.55 131.21 55.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.019 2.528 . . . . 2.1699999999999999 106.521 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.3 mtm -125.75 136.68 53.42 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.468 1.031 . . . . 2.2999999999999998 113.036 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.25 112.35 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.928 1.291 . . . . 1.1799999999999999 108.227 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.1 134.72 34.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.699 1.6 . . . . 3.5099999999999998 111.661 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.67 -39.92 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.233 0.827 . . . . 1.6499999999999999 113.233 -158.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.35 163.55 12.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.341 0.972 . . . . 1.46 110.685 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.75 109.26 1.34 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.481 -1.048 . . . . 1.74 110.481 166.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.81 26.58 0.09 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.883 2.873 . . . . 4.9400000000000004 112.969 -167.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.72 21.6 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.045 1.868 . . . . 3.3300000000000001 116.045 -158.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.5 mtm -98.68 152.91 19.13 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.394 1.257 . . . . 2.96 114.394 -160.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.3 p -140.15 150.32 44.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.324 1.85 . . . . 3.9900000000000002 110.463 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.9 t0 58.39 84.27 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.247 2.219 . . . . 4.6600000000000001 114.448 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.1 156.95 11.56 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.936 1.694 . . . . 3.5499999999999998 109.698 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.76 25.38 0.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.93 3.086 . . . . 3.3399999999999999 114.059 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -134.25 129.36 19.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.206 1.002 . . . . 5.4900000000000002 109.941 163.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.88 138.7 45.27 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.889 2.393 . . . . 3.52 111.085 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 60.45 22.48 12.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.809 1.643 . . . . 4.4800000000000004 112.117 -171.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.45 0.13 29.02 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.004 1.288 . . . . 3.0499999999999998 114.554 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.37 -9.46 24.4 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.925 2.202 . . . . 2.0499999999999998 113.957 -166.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.95 1.11 56.29 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.449 1.625 . . . . 1.78 116.324 -171.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.84 62.23 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 118.995 1.398 . . . . 1.79 116.485 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -79.31 155.96 28.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.014 1.725 . . . . 1.8400000000000001 110.771 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 136.01 49.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 6.0599999999999996 111.457 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -82.4 -32.61 29.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.518 1.127 . . . . 3.48 111.349 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.91 42.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.431 1.092 . . . . 0.51000000000000001 113.066 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.56 151.72 48.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.031 2.132 . . . . 1.46 110.479 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.07 125.15 1.78 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.301 1.429 . . . . 0.93999999999999995 111.873 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.6 132.45 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.835 1.254 . . . . 2.4700000000000002 110.87 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.06 131.4 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.032 1.333 . . . . 1.1499999999999999 110.533 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.4 mttt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 123.526 0.73 . . . . 4.3600000000000003 111.874 179.398 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.202 -0.666 . . . . 2.5600000000000001 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.39 143.1 45.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.196 1.362 . . . . 1.8899999999999999 113.974 -147.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -155.19 132.67 11.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.06 1.344 . . . . 2.52 110.454 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.38 97.07 7.19 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.842 -1.161 . . . . 5.0899999999999999 113.029 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.4 t -77.54 122.79 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 1.47 109.799 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.75 105.1 1.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.212 1.387 . . . . 0.79000000000000004 110.638 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.4 mtp -91.57 108.56 19.99 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.925 0.713 . . . . 2.1400000000000001 112.925 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -69.4 141.95 54.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.938 0.895 . . . . 2.8399999999999999 111.31 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.29 134.83 52.33 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.633 -0.877 . . . . 2.5499999999999998 108.633 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.69 159.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.091 0.556 . . . . 1.3600000000000001 111.578 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -155.23 -152.32 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.375 1.47 . . . . 2.7200000000000002 109.927 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -18.07 44.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.429 1.492 . . . . 2.48 113.429 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.84 -3.32 47.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.655 1.182 . . . . 3.3500000000000001 111.543 164.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 -133.41 11.78 Favored Glycine 0 CA--C 1.525 0.684 0 O-C-N 120.812 -1.18 . . . . 1.48 110.464 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.42 130.12 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.249 1.42 . . . . 2.5 111.657 -165.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.54 -100.07 2.16 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.645 1.593 . . . . 1.23 112.291 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -151.06 152.43 33.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.134 1.774 . . . . 4.71 109.065 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.5 t -87.99 155.1 20.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.22 1.01 . . . . 1.8400000000000001 112.308 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -135.37 2.9 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 3.4300000000000002 112.438 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.78 142.83 3.63 Favored Glycine 0 CA--C 1.524 0.62 0 O-C-N 121.468 -0.77 . . . . 0.81999999999999995 112.72 -162.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.504 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 3.1 p -97.88 175.82 6.01 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 166.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.52 129.07 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.594 -0.891 . . . . 0.68000000000000005 108.594 160.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.7 p -87.38 121.26 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 O-C-N 123.574 0.546 . . . . 1.53 110.995 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.52 128.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.303 1.841 . . . . 1.6200000000000001 107.284 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.56 111.71 13.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.497 1.142 . . . . 2.27 111.118 164.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -86.31 145.78 26.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.418 2.287 . . . . 5.3700000000000001 113.447 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.302 8.5 t -163.16 160.5 24.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 125.179 2.418 . . . . 1.8400000000000001 110.775 -158.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -23.18 -53.18 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 110.712 -2.949 . . . . 3.7799999999999998 113.387 148.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.12 12.2 65.04 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 125.225 1.393 . . . . 1.04 116.179 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.66 -172.38 35.9 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 130.499 3.904 . . . . 1.48 115.272 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.1 mt -51.59 99.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.798 2.039 . . . . 1.0 113.86 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -81.01 104.48 11.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.788 1.235 . . . . 2.2599999999999998 110.849 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 47' ' ' PHE . 1.3 t80 -94.33 120.88 35.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.175 2.19 . . . . 0.81999999999999995 110.265 -173.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.5 m -127.65 115.92 21.01 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.036 -0.983 . . . . 0.94999999999999996 109.286 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -85.03 154.92 11.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.455 2.77 . . . . 0.65000000000000002 113.562 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.504 ' CD2' ' HG1' ' A' ' 21' ' ' THR 0.282 1.8 p80 -147.06 62.25 1.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.3 1.047 . . . . 1.5 111.873 168.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.68 146.21 47.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.404 1.481 . . . . 0.81999999999999995 112.05 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -133.57 25.4 4.07 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 117.483 2.401 . . . . 3.8700000000000001 117.483 -158.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.54 25.02 0.4 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.817 1.414 . . . . 1.6299999999999999 114.817 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.92 162.91 34.21 Favored Pre-proline 0 N--CA 1.474 0.773 0 O-C-N 120.907 -1.121 . . . . 2.7200000000000002 111.297 -174.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.27 128.12 25.24 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 N-CA-C 109.36 -1.054 . . . . 1.05 109.36 162.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -87.45 20.17 1.24 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 124.399 3.399 . . . . 1.1399999999999999 113.78 -149.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.18 150.2 18.2 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.576 . . . . 2.5099999999999998 109.447 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -44.15 143.23 1.23 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 127.365 2.266 . . . . 2.8999999999999999 115.852 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -126.74 125.98 42.69 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 125.679 1.592 . . . . 1.1799999999999999 113.408 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.32 159.99 7.92 Favored Glycine 0 CA--C 1.54 1.62 0 O-C-N 120.863 -1.148 . . . . 0.65000000000000002 112.581 171.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CE2' ' CD2' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -137.15 126.4 24.72 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.617 -0.931 . . . . 3.6499999999999999 108.832 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.443 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 17.1 m170 -120.85 159.3 25.77 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.558 1.318 . . . . 1.0800000000000001 114.558 166.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.3 mt -103.18 139.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.558 1.943 . . . . 0.79000000000000004 107.371 157.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -113.59 166.26 11.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.223 . . . . 1.2 111.137 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.56 64.78 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.494 1.294 . . . . 0.80000000000000004 114.494 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -110.84 -158.22 0.64 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.939 1.296 . . . . 1.52 111.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.42 0.19 8.05 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 119.46 2.544 . . . . 2.1299999999999999 119.46 -147.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 t -155.78 138.76 15.41 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.816 3.308 . . . . 3.6299999999999999 117.271 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.7 m -68.44 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 130.199 3.399 . . . . 1.3500000000000001 115.112 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.18 118.82 48.64 Favored Pre-proline 0 N--CA 1.475 0.788 0 O-C-N 119.446 -2.034 . . . . 3.1600000000000001 111.746 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.66 146.3 16.77 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.662 2.908 . . . . 1.3999999999999999 111.711 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.24 138.88 32.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.63 -0.714 . . . . 2.0299999999999998 110.291 154.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.57 106.54 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.792 -1.188 . . . . 3.3599999999999999 107.792 160.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -151.98 136.54 16.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.578 1.551 . . . . 6.75 110.246 -161.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.4 t0 50.46 45.51 26.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.85 1.26 . . . . 4.1600000000000001 112.83 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 -19.49 48.97 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.065 1.793 . . . . 3.1899999999999999 115.389 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.66 163.6 34.36 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.352 1.576 . . . . 3.7999999999999998 113.379 -156.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.57 121.83 26.81 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.497 -1.377 . . . . 2.4700000000000002 111.175 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -76.61 20.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 114.656 1.354 . . . . 3.9399999999999999 114.656 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.99 -56.96 0.57 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.146 2.578 . . . . 2.0899999999999999 114.685 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.44 118.76 0.55 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.252 2.221 . . . . 1.8799999999999999 108.911 172.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.11 -43.8 7.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.581 0.752 . . . . 4.96 110.677 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.2 -2.38 7.99 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.221 1.193 . . . . 1.6699999999999999 114.221 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.13 -24.25 23.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.018 1.327 . . . . 1.03 112.474 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.68 -176.94 41.87 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.713 1.142 . . . . 2.3900000000000001 112.878 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.62 -176.57 29.65 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.906 -0.761 . . . . 1.6799999999999999 112.834 171.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -55.59 150.38 12.36 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.936 -0.744 . . . . 2.23 109.487 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.99 100.35 0.41 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.911 0.778 . . . . 2.3999999999999999 112.002 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -163.78 123.15 1.32 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 129.279 3.032 . . . . 4.9699999999999998 108.926 165.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -92.16 -16.64 1.05 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.04 2.493 . . . . 2.3100000000000001 114.283 173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -169.88 -14.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.437 2.384 . . . . 4.1799999999999997 117.437 -166.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -59.09 -36.62 75.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.957 1.708 . . . . 4.1100000000000003 112.742 -170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -172.93 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.182 0.993 . . . . 2.7400000000000002 113.225 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 -17.48 8.06 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.29 -1.283 . . . . 2.29 113.834 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -78.08 154.49 31.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.175 1.988 . . . . 6.6500000000000004 112.077 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -79.68 150.52 30.89 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.012 -1.055 . . . . 1.8100000000000001 112.589 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.428 ' CG ' ' H ' ' A' ' 84' ' ' GLY . 4.6 tt0 -79.39 -166.01 0.88 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.598 0.759 . . . . 3.27 110.076 175.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' A' ' 83' ' ' GLU . . . 165.45 -140.5 6.43 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 120.746 -1.221 . . . . 2.21 111.79 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.15 -9.82 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.458 2.772 . . . . 3.4199999999999999 114.23 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.98 174.41 5.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.817 2.047 . . . . 5.5499999999999998 109.164 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.98 -138.4 16.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.663 0.649 . . . . 4.5099999999999998 111.497 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.08 135.81 3.91 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.511 1.524 . . . . 6.6900000000000004 107.597 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.87 -135.28 3.22 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.258 1.409 . . . . 2.6600000000000001 113.397 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -75.7 136.25 40.37 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.145 -0.62 . . . . 4.54 110.542 169.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -12.84 61.69 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 3.8500000000000001 113.586 170.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.09 18.51 13.0 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.874 1.702 . . . . 0.98999999999999999 115.999 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -108.9 133.11 53.35 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.155 1.478 . . . . 1.47 110.585 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.11 154.23 80.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.035 1.334 . . . . 3.1200000000000001 110.654 -163.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.75 163.9 37.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.41 2.74 . . . . 1.03 112.987 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.14 119.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 114.975 -1.012 . . . . 3.0600000000000001 112.101 -160.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 87.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.112 2.965 . . . . 2.6499999999999999 109.685 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.25 147.55 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.452 -0.78 . . . . 1.29 110.086 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.55 150.16 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 127.635 2.374 . . . . 2.5299999999999998 106.108 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.52 160.21 27.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.575 0.625 . . . . 2.4399999999999999 111.147 168.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -14.79 0.86 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 116.63 2.085 . . . . 2.4500000000000002 116.63 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.93 -5.78 37.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.359 2.264 . . . . 2.6299999999999999 113.395 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.5 52.01 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.674 1.131 . . . . 0.79000000000000004 115.184 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.6 mt -111.89 132.5 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.432 1.493 . . . . 1.7 110.191 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.7 144.63 32.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.522 1.529 . . . . 1.0700000000000001 112.198 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -151.31 -5.73 0.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.346 1.858 . . . . 1.8600000000000001 113.806 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -70.18 118.53 64.77 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.226 1.81 . . . . 4.5199999999999996 111.493 -174.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.15 146.73 32.46 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.884 2.389 . . . . 1.28 111.479 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.16 175.17 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.911 1.684 . . . . 1.6100000000000001 109.627 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 m -150.57 133.19 15.75 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.305 0.957 . . . . 1.1200000000000001 110.449 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.3 105.41 54.03 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-O 118.745 -0.645 . . . . 1.04 112.043 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.67 -16.16 21.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.233 2.622 . . . . 1.4099999999999999 115.631 -171.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -66.77 -43.25 84.53 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.252 0.834 . . . . 5.5300000000000002 113.252 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.95 151.25 38.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 3.02 110.336 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -144.27 46.4 1.42 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.819 1.248 . . . . 4.8700000000000001 113.265 -169.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 m 151.22 142.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 130.874 3.67 . . . . 2.2400000000000002 113.554 166.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.19 -33.63 53.54 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.826 -1.171 . . . . 2.1699999999999999 111.636 164.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -20.92 5.72 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.794 1.775 . . . . 3.1699999999999999 115.794 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -92.25 -16.98 25.43 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.607 1.549 . . . . 3.0600000000000001 113.709 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.67 -1.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.993 1.479 . . . . 1.03 114.993 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -8.4 13.24 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 117.121 2.267 . . . . 3.6899999999999999 117.121 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -104.97 -8.12 18.8 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.207 1.403 . . . . 2.8700000000000001 113.395 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -96.16 168.56 10.52 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.932 1.293 . . . . 2.4700000000000002 114.338 -167.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.9 156.84 17.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.125 1.37 . . . . 0.90000000000000002 112.41 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 pp -131.96 155.0 48.73 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.924 1.69 . . . . 3.3399999999999999 111.193 169.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 67.9 mtt -136.28 139.74 42.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.607 0.763 . . . . 1.8999999999999999 112.587 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.03 121.62 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.293 1.437 . . . . 0.83999999999999997 107.779 166.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -114.01 145.75 41.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.448 1.499 . . . . 2.98 112.654 -161.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.0 -32.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 126.119 1.768 . . . . 1.5900000000000001 113.762 -159.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.68 167.37 20.04 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.782 1.182 . . . . 1.3700000000000001 111.703 168.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.97 163.68 50.43 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.241 1.401 . . . . 1.3500000000000001 112.759 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.443 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 20.2 t0 -116.51 11.93 14.97 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.199 1.555 . . . . 2.4500000000000002 115.199 -142.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -70.95 -10.47 59.74 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.441 -1.412 . . . . 3.04 114.638 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.2 mtm -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.664 1.586 . . . . 2.77 113.403 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 t -84.77 -175.39 5.75 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.61 -0.681 . . . . 3.6099999999999999 112.27 161.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 61.31 -16.05 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 129.053 2.941 . . . . 4.79 117.316 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -67.67 147.27 98.67 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.098 1.359 . . . . 3.4900000000000002 111.851 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.95 -25.0 32.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.612 2.875 . . . . 2.21 112.718 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -104.65 84.98 1.05 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.43 -0.952 . . . . 4.8099999999999996 108.43 157.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.58 154.25 73.05 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.753 2.302 . . . . 3.8100000000000001 111.041 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 65.58 5.48 3.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.684 1.994 . . . . 5.1900000000000004 112.946 -169.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.42 14.52 54.48 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.718 1.151 . . . . 3.5 114.429 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.45 44.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.972 1.272 . . . . 2.8900000000000001 114.035 -167.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.1 -16.65 66.92 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.209 1.385 . . . . 2.0800000000000001 113.164 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.68 0.08 29.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.149 1.357 . . . . 2.3199999999999998 114.628 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.0 p -71.75 160.66 32.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.127 1.463 . . . . 2.3399999999999999 109.924 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.51 150.72 20.21 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.762 1.225 . . . . 6.2999999999999998 114.001 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -109.24 -37.92 5.65 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.317 0.647 . . . . 3.7999999999999998 110.793 154.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.75 155.04 47.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.79 0.836 . . . . 0.55000000000000004 112.69 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.1 t -139.09 147.51 42.07 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.223 2.209 . . . . 1.4099999999999999 109.821 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 123.99 1.72 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.978 1.275 . . . . 0.73999999999999999 112.624 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.22 126.19 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.792 1.237 . . . . 2.3700000000000001 110.144 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 36.8 mt -80.87 142.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.642 1.177 . . . . 1.26 109.184 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 10.5 mmpt? . . . . . 0 CA--C 1.542 0.672 0 O-C-N 120.726 -1.234 . . . . 3.8700000000000001 111.811 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.107 -0.331 . . . . 2.6099999999999999 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -132.49 146.23 51.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.011 1.485 . . . . 1.6399999999999999 115.011 -133.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -156.04 135.51 12.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.287 1.518 . . . . 2.7999999999999998 111.603 164.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 19.6 ttmt -108.51 87.5 2.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.229 2.212 . . . . 3.9100000000000001 110.974 -165.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.23 125.4 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.21 1.189 . . . . 3.4500000000000002 114.21 -171.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.0 100.68 0.59 Allowed Glycine 0 C--N 1.339 0.709 0 C-N-CA 125.191 1.377 . . . . 0.92000000000000004 110.525 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.28 128.92 34.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.653 0.74 . . . . 2.5 111.931 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -111.09 143.4 41.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.904 2.081 . . . . 2.8700000000000001 111.658 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.2 mt -80.83 56.26 2.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.599 1.16 . . . . 1.7 112.904 -169.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.1 153.45 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 122.262 1.029 . . . . 1.8899999999999999 113.603 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -160.06 -156.26 0.48 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 125.728 1.611 . . . . 3.0099999999999998 109.051 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.14 8.88 0.49 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.37 1.868 . . . . 1.75 114.075 -172.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -108.46 -7.52 15.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.815 1.646 . . . . 2.8199999999999998 111.114 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.81 -142.63 17.14 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.644 -0.983 . . . . 1.1499999999999999 110.644 -160.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -92.53 136.3 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.159 1.783 . . . . 1.3100000000000001 110.907 -167.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.47 -68.26 0.28 Allowed Glycine 0 N--CA 1.473 1.146 0 C-N-CA 124.421 1.01 . . . . 1.6200000000000001 115.316 -166.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.3 154.98 10.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.207 1.803 . . . . 2.23 110.8 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -129.82 122.42 28.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.9 -1.125 . . . . 2.1699999999999999 112.273 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.65 25.97 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.458 1.503 . . . . 7.04 110.842 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.87 38.12 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.756 -0.59 . . . . 0.79000000000000004 114.32 161.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.492 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 8.0 p -99.24 -179.28 4.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.963 0.905 . . . . 1.1699999999999999 110.392 169.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -129.53 132.58 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.929 -1.137 . . . . 0.56000000000000005 107.929 150.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 14.8 p -85.84 120.7 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.963 0.411 . . . . 1.45 110.761 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.58 138.93 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 124.917 1.287 . . . . 2.6200000000000001 107.881 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.94 104.95 3.49 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.16 1.384 . . . . 2.2799999999999998 109.56 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 151.08 44.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.032 -0.531 . . . . 2.8199999999999998 111.558 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -158.38 -177.49 6.58 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.854 0.862 . . . . 1.53 110.547 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.5 -9.4 48.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.487 1.915 . . . . 3.7400000000000002 113.001 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.45 16.27 41.37 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.854 1.693 . . . . 1.25 114.424 163.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.88 -151.42 23.86 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 127.235 2.35 . . . . 1.1200000000000001 116.635 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.54 96.66 4.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.227 1.011 . . . . 2.21 111.728 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -70.77 143.32 51.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.086 0.954 . . . . 2.7999999999999998 109.755 166.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -142.65 118.88 10.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.105 1.762 . . . . 0.66000000000000003 109.363 -167.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -123.44 109.5 30.89 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.173 -0.918 . . . . 1.73 108.831 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.4 164.31 19.11 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.818 3.012 . . . . 0.56999999999999995 110.929 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.492 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 1.3 p80 -158.63 33.78 0.23 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.314 0.857 . . . . 1.5700000000000001 113.314 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 mp -91.77 136.06 33.43 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.378 -1.451 . . . . 1.1899999999999999 112.018 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 14.98 21.63 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.499 2.037 . . . . 3.5 116.499 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.59 88.07 1.19 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.664 -0.648 . . . . 1.8300000000000001 112.059 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 163.32 26.9 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.264 1.425 . . . . 2.54 111.298 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.51 124.31 13.09 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.013 1.809 . . . . 0.95999999999999996 110.556 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -84.47 45.17 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 127.203 5.269 . . . . 1.3500000000000001 112.268 -163.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.13 -130.46 7.02 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 123.184 1.436 . . . . 1.45 111.866 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -147.56 127.95 13.99 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.253 1.421 . . . . 2.8700000000000001 109.264 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -130.19 154.48 47.49 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.578 0.955 . . . . 1.22 113.578 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.35 155.87 51.75 Favored Glycine 0 CA--C 1.541 1.657 0 O-C-N 121.184 -0.948 . . . . 0.60999999999999999 112.192 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -130.85 122.57 27.31 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.054 -1.462 . . . . 3.4100000000000001 107.054 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 7.7 m170 -122.53 157.92 31.0 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.723 1.601 . . . . 1.1499999999999999 114.43 165.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.6 mt -94.24 154.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 128.27 2.628 . . . . 0.88 108.22 158.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -139.04 145.13 39.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.002 0.921 . . . . 1.1799999999999999 111.181 -170.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.57 67.0 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.242 1.941 . . . . 0.79000000000000004 116.242 -163.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.43 -179.27 5.06 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.415 1.086 . . . . 1.25 113.211 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.0 32.76 4.47 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.597 1.57 . . . . 1.3799999999999999 116.675 -163.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -138.69 104.12 5.02 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.224 1.512 . . . . 2.8399999999999999 111.705 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -70.2 13.09 0.18 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 116.701 2.111 . . . . 1.4199999999999999 116.701 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -84.45 131.52 49.96 Favored Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 119.694 -1.879 . . . . 3.1099999999999999 112.115 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.71 149.16 29.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.524 2.816 . . . . 1.25 112.418 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.74 150.36 26.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.003 -0.544 . . . . 1.6100000000000001 110.38 156.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.0 mm -117.14 136.76 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.829 1.652 . . . . 2.8399999999999999 107.697 173.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -14.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.678 2.103 . . . . 6.5599999999999996 116.678 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.36 46.7 0.28 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.795 1.18 . . . . 3.3999999999999999 113.611 -163.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.1 22.3 68.75 Favored Glycine 0 N--CA 1.475 1.255 0 O-C-N 120.662 -1.274 . . . . 3.3500000000000001 113.295 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -163.32 155.22 17.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.293 1.837 . . . . 3.3399999999999999 110.501 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.0 138.51 46.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.243 1.417 . . . . 2.5299999999999998 111.749 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.82 39.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.969 1.308 . . . . 2.8300000000000001 111.377 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.4 -66.38 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.628 2.771 . . . . 2.5699999999999998 116.207 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.91 107.13 0.96 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.074 2.55 . . . . 1.98 108.057 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -76.48 -54.1 7.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.484 0.714 . . . . 6.0599999999999996 110.059 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.1 20.64 0.37 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.045 0.938 . . . . 2.2200000000000002 113.325 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.4 -11.99 38.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.226 1.411 . . . . 1.0600000000000001 112.08 157.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.18 -70.3 3.18 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 120.229 -1.544 . . . . 2.96 114.051 171.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.02 179.23 32.75 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.522 1.534 . . . . 2.3900000000000001 112.909 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -61.28 -7.31 2.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.663 2.097 . . . . 2.5699999999999998 116.663 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 tt 78.51 98.73 0.06 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.957 2.103 . . . . 3.6499999999999999 110.027 169.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -168.55 55.01 0.27 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 115.714 1.746 . . . . 3.5099999999999998 115.714 -148.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.39 -48.06 2.7 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.765 2.31 . . . . 2.6299999999999999 113.218 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -137.41 79.04 1.72 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.459 1.103 . . . . 4.6799999999999997 110.058 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.96 -77.67 0.58 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.601 1.16 . . . . 3.9300000000000002 109.769 166.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -178.6 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.894 2.077 . . . . 2.5499999999999998 111.414 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.55 -9.3 58.82 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.245 0.926 . . . . 2.0499999999999998 114.679 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.92 -14.35 61.9 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 116.052 1.871 . . . . 5.9100000000000001 116.052 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.9 t60 70.74 164.19 0.27 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.308 1.843 . . . . 1.9099999999999999 111.5 -166.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -157.28 -152.38 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.886 -1.134 . . . . 3.9500000000000002 112.216 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.27 -40.18 0.16 Allowed Glycine 0 CA--C 1.543 1.805 0 C-N-CA 127.938 2.685 . . . . 2.3599999999999999 113.213 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -112.34 -1.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.617 2.878 . . . . 3.6800000000000002 115.606 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.08 -7.19 0.82 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.116 1.895 . . . . 6.3600000000000003 116.116 -159.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.36 -23.03 5.71 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 119.712 -1.867 . . . . 4.6699999999999999 114.322 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.71 64.26 2.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.089 2.156 . . . . 5.6299999999999999 113.451 -168.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 -93.39 0.11 Allowed Glycine 0 N--CA 1.469 0.899 0 O-C-N 120.457 -1.402 . . . . 2.48 113.655 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -138.15 156.03 48.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.23 2.212 . . . . 4.6399999999999997 108.279 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -84.96 -21.72 29.46 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.523 1.056 . . . . 2.8500000000000001 113.131 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.63 19.84 22.15 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 117.806 -1.552 . . . . 1.1299999999999999 116.068 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -95.2 138.12 33.33 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 120.636 2.218 . . . . 1.49 111.065 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.49 155.66 79.82 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.945 1.698 . . . . 3.1099999999999999 110.391 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.02 162.04 43.01 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.417 2.744 . . . . 1.22 111.787 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.0 127.24 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.902 1.334 . . . . 2.1499999999999999 113.237 -160.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 85.04 3.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 129.438 3.095 . . . . 3.9900000000000002 108.57 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.12 149.55 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 1.01 109.152 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.27 133.6 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.663 1.185 . . . . 2.6099999999999999 110.281 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.45 141.99 58.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.754 1.02 . . . . 1.9299999999999999 113.754 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -46.42 -23.92 0.43 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 129.016 2.927 . . . . 2.77 117.581 -170.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.58 -19.31 45.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.139 1.775 . . . . 3.0499999999999998 112.482 -168.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.69 30.95 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.43 1.491 . . . . 1.05 113.483 -170.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.24 127.66 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.008 1.723 . . . . 1.45 108.492 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.76 136.54 33.06 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.131 0.972 . . . . 0.81999999999999995 110.547 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.3 t -153.11 -2.43 0.22 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.918 1.687 . . . . 2.0800000000000001 113.052 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -80.43 118.96 74.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 128.387 2.675 . . . . 5.0300000000000002 112.283 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.09 149.43 28.52 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.931 3.087 . . . . 1.45 112.971 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.03 166.62 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.98 1.712 . . . . 1.6499999999999999 110.591 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -138.99 137.1 36.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.9 1.28 . . . . 1.01 109.553 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -112.42 110.17 53.23 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.338 0.655 . . . . 1.0600000000000001 112.758 173.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.51 -0.95 11.13 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.879 3.052 . . . . 1.4299999999999999 114.692 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -73.87 -11.12 60.27 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.951 1.25 . . . . 5.3499999999999996 113.238 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.78 141.98 33.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.865 2.066 . . . . 3.6299999999999999 108.417 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 18.79 2.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.931 1.826 . . . . 8.3100000000000005 115.931 -160.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 85.9 p -153.24 164.72 37.58 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.821 1.248 . . . . 3.3300000000000001 108.329 167.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.0 tp -84.4 -34.61 23.5 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.676 -0.64 . . . . 3.21 109.657 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.65 -41.36 42.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 2.8900000000000001 113.078 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -72.92 -5.09 36.16 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.231 1.197 . . . . 2.2599999999999998 114.231 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.03 13.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.024 1.329 . . . . 0.91000000000000003 113.541 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -59.7 -5.07 0.79 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 117.361 2.356 . . . . 2.9300000000000002 117.361 -172.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.66 22.11 2.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.055 1.342 . . . . 3.5099999999999998 112.807 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -104.47 151.81 23.1 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.297 -0.877 . . . . 3.2799999999999998 112.866 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.47 148.42 27.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.836 -0.62 . . . . 0.92000000000000004 110.182 157.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.2 145.62 42.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.349 -0.982 . . . . 2.0600000000000001 108.349 156.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.9 150.86 52.12 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.201 0.815 . . . . 3.0 113.201 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.5 mt -99.06 132.9 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.098 1.759 . . . . 0.85999999999999999 108.146 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -123.19 143.39 50.05 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.098 1.359 . . . . 4.1500000000000004 112.197 -164.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 37.9 t -67.1 -35.4 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.922 -1.111 . . . . 1.8600000000000001 112.982 -160.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -108.19 150.74 17.0 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.182 0.896 . . . . 1.3400000000000001 111.937 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.89 147.81 40.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.634 1.111 . . . . 1.5800000000000001 111.376 159.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.436 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 25.3 t0 -103.4 -15.07 16.02 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.471 1.656 . . . . 2.9500000000000002 115.471 -138.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.24 51.98 0.57 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.415 1.635 . . . . 2.8999999999999999 115.415 -168.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.94 131.51 25.47 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.703 -1.248 . . . . 2.9300000000000002 112.316 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -138.06 -54.93 0.65 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.717 0.807 . . . . 3.6200000000000001 112.671 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.95 39.46 0.23 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.978 2.111 . . . . 4.2800000000000002 113.881 -164.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -124.18 163.58 35.03 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.155 2.582 . . . . 3.8700000000000001 109.773 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.84 -19.36 64.19 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.291 2.661 . . . . 2.75 113.755 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -127.81 136.47 29.03 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 118.856 0.753 . . . . 5.4100000000000001 109.944 148.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.52 162.37 41.11 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.919 2.413 . . . . 4.1299999999999999 110.176 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 mp 60.07 9.1 1.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.01 1.724 . . . . 4.7000000000000002 112.868 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 10.64 57.29 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.716 -1.24 . . . . 3.8700000000000001 114.139 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.7 83.07 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.434 1.016 . . . . 2.3799999999999999 113.891 -166.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.55 10.5 50.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.718 1.627 . . . . 1.97 115.006 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.83 -4.13 70.28 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.128 1.347 . . . . 1.77 114.537 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 p -62.71 157.99 19.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.048 1.339 . . . . 1.8400000000000001 110.319 164.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.68 150.11 27.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.043 1.337 . . . . 7.8700000000000001 113.381 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -107.52 -19.82 13.44 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.436 0.902 . . . . 3.77 113.436 162.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.24 156.32 23.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.205 0.911 . . . . 0.54000000000000004 112.851 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.23 163.61 15.42 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.393 1.477 . . . . 2.2799999999999998 110.114 157.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -151.96 134.44 4.58 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.821 1.676 . . . . 0.92000000000000004 110.371 159.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.52 129.65 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.482 1.113 . . . . 2.3199999999999998 109.873 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.4 mt -64.88 124.52 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.628 1.171 . . . . 1.2 112.052 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 113.168 0.803 . . . . 4.1100000000000003 113.168 177.559 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.479 ' H3 ' ' CD ' ' A' ' 26' ' ' GLU . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.72 0.295 . . . . 3.4100000000000001 110.484 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -150.84 155.78 39.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.206 1.402 . . . . 1.98 109.194 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -154.59 121.51 5.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.113 1.365 . . . . 2.6000000000000001 109.601 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -86.58 102.43 14.14 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.638 -1.289 . . . . 4.9100000000000001 108.834 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.1 121.28 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 119.882 1.219 . . . . 1.54 110.586 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.6 104.13 2.26 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.644 1.593 . . . . 1.0 110.983 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt -88.33 145.33 25.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.346 1.069 . . . . 2.4399999999999999 113.504 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -120.35 149.13 42.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.238 1.815 . . . . 2.8599999999999999 111.706 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.34 65.72 2.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.168 1.787 . . . . 1.45 111.139 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -74.39 157.84 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.705 1.202 . . . . 1.9299999999999999 112.836 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -159.97 -156.78 0.51 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.309 1.444 . . . . 3.21 109.722 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.32 60.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.324 2.25 . . . . 1.75 113.587 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -87.33 -15.74 37.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.172 1.789 . . . . 3.02 112.198 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.24 -139.62 14.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.724 1.154 . . . . 1.3300000000000001 110.717 -161.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.94 139.13 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 126.766 2.026 . . . . 2.0299999999999998 113.284 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.67 -104.03 2.25 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.595 2.045 . . . . 1.6000000000000001 113.26 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.12 149.57 42.0 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 127.264 2.226 . . . . 3.2799999999999998 113.482 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -96.47 140.87 30.47 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.742 -1.224 . . . . 2.4399999999999999 112.053 166.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.64 5.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 125.351 1.46 . . . . 3.3900000000000001 113.947 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.99 168.26 21.71 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.075 0.845 . . . . 1.02 112.639 -168.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 p -116.86 -175.76 2.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.337 1.055 . . . . 1.1599999999999999 109.162 170.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.08 135.65 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.441 -1.318 . . . . 0.70999999999999996 107.441 157.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.88 124.78 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.398 0.437 . . . . 1.53 110.203 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.7 127.67 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.371 1.068 . . . . 3.0 108.971 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -143.08 134.66 26.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.211 1.404 . . . . 2.04 110.452 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 117' ' ' LEU . 41.7 mt-10 -92.69 138.1 31.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.387 -1.733 . . . . 3.8199999999999998 112.087 -162.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 -175.51 4.99 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.577 -0.849 . . . . 2.1699999999999999 112.276 168.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -70.97 -6.97 42.81 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.956 1.095 . . . . 3.8799999999999999 113.956 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.67 12.15 53.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.764 1.649 . . . . 1.27 113.913 162.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -152.7 21.65 Favored Glycine 0 N--CA 1.462 0.418 0 C-N-CA 128.083 2.754 . . . . 1.0 116.225 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.3 mt -71.64 103.68 3.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.999 . . . . 1.1699999999999999 111.259 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -76.63 116.41 17.28 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.239 1.016 . . . . 2.8999999999999999 109.081 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -113.56 113.03 24.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.239 2.216 . . . . 1.0 109.19 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.8 m -120.8 107.19 38.46 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 108.124 -1.065 . . . . 0.95999999999999996 108.124 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.65 164.31 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.505 2.803 . . . . 0.5 110.685 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -152.67 30.63 0.52 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.133 0.968 . . . . 1.5900000000000001 112.669 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -89.78 132.76 35.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.919 -1.113 . . . . 1.0700000000000001 110.911 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -107.9 18.64 21.04 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.36 1.985 . . . . 2.73 116.36 -159.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.62 75.69 0.56 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.14 0.976 . . . . 1.5900000000000001 111.992 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.11 158.43 69.46 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.791 1.237 . . . . 2.6499999999999999 110.871 173.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.6 131.19 30.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.484 1.456 . . . . 1.24 110.879 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -87.2 34.76 0.43 Allowed 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 126.141 4.561 . . . . 1.22 113.203 -150.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.84 -135.07 8.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.99 1.757 . . . . 1.26 114.072 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.51 131.53 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.919 1.688 . . . . 2.3999999999999999 108.417 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -132.73 147.21 52.32 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 124.561 1.144 . . . . 1.3100000000000001 112.392 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.44 149.31 51.34 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.943 -1.098 . . . . 0.93999999999999995 111.458 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -124.75 111.4 15.51 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.492 -1.67 . . . . 3.2200000000000002 106.492 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -116.24 157.43 24.91 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.633 -1.292 . . . . 1.3500000000000001 113.697 171.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.28 152.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.594 1.557 . . . . 1.5600000000000001 107.518 157.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.68 146.9 46.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.526 1.13 . . . . 1.3700000000000001 108.768 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.12 70.28 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.388 1.625 . . . . 0.76000000000000001 115.388 -153.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -125.42 155.24 40.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.481 1.113 . . . . 2.1899999999999999 112.644 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.79 82.08 1.42 Allowed Glycine 0 N--CA 1.469 0.834 0 O-C-N 120.702 -1.249 . . . . 1.21 112.795 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -166.54 95.52 0.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.55 0.74 . . . . 2.6699999999999999 112.778 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.9 m -67.67 45.69 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.389 2.275 . . . . 1.45 113.635 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -121.05 127.12 26.35 Favored Pre-proline 0 CA--C 1.553 1.063 0 O-C-N 119.783 -1.823 . . . . 3.6400000000000001 111.113 -167.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -81.72 179.33 5.78 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.273 3.315 . . . . 1.3 114.562 -168.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.19 173.13 12.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.799 2.04 . . . . 1.7 109.669 160.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.97 134.5 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.909 1.283 . . . . 3.6699999999999999 108.194 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -150.78 143.05 24.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.642 1.577 . . . . 5.6299999999999999 110.14 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.61 25.96 13.86 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.204 1.187 . . . . 5.6299999999999999 114.204 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.77 17.54 65.51 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.414 1.006 . . . . 4.4900000000000002 115.001 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.16 162.56 39.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.173 1.487 . . . . 6.4000000000000004 112.903 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.2 129.05 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.436 1.095 . . . . 2.4500000000000002 111.384 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.41 -15.58 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.866 1.266 . . . . 3.0499999999999998 113.549 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 70.69 -49.26 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 128.482 2.713 . . . . 2.4900000000000002 113.574 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.67 106.69 3.71 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.24 1.016 . . . . 1.72 109.991 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -95.32 -43.5 8.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.483 1.113 . . . . 4.7000000000000002 110.533 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.68 -9.03 31.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.256 1.022 . . . . 1.5800000000000001 113.545 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.76 -15.63 60.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.334 1.235 . . . . 1.05 114.334 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.91 -173.67 55.32 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 120.572 -1.33 . . . . 2.1200000000000001 114.228 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.51 -171.05 25.75 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 124.73 1.157 . . . . 2.0600000000000001 113.131 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.471 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 1.8 m170 -64.87 8.91 0.1 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.898 2.079 . . . . 2.5699999999999998 114.649 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.1 tp 60.74 83.83 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.344 1.858 . . . . 2.4900000000000002 107.672 -164.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -160.4 19.24 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 117.408 2.373 . . . . 4.3300000000000001 117.408 -143.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.58 -31.77 20.67 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.232 1.955 . . . . 2.8700000000000001 115.498 -159.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -140.28 8.9 2.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.646 1.112 . . . . 3.6600000000000001 113.286 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.49 -41.99 19.04 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.05 -1.031 . . . . 3.7799999999999998 113.305 -164.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t 154.65 158.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 1 C-N-CA 132.237 4.215 . . . . 2.9300000000000002 107.414 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.07 -38.6 9.08 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 123.408 0.528 . . . . 3.5800000000000001 114.051 -171.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -77.77 176.25 9.2 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.362 1.065 . . . . 4.6799999999999997 113.734 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -124.29 158.9 31.47 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.29 1.036 . . . . 3.0899999999999999 112.105 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.603 ' CD ' ' H ' ' A' ' 84' ' ' GLY 0.286 2.7 pp20? -150.56 -116.71 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.066 1.136 . . . . 4.4100000000000001 114.066 -174.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.603 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 148.2 -55.5 0.5 Allowed Glycine 0 CA--C 1.547 2.086 0 C-N-CA 129.122 3.248 . . . . 3.1499999999999999 112.174 -171.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -97.95 -10.34 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.315 2.676 . . . . 3.77 116.714 -166.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 -15.4 0.5 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.241 2.312 . . . . 6.0800000000000001 117.241 -162.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 -8.22 32.02 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.738 1.855 . . . . 4.2000000000000002 117.738 166.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -72.69 56.55 0.4 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.527 2.163 . . . . 5.5099999999999998 113.252 170.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.82 110.17 0.27 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 120.717 -1.24 . . . . 3.1200000000000001 115.473 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.7 m170 59.99 -145.2 0.5 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.008 0.923 . . . . 5.1200000000000001 111.804 162.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.35 -28.43 0.54 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.791 1.034 . . . . 2.9100000000000001 113.791 153.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.14 29.16 2.82 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 125.0 1.286 . . . . 1.25 116.286 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 44.8 m-20 -99.2 134.72 41.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.969 1.307 . . . . 1.5600000000000001 110.232 171.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -131.37 152.25 80.19 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.167 1.387 . . . . 3.5 109.763 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.89 155.25 71.58 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.85 3.033 . . . . 1.48 111.418 -171.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.5 m -58.53 131.37 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 123.026 1.393 . . . . 2.1800000000000002 113.08 -166.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.54 87.87 0.67 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.521 1.928 . . . . 4.0 108.137 167.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.94 138.35 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.115 0.966 . . . . 0.93999999999999995 108.796 170.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -118.67 135.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 126.021 1.728 . . . . 2.52 107.111 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 149.11 50.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.773 0.715 . . . . 1.8200000000000001 111.673 175.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -15.22 1.06 Allowed 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 116.198 1.925 . . . . 2.4399999999999999 116.198 -175.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -91.1 -8.92 47.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.391 1.876 . . . . 2.8700000000000001 113.118 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 21.39 16.16 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 124.567 1.079 . . . . 1.1000000000000001 114.782 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.2 mp -125.12 126.52 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.592 1.557 . . . . 2.3999999999999999 107.582 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.87 112.68 22.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.397 -0.964 . . . . 0.73999999999999999 108.397 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.0 t -131.79 -2.92 3.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.65 1.58 . . . . 1.46 112.715 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -72.64 115.08 36.01 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 128.041 2.537 . . . . 4.9699999999999998 111.078 -173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.54 138.33 24.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.73 2.287 . . . . 1.22 110.965 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.88 165.17 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.857 1.263 . . . . 1.7 109.916 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.3 m -133.53 139.07 46.39 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.363 0.665 . . . . 1.4099999999999999 109.77 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.3 87.03 15.47 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.785 0.834 . . . . 1.0900000000000001 112.424 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 5.38 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.279 3.32 . . . . 1.46 115.31 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -77.36 -31.73 54.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.705 1.139 . . . . 6.0599999999999996 111.246 170.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.91 127.44 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.909 1.684 . . . . 3.79 107.948 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 1.74 10.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.947 1.091 . . . . 5.8200000000000003 113.947 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -154.08 165.69 35.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.077 1.751 . . . . 2.7400000000000002 112.208 158.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.534 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.4 mm? -64.17 -29.95 71.03 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.405 -0.81 . . . . 2.5099999999999998 111.081 162.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.12 -46.65 5.91 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.048 2.139 . . . . 2.9900000000000002 114.383 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -76.59 -2.54 33.05 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.728 1.381 . . . . 3.1600000000000001 114.728 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.08 13.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.087 1.355 . . . . 1.1899999999999999 112.096 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -57.6 -16.56 10.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.083 1.753 . . . . 2.6400000000000001 115.387 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.85 5.03 18.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 130.0 3.32 . . . . 4.7699999999999996 113.508 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.02 173.26 7.0 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.051 1.871 . . . . 2.1499999999999999 116.051 -158.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.77 144.13 33.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.15 1.38 . . . . 0.78000000000000003 111.63 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.05 131.8 52.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.761 1.624 . . . . 2.2200000000000002 107.581 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.1 mtt -132.79 124.27 27.73 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.24 0.83 . . . . 1.6899999999999999 113.24 -170.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.26 114.87 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.842 1.257 . . . . 1.04 108.43 171.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -99.31 147.36 25.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.48 1.912 . . . . 3.5699999999999998 112.29 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.74 -50.42 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.816 -0.611 . . . . 1.76 110.05 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.23 152.64 47.07 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.76 -0.536 . . . . 2.5699999999999998 111.76 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.61 -163.88 21.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.725 2.107 . . . . 2.4100000000000001 114.022 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -155.88 98.72 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.282 1.033 . . . . 3.2000000000000002 110.32 -170.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -176.83 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.103 1.761 . . . . 3.3199999999999998 113.908 -167.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.3 ptp -127.97 76.68 1.7 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.555 -1.341 . . . . 4.0599999999999996 113.264 -146.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 p -72.2 109.88 6.27 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.747 -1.22 . . . . 4.79 112.18 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 97.2 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 129.961 3.304 . . . . 3.8300000000000001 112.834 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.49 144.37 10.32 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.174 0.989 . . . . 7.5 112.073 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.64 -52.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.876 3.051 . . . . 2.5800000000000001 110.929 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -67.82 115.93 32.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.977 -1.12 . . . . 4.6399999999999997 107.977 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.79 164.77 34.65 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.886 2.391 . . . . 4.0300000000000002 113.29 -160.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.9 tp 71.13 -13.22 0.53 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.939 2.096 . . . . 5.79 115.244 164.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 125.26 -2.19 8.3 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.309 1.909 . . . . 4.79 115.014 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.31 -25.6 0.87 Allowed Glycine 0 CA--C 1.54 1.61 0 N-CA-C 117.249 1.66 . . . . 2.6099999999999999 117.249 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -112.11 60.21 0.34 Allowed Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.322 1.915 . . . . 2.8500000000000001 112.168 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.4 -1.89 88.91 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.497 1.523 . . . . 2.8100000000000001 114.797 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -63.11 146.8 52.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.524 1.162 . . . . 2.79 109.771 166.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -106.11 153.28 22.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.585 1.154 . . . . 5.21 110.025 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -98.2 -21.88 16.47 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.138 -0.458 . . . . 3.9700000000000002 111.974 155.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.81 161.87 36.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.588 1.329 . . . . 0.64000000000000001 114.588 174.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.0 t -142.42 152.09 42.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.256 2.222 . . . . 1.3 109.798 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.26 133.82 4.28 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.794 1.188 . . . . 1.1200000000000001 111.666 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 67.7 t -92.11 132.03 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.167 0.987 . . . . 2.3300000000000001 109.467 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -71.04 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.52 1.128 . . . . 1.1299999999999999 110.129 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt . . . . . 0 C--O 1.239 0.524 0 O-C-N 121.221 -0.925 . . . . 4.25 109.03 179.011 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.057 -0.72 . . . . 2.4300000000000002 109.057 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.3 154.9 43.53 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.183 1.179 . . . . 1.4099999999999999 114.183 -148.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -153.31 135.82 15.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.178 1.466 . . . . 3.6699999999999999 111.699 161.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -89.43 111.27 22.11 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.368 1.867 . . . . 3.9399999999999999 109.981 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.84 129.19 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 118.49 0.587 . . . . 1.5600000000000001 110.306 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.71 112.55 3.52 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.184 1.373 . . . . 1.0 110.295 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.8 mtp -91.35 85.53 5.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.464 0.65 . . . . 1.8799999999999999 110.61 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -68.36 139.77 55.85 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.979 0.912 . . . . 2.7799999999999998 111.969 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.31 135.09 55.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.296 -0.631 . . . . 1.3400000000000001 109.296 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.1 156.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.689 1.196 . . . . 1.3500000000000001 110.378 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 t -169.52 48.04 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.027 0.931 . . . . 2.2200000000000002 112.058 -169.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.22 -17.38 0.27 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.303 1.841 . . . . 1.78 115.181 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.37 -4.37 59.14 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.111 1.364 . . . . 2.77 112.035 171.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -159.11 14.91 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.8 1.667 . . . . 1.3300000000000001 112.331 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.6 t -67.17 128.2 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.577 1.551 . . . . 2.0899999999999999 111.07 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.49 -88.57 1.69 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.058 1.313 . . . . 1.4299999999999999 112.726 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.37 161.46 9.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.661 2.385 . . . . 2.8799999999999999 108.112 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 t -112.56 143.03 44.41 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.734 -1.229 . . . . 2.23 114.128 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.6 mm -108.5 37.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.579 1.552 . . . . 6.7300000000000004 110.937 167.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.32 -154.15 25.3 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.661 -0.649 . . . . 1.1799999999999999 113.738 161.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.43 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 10.4 p -140.06 179.53 6.57 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.009 1.324 . . . . 1.22 109.368 171.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.57 135.39 62.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.785 -1.191 . . . . 0.65000000000000002 107.785 160.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.39 127.27 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.348 0.405 . . . . 1.53 110.697 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.12 134.4 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.737 0.815 . . . . 2.0099999999999998 109.013 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -138.46 134.83 34.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.716 1.606 . . . . 2.0099999999999998 108.45 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 157.87 18.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.935 1.087 . . . . 3.54 113.935 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 t -152.26 173.78 14.59 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.668 1.187 . . . . 1.6799999999999999 108.427 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.38 -13.13 62.01 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.286 -0.884 . . . . 4.7400000000000002 112.058 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.41 18.53 57.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.885 1.707 . . . . 1.51 113.96 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 -143.02 21.17 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 127.692 2.568 . . . . 1.01 116.882 166.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.67 103.35 14.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.761 0.824 . . . . 0.81000000000000005 111.519 -162.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -80.38 110.61 15.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.183 1.793 . . . . 3.0699999999999998 110.286 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -99.52 119.63 38.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.649 2.779 . . . . 0.85999999999999999 109.188 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.6 m -129.41 110.45 17.79 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 119.858 1.208 . . . . 0.93999999999999995 108.538 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -85.4 166.65 10.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.451 2.767 . . . . 0.51000000000000001 111.426 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 3.7 p80 -152.36 18.26 0.64 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.258 1.207 . . . . 2.27 114.258 174.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.16 143.29 32.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.626 -1.296 . . . . 2.3700000000000001 111.324 -174.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 12.26 24.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.298 1.592 . . . . 3.8100000000000001 115.298 -171.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.31 72.17 1.24 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.884 -1.053 . . . . 1.6499999999999999 112.101 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.05 162.97 49.37 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 124.02 0.928 . . . . 2.2599999999999998 112.561 168.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.77 126.9 19.17 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.167 1.245 . . . . 1.49 111.243 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -88.56 33.98 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 125.938 4.425 . . . . 1.3999999999999999 113.285 -147.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.1 -133.09 6.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 123.48 1.6 . . . . 1.24 113.247 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -124.16 135.83 53.77 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.576 1.55 . . . . 2.7599999999999998 109.387 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.37 149.39 52.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.641 1.719 . . . . 1.6599999999999999 115.641 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 138.7 49.26 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 110.19 -1.164 . . . . 0.89000000000000001 110.19 160.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.16 107.26 6.03 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 105.738 -1.949 . . . . 3.4100000000000001 105.738 168.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -118.55 166.16 13.05 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.248 1.573 . . . . 1.8300000000000001 115.248 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.0 mt -96.17 139.87 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.565 1.946 . . . . 0.93000000000000005 109.026 162.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -137.68 152.51 49.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.795 2.438 . . . . 2.7000000000000002 110.42 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.89 -10.87 59.45 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 117.633 2.457 . . . . 1.3100000000000001 117.633 -157.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.73 135.24 36.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.935 1.698 . . . . 1.4399999999999999 112.434 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 59.53 4.35 Favored Glycine 0 N--CA 1.471 0.982 0 C-N-CA 125.572 1.558 . . . . 1.26 114.119 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.68 116.37 4.14 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.787 1.294 . . . . 3.6299999999999999 114.073 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.3 m -89.7 9.38 27.31 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.822 2.049 . . . . 1.3 113.474 -175.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -68.92 129.25 92.44 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.641 1.577 . . . . 3.5 111.855 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -97.7 166.73 0.82 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.652 3.568 . . . . 1.3200000000000001 113.513 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.96 169.62 8.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 2.6099999999999999 111.91 162.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mm -119.68 117.71 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.19 1.396 . . . . 3.4399999999999999 109.747 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -152.75 157.42 40.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.173 1.389 . . . . 5.4900000000000002 111.466 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.29 27.41 9.81 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 115.788 1.773 . . . . 3.6200000000000001 115.788 156.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.21 20.12 65.42 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.865 -1.147 . . . . 3.6099999999999999 115.023 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -160.76 -172.35 3.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.798 1.639 . . . . 3.2000000000000002 111.634 -169.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.22 139.82 35.7 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.9 -1.125 . . . . 1.8500000000000001 110.533 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.97 43.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.574 1.15 . . . . 2.52 112.431 -159.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.15 -65.97 0.06 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 129.007 2.923 . . . . 1.8700000000000001 116.053 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 176.48 95.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 1 C-N-CA 132.267 4.227 . . . . 1.6200000000000001 105.457 -175.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.85 -38.31 9.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.494 1.917 . . . . 4.7800000000000002 112.449 -158.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.76 31.73 0.09 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.324 1.449 . . . . 1.3300000000000001 114.26 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.13 -11.78 21.1 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.088 1.755 . . . . 1.9199999999999999 115.299 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 20.93 44.99 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.724 1.449 . . . . 3.7000000000000002 116.724 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.84 -99.94 1.81 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.231 1.516 . . . . 2.5 111.829 174.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -118.68 -117.79 0.32 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.445 1.898 . . . . 4.1100000000000003 106.981 164.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.1 tt -174.41 92.73 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.011 2.125 . . . . 3.46 107.794 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 173.26 146.7 0.2 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 127.917 2.487 . . . . 3.6000000000000001 111.826 -162.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.96 -38.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.258 2.639 . . . . 4.0700000000000003 113.877 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.23 26.0 0.2 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.876 1.216 . . . . 4.5499999999999998 113.736 -174.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.83 19.18 0.41 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.444 -1.41 . . . . 3.3599999999999999 114.541 -167.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.69 -30.22 0.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 128.825 2.85 . . . . 3.1499999999999999 114.17 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.18 -11.27 61.04 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.026 -1.43 . . . . 2.6699999999999999 115.83 167.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -61.21 -19.68 61.91 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.795 1.798 . . . . 5.2000000000000002 114.698 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.0 t60 98.9 167.0 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.758 2.823 . . . . 2.0499999999999998 112.269 154.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -65.77 145.74 55.61 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.125 1.157 . . . . 5.1900000000000004 114.125 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.23 -155.42 7.64 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.127 1.822 . . . . 3.9500000000000002 112.15 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.78 -43.04 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.65 2.233 . . . . 4.4100000000000001 111.72 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.03 -3.32 9.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.618 1.567 . . . . 5.8799999999999999 112.869 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.29 167.07 22.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.871 1.7 . . . . 5.1900000000000004 114.553 -170.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -158.03 177.38 11.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.372 1.869 . . . . 8.6699999999999999 108.931 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.76 -20.81 0.02 OUTLIER Glycine 0 N--CA 1.465 0.594 0 CA-C-O 118.114 -1.381 . . . . 2.6000000000000001 115.946 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.964 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 7.0 p-80 -159.87 153.97 23.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.563 1.681 . . . . 6.7300000000000004 113.246 169.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.93 -18.89 63.4 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.236 -0.915 . . . . 3.1299999999999999 113.318 -175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.42 5.75 83.75 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.46 1.505 . . . . 1.05 114.587 172.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.964 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 12.8 m-20 -65.12 133.32 51.33 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 119.551 1.675 . . . . 2.3500000000000001 107.742 160.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.29 159.8 36.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.722 1.209 . . . . 2.7400000000000002 110.148 -153.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.21 154.18 56.76 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.558 2.839 . . . . 1.05 111.652 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 m -73.95 137.2 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 122.972 1.367 . . . . 2.02 114.046 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.2 98.54 4.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.965 2.506 . . . . 2.9900000000000002 110.191 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.8 t -72.74 131.64 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.639 0.776 . . . . 1.0900000000000001 110.143 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.48 138.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.722 2.409 . . . . 2.8700000000000001 106.308 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 154.47 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.178 -0.951 . . . . 2.29 111.514 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -12.31 0.23 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 116.987 2.217 . . . . 2.3399999999999999 116.987 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.85 -21.58 26.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.13 2.172 . . . . 2.9399999999999999 113.098 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.62 9.52 23.03 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.327 1.441 . . . . 0.76000000000000001 115.251 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mt -116.35 135.91 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.104 1.362 . . . . 1.52 110.207 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.22 128.41 54.69 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.919 0.888 . . . . 0.93999999999999995 110.801 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -145.37 14.12 1.42 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.512 1.301 . . . . 1.6000000000000001 114.512 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -86.74 118.72 70.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.276 1.03 . . . . 2.9700000000000002 111.159 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.07 133.11 16.1 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.134 3.223 . . . . 1.3500000000000001 112.185 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.03 168.37 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 126.543 1.937 . . . . 1.9299999999999999 110.5 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.7 m -140.63 143.57 35.27 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.704 1.138 . . . . 1.29 112.052 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.46 99.36 51.16 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.978 1.311 . . . . 0.73999999999999999 113.123 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.53 18.59 0.94 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 125.201 3.934 . . . . 1.0700000000000001 114.873 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -73.05 -35.1 66.65 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.3 -0.875 . . . . 5.7999999999999998 111.634 171.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.35 165.12 11.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.287 2.235 . . . . 3.3300000000000001 109.133 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.08 2.64 3.64 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.994 1.109 . . . . 4.8700000000000001 113.994 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.7 p -152.14 166.91 30.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.204 1.802 . . . . 2.8399999999999999 110.438 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.7 tp -85.42 -44.62 12.6 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.458 -0.776 . . . . 2.4500000000000002 111.058 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.27 -23.81 62.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.212 1.405 . . . . 4.4500000000000002 113.853 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -12.32 60.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.842 1.053 . . . . 2.9199999999999999 113.842 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.93 15.86 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.931 1.292 . . . . 1.4199999999999999 113.29 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -51.15 -18.5 0.89 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 117.104 2.261 . . . . 3.7400000000000002 117.104 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -121.92 11.47 10.34 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.586 1.955 . . . . 4.4100000000000001 113.595 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -102.73 169.87 8.35 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.324 1.231 . . . . 2.5899999999999999 114.324 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.62 44.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.646 0.779 . . . . 1.0800000000000001 111.285 173.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.91 133.95 34.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.313 -1.736 . . . . 2.4100000000000001 106.313 156.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.12 131.16 34.4 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.539 1.063 . . . . 1.9399999999999999 112.171 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.93 114.35 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 107.074 -1.454 . . . . 1.1000000000000001 107.074 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -87.0 146.89 25.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.544 1.137 . . . . 3.8999999999999999 111.449 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.0 t -68.25 -37.61 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.193 0.597 . . . . 2.0899999999999999 110.474 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.39 -163.32 6.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.064 0.84 . . . . 2.5600000000000001 113.676 172.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.82 -146.32 10.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 127.466 2.46 . . . . 3.0699999999999998 109.298 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -157.11 149.54 23.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.702 0.801 . . . . 3.5600000000000001 110.967 161.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 56.3 t30 110.01 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 1 C-N-CA 131.703 4.001 . . . . 4.3200000000000003 109.453 -161.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.6 ptp -165.05 69.26 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 123.062 1.41 . . . . 4.1100000000000003 111.52 -162.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.6 p -97.76 0.09 46.27 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.253 2.221 . . . . 3.4399999999999999 115.357 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -164.05 63.95 0.15 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.753 -1.217 . . . . 3.3500000000000001 112.428 -163.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -130.31 149.78 74.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.072 1.349 . . . . 4.4000000000000004 108.466 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.19 -35.68 84.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.402 2.735 . . . . 2.3799999999999999 112.437 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -94.56 113.76 61.81 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.717 -1.216 . . . . 8.0399999999999991 107.717 148.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.2 163.15 38.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.921 2.414 . . . . 4.5800000000000001 111.104 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt 60.71 28.47 18.19 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.733 0.813 . . . . 5.1399999999999997 110.435 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.86 3.14 7.47 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.413 1.483 . . . . 2.77 115.154 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.74 87.5 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 118.919 1.359 . . . . 2.73 114.052 -166.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.39 33.23 4.17 Favored Glycine 0 N--CA 1.474 1.189 0 C-N-CA 125.707 1.622 . . . . 2.2000000000000002 114.594 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.19 -4.42 90.49 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.052 1.786 . . . . 2.2400000000000002 115.039 -174.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 p -65.12 152.56 43.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.003 1.401 . . . . 2.6200000000000001 110.752 165.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.35 132.48 54.08 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.486 1.114 . . . . 6.5199999999999996 109.103 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -74.65 -33.44 62.52 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.69 0.677 . . . . 3.79 110.307 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.18 145.13 29.4 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.898 1.444 . . . . 0.78000000000000003 114.898 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.5 t -68.69 -174.02 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 129.165 2.986 . . . . 2.6099999999999999 111.548 164.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 164.54 62.06 0.02 OUTLIER Glycine 0 N--CA 1.465 0.626 0 C-N-CA 125.241 1.4 . . . . 1.77 112.99 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.9 p -61.69 125.87 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.53 0.732 . . . . 3.6200000000000001 110.844 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.32 132.09 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.728 0.811 . . . . 1.1599999999999999 108.816 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 CA--C 1.539 0.551 0 O-C-N 121.223 -0.923 . . . . 4.5700000000000003 110.831 176.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.994 -0.373 . . . . 2.71 109.994 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -163.22 144.2 9.41 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.751 1.159 . . . . 1.8100000000000001 108.32 -169.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -149.0 130.25 14.6 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.978 1.37 . . . . 3.3999999999999999 111.118 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -80.99 106.99 13.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.842 1.657 . . . . 4.2400000000000002 109.407 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.19 122.09 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.605 0.639 . . . . 1.5 111.025 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.91 104.91 1.63 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.059 1.79 . . . . 0.70999999999999996 111.954 170.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.6 mmm -88.8 132.93 34.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.412 1.485 . . . . 3.1800000000000002 111.359 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -106.53 145.42 31.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.642 1.177 . . . . 2.2799999999999998 110.934 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 mt -61.11 142.42 56.7 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.549 1.14 . . . . 1.2 110.003 169.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.13 163.8 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.094 0.957 . . . . 1.8100000000000001 110.738 175.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t 177.29 69.52 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.253 2.221 . . . . 2.71 110.763 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 67.02 -29.89 0.15 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.372 2.269 . . . . 1.98 115.932 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -17.35 64.86 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.666 1.586 . . . . 3.5699999999999998 111.346 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.72 -160.53 17.18 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.368 1.937 . . . . 1.6699999999999999 111.35 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.23 128.89 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.552 1.141 . . . . 1.5600000000000001 109.74 169.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.81 -95.18 1.14 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 125.686 1.612 . . . . 1.5 113.26 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.58 166.18 34.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.217 1.407 . . . . 2.1000000000000001 110.8 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 t -93.13 151.32 19.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.421 1.488 . . . . 2.0499999999999998 114.341 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 15.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 127.192 2.197 . . . . 4.1299999999999999 113.587 -173.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.49 175.89 15.39 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.441 1.02 . . . . 0.73999999999999999 112.246 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.5 p -122.16 173.6 7.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.384 1.074 . . . . 1.25 109.273 173.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.16 132.18 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.489 -1.301 . . . . 0.70999999999999996 107.489 162.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -86.35 124.84 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.774 0.321 . . . . 1.7 110.591 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.95 128.48 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.768 -1.197 . . . . 1.75 107.768 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -137.74 112.64 9.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.518 1.151 . . . . 2.3500000000000001 110.483 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -70.31 111.44 5.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.437 2.295 . . . . 3.2200000000000002 112.064 -167.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 159.73 15.35 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.084 -1.08 . . . . 3.4199999999999999 108.084 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.93 -19.34 64.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.471 0.708 . . . . 4.4800000000000004 111.868 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.83 30.8 9.66 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.012 1.768 . . . . 2.1000000000000001 113.959 165.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.37 -135.31 9.84 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 119.921 2.728 . . . . 2.04 119.921 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.38 113.27 21.15 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.955 1.302 . . . . 0.92000000000000004 110.147 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.77 109.42 15.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.164 0.986 . . . . 2.6499999999999999 109.733 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t80 -92.05 121.08 33.27 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.19 1.796 . . . . 1.03 108.492 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.5 m -128.36 113.54 19.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 119.29 0.95 . . . . 1.3600000000000001 108.694 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.15 157.12 13.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.491 2.794 . . . . 0.76000000000000001 110.98 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.27 40.86 0.42 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.561 1.172 . . . . 2.8900000000000001 111.613 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -101.39 140.46 35.66 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.48 1.512 . . . . 0.84999999999999998 112.314 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 31.37 6.74 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.394 1.628 . . . . 2.0600000000000001 115.394 -167.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.27 65.17 0.69 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.075 0.95 . . . . 1.3999999999999999 111.972 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.86 157.58 32.55 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 113.896 1.073 . . . . 2.21 113.896 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.05 139.24 13.4 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 O-C-N 123.555 1.292 . . . . 1.71 112.083 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -77.97 31.14 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.867 1 C-N-CA 128.948 6.432 . . . . 2.1200000000000001 114.164 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.77 -135.96 6.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-O 123.58 1.655 . . . . 1.47 110.195 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -136.3 133.57 37.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.717 1.607 . . . . 2.8100000000000001 107.949 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -127.36 137.57 52.8 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.688 1.195 . . . . 1.3 109.58 -169.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 156.15 49.21 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 119.664 1.12 . . . . 0.70999999999999996 111.743 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.6 t80 -129.42 118.87 22.87 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.322 -1.362 . . . . 3.2000000000000002 107.322 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.464 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 8.8 m80 -118.09 157.69 26.41 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.427 2.01 . . . . 1.05 116.427 163.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -98.54 142.05 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.375 1.47 . . . . 0.90000000000000002 108.488 158.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -128.38 141.82 51.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.508 1.923 . . . . 1.1599999999999999 110.256 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.82 70.79 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.819 2.155 . . . . 0.84999999999999998 116.819 -158.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -120.63 154.48 35.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.194 1.398 . . . . 1.6200000000000001 111.746 171.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.43 84.17 1.58 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 120.844 -1.16 . . . . 1.23 113.301 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 t -166.76 95.71 0.52 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.745 1.017 . . . . 2.6400000000000001 113.745 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 16.0 m -62.31 10.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.001 1.852 . . . . 1.48 116.001 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -87.6 129.33 51.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 119.953 -1.717 . . . . 3.5099999999999998 110.031 -166.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.1 155.14 33.35 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.387 2.058 . . . . 1.5800000000000001 110.618 166.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.24 145.32 51.45 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.684 -0.635 . . . . 1.8999999999999999 110.218 158.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 mm -96.75 123.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.968 1.307 . . . . 3.8399999999999999 108.561 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -169.47 157.82 7.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.244 1.418 . . . . 6.0599999999999996 111.775 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.78 27.34 14.62 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.251 1.021 . . . . 4.5199999999999996 112.317 167.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.11 84.64 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 126.381 1.943 . . . . 3.8500000000000001 114.914 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.59 -152.64 0.41 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.451 1.501 . . . . 4.6299999999999999 109.902 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.04 146.02 21.32 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.161 -0.962 . . . . 2.1400000000000001 113.042 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.69 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.563 1.545 . . . . 2.3100000000000001 113.16 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 67.81 -61.23 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 127.969 2.508 . . . . 2.3500000000000001 116.584 168.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 166.35 99.83 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 C-N-CA 132.536 4.335 . . . . 1.8600000000000001 106.583 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -123.52 -45.97 2.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 3.6600000000000001 113.162 -157.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.07 -19.58 20.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.043 1.337 . . . . 1.48 113.391 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.13 -12.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.146 2.578 . . . . 0.94999999999999996 114.809 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.38 16.8 58.32 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.333 1.424 . . . . 3.21 115.022 163.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.17 -173.98 41.75 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.246 1.023 . . . . 2.1200000000000001 112.339 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -63.49 141.29 58.82 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.737 -0.861 . . . . 2.27 109.937 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.31 111.8 3.18 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.129 -0.357 . . . . 2.5099999999999998 110.248 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.5 t0 169.7 126.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 128.762 2.825 . . . . 5.6600000000000001 111.645 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.04 -36.51 1.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.104 1.869 . . . . 2.4500000000000002 113.65 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -165.57 8.41 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.804 2.52 . . . . 5.04 117.804 -156.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.99 -27.08 65.06 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.815 2.098 . . . . 4.8700000000000001 114.616 -170.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 165.89 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.967 3.307 . . . . 4.3899999999999997 110.832 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.74 -18.51 38.6 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.863 1.221 . . . . 3.02 114.63 169.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -69.87 -7.73 42.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.558 1.688 . . . . 8.3499999999999996 115.558 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.513 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 76.9 t60 68.56 157.13 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.825 2.45 . . . . 1.8600000000000001 112.774 -172.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 84' ' ' GLY . 2.6 pp20? -140.41 -136.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.586 0.755 . . . . 4.4900000000000002 112.315 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.517 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 144.33 -46.02 0.83 Allowed Glycine 0 CA--C 1.538 1.518 0 C-N-CA 130.401 3.857 . . . . 4.0300000000000002 110.483 -172.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -108.02 -10.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.663 2.909 . . . . 4.0999999999999996 115.633 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -139.26 -3.19 1.57 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.453 2.019 . . . . 5.2400000000000002 116.453 -159.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.1 -31.04 1.57 Allowed Glycine 0 N--CA 1.472 1.09 0 O-C-N 120.45 -1.406 . . . . 5.71 114.874 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -72.77 71.65 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.444 1.498 . . . . 5.7300000000000004 112.213 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.19 -91.61 0.09 OUTLIER Glycine 0 CA--C 1.523 0.579 0 C-N-CA 125.322 1.439 . . . . 2.6099999999999999 111.584 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -133.83 151.17 51.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.012 1.725 . . . . 4.6200000000000001 109.603 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.49 -28.71 68.79 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.219 0.918 . . . . 2.7999999999999998 113.169 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.15 16.37 55.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.863 1.697 . . . . 0.91000000000000003 115.357 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.513 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 89.1 m-20 -89.96 122.38 32.93 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.941 1.371 . . . . 2.21 109.867 168.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.43 158.93 41.91 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.527 1.531 . . . . 2.5800000000000001 109.795 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.97 171.42 18.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.429 2.753 . . . . 2.0499999999999998 111.759 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.42 131.71 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.7 1.37 . . . . 2.02 114.7 -163.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.65 94.52 0.59 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.221 2.608 . . . . 2.6699999999999999 108.307 164.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.22 140.15 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.969 0.908 . . . . 1.03 109.672 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.18 131.8 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.71 1.204 . . . . 2.7599999999999998 108.866 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.0 140.04 40.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.763 0.792 . . . . 2.1800000000000002 111.793 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.23 60.46 0.43 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.715 2.006 . . . . 4.6299999999999999 113.509 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.51 6.93 0.29 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.432 2.293 . . . . 3.9199999999999999 112.314 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.53 3.94 43.46 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 126.297 1.904 . . . . 2.29 115.406 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.65 132.21 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.301 1.05 . . . . 2.23 110.291 -167.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 126.51 33.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.837 -0.539 . . . . 0.80000000000000004 110.089 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 t -141.39 -0.95 1.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.715 1.376 . . . . 1.6499999999999999 114.715 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -87.26 123.29 70.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.955 1.302 . . . . 3.1600000000000001 110.895 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.93 149.45 42.16 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.037 3.158 . . . . 1.6100000000000001 112.466 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.93 158.05 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.812 1.245 . . . . 1.74 109.691 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.4 m -112.86 143.61 43.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.45 0.7 . . . . 1.53 109.157 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.36 84.37 0.73 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.64 1.576 . . . . 1.1200000000000001 110.671 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.89 1.54 7.56 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.845 3.03 . . . . 1.6000000000000001 113.707 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.445 HH11 ' HG3' ' A' ' 113' ' ' ARG . 6.5 ttm-85 -76.92 -25.12 52.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.037 0.935 . . . . 6.1200000000000001 112.404 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.09 178.86 4.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.691 1.996 . . . . 3.75 109.607 165.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -16.81 2.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.552 1.316 . . . . 4.8499999999999996 114.552 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -154.84 166.55 33.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.103 1.32 . . . . 2.46 112.734 -169.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.65 -29.44 16.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.866 0.866 . . . . 3.6699999999999999 111.244 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -28.98 70.14 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.86 -1.15 . . . . 3.3500000000000001 113.247 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.6 -17.47 63.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.471 0.708 . . . . 2.5800000000000001 112.89 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.73 13.91 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.485 0.92 . . . . 0.94999999999999996 113.485 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -59.68 -21.34 60.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.141 1.534 . . . . 3.27 115.141 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -134.03 105.54 6.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.561 1.544 . . . . 3.5099999999999998 107.983 160.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -158.84 163.32 36.75 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.969 2.908 . . . . 2.3500000000000001 109.329 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.62 158.45 16.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.493 0.663 . . . . 0.94999999999999996 110.676 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -130.69 117.0 18.81 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.295 2.238 . . . . 2.2200000000000002 106.876 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.8 mtt -117.67 122.01 42.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.731 0.696 . . . . 1.8700000000000001 111.172 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.97 115.93 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.909 -1.515 . . . . 1.03 106.909 166.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -98.58 151.12 21.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.298 1.839 . . . . 3.21 112.267 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.3 m -63.17 -29.52 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 114.641 1.349 . . . . 3.8799999999999999 114.641 -160.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.17 168.28 24.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.457 1.503 . . . . 1.72 110.852 167.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.58 136.82 22.22 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.082 1.801 . . . . 1.49 114.08 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.464 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -101.02 114.84 29.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.801 1.64 . . . . 3.5499999999999998 109.932 -178.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -167.47 36.18 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.177 0.991 . . . . 3.7200000000000002 112.514 -172.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.6 mtm -140.48 110.51 6.54 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.339 1.056 . . . . 2.8599999999999999 112.985 -165.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.7 m -93.08 156.78 16.66 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 3.3500000000000001 111.971 168.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.06 32.45 2.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.061 2.144 . . . . 6.1399999999999997 116.12 165.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -115.86 146.51 37.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.113 1.365 . . . . 3.73 110.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.1 17.77 0.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.54 3.493 . . . . 3.3500000000000001 114.069 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -98.53 113.38 64.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 121.107 -0.996 . . . . 8.5099999999999998 108.884 173.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.58 153.66 73.62 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.158 2.572 . . . . 6.1500000000000004 113.781 -156.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 tp 72.68 -1.14 3.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.66 1.984 . . . . 5.79 113.721 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 82' ' ' HIS . . . 106.26 38.11 2.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.137 1.351 . . . . 6.4100000000000001 113.224 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.02 -41.15 2.95 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.22 1.391 . . . . 5.1699999999999999 113.556 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.07 -19.48 65.95 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 118.389 1.095 . . . . 3.6099999999999999 115.407 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 46.53 -110.69 0.55 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.65 1.595 . . . . 3.3599999999999999 115.457 161.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 m -69.17 151.77 45.94 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.318 1.447 . . . . 3.6899999999999999 111.126 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.95 132.15 45.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.566 1.547 . . . . 5.5999999999999996 108.238 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -83.11 -42.8 16.96 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 120.092 1.314 . . . . 4.4100000000000001 110.373 169.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.03 151.82 33.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.053 0.941 . . . . 0.60999999999999999 112.645 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.0 t -127.36 148.37 50.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.873 2.069 . . . . 1.3999999999999999 111.09 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -145.44 155.67 26.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.592 2.52 . . . . 1.23 111.701 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.46 1.104 . . . . 2.1800000000000002 111.442 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.47 149.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.342 1.857 . . . . 2.4700000000000002 110.145 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.796 0 O-C-N 120.051 -1.655 . . . . 5.7400000000000002 110.938 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.244 0.068 . . . . 2.1000000000000001 110.948 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.5 148.16 22.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 1.8 109.201 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -151.15 127.2 10.44 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 123.191 1.472 . . . . 2.3799999999999999 110.943 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -105.19 97.36 7.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.019 1.728 . . . . 4.0700000000000003 111.663 -167.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.52 131.17 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 115.17 1.544 . . . . 3.4399999999999999 115.17 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.6 103.01 1.19 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.499 1.047 . . . . 1.01 110.79 167.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.5 mtp -85.34 131.16 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.503 0.721 . . . . 2.1400000000000001 110.406 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -110.7 145.38 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.115 1.366 . . . . 3.2000000000000002 113.108 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.4 mt -77.93 62.5 2.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.153 1.381 . . . . 1.7 111.673 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 m -55.07 130.79 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.246 1.418 . . . . 1.5900000000000001 112.02 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -158.63 72.18 0.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.007 1.484 . . . . 2.6400000000000001 115.007 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.51 -40.46 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.744 2.418 . . . . 1.6100000000000001 113.767 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.96 6.46 4.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.552 1.541 . . . . 3.1099999999999999 111.546 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.89 -159.14 31.24 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 126.079 1.8 . . . . 1.21 112.769 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -42.11 126.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.405 1.482 . . . . 1.3700000000000001 110.725 159.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.27 -60.26 0.26 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.067 1.318 . . . . 1.97 114.429 -170.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -174.79 160.2 2.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.499 1.92 . . . . 3.27 110.738 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -152.69 148.64 27.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.163 1.542 . . . . 2.8500000000000001 115.163 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.62 56.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 130.149 3.38 . . . . 7.7000000000000002 108.838 173.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.48 -177.94 39.92 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 113.226 -1.806 . . . . 0.67000000000000004 114.316 146.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.493 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 11.3 p -115.61 177.74 4.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.633 1.173 . . . . 1.01 110.928 171.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.04 133.31 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.336 -0.987 . . . . 0.56000000000000005 108.336 156.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.3 p -87.49 119.49 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.65 0.593 . . . . 1.5900000000000001 110.337 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.15 117.73 47.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.191 -1.411 . . . . 1.9099999999999999 107.191 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -119.76 125.35 48.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.288 1.435 . . . . 2.3999999999999999 108.563 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.22 130.99 34.34 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.371 -0.603 . . . . 3.3399999999999999 109.371 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.6 t -148.86 -179.62 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.166 0.439 . . . . 1.6000000000000001 110.378 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.22 -4.27 40.95 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.918 1.081 . . . . 3.71 113.918 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.3 9.57 67.28 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 124.159 0.885 . . . . 1.25 114.18 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.1 -146.47 21.97 Favored Glycine 0 N--CA 1.463 0.448 0 C-N-CA 128.417 2.913 . . . . 1.0 115.536 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.9 104.65 7.51 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.3 0.64 . . . . 0.87 111.107 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -84.6 115.18 22.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.791 2.036 . . . . 4.7400000000000002 109.988 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.26 104.65 14.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.776 1.63 . . . . 1.03 109.58 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.0 m -110.27 109.21 58.69 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.519 1.054 . . . . 1.04 108.346 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.1 159.36 18.0 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.586 2.858 . . . . 0.71999999999999997 111.127 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.493 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.2 p80 -146.41 27.23 1.14 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 121.418 0.628 . . . . 1.6200000000000001 112.479 170.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.85 140.86 30.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.805 -1.184 . . . . 0.95999999999999996 111.308 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 26.69 8.01 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.452 1.649 . . . . 2.21 115.452 -170.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.18 81.14 1.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.717 0.807 . . . . 1.55 110.933 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.72 163.36 41.29 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.839 1.256 . . . . 2.2200000000000002 110.407 168.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.29 128.97 24.02 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 121.006 1.137 . . . . 0.85999999999999999 110.619 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -79.8 25.23 0.6 Allowed 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 126.563 4.842 . . . . 1.1000000000000001 113.047 -162.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.6 -124.7 1.48 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 126.725 2.107 . . . . 1.3700000000000001 112.571 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -151.28 138.71 19.49 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.77 1.228 . . . . 3.5899999999999999 110.842 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -136.69 142.73 43.15 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.081 0.771 . . . . 1.27 113.081 -163.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.07 153.77 51.63 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 111.28 -0.728 . . . . 0.83999999999999997 111.28 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -131.79 115.54 16.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.49 1.116 . . . . 3.29 108.161 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -115.97 165.67 12.85 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 117.121 2.267 . . . . 1.0800000000000001 117.121 167.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.0 mt -108.05 148.34 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 128.414 2.686 . . . . 0.91000000000000003 108.045 154.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -126.16 163.39 23.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.94 1.296 . . . . 1.3799999999999999 110.425 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.4 75.91 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.586 1.699 . . . . 1.1000000000000001 115.586 -163.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.74 169.08 14.24 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.144 1.378 . . . . 2.1400000000000001 113.144 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.9 93.91 1.53 Allowed Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.005 1.288 . . . . 1.21 113.087 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -151.58 57.05 0.87 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.816 1.413 . . . . 4.4299999999999997 114.816 -165.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.6 m -64.72 37.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 116.505 2.039 . . . . 1.5 116.505 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -137.1 143.66 42.92 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 119.606 -1.934 . . . . 3.77 110.889 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.12 148.77 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.234 2.623 . . . . 1.0700000000000001 113.432 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.3 137.1 40.92 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.489 -0.778 . . . . 1.5700000000000001 109.669 157.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.73 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.993 -1.114 . . . . 3.1800000000000002 107.993 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -147.21 133.66 19.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.15 0.98 . . . . 4.8600000000000003 111.042 -160.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.21 19.22 5.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.181 1.393 . . . . 3.7200000000000002 113.151 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.05 63.15 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.086 1.327 . . . . 2.7999999999999998 115.313 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -137.27 -177.76 4.91 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.685 1.243 . . . . 3.46 111.714 169.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.85 115.59 26.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.186 0.994 . . . . 2.6600000000000001 112.456 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -87.2 79.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.106 1.362 . . . . 2.1699999999999999 110.47 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 19.89 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.33 3.452 . . . . 2.2999999999999998 117.991 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.44 41.64 0.88 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.557 1.943 . . . . 2.04 110.766 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -54.76 -37.19 65.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.144 -0.973 . . . . 4.0300000000000002 113.582 -169.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -4.48 17.98 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.54 1.311 . . . . 2.27 114.54 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.1 -7.45 58.9 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.085 -1.009 . . . . 1.49 113.706 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 -179.35 32.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.807 -1.183 . . . . 2.0499999999999998 113.882 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.26 175.51 50.96 Favored Glycine 0 N--CA 1.474 1.222 0 N-CA-C 110.998 -0.841 . . . . 2.7000000000000002 110.998 161.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.44 36.06 0.19 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.608 1.204 . . . . 2.9399999999999999 113.561 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.5 tp 65.07 78.62 0.28 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.705 2.002 . . . . 2.6600000000000001 112.349 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -156.15 124.68 2.94 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 126.543 1.937 . . . . 5.6200000000000001 111.152 166.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.25 -22.52 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.216 2.611 . . . . 2.6600000000000001 113.838 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -145.7 -31.11 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.255 1.946 . . . . 4.6500000000000004 116.255 -157.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -60.63 -42.33 96.68 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 121.111 1.778 . . . . 4.5700000000000003 111.561 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 179.52 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.909 2.484 . . . . 2.6099999999999999 112.419 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 -15.91 4.18 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.541 -1.349 . . . . 2.54 114.331 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -58.79 -82.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.614 1.965 . . . . 5.5199999999999996 113.39 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.68 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 81.1 t60 153.32 128.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 129.754 3.221 . . . . 1.71 110.479 -174.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -130.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.365 1.066 . . . . 3.71 111.94 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.24 -51.1 0.85 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.498 1.999 . . . . 2.7799999999999998 111.761 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -104.14 -22.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.692 2.261 . . . . 3.3599999999999999 114.877 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -157.25 28.61 0.3 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.302 1.41 . . . . 5.2400000000000002 114.539 -160.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.05 -12.07 5.64 Favored Glycine 0 N--CA 1.477 1.43 0 O-C-N 119.662 -1.899 . . . . 4.9800000000000004 116.425 166.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.89 83.56 3.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.152 1.381 . . . . 4.5800000000000001 112.491 -170.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.51 116.02 4.16 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 124.424 1.012 . . . . 3.0899999999999999 112.806 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.1 m170 90.52 123.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.978 2.511 . . . . 4.0800000000000001 110.973 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.38 -12.51 24.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.005 0.522 . . . . 3.0699999999999998 111.692 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.17 22.56 18.54 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.144 1.354 . . . . 1.1100000000000001 113.985 165.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.68 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 79.3 m-20 -101.26 124.85 47.6 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.374 1.587 . . . . 2.6600000000000001 109.71 164.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.52 164.15 20.7 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.825 1.65 . . . . 2.6400000000000001 109.316 -174.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.11 161.84 35.0 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.121 2.547 . . . . 1.27 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.63 131.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 122.608 1.194 . . . . 2.29 113.696 -165.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.85 86.25 4.09 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.439 2.696 . . . . 2.71 108.814 176.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 142.55 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.583 0.753 . . . . 1.5900000000000001 109.1 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -122.77 150.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.702 2.001 . . . . 2.6800000000000002 107.832 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -94.39 150.88 19.85 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.762 0.652 . . . . 3.25 112.762 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -42.77 -3.47 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 131.616 3.966 . . . . 3.52 118.518 176.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 -16.46 20.85 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 119.625 -1.922 . . . . 2.9399999999999999 112.507 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.9 27.49 7.01 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.718 1.628 . . . . 0.83999999999999997 112.796 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.2 mt -121.89 127.13 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.72 1.208 . . . . 2.0299999999999998 111.172 -171.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.84 123.95 29.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.932 0.893 . . . . 1.3999999999999999 108.926 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -139.0 -15.27 1.14 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.88 2.178 . . . . 3.0499999999999998 116.88 -167.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.48 127.91 74.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 121.413 1.915 . . . . 5.2699999999999996 112.812 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.14 85.69 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.258 3.305 . . . . 1.9099999999999999 110.06 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.01 122.16 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.826 0.851 . . . . 2.0800000000000001 110.045 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -120.03 126.93 52.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.529 0.732 . . . . 1.1799999999999999 110.54 -164.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.45 113.64 45.5 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.39 -0.814 . . . . 1.3100000000000001 112.626 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.79 8.59 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.96 3.107 . . . . 1.3400000000000001 113.447 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -71.78 -22.02 61.64 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.462 -0.774 . . . . 4.96 112.177 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.9 mt -139.52 160.16 40.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 130.155 3.382 . . . . 3.7400000000000002 106.532 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -148.26 10.23 0.87 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.948 2.203 . . . . 7.8499999999999996 116.948 -175.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 p -156.25 157.0 35.05 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.694 -0.629 . . . . 2.6000000000000001 110.934 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.97 -24.15 52.31 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.015 -1.053 . . . . 2.1600000000000001 112.653 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -54.31 -37.4 64.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.236 1.415 . . . . 3.8500000000000001 113.788 -176.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.19 -5.41 49.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.015 2.126 . . . . 2.23 114.256 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 4.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.033 1.333 . . . . 2.6699999999999999 113.135 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -66.07 7.08 0.32 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.832 2.16 . . . . 3.04 116.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.31 14.0 3.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.386 2.274 . . . . 3.54 111.163 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.53 159.0 43.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.136 1.532 . . . . 2.0499999999999998 115.136 -157.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.79 157.29 16.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.212 1.405 . . . . 0.73999999999999999 112.828 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 mt -120.41 136.2 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.533 2.733 . . . . 2.0499999999999998 107.6 173.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -125.94 128.27 47.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.908 0.776 . . . . 2.6299999999999999 112.122 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.08 122.92 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.799 -1.186 . . . . 1.0800000000000001 107.799 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -115.34 141.42 48.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.109 1.763 . . . . 3.1000000000000001 111.918 -160.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.81 -13.82 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 116.041 1.867 . . . . 3.9100000000000001 116.041 -156.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.36 160.32 25.47 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.309 -1.116 . . . . 1.4099999999999999 110.309 162.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.36 121.1 15.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.648 -1.381 . . . . 1.8500000000000001 109.648 163.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.63 1.28 14.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.984 0.914 . . . . 4.4299999999999997 112.945 -158.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -66.2 28.81 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 129.922 3.289 . . . . 3.46 115.867 -172.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.1 mtm -114.22 105.21 12.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.531 1.932 . . . . 3.3900000000000001 110.219 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 p -77.3 14.62 0.9 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.043 2.137 . . . . 3.3500000000000001 113.952 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.72 4.73 0.77 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.787 1.773 . . . . 4.5599999999999996 115.787 -155.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -96.35 143.02 25.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.114 0.965 . . . . 4.54 110.328 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.2 -27.1 29.52 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.735 2.957 . . . . 3.29 113.192 -173.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -87.01 107.74 15.66 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.706 -1.22 . . . . 4.7599999999999998 107.706 148.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.95 175.08 7.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.791 2.327 . . . . 3.6000000000000001 110.925 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 61.16 34.97 18.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.161 0.984 . . . . 3.98 109.175 -170.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.99 5.9 8.57 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.95 1.262 . . . . 3.6299999999999999 115.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.52 63.11 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-N 119.297 1.549 . . . . 2.5600000000000001 113.99 -165.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.15 16.29 59.44 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.967 2.223 . . . . 2.0299999999999998 113.97 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.76 -6.02 62.24 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.311 1.434 . . . . 1.8300000000000001 116.574 -170.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.3 m -66.98 162.53 21.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.369 1.585 . . . . 3.3799999999999999 110.401 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.84 139.0 31.11 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.405 2.282 . . . . 8.9399999999999995 114.375 -177.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.82 -27.52 9.25 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 118.921 0.782 . . . . 4.1100000000000003 112.654 154.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -154.6 155.37 34.6 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.658 1.117 . . . . 0.56999999999999995 113.637 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.42 147.86 50.53 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.426 1.891 . . . . 1.5600000000000001 110.499 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.41 134.14 4.4 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.791 1.186 . . . . 0.93999999999999995 112.515 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.12 133.91 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.139 1.375 . . . . 2.4300000000000002 109.009 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 mt -70.65 118.11 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 122.269 1.033 . . . . 1.1000000000000001 111.032 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 123.669 0.787 . . . . 8.9700000000000006 111.819 -177.715 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.253 -0.277 . . . . 3.6299999999999999 110.253 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -163.69 132.67 3.88 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.207 -1.558 . . . . 2.1600000000000001 107.394 -163.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -144.79 120.88 10.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.123 1.44 . . . . 3.8199999999999998 113.409 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.11 74.3 6.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.839 1.655 . . . . 4.8099999999999996 110.824 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 t -70.59 122.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.286 -0.884 . . . . 1.71 111.881 -158.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.51 90.29 0.37 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 128.708 3.052 . . . . 1.1899999999999999 112.11 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 mtt -82.69 148.53 27.86 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.601 1.161 . . . . 2.1000000000000001 111.311 170.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -115.95 158.32 23.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.475 1.131 . . . . 2.4100000000000001 110.915 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.09 124.8 26.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.958 1.303 . . . . 1.0800000000000001 107.496 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 m -143.51 151.21 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.385 1.074 . . . . 1.29 110.813 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 t 171.27 121.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.044 2.538 . . . . 4.0300000000000002 110.387 163.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.59 -38.26 0.27 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.515 2.726 . . . . 2.21 116.724 167.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -9.11 49.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.204 1.402 . . . . 2.9199999999999999 111.871 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.24 -156.19 19.95 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 125.277 1.418 . . . . 1.1200000000000001 113.385 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.92 110.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.209 1.403 . . . . 1.1799999999999999 110.301 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.67 -86.06 1.16 Allowed Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.226 1.393 . . . . 1.46 112.255 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.24 164.56 37.86 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.382 1.473 . . . . 1.99 109.392 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -104.52 170.32 7.96 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.363 1.065 . . . . 2.0600000000000001 113.339 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 pt -151.77 8.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 127.636 2.374 . . . . 3.4500000000000002 112.372 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.14 173.02 20.68 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.011 0.815 . . . . 0.76000000000000001 113.809 -166.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.1 p -131.44 173.97 10.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.558 1.943 . . . . 1.45 108.472 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.37 129.78 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 107.906 -1.146 . . . . 0.64000000000000001 107.906 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -78.38 109.95 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.612 0.642 . . . . 2.0699999999999998 109.788 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.79 125.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.539 -1.282 . . . . 1.6499999999999999 107.539 160.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.504 0.668 . . . . 2.3700000000000001 110.312 166.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.29 130.7 37.54 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.084 1.754 . . . . 3.5299999999999998 109.539 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -149.21 -179.77 7.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.039 0.447 . . . . 1.8999999999999999 110.272 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.06 -29.6 69.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.809 1.244 . . . . 3.5299999999999998 111.751 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.28 66.16 Favored Glycine 0 N--CA 1.471 1.009 0 C-N-CA 124.696 1.141 . . . . 1.45 114.885 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 -140.31 18.37 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 127.685 2.564 . . . . 1.23 114.734 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.28 93.79 7.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.201 1.0 . . . . 0.92000000000000004 110.15 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.4 tttp -76.19 108.78 9.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.364 1.466 . . . . 3.0800000000000001 108.869 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.1 t80 -97.78 110.37 22.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.024 2.53 . . . . 0.68999999999999995 109.309 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 5.6 m -124.19 115.09 27.53 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.889 1.222 . . . . 0.90000000000000002 109.635 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.25 155.96 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.12 2.546 . . . . 0.56999999999999995 111.42 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -149.93 54.12 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.566 1.174 . . . . 2.0699999999999998 111.007 166.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -107.24 134.56 50.15 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.921 1.288 . . . . 0.97999999999999998 111.232 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -109.25 21.15 17.48 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.265 1.95 . . . . 3.0600000000000001 116.265 -160.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.96 65.51 0.19 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.128 0.971 . . . . 1.52 113.567 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.53 161.28 49.07 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 124.519 1.128 . . . . 2.5499999999999998 111.968 174.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.03 128.72 21.28 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.675 1.583 . . . . 0.97999999999999998 109.904 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.74 41.75 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 1 C-N-CA 126.345 4.696 . . . . 1.21 112.553 -157.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.79 -132.83 7.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.974 1.749 . . . . 1.45 113.37 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -139.32 134.96 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.95 1.7 . . . . 3.1099999999999999 110.065 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -137.13 118.79 14.98 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.163 0.985 . . . . 1.25 111.754 -165.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.05 130.04 36.12 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.158 -1.177 . . . . 1.0900000000000001 110.158 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -108.87 124.4 50.58 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.962 -1.496 . . . . 3.3500000000000001 106.962 175.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -123.41 171.52 9.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.924 1.453 . . . . 1.22 114.924 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mt -108.79 137.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.342 1.457 . . . . 0.89000000000000001 109.297 158.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -109.62 175.32 5.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.074 1.75 . . . . 1.48 113.156 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.87 67.27 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.414 1.635 . . . . 1.45 115.414 -164.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -116.95 -167.18 1.26 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.082 1.353 . . . . 1.3999999999999999 111.152 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.46 86.39 0.18 Allowed Glycine 0 N--CA 1.472 1.05 0 O-C-N 120.794 -1.191 . . . . 1.46 114.117 -173.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -177.98 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.746 2.018 . . . . 3.0299999999999998 110.452 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.04 35.31 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.745 2.418 . . . . 1.27 116.632 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -115.13 134.19 22.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 120.207 -1.558 . . . . 4.4800000000000004 111.91 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -86.75 156.24 8.87 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.211 3.274 . . . . 1.3400000000000001 112.861 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.78 139.4 30.58 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.131 -0.94 . . . . 2.2799999999999998 109.676 156.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mm -86.11 115.96 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.749 -1.204 . . . . 3.0600000000000001 107.749 167.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -171.34 135.75 0.97 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.052 1.341 . . . . 5.8200000000000003 109.469 -149.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 t70 52.27 41.49 30.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.648 1.579 . . . . 4.1399999999999997 114.488 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.55 79.4 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.059 -1.026 . . . . 3.1099999999999999 114.578 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -152.34 -164.94 2.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.526 1.531 . . . . 3.7400000000000002 110.074 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.28 122.31 40.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.191 -0.943 . . . . 2.1099999999999999 110.857 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.7 t -79.4 79.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.254 -0.647 . . . . 3.1099999999999999 109.254 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 12.19 -68.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 131.298 3.839 . . . . 2.2999999999999998 117.677 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.04 74.92 1.0 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.752 1.621 . . . . 2.2400000000000002 109.81 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.51 -37.52 75.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.649 0.78 . . . . 4.9100000000000001 112.17 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.21 -3.52 52.58 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.251 1.204 . . . . 1.75 114.251 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.92 18.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.53 1.132 . . . . 1.3899999999999999 112.601 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.09 -177.87 50.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.266 1.266 . . . . 2.6400000000000001 116.266 162.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.42 -166.02 14.36 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.73 1.157 . . . . 1.6699999999999999 113.288 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -59.69 145.45 44.84 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 109.189 -0.671 . . . . 3.3199999999999998 109.189 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.5 tp -74.97 87.53 2.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.976 -1.077 . . . . 2.5499999999999998 110.783 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.64 110.11 0.96 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.449 1.5 . . . . 3.3199999999999998 112.632 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.46 -50.84 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.024 2.483 . . . . 2.7000000000000002 110.998 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -127.52 126.58 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.029 1.332 . . . . 4.1299999999999999 109.921 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.356 12.2 p30 162.52 -108.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.887 3.675 . . . . 3.7400000000000002 110.768 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -155.0 -40.35 0.09 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.485 1.514 . . . . 2.8599999999999999 112.609 -167.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.43 -49.59 4.21 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.079 0.847 . . . . 3.7400000000000002 114.658 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 20.7 ptmt -49.68 -51.33 39.08 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.446 1.647 . . . . 5.6100000000000003 115.446 -151.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.448 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 161.26 136.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 129.42 3.088 . . . . 2.8199999999999998 113.022 157.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.27 -57.52 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.199 1.185 . . . . 4.1699999999999999 114.199 -163.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.34 -108.91 0.19 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.019 1.771 . . . . 3.3199999999999998 114.901 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.23 -33.43 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.502 2.135 . . . . 5.04 113.462 -174.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -137.35 2.79 2.53 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.249 1.574 . . . . 6.29 115.249 -161.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.64 58.4 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.131 -1.606 . . . . 3.25 116.455 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -77.63 63.86 2.82 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.14 1.47 . . . . 6.8600000000000003 112.345 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.47 -144.55 4.86 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 116.645 1.418 . . . . 2.8799999999999999 116.645 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.948 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 14.2 p-80 -145.93 156.3 43.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.994 1.318 . . . . 6.3200000000000003 112.278 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.18 -22.47 64.76 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.644 1.35 . . . . 2.9300000000000002 114.644 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.422 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -96.13 4.66 65.25 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.595 2.045 . . . . 0.94999999999999996 114.957 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.948 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 8.6 m-20 -62.23 143.16 57.19 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.256 1.528 . . . . 2.3399999999999999 107.255 153.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.4 -174.58 0.43 Allowed Pre-proline 0 CA--C 1.56 1.352 0 O-C-N 120.844 -1.16 . . . . 2.6899999999999999 109.893 -155.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.99 169.94 14.23 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.632 2.222 . . . . 1.4199999999999999 112.722 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.94 126.99 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.878 0.871 . . . . 2.8599999999999999 110.975 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 81.8 1.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.869 2.068 . . . . 2.77 108.552 164.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.97 142.17 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.128 -1.064 . . . . 1.22 108.128 168.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.65 138.31 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.254 1.422 . . . . 2.5899999999999999 109.475 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 142.53 56.74 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 112.827 0.676 . . . . 1.8500000000000001 112.827 174.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -17.91 0.48 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.881 2.472 . . . . 2.4500000000000002 117.542 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -93.77 -12.4 29.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.245 1.418 . . . . 2.75 113.266 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 21.63 16.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.228 0.918 . . . . 0.88 114.847 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.27 125.53 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.418 -1.327 . . . . 2.23 107.418 169.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.5 125.96 34.11 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.492 -0.559 . . . . 0.68999999999999995 109.492 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -139.97 -6.51 1.26 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.193 2.197 . . . . 1.8500000000000001 112.953 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -73.22 113.83 25.65 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 128.0 2.52 . . . . 5.1299999999999999 111.827 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.01 142.94 28.43 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.333 2.689 . . . . 1.1799999999999999 111.907 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.84 168.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.469 1.508 . . . . 1.53 109.574 167.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -140.74 141.02 34.93 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 119.242 0.928 . . . . 1.01 110.459 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.95 95.15 16.39 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.374 1.07 . . . . 0.82999999999999996 111.122 172.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.25 6.49 4.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.568 3.512 . . . . 1.5600000000000001 114.431 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -85.92 -5.17 59.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.33 1.052 . . . . 4.8600000000000003 112.026 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.75 160.81 25.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.452 2.701 . . . . 3.2599999999999998 107.345 169.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.75 -7.21 1.1 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.008 1.485 . . . . 5.3499999999999996 115.008 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.8 m -133.81 130.27 37.71 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.099 0.96 . . . . 2.52 110.413 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -26.24 66.84 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.753 -1.217 . . . . 4.0800000000000001 111.019 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.74 -19.27 5.95 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.907 1.447 . . . . 3.5099999999999998 114.907 165.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.35 -13.55 60.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.94 1.246 . . . . 2.7000000000000002 112.067 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.42 2.34 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 114.263 1.209 . . . . 1.23 114.263 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -62.54 8.72 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 118.057 2.614 . . . . 3.3300000000000001 118.057 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.72 17.64 1.28 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.219 1.408 . . . . 3.23 112.193 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -144.24 169.74 17.32 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.758 1.623 . . . . 2.79 112.212 -168.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.98 139.55 35.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.784 1.234 . . . . 0.75 113.439 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.3 mt -80.39 146.8 31.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.831 1.652 . . . . 2.6099999999999999 108.359 158.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.02 126.89 22.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.03 0.832 . . . . 1.8 111.686 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.4 mt -88.62 111.55 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.374 -1.343 . . . . 0.84999999999999998 107.374 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.9 150.29 21.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.194 2.198 . . . . 3.6499999999999999 111.933 -175.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.29 -46.98 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 111.363 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.28 139.62 16.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.491 0.587 . . . . 2.0800000000000001 112.996 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.06 143.21 41.0 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.592 2.044 . . . . 1.96 113.348 170.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -80.3 97.01 6.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.694 1.198 . . . . 3.4199999999999999 111.037 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -177.68 -36.78 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.566 2.746 . . . . 4.4500000000000002 109.73 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.9 mtm -61.46 130.48 46.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.95 -1.094 . . . . 2.8199999999999998 112.964 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 t -157.77 -169.36 2.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.239 1.816 . . . . 3.2599999999999998 109.803 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 64.73 -35.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 129.598 3.159 . . . . 3.7799999999999998 116.405 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 155.64 14.32 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 127.029 2.132 . . . . 4.5599999999999996 110.771 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.06 -6.18 18.64 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.711 2.941 . . . . 2.4399999999999999 114.135 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -122.29 138.57 29.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.196 0.907 . . . . 4.6799999999999997 110.359 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.69 144.37 77.85 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.298 2.666 . . . . 4.2000000000000002 111.167 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.84 29.31 15.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.85 1.26 . . . . 6.79 111.357 -171.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.65 0.94 57.04 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.891 1.234 . . . . 3.1800000000000002 114.276 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.46 -13.2 15.77 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.432 1.491 . . . . 2.1200000000000001 112.848 -162.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 28.98 0.7 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.247 1.879 . . . . 1.6000000000000001 114.455 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.31 -20.0 77.89 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.751 1.643 . . . . 2.0899999999999999 113.089 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.5 p -60.94 155.39 19.99 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.613 1.565 . . . . 2.0299999999999998 111.754 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mmt-85 -111.55 159.69 17.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.366 1.466 . . . . 5.0700000000000003 111.214 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -107.27 -29.49 9.28 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.666 0.617 . . . . 3.77 112.666 152.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.48 38.3 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.141 -0.975 . . . . 0.66000000000000003 113.571 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 50.4 t -135.36 151.59 50.63 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.272 2.229 . . . . 1.6299999999999999 108.947 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -155.1 123.87 1.42 Allowed Glycine 0 N--CA 1.468 0.782 0 C-N-CA 123.966 0.793 . . . . 0.89000000000000001 113.096 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.9 127.87 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.039 1.335 . . . . 2.3599999999999999 109.492 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mt -79.14 125.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.257 1.027 . . . . 1.1599999999999999 110.983 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt . . . . . 0 C--O 1.238 0.489 0 C-N-CA 127.212 2.205 . . . . 4.5199999999999996 109.417 173.665 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.745 -0.465 . . . . 3.04 109.745 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -153.28 136.12 15.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.155 -1.054 . . . . 1.9399999999999999 108.155 -162.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.67 129.88 8.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.517 1.151 . . . . 2.6400000000000001 112.836 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -88.2 94.79 9.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.751 1.22 . . . . 5.1200000000000001 109.393 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.52 123.84 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.833 -0.542 . . . . 1.53 110.224 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.12 107.47 2.2 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.518 1.532 . . . . 0.80000000000000004 110.835 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 13.9 mmt -81.62 101.04 9.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.8 1.24 . . . . 2.3300000000000001 110.65 172.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.66 137.79 36.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.411 -0.959 . . . . 2.6600000000000001 108.411 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.07 138.88 58.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.422 -0.955 . . . . 1.47 108.422 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -136.36 163.48 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.829 0.852 . . . . 1.53 112.328 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -167.78 -148.2 0.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.677 1.991 . . . . 2.8500000000000001 108.404 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.96 17.38 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.941 3.697 . . . . 2.2400000000000002 115.686 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.84 -6.02 5.07 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.007 -1.683 . . . . 4.21 111.739 171.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.14 -141.72 31.85 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.224 -1.551 . . . . 2.5699999999999998 109.224 -158.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -39.22 113.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.752 1.621 . . . . 2.8300000000000001 112.531 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.52 -77.05 1.16 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.16 1.838 . . . . 1.45 112.335 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.67 153.77 25.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.492 0.717 . . . . 2.25 112.351 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -97.2 132.96 42.45 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.531 1.308 . . . . 1.8300000000000001 114.531 -170.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mm -122.19 -17.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.606 1.562 . . . . 6.1299999999999999 115.212 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.53 28.81 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 121.055 -1.028 . . . . 0.92000000000000004 113.306 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.432 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.6 p -95.52 176.45 6.17 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 164.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 t -135.49 129.99 49.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.001 -1.481 . . . . 0.59999999999999998 107.001 160.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -97.57 119.25 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.307 0.575 . . . . 1.4399999999999999 111.674 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.27 135.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.728 1.211 . . . . 2.0899999999999999 108.837 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -139.25 100.8 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.819 1.648 . . . . 2.5 108.791 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.7 132.9 38.38 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 128.039 2.536 . . . . 3.1699999999999999 109.709 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -154.63 -168.89 3.05 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.475 0.31 . . . . 1.6599999999999999 111.662 -166.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -57.36 -31.92 66.23 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.948 1.299 . . . . 5.1200000000000001 113.34 -176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.5 22.84 38.13 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.856 1.693 . . . . 1.1799999999999999 114.386 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.14 -144.82 23.96 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.686 1.136 . . . . 0.78000000000000003 114.355 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.3 mt -80.36 104.38 10.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.836 0.854 . . . . 0.79000000000000004 111.924 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -83.2 111.81 19.27 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.373 -0.829 . . . . 2.3700000000000001 110.696 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.417 ' CE2' ' CE1' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -97.52 125.51 42.27 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.105 1.762 . . . . 1.0800000000000001 110.151 -177.24 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 m -127.84 110.82 20.38 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 117.993 -1.003 . . . . 1.03 109.458 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -91.85 158.16 3.4 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.461 2.774 . . . . 0.56000000000000005 112.542 -169.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.432 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.4 p80 -148.23 36.47 0.83 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 121.741 0.781 . . . . 1.75 112.485 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -92.67 160.49 14.97 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.709 -1.869 . . . . 1.02 113.001 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 18.38 1.87 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.486 2.402 . . . . 2.3199999999999998 117.486 -167.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.58 70.89 0.61 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.002 0.921 . . . . 1.3100000000000001 110.198 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.18 168.56 12.57 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.187 0.995 . . . . 2.98 109.325 170.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -52.8 137.17 60.29 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.987 1.792 . . . . 1.3899999999999999 110.825 159.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -89.57 26.42 0.54 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.85 2.367 . . . . 1.7 114.243 -151.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.53 -149.23 8.64 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 123.387 1.548 . . . . 1.3400000000000001 115.677 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.38 139.97 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.268 2.227 . . . . 3.2599999999999998 111.511 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -131.47 131.63 43.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.522 0.729 . . . . 1.5 110.911 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.38 152.76 47.01 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-N 118.782 0.719 . . . . 0.85999999999999999 111.646 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.417 ' CE1' ' CE2' ' A' ' 33' ' ' PHE . 5.2 t80 -128.36 108.92 10.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.054 -1.462 . . . . 3.21 107.054 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -112.43 165.57 12.09 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.829 1.418 . . . . 0.96999999999999997 114.829 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.69 138.08 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.997 1.719 . . . . 1.72 108.251 158.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -118.31 155.01 31.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.258 1.823 . . . . 1.2 108.985 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.11 73.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.625 1.713 . . . . 0.83999999999999997 115.625 -157.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -132.21 163.63 28.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.283 1.033 . . . . 1.6200000000000001 112.816 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.47 84.58 1.16 Allowed Glycine 0 N--CA 1.469 0.85 0 O-C-N 120.822 -1.174 . . . . 0.94999999999999996 113.55 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -160.11 89.58 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.152 0.977 . . . . 2.7200000000000002 113.127 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.7 m -67.53 48.72 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.136 2.574 . . . . 1.45 113.759 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -131.61 139.79 36.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.215 1.406 . . . . 3.4900000000000002 112.663 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.38 166.19 4.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.887 3.058 . . . . 1.0600000000000001 112.848 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.67 144.32 42.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.073 0.949 . . . . 1.6799999999999999 110.098 164.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.4 59.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.224 1.01 . . . . 3.0299999999999998 109.742 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 152.65 42.8 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.774 -0.579 . . . . 5.2999999999999998 110.226 165.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t0 54.75 18.91 2.3 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.916 1.686 . . . . 3.75 114.131 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.18 77.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.075 1.321 . . . . 3.29 114.644 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.23 146.43 40.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.702 1.251 . . . . 3.9100000000000001 111.18 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.64 18.57 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.899 -1.125 . . . . 1.98 113.383 -165.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.08 92.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.545 1.138 . . . . 2.2999999999999998 109.645 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -24.95 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 130.193 3.397 . . . . 2.4199999999999999 118.61 -166.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.21 124.01 8.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.861 0.755 . . . . 1.8999999999999999 109.905 158.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.61 -48.7 4.24 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.846 0.858 . . . . 4.2400000000000002 110.252 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.28 -14.96 59.09 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.59 1.33 . . . . 1.3899999999999999 114.59 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.09 -7.9 10.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.931 1.292 . . . . 1.0 114.227 169.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.3 -28.09 11.81 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 120.58 -1.325 . . . . 3.1800000000000002 115.046 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.4 -170.93 20.82 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.396 1.474 . . . . 2.3500000000000001 111.774 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -60.85 148.69 38.52 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.077 0.938 . . . . 3.0299999999999998 110.149 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.5 tp -78.06 73.08 4.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.758 1.223 . . . . 2.8100000000000001 111.919 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.48 104.15 28.49 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.65 1.18 . . . . 3.8300000000000001 110.606 158.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.5 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.236 2.624 . . . . 2.4100000000000001 110.96 159.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -166.39 3.22 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.617 1.34 . . . . 4.8200000000000003 114.617 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -68.45 -27.3 66.05 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.311 -1.493 . . . . 3.96 114.27 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.9 m 114.47 139.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 1 C-N-CA 132.05 4.14 . . . . 4.8300000000000001 107.138 -161.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.16 -12.97 56.93 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.093 1.33 . . . . 2.1000000000000001 114.42 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -64.15 -6.0 5.84 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.441 2.015 . . . . 6.4000000000000004 116.441 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.2 t60 83.22 144.8 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.207 2.203 . . . . 2.2200000000000002 114.571 166.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -81.92 150.14 27.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.238 1.815 . . . . 3.6099999999999999 110.982 -173.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.04 -112.95 0.39 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.659 -1.079 . . . . 2.4700000000000002 114.619 171.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.63 -18.95 25.0 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.329 2.686 . . . . 3.6099999999999999 112.453 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -123.11 155.96 35.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.89 2.076 . . . . 4.9299999999999997 107.424 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.53 120.23 6.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.838 0.732 . . . . 4.0099999999999998 111.61 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.69 21.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.107 2.163 . . . . 4.5999999999999996 113.496 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.18 -151.8 13.33 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 123.208 1.449 . . . . 3.0699999999999998 115.177 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -74.87 139.95 43.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.041 -1.079 . . . . 4.1699999999999999 111.352 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -62.5 -21.65 65.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.342 0.497 . . . . 3.1600000000000001 112.342 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.94 26.32 6.15 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.669 1.604 . . . . 1.1299999999999999 115.425 172.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -111.17 131.68 54.91 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.778 1.789 . . . . 1.5 110.566 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.26 160.81 60.61 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.703 1.601 . . . . 3.4300000000000002 110.452 -163.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.49 159.69 32.28 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.607 2.871 . . . . 1.01 112.526 -170.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 m -69.55 132.08 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 123.251 1.5 . . . . 2.23 114.81 -163.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.97 75.11 4.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.5 3.12 . . . . 2.5800000000000001 109.072 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.06 136.09 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.046 -1.034 . . . . 1.24 111.398 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.17 162.92 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.094 0.958 . . . . 3.25 110.151 161.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -88.96 171.0 10.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.101 0.56 . . . . 2.6000000000000001 112.255 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -16.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 128.003 2.521 . . . . 2.9100000000000001 117.804 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -96.66 -7.39 34.26 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.052 2.141 . . . . 2.8999999999999999 113.381 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.46 21.0 30.51 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 119.135 0.879 . . . . 1.1399999999999999 114.755 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.25 129.09 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.428 1.114 . . . . 2.0499999999999998 111.961 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.42 126.85 45.39 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.29 2.236 . . . . 1.01 111.159 -172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -157.19 18.2 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.962 1.097 . . . . 1.6100000000000001 113.962 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -89.35 113.34 56.07 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.47 1.108 . . . . 3.2799999999999998 109.372 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.54 138.91 19.92 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.191 3.261 . . . . 1.0700000000000001 111.365 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.84 167.41 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.454 1.101 . . . . 1.55 111.464 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -136.5 134.09 37.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.256 1.022 . . . . 1.1799999999999999 110.59 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.22 93.49 39.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.315 1.046 . . . . 0.83999999999999997 112.674 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -77.65 94.77 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.361 2.707 . . . . 3.1800000000000002 108.452 160.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -50.7 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.967 1.707 . . . . 5.9800000000000004 109.11 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.12 162.57 25.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.078 1.351 . . . . 3.2000000000000002 108.103 141.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -121.22 -24.67 5.43 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.219 1.192 . . . . 5.4000000000000004 114.219 162.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 m -124.16 150.43 45.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.607 1.094 . . . . 2.7400000000000002 113.922 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -37.2 86.57 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.208 -0.932 . . . . 3.9300000000000002 110.842 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.93 -16.92 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.231 1.567 . . . . 3.8900000000000001 115.231 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -83.53 -6.87 59.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 2.79 112.313 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.05 11.92 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.522 1.129 . . . . 0.92000000000000004 113.417 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -65.66 13.25 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 117.756 2.502 . . . . 3.6299999999999999 117.756 -172.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.73 23.14 0.69 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.423 1.889 . . . . 3.1299999999999999 112.018 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -121.02 174.87 6.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.292 1.219 . . . . 2.1699999999999999 114.292 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.28 140.48 44.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.722 1.209 . . . . 0.60999999999999999 111.249 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.87 141.42 28.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 2.2799999999999998 107.056 161.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.4 mtt -133.34 131.51 40.2 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.408 1.004 . . . . 1.6100000000000001 112.173 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.3 110.37 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.64 1.176 . . . . 0.79000000000000004 108.298 170.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.83 142.99 29.36 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.876 2.071 . . . . 3.4300000000000002 111.737 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -58.95 -38.51 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 112.974 0.731 . . . . 1.8 112.974 -164.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.17 169.92 14.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.722 1.153 . . . . 1.9299999999999999 111.473 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.26 166.78 24.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.458 1.028 . . . . 1.8500000000000001 112.559 161.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.6 6.18 1.84 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.217 1.192 . . . . 2.7799999999999998 114.217 -134.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.005 2.122 . . . . 3.9900000000000002 114.759 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.5 mtm -138.71 63.44 1.52 Allowed 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.402 -1.436 . . . . 2.7999999999999998 113.375 -161.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -64.69 -34.28 77.94 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.337 1.236 . . . . 3.5099999999999998 114.337 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.38 67.34 9.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.965 1.098 . . . . 3.7999999999999998 113.965 -162.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.61 154.81 25.97 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.703 1.601 . . . . 3.2400000000000002 110.989 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.37 -23.15 38.49 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.466 2.777 . . . . 2.9199999999999999 112.426 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.98 90.22 1.49 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.002 -1.11 . . . . 4.8200000000000003 108.002 154.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.0 169.28 18.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.077 2.518 . . . . 4.5599999999999996 111.445 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt 70.47 16.52 7.04 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.381 1.872 . . . . 4.5700000000000003 110.602 -167.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 3.48 24.38 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.208 1.385 . . . . 3.1499999999999999 113.839 -164.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.79 -1.34 52.23 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.785 1.659 . . . . 2.2200000000000002 114.036 -165.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.3 43.41 1.28 Allowed Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.53 2.014 . . . . 1.71 115.239 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.58 -16.93 77.7 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.835 1.207 . . . . 2.3100000000000001 115.055 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 p -76.52 146.71 38.25 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.532 1.533 . . . . 1.8500000000000001 112.742 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -105.23 138.98 40.57 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.83 1.652 . . . . 5.2300000000000004 110.39 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -91.55 -28.82 17.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.625 0.37 . . . . 4.0499999999999998 111.266 164.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.72 159.68 44.15 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.608 0.966 . . . . 0.48999999999999999 113.608 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 32.7 t -140.92 146.7 37.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.965 2.106 . . . . 1.4099999999999999 110.316 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -141.98 100.44 0.26 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.079 1.799 . . . . 0.78000000000000003 111.633 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.75 135.86 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.013 1.325 . . . . 3.4300000000000002 111.729 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.56 150.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.37 1.468 . . . . 1.5 110.712 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.476 0.844 0 O-C-N 121.599 -0.688 . . . . 4.3799999999999999 112.644 -177.404 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.549 0.214 . . . . 2.1899999999999999 111.55 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -153.61 152.68 31.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.853 1.261 . . . . 1.5600000000000001 109.549 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.2 132.4 11.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 123.071 1.415 . . . . 2.3100000000000001 110.065 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -90.01 124.8 35.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 5.1100000000000003 111.241 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.01 101.06 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 120.859 -1.15 . . . . 1.9099999999999999 108.282 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 109.36 2.81 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.272 1.415 . . . . 1.22 109.907 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 77.6 mmm -87.35 149.35 24.56 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.925 0.89 . . . . 3.1600000000000001 110.685 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.62 145.73 50.02 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.823 1.649 . . . . 2.5600000000000001 109.954 168.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.79 140.43 58.87 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.617 -0.677 . . . . 1.6000000000000001 109.572 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.79 152.61 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.693 0.759 . . . . 1.25 110.821 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -151.87 -165.08 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.794 1.638 . . . . 2.6400000000000001 107.599 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.4 -0.15 1.22 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.233 2.213 . . . . 2.4199999999999999 113.326 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -109.71 -9.98 14.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.502 1.921 . . . . 2.9100000000000001 111.875 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.53 -161.85 21.39 Favored Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.014 1.292 . . . . 1.29 113.85 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.71 127.32 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.392 1.877 . . . . 1.3200000000000001 111.693 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.69 -86.09 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.643 1.592 . . . . 1.47 114.262 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.49 170.5 22.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.784 2.434 . . . . 2.3999999999999999 109.199 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -106.22 159.47 16.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.404 1.261 . . . . 1.6100000000000001 114.404 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.76 8.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 128.899 2.879 . . . . 4.1500000000000004 113.034 -169.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.13 168.67 15.47 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.694 1.14 . . . . 1.03 113.4 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.402 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.4 p -115.19 -177.27 3.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.534 1.534 . . . . 1.1000000000000001 109.335 173.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.45 138.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.821 -1.548 . . . . 0.68999999999999995 106.821 158.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 p -91.78 131.87 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.077 0.398 . . . . 1.53 110.556 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -107.63 131.66 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.343 1.057 . . . . 2.1299999999999999 109.218 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.51 145.18 50.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.92 0.888 . . . . 1.9199999999999999 111.036 170.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.354 8.4 tm-20 -101.38 107.23 18.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.741 2.816 . . . . 3.79 108.129 -162.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -130.7 175.6 8.89 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.839 1.199 . . . . 3.4500000000000002 112.128 -167.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.82 -8.41 57.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.436 1.094 . . . . 5.6299999999999999 112.794 172.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.71 14.63 58.94 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.035 1.302 . . . . 1.1599999999999999 113.27 159.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.27 -151.05 32.57 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 128.299 2.857 . . . . 0.90000000000000002 115.592 174.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -69.68 112.76 6.37 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.758 -0.848 . . . . 1.23 112.963 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -88.86 106.77 18.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.938 2.095 . . . . 2.6600000000000001 110.787 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -92.8 117.09 29.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.574 2.35 . . . . 0.75 108.912 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -125.77 114.93 24.69 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-N 120.478 1.49 . . . . 1.01 109.327 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.1 163.4 5.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.323 2.682 . . . . 0.62 112.379 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.402 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.2 p80 -151.86 20.37 0.69 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.703 1.001 . . . . 1.8400000000000001 113.703 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.74 145.21 28.04 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.011 -1.055 . . . . 1.03 111.749 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -119.2 19.91 12.74 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.869 1.803 . . . . 4.1200000000000001 115.869 -164.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.86 54.81 0.66 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.794 0.838 . . . . 1.51 112.174 -165.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.95 160.34 69.03 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.997 0.919 . . . . 2.6099999999999999 112.553 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.59 132.73 39.17 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.871 1.714 . . . . 1.3999999999999999 110.711 174.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -89.04 25.39 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.679 2.253 . . . . 1.49 114.259 -143.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.34 -152.85 12.49 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 116.908 1.523 . . . . 1.25 116.908 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.96 147.04 23.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.95 2.1 . . . . 2.4700000000000002 109.851 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -149.2 148.15 29.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.087 0.955 . . . . 1.3600000000000001 112.842 -165.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.53 156.63 53.51 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.191 -0.943 . . . . 0.68000000000000005 110.936 162.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.34 121.59 11.56 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 106.134 -1.802 . . . . 3.29 106.134 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -126.99 170.69 12.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.685 1.735 . . . . 1.0900000000000001 115.685 175.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -101.56 143.06 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.281 1.832 . . . . 0.88 109.492 160.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -129.57 141.09 51.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.712 2.005 . . . . 1.3400000000000001 109.641 -172.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -28.49 66.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.059 2.244 . . . . 0.75 117.059 -158.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -127.29 152.17 47.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.443 1.019 . . . . 1.52 112.739 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.81 78.79 1.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.358 0.98 . . . . 1.1899999999999999 111.785 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -164.54 72.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.103 0.954 . . . . 2.75 113.316 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.4 m -68.16 8.84 0.38 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.83 2.159 . . . . 1.6000000000000001 116.83 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.17 138.79 52.55 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.089 -1.632 . . . . 3.7200000000000002 110.771 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.28 165.67 6.77 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.217 3.278 . . . . 1.78 111.341 172.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.56 -172.08 2.58 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.54 0.686 . . . . 3.1000000000000001 109.808 150.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.1 mm -96.64 146.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.728 1.211 . . . . 4.1600000000000001 109.402 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.0 138.95 3.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.504 2.322 . . . . 6.8200000000000003 108.866 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.84 32.0 16.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.233 1.413 . . . . 5.9000000000000004 112.621 -173.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.89 3.53 87.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.186 1.374 . . . . 3.6200000000000001 115.605 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.98 157.91 45.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.077 1.438 . . . . 5.9500000000000002 112.563 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.51 131.52 34.63 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.886 -1.134 . . . . 2.6200000000000001 112.269 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.0 33.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.382 0.882 . . . . 2.6000000000000001 113.382 -172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.61 -6.38 0.12 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 119.184 3.031 . . . . 2.6299999999999999 119.184 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 131.93 101.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 1 C-N-CA 133.005 4.522 . . . . 1.45 106.506 -173.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.41 -59.41 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.203 1.001 . . . . 4.7000000000000002 111.872 -154.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.31 -17.86 59.84 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.156 0.798 . . . . 1.6000000000000001 113.156 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.96 0.68 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.031 2.132 . . . . 0.89000000000000001 115.634 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.69 25.29 9.99 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 116.272 1.269 . . . . 2.9300000000000002 116.272 159.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 -119.83 5.12 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 110.452 -1.059 . . . . 2.7799999999999998 110.452 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -97.47 -102.47 0.19 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.144 -1.058 . . . . 3.54 108.144 149.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.5 tp -174.24 93.32 0.08 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.494 2.318 . . . . 2.7200000000000002 108.672 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -159.64 124.52 2.19 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 125.651 1.581 . . . . 4.2400000000000002 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.03 -31.56 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.478 2.785 . . . . 2.7000000000000002 114.568 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -160.2 -7.91 0.05 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.328 1.422 . . . . 4.4199999999999999 114.388 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -76.01 -48.89 19.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.244 1.018 . . . . 3.2799999999999998 112.61 -160.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -163.34 -41.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.473 1.286 . . . . 3.3300000000000001 114.473 -174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.52 -19.98 2.32 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.047 -1.418 . . . . 2.3599999999999999 114.538 -167.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -72.0 -80.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.212 2.006 . . . . 4.9100000000000001 113.289 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.8 t60 160.69 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 130.27 3.428 . . . . 1.6399999999999999 111.027 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.461 ' CG ' ' H ' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -71.75 -154.29 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.345 1.458 . . . . 3.2400000000000002 111.939 173.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 83' ' ' GLU . . . 113.76 -80.1 0.28 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.801 1.667 . . . . 3.0800000000000001 112.259 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.49 -7.77 5.6 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.849 3.033 . . . . 5.3700000000000001 113.668 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -153.45 145.18 23.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.607 1.563 . . . . 5.2400000000000002 110.457 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.35 84.25 1.42 Allowed Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.986 1.279 . . . . 3.6000000000000001 112.068 -173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.72 13.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.526 1.53 . . . . 5.0599999999999996 113.011 -162.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.3 -161.68 37.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.489 1.519 . . . . 2.29 115.223 -168.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -74.58 133.68 42.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.924 -0.638 . . . . 4.7999999999999998 109.65 173.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.93 2.66 3.26 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.085 1.883 . . . . 3.5299999999999998 116.085 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.87 0.32 51.97 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.892 1.711 . . . . 1.25 115.129 168.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -79.0 147.02 33.04 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.956 1.378 . . . . 1.6799999999999999 111.673 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.92 159.05 27.33 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.812 0.845 . . . . 2.5800000000000001 110.282 -144.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.04 149.33 64.96 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.359 2.706 . . . . 1.21 112.419 -171.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.37 128.23 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.438 1.113 . . . . 2.25 112.983 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.0 tp -82.51 132.09 35.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.513 2.725 . . . . 3.52 110.315 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.69 137.67 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.84 -1.162 . . . . 1.0800000000000001 109.662 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.49 151.97 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 107.434 -1.321 . . . . 3.48 107.434 161.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.06 157.5 26.7 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.384 0.513 . . . . 2.1699999999999999 112.384 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -10.11 2.3 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.724 1.75 . . . . 3.7000000000000002 115.724 -174.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.79 -12.59 41.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 2.4399999999999999 113.597 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.63 17.04 11.66 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.081 1.324 . . . . 0.83999999999999997 116.037 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.46 134.96 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.541 1.171 . . . . 2.8300000000000001 110.707 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.14 135.6 33.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.891 1.676 . . . . 1.1699999999999999 111.379 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -158.83 -19.79 0.07 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.271 1.582 . . . . 1.5800000000000001 115.271 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.37 122.33 82.58 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.403 1.002 . . . . 3.6800000000000002 110.097 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.71 163.22 18.75 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.511 2.807 . . . . 1.5700000000000001 111.989 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 m -141.26 160.51 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.157 1.383 . . . . 1.5900000000000001 110.267 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 138.41 52.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.948 0.899 . . . . 1.1499999999999999 109.743 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.97 88.23 6.65 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.522 1.129 . . . . 0.76000000000000001 112.051 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.76 5.41 1.71 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.041 3.16 . . . . 1.3300000000000001 115.974 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -15.47 52.44 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.531 1.06 . . . . 10.17 112.633 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.93 136.65 20.52 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.04 0.936 . . . . 4.2000000000000002 111.754 -170.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 9.36 1.44 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.235 1.939 . . . . 6.7699999999999996 116.235 -154.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -147.54 128.19 14.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.538 -0.541 . . . . 2.4300000000000002 109.538 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.77 -29.85 67.1 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.725 1.148 . . . . 2.4500000000000002 112.436 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.49 -24.23 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.291 1.837 . . . . 3.04 114.284 171.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.61 -4.46 58.95 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 120.093 1.315 . . . . 2.6099999999999999 114.25 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.03 12.96 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.586 1.154 . . . . 1.0600000000000001 113.874 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.38 17.16 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.197 2.295 . . . . 3.2999999999999998 117.197 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -150.09 11.6 0.73 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.503 1.921 . . . . 3.0 112.383 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -100.84 172.06 7.28 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.63 -1.294 . . . . 2.1600000000000001 113.418 -171.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.14 144.28 35.75 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.883 0.873 . . . . 0.56999999999999995 110.212 161.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.9 141.09 36.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.779 1.632 . . . . 2.4700000000000002 106.673 164.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.5 mtt -137.32 130.56 30.94 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.946 -1.096 . . . . 1.8100000000000001 111.975 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.4 mt -83.85 131.68 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.092 -1.077 . . . . 0.89000000000000001 108.092 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.2 149.1 42.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.611 1.564 . . . . 3.6400000000000001 112.125 -168.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.5 -52.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.655 -0.653 . . . . 1.6599999999999999 110.005 -168.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.85 169.17 29.51 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.127 0.87 . . . . 1.4299999999999999 111.769 169.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.22 -164.49 5.98 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.967 2.699 . . . . 2.6299999999999999 115.913 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.39 84.01 2.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.018 2.127 . . . . 3.4199999999999999 106.676 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -160.39 -8.06 0.05 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.254 1.576 . . . . 4.2000000000000002 115.254 -165.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.5 ptp -148.31 142.06 25.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.242 1.383 . . . . 3.6099999999999999 113.945 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 p -156.82 12.89 0.26 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.146 1.165 . . . . 3.54 114.146 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.51 -40.38 14.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.138 1.775 . . . . 4.5999999999999996 113.845 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.51 143.35 79.09 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.94 0.896 . . . . 4.1200000000000001 112.036 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.81 -31.84 24.28 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.148 2.565 . . . . 2.2799999999999998 114.751 -165.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -73.81 115.45 42.2 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.289 1.404 . . . . 4.8200000000000003 108.731 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.23 144.84 64.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.014 2.476 . . . . 3.0800000000000001 112.716 -159.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 58.98 19.32 7.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.103 1.761 . . . . 4.1200000000000001 112.638 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.97 56.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.813 -0.993 . . . . 3.1899999999999999 113.755 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.89 -8.35 73.52 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.964 1.745 . . . . 2.2200000000000002 114.418 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.01 -8.84 79.22 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.14 1.47 . . . . 1.5900000000000001 116.097 -169.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.83 2.29 25.73 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.921 1.248 . . . . 1.8899999999999999 115.5 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 p -69.42 151.38 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.924 1.69 . . . . 1.8400000000000001 110.789 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.31 150.16 22.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.318 1.447 . . . . 6.1699999999999999 110.268 -172.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -110.43 -34.77 6.23 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.31 0.485 . . . . 3.75 112.31 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.8 144.74 24.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.776 1.028 . . . . 0.96999999999999997 113.776 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.9 t -104.82 139.61 39.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.93 2.492 . . . . 2.1200000000000001 110.903 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.27 87.67 0.25 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.978 2.704 . . . . 1.29 111.052 173.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.98 135.53 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.84 . . . . 2.2400000000000002 109.246 166.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.42 137.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.626 1.17 . . . . 2.4500000000000002 111.359 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 11.2 mmpt? . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.183 . . . . 4.3600000000000003 113.504 -175.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 121.752 0.787 . . . . 2.02 111.38 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -169.12 151.77 4.84 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.551 1.54 . . . . 1.98 108.143 -154.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.9 124.07 5.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 123.05 1.405 . . . . 2.6299999999999999 111.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -84.15 89.52 7.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.928 2.091 . . . . 4.4400000000000004 110.796 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -87.28 116.44 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.475 -0.765 . . . . 1.5 110.239 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.34 109.0 2.66 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.238 1.399 . . . . 0.72999999999999998 110.009 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.8 mtp -94.02 140.42 29.74 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.558 0.743 . . . . 2.1099999999999999 112.778 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -121.24 150.4 41.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.8 1.64 . . . . 2.6299999999999999 112.994 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.7 mt -71.6 73.42 0.77 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.207 2.603 . . . . 1.28 110.974 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.65 124.4 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.338 -0.851 . . . . 1.9399999999999999 109.947 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.5 t -160.28 74.49 0.55 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.963 1.098 . . . . 2.4199999999999999 113.963 -166.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.66 -42.62 0.52 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.167 2.187 . . . . 1.8999999999999999 114.561 163.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -6.7 50.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.947 1.299 . . . . 3.1800000000000002 112.071 169.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.47 -164.53 13.93 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.029 2.252 . . . . 1.8 111.496 -173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.56 129.8 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.054 . . . . 1.5900000000000001 110.255 161.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.64 -140.62 11.27 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.904 1.24 . . . . 2.0699999999999998 113.881 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.93 167.08 14.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.675 1.19 . . . . 2.2999999999999998 111.087 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -103.22 172.94 6.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.813 1.645 . . . . 2.2200000000000002 113.183 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.03 1.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 128.188 2.595 . . . . 4.2199999999999998 113.138 -165.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.17 -177.44 20.29 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.148 1.356 . . . . 0.59999999999999998 112.714 -166.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.87 165.43 18.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.075 0.95 . . . . 1.3799999999999999 109.411 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.67 129.32 66.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.558 -1.275 . . . . 0.66000000000000003 107.558 157.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.18 130.63 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 122.011 0.91 . . . . 3.9300000000000002 110.204 166.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -99.39 139.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.9 -1.148 . . . . 1.75 107.9 167.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -135.52 127.06 28.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.908 1.283 . . . . 2.3199999999999998 109.935 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.03 140.0 29.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.207 0.603 . . . . 3.5699999999999998 111.059 -171.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t -154.54 -178.99 7.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.5 0.72 . . . . 2.02 110.433 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -64.38 -23.8 67.41 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.659 1.584 . . . . 3.7999999999999998 113.546 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.07 16.68 59.02 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.283 1.42 . . . . 1.4299999999999999 113.848 166.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.44 -144.49 31.81 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 129.241 3.305 . . . . 1.1200000000000001 114.859 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.2 mt -71.71 109.17 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.291 0.636 . . . . 0.88 111.088 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -80.58 107.34 13.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.268 1.427 . . . . 3.1600000000000001 109.594 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -91.75 116.52 28.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.035 1.734 . . . . 0.73999999999999999 109.713 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.8 m -128.87 106.52 18.35 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.877 -0.582 . . . . 1.21 110.332 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.09 154.72 14.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.897 3.065 . . . . 0.55000000000000004 112.405 -171.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -146.01 48.88 1.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.664 0.745 . . . . 1.8700000000000001 112.626 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.47 150.95 24.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 1.04 112.228 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 22.0 5.52 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.393 1.627 . . . . 2.0699999999999998 115.393 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.24 83.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.112 0.965 . . . . 2.0699999999999998 110.706 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 164.68 31.62 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 124.803 1.241 . . . . 2.3799999999999999 110.535 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.48 138.46 85.92 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.13 1.22 . . . . 1.3600000000000001 110.07 169.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -90.81 24.67 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.333 2.022 . . . . 1.52 114.428 -151.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.5 -154.62 20.58 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.181 1.372 . . . . 1.3 115.28 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 152.29 19.07 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.064 -1.256 . . . . 2.7000000000000002 110.539 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -149.41 122.78 9.03 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.674 1.59 . . . . 1.6899999999999999 111.291 -162.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.56 150.29 3.54 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 120.307 1.412 . . . . 0.83999999999999997 112.175 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.448 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -135.97 125.58 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.248 -1.39 . . . . 3.4100000000000001 107.248 173.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -124.28 172.31 9.19 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.118 1.525 . . . . 1.3100000000000001 115.118 167.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.38 141.66 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.747 1.619 . . . . 0.96999999999999997 109.168 159.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.27 154.3 46.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.986 2.114 . . . . 1.0600000000000001 110.583 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.93 60.63 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 117.362 2.356 . . . . 1.1000000000000001 117.362 -150.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -137.69 148.86 46.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.122 1.328 . . . . 1.8500000000000001 113.325 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.57 74.18 2.14 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.581 1.086 . . . . 1.3200000000000001 114.151 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 t -164.79 76.9 0.31 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.058 0.932 . . . . 2.8300000000000001 113.346 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.9 m -70.02 28.43 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.951 2.1 . . . . 1.8300000000000001 115.74 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -92.22 135.44 26.95 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.514 -1.366 . . . . 3.29 110.943 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.17 157.2 11.21 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.274 3.316 . . . . 1.3400000000000001 113.231 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.77 144.53 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.104 0.962 . . . . 2.0600000000000001 110.08 161.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mm -97.76 48.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.316 1.047 . . . . 3.7000000000000002 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -61.89 137.83 58.29 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.761 -1.212 . . . . 6.2800000000000002 111.313 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.94 26.35 9.73 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.182 0.993 . . . . 4.0800000000000001 112.921 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.71 83.34 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.96 -1.087 . . . . 3.0699999999999998 114.723 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.91 144.46 48.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.264 1.532 . . . . 3.8199999999999998 111.178 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.3 105.8 12.78 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.835 -1.165 . . . . 1.8 111.776 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 t -77.98 62.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.402 1.481 . . . . 3.0299999999999998 111.688 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.2 -63.15 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.852 3.261 . . . . 2.27 116.756 169.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.4 119.8 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 131.555 3.942 . . . . 2.3799999999999999 108.648 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -100.46 -47.75 4.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.693 1.133 . . . . 4.8399999999999999 111.561 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.8 2.92 4.68 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 115.21 1.559 . . . . 1.71 115.21 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.52 -3.84 48.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.119 2.168 . . . . 1.6100000000000001 114.674 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 -13.83 55.01 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.037 1.575 . . . . 3.7400000000000002 117.037 165.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.09 -168.78 15.18 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.043 1.306 . . . . 2.1200000000000001 114.697 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 12.64 1.63 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.196 2.199 . . . . 2.3100000000000001 114.107 -175.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.8 tp 61.25 56.2 2.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.15 1.78 . . . . 2.3700000000000001 109.15 -169.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -122.74 62.94 18.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.901 2.08 . . . . 4.2199999999999998 112.414 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.43 -38.43 26.05 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.83 2.353 . . . . 2.3799999999999999 112.689 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -168.4 139.22 2.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.631 1.972 . . . . 4.1100000000000003 107.664 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 p30 157.69 -162.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 130.348 3.459 . . . . 4.6200000000000001 110.337 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -74.49 -11.83 60.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.265 2.626 . . . . 3.1299999999999999 116.048 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.65 -32.17 1.66 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.977 1.275 . . . . 2.6299999999999999 116.081 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -64.91 -9.84 24.23 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.151 2.278 . . . . 5.9900000000000002 117.151 -167.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.4 t60 75.08 153.52 0.14 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.427 2.291 . . . . 2.1000000000000001 112.238 -171.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -152.13 148.51 27.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.287 1.835 . . . . 4.9299999999999997 109.874 -169.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.35 -82.39 1.07 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.055 -1.414 . . . . 3.3399999999999999 109.882 163.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.01 -26.12 3.1 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.898 3.065 . . . . 4.54 115.942 -166.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.54 -157.55 0.62 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 120.091 1.314 . . . . 5.2999999999999998 111.383 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.98 13.59 37.7 Favored Glycine 0 N--CA 1.475 1.287 0 C-N-CA 124.979 1.276 . . . . 4.79 115.195 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -100.25 51.76 0.89 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.052 1.426 . . . . 5.7400000000000002 112.301 -169.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.61 -143.71 4.9 Favored Glycine 0 N--CA 1.473 1.101 0 O-C-N 120.921 -1.112 . . . . 2.6699999999999999 115.608 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.06 147.73 22.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.705 1.202 . . . . 5.0099999999999998 112.405 -168.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.88 -20.97 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.682 1.364 . . . . 2.8799999999999999 114.682 -174.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.06 -2.06 86.4 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.297 0.951 . . . . 1.02 114.796 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.98 136.63 33.98 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.517 1.127 . . . . 1.77 111.99 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.42 167.61 14.17 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 126.092 1.757 . . . . 2.6800000000000002 109.861 -143.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.82 173.95 11.53 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.281 3.321 . . . . 1.0700000000000001 113.792 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.37 125.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.638 1.175 . . . . 2.9900000000000002 112.186 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 90.31 2.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.58 2.752 . . . . 2.79 109.854 166.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.9 t -68.28 126.44 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.018 -1.051 . . . . 0.92000000000000004 109.092 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.97 162.67 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.931 1.292 . . . . 3.3599999999999999 108.411 167.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.47 160.47 16.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.759 1.022 . . . . 2.21 113.759 -176.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -15.68 0.29 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 127.957 2.503 . . . . 2.4700000000000002 117.438 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.09 -0.93 38.06 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.907 1.683 . . . . 3.2000000000000002 113.089 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.8 25.66 22.01 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.93 1.252 . . . . 0.96999999999999997 114.432 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.9 mt -129.64 140.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 1.5900000000000001 109.955 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.4 129.0 56.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.349 1.86 . . . . 1.0600000000000001 111.607 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 t -153.31 0.74 0.25 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.784 1.772 . . . . 1.6000000000000001 115.784 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -86.03 126.77 64.4 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.585 1.154 . . . . 3.3799999999999999 110.542 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.05 156.3 26.41 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.095 2.53 . . . . 1.3100000000000001 112.16 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.92 167.06 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 126.358 1.863 . . . . 1.71 109.591 167.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 m -140.06 140.48 36.14 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 1.23 111.053 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.63 114.24 15.54 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.482 1.113 . . . . 1.52 112.691 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.14 5.15 6.2 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.26 3.307 . . . . 1.5 115.213 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -77.36 -19.17 56.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.566 0.951 . . . . 5.2800000000000002 113.566 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.56 144.99 46.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.423 1.889 . . . . 3.75 106.946 169.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -131.06 -9.37 3.84 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.455 1.28 . . . . 4.9900000000000002 114.455 -160.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -157.98 142.2 15.98 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.929 1.292 . . . . 2.4399999999999999 111.781 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.081 -1.012 . . . . 3.6499999999999999 113.172 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.97 -15.65 45.37 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 119.533 1.06 . . . . 3.1299999999999999 113.168 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.11 -22.29 63.98 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.47 -0.769 . . . . 2.3100000000000001 112.793 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.02 20.97 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.655 1.582 . . . . 1.1699999999999999 112.689 -167.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -68.86 27.47 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.215 2.206 . . . . 2.8599999999999999 116.012 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.96 3.02 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.529 2.732 . . . . 3.21 113.024 173.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -108.19 172.15 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 2.1600000000000001 113.149 -166.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.0 150.06 39.23 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.247 1.019 . . . . 0.87 113.195 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.3 mt -89.66 152.29 21.44 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.169 1.788 . . . . 2.9100000000000001 109.01 161.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.8 mtt -141.31 127.8 20.06 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.597 0.635 . . . . 1.6399999999999999 112.185 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.45 130.73 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.957 1.303 . . . . 0.88 107.577 166.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.28 137.59 53.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.218 2.207 . . . . 3.04 111.236 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -64.85 -42.83 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.326 1.05 . . . . 1.73 112.781 -161.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -88.0 -106.01 0.95 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.1 1.333 . . . . 2.6600000000000001 112.041 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.48 -166.99 29.39 Favored Glycine 0 N--CA 1.462 0.404 0 O-C-N 121.233 -1.157 . . . . 2.7200000000000002 111.75 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -162.9 145.97 10.82 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.622 1.169 . . . . 3.25 109.911 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 114.27 55.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 130.294 3.438 . . . . 4.7999999999999998 108.121 -154.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.3 ptp -169.63 37.02 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.044 1.338 . . . . 3.3300000000000001 113.455 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.61 61.31 2.31 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.078 -1.639 . . . . 3.5099999999999998 114.911 -169.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -140.25 -45.54 0.42 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 116.613 2.079 . . . . 4.2999999999999998 116.613 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.43 148.32 44.12 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.753 1.39 . . . . 3.8900000000000001 114.753 -156.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.44 -9.19 24.78 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.312 3.341 . . . . 2.3399999999999999 115.555 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -101.43 78.34 0.21 Allowed Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.587 -0.894 . . . . 5.6699999999999999 108.587 154.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.73 152.38 82.21 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.758 2.972 . . . . 3.52 112.355 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 mt 69.08 27.98 5.17 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.641 1.577 . . . . 4.7699999999999996 110.296 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.42 13.52 58.46 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.318 1.437 . . . . 3.5 114.626 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.94 -6.9 46.32 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 118.676 1.238 . . . . 2.3599999999999999 114.375 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.87 5.94 56.73 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.488 1.994 . . . . 2.5899999999999999 114.089 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.8 2.56 7.91 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 118.613 1.206 . . . . 2.4399999999999999 115.022 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 p -64.26 144.64 56.99 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.359 1.463 . . . . 2.0899999999999999 109.655 169.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.92 137.58 36.92 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.001 0.92 . . . . 6.6500000000000004 112.605 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -91.46 -27.85 18.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.284 0.634 . . . . 3.6200000000000001 111.281 158.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.24 153.11 28.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.174 0.805 . . . . 0.60999999999999999 113.174 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.54 165.52 16.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.382 1.473 . . . . 2.3300000000000001 110.755 165.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -160.82 136.43 4.46 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.658 1.123 . . . . 0.84999999999999998 112.797 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.11 133.45 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.657 1.183 . . . . 2.6899999999999999 110.603 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.0 141.2 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.503 1.121 . . . . 1.9199999999999999 111.068 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 123.981 0.913 . . . . 4.7599999999999998 112.769 -174.637 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.413 -0.217 . . . . 2.1800000000000002 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -135.87 150.04 49.23 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.394 -1.441 . . . . 1.6200000000000001 114.763 -141.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -155.72 123.85 5.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.675 1.59 . . . . 2.3599999999999999 108.703 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.93 108.29 18.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.714 1.605 . . . . 6.2300000000000004 110.512 -171.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.15 126.38 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.339 0.656 . . . . 1.46 110.14 -165.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.94 113.34 4.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.277 1.417 . . . . 0.77000000000000002 110.549 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.4 mmt -97.33 113.16 24.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.448 1.499 . . . . 2.1200000000000001 110.586 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -102.2 149.55 24.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.287 1.035 . . . . 3.1699999999999999 112.108 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.31 61.98 1.25 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.395 1.078 . . . . 1.73 112.645 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.43 147.48 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.342 1.057 . . . . 1.6100000000000001 112.489 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -177.44 134.85 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.798 1.639 . . . . 2.3799999999999999 111.338 163.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.67 -44.16 0.25 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.03 2.932 . . . . 1.74 117.062 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 11.11 33.75 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.148 1.779 . . . . 3.7599999999999998 110.844 172.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -133.23 11.69 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.996 1.284 . . . . 1.1599999999999999 110.684 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.19 134.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.862 1.665 . . . . 2.1299999999999999 111.031 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.53 -82.47 1.42 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.837 1.208 . . . . 2.3199999999999998 111.924 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.2 158.29 18.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.078 1.351 . . . . 2.5899999999999999 111.355 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.0 t -97.92 145.47 26.43 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.728 1.211 . . . . 2.6299999999999999 112.977 -169.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.3 pt -142.85 3.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 114.837 1.421 . . . . 3.6000000000000001 114.837 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.73 178.35 35.58 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 120.895 -1.128 . . . . 0.75 114.023 -170.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.49 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 1.2 p -131.14 178.41 6.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.352 1.061 . . . . 1.24 109.054 171.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -131.05 133.99 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.095 -1.076 . . . . 0.45000000000000001 108.095 162.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 8.7 p -90.65 127.8 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.604 0.362 . . . . 1.45 110.721 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.8 136.65 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.289 1.036 . . . . 2.4100000000000001 108.825 169.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -141.91 113.5 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.215 1.406 . . . . 1.8500000000000001 110.744 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.77 153.55 39.94 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.733 0.813 . . . . 3.1200000000000001 112.063 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 t -167.68 -177.68 3.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.542 1.937 . . . . 1.54 109.149 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -53.1 -40.75 64.37 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.257 1.423 . . . . 3.8199999999999998 112.497 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 15.16 56.71 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.22 1.39 . . . . 0.91000000000000003 114.44 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 -152.78 42.48 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 127.36 2.41 . . . . 0.75 115.334 173.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.53 104.34 0.99 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.701 0.801 . . . . 0.78000000000000003 113.135 -169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -80.12 110.42 15.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.008 1.723 . . . . 3.1899999999999999 109.964 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.6 t80 -100.85 114.87 29.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.457 2.703 . . . . 0.79000000000000004 108.928 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.6 m -122.73 111.18 31.34 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 119.776 1.171 . . . . 0.95999999999999996 108.948 175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -84.08 158.55 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.525 2.817 . . . . 0.46000000000000002 111.66 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.49 ' CD2' ' HG1' ' A' ' 21' ' ' THR 0.263 1.7 p80 -152.52 65.06 0.81 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 122.5 1.143 . . . . 1.52 111.664 172.145 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.59 151.26 45.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.35 1.86 . . . . 0.83999999999999997 111.535 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 37.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 117.509 2.411 . . . . 2.4500000000000002 117.509 -159.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.45 13.03 1.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.978 1.473 . . . . 2.4100000000000001 114.978 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.33 161.82 50.56 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 119.124 -0.465 . . . . 2.9199999999999999 111.359 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -60.96 129.78 30.18 Favored 'Trans proline' 0 N--CA 1.431 -2.157 0 O-C-N 123.241 1.127 . . . . 1.1599999999999999 109.756 162.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -86.45 22.86 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.665 3.577 . . . . 1.29 113.269 -150.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.52 153.04 17.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 126.167 1.842 . . . . 1.9399999999999999 110.49 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -45.28 137.03 4.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.005 2.522 . . . . 3.2999999999999998 113.72 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -126.93 129.42 48.13 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 125.533 1.533 . . . . 1.1299999999999999 111.704 -172.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.14 158.18 1.72 Allowed Glycine 0 CA--C 1.543 1.843 0 CA-C-N 119.276 0.944 . . . . 0.81000000000000005 114.016 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.3 t80 -145.39 116.3 7.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.147 1.779 . . . . 3.21 106.65 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -126.12 168.75 13.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.388 1.995 . . . . 0.92000000000000004 116.388 165.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -99.08 135.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.391 1.876 . . . . 1.25 110.09 154.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -105.6 176.14 5.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.822 1.649 . . . . 1.25 111.963 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.9 62.59 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 116.744 2.127 . . . . 1.3300000000000001 116.744 -166.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -126.06 -159.68 0.93 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.6 1.56 . . . . 1.48 111.277 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.87 66.73 0.37 Allowed Glycine 0 N--CA 1.476 1.323 0 N-CA-C 116.677 1.431 . . . . 1.78 116.677 -162.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -174.69 116.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.236 1.814 . . . . 3.23 111.974 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -67.62 33.0 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 128.043 2.537 . . . . 1.46 115.183 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -104.89 126.61 30.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 119.996 -1.69 . . . . 3.1600000000000001 111.379 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.52 150.97 13.24 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.073 3.182 . . . . 1.3200000000000001 112.889 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 169.08 8.94 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.179 0.992 . . . . 2.2000000000000002 110.196 154.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 mm -97.9 124.1 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.948 -1.13 . . . . 3.3399999999999999 107.948 162.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -139.54 109.22 6.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.278 1.431 . . . . 5.6699999999999999 109.179 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t0 60.43 63.04 1.43 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.161 1.785 . . . . 4.2000000000000002 112.747 -166.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.39 13.33 54.34 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 115.711 1.045 . . . . 3.23 115.711 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -147.48 150.11 33.95 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.027 1.731 . . . . 3.8900000000000001 110.209 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.05 34.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.998 0.519 . . . . 1.6799999999999999 111.896 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.5 t -67.94 -3.98 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.188 1.795 . . . . 3.3599999999999999 113.466 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.47 -50.56 0.69 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.499 2.72 . . . . 2.1600000000000001 112.575 -174.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.51 111.25 2.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.178 1.791 . . . . 1.9199999999999999 109.682 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.89 -39.7 12.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.239 0.616 . . . . 5.0700000000000003 110.691 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.01 -4.2 30.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.114 1.153 . . . . 1.98 114.114 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.0 -18.9 27.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.178 1.391 . . . . 1.3 112.631 168.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.31 178.1 31.53 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 122.319 0.955 . . . . 2.8500000000000001 113.516 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.69 -163.65 39.31 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.531 1.062 . . . . 1.74 112.894 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -56.31 128.29 35.09 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.763 0.825 . . . . 3.04 109.591 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.32 66.72 0.18 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.681 1.993 . . . . 2.9500000000000002 112.34 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -111.21 113.55 54.2 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 4.6699999999999999 108.989 164.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -84.68 -31.27 0.46 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.288 1.992 . . . . 2.48 113.302 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 176.9 29.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.869 2.068 . . . . 3.79 111.289 -165.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -119.07 -21.19 7.76 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.56 -1.209 . . . . 4.2400000000000002 113.261 -164.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t 155.16 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 130.607 3.563 . . . . 2.6299999999999999 111.172 158.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.33 -11.29 61.69 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.8 1.191 . . . . 2.2200000000000002 115.494 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -73.79 1.78 9.76 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 116.019 1.859 . . . . 5.46 116.019 -173.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.6 t60 87.75 135.16 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 129.045 2.938 . . . . 1.97 114.151 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.65 19.33 14.61 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.981 1.712 . . . . 4.8399999999999999 114.385 -152.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.78 -35.68 31.04 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-O 117.642 -1.643 . . . . 3.0099999999999998 114.735 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -111.83 -2.39 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 124.316 3.344 . . . . 3.9199999999999999 114.153 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -143.82 145.93 32.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.875 1.67 . . . . 5.2400000000000002 108.457 -172.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.12 6.5 35.09 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.586 1.394 . . . . 4.0 116.586 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.81 130.34 15.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.051 1.426 . . . . 5.7999999999999998 109.721 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.69 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-O 115.709 -2.717 . . . . 3.3300000000000001 118.22 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.794 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 0.3 OUTLIER 152.99 118.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 129.145 2.978 . . . . 6.6299999999999999 110.924 -175.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.3 tt -67.03 -28.43 68.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.47 1.108 . . . . 3.9399999999999999 113.369 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -88.18 15.7 55.04 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.416 1.484 . . . . 1.04 115.179 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.794 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 78.7 m-20 -76.11 147.65 38.43 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.2 1.5 . . . . 1.55 110.751 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.17 166.03 17.38 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.607 0.763 . . . . 2.6400000000000001 110.368 -146.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.06 148.53 19.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.877 3.051 . . . . 1.45 112.271 -171.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.89 135.16 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 122.108 0.956 . . . . 2.6600000000000001 111.38 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 108.83 19.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.026 2.53 . . . . 3.9399999999999999 110.428 -172.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.4 t -78.24 131.35 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.365 -0.835 . . . . 2.1200000000000001 111.935 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.68 141.31 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.67 2.388 . . . . 2.52 106.423 166.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.51 164.3 22.07 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.134 0.424 . . . . 1.95 111.484 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -16.67 0.29 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 127.421 2.289 . . . . 2.3500000000000001 116.89 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.62 -1.41 43.81 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.181 1.792 . . . . 2.4100000000000001 113.434 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.29 53.84 Favored Glycine 0 N--CA 1.473 1.119 0 O-C-N 121.185 -0.947 . . . . 0.98999999999999999 114.851 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.8 mt -106.14 121.97 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.217 1.007 . . . . 2.0 110.806 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.4 122.56 33.38 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.342 1.057 . . . . 0.88 109.092 168.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -155.48 8.68 0.27 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.135 1.161 . . . . 2.3900000000000001 114.135 -167.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.62 123.61 49.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.868 1.267 . . . . 3.3599999999999999 110.473 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.75 134.75 26.56 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.189 3.259 . . . . 1.3899999999999999 111.963 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.0 163.77 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 126.342 1.857 . . . . 1.99 109.261 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 m -144.14 141.0 29.71 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.993 1.269 . . . . 1.1499999999999999 112.112 -167.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -121.17 106.05 39.01 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.554 1.142 . . . . 0.96999999999999997 113.381 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.1 7.42 1.74 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.727 3.618 . . . . 1.1899999999999999 114.637 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -75.4 -25.7 57.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.812 1.645 . . . . 7.8700000000000001 112.735 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.99 135.59 53.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.313 -1.736 . . . . 3.4199999999999999 106.313 168.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -113.05 -2.65 14.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 4.9800000000000004 113.579 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.4 t -141.11 174.06 10.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.353 0.979 . . . . 2.6200000000000001 111.752 158.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.43 -24.27 64.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.165 -0.959 . . . . 2.04 111.09 157.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -60.01 -28.62 67.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.352 1.461 . . . . 2.8300000000000001 114.639 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -78.91 -16.1 57.45 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.199 1.185 . . . . 2.6400000000000001 114.199 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.1 m -124.42 16.35 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 125.195 1.398 . . . . 1.3799999999999999 113.291 -172.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -65.44 8.64 0.15 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 128.242 2.617 . . . . 3.25 117.579 -171.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 41.76 0.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.273 1.429 . . . . 3.7000000000000002 112.171 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -134.49 168.28 19.23 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.937 1.295 . . . . 2.3399999999999999 113.685 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.7 146.69 26.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.503 1.521 . . . . 0.65000000000000002 114.259 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.37 145.39 30.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.921 2.489 . . . . 2.1499999999999999 107.809 167.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 52.3 mtt -140.65 143.4 35.13 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.294 -0.879 . . . . 1.8400000000000001 112.427 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mt -99.75 123.6 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.772 1.629 . . . . 0.85999999999999999 108.444 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -109.02 143.29 38.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.293 1.837 . . . . 4.1299999999999999 111.39 -165.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.12 -37.78 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.865 -1.147 . . . . 1.8200000000000001 111.914 -169.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.93 153.34 20.06 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.913 0.768 . . . . 1.2 112.125 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.35 -178.9 25.6 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.891 1.71 . . . . 1.3100000000000001 113.128 163.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -137.01 14.87 3.07 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.027 1.491 . . . . 3.29 115.027 -126.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -105.16 21.82 16.44 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.709 1.374 . . . . 3.0 114.709 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtm -96.55 129.65 43.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.859 -1.151 . . . . 3.3500000000000001 112.363 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.2 p -126.7 4.93 6.71 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.766 1.395 . . . . 3.3599999999999999 114.766 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -157.09 124.61 5.33 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.887 -1.133 . . . . 3.5299999999999998 109.464 -169.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -174.09 142.25 0.85 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 117.926 -1.035 . . . . 3.6899999999999999 109.558 -167.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.11 -15.12 29.0 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.08 2.52 . . . . 2.7799999999999998 113.762 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -129.23 133.85 25.62 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.811 1.645 . . . . 5.2999999999999998 108.955 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.9 124.82 15.7 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.215 2.61 . . . . 3.7400000000000002 111.783 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp 58.88 5.2 0.48 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.689 1.996 . . . . 4.0700000000000003 114.007 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.87 9.08 44.8 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.883 -1.136 . . . . 4.1799999999999997 114.574 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.92 -0.27 33.85 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.411 1.482 . . . . 3.0 114.345 -167.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.87 7.34 5.5 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.342 1.449 . . . . 2.0 115.646 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.24 -6.03 78.63 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.873 1.337 . . . . 2.6099999999999999 112.921 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 p -70.07 134.06 47.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.356 1.862 . . . . 2.5499999999999998 110.693 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.43 147.27 45.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.355 1.462 . . . . 5.9800000000000004 112.02 -172.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -106.3 -17.16 14.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.249 -0.881 . . . . 3.71 112.93 169.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.85 33.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.856 1.428 . . . . 0.54000000000000004 114.856 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -135.74 149.12 49.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.198 2.199 . . . . 1.3200000000000001 110.238 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.5 1.71 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.342 1.925 . . . . 0.87 112.474 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.63 141.71 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.569 1.148 . . . . 3.4399999999999999 112.592 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -77.14 141.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.57 1.148 . . . . 1.3100000000000001 110.868 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 124.332 1.053 . . . . 4.7699999999999996 110.977 171.366 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.988 -0.745 . . . . 2.5 108.988 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -128.71 133.53 48.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.899 -1.751 . . . . 2.5600000000000001 112.504 -137.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -146.69 127.68 14.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 123.226 1.489 . . . . 2.5 112.711 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -109.86 90.94 3.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.251 1.42 . . . . 4.7000000000000002 110.216 -162.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.5 t -90.04 120.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.89 0.476 . . . . 1.48 110.299 -163.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.48 105.4 1.78 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.972 1.272 . . . . 0.79000000000000004 110.639 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 mmt -85.13 110.49 19.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.999 1.32 . . . . 2.3799999999999999 110.57 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -98.25 143.78 28.38 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.95 0.9 . . . . 2.7999999999999998 111.452 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.3 63.01 3.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.895 1.278 . . . . 1.29 111.55 -175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.35 136.79 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.551 0.74 . . . . 1.96 111.205 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -157.96 139.87 14.03 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.597 0.359 . . . . 2.54 111.514 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 26.76 -42.99 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.884 1 C-N-CA 134.638 5.175 . . . . 1.3799999999999999 120.763 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -80.17 -23.26 41.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.825 1.25 . . . . 3.9300000000000002 111.791 166.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.5 -141.08 13.02 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.846 1.212 . . . . 1.23 111.541 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.5 t -54.81 128.79 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.117 1.367 . . . . 1.7 111.78 -174.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.26 -111.0 3.54 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.151 1.834 . . . . 1.22 111.701 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.68 169.35 15.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.515 1.126 . . . . 2.04 110.945 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.9 t -109.44 156.81 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.058 -1.026 . . . . 2.0099999999999998 111.994 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 pt -147.33 9.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.733 2.013 . . . . 3.4199999999999999 113.114 -172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.57 162.78 10.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.642 1.115 . . . . 0.81999999999999995 112.743 -167.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -104.45 -177.99 3.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.23 1.012 . . . . 1.04 109.316 168.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.4 t -124.43 130.87 73.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 106.848 -1.538 . . . . 0.42999999999999999 106.848 151.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -87.72 123.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.727 -0.471 . . . . 2.0299999999999998 109.727 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.86 119.98 45.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.04 -1.096 . . . . 2.1200000000000001 108.04 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -118.47 111.33 18.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.835 0.854 . . . . 1.9399999999999999 110.848 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 130.47 46.57 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 127.124 2.17 . . . . 3.9100000000000001 111.165 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 t -161.18 -172.0 3.25 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.705 1.002 . . . . 2.3900000000000001 113.705 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.32 -31.29 43.49 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.523 1.529 . . . . 6.75 112.721 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.57 17.9 57.56 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 124.962 1.267 . . . . 1.9299999999999999 115.179 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.29 -140.43 28.4 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.22 1.39 . . . . 1.22 111.372 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.59 107.89 7.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.284 0.634 . . . . 0.90000000000000002 111.13 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -87.83 107.51 18.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.771 1.228 . . . . 2.3399999999999999 111.263 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.34 104.61 16.02 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.596 1.958 . . . . 0.66000000000000003 109.763 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 m -113.69 106.66 53.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.1 162.06 17.98 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.371 3.38 . . . . 0.5 109.928 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -153.02 34.7 0.47 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.982 0.896 . . . . 1.45 112.346 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -97.26 142.85 28.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.703 1.201 . . . . 0.84999999999999998 111.21 -174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.38 23.1 9.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.154 1.909 . . . . 2.25 116.154 -166.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.51 57.51 0.63 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.672 0.789 . . . . 1.4299999999999999 112.806 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.03 15.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.115 0.966 . . . . 2.54 111.57 172.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.73 134.36 46.77 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 122.058 1.839 . . . . 1.03 110.973 166.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -84.18 27.31 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.706 1 C-N-CA 126.692 4.928 . . . . 1.1899999999999999 114.825 -152.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.79 -134.79 8.16 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.398 1.475 . . . . 1.25 115.091 -172.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -120.17 136.5 54.6 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.647 1.579 . . . . 2.29 108.588 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -124.87 143.64 50.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.18 0.992 . . . . 1.27 112.631 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.9 153.68 52.32 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.917 -0.873 . . . . 0.66000000000000003 110.917 169.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -124.07 118.41 26.88 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.277 -1.379 . . . . 3.3799999999999999 107.277 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -116.5 160.95 19.86 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.068 1.507 . . . . 1.01 115.068 168.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.13 148.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.521 2.329 . . . . 1.1599999999999999 108.332 158.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -134.62 145.37 48.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 1.1200000000000001 111.001 -174.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.46 87.58 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.784 1.772 . . . . 0.79000000000000004 115.784 -159.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -116.76 148.63 40.97 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.658 1.183 . . . . 1.25 112.989 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.69 72.57 2.81 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.769 1.176 . . . . 1.25 113.803 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -164.36 96.06 0.76 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.174 0.987 . . . . 2.4399999999999999 113.422 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -65.39 22.73 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.155 2.182 . . . . 1.3100000000000001 116.44 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -86.18 129.34 54.13 Favored Pre-proline 0 CA--C 1.55 0.957 0 O-C-N 119.802 -1.811 . . . . 3.0899999999999999 112.446 -166.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -95.62 173.26 1.11 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.897 3.731 . . . . 1.75 111.99 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.5 154.07 45.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.12 1.368 . . . . 2.6200000000000001 110.956 165.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -85.05 113.55 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.205 -1.405 . . . . 4.3399999999999999 107.205 157.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -138.47 121.37 16.59 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.716 1.206 . . . . 5.6699999999999999 108.547 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 57.69 40.01 26.86 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.755 1.222 . . . . 4.2199999999999998 112.548 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.37 9.92 86.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.579 1.085 . . . . 3.27 115.34 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.02 154.09 48.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.001 1.401 . . . . 3.7000000000000002 110.727 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.56 113.13 24.79 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.51 -0.744 . . . . 2.9900000000000002 111.717 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.35 33.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 116.054 1.872 . . . . 3.96 116.054 -163.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.68 -63.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.365 2.666 . . . . 2.5499999999999998 114.105 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.75 108.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 131.581 3.952 . . . . 1.6899999999999999 107.6 -176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -110.54 -39.2 4.98 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.141 0.976 . . . . 3.9900000000000002 111.817 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -19.73 62.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.538 0.94 . . . . 1.3300000000000001 113.538 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -9.14 53.84 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.299 1.84 . . . . 0.84999999999999998 113.61 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.55 54.65 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.602 -1.312 . . . . 2.1600000000000001 112.629 -174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 179.47 51.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.897 0.76 . . . . 2.04 112.993 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.44 31.12 0.06 Allowed 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 114.197 1.184 . . . . 2.8300000000000001 114.197 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.6 tp 64.92 88.85 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.041 2.137 . . . . 2.5899999999999999 112.654 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -166.37 121.49 0.91 Allowed Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.136 2.174 . . . . 4.9500000000000002 110.619 163.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -90.57 -14.16 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.255 2.636 . . . . 2.48 114.118 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -154.33 -37.05 0.1 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.306 1.965 . . . . 6.0999999999999996 116.306 -159.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -60.33 -32.92 71.7 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.478 1.49 . . . . 4.1399999999999997 113.669 -163.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 t 171.78 -26.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.792 2.837 . . . . 3.0899999999999999 111.551 163.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 5.12 82.76 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.048 -1.033 . . . . 2.3700000000000001 115.287 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -74.44 -25.95 59.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 115.17 1.544 . . . . 7.0700000000000003 115.17 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.6 t60 99.03 145.79 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 129.35 3.06 . . . . 2.25 111.79 -168.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -119.58 -153.59 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 3.8599999999999999 112.85 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.81 -138.32 6.71 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 117.659 -1.634 . . . . 2.5800000000000001 109.37 -155.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.08 -27.2 65.48 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.016 2.477 . . . . 3.2599999999999998 113.96 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.66 -9.44 58.25 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.976 1.102 . . . . 5.9100000000000001 113.976 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.01 19.98 70.4 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 116.812 1.485 . . . . 4.0899999999999999 116.812 167.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.98 100.52 3.95 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.595 1.197 . . . . 6.1399999999999997 111.0 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.94 -34.92 0.13 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-O 117.193 -1.893 . . . . 3.2400000000000002 116.128 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -161.83 128.34 3.77 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.756 2.022 . . . . 4.5800000000000001 110.719 157.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.66 -21.42 66.11 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.132 1.16 . . . . 3.6000000000000001 114.132 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.66 23.0 9.41 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.801 1.191 . . . . 0.94999999999999996 114.91 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.15 134.3 41.4 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.075 1.437 . . . . 1.5800000000000001 110.444 165.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.28 161.08 62.49 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.385 1.874 . . . . 3.04 110.335 -168.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.89 167.84 25.52 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.572 2.848 . . . . 1.6499999999999999 112.317 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 m -75.79 147.17 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.845 1.307 . . . . 2.5299999999999998 113.89 -164.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.94 97.09 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 130.557 3.543 . . . . 3.75 108.397 -175.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 t -83.09 147.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.986 1.315 . . . . 0.96999999999999997 111.797 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.77 142.41 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.331 2.252 . . . . 2.5699999999999998 107.93 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.405 HD21 ' C ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -71.71 160.25 32.95 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.406 0.548 . . . . 2.3300000000000001 111.688 175.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -57.57 -4.17 0.24 Allowed 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 116.91 2.189 . . . . 3.3999999999999999 116.91 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -111.8 -11.23 13.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.263 1.425 . . . . 3.0 114.562 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.19 32.61 3.2 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 116.627 1.411 . . . . 0.89000000000000001 116.627 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.0 mt -121.3 135.89 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.543 1.537 . . . . 1.6499999999999999 108.62 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.24 130.14 55.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.247 1.019 . . . . 0.71999999999999997 110.14 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -148.98 10.06 0.79 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.811 2.152 . . . . 1.6899999999999999 116.811 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.58 130.59 40.74 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 120.349 1.431 . . . . 6.04 114.167 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.12 87.33 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.908 3.072 . . . . 2.04 111.742 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.2 t -72.31 160.3 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.295 1.438 . . . . 2.9500000000000002 108.993 172.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.5 m -142.82 131.88 23.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.653 -1.279 . . . . 1.9399999999999999 111.505 -171.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.02 91.23 49.71 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.205 1.002 . . . . 0.85999999999999999 113.4 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.34 2.46 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.227 3.285 . . . . 1.3 115.201 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -72.06 -26.33 62.14 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.025 0.83 . . . . 4.6799999999999997 111.555 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.86 151.51 26.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.673 2.389 . . . . 3.0299999999999998 108.822 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -138.21 12.81 2.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.989 1.315 . . . . 5.6200000000000001 114.044 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.6 t -160.76 152.24 19.36 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.98 -1.075 . . . . 2.8900000000000001 112.269 161.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.94 -28.55 62.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.204 -0.427 . . . . 2.1600000000000001 111.635 161.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -54.79 -28.73 51.26 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.105 0.962 . . . . 2.7999999999999998 112.813 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.17 -12.61 60.63 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.874 0.87 . . . . 2.3599999999999999 112.766 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.08 12.44 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.417 1.487 . . . . 0.85999999999999999 113.028 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -63.79 -1.71 1.49 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 117.224 2.305 . . . . 2.9300000000000002 117.224 -169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -146.15 19.97 1.4 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.249 1.82 . . . . 3.1499999999999999 111.941 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -104.8 -176.51 3.1 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.026 1.73 . . . . 2.3300000000000001 112.974 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.21 160.42 22.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.526 1.13 . . . . 0.83999999999999997 112.368 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 mt -126.63 141.4 51.86 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 129.136 2.974 . . . . 2.2999999999999998 106.038 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.26 138.8 48.02 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.129 0.877 . . . . 1.71 112.561 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -99.53 116.11 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.46 1.504 . . . . 0.92000000000000004 107.871 170.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -110.82 145.45 38.16 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.963 1.305 . . . . 2.8500000000000001 113.266 -162.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.53 -34.7 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.392 1.077 . . . . 1.5900000000000001 113.436 -154.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.2 151.87 18.3 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.978 -0.849 . . . . 1.4099999999999999 110.978 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -56.06 148.93 27.47 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.062 0.839 . . . . 1.8500000000000001 111.006 162.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -127.05 133.9 50.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.359 1.076 . . . . 3.3300000000000001 113.232 -159.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -156.48 10.02 0.24 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.794 2.437 . . . . 3.3500000000000001 111.637 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -83.76 66.71 9.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.007 1.114 . . . . 4.29 114.007 -157.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.5 p -75.23 30.91 0.1 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.075 1.139 . . . . 3.3300000000000001 114.075 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -165.62 147.15 7.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.745 2.018 . . . . 4.04 111.077 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 155.42 153.35 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 130.489 3.516 . . . . 4.3899999999999997 111.767 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -86.72 -17.15 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.26 3.307 . . . . 2.3500000000000001 112.863 163.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -91.33 144.02 29.12 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.878 1.271 . . . . 4.5499999999999998 110.339 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -73.5 160.01 45.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.178 2.586 . . . . 5.5700000000000003 113.228 -166.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.31 2.48 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.606 1.963 . . . . 6.6500000000000004 114.756 170.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.83 3.67 80.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.733 1.159 . . . . 4.2199999999999998 114.159 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.96 -65.65 4.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.279 1.418 . . . . 2.1400000000000001 112.958 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.47 64.33 Favored Glycine 0 N--CA 1.476 1.367 0 C-N-CA 124.278 0.942 . . . . 1.79 115.233 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.72 10.72 16.91 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.909 1.718 . . . . 2.52 115.582 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 p -71.39 156.05 39.92 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.581 1.691 . . . . 2.27 109.547 162.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.97 143.26 30.39 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.931 1.086 . . . . 7.2300000000000004 113.931 -173.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -99.63 -23.69 14.97 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.239 0.616 . . . . 3.7000000000000002 111.402 153.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.89 158.31 43.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.251 0.932 . . . . 0.58999999999999997 113.453 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.46 150.07 51.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.383 1.873 . . . . 1.6200000000000001 110.05 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 107.84 0.37 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.049 1.785 . . . . 0.84999999999999998 112.007 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.04 139.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.595 1.158 . . . . 3.75 110.722 165.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.69 117.82 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.788 -0.57 . . . . 2.3900000000000001 110.202 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 125.629 1.572 . . . . 5.2800000000000002 110.222 179.386 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 119.276 -0.392 . . . . 2.3700000000000001 110.627 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -155.47 140.6 17.46 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 119.625 -1.922 . . . . 1.5900000000000001 111.847 -172.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.33 146.4 21.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.542 1.163 . . . . 3.0600000000000001 111.881 166.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -109.55 116.94 32.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.571 1.549 . . . . 5.3600000000000003 113.423 -176.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -103.79 120.97 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.852 -1.155 . . . . 1.6699999999999999 110.822 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.8 108.63 2.99 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.557 2.027 . . . . 0.76000000000000001 112.159 178.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 35.0 mtt -90.43 139.17 30.93 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.953 1.834 . . . . 2.3399999999999999 115.953 -176.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -115.5 146.39 41.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.812 2.045 . . . . 3.0800000000000001 113.504 -174.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.98 63.08 4.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.555 1.542 . . . . 1.5700000000000001 113.066 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.8 105.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 120.929 -1.107 . . . . 1.8 113.006 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.3 t -132.3 73.29 1.52 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.017 0.927 . . . . 2.5899999999999999 112.424 -173.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 71.19 -47.3 0.66 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.839 2.456 . . . . 1.52 114.032 172.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.64 -12.58 61.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.819 1.248 . . . . 2.7799999999999998 112.085 174.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.67 -165.49 12.65 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.679 1.609 . . . . 1.3100000000000001 113.542 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.57 134.35 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.856 1.663 . . . . 1.47 110.547 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.34 -83.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.214 1.388 . . . . 2.6600000000000001 113.732 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -100.49 130.87 46.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.003 1.721 . . . . 3.6499999999999999 111.941 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -108.14 138.07 45.04 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.109 -0.994 . . . . 1.8 109.857 175.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mm -125.16 -16.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.86 1.43 . . . . 5.6399999999999997 114.86 -170.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.46 158.35 27.63 Favored Glycine 0 CA--C 1.521 0.467 0 O-C-N 121.518 -0.739 . . . . 1.29 111.907 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.431 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 2.6 p -88.34 173.98 8.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.062 0.934 . . . . 1.1100000000000001 109.219 163.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.1 132.91 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.896 -1.52 . . . . 0.64000000000000001 106.896 148.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.47 128.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 123.551 0.532 . . . . 1.96 110.174 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.48 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 125.283 1.433 . . . . 2.5800000000000001 108.208 -173.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.61 117.07 34.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 123.067 1.413 . . . . 1.8400000000000001 110.189 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.259 0.8 OUTLIER -81.95 122.03 27.25 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.205 3.402 . . . . 2.96 109.895 -169.481 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.0 t -144.2 178.44 7.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.17 0.986 . . . . 1.8200000000000001 111.12 -173.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -28.98 68.06 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.491 1.916 . . . . 4.71 110.357 -176.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 13.7 60.59 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.563 1.554 . . . . 1.1200000000000001 115.289 163.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.62 -151.17 21.15 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 127.627 2.537 . . . . 0.81999999999999995 116.552 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.54 101.2 4.8 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.869 . . . . 2.2599999999999998 111.53 -175.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.5 105.2 10.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.622 1.169 . . . . 2.3500000000000001 110.833 173.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -93.86 116.64 29.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.575 2.35 . . . . 0.78000000000000003 109.975 -172.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -123.36 112.55 29.65 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 119.824 1.193 . . . . 0.95999999999999996 108.824 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.53 159.45 10.86 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.169 3.246 . . . . 0.59999999999999998 111.996 -173.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 3.2 p80 -150.06 39.61 0.77 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.24 0.543 . . . . 1.6499999999999999 112.287 171.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.48 142.34 28.68 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.032 -1.668 . . . . 1.1000000000000001 112.828 -172.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 91.83 3.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.119 1.368 . . . . 2.3900000000000001 113.436 -171.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 133.1 103.47 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 130.404 3.481 . . . . 2.0 107.227 -171.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.523 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -160.84 160.01 25.18 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 131.603 3.961 . . . . 4.1100000000000003 106.67 167.103 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -63.48 140.27 75.01 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 O-C-N 122.64 0.81 . . . . 1.4299999999999999 110.094 157.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -86.67 31.48 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.554 2.836 . . . . 1.6699999999999999 113.513 -152.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.33 -177.44 14.99 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.154 1.359 . . . . 2.1499999999999999 113.527 -175.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -64.77 129.93 41.62 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 125.336 1.454 . . . . 3.3599999999999999 112.605 -168.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -125.57 131.34 52.75 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.594 1.158 . . . . 1.0800000000000001 110.209 -176.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.0 169.52 50.78 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 119.368 0.986 . . . . 0.64000000000000001 112.753 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 4.1 t80 -137.9 114.71 10.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.969 1.308 . . . . 3.27 108.827 174.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -118.61 163.27 17.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.987 1.477 . . . . 0.89000000000000001 114.987 163.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.17 144.46 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.825 1.65 . . . . 0.84999999999999998 108.311 155.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -119.02 157.16 28.33 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.276 1.03 . . . . 1.04 111.761 173.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -20.48 66.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 117.197 2.295 . . . . 0.71999999999999997 117.197 -162.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -132.43 -174.8 3.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.067 1.747 . . . . 1.3999999999999999 111.8 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 50.93 0.87 Allowed Glycine 0 N--CA 1.471 1.026 0 N-CA-C 116.316 1.286 . . . . 1.2 116.316 -160.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 t -157.89 110.95 2.44 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.513 1.656 . . . . 2.8799999999999999 112.595 167.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.99 5.19 0.1 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.588 2.355 . . . . 1.3700000000000001 116.945 -173.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -83.84 140.56 40.6 Favored Pre-proline 0 CA--C 1.546 0.821 0 O-C-N 120.461 -1.399 . . . . 3.9500000000000002 112.72 -167.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.84 148.84 12.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.04 3.16 . . . . 1.3100000000000001 112.215 173.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.38 21.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.757 0.823 . . . . 1.8100000000000001 111.204 156.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.1 mm -114.48 103.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.852 1.261 . . . . 2.9300000000000002 109.428 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HE2' ' OD2' ' A' ' 61' ' ' ASP . 16.5 mtpt -101.63 149.13 24.44 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.393 1.477 . . . . 6.3799999999999999 110.051 168.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.416 ' OD2' ' HE2' ' A' ' 60' ' ' LYS . 12.8 m-20 46.59 39.02 6.25 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.276 1.213 . . . . 4.25 114.276 161.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.6 25.38 75.27 Favored Glycine 0 CA--C 1.537 1.406 0 CA-C-O 118.291 -1.283 . . . . 3.21 115.556 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -156.07 158.25 37.46 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.395 2.098 . . . . 3.7000000000000002 112.98 -177.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.14 139.73 31.88 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.354 -0.841 . . . . 1.95 113.0 -173.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 m -85.36 13.8 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 114.862 1.43 . . . . 3.96 114.862 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.81 -51.41 0.7 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.849 2.46 . . . . 1.8 113.792 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.81 141.53 4.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.061 1.744 . . . . 2.1699999999999999 109.419 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.32 -50.99 1.99 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.969 0.508 . . . . 4.8700000000000001 111.424 173.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.3 1.24 6.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.549 1.314 . . . . 1.73 114.549 -177.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 -18.7 35.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.277 1.431 . . . . 0.91000000000000003 112.522 166.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 -177.22 53.79 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 122.565 1.092 . . . . 2.23 114.764 176.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.86 179.9 37.35 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.941 1.258 . . . . 1.95 113.669 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -69.51 5.06 1.49 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.042 1.867 . . . . 2.6299999999999999 116.042 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.3 tp 63.48 89.54 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.9 2.08 . . . . 2.52 109.697 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -159.96 23.1 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 117.473 2.397 . . . . 3.4500000000000002 117.473 -156.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -61.37 -26.01 80.91 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.336 2.691 . . . . 2.1600000000000001 116.552 -152.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -131.4 22.75 4.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.197 0.999 . . . . 4.2199999999999998 111.62 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -89.94 -58.98 2.32 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.815 -1.178 . . . . 3.4100000000000001 113.294 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 159.84 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.294 3.037 . . . . 2.6200000000000001 111.293 -175.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.07 61.88 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.087 -1.396 . . . . 2.02 115.336 176.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -72.14 -30.33 64.93 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.462 2.131 . . . . 6.0099999999999998 114.348 -175.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.46 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 58.9 t60 86.67 155.03 0.07 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 129.003 2.921 . . . . 1.6499999999999999 111.651 -166.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.74 -130.59 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.773 1.229 . . . . 3.8599999999999999 111.861 -173.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 145.11 -44.82 0.86 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 127.883 2.659 . . . . 2.8599999999999999 112.601 -174.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -111.39 -11.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.42 2.747 . . . . 3.2799999999999998 116.317 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -145.61 0.86 0.89 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.883 1.674 . . . . 4.5800000000000001 115.233 -153.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.99 -12.91 21.88 Favored Glycine 0 N--CA 1.476 1.345 0 O-C-N 120.462 -1.399 . . . . 4.3200000000000003 114.5 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.48 38.43 0.19 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.679 2.392 . . . . 6.5899999999999999 114.294 -166.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.94 -87.29 0.06 OUTLIER Glycine 0 C--N 1.342 0.902 0 O-C-N 120.427 -1.421 . . . . 2.5 114.911 -170.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -142.96 143.73 32.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.438 1.895 . . . . 4.5599999999999996 110.357 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -77.09 -14.43 59.81 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.829 1.195 . . . . 4.1100000000000003 114.013 170.171 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.63 3.37 79.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.296 -1.28 . . . . 0.98999999999999999 115.802 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.46 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 78.9 m-20 -94.2 129.25 40.88 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 119.424 1.612 . . . . 2.6200000000000001 112.08 -177.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -117.26 168.7 8.54 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.871 2.068 . . . . 2.8999999999999999 110.221 -177.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -81.44 167.4 17.3 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.066 2.51 . . . . 1.6100000000000001 111.859 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.64 137.87 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 115.829 1.788 . . . . 2.2200000000000002 115.829 -163.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.22 95.19 4.26 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 130.845 3.658 . . . . 2.52 110.059 170.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.34 131.26 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.919 -1.113 . . . . 1.1299999999999999 111.759 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -118.03 149.5 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 127.328 2.251 . . . . 3.8199999999999998 109.082 167.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.87 166.36 19.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.723 1.009 . . . . 2.6899999999999999 113.723 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -13.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 119.389 3.107 . . . . 2.5099999999999998 119.389 -178.224 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -119.77 -4.4 10.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.639 1.576 . . . . 4.1100000000000003 114.355 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.09 38.77 2.25 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 116.785 1.474 . . . . 1.22 116.785 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mm -126.6 130.84 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-N 119.507 1.653 . . . . 3.8500000000000001 111.903 166.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.46 132.64 37.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.931 1.292 . . . . 0.93000000000000005 111.17 174.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 t -151.66 -14.2 0.2 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.992 1.849 . . . . 1.9299999999999999 115.992 -170.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.33 133.02 43.31 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 120.398 1.454 . . . . 3.5899999999999999 112.117 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.73 146.74 24.04 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.862 3.042 . . . . 1.04 112.372 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.25 170.72 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.356 1.863 . . . . 1.52 110.005 172.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 m -135.68 140.76 44.71 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.152 0.887 . . . . 1.1599999999999999 110.971 -175.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.56 87.3 41.22 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.096 1.358 . . . . 1.05 112.305 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.82 -7.98 14.5 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.408 3.405 . . . . 1.6799999999999999 114.95 176.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -65.23 -27.27 68.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.426 -0.796 . . . . 4.9000000000000004 110.921 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.33 142.8 50.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.796 2.039 . . . . 3.3900000000000001 109.265 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 32.46 0.54 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.074 1.35 . . . . 7.2000000000000002 113.239 -166.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.6 m -179.81 136.21 0.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.134 2.574 . . . . 2.2599999999999998 109.867 162.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -32.67 63.34 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 118.946 0.794 . . . . 2.1899999999999999 111.321 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.8 -27.47 29.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.617 1.567 . . . . 3.2999999999999998 113.65 174.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.37 -28.98 68.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.184 0.902 . . . . 2.52 112.41 173.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.93 11.96 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.799 1.64 . . . . 1.1100000000000001 113.063 -161.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.08 -26.39 15.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.307 1.843 . . . . 2.8100000000000001 115.322 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -10.46 55.52 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.809 2.044 . . . . 3.77 114.587 177.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.24 168.84 9.95 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.986 1.476 . . . . 2.8300000000000001 114.986 -154.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.56 151.5 31.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.337 1.455 . . . . 0.68000000000000005 112.053 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.22 143.77 39.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.488 1.915 . . . . 2.2599999999999998 107.854 171.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.0 mtt -137.64 139.5 40.32 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.85 0.75 . . . . 1.5900000000000001 111.946 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.7 mt -100.41 126.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.569 1.548 . . . . 0.97999999999999998 108.346 171.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -105.85 149.26 26.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.995 1.318 . . . . 4.4199999999999999 113.43 -162.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.06 -43.0 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.924 0.89 . . . . 1.6399999999999999 111.827 -167.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.89 171.3 27.15 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.857 -0.897 . . . . 1.1899999999999999 110.857 158.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.45 -147.88 0.02 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.328 2.871 . . . . 2.2000000000000002 114.573 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.52 54.03 0.48 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 123.746 1.736 . . . . 3.25 112.114 -150.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -160.94 27.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.511 -1.677 . . . . 3.8700000000000001 111.655 -162.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 70.5 mtm -132.86 116.25 16.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.529 1.132 . . . . 3.6600000000000001 111.355 -162.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.415 ' N ' HE22 ' A' ' 137' ' ' GLN . 3.4 t -158.44 176.91 11.83 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.597 1.159 . . . . 3.4700000000000002 110.738 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 68.45 25.59 6.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.634 1.974 . . . . 3.77 114.012 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.415 HE22 ' N ' ' A' ' 135' ' ' SER . 0.0 OUTLIER -127.94 153.27 78.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.498 1.119 . . . . 4.0599999999999996 111.774 178.21 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 -13.85 31.6 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.781 2.987 . . . . 2.04 114.478 -170.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -100.07 87.11 0.68 Allowed Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 117.818 -1.087 . . . . 5.5499999999999998 108.596 157.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.77 151.95 60.38 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.933 2.422 . . . . 3.7200000000000002 111.562 -174.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mp 67.38 22.48 9.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 4.4699999999999998 110.301 -168.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.02 -7.58 4.26 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.569 1.557 . . . . 2.8599999999999999 114.612 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.81 1.35 87.2 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.096 1.332 . . . . 2.1299999999999999 114.011 -163.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.7 67.05 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-N 118.982 1.391 . . . . 1.8200000000000001 114.878 -175.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.59 12.58 7.77 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.564 1.554 . . . . 2.0099999999999998 116.704 -169.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.4 p -75.18 169.1 18.71 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.341 1.57 . . . . 2.25 110.196 169.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 137.82 51.15 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.5 1.12 . . . . 6.4400000000000004 111.97 -173.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 3.5 t80 -85.26 -26.21 26.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.686 0.676 . . . . 3.48 111.881 162.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.01 157.78 36.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.236 0.828 . . . . 0.55000000000000004 113.236 173.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.8 t -136.68 148.56 47.45 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.646 1.978 . . . . 1.5 110.768 175.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -148.69 121.8 1.38 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.042 1.306 . . . . 0.80000000000000004 113.038 178.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.02 135.43 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.851 1.66 . . . . 2.3300000000000001 110.911 175.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.6 mt -79.21 155.02 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.068 1.347 . . . . 1.1599999999999999 111.036 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? . . . . . 0 CA--C 1.544 0.718 0 O-C-N 119.997 -1.689 . . . . 4.1500000000000004 110.949 169.783 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.609 -0.886 . . . . 2.46 108.609 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -142.54 150.01 39.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.88 1.437 . . . . 1.4399999999999999 114.88 -133.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.04 141.25 17.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.468 1.128 . . . . 2.9500000000000002 109.825 167.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -90.67 135.39 33.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.617 -0.72 . . . . 3.6600000000000001 111.384 176.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.7 t -121.96 125.13 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.276 -0.89 . . . . 1.55 111.108 177.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.13 115.17 4.14 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.836 1.207 . . . . 1.1399999999999999 110.168 172.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.4 mtp -96.57 107.51 19.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.711 1.204 . . . . 2.02 109.695 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -93.98 146.21 24.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.813 0.671 . . . . 3.21 112.813 -169.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.4 62.75 1.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.378 1.071 . . . . 1.74 113.243 -175.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.6 m -58.54 131.84 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.507 -0.745 . . . . 1.74 111.121 171.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -150.2 48.31 0.91 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.243 1.021 . . . . 2.5800000000000001 110.943 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.04 -36.7 0.32 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 128.703 2.801 . . . . 1.54 112.004 -178.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.295 0.0 OUTLIER -78.28 41.84 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.248 1.419 . . . . 3.29 114.1 174.205 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.17 -155.97 41.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.855 1.217 . . . . 1.97 112.362 175.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.82 125.28 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.158 -1.053 . . . . 1.75 108.158 163.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.35 -82.06 1.55 Allowed Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.995 0.807 . . . . 2.1099999999999999 112.113 -166.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -158.37 164.83 35.95 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 122.389 1.09 . . . . 2.3100000000000001 112.579 167.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 t -103.16 146.76 27.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.758 1.623 . . . . 2.1800000000000002 112.373 -176.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 pt -148.72 10.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.623 1.569 . . . . 3.4500000000000002 113.516 -164.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.02 177.68 19.12 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.78 1.181 . . . . 0.85999999999999999 112.364 -165.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.442 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 3.8 p -129.47 -176.92 4.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.275 1.03 . . . . 1.27 109.984 170.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.6 t -126.52 136.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 124.273 1.029 . . . . 0.56000000000000005 108.367 159.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.56 133.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 123.198 0.312 . . . . 1.49 110.325 171.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mt -108.77 133.78 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.871 -0.789 . . . . 2.3700000000000001 108.871 168.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -139.04 96.6 3.14 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.343 1.857 . . . . 2.2000000000000002 110.068 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 141.65 57.36 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 127.301 2.24 . . . . 4.3399999999999999 111.597 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -156.39 177.52 11.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.745 0.783 . . . . 1.5700000000000001 111.286 175.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.54 -18.51 62.17 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 3.96 112.012 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 7.26 81.13 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.927 1.251 . . . . 1.21 115.355 166.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.78 -169.66 42.93 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 129.458 3.409 . . . . 0.89000000000000001 116.145 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.24 105.45 0.34 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.353 1.461 . . . . 0.93000000000000005 112.03 -175.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -84.75 113.4 21.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 2.6499999999999999 109.115 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -95.01 127.77 41.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.735 2.014 . . . . 0.90000000000000002 108.999 -177.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -137.64 109.77 8.69 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.501 1.501 . . . . 1.6100000000000001 109.715 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.9 162.99 18.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.775 2.983 . . . . 0.66000000000000003 111.335 -175.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.442 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.4 p80 -150.11 30.7 0.7 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.051 0.76 . . . . 1.74 113.051 174.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.06 140.82 29.47 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.672 -1.267 . . . . 0.96999999999999997 112.425 -173.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 26.74 9.82 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.082 1.882 . . . . 2.0099999999999998 116.082 -168.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.65 65.26 0.67 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.131 0.572 . . . . 1.5700000000000001 112.127 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.2 159.39 69.92 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 121.731 -0.606 . . . . 2.23 111.934 170.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -63.79 129.5 24.99 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 120.933 1.089 . . . . 0.88 111.286 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.46 37.53 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.583 1 C-N-CA 126.752 4.968 . . . . 1.24 113.251 -153.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.21 -135.4 7.31 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 123.52 1.622 . . . . 1.4299999999999999 112.165 -177.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -116.28 139.27 50.55 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.011 1.325 . . . . 2.5299999999999998 109.431 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -143.54 144.14 31.83 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.041 0.936 . . . . 1.6399999999999999 110.568 -168.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.95 160.85 52.21 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 110.262 -1.135 . . . . 0.94999999999999996 110.262 174.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 128.31 22.79 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 106.801 -1.555 . . . . 3.1899999999999999 106.801 166.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 93' ' ' ASP . 65.6 m170 -127.99 167.82 16.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.436 2.013 . . . . 1.23 116.436 173.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.7 146.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.716 1.606 . . . . 1.1899999999999999 109.679 151.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.89 161.27 32.23 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.677 2.791 . . . . 1.1200000000000001 108.849 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -26.44 67.32 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.118 2.266 . . . . 0.90000000000000002 117.118 -157.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -140.36 165.65 26.85 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.184 1.394 . . . . 2.0800000000000001 113.271 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.13 104.11 2.68 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 120.806 -1.184 . . . . 1.1799999999999999 114.801 -172.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m 177.56 -173.56 0.12 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.773 3.229 . . . . 3.4500000000000002 109.443 171.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.8 m -120.03 -23.84 6.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.1 1.36 . . . . 2.4100000000000001 113.843 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -76.23 142.51 71.89 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.14 1.163 . . . . 3.0600000000000001 114.14 -158.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.64 160.2 21.97 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.35 3.367 . . . . 1.3100000000000001 112.41 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.84 154.61 19.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.432 0.693 . . . . 1.9199999999999999 109.954 158.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.72 123.7 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.206 1.002 . . . . 2.7200000000000002 108.86 -178.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -169.12 159.76 9.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.498 1.919 . . . . 6.4000000000000004 109.379 -175.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 t70 58.39 27.82 15.94 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.862 -1.149 . . . . 4.3600000000000003 113.234 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.03 14.52 82.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.991 1.281 . . . . 2.7599999999999998 115.032 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -152.65 164.02 38.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.391 1.595 . . . . 3.4900000000000002 113.683 -168.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.71 113.75 26.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 2.1600000000000001 111.109 -178.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.76 57.25 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.785 2.034 . . . . 2.6200000000000001 110.932 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.48 -68.13 0.12 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.964 2.505 . . . . 2.8700000000000001 116.391 160.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -175.77 47.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.834 2.453 . . . . 2.3599999999999999 113.024 -167.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -59.48 -21.36 59.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.134 -1.604 . . . . 4.5099999999999998 113.658 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.38 -19.94 62.21 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 119.669 -1.894 . . . . 2.2799999999999998 112.874 170.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 -9.27 26.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.199 1.8 . . . . 1.3 113.606 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.63 165.21 32.65 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.018 -1.051 . . . . 2.9199999999999999 113.355 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.98 -173.09 23.98 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.855 -0.791 . . . . 1.77 112.752 168.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -44.66 138.92 3.14 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.515 0.726 . . . . 2.73 109.275 163.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 66.13 1.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.263 1.825 . . . . 4.4699999999999998 112.796 -165.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -110.06 83.79 3.2 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 129.002 2.921 . . . . 4.1299999999999999 108.226 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.36 -21.53 37.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.775 2.984 . . . . 3.2400000000000002 114.733 -176.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 6.26 0.24 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.293 0.849 . . . . 9.5600000000000005 113.293 153.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.71 -38.94 67.34 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.365 -1.46 . . . . 4.2599999999999998 114.828 -144.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t 169.26 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.267 2.227 . . . . 4.3700000000000001 112.078 -170.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.27 43.84 4.85 Favored Glycine 0 N--CA 1.47 0.931 0 CA-C-O 118.955 -0.914 . . . . 3.5699999999999998 113.077 176.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.316 12.9 ptmt -143.4 -101.08 0.12 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.912 1.449 . . . . 4.6200000000000001 114.912 -176.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.452 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -163.88 144.2 8.43 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 117.355 2.354 . . . . 2.6200000000000001 117.355 -157.533 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.64 -130.6 0.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.202 2.201 . . . . 4.0800000000000001 107.738 160.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.49 -89.59 0.56 Allowed Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.761 1.648 . . . . 2.96 111.868 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -98.33 -21.0 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.297 2.665 . . . . 3.1299999999999999 114.993 -172.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 157.77 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.684 3.194 . . . . 5.4199999999999999 110.427 -161.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.76 -151.6 28.1 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.532 1.539 . . . . 4.7199999999999998 114.592 -172.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.78 13.18 0.27 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.43 2.011 . . . . 7.6799999999999997 116.43 -160.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.08 -178.55 38.42 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 120.251 1.387 . . . . 2.79 113.071 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.773 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 19.3 t-160 57.32 96.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.246 1.818 . . . . 6.5899999999999999 115.007 170.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 65.37 6.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.693 -1.254 . . . . 3.77 110.938 169.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.03 7.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.789 -1.562 . . . . 2.3199999999999998 116.472 -176.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.773 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 3.2 m-20 -74.66 147.28 41.67 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.15 1.475 . . . . 1.8999999999999999 108.85 157.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.48 171.85 6.9 Favored Pre-proline 0 CA--C 1.555 1.151 0 O-C-N 121.314 -0.866 . . . . 2.6800000000000002 110.521 -142.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.89 133.21 19.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.326 2.018 . . . . 2.1200000000000001 110.403 -174.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.01 132.39 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 123.362 1.554 . . . . 2.29 112.766 -175.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -68.43 91.93 0.42 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.46 2.304 . . . . 3.79 110.253 168.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.14 131.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.028 -1.045 . . . . 1.2 109.133 166.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.77 133.55 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.407 1.883 . . . . 2.5600000000000001 106.915 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.41 154.57 22.73 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.808 0.731 . . . . 1.8600000000000001 112.359 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -24.17 0.4 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.924 2.565 . . . . 2.77 117.924 -167.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -93.22 -6.36 47.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.51 1.524 . . . . 2.9900000000000002 114.103 -176.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.25 20.71 8.48 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 125.072 1.32 . . . . 0.93000000000000005 115.487 175.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.71 127.81 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 118.161 0.98 . . . . 1.6399999999999999 109.984 -176.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.68 118.94 31.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 0.90000000000000002 109.291 169.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.1 t -135.48 4.45 3.13 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.963 1.305 . . . . 1.48 113.695 -178.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.01 119.74 69.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.856 1.662 . . . . 3.3500000000000001 112.982 -165.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.88 136.38 16.64 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.632 2.888 . . . . 1.21 112.402 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.97 173.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 126.557 1.943 . . . . 1.8700000000000001 109.848 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 m -145.5 140.26 27.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.537 1.062 . . . . 1.1599999999999999 110.971 -174.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.34 90.64 5.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.609 1.163 . . . . 0.70999999999999996 111.858 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.82 -2.61 11.21 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.09 3.193 . . . . 1.1699999999999999 115.293 -176.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.68 -15.95 61.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.379 1.472 . . . . 5.5599999999999996 112.396 176.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.09 145.31 49.99 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.67 1.988 . . . . 3.8700000000000001 107.684 175.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -147.44 32.9 0.88 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.603 2.361 . . . . 5.6299999999999999 111.625 -175.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -163.86 141.8 7.35 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.082 1.353 . . . . 2.3500000000000001 111.503 156.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.0 tp -65.96 -23.71 66.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.084 -1.01 . . . . 2.4900000000000002 110.685 175.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.07 -24.99 60.68 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.514 1.126 . . . . 2.6600000000000001 113.098 169.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -68.19 -15.87 63.75 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.641 1.11 . . . . 2.77 112.392 174.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.93 8.08 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 114.192 1.182 . . . . 1.01 114.192 -172.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -69.93 5.28 1.62 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 116.274 1.953 . . . . 3.9399999999999999 116.274 -171.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.46 9.09 3.98 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.137 2.175 . . . . 2.6899999999999999 112.195 177.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -110.45 -178.34 3.47 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.115 1.366 . . . . 2.54 114.311 -168.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.51 149.88 41.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.988 1.315 . . . . 0.87 111.8 172.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.07 154.24 17.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.669 1.988 . . . . 2.29 107.828 165.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.5 mtt -142.09 141.17 32.71 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.367 -0.833 . . . . 1.77 113.067 170.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.9 mt -88.34 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 108.18 -1.045 . . . . 1.25 108.18 165.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.21 152.64 47.12 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.205 1.557 . . . . 3.25 115.205 -165.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.06 -53.53 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.727 1.611 . . . . 1.8300000000000001 112.762 -159.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.56 179.39 52.44 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.573 -1.411 . . . . 1.3300000000000001 109.573 158.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.82 -143.87 0.03 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 127.236 2.351 . . . . 2.29 112.553 168.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.4 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 32.9 t0 -151.53 59.92 0.88 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.185 1.18 . . . . 3.5899999999999999 114.185 -169.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -149.31 21.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.219 1.008 . . . . 3.0099999999999998 113.564 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.06 142.71 52.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.017 1.327 . . . . 5.8899999999999997 112.672 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.4 p -85.04 166.49 16.65 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.88 1.272 . . . . 6.7400000000000002 112.864 172.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.92 142.43 51.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.814 0.846 . . . . 6.71 112.172 177.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.87 156.76 34.4 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.816 1.246 . . . . 4.5899999999999999 109.581 -160.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.03 -0.06 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.019 3.146 . . . . 2.6000000000000001 114.169 174.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -116.79 132.85 23.19 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.169 0.988 . . . . 7.5300000000000002 108.557 159.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.86 164.68 32.58 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.791 2.327 . . . . 3.96 112.286 -173.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt 69.55 4.84 4.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.814 2.046 . . . . 5.21 113.729 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.57 15.16 77.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.103 0.859 . . . . 3.48 113.359 -175.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.46 -51.52 3.34 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.537 1.541 . . . . 2.1299999999999999 113.757 -178.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.46 -10.5 73.62 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.333 1.444 . . . . 1.99 115.044 -176.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.49 42.44 1.97 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.653 1.597 . . . . 3.6299999999999999 113.937 -178.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.7 p -119.39 163.64 16.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 128.473 2.709 . . . . 4.4900000000000002 109.84 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.47 140.17 29.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.667 2.099 . . . . 7.2599999999999998 116.667 -166.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -98.99 -20.77 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.103 1.361 . . . . 4.2199999999999998 112.195 155.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.69 153.39 29.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.169 0.895 . . . . 0.81000000000000005 113.151 173.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 19.0 p -84.66 -149.86 0.12 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.723 1.609 . . . . 2.98 111.88 171.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.17 81.11 0.03 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.28 0.943 . . . . 1.6799999999999999 113.806 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.69 120.1 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.386 1.075 . . . . 2.98 111.568 176.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 71.2 mt -79.76 138.72 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.147 -0.686 . . . . 1.3200000000000001 109.147 173.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.549 0.939 0 O-C-N 120.503 -1.373 . . . . 4.6399999999999997 111.335 -176.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.379 -0.6 . . . . 2.4399999999999999 109.379 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -138.38 158.46 44.24 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.832 -1.167 . . . . 1.3300000000000001 114.089 -145.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -160.41 116.65 2.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.518 1.527 . . . . 3.4700000000000002 108.118 -175.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -90.46 143.14 27.04 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.884 -1.135 . . . . 5.1500000000000004 110.475 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.64 85.59 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 122.424 1.107 . . . . 1.52 111.707 177.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -32.07 114.52 0.08 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 127.252 2.358 . . . . 1.8500000000000001 113.131 147.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.8 mtt -101.9 148.41 25.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 113.79 -1.205 . . . . 2.0800000000000001 113.365 171.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.22 148.38 35.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 2.2999999999999998 110.647 168.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.1 mt -61.18 135.93 57.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.512 -0.922 . . . . 1.3200000000000001 108.512 166.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.5 143.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.423 1.089 . . . . 1.5 108.912 173.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -171.68 91.87 0.13 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.512 -0.921 . . . . 2.4399999999999999 108.512 -174.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.85 -62.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.943 2.097 . . . . 2.1299999999999999 113.507 -177.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.265 0.1 OUTLIER -80.76 12.62 3.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.91 1.684 . . . . 5.9299999999999997 114.859 -173.212 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.14 -151.02 32.77 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.221 0.915 . . . . 1.28 112.049 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.98 110.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.452 1.901 . . . . 1.21 111.835 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.58 -72.3 1.11 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.901 1.239 . . . . 1.7 113.636 -175.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.92 153.44 16.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.645 1.178 . . . . 2.4399999999999999 111.649 -175.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -92.97 145.22 24.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.014 1.726 . . . . 1.8500000000000001 114.523 -165.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 5.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 115.949 1.833 . . . . 4.4900000000000002 115.949 -177.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.74 175.54 20.58 Favored Glycine 0 N--CA 1.467 0.704 0 O-C-N 121.197 -0.94 . . . . 0.68999999999999995 113.86 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 m -115.34 156.51 25.36 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.975 1.31 . . . . 4.1799999999999997 108.859 172.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.49 133.43 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.889 -1.152 . . . . 0.68000000000000005 107.889 152.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -91.61 129.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 117.872 0.305 . . . . 1.3999999999999999 110.911 175.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mt -100.42 129.87 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.406 -0.961 . . . . 2.3900000000000001 108.406 170.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -133.21 123.55 25.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.272 1.029 . . . . 2.0600000000000001 109.279 167.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -78.56 157.98 28.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 112.252 0.464 . . . . 3.48 112.252 -177.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 t -156.36 178.49 10.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.906 0.86 . . . . 1.73 109.834 168.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -63.83 -13.42 44.47 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.419 2.288 . . . . 3.8599999999999999 113.137 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.22 8.73 53.47 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.104 1.812 . . . . 1.4299999999999999 115.437 165.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.68 -162.85 28.08 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 130.643 3.973 . . . . 0.93999999999999995 117.638 171.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.55 108.02 2.28 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.357 1.063 . . . . 0.80000000000000004 111.738 -172.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -85.98 109.75 18.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.41 1.084 . . . . 2.3999999999999999 110.209 173.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.8 t80 -94.29 112.81 24.63 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.375 2.27 . . . . 0.68000000000000005 108.835 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 m -120.1 112.31 34.84 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 120.003 1.274 . . . . 1.1499999999999999 108.58 -176.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.58 150.6 7.57 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.011 2.474 . . . . 0.59999999999999998 113.156 -171.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -147.51 41.98 1.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.356 1.074 . . . . 1.6299999999999999 112.547 171.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.19 156.51 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.707 1.603 . . . . 0.93000000000000005 113.845 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 167.0 18.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.131 -1.85 . . . . 3.3300000000000001 109.211 176.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.55 19.42 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.14 2.576 . . . . 1.6499999999999999 113.566 172.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.33 164.75 23.56 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 121.678 -0.639 . . . . 3.0 110.231 174.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.29 145.3 96.05 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 120.296 0.664 . . . . 0.93999999999999995 111.578 165.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -85.39 25.61 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 125.111 3.874 . . . . 1.25 114.253 -153.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.84 -141.1 6.7 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 125.216 1.389 . . . . 1.28 116.012 -174.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.3 141.92 29.06 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.67 2.388 . . . . 2.3999999999999999 110.451 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -136.18 137.66 41.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.463 1.105 . . . . 1.8600000000000001 111.449 -172.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 157.38 52.34 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.899 -1.126 . . . . 0.98999999999999999 111.631 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 8.4 t80 -130.98 112.92 13.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.155 -1.424 . . . . 3.29 107.155 173.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -118.48 162.21 18.72 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.127 -0.983 . . . . 1.1799999999999999 113.518 165.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.41 135.08 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.429 1.492 . . . . 0.92000000000000004 107.281 159.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -115.06 159.08 21.25 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.602 0.761 . . . . 1.1799999999999999 109.659 170.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.13 79.59 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.827 1.788 . . . . 1.01 115.827 -160.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.97 143.64 48.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.398 1.079 . . . . 1.3899999999999999 113.019 -173.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.55 62.18 2.75 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.512 1.53 . . . . 1.1499999999999999 114.941 -176.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -162.73 89.88 0.68 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.408 1.604 . . . . 2.5099999999999998 115.225 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.0 m -74.15 74.25 1.76 Allowed 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.041 -1.662 . . . . 2.7400000000000002 111.8 166.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -122.27 144.95 43.0 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.239 1.016 . . . . 3.2200000000000002 110.365 174.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.05 162.43 10.2 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.971 2.447 . . . . 1.53 113.831 -167.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.51 128.78 55.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.387 1.075 . . . . 2.0299999999999998 108.935 161.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mm -90.71 38.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.456 1.122 . . . . 3.2799999999999998 110.009 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -66.72 130.34 42.84 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.929 1.291 . . . . 4.8600000000000003 110.976 -167.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t70 57.65 21.76 7.58 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.148 1.166 . . . . 3.7200000000000002 114.148 -176.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.05 76.01 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.148 0.88 . . . . 2.9399999999999999 114.495 177.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.75 134.88 52.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.401 1.601 . . . . 3.48 110.71 172.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.74 95.11 9.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.319 -0.863 . . . . 2.0600000000000001 112.104 -169.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.73 95.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.596 1.558 . . . . 2.8300000000000001 108.594 173.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.4 -25.88 0.47 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 119.797 3.258 . . . . 3.3700000000000001 119.797 -156.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.67 38.06 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 120.128 1.331 . . . . 1.6299999999999999 114.267 -168.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.26 -34.12 73.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.224 1.01 . . . . 4.7699999999999996 113.076 -177.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.68 0.55 1.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.036 1.495 . . . . 1.6100000000000001 115.036 -175.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.57 -10.84 59.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.217 1.407 . . . . 1.1799999999999999 113.856 175.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.33 32.89 12.58 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 116.796 1.479 . . . . 3.1800000000000002 116.796 164.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.57 -178.58 31.54 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 119.452 1.626 . . . . 2.0299999999999998 114.457 174.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -76.2 22.58 0.16 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.197 1.554 . . . . 2.3700000000000001 115.197 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.254 31.1 tp 64.41 36.16 9.12 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.143 1.377 . . . . 2.6099999999999999 111.508 172.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -123.17 49.55 2.54 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 116.371 1.989 . . . . 3.6099999999999999 116.371 -161.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.33 -29.14 46.44 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.51 2.14 . . . . 3.1000000000000001 113.028 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -127.16 34.88 4.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.649 1.18 . . . . 4.4699999999999998 111.905 -168.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -119.84 -153.6 0.55 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.834 1.254 . . . . 3.3700000000000001 110.882 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.6 p -88.99 -25.17 22.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.271 1.428 . . . . 3.8700000000000001 113.174 175.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.31 88.78 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.392 0.996 . . . . 2.0299999999999998 114.74 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -98.05 7.94 45.53 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 116.116 1.895 . . . . 5.8399999999999999 116.116 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.7 t60 68.61 168.04 0.27 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.961 1.704 . . . . 2.46 112.768 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -150.17 155.25 39.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.793 1.405 . . . . 3.6000000000000001 114.793 -149.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.33 -155.06 6.89 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 126.291 1.9 . . . . 2.6000000000000001 112.873 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.26 -9.79 24.83 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.861 3.041 . . . . 4.5199999999999996 113.041 173.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.31 162.56 32.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.48 1.912 . . . . 6.3499999999999996 109.159 166.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.42 -159.71 23.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.28 0.943 . . . . 5.7199999999999998 112.84 -172.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.95 137.21 3.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.393 2.277 . . . . 5.5300000000000002 105.876 168.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.7 -72.87 0.02 OUTLIER Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.195 0.902 . . . . 2.77 114.282 -172.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -150.85 125.75 9.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.596 1.959 . . . . 4.9900000000000002 110.801 -173.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -62.45 -20.38 64.47 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.223 1.194 . . . . 3.7000000000000002 114.223 175.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.39 8.22 59.03 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.631 2.062 . . . . 1.3300000000000001 116.031 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.39 139.75 30.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.995 1.397 . . . . 1.6499999999999999 111.154 167.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.61 163.63 49.75 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 126.784 2.034 . . . . 3.1000000000000001 110.077 -172.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.77 162.43 26.91 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.141 2.561 . . . . 1.3600000000000001 112.304 -172.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.12 141.92 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.699 1.37 . . . . 2.2000000000000002 114.699 -164.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.12 107.09 18.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 130.675 3.59 . . . . 2.6400000000000001 108.682 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.34 137.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.907 -1.121 . . . . 1.0600000000000001 110.575 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.9 m -109.09 161.2 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.356 0.662 . . . . 3.3799999999999999 109.962 164.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.91 165.07 16.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.864 0.466 . . . . 2.0299999999999998 110.927 175.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.72 4.79 0.14 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 117.568 2.433 . . . . 4.04 117.568 -161.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -104.17 -11.08 17.48 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.27 2.628 . . . . 3.4500000000000002 113.395 176.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.49 24.48 12.26 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 121.365 -0.834 . . . . 1.04 114.675 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.5 mt -126.05 129.84 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.629 1.172 . . . . 2.04 110.92 -176.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.22 147.66 24.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.099 2.16 . . . . 1.1799999999999999 112.075 -172.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.97 -21.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.89 1.276 . . . . 1.7 114.057 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.53 116.95 50.61 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.457 1.103 . . . . 3.0600000000000001 110.447 176.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -85.07 163.13 11.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.592 2.862 . . . . 1.3400000000000001 112.349 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.85 161.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.723 1.209 . . . . 1.54 110.577 170.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 m -124.04 139.81 53.58 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.327 1.051 . . . . 1.1799999999999999 110.041 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.58 97.85 29.71 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.21 1.004 . . . . 0.91000000000000003 110.79 174.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.88 -0.8 10.36 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.925 3.083 . . . . 1.3600000000000001 114.333 -176.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -86.94 -2.76 58.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.627 1.571 . . . . 4.7800000000000002 112.696 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.1 mt -141.53 123.86 15.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.52 2.328 . . . . 3.5800000000000001 106.242 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -116.18 5.66 13.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.857 1.263 . . . . 5.3399999999999999 114.158 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.7 t -149.38 150.05 31.83 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.441 0.904 . . . . 2.5099999999999998 113.441 175.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.78 -28.68 70.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.377 -0.827 . . . . 2.1800000000000002 112.569 170.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.01 -18.57 65.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.065 1.302 . . . . 3.6699999999999999 113.58 -177.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.03 -19.49 61.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.338 1.055 . . . . 2.46 112.121 172.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.47 7.26 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.656 1.182 . . . . 0.92000000000000004 113.941 -170.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -63.68 5.67 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.263 2.32 . . . . 3.1899999999999999 117.263 -174.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.54 0.43 2.49 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.713 2.005 . . . . 3.0 112.607 -178.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -95.81 171.71 8.48 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.457 1.503 . . . . 2.2000000000000002 113.577 -168.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.73 150.28 27.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.511 1.124 . . . . 0.60999999999999999 111.984 165.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 mt -122.4 140.29 52.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.41 2.284 . . . . 2.25 107.803 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.463 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -143.23 146.81 33.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.418 1.008 . . . . 3.7599999999999998 113.599 177.937 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.8 119.14 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.274 1.43 . . . . 1.3200000000000001 108.301 166.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 126' ' ' MET . 74.6 m80 -98.57 148.44 23.78 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.672 1.589 . . . . 4.4000000000000004 112.013 -168.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.8 -46.37 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.173 0.589 . . . . 2.1200000000000001 112.144 -158.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.35 169.71 13.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.79 1.186 . . . . 2.0800000000000001 111.14 164.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.28 -174.6 4.68 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.216 1.865 . . . . 1.8300000000000001 113.433 170.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -159.91 166.22 30.58 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.787 0.835 . . . . 3.5299999999999998 111.914 -166.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.0 p30 159.04 23.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 132.721 4.408 . . . . 3.3900000000000001 111.625 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 72.9 mtm -92.37 106.84 18.76 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.897 -1.127 . . . . 3.9300000000000002 112.504 -165.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 p -93.05 158.86 15.56 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.656 -1.277 . . . . 4.0 113.903 169.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.2 t0 65.58 17.96 11.08 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.417 2.006 . . . . 5.4100000000000001 116.417 155.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.9 157.08 49.17 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 120.699 -1.251 . . . . 6.8799999999999999 113.675 -172.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.36 -21.75 3.52 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.667 2.911 . . . . 3.21 114.134 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -102.92 95.74 6.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.088 -1.007 . . . . 8.5899999999999999 108.382 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.65 143.78 75.99 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.566 2.177 . . . . 3.9100000000000001 111.504 -164.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 77.06 -10.74 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.472 2.709 . . . . 4.9000000000000004 113.013 -174.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 62.58 15.41 53.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 2.9700000000000002 115.66 170.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.1 -21.8 32.45 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.912 1.244 . . . . 2.6499999999999999 113.631 -170.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.89 -8.18 52.21 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.403 1.478 . . . . 2.79 114.009 176.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.69 -5.14 83.01 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.025 1.298 . . . . 2.3599999999999999 114.514 170.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.6 p -75.78 132.28 40.33 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.894 1.347 . . . . 2.5600000000000001 110.174 175.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -97.84 135.08 40.11 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.167 0.987 . . . . 7.3300000000000001 110.192 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -91.0 -40.04 11.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.047 0.385 . . . . 3.4500000000000002 110.326 164.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.52 29.26 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.909 0.884 . . . . 1.1399999999999999 111.931 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.2 m -114.73 145.03 42.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.891 2.076 . . . . 2.8700000000000001 111.233 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.74 167.65 26.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.919 1.723 . . . . 1.3700000000000001 113.225 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.9 t -135.54 141.91 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.738 1.215 . . . . 2.27 109.734 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.2 mt -89.06 143.47 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.738 1.215 . . . . 1.2 110.774 -176.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 5.2000000000000002 111.287 -177.27 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.238 0.542 . . . . 2.21 110.659 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -148.43 149.78 32.32 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.856 0.862 . . . . 1.52 110.362 -172.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.04 132.05 16.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.657 1.217 . . . . 2.23 110.053 171.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -88.56 109.79 20.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.179 0.992 . . . . 4.4699999999999998 111.559 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -87.02 105.51 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.609 -1.307 . . . . 1.8100000000000001 108.885 -169.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.38 108.81 1.8 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.651 1.596 . . . . 1.54 109.953 169.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.7 mtt -109.41 154.03 23.16 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.275 1.43 . . . . 2.1800000000000002 112.508 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -145.9 149.68 34.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.56 1.544 . . . . 3.0600000000000001 112.003 -169.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.41 66.1 3.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.953 1.301 . . . . 1.6000000000000001 111.435 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.25 144.83 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.698 0.799 . . . . 1.51 111.599 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.4 t -172.69 72.19 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.451 1.1 . . . . 2.0499999999999998 111.152 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.11 -19.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.866 2.066 . . . . 1.8799999999999999 114.834 173.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -28.86 66.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.479 1.912 . . . . 3.0600000000000001 110.006 164.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.47 -159.23 24.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.182 1.372 . . . . 1.3200000000000001 111.067 -154.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -46.15 127.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.411 1.884 . . . . 1.6000000000000001 111.122 165.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.79 -68.02 0.18 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.607 1.575 . . . . 1.6599999999999999 114.039 -173.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.156 1.382 . . . . 2.2599999999999998 110.543 171.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -109.25 172.23 6.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.737 -1.227 . . . . 2.1800000000000002 112.571 178.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.7 pt -151.19 5.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 128.98 2.912 . . . . 3.6800000000000002 112.479 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.53 159.37 9.08 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 121.137 -0.977 . . . . 0.92000000000000004 113.751 -161.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 p -125.99 -178.5 4.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.683 1.993 . . . . 1.98 106.74 173.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.52 125.83 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.359 -0.978 . . . . 0.60999999999999999 108.359 169.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.417 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.0 p -74.77 124.69 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 117.978 0.354 . . . . 1.5800000000000001 110.599 170.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -98.41 131.43 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 108.298 -1.001 . . . . 2.1499999999999999 108.298 163.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -140.05 121.47 15.05 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.132 1.373 . . . . 1.8100000000000001 108.572 178.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.74 150.26 21.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.801 0.667 . . . . 3.0499999999999998 112.801 -169.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.6 178.9 9.57 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.108 0.563 . . . . 1.5 110.546 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -60.53 -30.81 69.98 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.676 1.19 . . . . 3.6099999999999999 110.958 175.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.6 13.96 53.54 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.164 1.364 . . . . 0.97999999999999998 114.953 168.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.31 -148.49 20.71 Favored Glycine 0 N--CA 1.468 0.782 0 C-N-CA 127.167 2.318 . . . . 0.81000000000000005 116.268 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.2 mt -79.18 101.54 8.0 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.169 -0.606 . . . . 0.80000000000000004 110.862 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -75.73 112.37 12.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 3.54 109.587 171.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -98.79 109.07 21.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 128.02 2.528 . . . . 0.62 108.14 -178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.417 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.5 m -111.13 105.64 57.11 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.335 -1.357 . . . . 1.04 107.335 176.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.31 153.23 24.17 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.316 2.677 . . . . 0.84999999999999998 110.846 -171.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.97 63.37 0.65 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.177 0.989 . . . . 3.3700000000000001 111.013 178.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.25 141.78 51.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.057 2.143 . . . . 1.0700000000000001 111.528 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -129.32 20.82 5.71 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 118.029 2.603 . . . . 4.3399999999999999 118.029 -158.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.43 19.58 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 115.581 1.697 . . . . 1.8999999999999999 115.581 -173.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.78 165.35 19.12 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 121.492 -0.755 . . . . 3.0099999999999998 110.856 -171.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.95 131.26 26.65 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 N-CA-C 109.806 -0.882 . . . . 1.25 109.806 163.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -88.88 34.2 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.272 3.315 . . . . 1.28 112.402 -148.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.44 -122.54 4.8 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 123.821 1.79 . . . . 1.51 113.616 -178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -134.88 142.41 46.58 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 126.372 1.869 . . . . 3.1000000000000001 109.747 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -134.59 145.87 49.07 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.572 1.149 . . . . 1.3100000000000001 111.707 -173.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.82 157.16 26.72 Favored Glycine 0 CA--C 1.542 1.758 0 O-C-N 121.024 -1.048 . . . . 0.75 111.951 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -145.56 120.51 10.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.791 1.237 . . . . 3.3700000000000001 108.086 168.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.12 165.16 24.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.702 1.742 . . . . 1.27 115.702 164.077 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.0 mt -89.96 144.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.398 1.479 . . . . 1.1200000000000001 109.143 160.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -127.44 170.19 12.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.885 2.074 . . . . 1.3400000000000001 111.361 -178.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.98 52.74 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.99 2.218 . . . . 1.02 116.99 -160.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -110.51 -157.41 0.61 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.752 1.221 . . . . 2.7000000000000002 111.477 -175.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.12 -27.63 8.67 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 117.65 1.82 . . . . 2.3900000000000001 117.65 -155.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 175.8 140.12 0.06 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.963 2.382 . . . . 4.75 113.877 -173.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.58 67.08 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 117.354 2.353 . . . . 3.5800000000000001 117.354 -176.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -94.09 152.04 40.09 Favored Pre-proline 0 CA--C 1.55 0.963 0 O-C-N 121.053 -1.029 . . . . 3.4700000000000002 110.689 160.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -90.22 177.63 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.207 3.272 . . . . 1.8700000000000001 112.673 -168.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.67 147.21 37.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.995 1.318 . . . . 1.72 110.624 172.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.87 126.94 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.915 0.886 . . . . 2.8100000000000001 110.989 -174.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.86 156.47 22.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.706 2.402 . . . . 6.8200000000000003 110.73 173.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 52.09 37.33 21.23 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.078 1.51 . . . . 4.1799999999999997 115.078 167.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.88 79.38 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.003 -1.061 . . . . 2.7400000000000002 114.351 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.07 156.04 42.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.857 1.328 . . . . 5.6799999999999997 113.528 -176.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.77 121.78 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.647 0.779 . . . . 1.96 108.909 164.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.41 132.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.719 1.208 . . . . 3.0 108.567 171.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.3 -37.75 17.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.808 1.243 . . . . 2.1400000000000001 114.148 -172.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -179.98 123.74 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.465 2.706 . . . . 1.8400000000000001 110.307 175.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -121.49 -29.07 4.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.905 1.282 . . . . 4.2199999999999998 112.547 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.96 -0.29 8.98 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.202 -1.561 . . . . 1.8600000000000001 114.071 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.56 -17.46 33.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.734 1.614 . . . . 1.27 113.273 164.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.59 179.61 52.81 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.642 1.591 . . . . 2.5099999999999998 114.439 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.5 -172.8 25.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.946 0.784 . . . . 1.6200000000000001 112.864 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.94 24.07 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.047 1.739 . . . . 2.2000000000000002 115.627 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.9 tp 52.29 49.04 21.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.211 1.405 . . . . 2.6699999999999999 110.493 176.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -151.49 110.8 2.98 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.433 -0.803 . . . . 4.29 112.634 -171.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -91.72 -18.96 0.84 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.012 2.475 . . . . 3.2400000000000002 113.766 174.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -159.25 -22.56 0.07 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.938 1.829 . . . . 4.1399999999999997 115.938 -163.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -64.76 -35.86 82.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.751 1.614 . . . . 3.5800000000000001 112.366 -171.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -165.91 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.991 2.517 . . . . 4.3600000000000003 111.263 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.18 11.14 70.12 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.515 1.531 . . . . 2.3900000000000001 112.73 -177.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -167.16 -105.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.245 1.818 . . . . 6.4100000000000001 113.033 -166.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.433 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 4.2 t60 -161.43 141.57 10.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.727 1.751 . . . . 2.7400000000000002 115.727 -161.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.43 149.83 36.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.092 0.957 . . . . 4.0 113.293 174.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.52 -145.63 17.88 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 110.316 -1.114 . . . . 3.4900000000000002 110.316 156.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.39 17.56 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.996 3.131 . . . . 3.9199999999999999 114.253 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.63 -11.08 8.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.691 1.596 . . . . 4.7800000000000002 114.429 -157.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.14 -7.68 81.58 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 116.955 1.542 . . . . 4.5099999999999998 116.955 169.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -78.02 83.16 4.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 1.585 . . . . 6.5700000000000003 109.383 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.8 -177.1 14.89 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 123.936 0.779 . . . . 4.0499999999999998 114.812 -168.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.998 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 5.4 p-80 -92.04 157.92 16.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.693 0.797 . . . . 7.0499999999999998 111.274 169.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -10.12 12.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.118 1.525 . . . . 4.5 115.118 -179.151 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.529 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -115.24 19.9 14.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.798 2.142 . . . . 1.5800000000000001 113.753 173.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.998 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 69.0 m-20 -73.86 135.12 43.36 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.42 1.11 . . . . 2.5099999999999998 109.491 164.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.01 160.48 31.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.16 1.384 . . . . 2.7000000000000002 110.294 -147.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.11 168.77 20.07 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.216 3.277 . . . . 1.4399999999999999 111.633 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 m -82.0 142.89 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 122.894 1.33 . . . . 2.1299999999999999 113.374 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.76 92.73 3.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 129.061 2.944 . . . . 2.75 109.204 172.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 95.9 t -74.75 137.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.875 0.87 . . . . 1.3100000000000001 110.366 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.99 143.22 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.427 2.291 . . . . 2.3799999999999999 106.305 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.8 164.49 12.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.858 0.754 . . . . 2.0499999999999998 111.701 174.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.64 -23.82 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 129.597 3.159 . . . . 2.9399999999999999 118.112 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.88 -23.5 52.61 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.935 1.694 . . . . 3.9700000000000002 112.463 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.46 17.73 32.91 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.948 1.737 . . . . 0.88 112.941 -161.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.1 mt -111.81 119.99 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.962 1.305 . . . . 1.48 110.966 -176.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.84 127.52 39.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.775 1.23 . . . . 1.1399999999999999 109.732 168.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -156.2 4.49 0.17 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.233 1.568 . . . . 1.6399999999999999 115.233 -175.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.22 135.9 26.39 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 119.81 1.186 . . . . 3.5800000000000001 110.638 172.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.0 141.72 49.14 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.017 3.145 . . . . 1.3 112.189 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.09 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.823 2.049 . . . . 2.5699999999999998 108.151 173.019 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.4 m -145.96 139.64 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.931 1.241 . . . . 0.85999999999999999 111.707 -178.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.01 94.06 5.05 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.26 1.024 . . . . 0.81999999999999995 112.462 169.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.79 -5.07 16.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.133 3.222 . . . . 1.3500000000000001 113.933 172.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -73.11 -7.92 53.45 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.146 1.778 . . . . 5.75 111.863 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.6 mt -124.28 177.16 6.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.735 2.414 . . . . 3.5899999999999999 109.821 170.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -144.39 -20.69 0.54 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.012 1.856 . . . . 4.8099999999999996 116.012 -172.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -144.03 163.25 34.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.847 1.203 . . . . 1.99 112.399 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.23 61.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.285 -0.884 . . . . 2.4700000000000002 110.297 174.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.95 -27.68 69.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.378 1.071 . . . . 3.1299999999999999 113.503 -166.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.48 -20.36 62.09 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.753 1.621 . . . . 2.21 113.869 175.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.33 8.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.374 1.47 . . . . 1.1699999999999999 112.984 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -62.08 -4.41 1.67 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.107 1.891 . . . . 3.23 116.107 -175.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -137.67 24.26 2.88 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.318 2.247 . . . . 3.0099999999999998 110.814 -160.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -130.68 158.44 40.06 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.332 1.453 . . . . 2.2000000000000002 113.931 -168.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.76 150.65 20.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.097 1.759 . . . . 1.0900000000000001 112.987 168.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.4 mp -127.36 121.01 29.82 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.043 2.137 . . . . 4.2300000000000004 109.86 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -103.06 131.65 49.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.786 0.835 . . . . 2.9100000000000001 111.405 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.6 mt -93.52 123.38 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 107.818 -1.179 . . . . 0.85999999999999999 107.818 160.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -112.89 140.86 47.33 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.427 1.491 . . . . 2.9100000000000001 112.262 -159.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.03 -41.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.555 -0.716 . . . . 1.6899999999999999 111.585 -168.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.23 163.57 15.0 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.493 0.568 . . . . 1.46 112.135 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.22 87.72 1.49 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.08 -1.208 . . . . 1.8500000000000001 110.08 173.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -61.78 122.61 15.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.797 0.839 . . . . 4.2999999999999998 111.645 178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 171.81 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.239 2.616 . . . . 4.1799999999999997 109.662 -157.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.9 ptp -74.15 60.42 0.79 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.345 1.458 . . . . 4.0300000000000002 112.192 171.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 t -74.08 -20.38 60.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.186 1.794 . . . . 4.04 115.111 -165.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -81.87 76.18 8.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 3.3599999999999999 112.269 -173.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -169.56 156.69 6.42 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.08 1.352 . . . . 3.9199999999999999 111.78 -179.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.89 -9.65 18.15 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.711 2.941 . . . . 3.2000000000000002 113.64 176.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -93.2 106.12 18.45 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 119.229 0.922 . . . . 5.29 109.0 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.46 160.22 47.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.104 2.536 . . . . 3.7200000000000002 113.274 -158.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.58 32.22 21.92 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.834 1.654 . . . . 4.4900000000000002 111.501 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.34 67.45 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.668 1.128 . . . . 3.0800000000000001 114.333 -177.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.94 -17.0 18.34 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.156 1.36 . . . . 1.98 113.242 -164.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.92 8.24 60.6 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.006 1.765 . . . . 1.5700000000000001 114.844 -176.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.49 68.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.302 1.43 . . . . 1.72 115.801 -170.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -58.47 154.46 13.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.181 1.49 . . . . 1.8899999999999999 110.482 168.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 mmt-85 -96.39 138.47 33.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.388 1.075 . . . . 4.6299999999999999 109.453 -176.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.86 -18.8 16.22 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.955 0.798 . . . . 4.7800000000000002 111.774 154.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.31 168.79 25.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.537 1.135 . . . . 0.88 111.409 164.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -152.98 153.26 32.58 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.057 1.343 . . . . 1.8700000000000001 110.697 172.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -153.17 178.67 30.1 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.181 1.372 . . . . 1.6899999999999999 114.305 -175.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 139.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.05 1.34 . . . . 3.5600000000000001 111.302 -171.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 76.2 mt -92.86 143.03 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.44 1.096 . . . . 1.49 109.613 171.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt . . . . . 0 N--CA 1.471 0.62 0 O-C-N 120.67 -1.269 . . . . 4.3899999999999997 112.508 177.128 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.717 -0.846 . . . . 1.96 108.717 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.22 156.12 47.32 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.167 1.349 . . . . 1.6499999999999999 114.187 -148.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.68 127.54 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.897 1.679 . . . . 2.3199999999999998 108.872 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -103.31 98.82 8.68 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.684 1.993 . . . . 4.96 109.708 -174.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -87.77 129.45 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 114.177 1.177 . . . . 3.4900000000000002 114.177 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.47 103.78 0.73 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.672 1.129 . . . . 1.0 111.057 167.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.31 110.97 13.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.942 1.297 . . . . 2.3300000000000001 109.971 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -108.66 147.15 32.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 2.5800000000000001 111.4 -170.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.21 61.18 2.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.981 -1.075 . . . . 1.3999999999999999 113.192 -171.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.87 154.86 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.281 1.432 . . . . 1.8600000000000001 113.211 -177.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -169.97 -152.97 0.1 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.602 1.561 . . . . 3.3300000000000001 109.295 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -11.82 2.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 129.03 2.932 . . . . 1.5900000000000001 116.06 -175.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.82 0.49 32.74 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.953 1.301 . . . . 4.1900000000000004 112.057 174.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.67 -147.15 21.08 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.695 1.14 . . . . 1.51 110.458 -165.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -54.23 134.89 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.732 2.013 . . . . 1.5600000000000001 112.808 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.28 -112.29 3.66 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.757 1.646 . . . . 1.2 112.803 -175.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.89 166.97 20.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.834 0.817 . . . . 2.3999999999999999 111.555 168.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.6 t -93.33 148.98 21.57 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.264 1.026 . . . . 2.6699999999999999 113.192 -174.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 pt -142.1 2.23 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.296 1.438 . . . . 3.4500000000000002 113.915 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.33 170.25 22.8 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.042 -1.036 . . . . 0.72999999999999998 112.703 -173.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.422 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 14.4 p -107.66 178.73 4.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.023 0.929 . . . . 1.1100000000000001 110.332 171.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.56 132.54 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.526 -1.287 . . . . 0.45000000000000001 107.526 152.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.9 p -85.09 119.92 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.72 0.638 . . . . 1.54 109.77 174.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -102.65 130.23 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.227 -1.397 . . . . 1.9399999999999999 107.227 174.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -136.78 120.5 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.725 0.81 . . . . 2.3199999999999998 111.232 176.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.41 140.73 48.53 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.247 0.619 . . . . 3.6899999999999999 111.58 178.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -143.57 -179.92 6.73 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.387 1.075 . . . . 1.79 108.649 164.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -68.03 -28.29 67.27 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.675 2.39 . . . . 5.21 111.812 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.45 17.87 54.41 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.016 1.769 . . . . 1.55 114.639 162.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.88 -159.01 26.38 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 127.365 2.412 . . . . 1.0800000000000001 118.411 164.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.97 104.08 8.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.736 0.815 . . . . 0.78000000000000003 111.371 -168.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -79.94 110.43 15.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.763 1.625 . . . . 3.0800000000000001 110.217 174.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.403 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 4.0 t80 -99.06 118.73 36.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.294 2.238 . . . . 0.57999999999999996 109.475 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.408 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 78.7 m -124.82 111.98 27.24 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-N 119.292 0.951 . . . . 2.0299999999999998 109.103 176.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.83 165.21 17.8 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.6 2.867 . . . . 0.62 111.008 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 1.5 p80 -151.0 25.89 0.72 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.495 0.718 . . . . 1.5600000000000001 112.099 173.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.87 148.23 25.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.498 1.119 . . . . 1.1399999999999999 113.33 -170.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 144.5 49.47 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.974 1.31 . . . . 2.3999999999999999 108.56 168.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.93 45.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 128.203 2.601 . . . . 2.04 112.514 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.76 160.98 40.25 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.433 1.093 . . . . 2.6899999999999999 110.537 169.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.26 125.55 14.22 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 121.124 1.216 . . . . 1.1899999999999999 110.375 169.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -80.47 74.5 5.51 Favored 'Trans proline' 0 N--CA 1.451 -1.015 1 C-N-CA 125.413 4.075 . . . . 1.8500000000000001 109.925 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.88 -173.76 13.2 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 116.343 -2.837 . . . . 1.6699999999999999 111.932 132.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -56.81 140.61 47.37 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.003 1.321 . . . . 2.75 111.668 175.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -136.83 125.47 23.77 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.902 1.281 . . . . 1.4099999999999999 112.746 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.04 149.91 3.26 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.325 0.964 . . . . 0.81999999999999995 113.229 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.403 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.2 t80 -132.4 132.03 42.41 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.598 1.559 . . . . 3.3100000000000001 106.82 176.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -136.1 168.63 19.02 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 114.867 1.432 . . . . 1.01 114.867 170.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.6 139.51 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.664 1.586 . . . . 1.1399999999999999 109.545 158.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.55 165.24 13.79 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.962 2.105 . . . . 1.0600000000000001 111.358 177.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.86 64.43 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.141 1.534 . . . . 0.83999999999999997 115.141 -159.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -123.73 152.44 42.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.929 0.892 . . . . 1.8500000000000001 113.074 178.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.95 79.81 1.82 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 125.596 1.57 . . . . 0.98999999999999999 110.975 174.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -166.53 59.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.46 0.704 . . . . 4.2699999999999996 112.523 -165.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.8 m -67.2 66.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.284 1.834 . . . . 1.8600000000000001 113.115 173.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -130.53 156.53 79.52 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.219 2.208 . . . . 3.8700000000000001 108.315 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.16 133.88 15.35 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.005 1.803 . . . . 1.29 110.216 176.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 176.38 6.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.058 -0.974 . . . . 3.3799999999999999 109.917 161.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -103.2 128.62 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.887 -0.783 . . . . 6.3399999999999999 108.887 165.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -94.45 -71.31 0.67 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 118.644 -0.694 . . . . 8.5199999999999996 109.244 161.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.75 106.66 9.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.209 1.403 . . . . 4.71 109.124 169.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.73 -44.9 0.65 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.501 2.0 . . . . 5.1600000000000001 116.852 174.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.14 158.41 18.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.222 1.409 . . . . 3.1099999999999999 114.026 -161.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.93 95.98 4.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.961 1.704 . . . . 2.4700000000000002 111.867 -171.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.92 80.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.93 0.872 . . . . 4.1799999999999997 112.159 -177.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 46.28 -104.7 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.869 2.467 . . . . 2.1699999999999999 114.928 163.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.15 25.13 9.74 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.401 1.48 . . . . 2.1800000000000002 111.979 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -81.67 11.49 4.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.519 1.127 . . . . 8.5500000000000007 113.501 -174.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.64 -6.61 57.47 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.143 -0.973 . . . . 2.5699999999999998 112.677 158.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.21 23.8 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.684 1.594 . . . . 1.3 114.311 175.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.15 4.0 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.5 1.524 . . . . 3.6499999999999999 115.646 167.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.14 -176.85 30.26 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.791 1.186 . . . . 1.95 112.486 -171.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -81.33 62.29 5.17 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 2.46 110.532 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.8 tp 25.21 65.6 0.05 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.627 2.371 . . . . 2.4700000000000002 112.537 -174.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -127.14 60.65 43.57 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.038 2.135 . . . . 4.8300000000000001 112.057 -158.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.47 -41.16 9.25 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.387 2.058 . . . . 2.6400000000000001 109.994 169.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -152.9 165.64 34.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.283 1.833 . . . . 5.7000000000000002 110.03 167.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 140.88 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 1 C-N-CA 132.706 4.402 . . . . 3.75 113.209 163.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t 150.99 -56.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 130.726 3.61 . . . . 3.0800000000000001 110.785 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.09 -11.26 69.51 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.342 1.449 . . . . 2.4300000000000002 115.093 -178.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.48 -25.04 61.86 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.749 1.775 . . . . 4.8300000000000001 115.243 -176.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.605 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 24.7 t60 75.44 126.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.393 2.677 . . . . 2.6800000000000002 113.354 176.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 -57.13 2.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.824 0.849 . . . . 7.4500000000000002 112.873 165.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.62 -85.13 0.38 Allowed Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.291 -1.283 . . . . 4.9100000000000001 110.208 -156.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.38 -128.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.857 3.705 . . . . 6.7599999999999998 111.863 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.73 51.25 1.34 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.498 -1.376 . . . . 10.800000000000001 114.693 -159.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.14 -107.55 0.5 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.443 1.021 . . . . 3.4900000000000002 111.198 167.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -16.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.259 1.024 . . . . 5.3200000000000003 113.505 171.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.11 92.39 1.15 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.378 0.99 . . . . 3.8599999999999999 111.897 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.42 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 9.1 t-160 71.42 97.84 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.896 2.078 . . . . 6.6500000000000004 113.711 162.244 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -16.61 64.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.506 1.669 . . . . 4.5300000000000002 115.506 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.84 8.55 79.31 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.81 1.671 . . . . 1.3300000000000001 113.979 175.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.605 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 72.8 m-20 -80.57 155.05 27.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 3.3799999999999999 109.93 153.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.54 154.54 21.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 121.029 -1.044 . . . . 2.48 111.609 -133.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.04 143.1 64.29 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.705 2.937 . . . . 1.24 111.89 -171.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.45 133.49 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.724 0.81 . . . . 2.79 111.473 -163.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.84 99.41 2.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.832 2.053 . . . . 2.8199999999999998 109.044 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.0 t -78.23 121.6 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.496 -0.753 . . . . 1.1200000000000001 109.811 177.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.81 131.41 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.654 1.982 . . . . 2.7400000000000002 108.361 175.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -81.05 148.24 29.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.643 0.656 . . . . 3.3100000000000001 112.275 175.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -40.03 -25.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.338 3.055 . . . . 2.75 117.035 -172.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.01 -19.76 62.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.608 1.963 . . . . 4.1100000000000003 113.444 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 31.8 6.24 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.309 1.433 . . . . 1.01 112.852 -172.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.98 145.02 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.954 1.702 . . . . 1.4399999999999999 108.581 -168.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -124.82 114.85 19.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.059 1.343 . . . . 0.88 110.968 -177.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -125.94 -9.75 6.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.437 1.273 . . . . 2.0699999999999998 114.437 172.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.8 120.04 79.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.833 0.742 . . . . 3.1400000000000001 110.744 -167.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -85.62 153.8 10.33 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.716 2.944 . . . . 1.1200000000000001 112.632 -174.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.08 164.39 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.975 1.71 . . . . 1.49 110.146 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.9 m -137.23 136.39 38.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.648 1.113 . . . . 0.98999999999999999 110.316 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.34 99.79 13.85 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.964 0.906 . . . . 0.88 112.159 175.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.21 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.249 3.299 . . . . 1.0900000000000001 114.79 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.89 5.74 13.01 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.379 0.991 . . . . 5.7199999999999998 112.648 174.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.4 mt -140.92 171.94 13.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 129.244 3.018 . . . . 3.5299999999999998 107.571 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.34 2.35 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.612 1.708 . . . . 8.0899999999999999 115.612 -174.24 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -147.38 156.15 42.63 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.092 -1.005 . . . . 2.29 112.203 176.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.42 -26.03 63.48 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.204 -0.935 . . . . 2.25 111.336 161.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.18 -44.31 79.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.508 1.123 . . . . 4.0099999999999998 113.032 -173.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.68 -8.39 34.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.336 1.454 . . . . 2.5499999999999998 113.446 177.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.52 20.51 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.897 1.279 . . . . 1.04 113.591 -177.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -68.09 -6.17 21.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.945 2.202 . . . . 3.4700000000000002 116.945 -172.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.72 39.37 1.67 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.897 1.679 . . . . 3.4399999999999999 110.668 178.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -117.55 149.1 41.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.453 1.101 . . . . 2.2000000000000002 112.853 -175.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.72 133.12 33.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.409 1.084 . . . . 0.92000000000000004 111.23 166.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.14 136.06 46.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.06 -1.089 . . . . 4.1200000000000001 108.06 165.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.0 mtt -132.1 133.42 44.3 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.217 0.607 . . . . 1.5700000000000001 111.984 -167.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.31 132.95 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.909 1.283 . . . . 0.83999999999999997 108.294 168.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 142.41 50.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.738 2.015 . . . . 3.25 110.387 -159.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.73 -46.86 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.209 -0.932 . . . . 2.02 111.732 -168.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.11 138.68 20.98 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 118.467 0.576 . . . . 1.6499999999999999 111.859 175.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.06 146.94 49.11 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.773 1.654 . . . . 1.45 111.85 167.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -95.4 76.04 3.35 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.379 0.881 . . . . 2.9300000000000002 113.379 -156.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -163.66 56.23 0.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.182 0.993 . . . . 3.79 112.025 -171.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.28 119.31 5.42 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.91 -1.119 . . . . 2.7400000000000002 113.27 -171.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 t -146.5 -170.23 3.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.46 1.904 . . . . 3.4700000000000002 110.538 -178.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 71.35 -41.24 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 129.147 2.979 . . . . 3.6699999999999999 114.636 169.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -60.57 150.44 74.63 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 4.2400000000000002 111.707 173.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.01 -21.09 72.98 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.204 2.603 . . . . 2.4500000000000002 112.739 176.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -101.02 89.4 1.27 Allowed Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.836 0.854 . . . . 5.9000000000000004 109.923 158.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.9 161.16 43.57 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.484 . . . . 4.3099999999999996 110.243 172.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 60.53 9.45 2.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.956 1.302 . . . . 4.0899999999999999 111.953 -164.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 68.36 3.85 34.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.635 1.112 . . . . 3.3300000000000001 113.69 -167.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.12 3.27 58.99 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.322 1.439 . . . . 2.52 114.036 -164.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.79 42.37 1.3 Allowed Glycine 0 N--CA 1.476 1.341 0 C-N-CA 127.148 2.309 . . . . 1.9099999999999999 116.04 -173.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.1 71.36 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.34 0.972 . . . . 2.7599999999999998 113.437 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 p -61.4 136.81 58.16 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.591 1.956 . . . . 2.5099999999999998 112.075 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -99.29 162.29 13.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.858 1.663 . . . . 5.1699999999999999 110.974 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -118.68 -19.36 8.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.153 0.797 . . . . 3.79 113.153 151.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.34 163.05 30.99 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.885 1.221 . . . . 0.56000000000000005 114.05 173.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.2 t -132.27 144.02 50.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 1.6299999999999999 110.786 164.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -132.17 101.43 0.46 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.872 2.177 . . . . 1.3400000000000001 109.571 168.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.25 130.12 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.565 1.146 . . . . 2.4500000000000002 108.789 172.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 15.2 mt -60.4 127.7 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.404 0.681 . . . . 1.6499999999999999 111.625 -178.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 10.9 mmpt? . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 113.148 0.795 . . . . 4.2199999999999998 113.148 178.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.624 0.249 . . . . 4.1799999999999997 110.616 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -151.82 130.92 12.66 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.67 -1.233 . . . . 2.23 107.67 174.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -126.21 111.13 14.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.173 0.989 . . . . 3.46 110.722 -171.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 23' ' ' VAL 0.284 0.1 OUTLIER -79.41 77.32 5.97 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.122 -0.986 . . . . 4.79 111.214 174.47 . . . . . . . . 4 4 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.1 120.62 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.501 -0.75 . . . . 1.4399999999999999 110.133 -169.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.56 99.32 0.9 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.446 1.498 . . . . 0.81000000000000005 111.088 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.3 mmm -75.34 97.68 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.719 1.208 . . . . 2.8599999999999999 110.197 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.57 141.55 41.1 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.653 -0.654 . . . . 2.5499999999999998 110.717 174.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.95 131.17 44.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.878 0.871 . . . . 1.1699999999999999 109.208 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 m -143.43 160.71 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 113.498 0.925 . . . . 1.3799999999999999 113.498 -175.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -172.76 -159.06 0.11 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.369 2.668 . . . . 3.0899999999999999 107.886 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.84 62.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.539 1.936 . . . . 1.98 113.822 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -72.31 -9.43 58.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 3.8199999999999998 112.531 171.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.37 -135.27 13.05 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.54 1.064 . . . . 1.24 111.192 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.65 132.33 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 1.5900000000000001 110.702 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.13 -104.51 2.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.747 1.642 . . . . 1.23 112.84 -175.131 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.73 168.69 19.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.569 1.147 . . . . 2.48 110.372 170.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.7 t -98.14 137.91 36.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.832 -1.168 . . . . 2.0600000000000001 111.576 178.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.92 5.1 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.092 1.357 . . . . 3.4900000000000002 113.935 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.08 172.44 32.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.777 2.608 . . . . 0.85999999999999999 112.395 166.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.476 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.8 p -96.91 175.69 6.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.322 0.649 . . . . 1.0 110.084 169.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.75 130.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.795 -1.187 . . . . 0.68000000000000005 107.795 151.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 4' ' ' LYS 0.258 9.2 p -84.97 113.26 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.352 0.596 . . . . 1.5 111.447 178.004 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.9 mt -87.26 127.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.542 -1.208 . . . . 1.5800000000000001 108.012 169.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -132.22 124.89 29.85 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.71 1.204 . . . . 1.8799999999999999 109.329 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -83.11 142.65 31.1 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.865 0.466 . . . . 4.1699999999999999 111.624 -174.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -157.82 -179.19 7.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.7 0.8 . . . . 1.75 110.411 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.61 -15.73 63.62 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.136 -0.977 . . . . 3.7599999999999998 112.543 177.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.81 6.61 79.61 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.57 1.081 . . . . 1.21 115.153 163.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.04 -141.09 18.25 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 127.183 2.325 . . . . 1.23 114.82 174.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.49 96.22 3.44 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.553 1.141 . . . . 0.90000000000000002 111.659 -175.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -76.38 111.46 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.675 1.19 . . . . 2.3999999999999999 109.483 172.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.02 116.96 29.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.305 2.242 . . . . 0.59999999999999998 109.867 -175.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -130.81 114.12 16.52 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 120.257 1.389 . . . . 1.1599999999999999 110.674 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.95 162.53 7.43 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.089 2.526 . . . . 0.98999999999999999 113.099 -171.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.476 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 1.9 p80 -151.43 29.88 0.62 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.955 0.902 . . . . 1.5900000000000001 112.798 171.157 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -92.91 150.46 20.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.963 1.305 . . . . 1.1299999999999999 112.658 -171.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.18 27.09 4.84 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.008 1.855 . . . . 2.2200000000000002 116.008 -168.346 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.52 79.9 0.73 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.868 0.867 . . . . 1.6000000000000001 112.387 174.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.36 161.44 47.44 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 124.2 1.0 . . . . 2.3999999999999999 112.479 173.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.6 134.7 45.54 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.267 1.311 . . . . 1.24 111.806 175.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -88.01 23.19 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.921 2.414 . . . . 1.23 115.126 -144.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.78 -153.05 11.48 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.874 1.226 . . . . 1.27 115.974 -172.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -78.47 150.97 32.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.463 2.305 . . . . 2.8900000000000001 111.157 171.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -149.13 141.23 23.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.923 0.889 . . . . 1.78 112.221 -173.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 153.16 51.67 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 109.561 -1.416 . . . . 0.66000000000000003 109.561 164.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.14 102.51 3.38 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.101 -1.444 . . . . 3.4399999999999999 107.101 169.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -106.82 171.07 7.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.076 1.51 . . . . 1.0600000000000001 115.076 178.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -101.33 131.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.511 1.524 . . . . 0.85999999999999999 108.689 160.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -108.23 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.802 1.241 . . . . 2.98 110.669 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.09 63.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.144 1.535 . . . . 0.89000000000000001 115.144 -161.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -127.23 151.32 48.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.648 1.179 . . . . 2.29 111.919 173.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.1 81.76 1.69 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.581 1.086 . . . . 1.24 113.193 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 t -170.24 138.59 1.64 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.146 0.978 . . . . 2.5899999999999999 113.227 173.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.1 m -79.11 -5.15 53.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.038 1.735 . . . . 1.9399999999999999 114.217 172.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -78.58 132.89 64.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 O-C-N 120.081 -1.637 . . . . 3.5 113.159 -160.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -79.39 170.03 17.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.514 2.809 . . . . 1.4099999999999999 111.684 172.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -119.16 165.24 14.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.482 1.513 . . . . 1.98 110.196 167.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.66 134.34 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.259 1.023 . . . . 2.96 111.207 -167.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -156.54 134.56 11.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.62 1.568 . . . . 6.75 108.704 173.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.4 t0 55.05 46.72 23.58 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.841 0.856 . . . . 5.0999999999999996 112.19 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.68 7.27 58.17 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.884 1.113 . . . . 3.8199999999999998 115.884 173.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.75 162.26 33.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.855 1.327 . . . . 4.2400000000000002 111.764 -176.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.42 125.93 53.74 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.229 1.012 . . . . 2.1899999999999999 112.254 -167.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.01 24.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 116.512 2.041 . . . . 4.2300000000000004 116.512 -164.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.5 8.23 2.14 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 117.015 2.228 . . . . 2.2200000000000002 117.015 170.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 137.26 115.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 1 C-N-CA 132.278 4.231 . . . . 2.0699999999999998 110.081 165.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.78 -37.76 4.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.564 1.145 . . . . 4.0899999999999999 110.32 172.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.18 -6.6 6.93 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.252 1.204 . . . . 1.3700000000000001 114.252 177.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.32 -14.99 62.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.811 1.245 . . . . 1.3999999999999999 113.292 168.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.8 51.63 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.805 -1.184 . . . . 3.1200000000000001 115.111 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.09 -172.55 55.26 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.699 1.142 . . . . 2.27 112.25 -169.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.543 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 26.8 m170 -65.31 138.85 58.45 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.277 -1.131 . . . . 2.5 111.387 174.513 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.69 119.87 13.78 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.28 0.632 . . . . 2.7200000000000002 112.067 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.97 125.87 5.06 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.02 2.128 . . . . 4.7599999999999998 110.97 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.04 -19.98 3.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.455 2.77 . . . . 4.4500000000000002 115.218 178.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 155.6 14.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 128.249 2.62 . . . . 4.0700000000000003 114.608 -170.134 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.2 -38.78 71.47 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.317 -1.489 . . . . 3.3199999999999998 112.401 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.2 t 157.01 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 131.204 3.802 . . . . 3.4399999999999999 110.621 177.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.45 1.77 66.11 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.416 1.008 . . . . 2.2200000000000002 114.248 179.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -73.25 -30.42 63.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.097 1.448 . . . . 4.4400000000000004 114.72 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.2 t60 117.2 148.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 130.853 3.661 . . . . 2.1600000000000001 112.806 -171.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -143.56 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.035 1.734 . . . . 3.9399999999999999 110.052 173.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.91 -132.56 9.93 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.244 -1.309 . . . . 2.5099999999999998 113.168 167.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.83 -17.45 22.74 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.934 3.09 . . . . 4.0800000000000001 114.885 -167.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -171.75 149.15 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.439 1.895 . . . . 5.6500000000000004 109.682 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.01 -145.2 16.92 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.375 0.988 . . . . 4.5499999999999998 113.242 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.16 145.52 4.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.353 2.661 . . . . 6.8300000000000001 106.324 -179.278 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.34 -20.81 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 CA-C-O 117.057 -1.968 . . . . 3.1400000000000001 116.627 173.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -152.22 118.57 5.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.346 1.573 . . . . 4.79 110.199 160.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.25 -12.42 41.04 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.306 1.595 . . . . 3.6000000000000001 115.306 177.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.56 -4.92 90.15 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.995 1.283 . . . . 1.1799999999999999 115.067 173.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.543 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 66.5 m-20 -74.91 153.98 38.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.756 0.823 . . . . 1.6299999999999999 110.828 168.596 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.37 161.6 29.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.86 1.264 . . . . 2.6299999999999999 109.733 -149.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.56 157.78 57.81 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.489 2.792 . . . . 1.3200000000000001 111.86 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.72 143.13 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.223 1.011 . . . . 2.1400000000000001 113.22 -173.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -88.97 123.07 32.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.998 2.119 . . . . 3.5299999999999998 110.057 172.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.76 136.34 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.437 0.695 . . . . 1.27 109.833 172.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.2 158.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.459 -1.312 . . . . 3.5499999999999998 107.459 160.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.74 159.56 17.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.64 0.978 . . . . 2.1299999999999999 113.64 -174.488 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -41.94 -17.91 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 129.79 3.236 . . . . 2.96 117.726 177.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -97.24 -13.52 21.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.62 1.568 . . . . 2.5099999999999998 113.928 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.55 22.95 8.64 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.121 1.343 . . . . 0.81000000000000005 115.291 177.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.06 135.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.496 1.518 . . . . 1.77 110.228 -178.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.08 120.39 34.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.315 1.446 . . . . 1.0 110.686 -179.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t -150.45 16.04 0.8 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.452 1.101 . . . . 2.1099999999999999 113.962 -169.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -113.05 130.18 23.81 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.966 0.906 . . . . 3.8900000000000001 110.998 177.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.13 158.35 52.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.619 2.879 . . . . 1.3899999999999999 110.885 175.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.46 166.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.38 1.872 . . . . 3.3999999999999999 107.557 169.587 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.1 m -140.15 136.58 33.65 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.223 0.92 . . . . 0.95999999999999996 108.982 171.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.94 87.96 9.36 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.388 1.075 . . . . 1.1299999999999999 111.192 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.48 23.63 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.931 3.754 . . . . 1.1299999999999999 114.146 -179.01 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 -94.01 -20.68 19.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.95 1.3 . . . . 4.6200000000000001 112.045 174.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.11 135.47 53.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.838 2.055 . . . . 3.79 107.155 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -92.38 -38.68 11.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.521 0.728 . . . . 6.3300000000000001 111.775 -177.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.31 154.32 51.57 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.393 1.627 . . . . 3.8100000000000001 115.393 -172.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.38 -42.73 70.68 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.379 1.071 . . . . 2.5600000000000001 110.891 170.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.17 -21.89 3.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.266 1.826 . . . . 4.4199999999999999 113.478 177.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.43 -13.06 38.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.262 1.025 . . . . 3.3900000000000001 113.061 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 m -120.74 7.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.025 1.73 . . . . 1.1399999999999999 113.484 -178.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -43.64 -15.08 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.804 3.241 . . . . 4.2000000000000002 117.643 171.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -128.24 3.37 5.76 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.117 2.567 . . . . 5.1200000000000001 113.378 -167.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -127.07 174.37 8.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.834 1.254 . . . . 3.0499999999999998 113.719 -168.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.89 143.07 47.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.227 1.011 . . . . 0.78000000000000003 112.454 179.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.0 mt -73.46 155.37 39.32 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.451 1.5 . . . . 2.8300000000000001 108.437 156.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 19.2 ttm -147.05 122.58 10.42 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.75 -0.594 . . . . 2.5699999999999998 110.677 158.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.3 mt -80.25 122.55 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.513 -1.291 . . . . 1.01 107.513 171.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -100.81 147.47 26.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.134 2.174 . . . . 3.2400000000000002 111.763 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.25 -54.78 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.302 -0.874 . . . . 2.0800000000000001 110.129 -171.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.8 164.41 39.2 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.547 -0.621 . . . . 1.1899999999999999 111.547 166.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.1 -144.05 0.03 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 129.162 3.268 . . . . 2.27 115.036 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -162.95 69.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.682 1.993 . . . . 2.9700000000000002 107.663 -170.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -157.45 14.92 0.25 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.295 -1.32 . . . . 4.54 113.958 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.8 149.58 16.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.924 1.29 . . . . 5.2999999999999998 112.185 174.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.9 m -128.99 -170.58 2.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.907 1.283 . . . . 4.0899999999999999 111.834 -168.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.41 -26.48 0.18 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 128.452 2.701 . . . . 4.8499999999999996 115.955 158.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -70.01 146.41 95.04 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.23 1.812 . . . . 4.3799999999999999 111.195 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.41 -32.16 50.54 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.352 2.702 . . . . 2.7599999999999998 113.281 -171.271 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -80.38 115.19 53.2 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.23 0.923 . . . . 5.3300000000000001 108.906 160.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.75 152.14 82.46 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.23 2.62 . . . . 3.23 112.336 -172.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp 59.52 22.51 11.1 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.852 1.661 . . . . 5.1100000000000003 111.444 -169.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.83 14.85 66.03 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 120.958 -1.089 . . . . 3.5800000000000001 113.508 -172.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 108.49 -7.93 34.61 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.722 1.63 . . . . 2.2799999999999998 114.037 -168.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.83 10.75 1.07 Allowed Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.358 1.579 . . . . 1.95 116.178 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 -12.41 73.56 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.207 1.504 . . . . 1.8600000000000001 114.426 175.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.8 p -74.88 147.84 40.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.293 1.837 . . . . 2.29 112.555 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -110.17 150.07 29.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.563 1.545 . . . . 5.1799999999999997 111.076 -172.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -106.93 -39.16 5.84 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.241 0.46 . . . . 3.9300000000000002 112.241 160.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.36 144.73 24.03 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.382 1.623 . . . . 0.68999999999999995 115.382 -175.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.5 t -100.51 137.99 38.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.968 2.507 . . . . 1.5 111.307 173.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -133.46 87.11 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.56 1.553 . . . . 1.1399999999999999 112.124 175.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.17 130.41 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.808 1.804 . . . . 2.2000000000000002 110.656 173.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 mt -100.64 154.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 126.468 1.907 . . . . 1.7 110.279 -172.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.52 0 C-N-CA 126.108 1.763 . . . . 5.8200000000000003 110.408 174.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.381 -0.599 . . . . 3.71 109.381 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.23 152.04 28.83 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.257 -0.902 . . . . 2.0099999999999998 109.086 -175.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -144.57 116.19 8.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.332 1.539 . . . . 2.48 112.825 176.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -78.8 82.95 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 127.606 2.362 . . . . 3.7000000000000002 110.569 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -75.79 110.99 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.057 -1.027 . . . . 3.1600000000000001 112.28 -177.228 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.6 100.48 0.49 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.404 1.954 . . . . 1.1899999999999999 110.81 177.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 mmt -72.85 125.52 27.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.849 1.66 . . . . 2.52 112.399 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -101.62 153.61 19.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.786 0.803 . . . . 2.4300000000000002 110.923 157.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.9 mt -58.48 143.57 45.23 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.347 1.459 . . . . 1.3600000000000001 109.18 163.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 m -141.6 166.1 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.065 0.946 . . . . 1.5800000000000001 111.535 172.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 t -172.38 -161.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.616 2.366 . . . . 3.2200000000000002 108.176 -177.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.93 14.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.449 2.7 . . . . 2.3300000000000001 114.507 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.06 -12.5 10.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.058 1.343 . . . . 3.2200000000000002 111.349 172.655 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 -146.25 19.8 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 119.197 0.908 . . . . 1.8600000000000001 110.893 -167.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 82.0 t -62.28 126.38 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.228 1.811 . . . . 2.2999999999999998 112.423 -177.07 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.28 -133.19 6.44 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.539 2.019 . . . . 1.4099999999999999 113.17 177.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.09 145.64 46.34 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 124.52 1.128 . . . . 3.1600000000000001 110.811 176.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.7 t -75.19 133.58 41.4 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.713 -0.617 . . . . 2.79 109.438 164.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 tt -116.36 -37.05 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 127.908 2.483 . . . . 5.0599999999999996 111.546 -174.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.29 -178.83 38.08 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.39 -0.909 . . . . 1.46 113.443 -145.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 171.06 12.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.97 -1.122 . . . . 1.3200000000000001 107.97 148.657 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t -120.58 132.01 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 106.471 -1.677 . . . . 0.71999999999999997 106.471 144.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 17.7 m -83.99 129.51 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 C-N-CA 119.744 -0.782 . . . . 4.4800000000000004 109.803 172.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.45 125.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.623 -0.881 . . . . 1.8600000000000001 108.623 175.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.68 126.9 30.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.736 1.214 . . . . 2.4700000000000002 109.96 178.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.78 141.79 29.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.797 0.839 . . . . 3.8399999999999999 112.946 -172.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -149.63 -176.61 5.47 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.897 0.879 . . . . 1.47 109.684 174.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -75.54 -11.98 60.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.272 -0.892 . . . . 4.1600000000000001 112.488 174.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.41 7.04 69.78 Favored Glycine 0 N--CA 1.477 1.411 0 O-C-N 120.758 -1.214 . . . . 1.1399999999999999 114.312 157.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.62 -145.58 26.42 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 127.819 2.628 . . . . 0.78000000000000003 114.598 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.4 109.46 7.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.187 0.595 . . . . 0.84999999999999998 110.704 -173.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -82.78 106.68 14.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.348 1.059 . . . . 2.2999999999999998 110.397 174.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.429 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -85.85 110.11 19.16 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.044 1.338 . . . . 0.84999999999999998 108.345 175.614 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.438 ' HB ' ' CG2' ' A' ' 23' ' ' VAL . 33.4 m -114.6 98.78 50.28 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 119.718 1.144 . . . . 1.48 108.792 178.066 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -85.73 153.51 10.16 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.244 3.296 . . . . 0.89000000000000001 111.497 -172.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -150.66 41.22 0.77 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.998 0.904 . . . . 1.5 112.725 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mp -93.02 148.95 21.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.273 1.829 . . . . 1.1499999999999999 112.193 -176.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.86 40.25 2.16 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.24 1.57 . . . . 2.02 115.24 -169.265 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.33 48.53 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 1.3899999999999999 112.207 -175.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.04 161.0 47.07 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 121.261 -0.9 . . . . 2.1800000000000002 112.466 176.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.26 131.09 36.92 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.595 1.53 . . . . 1.3400000000000001 110.18 171.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -90.46 30.64 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.722 1 C-N-CA 126.567 4.845 . . . . 1.5 112.176 -151.976 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.79 166.68 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 125.582 1.563 . . . . 2.1400000000000001 109.762 173.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -67.44 143.8 56.06 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.889 0.875 . . . . 2.8900000000000001 112.814 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -129.69 150.83 50.84 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.076 1.35 . . . . 1.3 111.614 -172.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.84 163.5 24.23 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.519 0.6 . . . . 0.66000000000000003 113.486 168.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CZ ' ' CG ' ' A' ' 33' ' ' PHE . 9.4 t80 -140.76 119.86 12.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.15 1.38 . . . . 3.5099999999999998 108.398 176.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -134.76 149.12 50.38 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.433 -0.792 . . . . 0.93999999999999995 112.521 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.3 136.61 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.607 1.963 . . . . 1.1699999999999999 107.792 165.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -132.8 133.84 43.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.201 1.0 . . . . 1.5900000000000001 110.652 -163.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.19 65.67 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.628 2.084 . . . . 0.84999999999999998 116.628 -155.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -118.97 152.3 36.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.988 0.915 . . . . 1.6799999999999999 112.688 167.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.98 59.75 4.48 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.647 1.118 . . . . 1.1499999999999999 112.45 170.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 m -148.73 63.9 1.06 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.818 1.044 . . . . 3.8100000000000001 113.818 -157.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.8 m -65.39 26.66 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 116.452 2.019 . . . . 1.74 116.452 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -78.14 139.13 60.53 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 119.919 -1.738 . . . . 3.8900000000000001 110.788 175.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.31 143.19 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.753 2.302 . . . . 1.3899999999999999 111.211 174.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 128.87 35.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.914 0.486 . . . . 2.5099999999999998 110.461 172.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.44 125.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.215 1.006 . . . . 2.8199999999999998 110.694 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -166.09 128.17 1.92 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.386 0.674 . . . . 5.7699999999999996 112.74 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 57.77 52.88 7.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.655 1.582 . . . . 4.8099999999999996 114.1 169.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.78 77.48 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.082 -1.011 . . . . 3.6400000000000001 114.544 175.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.94 -164.08 1.35 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.41 1.884 . . . . 4.7800000000000002 109.178 -177.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.34 144.71 23.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.222 -0.924 . . . . 2.8599999999999999 112.651 -177.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 t -80.82 98.78 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.97 0.908 . . . . 2.8999999999999999 109.934 -172.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.97 97.59 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.392 2.277 . . . . 3.4300000000000002 115.105 -170.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.45 30.73 17.29 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.524 1.93 . . . . 2.21 114.27 174.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.65 -32.36 73.82 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.271 0.841 . . . . 5.3799999999999999 113.271 -178.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.48 -15.62 50.96 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.898 1.073 . . . . 2.3799999999999999 113.898 -175.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -3.46 13.9 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.312 1.445 . . . . 1.25 113.585 172.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.22 -171.32 32.34 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.943 1.247 . . . . 2.4900000000000002 113.53 175.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.57 -167.0 39.74 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.74 1.162 . . . . 2.3500000000000001 112.189 165.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.442 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 33.1 m170 -74.13 40.06 0.12 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.551 1.94 . . . . 3.29 112.833 -178.483 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp 49.82 61.45 3.16 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.904 1.682 . . . . 2.5600000000000001 109.854 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -121.65 51.02 2.53 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.299 1.839 . . . . 3.9300000000000002 114.419 -163.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.2 -18.91 39.42 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.862 3.041 . . . . 2.27 115.865 -166.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.0 31.79 0.06 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.35 0.977 . . . . 4.7999999999999998 112.46 -171.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.03 -60.41 1.68 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.655 0.983 . . . . 3.73 113.655 -163.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 t 167.99 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.317 2.647 . . . . 4.0199999999999996 108.54 -162.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.95 -30.93 8.93 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.857 0.741 . . . . 3.23 113.03 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 11.7 ptmt -88.74 -177.89 5.64 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 117.88 0.84 . . . . 4.8700000000000001 112.138 173.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -124.88 164.89 19.07 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.888 1.07 . . . . 3.0699999999999998 113.888 -155.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -138.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.449 1.1 . . . . 4.5700000000000003 111.478 -179.072 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.51 -138.09 18.48 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 109.067 -1.613 . . . . 2.8900000000000001 109.067 -158.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.08 -32.08 64.52 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.344 2.03 . . . . 3.5800000000000001 113.456 -171.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.03 -1.54 57.17 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 6.0099999999999998 113.43 -176.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.43 -12.56 0.93 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 118.316 2.086 . . . . 3.71 118.316 167.001 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -84.33 44.85 1.06 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.182 1.491 . . . . 5.9800000000000004 114.393 -163.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.63 -147.67 6.33 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 117.477 1.751 . . . . 2.8300000000000001 117.477 -168.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -118.15 154.49 32.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.827 1.651 . . . . 4.8399999999999999 112.297 -157.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.16 -27.22 65.34 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.475 0.917 . . . . 2.98 113.475 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.4 21.6 16.74 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.58 -1.122 . . . . 1.01 114.581 176.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.442 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 75.7 m-20 -97.35 136.07 38.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.874 1.337 . . . . 1.79 111.063 169.34 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mp -136.6 165.9 31.7 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 125.676 1.59 . . . . 3.4100000000000001 109.345 -172.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.99 161.08 13.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.026 2.484 . . . . 1.3100000000000001 111.387 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.18 133.82 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.334 1.54 . . . . 2.04 115.044 -164.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 87.01 2.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.096 2.558 . . . . 2.6099999999999999 109.319 170.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.99 133.01 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.139 0.576 . . . . 0.94999999999999996 110.809 175.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.7 136.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.956 2.102 . . . . 2.7200000000000002 106.408 173.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.49 162.99 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.425 -0.321 . . . . 2.3700000000000001 111.834 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.69 -22.52 0.08 Allowed 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 117.899 2.555 . . . . 2.5699999999999998 117.899 -177.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -7.67 52.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.462 1.905 . . . . 2.6499999999999999 113.45 -176.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.22 30.39 11.04 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 124.274 0.94 . . . . 0.88 114.197 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.0 mt -124.29 133.57 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.17 1.388 . . . . 1.54 110.165 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.6 139.03 40.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.958 1.703 . . . . 0.79000000000000004 111.205 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -151.15 -11.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.588 2.44 . . . . 2.3100000000000001 117.588 -166.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.83 117.97 53.39 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 121.459 1.936 . . . . 4.2000000000000002 113.619 -172.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.01 78.01 2.63 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.951 3.1 . . . . 2.5699999999999998 110.216 171.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.57 148.78 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.747 1.619 . . . . 4.9800000000000004 109.908 175.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.36 139.18 52.53 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.956 -0.757 . . . . 1.8400000000000001 108.956 160.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -124.87 99.73 34.73 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.646 0.779 . . . . 1.04 111.922 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.31 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.184 3.256 . . . . 1.49 113.761 178.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -31.47 72.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.909 0.884 . . . . 5.6500000000000004 111.134 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.17 151.86 37.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.548 2.739 . . . . 3.2000000000000002 106.868 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -135.35 11.98 3.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.301 1.223 . . . . 5.3200000000000003 114.301 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -150.25 169.09 22.16 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.999 -1.688 . . . . 2.8300000000000001 111.011 160.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.05 -43.32 11.79 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.104 -0.997 . . . . 2.4500000000000002 112.104 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -64.85 -19.55 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.897 1.073 . . . . 3.04 113.897 -176.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -16.21 63.98 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.626 0.973 . . . . 2.5 113.626 171.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.2 24.07 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.942 1.697 . . . . 1.3600000000000001 112.802 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -53.95 -9.14 0.22 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.654 2.465 . . . . 4.0999999999999996 117.654 178.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.68 50.33 1.37 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.668 1.587 . . . . 2.8999999999999999 109.875 -169.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -142.62 150.22 40.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.7 1.6 . . . . 3.5299999999999998 112.347 -169.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.68 137.5 32.27 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.834 -0.541 . . . . 1.0600000000000001 111.367 167.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.97 122.09 40.67 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.829 -0.804 . . . . 5.1100000000000003 108.829 154.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 31.1 mtt -122.62 124.26 43.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.386 0.674 . . . . 1.6399999999999999 111.073 -173.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.0 mt -77.17 114.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 107.685 -1.228 . . . . 0.87 107.685 171.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.78 137.8 40.51 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.232 1.413 . . . . 4.0 112.629 -162.028 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.28 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.332 -0.855 . . . . 1.9399999999999999 111.349 -165.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.76 133.42 11.79 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 118.306 0.503 . . . . 2.1099999999999999 112.258 172.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.53 154.36 21.57 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.517 1.532 . . . . 1.4199999999999999 112.183 156.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -112.34 36.59 3.33 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.53 0.937 . . . . 3.4199999999999999 113.53 -128.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.2 5.97 40.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.961 1.304 . . . . 4.3700000000000001 113.851 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.6 tpp -98.16 132.88 43.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.954 1.464 . . . . 4.21 114.954 -157.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.8 p -176.66 171.19 2.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.554 2.341 . . . . 4.3300000000000001 111.1 159.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t70 92.44 65.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.176 2.99 . . . . 4.4000000000000004 111.61 -177.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -151.8 159.68 32.77 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.307 1.843 . . . . 4.0800000000000001 109.467 -173.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 -9.17 21.44 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.237 3.291 . . . . 3.75 114.417 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -125.13 142.33 41.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.725 1.21 . . . . 5.4400000000000004 109.241 166.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.33 134.92 54.66 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.314 2.01 . . . . 4.0800000000000001 111.089 -175.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.5 mt 63.41 17.97 10.69 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.49 1.516 . . . . 4.7699999999999996 112.527 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.39 7.43 60.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.763 1.173 . . . . 4.04 113.941 -174.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.16 -8.28 75.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.17 1.367 . . . . 3.5 113.953 -168.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.36 0.18 42.5 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 119.378 1.589 . . . . 2.23 115.043 -176.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.84 5.71 45.8 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.984 1.754 . . . . 2.1600000000000001 115.171 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 p -70.38 159.9 33.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.885 1.342 . . . . 2.48 110.864 173.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -112.84 136.1 52.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.489 1.516 . . . . 6.6900000000000004 109.894 -172.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -90.83 -35.98 14.49 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.157 0.89 . . . . 3.6000000000000001 112.129 166.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.36 150.14 31.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.519 0.727 . . . . 0.83999999999999997 112.456 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 t -127.07 131.43 50.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.343 1.857 . . . . 1.77 111.505 -178.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -126.37 97.03 0.48 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.784 2.135 . . . . 1.54 110.465 166.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.76 125.26 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.587 1.155 . . . . 2.3100000000000001 109.218 172.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.5 mt -58.3 117.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.742 0.782 . . . . 1.79 109.668 176.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 116.059 -0.518 . . . . 5.3700000000000001 111.602 177.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.658 -0.497 . . . . 2.0099999999999998 109.658 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.07 152.85 42.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.572 1.323 . . . . 1.3400000000000001 114.572 -145.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 132.49 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 123.152 1.453 . . . . 2.9700000000000002 112.057 159.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -94.71 71.46 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.154 1.382 . . . . 4.2300000000000004 111.213 -166.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.17 119.29 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.211 -0.931 . . . . 1.95 110.738 -156.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.02 97.25 1.38 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 126.189 1.852 . . . . 1.01 110.185 -173.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 29.8 mtt -80.22 131.38 35.68 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.574 0.749 . . . . 2.1899999999999999 112.158 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.0 150.54 22.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.721 0.808 . . . . 2.7799999999999998 109.878 172.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.1 mt -64.31 140.87 58.91 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.363 -0.977 . . . . 1.3700000000000001 108.363 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.16 158.11 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 118.511 0.596 . . . . 1.5 112.202 -177.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -171.44 -150.36 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.921 2.089 . . . . 2.6000000000000001 108.252 173.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.02 -8.35 3.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 128.473 2.709 . . . . 2.3799999999999999 114.837 -178.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.19 -14.7 32.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.903 0.881 . . . . 4.2800000000000002 112.065 169.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.85 -142.47 21.65 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.134 0.873 . . . . 1.51 110.968 -162.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.31 120.96 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.555 1.542 . . . . 1.52 111.757 176.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.97 -133.22 7.13 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 125.993 1.759 . . . . 1.9299999999999999 111.705 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.83 171.48 7.3 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.717 -0.872 . . . . 3.75 110.845 170.247 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -109.26 137.66 46.8 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.006 1.323 . . . . 2.04 113.502 -176.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.94 4.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.325 1.85 . . . . 3.46 112.887 177.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.33 153.18 7.63 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.489 -0.757 . . . . 0.59999999999999998 113.903 -168.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.498 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.5 p -90.33 175.2 7.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.917 -0.771 . . . . 1.1200000000000001 108.917 161.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.68 129.45 75.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 106.218 -1.771 . . . . 0.45000000000000001 106.218 148.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.95 118.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.374 -0.602 . . . . 1.5 109.374 178.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.7 mt -99.0 126.7 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.147 -1.427 . . . . 2.25 107.147 175.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -128.24 122.06 30.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.164 0.983 . . . . 2.5899999999999999 111.27 169.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 124.58 23.19 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.501 1.92 . . . . 3.2799999999999998 109.52 171.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.6 p -138.25 174.56 10.43 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.341 0.591 . . . . 3.7599999999999998 111.416 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.44 -23.86 64.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.267 -0.896 . . . . 3.5600000000000001 112.496 172.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.38 13.84 66.49 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.794 1.188 . . . . 1.3799999999999999 114.65 170.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.77 -158.03 31.7 Favored Glycine 0 N--CA 1.469 0.877 0 C-N-CA 126.732 2.11 . . . . 1.0800000000000001 114.559 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.51 96.72 2.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.958 0.903 . . . . 1.02 111.738 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -72.81 116.59 13.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.72 2.008 . . . . 3.6699999999999999 109.975 172.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -109.12 111.48 23.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.309 2.244 . . . . 0.68999999999999995 109.768 -174.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.9 m -119.85 114.29 34.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-O 118.275 -0.869 . . . . 0.92000000000000004 108.986 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.45 160.74 9.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.048 2.498 . . . . 0.46999999999999997 112.781 -174.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.498 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 3.3 p80 -150.51 26.39 0.76 Allowed 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.546 0.943 . . . . 1.6799999999999999 113.546 172.348 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.91 143.53 31.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.87 112.83 -176.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.18 128.28 48.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 117.575 -1.202 . . . . 2.3700000000000001 110.673 174.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 131.12 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 129.838 3.255 . . . . 1.97 115.971 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.92 159.66 31.82 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.115 0.966 . . . . 2.48 112.215 -172.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -59.77 133.39 50.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.511 2.141 . . . . 0.90000000000000002 111.408 171.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -92.97 43.08 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.019 2.48 . . . . 1.02 112.589 -150.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.25 -158.01 10.05 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 122.895 1.275 . . . . 1.1599999999999999 115.724 -175.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -81.11 145.0 31.29 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.668 2.387 . . . . 2.8199999999999998 111.735 173.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -152.39 138.05 17.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.783 1.633 . . . . 1.3799999999999999 110.018 -174.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.77 165.28 54.81 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 120.398 1.454 . . . . 0.81999999999999995 114.194 169.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -130.36 121.98 27.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.551 1.541 . . . . 3.4700000000000002 107.22 177.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -121.74 156.34 33.34 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.179 1.354 . . . . 1.47 112.677 173.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.13 141.05 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.914 1.686 . . . . 1.24 108.839 158.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -119.86 -179.09 3.8 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.767 1.627 . . . . 1.3700000000000001 110.254 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.69 56.24 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.807 2.151 . . . . 1.23 116.807 -166.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -132.84 159.9 38.47 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.954 1.252 . . . . 1.5600000000000001 114.015 178.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.63 65.79 4.0 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.972 1.749 . . . . 1.03 113.14 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -146.06 76.15 1.44 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.482 0.919 . . . . 2.79 113.482 -168.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.1 m -60.54 38.49 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 129.303 3.041 . . . . 1.6100000000000001 117.636 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -120.15 168.9 9.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 119.789 -1.819 . . . . 3.4700000000000002 112.042 -166.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.22 145.94 17.46 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.566 2.177 . . . . 1.55 111.085 168.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.06 153.23 18.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.621 -0.718 . . . . 3.1400000000000001 109.353 159.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.81 116.22 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.083 -1.451 . . . . 4.79 107.083 163.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -79.51 -47.1 16.16 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.706 0.765 . . . . 8.7200000000000006 110.418 178.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -176.09 118.76 0.15 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.358 3.063 . . . . 5.8200000000000003 106.511 171.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.44 -4.46 0.95 Allowed Glycine 0 CA--C 1.54 1.65 0 N-CA-C 117.556 1.782 . . . . 3.9399999999999999 117.556 175.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -159.99 157.39 28.71 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.74 1.77 . . . . 3.7999999999999998 111.71 -171.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.49 133.98 34.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.4 1.08 . . . . 1.99 112.221 -173.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.4 t -115.3 103.57 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.031 1.333 . . . . 3.73 109.001 171.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.98 110.72 4.03 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.342 1.457 . . . . 3.9700000000000002 112.194 -177.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 122.1 -24.65 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 131.136 3.774 . . . . 3.5600000000000001 113.876 171.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.85 -11.28 58.29 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.412 1.46 . . . . 6.29 114.246 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.782 -1.199 . . . . 3.0600000000000001 112.785 168.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.65 3.44 16.37 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.355 1.062 . . . . 1.3700000000000001 113.133 173.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.1 178.75 38.81 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.366 0.984 . . . . 2.21 113.564 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.2 -167.81 10.19 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.374 0.988 . . . . 1.99 112.952 171.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -72.29 52.34 0.26 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.222 1.809 . . . . 2.3999999999999999 111.501 174.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.6 tp 37.3 58.67 1.23 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.71 2.004 . . . . 2.7599999999999998 111.465 178.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 85.02 55.57 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.216 1.806 . . . . 4.8200000000000003 112.273 -150.305 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.81 -63.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.648 2.899 . . . . 2.2200000000000002 111.672 175.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -143.43 129.38 19.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.473 -1.677 . . . . 6.5899999999999999 106.473 173.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 p30 174.73 -97.65 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.532 1.933 . . . . 4.5700000000000003 112.196 179.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t 174.97 -45.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.991 2.516 . . . . 3.1200000000000001 109.739 -166.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.14 -39.8 3.1 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 126.141 1.829 . . . . 3.9399999999999999 116.374 149.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -43.26 -51.41 6.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.831 1.653 . . . . 4.9800000000000004 113.546 -170.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.443 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 162.48 150.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.605 3.162 . . . . 3.1400000000000001 112.564 168.067 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -82.85 167.26 18.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.267 0.556 . . . . 3.4399999999999999 112.057 171.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.88 -109.97 0.78 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.595 -1.669 . . . . 5.4100000000000001 110.95 -167.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.02 -27.03 36.68 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.768 2.979 . . . . 7.5800000000000001 114.711 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.75 10.55 3.39 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.931 1.293 . . . . 9.6300000000000008 112.454 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.62 73.23 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.025 -0.875 . . . . 4.46 114.807 171.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -82.94 51.14 1.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.265 1.532 . . . . 7.0700000000000003 113.839 -166.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.81 -171.66 42.13 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 117.249 1.66 . . . . 3.4399999999999999 117.249 -167.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.947 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 16.6 p-80 -139.74 157.13 46.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.922 1.689 . . . . 6.3899999999999997 110.848 171.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -69.36 24.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.582 1.553 . . . . 3.4500000000000002 115.186 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -153.56 23.46 0.74 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 128.572 2.987 . . . . 1.3899999999999999 113.042 178.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.947 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 10.5 m-20 -80.53 138.62 36.53 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 106.75 -1.574 . . . . 2.1299999999999999 106.75 154.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mp -143.59 147.8 40.81 Favored Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 121.744 2.065 . . . . 3.2999999999999998 112.577 -171.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.94 157.94 54.13 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.124 3.216 . . . . 1.1699999999999999 113.254 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.67 125.97 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 115.429 1.64 . . . . 2.2000000000000002 115.429 -156.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 67.93 0.8 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.912 2.885 . . . . 2.4900000000000002 110.313 170.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.8 134.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.508 -0.745 . . . . 1.24 109.429 174.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 m -115.0 152.14 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.006 0.922 . . . . 3.29 108.9 175.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.56 157.07 38.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.531 0.567 . . . . 2.7400000000000002 112.531 -176.293 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -50.56 -22.55 2.04 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 126.935 2.094 . . . . 2.5099999999999998 115.527 179.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -88.88 3.56 50.87 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.888 2.475 . . . . 3.7599999999999998 113.892 -178.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 30.08 21.19 Favored Glycine 0 N--CA 1.475 1.277 0 O-C-N 121.135 -0.978 . . . . 0.81000000000000005 115.283 173.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.8 131.56 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.252 1.421 . . . . 1.53 109.535 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.83 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.651 1.18 . . . . 1.24 109.969 176.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 t -149.4 -33.75 0.2 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.106 1.362 . . . . 1.95 113.183 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -66.13 121.52 76.73 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.848 0.859 . . . . 3.1099999999999999 111.048 -178.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.65 152.31 22.66 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.149 3.233 . . . . 1.3600000000000001 112.354 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.27 175.99 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.456 1.503 . . . . 1.55 110.22 170.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.6 m -146.39 143.81 29.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.587 1.155 . . . . 1.0600000000000001 109.994 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.17 101.63 31.66 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.7 1.2 . . . . 1.6599999999999999 111.766 175.365 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.38 -5.81 10.12 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.981 2.454 . . . . 1.6499999999999999 116.195 -166.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -77.43 -17.13 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.553 1.524 . . . . 11.300000000000001 113.188 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.15 153.55 19.16 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.92 1.688 . . . . 3.8700000000000001 109.421 -177.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 28.63 1.21 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.878 1.671 . . . . 5.1399999999999997 111.333 170.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.7 m -163.29 133.54 4.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.344 1.857 . . . . 2.3900000000000001 110.819 171.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.42 -27.47 67.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.271 1.428 . . . . 2.6899999999999999 110.488 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.42 -26.88 5.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.396 1.878 . . . . 3.6000000000000001 113.687 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -65.84 -11.67 48.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.461 1.105 . . . . 2.5800000000000001 113.486 176.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.52 15.49 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.162 1.171 . . . . 0.82999999999999996 114.162 -172.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -69.06 9.24 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 118.1 2.63 . . . . 2.9900000000000002 118.1 -169.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -151.72 29.71 0.6 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.765 1.626 . . . . 3.3700000000000001 111.676 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -116.47 155.22 28.97 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.788 -1.195 . . . . 3.6299999999999999 112.222 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.97 141.26 28.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.296 0.638 . . . . 0.84999999999999998 110.46 166.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 141.67 43.82 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.175 -0.676 . . . . 2.0899999999999999 109.175 160.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.0 mtt -134.24 135.29 42.83 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.375 0.67 . . . . 1.77 112.594 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.5 mt -82.13 105.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.609 1.163 . . . . 0.89000000000000001 108.65 172.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.11 139.75 30.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.106 1.762 . . . . 3.7400000000000002 110.979 -176.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.54 -39.08 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.871 -1.143 . . . . 2.0699999999999998 112.443 -162.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -94.99 144.12 17.0 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.205 0.907 . . . . 1.5 112.043 176.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.39 156.64 25.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 127.014 2.245 . . . . 1.72 115.053 175.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.66 53.26 0.7 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.517 1.151 . . . . 3.2000000000000002 113.268 -147.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -141.64 2.35 1.6 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.634 1.574 . . . . 2.98 113.423 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.2 mtm -92.6 126.47 37.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.121 0.968 . . . . 2.6899999999999999 111.683 -171.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 -158.3 0.82 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.536 1.134 . . . . 3.4199999999999999 110.921 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.24 -38.51 0.41 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 129.911 3.284 . . . . 3.6499999999999999 114.135 -176.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -67.65 146.26 98.46 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.724 2.01 . . . . 3.3100000000000001 113.42 -166.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.89 -40.44 44.16 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.521 3.481 . . . . 2.3500000000000001 112.204 -172.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.23 101.42 11.23 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 105.889 -1.893 . . . . 5.0199999999999996 105.889 162.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -75.77 179.44 6.25 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.429 2.753 . . . . 3.6800000000000002 113.338 -162.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.1 mt 66.53 1.08 2.0 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.887 2.075 . . . . 4.6399999999999997 113.987 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.74 27.12 67.83 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.698 1.135 . . . . 3.1499999999999999 112.388 -175.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.6 -8.88 79.12 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.018 1.294 . . . . 2.4399999999999999 114.354 -171.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.78 22.09 0.57 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.349 1.928 . . . . 2.1899999999999999 115.86 -177.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.16 -15.26 65.04 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.936 1.255 . . . . 1.8799999999999999 113.147 167.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.4 p -74.27 151.58 39.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.639 1.22 . . . . 1.98 110.013 172.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.93 142.31 30.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.472 1.109 . . . . 6.7599999999999998 112.581 -171.59 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.34 -33.88 12.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.555 0.742 . . . . 4.21 112.235 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.89 155.99 41.66 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.259 1.024 . . . . 0.62 113.038 -176.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.43 151.67 45.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.932 2.093 . . . . 1.4299999999999999 111.334 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.28 126.76 2.89 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.99 1.281 . . . . 0.87 112.545 173.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.48 123.45 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.955 1.302 . . . . 2.3399999999999999 109.972 171.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.69 113.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.719 -0.845 . . . . 1.1100000000000001 108.719 170.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt . . . . . 0 CA--C 1.54 0.585 0 O-C-N 121.745 -0.597 . . . . 4.2999999999999998 111.121 -174.757 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.528 -0.545 . . . . 2.0099999999999998 109.528 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -131.78 135.19 46.59 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.65 -1.281 . . . . 2.6200000000000001 113.788 -137.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -144.7 148.8 34.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.134 1.373 . . . . 2.8999999999999999 108.587 173.202 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -126.5 99.95 6.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.778 1.231 . . . . 5.2599999999999998 110.866 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -90.29 122.24 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 121.861 -0.524 . . . . 1.49 109.985 -173.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.2 104.7 2.06 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.905 1.717 . . . . 0.78000000000000003 110.752 174.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 mmm -86.93 89.45 7.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.422 1.489 . . . . 2.6000000000000001 110.655 -175.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -75.39 148.37 39.24 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.231 -0.918 . . . . 2.7599999999999998 111.04 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.13 140.72 58.24 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.53 -0.732 . . . . 1.3300000000000001 109.796 174.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.7 138.82 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.892 0.877 . . . . 1.5 110.316 177.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -171.85 69.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.979 0.912 . . . . 2.6800000000000002 111.909 -170.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 74.37 -42.46 0.5 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.592 2.357 . . . . 1.52 114.285 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.39 -9.22 58.23 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.486 1.039 . . . . 4.0800000000000001 112.163 174.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.91 -147.82 17.99 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 125.909 1.719 . . . . 1.27 111.455 -173.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.8 t -58.85 127.04 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.795 1.638 . . . . 1.26 110.212 174.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.78 -97.71 2.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.32 0.962 . . . . 1.48 113.694 -168.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.29 127.93 12.41 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.707 1.203 . . . . 2.7200000000000002 109.864 -170.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 t -90.98 149.95 21.66 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.056 1.132 . . . . 1.8999999999999999 114.056 -160.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -143.07 -6.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 115.289 1.589 . . . . 3.5499999999999998 115.289 -173.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.5 153.73 13.31 Favored Glycine 0 N--CA 1.469 0.861 0 O-C-N 120.625 -1.297 . . . . 0.72999999999999998 114.556 -175.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 p -107.19 176.16 5.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.434 -0.95 . . . . 1.0800000000000001 108.434 163.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.08 134.03 66.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.44 -0.948 . . . . 0.82999999999999996 108.44 158.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.5 p -88.48 130.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.7 0.625 . . . . 1.5800000000000001 110.296 173.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.26 114.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.064 2.146 . . . . 2.3599999999999999 108.399 -173.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.08 105.93 11.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.74 0.816 . . . . 2.1200000000000001 111.348 175.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 133.76 55.24 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.107 2.563 . . . . 3.7000000000000002 111.176 172.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 t -164.02 -172.02 2.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.209 0.604 . . . . 2.3700000000000001 111.089 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.54 -38.25 66.38 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.674 1.189 . . . . 3.6400000000000001 111.685 178.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.74 12.36 41.89 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.867 1.222 . . . . 1.46 115.297 173.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 -145.82 32.65 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 127.824 2.63 . . . . 0.97999999999999998 112.042 -177.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.89 102.21 6.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.997 0.919 . . . . 1.02 111.614 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.59 109.97 12.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.093 0.957 . . . . 2.6699999999999999 110.556 175.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.95 105.77 17.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.875 2.47 . . . . 1.1799999999999999 110.191 -169.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.0 m -110.7 108.99 57.99 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 107.84 -1.17 . . . . 1.5 107.84 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.43 157.11 22.27 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.807 2.338 . . . . 0.89000000000000001 111.211 -177.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -142.78 37.09 1.44 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.911 0.862 . . . . 1.8899999999999999 111.253 169.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -91.49 158.67 16.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 123.123 1.439 . . . . 1.04 113.841 -174.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HE3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -144.01 159.32 42.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.032 2.133 . . . . 2.96 108.38 174.525 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.52 23.66 0.08 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.465 2.706 . . . . 1.8300000000000001 113.381 171.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -92.89 161.75 30.74 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 121.484 -0.76 . . . . 3.0 110.773 174.158 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.63 135.33 52.2 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 O-C-N 122.655 0.818 . . . . 1.03 110.068 164.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -92.65 24.05 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.968 3.112 . . . . 1.23 112.942 -149.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.7 158.11 15.1 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.003 -1.239 . . . . 2.2400000000000002 110.003 167.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -51.2 130.9 27.38 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 128.302 2.641 . . . . 3.1600000000000001 114.915 -175.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -103.83 138.36 40.53 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.832 1.253 . . . . 1.6499999999999999 112.577 -171.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.63 150.66 50.91 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.926 -0.87 . . . . 0.87 110.926 166.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.92 119.85 28.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.099 -1.445 . . . . 3.3799999999999999 107.099 175.198 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.423 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 64.7 m170 -115.25 153.64 30.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.922 0.889 . . . . 1.1399999999999999 113.27 171.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -94.75 144.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.396 1.078 . . . . 1.0 109.03 150.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -118.74 156.85 28.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.15 1.78 . . . . 1.1100000000000001 110.214 176.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.1 62.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 117.101 2.26 . . . . 1.1100000000000001 117.101 -159.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -134.75 -179.2 5.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.8 2.04 . . . . 1.7 110.44 175.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.84 100.55 0.54 Allowed Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.576 -1.327 . . . . 1.25 113.629 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.4 t 175.71 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.079 2.152 . . . . 2.4500000000000002 110.987 173.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.2 m -71.4 43.43 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 126.902 2.081 . . . . 1.5800000000000001 115.019 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -106.95 127.95 27.03 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.308 -1.495 . . . . 3.3100000000000001 111.276 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.84 162.34 29.63 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.824 3.016 . . . . 1.27 112.305 173.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.12 145.76 40.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.125 0.97 . . . . 1.7 109.467 160.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mm -102.07 22.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.669 1.188 . . . . 3.4300000000000002 111.321 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.14 129.46 27.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.131 1.373 . . . . 5.1500000000000004 112.2 -175.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 t0 69.83 25.87 4.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.678 1.591 . . . . 3.3500000000000001 112.737 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.64 28.07 44.55 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.722 1.153 . . . . 2.6499999999999999 113.541 172.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -158.26 132.54 8.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.009 0.904 . . . . 3.25 110.773 -166.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.8 104.0 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.394 -0.816 . . . . 2.2400000000000002 111.277 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.61 41.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.674 1.589 . . . . 2.5699999999999998 112.414 -175.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.46 -63.15 0.26 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.991 2.916 . . . . 2.0800000000000001 115.563 172.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.77 128.31 2.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.074 2.55 . . . . 1.6399999999999999 108.315 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -116.48 -46.71 2.76 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.435 1.094 . . . . 4.9000000000000004 111.72 -177.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.54 -18.73 64.42 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.712 1.004 . . . . 1.5600000000000001 113.712 -174.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.1 -8.39 56.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.161 1.384 . . . . 1.21 113.45 168.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.64 174.4 49.27 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 120.608 -1.307 . . . . 2.6299999999999999 112.699 -172.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.37 -160.52 19.5 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 122.156 -0.614 . . . . 1.5700000000000001 111.768 168.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -48.4 144.0 4.39 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.466 -0.568 . . . . 2.7999999999999998 109.466 165.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.3 61.01 0.3 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.515 1.526 . . . . 4.0999999999999996 112.152 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -118.85 -1.21 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 120.724 3.602 . . . . 4.0499999999999998 120.724 -147.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.66 -56.84 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 123.505 2.288 . . . . 3.8399999999999999 114.885 -151.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -92.76 54.85 2.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.632 1.173 . . . . 4.1699999999999999 111.236 -177.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -123.94 -75.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.324 1.05 . . . . 3.3900000000000001 111.651 174.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t 168.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 130.02 3.328 . . . . 2.7799999999999998 111.257 -175.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.48 0.19 73.4 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 115.408 0.923 . . . . 1.97 115.408 164.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -84.22 3.87 33.33 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.604 1.705 . . . . 5.7300000000000004 115.604 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 45.2 t60 62.25 -174.25 0.14 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.911 1.284 . . . . 1.8600000000000001 111.662 -169.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.413 ' H ' ' CG ' ' A' ' 82' ' ' HIS . 8.9 pt-20 -158.27 -155.14 0.47 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.558 -1.339 . . . . 3.98 111.467 -172.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.43 -101.56 0.64 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.041 -1.422 . . . . 2.8300000000000001 111.007 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.9 -15.38 32.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.501 2.8 . . . . 4.0 113.357 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.59 157.37 12.39 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.77 2.828 . . . . 6.8700000000000001 108.333 179.215 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.5 179.75 29.55 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.223 0.902 . . . . 5.2000000000000002 114.857 177.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -156.13 35.64 0.34 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.935 2.094 . . . . 5.9299999999999997 109.426 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.61 4.56 63.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 116.822 -2.099 . . . . 3.2999999999999998 116.703 -172.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.569 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 10.5 t-160 -177.12 99.5 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.358 1.863 . . . . 6.0300000000000002 111.561 171.551 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -14.19 62.78 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.104 1.89 . . . . 4.1500000000000004 116.104 -176.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 25.37 28.22 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 127.273 2.368 . . . . 1.6599999999999999 115.537 -170.088 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD2' ' ND1' ' A' ' 90' ' ' HIS . 46.4 m-20 -93.14 151.73 19.67 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.205 1.402 . . . . 3.0499999999999998 110.384 167.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.63 157.91 76.23 Favored Pre-proline 0 CA--C 1.556 1.198 0 O-C-N 120.95 -1.094 . . . . 3.1800000000000002 111.706 -161.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.7 162.38 41.41 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.96 3.106 . . . . 1.0900000000000001 112.509 -171.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -83.19 128.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 123.431 1.586 . . . . 2.2400000000000002 112.977 -161.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.03 83.22 6.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.556 2.742 . . . . 3.6000000000000001 110.033 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.53 143.62 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 125.598 1.559 . . . . 1.1200000000000001 111.105 176.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 157.25 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 127.598 2.359 . . . . 2.6299999999999999 107.913 170.159 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 163.26 23.0 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 118.743 -0.646 . . . . 2.52 111.852 170.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -19.35 2.2 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.312 1.967 . . . . 3.5299999999999998 116.312 -174.028 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -94.37 -2.33 52.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.658 1.583 . . . . 3.8599999999999999 114.578 177.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.12 31.44 8.49 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.149 0.886 . . . . 1.3100000000000001 115.174 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -116.53 133.78 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.768 1.627 . . . . 1.4099999999999999 109.449 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.18 108.81 19.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.441 1.496 . . . . 0.81000000000000005 109.546 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 t -131.43 24.59 4.8 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.079 1.752 . . . . 1.5700000000000001 111.291 172.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.79 108.54 43.72 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.917 1.687 . . . . 3.04 108.933 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 129.87 14.65 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.791 2.327 . . . . 1.3 110.378 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.29 172.17 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.163 1.385 . . . . 1.8300000000000001 108.972 175.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.3 m -151.22 145.59 25.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.226 0.921 . . . . 1.3500000000000001 109.954 -171.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -112.45 89.64 12.99 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 112.992 0.738 . . . . 1.1000000000000001 112.992 176.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 -4.91 12.86 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.856 3.038 . . . . 1.6299999999999999 114.307 172.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -73.72 -18.92 60.94 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.751 2.02 . . . . 4.6900000000000004 112.046 176.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.38 164.02 13.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.379 2.272 . . . . 3.7200000000000002 108.405 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -154.37 6.11 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.295 1.591 . . . . 5.0300000000000002 115.295 -172.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 t -168.95 130.41 1.2 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.338 -1.476 . . . . 2.2799999999999998 113.099 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.35 -26.94 61.78 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.583 -1.323 . . . . 2.1000000000000001 111.946 174.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.13 -16.69 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.676 1.361 . . . . 3.0899999999999999 114.676 175.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.68 -12.89 52.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.385 1.448 . . . . 3.1899999999999999 113.056 171.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.41 3.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.353 1.461 . . . . 1.0900000000000001 114.587 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -62.35 -2.56 1.05 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.057 2.243 . . . . 3.2999999999999998 117.057 -175.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -148.85 29.38 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.036 1.735 . . . . 3.2999999999999998 110.826 174.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -111.87 -179.53 3.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.83 1.652 . . . . 2.6400000000000001 111.578 178.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.31 151.74 48.95 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.003 -1.061 . . . . 0.68999999999999995 111.124 168.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.74 153.48 33.34 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.441 1.097 . . . . 3.0099999999999998 110.696 164.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.3 mtt -136.97 130.98 32.32 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.329 0.652 . . . . 1.5700000000000001 110.94 -170.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.0 mt -84.74 109.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.131 -1.433 . . . . 1.02 107.131 168.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -91.95 147.03 23.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.002 2.121 . . . . 3.1699999999999999 111.191 -175.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.71 -37.58 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.876 -1.14 . . . . 1.97 113.397 -162.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.16 170.92 15.16 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 124.506 1.05 . . . . 1.9199999999999999 111.774 170.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.46 169.34 37.19 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 1.5700000000000001 113.884 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.423 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 24.0 t0 -125.96 11.64 7.73 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.896 1.813 . . . . 2.46 115.896 -141.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.21 9.21 0.46 Allowed 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.126 -1.609 . . . . 3.4700000000000002 115.229 -177.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.1 mtm -81.19 79.29 7.87 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.527 1.531 . . . . 3.6800000000000002 112.31 -172.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -81.68 -5.09 57.77 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.957 0.903 . . . . 3.3300000000000001 113.352 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -149.3 145.05 26.86 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.152 -1.592 . . . . 3.8700000000000001 111.566 -173.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 151.27 153.88 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.091 1 C-N-CA 132.049 4.139 . . . . 4.0999999999999996 110.166 173.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.71 -12.1 22.11 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.306 2.671 . . . . 2.1499999999999999 114.382 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -77.93 116.0 54.99 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 119.76 1.164 . . . . 6.1500000000000004 108.927 165.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.84 173.33 12.09 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.161 2.574 . . . . 4.9100000000000001 112.948 -168.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.8 mt 67.04 11.21 8.26 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.355 1.862 . . . . 7.4299999999999997 113.904 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.28 6.62 59.91 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.437 1.494 . . . . 5.5700000000000003 114.481 177.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.93 -50.67 2.67 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.127 1.463 . . . . 3.3999999999999999 114.581 175.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.31 45.14 1.73 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 126.58 2.038 . . . . 2.2000000000000002 114.602 -175.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.74 -15.12 68.49 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.674 1.13 . . . . 2.3700000000000001 114.657 -175.014 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.8 p -67.68 125.09 25.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.216 1.406 . . . . 2.29 112.244 -175.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 -91.01 150.41 21.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.011 1.724 . . . . 5.1600000000000001 110.098 176.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.409 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 11.0 t80 -112.49 -42.04 3.74 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.795 0.725 . . . . 3.25 112.265 161.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.99 142.79 32.97 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.316 0.646 . . . . 0.68999999999999995 112.607 177.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.02 143.44 44.31 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.503 1.521 . . . . 1.3200000000000001 111.113 176.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.57 81.66 0.3 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 128.083 2.754 . . . . 1.1499999999999999 110.962 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.76 135.66 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 118.091 0.945 . . . . 3.48 110.949 166.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.2 mt -107.54 140.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.045 1.338 . . . . 1.51 110.341 -167.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 4.6200000000000001 109.822 177.493 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.568 -0.253 . . . . 3.8799999999999999 110.989 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -155.67 152.45 28.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.095 1.358 . . . . 2.5499999999999998 110.121 -170.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.84 122.73 5.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.055 0.931 . . . . 2.6899999999999999 112.669 173.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.76 82.41 5.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.994 -1.066 . . . . 4.2699999999999996 113.225 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.69 116.05 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.22 -0.925 . . . . 1.9299999999999999 111.778 -169.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.09 90.38 1.2 Allowed Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.462 1.982 . . . . 1.1599999999999999 112.319 -177.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mmt -72.81 120.8 18.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.95 . . . . 2.0899999999999999 113.13 -175.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -104.44 144.37 31.75 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.074 1.75 . . . . 3.52 112.033 -178.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.64 66.53 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.42 1.088 . . . . 2.6299999999999999 111.105 175.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 m -67.46 138.88 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.552 1.141 . . . . 1.5 110.304 174.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -165.81 61.1 0.11 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.745 0.784 . . . . 2.21 112.317 -171.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.61 -26.79 0.17 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.965 2.506 . . . . 1.8100000000000001 115.265 171.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -17.44 61.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.301 2.24 . . . . 2.7000000000000002 112.117 173.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.8 -168.04 13.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.545 2.022 . . . . 2.1800000000000002 109.963 -160.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.2 t -56.64 139.5 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.327 0.651 . . . . 1.48 110.19 155.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.74 -128.2 4.7 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.927 1.727 . . . . 1.3799999999999999 112.065 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.421 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -116.67 162.75 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.755 1.622 . . . . 5.9299999999999997 111.009 178.224 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -128.45 156.5 43.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.083 0.953 . . . . 1.6899999999999999 112.745 -164.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.74 7.53 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 125.005 1.322 . . . . 3.9100000000000001 114.388 -162.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.84 173.82 24.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.063 1.315 . . . . 0.57999999999999996 112.975 -179.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.421 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 4.2 p -105.18 174.34 5.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.78 0.832 . . . . 1.04 109.817 168.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 t -123.46 126.67 73.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.962 -1.496 . . . . 0.85999999999999999 106.962 151.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.55 119.7 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 123.279 0.362 . . . . 1.47 111.408 -177.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.33 126.74 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.847 1.259 . . . . 2.27 108.545 174.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -130.34 127.16 38.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.917 0.887 . . . . 2.3300000000000001 109.896 170.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.05 136.67 38.68 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.516 1.927 . . . . 3.3700000000000001 112.302 -171.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.58 -175.53 5.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.254 0.934 . . . . 1.9399999999999999 111.361 175.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.24 -30.62 70.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.013 0.925 . . . . 4.0499999999999998 112.037 -179.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.11 11.77 41.07 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.892 0.758 . . . . 1.1599999999999999 113.762 166.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.36 -141.16 21.92 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 127.441 2.448 . . . . 0.91000000000000003 114.742 176.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.11 101.9 9.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.057 0.943 . . . . 0.84999999999999998 111.296 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -78.06 108.24 11.21 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.983 1.313 . . . . 2.3900000000000001 110.594 175.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -102.69 117.1 33.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.458 2.303 . . . . 0.78000000000000003 110.269 -171.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -127.58 112.36 20.9 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 117.765 -1.112 . . . . 1.1599999999999999 109.716 -172.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -88.62 159.43 6.42 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.188 2.592 . . . . 0.54000000000000004 112.224 -173.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 6.3 p80 -151.08 25.31 0.72 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.446 0.906 . . . . 1.6399999999999999 113.446 173.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.31 136.58 33.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.814 0.846 . . . . 0.85999999999999999 112.822 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.09 156.98 18.99 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.677 -0.692 . . . . 2.6000000000000001 111.198 161.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.15 20.39 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.806 2.442 . . . . 2.1299999999999999 114.675 156.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.89 154.29 41.13 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 2.3500000000000001 112.458 176.252 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.07 137.68 45.1 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 O-C-N 122.953 0.975 . . . . 1.76 110.911 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -85.24 51.74 3.12 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.489 3.459 . . . . 2.0299999999999998 112.283 -162.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 -162.42 13.99 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 114.868 -1.06 . . . . 1.1899999999999999 114.047 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.46 140.28 32.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.256 1.822 . . . . 2.6899999999999999 110.214 171.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.87 136.55 30.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 1.6299999999999999 109.683 -177.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.72 169.61 29.71 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.629 0.65 . . . . 0.72999999999999998 112.347 167.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.39 132.68 10.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.209 1.404 . . . . 3.3599999999999999 108.566 171.112 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.473 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 15.6 m170 -129.79 170.49 13.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.231 1.567 . . . . 0.77000000000000002 115.231 168.633 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.3 mt -99.01 147.1 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.629 1.572 . . . . 0.78000000000000003 109.151 153.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.59 152.34 40.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.168 1.787 . . . . 1.02 110.503 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.35 -31.44 72.57 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.435 2.013 . . . . 1.03 116.435 -160.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -113.73 169.8 8.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.858 1.663 . . . . 1.4399999999999999 112.528 177.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.02 67.41 0.22 Allowed Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.948 1.139 . . . . 1.02 115.948 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -166.88 120.5 1.02 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 119.459 1.629 . . . . 2.4900000000000002 114.572 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.4 m -69.93 -6.34 32.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.34 1.856 . . . . 1.4299999999999999 115.157 176.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -63.96 145.02 98.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 O-C-N 120.993 -1.067 . . . . 3.2799999999999998 111.825 -168.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.23 150.2 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.978 2.452 . . . . 1.52 111.752 179.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.25 140.96 34.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.517 0.727 . . . . 1.95 109.723 161.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.92 126.75 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.13 -1.063 . . . . 3.0600000000000001 108.13 169.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -167.32 144.91 4.65 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.731 1.612 . . . . 6.0199999999999996 109.971 -163.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 59.88 -104.73 0.2 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.072 1.349 . . . . 4.1399999999999997 108.003 -163.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.68 25.4 3.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.934 1.73 . . . . 3.46 113.501 170.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.88 179.62 9.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.094 1.447 . . . . 5.96 113.318 -167.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.57 108.53 20.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.812 1.245 . . . . 1.8799999999999999 112.679 -171.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.25 91.43 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.829 1.252 . . . . 2.4100000000000001 109.937 -179.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.15 114.7 2.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.567 1.547 . . . . 3.6800000000000002 112.859 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.26 39.18 7.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.54 1.536 . . . . 2.9399999999999999 113.395 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.84 -43.0 90.64 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.409 0.684 . . . . 4.4199999999999999 109.896 158.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.78 78.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.664 1.186 . . . . 1.8 113.002 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -16.36 8.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.816 2.046 . . . . 0.90000000000000002 115.416 179.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.89 176.25 45.35 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 120.072 1.305 . . . . 2.3100000000000001 112.561 -172.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.24 -175.92 22.72 Favored Glycine 0 N--CA 1.474 1.181 0 N-CA-C 111.732 -0.547 . . . . 2.0899999999999999 111.732 163.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -70.17 35.88 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.907 1.447 . . . . 3.0899999999999999 114.907 -176.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 71.81 89.73 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.2 1.8 . . . . 4.6600000000000001 109.691 175.317 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.25 102.47 1.24 Allowed Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 127.287 2.235 . . . . 3.8700000000000001 110.03 -172.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.42 -54.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.259 2.64 . . . . 2.29 111.561 173.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -132.37 15.2 4.55 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.052 1.296 . . . . 4.4800000000000004 113.651 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.91 -47.17 63.52 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.427 -1.421 . . . . 3.6099999999999999 111.388 -171.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t 178.16 -65.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.287 2.235 . . . . 2.8999999999999999 111.855 175.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.29 -21.14 6.13 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.825 1.203 . . . . 2.1200000000000001 114.502 -170.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -82.62 168.61 17.14 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.117 1.959 . . . . 5.1900000000000004 113.83 170.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -84.52 146.09 27.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.336 1.054 . . . . 2.6000000000000001 112.875 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 84' ' ' GLY . 7.1 tt0 -106.87 -156.81 0.59 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.505 1.122 . . . . 3.54 112.56 -178.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.431 ' H ' ' HG2' ' A' ' 83' ' ' GLU . . . -160.47 -128.34 0.95 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 127.23 2.348 . . . . 3.1299999999999999 110.478 179.081 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.95 -27.22 12.38 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.363 2.709 . . . . 5.7400000000000002 113.353 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -174.18 164.85 4.07 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.664 2.386 . . . . 8.8699999999999992 109.979 171.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.22 -135.36 7.72 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 125.796 1.665 . . . . 3.8100000000000001 109.977 -174.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -142.67 116.13 9.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.289 1.044 . . . . 5.4900000000000002 112.079 166.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.58 -139.44 3.24 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 127.474 2.464 . . . . 2.1400000000000001 109.179 166.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -75.49 139.7 42.37 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 117.806 0.803 . . . . 4.6799999999999997 112.674 176.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.5 -15.84 62.84 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.711 1.375 . . . . 2.9300000000000002 114.711 177.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.03 9.79 76.15 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 118.496 -1.169 . . . . 0.95999999999999996 114.892 175.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -82.84 136.09 34.74 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.87 1.335 . . . . 1.6499999999999999 111.497 171.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 171.2 7.26 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.983 0.913 . . . . 2.6600000000000001 111.066 -138.24 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.46 159.52 32.45 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.372 2.715 . . . . 1.5800000000000001 112.45 -169.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -85.26 126.51 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 122.908 1.337 . . . . 2.0299999999999998 113.423 -173.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.17 68.64 5.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.972 2.909 . . . . 2.6099999999999999 110.878 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.53 144.76 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.73 0.812 . . . . 1.29 110.749 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.91 135.61 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 4.5300000000000002 109.478 169.548 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.12 154.22 42.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.843 1.257 . . . . 3.21 113.876 178.015 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -33.34 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 131.188 3.795 . . . . 4.0499999999999998 118.953 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -78.72 -21.52 47.94 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.567 1.547 . . . . 3.54 113.319 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.2 34.48 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 124.338 0.971 . . . . 1.3500000000000001 114.852 178.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mt -124.32 117.13 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.037 1.335 . . . . 1.8999999999999999 109.413 178.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 125.63 28.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.194 0.998 . . . . 0.73999999999999999 111.152 -177.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 t -142.7 -7.14 0.86 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.592 1.557 . . . . 1.54 113.502 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.0 117.38 64.66 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.038 -1.038 . . . . 3.27 111.193 -175.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 136.57 14.64 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.446 2.764 . . . . 1.0700000000000001 111.281 176.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 m -139.97 155.82 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.785 1.234 . . . . 1.53 110.336 176.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.3 m -135.48 138.91 43.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.712 0.687 . . . . 0.93999999999999995 110.915 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.29 99.77 50.25 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.237 1.015 . . . . 0.77000000000000002 112.885 -174.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.22 -1.29 11.29 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.58 3.52 . . . . 1.28 115.384 -178.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -71.71 -25.32 62.03 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.158 0.89 . . . . 4.7199999999999998 111.855 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.79 133.04 56.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.003 2.521 . . . . 3.0800000000000001 106.802 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 12.29 1.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.756 1.021 . . . . 8.0299999999999994 113.756 -164.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.4 p -132.45 164.09 27.32 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.054 -0.721 . . . . 3.5499999999999998 109.054 146.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.8 -26.68 22.73 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.649 -0.657 . . . . 4.0 110.547 168.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.28 -44.89 44.39 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.391 1.476 . . . . 3.1499999999999999 113.055 168.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.7 -2.34 14.23 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.877 1.066 . . . . 2.4500000000000002 113.877 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 18.02 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.304 1.441 . . . . 1.03 113.806 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -64.99 -4.27 4.42 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 118.135 2.642 . . . . 2.8999999999999999 118.135 -170.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.3 58.76 0.9 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.05 1.74 . . . . 4.3399999999999999 109.9 169.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -114.58 147.93 38.77 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.081 1.352 . . . . 2.2999999999999998 110.751 173.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.38 140.47 31.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.813 0.845 . . . . 0.93000000000000005 110.354 164.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.41 149.12 36.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.558 1.943 . . . . 4.0099999999999998 107.534 170.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.6 mtt -132.97 137.73 46.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.813 0.279 . . . . 1.8999999999999999 111.728 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.53 124.36 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.967 -1.494 . . . . 0.83999999999999997 106.967 165.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.32 137.97 51.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.289 1.036 . . . . 2.8100000000000001 112.17 -162.25 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.69 -32.96 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.486 1.291 . . . . 4.1399999999999997 114.486 -154.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.02 152.61 19.74 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.003 1.287 . . . . 1.6200000000000001 111.55 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.9 140.35 16.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.907 1.717 . . . . 1.76 113.644 175.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.473 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 15.5 t0 -83.28 -0.02 47.75 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.284 1.587 . . . . 2.4199999999999999 115.284 -152.394 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -77.2 -16.59 59.02 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.939 1.696 . . . . 4.04 114.977 -168.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.4 ptp -78.59 45.4 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.518 1.527 . . . . 3.5600000000000001 113.829 -171.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 m -83.2 -33.76 26.08 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 117.902 2.556 . . . . 4.75 117.902 -146.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -92.95 21.77 5.45 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.296 1.039 . . . . 4.4400000000000004 113.466 -162.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -75.22 146.43 81.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.546 1.138 . . . . 4.6100000000000003 112.454 -172.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.07 -14.54 41.16 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.619 2.879 . . . . 2.1899999999999999 112.913 173.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -83.58 101.77 1.55 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.695 -0.854 . . . . 4.8499999999999996 108.695 151.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.24 146.28 93.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.387 2.058 . . . . 3.5099999999999998 110.422 -177.202 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 71.15 -3.25 2.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.783 2.033 . . . . 4.6399999999999997 112.927 -173.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.88 40.02 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.817 1.675 . . . . 2.8399999999999999 115.839 168.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.5 -38.45 3.01 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.309 1.433 . . . . 2.48 112.678 -167.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.31 -25.74 63.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.961 1.267 . . . . 2.0 114.349 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.43 2.7 14.05 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.88 1.228 . . . . 2.2999999999999998 115.312 172.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.9 m -66.2 152.27 45.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.761 1.28 . . . . 3.1699999999999999 108.885 164.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.66 133.24 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.276 1.03 . . . . 5.8600000000000003 110.513 -169.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -98.09 -16.64 19.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.176 0.59 . . . . 3.5099999999999998 111.366 156.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.49 160.73 35.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.137 0.88 . . . . 0.69999999999999996 112.977 164.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.6 t -133.04 150.72 52.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.423 1.889 . . . . 1.54 109.825 167.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.21 136.34 4.38 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.393 1.473 . . . . 0.97999999999999998 111.701 -178.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.96 139.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.119 0.968 . . . . 2.7400000000000002 111.502 -174.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.03 149.55 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.172 1.389 . . . . 1.5900000000000001 111.862 174.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 C--O 1.238 0.491 0 C-N-CA 125.311 1.444 . . . . 4.0800000000000001 111.38 -176.411 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 119.544 -0.265 . . . . 2.1200000000000001 110.756 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.78 152.62 35.5 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.763 -1.211 . . . . 1.47 113.228 -164.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -147.59 130.96 16.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.138 1.775 . . . . 2.2200000000000002 109.599 174.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.44 96.66 10.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 5.9900000000000002 111.117 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 t -90.15 112.32 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 120.597 -1.314 . . . . 1.6200000000000001 109.147 -169.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.28 109.55 2.81 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.781 1.181 . . . . 0.95999999999999996 110.363 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.2 mtp -96.52 131.12 43.45 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.453 0.701 . . . . 2.2000000000000002 111.486 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -105.06 155.61 18.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.465 1.126 . . . . 2.6699999999999999 110.534 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.84 145.29 54.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.412 1.485 . . . . 1.49 109.451 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.4 m -140.07 140.46 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.507 0.723 . . . . 1.3300000000000001 111.085 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.08 57.9 0.1 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.788 0.662 . . . . 2.3500000000000001 112.788 -167.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 77.34 -21.48 0.33 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.949 2.1 . . . . 1.54 114.073 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -19.99 28.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.251 1.02 . . . . 3.1499999999999999 112.858 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.57 -147.93 16.32 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 125.411 1.482 . . . . 1.0800000000000001 111.327 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.05 123.2 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.169 1.788 . . . . 1.3899999999999999 111.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.32 -137.8 9.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.748 1.642 . . . . 1.5700000000000001 112.021 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -90.31 170.11 10.53 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.258 -0.554 . . . . 2.23 110.049 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 t -105.95 157.66 17.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.991 0.9 . . . . 2.1899999999999999 112.201 162.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.95 0.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.715 2.806 . . . . 3.7000000000000002 112.822 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 147.25 6.21 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.571 2.034 . . . . 0.91000000000000003 111.914 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.436 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 4.9 p -88.08 -177.44 5.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.297 -1.001 . . . . 1.02 108.297 159.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.3 134.28 65.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.554 -1.276 . . . . 0.56999999999999995 107.554 149.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.2 p -82.95 127.09 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.596 -0.52 . . . . 1.4099999999999999 109.596 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.8 mt -103.88 130.64 54.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.219 -1.03 . . . . 1.74 108.219 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.41 112.12 8.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.656 1.182 . . . . 2.1499999999999999 109.131 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -77.77 144.49 37.11 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.773 -0.579 . . . . 3.3199999999999998 111.157 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 t -148.24 178.13 8.83 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.356 -0.979 . . . . 1.97 108.356 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -70.36 -14.95 62.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.162 0.585 . . . . 3.3900000000000001 112.176 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.41 12.9 67.47 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.22 1.391 . . . . 1.1000000000000001 114.845 163.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.98 -155.89 22.15 Favored Glycine 0 N--CA 1.467 0.741 0 C-N-CA 127.492 2.473 . . . . 0.81000000000000005 117.224 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -71.63 101.99 2.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.664 0.785 . . . . 0.78000000000000003 111.87 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -71.29 117.3 12.65 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.841 1.256 . . . . 2.7400000000000002 109.163 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.48 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -95.88 127.52 41.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.027 1.731 . . . . 0.95999999999999996 108.162 174.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.412 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 19.9 m -129.62 105.03 17.27 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 119.916 1.235 . . . . 1.45 107.972 167.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.75 164.87 29.58 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.112 2.541 . . . . 0.67000000000000004 110.066 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.436 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 1.3 p80 -155.42 43.66 0.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 122.356 1.074 . . . . 1.54 109.251 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.15 134.83 44.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.891 1.276 . . . . 2.25 112.089 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.492 ' HE3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -104.63 164.47 11.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.962 2.505 . . . . 3.2599999999999998 109.056 168.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.57 16.06 0.38 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.778 2.431 . . . . 1.79 114.195 163.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.36 160.5 36.93 Favored Pre-proline 0 CA--C 1.511 -0.545 0 O-C-N 121.871 -0.518 . . . . 3.0 110.42 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.8 128.45 23.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 O-C-N 123.451 1.237 . . . . 1.1699999999999999 110.307 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -85.8 31.31 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 125.101 3.867 . . . . 1.3100000000000001 113.471 -147.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.08 -122.18 4.29 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 126.399 1.952 . . . . 1.1799999999999999 113.124 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.84 138.21 35.57 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.095 2.158 . . . . 2.5099999999999998 108.386 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -137.88 123.0 19.19 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 123.683 0.793 . . . . 1.55 112.942 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.15 149.26 7.56 Favored Glycine 0 CA--C 1.54 1.656 0 O-C-N 121.336 -0.852 . . . . 0.69999999999999996 112.307 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.7 t80 -124.96 115.4 20.51 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.802 1.301 . . . . 3.3300000000000001 107.5 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -115.03 162.31 17.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.724 1.379 . . . . 1.1799999999999999 114.724 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.2 mt -107.75 143.6 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.765 2.026 . . . . 0.79000000000000004 107.388 155.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -118.41 161.09 20.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.504 1.122 . . . . 1.1100000000000001 112.03 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.62 73.22 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.558 1.318 . . . . 0.85999999999999999 114.558 -163.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -101.92 177.77 4.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.69 1.196 . . . . 2.0099999999999998 111.61 164.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.49 90.2 0.55 Allowed Glycine 0 N--CA 1.469 0.856 0 C-N-CA 124.621 1.105 . . . . 0.91000000000000003 112.003 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -166.4 99.03 0.6 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.356 1.078 . . . . 2.54 113.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.7 m -71.48 45.52 0.11 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.942 2.097 . . . . 1.6399999999999999 113.802 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.55 148.41 42.85 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.172 -1.58 . . . . 3.6099999999999999 111.452 -171.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.51 165.02 9.37 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.473 3.449 . . . . 1.8100000000000001 112.139 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.65 148.96 40.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.425 1.09 . . . . 2.1699999999999999 110.013 166.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.45 134.43 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.323 1.449 . . . . 2.52 108.091 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -162.9 143.6 9.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.305 1.442 . . . . 6.3899999999999997 109.21 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t0 53.21 41.38 32.14 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.358 0.981 . . . . 4.0199999999999996 113.471 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 14.45 73.14 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.936 -0.925 . . . . 2.8799999999999999 115.086 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.38 156.79 44.39 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.446 1.623 . . . . 3.8300000000000001 111.717 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.09 138.98 44.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.377 0.88 . . . . 1.97 113.377 -170.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.83 134.06 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.265 1.426 . . . . 3.2799999999999998 109.037 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.52 -48.47 10.19 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.263 1.579 . . . . 2.6499999999999999 115.263 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.61 122.45 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 130.578 3.551 . . . . 2.71 107.412 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -154.45 -8.31 0.14 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.43 1.092 . . . . 6.79 113.849 -164.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.53 62.47 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 121.088 1.767 . . . . 1.75 113.048 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.0 -8.36 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.167 1.787 . . . . 1.25 114.708 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.4 -165.3 38.93 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 121.344 1.884 . . . . 2.5800000000000001 113.035 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.69 179.35 53.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.27 0.938 . . . . 1.6399999999999999 112.358 165.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . 0.291 0.2 OUTLIER -77.57 54.03 1.14 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.335 1.054 . . . . 3.8399999999999999 113.655 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.9 tp 54.87 69.19 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.921 2.488 . . . . 2.5499999999999998 111.484 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.45 65.52 11.76 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 129.0 2.92 . . . . 4.5899999999999999 113.009 -162.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.88 -58.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.382 2.721 . . . . 2.4900000000000002 113.436 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -137.7 125.96 23.15 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.29 1.036 . . . . 4.7599999999999998 109.51 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -174.89 -95.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.553 1.541 . . . . 6.0300000000000002 112.096 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 t 171.19 -23.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 128.713 2.805 . . . . 3.9399999999999999 112.604 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.78 -34.17 4.47 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 125.892 1.71 . . . . 3.4399999999999999 111.646 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -52.25 144.64 12.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.409 1.1 . . . . 7.8399999999999999 111.912 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -96.26 147.86 23.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.371 1.868 . . . . 2.3500000000000001 111.326 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.1 131.6 45.72 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.529 -0.915 . . . . 4.3899999999999997 108.529 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.19 -145.38 5.2 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.548 -1.14 . . . . 2.9700000000000002 114.108 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.47 -18.89 22.46 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.302 2.668 . . . . 3.23 114.265 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -165.29 146.81 7.52 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.863 1.265 . . . . 5.5099999999999998 110.834 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.88 -135.79 13.13 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.262 0.934 . . . . 5.1399999999999997 111.917 -171.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -165.71 157.89 14.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.435 1.494 . . . . 7.0700000000000003 109.451 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.18 -126.61 0.83 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.199 0.839 . . . . 2.6600000000000001 115.199 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 145.4 25.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.47 1.508 . . . . 4.9100000000000001 111.985 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.58 -11.31 57.5 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.16 1.17 . . . . 2.9100000000000001 114.16 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.01 32.2 4.72 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.216 1.389 . . . . 1.1599999999999999 114.858 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.97 131.64 56.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.008 1.323 . . . . 1.6699999999999999 111.16 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mp -142.32 159.46 58.12 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 125.646 1.579 . . . . 2.98 111.079 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.11 152.0 56.08 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.942 2.428 . . . . 1.05 113.083 -169.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.32 130.95 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.343 1.457 . . . . 3.3100000000000001 112.758 -162.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.33 88.43 2.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.019 2.928 . . . . 2.6600000000000001 109.87 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.67 136.06 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.03 0.932 . . . . 0.90000000000000002 110.587 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.87 138.99 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 127.418 2.287 . . . . 2.4700000000000002 106.295 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.19 161.28 30.12 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.263 -0.898 . . . . 2.3500000000000001 111.276 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -19.2 0.85 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.731 2.123 . . . . 2.6299999999999999 116.731 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.84 1.89 55.4 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.487 2.315 . . . . 2.73 112.812 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.15 23.21 41.75 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 125.258 1.408 . . . . 1.01 114.462 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -123.49 131.8 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.334 1.054 . . . . 1.6399999999999999 111.044 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.02 140.17 44.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.009 1.724 . . . . 1.1299999999999999 111.604 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -140.91 -2.9 1.28 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.745 1.757 . . . . 2.23 115.745 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.3 111.85 3.71 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 114.791 1.404 . . . . 3.2799999999999998 114.791 -165.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.23 101.89 1.18 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.014 2.476 . . . . 2.48 110.079 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.0 178.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.145 1.778 . . . . 2.6400000000000001 110.203 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.0 m -146.92 142.48 27.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.675 0.79 . . . . 1.49 110.621 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.88 106.97 56.45 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.494 1.118 . . . . 0.93999999999999995 110.422 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.61 7.44 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.663 2.909 . . . . 1.04 113.218 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -17.98 63.32 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.229 1.412 . . . . 6.4800000000000004 113.425 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mp -152.82 155.77 37.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.862 3.265 . . . . 3.5299999999999998 108.09 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.304 0.0 OUTLIER -147.94 43.35 1.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.545 2.054 . . . . 5.9800000000000004 116.545 -173.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -175.99 147.36 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.638 1.975 . . . . 2.75 110.161 167.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.75 -28.42 68.69 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 2.3100000000000001 111.717 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.16 -19.23 19.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.123 1.369 . . . . 3.3599999999999999 114.301 173.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.72 -7.94 59.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.565 1.146 . . . . 2.71 112.496 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.27 0.78 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 114.912 1.449 . . . . 1.4199999999999999 114.912 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -72.23 20.22 0.07 Allowed 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.682 2.105 . . . . 4.2800000000000002 116.682 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -142.47 15.8 2.01 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.454 1.901 . . . . 3.0099999999999998 111.322 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -128.91 175.84 8.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.581 1.552 . . . . 3.3300000000000001 112.748 -164.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.15 149.11 39.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.563 1.145 . . . . 0.76000000000000001 112.04 166.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.2 mt -82.22 155.35 24.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.303 1.441 . . . . 2.8500000000000001 109.056 158.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.4 ttm -149.45 122.88 9.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.395 . . . . 2.5299999999999998 111.97 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -94.32 109.25 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.779 1.232 . . . . 0.85999999999999999 108.658 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.4 147.9 22.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.415 2.286 . . . . 3.4399999999999999 113.218 -167.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 t -67.88 -38.54 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.049 -1.032 . . . . 2.0699999999999998 112.332 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.51 155.92 17.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.632 0.634 . . . . 1.48 111.619 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.71 165.6 28.69 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.374 0.988 . . . . 1.3899999999999999 111.758 157.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -122.65 23.5 9.51 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.189 1.181 . . . . 2.6400000000000001 114.189 -136.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -93.72 4.25 54.22 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 116.397 1.999 . . . . 3.04 116.397 -167.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -131.88 151.27 51.81 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.677 1.732 . . . . 4.0999999999999996 115.677 -168.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.0 p -140.27 11.12 2.35 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.666 2.386 . . . . 3.54 112.89 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -118.65 14.7 13.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.219 1.408 . . . . 4.7699999999999996 112.436 -145.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -121.31 163.17 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.758 2.823 . . . . 3.2799999999999998 107.969 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.02 -10.12 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.828 2.352 . . . . 2.6200000000000001 114.441 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.13 133.03 22.58 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.321 1.449 . . . . 6.7199999999999998 109.757 165.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 165.9 31.35 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.64 2.893 . . . . 4.3600000000000003 113.175 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.92 25.48 14.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.293 1.837 . . . . 6.0999999999999996 111.647 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.59 13.72 59.14 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.989 -1.069 . . . . 3.3900000000000001 114.04 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 106.14 -7.7 41.05 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.619 1.58 . . . . 2.0 113.984 -168.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.19 22.08 0.63 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 126.303 1.906 . . . . 1.5600000000000001 115.887 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.86 74.68 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.364 1.459 . . . . 1.98 114.294 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.2 p -73.24 163.31 28.29 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.5 1.52 . . . . 2.0299999999999998 110.921 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 145.02 30.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.768 1.227 . . . . 6.29 111.555 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -92.16 -34.02 14.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.996 0.919 . . . . 4.0999999999999996 112.436 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.83 154.57 42.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.956 0.902 . . . . 0.59999999999999998 113.116 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.3 t -138.9 153.71 48.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.405 2.282 . . . . 1.4299999999999999 109.769 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.99 114.64 0.62 Allowed Glycine 0 N--CA 1.467 0.706 0 C-N-CA 124.088 0.851 . . . . 0.88 113.051 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.88 130.75 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.915 1.286 . . . . 2.54 110.514 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mp -76.4 132.81 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 2.23 109.54 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 118.492 -0.766 . . . . 5.3700000000000001 112.954 -176.339 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 119.479 -0.296 . . . . 2.7599999999999998 110.414 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -131.79 140.34 49.17 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.603 1.705 . . . . 2.2400000000000002 115.603 -137.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.89 136.87 34.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.144 0.973 . . . . 2.5600000000000001 111.569 161.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 98.16 11.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.624 1.17 . . . . 5.7300000000000004 111.36 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.03 118.55 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 120.8 -1.188 . . . . 1.53 109.614 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.42 111.31 3.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.478 1.513 . . . . 1.26 112.013 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 mmt -84.24 124.52 31.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.772 1.229 . . . . 2.3799999999999999 112.518 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -113.03 149.29 33.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.487 0.661 . . . . 2.3500000000000001 111.008 164.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -56.99 140.13 49.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.431 1.092 . . . . 1.3 109.635 171.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.36 147.28 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.43 0.559 . . . . 1.96 111.479 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -167.97 49.51 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.822 0.849 . . . . 2.5699999999999998 112.67 -168.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.42 -31.75 0.23 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.046 2.138 . . . . 1.8500000000000001 114.316 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -2.37 10.74 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.34 0.973 . . . . 2.9500000000000002 111.619 160.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.93 -140.01 16.71 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.671 1.129 . . . . 1.8400000000000001 111.03 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.05 122.34 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.723 1.609 . . . . 1.52 111.165 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.57 -134.99 8.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 126.176 1.846 . . . . 1.74 113.25 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.84 146.24 35.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.16 1.384 . . . . 3.4399999999999999 110.984 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 t -83.89 142.9 30.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 2.1000000000000001 110.878 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.8 -0.24 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.617 1.34 . . . . 4.3300000000000001 114.617 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.21 167.49 14.4 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.673 1.13 . . . . 0.82999999999999996 111.843 -171.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 p -103.3 176.14 5.25 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.569 -0.9 . . . . 1.22 108.569 161.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -119.19 131.36 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.718 -1.586 . . . . 0.75 106.718 148.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -84.88 123.97 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.921 -0.4 . . . . 1.52 109.921 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -98.32 117.91 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.177 -1.046 . . . . 1.8799999999999999 108.177 173.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -119.43 107.96 13.97 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.514 1.526 . . . . 1.9299999999999999 109.717 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.65 147.7 31.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.578 0.955 . . . . 3.9300000000000002 113.578 -172.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -179.58 7.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.719 0.808 . . . . 1.8400000000000001 110.96 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.16 -28.2 69.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.302 1.041 . . . . 3.7799999999999998 111.842 174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.9 10.34 60.48 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.448 1.023 . . . . 1.2 114.657 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.7 -145.74 23.97 Favored Glycine 0 N--CA 1.461 0.342 0 C-N-CA 129.15 3.262 . . . . 0.84999999999999998 114.895 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.6 95.19 7.09 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.916 0.886 . . . . 0.83999999999999997 110.488 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -71.66 107.18 4.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.108 0.963 . . . . 3.0800000000000001 109.856 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 t80 -99.9 105.46 17.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 117.254 -1.355 . . . . 0.65000000000000002 108.716 -167.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.4 m -116.05 109.07 45.21 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.789 1.632 . . . . 1.3 109.216 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.63 151.76 17.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.888 3.059 . . . . 0.71999999999999997 111.654 -176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -141.53 23.68 2.12 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.555 0.693 . . . . 1.75 112.599 171.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -80.11 157.7 26.58 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 126.644 1.978 . . . . 1.02 113.872 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.29 170.31 16.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.661 -1.609 . . . . 3.1899999999999999 109.831 165.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.81 22.93 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.607 2.763 . . . . 1.6599999999999999 112.92 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.85 160.82 26.25 Favored Pre-proline 0 CA--C 1.51 -0.591 0 C-N-CA 123.472 0.709 . . . . 2.8700000000000001 111.56 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.15 127.44 20.22 Favored 'Trans proline' 0 N--CA 1.426 -2.456 0 O-C-N 123.531 1.28 . . . . 1.0 110.482 168.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -88.8 31.78 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.51 3.474 . . . . 1.4399999999999999 112.654 -144.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.37 -120.94 4.84 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 126.22 1.866 . . . . 1.8700000000000001 113.405 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.32 145.07 48.26 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.971 2.108 . . . . 2.54 109.643 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.58 144.01 41.8 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.052 0.941 . . . . 1.04 111.409 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.95 165.57 37.86 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.136 -0.978 . . . . 0.92000000000000004 111.215 168.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -146.55 126.9 13.97 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.358 -1.349 . . . . 3.4700000000000002 107.358 169.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -122.81 167.23 13.78 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.466 1.284 . . . . 1.3500000000000001 114.466 163.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.7 mt -85.24 148.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.132 0.973 . . . . 1.02 108.836 151.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.38 153.74 41.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.822 2.049 . . . . 1.1899999999999999 108.318 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.72 72.67 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.97 1.841 . . . . 1.23 115.97 -159.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.23 -179.59 5.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.43 1.892 . . . . 1.8899999999999999 112.035 -170.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.41 125.78 7.13 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.548 -1.14 . . . . 2.0899999999999999 111.497 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 m 142.73 101.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 130.569 3.548 . . . . 2.6800000000000002 112.526 164.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 61.1 m -63.82 23.18 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 127.56 2.344 . . . . 1.3 115.709 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.08 130.18 33.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.528 -1.982 . . . . 3.27 110.737 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.29 157.9 14.88 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.225 3.283 . . . . 1.1100000000000001 111.544 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.57 174.49 7.73 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 1.8700000000000001 111.399 159.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.72 138.43 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.134 1.374 . . . . 2.7799999999999998 107.967 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.29 -124.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.182 0.593 . . . . 7.8300000000000001 111.378 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.87 -31.32 66.59 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.901 1.68 . . . . 5.0599999999999996 115.353 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 44.17 0.02 OUTLIER Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.135 0.874 . . . . 3.2799999999999998 112.164 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 172.71 158.41 0.11 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.306 2.642 . . . . 4.3099999999999996 109.281 -164.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.6 141.89 47.17 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.131 1.16 . . . . 1.8400000000000001 114.131 -161.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.18 61.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.58 1.552 . . . . 2.1800000000000002 111.651 -167.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.99 -72.2 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 127.431 2.292 . . . . 2.1200000000000001 115.498 166.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.93 106.6 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 1 C-N-CA 132.906 4.482 . . . . 1.6899999999999999 105.575 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -115.54 -46.49 2.86 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.378 1.071 . . . . 3.96 113.62 -155.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.62 -13.51 62.14 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.2 1.185 . . . . 1.51 114.2 -171.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -12.74 61.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.729 2.012 . . . . 1.4299999999999999 113.664 167.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.33 169.4 44.23 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.789 -1.194 . . . . 2.9500000000000002 112.638 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.69 -161.93 8.84 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.941 -0.864 . . . . 1.9199999999999999 110.941 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -42.81 141.33 1.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.601 -0.518 . . . . 2.4700000000000002 109.601 160.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.11 74.61 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.546 1.538 . . . . 4.5999999999999996 112.529 -170.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -132.73 58.81 38.66 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 126.717 2.007 . . . . 4.0599999999999996 112.681 -160.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.51 -37.56 29.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.062 1.841 . . . . 3.27 110.411 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -149.0 146.93 28.01 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.62 2.768 . . . . 4.29 105.805 162.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 p30 166.34 -47.42 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.115 2.166 . . . . 4.9299999999999997 114.327 168.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 t 172.74 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.428 2.691 . . . . 3.3199999999999998 111.425 -167.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.47 22.19 51.74 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 123.782 0.706 . . . . 2.4100000000000001 114.135 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -160.29 -116.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.963 1.305 . . . . 5.0 113.438 -167.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.456 ' CE1' ' CG ' ' A' ' 93' ' ' ASP . 2.8 t60 -160.05 145.24 15.09 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 119.833 -1.792 . . . . 2.1699999999999999 114.988 -170.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.65 -129.83 0.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.555 1.542 . . . . 4.29 111.164 170.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.55 -88.75 0.4 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.627 1.584 . . . . 3.1400000000000001 110.964 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -33.56 6.47 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.186 2.591 . . . . 4.4500000000000002 112.636 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.23 129.48 31.64 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.284 1.434 . . . . 5.5599999999999996 107.95 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.41 64.04 2.91 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 125.249 1.404 . . . . 3.8900000000000001 115.641 -158.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.09 98.71 11.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.996 0.918 . . . . 4.8799999999999999 112.92 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.99 -72.3 2.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 116.025 1.17 . . . . 4.8799999999999999 116.025 155.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -75.09 93.24 2.73 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.314 1.057 . . . . 5.9299999999999997 113.132 -164.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.78 64.03 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.926 1.454 . . . . 4.5300000000000002 114.926 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.7 -0.13 89.85 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.965 1.269 . . . . 1.6899999999999999 114.644 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' CG ' ' CE1' ' A' ' 82' ' ' HIS . 37.7 m-20 -67.03 134.25 51.54 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 118.297 1.048 . . . . 2.8100000000000001 108.651 161.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.28 168.25 11.66 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.096 0.958 . . . . 3.04 111.515 -149.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.12 165.23 28.39 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.279 2.653 . . . . 1.4199999999999999 112.682 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -85.63 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 122.824 1.297 . . . . 2.5499999999999998 112.983 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.59 97.3 2.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.309 3.444 . . . . 2.7000000000000002 109.832 172.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.36 139.15 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.333 1.053 . . . . 1.75 111.37 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.44 140.86 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.039 2.135 . . . . 2.5099999999999998 107.453 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.93 160.94 21.98 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.364 -0.835 . . . . 2.9100000000000001 112.024 174.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -20.38 4.44 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 115.539 1.681 . . . . 2.9199999999999999 115.539 -174.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -85.25 4.48 34.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.361 1.864 . . . . 3.3399999999999999 113.528 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.85 56.69 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 124.588 1.09 . . . . 0.90000000000000002 114.19 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.57 135.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.288 1.835 . . . . 1.8100000000000001 109.513 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 149.58 24.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.698 1.199 . . . . 0.98999999999999999 110.953 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.8 t -159.55 -34.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.672 0.989 . . . . 1.74 113.672 -166.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.69 122.33 85.46 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.111 1.364 . . . . 3.77 111.64 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.18 136.72 16.43 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.91 2.406 . . . . 1.6399999999999999 111.441 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.27 74.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 122.976 1.37 . . . . 2.29 112.096 -167.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.2 m -57.07 137.67 55.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.538 2.335 . . . . 2.2400000000000002 113.022 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.56 98.04 22.36 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.757 1.223 . . . . 0.81000000000000005 111.34 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.63 3.68 5.21 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.29 3.326 . . . . 1.24 113.938 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -76.99 -16.27 59.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.287 1.435 . . . . 4.7800000000000002 112.383 -176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.46 -179.52 4.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.985 2.114 . . . . 3.5099999999999998 107.704 166.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -53.77 2.68 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.32 -0.862 . . . . 4.6699999999999999 111.673 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -127.37 163.44 24.0 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.175 1.546 . . . . 2.3500000000000001 115.175 -149.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tp -74.22 -34.99 63.85 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.595 -1.316 . . . . 2.8799999999999999 111.977 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.42 -35.86 65.85 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.123 1.369 . . . . 3.4100000000000001 113.698 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.33 -3.13 38.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.405 1.261 . . . . 2.1000000000000001 114.405 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.48 7.94 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.483 1.038 . . . . 1.01 113.447 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.07 -10.67 4.56 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.278 1.955 . . . . 3.75 116.278 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -147.03 18.9 1.25 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.614 1.965 . . . . 3.52 111.537 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -101.45 -160.36 0.79 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.405 1.482 . . . . 2.4300000000000002 112.274 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.47 160.71 39.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.081 1.352 . . . . 1.2 112.332 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 19.8 mt -113.62 149.69 34.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.3 2.64 . . . . 2.5600000000000001 108.093 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.5 mtt -137.59 128.13 26.67 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.524 1.056 . . . . 1.8 111.264 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.82 108.53 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.794 -1.187 . . . . 0.88 107.794 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -86.93 144.21 27.05 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.881 1.672 . . . . 3.3100000000000001 113.142 -165.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.57 -43.6 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.099 -1.0 . . . . 1.72 112.035 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.38 172.0 25.98 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.914 -0.874 . . . . 1.3200000000000001 110.914 162.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.53 160.85 6.13 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.063 1.316 . . . . 1.4199999999999999 112.587 165.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -40.38 94.98 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.76 1.224 . . . . 3.46 114.14 -169.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.27 36.96 0.16 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 117.586 2.439 . . . . 2.8500000000000001 117.586 -151.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -108.46 148.19 30.56 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.562 1.545 . . . . 3.8799999999999999 112.372 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -149.48 -141.01 0.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.115 0.966 . . . . 3.5499999999999998 111.125 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.36 111.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.677 2.391 . . . . 5.5599999999999996 114.954 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -154.3 160.99 30.35 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.706 2.002 . . . . 3.9199999999999999 109.461 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.78 12.51 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 124.522 3.482 . . . . 4.0800000000000001 114.747 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -132.36 140.81 39.11 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.519 1.528 . . . . 6.1100000000000003 110.151 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.47 151.61 82.0 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.983 3.122 . . . . 6.3700000000000001 112.955 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.63 21.19 6.97 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.956 1.702 . . . . 6.1600000000000001 113.415 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.93 80.81 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.531 1.062 . . . . 4.3300000000000001 113.62 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.97 -48.66 3.05 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.454 1.502 . . . . 2.25 113.029 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.37 18.84 5.12 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.189 1.852 . . . . 1.8500000000000001 114.956 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.28 -19.82 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.995 1.283 . . . . 1.98 114.098 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.7 p -66.31 145.41 55.76 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.683 1.593 . . . . 1.75 111.714 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.17 136.81 48.62 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.309 1.444 . . . . 5.5800000000000001 110.276 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -75.63 -37.06 60.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 3.3199999999999998 110.411 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.31 152.21 41.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.497 1.119 . . . . 0.73999999999999999 112.861 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 52.1 t -121.42 147.79 45.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.792 2.037 . . . . 1.6299999999999999 109.866 171.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -138.93 91.38 0.2 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.01 1.767 . . . . 1.0700000000000001 111.704 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.29 135.13 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.918 1.287 . . . . 4.1399999999999997 111.587 166.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mt -97.03 151.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 1.6200000000000001 109.93 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? . . . . . 0 N--CA 1.471 0.581 0 O-C-N 121.382 -0.824 . . . . 5.7000000000000002 110.708 177.358 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.138 -0.69 . . . . 2.2599999999999998 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 m -114.79 131.02 56.94 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.221 1.373 . . . . 1.6200000000000001 112.897 -153.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.76 141.53 48.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.624 2.37 . . . . 2.96 107.191 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -120.47 86.3 2.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.937 -1.102 . . . . 4.3600000000000003 110.82 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.11 118.68 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 121.6 -0.687 . . . . 1.49 109.672 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.92 104.01 1.02 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.142 1.354 . . . . 0.79000000000000004 109.953 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 mtp -97.84 137.92 35.97 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.154 0.982 . . . . 1.9099999999999999 110.735 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -129.38 147.35 51.19 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.922 0.889 . . . . 3.02 112.092 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.14 142.93 56.35 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.127 1.371 . . . . 1.48 109.58 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 m -142.13 161.44 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.316 1.046 . . . . 1.6399999999999999 112.851 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t 155.65 124.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.756 2.822 . . . . 3.1499999999999999 111.423 144.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.57 -37.69 0.38 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.439 2.696 . . . . 2.4900000000000002 115.516 164.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -7.87 56.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.585 1.554 . . . . 4.2999999999999998 111.367 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -149.48 18.1 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 125.478 1.513 . . . . 1.6000000000000001 112.386 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.05 130.79 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.65 1.58 . . . . 1.8799999999999999 110.558 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.8 -134.48 8.54 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 125.68 1.609 . . . . 2.3300000000000001 113.351 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.83 153.49 24.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.162 2.185 . . . . 4.2699999999999996 112.153 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -94.49 139.01 31.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.419 0.628 . . . . 2.0499999999999998 112.02 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.7 10.63 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.764 1.626 . . . . 3.6400000000000001 112.385 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 154.18 146.69 4.46 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.722 1.63 . . . . 0.67000000000000004 111.265 -166.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.5 p -88.87 174.52 7.9 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.184 -1.043 . . . . 1.1699999999999999 108.184 158.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.42 129.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.622 -1.251 . . . . 0.81000000000000005 107.622 165.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.4 p -82.83 129.25 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.534 0.683 . . . . 2.1400000000000001 109.824 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.46 109.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.501 -1.666 . . . . 1.96 106.501 169.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -116.0 108.28 16.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 123.098 1.427 . . . . 2.5299999999999998 110.741 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.06 142.83 56.36 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 127.476 2.31 . . . . 4.1399999999999997 111.707 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -154.7 177.01 11.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.535 1.16 . . . . 1.5 111.392 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.55 -25.24 66.01 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.991 0.916 . . . . 4.25 110.661 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.18 14.89 61.04 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.426 1.489 . . . . 1.0900000000000001 115.949 166.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.03 -164.39 51.46 Favored Glycine 0 N--CA 1.47 0.929 0 C-N-CA 129.74 3.543 . . . . 0.89000000000000001 115.095 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.35 104.56 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.445 1.498 . . . . 1.1200000000000001 112.145 -168.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -82.37 104.16 12.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.159 0.983 . . . . 2.27 109.805 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -91.8 110.02 21.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.017 2.127 . . . . 0.89000000000000001 109.567 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 12.0 m -122.32 115.04 30.21 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.836 1.198 . . . . 1.1699999999999999 108.563 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.93 164.44 27.5 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.101 2.534 . . . . 0.65000000000000002 110.867 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -160.03 51.39 0.32 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.316 1.055 . . . . 2.6800000000000002 111.288 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 150.86 32.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.069 1.348 . . . . 0.92000000000000004 112.013 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.27 38.39 3.13 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.221 1.934 . . . . 2.1099999999999999 116.221 -160.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.76 12.0 0.59 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.483 2.031 . . . . 1.6000000000000001 116.483 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.94 160.71 25.37 Favored Pre-proline 0 N--CA 1.477 0.896 0 N-CA-C 114.186 1.18 . . . . 2.2799999999999998 114.186 -169.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.93 130.87 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.328 1.352 . . . . 0.90000000000000002 112.708 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.66 48.08 2.07 Favored 'Trans proline' 0 C--N 1.35 0.653 1 C-N-CA 126.957 5.105 . . . . 1.04 112.755 -158.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.94 -140.09 7.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.414 1.563 . . . . 1.23 113.287 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.04 134.51 53.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.821 1.648 . . . . 2.8399999999999999 108.534 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -139.88 125.21 18.94 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 125.157 1.383 . . . . 1.5900000000000001 111.017 -162.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.79 154.78 9.11 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.642 -1.286 . . . . 0.60999999999999999 112.457 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.38 127.51 29.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.958 1.303 . . . . 3.29 107.719 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 50.3 m170 -121.92 169.77 10.47 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 117.027 2.232 . . . . 1.23 117.027 168.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.16 138.79 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.508 1.923 . . . . 0.89000000000000001 109.254 152.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.14 164.94 16.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.217 2.607 . . . . 1.21 110.602 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.86 -62.79 1.42 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.697 1.369 . . . . 1.47 114.697 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 -97.6 146.93 24.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.652 0.612 . . . . 1.9199999999999999 112.652 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.74 62.83 2.38 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.634 1.111 . . . . 1.23 112.322 168.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -149.73 77.73 1.34 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.72 1.208 . . . . 3.3100000000000001 112.589 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.0 m -64.16 9.42 0.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 116.331 1.974 . . . . 1.3200000000000001 116.331 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -72.44 151.71 91.87 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 119.743 -1.848 . . . . 3.6899999999999999 112.53 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.0 152.15 67.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.257 2.638 . . . . 1.77 111.316 171.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.68 147.79 22.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.546 0.738 . . . . 3.6899999999999999 110.914 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mm -86.45 104.64 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.528 -0.916 . . . . 5.4699999999999998 108.528 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -162.34 138.96 7.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.265 1.026 . . . . 8.5500000000000007 109.909 -157.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t0 51.27 35.79 14.48 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 6.4500000000000002 113.85 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.61 11.0 85.88 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.527 -1.151 . . . . 4.6200000000000001 115.323 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -150.31 169.3 21.71 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.07 1.935 . . . . 3.3399999999999999 113.24 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.77 94.95 8.81 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.838 0.855 . . . . 2.7799999999999998 109.873 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.54 88.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.746 0.818 . . . . 3.4700000000000002 111.593 -170.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 55.69 -86.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.245 2.618 . . . . 2.1400000000000001 115.025 159.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.73 99.04 0.31 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.748 2.819 . . . . 2.7200000000000002 107.253 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -149.34 -17.46 0.28 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.284 1.216 . . . . 7.0199999999999996 114.284 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.04 -9.22 4.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.661 1.184 . . . . 2.0499999999999998 113.55 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 2.65 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.185 2.194 . . . . 1.1000000000000001 113.671 164.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 16.29 26.93 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.563 1.554 . . . . 3.04 114.255 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -114.6 4.86 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.248 -1.541 . . . . 3.23 109.248 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -97.35 -101.67 0.19 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.983 1.313 . . . . 3.8599999999999999 107.652 158.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.9 tp -160.95 79.45 0.61 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.228 2.211 . . . . 2.79 106.759 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.74 68.97 63.07 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.772 -1.104 . . . . 4.9800000000000004 111.111 -152.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.04 -44.93 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.821 2.347 . . . . 2.4900000000000002 113.6 -168.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -154.87 -151.71 0.37 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.287 1.835 . . . . 5.6100000000000003 108.916 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 75.23 -60.82 0.5 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.551 2.74 . . . . 4.4299999999999997 112.84 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 177.29 -19.45 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.927 2.491 . . . . 3.3500000000000001 113.328 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.73 49.17 76.46 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.039 1.29 . . . . 2.8799999999999999 114.896 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -143.96 18.29 1.78 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.662 1.727 . . . . 5.7699999999999996 115.662 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.8 t60 90.05 173.24 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.52 2.328 . . . . 2.8100000000000001 112.871 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -162.1 51.91 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.897 1.279 . . . . 4.8799999999999999 110.136 -161.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.01 -47.95 1.29 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-O 117.973 -1.459 . . . . 2.9900000000000002 114.997 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -103.43 -23.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.179 3.253 . . . . 4.79 113.831 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.97 172.99 1.57 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.793 2.437 . . . . 5.75 108.758 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.19 -159.05 32.13 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.064 0.84 . . . . 4.9500000000000002 113.516 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -153.52 28.71 0.49 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 6.8600000000000003 112.245 -168.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.18 16.65 60.87 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.105 -2.497 . . . . 3.5299999999999998 117.698 -165.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.466 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 2.6 t-160 170.06 99.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 128.396 2.678 . . . . 6.5099999999999998 111.059 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.49 2.79 2.78 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.578 1.696 . . . . 2.9900000000000002 115.578 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -102.42 3.97 50.83 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.322 1.439 . . . . 1.02 113.459 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' OD1' ' CE1' ' A' ' 90' ' ' HIS . 64.3 m-20 -71.93 137.09 47.12 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.525 1.162 . . . . 1.6599999999999999 109.619 165.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.86 169.04 11.06 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.762 1.225 . . . . 2.6400000000000001 109.915 -144.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.52 157.8 55.36 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.714 2.276 . . . . 1.28 111.866 -172.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.8 125.23 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.227 1.011 . . . . 3.46 109.85 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.39 114.34 3.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 128.365 2.666 . . . . 3.9300000000000002 109.872 168.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.87 143.32 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 120.966 -1.083 . . . . 1.1000000000000001 108.628 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -123.2 124.61 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 106.261 -1.755 . . . . 2.6699999999999999 106.261 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.7 152.91 41.21 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.06 0.845 . . . . 1.8899999999999999 111.933 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -4.24 0.05 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 117.539 2.422 . . . . 2.23 117.539 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.06 4.42 10.89 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.793 1.637 . . . . 3.0299999999999998 114.016 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.52 16.51 17.68 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 116.226 1.25 . . . . 0.92000000000000004 116.226 166.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.65 134.08 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.128 1.371 . . . . 1.53 107.932 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.22 120.68 40.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.331 0.652 . . . . 0.82999999999999996 109.352 168.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -132.21 2.81 3.94 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.135 1.774 . . . . 1.6599999999999999 112.745 172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -82.89 117.76 69.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.687 1.995 . . . . 5.0999999999999996 111.983 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.33 147.27 18.05 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.475 2.783 . . . . 1.25 113.473 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.29 176.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.515 1.926 . . . . 1.5600000000000001 109.83 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.8 m -139.73 140.83 36.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.069 0.947 . . . . 0.91000000000000003 110.142 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.72 91.48 6.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.24 1.016 . . . . 0.82999999999999996 110.56 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.29 -8.92 24.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.818 3.012 . . . . 1.46 115.006 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -58.96 -29.17 66.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.178 1.391 . . . . 4.8700000000000001 113.751 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.52 164.98 11.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.131 1.772 . . . . 3.2999999999999998 110.389 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.95 24.6 0.5 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.596 1.558 . . . . 4.79 114.109 -170.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -178.57 148.5 0.45 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.441 2.296 . . . . 2.2000000000000002 112.507 170.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.75 -27.5 69.32 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.53 -1.356 . . . . 2.1699999999999999 111.269 166.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.44 -16.14 0.32 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.299 2.24 . . . . 2.8199999999999998 114.062 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -9.24 40.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.366 1.466 . . . . 2.4900000000000002 113.733 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.5 m -130.19 11.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.552 1.541 . . . . 1.2 113.134 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -62.59 -3.36 1.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.494 2.405 . . . . 3.46 117.494 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.27 29.93 0.78 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.358 1.863 . . . . 2.9700000000000002 110.726 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -121.82 175.02 6.5 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.825 1.65 . . . . 2.48 113.038 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.01 149.2 43.03 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.501 1.12 . . . . 0.68999999999999995 111.782 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.43 170.42 16.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.041 1.336 . . . . 3.02 109.241 158.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 44.9 ttm -151.19 124.96 9.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.37 -0.831 . . . . 3.1299999999999999 111.454 163.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.5 120.98 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.164 -1.05 . . . . 1.1200000000000001 108.164 167.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -105.13 148.49 26.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.869 2.068 . . . . 2.8900000000000001 112.007 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.35 -25.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.718 -1.239 . . . . 1.6599999999999999 113.209 -162.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -129.28 162.55 22.64 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.135 0.874 . . . . 1.29 111.55 168.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.82 144.94 47.56 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.357 0.98 . . . . 1.5800000000000001 113.081 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 37.6 t70 -97.95 -8.86 27.19 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.992 1.849 . . . . 2.6600000000000001 115.992 -147.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -59.96 -25.61 65.34 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.939 1.296 . . . . 4.9199999999999999 113.407 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 76.4 mtm -82.11 61.64 5.47 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 3.3900000000000001 113.899 -167.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.6 p -91.82 -147.47 0.22 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.655 -1.278 . . . . 3.7000000000000002 110.846 156.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t0 58.35 42.25 21.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.456 1.502 . . . . 4.5599999999999996 112.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.92 156.51 5.96 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.509 1.924 . . . . 4.0099999999999998 109.64 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.25 -19.2 22.73 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.116 2.544 . . . . 2.7799999999999998 114.327 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.59 119.91 76.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.216 1.371 . . . . 8.8800000000000008 109.903 167.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.85 118.8 5.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.504 2.136 . . . . 5.1399999999999997 110.179 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 56.64 27.12 12.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.182 1.393 . . . . 4.9500000000000002 112.186 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.07 17.52 63.56 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 121.042 -1.036 . . . . 3.6000000000000001 113.333 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.07 3.78 75.7 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.6 1.571 . . . . 3.1400000000000001 114.367 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.28 -5.91 75.35 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.252 1.526 . . . . 2.1800000000000002 114.845 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.43 -12.0 80.04 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.235 1.398 . . . . 2.02 115.326 -170.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.67 161.6 5.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.069 1.348 . . . . 1.9199999999999999 110.152 164.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 136.15 40.31 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 5.3700000000000001 112.65 -169.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -101.04 -25.63 13.99 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.261 1.424 . . . . 3.8399999999999999 113.294 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.73 144.09 22.31 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.466 2.024 . . . . 0.70999999999999996 116.466 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.76 170.29 14.92 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.209 3.403 . . . . 2.8799999999999999 112.186 165.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 179.94 83.15 0.06 OUTLIER Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.884 1.706 . . . . 1.46 112.41 166.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.94 130.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 118.026 0.913 . . . . 2.1899999999999999 110.704 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 27.3 mt -102.9 140.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.52 1.528 . . . . 1.6399999999999999 111.377 -169.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 mptt . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 124.774 1.23 . . . . 4.3499999999999996 108.733 161.581 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 119.424 -0.322 . . . . 2.73 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.73 154.39 33.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 118.984 -2.323 . . . . 1.7 116.995 -141.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.07 138.97 18.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.68 -1.6 . . . . 3.4300000000000002 111.328 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.81 113.82 27.08 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.803 -1.186 . . . . 5.7000000000000002 112.03 176.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.8 t -88.63 118.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.551 -0.537 . . . . 1.5800000000000001 109.551 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.34 103.09 2.36 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.152 1.358 . . . . 1.1100000000000001 110.323 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 41.8 mtt -81.85 148.83 28.62 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.439 0.904 . . . . 1.98 113.439 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -114.23 151.52 32.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 2.4700000000000002 110.134 167.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 mt -64.49 144.44 57.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.853 0.861 . . . . 1.1699999999999999 109.112 171.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 m -133.69 149.32 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.2 0.6 . . . . 1.53 111.36 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -174.55 53.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.143 0.977 . . . . 2.3700000000000001 112.53 -168.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.49 -14.21 0.42 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.051 1.74 . . . . 1.55 115.094 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.15 -9.9 58.97 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.363 -0.836 . . . . 3.2999999999999998 110.994 160.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -129.69 9.39 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.517 -1.433 . . . . 1.3 109.517 -163.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.7 t -74.33 126.9 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.925 1.69 . . . . 1.24 111.299 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.34 -135.53 8.93 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.066 1.793 . . . . 1.45 112.554 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.93 164.11 12.86 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.983 -0.716 . . . . 2.0600000000000001 111.784 173.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.0 t -100.1 152.0 20.74 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.309 1.044 . . . . 1.8200000000000001 112.757 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.435 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 1.4 pp -144.21 4.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 128.178 2.591 . . . . 3.6600000000000001 113.495 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.53 170.69 27.71 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.205 1.383 . . . . 0.72999999999999998 114.266 172.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.471 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 1.5 p -109.74 177.66 4.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.989 1.316 . . . . 1.1200000000000001 109.889 172.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.83 131.84 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.736 -1.209 . . . . 0.5 107.736 158.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 9.0 p -85.89 123.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 123.579 0.549 . . . . 1.48 110.377 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mt -105.38 126.08 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 125.858 1.663 . . . . 2.1299999999999999 107.884 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -135.5 107.62 7.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.413 1.085 . . . . 2.0800000000000001 109.958 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -74.07 144.08 45.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.613 0.765 . . . . 3.6000000000000001 112.043 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -159.94 -174.58 4.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.708 1.203 . . . . 1.72 109.751 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.34 -26.51 65.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.627 1.571 . . . . 3.1699999999999999 112.75 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.94 13.86 65.81 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 124.851 1.215 . . . . 0.97999999999999998 114.754 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.95 -147.02 32.94 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 127.396 2.427 . . . . 0.80000000000000004 114.399 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.4 mt -76.26 99.46 4.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.986 0.915 . . . . 0.80000000000000004 112.017 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -77.69 114.16 16.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.13 1.372 . . . . 2.6699999999999999 110.397 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.73 116.79 32.63 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.485 2.314 . . . . 0.85999999999999999 109.896 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.433 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.9 m -122.49 115.17 29.93 Favored Pre-proline 0 N--CA 1.477 0.875 0 CA-C-O 118.278 -0.868 . . . . 0.92000000000000004 108.755 176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.22 162.86 4.67 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.91 3.073 . . . . 0.46999999999999997 112.007 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.471 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.3 p80 -151.32 33.31 0.57 Allowed 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.12 0.962 . . . . 1.73 112.606 173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -95.75 150.05 20.82 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.911 1.684 . . . . 0.82999999999999996 113.903 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.5 162.37 24.13 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.516 1.526 . . . . 3.0899999999999999 109.217 174.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.28 21.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.933 2.893 . . . . 1.97 113.789 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.57 155.87 38.1 Favored Pre-proline 0 CA--C 1.51 -0.576 0 C-N-CA 123.857 0.863 . . . . 3.5499999999999998 112.442 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.56 140.36 47.28 Favored 'Trans proline' 0 N--CA 1.427 -2.385 0 O-C-N 123.269 1.142 . . . . 1.22 111.625 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -88.26 32.01 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.839 2.359 . . . . 1.52 114.568 -148.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.89 -147.35 14.02 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.532 1.073 . . . . 1.1899999999999999 113.912 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -81.57 131.51 35.28 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.964 -1.315 . . . . 2.6800000000000002 110.592 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -102.66 135.53 44.14 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.243 -1.021 . . . . 2.2400000000000002 108.243 164.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.55 161.7 21.58 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.852 -0.899 . . . . 1.02 110.852 166.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -146.84 122.34 10.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.915 -1.143 . . . . 3.3599999999999999 107.915 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -126.8 167.65 15.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.207 1.188 . . . . 1.0600000000000001 114.207 159.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.32 145.66 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.08 1.352 . . . . 2.02 107.721 152.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -123.92 158.64 31.51 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.202 1.401 . . . . 1.0900000000000001 110.969 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.42 69.03 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.465 1.654 . . . . 0.68000000000000005 115.465 -163.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -126.48 -174.58 3.16 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.357 1.463 . . . . 1.3600000000000001 112.195 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.97 30.52 5.03 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 117.776 1.87 . . . . 1.4299999999999999 117.776 -156.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.6 m -159.06 114.4 2.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 121.692 2.746 . . . . 3.2799999999999998 115.0 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.3 m -68.83 76.93 0.31 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.385 1.564 . . . . 2.7400000000000002 112.644 167.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -116.56 134.38 22.89 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 124.981 1.312 . . . . 3.8199999999999998 109.134 167.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.11 144.63 21.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.293 2.662 . . . . 1.3500000000000001 110.18 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.91 131.51 42.31 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.08 -0.711 . . . . 1.76 109.08 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.4 mm -99.15 110.0 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.952 -1.129 . . . . 3.9399999999999999 107.952 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -166.81 154.51 9.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 7.3499999999999996 111.003 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t70 41.31 54.86 3.45 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.527 1.531 . . . . 4.2000000000000002 114.853 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.11 87.75 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.722 -1.599 . . . . 2.9199999999999999 115.653 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -153.67 171.89 18.12 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.462 2.131 . . . . 3.1099999999999999 114.161 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 114.59 26.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.215 1.406 . . . . 3.6699999999999999 109.565 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.33 74.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.482 1.113 . . . . 2.2799999999999998 111.02 -172.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.7 -73.51 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.257 2.623 . . . . 2.1699999999999999 116.328 161.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.78 69.23 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 130.801 3.64 . . . . 2.1200000000000001 107.308 -165.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.26 -42.51 14.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.302 1.441 . . . . 4.5 112.236 -165.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.17 5.99 1.46 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.866 1.432 . . . . 1.3300000000000001 114.866 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.74 66.1 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.362 1.065 . . . . 1.2 112.526 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.23 -175.42 51.28 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 119.497 1.044 . . . . 2.3599999999999999 113.066 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.2 170.43 37.95 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.805 1.193 . . . . 1.74 113.298 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.465 ' CD2' ' H ' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -78.22 38.67 0.29 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.036 2.134 . . . . 4.4000000000000004 112.385 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.4 tp 56.73 72.59 0.5 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.132 2.573 . . . . 2.48 110.213 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -153.14 5.95 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 118.17 2.656 . . . . 4.54 118.17 -140.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.39 -26.72 24.3 Favored 'Trans proline' 0 C--N 1.358 1.063 0 CA-C-N 123.906 2.431 . . . . 3.8199999999999998 116.151 -162.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.67 138.14 19.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.4 1.454 . . . . 3.4700000000000002 111.043 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 p30 161.61 -159.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 129.676 3.19 . . . . 5.0700000000000003 109.381 -161.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 t -72.74 -14.12 61.48 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.625 1.342 . . . . 5.0199999999999996 114.625 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.83 -58.38 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.946 1.26 . . . . 4.3300000000000001 113.124 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttt -69.32 163.89 24.09 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.963 1.381 . . . . 7.0599999999999996 113.754 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.34 137.31 55.94 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.201 -0.937 . . . . 2.4399999999999999 111.252 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -76.17 156.04 34.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.153 0.581 . . . . 3.5 112.064 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.2 -157.15 27.13 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.178 1.371 . . . . 3.5899999999999999 112.149 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.14 -23.8 28.67 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.169 2.58 . . . . 4.7400000000000002 111.938 172.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -153.59 176.43 12.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.873 2.069 . . . . 7.9100000000000001 108.626 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.43 -126.63 7.97 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.074 -1.21 . . . . 4.7000000000000002 110.074 -165.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.448 ' NE2' ' H ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -165.95 157.16 13.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.006 0.903 . . . . 5.3200000000000003 110.133 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.448 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . 166.31 -137.13 4.49 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.833 2.635 . . . . 2.6899999999999999 110.669 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -90.9 136.03 33.34 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.781 -0.835 . . . . 5.5199999999999996 112.378 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.53 -33.25 75.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.44 -0.788 . . . . 2.7799999999999998 113.064 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.52 6.13 83.02 Favored Glycine 0 N--CA 1.474 1.18 0 N-CA-C 115.717 1.047 . . . . 0.91000000000000003 115.717 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -67.98 130.18 42.17 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 118.772 1.286 . . . . 1.8 109.075 161.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.82 161.93 40.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.477 1.511 . . . . 2.6099999999999999 110.327 -151.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.31 144.86 20.92 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.427 2.751 . . . . 1.1699999999999999 111.63 -168.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.18 132.45 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.612 1.196 . . . . 2.1299999999999999 113.533 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.87 81.76 1.65 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.807 2.443 . . . . 2.5699999999999998 109.37 169.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.87 131.78 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.421 -0.799 . . . . 1.3400000000000001 109.657 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.51 153.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.253 1.021 . . . . 3.1200000000000001 108.48 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.04 159.36 33.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.732 -0.605 . . . . 2.4700000000000002 111.93 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -49.09 -19.32 0.41 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.173 2.189 . . . . 4.3399999999999999 115.865 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.12 8.1 32.02 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 127.83 2.452 . . . . 4.5800000000000001 112.117 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.48 23.81 15.51 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 117.582 1.793 . . . . 1.25 117.582 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -139.55 134.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.961 1.305 . . . . 1.75 111.29 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.85 118.65 26.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.306 2.242 . . . . 1.01 110.786 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 t -146.94 -3.88 0.57 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.266 1.209 . . . . 2.2999999999999998 114.266 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.73 118.61 72.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.335 1.454 . . . . 3.29 112.219 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.79 125.82 11.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.262 3.308 . . . . 1.1100000000000001 110.227 170.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 175.11 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.581 1.552 . . . . 1.6100000000000001 109.946 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 m -148.4 140.04 23.65 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.303 0.956 . . . . 0.89000000000000001 110.049 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.23 96.12 29.09 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.55 1.14 . . . . 0.80000000000000004 111.636 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.32 7.87 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.254 3.303 . . . . 1.1499999999999999 114.391 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -81.72 -23.65 36.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.32 1.448 . . . . 4.7400000000000002 111.6 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.81 139.32 48.85 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.881 1.673 . . . . 3.71 107.863 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -107.1 -21.29 13.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 115.204 1.557 . . . . 4.5999999999999996 115.204 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.5 t -152.96 155.07 36.27 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.942 1.246 . . . . 2.6099999999999999 114.005 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -57.39 -32.3 66.68 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.131 0.572 . . . . 2.1400000000000001 112.433 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -64.08 -14.66 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.03 1.493 . . . . 3.2599999999999998 115.03 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -72.49 -20.28 61.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.217 0.917 . . . . 2.6200000000000001 112.252 167.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.43 10.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.223 1.409 . . . . 0.91000000000000003 113.96 -163.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -46.39 -20.84 0.13 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.02 2.928 . . . . 5.1399999999999997 116.578 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -117.92 9.11 12.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.201 2.6 . . . . 4.5800000000000001 113.221 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.5 168.14 12.97 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.493 1.294 . . . . 2.1099999999999999 114.493 -160.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.82 158.31 24.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.997 1.319 . . . . 1.1899999999999999 111.565 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.08 150.86 39.29 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.664 1.586 . . . . 2.2599999999999998 108.967 172.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.28 139.64 50.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.063 0.764 . . . . 3.2799999999999998 113.063 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.75 104.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.936 -1.505 . . . . 1.05 106.936 159.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.93 150.05 34.1 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.929 2.091 . . . . 2.8799999999999999 111.65 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.67 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.859 -1.151 . . . . 1.97 112.648 -163.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.7 170.97 14.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.119 1.342 . . . . 1.9199999999999999 111.187 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.49 151.03 50.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.576 1.084 . . . . 1.79 113.072 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.16 -21.43 11.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.094 1.516 . . . . 3.2000000000000002 115.094 -152.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -75.44 8.52 2.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.468 1.655 . . . . 3.2999999999999998 115.468 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -81.22 55.54 2.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.976 1.311 . . . . 3.3799999999999999 111.197 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -81.79 33.98 0.39 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.962 2.505 . . . . 4.3799999999999999 115.211 -163.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.19 19.37 7.61 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.665 1.586 . . . . 5.9100000000000001 113.033 -163.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -147.47 154.61 45.29 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.927 1.691 . . . . 3.9500000000000002 110.525 -167.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.09 7.29 2.14 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.046 3.164 . . . . 2.9100000000000001 114.241 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -107.12 99.77 28.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.021 1.328 . . . . 6.5700000000000003 108.666 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.92 166.69 26.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.234 2.623 . . . . 3.4900000000000002 111.949 -170.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt 64.83 27.18 12.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.269 1.428 . . . . 4.4800000000000004 111.878 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.7 1.62 31.91 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.741 1.639 . . . . 3.7599999999999998 114.7 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.49 -15.18 60.76 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.778 1.18 . . . . 2.3500000000000001 113.063 -162.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.96 24.8 3.23 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.198 1.856 . . . . 2.0499999999999998 113.678 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.62 -15.98 73.69 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.116 1.341 . . . . 1.72 115.246 -169.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 p -69.01 147.39 51.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.554 1.177 . . . . 1.99 110.035 167.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 131.93 47.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 5.2300000000000004 109.818 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -81.94 -44.13 17.17 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.214 0.605 . . . . 3.54 109.554 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.29 155.76 45.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.294 1.038 . . . . 0.73999999999999999 112.717 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 41.0 t -143.52 151.23 40.01 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.136 2.175 . . . . 1.29 111.331 -174.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.68 149.59 18.31 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.739 1.161 . . . . 1.47 113.842 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.98 149.09 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.1 1.76 . . . . 3.5600000000000001 112.36 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.33 147.11 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.492 1.917 . . . . 1.1000000000000001 111.923 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.744 0 C-N-CA 126.455 1.902 . . . . 5.0599999999999996 109.683 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 109.115 -0.698 . . . . 2.3599999999999999 109.115 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -122.38 143.21 49.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.593 1.542 . . . . 1.9299999999999999 114.454 -148.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -154.76 147.55 24.4 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.493 . . . . 3.04 109.584 168.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.43 77.16 1.77 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.679 1.592 . . . . 5.9199999999999999 112.671 -160.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.17 112.19 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 120.55 -1.344 . . . . 1.5800000000000001 111.377 -162.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.32 101.58 0.52 Allowed Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.878 2.18 . . . . 0.78000000000000003 111.476 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.2 mmm -79.93 126.15 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.833 1.253 . . . . 2.8599999999999999 111.133 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -105.56 149.26 26.42 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.786 1.279 . . . . 2.6000000000000001 112.973 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.71 65.66 1.37 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.371 2.268 . . . . 1.3799999999999999 111.619 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -73.12 141.82 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.767 0.827 . . . . 1.6699999999999999 111.005 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -148.72 -159.57 1.05 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.889 -1.05 . . . . 2.6800000000000002 109.049 171.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.06 -3.0 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.491 1.516 . . . . 2.0600000000000001 112.382 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 8.92 44.07 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.965 1.706 . . . . 3.3900000000000001 111.633 171.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 -164.69 26.73 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 125.047 1.308 . . . . 1.75 112.835 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.94 126.51 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.629 1.171 . . . . 2.52 110.774 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.87 -137.23 9.45 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 125.577 1.56 . . . . 1.8300000000000001 113.355 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.32 150.91 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.685 1.594 . . . . 3.7400000000000002 112.546 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -79.45 145.76 33.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.469 0.708 . . . . 2.2400000000000002 110.222 161.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.37 3.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.313 1.845 . . . . 4.0 114.091 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.77 163.85 14.66 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.808 1.671 . . . . 0.71999999999999997 112.717 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -96.24 158.87 15.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.142 -0.688 . . . . 1.5800000000000001 109.142 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.4 t -105.15 132.46 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.352 -1.351 . . . . 0.66000000000000003 107.352 152.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 12.2 p -87.3 128.22 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.311 0.577 . . . . 2.0299999999999998 110.536 172.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 126.46 1.904 . . . . 2.27 107.714 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -131.83 112.57 12.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.048 0.928 . . . . 1.9099999999999999 111.198 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 137.49 57.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 128.25 2.62 . . . . 4.1900000000000004 112.463 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.312 14.8 t -151.2 161.84 41.98 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 124.543 2.116 . . . . 1.6000000000000001 111.064 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -21.23 -41.19 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.573 -2.558 . . . . 3.8100000000000001 115.266 146.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.5 12.05 59.76 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 126.035 1.779 . . . . 0.90000000000000002 117.012 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.36 -152.0 23.94 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 130.225 3.774 . . . . 0.80000000000000004 114.708 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.51 102.59 4.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.281 -1.129 . . . . 0.82999999999999996 111.45 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -76.43 115.96 16.66 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.313 -0.867 . . . . 2.1899999999999999 109.882 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -105.69 110.54 22.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.477 2.311 . . . . 0.60999999999999999 109.623 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.401 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 11.8 m -114.47 110.27 47.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 119.79 1.177 . . . . 0.95999999999999996 108.095 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.61 152.68 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.382 2.722 . . . . 0.69999999999999996 110.89 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 40.4 0.77 Allowed 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.168 1.461 . . . . 2.8500000000000001 111.231 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mp -103.54 141.7 35.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.539 1.936 . . . . 1.22 112.977 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.33 160.08 15.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.451 -1.249 . . . . 3.3500000000000001 109.805 170.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 97.69 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.521 2.728 . . . . 1.53 115.099 160.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 156.24 35.81 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 118.886 0.766 . . . . 2.4500000000000002 111.86 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.82 136.45 57.53 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.915 1.744 . . . . 1.0700000000000001 110.589 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -86.97 34.58 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.564 2.843 . . . . 1.26 114.736 -151.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.62 -140.84 11.62 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.729 1.157 . . . . 1.25 114.072 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -120.3 153.93 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.795 -0.826 . . . . 3.3100000000000001 110.414 165.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -138.23 133.69 33.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.615 0.766 . . . . 1.02 110.203 -163.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 163.44 23.77 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 111.015 -0.834 . . . . 0.71999999999999997 111.015 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -135.95 132.25 36.17 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 106.086 -1.82 . . . . 3.2000000000000002 106.086 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -137.85 158.24 44.76 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.149 -0.97 . . . . 1.02 112.815 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.54 142.85 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 127.42 2.288 . . . . 1.1000000000000001 108.006 163.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -123.28 156.38 35.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.077 1.351 . . . . 1.0700000000000001 110.663 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.75 78.73 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.974 1.842 . . . . 0.68999999999999995 115.974 -159.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -116.33 -177.66 3.23 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.576 1.55 . . . . 1.3 111.483 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.81 97.49 0.31 Allowed Glycine 0 N--CA 1.47 0.902 0 O-C-N 120.769 -1.207 . . . . 0.93000000000000005 113.441 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 t 173.87 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.605 2.362 . . . . 2.5699999999999998 109.638 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.5 m -70.11 31.15 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 115.976 1.843 . . . . 1.3100000000000001 115.976 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -84.54 124.91 72.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 119.724 -1.86 . . . . 4.1299999999999999 111.158 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.07 144.27 13.29 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.307 2.671 . . . . 1.1699999999999999 111.253 173.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.2 153.75 29.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.997 0.519 . . . . 1.75 110.583 164.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.03 132.25 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.984 -1.072 . . . . 2.5 111.07 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.21 172.95 11.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.275 2.63 . . . . 5.6600000000000001 110.055 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -47.4 114.06 0.81 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.663 1.185 . . . . 5.1500000000000004 112.406 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.13 6.47 53.38 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.986 -1.452 . . . . 4.3700000000000001 115.715 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.93 129.14 10.48 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.809 2.304 . . . . 3.6299999999999999 114.378 -167.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.86 117.56 30.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.984 0.914 . . . . 1.77 108.826 165.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.37 74.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.224 1.81 . . . . 2.4300000000000002 111.172 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.43 -73.58 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.863 2.865 . . . . 2.9300000000000002 115.864 164.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.48 38.09 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 130.023 3.329 . . . . 2.46 109.332 -166.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.6 -25.49 62.69 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.293 1.22 . . . . 4.0999999999999996 114.293 -167.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -13.09 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.034 1.288 . . . . 1.3500000000000001 113.908 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.82 -4.24 57.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.63 1.572 . . . . 1.4199999999999999 113.02 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 -179.98 53.11 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.787 -1.196 . . . . 2.5699999999999998 114.22 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.89 -179.3 48.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.99 0.805 . . . . 1.54 111.631 166.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -53.67 137.79 36.47 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 118.585 -0.721 . . . . 2.1899999999999999 109.812 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.76 116.46 4.08 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.818 0.736 . . . . 2.4300000000000002 111.642 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -149.32 101.79 3.33 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.81 2.044 . . . . 4.1100000000000003 109.207 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.36 -46.43 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.639 1.559 . . . . 3.8799999999999999 111.111 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -164.16 13.91 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.794 2.038 . . . . 3.9199999999999999 113.083 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -56.87 -39.62 74.67 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.2 -1.562 . . . . 3.3300000000000001 113.543 -170.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t 146.11 -28.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 1 C-N-CA 132.069 4.148 . . . . 3.1600000000000001 111.201 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.73 58.14 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 117.016 1.566 . . . . 2.46 117.016 162.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.85 -67.31 0.79 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.536 1.668 . . . . 8.6999999999999993 112.449 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 t60 171.69 157.54 0.09 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.811 2.844 . . . . 1.6799999999999999 111.549 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.65 133.28 32.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.743 1.217 . . . . 4.2300000000000004 108.69 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.51 -95.29 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 109.404 -1.478 . . . . 2.9300000000000002 109.404 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.76 29.46 0.41 Allowed 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 124.589 3.526 . . . . 3.5899999999999999 112.631 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -146.23 -179.63 6.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.433 1.893 . . . . 5.5499999999999998 109.457 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.15 107.21 0.7 Allowed Glycine 0 N--CA 1.472 1.061 0 N-CA-C 109.095 -1.602 . . . . 4.6200000000000001 109.095 164.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -168.84 -5.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.059 1.503 . . . . 6.6799999999999997 115.059 -149.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -34.98 0.02 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 118.105 2.002 . . . . 3.1299999999999999 118.105 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.49 115.22 3.39 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.201 2.0 . . . . 4.6600000000000001 110.831 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.02 -11.35 7.95 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.479 1.659 . . . . 2.9399999999999999 115.479 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.01 -0.16 89.23 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.963 -1.465 . . . . 0.93999999999999995 116.094 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -85.09 134.86 34.18 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 120.5 2.15 . . . . 1.5 112.673 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 mt -123.95 160.78 50.27 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.596 1.558 . . . . 4.0800000000000001 112.065 -164.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.06 162.23 43.37 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.749 2.966 . . . . 1.22 112.247 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.08 127.88 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 123.355 1.55 . . . . 2.0600000000000001 114.56 -162.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.07 82.25 5.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.87 2.868 . . . . 2.8399999999999999 109.492 174.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.26 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.071 -1.018 . . . . 1.5900000000000001 109.29 171.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.89 157.96 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.347 1.059 . . . . 3.0299999999999998 110.077 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.16 159.46 27.41 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.895 1.072 . . . . 2.75 113.895 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -49.67 -20.57 0.83 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 127.502 2.321 . . . . 5.3799999999999999 117.148 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.13 0.92 27.89 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.211 1.559 . . . . 3.9700000000000002 115.211 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.99 42.25 2.67 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 116.0 1.16 . . . . 1.2 116.0 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.89 135.46 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.878 1.271 . . . . 1.46 109.522 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.32 118.1 31.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.572 1.949 . . . . 0.89000000000000001 109.238 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -156.54 21.61 0.34 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.737 1.384 . . . . 1.96 114.737 -167.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -134.83 143.48 46.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.149 1.779 . . . . 4.3700000000000001 108.785 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -85.13 162.48 11.54 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.191 3.261 . . . . 1.47 114.362 -170.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.45 172.17 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 126.315 1.846 . . . . 1.6399999999999999 109.722 166.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -141.39 146.5 36.68 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 119.925 1.239 . . . . 0.95999999999999996 111.097 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.72 87.06 3.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.832 1.253 . . . . 1.1699999999999999 113.961 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.5 2.1 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.481 2.787 . . . . 1.3999999999999999 114.732 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -76.86 -11.27 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.695 1.134 . . . . 6.0199999999999996 111.673 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.31 164.87 13.88 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.005 2.122 . . . . 3.3799999999999999 110.711 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -152.08 11.09 0.54 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.528 1.931 . . . . 4.8600000000000003 114.187 173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -159.18 149.3 19.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.324 -1.485 . . . . 2.4900000000000002 113.716 163.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -57.49 -24.53 56.39 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.084 -1.01 . . . . 2.3300000000000001 111.38 162.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -52.03 -31.74 31.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.212 1.005 . . . . 3.0099999999999998 112.768 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.032 1.333 . . . . 2.7799999999999998 112.399 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.04 11.27 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.086 1.354 . . . . 1.04 113.539 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.3 pttt -61.54 7.14 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.984 2.587 . . . . 3.6699999999999999 117.984 -171.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -156.33 22.19 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.48 1.912 . . . . 3.5 111.748 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -113.34 170.53 8.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.846 1.259 . . . . 2.1200000000000001 114.31 -169.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.08 150.3 23.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.609 1.164 . . . . 0.64000000000000001 112.372 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.4 145.27 40.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.864 2.066 . . . . 2.0699999999999998 107.585 165.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -130.65 136.56 48.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.824 0.738 . . . . 2.3199999999999998 112.179 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 88.3 mt -94.26 124.37 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.518 -1.29 . . . . 1.0700000000000001 107.518 167.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -120.29 143.1 48.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.319 1.048 . . . . 2.7999999999999998 112.485 -156.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.25 -37.59 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.898 -1.126 . . . . 1.6299999999999999 112.983 -153.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.9 141.06 16.63 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.78 0.705 . . . . 1.3 112.141 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -47.43 134.45 14.05 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 126.01 1.767 . . . . 2.1499999999999999 112.109 164.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -76.11 1.72 14.88 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.22 1.408 . . . . 2.8999999999999999 113.001 -167.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -66.29 -1.47 3.41 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 119.727 -1.858 . . . . 5.4400000000000004 114.24 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 ptp -93.07 10.35 31.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.288 1.835 . . . . 4.5899999999999999 114.149 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.4 p -47.83 -21.96 0.49 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.812 2.152 . . . . 5.0999999999999996 116.812 -171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.44 -10.42 59.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.089 2.956 . . . . 7.9900000000000002 115.618 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -53.01 148.64 13.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 114.276 1.213 . . . . 4.8399999999999999 114.276 -166.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.36 30.59 0.34 Allowed 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.361 3.374 . . . . 3.6699999999999999 112.234 170.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 140.32 35.26 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.544 1.538 . . . . 5.3700000000000001 109.19 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.71 162.26 32.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.416 2.744 . . . . 3.8700000000000001 112.965 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 71.6 mt 64.39 16.08 9.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.778 1.631 . . . . 5.5999999999999996 114.033 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.03 12.08 58.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.065 1.317 . . . . 5.2699999999999996 114.955 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.33 -64.35 3.79 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.889 1.345 . . . . 3.4900000000000002 112.992 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.17 0.45 31.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.906 1.241 . . . . 2.25 114.949 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.1 9.44 12.37 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.703 2.097 . . . . 2.6499999999999999 116.071 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.0 p -69.04 146.95 52.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.744 1.772 . . . . 2.3599999999999999 108.996 161.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 143.18 27.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.036 -1.04 . . . . 6.2000000000000002 112.942 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -102.2 -26.54 13.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.196 0.598 . . . . 3.3700000000000001 111.849 158.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.96 149.18 28.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.653 -0.654 . . . . 0.52000000000000002 112.664 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.2 t -120.32 144.07 48.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.097 2.159 . . . . 1.46 109.714 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -139.43 104.51 0.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 126.341 1.924 . . . . 0.94999999999999996 111.18 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -83.0 130.37 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.339 1.069 . . . . 2.4500000000000002 110.334 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.74 133.45 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.144 1.378 . . . . 1.1200000000000001 110.677 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 125.863 1.665 . . . . 5.2400000000000002 108.576 176.466 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.187 -0.301 . . . . 2.79 110.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.78 159.63 40.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.786 1.773 . . . . 1.6699999999999999 115.786 -151.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -148.37 136.95 21.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.476 1.511 . . . . 2.9500000000000002 109.459 159.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -83.41 103.63 12.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.429 1.092 . . . . 4.4000000000000004 112.031 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.8 t -79.02 114.36 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.253 -0.904 . . . . 1.49 109.079 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.44 105.57 1.81 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.25 1.405 . . . . 0.87 111.425 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.7 mmm -84.13 122.42 28.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.712 1.205 . . . . 3.1600000000000001 111.365 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.16 151.79 23.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.756 0.789 . . . . 2.4399999999999999 111.185 166.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.52 136.31 57.97 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.083 0.953 . . . . 1.3400000000000001 109.706 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.53 140.59 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.393 -0.965 . . . . 1.47 108.393 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 t -151.44 17.61 0.72 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.597 0.759 . . . . 2.7599999999999998 111.85 -165.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . 69.61 -21.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.538 2.335 . . . . 1.6299999999999999 113.371 -171.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -71.8 28.18 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 119.879 1.218 . . . . 4.0099999999999998 111.985 163.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 12' ' ' ALA . . . 83.08 -174.78 52.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.562 2.029 . . . . 1.6000000000000001 113.201 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.67 119.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.178 0.991 . . . . 1.77 108.608 153.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.04 -69.37 1.02 Allowed Glycine 0 N--CA 1.466 0.638 0 CA-C-O 122.159 0.866 . . . . 1.53 114.129 -170.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 153.88 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.106 1.363 . . . . 2.54 109.537 -165.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -89.59 152.61 21.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.271 1.428 . . . . 1.9199999999999999 112.983 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.42 -2.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 115.196 1.554 . . . . 4.4299999999999997 115.196 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.77 175.05 20.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.561 2.029 . . . . 0.77000000000000002 111.792 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.421 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 3.7 p -104.71 175.21 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.583 -0.951 . . . . 1.04 109.378 167.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.74 131.25 73.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.663 -1.606 . . . . 0.56000000000000005 106.663 152.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.4 p -80.89 122.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.667 -0.494 . . . . 2.1499999999999999 109.667 172.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.4 mt -94.48 127.31 46.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 107.374 -1.343 . . . . 1.9199999999999999 107.374 165.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.38 123.56 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.17 1.388 . . . . 1.98 108.701 171.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 151.0 33.17 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 121.026 -0.269 . . . . 3.23 111.049 172.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -161.29 -173.82 4.01 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.405 0.682 . . . . 1.8300000000000001 109.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -59.73 -25.64 65.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.857 1.263 . . . . 5.5800000000000001 113.353 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.36 16.45 61.04 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.558 1.075 . . . . 1.1399999999999999 114.66 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.7 -140.44 24.23 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 125.334 1.445 . . . . 0.73999999999999999 114.002 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.19 98.38 4.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.194 0.998 . . . . 0.96999999999999997 112.105 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.95 111.22 14.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.2 1.4 . . . . 2.8599999999999999 110.785 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.71 117.58 29.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.255 2.222 . . . . 0.68999999999999995 108.835 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.8 m -123.95 110.69 29.27 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-N 119.796 1.18 . . . . 1.0800000000000001 108.986 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.74 158.34 10.47 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.974 3.116 . . . . 0.46999999999999997 111.341 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.3 p80 -149.06 29.32 0.81 Allowed 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.794 0.807 . . . . 1.5 113.058 174.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.77 148.77 21.94 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.542 1.537 . . . . 1.0900000000000001 111.915 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.52 23.38 6.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.853 2.168 . . . . 1.96 116.853 -164.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.73 69.2 0.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.888 0.875 . . . . 1.6599999999999999 111.351 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.13 160.94 66.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.88 0.872 . . . . 2.2799999999999998 112.007 170.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.28 127.68 18.79 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.052 1.168 . . . . 1.02 110.343 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -83.58 33.39 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.901 1 C-N-CA 126.053 4.502 . . . . 1.24 113.152 -159.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.72 -131.6 4.46 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 123.411 1.562 . . . . 1.1799999999999999 112.131 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.0 147.27 52.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.667 1.587 . . . . 3.8900000000000001 109.548 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.7 122.64 15.52 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.72 0.808 . . . . 1.54 112.25 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.73 155.05 1.67 Allowed Glycine 0 CA--C 1.543 1.794 0 C-N-CA 123.936 0.779 . . . . 1.03 113.057 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.93 112.5 11.31 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.206 -1.405 . . . . 3.2400000000000002 107.206 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -116.33 158.79 22.89 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.249 1.203 . . . . 0.95999999999999996 114.249 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -99.23 151.27 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.236 1.414 . . . . 0.81999999999999995 107.88 154.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.23 153.45 47.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.174 1.79 . . . . 1.1100000000000001 107.648 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.83 71.68 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.909 1.448 . . . . 1.0 114.909 -163.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -119.22 161.21 20.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.19 1.796 . . . . 1.97 112.371 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.13 86.02 0.56 Allowed Glycine 0 N--CA 1.467 0.715 0 C-N-CA 124.682 1.134 . . . . 1.0700000000000001 112.773 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 t -171.11 94.15 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.718 1.207 . . . . 2.3799999999999999 113.011 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 68.3 m -65.92 14.55 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 117.097 2.258 . . . . 1.3600000000000001 117.097 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -101.96 147.85 34.49 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 119.787 -1.821 . . . . 3.8300000000000001 113.965 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.37 161.42 11.19 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.723 3.615 . . . . 1.1499999999999999 112.602 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.31 14.13 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.605 0.762 . . . . 2.21 111.213 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.23 115.34 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.345 1.058 . . . . 3.71 109.643 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -146.34 147.06 30.94 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.85 1.66 . . . . 6.3799999999999999 110.704 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t0 53.13 32.18 12.68 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.617 1.34 . . . . 4.4500000000000002 114.617 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.1 6.48 87.54 Favored Glycine 0 CA--C 1.535 1.343 0 O-C-N 121.105 -0.997 . . . . 4.0300000000000002 114.771 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -141.58 -161.79 1.28 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.57 1.548 . . . . 4.4400000000000004 110.509 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.14 138.64 49.56 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.919 -1.113 . . . . 2.0099999999999998 113.027 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 t -82.24 60.75 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.838 1.655 . . . . 2.6600000000000001 111.029 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 47.17 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.154 2.582 . . . . 2.0 115.874 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.93 84.38 0.81 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.411 2.684 . . . . 1.47 107.556 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -84.72 -46.71 11.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.237 1.415 . . . . 3.98 112.03 -167.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -12.34 57.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.321 1.23 . . . . 1.28 114.321 -164.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.74 -22.82 59.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.562 1.545 . . . . 0.89000000000000001 113.897 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.55 -174.97 17.77 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 120.398 1.454 . . . . 2.3900000000000001 114.278 -176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 -155.57 22.44 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.129 1.347 . . . . 1.8300000000000001 110.832 164.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -71.36 34.41 0.05 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 118.957 1.379 . . . . 2.4100000000000001 113.783 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.11 46.04 3.85 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.452 1.501 . . . . 4.0899999999999999 109.536 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -128.32 44.95 1.47 Allowed Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 116.3 1.963 . . . . 4.4000000000000004 116.3 -148.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.39 -20.81 31.38 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.834 2.356 . . . . 3.6600000000000001 113.722 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -166.65 143.32 4.77 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.82 1.648 . . . . 4.2999999999999998 110.5 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 164.75 -23.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 129.501 3.12 . . . . 3.8399999999999999 113.435 170.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 t 139.18 -2.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 1 C-N-CA 131.829 4.052 . . . . 3.5299999999999998 112.855 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.26 2.73 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.549 1.38 . . . . 2.8100000000000001 116.549 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -86.71 172.5 10.14 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.43 1.615 . . . . 5.6200000000000001 113.73 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -107.68 143.92 35.51 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.068 1.347 . . . . 1.99 112.921 -173.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -152.86 -173.19 4.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.222 1.409 . . . . 3.8300000000000001 109.967 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.38 -52.1 0.01 OUTLIER Glycine 0 CA--C 1.544 1.854 0 CA-C-O 116.977 -2.013 . . . . 4.1500000000000004 115.022 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -105.0 -20.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.875 2.383 . . . . 5.5 116.939 -164.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 177.27 17.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.44 1.496 . . . . 8.0500000000000007 114.369 -165.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.83 -150.05 21.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.494 1.521 . . . . 3.9100000000000001 112.25 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -135.92 135.9 40.03 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.741 -1.207 . . . . 6.5599999999999996 107.741 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.75 -157.72 30.02 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.419 0.554 . . . . 2.9500000000000002 114.434 -173.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 136.75 58.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.286 0.634 . . . . 4.8300000000000001 112.665 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -11.9 60.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.681 0.993 . . . . 3.6899999999999999 113.681 169.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.08 14.77 36.75 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.794 -1.559 . . . . 1.29 115.439 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -106.99 131.93 53.5 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 119.614 1.707 . . . . 1.5700000000000001 112.267 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -131.37 170.51 11.1 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.067 2.147 . . . . 3.0099999999999998 110.418 -168.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.22 152.9 21.29 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.403 2.068 . . . . 1.03 111.868 -172.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.85 128.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.795 1.238 . . . . 3.1899999999999999 112.95 -168.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.38 82.17 1.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.151 2.18 . . . . 2.6200000000000001 108.894 168.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.49 141.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.51 1.124 . . . . 1.5 109.161 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.93 150.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.419 1.888 . . . . 2.8300000000000001 108.866 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 143.49 26.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.057 0.844 . . . . 1.8799999999999999 112.683 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -19.83 -45.19 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.353 4.661 . . . . 4.2699999999999996 117.463 174.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.23 -29.37 65.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.943 1.297 . . . . 3.7000000000000002 112.633 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.11 20.72 6.2 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.807 1.67 . . . . 0.95999999999999996 113.463 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.6 mt -121.71 133.99 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 1.4099999999999999 109.888 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.63 131.01 49.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.615 1.166 . . . . 0.73999999999999999 110.322 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 t -152.37 4.18 0.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.427 2.01 . . . . 1.3700000000000001 116.427 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -100.98 136.96 19.64 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.877 1.217 . . . . 3.8500000000000001 111.334 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.14 146.8 47.08 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.526 3.484 . . . . 1.05 112.178 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.11 161.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.448 1.499 . . . . 1.54 109.442 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -139.25 134.87 33.25 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.341 0.973 . . . . 1.4199999999999999 110.747 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.8 105.32 49.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.957 0.903 . . . . 1.1200000000000001 112.609 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.84 13.05 0.63 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.372 3.382 . . . . 1.4099999999999999 113.299 167.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -64.27 -41.26 97.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.096 1.758 . . . . 5.1100000000000003 110.737 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -111.41 151.73 28.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 3.6699999999999999 107.258 166.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -97.04 -22.07 17.02 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.586 0.958 . . . . 5.4800000000000004 113.586 -174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.16 160.86 43.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.039 1.745 . . . . 2.7000000000000002 115.344 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.43 -30.68 68.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.457 1.503 . . . . 2.5800000000000001 111.889 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -67.27 -2.75 6.42 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.807 2.043 . . . . 2.7599999999999998 113.313 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -96.86 -13.13 22.72 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.195 1.798 . . . . 2.46 113.277 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.18 7.83 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.631 1.105 . . . . 1.26 113.898 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -60.38 -12.6 9.76 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.854 2.168 . . . . 3.6600000000000001 116.854 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.39 16.75 13.87 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.55 1.94 . . . . 4.5800000000000001 114.08 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -121.2 -173.91 2.72 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.956 1.465 . . . . 2.3100000000000001 114.956 -165.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.5 156.56 47.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.508 1.523 . . . . 0.72999999999999998 111.555 169.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mp -118.3 130.0 55.78 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.525 1.93 . . . . 2.1299999999999999 108.489 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.2 mtt -116.98 128.72 55.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.46 0.573 . . . . 1.77 111.772 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.02 103.51 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.61 -1.256 . . . . 0.92000000000000004 107.61 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -87.02 146.1 26.24 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.187 1.795 . . . . 3.4199999999999999 113.034 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.2 t -64.65 -30.32 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.983 -1.073 . . . . 2.0899999999999999 113.409 -164.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.14 149.66 18.07 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.316 0.96 . . . . 1.3899999999999999 112.63 172.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.27 150.48 11.1 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.104 1.811 . . . . 1.5900000000000001 112.952 162.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.01 0.55 38.32 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.2 1.185 . . . . 2.4900000000000002 114.2 -141.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -81.55 -7.27 59.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.356 1.613 . . . . 3.0299999999999998 115.356 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 65.9 mtm -84.45 109.75 18.12 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.74 1.216 . . . . 2.98 110.486 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -137.01 -45.35 0.57 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.17 0.988 . . . . 3.1000000000000001 112.759 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.41 80.64 8.53 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.123 -0.986 . . . . 3.8599999999999999 110.715 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 175.88 147.49 0.26 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 128.491 2.716 . . . . 3.8799999999999999 110.272 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.33 -27.59 47.66 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 2.1299999999999999 114.029 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -109.91 87.75 6.07 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.802 0.841 . . . . 7.8399999999999999 109.125 165.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.67 169.16 16.54 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.914 2.41 . . . . 5.1299999999999999 111.307 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt 66.3 6.04 4.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.523 1.929 . . . . 5.6100000000000003 113.416 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.2 26.92 74.23 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 119.154 0.888 . . . . 4.4199999999999999 113.2 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.57 -9.35 77.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.778 1.18 . . . . 2.7599999999999998 113.186 -166.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 22.43 0.57 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.884 2.183 . . . . 1.8899999999999999 115.851 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.75 75.35 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 118.455 1.128 . . . . 2.1000000000000001 112.337 166.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.7 p -65.21 156.86 30.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.454 1.502 . . . . 2.0299999999999998 110.896 162.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.25 137.67 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.761 1.224 . . . . 5.8799999999999999 110.582 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -82.37 -37.47 25.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.185 0.994 . . . . 3.5699999999999998 111.697 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.1 149.38 32.93 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.038 0.935 . . . . 0.56999999999999995 111.814 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.27 146.71 50.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.975 1.71 . . . . 1.5700000000000001 110.783 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -131.66 90.43 0.28 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.463 2.459 . . . . 1.0 111.352 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.28 140.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.589 1.156 . . . . 3.8799999999999999 112.47 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.72 151.45 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.728 1.611 . . . . 1.3700000000000001 111.246 -170.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 O-C-N 120.912 -1.117 . . . . 5.0300000000000002 112.43 171.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 109.437 -0.579 . . . . 2.27 109.437 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.55 154.11 26.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.732 1.213 . . . . 1.6299999999999999 109.859 -172.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -149.17 125.77 11.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.921 1.343 . . . . 2.9300000000000002 110.27 170.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -83.83 109.89 17.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.064 1.746 . . . . 3.9399999999999999 110.528 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.66 124.47 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 120.089 1.313 . . . . 1.6399999999999999 110.482 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.25 110.95 3.17 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 125.669 1.604 . . . . 0.81000000000000005 110.752 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.5 mtp -96.74 131.7 43.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.253 1.021 . . . . 2.04 111.121 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.65 142.91 45.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.066 1.346 . . . . 2.6899999999999999 111.524 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.7 mt -65.68 137.65 57.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.858 0.863 . . . . 1.3400000000000001 108.862 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.33 144.44 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.688 0.795 . . . . 1.3799999999999999 111.432 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.1 t -163.79 72.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.677 0.791 . . . . 2.2400000000000002 112.473 -169.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 72.0 -33.47 0.27 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.029 2.531 . . . . 1.71 115.44 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -33.78 68.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.353 1.461 . . . . 3.4700000000000002 110.082 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.39 -158.67 24.53 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 125.909 1.718 . . . . 1.54 112.023 -169.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.84 126.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.391 1.476 . . . . 1.46 110.899 171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.91 -136.78 9.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.492 1.52 . . . . 1.99 111.504 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.34 165.64 12.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.411 -1.052 . . . . 1.97 112.555 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -104.06 162.18 13.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.863 1.315 . . . . 2.3799999999999999 114.443 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pp -147.48 4.53 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 130.431 3.492 . . . . 3.6699999999999999 113.262 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.49 148.09 5.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.959 1.742 . . . . 0.91000000000000003 112.856 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 p -99.46 -179.9 4.36 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.184 -1.043 . . . . 1.1100000000000001 108.184 163.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.2 134.52 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.211 -1.033 . . . . 0.68000000000000005 108.211 163.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.5 p -81.54 122.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.49 -0.559 . . . . 2.1600000000000001 109.49 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -107.42 133.14 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.557 -0.905 . . . . 2.8500000000000001 108.557 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.22 124.91 18.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.547 1.539 . . . . 2.1600000000000001 107.498 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.34 128.66 47.4 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.515 0.726 . . . . 3.5600000000000001 109.703 -168.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -151.5 -174.53 4.86 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.633 0.235 . . . . 1.52 111.633 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.17 -24.97 68.13 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.933 -1.105 . . . . 4.25 112.619 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.99 9.95 64.55 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 124.834 1.207 . . . . 1.1200000000000001 114.609 167.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.29 -140.19 23.43 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 126.668 2.08 . . . . 0.70999999999999996 112.988 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.87 93.47 5.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.9 0.88 . . . . 0.81000000000000005 110.49 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -72.69 131.57 42.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.483 1.913 . . . . 3.7400000000000002 109.22 166.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -127.93 106.72 9.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.99 2.116 . . . . 0.79000000000000004 108.176 -168.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 25.4 m -105.4 107.1 58.36 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.834 1.197 . . . . 2.1600000000000001 108.027 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.05 156.11 30.09 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.028 2.486 . . . . 0.80000000000000004 110.496 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.0 39.65 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.687 1.232 . . . . 2.9100000000000001 110.359 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.54 150.02 20.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 126.794 2.038 . . . . 1.1399999999999999 111.733 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.5 162.34 31.45 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.339 -1.301 . . . . 3.1299999999999999 109.494 170.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.21 23.64 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.484 3.114 . . . . 1.79 112.66 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.517 HD11 ' HH ' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.18 152.51 57.19 Favored Pre-proline 0 CA--C 1.487 -1.46 0 C-N-CA 125.249 1.42 . . . . 3.3399999999999999 112.56 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -76.0 142.7 25.2 Favored 'Trans proline' 0 N--CA 1.413 -3.218 0 C-N-CA 116.599 -1.801 . . . . 1.6599999999999999 111.286 -165.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -80.97 31.3 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.626 1 C-N-CA 127.89 5.727 . . . . 1.5700000000000001 114.127 -155.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.86 -127.98 6.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 123.567 1.648 . . . . 1.6899999999999999 110.958 174.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -120.51 145.93 46.79 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 127.567 2.347 . . . . 3.0699999999999998 110.383 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -139.9 125.11 18.8 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 124.158 0.983 . . . . 1.27 112.404 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.31 149.79 9.41 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.607 -0.683 . . . . 0.66000000000000003 111.778 169.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -135.97 127.52 28.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.951 1.7 . . . . 3.2000000000000002 106.503 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -130.06 167.85 17.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.4 2.37 . . . . 1.1599999999999999 117.4 166.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.0 mt -101.0 146.43 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.637 1.975 . . . . 0.92000000000000004 108.929 155.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -124.08 155.72 37.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.179 1.792 . . . . 1.8700000000000001 110.541 -170.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.91 -37.91 70.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.948 1.462 . . . . 0.77000000000000002 114.948 -162.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -116.64 -179.34 3.65 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.335 1.454 . . . . 1.26 111.033 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.98 51.05 0.86 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 116.646 1.419 . . . . 1.05 116.646 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -153.22 123.93 7.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.661 1.731 . . . . 2.6499999999999999 112.45 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.1 m -68.77 -2.88 10.42 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.603 1.705 . . . . 2.0299999999999998 115.603 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.8 136.6 38.85 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 120.25 -1.531 . . . . 3.3700000000000001 112.02 -162.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -96.88 160.81 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.184 3.256 . . . . 1.73 113.384 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.76 177.3 4.88 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.103 1.361 . . . . 2.6899999999999999 110.915 156.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.25 124.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.579 1.152 . . . . 3.0 108.773 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -104.54 -178.86 3.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.579 1.952 . . . . 5.1399999999999997 109.911 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.33 104.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.529 0.937 . . . . 4.5599999999999996 113.529 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.06 18.03 70.45 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.262 -1.299 . . . . 4.1399999999999997 115.367 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -158.15 134.49 9.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.377 2.089 . . . . 5.0499999999999998 114.818 -169.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.6 130.33 35.01 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.107 -0.996 . . . . 2.04 110.312 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -81.36 49.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.396 . . . . 3.2599999999999998 111.675 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.57 -57.47 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 130.608 3.563 . . . . 2.8799999999999999 117.817 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 163.38 85.35 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 1 C-N-CA 134.228 5.011 . . . . 1.6200000000000001 105.17 -167.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.85 -50.53 7.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.103 0.961 . . . . 5.2599999999999998 111.91 -155.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.56 15.02 0.11 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.12 1.156 . . . . 1.8600000000000001 114.12 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.65 -15.04 35.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.431 1.892 . . . . 0.91000000000000003 112.7 165.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.08 9.68 85.38 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.737 1.455 . . . . 2.7799999999999998 116.737 168.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.04 -166.37 52.8 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.133 1.466 . . . . 2.6499999999999999 112.277 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -61.97 149.87 39.47 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.707 0.753 . . . . 2.5699999999999998 111.22 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 tp -67.98 110.18 3.79 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.904 -0.497 . . . . 2.6800000000000002 111.122 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.81 159.93 2.42 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 130.46 3.504 . . . . 3.4300000000000002 109.006 164.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -90.09 -18.6 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.328 2.019 . . . . 2.8399999999999999 115.712 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 178.55 -3.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.613 2.079 . . . . 4.9800000000000004 116.613 -163.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -58.92 -48.53 81.13 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.096 1.517 . . . . 3.73 115.096 -147.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 161.61 170.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.952 3.301 . . . . 3.6800000000000002 109.467 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.93 -15.62 78.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.318 0.961 . . . . 4.8799999999999999 113.779 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.92 145.38 55.99 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.104 1.452 . . . . 5.1600000000000001 110.348 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -117.46 143.87 45.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.234 1.013 . . . . 2.6000000000000001 112.299 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.74 117.56 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 3.7599999999999998 111.852 -161.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.05 171.53 35.7 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.004 1.288 . . . . 3.0 111.958 171.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.74 -3.33 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.907 3.738 . . . . 4.71 115.876 -168.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -160.69 29.22 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.584 2.354 . . . . 8.0600000000000005 110.675 171.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.76 -141.15 7.76 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.098 2.285 . . . . 4.0099999999999998 112.224 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -151.97 148.07 27.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.336 1.068 . . . . 5.71 112.055 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.12 -91.59 0.08 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.433 1.968 . . . . 2.23 112.524 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -134.76 134.25 40.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.136 1.375 . . . . 4.9400000000000004 110.285 -169.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -67.06 -21.63 65.89 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.63 1.344 . . . . 2.9300000000000002 114.63 -170.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.68 -2.65 76.64 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.707 1.146 . . . . 1.04 115.128 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -72.71 133.58 44.64 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.796 1.298 . . . . 1.5700000000000001 109.949 169.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.92 163.9 26.35 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.993 1.317 . . . . 2.5299999999999998 110.645 -150.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.3 145.79 34.87 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.514 2.809 . . . . 1.1200000000000001 111.899 -167.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.16 130.35 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.587 1.184 . . . . 3.77 110.446 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 125.31 31.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 131.128 3.771 . . . . 3.77 110.446 -172.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -97.06 140.18 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.336 1.055 . . . . 1.3899999999999999 111.88 -172.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.16 141.07 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.539 1.936 . . . . 2.5299999999999998 108.248 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -103.47 157.5 17.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.693 1.197 . . . . 3.0099999999999998 112.53 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.74 50.08 0.43 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.673 2.389 . . . . 3.0499999999999998 115.649 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -128.34 1.49 5.7 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.402 -1.726 . . . . 3.7200000000000002 111.221 150.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.29 27.47 13.33 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.441 1.972 . . . . 0.84999999999999998 113.883 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.29 138.53 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.533 1.533 . . . . 1.6699999999999999 110.255 -165.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.15 127.72 53.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.354 0.979 . . . . 1.3600000000000001 109.925 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 t -149.03 9.18 0.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.845 1.424 . . . . 1.3799999999999999 114.845 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -100.73 130.77 24.68 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.922 1.289 . . . . 3.5699999999999998 110.306 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.14 140.56 17.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.078 2.519 . . . . 1.0700000000000001 112.252 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.63 160.64 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.04 1.736 . . . . 1.5600000000000001 109.499 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.0 m -144.73 132.55 21.23 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.384 0.993 . . . . 1.1499999999999999 111.423 -167.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.84 97.25 27.94 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.744 1.218 . . . . 0.77000000000000002 112.916 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.0 -2.52 12.77 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.582 3.521 . . . . 1.1799999999999999 115.905 -177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -88.15 -2.44 58.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.548 1.139 . . . . 4.4400000000000004 113.361 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.55 169.72 9.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.976 2.51 . . . . 3.3300000000000001 107.834 164.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -152.67 5.74 0.39 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 117.038 2.236 . . . . 4.71 117.038 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 m -158.1 167.95 28.42 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.987 1.267 . . . . 2.4100000000000001 113.291 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.81 -20.06 63.46 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.957 -1.09 . . . . 2.1400000000000001 111.863 163.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.52 -35.86 78.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.587 1.155 . . . . 3.54 113.657 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -68.51 -13.11 62.1 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.366 1.247 . . . . 3.1800000000000002 114.366 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.16 17.58 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.747 1.219 . . . . 1.0800000000000001 113.539 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -67.44 19.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 128.308 2.643 . . . . 3.0499999999999998 116.977 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -165.96 26.28 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.788 2.435 . . . . 2.9500000000000002 110.94 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -134.6 170.64 15.49 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.952 -1.092 . . . . 2.0800000000000001 113.629 -167.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.5 157.09 25.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.03 1.332 . . . . 0.83999999999999997 112.543 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.35 135.04 51.06 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.871 2.068 . . . . 2.1800000000000002 107.294 168.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.09 138.19 54.3 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.383 0.673 . . . . 2.9900000000000002 111.444 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.33 133.48 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.443 1.116 . . . . 2.0800000000000001 110.278 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.22 135.5 51.67 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.324 1.85 . . . . 3.04 110.828 -155.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -73.53 -15.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.791 1.404 . . . . 3.6899999999999999 114.791 -151.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.03 169.53 24.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.401 1.477 . . . . 1.95 109.891 162.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.2 147.84 34.16 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 117.88 0.84 . . . . 1.8400000000000001 111.786 165.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.64 -22.04 0.89 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.352 1.242 . . . . 3.7599999999999998 114.352 -138.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.6 47.43 0.17 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.85 2.46 . . . . 4.1699999999999999 115.422 -172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 41.4 mtm -105.99 133.32 50.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.918 1.687 . . . . 2.77 112.493 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.9 p -99.18 -36.19 9.74 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.129 1.772 . . . . 4.0700000000000003 114.768 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.39 2.9 54.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.538 1.31 . . . . 4.1500000000000004 114.538 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.62 144.09 32.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.887 0.875 . . . . 3.9700000000000002 110.669 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -41.47 9.06 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.311 2.674 . . . . 2.3399999999999999 112.59 -173.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -83.15 136.94 43.13 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.729 -0.653 . . . . 5.5999999999999996 109.943 158.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.88 167.37 26.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.171 2.581 . . . . 3.48 111.034 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt 66.33 31.11 8.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.971 1.308 . . . . 4.5899999999999999 110.953 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.22 11.2 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.059 1.314 . . . . 3.0 114.223 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.6 -20.76 29.5 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.098 1.808 . . . . 2.8900000000000001 114.392 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.42 -3.31 47.35 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.387 1.47 . . . . 4.3099999999999996 114.617 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.9 46.77 1.8 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.587 1.565 . . . . 4.3600000000000003 115.59 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.2 m -58.79 158.03 8.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.382 1.873 . . . . 2.9100000000000001 110.338 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.45 150.5 28.29 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.281 -1.512 . . . . 6.6500000000000004 113.042 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.517 ' HH ' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -100.73 -32.83 10.52 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 118.817 -0.611 . . . . 8.5800000000000001 111.251 153.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.29 152.47 37.17 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 116.482 2.03 . . . . 0.84999999999999998 116.482 -172.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.0 t -99.2 -177.69 3.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 129.26 3.024 . . . . 1.5900000000000001 110.368 164.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 176.09 91.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 127.427 2.442 . . . . 1.3400000000000001 111.456 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.07 133.62 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 2.1499999999999999 110.024 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.16 128.1 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.468 1.107 . . . . 1.1100000000000001 110.962 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 82.9 mttt . . . . . 0 N--CA 1.472 0.662 0 C-N-CA 123.992 0.917 . . . . 4.79 111.214 -173.063 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 108.99 -0.744 . . . . 2.5899999999999999 108.99 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.7 148.06 23.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.228 1.011 . . . . 3.3300000000000001 113.568 -167.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -153.23 116.99 4.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 2.6000000000000001 109.248 165.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -97.35 108.36 21.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.747 -1.22 . . . . 4.4199999999999999 109.439 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.61 125.92 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.386 0.539 . . . . 1.49 109.886 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.0 114.17 4.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.958 1.266 . . . . 0.73999999999999999 110.171 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.4 mtt -98.09 129.78 44.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.963 0.905 . . . . 2.2000000000000002 111.726 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -107.44 147.83 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.135 1.374 . . . . 2.6400000000000001 110.717 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.5 mt -65.28 139.96 58.66 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.19 1.396 . . . . 1.1599999999999999 109.382 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.0 m -135.27 155.6 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 119.233 0.924 . . . . 1.5700000000000001 111.683 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.1 55.74 0.1 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.127 0.788 . . . . 2.3399999999999999 113.127 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.86 -36.72 0.37 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 127.196 2.199 . . . . 2.29 113.849 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -22.01 57.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 4.6100000000000003 112.283 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.63 -159.81 24.61 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 124.933 1.254 . . . . 1.1299999999999999 112.91 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 t -80.71 130.08 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.512 1.925 . . . . 1.5900000000000001 110.996 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.22 -135.33 8.07 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.4 1.476 . . . . 1.8600000000000001 112.49 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -104.86 172.29 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.942 0.897 . . . . 2.7400000000000002 111.315 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -109.43 141.13 42.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.77 0.828 . . . . 2.1099999999999999 112.473 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mm -118.73 23.85 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 127.068 2.147 . . . . 7.1299999999999999 110.937 164.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.2 173.04 33.37 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.32 -0.863 . . . . 0.90000000000000002 114.83 160.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.514 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.0 p -102.06 -179.49 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.28 1.032 . . . . 1.1299999999999999 109.542 170.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -132.55 135.27 57.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.769 -1.197 . . . . 0.68999999999999995 107.769 160.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.33 128.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.065 0.228 . . . . 1.47 110.626 174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.54 133.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.824 -0.806 . . . . 2.1600000000000001 108.824 161.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.21 128.16 53.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.547 0.739 . . . . 1.96 110.417 156.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 122.27 17.97 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.831 0.852 . . . . 4.0499999999999998 109.25 164.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -135.96 -178.51 5.17 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.33 -0.248 . . . . 1.8600000000000001 110.33 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -54.3 -46.34 72.77 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.866 -1.147 . . . . 5.3600000000000003 110.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.6 17.85 9.93 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.092 1.33 . . . . 1.3100000000000001 115.774 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.84 -144.08 20.13 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 126.698 2.094 . . . . 0.93000000000000005 114.071 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.72 99.52 5.89 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.996 0.903 . . . . 0.76000000000000001 111.224 -170.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 108.16 5.11 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.195 1.798 . . . . 6.0899999999999999 110.177 169.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.402 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 4.4 t80 -101.33 107.42 18.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.353 1.861 . . . . 0.67000000000000004 109.888 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.3 m -117.14 111.58 40.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 119.247 0.93 . . . . 1.7 109.064 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -84.01 166.37 12.98 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.032 3.155 . . . . 0.76000000000000001 111.415 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.514 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 3.2 p80 -150.2 18.71 0.86 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.761 1.393 . . . . 2.0800000000000001 114.761 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.58 140.89 35.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.208 1.003 . . . . 1.1499999999999999 111.857 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -116.52 35.92 4.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.731 1.752 . . . . 2.46 115.731 -166.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.77 49.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.651 0.78 . . . . 1.26 112.165 -165.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 157.54 70.86 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 2.29 112.578 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.0 141.64 40.62 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 O-C-N 122.985 0.992 . . . . 1.22 111.233 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.92 39.59 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 125.282 3.988 . . . . 1.3500000000000001 113.647 -156.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.83 -159.94 12.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.921 1.248 . . . . 1.1399999999999999 114.056 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -89.22 137.46 32.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.662 1.985 . . . . 2.8900000000000001 111.391 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -140.43 143.18 35.46 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.978 0.911 . . . . 1.6200000000000001 109.62 -173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.06 161.97 46.82 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 119.029 0.831 . . . . 0.63 112.112 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.402 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.9 t80 -144.51 124.86 13.83 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.326 -1.731 . . . . 3.23 106.326 166.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.57 166.01 24.21 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.962 1.467 . . . . 1.4199999999999999 114.962 165.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 mt -91.06 148.4 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.922 1.689 . . . . 0.84999999999999998 109.341 159.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -126.42 160.49 30.32 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.355 1.462 . . . . 1.0900000000000001 109.872 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.3 -20.2 65.58 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 116.609 2.077 . . . . 0.79000000000000004 116.609 -162.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -134.9 166.54 22.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.061 1.744 . . . . 1.3799999999999999 112.883 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 83.91 0.34 Allowed Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.151 1.358 . . . . 1.04 112.433 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.8 m -171.5 90.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.595 1.558 . . . . 2.9900000000000002 110.202 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 59.0 m -64.86 45.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 127.0 2.12 . . . . 1.3600000000000001 114.98 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -118.59 136.69 24.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 119.579 -1.95 . . . . 3.6699999999999999 110.786 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.61 168.74 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.185 3.256 . . . . 1.1799999999999999 111.686 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.18 144.98 25.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.016 -0.538 . . . . 1.78 109.772 155.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -109.92 117.35 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.118 1.367 . . . . 3.1299999999999999 108.34 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -166.41 146.4 6.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.962 1.305 . . . . 5.1299999999999999 110.6 -163.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 63.22 18.39 10.94 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.085 -1.009 . . . . 3.27 113.686 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.8 13.46 81.33 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.595 -1.315 . . . . 2.7599999999999998 114.217 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.82 174.54 10.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.643 1.577 . . . . 3.1000000000000001 110.793 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.6 151.04 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.371 -0.831 . . . . 1.6399999999999999 111.89 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.23 95.26 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.148 1.379 . . . . 2.2400000000000002 109.977 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 15.41 -85.41 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 129.396 3.079 . . . . 2.3599999999999999 116.091 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 130.62 12.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.619 1.968 . . . . 1.79 106.818 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -116.66 -46.0 2.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.512 1.925 . . . . 4.0 110.864 -165.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.5 -9.85 38.69 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.896 1.073 . . . . 1.29 113.896 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.48 59.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.683 1.593 . . . . 0.91000000000000003 113.185 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.1 173.5 48.7 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 119.487 1.039 . . . . 2.4100000000000001 112.948 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.56 -177.89 42.15 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.78 0.705 . . . . 1.75 112.444 165.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -49.01 140.15 9.44 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.252 0.526 . . . . 2.1699999999999999 110.306 168.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.93 101.73 0.88 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.416 0.895 . . . . 4.5300000000000002 113.416 -170.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -150.45 130.33 6.71 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 128.009 2.524 . . . . 5.2999999999999998 108.547 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.14 -39.35 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.337 2.025 . . . . 3.0099999999999998 113.918 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.67 31.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.463 1.905 . . . . 5.4299999999999997 114.548 -169.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -73.25 -44.15 59.89 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.115 -1.616 . . . . 4.3799999999999999 110.855 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.6 t 177.07 -37.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.277 1.831 . . . . 3.6099999999999999 113.378 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 5.91 79.13 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 117.853 -1.526 . . . . 2.52 116.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.255 19.2 ptmt -102.39 17.71 22.86 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 117.712 2.486 . . . . 5.54 117.712 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 t60 83.54 168.85 0.1 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 127.126 2.17 . . . . 2.3199999999999998 114.753 164.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -25.04 0.1 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.671 2.1 . . . . 5.1299999999999999 116.671 -154.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.6 -46.14 7.13 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 118.334 2.093 . . . . 2.73 118.334 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -90.02 -12.63 2.77 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.192 2.496 . . . . 4.2199999999999998 113.859 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -147.29 -104.17 0.09 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 6.0499999999999998 108.817 -161.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.68 98.73 0.14 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 119.17 0.896 . . . . 3.3900000000000001 114.23 170.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -159.79 44.76 0.23 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.578 1.151 . . . . 5.3499999999999996 109.741 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.43 -129.68 1.14 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 115.868 1.107 . . . . 2.6600000000000001 115.868 -166.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -95.36 146.2 24.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.236 1.014 . . . . 4.1900000000000004 113.663 -154.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -24.61 33.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.683 0.994 . . . . 4.1900000000000004 113.683 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.27 11.28 69.16 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.347 0.975 . . . . 1.48 114.91 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.8 149.79 32.5 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 117.95 0.875 . . . . 2.46 110.716 163.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.85 166.35 16.53 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.233 1.013 . . . . 2.7000000000000002 110.256 -141.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.37 157.01 50.13 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.605 2.87 . . . . 1.4199999999999999 111.654 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -73.21 128.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.647 1.213 . . . . 2.0299999999999998 112.34 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.09 63.37 5.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.773 2.829 . . . . 4.3600000000000003 110.792 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.87 144.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.088 -1.007 . . . . 1.6499999999999999 110.748 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 135.39 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.684 -0.858 . . . . 4.3499999999999996 108.684 162.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 159.34 25.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.131 1.772 . . . . 3.71 112.52 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.79 -8.68 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 119.867 3.284 . . . . 2.6299999999999999 119.867 -161.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -95.94 -36.3 11.12 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.883 1.673 . . . . 2.8500000000000001 114.589 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 115.01 14.39 8.53 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.922 1.529 . . . . 1.3100000000000001 116.922 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.9 mt -105.82 116.99 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.937 1.369 . . . . 2.2599999999999998 109.883 165.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.09 122.58 21.2 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.921 0.489 . . . . 0.79000000000000004 109.951 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -149.23 17.5 0.95 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.351 . . . . 1.6699999999999999 112.733 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -87.29 112.19 46.3 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.134 1.374 . . . . 3.0 111.526 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.9 107.09 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.89 2.393 . . . . 1.1599999999999999 109.973 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.67 145.93 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.501 1.12 . . . . 1.71 109.582 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -127.36 131.97 50.28 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.016 0.825 . . . . 1.8500000000000001 111.014 -168.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.23 96.67 40.11 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.976 0.91 . . . . 0.80000000000000004 112.326 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.12 6.66 1.35 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.93 3.086 . . . . 1.01 113.293 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.08 -29.01 67.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.041 1.337 . . . . 6.2400000000000002 112.965 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.6 153.84 32.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.033 2.133 . . . . 2.98 108.118 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 10.71 6.75 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.805 1.242 . . . . 6.4400000000000004 112.581 -174.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -167.13 150.72 6.58 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.974 -1.079 . . . . 2.29 112.99 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -71.52 -33.6 69.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.561 0.744 . . . . 2.7799999999999998 110.655 162.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.405 ' CG ' ' HZ1' ' A' ' 121' ' ' LYS . 10.4 t70 -61.02 -26.57 67.71 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.278 1.214 . . . . 3.3399999999999999 114.278 -173.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -84.58 -0.57 53.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.075 1.35 . . . . 2.2799999999999998 113.395 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.81 12.96 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.581 1.152 . . . . 0.95999999999999996 113.922 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.405 ' HZ1' ' CG ' ' A' ' 118' ' ' ASP . 48.8 pttt -69.93 17.45 0.05 Allowed 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 116.719 2.118 . . . . 3.23 116.719 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -156.18 29.7 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.534 1.933 . . . . 2.8399999999999999 110.624 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -139.62 157.74 45.28 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.168 1.387 . . . . 2.5299999999999998 114.12 -167.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.96 149.09 22.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.99 1.316 . . . . 0.64000000000000001 112.998 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.55 131.21 55.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.019 2.528 . . . . 2.1699999999999999 106.521 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.3 mtm -125.75 136.68 53.42 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.468 1.031 . . . . 2.2999999999999998 113.036 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.25 112.35 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.928 1.291 . . . . 1.1799999999999999 108.227 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.1 134.72 34.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.699 1.6 . . . . 3.5099999999999998 111.661 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.67 -39.92 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.233 0.827 . . . . 1.6499999999999999 113.233 -158.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.35 163.55 12.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.341 0.972 . . . . 1.46 110.685 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.75 109.26 1.34 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.481 -1.048 . . . . 1.74 110.481 166.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.81 26.58 0.09 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.883 2.873 . . . . 4.9400000000000004 112.969 -167.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.72 21.6 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.045 1.868 . . . . 3.3300000000000001 116.045 -158.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.5 mtm -98.68 152.91 19.13 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.394 1.257 . . . . 2.96 114.394 -160.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.3 p -140.15 150.32 44.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.324 1.85 . . . . 3.9900000000000002 110.463 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.9 t0 58.39 84.27 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.247 2.219 . . . . 4.6600000000000001 114.448 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.1 156.95 11.56 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.936 1.694 . . . . 3.5499999999999998 109.698 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.76 25.38 0.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.93 3.086 . . . . 3.3399999999999999 114.059 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -134.25 129.36 19.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.206 1.002 . . . . 5.4900000000000002 109.941 163.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.88 138.7 45.27 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.889 2.393 . . . . 3.52 111.085 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 60.45 22.48 12.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.809 1.643 . . . . 4.4800000000000004 112.117 -171.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.45 0.13 29.02 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.004 1.288 . . . . 3.0499999999999998 114.554 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.37 -9.46 24.4 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.925 2.202 . . . . 2.0499999999999998 113.957 -166.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.95 1.11 56.29 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.449 1.625 . . . . 1.78 116.324 -171.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.84 62.23 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 118.995 1.398 . . . . 1.79 116.485 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -79.31 155.96 28.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.014 1.725 . . . . 1.8400000000000001 110.771 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 136.01 49.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 6.0599999999999996 111.457 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -82.4 -32.61 29.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.518 1.127 . . . . 3.48 111.349 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.91 42.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.431 1.092 . . . . 0.51000000000000001 113.066 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.56 151.72 48.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.031 2.132 . . . . 1.46 110.479 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.07 125.15 1.78 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.301 1.429 . . . . 0.93999999999999995 111.873 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.6 132.45 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.835 1.254 . . . . 2.4700000000000002 110.87 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.06 131.4 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.032 1.333 . . . . 1.1499999999999999 110.533 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.4 mttt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 123.526 0.73 . . . . 4.3600000000000003 111.874 179.398 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.202 -0.666 . . . . 2.5600000000000001 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.39 143.1 45.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.196 1.362 . . . . 1.8899999999999999 113.974 -147.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -155.19 132.67 11.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.06 1.344 . . . . 2.52 110.454 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.38 97.07 7.19 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.842 -1.161 . . . . 5.0899999999999999 113.029 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.4 t -77.54 122.79 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 1.47 109.799 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.75 105.1 1.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.212 1.387 . . . . 0.79000000000000004 110.638 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.4 mtp -91.57 108.56 19.99 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.925 0.713 . . . . 2.1400000000000001 112.925 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -69.4 141.95 54.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.938 0.895 . . . . 2.8399999999999999 111.31 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.29 134.83 52.33 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.633 -0.877 . . . . 2.5499999999999998 108.633 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.69 159.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.091 0.556 . . . . 1.3600000000000001 111.578 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -155.23 -152.32 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.375 1.47 . . . . 2.7200000000000002 109.927 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -18.07 44.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.429 1.492 . . . . 2.48 113.429 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.84 -3.32 47.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.655 1.182 . . . . 3.3500000000000001 111.543 164.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 -133.41 11.78 Favored Glycine 0 CA--C 1.525 0.684 0 O-C-N 120.812 -1.18 . . . . 1.48 110.464 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.42 130.12 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.249 1.42 . . . . 2.5 111.657 -165.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.54 -100.07 2.16 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.645 1.593 . . . . 1.23 112.291 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -151.06 152.43 33.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.134 1.774 . . . . 4.71 109.065 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.5 t -87.99 155.1 20.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.22 1.01 . . . . 1.8400000000000001 112.308 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -135.37 2.9 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 3.4300000000000002 112.438 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.78 142.83 3.63 Favored Glycine 0 CA--C 1.524 0.62 0 O-C-N 121.468 -0.77 . . . . 0.81999999999999995 112.72 -162.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.504 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 3.1 p -97.88 175.82 6.01 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 166.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.52 129.07 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.594 -0.891 . . . . 0.68000000000000005 108.594 160.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.7 p -87.38 121.26 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 O-C-N 123.574 0.546 . . . . 1.53 110.995 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.52 128.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.303 1.841 . . . . 1.6200000000000001 107.284 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.56 111.71 13.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.497 1.142 . . . . 2.27 111.118 164.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -86.31 145.78 26.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.418 2.287 . . . . 5.3700000000000001 113.447 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.302 8.5 t -163.16 160.5 24.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 125.179 2.418 . . . . 1.8400000000000001 110.775 -158.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -23.18 -53.18 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 110.712 -2.949 . . . . 3.7799999999999998 113.387 148.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.12 12.2 65.04 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 125.225 1.393 . . . . 1.04 116.179 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.66 -172.38 35.9 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 130.499 3.904 . . . . 1.48 115.272 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.1 mt -51.59 99.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.798 2.039 . . . . 1.0 113.86 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -81.01 104.48 11.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.788 1.235 . . . . 2.2599999999999998 110.849 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 47' ' ' PHE . 1.3 t80 -94.33 120.88 35.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.175 2.19 . . . . 0.81999999999999995 110.265 -173.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.5 m -127.65 115.92 21.01 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.036 -0.983 . . . . 0.94999999999999996 109.286 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -85.03 154.92 11.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.455 2.77 . . . . 0.65000000000000002 113.562 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.504 ' CD2' ' HG1' ' A' ' 21' ' ' THR 0.282 1.8 p80 -147.06 62.25 1.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.3 1.047 . . . . 1.5 111.873 168.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.68 146.21 47.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.404 1.481 . . . . 0.81999999999999995 112.05 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -133.57 25.4 4.07 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 117.483 2.401 . . . . 3.8700000000000001 117.483 -158.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.54 25.02 0.4 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.817 1.414 . . . . 1.6299999999999999 114.817 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.92 162.91 34.21 Favored Pre-proline 0 N--CA 1.474 0.773 0 O-C-N 120.907 -1.121 . . . . 2.7200000000000002 111.297 -174.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.27 128.12 25.24 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 N-CA-C 109.36 -1.054 . . . . 1.05 109.36 162.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -87.45 20.17 1.24 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 124.399 3.399 . . . . 1.1399999999999999 113.78 -149.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.18 150.2 18.2 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.576 . . . . 2.5099999999999998 109.447 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -44.15 143.23 1.23 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 127.365 2.266 . . . . 2.8999999999999999 115.852 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -126.74 125.98 42.69 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 125.679 1.592 . . . . 1.1799999999999999 113.408 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.32 159.99 7.92 Favored Glycine 0 CA--C 1.54 1.62 0 O-C-N 120.863 -1.148 . . . . 0.65000000000000002 112.581 171.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CE2' ' CD2' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -137.15 126.4 24.72 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.617 -0.931 . . . . 3.6499999999999999 108.832 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.443 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 17.1 m170 -120.85 159.3 25.77 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.558 1.318 . . . . 1.0800000000000001 114.558 166.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.3 mt -103.18 139.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.558 1.943 . . . . 0.79000000000000004 107.371 157.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -113.59 166.26 11.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.223 . . . . 1.2 111.137 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.56 64.78 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.494 1.294 . . . . 0.80000000000000004 114.494 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -110.84 -158.22 0.64 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.939 1.296 . . . . 1.52 111.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.42 0.19 8.05 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 119.46 2.544 . . . . 2.1299999999999999 119.46 -147.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 t -155.78 138.76 15.41 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.816 3.308 . . . . 3.6299999999999999 117.271 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.7 m -68.44 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 130.199 3.399 . . . . 1.3500000000000001 115.112 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.18 118.82 48.64 Favored Pre-proline 0 N--CA 1.475 0.788 0 O-C-N 119.446 -2.034 . . . . 3.1600000000000001 111.746 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.66 146.3 16.77 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.662 2.908 . . . . 1.3999999999999999 111.711 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.24 138.88 32.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.63 -0.714 . . . . 2.0299999999999998 110.291 154.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.57 106.54 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.792 -1.188 . . . . 3.3599999999999999 107.792 160.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -151.98 136.54 16.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.578 1.551 . . . . 6.75 110.246 -161.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.4 t0 50.46 45.51 26.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.85 1.26 . . . . 4.1600000000000001 112.83 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 -19.49 48.97 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.065 1.793 . . . . 3.1899999999999999 115.389 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.66 163.6 34.36 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.352 1.576 . . . . 3.7999999999999998 113.379 -156.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.57 121.83 26.81 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.497 -1.377 . . . . 2.4700000000000002 111.175 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -76.61 20.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 114.656 1.354 . . . . 3.9399999999999999 114.656 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.99 -56.96 0.57 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.146 2.578 . . . . 2.0899999999999999 114.685 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.44 118.76 0.55 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.252 2.221 . . . . 1.8799999999999999 108.911 172.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.11 -43.8 7.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.581 0.752 . . . . 4.96 110.677 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.2 -2.38 7.99 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.221 1.193 . . . . 1.6699999999999999 114.221 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.13 -24.25 23.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.018 1.327 . . . . 1.03 112.474 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.68 -176.94 41.87 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.713 1.142 . . . . 2.3900000000000001 112.878 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.62 -176.57 29.65 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.906 -0.761 . . . . 1.6799999999999999 112.834 171.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -55.59 150.38 12.36 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.936 -0.744 . . . . 2.23 109.487 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.99 100.35 0.41 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.911 0.778 . . . . 2.3999999999999999 112.002 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -163.78 123.15 1.32 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 129.279 3.032 . . . . 4.9699999999999998 108.926 165.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -92.16 -16.64 1.05 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.04 2.493 . . . . 2.3100000000000001 114.283 173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -169.88 -14.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.437 2.384 . . . . 4.1799999999999997 117.437 -166.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -59.09 -36.62 75.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.957 1.708 . . . . 4.1100000000000003 112.742 -170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -172.93 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.182 0.993 . . . . 2.7400000000000002 113.225 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 -17.48 8.06 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.29 -1.283 . . . . 2.29 113.834 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -78.08 154.49 31.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.175 1.988 . . . . 6.6500000000000004 112.077 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -79.68 150.52 30.89 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.012 -1.055 . . . . 1.8100000000000001 112.589 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' CG ' ' H ' ' A' ' 84' ' ' GLY . 4.6 tt0 -79.39 -166.01 0.88 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.598 0.759 . . . . 3.27 110.076 175.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' A' ' 83' ' ' GLU . . . 165.45 -140.5 6.43 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 120.746 -1.221 . . . . 2.21 111.79 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.15 -9.82 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.458 2.772 . . . . 3.4199999999999999 114.23 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.98 174.41 5.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.817 2.047 . . . . 5.5499999999999998 109.164 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.98 -138.4 16.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.663 0.649 . . . . 4.5099999999999998 111.497 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.08 135.81 3.91 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.511 1.524 . . . . 6.6900000000000004 107.597 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.87 -135.28 3.22 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.258 1.409 . . . . 2.6600000000000001 113.397 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -75.7 136.25 40.37 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.145 -0.62 . . . . 4.54 110.542 169.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -12.84 61.69 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 3.8500000000000001 113.586 170.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.09 18.51 13.0 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.874 1.702 . . . . 0.98999999999999999 115.999 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -108.9 133.11 53.35 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.155 1.478 . . . . 1.47 110.585 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.11 154.23 80.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.035 1.334 . . . . 3.1200000000000001 110.654 -163.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.75 163.9 37.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.41 2.74 . . . . 1.03 112.987 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.14 119.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 114.975 -1.012 . . . . 3.0600000000000001 112.101 -160.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 87.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.112 2.965 . . . . 2.6499999999999999 109.685 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.25 147.55 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.452 -0.78 . . . . 1.29 110.086 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.55 150.16 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 127.635 2.374 . . . . 2.5299999999999998 106.108 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.52 160.21 27.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.575 0.625 . . . . 2.4399999999999999 111.147 168.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -14.79 0.86 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 116.63 2.085 . . . . 2.4500000000000002 116.63 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.93 -5.78 37.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.359 2.264 . . . . 2.6299999999999999 113.395 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.5 52.01 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.674 1.131 . . . . 0.79000000000000004 115.184 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.6 mt -111.89 132.5 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.432 1.493 . . . . 1.7 110.191 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.7 144.63 32.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.522 1.529 . . . . 1.0700000000000001 112.198 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -151.31 -5.73 0.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.346 1.858 . . . . 1.8600000000000001 113.806 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -70.18 118.53 64.77 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.226 1.81 . . . . 4.5199999999999996 111.493 -174.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.15 146.73 32.46 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.884 2.389 . . . . 1.28 111.479 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.16 175.17 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.911 1.684 . . . . 1.6100000000000001 109.627 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 m -150.57 133.19 15.75 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.305 0.957 . . . . 1.1200000000000001 110.449 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.3 105.41 54.03 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-O 118.745 -0.645 . . . . 1.04 112.043 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.67 -16.16 21.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.233 2.622 . . . . 1.4099999999999999 115.631 -171.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -66.77 -43.25 84.53 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.252 0.834 . . . . 5.5300000000000002 113.252 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.95 151.25 38.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 3.02 110.336 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -144.27 46.4 1.42 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.819 1.248 . . . . 4.8700000000000001 113.265 -169.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 m 151.22 142.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 130.874 3.67 . . . . 2.2400000000000002 113.554 166.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.19 -33.63 53.54 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.826 -1.171 . . . . 2.1699999999999999 111.636 164.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -20.92 5.72 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.794 1.775 . . . . 3.1699999999999999 115.794 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -92.25 -16.98 25.43 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.607 1.549 . . . . 3.0600000000000001 113.709 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.67 -1.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.993 1.479 . . . . 1.03 114.993 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -8.4 13.24 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 117.121 2.267 . . . . 3.6899999999999999 117.121 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -104.97 -8.12 18.8 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.207 1.403 . . . . 2.8700000000000001 113.395 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -96.16 168.56 10.52 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.932 1.293 . . . . 2.4700000000000002 114.338 -167.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.9 156.84 17.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.125 1.37 . . . . 0.90000000000000002 112.41 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 pp -131.96 155.0 48.73 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.924 1.69 . . . . 3.3399999999999999 111.193 169.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 67.9 mtt -136.28 139.74 42.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.607 0.763 . . . . 1.8999999999999999 112.587 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.03 121.62 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.293 1.437 . . . . 0.83999999999999997 107.779 166.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -114.01 145.75 41.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.448 1.499 . . . . 2.98 112.654 -161.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.0 -32.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 126.119 1.768 . . . . 1.5900000000000001 113.762 -159.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.68 167.37 20.04 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.782 1.182 . . . . 1.3700000000000001 111.703 168.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.97 163.68 50.43 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.241 1.401 . . . . 1.3500000000000001 112.759 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.443 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 20.2 t0 -116.51 11.93 14.97 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.199 1.555 . . . . 2.4500000000000002 115.199 -142.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -70.95 -10.47 59.74 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.441 -1.412 . . . . 3.04 114.638 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.2 mtm -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.664 1.586 . . . . 2.77 113.403 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 t -84.77 -175.39 5.75 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.61 -0.681 . . . . 3.6099999999999999 112.27 161.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 61.31 -16.05 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 129.053 2.941 . . . . 4.79 117.316 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -67.67 147.27 98.67 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.098 1.359 . . . . 3.4900000000000002 111.851 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.95 -25.0 32.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.612 2.875 . . . . 2.21 112.718 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -104.65 84.98 1.05 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.43 -0.952 . . . . 4.8099999999999996 108.43 157.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.58 154.25 73.05 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.753 2.302 . . . . 3.8100000000000001 111.041 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 65.58 5.48 3.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.684 1.994 . . . . 5.1900000000000004 112.946 -169.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.42 14.52 54.48 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.718 1.151 . . . . 3.5 114.429 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.45 44.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.972 1.272 . . . . 2.8900000000000001 114.035 -167.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.1 -16.65 66.92 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.209 1.385 . . . . 2.0800000000000001 113.164 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.68 0.08 29.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.149 1.357 . . . . 2.3199999999999998 114.628 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.0 p -71.75 160.66 32.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.127 1.463 . . . . 2.3399999999999999 109.924 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.51 150.72 20.21 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.762 1.225 . . . . 6.2999999999999998 114.001 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -109.24 -37.92 5.65 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.317 0.647 . . . . 3.7999999999999998 110.793 154.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.75 155.04 47.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.79 0.836 . . . . 0.55000000000000004 112.69 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.1 t -139.09 147.51 42.07 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.223 2.209 . . . . 1.4099999999999999 109.821 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 123.99 1.72 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.978 1.275 . . . . 0.73999999999999999 112.624 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.22 126.19 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.792 1.237 . . . . 2.3700000000000001 110.144 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 36.8 mt -80.87 142.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.642 1.177 . . . . 1.26 109.184 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 10.5 mmpt? . . . . . 0 CA--C 1.542 0.672 0 O-C-N 120.726 -1.234 . . . . 3.8700000000000001 111.811 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.107 -0.331 . . . . 2.6099999999999999 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -132.49 146.23 51.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.011 1.485 . . . . 1.6399999999999999 115.011 -133.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -156.04 135.51 12.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.287 1.518 . . . . 2.7999999999999998 111.603 164.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 19.6 ttmt -108.51 87.5 2.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.229 2.212 . . . . 3.9100000000000001 110.974 -165.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.23 125.4 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.21 1.189 . . . . 3.4500000000000002 114.21 -171.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.0 100.68 0.59 Allowed Glycine 0 C--N 1.339 0.709 0 C-N-CA 125.191 1.377 . . . . 0.92000000000000004 110.525 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.28 128.92 34.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.653 0.74 . . . . 2.5 111.931 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -111.09 143.4 41.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.904 2.081 . . . . 2.8700000000000001 111.658 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.2 mt -80.83 56.26 2.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.599 1.16 . . . . 1.7 112.904 -169.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.1 153.45 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 122.262 1.029 . . . . 1.8899999999999999 113.603 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -160.06 -156.26 0.48 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 125.728 1.611 . . . . 3.0099999999999998 109.051 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.14 8.88 0.49 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.37 1.868 . . . . 1.75 114.075 -172.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -108.46 -7.52 15.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.815 1.646 . . . . 2.8199999999999998 111.114 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.81 -142.63 17.14 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.644 -0.983 . . . . 1.1499999999999999 110.644 -160.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -92.53 136.3 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.159 1.783 . . . . 1.3100000000000001 110.907 -167.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.47 -68.26 0.28 Allowed Glycine 0 N--CA 1.473 1.146 0 C-N-CA 124.421 1.01 . . . . 1.6200000000000001 115.316 -166.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.3 154.98 10.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.207 1.803 . . . . 2.23 110.8 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -129.82 122.42 28.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.9 -1.125 . . . . 2.1699999999999999 112.273 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.65 25.97 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.458 1.503 . . . . 7.04 110.842 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.87 38.12 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.756 -0.59 . . . . 0.79000000000000004 114.32 161.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.492 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 8.0 p -99.24 -179.28 4.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.963 0.905 . . . . 1.1699999999999999 110.392 169.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -129.53 132.58 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.929 -1.137 . . . . 0.56000000000000005 107.929 150.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 14.8 p -85.84 120.7 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.963 0.411 . . . . 1.45 110.761 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.58 138.93 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 124.917 1.287 . . . . 2.6200000000000001 107.881 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.94 104.95 3.49 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.16 1.384 . . . . 2.2799999999999998 109.56 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 151.08 44.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.032 -0.531 . . . . 2.8199999999999998 111.558 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -158.38 -177.49 6.58 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.854 0.862 . . . . 1.53 110.547 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.5 -9.4 48.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.487 1.915 . . . . 3.7400000000000002 113.001 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.45 16.27 41.37 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.854 1.693 . . . . 1.25 114.424 163.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.88 -151.42 23.86 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 127.235 2.35 . . . . 1.1200000000000001 116.635 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.54 96.66 4.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.227 1.011 . . . . 2.21 111.728 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -70.77 143.32 51.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.086 0.954 . . . . 2.7999999999999998 109.755 166.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -142.65 118.88 10.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.105 1.762 . . . . 0.66000000000000003 109.363 -167.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -123.44 109.5 30.89 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.173 -0.918 . . . . 1.73 108.831 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.4 164.31 19.11 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.818 3.012 . . . . 0.56999999999999995 110.929 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.492 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 1.3 p80 -158.63 33.78 0.23 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.314 0.857 . . . . 1.5700000000000001 113.314 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 mp -91.77 136.06 33.43 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.378 -1.451 . . . . 1.1899999999999999 112.018 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 14.98 21.63 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.499 2.037 . . . . 3.5 116.499 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.59 88.07 1.19 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.664 -0.648 . . . . 1.8300000000000001 112.059 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 163.32 26.9 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.264 1.425 . . . . 2.54 111.298 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.51 124.31 13.09 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.013 1.809 . . . . 0.95999999999999996 110.556 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -84.47 45.17 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 127.203 5.269 . . . . 1.3500000000000001 112.268 -163.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.13 -130.46 7.02 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 123.184 1.436 . . . . 1.45 111.866 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -147.56 127.95 13.99 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.253 1.421 . . . . 2.8700000000000001 109.264 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -130.19 154.48 47.49 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.578 0.955 . . . . 1.22 113.578 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.35 155.87 51.75 Favored Glycine 0 CA--C 1.541 1.657 0 O-C-N 121.184 -0.948 . . . . 0.60999999999999999 112.192 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -130.85 122.57 27.31 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.054 -1.462 . . . . 3.4100000000000001 107.054 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 7.7 m170 -122.53 157.92 31.0 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.723 1.601 . . . . 1.1499999999999999 114.43 165.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.6 mt -94.24 154.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 128.27 2.628 . . . . 0.88 108.22 158.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -139.04 145.13 39.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.002 0.921 . . . . 1.1799999999999999 111.181 -170.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.57 67.0 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.242 1.941 . . . . 0.79000000000000004 116.242 -163.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.43 -179.27 5.06 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.415 1.086 . . . . 1.25 113.211 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.0 32.76 4.47 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.597 1.57 . . . . 1.3799999999999999 116.675 -163.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -138.69 104.12 5.02 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.224 1.512 . . . . 2.8399999999999999 111.705 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -70.2 13.09 0.18 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 116.701 2.111 . . . . 1.4199999999999999 116.701 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -84.45 131.52 49.96 Favored Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 119.694 -1.879 . . . . 3.1099999999999999 112.115 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.71 149.16 29.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.524 2.816 . . . . 1.25 112.418 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.74 150.36 26.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.003 -0.544 . . . . 1.6100000000000001 110.38 156.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.0 mm -117.14 136.76 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.829 1.652 . . . . 2.8399999999999999 107.697 173.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -14.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.678 2.103 . . . . 6.5599999999999996 116.678 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.36 46.7 0.28 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.795 1.18 . . . . 3.3999999999999999 113.611 -163.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.1 22.3 68.75 Favored Glycine 0 N--CA 1.475 1.255 0 O-C-N 120.662 -1.274 . . . . 3.3500000000000001 113.295 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -163.32 155.22 17.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.293 1.837 . . . . 3.3399999999999999 110.501 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.0 138.51 46.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.243 1.417 . . . . 2.5299999999999998 111.749 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.82 39.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.969 1.308 . . . . 2.8300000000000001 111.377 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.4 -66.38 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.628 2.771 . . . . 2.5699999999999998 116.207 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.91 107.13 0.96 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.074 2.55 . . . . 1.98 108.057 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -76.48 -54.1 7.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.484 0.714 . . . . 6.0599999999999996 110.059 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.1 20.64 0.37 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.045 0.938 . . . . 2.2200000000000002 113.325 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.4 -11.99 38.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.226 1.411 . . . . 1.0600000000000001 112.08 157.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.18 -70.3 3.18 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 120.229 -1.544 . . . . 2.96 114.051 171.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.02 179.23 32.75 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.522 1.534 . . . . 2.3900000000000001 112.909 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -61.28 -7.31 2.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.663 2.097 . . . . 2.5699999999999998 116.663 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 tt 78.51 98.73 0.06 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.957 2.103 . . . . 3.6499999999999999 110.027 169.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -168.55 55.01 0.27 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 115.714 1.746 . . . . 3.5099999999999998 115.714 -148.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.39 -48.06 2.7 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.765 2.31 . . . . 2.6299999999999999 113.218 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -137.41 79.04 1.72 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.459 1.103 . . . . 4.6799999999999997 110.058 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.96 -77.67 0.58 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.601 1.16 . . . . 3.9300000000000002 109.769 166.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -178.6 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.894 2.077 . . . . 2.5499999999999998 111.414 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.55 -9.3 58.82 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.245 0.926 . . . . 2.0499999999999998 114.679 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.92 -14.35 61.9 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 116.052 1.871 . . . . 5.9100000000000001 116.052 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.9 t60 70.74 164.19 0.27 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.308 1.843 . . . . 1.9099999999999999 111.5 -166.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -157.28 -152.38 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.886 -1.134 . . . . 3.9500000000000002 112.216 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.27 -40.18 0.16 Allowed Glycine 0 CA--C 1.543 1.805 0 C-N-CA 127.938 2.685 . . . . 2.3599999999999999 113.213 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -112.34 -1.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.617 2.878 . . . . 3.6800000000000002 115.606 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.08 -7.19 0.82 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.116 1.895 . . . . 6.3600000000000003 116.116 -159.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.36 -23.03 5.71 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 119.712 -1.867 . . . . 4.6699999999999999 114.322 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.71 64.26 2.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.089 2.156 . . . . 5.6299999999999999 113.451 -168.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 -93.39 0.11 Allowed Glycine 0 N--CA 1.469 0.899 0 O-C-N 120.457 -1.402 . . . . 2.48 113.655 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -138.15 156.03 48.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.23 2.212 . . . . 4.6399999999999997 108.279 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -84.96 -21.72 29.46 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.523 1.056 . . . . 2.8500000000000001 113.131 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.63 19.84 22.15 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 117.806 -1.552 . . . . 1.1299999999999999 116.068 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -95.2 138.12 33.33 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 120.636 2.218 . . . . 1.49 111.065 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.49 155.66 79.82 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.945 1.698 . . . . 3.1099999999999999 110.391 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.02 162.04 43.01 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.417 2.744 . . . . 1.22 111.787 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.0 127.24 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.902 1.334 . . . . 2.1499999999999999 113.237 -160.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 85.04 3.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 129.438 3.095 . . . . 3.9900000000000002 108.57 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.12 149.55 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 1.01 109.152 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.27 133.6 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.663 1.185 . . . . 2.6099999999999999 110.281 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.45 141.99 58.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.754 1.02 . . . . 1.9299999999999999 113.754 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -46.42 -23.92 0.43 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 129.016 2.927 . . . . 2.77 117.581 -170.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.58 -19.31 45.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.139 1.775 . . . . 3.0499999999999998 112.482 -168.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.69 30.95 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.43 1.491 . . . . 1.05 113.483 -170.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.24 127.66 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.008 1.723 . . . . 1.45 108.492 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.76 136.54 33.06 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.131 0.972 . . . . 0.81999999999999995 110.547 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.3 t -153.11 -2.43 0.22 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.918 1.687 . . . . 2.0800000000000001 113.052 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -80.43 118.96 74.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 128.387 2.675 . . . . 5.0300000000000002 112.283 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.09 149.43 28.52 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.931 3.087 . . . . 1.45 112.971 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.03 166.62 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.98 1.712 . . . . 1.6499999999999999 110.591 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -138.99 137.1 36.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.9 1.28 . . . . 1.01 109.553 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -112.42 110.17 53.23 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.338 0.655 . . . . 1.0600000000000001 112.758 173.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.51 -0.95 11.13 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.879 3.052 . . . . 1.4299999999999999 114.692 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -73.87 -11.12 60.27 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.951 1.25 . . . . 5.3499999999999996 113.238 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.78 141.98 33.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.865 2.066 . . . . 3.6299999999999999 108.417 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 18.79 2.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.931 1.826 . . . . 8.3100000000000005 115.931 -160.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 85.9 p -153.24 164.72 37.58 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.821 1.248 . . . . 3.3300000000000001 108.329 167.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.0 tp -84.4 -34.61 23.5 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.676 -0.64 . . . . 3.21 109.657 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.65 -41.36 42.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 2.8900000000000001 113.078 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -72.92 -5.09 36.16 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.231 1.197 . . . . 2.2599999999999998 114.231 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.03 13.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.024 1.329 . . . . 0.91000000000000003 113.541 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -59.7 -5.07 0.79 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 117.361 2.356 . . . . 2.9300000000000002 117.361 -172.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.66 22.11 2.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.055 1.342 . . . . 3.5099999999999998 112.807 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -104.47 151.81 23.1 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.297 -0.877 . . . . 3.2799999999999998 112.866 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.47 148.42 27.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.836 -0.62 . . . . 0.92000000000000004 110.182 157.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.2 145.62 42.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.349 -0.982 . . . . 2.0600000000000001 108.349 156.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.9 150.86 52.12 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.201 0.815 . . . . 3.0 113.201 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.5 mt -99.06 132.9 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.098 1.759 . . . . 0.85999999999999999 108.146 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -123.19 143.39 50.05 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.098 1.359 . . . . 4.1500000000000004 112.197 -164.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 37.9 t -67.1 -35.4 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.922 -1.111 . . . . 1.8600000000000001 112.982 -160.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -108.19 150.74 17.0 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.182 0.896 . . . . 1.3400000000000001 111.937 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.89 147.81 40.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.634 1.111 . . . . 1.5800000000000001 111.376 159.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.436 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 25.3 t0 -103.4 -15.07 16.02 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.471 1.656 . . . . 2.9500000000000002 115.471 -138.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.24 51.98 0.57 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.415 1.635 . . . . 2.8999999999999999 115.415 -168.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.94 131.51 25.47 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.703 -1.248 . . . . 2.9300000000000002 112.316 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -138.06 -54.93 0.65 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.717 0.807 . . . . 3.6200000000000001 112.671 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.95 39.46 0.23 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.978 2.111 . . . . 4.2800000000000002 113.881 -164.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -124.18 163.58 35.03 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.155 2.582 . . . . 3.8700000000000001 109.773 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.84 -19.36 64.19 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.291 2.661 . . . . 2.75 113.755 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -127.81 136.47 29.03 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 118.856 0.753 . . . . 5.4100000000000001 109.944 148.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.52 162.37 41.11 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.919 2.413 . . . . 4.1299999999999999 110.176 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 mp 60.07 9.1 1.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.01 1.724 . . . . 4.7000000000000002 112.868 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 10.64 57.29 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.716 -1.24 . . . . 3.8700000000000001 114.139 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.7 83.07 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.434 1.016 . . . . 2.3799999999999999 113.891 -166.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.55 10.5 50.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.718 1.627 . . . . 1.97 115.006 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.83 -4.13 70.28 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.128 1.347 . . . . 1.77 114.537 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 p -62.71 157.99 19.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.048 1.339 . . . . 1.8400000000000001 110.319 164.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.68 150.11 27.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.043 1.337 . . . . 7.8700000000000001 113.381 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -107.52 -19.82 13.44 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.436 0.902 . . . . 3.77 113.436 162.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.24 156.32 23.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.205 0.911 . . . . 0.54000000000000004 112.851 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.23 163.61 15.42 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.393 1.477 . . . . 2.2799999999999998 110.114 157.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -151.96 134.44 4.58 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.821 1.676 . . . . 0.92000000000000004 110.371 159.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.52 129.65 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.482 1.113 . . . . 2.3199999999999998 109.873 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.4 mt -64.88 124.52 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.628 1.171 . . . . 1.2 112.052 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 113.168 0.803 . . . . 4.1100000000000003 113.168 177.559 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.479 ' H3 ' ' CD ' ' A' ' 26' ' ' GLU . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.72 0.295 . . . . 3.4100000000000001 110.484 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -150.84 155.78 39.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.206 1.402 . . . . 1.98 109.194 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -154.59 121.51 5.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.113 1.365 . . . . 2.6000000000000001 109.601 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -86.58 102.43 14.14 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.638 -1.289 . . . . 4.9100000000000001 108.834 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.1 121.28 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 119.882 1.219 . . . . 1.54 110.586 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.6 104.13 2.26 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.644 1.593 . . . . 1.0 110.983 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt -88.33 145.33 25.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.346 1.069 . . . . 2.4399999999999999 113.504 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -120.35 149.13 42.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.238 1.815 . . . . 2.8599999999999999 111.706 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.34 65.72 2.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.168 1.787 . . . . 1.45 111.139 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -74.39 157.84 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.705 1.202 . . . . 1.9299999999999999 112.836 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -159.97 -156.78 0.51 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.309 1.444 . . . . 3.21 109.722 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.32 60.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.324 2.25 . . . . 1.75 113.587 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -87.33 -15.74 37.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.172 1.789 . . . . 3.02 112.198 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.24 -139.62 14.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.724 1.154 . . . . 1.3300000000000001 110.717 -161.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.94 139.13 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 126.766 2.026 . . . . 2.0299999999999998 113.284 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.67 -104.03 2.25 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.595 2.045 . . . . 1.6000000000000001 113.26 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.12 149.57 42.0 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 127.264 2.226 . . . . 3.2799999999999998 113.482 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -96.47 140.87 30.47 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.742 -1.224 . . . . 2.4399999999999999 112.053 166.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.64 5.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 125.351 1.46 . . . . 3.3900000000000001 113.947 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.99 168.26 21.71 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.075 0.845 . . . . 1.02 112.639 -168.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 p -116.86 -175.76 2.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.337 1.055 . . . . 1.1599999999999999 109.162 170.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.08 135.65 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.441 -1.318 . . . . 0.70999999999999996 107.441 157.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.88 124.78 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.398 0.437 . . . . 1.53 110.203 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.7 127.67 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.371 1.068 . . . . 3.0 108.971 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -143.08 134.66 26.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.211 1.404 . . . . 2.04 110.452 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 117' ' ' LEU . 41.7 mt-10 -92.69 138.1 31.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.387 -1.733 . . . . 3.8199999999999998 112.087 -162.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 -175.51 4.99 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.577 -0.849 . . . . 2.1699999999999999 112.276 168.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -70.97 -6.97 42.81 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.956 1.095 . . . . 3.8799999999999999 113.956 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.67 12.15 53.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.764 1.649 . . . . 1.27 113.913 162.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -152.7 21.65 Favored Glycine 0 N--CA 1.462 0.418 0 C-N-CA 128.083 2.754 . . . . 1.0 116.225 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.3 mt -71.64 103.68 3.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.999 . . . . 1.1699999999999999 111.259 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -76.63 116.41 17.28 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.239 1.016 . . . . 2.8999999999999999 109.081 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -113.56 113.03 24.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.239 2.216 . . . . 1.0 109.19 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.8 m -120.8 107.19 38.46 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 108.124 -1.065 . . . . 0.95999999999999996 108.124 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.65 164.31 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.505 2.803 . . . . 0.5 110.685 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -152.67 30.63 0.52 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.133 0.968 . . . . 1.5900000000000001 112.669 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -89.78 132.76 35.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.919 -1.113 . . . . 1.0700000000000001 110.911 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -107.9 18.64 21.04 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.36 1.985 . . . . 2.73 116.36 -159.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.62 75.69 0.56 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.14 0.976 . . . . 1.5900000000000001 111.992 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.11 158.43 69.46 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.791 1.237 . . . . 2.6499999999999999 110.871 173.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.6 131.19 30.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.484 1.456 . . . . 1.24 110.879 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -87.2 34.76 0.43 Allowed 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 126.141 4.561 . . . . 1.22 113.203 -150.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.84 -135.07 8.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.99 1.757 . . . . 1.26 114.072 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.51 131.53 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.919 1.688 . . . . 2.3999999999999999 108.417 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -132.73 147.21 52.32 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 124.561 1.144 . . . . 1.3100000000000001 112.392 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.44 149.31 51.34 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.943 -1.098 . . . . 0.93999999999999995 111.458 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -124.75 111.4 15.51 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.492 -1.67 . . . . 3.2200000000000002 106.492 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -116.24 157.43 24.91 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.633 -1.292 . . . . 1.3500000000000001 113.697 171.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.28 152.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.594 1.557 . . . . 1.5600000000000001 107.518 157.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.68 146.9 46.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.526 1.13 . . . . 1.3700000000000001 108.768 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.12 70.28 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.388 1.625 . . . . 0.76000000000000001 115.388 -153.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -125.42 155.24 40.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.481 1.113 . . . . 2.1899999999999999 112.644 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.79 82.08 1.42 Allowed Glycine 0 N--CA 1.469 0.834 0 O-C-N 120.702 -1.249 . . . . 1.21 112.795 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -166.54 95.52 0.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.55 0.74 . . . . 2.6699999999999999 112.778 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.9 m -67.67 45.69 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.389 2.275 . . . . 1.45 113.635 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -121.05 127.12 26.35 Favored Pre-proline 0 CA--C 1.553 1.063 0 O-C-N 119.783 -1.823 . . . . 3.6400000000000001 111.113 -167.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -81.72 179.33 5.78 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.273 3.315 . . . . 1.3 114.562 -168.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.19 173.13 12.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.799 2.04 . . . . 1.7 109.669 160.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.97 134.5 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.909 1.283 . . . . 3.6699999999999999 108.194 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -150.78 143.05 24.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.642 1.577 . . . . 5.6299999999999999 110.14 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.61 25.96 13.86 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.204 1.187 . . . . 5.6299999999999999 114.204 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.77 17.54 65.51 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.414 1.006 . . . . 4.4900000000000002 115.001 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.16 162.56 39.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.173 1.487 . . . . 6.4000000000000004 112.903 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.2 129.05 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.436 1.095 . . . . 2.4500000000000002 111.384 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.41 -15.58 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.866 1.266 . . . . 3.0499999999999998 113.549 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 70.69 -49.26 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 128.482 2.713 . . . . 2.4900000000000002 113.574 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.67 106.69 3.71 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.24 1.016 . . . . 1.72 109.991 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -95.32 -43.5 8.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.483 1.113 . . . . 4.7000000000000002 110.533 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.68 -9.03 31.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.256 1.022 . . . . 1.5800000000000001 113.545 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.76 -15.63 60.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.334 1.235 . . . . 1.05 114.334 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.91 -173.67 55.32 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 120.572 -1.33 . . . . 2.1200000000000001 114.228 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.51 -171.05 25.75 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 124.73 1.157 . . . . 2.0600000000000001 113.131 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -64.87 8.91 0.1 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.898 2.079 . . . . 2.5699999999999998 114.649 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.1 tp 60.74 83.83 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.344 1.858 . . . . 2.4900000000000002 107.672 -164.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -160.4 19.24 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 117.408 2.373 . . . . 4.3300000000000001 117.408 -143.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.58 -31.77 20.67 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.232 1.955 . . . . 2.8700000000000001 115.498 -159.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -140.28 8.9 2.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.646 1.112 . . . . 3.6600000000000001 113.286 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.49 -41.99 19.04 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.05 -1.031 . . . . 3.7799999999999998 113.305 -164.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t 154.65 158.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 1 C-N-CA 132.237 4.215 . . . . 2.9300000000000002 107.414 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.07 -38.6 9.08 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 123.408 0.528 . . . . 3.5800000000000001 114.051 -171.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -77.77 176.25 9.2 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.362 1.065 . . . . 4.6799999999999997 113.734 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -124.29 158.9 31.47 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.29 1.036 . . . . 3.0899999999999999 112.105 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.603 ' CD ' ' H ' ' A' ' 84' ' ' GLY 0.286 2.7 pp20? -150.56 -116.71 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.066 1.136 . . . . 4.4100000000000001 114.066 -174.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.603 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 148.2 -55.5 0.5 Allowed Glycine 0 CA--C 1.547 2.086 0 C-N-CA 129.122 3.248 . . . . 3.1499999999999999 112.174 -171.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -97.95 -10.34 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.315 2.676 . . . . 3.77 116.714 -166.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 -15.4 0.5 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.241 2.312 . . . . 6.0800000000000001 117.241 -162.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 -8.22 32.02 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.738 1.855 . . . . 4.2000000000000002 117.738 166.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -72.69 56.55 0.4 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.527 2.163 . . . . 5.5099999999999998 113.252 170.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.82 110.17 0.27 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 120.717 -1.24 . . . . 3.1200000000000001 115.473 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.7 m170 59.99 -145.2 0.5 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.008 0.923 . . . . 5.1200000000000001 111.804 162.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.35 -28.43 0.54 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.791 1.034 . . . . 2.9100000000000001 113.791 153.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.14 29.16 2.82 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 125.0 1.286 . . . . 1.25 116.286 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -99.2 134.72 41.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.969 1.307 . . . . 1.5600000000000001 110.232 171.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -131.37 152.25 80.19 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.167 1.387 . . . . 3.5 109.763 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.89 155.25 71.58 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.85 3.033 . . . . 1.48 111.418 -171.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.5 m -58.53 131.37 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 123.026 1.393 . . . . 2.1800000000000002 113.08 -166.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.54 87.87 0.67 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.521 1.928 . . . . 4.0 108.137 167.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.94 138.35 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.115 0.966 . . . . 0.93999999999999995 108.796 170.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -118.67 135.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 126.021 1.728 . . . . 2.52 107.111 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 149.11 50.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.773 0.715 . . . . 1.8200000000000001 111.673 175.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -15.22 1.06 Allowed 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 116.198 1.925 . . . . 2.4399999999999999 116.198 -175.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -91.1 -8.92 47.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.391 1.876 . . . . 2.8700000000000001 113.118 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 21.39 16.16 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 124.567 1.079 . . . . 1.1000000000000001 114.782 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.2 mp -125.12 126.52 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.592 1.557 . . . . 2.3999999999999999 107.582 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.87 112.68 22.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.397 -0.964 . . . . 0.73999999999999999 108.397 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.0 t -131.79 -2.92 3.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.65 1.58 . . . . 1.46 112.715 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -72.64 115.08 36.01 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 128.041 2.537 . . . . 4.9699999999999998 111.078 -173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.54 138.33 24.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.73 2.287 . . . . 1.22 110.965 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.88 165.17 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.857 1.263 . . . . 1.7 109.916 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.3 m -133.53 139.07 46.39 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.363 0.665 . . . . 1.4099999999999999 109.77 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.3 87.03 15.47 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.785 0.834 . . . . 1.0900000000000001 112.424 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 5.38 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.279 3.32 . . . . 1.46 115.31 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -77.36 -31.73 54.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.705 1.139 . . . . 6.0599999999999996 111.246 170.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.91 127.44 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.909 1.684 . . . . 3.79 107.948 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 1.74 10.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.947 1.091 . . . . 5.8200000000000003 113.947 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -154.08 165.69 35.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.077 1.751 . . . . 2.7400000000000002 112.208 158.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.534 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.4 mm? -64.17 -29.95 71.03 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.405 -0.81 . . . . 2.5099999999999998 111.081 162.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.12 -46.65 5.91 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.048 2.139 . . . . 2.9900000000000002 114.383 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -76.59 -2.54 33.05 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.728 1.381 . . . . 3.1600000000000001 114.728 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.08 13.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.087 1.355 . . . . 1.1899999999999999 112.096 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -57.6 -16.56 10.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.083 1.753 . . . . 2.6400000000000001 115.387 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.85 5.03 18.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 130.0 3.32 . . . . 4.7699999999999996 113.508 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.02 173.26 7.0 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.051 1.871 . . . . 2.1499999999999999 116.051 -158.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.77 144.13 33.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.15 1.38 . . . . 0.78000000000000003 111.63 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.05 131.8 52.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.761 1.624 . . . . 2.2200000000000002 107.581 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.1 mtt -132.79 124.27 27.73 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.24 0.83 . . . . 1.6899999999999999 113.24 -170.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.26 114.87 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.842 1.257 . . . . 1.04 108.43 171.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -99.31 147.36 25.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.48 1.912 . . . . 3.5699999999999998 112.29 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.74 -50.42 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.816 -0.611 . . . . 1.76 110.05 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.23 152.64 47.07 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.76 -0.536 . . . . 2.5699999999999998 111.76 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.61 -163.88 21.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.725 2.107 . . . . 2.4100000000000001 114.022 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -155.88 98.72 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.282 1.033 . . . . 3.2000000000000002 110.32 -170.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -176.83 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.103 1.761 . . . . 3.3199999999999998 113.908 -167.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.3 ptp -127.97 76.68 1.7 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.555 -1.341 . . . . 4.0599999999999996 113.264 -146.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 p -72.2 109.88 6.27 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.747 -1.22 . . . . 4.79 112.18 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 97.2 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 129.961 3.304 . . . . 3.8300000000000001 112.834 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.49 144.37 10.32 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.174 0.989 . . . . 7.5 112.073 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.64 -52.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.876 3.051 . . . . 2.5800000000000001 110.929 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -67.82 115.93 32.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.977 -1.12 . . . . 4.6399999999999997 107.977 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.79 164.77 34.65 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.886 2.391 . . . . 4.0300000000000002 113.29 -160.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.9 tp 71.13 -13.22 0.53 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.939 2.096 . . . . 5.79 115.244 164.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 125.26 -2.19 8.3 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.309 1.909 . . . . 4.79 115.014 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.31 -25.6 0.87 Allowed Glycine 0 CA--C 1.54 1.61 0 N-CA-C 117.249 1.66 . . . . 2.6099999999999999 117.249 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -112.11 60.21 0.34 Allowed Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.322 1.915 . . . . 2.8500000000000001 112.168 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.4 -1.89 88.91 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.497 1.523 . . . . 2.8100000000000001 114.797 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -63.11 146.8 52.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.524 1.162 . . . . 2.79 109.771 166.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -106.11 153.28 22.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.585 1.154 . . . . 5.21 110.025 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -98.2 -21.88 16.47 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.138 -0.458 . . . . 3.9700000000000002 111.974 155.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.81 161.87 36.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.588 1.329 . . . . 0.64000000000000001 114.588 174.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.0 t -142.42 152.09 42.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.256 2.222 . . . . 1.3 109.798 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.26 133.82 4.28 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.794 1.188 . . . . 1.1200000000000001 111.666 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 67.7 t -92.11 132.03 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.167 0.987 . . . . 2.3300000000000001 109.467 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -71.04 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.52 1.128 . . . . 1.1299999999999999 110.129 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt . . . . . 0 C--O 1.239 0.524 0 O-C-N 121.221 -0.925 . . . . 4.25 109.03 179.011 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.057 -0.72 . . . . 2.4300000000000002 109.057 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.3 154.9 43.53 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.183 1.179 . . . . 1.4099999999999999 114.183 -148.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -153.31 135.82 15.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.178 1.466 . . . . 3.6699999999999999 111.699 161.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -89.43 111.27 22.11 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.368 1.867 . . . . 3.9399999999999999 109.981 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.84 129.19 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 118.49 0.587 . . . . 1.5600000000000001 110.306 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.71 112.55 3.52 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.184 1.373 . . . . 1.0 110.295 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.8 mtp -91.35 85.53 5.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.464 0.65 . . . . 1.8799999999999999 110.61 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -68.36 139.77 55.85 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.979 0.912 . . . . 2.7799999999999998 111.969 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.31 135.09 55.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.296 -0.631 . . . . 1.3400000000000001 109.296 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.1 156.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.689 1.196 . . . . 1.3500000000000001 110.378 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 t -169.52 48.04 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.027 0.931 . . . . 2.2200000000000002 112.058 -169.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.22 -17.38 0.27 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.303 1.841 . . . . 1.78 115.181 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.37 -4.37 59.14 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.111 1.364 . . . . 2.77 112.035 171.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -159.11 14.91 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.8 1.667 . . . . 1.3300000000000001 112.331 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.6 t -67.17 128.2 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.577 1.551 . . . . 2.0899999999999999 111.07 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.49 -88.57 1.69 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.058 1.313 . . . . 1.4299999999999999 112.726 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.37 161.46 9.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.661 2.385 . . . . 2.8799999999999999 108.112 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 t -112.56 143.03 44.41 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.734 -1.229 . . . . 2.23 114.128 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.6 mm -108.5 37.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.579 1.552 . . . . 6.7300000000000004 110.937 167.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.32 -154.15 25.3 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.661 -0.649 . . . . 1.1799999999999999 113.738 161.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.43 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 10.4 p -140.06 179.53 6.57 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.009 1.324 . . . . 1.22 109.368 171.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.57 135.39 62.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.785 -1.191 . . . . 0.65000000000000002 107.785 160.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.39 127.27 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.348 0.405 . . . . 1.53 110.697 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.12 134.4 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.737 0.815 . . . . 2.0099999999999998 109.013 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -138.46 134.83 34.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.716 1.606 . . . . 2.0099999999999998 108.45 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 157.87 18.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.935 1.087 . . . . 3.54 113.935 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 t -152.26 173.78 14.59 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.668 1.187 . . . . 1.6799999999999999 108.427 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.38 -13.13 62.01 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.286 -0.884 . . . . 4.7400000000000002 112.058 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.41 18.53 57.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.885 1.707 . . . . 1.51 113.96 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 -143.02 21.17 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 127.692 2.568 . . . . 1.01 116.882 166.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.67 103.35 14.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.761 0.824 . . . . 0.81000000000000005 111.519 -162.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -80.38 110.61 15.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.183 1.793 . . . . 3.0699999999999998 110.286 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -99.52 119.63 38.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.649 2.779 . . . . 0.85999999999999999 109.188 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.6 m -129.41 110.45 17.79 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 119.858 1.208 . . . . 0.93999999999999995 108.538 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -85.4 166.65 10.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.451 2.767 . . . . 0.51000000000000001 111.426 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 3.7 p80 -152.36 18.26 0.64 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.258 1.207 . . . . 2.27 114.258 174.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.16 143.29 32.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.626 -1.296 . . . . 2.3700000000000001 111.324 -174.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 12.26 24.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.298 1.592 . . . . 3.8100000000000001 115.298 -171.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.31 72.17 1.24 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.884 -1.053 . . . . 1.6499999999999999 112.101 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.05 162.97 49.37 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 124.02 0.928 . . . . 2.2599999999999998 112.561 168.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.77 126.9 19.17 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.167 1.245 . . . . 1.49 111.243 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -88.56 33.98 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 125.938 4.425 . . . . 1.3999999999999999 113.285 -147.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.1 -133.09 6.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 123.48 1.6 . . . . 1.24 113.247 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -124.16 135.83 53.77 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.576 1.55 . . . . 2.7599999999999998 109.387 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.37 149.39 52.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.641 1.719 . . . . 1.6599999999999999 115.641 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 138.7 49.26 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 110.19 -1.164 . . . . 0.89000000000000001 110.19 160.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.16 107.26 6.03 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 105.738 -1.949 . . . . 3.4100000000000001 105.738 168.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -118.55 166.16 13.05 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.248 1.573 . . . . 1.8300000000000001 115.248 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.0 mt -96.17 139.87 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.565 1.946 . . . . 0.93000000000000005 109.026 162.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -137.68 152.51 49.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.795 2.438 . . . . 2.7000000000000002 110.42 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.89 -10.87 59.45 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 117.633 2.457 . . . . 1.3100000000000001 117.633 -157.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.73 135.24 36.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.935 1.698 . . . . 1.4399999999999999 112.434 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 59.53 4.35 Favored Glycine 0 N--CA 1.471 0.982 0 C-N-CA 125.572 1.558 . . . . 1.26 114.119 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.68 116.37 4.14 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.787 1.294 . . . . 3.6299999999999999 114.073 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.3 m -89.7 9.38 27.31 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.822 2.049 . . . . 1.3 113.474 -175.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -68.92 129.25 92.44 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.641 1.577 . . . . 3.5 111.855 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -97.7 166.73 0.82 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.652 3.568 . . . . 1.3200000000000001 113.513 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.96 169.62 8.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 2.6099999999999999 111.91 162.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mm -119.68 117.71 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.19 1.396 . . . . 3.4399999999999999 109.747 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -152.75 157.42 40.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.173 1.389 . . . . 5.4900000000000002 111.466 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.29 27.41 9.81 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 115.788 1.773 . . . . 3.6200000000000001 115.788 156.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.21 20.12 65.42 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.865 -1.147 . . . . 3.6099999999999999 115.023 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -160.76 -172.35 3.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.798 1.639 . . . . 3.2000000000000002 111.634 -169.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.22 139.82 35.7 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.9 -1.125 . . . . 1.8500000000000001 110.533 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.97 43.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.574 1.15 . . . . 2.52 112.431 -159.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.15 -65.97 0.06 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 129.007 2.923 . . . . 1.8700000000000001 116.053 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 176.48 95.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 1 C-N-CA 132.267 4.227 . . . . 1.6200000000000001 105.457 -175.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.85 -38.31 9.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.494 1.917 . . . . 4.7800000000000002 112.449 -158.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.76 31.73 0.09 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.324 1.449 . . . . 1.3300000000000001 114.26 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.13 -11.78 21.1 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.088 1.755 . . . . 1.9199999999999999 115.299 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 20.93 44.99 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.724 1.449 . . . . 3.7000000000000002 116.724 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.84 -99.94 1.81 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.231 1.516 . . . . 2.5 111.829 174.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -118.68 -117.79 0.32 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.445 1.898 . . . . 4.1100000000000003 106.981 164.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.1 tt -174.41 92.73 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.011 2.125 . . . . 3.46 107.794 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 173.26 146.7 0.2 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 127.917 2.487 . . . . 3.6000000000000001 111.826 -162.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.96 -38.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.258 2.639 . . . . 4.0700000000000003 113.877 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.23 26.0 0.2 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.876 1.216 . . . . 4.5499999999999998 113.736 -174.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.83 19.18 0.41 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.444 -1.41 . . . . 3.3599999999999999 114.541 -167.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.69 -30.22 0.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 128.825 2.85 . . . . 3.1499999999999999 114.17 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.18 -11.27 61.04 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.026 -1.43 . . . . 2.6699999999999999 115.83 167.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -61.21 -19.68 61.91 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.795 1.798 . . . . 5.2000000000000002 114.698 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.0 t60 98.9 167.0 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.758 2.823 . . . . 2.0499999999999998 112.269 154.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -65.77 145.74 55.61 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.125 1.157 . . . . 5.1900000000000004 114.125 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.23 -155.42 7.64 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.127 1.822 . . . . 3.9500000000000002 112.15 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.78 -43.04 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.65 2.233 . . . . 4.4100000000000001 111.72 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.03 -3.32 9.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.618 1.567 . . . . 5.8799999999999999 112.869 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.29 167.07 22.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.871 1.7 . . . . 5.1900000000000004 114.553 -170.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -158.03 177.38 11.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.372 1.869 . . . . 8.6699999999999999 108.931 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.76 -20.81 0.02 OUTLIER Glycine 0 N--CA 1.465 0.594 0 CA-C-O 118.114 -1.381 . . . . 2.6000000000000001 115.946 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -159.87 153.97 23.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.563 1.681 . . . . 6.7300000000000004 113.246 169.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.93 -18.89 63.4 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.236 -0.915 . . . . 3.1299999999999999 113.318 -175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.42 5.75 83.75 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.46 1.505 . . . . 1.05 114.587 172.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -65.12 133.32 51.33 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 119.551 1.675 . . . . 2.3500000000000001 107.742 160.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.29 159.8 36.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.722 1.209 . . . . 2.7400000000000002 110.148 -153.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.21 154.18 56.76 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.558 2.839 . . . . 1.05 111.652 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 m -73.95 137.2 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 122.972 1.367 . . . . 2.02 114.046 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.2 98.54 4.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.965 2.506 . . . . 2.9900000000000002 110.191 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.8 t -72.74 131.64 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.639 0.776 . . . . 1.0900000000000001 110.143 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.48 138.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.722 2.409 . . . . 2.8700000000000001 106.308 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 154.47 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.178 -0.951 . . . . 2.29 111.514 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -12.31 0.23 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 116.987 2.217 . . . . 2.3399999999999999 116.987 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.85 -21.58 26.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.13 2.172 . . . . 2.9399999999999999 113.098 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.62 9.52 23.03 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.327 1.441 . . . . 0.76000000000000001 115.251 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mt -116.35 135.91 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.104 1.362 . . . . 1.52 110.207 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.22 128.41 54.69 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.919 0.888 . . . . 0.93999999999999995 110.801 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -145.37 14.12 1.42 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.512 1.301 . . . . 1.6000000000000001 114.512 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -86.74 118.72 70.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.276 1.03 . . . . 2.9700000000000002 111.159 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.07 133.11 16.1 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.134 3.223 . . . . 1.3500000000000001 112.185 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.03 168.37 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 126.543 1.937 . . . . 1.9299999999999999 110.5 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.7 m -140.63 143.57 35.27 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.704 1.138 . . . . 1.29 112.052 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.46 99.36 51.16 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.978 1.311 . . . . 0.73999999999999999 113.123 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.53 18.59 0.94 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 125.201 3.934 . . . . 1.0700000000000001 114.873 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -73.05 -35.1 66.65 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.3 -0.875 . . . . 5.7999999999999998 111.634 171.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.35 165.12 11.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.287 2.235 . . . . 3.3300000000000001 109.133 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.08 2.64 3.64 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.994 1.109 . . . . 4.8700000000000001 113.994 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.7 p -152.14 166.91 30.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.204 1.802 . . . . 2.8399999999999999 110.438 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.7 tp -85.42 -44.62 12.6 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.458 -0.776 . . . . 2.4500000000000002 111.058 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.27 -23.81 62.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.212 1.405 . . . . 4.4500000000000002 113.853 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -12.32 60.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.842 1.053 . . . . 2.9199999999999999 113.842 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.93 15.86 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.931 1.292 . . . . 1.4199999999999999 113.29 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -51.15 -18.5 0.89 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 117.104 2.261 . . . . 3.7400000000000002 117.104 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -121.92 11.47 10.34 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.586 1.955 . . . . 4.4100000000000001 113.595 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -102.73 169.87 8.35 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.324 1.231 . . . . 2.5899999999999999 114.324 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.62 44.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.646 0.779 . . . . 1.0800000000000001 111.285 173.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.91 133.95 34.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.313 -1.736 . . . . 2.4100000000000001 106.313 156.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.12 131.16 34.4 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.539 1.063 . . . . 1.9399999999999999 112.171 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.93 114.35 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 107.074 -1.454 . . . . 1.1000000000000001 107.074 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -87.0 146.89 25.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.544 1.137 . . . . 3.8999999999999999 111.449 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.0 t -68.25 -37.61 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.193 0.597 . . . . 2.0899999999999999 110.474 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.39 -163.32 6.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.064 0.84 . . . . 2.5600000000000001 113.676 172.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.82 -146.32 10.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 127.466 2.46 . . . . 3.0699999999999998 109.298 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -157.11 149.54 23.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.702 0.801 . . . . 3.5600000000000001 110.967 161.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 56.3 t30 110.01 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 1 C-N-CA 131.703 4.001 . . . . 4.3200000000000003 109.453 -161.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.6 ptp -165.05 69.26 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 123.062 1.41 . . . . 4.1100000000000003 111.52 -162.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.6 p -97.76 0.09 46.27 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.253 2.221 . . . . 3.4399999999999999 115.357 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -164.05 63.95 0.15 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.753 -1.217 . . . . 3.3500000000000001 112.428 -163.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -130.31 149.78 74.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.072 1.349 . . . . 4.4000000000000004 108.466 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.19 -35.68 84.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.402 2.735 . . . . 2.3799999999999999 112.437 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -94.56 113.76 61.81 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.717 -1.216 . . . . 8.0399999999999991 107.717 148.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.2 163.15 38.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.921 2.414 . . . . 4.5800000000000001 111.104 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt 60.71 28.47 18.19 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.733 0.813 . . . . 5.1399999999999997 110.435 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.86 3.14 7.47 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.413 1.483 . . . . 2.77 115.154 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.74 87.5 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 118.919 1.359 . . . . 2.73 114.052 -166.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.39 33.23 4.17 Favored Glycine 0 N--CA 1.474 1.189 0 C-N-CA 125.707 1.622 . . . . 2.2000000000000002 114.594 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.19 -4.42 90.49 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.052 1.786 . . . . 2.2400000000000002 115.039 -174.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 p -65.12 152.56 43.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.003 1.401 . . . . 2.6200000000000001 110.752 165.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.35 132.48 54.08 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.486 1.114 . . . . 6.5199999999999996 109.103 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -74.65 -33.44 62.52 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.69 0.677 . . . . 3.79 110.307 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.18 145.13 29.4 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.898 1.444 . . . . 0.78000000000000003 114.898 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.5 t -68.69 -174.02 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 129.165 2.986 . . . . 2.6099999999999999 111.548 164.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 164.54 62.06 0.02 OUTLIER Glycine 0 N--CA 1.465 0.626 0 C-N-CA 125.241 1.4 . . . . 1.77 112.99 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.9 p -61.69 125.87 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.53 0.732 . . . . 3.6200000000000001 110.844 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.32 132.09 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.728 0.811 . . . . 1.1599999999999999 108.816 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 CA--C 1.539 0.551 0 O-C-N 121.223 -0.923 . . . . 4.5700000000000003 110.831 176.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.994 -0.373 . . . . 2.71 109.994 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -163.22 144.2 9.41 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.751 1.159 . . . . 1.8100000000000001 108.32 -169.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -149.0 130.25 14.6 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.978 1.37 . . . . 3.3999999999999999 111.118 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -80.99 106.99 13.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.842 1.657 . . . . 4.2400000000000002 109.407 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.19 122.09 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.605 0.639 . . . . 1.5 111.025 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.91 104.91 1.63 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.059 1.79 . . . . 0.70999999999999996 111.954 170.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.6 mmm -88.8 132.93 34.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.412 1.485 . . . . 3.1800000000000002 111.359 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -106.53 145.42 31.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.642 1.177 . . . . 2.2799999999999998 110.934 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 mt -61.11 142.42 56.7 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.549 1.14 . . . . 1.2 110.003 169.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.13 163.8 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.094 0.957 . . . . 1.8100000000000001 110.738 175.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t 177.29 69.52 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.253 2.221 . . . . 2.71 110.763 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 67.02 -29.89 0.15 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.372 2.269 . . . . 1.98 115.932 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -17.35 64.86 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.666 1.586 . . . . 3.5699999999999998 111.346 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.72 -160.53 17.18 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.368 1.937 . . . . 1.6699999999999999 111.35 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.23 128.89 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.552 1.141 . . . . 1.5600000000000001 109.74 169.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.81 -95.18 1.14 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 125.686 1.612 . . . . 1.5 113.26 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.58 166.18 34.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.217 1.407 . . . . 2.1000000000000001 110.8 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 t -93.13 151.32 19.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.421 1.488 . . . . 2.0499999999999998 114.341 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 15.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 127.192 2.197 . . . . 4.1299999999999999 113.587 -173.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.49 175.89 15.39 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.441 1.02 . . . . 0.73999999999999999 112.246 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.5 p -122.16 173.6 7.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.384 1.074 . . . . 1.25 109.273 173.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.16 132.18 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.489 -1.301 . . . . 0.70999999999999996 107.489 162.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -86.35 124.84 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.774 0.321 . . . . 1.7 110.591 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.95 128.48 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.768 -1.197 . . . . 1.75 107.768 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -137.74 112.64 9.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.518 1.151 . . . . 2.3500000000000001 110.483 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -70.31 111.44 5.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.437 2.295 . . . . 3.2200000000000002 112.064 -167.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 159.73 15.35 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.084 -1.08 . . . . 3.4199999999999999 108.084 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.93 -19.34 64.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.471 0.708 . . . . 4.4800000000000004 111.868 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.83 30.8 9.66 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.012 1.768 . . . . 2.1000000000000001 113.959 165.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.37 -135.31 9.84 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 119.921 2.728 . . . . 2.04 119.921 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.38 113.27 21.15 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.955 1.302 . . . . 0.92000000000000004 110.147 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.77 109.42 15.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.164 0.986 . . . . 2.6499999999999999 109.733 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t80 -92.05 121.08 33.27 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.19 1.796 . . . . 1.03 108.492 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.5 m -128.36 113.54 19.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 119.29 0.95 . . . . 1.3600000000000001 108.694 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.15 157.12 13.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.491 2.794 . . . . 0.76000000000000001 110.98 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.27 40.86 0.42 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.561 1.172 . . . . 2.8900000000000001 111.613 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -101.39 140.46 35.66 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.48 1.512 . . . . 0.84999999999999998 112.314 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 31.37 6.74 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.394 1.628 . . . . 2.0600000000000001 115.394 -167.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.27 65.17 0.69 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.075 0.95 . . . . 1.3999999999999999 111.972 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.86 157.58 32.55 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 113.896 1.073 . . . . 2.21 113.896 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.05 139.24 13.4 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 O-C-N 123.555 1.292 . . . . 1.71 112.083 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -77.97 31.14 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.867 1 C-N-CA 128.948 6.432 . . . . 2.1200000000000001 114.164 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.77 -135.96 6.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-O 123.58 1.655 . . . . 1.47 110.195 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -136.3 133.57 37.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.717 1.607 . . . . 2.8100000000000001 107.949 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -127.36 137.57 52.8 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.688 1.195 . . . . 1.3 109.58 -169.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 156.15 49.21 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 119.664 1.12 . . . . 0.70999999999999996 111.743 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.6 t80 -129.42 118.87 22.87 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.322 -1.362 . . . . 3.2000000000000002 107.322 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.464 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 8.8 m80 -118.09 157.69 26.41 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.427 2.01 . . . . 1.05 116.427 163.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -98.54 142.05 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.375 1.47 . . . . 0.90000000000000002 108.488 158.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -128.38 141.82 51.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.508 1.923 . . . . 1.1599999999999999 110.256 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.82 70.79 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.819 2.155 . . . . 0.84999999999999998 116.819 -158.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -120.63 154.48 35.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.194 1.398 . . . . 1.6200000000000001 111.746 171.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.43 84.17 1.58 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 120.844 -1.16 . . . . 1.23 113.301 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 t -166.76 95.71 0.52 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.745 1.017 . . . . 2.6400000000000001 113.745 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 16.0 m -62.31 10.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.001 1.852 . . . . 1.48 116.001 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -87.6 129.33 51.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 119.953 -1.717 . . . . 3.5099999999999998 110.031 -166.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.1 155.14 33.35 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.387 2.058 . . . . 1.5800000000000001 110.618 166.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.24 145.32 51.45 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.684 -0.635 . . . . 1.8999999999999999 110.218 158.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 mm -96.75 123.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.968 1.307 . . . . 3.8399999999999999 108.561 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -169.47 157.82 7.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.244 1.418 . . . . 6.0599999999999996 111.775 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.78 27.34 14.62 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.251 1.021 . . . . 4.5199999999999996 112.317 167.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.11 84.64 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 126.381 1.943 . . . . 3.8500000000000001 114.914 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.59 -152.64 0.41 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.451 1.501 . . . . 4.6299999999999999 109.902 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.04 146.02 21.32 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.161 -0.962 . . . . 2.1400000000000001 113.042 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.69 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.563 1.545 . . . . 2.3100000000000001 113.16 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 67.81 -61.23 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 127.969 2.508 . . . . 2.3500000000000001 116.584 168.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 166.35 99.83 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 C-N-CA 132.536 4.335 . . . . 1.8600000000000001 106.583 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -123.52 -45.97 2.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 3.6600000000000001 113.162 -157.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.07 -19.58 20.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.043 1.337 . . . . 1.48 113.391 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.13 -12.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.146 2.578 . . . . 0.94999999999999996 114.809 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.38 16.8 58.32 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.333 1.424 . . . . 3.21 115.022 163.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.17 -173.98 41.75 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.246 1.023 . . . . 2.1200000000000001 112.339 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -63.49 141.29 58.82 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.737 -0.861 . . . . 2.27 109.937 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.31 111.8 3.18 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.129 -0.357 . . . . 2.5099999999999998 110.248 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.5 t0 169.7 126.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 128.762 2.825 . . . . 5.6600000000000001 111.645 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.04 -36.51 1.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.104 1.869 . . . . 2.4500000000000002 113.65 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -165.57 8.41 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.804 2.52 . . . . 5.04 117.804 -156.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.99 -27.08 65.06 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.815 2.098 . . . . 4.8700000000000001 114.616 -170.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 165.89 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.967 3.307 . . . . 4.3899999999999997 110.832 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.74 -18.51 38.6 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.863 1.221 . . . . 3.02 114.63 169.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -69.87 -7.73 42.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.558 1.688 . . . . 8.3499999999999996 115.558 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.409 ' CD2' ' HA3' ' A' ' 142' ' ' GLY . 76.9 t60 68.56 157.13 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.825 2.45 . . . . 1.8600000000000001 112.774 -172.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 84' ' ' GLY . 2.6 pp20? -140.41 -136.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.586 0.755 . . . . 4.4900000000000002 112.315 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.517 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 144.33 -46.02 0.83 Allowed Glycine 0 CA--C 1.538 1.518 0 C-N-CA 130.401 3.857 . . . . 4.0300000000000002 110.483 -172.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -108.02 -10.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.663 2.909 . . . . 4.0999999999999996 115.633 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -139.26 -3.19 1.57 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.453 2.019 . . . . 5.2400000000000002 116.453 -159.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.1 -31.04 1.57 Allowed Glycine 0 N--CA 1.472 1.09 0 O-C-N 120.45 -1.406 . . . . 5.71 114.874 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -72.77 71.65 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.444 1.498 . . . . 5.7300000000000004 112.213 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.19 -91.61 0.09 OUTLIER Glycine 0 CA--C 1.523 0.579 0 C-N-CA 125.322 1.439 . . . . 2.6099999999999999 111.584 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -133.83 151.17 51.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.012 1.725 . . . . 4.6200000000000001 109.603 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.49 -28.71 68.79 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.219 0.918 . . . . 2.7999999999999998 113.169 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.15 16.37 55.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.863 1.697 . . . . 0.91000000000000003 115.357 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -89.96 122.38 32.93 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.941 1.371 . . . . 2.21 109.867 168.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.43 158.93 41.91 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.527 1.531 . . . . 2.5800000000000001 109.795 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.97 171.42 18.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.429 2.753 . . . . 2.0499999999999998 111.759 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.42 131.71 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.7 1.37 . . . . 2.02 114.7 -163.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.65 94.52 0.59 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.221 2.608 . . . . 2.6699999999999999 108.307 164.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.22 140.15 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.969 0.908 . . . . 1.03 109.672 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.18 131.8 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.71 1.204 . . . . 2.7599999999999998 108.866 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.0 140.04 40.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.763 0.792 . . . . 2.1800000000000002 111.793 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.23 60.46 0.43 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.715 2.006 . . . . 4.6299999999999999 113.509 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.51 6.93 0.29 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.432 2.293 . . . . 3.9199999999999999 112.314 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.53 3.94 43.46 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 126.297 1.904 . . . . 2.29 115.406 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.65 132.21 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.301 1.05 . . . . 2.23 110.291 -167.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 126.51 33.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.837 -0.539 . . . . 0.80000000000000004 110.089 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 t -141.39 -0.95 1.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.715 1.376 . . . . 1.6499999999999999 114.715 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -87.26 123.29 70.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.955 1.302 . . . . 3.1600000000000001 110.895 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.93 149.45 42.16 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.037 3.158 . . . . 1.6100000000000001 112.466 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.93 158.05 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.812 1.245 . . . . 1.74 109.691 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.4 m -112.86 143.61 43.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.45 0.7 . . . . 1.53 109.157 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.36 84.37 0.73 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.64 1.576 . . . . 1.1200000000000001 110.671 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.89 1.54 7.56 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.845 3.03 . . . . 1.6000000000000001 113.707 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.445 HH11 ' HG3' ' A' ' 113' ' ' ARG . 6.5 ttm-85 -76.92 -25.12 52.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.037 0.935 . . . . 6.1200000000000001 112.404 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.09 178.86 4.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.691 1.996 . . . . 3.75 109.607 165.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -16.81 2.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.552 1.316 . . . . 4.8499999999999996 114.552 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -154.84 166.55 33.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.103 1.32 . . . . 2.46 112.734 -169.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.65 -29.44 16.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.866 0.866 . . . . 3.6699999999999999 111.244 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -28.98 70.14 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.86 -1.15 . . . . 3.3500000000000001 113.247 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.6 -17.47 63.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.471 0.708 . . . . 2.5800000000000001 112.89 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.73 13.91 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.485 0.92 . . . . 0.94999999999999996 113.485 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -59.68 -21.34 60.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.141 1.534 . . . . 3.27 115.141 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -134.03 105.54 6.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.561 1.544 . . . . 3.5099999999999998 107.983 160.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -158.84 163.32 36.75 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.969 2.908 . . . . 2.3500000000000001 109.329 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.62 158.45 16.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.493 0.663 . . . . 0.94999999999999996 110.676 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -130.69 117.0 18.81 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.295 2.238 . . . . 2.2200000000000002 106.876 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.8 mtt -117.67 122.01 42.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.731 0.696 . . . . 1.8700000000000001 111.172 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.97 115.93 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.909 -1.515 . . . . 1.03 106.909 166.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -98.58 151.12 21.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.298 1.839 . . . . 3.21 112.267 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.3 m -63.17 -29.52 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 114.641 1.349 . . . . 3.8799999999999999 114.641 -160.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.17 168.28 24.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.457 1.503 . . . . 1.72 110.852 167.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.58 136.82 22.22 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.082 1.801 . . . . 1.49 114.08 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.464 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -101.02 114.84 29.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.801 1.64 . . . . 3.5499999999999998 109.932 -178.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -167.47 36.18 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.177 0.991 . . . . 3.7200000000000002 112.514 -172.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.6 mtm -140.48 110.51 6.54 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.339 1.056 . . . . 2.8599999999999999 112.985 -165.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.7 m -93.08 156.78 16.66 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 3.3500000000000001 111.971 168.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.06 32.45 2.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.061 2.144 . . . . 6.1399999999999997 116.12 165.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -115.86 146.51 37.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.113 1.365 . . . . 3.73 110.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.1 17.77 0.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.54 3.493 . . . . 3.3500000000000001 114.069 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -98.53 113.38 64.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 121.107 -0.996 . . . . 8.5099999999999998 108.884 173.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.58 153.66 73.62 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.158 2.572 . . . . 6.1500000000000004 113.781 -156.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 tp 72.68 -1.14 3.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.66 1.984 . . . . 5.79 113.721 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 82' ' ' HIS . . . 106.26 38.11 2.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.137 1.351 . . . . 6.4100000000000001 113.224 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.02 -41.15 2.95 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.22 1.391 . . . . 5.1699999999999999 113.556 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.07 -19.48 65.95 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 118.389 1.095 . . . . 3.6099999999999999 115.407 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 46.53 -110.69 0.55 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.65 1.595 . . . . 3.3599999999999999 115.457 161.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 m -69.17 151.77 45.94 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.318 1.447 . . . . 3.6899999999999999 111.126 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.95 132.15 45.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.566 1.547 . . . . 5.5999999999999996 108.238 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -83.11 -42.8 16.96 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 120.092 1.314 . . . . 4.4100000000000001 110.373 169.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.03 151.82 33.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.053 0.941 . . . . 0.60999999999999999 112.645 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.0 t -127.36 148.37 50.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.873 2.069 . . . . 1.3999999999999999 111.09 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -145.44 155.67 26.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.592 2.52 . . . . 1.23 111.701 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.46 1.104 . . . . 2.1800000000000002 111.442 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.47 149.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.342 1.857 . . . . 2.4700000000000002 110.145 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.796 0 O-C-N 120.051 -1.655 . . . . 5.7400000000000002 110.938 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.244 0.068 . . . . 2.1000000000000001 110.948 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.5 148.16 22.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 1.8 109.201 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -151.15 127.2 10.44 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 123.191 1.472 . . . . 2.3799999999999999 110.943 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -105.19 97.36 7.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.019 1.728 . . . . 4.0700000000000003 111.663 -167.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.52 131.17 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 115.17 1.544 . . . . 3.4399999999999999 115.17 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.6 103.01 1.19 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.499 1.047 . . . . 1.01 110.79 167.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.5 mtp -85.34 131.16 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.503 0.721 . . . . 2.1400000000000001 110.406 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -110.7 145.38 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.115 1.366 . . . . 3.2000000000000002 113.108 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.4 mt -77.93 62.5 2.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.153 1.381 . . . . 1.7 111.673 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 m -55.07 130.79 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.246 1.418 . . . . 1.5900000000000001 112.02 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -158.63 72.18 0.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.007 1.484 . . . . 2.6400000000000001 115.007 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.51 -40.46 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.744 2.418 . . . . 1.6100000000000001 113.767 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.96 6.46 4.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.552 1.541 . . . . 3.1099999999999999 111.546 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.89 -159.14 31.24 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 126.079 1.8 . . . . 1.21 112.769 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -42.11 126.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.405 1.482 . . . . 1.3700000000000001 110.725 159.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.27 -60.26 0.26 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.067 1.318 . . . . 1.97 114.429 -170.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -174.79 160.2 2.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.499 1.92 . . . . 3.27 110.738 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -152.69 148.64 27.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.163 1.542 . . . . 2.8500000000000001 115.163 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.62 56.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 130.149 3.38 . . . . 7.7000000000000002 108.838 173.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.48 -177.94 39.92 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 113.226 -1.806 . . . . 0.67000000000000004 114.316 146.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.493 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 11.3 p -115.61 177.74 4.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.633 1.173 . . . . 1.01 110.928 171.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.04 133.31 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.336 -0.987 . . . . 0.56000000000000005 108.336 156.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.3 p -87.49 119.49 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.65 0.593 . . . . 1.5900000000000001 110.337 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.15 117.73 47.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.191 -1.411 . . . . 1.9099999999999999 107.191 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -119.76 125.35 48.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.288 1.435 . . . . 2.3999999999999999 108.563 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.22 130.99 34.34 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.371 -0.603 . . . . 3.3399999999999999 109.371 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.6 t -148.86 -179.62 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.166 0.439 . . . . 1.6000000000000001 110.378 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.22 -4.27 40.95 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.918 1.081 . . . . 3.71 113.918 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.3 9.57 67.28 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 124.159 0.885 . . . . 1.25 114.18 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.1 -146.47 21.97 Favored Glycine 0 N--CA 1.463 0.448 0 C-N-CA 128.417 2.913 . . . . 1.0 115.536 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.9 104.65 7.51 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.3 0.64 . . . . 0.87 111.107 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -84.6 115.18 22.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.791 2.036 . . . . 4.7400000000000002 109.988 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.26 104.65 14.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.776 1.63 . . . . 1.03 109.58 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.0 m -110.27 109.21 58.69 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.519 1.054 . . . . 1.04 108.346 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.1 159.36 18.0 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.586 2.858 . . . . 0.71999999999999997 111.127 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.493 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.2 p80 -146.41 27.23 1.14 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 121.418 0.628 . . . . 1.6200000000000001 112.479 170.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.85 140.86 30.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.805 -1.184 . . . . 0.95999999999999996 111.308 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 26.69 8.01 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.452 1.649 . . . . 2.21 115.452 -170.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.18 81.14 1.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.717 0.807 . . . . 1.55 110.933 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.72 163.36 41.29 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.839 1.256 . . . . 2.2200000000000002 110.407 168.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.29 128.97 24.02 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 121.006 1.137 . . . . 0.85999999999999999 110.619 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -79.8 25.23 0.6 Allowed 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 126.563 4.842 . . . . 1.1000000000000001 113.047 -162.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.6 -124.7 1.48 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 126.725 2.107 . . . . 1.3700000000000001 112.571 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -151.28 138.71 19.49 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.77 1.228 . . . . 3.5899999999999999 110.842 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -136.69 142.73 43.15 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.081 0.771 . . . . 1.27 113.081 -163.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.07 153.77 51.63 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 111.28 -0.728 . . . . 0.83999999999999997 111.28 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -131.79 115.54 16.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.49 1.116 . . . . 3.29 108.161 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -115.97 165.67 12.85 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 117.121 2.267 . . . . 1.0800000000000001 117.121 167.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.0 mt -108.05 148.34 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 128.414 2.686 . . . . 0.91000000000000003 108.045 154.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -126.16 163.39 23.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.94 1.296 . . . . 1.3799999999999999 110.425 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.4 75.91 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.586 1.699 . . . . 1.1000000000000001 115.586 -163.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.74 169.08 14.24 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.144 1.378 . . . . 2.1400000000000001 113.144 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.9 93.91 1.53 Allowed Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.005 1.288 . . . . 1.21 113.087 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -151.58 57.05 0.87 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.816 1.413 . . . . 4.4299999999999997 114.816 -165.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.6 m -64.72 37.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 116.505 2.039 . . . . 1.5 116.505 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -137.1 143.66 42.92 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 119.606 -1.934 . . . . 3.77 110.889 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.12 148.77 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.234 2.623 . . . . 1.0700000000000001 113.432 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.3 137.1 40.92 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.489 -0.778 . . . . 1.5700000000000001 109.669 157.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.73 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.993 -1.114 . . . . 3.1800000000000002 107.993 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -147.21 133.66 19.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.15 0.98 . . . . 4.8600000000000003 111.042 -160.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.21 19.22 5.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.181 1.393 . . . . 3.7200000000000002 113.151 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.05 63.15 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.086 1.327 . . . . 2.7999999999999998 115.313 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -137.27 -177.76 4.91 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.685 1.243 . . . . 3.46 111.714 169.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.85 115.59 26.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.186 0.994 . . . . 2.6600000000000001 112.456 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -87.2 79.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.106 1.362 . . . . 2.1699999999999999 110.47 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 19.89 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.33 3.452 . . . . 2.2999999999999998 117.991 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.44 41.64 0.88 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.557 1.943 . . . . 2.04 110.766 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -54.76 -37.19 65.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.144 -0.973 . . . . 4.0300000000000002 113.582 -169.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -4.48 17.98 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.54 1.311 . . . . 2.27 114.54 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.1 -7.45 58.9 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.085 -1.009 . . . . 1.49 113.706 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 -179.35 32.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.807 -1.183 . . . . 2.0499999999999998 113.882 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.26 175.51 50.96 Favored Glycine 0 N--CA 1.474 1.222 0 N-CA-C 110.998 -0.841 . . . . 2.7000000000000002 110.998 161.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.44 36.06 0.19 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.608 1.204 . . . . 2.9399999999999999 113.561 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.5 tp 65.07 78.62 0.28 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.705 2.002 . . . . 2.6600000000000001 112.349 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -156.15 124.68 2.94 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 126.543 1.937 . . . . 5.6200000000000001 111.152 166.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.25 -22.52 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.216 2.611 . . . . 2.6600000000000001 113.838 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -145.7 -31.11 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.255 1.946 . . . . 4.6500000000000004 116.255 -157.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -60.63 -42.33 96.68 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 121.111 1.778 . . . . 4.5700000000000003 111.561 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 179.52 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.909 2.484 . . . . 2.6099999999999999 112.419 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 -15.91 4.18 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.541 -1.349 . . . . 2.54 114.331 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -58.79 -82.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.614 1.965 . . . . 5.5199999999999996 113.39 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 81.1 t60 153.32 128.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 129.754 3.221 . . . . 1.71 110.479 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -130.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.365 1.066 . . . . 3.71 111.94 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.24 -51.1 0.85 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.498 1.999 . . . . 2.7799999999999998 111.761 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -104.14 -22.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.692 2.261 . . . . 3.3599999999999999 114.877 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -157.25 28.61 0.3 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.302 1.41 . . . . 5.2400000000000002 114.539 -160.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.05 -12.07 5.64 Favored Glycine 0 N--CA 1.477 1.43 0 O-C-N 119.662 -1.899 . . . . 4.9800000000000004 116.425 166.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.89 83.56 3.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.152 1.381 . . . . 4.5800000000000001 112.491 -170.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.51 116.02 4.16 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 124.424 1.012 . . . . 3.0899999999999999 112.806 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.1 m170 90.52 123.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.978 2.511 . . . . 4.0800000000000001 110.973 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.38 -12.51 24.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.005 0.522 . . . . 3.0699999999999998 111.692 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.17 22.56 18.54 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.144 1.354 . . . . 1.1100000000000001 113.985 165.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -101.26 124.85 47.6 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.374 1.587 . . . . 2.6600000000000001 109.71 164.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.52 164.15 20.7 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.825 1.65 . . . . 2.6400000000000001 109.316 -174.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.11 161.84 35.0 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.121 2.547 . . . . 1.27 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.63 131.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 122.608 1.194 . . . . 2.29 113.696 -165.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.85 86.25 4.09 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.439 2.696 . . . . 2.71 108.814 176.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 142.55 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.583 0.753 . . . . 1.5900000000000001 109.1 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -122.77 150.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.702 2.001 . . . . 2.6800000000000002 107.832 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -94.39 150.88 19.85 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.762 0.652 . . . . 3.25 112.762 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -42.77 -3.47 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 131.616 3.966 . . . . 3.52 118.518 176.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 -16.46 20.85 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 119.625 -1.922 . . . . 2.9399999999999999 112.507 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.9 27.49 7.01 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.718 1.628 . . . . 0.83999999999999997 112.796 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.2 mt -121.89 127.13 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.72 1.208 . . . . 2.0299999999999998 111.172 -171.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.84 123.95 29.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.932 0.893 . . . . 1.3999999999999999 108.926 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -139.0 -15.27 1.14 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.88 2.178 . . . . 3.0499999999999998 116.88 -167.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.48 127.91 74.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 121.413 1.915 . . . . 5.2699999999999996 112.812 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.14 85.69 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.258 3.305 . . . . 1.9099999999999999 110.06 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.01 122.16 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.826 0.851 . . . . 2.0800000000000001 110.045 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -120.03 126.93 52.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.529 0.732 . . . . 1.1799999999999999 110.54 -164.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.45 113.64 45.5 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.39 -0.814 . . . . 1.3100000000000001 112.626 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.79 8.59 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.96 3.107 . . . . 1.3400000000000001 113.447 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -71.78 -22.02 61.64 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.462 -0.774 . . . . 4.96 112.177 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.9 mt -139.52 160.16 40.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 130.155 3.382 . . . . 3.7400000000000002 106.532 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -148.26 10.23 0.87 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.948 2.203 . . . . 7.8499999999999996 116.948 -175.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 p -156.25 157.0 35.05 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.694 -0.629 . . . . 2.6000000000000001 110.934 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.97 -24.15 52.31 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.015 -1.053 . . . . 2.1600000000000001 112.653 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -54.31 -37.4 64.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.236 1.415 . . . . 3.8500000000000001 113.788 -176.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.19 -5.41 49.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.015 2.126 . . . . 2.23 114.256 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 4.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.033 1.333 . . . . 2.6699999999999999 113.135 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -66.07 7.08 0.32 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.832 2.16 . . . . 3.04 116.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.31 14.0 3.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.386 2.274 . . . . 3.54 111.163 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.53 159.0 43.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.136 1.532 . . . . 2.0499999999999998 115.136 -157.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.79 157.29 16.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.212 1.405 . . . . 0.73999999999999999 112.828 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 mt -120.41 136.2 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.533 2.733 . . . . 2.0499999999999998 107.6 173.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -125.94 128.27 47.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.908 0.776 . . . . 2.6299999999999999 112.122 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.08 122.92 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.799 -1.186 . . . . 1.0800000000000001 107.799 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -115.34 141.42 48.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.109 1.763 . . . . 3.1000000000000001 111.918 -160.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.81 -13.82 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 116.041 1.867 . . . . 3.9100000000000001 116.041 -156.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.36 160.32 25.47 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.309 -1.116 . . . . 1.4099999999999999 110.309 162.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.36 121.1 15.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.648 -1.381 . . . . 1.8500000000000001 109.648 163.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.63 1.28 14.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.984 0.914 . . . . 4.4299999999999997 112.945 -158.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -66.2 28.81 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 129.922 3.289 . . . . 3.46 115.867 -172.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.1 mtm -114.22 105.21 12.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.531 1.932 . . . . 3.3900000000000001 110.219 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 p -77.3 14.62 0.9 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.043 2.137 . . . . 3.3500000000000001 113.952 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.72 4.73 0.77 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.787 1.773 . . . . 4.5599999999999996 115.787 -155.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -96.35 143.02 25.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.114 0.965 . . . . 4.54 110.328 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.2 -27.1 29.52 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.735 2.957 . . . . 3.29 113.192 -173.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -87.01 107.74 15.66 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.706 -1.22 . . . . 4.7599999999999998 107.706 148.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.95 175.08 7.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.791 2.327 . . . . 3.6000000000000001 110.925 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 61.16 34.97 18.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.161 0.984 . . . . 3.98 109.175 -170.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.99 5.9 8.57 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.95 1.262 . . . . 3.6299999999999999 115.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.52 63.11 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-N 119.297 1.549 . . . . 2.5600000000000001 113.99 -165.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.15 16.29 59.44 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.967 2.223 . . . . 2.0299999999999998 113.97 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.76 -6.02 62.24 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.311 1.434 . . . . 1.8300000000000001 116.574 -170.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.3 m -66.98 162.53 21.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.369 1.585 . . . . 3.3799999999999999 110.401 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.84 139.0 31.11 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.405 2.282 . . . . 8.9399999999999995 114.375 -177.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.82 -27.52 9.25 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 118.921 0.782 . . . . 4.1100000000000003 112.654 154.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -154.6 155.37 34.6 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.658 1.117 . . . . 0.56999999999999995 113.637 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.42 147.86 50.53 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.426 1.891 . . . . 1.5600000000000001 110.499 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.41 134.14 4.4 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.791 1.186 . . . . 0.93999999999999995 112.515 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.12 133.91 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.139 1.375 . . . . 2.4300000000000002 109.009 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 mt -70.65 118.11 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 122.269 1.033 . . . . 1.1000000000000001 111.032 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 123.669 0.787 . . . . 8.9700000000000006 111.819 -177.715 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.253 -0.277 . . . . 3.6299999999999999 110.253 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -163.69 132.67 3.88 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.207 -1.558 . . . . 2.1600000000000001 107.394 -163.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -144.79 120.88 10.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.123 1.44 . . . . 3.8199999999999998 113.409 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.11 74.3 6.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.839 1.655 . . . . 4.8099999999999996 110.824 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 t -70.59 122.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.286 -0.884 . . . . 1.71 111.881 -158.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.51 90.29 0.37 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 128.708 3.052 . . . . 1.1899999999999999 112.11 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 mtt -82.69 148.53 27.86 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.601 1.161 . . . . 2.1000000000000001 111.311 170.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -115.95 158.32 23.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.475 1.131 . . . . 2.4100000000000001 110.915 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.09 124.8 26.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.958 1.303 . . . . 1.0800000000000001 107.496 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 m -143.51 151.21 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.385 1.074 . . . . 1.29 110.813 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 t 171.27 121.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.044 2.538 . . . . 4.0300000000000002 110.387 163.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.59 -38.26 0.27 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.515 2.726 . . . . 2.21 116.724 167.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -9.11 49.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.204 1.402 . . . . 2.9199999999999999 111.871 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.24 -156.19 19.95 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 125.277 1.418 . . . . 1.1200000000000001 113.385 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.92 110.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.209 1.403 . . . . 1.1799999999999999 110.301 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.67 -86.06 1.16 Allowed Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.226 1.393 . . . . 1.46 112.255 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.24 164.56 37.86 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.382 1.473 . . . . 1.99 109.392 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -104.52 170.32 7.96 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.363 1.065 . . . . 2.0600000000000001 113.339 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 pt -151.77 8.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 127.636 2.374 . . . . 3.4500000000000002 112.372 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.14 173.02 20.68 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.011 0.815 . . . . 0.76000000000000001 113.809 -166.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.1 p -131.44 173.97 10.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.558 1.943 . . . . 1.45 108.472 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.37 129.78 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 107.906 -1.146 . . . . 0.64000000000000001 107.906 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -78.38 109.95 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.612 0.642 . . . . 2.0699999999999998 109.788 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.79 125.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.539 -1.282 . . . . 1.6499999999999999 107.539 160.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.504 0.668 . . . . 2.3700000000000001 110.312 166.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.29 130.7 37.54 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.084 1.754 . . . . 3.5299999999999998 109.539 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -149.21 -179.77 7.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.039 0.447 . . . . 1.8999999999999999 110.272 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.06 -29.6 69.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.809 1.244 . . . . 3.5299999999999998 111.751 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.28 66.16 Favored Glycine 0 N--CA 1.471 1.009 0 C-N-CA 124.696 1.141 . . . . 1.45 114.885 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 -140.31 18.37 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 127.685 2.564 . . . . 1.23 114.734 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.28 93.79 7.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.201 1.0 . . . . 0.92000000000000004 110.15 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.4 tttp -76.19 108.78 9.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.364 1.466 . . . . 3.0800000000000001 108.869 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.1 t80 -97.78 110.37 22.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.024 2.53 . . . . 0.68999999999999995 109.309 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 5.6 m -124.19 115.09 27.53 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.889 1.222 . . . . 0.90000000000000002 109.635 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.25 155.96 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.12 2.546 . . . . 0.56999999999999995 111.42 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -149.93 54.12 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.566 1.174 . . . . 2.0699999999999998 111.007 166.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -107.24 134.56 50.15 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.921 1.288 . . . . 0.97999999999999998 111.232 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -109.25 21.15 17.48 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.265 1.95 . . . . 3.0600000000000001 116.265 -160.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.96 65.51 0.19 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.128 0.971 . . . . 1.52 113.567 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.53 161.28 49.07 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 124.519 1.128 . . . . 2.5499999999999998 111.968 174.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.03 128.72 21.28 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.675 1.583 . . . . 0.97999999999999998 109.904 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.74 41.75 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 1 C-N-CA 126.345 4.696 . . . . 1.21 112.553 -157.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.79 -132.83 7.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.974 1.749 . . . . 1.45 113.37 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -139.32 134.96 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.95 1.7 . . . . 3.1099999999999999 110.065 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -137.13 118.79 14.98 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.163 0.985 . . . . 1.25 111.754 -165.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.05 130.04 36.12 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.158 -1.177 . . . . 1.0900000000000001 110.158 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -108.87 124.4 50.58 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.962 -1.496 . . . . 3.3500000000000001 106.962 175.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -123.41 171.52 9.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.924 1.453 . . . . 1.22 114.924 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mt -108.79 137.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.342 1.457 . . . . 0.89000000000000001 109.297 158.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -109.62 175.32 5.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.074 1.75 . . . . 1.48 113.156 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.87 67.27 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.414 1.635 . . . . 1.45 115.414 -164.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -116.95 -167.18 1.26 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.082 1.353 . . . . 1.3999999999999999 111.152 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.46 86.39 0.18 Allowed Glycine 0 N--CA 1.472 1.05 0 O-C-N 120.794 -1.191 . . . . 1.46 114.117 -173.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -177.98 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.746 2.018 . . . . 3.0299999999999998 110.452 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.04 35.31 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.745 2.418 . . . . 1.27 116.632 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -115.13 134.19 22.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 120.207 -1.558 . . . . 4.4800000000000004 111.91 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -86.75 156.24 8.87 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.211 3.274 . . . . 1.3400000000000001 112.861 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.78 139.4 30.58 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.131 -0.94 . . . . 2.2799999999999998 109.676 156.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mm -86.11 115.96 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.749 -1.204 . . . . 3.0600000000000001 107.749 167.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -171.34 135.75 0.97 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.052 1.341 . . . . 5.8200000000000003 109.469 -149.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 t70 52.27 41.49 30.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.648 1.579 . . . . 4.1399999999999997 114.488 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.55 79.4 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.059 -1.026 . . . . 3.1099999999999999 114.578 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -152.34 -164.94 2.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.526 1.531 . . . . 3.7400000000000002 110.074 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.28 122.31 40.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.191 -0.943 . . . . 2.1099999999999999 110.857 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.7 t -79.4 79.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.254 -0.647 . . . . 3.1099999999999999 109.254 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 12.19 -68.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 131.298 3.839 . . . . 2.2999999999999998 117.677 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.04 74.92 1.0 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.752 1.621 . . . . 2.2400000000000002 109.81 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.51 -37.52 75.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.649 0.78 . . . . 4.9100000000000001 112.17 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.21 -3.52 52.58 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.251 1.204 . . . . 1.75 114.251 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.92 18.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.53 1.132 . . . . 1.3899999999999999 112.601 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.09 -177.87 50.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.266 1.266 . . . . 2.6400000000000001 116.266 162.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.42 -166.02 14.36 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.73 1.157 . . . . 1.6699999999999999 113.288 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -59.69 145.45 44.84 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 109.189 -0.671 . . . . 3.3199999999999998 109.189 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.5 tp -74.97 87.53 2.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.976 -1.077 . . . . 2.5499999999999998 110.783 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.64 110.11 0.96 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.449 1.5 . . . . 3.3199999999999998 112.632 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.46 -50.84 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.024 2.483 . . . . 2.7000000000000002 110.998 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -127.52 126.58 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.029 1.332 . . . . 4.1299999999999999 109.921 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.356 12.2 p30 162.52 -108.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.887 3.675 . . . . 3.7400000000000002 110.768 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -155.0 -40.35 0.09 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.485 1.514 . . . . 2.8599999999999999 112.609 -167.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.43 -49.59 4.21 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.079 0.847 . . . . 3.7400000000000002 114.658 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 20.7 ptmt -49.68 -51.33 39.08 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.446 1.647 . . . . 5.6100000000000003 115.446 -151.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.448 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 161.26 136.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 129.42 3.088 . . . . 2.8199999999999998 113.022 157.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.27 -57.52 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.199 1.185 . . . . 4.1699999999999999 114.199 -163.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.34 -108.91 0.19 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.019 1.771 . . . . 3.3199999999999998 114.901 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.23 -33.43 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.502 2.135 . . . . 5.04 113.462 -174.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -137.35 2.79 2.53 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.249 1.574 . . . . 6.29 115.249 -161.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.64 58.4 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.131 -1.606 . . . . 3.25 116.455 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -77.63 63.86 2.82 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.14 1.47 . . . . 6.8600000000000003 112.345 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.47 -144.55 4.86 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 116.645 1.418 . . . . 2.8799999999999999 116.645 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.422 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 14.2 p-80 -145.93 156.3 43.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.994 1.318 . . . . 6.3200000000000003 112.278 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.18 -22.47 64.76 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.644 1.35 . . . . 2.9300000000000002 114.644 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.422 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -96.13 4.66 65.25 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.595 2.045 . . . . 0.94999999999999996 114.957 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' OD1' ' CE1' ' A' ' 82' ' ' HIS . 8.6 m-20 -62.23 143.16 57.19 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.256 1.528 . . . . 2.3399999999999999 107.255 153.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.4 -174.58 0.43 Allowed Pre-proline 0 CA--C 1.56 1.352 0 O-C-N 120.844 -1.16 . . . . 2.6899999999999999 109.893 -155.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.99 169.94 14.23 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.632 2.222 . . . . 1.4199999999999999 112.722 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.94 126.99 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.878 0.871 . . . . 2.8599999999999999 110.975 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 81.8 1.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.869 2.068 . . . . 2.77 108.552 164.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.97 142.17 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.128 -1.064 . . . . 1.22 108.128 168.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.65 138.31 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.254 1.422 . . . . 2.5899999999999999 109.475 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 142.53 56.74 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 112.827 0.676 . . . . 1.8500000000000001 112.827 174.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -17.91 0.48 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.881 2.472 . . . . 2.4500000000000002 117.542 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -93.77 -12.4 29.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.245 1.418 . . . . 2.75 113.266 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 21.63 16.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.228 0.918 . . . . 0.88 114.847 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.27 125.53 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.418 -1.327 . . . . 2.23 107.418 169.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.5 125.96 34.11 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.492 -0.559 . . . . 0.68999999999999995 109.492 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -139.97 -6.51 1.26 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.193 2.197 . . . . 1.8500000000000001 112.953 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -73.22 113.83 25.65 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 128.0 2.52 . . . . 5.1299999999999999 111.827 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.01 142.94 28.43 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.333 2.689 . . . . 1.1799999999999999 111.907 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.84 168.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.469 1.508 . . . . 1.53 109.574 167.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -140.74 141.02 34.93 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 119.242 0.928 . . . . 1.01 110.459 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.95 95.15 16.39 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.374 1.07 . . . . 0.82999999999999996 111.122 172.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.25 6.49 4.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.568 3.512 . . . . 1.5600000000000001 114.431 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -85.92 -5.17 59.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.33 1.052 . . . . 4.8600000000000003 112.026 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.75 160.81 25.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.452 2.701 . . . . 3.2599999999999998 107.345 169.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.75 -7.21 1.1 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.008 1.485 . . . . 5.3499999999999996 115.008 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.8 m -133.81 130.27 37.71 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.099 0.96 . . . . 2.52 110.413 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -26.24 66.84 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.753 -1.217 . . . . 4.0800000000000001 111.019 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.74 -19.27 5.95 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.907 1.447 . . . . 3.5099999999999998 114.907 165.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.35 -13.55 60.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.94 1.246 . . . . 2.7000000000000002 112.067 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.42 2.34 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 114.263 1.209 . . . . 1.23 114.263 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -62.54 8.72 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 118.057 2.614 . . . . 3.3300000000000001 118.057 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.72 17.64 1.28 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.219 1.408 . . . . 3.23 112.193 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -144.24 169.74 17.32 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.758 1.623 . . . . 2.79 112.212 -168.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.98 139.55 35.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.784 1.234 . . . . 0.75 113.439 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.3 mt -80.39 146.8 31.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.831 1.652 . . . . 2.6099999999999999 108.359 158.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.02 126.89 22.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.03 0.832 . . . . 1.8 111.686 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.4 mt -88.62 111.55 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.374 -1.343 . . . . 0.84999999999999998 107.374 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.9 150.29 21.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.194 2.198 . . . . 3.6499999999999999 111.933 -175.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.29 -46.98 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 111.363 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.28 139.62 16.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.491 0.587 . . . . 2.0800000000000001 112.996 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.06 143.21 41.0 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.592 2.044 . . . . 1.96 113.348 170.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -80.3 97.01 6.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.694 1.198 . . . . 3.4199999999999999 111.037 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -177.68 -36.78 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.566 2.746 . . . . 4.4500000000000002 109.73 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.9 mtm -61.46 130.48 46.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.95 -1.094 . . . . 2.8199999999999998 112.964 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 t -157.77 -169.36 2.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.239 1.816 . . . . 3.2599999999999998 109.803 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 64.73 -35.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 129.598 3.159 . . . . 3.7799999999999998 116.405 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 155.64 14.32 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 127.029 2.132 . . . . 4.5599999999999996 110.771 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.06 -6.18 18.64 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.711 2.941 . . . . 2.4399999999999999 114.135 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -122.29 138.57 29.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.196 0.907 . . . . 4.6799999999999997 110.359 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.69 144.37 77.85 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.298 2.666 . . . . 4.2000000000000002 111.167 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.84 29.31 15.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.85 1.26 . . . . 6.79 111.357 -171.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.65 0.94 57.04 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.891 1.234 . . . . 3.1800000000000002 114.276 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.46 -13.2 15.77 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.432 1.491 . . . . 2.1200000000000001 112.848 -162.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 28.98 0.7 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.247 1.879 . . . . 1.6000000000000001 114.455 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.31 -20.0 77.89 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.751 1.643 . . . . 2.0899999999999999 113.089 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.5 p -60.94 155.39 19.99 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.613 1.565 . . . . 2.0299999999999998 111.754 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mmt-85 -111.55 159.69 17.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.366 1.466 . . . . 5.0700000000000003 111.214 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -107.27 -29.49 9.28 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.666 0.617 . . . . 3.77 112.666 152.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.48 38.3 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.141 -0.975 . . . . 0.66000000000000003 113.571 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 50.4 t -135.36 151.59 50.63 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.272 2.229 . . . . 1.6299999999999999 108.947 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -155.1 123.87 1.42 Allowed Glycine 0 N--CA 1.468 0.782 0 C-N-CA 123.966 0.793 . . . . 0.89000000000000001 113.096 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.9 127.87 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.039 1.335 . . . . 2.3599999999999999 109.492 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mt -79.14 125.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.257 1.027 . . . . 1.1599999999999999 110.983 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt . . . . . 0 C--O 1.238 0.489 0 C-N-CA 127.212 2.205 . . . . 4.5199999999999996 109.417 173.665 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.745 -0.465 . . . . 3.04 109.745 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -153.28 136.12 15.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.155 -1.054 . . . . 1.9399999999999999 108.155 -162.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.67 129.88 8.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.517 1.151 . . . . 2.6400000000000001 112.836 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -88.2 94.79 9.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.751 1.22 . . . . 5.1200000000000001 109.393 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.52 123.84 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.833 -0.542 . . . . 1.53 110.224 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.12 107.47 2.2 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.518 1.532 . . . . 0.80000000000000004 110.835 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 13.9 mmt -81.62 101.04 9.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.8 1.24 . . . . 2.3300000000000001 110.65 172.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.66 137.79 36.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.411 -0.959 . . . . 2.6600000000000001 108.411 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.07 138.88 58.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.422 -0.955 . . . . 1.47 108.422 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -136.36 163.48 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.829 0.852 . . . . 1.53 112.328 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -167.78 -148.2 0.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.677 1.991 . . . . 2.8500000000000001 108.404 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.96 17.38 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.941 3.697 . . . . 2.2400000000000002 115.686 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.84 -6.02 5.07 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.007 -1.683 . . . . 4.21 111.739 171.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.14 -141.72 31.85 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.224 -1.551 . . . . 2.5699999999999998 109.224 -158.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -39.22 113.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.752 1.621 . . . . 2.8300000000000001 112.531 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.52 -77.05 1.16 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.16 1.838 . . . . 1.45 112.335 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.67 153.77 25.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.492 0.717 . . . . 2.25 112.351 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -97.2 132.96 42.45 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.531 1.308 . . . . 1.8300000000000001 114.531 -170.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mm -122.19 -17.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.606 1.562 . . . . 6.1299999999999999 115.212 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.53 28.81 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 121.055 -1.028 . . . . 0.92000000000000004 113.306 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.432 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.6 p -95.52 176.45 6.17 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 164.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 t -135.49 129.99 49.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.001 -1.481 . . . . 0.59999999999999998 107.001 160.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -97.57 119.25 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.307 0.575 . . . . 1.4399999999999999 111.674 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.27 135.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.728 1.211 . . . . 2.0899999999999999 108.837 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -139.25 100.8 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.819 1.648 . . . . 2.5 108.791 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.7 132.9 38.38 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 128.039 2.536 . . . . 3.1699999999999999 109.709 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -154.63 -168.89 3.05 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.475 0.31 . . . . 1.6599999999999999 111.662 -166.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -57.36 -31.92 66.23 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.948 1.299 . . . . 5.1200000000000001 113.34 -176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.5 22.84 38.13 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.856 1.693 . . . . 1.1799999999999999 114.386 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.14 -144.82 23.96 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.686 1.136 . . . . 0.78000000000000003 114.355 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.3 mt -80.36 104.38 10.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.836 0.854 . . . . 0.79000000000000004 111.924 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -83.2 111.81 19.27 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.373 -0.829 . . . . 2.3700000000000001 110.696 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.417 ' CE2' ' CE1' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -97.52 125.51 42.27 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.105 1.762 . . . . 1.0800000000000001 110.151 -177.24 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 m -127.84 110.82 20.38 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 117.993 -1.003 . . . . 1.03 109.458 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -91.85 158.16 3.4 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.461 2.774 . . . . 0.56000000000000005 112.542 -169.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.432 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.4 p80 -148.23 36.47 0.83 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 121.741 0.781 . . . . 1.75 112.485 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -92.67 160.49 14.97 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.709 -1.869 . . . . 1.02 113.001 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 18.38 1.87 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.486 2.402 . . . . 2.3199999999999998 117.486 -167.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.58 70.89 0.61 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.002 0.921 . . . . 1.3100000000000001 110.198 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.18 168.56 12.57 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.187 0.995 . . . . 2.98 109.325 170.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -52.8 137.17 60.29 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.987 1.792 . . . . 1.3899999999999999 110.825 159.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -89.57 26.42 0.54 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.85 2.367 . . . . 1.7 114.243 -151.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.53 -149.23 8.64 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 123.387 1.548 . . . . 1.3400000000000001 115.677 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.38 139.97 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.268 2.227 . . . . 3.2599999999999998 111.511 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -131.47 131.63 43.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.522 0.729 . . . . 1.5 110.911 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.38 152.76 47.01 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-N 118.782 0.719 . . . . 0.85999999999999999 111.646 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.417 ' CE1' ' CE2' ' A' ' 33' ' ' PHE . 5.2 t80 -128.36 108.92 10.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.054 -1.462 . . . . 3.21 107.054 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -112.43 165.57 12.09 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.829 1.418 . . . . 0.96999999999999997 114.829 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.69 138.08 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.997 1.719 . . . . 1.72 108.251 158.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -118.31 155.01 31.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.258 1.823 . . . . 1.2 108.985 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.11 73.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.625 1.713 . . . . 0.83999999999999997 115.625 -157.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -132.21 163.63 28.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.283 1.033 . . . . 1.6200000000000001 112.816 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.47 84.58 1.16 Allowed Glycine 0 N--CA 1.469 0.85 0 O-C-N 120.822 -1.174 . . . . 0.94999999999999996 113.55 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -160.11 89.58 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.152 0.977 . . . . 2.7200000000000002 113.127 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.7 m -67.53 48.72 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.136 2.574 . . . . 1.45 113.759 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -131.61 139.79 36.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.215 1.406 . . . . 3.4900000000000002 112.663 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.38 166.19 4.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.887 3.058 . . . . 1.0600000000000001 112.848 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.67 144.32 42.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.073 0.949 . . . . 1.6799999999999999 110.098 164.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.4 59.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.224 1.01 . . . . 3.0299999999999998 109.742 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 152.65 42.8 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.774 -0.579 . . . . 5.2999999999999998 110.226 165.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t0 54.75 18.91 2.3 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.916 1.686 . . . . 3.75 114.131 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.18 77.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.075 1.321 . . . . 3.29 114.644 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.23 146.43 40.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.702 1.251 . . . . 3.9100000000000001 111.18 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.64 18.57 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.899 -1.125 . . . . 1.98 113.383 -165.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.08 92.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.545 1.138 . . . . 2.2999999999999998 109.645 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -24.95 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 130.193 3.397 . . . . 2.4199999999999999 118.61 -166.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.21 124.01 8.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.861 0.755 . . . . 1.8999999999999999 109.905 158.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.61 -48.7 4.24 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.846 0.858 . . . . 4.2400000000000002 110.252 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.28 -14.96 59.09 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.59 1.33 . . . . 1.3899999999999999 114.59 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.09 -7.9 10.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.931 1.292 . . . . 1.0 114.227 169.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.3 -28.09 11.81 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 120.58 -1.325 . . . . 3.1800000000000002 115.046 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.4 -170.93 20.82 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.396 1.474 . . . . 2.3500000000000001 111.774 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -60.85 148.69 38.52 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.077 0.938 . . . . 3.0299999999999998 110.149 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.5 tp -78.06 73.08 4.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.758 1.223 . . . . 2.8100000000000001 111.919 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.48 104.15 28.49 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.65 1.18 . . . . 3.8300000000000001 110.606 158.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.5 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.236 2.624 . . . . 2.4100000000000001 110.96 159.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -166.39 3.22 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.617 1.34 . . . . 4.8200000000000003 114.617 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -68.45 -27.3 66.05 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.311 -1.493 . . . . 3.96 114.27 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.9 m 114.47 139.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 1 C-N-CA 132.05 4.14 . . . . 4.8300000000000001 107.138 -161.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.16 -12.97 56.93 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.093 1.33 . . . . 2.1000000000000001 114.42 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -64.15 -6.0 5.84 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.441 2.015 . . . . 6.4000000000000004 116.441 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.2 t60 83.22 144.8 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.207 2.203 . . . . 2.2200000000000002 114.571 166.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -81.92 150.14 27.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.238 1.815 . . . . 3.6099999999999999 110.982 -173.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.04 -112.95 0.39 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.659 -1.079 . . . . 2.4700000000000002 114.619 171.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.63 -18.95 25.0 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.329 2.686 . . . . 3.6099999999999999 112.453 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -123.11 155.96 35.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.89 2.076 . . . . 4.9299999999999997 107.424 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.53 120.23 6.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.838 0.732 . . . . 4.0099999999999998 111.61 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.69 21.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.107 2.163 . . . . 4.5999999999999996 113.496 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.18 -151.8 13.33 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 123.208 1.449 . . . . 3.0699999999999998 115.177 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -74.87 139.95 43.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.041 -1.079 . . . . 4.1699999999999999 111.352 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -62.5 -21.65 65.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.342 0.497 . . . . 3.1600000000000001 112.342 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.94 26.32 6.15 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.669 1.604 . . . . 1.1299999999999999 115.425 172.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -111.17 131.68 54.91 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.778 1.789 . . . . 1.5 110.566 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.26 160.81 60.61 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.703 1.601 . . . . 3.4300000000000002 110.452 -163.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.49 159.69 32.28 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.607 2.871 . . . . 1.01 112.526 -170.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 m -69.55 132.08 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 123.251 1.5 . . . . 2.23 114.81 -163.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.97 75.11 4.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.5 3.12 . . . . 2.5800000000000001 109.072 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.06 136.09 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.046 -1.034 . . . . 1.24 111.398 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.17 162.92 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.094 0.958 . . . . 3.25 110.151 161.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -88.96 171.0 10.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.101 0.56 . . . . 2.6000000000000001 112.255 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -16.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 128.003 2.521 . . . . 2.9100000000000001 117.804 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -96.66 -7.39 34.26 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.052 2.141 . . . . 2.8999999999999999 113.381 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.46 21.0 30.51 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 119.135 0.879 . . . . 1.1399999999999999 114.755 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.25 129.09 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.428 1.114 . . . . 2.0499999999999998 111.961 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.42 126.85 45.39 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.29 2.236 . . . . 1.01 111.159 -172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -157.19 18.2 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.962 1.097 . . . . 1.6100000000000001 113.962 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -89.35 113.34 56.07 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.47 1.108 . . . . 3.2799999999999998 109.372 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.54 138.91 19.92 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.191 3.261 . . . . 1.0700000000000001 111.365 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.84 167.41 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.454 1.101 . . . . 1.55 111.464 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -136.5 134.09 37.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.256 1.022 . . . . 1.1799999999999999 110.59 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.22 93.49 39.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.315 1.046 . . . . 0.83999999999999997 112.674 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -77.65 94.77 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.361 2.707 . . . . 3.1800000000000002 108.452 160.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -50.7 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.967 1.707 . . . . 5.9800000000000004 109.11 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.12 162.57 25.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.078 1.351 . . . . 3.2000000000000002 108.103 141.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -121.22 -24.67 5.43 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.219 1.192 . . . . 5.4000000000000004 114.219 162.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 m -124.16 150.43 45.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.607 1.094 . . . . 2.7400000000000002 113.922 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -37.2 86.57 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.208 -0.932 . . . . 3.9300000000000002 110.842 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.93 -16.92 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.231 1.567 . . . . 3.8900000000000001 115.231 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -83.53 -6.87 59.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 2.79 112.313 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.05 11.92 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.522 1.129 . . . . 0.92000000000000004 113.417 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -65.66 13.25 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 117.756 2.502 . . . . 3.6299999999999999 117.756 -172.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.73 23.14 0.69 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.423 1.889 . . . . 3.1299999999999999 112.018 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -121.02 174.87 6.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.292 1.219 . . . . 2.1699999999999999 114.292 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.28 140.48 44.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.722 1.209 . . . . 0.60999999999999999 111.249 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.87 141.42 28.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 2.2799999999999998 107.056 161.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.4 mtt -133.34 131.51 40.2 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.408 1.004 . . . . 1.6100000000000001 112.173 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.3 110.37 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.64 1.176 . . . . 0.79000000000000004 108.298 170.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.83 142.99 29.36 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.876 2.071 . . . . 3.4300000000000002 111.737 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -58.95 -38.51 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 112.974 0.731 . . . . 1.8 112.974 -164.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.17 169.92 14.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.722 1.153 . . . . 1.9299999999999999 111.473 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.26 166.78 24.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.458 1.028 . . . . 1.8500000000000001 112.559 161.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.6 6.18 1.84 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.217 1.192 . . . . 2.7799999999999998 114.217 -134.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.005 2.122 . . . . 3.9900000000000002 114.759 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.5 mtm -138.71 63.44 1.52 Allowed 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.402 -1.436 . . . . 2.7999999999999998 113.375 -161.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -64.69 -34.28 77.94 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.337 1.236 . . . . 3.5099999999999998 114.337 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.38 67.34 9.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.965 1.098 . . . . 3.7999999999999998 113.965 -162.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.61 154.81 25.97 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.703 1.601 . . . . 3.2400000000000002 110.989 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.37 -23.15 38.49 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.466 2.777 . . . . 2.9199999999999999 112.426 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.98 90.22 1.49 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.002 -1.11 . . . . 4.8200000000000003 108.002 154.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.0 169.28 18.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.077 2.518 . . . . 4.5599999999999996 111.445 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt 70.47 16.52 7.04 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.381 1.872 . . . . 4.5700000000000003 110.602 -167.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 3.48 24.38 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.208 1.385 . . . . 3.1499999999999999 113.839 -164.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.79 -1.34 52.23 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.785 1.659 . . . . 2.2200000000000002 114.036 -165.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.3 43.41 1.28 Allowed Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.53 2.014 . . . . 1.71 115.239 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.58 -16.93 77.7 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.835 1.207 . . . . 2.3100000000000001 115.055 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 p -76.52 146.71 38.25 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.532 1.533 . . . . 1.8500000000000001 112.742 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -105.23 138.98 40.57 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.83 1.652 . . . . 5.2300000000000004 110.39 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -91.55 -28.82 17.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.625 0.37 . . . . 4.0499999999999998 111.266 164.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.72 159.68 44.15 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.608 0.966 . . . . 0.48999999999999999 113.608 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 32.7 t -140.92 146.7 37.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.965 2.106 . . . . 1.4099999999999999 110.316 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -141.98 100.44 0.26 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.079 1.799 . . . . 0.78000000000000003 111.633 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.75 135.86 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.013 1.325 . . . . 3.4300000000000002 111.729 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.56 150.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.37 1.468 . . . . 1.5 110.712 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.476 0.844 0 O-C-N 121.599 -0.688 . . . . 4.3799999999999999 112.644 -177.404 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.549 0.214 . . . . 2.1899999999999999 111.55 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -153.61 152.68 31.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.853 1.261 . . . . 1.5600000000000001 109.549 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.2 132.4 11.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 123.071 1.415 . . . . 2.3100000000000001 110.065 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -90.01 124.8 35.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 5.1100000000000003 111.241 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.01 101.06 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 120.859 -1.15 . . . . 1.9099999999999999 108.282 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 109.36 2.81 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.272 1.415 . . . . 1.22 109.907 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 77.6 mmm -87.35 149.35 24.56 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.925 0.89 . . . . 3.1600000000000001 110.685 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.62 145.73 50.02 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.823 1.649 . . . . 2.5600000000000001 109.954 168.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.79 140.43 58.87 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.617 -0.677 . . . . 1.6000000000000001 109.572 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.79 152.61 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.693 0.759 . . . . 1.25 110.821 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -151.87 -165.08 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.794 1.638 . . . . 2.6400000000000001 107.599 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.4 -0.15 1.22 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.233 2.213 . . . . 2.4199999999999999 113.326 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -109.71 -9.98 14.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.502 1.921 . . . . 2.9100000000000001 111.875 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.53 -161.85 21.39 Favored Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.014 1.292 . . . . 1.29 113.85 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.71 127.32 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.392 1.877 . . . . 1.3200000000000001 111.693 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.69 -86.09 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.643 1.592 . . . . 1.47 114.262 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.49 170.5 22.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.784 2.434 . . . . 2.3999999999999999 109.199 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -106.22 159.47 16.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.404 1.261 . . . . 1.6100000000000001 114.404 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.76 8.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 128.899 2.879 . . . . 4.1500000000000004 113.034 -169.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.13 168.67 15.47 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.694 1.14 . . . . 1.03 113.4 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.402 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.4 p -115.19 -177.27 3.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.534 1.534 . . . . 1.1000000000000001 109.335 173.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.45 138.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.821 -1.548 . . . . 0.68999999999999995 106.821 158.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 p -91.78 131.87 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.077 0.398 . . . . 1.53 110.556 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -107.63 131.66 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.343 1.057 . . . . 2.1299999999999999 109.218 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.51 145.18 50.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.92 0.888 . . . . 1.9199999999999999 111.036 170.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.354 8.4 tm-20 -101.38 107.23 18.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.741 2.816 . . . . 3.79 108.129 -162.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -130.7 175.6 8.89 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.839 1.199 . . . . 3.4500000000000002 112.128 -167.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.82 -8.41 57.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.436 1.094 . . . . 5.6299999999999999 112.794 172.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.71 14.63 58.94 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.035 1.302 . . . . 1.1599999999999999 113.27 159.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.27 -151.05 32.57 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 128.299 2.857 . . . . 0.90000000000000002 115.592 174.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -69.68 112.76 6.37 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.758 -0.848 . . . . 1.23 112.963 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -88.86 106.77 18.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.938 2.095 . . . . 2.6600000000000001 110.787 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -92.8 117.09 29.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.574 2.35 . . . . 0.75 108.912 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -125.77 114.93 24.69 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-N 120.478 1.49 . . . . 1.01 109.327 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.1 163.4 5.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.323 2.682 . . . . 0.62 112.379 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.402 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.2 p80 -151.86 20.37 0.69 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.703 1.001 . . . . 1.8400000000000001 113.703 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.74 145.21 28.04 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.011 -1.055 . . . . 1.03 111.749 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -119.2 19.91 12.74 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.869 1.803 . . . . 4.1200000000000001 115.869 -164.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.86 54.81 0.66 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.794 0.838 . . . . 1.51 112.174 -165.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.95 160.34 69.03 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.997 0.919 . . . . 2.6099999999999999 112.553 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.59 132.73 39.17 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.871 1.714 . . . . 1.3999999999999999 110.711 174.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -89.04 25.39 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.679 2.253 . . . . 1.49 114.259 -143.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.34 -152.85 12.49 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 116.908 1.523 . . . . 1.25 116.908 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.96 147.04 23.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.95 2.1 . . . . 2.4700000000000002 109.851 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -149.2 148.15 29.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.087 0.955 . . . . 1.3600000000000001 112.842 -165.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.53 156.63 53.51 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.191 -0.943 . . . . 0.68000000000000005 110.936 162.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.34 121.59 11.56 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 106.134 -1.802 . . . . 3.29 106.134 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -126.99 170.69 12.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.685 1.735 . . . . 1.0900000000000001 115.685 175.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -101.56 143.06 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.281 1.832 . . . . 0.88 109.492 160.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -129.57 141.09 51.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.712 2.005 . . . . 1.3400000000000001 109.641 -172.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -28.49 66.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.059 2.244 . . . . 0.75 117.059 -158.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -127.29 152.17 47.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.443 1.019 . . . . 1.52 112.739 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.81 78.79 1.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.358 0.98 . . . . 1.1899999999999999 111.785 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -164.54 72.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.103 0.954 . . . . 2.75 113.316 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.4 m -68.16 8.84 0.38 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.83 2.159 . . . . 1.6000000000000001 116.83 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.17 138.79 52.55 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.089 -1.632 . . . . 3.7200000000000002 110.771 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.28 165.67 6.77 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.217 3.278 . . . . 1.78 111.341 172.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.56 -172.08 2.58 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.54 0.686 . . . . 3.1000000000000001 109.808 150.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.1 mm -96.64 146.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.728 1.211 . . . . 4.1600000000000001 109.402 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.0 138.95 3.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.504 2.322 . . . . 6.8200000000000003 108.866 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.84 32.0 16.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.233 1.413 . . . . 5.9000000000000004 112.621 -173.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.89 3.53 87.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.186 1.374 . . . . 3.6200000000000001 115.605 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.98 157.91 45.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.077 1.438 . . . . 5.9500000000000002 112.563 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.51 131.52 34.63 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.886 -1.134 . . . . 2.6200000000000001 112.269 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.0 33.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.382 0.882 . . . . 2.6000000000000001 113.382 -172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.61 -6.38 0.12 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 119.184 3.031 . . . . 2.6299999999999999 119.184 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 131.93 101.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 1 C-N-CA 133.005 4.522 . . . . 1.45 106.506 -173.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.41 -59.41 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.203 1.001 . . . . 4.7000000000000002 111.872 -154.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.31 -17.86 59.84 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.156 0.798 . . . . 1.6000000000000001 113.156 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.96 0.68 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.031 2.132 . . . . 0.89000000000000001 115.634 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.69 25.29 9.99 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 116.272 1.269 . . . . 2.9300000000000002 116.272 159.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 -119.83 5.12 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 110.452 -1.059 . . . . 2.7799999999999998 110.452 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -97.47 -102.47 0.19 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.144 -1.058 . . . . 3.54 108.144 149.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.5 tp -174.24 93.32 0.08 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.494 2.318 . . . . 2.7200000000000002 108.672 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -159.64 124.52 2.19 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 125.651 1.581 . . . . 4.2400000000000002 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.03 -31.56 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.478 2.785 . . . . 2.7000000000000002 114.568 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -160.2 -7.91 0.05 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.328 1.422 . . . . 4.4199999999999999 114.388 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -76.01 -48.89 19.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.244 1.018 . . . . 3.2799999999999998 112.61 -160.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -163.34 -41.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.473 1.286 . . . . 3.3300000000000001 114.473 -174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.52 -19.98 2.32 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.047 -1.418 . . . . 2.3599999999999999 114.538 -167.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -72.0 -80.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.212 2.006 . . . . 4.9100000000000001 113.289 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.8 t60 160.69 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 130.27 3.428 . . . . 1.6399999999999999 111.027 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.461 ' CG ' ' H ' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -71.75 -154.29 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.345 1.458 . . . . 3.2400000000000002 111.939 173.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 83' ' ' GLU . . . 113.76 -80.1 0.28 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.801 1.667 . . . . 3.0800000000000001 112.259 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.49 -7.77 5.6 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.849 3.033 . . . . 5.3700000000000001 113.668 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -153.45 145.18 23.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.607 1.563 . . . . 5.2400000000000002 110.457 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.35 84.25 1.42 Allowed Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.986 1.279 . . . . 3.6000000000000001 112.068 -173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.72 13.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.526 1.53 . . . . 5.0599999999999996 113.011 -162.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.3 -161.68 37.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.489 1.519 . . . . 2.29 115.223 -168.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -74.58 133.68 42.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.924 -0.638 . . . . 4.7999999999999998 109.65 173.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.93 2.66 3.26 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.085 1.883 . . . . 3.5299999999999998 116.085 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.87 0.32 51.97 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.892 1.711 . . . . 1.25 115.129 168.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -79.0 147.02 33.04 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.956 1.378 . . . . 1.6799999999999999 111.673 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.92 159.05 27.33 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.812 0.845 . . . . 2.5800000000000001 110.282 -144.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.04 149.33 64.96 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.359 2.706 . . . . 1.21 112.419 -171.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.37 128.23 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.438 1.113 . . . . 2.25 112.983 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.0 tp -82.51 132.09 35.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.513 2.725 . . . . 3.52 110.315 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.69 137.67 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.84 -1.162 . . . . 1.0800000000000001 109.662 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.49 151.97 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 107.434 -1.321 . . . . 3.48 107.434 161.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.06 157.5 26.7 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.384 0.513 . . . . 2.1699999999999999 112.384 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -10.11 2.3 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.724 1.75 . . . . 3.7000000000000002 115.724 -174.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.79 -12.59 41.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 2.4399999999999999 113.597 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.63 17.04 11.66 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.081 1.324 . . . . 0.83999999999999997 116.037 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.46 134.96 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.541 1.171 . . . . 2.8300000000000001 110.707 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.14 135.6 33.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.891 1.676 . . . . 1.1699999999999999 111.379 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -158.83 -19.79 0.07 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.271 1.582 . . . . 1.5800000000000001 115.271 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.37 122.33 82.58 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.403 1.002 . . . . 3.6800000000000002 110.097 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.71 163.22 18.75 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.511 2.807 . . . . 1.5700000000000001 111.989 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 m -141.26 160.51 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.157 1.383 . . . . 1.5900000000000001 110.267 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 138.41 52.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.948 0.899 . . . . 1.1499999999999999 109.743 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.97 88.23 6.65 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.522 1.129 . . . . 0.76000000000000001 112.051 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.76 5.41 1.71 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.041 3.16 . . . . 1.3300000000000001 115.974 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -15.47 52.44 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.531 1.06 . . . . 10.17 112.633 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.93 136.65 20.52 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.04 0.936 . . . . 4.2000000000000002 111.754 -170.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 9.36 1.44 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.235 1.939 . . . . 6.7699999999999996 116.235 -154.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -147.54 128.19 14.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.538 -0.541 . . . . 2.4300000000000002 109.538 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.77 -29.85 67.1 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.725 1.148 . . . . 2.4500000000000002 112.436 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.49 -24.23 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.291 1.837 . . . . 3.04 114.284 171.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.61 -4.46 58.95 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 120.093 1.315 . . . . 2.6099999999999999 114.25 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.03 12.96 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.586 1.154 . . . . 1.0600000000000001 113.874 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.38 17.16 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.197 2.295 . . . . 3.2999999999999998 117.197 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -150.09 11.6 0.73 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.503 1.921 . . . . 3.0 112.383 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -100.84 172.06 7.28 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.63 -1.294 . . . . 2.1600000000000001 113.418 -171.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.14 144.28 35.75 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.883 0.873 . . . . 0.56999999999999995 110.212 161.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.9 141.09 36.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.779 1.632 . . . . 2.4700000000000002 106.673 164.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.5 mtt -137.32 130.56 30.94 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.946 -1.096 . . . . 1.8100000000000001 111.975 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.4 mt -83.85 131.68 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.092 -1.077 . . . . 0.89000000000000001 108.092 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.2 149.1 42.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.611 1.564 . . . . 3.6400000000000001 112.125 -168.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.5 -52.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.655 -0.653 . . . . 1.6599999999999999 110.005 -168.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.85 169.17 29.51 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.127 0.87 . . . . 1.4299999999999999 111.769 169.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.22 -164.49 5.98 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.967 2.699 . . . . 2.6299999999999999 115.913 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.39 84.01 2.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.018 2.127 . . . . 3.4199999999999999 106.676 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -160.39 -8.06 0.05 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.254 1.576 . . . . 4.2000000000000002 115.254 -165.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.5 ptp -148.31 142.06 25.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.242 1.383 . . . . 3.6099999999999999 113.945 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 p -156.82 12.89 0.26 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.146 1.165 . . . . 3.54 114.146 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.51 -40.38 14.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.138 1.775 . . . . 4.5999999999999996 113.845 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.51 143.35 79.09 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.94 0.896 . . . . 4.1200000000000001 112.036 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.81 -31.84 24.28 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.148 2.565 . . . . 2.2799999999999998 114.751 -165.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -73.81 115.45 42.2 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.289 1.404 . . . . 4.8200000000000003 108.731 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.23 144.84 64.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.014 2.476 . . . . 3.0800000000000001 112.716 -159.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 58.98 19.32 7.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.103 1.761 . . . . 4.1200000000000001 112.638 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.97 56.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.813 -0.993 . . . . 3.1899999999999999 113.755 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.89 -8.35 73.52 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.964 1.745 . . . . 2.2200000000000002 114.418 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.01 -8.84 79.22 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.14 1.47 . . . . 1.5900000000000001 116.097 -169.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.83 2.29 25.73 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.921 1.248 . . . . 1.8899999999999999 115.5 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 p -69.42 151.38 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.924 1.69 . . . . 1.8400000000000001 110.789 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.31 150.16 22.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.318 1.447 . . . . 6.1699999999999999 110.268 -172.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -110.43 -34.77 6.23 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.31 0.485 . . . . 3.75 112.31 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.8 144.74 24.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.776 1.028 . . . . 0.96999999999999997 113.776 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.9 t -104.82 139.61 39.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.93 2.492 . . . . 2.1200000000000001 110.903 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.27 87.67 0.25 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.978 2.704 . . . . 1.29 111.052 173.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.98 135.53 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.84 . . . . 2.2400000000000002 109.246 166.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.42 137.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.626 1.17 . . . . 2.4500000000000002 111.359 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 11.2 mmpt? . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.183 . . . . 4.3600000000000003 113.504 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 121.752 0.787 . . . . 2.02 111.38 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -169.12 151.77 4.84 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.551 1.54 . . . . 1.98 108.143 -154.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.9 124.07 5.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 123.05 1.405 . . . . 2.6299999999999999 111.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -84.15 89.52 7.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.928 2.091 . . . . 4.4400000000000004 110.796 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -87.28 116.44 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.475 -0.765 . . . . 1.5 110.239 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.34 109.0 2.66 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.238 1.399 . . . . 0.72999999999999998 110.009 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.8 mtp -94.02 140.42 29.74 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.558 0.743 . . . . 2.1099999999999999 112.778 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -121.24 150.4 41.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.8 1.64 . . . . 2.6299999999999999 112.994 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.7 mt -71.6 73.42 0.77 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.207 2.603 . . . . 1.28 110.974 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.65 124.4 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.338 -0.851 . . . . 1.9399999999999999 109.947 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.5 t -160.28 74.49 0.55 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.963 1.098 . . . . 2.4199999999999999 113.963 -166.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.66 -42.62 0.52 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.167 2.187 . . . . 1.8999999999999999 114.561 163.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -6.7 50.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.947 1.299 . . . . 3.1800000000000002 112.071 169.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.47 -164.53 13.93 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.029 2.252 . . . . 1.8 111.496 -173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.56 129.8 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.054 . . . . 1.5900000000000001 110.255 161.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.64 -140.62 11.27 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.904 1.24 . . . . 2.0699999999999998 113.881 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.93 167.08 14.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.675 1.19 . . . . 2.2999999999999998 111.087 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -103.22 172.94 6.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.813 1.645 . . . . 2.2200000000000002 113.183 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.03 1.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 128.188 2.595 . . . . 4.2199999999999998 113.138 -165.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.17 -177.44 20.29 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.148 1.356 . . . . 0.59999999999999998 112.714 -166.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.87 165.43 18.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.075 0.95 . . . . 1.3799999999999999 109.411 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.67 129.32 66.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.558 -1.275 . . . . 0.66000000000000003 107.558 157.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.18 130.63 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 122.011 0.91 . . . . 3.9300000000000002 110.204 166.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -99.39 139.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.9 -1.148 . . . . 1.75 107.9 167.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -135.52 127.06 28.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.908 1.283 . . . . 2.3199999999999998 109.935 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.03 140.0 29.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.207 0.603 . . . . 3.5699999999999998 111.059 -171.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t -154.54 -178.99 7.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.5 0.72 . . . . 2.02 110.433 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -64.38 -23.8 67.41 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.659 1.584 . . . . 3.7999999999999998 113.546 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.07 16.68 59.02 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.283 1.42 . . . . 1.4299999999999999 113.848 166.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.44 -144.49 31.81 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 129.241 3.305 . . . . 1.1200000000000001 114.859 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.2 mt -71.71 109.17 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.291 0.636 . . . . 0.88 111.088 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -80.58 107.34 13.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.268 1.427 . . . . 3.1600000000000001 109.594 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -91.75 116.52 28.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.035 1.734 . . . . 0.73999999999999999 109.713 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.8 m -128.87 106.52 18.35 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.877 -0.582 . . . . 1.21 110.332 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.09 154.72 14.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.897 3.065 . . . . 0.55000000000000004 112.405 -171.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -146.01 48.88 1.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.664 0.745 . . . . 1.8700000000000001 112.626 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.47 150.95 24.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 1.04 112.228 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 22.0 5.52 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.393 1.627 . . . . 2.0699999999999998 115.393 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.24 83.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.112 0.965 . . . . 2.0699999999999998 110.706 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 164.68 31.62 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 124.803 1.241 . . . . 2.3799999999999999 110.535 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.48 138.46 85.92 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.13 1.22 . . . . 1.3600000000000001 110.07 169.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -90.81 24.67 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.333 2.022 . . . . 1.52 114.428 -151.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.5 -154.62 20.58 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.181 1.372 . . . . 1.3 115.28 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 152.29 19.07 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.064 -1.256 . . . . 2.7000000000000002 110.539 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -149.41 122.78 9.03 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.674 1.59 . . . . 1.6899999999999999 111.291 -162.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.56 150.29 3.54 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 120.307 1.412 . . . . 0.83999999999999997 112.175 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.448 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -135.97 125.58 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.248 -1.39 . . . . 3.4100000000000001 107.248 173.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -124.28 172.31 9.19 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.118 1.525 . . . . 1.3100000000000001 115.118 167.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.38 141.66 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.747 1.619 . . . . 0.96999999999999997 109.168 159.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.27 154.3 46.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.986 2.114 . . . . 1.0600000000000001 110.583 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.93 60.63 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 117.362 2.356 . . . . 1.1000000000000001 117.362 -150.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -137.69 148.86 46.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.122 1.328 . . . . 1.8500000000000001 113.325 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.57 74.18 2.14 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.581 1.086 . . . . 1.3200000000000001 114.151 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 t -164.79 76.9 0.31 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.058 0.932 . . . . 2.8300000000000001 113.346 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.9 m -70.02 28.43 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.951 2.1 . . . . 1.8300000000000001 115.74 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -92.22 135.44 26.95 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.514 -1.366 . . . . 3.29 110.943 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.17 157.2 11.21 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.274 3.316 . . . . 1.3400000000000001 113.231 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.77 144.53 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.104 0.962 . . . . 2.0600000000000001 110.08 161.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mm -97.76 48.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.316 1.047 . . . . 3.7000000000000002 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -61.89 137.83 58.29 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.761 -1.212 . . . . 6.2800000000000002 111.313 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.94 26.35 9.73 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.182 0.993 . . . . 4.0800000000000001 112.921 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.71 83.34 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.96 -1.087 . . . . 3.0699999999999998 114.723 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.91 144.46 48.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.264 1.532 . . . . 3.8199999999999998 111.178 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.3 105.8 12.78 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.835 -1.165 . . . . 1.8 111.776 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 t -77.98 62.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.402 1.481 . . . . 3.0299999999999998 111.688 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.2 -63.15 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.852 3.261 . . . . 2.27 116.756 169.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.4 119.8 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 131.555 3.942 . . . . 2.3799999999999999 108.648 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -100.46 -47.75 4.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.693 1.133 . . . . 4.8399999999999999 111.561 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.8 2.92 4.68 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 115.21 1.559 . . . . 1.71 115.21 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.52 -3.84 48.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.119 2.168 . . . . 1.6100000000000001 114.674 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 -13.83 55.01 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.037 1.575 . . . . 3.7400000000000002 117.037 165.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.09 -168.78 15.18 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.043 1.306 . . . . 2.1200000000000001 114.697 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 12.64 1.63 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.196 2.199 . . . . 2.3100000000000001 114.107 -175.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.8 tp 61.25 56.2 2.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.15 1.78 . . . . 2.3700000000000001 109.15 -169.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -122.74 62.94 18.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.901 2.08 . . . . 4.2199999999999998 112.414 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.43 -38.43 26.05 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.83 2.353 . . . . 2.3799999999999999 112.689 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -168.4 139.22 2.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.631 1.972 . . . . 4.1100000000000003 107.664 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 p30 157.69 -162.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 130.348 3.459 . . . . 4.6200000000000001 110.337 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -74.49 -11.83 60.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.265 2.626 . . . . 3.1299999999999999 116.048 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.65 -32.17 1.66 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.977 1.275 . . . . 2.6299999999999999 116.081 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -64.91 -9.84 24.23 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.151 2.278 . . . . 5.9900000000000002 117.151 -167.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.4 t60 75.08 153.52 0.14 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.427 2.291 . . . . 2.1000000000000001 112.238 -171.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -152.13 148.51 27.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.287 1.835 . . . . 4.9299999999999997 109.874 -169.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.35 -82.39 1.07 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.055 -1.414 . . . . 3.3399999999999999 109.882 163.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.01 -26.12 3.1 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.898 3.065 . . . . 4.54 115.942 -166.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.54 -157.55 0.62 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 120.091 1.314 . . . . 5.2999999999999998 111.383 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.98 13.59 37.7 Favored Glycine 0 N--CA 1.475 1.287 0 C-N-CA 124.979 1.276 . . . . 4.79 115.195 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -100.25 51.76 0.89 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.052 1.426 . . . . 5.7400000000000002 112.301 -169.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.61 -143.71 4.9 Favored Glycine 0 N--CA 1.473 1.101 0 O-C-N 120.921 -1.112 . . . . 2.6699999999999999 115.608 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.06 147.73 22.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.705 1.202 . . . . 5.0099999999999998 112.405 -168.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.88 -20.97 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.682 1.364 . . . . 2.8799999999999999 114.682 -174.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.06 -2.06 86.4 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.297 0.951 . . . . 1.02 114.796 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.98 136.63 33.98 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.517 1.127 . . . . 1.77 111.99 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.42 167.61 14.17 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 126.092 1.757 . . . . 2.6800000000000002 109.861 -143.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.82 173.95 11.53 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.281 3.321 . . . . 1.0700000000000001 113.792 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.37 125.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.638 1.175 . . . . 2.9900000000000002 112.186 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 90.31 2.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.58 2.752 . . . . 2.79 109.854 166.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.9 t -68.28 126.44 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.018 -1.051 . . . . 0.92000000000000004 109.092 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.97 162.67 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.931 1.292 . . . . 3.3599999999999999 108.411 167.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.47 160.47 16.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.759 1.022 . . . . 2.21 113.759 -176.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -15.68 0.29 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 127.957 2.503 . . . . 2.4700000000000002 117.438 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.09 -0.93 38.06 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.907 1.683 . . . . 3.2000000000000002 113.089 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.8 25.66 22.01 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.93 1.252 . . . . 0.96999999999999997 114.432 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.9 mt -129.64 140.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 1.5900000000000001 109.955 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.4 129.0 56.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.349 1.86 . . . . 1.0600000000000001 111.607 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 t -153.31 0.74 0.25 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.784 1.772 . . . . 1.6000000000000001 115.784 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -86.03 126.77 64.4 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.585 1.154 . . . . 3.3799999999999999 110.542 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.05 156.3 26.41 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.095 2.53 . . . . 1.3100000000000001 112.16 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.92 167.06 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 126.358 1.863 . . . . 1.71 109.591 167.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 m -140.06 140.48 36.14 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 1.23 111.053 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.63 114.24 15.54 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.482 1.113 . . . . 1.52 112.691 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.14 5.15 6.2 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.26 3.307 . . . . 1.5 115.213 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -77.36 -19.17 56.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.566 0.951 . . . . 5.2800000000000002 113.566 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.56 144.99 46.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.423 1.889 . . . . 3.75 106.946 169.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -131.06 -9.37 3.84 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.455 1.28 . . . . 4.9900000000000002 114.455 -160.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -157.98 142.2 15.98 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.929 1.292 . . . . 2.4399999999999999 111.781 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.081 -1.012 . . . . 3.6499999999999999 113.172 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.97 -15.65 45.37 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 119.533 1.06 . . . . 3.1299999999999999 113.168 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.11 -22.29 63.98 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.47 -0.769 . . . . 2.3100000000000001 112.793 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.02 20.97 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.655 1.582 . . . . 1.1699999999999999 112.689 -167.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -68.86 27.47 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.215 2.206 . . . . 2.8599999999999999 116.012 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.96 3.02 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.529 2.732 . . . . 3.21 113.024 173.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -108.19 172.15 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 2.1600000000000001 113.149 -166.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.0 150.06 39.23 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.247 1.019 . . . . 0.87 113.195 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.3 mt -89.66 152.29 21.44 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.169 1.788 . . . . 2.9100000000000001 109.01 161.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.8 mtt -141.31 127.8 20.06 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.597 0.635 . . . . 1.6399999999999999 112.185 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.45 130.73 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.957 1.303 . . . . 0.88 107.577 166.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.28 137.59 53.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.218 2.207 . . . . 3.04 111.236 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -64.85 -42.83 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.326 1.05 . . . . 1.73 112.781 -161.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -88.0 -106.01 0.95 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.1 1.333 . . . . 2.6600000000000001 112.041 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.48 -166.99 29.39 Favored Glycine 0 N--CA 1.462 0.404 0 O-C-N 121.233 -1.157 . . . . 2.7200000000000002 111.75 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -162.9 145.97 10.82 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.622 1.169 . . . . 3.25 109.911 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 114.27 55.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 130.294 3.438 . . . . 4.7999999999999998 108.121 -154.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.3 ptp -169.63 37.02 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.044 1.338 . . . . 3.3300000000000001 113.455 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.61 61.31 2.31 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.078 -1.639 . . . . 3.5099999999999998 114.911 -169.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -140.25 -45.54 0.42 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 116.613 2.079 . . . . 4.2999999999999998 116.613 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.43 148.32 44.12 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.753 1.39 . . . . 3.8900000000000001 114.753 -156.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.44 -9.19 24.78 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.312 3.341 . . . . 2.3399999999999999 115.555 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -101.43 78.34 0.21 Allowed Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.587 -0.894 . . . . 5.6699999999999999 108.587 154.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.73 152.38 82.21 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.758 2.972 . . . . 3.52 112.355 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 mt 69.08 27.98 5.17 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.641 1.577 . . . . 4.7699999999999996 110.296 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.42 13.52 58.46 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.318 1.437 . . . . 3.5 114.626 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.94 -6.9 46.32 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 118.676 1.238 . . . . 2.3599999999999999 114.375 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.87 5.94 56.73 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.488 1.994 . . . . 2.5899999999999999 114.089 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.8 2.56 7.91 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 118.613 1.206 . . . . 2.4399999999999999 115.022 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 p -64.26 144.64 56.99 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.359 1.463 . . . . 2.0899999999999999 109.655 169.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.92 137.58 36.92 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.001 0.92 . . . . 6.6500000000000004 112.605 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -91.46 -27.85 18.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.284 0.634 . . . . 3.6200000000000001 111.281 158.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.24 153.11 28.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.174 0.805 . . . . 0.60999999999999999 113.174 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.54 165.52 16.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.382 1.473 . . . . 2.3300000000000001 110.755 165.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -160.82 136.43 4.46 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.658 1.123 . . . . 0.84999999999999998 112.797 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.11 133.45 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.657 1.183 . . . . 2.6899999999999999 110.603 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.0 141.2 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.503 1.121 . . . . 1.9199999999999999 111.068 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 123.981 0.913 . . . . 4.7599999999999998 112.769 -174.637 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.413 -0.217 . . . . 2.1800000000000002 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -135.87 150.04 49.23 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.394 -1.441 . . . . 1.6200000000000001 114.763 -141.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -155.72 123.85 5.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.675 1.59 . . . . 2.3599999999999999 108.703 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.93 108.29 18.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.714 1.605 . . . . 6.2300000000000004 110.512 -171.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.15 126.38 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.339 0.656 . . . . 1.46 110.14 -165.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.94 113.34 4.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.277 1.417 . . . . 0.77000000000000002 110.549 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.4 mmt -97.33 113.16 24.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.448 1.499 . . . . 2.1200000000000001 110.586 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -102.2 149.55 24.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.287 1.035 . . . . 3.1699999999999999 112.108 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.31 61.98 1.25 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.395 1.078 . . . . 1.73 112.645 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.43 147.48 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.342 1.057 . . . . 1.6100000000000001 112.489 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -177.44 134.85 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.798 1.639 . . . . 2.3799999999999999 111.338 163.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.67 -44.16 0.25 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.03 2.932 . . . . 1.74 117.062 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 11.11 33.75 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.148 1.779 . . . . 3.7599999999999998 110.844 172.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -133.23 11.69 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.996 1.284 . . . . 1.1599999999999999 110.684 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.19 134.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.862 1.665 . . . . 2.1299999999999999 111.031 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.53 -82.47 1.42 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.837 1.208 . . . . 2.3199999999999998 111.924 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.2 158.29 18.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.078 1.351 . . . . 2.5899999999999999 111.355 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.0 t -97.92 145.47 26.43 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.728 1.211 . . . . 2.6299999999999999 112.977 -169.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.3 pt -142.85 3.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 114.837 1.421 . . . . 3.6000000000000001 114.837 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.73 178.35 35.58 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 120.895 -1.128 . . . . 0.75 114.023 -170.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.49 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 1.2 p -131.14 178.41 6.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.352 1.061 . . . . 1.24 109.054 171.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -131.05 133.99 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.095 -1.076 . . . . 0.45000000000000001 108.095 162.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 8.7 p -90.65 127.8 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.604 0.362 . . . . 1.45 110.721 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.8 136.65 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.289 1.036 . . . . 2.4100000000000001 108.825 169.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -141.91 113.5 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.215 1.406 . . . . 1.8500000000000001 110.744 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.77 153.55 39.94 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.733 0.813 . . . . 3.1200000000000001 112.063 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 t -167.68 -177.68 3.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.542 1.937 . . . . 1.54 109.149 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -53.1 -40.75 64.37 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.257 1.423 . . . . 3.8199999999999998 112.497 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 15.16 56.71 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.22 1.39 . . . . 0.91000000000000003 114.44 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 -152.78 42.48 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 127.36 2.41 . . . . 0.75 115.334 173.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.53 104.34 0.99 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.701 0.801 . . . . 0.78000000000000003 113.135 -169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -80.12 110.42 15.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.008 1.723 . . . . 3.1899999999999999 109.964 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.6 t80 -100.85 114.87 29.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.457 2.703 . . . . 0.79000000000000004 108.928 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.6 m -122.73 111.18 31.34 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 119.776 1.171 . . . . 0.95999999999999996 108.948 175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -84.08 158.55 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.525 2.817 . . . . 0.46000000000000002 111.66 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.49 ' CD2' ' HG1' ' A' ' 21' ' ' THR 0.263 1.7 p80 -152.52 65.06 0.81 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 122.5 1.143 . . . . 1.52 111.664 172.145 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.59 151.26 45.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.35 1.86 . . . . 0.83999999999999997 111.535 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 37.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 117.509 2.411 . . . . 2.4500000000000002 117.509 -159.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.45 13.03 1.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.978 1.473 . . . . 2.4100000000000001 114.978 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.33 161.82 50.56 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 119.124 -0.465 . . . . 2.9199999999999999 111.359 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -60.96 129.78 30.18 Favored 'Trans proline' 0 N--CA 1.431 -2.157 0 O-C-N 123.241 1.127 . . . . 1.1599999999999999 109.756 162.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -86.45 22.86 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.665 3.577 . . . . 1.29 113.269 -150.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.52 153.04 17.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 126.167 1.842 . . . . 1.9399999999999999 110.49 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -45.28 137.03 4.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.005 2.522 . . . . 3.2999999999999998 113.72 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -126.93 129.42 48.13 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 125.533 1.533 . . . . 1.1299999999999999 111.704 -172.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.14 158.18 1.72 Allowed Glycine 0 CA--C 1.543 1.843 0 CA-C-N 119.276 0.944 . . . . 0.81000000000000005 114.016 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.3 t80 -145.39 116.3 7.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.147 1.779 . . . . 3.21 106.65 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -126.12 168.75 13.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.388 1.995 . . . . 0.92000000000000004 116.388 165.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -99.08 135.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.391 1.876 . . . . 1.25 110.09 154.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -105.6 176.14 5.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.822 1.649 . . . . 1.25 111.963 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.9 62.59 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 116.744 2.127 . . . . 1.3300000000000001 116.744 -166.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -126.06 -159.68 0.93 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.6 1.56 . . . . 1.48 111.277 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.87 66.73 0.37 Allowed Glycine 0 N--CA 1.476 1.323 0 N-CA-C 116.677 1.431 . . . . 1.78 116.677 -162.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -174.69 116.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.236 1.814 . . . . 3.23 111.974 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -67.62 33.0 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 128.043 2.537 . . . . 1.46 115.183 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -104.89 126.61 30.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 119.996 -1.69 . . . . 3.1600000000000001 111.379 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.52 150.97 13.24 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.073 3.182 . . . . 1.3200000000000001 112.889 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 169.08 8.94 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.179 0.992 . . . . 2.2000000000000002 110.196 154.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 mm -97.9 124.1 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.948 -1.13 . . . . 3.3399999999999999 107.948 162.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -139.54 109.22 6.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.278 1.431 . . . . 5.6699999999999999 109.179 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t0 60.43 63.04 1.43 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.161 1.785 . . . . 4.2000000000000002 112.747 -166.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.39 13.33 54.34 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 115.711 1.045 . . . . 3.23 115.711 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -147.48 150.11 33.95 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.027 1.731 . . . . 3.8900000000000001 110.209 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.05 34.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.998 0.519 . . . . 1.6799999999999999 111.896 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.5 t -67.94 -3.98 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.188 1.795 . . . . 3.3599999999999999 113.466 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.47 -50.56 0.69 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.499 2.72 . . . . 2.1600000000000001 112.575 -174.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.51 111.25 2.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.178 1.791 . . . . 1.9199999999999999 109.682 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.89 -39.7 12.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.239 0.616 . . . . 5.0700000000000003 110.691 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.01 -4.2 30.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.114 1.153 . . . . 1.98 114.114 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.0 -18.9 27.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.178 1.391 . . . . 1.3 112.631 168.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.31 178.1 31.53 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 122.319 0.955 . . . . 2.8500000000000001 113.516 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.69 -163.65 39.31 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.531 1.062 . . . . 1.74 112.894 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -56.31 128.29 35.09 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.763 0.825 . . . . 3.04 109.591 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.32 66.72 0.18 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.681 1.993 . . . . 2.9500000000000002 112.34 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -111.21 113.55 54.2 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 4.6699999999999999 108.989 164.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -84.68 -31.27 0.46 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.288 1.992 . . . . 2.48 113.302 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 176.9 29.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.869 2.068 . . . . 3.79 111.289 -165.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -119.07 -21.19 7.76 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.56 -1.209 . . . . 4.2400000000000002 113.261 -164.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t 155.16 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 130.607 3.563 . . . . 2.6299999999999999 111.172 158.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.33 -11.29 61.69 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.8 1.191 . . . . 2.2200000000000002 115.494 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -73.79 1.78 9.76 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 116.019 1.859 . . . . 5.46 116.019 -173.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.6 t60 87.75 135.16 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 129.045 2.938 . . . . 1.97 114.151 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.65 19.33 14.61 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.981 1.712 . . . . 4.8399999999999999 114.385 -152.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.78 -35.68 31.04 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-O 117.642 -1.643 . . . . 3.0099999999999998 114.735 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -111.83 -2.39 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 124.316 3.344 . . . . 3.9199999999999999 114.153 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -143.82 145.93 32.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.875 1.67 . . . . 5.2400000000000002 108.457 -172.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.12 6.5 35.09 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.586 1.394 . . . . 4.0 116.586 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.81 130.34 15.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.051 1.426 . . . . 5.7999999999999998 109.721 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.69 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-O 115.709 -2.717 . . . . 3.3300000000000001 118.22 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.441 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.3 OUTLIER 152.99 118.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 129.145 2.978 . . . . 6.6299999999999999 110.924 -175.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.3 tt -67.03 -28.43 68.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.47 1.108 . . . . 3.9399999999999999 113.369 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -88.18 15.7 55.04 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.416 1.484 . . . . 1.04 115.179 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.441 ' OD1' ' CE1' ' A' ' 90' ' ' HIS . 78.7 m-20 -76.11 147.65 38.43 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.2 1.5 . . . . 1.55 110.751 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.17 166.03 17.38 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.607 0.763 . . . . 2.6400000000000001 110.368 -146.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.06 148.53 19.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.877 3.051 . . . . 1.45 112.271 -171.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.89 135.16 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 122.108 0.956 . . . . 2.6600000000000001 111.38 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 108.83 19.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.026 2.53 . . . . 3.9399999999999999 110.428 -172.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.4 t -78.24 131.35 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.365 -0.835 . . . . 2.1200000000000001 111.935 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.68 141.31 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.67 2.388 . . . . 2.52 106.423 166.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.51 164.3 22.07 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.134 0.424 . . . . 1.95 111.484 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -16.67 0.29 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 127.421 2.289 . . . . 2.3500000000000001 116.89 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.62 -1.41 43.81 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.181 1.792 . . . . 2.4100000000000001 113.434 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.29 53.84 Favored Glycine 0 N--CA 1.473 1.119 0 O-C-N 121.185 -0.947 . . . . 0.98999999999999999 114.851 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.8 mt -106.14 121.97 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.217 1.007 . . . . 2.0 110.806 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.4 122.56 33.38 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.342 1.057 . . . . 0.88 109.092 168.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -155.48 8.68 0.27 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.135 1.161 . . . . 2.3900000000000001 114.135 -167.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.62 123.61 49.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.868 1.267 . . . . 3.3599999999999999 110.473 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.75 134.75 26.56 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.189 3.259 . . . . 1.3899999999999999 111.963 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.0 163.77 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 126.342 1.857 . . . . 1.99 109.261 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 m -144.14 141.0 29.71 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.993 1.269 . . . . 1.1499999999999999 112.112 -167.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -121.17 106.05 39.01 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.554 1.142 . . . . 0.96999999999999997 113.381 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.1 7.42 1.74 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.727 3.618 . . . . 1.1899999999999999 114.637 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -75.4 -25.7 57.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.812 1.645 . . . . 7.8700000000000001 112.735 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.99 135.59 53.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.313 -1.736 . . . . 3.4199999999999999 106.313 168.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -113.05 -2.65 14.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 4.9800000000000004 113.579 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.4 t -141.11 174.06 10.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.353 0.979 . . . . 2.6200000000000001 111.752 158.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.43 -24.27 64.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.165 -0.959 . . . . 2.04 111.09 157.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -60.01 -28.62 67.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.352 1.461 . . . . 2.8300000000000001 114.639 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -78.91 -16.1 57.45 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.199 1.185 . . . . 2.6400000000000001 114.199 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.1 m -124.42 16.35 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 125.195 1.398 . . . . 1.3799999999999999 113.291 -172.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -65.44 8.64 0.15 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 128.242 2.617 . . . . 3.25 117.579 -171.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 41.76 0.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.273 1.429 . . . . 3.7000000000000002 112.171 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -134.49 168.28 19.23 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.937 1.295 . . . . 2.3399999999999999 113.685 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.7 146.69 26.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.503 1.521 . . . . 0.65000000000000002 114.259 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.37 145.39 30.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.921 2.489 . . . . 2.1499999999999999 107.809 167.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 52.3 mtt -140.65 143.4 35.13 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.294 -0.879 . . . . 1.8400000000000001 112.427 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mt -99.75 123.6 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.772 1.629 . . . . 0.85999999999999999 108.444 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -109.02 143.29 38.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.293 1.837 . . . . 4.1299999999999999 111.39 -165.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.12 -37.78 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.865 -1.147 . . . . 1.8200000000000001 111.914 -169.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.93 153.34 20.06 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.913 0.768 . . . . 1.2 112.125 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.35 -178.9 25.6 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.891 1.71 . . . . 1.3100000000000001 113.128 163.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -137.01 14.87 3.07 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.027 1.491 . . . . 3.29 115.027 -126.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -105.16 21.82 16.44 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.709 1.374 . . . . 3.0 114.709 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtm -96.55 129.65 43.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.859 -1.151 . . . . 3.3500000000000001 112.363 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.2 p -126.7 4.93 6.71 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.766 1.395 . . . . 3.3599999999999999 114.766 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -157.09 124.61 5.33 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.887 -1.133 . . . . 3.5299999999999998 109.464 -169.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -174.09 142.25 0.85 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 117.926 -1.035 . . . . 3.6899999999999999 109.558 -167.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.11 -15.12 29.0 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.08 2.52 . . . . 2.7799999999999998 113.762 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -129.23 133.85 25.62 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.811 1.645 . . . . 5.2999999999999998 108.955 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.9 124.82 15.7 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.215 2.61 . . . . 3.7400000000000002 111.783 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp 58.88 5.2 0.48 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.689 1.996 . . . . 4.0700000000000003 114.007 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.87 9.08 44.8 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.883 -1.136 . . . . 4.1799999999999997 114.574 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.92 -0.27 33.85 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.411 1.482 . . . . 3.0 114.345 -167.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.87 7.34 5.5 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.342 1.449 . . . . 2.0 115.646 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.24 -6.03 78.63 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.873 1.337 . . . . 2.6099999999999999 112.921 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 p -70.07 134.06 47.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.356 1.862 . . . . 2.5499999999999998 110.693 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.43 147.27 45.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.355 1.462 . . . . 5.9800000000000004 112.02 -172.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -106.3 -17.16 14.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.249 -0.881 . . . . 3.71 112.93 169.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.85 33.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.856 1.428 . . . . 0.54000000000000004 114.856 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -135.74 149.12 49.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.198 2.199 . . . . 1.3200000000000001 110.238 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.5 1.71 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.342 1.925 . . . . 0.87 112.474 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.63 141.71 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.569 1.148 . . . . 3.4399999999999999 112.592 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -77.14 141.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.57 1.148 . . . . 1.3100000000000001 110.868 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 124.332 1.053 . . . . 4.7699999999999996 110.977 171.366 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.988 -0.745 . . . . 2.5 108.988 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -128.71 133.53 48.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.899 -1.751 . . . . 2.5600000000000001 112.504 -137.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -146.69 127.68 14.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 123.226 1.489 . . . . 2.5 112.711 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -109.86 90.94 3.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.251 1.42 . . . . 4.7000000000000002 110.216 -162.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.5 t -90.04 120.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.89 0.476 . . . . 1.48 110.299 -163.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.48 105.4 1.78 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.972 1.272 . . . . 0.79000000000000004 110.639 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 mmt -85.13 110.49 19.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.999 1.32 . . . . 2.3799999999999999 110.57 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -98.25 143.78 28.38 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.95 0.9 . . . . 2.7999999999999998 111.452 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.3 63.01 3.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.895 1.278 . . . . 1.29 111.55 -175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.35 136.79 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.551 0.74 . . . . 1.96 111.205 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -157.96 139.87 14.03 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.597 0.359 . . . . 2.54 111.514 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 26.76 -42.99 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.884 1 C-N-CA 134.638 5.175 . . . . 1.3799999999999999 120.763 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -80.17 -23.26 41.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.825 1.25 . . . . 3.9300000000000002 111.791 166.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.5 -141.08 13.02 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.846 1.212 . . . . 1.23 111.541 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.5 t -54.81 128.79 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.117 1.367 . . . . 1.7 111.78 -174.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.26 -111.0 3.54 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.151 1.834 . . . . 1.22 111.701 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.68 169.35 15.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.515 1.126 . . . . 2.04 110.945 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.9 t -109.44 156.81 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.058 -1.026 . . . . 2.0099999999999998 111.994 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 pt -147.33 9.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.733 2.013 . . . . 3.4199999999999999 113.114 -172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.57 162.78 10.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.642 1.115 . . . . 0.81999999999999995 112.743 -167.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -104.45 -177.99 3.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.23 1.012 . . . . 1.04 109.316 168.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.4 t -124.43 130.87 73.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 106.848 -1.538 . . . . 0.42999999999999999 106.848 151.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -87.72 123.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.727 -0.471 . . . . 2.0299999999999998 109.727 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.86 119.98 45.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.04 -1.096 . . . . 2.1200000000000001 108.04 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -118.47 111.33 18.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.835 0.854 . . . . 1.9399999999999999 110.848 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 130.47 46.57 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 127.124 2.17 . . . . 3.9100000000000001 111.165 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 t -161.18 -172.0 3.25 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.705 1.002 . . . . 2.3900000000000001 113.705 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.32 -31.29 43.49 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.523 1.529 . . . . 6.75 112.721 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.57 17.9 57.56 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 124.962 1.267 . . . . 1.9299999999999999 115.179 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.29 -140.43 28.4 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.22 1.39 . . . . 1.22 111.372 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.59 107.89 7.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.284 0.634 . . . . 0.90000000000000002 111.13 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -87.83 107.51 18.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.771 1.228 . . . . 2.3399999999999999 111.263 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.34 104.61 16.02 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.596 1.958 . . . . 0.66000000000000003 109.763 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 m -113.69 106.66 53.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.1 162.06 17.98 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.371 3.38 . . . . 0.5 109.928 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -153.02 34.7 0.47 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.982 0.896 . . . . 1.45 112.346 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -97.26 142.85 28.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.703 1.201 . . . . 0.84999999999999998 111.21 -174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.38 23.1 9.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.154 1.909 . . . . 2.25 116.154 -166.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.51 57.51 0.63 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.672 0.789 . . . . 1.4299999999999999 112.806 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.03 15.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.115 0.966 . . . . 2.54 111.57 172.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.73 134.36 46.77 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 122.058 1.839 . . . . 1.03 110.973 166.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -84.18 27.31 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.706 1 C-N-CA 126.692 4.928 . . . . 1.1899999999999999 114.825 -152.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.79 -134.79 8.16 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.398 1.475 . . . . 1.25 115.091 -172.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -120.17 136.5 54.6 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.647 1.579 . . . . 2.29 108.588 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -124.87 143.64 50.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.18 0.992 . . . . 1.27 112.631 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.9 153.68 52.32 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.917 -0.873 . . . . 0.66000000000000003 110.917 169.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -124.07 118.41 26.88 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.277 -1.379 . . . . 3.3799999999999999 107.277 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -116.5 160.95 19.86 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.068 1.507 . . . . 1.01 115.068 168.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.13 148.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.521 2.329 . . . . 1.1599999999999999 108.332 158.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -134.62 145.37 48.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 1.1200000000000001 111.001 -174.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.46 87.58 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.784 1.772 . . . . 0.79000000000000004 115.784 -159.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -116.76 148.63 40.97 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.658 1.183 . . . . 1.25 112.989 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.69 72.57 2.81 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.769 1.176 . . . . 1.25 113.803 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -164.36 96.06 0.76 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.174 0.987 . . . . 2.4399999999999999 113.422 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -65.39 22.73 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.155 2.182 . . . . 1.3100000000000001 116.44 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -86.18 129.34 54.13 Favored Pre-proline 0 CA--C 1.55 0.957 0 O-C-N 119.802 -1.811 . . . . 3.0899999999999999 112.446 -166.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -95.62 173.26 1.11 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.897 3.731 . . . . 1.75 111.99 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.5 154.07 45.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.12 1.368 . . . . 2.6200000000000001 110.956 165.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -85.05 113.55 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.205 -1.405 . . . . 4.3399999999999999 107.205 157.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -138.47 121.37 16.59 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.716 1.206 . . . . 5.6699999999999999 108.547 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 57.69 40.01 26.86 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.755 1.222 . . . . 4.2199999999999998 112.548 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.37 9.92 86.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.579 1.085 . . . . 3.27 115.34 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.02 154.09 48.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.001 1.401 . . . . 3.7000000000000002 110.727 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.56 113.13 24.79 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.51 -0.744 . . . . 2.9900000000000002 111.717 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.35 33.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 116.054 1.872 . . . . 3.96 116.054 -163.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.68 -63.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.365 2.666 . . . . 2.5499999999999998 114.105 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.75 108.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 131.581 3.952 . . . . 1.6899999999999999 107.6 -176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -110.54 -39.2 4.98 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.141 0.976 . . . . 3.9900000000000002 111.817 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -19.73 62.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.538 0.94 . . . . 1.3300000000000001 113.538 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -9.14 53.84 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.299 1.84 . . . . 0.84999999999999998 113.61 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.55 54.65 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.602 -1.312 . . . . 2.1600000000000001 112.629 -174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 179.47 51.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.897 0.76 . . . . 2.04 112.993 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.44 31.12 0.06 Allowed 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 114.197 1.184 . . . . 2.8300000000000001 114.197 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.6 tp 64.92 88.85 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.041 2.137 . . . . 2.5899999999999999 112.654 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -166.37 121.49 0.91 Allowed Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.136 2.174 . . . . 4.9500000000000002 110.619 163.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -90.57 -14.16 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.255 2.636 . . . . 2.48 114.118 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -154.33 -37.05 0.1 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.306 1.965 . . . . 6.0999999999999996 116.306 -159.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -60.33 -32.92 71.7 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.478 1.49 . . . . 4.1399999999999997 113.669 -163.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 t 171.78 -26.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.792 2.837 . . . . 3.0899999999999999 111.551 163.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 5.12 82.76 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.048 -1.033 . . . . 2.3700000000000001 115.287 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -74.44 -25.95 59.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 115.17 1.544 . . . . 7.0700000000000003 115.17 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.6 t60 99.03 145.79 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 129.35 3.06 . . . . 2.25 111.79 -168.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -119.58 -153.59 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 3.8599999999999999 112.85 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.81 -138.32 6.71 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 117.659 -1.634 . . . . 2.5800000000000001 109.37 -155.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.08 -27.2 65.48 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.016 2.477 . . . . 3.2599999999999998 113.96 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.66 -9.44 58.25 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.976 1.102 . . . . 5.9100000000000001 113.976 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.01 19.98 70.4 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 116.812 1.485 . . . . 4.0899999999999999 116.812 167.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.98 100.52 3.95 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.595 1.197 . . . . 6.1399999999999997 111.0 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.94 -34.92 0.13 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-O 117.193 -1.893 . . . . 3.2400000000000002 116.128 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -161.83 128.34 3.77 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.756 2.022 . . . . 4.5800000000000001 110.719 157.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.66 -21.42 66.11 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.132 1.16 . . . . 3.6000000000000001 114.132 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.66 23.0 9.41 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.801 1.191 . . . . 0.94999999999999996 114.91 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.15 134.3 41.4 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.075 1.437 . . . . 1.5800000000000001 110.444 165.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.28 161.08 62.49 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.385 1.874 . . . . 3.04 110.335 -168.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.89 167.84 25.52 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.572 2.848 . . . . 1.6499999999999999 112.317 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 m -75.79 147.17 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.845 1.307 . . . . 2.5299999999999998 113.89 -164.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.94 97.09 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 130.557 3.543 . . . . 3.75 108.397 -175.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 t -83.09 147.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.986 1.315 . . . . 0.96999999999999997 111.797 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.77 142.41 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.331 2.252 . . . . 2.5699999999999998 107.93 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.405 HD21 ' C ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -71.71 160.25 32.95 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.406 0.548 . . . . 2.3300000000000001 111.688 175.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -57.57 -4.17 0.24 Allowed 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 116.91 2.189 . . . . 3.3999999999999999 116.91 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -111.8 -11.23 13.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.263 1.425 . . . . 3.0 114.562 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.19 32.61 3.2 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 116.627 1.411 . . . . 0.89000000000000001 116.627 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.0 mt -121.3 135.89 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.543 1.537 . . . . 1.6499999999999999 108.62 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.24 130.14 55.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.247 1.019 . . . . 0.71999999999999997 110.14 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -148.98 10.06 0.79 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.811 2.152 . . . . 1.6899999999999999 116.811 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.58 130.59 40.74 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 120.349 1.431 . . . . 6.04 114.167 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.12 87.33 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.908 3.072 . . . . 2.04 111.742 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.2 t -72.31 160.3 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.295 1.438 . . . . 2.9500000000000002 108.993 172.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.5 m -142.82 131.88 23.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.653 -1.279 . . . . 1.9399999999999999 111.505 -171.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.02 91.23 49.71 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.205 1.002 . . . . 0.85999999999999999 113.4 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.34 2.46 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.227 3.285 . . . . 1.3 115.201 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -72.06 -26.33 62.14 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.025 0.83 . . . . 4.6799999999999997 111.555 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.86 151.51 26.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.673 2.389 . . . . 3.0299999999999998 108.822 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -138.21 12.81 2.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.989 1.315 . . . . 5.6200000000000001 114.044 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.6 t -160.76 152.24 19.36 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.98 -1.075 . . . . 2.8900000000000001 112.269 161.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.94 -28.55 62.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.204 -0.427 . . . . 2.1600000000000001 111.635 161.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -54.79 -28.73 51.26 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.105 0.962 . . . . 2.7999999999999998 112.813 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.17 -12.61 60.63 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.874 0.87 . . . . 2.3599999999999999 112.766 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.08 12.44 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.417 1.487 . . . . 0.85999999999999999 113.028 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -63.79 -1.71 1.49 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 117.224 2.305 . . . . 2.9300000000000002 117.224 -169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -146.15 19.97 1.4 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.249 1.82 . . . . 3.1499999999999999 111.941 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -104.8 -176.51 3.1 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.026 1.73 . . . . 2.3300000000000001 112.974 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.21 160.42 22.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.526 1.13 . . . . 0.83999999999999997 112.368 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 mt -126.63 141.4 51.86 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 129.136 2.974 . . . . 2.2999999999999998 106.038 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.26 138.8 48.02 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.129 0.877 . . . . 1.71 112.561 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -99.53 116.11 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.46 1.504 . . . . 0.92000000000000004 107.871 170.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -110.82 145.45 38.16 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.963 1.305 . . . . 2.8500000000000001 113.266 -162.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.53 -34.7 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.392 1.077 . . . . 1.5900000000000001 113.436 -154.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.2 151.87 18.3 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.978 -0.849 . . . . 1.4099999999999999 110.978 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -56.06 148.93 27.47 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.062 0.839 . . . . 1.8500000000000001 111.006 162.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -127.05 133.9 50.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.359 1.076 . . . . 3.3300000000000001 113.232 -159.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -156.48 10.02 0.24 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.794 2.437 . . . . 3.3500000000000001 111.637 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -83.76 66.71 9.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.007 1.114 . . . . 4.29 114.007 -157.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.5 p -75.23 30.91 0.1 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.075 1.139 . . . . 3.3300000000000001 114.075 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -165.62 147.15 7.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.745 2.018 . . . . 4.04 111.077 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 155.42 153.35 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 130.489 3.516 . . . . 4.3899999999999997 111.767 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -86.72 -17.15 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.26 3.307 . . . . 2.3500000000000001 112.863 163.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -91.33 144.02 29.12 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.878 1.271 . . . . 4.5499999999999998 110.339 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -73.5 160.01 45.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.178 2.586 . . . . 5.5700000000000003 113.228 -166.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.31 2.48 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.606 1.963 . . . . 6.6500000000000004 114.756 170.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.83 3.67 80.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.733 1.159 . . . . 4.2199999999999998 114.159 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.96 -65.65 4.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.279 1.418 . . . . 2.1400000000000001 112.958 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.47 64.33 Favored Glycine 0 N--CA 1.476 1.367 0 C-N-CA 124.278 0.942 . . . . 1.79 115.233 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.72 10.72 16.91 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.909 1.718 . . . . 2.52 115.582 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 p -71.39 156.05 39.92 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.581 1.691 . . . . 2.27 109.547 162.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.97 143.26 30.39 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.931 1.086 . . . . 7.2300000000000004 113.931 -173.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -99.63 -23.69 14.97 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.239 0.616 . . . . 3.7000000000000002 111.402 153.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.89 158.31 43.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.251 0.932 . . . . 0.58999999999999997 113.453 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.46 150.07 51.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.383 1.873 . . . . 1.6200000000000001 110.05 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 107.84 0.37 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.049 1.785 . . . . 0.84999999999999998 112.007 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.04 139.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.595 1.158 . . . . 3.75 110.722 165.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.69 117.82 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.788 -0.57 . . . . 2.3900000000000001 110.202 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 125.629 1.572 . . . . 5.2800000000000002 110.222 179.386 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 119.276 -0.392 . . . . 2.3700000000000001 110.627 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -155.47 140.6 17.46 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 119.625 -1.922 . . . . 1.5900000000000001 111.847 -172.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.33 146.4 21.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.542 1.163 . . . . 3.0600000000000001 111.881 166.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -109.55 116.94 32.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.571 1.549 . . . . 5.3600000000000003 113.423 -176.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -103.79 120.97 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.852 -1.155 . . . . 1.6699999999999999 110.822 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.8 108.63 2.99 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.557 2.027 . . . . 0.76000000000000001 112.159 178.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 35.0 mtt -90.43 139.17 30.93 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.953 1.834 . . . . 2.3399999999999999 115.953 -176.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -115.5 146.39 41.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.812 2.045 . . . . 3.0800000000000001 113.504 -174.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.98 63.08 4.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.555 1.542 . . . . 1.5700000000000001 113.066 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.8 105.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 120.929 -1.107 . . . . 1.8 113.006 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.3 t -132.3 73.29 1.52 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.017 0.927 . . . . 2.5899999999999999 112.424 -173.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 71.19 -47.3 0.66 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.839 2.456 . . . . 1.52 114.032 172.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.64 -12.58 61.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.819 1.248 . . . . 2.7799999999999998 112.085 174.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.67 -165.49 12.65 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.679 1.609 . . . . 1.3100000000000001 113.542 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.57 134.35 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.856 1.663 . . . . 1.47 110.547 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.34 -83.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.214 1.388 . . . . 2.6600000000000001 113.732 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -100.49 130.87 46.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.003 1.721 . . . . 3.6499999999999999 111.941 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -108.14 138.07 45.04 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.109 -0.994 . . . . 1.8 109.857 175.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mm -125.16 -16.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.86 1.43 . . . . 5.6399999999999997 114.86 -170.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.46 158.35 27.63 Favored Glycine 0 CA--C 1.521 0.467 0 O-C-N 121.518 -0.739 . . . . 1.29 111.907 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.431 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 2.6 p -88.34 173.98 8.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.062 0.934 . . . . 1.1100000000000001 109.219 163.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.1 132.91 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.896 -1.52 . . . . 0.64000000000000001 106.896 148.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.47 128.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 123.551 0.532 . . . . 1.96 110.174 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.48 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 125.283 1.433 . . . . 2.5800000000000001 108.208 -173.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.61 117.07 34.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 123.067 1.413 . . . . 1.8400000000000001 110.189 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.259 0.8 OUTLIER -81.95 122.03 27.25 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.205 3.402 . . . . 2.96 109.895 -169.481 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.0 t -144.2 178.44 7.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.17 0.986 . . . . 1.8200000000000001 111.12 -173.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -28.98 68.06 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.491 1.916 . . . . 4.71 110.357 -176.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 13.7 60.59 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.563 1.554 . . . . 1.1200000000000001 115.289 163.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.62 -151.17 21.15 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 127.627 2.537 . . . . 0.81999999999999995 116.552 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.54 101.2 4.8 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.869 . . . . 2.2599999999999998 111.53 -175.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.5 105.2 10.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.622 1.169 . . . . 2.3500000000000001 110.833 173.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -93.86 116.64 29.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.575 2.35 . . . . 0.78000000000000003 109.975 -172.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -123.36 112.55 29.65 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 119.824 1.193 . . . . 0.95999999999999996 108.824 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.53 159.45 10.86 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.169 3.246 . . . . 0.59999999999999998 111.996 -173.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 3.2 p80 -150.06 39.61 0.77 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.24 0.543 . . . . 1.6499999999999999 112.287 171.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.48 142.34 28.68 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.032 -1.668 . . . . 1.1000000000000001 112.828 -172.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 91.83 3.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.119 1.368 . . . . 2.3900000000000001 113.436 -171.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 133.1 103.47 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 130.404 3.481 . . . . 2.0 107.227 -171.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.523 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -160.84 160.01 25.18 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 131.603 3.961 . . . . 4.1100000000000003 106.67 167.103 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -63.48 140.27 75.01 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 O-C-N 122.64 0.81 . . . . 1.4299999999999999 110.094 157.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -86.67 31.48 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.554 2.836 . . . . 1.6699999999999999 113.513 -152.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.33 -177.44 14.99 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.154 1.359 . . . . 2.1499999999999999 113.527 -175.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -64.77 129.93 41.62 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 125.336 1.454 . . . . 3.3599999999999999 112.605 -168.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -125.57 131.34 52.75 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.594 1.158 . . . . 1.0800000000000001 110.209 -176.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.0 169.52 50.78 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 119.368 0.986 . . . . 0.64000000000000001 112.753 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 4.1 t80 -137.9 114.71 10.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.969 1.308 . . . . 3.27 108.827 174.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -118.61 163.27 17.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.987 1.477 . . . . 0.89000000000000001 114.987 163.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.17 144.46 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.825 1.65 . . . . 0.84999999999999998 108.311 155.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -119.02 157.16 28.33 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.276 1.03 . . . . 1.04 111.761 173.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -20.48 66.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 117.197 2.295 . . . . 0.71999999999999997 117.197 -162.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -132.43 -174.8 3.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.067 1.747 . . . . 1.3999999999999999 111.8 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 50.93 0.87 Allowed Glycine 0 N--CA 1.471 1.026 0 N-CA-C 116.316 1.286 . . . . 1.2 116.316 -160.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 t -157.89 110.95 2.44 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.513 1.656 . . . . 2.8799999999999999 112.595 167.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.99 5.19 0.1 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.588 2.355 . . . . 1.3700000000000001 116.945 -173.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -83.84 140.56 40.6 Favored Pre-proline 0 CA--C 1.546 0.821 0 O-C-N 120.461 -1.399 . . . . 3.9500000000000002 112.72 -167.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.84 148.84 12.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.04 3.16 . . . . 1.3100000000000001 112.215 173.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.38 21.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.757 0.823 . . . . 1.8100000000000001 111.204 156.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.1 mm -114.48 103.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.852 1.261 . . . . 2.9300000000000002 109.428 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HE2' ' OD2' ' A' ' 61' ' ' ASP . 16.5 mtpt -101.63 149.13 24.44 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.393 1.477 . . . . 6.3799999999999999 110.051 168.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.416 ' OD2' ' HE2' ' A' ' 60' ' ' LYS . 12.8 m-20 46.59 39.02 6.25 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.276 1.213 . . . . 4.25 114.276 161.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.6 25.38 75.27 Favored Glycine 0 CA--C 1.537 1.406 0 CA-C-O 118.291 -1.283 . . . . 3.21 115.556 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -156.07 158.25 37.46 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.395 2.098 . . . . 3.7000000000000002 112.98 -177.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.14 139.73 31.88 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.354 -0.841 . . . . 1.95 113.0 -173.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 m -85.36 13.8 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 114.862 1.43 . . . . 3.96 114.862 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.81 -51.41 0.7 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.849 2.46 . . . . 1.8 113.792 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.81 141.53 4.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.061 1.744 . . . . 2.1699999999999999 109.419 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.32 -50.99 1.99 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.969 0.508 . . . . 4.8700000000000001 111.424 173.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.3 1.24 6.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.549 1.314 . . . . 1.73 114.549 -177.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 -18.7 35.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.277 1.431 . . . . 0.91000000000000003 112.522 166.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 -177.22 53.79 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 122.565 1.092 . . . . 2.23 114.764 176.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.86 179.9 37.35 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.941 1.258 . . . . 1.95 113.669 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -69.51 5.06 1.49 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.042 1.867 . . . . 2.6299999999999999 116.042 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.3 tp 63.48 89.54 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.9 2.08 . . . . 2.52 109.697 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -159.96 23.1 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 117.473 2.397 . . . . 3.4500000000000002 117.473 -156.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -61.37 -26.01 80.91 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.336 2.691 . . . . 2.1600000000000001 116.552 -152.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -131.4 22.75 4.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.197 0.999 . . . . 4.2199999999999998 111.62 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -89.94 -58.98 2.32 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.815 -1.178 . . . . 3.4100000000000001 113.294 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 159.84 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.294 3.037 . . . . 2.6200000000000001 111.293 -175.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.07 61.88 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.087 -1.396 . . . . 2.02 115.336 176.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -72.14 -30.33 64.93 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.462 2.131 . . . . 6.0099999999999998 114.348 -175.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.9 t60 86.67 155.03 0.07 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 129.003 2.921 . . . . 1.6499999999999999 111.651 -166.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.74 -130.59 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.773 1.229 . . . . 3.8599999999999999 111.861 -173.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 145.11 -44.82 0.86 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 127.883 2.659 . . . . 2.8599999999999999 112.601 -174.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -111.39 -11.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.42 2.747 . . . . 3.2799999999999998 116.317 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -145.61 0.86 0.89 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.883 1.674 . . . . 4.5800000000000001 115.233 -153.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.99 -12.91 21.88 Favored Glycine 0 N--CA 1.476 1.345 0 O-C-N 120.462 -1.399 . . . . 4.3200000000000003 114.5 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.48 38.43 0.19 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.679 2.392 . . . . 6.5899999999999999 114.294 -166.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.94 -87.29 0.06 OUTLIER Glycine 0 C--N 1.342 0.902 0 O-C-N 120.427 -1.421 . . . . 2.5 114.911 -170.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -142.96 143.73 32.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.438 1.895 . . . . 4.5599999999999996 110.357 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -77.09 -14.43 59.81 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.829 1.195 . . . . 4.1100000000000003 114.013 170.171 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.63 3.37 79.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.296 -1.28 . . . . 0.98999999999999999 115.802 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -94.2 129.25 40.88 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 119.424 1.612 . . . . 2.6200000000000001 112.08 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -117.26 168.7 8.54 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.871 2.068 . . . . 2.8999999999999999 110.221 -177.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -81.44 167.4 17.3 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.066 2.51 . . . . 1.6100000000000001 111.859 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.64 137.87 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 115.829 1.788 . . . . 2.2200000000000002 115.829 -163.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.22 95.19 4.26 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 130.845 3.658 . . . . 2.52 110.059 170.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.34 131.26 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.919 -1.113 . . . . 1.1299999999999999 111.759 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -118.03 149.5 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 127.328 2.251 . . . . 3.8199999999999998 109.082 167.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.87 166.36 19.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.723 1.009 . . . . 2.6899999999999999 113.723 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -13.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 119.389 3.107 . . . . 2.5099999999999998 119.389 -178.224 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -119.77 -4.4 10.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.639 1.576 . . . . 4.1100000000000003 114.355 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.09 38.77 2.25 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 116.785 1.474 . . . . 1.22 116.785 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mm -126.6 130.84 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-N 119.507 1.653 . . . . 3.8500000000000001 111.903 166.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.46 132.64 37.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.931 1.292 . . . . 0.93000000000000005 111.17 174.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 t -151.66 -14.2 0.2 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.992 1.849 . . . . 1.9299999999999999 115.992 -170.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.33 133.02 43.31 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 120.398 1.454 . . . . 3.5899999999999999 112.117 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.73 146.74 24.04 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.862 3.042 . . . . 1.04 112.372 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.25 170.72 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.356 1.863 . . . . 1.52 110.005 172.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 m -135.68 140.76 44.71 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.152 0.887 . . . . 1.1599999999999999 110.971 -175.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.56 87.3 41.22 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.096 1.358 . . . . 1.05 112.305 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.82 -7.98 14.5 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.408 3.405 . . . . 1.6799999999999999 114.95 176.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -65.23 -27.27 68.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.426 -0.796 . . . . 4.9000000000000004 110.921 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.33 142.8 50.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.796 2.039 . . . . 3.3900000000000001 109.265 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 32.46 0.54 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.074 1.35 . . . . 7.2000000000000002 113.239 -166.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.6 m -179.81 136.21 0.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.134 2.574 . . . . 2.2599999999999998 109.867 162.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -32.67 63.34 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 118.946 0.794 . . . . 2.1899999999999999 111.321 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.8 -27.47 29.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.617 1.567 . . . . 3.2999999999999998 113.65 174.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.37 -28.98 68.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.184 0.902 . . . . 2.52 112.41 173.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.93 11.96 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.799 1.64 . . . . 1.1100000000000001 113.063 -161.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.08 -26.39 15.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.307 1.843 . . . . 2.8100000000000001 115.322 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -10.46 55.52 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.809 2.044 . . . . 3.77 114.587 177.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.24 168.84 9.95 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.986 1.476 . . . . 2.8300000000000001 114.986 -154.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.56 151.5 31.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.337 1.455 . . . . 0.68000000000000005 112.053 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.22 143.77 39.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.488 1.915 . . . . 2.2599999999999998 107.854 171.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.0 mtt -137.64 139.5 40.32 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.85 0.75 . . . . 1.5900000000000001 111.946 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.7 mt -100.41 126.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.569 1.548 . . . . 0.97999999999999998 108.346 171.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -105.85 149.26 26.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.995 1.318 . . . . 4.4199999999999999 113.43 -162.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.06 -43.0 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.924 0.89 . . . . 1.6399999999999999 111.827 -167.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.89 171.3 27.15 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.857 -0.897 . . . . 1.1899999999999999 110.857 158.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.45 -147.88 0.02 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.328 2.871 . . . . 2.2000000000000002 114.573 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.52 54.03 0.48 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 123.746 1.736 . . . . 3.25 112.114 -150.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -160.94 27.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.511 -1.677 . . . . 3.8700000000000001 111.655 -162.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 70.5 mtm -132.86 116.25 16.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.529 1.132 . . . . 3.6600000000000001 111.355 -162.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.415 ' N ' HE22 ' A' ' 137' ' ' GLN . 3.4 t -158.44 176.91 11.83 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.597 1.159 . . . . 3.4700000000000002 110.738 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 68.45 25.59 6.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.634 1.974 . . . . 3.77 114.012 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.415 HE22 ' N ' ' A' ' 135' ' ' SER . 0.0 OUTLIER -127.94 153.27 78.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.498 1.119 . . . . 4.0599999999999996 111.774 178.21 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 -13.85 31.6 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.781 2.987 . . . . 2.04 114.478 -170.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -100.07 87.11 0.68 Allowed Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 117.818 -1.087 . . . . 5.5499999999999998 108.596 157.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.77 151.95 60.38 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.933 2.422 . . . . 3.7200000000000002 111.562 -174.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mp 67.38 22.48 9.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 4.4699999999999998 110.301 -168.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.02 -7.58 4.26 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.569 1.557 . . . . 2.8599999999999999 114.612 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.81 1.35 87.2 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.096 1.332 . . . . 2.1299999999999999 114.011 -163.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.7 67.05 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-N 118.982 1.391 . . . . 1.8200000000000001 114.878 -175.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.59 12.58 7.77 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.564 1.554 . . . . 2.0099999999999998 116.704 -169.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.4 p -75.18 169.1 18.71 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.341 1.57 . . . . 2.25 110.196 169.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 137.82 51.15 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.5 1.12 . . . . 6.4400000000000004 111.97 -173.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 3.5 t80 -85.26 -26.21 26.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.686 0.676 . . . . 3.48 111.881 162.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.01 157.78 36.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.236 0.828 . . . . 0.55000000000000004 113.236 173.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.8 t -136.68 148.56 47.45 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.646 1.978 . . . . 1.5 110.768 175.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -148.69 121.8 1.38 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.042 1.306 . . . . 0.80000000000000004 113.038 178.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.02 135.43 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.851 1.66 . . . . 2.3300000000000001 110.911 175.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.6 mt -79.21 155.02 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.068 1.347 . . . . 1.1599999999999999 111.036 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? . . . . . 0 CA--C 1.544 0.718 0 O-C-N 119.997 -1.689 . . . . 4.1500000000000004 110.949 169.783 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.609 -0.886 . . . . 2.46 108.609 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -142.54 150.01 39.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.88 1.437 . . . . 1.4399999999999999 114.88 -133.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.04 141.25 17.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.468 1.128 . . . . 2.9500000000000002 109.825 167.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -90.67 135.39 33.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.617 -0.72 . . . . 3.6600000000000001 111.384 176.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.7 t -121.96 125.13 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.276 -0.89 . . . . 1.55 111.108 177.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.13 115.17 4.14 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.836 1.207 . . . . 1.1399999999999999 110.168 172.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.4 mtp -96.57 107.51 19.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.711 1.204 . . . . 2.02 109.695 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -93.98 146.21 24.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.813 0.671 . . . . 3.21 112.813 -169.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.4 62.75 1.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.378 1.071 . . . . 1.74 113.243 -175.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.6 m -58.54 131.84 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.507 -0.745 . . . . 1.74 111.121 171.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -150.2 48.31 0.91 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.243 1.021 . . . . 2.5800000000000001 110.943 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.04 -36.7 0.32 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 128.703 2.801 . . . . 1.54 112.004 -178.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.295 0.0 OUTLIER -78.28 41.84 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.248 1.419 . . . . 3.29 114.1 174.205 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.17 -155.97 41.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.855 1.217 . . . . 1.97 112.362 175.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.82 125.28 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.158 -1.053 . . . . 1.75 108.158 163.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.35 -82.06 1.55 Allowed Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.995 0.807 . . . . 2.1099999999999999 112.113 -166.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -158.37 164.83 35.95 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 122.389 1.09 . . . . 2.3100000000000001 112.579 167.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 t -103.16 146.76 27.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.758 1.623 . . . . 2.1800000000000002 112.373 -176.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 pt -148.72 10.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.623 1.569 . . . . 3.4500000000000002 113.516 -164.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.02 177.68 19.12 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.78 1.181 . . . . 0.85999999999999999 112.364 -165.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.442 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 3.8 p -129.47 -176.92 4.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.275 1.03 . . . . 1.27 109.984 170.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.6 t -126.52 136.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 124.273 1.029 . . . . 0.56000000000000005 108.367 159.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.56 133.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 123.198 0.312 . . . . 1.49 110.325 171.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mt -108.77 133.78 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.871 -0.789 . . . . 2.3700000000000001 108.871 168.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -139.04 96.6 3.14 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.343 1.857 . . . . 2.2000000000000002 110.068 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 141.65 57.36 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 127.301 2.24 . . . . 4.3399999999999999 111.597 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -156.39 177.52 11.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.745 0.783 . . . . 1.5700000000000001 111.286 175.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.54 -18.51 62.17 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 3.96 112.012 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 7.26 81.13 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.927 1.251 . . . . 1.21 115.355 166.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.78 -169.66 42.93 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 129.458 3.409 . . . . 0.89000000000000001 116.145 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.24 105.45 0.34 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.353 1.461 . . . . 0.93000000000000005 112.03 -175.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -84.75 113.4 21.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 2.6499999999999999 109.115 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -95.01 127.77 41.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.735 2.014 . . . . 0.90000000000000002 108.999 -177.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -137.64 109.77 8.69 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.501 1.501 . . . . 1.6100000000000001 109.715 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.9 162.99 18.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.775 2.983 . . . . 0.66000000000000003 111.335 -175.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.442 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 2.4 p80 -150.11 30.7 0.7 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.051 0.76 . . . . 1.74 113.051 174.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.06 140.82 29.47 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.672 -1.267 . . . . 0.96999999999999997 112.425 -173.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 26.74 9.82 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.082 1.882 . . . . 2.0099999999999998 116.082 -168.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.65 65.26 0.67 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.131 0.572 . . . . 1.5700000000000001 112.127 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.2 159.39 69.92 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 121.731 -0.606 . . . . 2.23 111.934 170.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -63.79 129.5 24.99 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 120.933 1.089 . . . . 0.88 111.286 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.46 37.53 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.583 1 C-N-CA 126.752 4.968 . . . . 1.24 113.251 -153.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.21 -135.4 7.31 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 123.52 1.622 . . . . 1.4299999999999999 112.165 -177.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -116.28 139.27 50.55 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.011 1.325 . . . . 2.5299999999999998 109.431 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -143.54 144.14 31.83 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.041 0.936 . . . . 1.6399999999999999 110.568 -168.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.95 160.85 52.21 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 110.262 -1.135 . . . . 0.94999999999999996 110.262 174.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 128.31 22.79 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 106.801 -1.555 . . . . 3.1899999999999999 106.801 166.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 93' ' ' ASP . 65.6 m170 -127.99 167.82 16.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.436 2.013 . . . . 1.23 116.436 173.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.7 146.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.716 1.606 . . . . 1.1899999999999999 109.679 151.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.89 161.27 32.23 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.677 2.791 . . . . 1.1200000000000001 108.849 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -26.44 67.32 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.118 2.266 . . . . 0.90000000000000002 117.118 -157.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -140.36 165.65 26.85 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.184 1.394 . . . . 2.0800000000000001 113.271 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.13 104.11 2.68 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 120.806 -1.184 . . . . 1.1799999999999999 114.801 -172.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m 177.56 -173.56 0.12 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.773 3.229 . . . . 3.4500000000000002 109.443 171.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.8 m -120.03 -23.84 6.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.1 1.36 . . . . 2.4100000000000001 113.843 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -76.23 142.51 71.89 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.14 1.163 . . . . 3.0600000000000001 114.14 -158.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.64 160.2 21.97 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.35 3.367 . . . . 1.3100000000000001 112.41 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.84 154.61 19.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.432 0.693 . . . . 1.9199999999999999 109.954 158.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.72 123.7 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.206 1.002 . . . . 2.7200000000000002 108.86 -178.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -169.12 159.76 9.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.498 1.919 . . . . 6.4000000000000004 109.379 -175.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 t70 58.39 27.82 15.94 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.862 -1.149 . . . . 4.3600000000000003 113.234 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.03 14.52 82.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.991 1.281 . . . . 2.7599999999999998 115.032 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -152.65 164.02 38.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.391 1.595 . . . . 3.4900000000000002 113.683 -168.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.71 113.75 26.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 2.1600000000000001 111.109 -178.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.76 57.25 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.785 2.034 . . . . 2.6200000000000001 110.932 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.48 -68.13 0.12 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.964 2.505 . . . . 2.8700000000000001 116.391 160.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -175.77 47.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.834 2.453 . . . . 2.3599999999999999 113.024 -167.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -59.48 -21.36 59.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.134 -1.604 . . . . 4.5099999999999998 113.658 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.38 -19.94 62.21 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 119.669 -1.894 . . . . 2.2799999999999998 112.874 170.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 -9.27 26.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.199 1.8 . . . . 1.3 113.606 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.63 165.21 32.65 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.018 -1.051 . . . . 2.9199999999999999 113.355 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.98 -173.09 23.98 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.855 -0.791 . . . . 1.77 112.752 168.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -44.66 138.92 3.14 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.515 0.726 . . . . 2.73 109.275 163.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 66.13 1.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.263 1.825 . . . . 4.4699999999999998 112.796 -165.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -110.06 83.79 3.2 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 129.002 2.921 . . . . 4.1299999999999999 108.226 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.36 -21.53 37.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.775 2.984 . . . . 3.2400000000000002 114.733 -176.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 6.26 0.24 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.293 0.849 . . . . 9.5600000000000005 113.293 153.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.71 -38.94 67.34 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.365 -1.46 . . . . 4.2599999999999998 114.828 -144.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t 169.26 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.267 2.227 . . . . 4.3700000000000001 112.078 -170.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.27 43.84 4.85 Favored Glycine 0 N--CA 1.47 0.931 0 CA-C-O 118.955 -0.914 . . . . 3.5699999999999998 113.077 176.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.316 12.9 ptmt -143.4 -101.08 0.12 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.912 1.449 . . . . 4.6200000000000001 114.912 -176.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.427 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -163.88 144.2 8.43 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 117.355 2.354 . . . . 2.6200000000000001 117.355 -157.533 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.64 -130.6 0.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.202 2.201 . . . . 4.0800000000000001 107.738 160.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.49 -89.59 0.56 Allowed Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.761 1.648 . . . . 2.96 111.868 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -98.33 -21.0 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.297 2.665 . . . . 3.1299999999999999 114.993 -172.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 157.77 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.684 3.194 . . . . 5.4199999999999999 110.427 -161.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.76 -151.6 28.1 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.532 1.539 . . . . 4.7199999999999998 114.592 -172.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.78 13.18 0.27 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.43 2.011 . . . . 7.6799999999999997 116.43 -160.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.08 -178.55 38.42 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 120.251 1.387 . . . . 2.79 113.071 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 57.32 96.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.246 1.818 . . . . 6.5899999999999999 115.007 170.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 65.37 6.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.693 -1.254 . . . . 3.77 110.938 169.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.03 7.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.789 -1.562 . . . . 2.3199999999999998 116.472 -176.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' ' CE1' ' A' ' 82' ' ' HIS . 3.2 m-20 -74.66 147.28 41.67 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.15 1.475 . . . . 1.8999999999999999 108.85 157.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.48 171.85 6.9 Favored Pre-proline 0 CA--C 1.555 1.151 0 O-C-N 121.314 -0.866 . . . . 2.6800000000000002 110.521 -142.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.89 133.21 19.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.326 2.018 . . . . 2.1200000000000001 110.403 -174.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.01 132.39 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 123.362 1.554 . . . . 2.29 112.766 -175.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -68.43 91.93 0.42 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.46 2.304 . . . . 3.79 110.253 168.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.14 131.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.028 -1.045 . . . . 1.2 109.133 166.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.77 133.55 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.407 1.883 . . . . 2.5600000000000001 106.915 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.41 154.57 22.73 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.808 0.731 . . . . 1.8600000000000001 112.359 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -24.17 0.4 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.924 2.565 . . . . 2.77 117.924 -167.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -93.22 -6.36 47.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.51 1.524 . . . . 2.9900000000000002 114.103 -176.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.25 20.71 8.48 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 125.072 1.32 . . . . 0.93000000000000005 115.487 175.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.71 127.81 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 118.161 0.98 . . . . 1.6399999999999999 109.984 -176.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.68 118.94 31.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 0.90000000000000002 109.291 169.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.1 t -135.48 4.45 3.13 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.963 1.305 . . . . 1.48 113.695 -178.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.01 119.74 69.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.856 1.662 . . . . 3.3500000000000001 112.982 -165.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.88 136.38 16.64 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.632 2.888 . . . . 1.21 112.402 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.97 173.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 126.557 1.943 . . . . 1.8700000000000001 109.848 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 m -145.5 140.26 27.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.537 1.062 . . . . 1.1599999999999999 110.971 -174.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.34 90.64 5.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.609 1.163 . . . . 0.70999999999999996 111.858 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.82 -2.61 11.21 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.09 3.193 . . . . 1.1699999999999999 115.293 -176.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.68 -15.95 61.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.379 1.472 . . . . 5.5599999999999996 112.396 176.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.09 145.31 49.99 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.67 1.988 . . . . 3.8700000000000001 107.684 175.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -147.44 32.9 0.88 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.603 2.361 . . . . 5.6299999999999999 111.625 -175.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -163.86 141.8 7.35 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.082 1.353 . . . . 2.3500000000000001 111.503 156.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.0 tp -65.96 -23.71 66.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.084 -1.01 . . . . 2.4900000000000002 110.685 175.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.07 -24.99 60.68 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.514 1.126 . . . . 2.6600000000000001 113.098 169.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -68.19 -15.87 63.75 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.641 1.11 . . . . 2.77 112.392 174.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.93 8.08 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 114.192 1.182 . . . . 1.01 114.192 -172.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -69.93 5.28 1.62 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 116.274 1.953 . . . . 3.9399999999999999 116.274 -171.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.46 9.09 3.98 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.137 2.175 . . . . 2.6899999999999999 112.195 177.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -110.45 -178.34 3.47 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.115 1.366 . . . . 2.54 114.311 -168.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.51 149.88 41.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.988 1.315 . . . . 0.87 111.8 172.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.07 154.24 17.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.669 1.988 . . . . 2.29 107.828 165.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.5 mtt -142.09 141.17 32.71 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.367 -0.833 . . . . 1.77 113.067 170.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.9 mt -88.34 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 108.18 -1.045 . . . . 1.25 108.18 165.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.21 152.64 47.12 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.205 1.557 . . . . 3.25 115.205 -165.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.06 -53.53 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.727 1.611 . . . . 1.8300000000000001 112.762 -159.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.56 179.39 52.44 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.573 -1.411 . . . . 1.3300000000000001 109.573 158.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.82 -143.87 0.03 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 127.236 2.351 . . . . 2.29 112.553 168.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.4 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 32.9 t0 -151.53 59.92 0.88 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.185 1.18 . . . . 3.5899999999999999 114.185 -169.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -149.31 21.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.219 1.008 . . . . 3.0099999999999998 113.564 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.06 142.71 52.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.017 1.327 . . . . 5.8899999999999997 112.672 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.4 p -85.04 166.49 16.65 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.88 1.272 . . . . 6.7400000000000002 112.864 172.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.92 142.43 51.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.814 0.846 . . . . 6.71 112.172 177.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.87 156.76 34.4 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.816 1.246 . . . . 4.5899999999999999 109.581 -160.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.03 -0.06 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.019 3.146 . . . . 2.6000000000000001 114.169 174.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -116.79 132.85 23.19 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.169 0.988 . . . . 7.5300000000000002 108.557 159.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.86 164.68 32.58 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.791 2.327 . . . . 3.96 112.286 -173.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt 69.55 4.84 4.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.814 2.046 . . . . 5.21 113.729 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.57 15.16 77.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.103 0.859 . . . . 3.48 113.359 -175.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.46 -51.52 3.34 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.537 1.541 . . . . 2.1299999999999999 113.757 -178.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.46 -10.5 73.62 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.333 1.444 . . . . 1.99 115.044 -176.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.49 42.44 1.97 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.653 1.597 . . . . 3.6299999999999999 113.937 -178.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.7 p -119.39 163.64 16.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 128.473 2.709 . . . . 4.4900000000000002 109.84 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.47 140.17 29.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.667 2.099 . . . . 7.2599999999999998 116.667 -166.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -98.99 -20.77 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.103 1.361 . . . . 4.2199999999999998 112.195 155.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.69 153.39 29.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.169 0.895 . . . . 0.81000000000000005 113.151 173.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 19.0 p -84.66 -149.86 0.12 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.723 1.609 . . . . 2.98 111.88 171.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.17 81.11 0.03 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.28 0.943 . . . . 1.6799999999999999 113.806 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.69 120.1 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.386 1.075 . . . . 2.98 111.568 176.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 71.2 mt -79.76 138.72 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.147 -0.686 . . . . 1.3200000000000001 109.147 173.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.549 0.939 0 O-C-N 120.503 -1.373 . . . . 4.6399999999999997 111.335 -176.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.379 -0.6 . . . . 2.4399999999999999 109.379 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -138.38 158.46 44.24 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.832 -1.167 . . . . 1.3300000000000001 114.089 -145.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -160.41 116.65 2.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.518 1.527 . . . . 3.4700000000000002 108.118 -175.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -90.46 143.14 27.04 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.884 -1.135 . . . . 5.1500000000000004 110.475 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.64 85.59 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 122.424 1.107 . . . . 1.52 111.707 177.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -32.07 114.52 0.08 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 127.252 2.358 . . . . 1.8500000000000001 113.131 147.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.8 mtt -101.9 148.41 25.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 113.79 -1.205 . . . . 2.0800000000000001 113.365 171.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.22 148.38 35.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 2.2999999999999998 110.647 168.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.1 mt -61.18 135.93 57.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.512 -0.922 . . . . 1.3200000000000001 108.512 166.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.5 143.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.423 1.089 . . . . 1.5 108.912 173.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -171.68 91.87 0.13 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.512 -0.921 . . . . 2.4399999999999999 108.512 -174.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.85 -62.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.943 2.097 . . . . 2.1299999999999999 113.507 -177.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.265 0.1 OUTLIER -80.76 12.62 3.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.91 1.684 . . . . 5.9299999999999997 114.859 -173.212 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.14 -151.02 32.77 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.221 0.915 . . . . 1.28 112.049 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.98 110.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.452 1.901 . . . . 1.21 111.835 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.58 -72.3 1.11 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.901 1.239 . . . . 1.7 113.636 -175.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.92 153.44 16.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.645 1.178 . . . . 2.4399999999999999 111.649 -175.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -92.97 145.22 24.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.014 1.726 . . . . 1.8500000000000001 114.523 -165.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 5.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 115.949 1.833 . . . . 4.4900000000000002 115.949 -177.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.74 175.54 20.58 Favored Glycine 0 N--CA 1.467 0.704 0 O-C-N 121.197 -0.94 . . . . 0.68999999999999995 113.86 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 m -115.34 156.51 25.36 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.975 1.31 . . . . 4.1799999999999997 108.859 172.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.49 133.43 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.889 -1.152 . . . . 0.68000000000000005 107.889 152.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -91.61 129.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 117.872 0.305 . . . . 1.3999999999999999 110.911 175.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mt -100.42 129.87 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.406 -0.961 . . . . 2.3900000000000001 108.406 170.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -133.21 123.55 25.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.272 1.029 . . . . 2.0600000000000001 109.279 167.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -78.56 157.98 28.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 112.252 0.464 . . . . 3.48 112.252 -177.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 t -156.36 178.49 10.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.906 0.86 . . . . 1.73 109.834 168.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -63.83 -13.42 44.47 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.419 2.288 . . . . 3.8599999999999999 113.137 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.22 8.73 53.47 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.104 1.812 . . . . 1.4299999999999999 115.437 165.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.68 -162.85 28.08 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 130.643 3.973 . . . . 0.93999999999999995 117.638 171.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.55 108.02 2.28 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.357 1.063 . . . . 0.80000000000000004 111.738 -172.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -85.98 109.75 18.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.41 1.084 . . . . 2.3999999999999999 110.209 173.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.8 t80 -94.29 112.81 24.63 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.375 2.27 . . . . 0.68000000000000005 108.835 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 m -120.1 112.31 34.84 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 120.003 1.274 . . . . 1.1499999999999999 108.58 -176.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.58 150.6 7.57 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.011 2.474 . . . . 0.59999999999999998 113.156 -171.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -147.51 41.98 1.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.356 1.074 . . . . 1.6299999999999999 112.547 171.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.19 156.51 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.707 1.603 . . . . 0.93000000000000005 113.845 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 167.0 18.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.131 -1.85 . . . . 3.3300000000000001 109.211 176.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.55 19.42 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.14 2.576 . . . . 1.6499999999999999 113.566 172.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.33 164.75 23.56 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 121.678 -0.639 . . . . 3.0 110.231 174.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.29 145.3 96.05 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 120.296 0.664 . . . . 0.93999999999999995 111.578 165.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -85.39 25.61 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 125.111 3.874 . . . . 1.25 114.253 -153.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.84 -141.1 6.7 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 125.216 1.389 . . . . 1.28 116.012 -174.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.3 141.92 29.06 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.67 2.388 . . . . 2.3999999999999999 110.451 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -136.18 137.66 41.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.463 1.105 . . . . 1.8600000000000001 111.449 -172.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 157.38 52.34 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.899 -1.126 . . . . 0.98999999999999999 111.631 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 8.4 t80 -130.98 112.92 13.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.155 -1.424 . . . . 3.29 107.155 173.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -118.48 162.21 18.72 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.127 -0.983 . . . . 1.1799999999999999 113.518 165.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.41 135.08 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.429 1.492 . . . . 0.92000000000000004 107.281 159.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -115.06 159.08 21.25 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.602 0.761 . . . . 1.1799999999999999 109.659 170.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.13 79.59 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.827 1.788 . . . . 1.01 115.827 -160.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.97 143.64 48.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.398 1.079 . . . . 1.3899999999999999 113.019 -173.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.55 62.18 2.75 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.512 1.53 . . . . 1.1499999999999999 114.941 -176.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -162.73 89.88 0.68 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.408 1.604 . . . . 2.5099999999999998 115.225 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.0 m -74.15 74.25 1.76 Allowed 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.041 -1.662 . . . . 2.7400000000000002 111.8 166.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -122.27 144.95 43.0 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.239 1.016 . . . . 3.2200000000000002 110.365 174.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.05 162.43 10.2 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.971 2.447 . . . . 1.53 113.831 -167.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.51 128.78 55.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.387 1.075 . . . . 2.0299999999999998 108.935 161.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mm -90.71 38.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.456 1.122 . . . . 3.2799999999999998 110.009 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -66.72 130.34 42.84 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.929 1.291 . . . . 4.8600000000000003 110.976 -167.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t70 57.65 21.76 7.58 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.148 1.166 . . . . 3.7200000000000002 114.148 -176.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.05 76.01 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.148 0.88 . . . . 2.9399999999999999 114.495 177.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.75 134.88 52.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.401 1.601 . . . . 3.48 110.71 172.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.74 95.11 9.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.319 -0.863 . . . . 2.0600000000000001 112.104 -169.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.73 95.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.596 1.558 . . . . 2.8300000000000001 108.594 173.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.4 -25.88 0.47 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 119.797 3.258 . . . . 3.3700000000000001 119.797 -156.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.67 38.06 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 120.128 1.331 . . . . 1.6299999999999999 114.267 -168.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.26 -34.12 73.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.224 1.01 . . . . 4.7699999999999996 113.076 -177.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.68 0.55 1.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.036 1.495 . . . . 1.6100000000000001 115.036 -175.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.57 -10.84 59.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.217 1.407 . . . . 1.1799999999999999 113.856 175.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.33 32.89 12.58 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 116.796 1.479 . . . . 3.1800000000000002 116.796 164.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.57 -178.58 31.54 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 119.452 1.626 . . . . 2.0299999999999998 114.457 174.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -76.2 22.58 0.16 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.197 1.554 . . . . 2.3700000000000001 115.197 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.254 31.1 tp 64.41 36.16 9.12 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.143 1.377 . . . . 2.6099999999999999 111.508 172.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -123.17 49.55 2.54 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 116.371 1.989 . . . . 3.6099999999999999 116.371 -161.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.33 -29.14 46.44 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.51 2.14 . . . . 3.1000000000000001 113.028 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -127.16 34.88 4.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.649 1.18 . . . . 4.4699999999999998 111.905 -168.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -119.84 -153.6 0.55 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.834 1.254 . . . . 3.3700000000000001 110.882 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.6 p -88.99 -25.17 22.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.271 1.428 . . . . 3.8700000000000001 113.174 175.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.31 88.78 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.392 0.996 . . . . 2.0299999999999998 114.74 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -98.05 7.94 45.53 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 116.116 1.895 . . . . 5.8399999999999999 116.116 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.7 t60 68.61 168.04 0.27 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.961 1.704 . . . . 2.46 112.768 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -150.17 155.25 39.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.793 1.405 . . . . 3.6000000000000001 114.793 -149.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.33 -155.06 6.89 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 126.291 1.9 . . . . 2.6000000000000001 112.873 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.26 -9.79 24.83 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.861 3.041 . . . . 4.5199999999999996 113.041 173.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.31 162.56 32.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.48 1.912 . . . . 6.3499999999999996 109.159 166.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.42 -159.71 23.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.28 0.943 . . . . 5.7199999999999998 112.84 -172.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.95 137.21 3.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.393 2.277 . . . . 5.5300000000000002 105.876 168.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.7 -72.87 0.02 OUTLIER Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.195 0.902 . . . . 2.77 114.282 -172.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -150.85 125.75 9.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.596 1.959 . . . . 4.9900000000000002 110.801 -173.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -62.45 -20.38 64.47 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.223 1.194 . . . . 3.7000000000000002 114.223 175.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.39 8.22 59.03 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.631 2.062 . . . . 1.3300000000000001 116.031 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.39 139.75 30.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.995 1.397 . . . . 1.6499999999999999 111.154 167.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.61 163.63 49.75 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 126.784 2.034 . . . . 3.1000000000000001 110.077 -172.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.77 162.43 26.91 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.141 2.561 . . . . 1.3600000000000001 112.304 -172.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.12 141.92 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.699 1.37 . . . . 2.2000000000000002 114.699 -164.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.12 107.09 18.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 130.675 3.59 . . . . 2.6400000000000001 108.682 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.34 137.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.907 -1.121 . . . . 1.0600000000000001 110.575 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.9 m -109.09 161.2 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.356 0.662 . . . . 3.3799999999999999 109.962 164.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.91 165.07 16.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.864 0.466 . . . . 2.0299999999999998 110.927 175.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.72 4.79 0.14 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 117.568 2.433 . . . . 4.04 117.568 -161.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -104.17 -11.08 17.48 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.27 2.628 . . . . 3.4500000000000002 113.395 176.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.49 24.48 12.26 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 121.365 -0.834 . . . . 1.04 114.675 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.5 mt -126.05 129.84 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.629 1.172 . . . . 2.04 110.92 -176.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.22 147.66 24.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.099 2.16 . . . . 1.1799999999999999 112.075 -172.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.97 -21.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.89 1.276 . . . . 1.7 114.057 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.53 116.95 50.61 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.457 1.103 . . . . 3.0600000000000001 110.447 176.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -85.07 163.13 11.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.592 2.862 . . . . 1.3400000000000001 112.349 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.85 161.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.723 1.209 . . . . 1.54 110.577 170.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 m -124.04 139.81 53.58 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.327 1.051 . . . . 1.1799999999999999 110.041 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.58 97.85 29.71 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.21 1.004 . . . . 0.91000000000000003 110.79 174.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.88 -0.8 10.36 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.925 3.083 . . . . 1.3600000000000001 114.333 -176.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -86.94 -2.76 58.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.627 1.571 . . . . 4.7800000000000002 112.696 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.1 mt -141.53 123.86 15.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.52 2.328 . . . . 3.5800000000000001 106.242 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -116.18 5.66 13.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.857 1.263 . . . . 5.3399999999999999 114.158 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.7 t -149.38 150.05 31.83 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.441 0.904 . . . . 2.5099999999999998 113.441 175.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.78 -28.68 70.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.377 -0.827 . . . . 2.1800000000000002 112.569 170.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.01 -18.57 65.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.065 1.302 . . . . 3.6699999999999999 113.58 -177.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.03 -19.49 61.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.338 1.055 . . . . 2.46 112.121 172.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.47 7.26 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.656 1.182 . . . . 0.92000000000000004 113.941 -170.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -63.68 5.67 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.263 2.32 . . . . 3.1899999999999999 117.263 -174.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.54 0.43 2.49 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.713 2.005 . . . . 3.0 112.607 -178.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -95.81 171.71 8.48 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.457 1.503 . . . . 2.2000000000000002 113.577 -168.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.73 150.28 27.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.511 1.124 . . . . 0.60999999999999999 111.984 165.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 mt -122.4 140.29 52.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.41 2.284 . . . . 2.25 107.803 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.463 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -143.23 146.81 33.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.418 1.008 . . . . 3.7599999999999998 113.599 177.937 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.8 119.14 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.274 1.43 . . . . 1.3200000000000001 108.301 166.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 126' ' ' MET . 74.6 m80 -98.57 148.44 23.78 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.672 1.589 . . . . 4.4000000000000004 112.013 -168.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.8 -46.37 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.173 0.589 . . . . 2.1200000000000001 112.144 -158.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.35 169.71 13.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.79 1.186 . . . . 2.0800000000000001 111.14 164.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.28 -174.6 4.68 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.216 1.865 . . . . 1.8300000000000001 113.433 170.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -159.91 166.22 30.58 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.787 0.835 . . . . 3.5299999999999998 111.914 -166.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.0 p30 159.04 23.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 132.721 4.408 . . . . 3.3900000000000001 111.625 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 72.9 mtm -92.37 106.84 18.76 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.897 -1.127 . . . . 3.9300000000000002 112.504 -165.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 p -93.05 158.86 15.56 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.656 -1.277 . . . . 4.0 113.903 169.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.2 t0 65.58 17.96 11.08 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.417 2.006 . . . . 5.4100000000000001 116.417 155.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.9 157.08 49.17 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 120.699 -1.251 . . . . 6.8799999999999999 113.675 -172.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.36 -21.75 3.52 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.667 2.911 . . . . 3.21 114.134 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -102.92 95.74 6.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.088 -1.007 . . . . 8.5899999999999999 108.382 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.65 143.78 75.99 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.566 2.177 . . . . 3.9100000000000001 111.504 -164.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 77.06 -10.74 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.472 2.709 . . . . 4.9000000000000004 113.013 -174.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 62.58 15.41 53.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 2.9700000000000002 115.66 170.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.1 -21.8 32.45 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.912 1.244 . . . . 2.6499999999999999 113.631 -170.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.89 -8.18 52.21 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.403 1.478 . . . . 2.79 114.009 176.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.69 -5.14 83.01 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.025 1.298 . . . . 2.3599999999999999 114.514 170.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.6 p -75.78 132.28 40.33 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.894 1.347 . . . . 2.5600000000000001 110.174 175.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -97.84 135.08 40.11 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.167 0.987 . . . . 7.3300000000000001 110.192 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -91.0 -40.04 11.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.047 0.385 . . . . 3.4500000000000002 110.326 164.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.52 29.26 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.909 0.884 . . . . 1.1399999999999999 111.931 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.2 m -114.73 145.03 42.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.891 2.076 . . . . 2.8700000000000001 111.233 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.74 167.65 26.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.919 1.723 . . . . 1.3700000000000001 113.225 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.9 t -135.54 141.91 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.738 1.215 . . . . 2.27 109.734 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.2 mt -89.06 143.47 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.738 1.215 . . . . 1.2 110.774 -176.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 5.2000000000000002 111.287 -177.27 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.238 0.542 . . . . 2.21 110.659 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -148.43 149.78 32.32 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.856 0.862 . . . . 1.52 110.362 -172.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.04 132.05 16.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.657 1.217 . . . . 2.23 110.053 171.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -88.56 109.79 20.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.179 0.992 . . . . 4.4699999999999998 111.559 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -87.02 105.51 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.609 -1.307 . . . . 1.8100000000000001 108.885 -169.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.38 108.81 1.8 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.651 1.596 . . . . 1.54 109.953 169.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.7 mtt -109.41 154.03 23.16 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.275 1.43 . . . . 2.1800000000000002 112.508 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -145.9 149.68 34.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.56 1.544 . . . . 3.0600000000000001 112.003 -169.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.41 66.1 3.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.953 1.301 . . . . 1.6000000000000001 111.435 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.25 144.83 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.698 0.799 . . . . 1.51 111.599 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.4 t -172.69 72.19 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.451 1.1 . . . . 2.0499999999999998 111.152 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.11 -19.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.866 2.066 . . . . 1.8799999999999999 114.834 173.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -28.86 66.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.479 1.912 . . . . 3.0600000000000001 110.006 164.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.47 -159.23 24.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.182 1.372 . . . . 1.3200000000000001 111.067 -154.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -46.15 127.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.411 1.884 . . . . 1.6000000000000001 111.122 165.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.79 -68.02 0.18 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.607 1.575 . . . . 1.6599999999999999 114.039 -173.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.156 1.382 . . . . 2.2599999999999998 110.543 171.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -109.25 172.23 6.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.737 -1.227 . . . . 2.1800000000000002 112.571 178.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.7 pt -151.19 5.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 128.98 2.912 . . . . 3.6800000000000002 112.479 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.53 159.37 9.08 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 121.137 -0.977 . . . . 0.92000000000000004 113.751 -161.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 p -125.99 -178.5 4.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.683 1.993 . . . . 1.98 106.74 173.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.52 125.83 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.359 -0.978 . . . . 0.60999999999999999 108.359 169.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.417 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.0 p -74.77 124.69 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 117.978 0.354 . . . . 1.5800000000000001 110.599 170.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -98.41 131.43 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 108.298 -1.001 . . . . 2.1499999999999999 108.298 163.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -140.05 121.47 15.05 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.132 1.373 . . . . 1.8100000000000001 108.572 178.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.74 150.26 21.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.801 0.667 . . . . 3.0499999999999998 112.801 -169.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.6 178.9 9.57 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.108 0.563 . . . . 1.5 110.546 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -60.53 -30.81 69.98 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.676 1.19 . . . . 3.6099999999999999 110.958 175.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.6 13.96 53.54 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.164 1.364 . . . . 0.97999999999999998 114.953 168.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.31 -148.49 20.71 Favored Glycine 0 N--CA 1.468 0.782 0 C-N-CA 127.167 2.318 . . . . 0.81000000000000005 116.268 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.2 mt -79.18 101.54 8.0 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.169 -0.606 . . . . 0.80000000000000004 110.862 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -75.73 112.37 12.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 3.54 109.587 171.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -98.79 109.07 21.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 128.02 2.528 . . . . 0.62 108.14 -178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.417 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.5 m -111.13 105.64 57.11 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.335 -1.357 . . . . 1.04 107.335 176.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.31 153.23 24.17 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.316 2.677 . . . . 0.84999999999999998 110.846 -171.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.97 63.37 0.65 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.177 0.989 . . . . 3.3700000000000001 111.013 178.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.25 141.78 51.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.057 2.143 . . . . 1.0700000000000001 111.528 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -129.32 20.82 5.71 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 118.029 2.603 . . . . 4.3399999999999999 118.029 -158.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.43 19.58 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 115.581 1.697 . . . . 1.8999999999999999 115.581 -173.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.78 165.35 19.12 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 121.492 -0.755 . . . . 3.0099999999999998 110.856 -171.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.95 131.26 26.65 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 N-CA-C 109.806 -0.882 . . . . 1.25 109.806 163.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -88.88 34.2 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.272 3.315 . . . . 1.28 112.402 -148.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.44 -122.54 4.8 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 123.821 1.79 . . . . 1.51 113.616 -178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -134.88 142.41 46.58 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 126.372 1.869 . . . . 3.1000000000000001 109.747 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -134.59 145.87 49.07 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.572 1.149 . . . . 1.3100000000000001 111.707 -173.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.82 157.16 26.72 Favored Glycine 0 CA--C 1.542 1.758 0 O-C-N 121.024 -1.048 . . . . 0.75 111.951 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -145.56 120.51 10.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.791 1.237 . . . . 3.3700000000000001 108.086 168.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.12 165.16 24.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.702 1.742 . . . . 1.27 115.702 164.077 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.0 mt -89.96 144.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.398 1.479 . . . . 1.1200000000000001 109.143 160.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -127.44 170.19 12.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.885 2.074 . . . . 1.3400000000000001 111.361 -178.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.98 52.74 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.99 2.218 . . . . 1.02 116.99 -160.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -110.51 -157.41 0.61 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.752 1.221 . . . . 2.7000000000000002 111.477 -175.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.12 -27.63 8.67 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 117.65 1.82 . . . . 2.3900000000000001 117.65 -155.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 175.8 140.12 0.06 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.963 2.382 . . . . 4.75 113.877 -173.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.58 67.08 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 117.354 2.353 . . . . 3.5800000000000001 117.354 -176.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -94.09 152.04 40.09 Favored Pre-proline 0 CA--C 1.55 0.963 0 O-C-N 121.053 -1.029 . . . . 3.4700000000000002 110.689 160.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -90.22 177.63 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.207 3.272 . . . . 1.8700000000000001 112.673 -168.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.67 147.21 37.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.995 1.318 . . . . 1.72 110.624 172.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.87 126.94 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.915 0.886 . . . . 2.8100000000000001 110.989 -174.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.86 156.47 22.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.706 2.402 . . . . 6.8200000000000003 110.73 173.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 52.09 37.33 21.23 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.078 1.51 . . . . 4.1799999999999997 115.078 167.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.88 79.38 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.003 -1.061 . . . . 2.7400000000000002 114.351 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.07 156.04 42.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.857 1.328 . . . . 5.6799999999999997 113.528 -176.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.77 121.78 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.647 0.779 . . . . 1.96 108.909 164.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.41 132.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.719 1.208 . . . . 3.0 108.567 171.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.3 -37.75 17.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.808 1.243 . . . . 2.1400000000000001 114.148 -172.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -179.98 123.74 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.465 2.706 . . . . 1.8400000000000001 110.307 175.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -121.49 -29.07 4.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.905 1.282 . . . . 4.2199999999999998 112.547 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.96 -0.29 8.98 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.202 -1.561 . . . . 1.8600000000000001 114.071 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.56 -17.46 33.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.734 1.614 . . . . 1.27 113.273 164.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.59 179.61 52.81 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.642 1.591 . . . . 2.5099999999999998 114.439 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.5 -172.8 25.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.946 0.784 . . . . 1.6200000000000001 112.864 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.94 24.07 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.047 1.739 . . . . 2.2000000000000002 115.627 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.9 tp 52.29 49.04 21.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.211 1.405 . . . . 2.6699999999999999 110.493 176.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -151.49 110.8 2.98 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.433 -0.803 . . . . 4.29 112.634 -171.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -91.72 -18.96 0.84 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.012 2.475 . . . . 3.2400000000000002 113.766 174.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -159.25 -22.56 0.07 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.938 1.829 . . . . 4.1399999999999997 115.938 -163.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -64.76 -35.86 82.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.751 1.614 . . . . 3.5800000000000001 112.366 -171.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -165.91 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.991 2.517 . . . . 4.3600000000000003 111.263 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.18 11.14 70.12 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.515 1.531 . . . . 2.3900000000000001 112.73 -177.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -167.16 -105.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.245 1.818 . . . . 6.4100000000000001 113.033 -166.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -161.43 141.57 10.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.727 1.751 . . . . 2.7400000000000002 115.727 -161.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.43 149.83 36.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.092 0.957 . . . . 4.0 113.293 174.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.52 -145.63 17.88 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 110.316 -1.114 . . . . 3.4900000000000002 110.316 156.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.39 17.56 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.996 3.131 . . . . 3.9199999999999999 114.253 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.63 -11.08 8.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.691 1.596 . . . . 4.7800000000000002 114.429 -157.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.14 -7.68 81.58 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 116.955 1.542 . . . . 4.5099999999999998 116.955 169.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -78.02 83.16 4.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 1.585 . . . . 6.5700000000000003 109.383 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.8 -177.1 14.89 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 123.936 0.779 . . . . 4.0499999999999998 114.812 -168.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.529 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 5.4 p-80 -92.04 157.92 16.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.693 0.797 . . . . 7.0499999999999998 111.274 169.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -10.12 12.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.118 1.525 . . . . 4.5 115.118 -179.151 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.529 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -115.24 19.9 14.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.798 2.142 . . . . 1.5800000000000001 113.753 173.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -73.86 135.12 43.36 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.42 1.11 . . . . 2.5099999999999998 109.491 164.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.01 160.48 31.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.16 1.384 . . . . 2.7000000000000002 110.294 -147.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.11 168.77 20.07 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.216 3.277 . . . . 1.4399999999999999 111.633 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 m -82.0 142.89 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 122.894 1.33 . . . . 2.1299999999999999 113.374 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.76 92.73 3.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 129.061 2.944 . . . . 2.75 109.204 172.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 95.9 t -74.75 137.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.875 0.87 . . . . 1.3100000000000001 110.366 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.99 143.22 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.427 2.291 . . . . 2.3799999999999999 106.305 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.8 164.49 12.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.858 0.754 . . . . 2.0499999999999998 111.701 174.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.64 -23.82 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 129.597 3.159 . . . . 2.9399999999999999 118.112 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.88 -23.5 52.61 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.935 1.694 . . . . 3.9700000000000002 112.463 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.46 17.73 32.91 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.948 1.737 . . . . 0.88 112.941 -161.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.1 mt -111.81 119.99 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.962 1.305 . . . . 1.48 110.966 -176.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.84 127.52 39.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.775 1.23 . . . . 1.1399999999999999 109.732 168.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -156.2 4.49 0.17 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.233 1.568 . . . . 1.6399999999999999 115.233 -175.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.22 135.9 26.39 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 119.81 1.186 . . . . 3.5800000000000001 110.638 172.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.0 141.72 49.14 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.017 3.145 . . . . 1.3 112.189 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.09 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.823 2.049 . . . . 2.5699999999999998 108.151 173.019 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.4 m -145.96 139.64 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.931 1.241 . . . . 0.85999999999999999 111.707 -178.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.01 94.06 5.05 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.26 1.024 . . . . 0.81999999999999995 112.462 169.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.79 -5.07 16.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.133 3.222 . . . . 1.3500000000000001 113.933 172.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -73.11 -7.92 53.45 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.146 1.778 . . . . 5.75 111.863 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.6 mt -124.28 177.16 6.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.735 2.414 . . . . 3.5899999999999999 109.821 170.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -144.39 -20.69 0.54 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.012 1.856 . . . . 4.8099999999999996 116.012 -172.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -144.03 163.25 34.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.847 1.203 . . . . 1.99 112.399 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.23 61.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.285 -0.884 . . . . 2.4700000000000002 110.297 174.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.95 -27.68 69.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.378 1.071 . . . . 3.1299999999999999 113.503 -166.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.48 -20.36 62.09 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.753 1.621 . . . . 2.21 113.869 175.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.33 8.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.374 1.47 . . . . 1.1699999999999999 112.984 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -62.08 -4.41 1.67 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.107 1.891 . . . . 3.23 116.107 -175.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -137.67 24.26 2.88 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.318 2.247 . . . . 3.0099999999999998 110.814 -160.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -130.68 158.44 40.06 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.332 1.453 . . . . 2.2000000000000002 113.931 -168.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.76 150.65 20.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.097 1.759 . . . . 1.0900000000000001 112.987 168.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.4 mp -127.36 121.01 29.82 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.043 2.137 . . . . 4.2300000000000004 109.86 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -103.06 131.65 49.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.786 0.835 . . . . 2.9100000000000001 111.405 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.6 mt -93.52 123.38 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 107.818 -1.179 . . . . 0.85999999999999999 107.818 160.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -112.89 140.86 47.33 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.427 1.491 . . . . 2.9100000000000001 112.262 -159.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.03 -41.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.555 -0.716 . . . . 1.6899999999999999 111.585 -168.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.23 163.57 15.0 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.493 0.568 . . . . 1.46 112.135 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.22 87.72 1.49 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.08 -1.208 . . . . 1.8500000000000001 110.08 173.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -61.78 122.61 15.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.797 0.839 . . . . 4.2999999999999998 111.645 178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 171.81 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.239 2.616 . . . . 4.1799999999999997 109.662 -157.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.9 ptp -74.15 60.42 0.79 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.345 1.458 . . . . 4.0300000000000002 112.192 171.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 t -74.08 -20.38 60.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.186 1.794 . . . . 4.04 115.111 -165.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -81.87 76.18 8.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 3.3599999999999999 112.269 -173.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -169.56 156.69 6.42 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.08 1.352 . . . . 3.9199999999999999 111.78 -179.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.89 -9.65 18.15 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.711 2.941 . . . . 3.2000000000000002 113.64 176.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -93.2 106.12 18.45 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 119.229 0.922 . . . . 5.29 109.0 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.46 160.22 47.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.104 2.536 . . . . 3.7200000000000002 113.274 -158.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.58 32.22 21.92 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.834 1.654 . . . . 4.4900000000000002 111.501 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.34 67.45 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.668 1.128 . . . . 3.0800000000000001 114.333 -177.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.94 -17.0 18.34 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.156 1.36 . . . . 1.98 113.242 -164.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.92 8.24 60.6 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.006 1.765 . . . . 1.5700000000000001 114.844 -176.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.49 68.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.302 1.43 . . . . 1.72 115.801 -170.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -58.47 154.46 13.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.181 1.49 . . . . 1.8899999999999999 110.482 168.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 mmt-85 -96.39 138.47 33.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.388 1.075 . . . . 4.6299999999999999 109.453 -176.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.86 -18.8 16.22 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.955 0.798 . . . . 4.7800000000000002 111.774 154.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.31 168.79 25.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.537 1.135 . . . . 0.88 111.409 164.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -152.98 153.26 32.58 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.057 1.343 . . . . 1.8700000000000001 110.697 172.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -153.17 178.67 30.1 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.181 1.372 . . . . 1.6899999999999999 114.305 -175.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 139.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.05 1.34 . . . . 3.5600000000000001 111.302 -171.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 76.2 mt -92.86 143.03 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.44 1.096 . . . . 1.49 109.613 171.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt . . . . . 0 N--CA 1.471 0.62 0 O-C-N 120.67 -1.269 . . . . 4.3899999999999997 112.508 177.128 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.717 -0.846 . . . . 1.96 108.717 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.22 156.12 47.32 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.167 1.349 . . . . 1.6499999999999999 114.187 -148.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.68 127.54 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.897 1.679 . . . . 2.3199999999999998 108.872 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -103.31 98.82 8.68 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.684 1.993 . . . . 4.96 109.708 -174.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -87.77 129.45 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 114.177 1.177 . . . . 3.4900000000000002 114.177 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.47 103.78 0.73 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.672 1.129 . . . . 1.0 111.057 167.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.31 110.97 13.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.942 1.297 . . . . 2.3300000000000001 109.971 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -108.66 147.15 32.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 2.5800000000000001 111.4 -170.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.21 61.18 2.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.981 -1.075 . . . . 1.3999999999999999 113.192 -171.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.87 154.86 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.281 1.432 . . . . 1.8600000000000001 113.211 -177.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -169.97 -152.97 0.1 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.602 1.561 . . . . 3.3300000000000001 109.295 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -11.82 2.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 129.03 2.932 . . . . 1.5900000000000001 116.06 -175.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.82 0.49 32.74 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.953 1.301 . . . . 4.1900000000000004 112.057 174.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.67 -147.15 21.08 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.695 1.14 . . . . 1.51 110.458 -165.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -54.23 134.89 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.732 2.013 . . . . 1.5600000000000001 112.808 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.28 -112.29 3.66 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.757 1.646 . . . . 1.2 112.803 -175.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.89 166.97 20.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.834 0.817 . . . . 2.3999999999999999 111.555 168.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.6 t -93.33 148.98 21.57 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.264 1.026 . . . . 2.6699999999999999 113.192 -174.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 pt -142.1 2.23 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.296 1.438 . . . . 3.4500000000000002 113.915 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.33 170.25 22.8 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.042 -1.036 . . . . 0.72999999999999998 112.703 -173.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.422 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 14.4 p -107.66 178.73 4.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.023 0.929 . . . . 1.1100000000000001 110.332 171.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.56 132.54 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.526 -1.287 . . . . 0.45000000000000001 107.526 152.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.9 p -85.09 119.92 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.72 0.638 . . . . 1.54 109.77 174.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -102.65 130.23 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.227 -1.397 . . . . 1.9399999999999999 107.227 174.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -136.78 120.5 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.725 0.81 . . . . 2.3199999999999998 111.232 176.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.41 140.73 48.53 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.247 0.619 . . . . 3.6899999999999999 111.58 178.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -143.57 -179.92 6.73 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.387 1.075 . . . . 1.79 108.649 164.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -68.03 -28.29 67.27 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.675 2.39 . . . . 5.21 111.812 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.45 17.87 54.41 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.016 1.769 . . . . 1.55 114.639 162.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.88 -159.01 26.38 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 127.365 2.412 . . . . 1.0800000000000001 118.411 164.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.97 104.08 8.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.736 0.815 . . . . 0.78000000000000003 111.371 -168.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -79.94 110.43 15.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.763 1.625 . . . . 3.0800000000000001 110.217 174.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.403 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 4.0 t80 -99.06 118.73 36.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.294 2.238 . . . . 0.57999999999999996 109.475 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.408 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 78.7 m -124.82 111.98 27.24 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-N 119.292 0.951 . . . . 2.0299999999999998 109.103 176.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.83 165.21 17.8 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.6 2.867 . . . . 0.62 111.008 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 1.5 p80 -151.0 25.89 0.72 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.495 0.718 . . . . 1.5600000000000001 112.099 173.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.87 148.23 25.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.498 1.119 . . . . 1.1399999999999999 113.33 -170.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 144.5 49.47 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.974 1.31 . . . . 2.3999999999999999 108.56 168.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.93 45.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 128.203 2.601 . . . . 2.04 112.514 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.76 160.98 40.25 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.433 1.093 . . . . 2.6899999999999999 110.537 169.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.26 125.55 14.22 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 121.124 1.216 . . . . 1.1899999999999999 110.375 169.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -80.47 74.5 5.51 Favored 'Trans proline' 0 N--CA 1.451 -1.015 1 C-N-CA 125.413 4.075 . . . . 1.8500000000000001 109.925 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.88 -173.76 13.2 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 116.343 -2.837 . . . . 1.6699999999999999 111.932 132.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -56.81 140.61 47.37 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.003 1.321 . . . . 2.75 111.668 175.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -136.83 125.47 23.77 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.902 1.281 . . . . 1.4099999999999999 112.746 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.04 149.91 3.26 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.325 0.964 . . . . 0.81999999999999995 113.229 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.403 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.2 t80 -132.4 132.03 42.41 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.598 1.559 . . . . 3.3100000000000001 106.82 176.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -136.1 168.63 19.02 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 114.867 1.432 . . . . 1.01 114.867 170.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.6 139.51 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.664 1.586 . . . . 1.1399999999999999 109.545 158.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.55 165.24 13.79 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.962 2.105 . . . . 1.0600000000000001 111.358 177.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.86 64.43 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.141 1.534 . . . . 0.83999999999999997 115.141 -159.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -123.73 152.44 42.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.929 0.892 . . . . 1.8500000000000001 113.074 178.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.95 79.81 1.82 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 125.596 1.57 . . . . 0.98999999999999999 110.975 174.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -166.53 59.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.46 0.704 . . . . 4.2699999999999996 112.523 -165.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.8 m -67.2 66.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.284 1.834 . . . . 1.8600000000000001 113.115 173.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -130.53 156.53 79.52 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.219 2.208 . . . . 3.8700000000000001 108.315 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.16 133.88 15.35 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.005 1.803 . . . . 1.29 110.216 176.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 176.38 6.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.058 -0.974 . . . . 3.3799999999999999 109.917 161.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -103.2 128.62 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.887 -0.783 . . . . 6.3399999999999999 108.887 165.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -94.45 -71.31 0.67 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 118.644 -0.694 . . . . 8.5199999999999996 109.244 161.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.75 106.66 9.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.209 1.403 . . . . 4.71 109.124 169.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.73 -44.9 0.65 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.501 2.0 . . . . 5.1600000000000001 116.852 174.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.14 158.41 18.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.222 1.409 . . . . 3.1099999999999999 114.026 -161.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.93 95.98 4.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.961 1.704 . . . . 2.4700000000000002 111.867 -171.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.92 80.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.93 0.872 . . . . 4.1799999999999997 112.159 -177.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 46.28 -104.7 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.869 2.467 . . . . 2.1699999999999999 114.928 163.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.15 25.13 9.74 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.401 1.48 . . . . 2.1800000000000002 111.979 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -81.67 11.49 4.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.519 1.127 . . . . 8.5500000000000007 113.501 -174.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.64 -6.61 57.47 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.143 -0.973 . . . . 2.5699999999999998 112.677 158.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.21 23.8 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.684 1.594 . . . . 1.3 114.311 175.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.15 4.0 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.5 1.524 . . . . 3.6499999999999999 115.646 167.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.14 -176.85 30.26 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.791 1.186 . . . . 1.95 112.486 -171.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -81.33 62.29 5.17 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 2.46 110.532 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.8 tp 25.21 65.6 0.05 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.627 2.371 . . . . 2.4700000000000002 112.537 -174.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -127.14 60.65 43.57 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.038 2.135 . . . . 4.8300000000000001 112.057 -158.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.47 -41.16 9.25 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.387 2.058 . . . . 2.6400000000000001 109.994 169.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -152.9 165.64 34.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.283 1.833 . . . . 5.7000000000000002 110.03 167.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 140.88 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 1 C-N-CA 132.706 4.402 . . . . 3.75 113.209 163.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t 150.99 -56.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 130.726 3.61 . . . . 3.0800000000000001 110.785 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.09 -11.26 69.51 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.342 1.449 . . . . 2.4300000000000002 115.093 -178.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.48 -25.04 61.86 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.749 1.775 . . . . 4.8300000000000001 115.243 -176.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.416 ' CE1' ' CG ' ' A' ' 93' ' ' ASP . 24.7 t60 75.44 126.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.393 2.677 . . . . 2.6800000000000002 113.354 176.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 -57.13 2.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.824 0.849 . . . . 7.4500000000000002 112.873 165.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.62 -85.13 0.38 Allowed Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.291 -1.283 . . . . 4.9100000000000001 110.208 -156.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.38 -128.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.857 3.705 . . . . 6.7599999999999998 111.863 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.73 51.25 1.34 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.498 -1.376 . . . . 10.800000000000001 114.693 -159.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.14 -107.55 0.5 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.443 1.021 . . . . 3.4900000000000002 111.198 167.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -16.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.259 1.024 . . . . 5.3200000000000003 113.505 171.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.11 92.39 1.15 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.378 0.99 . . . . 3.8599999999999999 111.897 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 71.42 97.84 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.896 2.078 . . . . 6.6500000000000004 113.711 162.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -16.61 64.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.506 1.669 . . . . 4.5300000000000002 115.506 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.84 8.55 79.31 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.81 1.671 . . . . 1.3300000000000001 113.979 175.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' CG ' ' CE1' ' A' ' 82' ' ' HIS . 72.8 m-20 -80.57 155.05 27.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 3.3799999999999999 109.93 153.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.54 154.54 21.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 121.029 -1.044 . . . . 2.48 111.609 -133.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.04 143.1 64.29 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.705 2.937 . . . . 1.24 111.89 -171.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.45 133.49 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.724 0.81 . . . . 2.79 111.473 -163.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.84 99.41 2.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.832 2.053 . . . . 2.8199999999999998 109.044 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.0 t -78.23 121.6 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.496 -0.753 . . . . 1.1200000000000001 109.811 177.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.81 131.41 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.654 1.982 . . . . 2.7400000000000002 108.361 175.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -81.05 148.24 29.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.643 0.656 . . . . 3.3100000000000001 112.275 175.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -40.03 -25.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.338 3.055 . . . . 2.75 117.035 -172.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.01 -19.76 62.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.608 1.963 . . . . 4.1100000000000003 113.444 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 31.8 6.24 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.309 1.433 . . . . 1.01 112.852 -172.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.98 145.02 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.954 1.702 . . . . 1.4399999999999999 108.581 -168.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -124.82 114.85 19.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.059 1.343 . . . . 0.88 110.968 -177.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -125.94 -9.75 6.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.437 1.273 . . . . 2.0699999999999998 114.437 172.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.8 120.04 79.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.833 0.742 . . . . 3.1400000000000001 110.744 -167.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -85.62 153.8 10.33 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.716 2.944 . . . . 1.1200000000000001 112.632 -174.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.08 164.39 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.975 1.71 . . . . 1.49 110.146 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.9 m -137.23 136.39 38.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.648 1.113 . . . . 0.98999999999999999 110.316 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.34 99.79 13.85 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.964 0.906 . . . . 0.88 112.159 175.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.21 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.249 3.299 . . . . 1.0900000000000001 114.79 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.89 5.74 13.01 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.379 0.991 . . . . 5.7199999999999998 112.648 174.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.4 mt -140.92 171.94 13.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 129.244 3.018 . . . . 3.5299999999999998 107.571 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.34 2.35 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.612 1.708 . . . . 8.0899999999999999 115.612 -174.24 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -147.38 156.15 42.63 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.092 -1.005 . . . . 2.29 112.203 176.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.42 -26.03 63.48 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.204 -0.935 . . . . 2.25 111.336 161.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.18 -44.31 79.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.508 1.123 . . . . 4.0099999999999998 113.032 -173.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.68 -8.39 34.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.336 1.454 . . . . 2.5499999999999998 113.446 177.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.52 20.51 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.897 1.279 . . . . 1.04 113.591 -177.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -68.09 -6.17 21.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.945 2.202 . . . . 3.4700000000000002 116.945 -172.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.72 39.37 1.67 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.897 1.679 . . . . 3.4399999999999999 110.668 178.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -117.55 149.1 41.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.453 1.101 . . . . 2.2000000000000002 112.853 -175.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.72 133.12 33.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.409 1.084 . . . . 0.92000000000000004 111.23 166.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.14 136.06 46.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.06 -1.089 . . . . 4.1200000000000001 108.06 165.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.0 mtt -132.1 133.42 44.3 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.217 0.607 . . . . 1.5700000000000001 111.984 -167.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.31 132.95 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.909 1.283 . . . . 0.83999999999999997 108.294 168.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 142.41 50.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.738 2.015 . . . . 3.25 110.387 -159.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.73 -46.86 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.209 -0.932 . . . . 2.02 111.732 -168.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.11 138.68 20.98 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 118.467 0.576 . . . . 1.6499999999999999 111.859 175.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.06 146.94 49.11 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.773 1.654 . . . . 1.45 111.85 167.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -95.4 76.04 3.35 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.379 0.881 . . . . 2.9300000000000002 113.379 -156.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -163.66 56.23 0.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.182 0.993 . . . . 3.79 112.025 -171.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.28 119.31 5.42 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.91 -1.119 . . . . 2.7400000000000002 113.27 -171.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 t -146.5 -170.23 3.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.46 1.904 . . . . 3.4700000000000002 110.538 -178.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 71.35 -41.24 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 129.147 2.979 . . . . 3.6699999999999999 114.636 169.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -60.57 150.44 74.63 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 4.2400000000000002 111.707 173.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.01 -21.09 72.98 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.204 2.603 . . . . 2.4500000000000002 112.739 176.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -101.02 89.4 1.27 Allowed Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.836 0.854 . . . . 5.9000000000000004 109.923 158.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.9 161.16 43.57 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.484 . . . . 4.3099999999999996 110.243 172.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 60.53 9.45 2.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.956 1.302 . . . . 4.0899999999999999 111.953 -164.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 68.36 3.85 34.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.635 1.112 . . . . 3.3300000000000001 113.69 -167.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.12 3.27 58.99 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.322 1.439 . . . . 2.52 114.036 -164.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.79 42.37 1.3 Allowed Glycine 0 N--CA 1.476 1.341 0 C-N-CA 127.148 2.309 . . . . 1.9099999999999999 116.04 -173.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.1 71.36 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.34 0.972 . . . . 2.7599999999999998 113.437 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 p -61.4 136.81 58.16 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.591 1.956 . . . . 2.5099999999999998 112.075 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -99.29 162.29 13.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.858 1.663 . . . . 5.1699999999999999 110.974 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -118.68 -19.36 8.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.153 0.797 . . . . 3.79 113.153 151.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.34 163.05 30.99 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.885 1.221 . . . . 0.56000000000000005 114.05 173.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.2 t -132.27 144.02 50.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 1.6299999999999999 110.786 164.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -132.17 101.43 0.46 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.872 2.177 . . . . 1.3400000000000001 109.571 168.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.25 130.12 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.565 1.146 . . . . 2.4500000000000002 108.789 172.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 15.2 mt -60.4 127.7 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.404 0.681 . . . . 1.6499999999999999 111.625 -178.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 10.9 mmpt? . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 113.148 0.795 . . . . 4.2199999999999998 113.148 178.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.624 0.249 . . . . 4.1799999999999997 110.616 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -151.82 130.92 12.66 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.67 -1.233 . . . . 2.23 107.67 174.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -126.21 111.13 14.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.173 0.989 . . . . 3.46 110.722 -171.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 23' ' ' VAL 0.284 0.1 OUTLIER -79.41 77.32 5.97 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.122 -0.986 . . . . 4.79 111.214 174.47 . . . . . . . . 4 4 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.1 120.62 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.501 -0.75 . . . . 1.4399999999999999 110.133 -169.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.56 99.32 0.9 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.446 1.498 . . . . 0.81000000000000005 111.088 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.3 mmm -75.34 97.68 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.719 1.208 . . . . 2.8599999999999999 110.197 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.57 141.55 41.1 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.653 -0.654 . . . . 2.5499999999999998 110.717 174.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.95 131.17 44.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.878 0.871 . . . . 1.1699999999999999 109.208 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 m -143.43 160.71 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 113.498 0.925 . . . . 1.3799999999999999 113.498 -175.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -172.76 -159.06 0.11 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.369 2.668 . . . . 3.0899999999999999 107.886 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.84 62.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.539 1.936 . . . . 1.98 113.822 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -72.31 -9.43 58.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 3.8199999999999998 112.531 171.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.37 -135.27 13.05 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.54 1.064 . . . . 1.24 111.192 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.65 132.33 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 1.5900000000000001 110.702 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.13 -104.51 2.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.747 1.642 . . . . 1.23 112.84 -175.131 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.73 168.69 19.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.569 1.147 . . . . 2.48 110.372 170.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.7 t -98.14 137.91 36.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.832 -1.168 . . . . 2.0600000000000001 111.576 178.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.92 5.1 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.092 1.357 . . . . 3.4900000000000002 113.935 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.08 172.44 32.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.777 2.608 . . . . 0.85999999999999999 112.395 166.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.476 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.8 p -96.91 175.69 6.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.322 0.649 . . . . 1.0 110.084 169.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.75 130.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.795 -1.187 . . . . 0.68000000000000005 107.795 151.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 4' ' ' LYS 0.258 9.2 p -84.97 113.26 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.352 0.596 . . . . 1.5 111.447 178.004 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.9 mt -87.26 127.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.542 -1.208 . . . . 1.5800000000000001 108.012 169.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -132.22 124.89 29.85 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.71 1.204 . . . . 1.8799999999999999 109.329 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -83.11 142.65 31.1 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.865 0.466 . . . . 4.1699999999999999 111.624 -174.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -157.82 -179.19 7.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.7 0.8 . . . . 1.75 110.411 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.61 -15.73 63.62 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.136 -0.977 . . . . 3.7599999999999998 112.543 177.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.81 6.61 79.61 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.57 1.081 . . . . 1.21 115.153 163.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.04 -141.09 18.25 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 127.183 2.325 . . . . 1.23 114.82 174.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.49 96.22 3.44 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.553 1.141 . . . . 0.90000000000000002 111.659 -175.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -76.38 111.46 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.675 1.19 . . . . 2.3999999999999999 109.483 172.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.02 116.96 29.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.305 2.242 . . . . 0.59999999999999998 109.867 -175.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -130.81 114.12 16.52 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 120.257 1.389 . . . . 1.1599999999999999 110.674 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.95 162.53 7.43 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.089 2.526 . . . . 0.98999999999999999 113.099 -171.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.476 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 1.9 p80 -151.43 29.88 0.62 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.955 0.902 . . . . 1.5900000000000001 112.798 171.157 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -92.91 150.46 20.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.963 1.305 . . . . 1.1299999999999999 112.658 -171.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.18 27.09 4.84 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.008 1.855 . . . . 2.2200000000000002 116.008 -168.346 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.52 79.9 0.73 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.868 0.867 . . . . 1.6000000000000001 112.387 174.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.36 161.44 47.44 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 124.2 1.0 . . . . 2.3999999999999999 112.479 173.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.6 134.7 45.54 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.267 1.311 . . . . 1.24 111.806 175.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -88.01 23.19 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.921 2.414 . . . . 1.23 115.126 -144.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.78 -153.05 11.48 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.874 1.226 . . . . 1.27 115.974 -172.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -78.47 150.97 32.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.463 2.305 . . . . 2.8900000000000001 111.157 171.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -149.13 141.23 23.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.923 0.889 . . . . 1.78 112.221 -173.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 153.16 51.67 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 109.561 -1.416 . . . . 0.66000000000000003 109.561 164.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.14 102.51 3.38 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.101 -1.444 . . . . 3.4399999999999999 107.101 169.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -106.82 171.07 7.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.076 1.51 . . . . 1.0600000000000001 115.076 178.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -101.33 131.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.511 1.524 . . . . 0.85999999999999999 108.689 160.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -108.23 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.802 1.241 . . . . 2.98 110.669 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.09 63.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.144 1.535 . . . . 0.89000000000000001 115.144 -161.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -127.23 151.32 48.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.648 1.179 . . . . 2.29 111.919 173.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.1 81.76 1.69 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.581 1.086 . . . . 1.24 113.193 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 t -170.24 138.59 1.64 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.146 0.978 . . . . 2.5899999999999999 113.227 173.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.1 m -79.11 -5.15 53.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.038 1.735 . . . . 1.9399999999999999 114.217 172.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -78.58 132.89 64.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 O-C-N 120.081 -1.637 . . . . 3.5 113.159 -160.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -79.39 170.03 17.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.514 2.809 . . . . 1.4099999999999999 111.684 172.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -119.16 165.24 14.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.482 1.513 . . . . 1.98 110.196 167.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.66 134.34 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.259 1.023 . . . . 2.96 111.207 -167.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -156.54 134.56 11.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.62 1.568 . . . . 6.75 108.704 173.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.4 t0 55.05 46.72 23.58 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.841 0.856 . . . . 5.0999999999999996 112.19 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.68 7.27 58.17 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.884 1.113 . . . . 3.8199999999999998 115.884 173.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.75 162.26 33.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.855 1.327 . . . . 4.2400000000000002 111.764 -176.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.42 125.93 53.74 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.229 1.012 . . . . 2.1899999999999999 112.254 -167.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.01 24.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 116.512 2.041 . . . . 4.2300000000000004 116.512 -164.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.5 8.23 2.14 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 117.015 2.228 . . . . 2.2200000000000002 117.015 170.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 137.26 115.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 1 C-N-CA 132.278 4.231 . . . . 2.0699999999999998 110.081 165.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.78 -37.76 4.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.564 1.145 . . . . 4.0899999999999999 110.32 172.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.18 -6.6 6.93 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.252 1.204 . . . . 1.3700000000000001 114.252 177.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.32 -14.99 62.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.811 1.245 . . . . 1.3999999999999999 113.292 168.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.8 51.63 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.805 -1.184 . . . . 3.1200000000000001 115.111 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.09 -172.55 55.26 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.699 1.142 . . . . 2.27 112.25 -169.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -65.31 138.85 58.45 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.277 -1.131 . . . . 2.5 111.387 174.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.69 119.87 13.78 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.28 0.632 . . . . 2.7200000000000002 112.067 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.97 125.87 5.06 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.02 2.128 . . . . 4.7599999999999998 110.97 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.04 -19.98 3.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.455 2.77 . . . . 4.4500000000000002 115.218 178.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 155.6 14.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 128.249 2.62 . . . . 4.0700000000000003 114.608 -170.134 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.2 -38.78 71.47 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.317 -1.489 . . . . 3.3199999999999998 112.401 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.2 t 157.01 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 131.204 3.802 . . . . 3.4399999999999999 110.621 177.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.45 1.77 66.11 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.416 1.008 . . . . 2.2200000000000002 114.248 179.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -73.25 -30.42 63.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.097 1.448 . . . . 4.4400000000000004 114.72 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.2 t60 117.2 148.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 130.853 3.661 . . . . 2.1600000000000001 112.806 -171.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -143.56 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.035 1.734 . . . . 3.9399999999999999 110.052 173.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.91 -132.56 9.93 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.244 -1.309 . . . . 2.5099999999999998 113.168 167.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.83 -17.45 22.74 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.934 3.09 . . . . 4.0800000000000001 114.885 -167.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -171.75 149.15 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.439 1.895 . . . . 5.6500000000000004 109.682 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.01 -145.2 16.92 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.375 0.988 . . . . 4.5499999999999998 113.242 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.16 145.52 4.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.353 2.661 . . . . 6.8300000000000001 106.324 -179.278 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.34 -20.81 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 CA-C-O 117.057 -1.968 . . . . 3.1400000000000001 116.627 173.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -152.22 118.57 5.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.346 1.573 . . . . 4.79 110.199 160.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.25 -12.42 41.04 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.306 1.595 . . . . 3.6000000000000001 115.306 177.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.56 -4.92 90.15 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.995 1.283 . . . . 1.1799999999999999 115.067 173.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -74.91 153.98 38.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.756 0.823 . . . . 1.6299999999999999 110.828 168.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.37 161.6 29.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.86 1.264 . . . . 2.6299999999999999 109.733 -149.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.56 157.78 57.81 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.489 2.792 . . . . 1.3200000000000001 111.86 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.72 143.13 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.223 1.011 . . . . 2.1400000000000001 113.22 -173.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -88.97 123.07 32.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.998 2.119 . . . . 3.5299999999999998 110.057 172.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.76 136.34 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.437 0.695 . . . . 1.27 109.833 172.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.2 158.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.459 -1.312 . . . . 3.5499999999999998 107.459 160.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.74 159.56 17.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.64 0.978 . . . . 2.1299999999999999 113.64 -174.488 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -41.94 -17.91 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 129.79 3.236 . . . . 2.96 117.726 177.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -97.24 -13.52 21.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.62 1.568 . . . . 2.5099999999999998 113.928 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.55 22.95 8.64 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.121 1.343 . . . . 0.81000000000000005 115.291 177.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.06 135.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.496 1.518 . . . . 1.77 110.228 -178.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.08 120.39 34.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.315 1.446 . . . . 1.0 110.686 -179.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t -150.45 16.04 0.8 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.452 1.101 . . . . 2.1099999999999999 113.962 -169.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -113.05 130.18 23.81 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.966 0.906 . . . . 3.8900000000000001 110.998 177.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.13 158.35 52.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.619 2.879 . . . . 1.3899999999999999 110.885 175.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.46 166.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.38 1.872 . . . . 3.3999999999999999 107.557 169.587 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.1 m -140.15 136.58 33.65 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.223 0.92 . . . . 0.95999999999999996 108.982 171.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.94 87.96 9.36 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.388 1.075 . . . . 1.1299999999999999 111.192 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.48 23.63 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.931 3.754 . . . . 1.1299999999999999 114.146 -179.01 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 -94.01 -20.68 19.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.95 1.3 . . . . 4.6200000000000001 112.045 174.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.11 135.47 53.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.838 2.055 . . . . 3.79 107.155 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -92.38 -38.68 11.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.521 0.728 . . . . 6.3300000000000001 111.775 -177.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.31 154.32 51.57 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.393 1.627 . . . . 3.8100000000000001 115.393 -172.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.38 -42.73 70.68 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.379 1.071 . . . . 2.5600000000000001 110.891 170.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.17 -21.89 3.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.266 1.826 . . . . 4.4199999999999999 113.478 177.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.43 -13.06 38.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.262 1.025 . . . . 3.3900000000000001 113.061 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 m -120.74 7.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.025 1.73 . . . . 1.1399999999999999 113.484 -178.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -43.64 -15.08 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.804 3.241 . . . . 4.2000000000000002 117.643 171.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -128.24 3.37 5.76 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.117 2.567 . . . . 5.1200000000000001 113.378 -167.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -127.07 174.37 8.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.834 1.254 . . . . 3.0499999999999998 113.719 -168.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.89 143.07 47.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.227 1.011 . . . . 0.78000000000000003 112.454 179.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.0 mt -73.46 155.37 39.32 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.451 1.5 . . . . 2.8300000000000001 108.437 156.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 19.2 ttm -147.05 122.58 10.42 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.75 -0.594 . . . . 2.5699999999999998 110.677 158.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.3 mt -80.25 122.55 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.513 -1.291 . . . . 1.01 107.513 171.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -100.81 147.47 26.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.134 2.174 . . . . 3.2400000000000002 111.763 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.25 -54.78 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.302 -0.874 . . . . 2.0800000000000001 110.129 -171.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.8 164.41 39.2 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.547 -0.621 . . . . 1.1899999999999999 111.547 166.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.1 -144.05 0.03 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 129.162 3.268 . . . . 2.27 115.036 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -162.95 69.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.682 1.993 . . . . 2.9700000000000002 107.663 -170.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -157.45 14.92 0.25 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.295 -1.32 . . . . 4.54 113.958 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.8 149.58 16.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.924 1.29 . . . . 5.2999999999999998 112.185 174.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.9 m -128.99 -170.58 2.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.907 1.283 . . . . 4.0899999999999999 111.834 -168.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.41 -26.48 0.18 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 128.452 2.701 . . . . 4.8499999999999996 115.955 158.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -70.01 146.41 95.04 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.23 1.812 . . . . 4.3799999999999999 111.195 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.41 -32.16 50.54 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.352 2.702 . . . . 2.7599999999999998 113.281 -171.271 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -80.38 115.19 53.2 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.23 0.923 . . . . 5.3300000000000001 108.906 160.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.75 152.14 82.46 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.23 2.62 . . . . 3.23 112.336 -172.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp 59.52 22.51 11.1 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.852 1.661 . . . . 5.1100000000000003 111.444 -169.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.83 14.85 66.03 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 120.958 -1.089 . . . . 3.5800000000000001 113.508 -172.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 108.49 -7.93 34.61 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.722 1.63 . . . . 2.2799999999999998 114.037 -168.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.83 10.75 1.07 Allowed Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.358 1.579 . . . . 1.95 116.178 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 -12.41 73.56 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.207 1.504 . . . . 1.8600000000000001 114.426 175.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.8 p -74.88 147.84 40.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.293 1.837 . . . . 2.29 112.555 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -110.17 150.07 29.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.563 1.545 . . . . 5.1799999999999997 111.076 -172.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -106.93 -39.16 5.84 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.241 0.46 . . . . 3.9300000000000002 112.241 160.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.36 144.73 24.03 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.382 1.623 . . . . 0.68999999999999995 115.382 -175.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.5 t -100.51 137.99 38.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.968 2.507 . . . . 1.5 111.307 173.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -133.46 87.11 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.56 1.553 . . . . 1.1399999999999999 112.124 175.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.17 130.41 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.808 1.804 . . . . 2.2000000000000002 110.656 173.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 mt -100.64 154.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 126.468 1.907 . . . . 1.7 110.279 -172.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.52 0 C-N-CA 126.108 1.763 . . . . 5.8200000000000003 110.408 174.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.381 -0.599 . . . . 3.71 109.381 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.23 152.04 28.83 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.257 -0.902 . . . . 2.0099999999999998 109.086 -175.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -144.57 116.19 8.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.332 1.539 . . . . 2.48 112.825 176.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -78.8 82.95 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 127.606 2.362 . . . . 3.7000000000000002 110.569 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -75.79 110.99 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.057 -1.027 . . . . 3.1600000000000001 112.28 -177.228 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.6 100.48 0.49 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.404 1.954 . . . . 1.1899999999999999 110.81 177.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 mmt -72.85 125.52 27.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.849 1.66 . . . . 2.52 112.399 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -101.62 153.61 19.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.786 0.803 . . . . 2.4300000000000002 110.923 157.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.9 mt -58.48 143.57 45.23 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.347 1.459 . . . . 1.3600000000000001 109.18 163.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 m -141.6 166.1 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.065 0.946 . . . . 1.5800000000000001 111.535 172.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 t -172.38 -161.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.616 2.366 . . . . 3.2200000000000002 108.176 -177.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.93 14.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.449 2.7 . . . . 2.3300000000000001 114.507 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.06 -12.5 10.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.058 1.343 . . . . 3.2200000000000002 111.349 172.655 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 -146.25 19.8 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 119.197 0.908 . . . . 1.8600000000000001 110.893 -167.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 82.0 t -62.28 126.38 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.228 1.811 . . . . 2.2999999999999998 112.423 -177.07 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.28 -133.19 6.44 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.539 2.019 . . . . 1.4099999999999999 113.17 177.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.09 145.64 46.34 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 124.52 1.128 . . . . 3.1600000000000001 110.811 176.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.7 t -75.19 133.58 41.4 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.713 -0.617 . . . . 2.79 109.438 164.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 tt -116.36 -37.05 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 127.908 2.483 . . . . 5.0599999999999996 111.546 -174.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.29 -178.83 38.08 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.39 -0.909 . . . . 1.46 113.443 -145.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 171.06 12.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.97 -1.122 . . . . 1.3200000000000001 107.97 148.657 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t -120.58 132.01 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 106.471 -1.677 . . . . 0.71999999999999997 106.471 144.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 17.7 m -83.99 129.51 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 C-N-CA 119.744 -0.782 . . . . 4.4800000000000004 109.803 172.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.45 125.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.623 -0.881 . . . . 1.8600000000000001 108.623 175.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.68 126.9 30.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.736 1.214 . . . . 2.4700000000000002 109.96 178.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.78 141.79 29.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.797 0.839 . . . . 3.8399999999999999 112.946 -172.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -149.63 -176.61 5.47 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.897 0.879 . . . . 1.47 109.684 174.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -75.54 -11.98 60.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.272 -0.892 . . . . 4.1600000000000001 112.488 174.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.41 7.04 69.78 Favored Glycine 0 N--CA 1.477 1.411 0 O-C-N 120.758 -1.214 . . . . 1.1399999999999999 114.312 157.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.62 -145.58 26.42 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 127.819 2.628 . . . . 0.78000000000000003 114.598 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.4 109.46 7.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.187 0.595 . . . . 0.84999999999999998 110.704 -173.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -82.78 106.68 14.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.348 1.059 . . . . 2.2999999999999998 110.397 174.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.429 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -85.85 110.11 19.16 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.044 1.338 . . . . 0.84999999999999998 108.345 175.614 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HB ' ' CG2' ' A' ' 23' ' ' VAL . 33.4 m -114.6 98.78 50.28 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 119.718 1.144 . . . . 1.48 108.792 178.066 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -85.73 153.51 10.16 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.244 3.296 . . . . 0.89000000000000001 111.497 -172.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -150.66 41.22 0.77 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.998 0.904 . . . . 1.5 112.725 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mp -93.02 148.95 21.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.273 1.829 . . . . 1.1499999999999999 112.193 -176.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.86 40.25 2.16 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.24 1.57 . . . . 2.02 115.24 -169.265 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.33 48.53 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 1.3899999999999999 112.207 -175.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.04 161.0 47.07 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 121.261 -0.9 . . . . 2.1800000000000002 112.466 176.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.26 131.09 36.92 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.595 1.53 . . . . 1.3400000000000001 110.18 171.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -90.46 30.64 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.722 1 C-N-CA 126.567 4.845 . . . . 1.5 112.176 -151.976 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.79 166.68 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 125.582 1.563 . . . . 2.1400000000000001 109.762 173.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -67.44 143.8 56.06 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.889 0.875 . . . . 2.8900000000000001 112.814 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -129.69 150.83 50.84 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.076 1.35 . . . . 1.3 111.614 -172.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.84 163.5 24.23 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.519 0.6 . . . . 0.66000000000000003 113.486 168.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CZ ' ' CG ' ' A' ' 33' ' ' PHE . 9.4 t80 -140.76 119.86 12.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.15 1.38 . . . . 3.5099999999999998 108.398 176.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -134.76 149.12 50.38 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.433 -0.792 . . . . 0.93999999999999995 112.521 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.3 136.61 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.607 1.963 . . . . 1.1699999999999999 107.792 165.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -132.8 133.84 43.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.201 1.0 . . . . 1.5900000000000001 110.652 -163.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.19 65.67 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.628 2.084 . . . . 0.84999999999999998 116.628 -155.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -118.97 152.3 36.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.988 0.915 . . . . 1.6799999999999999 112.688 167.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.98 59.75 4.48 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.647 1.118 . . . . 1.1499999999999999 112.45 170.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 m -148.73 63.9 1.06 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.818 1.044 . . . . 3.8100000000000001 113.818 -157.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.8 m -65.39 26.66 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 116.452 2.019 . . . . 1.74 116.452 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -78.14 139.13 60.53 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 119.919 -1.738 . . . . 3.8900000000000001 110.788 175.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.31 143.19 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.753 2.302 . . . . 1.3899999999999999 111.211 174.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 128.87 35.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.914 0.486 . . . . 2.5099999999999998 110.461 172.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.44 125.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.215 1.006 . . . . 2.8199999999999998 110.694 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -166.09 128.17 1.92 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.386 0.674 . . . . 5.7699999999999996 112.74 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 57.77 52.88 7.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.655 1.582 . . . . 4.8099999999999996 114.1 169.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.78 77.48 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.082 -1.011 . . . . 3.6400000000000001 114.544 175.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.94 -164.08 1.35 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.41 1.884 . . . . 4.7800000000000002 109.178 -177.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.34 144.71 23.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.222 -0.924 . . . . 2.8599999999999999 112.651 -177.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 t -80.82 98.78 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.97 0.908 . . . . 2.8999999999999999 109.934 -172.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.97 97.59 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.392 2.277 . . . . 3.4300000000000002 115.105 -170.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.45 30.73 17.29 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.524 1.93 . . . . 2.21 114.27 174.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.65 -32.36 73.82 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.271 0.841 . . . . 5.3799999999999999 113.271 -178.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.48 -15.62 50.96 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.898 1.073 . . . . 2.3799999999999999 113.898 -175.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -3.46 13.9 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.312 1.445 . . . . 1.25 113.585 172.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.22 -171.32 32.34 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.943 1.247 . . . . 2.4900000000000002 113.53 175.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.57 -167.0 39.74 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.74 1.162 . . . . 2.3500000000000001 112.189 165.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -74.13 40.06 0.12 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.551 1.94 . . . . 3.29 112.833 -178.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp 49.82 61.45 3.16 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.904 1.682 . . . . 2.5600000000000001 109.854 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -121.65 51.02 2.53 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.299 1.839 . . . . 3.9300000000000002 114.419 -163.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.2 -18.91 39.42 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.862 3.041 . . . . 2.27 115.865 -166.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.0 31.79 0.06 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.35 0.977 . . . . 4.7999999999999998 112.46 -171.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.03 -60.41 1.68 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.655 0.983 . . . . 3.73 113.655 -163.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 t 167.99 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.317 2.647 . . . . 4.0199999999999996 108.54 -162.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.95 -30.93 8.93 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.857 0.741 . . . . 3.23 113.03 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 11.7 ptmt -88.74 -177.89 5.64 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 117.88 0.84 . . . . 4.8700000000000001 112.138 173.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -124.88 164.89 19.07 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.888 1.07 . . . . 3.0699999999999998 113.888 -155.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -138.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.449 1.1 . . . . 4.5700000000000003 111.478 -179.072 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.51 -138.09 18.48 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 109.067 -1.613 . . . . 2.8900000000000001 109.067 -158.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.08 -32.08 64.52 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.344 2.03 . . . . 3.5800000000000001 113.456 -171.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.03 -1.54 57.17 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 6.0099999999999998 113.43 -176.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.43 -12.56 0.93 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 118.316 2.086 . . . . 3.71 118.316 167.001 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -84.33 44.85 1.06 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.182 1.491 . . . . 5.9800000000000004 114.393 -163.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.63 -147.67 6.33 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 117.477 1.751 . . . . 2.8300000000000001 117.477 -168.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -118.15 154.49 32.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.827 1.651 . . . . 4.8399999999999999 112.297 -157.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.16 -27.22 65.34 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.475 0.917 . . . . 2.98 113.475 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.4 21.6 16.74 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.58 -1.122 . . . . 1.01 114.581 176.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -97.35 136.07 38.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.874 1.337 . . . . 1.79 111.063 169.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mp -136.6 165.9 31.7 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 125.676 1.59 . . . . 3.4100000000000001 109.345 -172.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.99 161.08 13.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.026 2.484 . . . . 1.3100000000000001 111.387 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.18 133.82 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.334 1.54 . . . . 2.04 115.044 -164.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 87.01 2.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.096 2.558 . . . . 2.6099999999999999 109.319 170.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.99 133.01 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.139 0.576 . . . . 0.94999999999999996 110.809 175.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.7 136.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.956 2.102 . . . . 2.7200000000000002 106.408 173.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.49 162.99 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.425 -0.321 . . . . 2.3700000000000001 111.834 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.69 -22.52 0.08 Allowed 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 117.899 2.555 . . . . 2.5699999999999998 117.899 -177.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -7.67 52.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.462 1.905 . . . . 2.6499999999999999 113.45 -176.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.22 30.39 11.04 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 124.274 0.94 . . . . 0.88 114.197 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.0 mt -124.29 133.57 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.17 1.388 . . . . 1.54 110.165 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.6 139.03 40.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.958 1.703 . . . . 0.79000000000000004 111.205 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -151.15 -11.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.588 2.44 . . . . 2.3100000000000001 117.588 -166.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.83 117.97 53.39 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 121.459 1.936 . . . . 4.2000000000000002 113.619 -172.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.01 78.01 2.63 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.951 3.1 . . . . 2.5699999999999998 110.216 171.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.57 148.78 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.747 1.619 . . . . 4.9800000000000004 109.908 175.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.36 139.18 52.53 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.956 -0.757 . . . . 1.8400000000000001 108.956 160.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -124.87 99.73 34.73 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.646 0.779 . . . . 1.04 111.922 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.31 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.184 3.256 . . . . 1.49 113.761 178.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -31.47 72.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.909 0.884 . . . . 5.6500000000000004 111.134 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.17 151.86 37.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.548 2.739 . . . . 3.2000000000000002 106.868 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -135.35 11.98 3.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.301 1.223 . . . . 5.3200000000000003 114.301 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -150.25 169.09 22.16 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.999 -1.688 . . . . 2.8300000000000001 111.011 160.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.05 -43.32 11.79 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.104 -0.997 . . . . 2.4500000000000002 112.104 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -64.85 -19.55 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.897 1.073 . . . . 3.04 113.897 -176.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -16.21 63.98 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.626 0.973 . . . . 2.5 113.626 171.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.2 24.07 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.942 1.697 . . . . 1.3600000000000001 112.802 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -53.95 -9.14 0.22 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.654 2.465 . . . . 4.0999999999999996 117.654 178.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.68 50.33 1.37 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.668 1.587 . . . . 2.8999999999999999 109.875 -169.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -142.62 150.22 40.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.7 1.6 . . . . 3.5299999999999998 112.347 -169.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.68 137.5 32.27 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.834 -0.541 . . . . 1.0600000000000001 111.367 167.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.97 122.09 40.67 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.829 -0.804 . . . . 5.1100000000000003 108.829 154.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 31.1 mtt -122.62 124.26 43.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.386 0.674 . . . . 1.6399999999999999 111.073 -173.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.0 mt -77.17 114.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 107.685 -1.228 . . . . 0.87 107.685 171.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.78 137.8 40.51 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.232 1.413 . . . . 4.0 112.629 -162.028 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.28 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.332 -0.855 . . . . 1.9399999999999999 111.349 -165.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.76 133.42 11.79 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 118.306 0.503 . . . . 2.1099999999999999 112.258 172.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.53 154.36 21.57 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.517 1.532 . . . . 1.4199999999999999 112.183 156.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -112.34 36.59 3.33 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.53 0.937 . . . . 3.4199999999999999 113.53 -128.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.2 5.97 40.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.961 1.304 . . . . 4.3700000000000001 113.851 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.6 tpp -98.16 132.88 43.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.954 1.464 . . . . 4.21 114.954 -157.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.8 p -176.66 171.19 2.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.554 2.341 . . . . 4.3300000000000001 111.1 159.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t70 92.44 65.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.176 2.99 . . . . 4.4000000000000004 111.61 -177.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -151.8 159.68 32.77 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.307 1.843 . . . . 4.0800000000000001 109.467 -173.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 -9.17 21.44 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.237 3.291 . . . . 3.75 114.417 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -125.13 142.33 41.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.725 1.21 . . . . 5.4400000000000004 109.241 166.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.33 134.92 54.66 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.314 2.01 . . . . 4.0800000000000001 111.089 -175.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.5 mt 63.41 17.97 10.69 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.49 1.516 . . . . 4.7699999999999996 112.527 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.39 7.43 60.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.763 1.173 . . . . 4.04 113.941 -174.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.16 -8.28 75.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.17 1.367 . . . . 3.5 113.953 -168.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.36 0.18 42.5 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 119.378 1.589 . . . . 2.23 115.043 -176.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.84 5.71 45.8 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.984 1.754 . . . . 2.1600000000000001 115.171 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 p -70.38 159.9 33.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.885 1.342 . . . . 2.48 110.864 173.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -112.84 136.1 52.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.489 1.516 . . . . 6.6900000000000004 109.894 -172.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -90.83 -35.98 14.49 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.157 0.89 . . . . 3.6000000000000001 112.129 166.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.36 150.14 31.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.519 0.727 . . . . 0.83999999999999997 112.456 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 t -127.07 131.43 50.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.343 1.857 . . . . 1.77 111.505 -178.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -126.37 97.03 0.48 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.784 2.135 . . . . 1.54 110.465 166.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.76 125.26 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.587 1.155 . . . . 2.3100000000000001 109.218 172.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.5 mt -58.3 117.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.742 0.782 . . . . 1.79 109.668 176.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 116.059 -0.518 . . . . 5.3700000000000001 111.602 177.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.658 -0.497 . . . . 2.0099999999999998 109.658 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.07 152.85 42.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.572 1.323 . . . . 1.3400000000000001 114.572 -145.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 132.49 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 123.152 1.453 . . . . 2.9700000000000002 112.057 159.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -94.71 71.46 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.154 1.382 . . . . 4.2300000000000004 111.213 -166.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.17 119.29 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.211 -0.931 . . . . 1.95 110.738 -156.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.02 97.25 1.38 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 126.189 1.852 . . . . 1.01 110.185 -173.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 29.8 mtt -80.22 131.38 35.68 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.574 0.749 . . . . 2.1899999999999999 112.158 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.0 150.54 22.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.721 0.808 . . . . 2.7799999999999998 109.878 172.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.1 mt -64.31 140.87 58.91 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.363 -0.977 . . . . 1.3700000000000001 108.363 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.16 158.11 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 118.511 0.596 . . . . 1.5 112.202 -177.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -171.44 -150.36 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.921 2.089 . . . . 2.6000000000000001 108.252 173.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.02 -8.35 3.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 128.473 2.709 . . . . 2.3799999999999999 114.837 -178.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.19 -14.7 32.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.903 0.881 . . . . 4.2800000000000002 112.065 169.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.85 -142.47 21.65 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.134 0.873 . . . . 1.51 110.968 -162.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.31 120.96 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.555 1.542 . . . . 1.52 111.757 176.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.97 -133.22 7.13 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 125.993 1.759 . . . . 1.9299999999999999 111.705 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.83 171.48 7.3 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.717 -0.872 . . . . 3.75 110.845 170.247 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -109.26 137.66 46.8 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.006 1.323 . . . . 2.04 113.502 -176.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.94 4.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.325 1.85 . . . . 3.46 112.887 177.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.33 153.18 7.63 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.489 -0.757 . . . . 0.59999999999999998 113.903 -168.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.498 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 5.5 p -90.33 175.2 7.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.917 -0.771 . . . . 1.1200000000000001 108.917 161.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.68 129.45 75.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 106.218 -1.771 . . . . 0.45000000000000001 106.218 148.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.95 118.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.374 -0.602 . . . . 1.5 109.374 178.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.7 mt -99.0 126.7 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.147 -1.427 . . . . 2.25 107.147 175.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -128.24 122.06 30.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.164 0.983 . . . . 2.5899999999999999 111.27 169.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 124.58 23.19 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.501 1.92 . . . . 3.2799999999999998 109.52 171.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.6 p -138.25 174.56 10.43 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.341 0.591 . . . . 3.7599999999999998 111.416 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.44 -23.86 64.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.267 -0.896 . . . . 3.5600000000000001 112.496 172.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.38 13.84 66.49 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.794 1.188 . . . . 1.3799999999999999 114.65 170.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.77 -158.03 31.7 Favored Glycine 0 N--CA 1.469 0.877 0 C-N-CA 126.732 2.11 . . . . 1.0800000000000001 114.559 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.51 96.72 2.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.958 0.903 . . . . 1.02 111.738 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -72.81 116.59 13.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.72 2.008 . . . . 3.6699999999999999 109.975 172.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -109.12 111.48 23.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.309 2.244 . . . . 0.68999999999999995 109.768 -174.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.9 m -119.85 114.29 34.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-O 118.275 -0.869 . . . . 0.92000000000000004 108.986 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.45 160.74 9.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.048 2.498 . . . . 0.46999999999999997 112.781 -174.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.498 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 3.3 p80 -150.51 26.39 0.76 Allowed 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.546 0.943 . . . . 1.6799999999999999 113.546 172.348 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.91 143.53 31.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.87 112.83 -176.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.18 128.28 48.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 117.575 -1.202 . . . . 2.3700000000000001 110.673 174.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 131.12 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 129.838 3.255 . . . . 1.97 115.971 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.92 159.66 31.82 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.115 0.966 . . . . 2.48 112.215 -172.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -59.77 133.39 50.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.511 2.141 . . . . 0.90000000000000002 111.408 171.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -92.97 43.08 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.019 2.48 . . . . 1.02 112.589 -150.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.25 -158.01 10.05 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 122.895 1.275 . . . . 1.1599999999999999 115.724 -175.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -81.11 145.0 31.29 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.668 2.387 . . . . 2.8199999999999998 111.735 173.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -152.39 138.05 17.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.783 1.633 . . . . 1.3799999999999999 110.018 -174.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.77 165.28 54.81 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 120.398 1.454 . . . . 0.81999999999999995 114.194 169.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -130.36 121.98 27.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.551 1.541 . . . . 3.4700000000000002 107.22 177.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -121.74 156.34 33.34 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.179 1.354 . . . . 1.47 112.677 173.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.13 141.05 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.914 1.686 . . . . 1.24 108.839 158.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -119.86 -179.09 3.8 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.767 1.627 . . . . 1.3700000000000001 110.254 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.69 56.24 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.807 2.151 . . . . 1.23 116.807 -166.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -132.84 159.9 38.47 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.954 1.252 . . . . 1.5600000000000001 114.015 178.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.63 65.79 4.0 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.972 1.749 . . . . 1.03 113.14 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -146.06 76.15 1.44 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.482 0.919 . . . . 2.79 113.482 -168.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.1 m -60.54 38.49 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 129.303 3.041 . . . . 1.6100000000000001 117.636 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -120.15 168.9 9.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 119.789 -1.819 . . . . 3.4700000000000002 112.042 -166.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.22 145.94 17.46 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.566 2.177 . . . . 1.55 111.085 168.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.06 153.23 18.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.621 -0.718 . . . . 3.1400000000000001 109.353 159.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.81 116.22 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.083 -1.451 . . . . 4.79 107.083 163.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -79.51 -47.1 16.16 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.706 0.765 . . . . 8.7200000000000006 110.418 178.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -176.09 118.76 0.15 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.358 3.063 . . . . 5.8200000000000003 106.511 171.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.44 -4.46 0.95 Allowed Glycine 0 CA--C 1.54 1.65 0 N-CA-C 117.556 1.782 . . . . 3.9399999999999999 117.556 175.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -159.99 157.39 28.71 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.74 1.77 . . . . 3.7999999999999998 111.71 -171.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.49 133.98 34.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.4 1.08 . . . . 1.99 112.221 -173.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.4 t -115.3 103.57 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.031 1.333 . . . . 3.73 109.001 171.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.98 110.72 4.03 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.342 1.457 . . . . 3.9700000000000002 112.194 -177.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 122.1 -24.65 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 131.136 3.774 . . . . 3.5600000000000001 113.876 171.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.85 -11.28 58.29 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.412 1.46 . . . . 6.29 114.246 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.782 -1.199 . . . . 3.0600000000000001 112.785 168.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.65 3.44 16.37 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.355 1.062 . . . . 1.3700000000000001 113.133 173.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.1 178.75 38.81 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.366 0.984 . . . . 2.21 113.564 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.2 -167.81 10.19 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.374 0.988 . . . . 1.99 112.952 171.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -72.29 52.34 0.26 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.222 1.809 . . . . 2.3999999999999999 111.501 174.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.6 tp 37.3 58.67 1.23 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.71 2.004 . . . . 2.7599999999999998 111.465 178.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 85.02 55.57 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.216 1.806 . . . . 4.8200000000000003 112.273 -150.305 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.81 -63.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.648 2.899 . . . . 2.2200000000000002 111.672 175.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -143.43 129.38 19.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.473 -1.677 . . . . 6.5899999999999999 106.473 173.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 p30 174.73 -97.65 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.532 1.933 . . . . 4.5700000000000003 112.196 179.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t 174.97 -45.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.991 2.516 . . . . 3.1200000000000001 109.739 -166.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.14 -39.8 3.1 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 126.141 1.829 . . . . 3.9399999999999999 116.374 149.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -43.26 -51.41 6.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.831 1.653 . . . . 4.9800000000000004 113.546 -170.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 162.48 150.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.605 3.162 . . . . 3.1400000000000001 112.564 168.067 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -82.85 167.26 18.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.267 0.556 . . . . 3.4399999999999999 112.057 171.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.88 -109.97 0.78 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.595 -1.669 . . . . 5.4100000000000001 110.95 -167.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.02 -27.03 36.68 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.768 2.979 . . . . 7.5800000000000001 114.711 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.75 10.55 3.39 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.931 1.293 . . . . 9.6300000000000008 112.454 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.62 73.23 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.025 -0.875 . . . . 4.46 114.807 171.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -82.94 51.14 1.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.265 1.532 . . . . 7.0700000000000003 113.839 -166.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.81 -171.66 42.13 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 117.249 1.66 . . . . 3.4399999999999999 117.249 -167.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -139.74 157.13 46.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.922 1.689 . . . . 6.3899999999999997 110.848 171.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -69.36 24.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.582 1.553 . . . . 3.4500000000000002 115.186 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -153.56 23.46 0.74 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 128.572 2.987 . . . . 1.3899999999999999 113.042 178.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' CE1' ' A' ' 82' ' ' HIS . 10.5 m-20 -80.53 138.62 36.53 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 106.75 -1.574 . . . . 2.1299999999999999 106.75 154.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mp -143.59 147.8 40.81 Favored Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 121.744 2.065 . . . . 3.2999999999999998 112.577 -171.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.94 157.94 54.13 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.124 3.216 . . . . 1.1699999999999999 113.254 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.67 125.97 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 115.429 1.64 . . . . 2.2000000000000002 115.429 -156.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 67.93 0.8 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.912 2.885 . . . . 2.4900000000000002 110.313 170.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.8 134.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.508 -0.745 . . . . 1.24 109.429 174.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 m -115.0 152.14 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.006 0.922 . . . . 3.29 108.9 175.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.56 157.07 38.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.531 0.567 . . . . 2.7400000000000002 112.531 -176.293 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -50.56 -22.55 2.04 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 126.935 2.094 . . . . 2.5099999999999998 115.527 179.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -88.88 3.56 50.87 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.888 2.475 . . . . 3.7599999999999998 113.892 -178.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 30.08 21.19 Favored Glycine 0 N--CA 1.475 1.277 0 O-C-N 121.135 -0.978 . . . . 0.81000000000000005 115.283 173.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.8 131.56 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.252 1.421 . . . . 1.53 109.535 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.83 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.651 1.18 . . . . 1.24 109.969 176.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 t -149.4 -33.75 0.2 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.106 1.362 . . . . 1.95 113.183 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -66.13 121.52 76.73 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.848 0.859 . . . . 3.1099999999999999 111.048 -178.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.65 152.31 22.66 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.149 3.233 . . . . 1.3600000000000001 112.354 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.27 175.99 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.456 1.503 . . . . 1.55 110.22 170.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.6 m -146.39 143.81 29.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.587 1.155 . . . . 1.0600000000000001 109.994 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.17 101.63 31.66 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.7 1.2 . . . . 1.6599999999999999 111.766 175.365 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.38 -5.81 10.12 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.981 2.454 . . . . 1.6499999999999999 116.195 -166.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -77.43 -17.13 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.553 1.524 . . . . 11.300000000000001 113.188 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.15 153.55 19.16 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.92 1.688 . . . . 3.8700000000000001 109.421 -177.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 28.63 1.21 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.878 1.671 . . . . 5.1399999999999997 111.333 170.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.7 m -163.29 133.54 4.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.344 1.857 . . . . 2.3900000000000001 110.819 171.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.42 -27.47 67.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.271 1.428 . . . . 2.6899999999999999 110.488 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.42 -26.88 5.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.396 1.878 . . . . 3.6000000000000001 113.687 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -65.84 -11.67 48.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.461 1.105 . . . . 2.5800000000000001 113.486 176.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.52 15.49 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.162 1.171 . . . . 0.82999999999999996 114.162 -172.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -69.06 9.24 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 118.1 2.63 . . . . 2.9900000000000002 118.1 -169.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -151.72 29.71 0.6 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.765 1.626 . . . . 3.3700000000000001 111.676 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -116.47 155.22 28.97 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.788 -1.195 . . . . 3.6299999999999999 112.222 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.97 141.26 28.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.296 0.638 . . . . 0.84999999999999998 110.46 166.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 141.67 43.82 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.175 -0.676 . . . . 2.0899999999999999 109.175 160.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.0 mtt -134.24 135.29 42.83 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.375 0.67 . . . . 1.77 112.594 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.5 mt -82.13 105.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.609 1.163 . . . . 0.89000000000000001 108.65 172.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.11 139.75 30.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.106 1.762 . . . . 3.7400000000000002 110.979 -176.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.54 -39.08 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.871 -1.143 . . . . 2.0699999999999998 112.443 -162.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -94.99 144.12 17.0 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.205 0.907 . . . . 1.5 112.043 176.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.39 156.64 25.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 127.014 2.245 . . . . 1.72 115.053 175.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.66 53.26 0.7 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.517 1.151 . . . . 3.2000000000000002 113.268 -147.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -141.64 2.35 1.6 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.634 1.574 . . . . 2.98 113.423 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.2 mtm -92.6 126.47 37.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.121 0.968 . . . . 2.6899999999999999 111.683 -171.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 -158.3 0.82 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.536 1.134 . . . . 3.4199999999999999 110.921 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.24 -38.51 0.41 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 129.911 3.284 . . . . 3.6499999999999999 114.135 -176.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -67.65 146.26 98.46 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.724 2.01 . . . . 3.3100000000000001 113.42 -166.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.89 -40.44 44.16 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.521 3.481 . . . . 2.3500000000000001 112.204 -172.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.23 101.42 11.23 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 105.889 -1.893 . . . . 5.0199999999999996 105.889 162.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -75.77 179.44 6.25 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.429 2.753 . . . . 3.6800000000000002 113.338 -162.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.1 mt 66.53 1.08 2.0 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.887 2.075 . . . . 4.6399999999999997 113.987 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.74 27.12 67.83 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.698 1.135 . . . . 3.1499999999999999 112.388 -175.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.6 -8.88 79.12 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.018 1.294 . . . . 2.4399999999999999 114.354 -171.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.78 22.09 0.57 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.349 1.928 . . . . 2.1899999999999999 115.86 -177.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.16 -15.26 65.04 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.936 1.255 . . . . 1.8799999999999999 113.147 167.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.4 p -74.27 151.58 39.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.639 1.22 . . . . 1.98 110.013 172.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.93 142.31 30.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.472 1.109 . . . . 6.7599999999999998 112.581 -171.59 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.34 -33.88 12.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.555 0.742 . . . . 4.21 112.235 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.89 155.99 41.66 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.259 1.024 . . . . 0.62 113.038 -176.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.43 151.67 45.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.932 2.093 . . . . 1.4299999999999999 111.334 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.28 126.76 2.89 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.99 1.281 . . . . 0.87 112.545 173.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.48 123.45 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.955 1.302 . . . . 2.3399999999999999 109.972 171.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.69 113.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.719 -0.845 . . . . 1.1100000000000001 108.719 170.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt . . . . . 0 CA--C 1.54 0.585 0 O-C-N 121.745 -0.597 . . . . 4.2999999999999998 111.121 -174.757 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.528 -0.545 . . . . 2.0099999999999998 109.528 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -131.78 135.19 46.59 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.65 -1.281 . . . . 2.6200000000000001 113.788 -137.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -144.7 148.8 34.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.134 1.373 . . . . 2.8999999999999999 108.587 173.202 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -126.5 99.95 6.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.778 1.231 . . . . 5.2599999999999998 110.866 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -90.29 122.24 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 121.861 -0.524 . . . . 1.49 109.985 -173.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.2 104.7 2.06 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.905 1.717 . . . . 0.78000000000000003 110.752 174.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 mmm -86.93 89.45 7.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.422 1.489 . . . . 2.6000000000000001 110.655 -175.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -75.39 148.37 39.24 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.231 -0.918 . . . . 2.7599999999999998 111.04 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.13 140.72 58.24 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.53 -0.732 . . . . 1.3300000000000001 109.796 174.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.7 138.82 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.892 0.877 . . . . 1.5 110.316 177.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -171.85 69.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.979 0.912 . . . . 2.6800000000000002 111.909 -170.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 74.37 -42.46 0.5 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.592 2.357 . . . . 1.52 114.285 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.39 -9.22 58.23 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.486 1.039 . . . . 4.0800000000000001 112.163 174.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.91 -147.82 17.99 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 125.909 1.719 . . . . 1.27 111.455 -173.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.8 t -58.85 127.04 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.795 1.638 . . . . 1.26 110.212 174.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.78 -97.71 2.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.32 0.962 . . . . 1.48 113.694 -168.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.29 127.93 12.41 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.707 1.203 . . . . 2.7200000000000002 109.864 -170.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 t -90.98 149.95 21.66 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.056 1.132 . . . . 1.8999999999999999 114.056 -160.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -143.07 -6.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 115.289 1.589 . . . . 3.5499999999999998 115.289 -173.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.5 153.73 13.31 Favored Glycine 0 N--CA 1.469 0.861 0 O-C-N 120.625 -1.297 . . . . 0.72999999999999998 114.556 -175.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 p -107.19 176.16 5.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.434 -0.95 . . . . 1.0800000000000001 108.434 163.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.08 134.03 66.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.44 -0.948 . . . . 0.82999999999999996 108.44 158.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.5 p -88.48 130.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.7 0.625 . . . . 1.5800000000000001 110.296 173.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.26 114.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.064 2.146 . . . . 2.3599999999999999 108.399 -173.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.08 105.93 11.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.74 0.816 . . . . 2.1200000000000001 111.348 175.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 133.76 55.24 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.107 2.563 . . . . 3.7000000000000002 111.176 172.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 t -164.02 -172.02 2.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.209 0.604 . . . . 2.3700000000000001 111.089 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.54 -38.25 66.38 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.674 1.189 . . . . 3.6400000000000001 111.685 178.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.74 12.36 41.89 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.867 1.222 . . . . 1.46 115.297 173.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 -145.82 32.65 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 127.824 2.63 . . . . 0.97999999999999998 112.042 -177.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.89 102.21 6.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.997 0.919 . . . . 1.02 111.614 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.59 109.97 12.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.093 0.957 . . . . 2.6699999999999999 110.556 175.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.95 105.77 17.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.875 2.47 . . . . 1.1799999999999999 110.191 -169.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.0 m -110.7 108.99 57.99 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 107.84 -1.17 . . . . 1.5 107.84 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.43 157.11 22.27 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.807 2.338 . . . . 0.89000000000000001 111.211 -177.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -142.78 37.09 1.44 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.911 0.862 . . . . 1.8899999999999999 111.253 169.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -91.49 158.67 16.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 123.123 1.439 . . . . 1.04 113.841 -174.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HE3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -144.01 159.32 42.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.032 2.133 . . . . 2.96 108.38 174.525 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.52 23.66 0.08 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.465 2.706 . . . . 1.8300000000000001 113.381 171.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -92.89 161.75 30.74 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 121.484 -0.76 . . . . 3.0 110.773 174.158 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.63 135.33 52.2 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 O-C-N 122.655 0.818 . . . . 1.03 110.068 164.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -92.65 24.05 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.968 3.112 . . . . 1.23 112.942 -149.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.7 158.11 15.1 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.003 -1.239 . . . . 2.2400000000000002 110.003 167.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -51.2 130.9 27.38 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 128.302 2.641 . . . . 3.1600000000000001 114.915 -175.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -103.83 138.36 40.53 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.832 1.253 . . . . 1.6499999999999999 112.577 -171.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.63 150.66 50.91 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.926 -0.87 . . . . 0.87 110.926 166.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.92 119.85 28.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.099 -1.445 . . . . 3.3799999999999999 107.099 175.198 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.423 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 64.7 m170 -115.25 153.64 30.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.922 0.889 . . . . 1.1399999999999999 113.27 171.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -94.75 144.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.396 1.078 . . . . 1.0 109.03 150.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -118.74 156.85 28.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.15 1.78 . . . . 1.1100000000000001 110.214 176.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.1 62.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 117.101 2.26 . . . . 1.1100000000000001 117.101 -159.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -134.75 -179.2 5.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.8 2.04 . . . . 1.7 110.44 175.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.84 100.55 0.54 Allowed Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.576 -1.327 . . . . 1.25 113.629 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.4 t 175.71 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.079 2.152 . . . . 2.4500000000000002 110.987 173.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.2 m -71.4 43.43 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 126.902 2.081 . . . . 1.5800000000000001 115.019 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -106.95 127.95 27.03 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.308 -1.495 . . . . 3.3100000000000001 111.276 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.84 162.34 29.63 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.824 3.016 . . . . 1.27 112.305 173.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.12 145.76 40.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.125 0.97 . . . . 1.7 109.467 160.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mm -102.07 22.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.669 1.188 . . . . 3.4300000000000002 111.321 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.14 129.46 27.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.131 1.373 . . . . 5.1500000000000004 112.2 -175.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 t0 69.83 25.87 4.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.678 1.591 . . . . 3.3500000000000001 112.737 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.64 28.07 44.55 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.722 1.153 . . . . 2.6499999999999999 113.541 172.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -158.26 132.54 8.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.009 0.904 . . . . 3.25 110.773 -166.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.8 104.0 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.394 -0.816 . . . . 2.2400000000000002 111.277 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.61 41.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.674 1.589 . . . . 2.5699999999999998 112.414 -175.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.46 -63.15 0.26 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.991 2.916 . . . . 2.0800000000000001 115.563 172.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.77 128.31 2.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.074 2.55 . . . . 1.6399999999999999 108.315 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -116.48 -46.71 2.76 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.435 1.094 . . . . 4.9000000000000004 111.72 -177.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.54 -18.73 64.42 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.712 1.004 . . . . 1.5600000000000001 113.712 -174.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.1 -8.39 56.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.161 1.384 . . . . 1.21 113.45 168.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.64 174.4 49.27 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 120.608 -1.307 . . . . 2.6299999999999999 112.699 -172.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.37 -160.52 19.5 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 122.156 -0.614 . . . . 1.5700000000000001 111.768 168.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -48.4 144.0 4.39 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.466 -0.568 . . . . 2.7999999999999998 109.466 165.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.3 61.01 0.3 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.515 1.526 . . . . 4.0999999999999996 112.152 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -118.85 -1.21 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 120.724 3.602 . . . . 4.0499999999999998 120.724 -147.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.66 -56.84 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 123.505 2.288 . . . . 3.8399999999999999 114.885 -151.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -92.76 54.85 2.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.632 1.173 . . . . 4.1699999999999999 111.236 -177.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -123.94 -75.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.324 1.05 . . . . 3.3900000000000001 111.651 174.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t 168.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 130.02 3.328 . . . . 2.7799999999999998 111.257 -175.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.48 0.19 73.4 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 115.408 0.923 . . . . 1.97 115.408 164.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -84.22 3.87 33.33 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.604 1.705 . . . . 5.7300000000000004 115.604 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.413 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 45.2 t60 62.25 -174.25 0.14 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.911 1.284 . . . . 1.8600000000000001 111.662 -169.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' H ' ' CG ' ' A' ' 82' ' ' HIS . 8.9 pt-20 -158.27 -155.14 0.47 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.558 -1.339 . . . . 3.98 111.467 -172.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.43 -101.56 0.64 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.041 -1.422 . . . . 2.8300000000000001 111.007 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.9 -15.38 32.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.501 2.8 . . . . 4.0 113.357 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.59 157.37 12.39 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.77 2.828 . . . . 6.8700000000000001 108.333 179.215 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.5 179.75 29.55 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.223 0.902 . . . . 5.2000000000000002 114.857 177.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -156.13 35.64 0.34 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.935 2.094 . . . . 5.9299999999999997 109.426 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.61 4.56 63.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 116.822 -2.099 . . . . 3.2999999999999998 116.703 -172.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -177.12 99.5 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.358 1.863 . . . . 6.0300000000000002 111.561 171.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -14.19 62.78 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.104 1.89 . . . . 4.1500000000000004 116.104 -176.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 25.37 28.22 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 127.273 2.368 . . . . 1.6599999999999999 115.537 -170.088 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -93.14 151.73 19.67 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.205 1.402 . . . . 3.0499999999999998 110.384 167.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.63 157.91 76.23 Favored Pre-proline 0 CA--C 1.556 1.198 0 O-C-N 120.95 -1.094 . . . . 3.1800000000000002 111.706 -161.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.7 162.38 41.41 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.96 3.106 . . . . 1.0900000000000001 112.509 -171.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -83.19 128.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 123.431 1.586 . . . . 2.2400000000000002 112.977 -161.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.03 83.22 6.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.556 2.742 . . . . 3.6000000000000001 110.033 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.53 143.62 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 125.598 1.559 . . . . 1.1200000000000001 111.105 176.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 157.25 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 127.598 2.359 . . . . 2.6299999999999999 107.913 170.159 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 163.26 23.0 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 118.743 -0.646 . . . . 2.52 111.852 170.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -19.35 2.2 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.312 1.967 . . . . 3.5299999999999998 116.312 -174.028 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -94.37 -2.33 52.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.658 1.583 . . . . 3.8599999999999999 114.578 177.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.12 31.44 8.49 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.149 0.886 . . . . 1.3100000000000001 115.174 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -116.53 133.78 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.768 1.627 . . . . 1.4099999999999999 109.449 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.18 108.81 19.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.441 1.496 . . . . 0.81000000000000005 109.546 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 t -131.43 24.59 4.8 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.079 1.752 . . . . 1.5700000000000001 111.291 172.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.79 108.54 43.72 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.917 1.687 . . . . 3.04 108.933 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 129.87 14.65 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.791 2.327 . . . . 1.3 110.378 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.29 172.17 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.163 1.385 . . . . 1.8300000000000001 108.972 175.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.3 m -151.22 145.59 25.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.226 0.921 . . . . 1.3500000000000001 109.954 -171.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -112.45 89.64 12.99 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 112.992 0.738 . . . . 1.1000000000000001 112.992 176.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 -4.91 12.86 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.856 3.038 . . . . 1.6299999999999999 114.307 172.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -73.72 -18.92 60.94 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.751 2.02 . . . . 4.6900000000000004 112.046 176.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.38 164.02 13.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.379 2.272 . . . . 3.7200000000000002 108.405 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -154.37 6.11 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.295 1.591 . . . . 5.0300000000000002 115.295 -172.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 t -168.95 130.41 1.2 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.338 -1.476 . . . . 2.2799999999999998 113.099 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.35 -26.94 61.78 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.583 -1.323 . . . . 2.1000000000000001 111.946 174.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.13 -16.69 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.676 1.361 . . . . 3.0899999999999999 114.676 175.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.68 -12.89 52.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.385 1.448 . . . . 3.1899999999999999 113.056 171.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.41 3.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.353 1.461 . . . . 1.0900000000000001 114.587 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -62.35 -2.56 1.05 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.057 2.243 . . . . 3.2999999999999998 117.057 -175.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -148.85 29.38 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.036 1.735 . . . . 3.2999999999999998 110.826 174.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -111.87 -179.53 3.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.83 1.652 . . . . 2.6400000000000001 111.578 178.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.31 151.74 48.95 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.003 -1.061 . . . . 0.68999999999999995 111.124 168.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.74 153.48 33.34 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.441 1.097 . . . . 3.0099999999999998 110.696 164.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.3 mtt -136.97 130.98 32.32 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.329 0.652 . . . . 1.5700000000000001 110.94 -170.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.0 mt -84.74 109.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.131 -1.433 . . . . 1.02 107.131 168.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -91.95 147.03 23.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.002 2.121 . . . . 3.1699999999999999 111.191 -175.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.71 -37.58 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.876 -1.14 . . . . 1.97 113.397 -162.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.16 170.92 15.16 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 124.506 1.05 . . . . 1.9199999999999999 111.774 170.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.46 169.34 37.19 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 1.5700000000000001 113.884 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.423 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 24.0 t0 -125.96 11.64 7.73 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.896 1.813 . . . . 2.46 115.896 -141.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.21 9.21 0.46 Allowed 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.126 -1.609 . . . . 3.4700000000000002 115.229 -177.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.1 mtm -81.19 79.29 7.87 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.527 1.531 . . . . 3.6800000000000002 112.31 -172.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -81.68 -5.09 57.77 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.957 0.903 . . . . 3.3300000000000001 113.352 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -149.3 145.05 26.86 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.152 -1.592 . . . . 3.8700000000000001 111.566 -173.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 151.27 153.88 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.091 1 C-N-CA 132.049 4.139 . . . . 4.0999999999999996 110.166 173.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.71 -12.1 22.11 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.306 2.671 . . . . 2.1499999999999999 114.382 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -77.93 116.0 54.99 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 119.76 1.164 . . . . 6.1500000000000004 108.927 165.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.84 173.33 12.09 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.161 2.574 . . . . 4.9100000000000001 112.948 -168.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.8 mt 67.04 11.21 8.26 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.355 1.862 . . . . 7.4299999999999997 113.904 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.28 6.62 59.91 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.437 1.494 . . . . 5.5700000000000003 114.481 177.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.93 -50.67 2.67 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.127 1.463 . . . . 3.3999999999999999 114.581 175.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.31 45.14 1.73 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 126.58 2.038 . . . . 2.2000000000000002 114.602 -175.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.74 -15.12 68.49 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.674 1.13 . . . . 2.3700000000000001 114.657 -175.014 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.8 p -67.68 125.09 25.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.216 1.406 . . . . 2.29 112.244 -175.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 -91.01 150.41 21.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.011 1.724 . . . . 5.1600000000000001 110.098 176.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.409 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 11.0 t80 -112.49 -42.04 3.74 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.795 0.725 . . . . 3.25 112.265 161.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.99 142.79 32.97 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.316 0.646 . . . . 0.68999999999999995 112.607 177.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.02 143.44 44.31 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.503 1.521 . . . . 1.3200000000000001 111.113 176.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.57 81.66 0.3 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 128.083 2.754 . . . . 1.1499999999999999 110.962 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.76 135.66 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 118.091 0.945 . . . . 3.48 110.949 166.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.2 mt -107.54 140.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.045 1.338 . . . . 1.51 110.341 -167.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 4.6200000000000001 109.822 177.493 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.568 -0.253 . . . . 3.8799999999999999 110.989 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -155.67 152.45 28.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.095 1.358 . . . . 2.5499999999999998 110.121 -170.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.84 122.73 5.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.055 0.931 . . . . 2.6899999999999999 112.669 173.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.76 82.41 5.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.994 -1.066 . . . . 4.2699999999999996 113.225 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.69 116.05 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.22 -0.925 . . . . 1.9299999999999999 111.778 -169.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.09 90.38 1.2 Allowed Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.462 1.982 . . . . 1.1599999999999999 112.319 -177.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mmt -72.81 120.8 18.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.95 . . . . 2.0899999999999999 113.13 -175.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -104.44 144.37 31.75 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.074 1.75 . . . . 3.52 112.033 -178.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.64 66.53 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.42 1.088 . . . . 2.6299999999999999 111.105 175.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 m -67.46 138.88 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.552 1.141 . . . . 1.5 110.304 174.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -165.81 61.1 0.11 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.745 0.784 . . . . 2.21 112.317 -171.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.61 -26.79 0.17 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.965 2.506 . . . . 1.8100000000000001 115.265 171.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -17.44 61.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.301 2.24 . . . . 2.7000000000000002 112.117 173.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.8 -168.04 13.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.545 2.022 . . . . 2.1800000000000002 109.963 -160.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.2 t -56.64 139.5 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.327 0.651 . . . . 1.48 110.19 155.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.74 -128.2 4.7 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.927 1.727 . . . . 1.3799999999999999 112.065 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.421 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -116.67 162.75 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.755 1.622 . . . . 5.9299999999999997 111.009 178.224 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -128.45 156.5 43.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.083 0.953 . . . . 1.6899999999999999 112.745 -164.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.74 7.53 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 125.005 1.322 . . . . 3.9100000000000001 114.388 -162.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.84 173.82 24.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.063 1.315 . . . . 0.57999999999999996 112.975 -179.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.421 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 4.2 p -105.18 174.34 5.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.78 0.832 . . . . 1.04 109.817 168.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 t -123.46 126.67 73.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.962 -1.496 . . . . 0.85999999999999999 106.962 151.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.55 119.7 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 123.279 0.362 . . . . 1.47 111.408 -177.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.33 126.74 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.847 1.259 . . . . 2.27 108.545 174.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -130.34 127.16 38.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.917 0.887 . . . . 2.3300000000000001 109.896 170.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.05 136.67 38.68 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.516 1.927 . . . . 3.3700000000000001 112.302 -171.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.58 -175.53 5.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.254 0.934 . . . . 1.9399999999999999 111.361 175.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.24 -30.62 70.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.013 0.925 . . . . 4.0499999999999998 112.037 -179.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.11 11.77 41.07 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.892 0.758 . . . . 1.1599999999999999 113.762 166.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.36 -141.16 21.92 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 127.441 2.448 . . . . 0.91000000000000003 114.742 176.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.11 101.9 9.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.057 0.943 . . . . 0.84999999999999998 111.296 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -78.06 108.24 11.21 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.983 1.313 . . . . 2.3900000000000001 110.594 175.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -102.69 117.1 33.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.458 2.303 . . . . 0.78000000000000003 110.269 -171.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -127.58 112.36 20.9 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 117.765 -1.112 . . . . 1.1599999999999999 109.716 -172.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -88.62 159.43 6.42 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.188 2.592 . . . . 0.54000000000000004 112.224 -173.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG1' ' A' ' 21' ' ' THR . 6.3 p80 -151.08 25.31 0.72 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.446 0.906 . . . . 1.6399999999999999 113.446 173.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.31 136.58 33.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.814 0.846 . . . . 0.85999999999999999 112.822 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.09 156.98 18.99 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.677 -0.692 . . . . 2.6000000000000001 111.198 161.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.15 20.39 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.806 2.442 . . . . 2.1299999999999999 114.675 156.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.89 154.29 41.13 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 2.3500000000000001 112.458 176.252 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.07 137.68 45.1 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 O-C-N 122.953 0.975 . . . . 1.76 110.911 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -85.24 51.74 3.12 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.489 3.459 . . . . 2.0299999999999998 112.283 -162.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 -162.42 13.99 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 114.868 -1.06 . . . . 1.1899999999999999 114.047 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.46 140.28 32.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.256 1.822 . . . . 2.6899999999999999 110.214 171.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.87 136.55 30.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 1.6299999999999999 109.683 -177.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.72 169.61 29.71 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.629 0.65 . . . . 0.72999999999999998 112.347 167.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.39 132.68 10.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.209 1.404 . . . . 3.3599999999999999 108.566 171.112 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.473 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 15.6 m170 -129.79 170.49 13.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.231 1.567 . . . . 0.77000000000000002 115.231 168.633 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.3 mt -99.01 147.1 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.629 1.572 . . . . 0.78000000000000003 109.151 153.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.59 152.34 40.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.168 1.787 . . . . 1.02 110.503 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.35 -31.44 72.57 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.435 2.013 . . . . 1.03 116.435 -160.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -113.73 169.8 8.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.858 1.663 . . . . 1.4399999999999999 112.528 177.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.02 67.41 0.22 Allowed Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.948 1.139 . . . . 1.02 115.948 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -166.88 120.5 1.02 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 119.459 1.629 . . . . 2.4900000000000002 114.572 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.4 m -69.93 -6.34 32.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.34 1.856 . . . . 1.4299999999999999 115.157 176.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -63.96 145.02 98.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 O-C-N 120.993 -1.067 . . . . 3.2799999999999998 111.825 -168.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.23 150.2 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.978 2.452 . . . . 1.52 111.752 179.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.25 140.96 34.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.517 0.727 . . . . 1.95 109.723 161.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.92 126.75 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.13 -1.063 . . . . 3.0600000000000001 108.13 169.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -167.32 144.91 4.65 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.731 1.612 . . . . 6.0199999999999996 109.971 -163.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 59.88 -104.73 0.2 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.072 1.349 . . . . 4.1399999999999997 108.003 -163.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.68 25.4 3.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.934 1.73 . . . . 3.46 113.501 170.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.88 179.62 9.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.094 1.447 . . . . 5.96 113.318 -167.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.57 108.53 20.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.812 1.245 . . . . 1.8799999999999999 112.679 -171.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.25 91.43 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.829 1.252 . . . . 2.4100000000000001 109.937 -179.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.15 114.7 2.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.567 1.547 . . . . 3.6800000000000002 112.859 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.26 39.18 7.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.54 1.536 . . . . 2.9399999999999999 113.395 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.84 -43.0 90.64 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.409 0.684 . . . . 4.4199999999999999 109.896 158.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.78 78.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.664 1.186 . . . . 1.8 113.002 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -16.36 8.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.816 2.046 . . . . 0.90000000000000002 115.416 179.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.89 176.25 45.35 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 120.072 1.305 . . . . 2.3100000000000001 112.561 -172.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.24 -175.92 22.72 Favored Glycine 0 N--CA 1.474 1.181 0 N-CA-C 111.732 -0.547 . . . . 2.0899999999999999 111.732 163.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -70.17 35.88 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.907 1.447 . . . . 3.0899999999999999 114.907 -176.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 71.81 89.73 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.2 1.8 . . . . 4.6600000000000001 109.691 175.317 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.25 102.47 1.24 Allowed Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 127.287 2.235 . . . . 3.8700000000000001 110.03 -172.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.42 -54.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.259 2.64 . . . . 2.29 111.561 173.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -132.37 15.2 4.55 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.052 1.296 . . . . 4.4800000000000004 113.651 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.91 -47.17 63.52 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.427 -1.421 . . . . 3.6099999999999999 111.388 -171.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t 178.16 -65.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.287 2.235 . . . . 2.8999999999999999 111.855 175.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.29 -21.14 6.13 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.825 1.203 . . . . 2.1200000000000001 114.502 -170.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -82.62 168.61 17.14 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.117 1.959 . . . . 5.1900000000000004 113.83 170.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -84.52 146.09 27.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.336 1.054 . . . . 2.6000000000000001 112.875 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 84' ' ' GLY . 7.1 tt0 -106.87 -156.81 0.59 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.505 1.122 . . . . 3.54 112.56 -178.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.431 ' H ' ' HG2' ' A' ' 83' ' ' GLU . . . -160.47 -128.34 0.95 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 127.23 2.348 . . . . 3.1299999999999999 110.478 179.081 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.95 -27.22 12.38 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.363 2.709 . . . . 5.7400000000000002 113.353 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -174.18 164.85 4.07 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.664 2.386 . . . . 8.8699999999999992 109.979 171.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.22 -135.36 7.72 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 125.796 1.665 . . . . 3.8100000000000001 109.977 -174.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -142.67 116.13 9.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.289 1.044 . . . . 5.4900000000000002 112.079 166.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.58 -139.44 3.24 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 127.474 2.464 . . . . 2.1400000000000001 109.179 166.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -75.49 139.7 42.37 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 117.806 0.803 . . . . 4.6799999999999997 112.674 176.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.5 -15.84 62.84 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.711 1.375 . . . . 2.9300000000000002 114.711 177.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.03 9.79 76.15 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 118.496 -1.169 . . . . 0.95999999999999996 114.892 175.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -82.84 136.09 34.74 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.87 1.335 . . . . 1.6499999999999999 111.497 171.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 171.2 7.26 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.983 0.913 . . . . 2.6600000000000001 111.066 -138.24 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.46 159.52 32.45 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.372 2.715 . . . . 1.5800000000000001 112.45 -169.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -85.26 126.51 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 122.908 1.337 . . . . 2.0299999999999998 113.423 -173.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.17 68.64 5.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.972 2.909 . . . . 2.6099999999999999 110.878 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.53 144.76 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.73 0.812 . . . . 1.29 110.749 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.91 135.61 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 4.5300000000000002 109.478 169.548 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.12 154.22 42.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.843 1.257 . . . . 3.21 113.876 178.015 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -33.34 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 131.188 3.795 . . . . 4.0499999999999998 118.953 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -78.72 -21.52 47.94 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.567 1.547 . . . . 3.54 113.319 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.2 34.48 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 124.338 0.971 . . . . 1.3500000000000001 114.852 178.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mt -124.32 117.13 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.037 1.335 . . . . 1.8999999999999999 109.413 178.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 125.63 28.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.194 0.998 . . . . 0.73999999999999999 111.152 -177.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 t -142.7 -7.14 0.86 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.592 1.557 . . . . 1.54 113.502 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.0 117.38 64.66 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.038 -1.038 . . . . 3.27 111.193 -175.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 136.57 14.64 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.446 2.764 . . . . 1.0700000000000001 111.281 176.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 m -139.97 155.82 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.785 1.234 . . . . 1.53 110.336 176.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.3 m -135.48 138.91 43.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.712 0.687 . . . . 0.93999999999999995 110.915 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.29 99.77 50.25 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.237 1.015 . . . . 0.77000000000000002 112.885 -174.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.22 -1.29 11.29 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.58 3.52 . . . . 1.28 115.384 -178.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -71.71 -25.32 62.03 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.158 0.89 . . . . 4.7199999999999998 111.855 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.79 133.04 56.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.003 2.521 . . . . 3.0800000000000001 106.802 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 12.29 1.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.756 1.021 . . . . 8.0299999999999994 113.756 -164.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.4 p -132.45 164.09 27.32 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.054 -0.721 . . . . 3.5499999999999998 109.054 146.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.8 -26.68 22.73 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.649 -0.657 . . . . 4.0 110.547 168.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.28 -44.89 44.39 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.391 1.476 . . . . 3.1499999999999999 113.055 168.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.7 -2.34 14.23 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.877 1.066 . . . . 2.4500000000000002 113.877 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 18.02 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.304 1.441 . . . . 1.03 113.806 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -64.99 -4.27 4.42 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 118.135 2.642 . . . . 2.8999999999999999 118.135 -170.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.3 58.76 0.9 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.05 1.74 . . . . 4.3399999999999999 109.9 169.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -114.58 147.93 38.77 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.081 1.352 . . . . 2.2999999999999998 110.751 173.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.38 140.47 31.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.813 0.845 . . . . 0.93000000000000005 110.354 164.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.41 149.12 36.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.558 1.943 . . . . 4.0099999999999998 107.534 170.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.6 mtt -132.97 137.73 46.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.813 0.279 . . . . 1.8999999999999999 111.728 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.53 124.36 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.967 -1.494 . . . . 0.83999999999999997 106.967 165.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.32 137.97 51.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.289 1.036 . . . . 2.8100000000000001 112.17 -162.25 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.69 -32.96 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.486 1.291 . . . . 4.1399999999999997 114.486 -154.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.02 152.61 19.74 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.003 1.287 . . . . 1.6200000000000001 111.55 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.9 140.35 16.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.907 1.717 . . . . 1.76 113.644 175.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.473 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 15.5 t0 -83.28 -0.02 47.75 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.284 1.587 . . . . 2.4199999999999999 115.284 -152.394 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -77.2 -16.59 59.02 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.939 1.696 . . . . 4.04 114.977 -168.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.4 ptp -78.59 45.4 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.518 1.527 . . . . 3.5600000000000001 113.829 -171.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 m -83.2 -33.76 26.08 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 117.902 2.556 . . . . 4.75 117.902 -146.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -92.95 21.77 5.45 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.296 1.039 . . . . 4.4400000000000004 113.466 -162.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -75.22 146.43 81.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.546 1.138 . . . . 4.6100000000000003 112.454 -172.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.07 -14.54 41.16 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.619 2.879 . . . . 2.1899999999999999 112.913 173.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -83.58 101.77 1.55 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.695 -0.854 . . . . 4.8499999999999996 108.695 151.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.24 146.28 93.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.387 2.058 . . . . 3.5099999999999998 110.422 -177.202 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 71.15 -3.25 2.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.783 2.033 . . . . 4.6399999999999997 112.927 -173.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.88 40.02 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.817 1.675 . . . . 2.8399999999999999 115.839 168.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.5 -38.45 3.01 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.309 1.433 . . . . 2.48 112.678 -167.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.31 -25.74 63.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.961 1.267 . . . . 2.0 114.349 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.43 2.7 14.05 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.88 1.228 . . . . 2.2999999999999998 115.312 172.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.9 m -66.2 152.27 45.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.761 1.28 . . . . 3.1699999999999999 108.885 164.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.66 133.24 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.276 1.03 . . . . 5.8600000000000003 110.513 -169.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -98.09 -16.64 19.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.176 0.59 . . . . 3.5099999999999998 111.366 156.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.49 160.73 35.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.137 0.88 . . . . 0.69999999999999996 112.977 164.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.6 t -133.04 150.72 52.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.423 1.889 . . . . 1.54 109.825 167.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.21 136.34 4.38 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.393 1.473 . . . . 0.97999999999999998 111.701 -178.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.96 139.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.119 0.968 . . . . 2.7400000000000002 111.502 -174.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.03 149.55 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.172 1.389 . . . . 1.5900000000000001 111.862 174.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 C--O 1.238 0.491 0 C-N-CA 125.311 1.444 . . . . 4.0800000000000001 111.38 -176.411 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 119.544 -0.265 . . . . 1.8300000000000001 110.756 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.78 152.62 35.5 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.763 -1.211 . . . . 1.04 113.228 -164.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -147.59 130.96 16.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.138 1.775 . . . . 2.2200000000000002 109.599 174.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.44 96.66 10.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 4.8799999999999999 111.117 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 t -90.15 112.32 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 120.597 -1.314 . . . . 1.22 109.147 -169.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.28 109.55 2.81 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.781 1.181 . . . . 0.95999999999999996 110.363 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.2 mtp -96.52 131.12 43.45 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.453 0.701 . . . . 1.1399999999999999 111.486 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -105.06 155.61 18.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.465 1.126 . . . . 2.6699999999999999 110.534 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.84 145.29 54.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.412 1.485 . . . . 1.49 109.451 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.4 m -140.07 140.46 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.507 0.723 . . . . 0.89000000000000001 111.085 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.08 57.9 0.1 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.788 0.662 . . . . 2.3500000000000001 112.788 -167.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 77.34 -21.48 0.33 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.949 2.1 . . . . 1.04 114.073 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -19.99 28.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.251 1.02 . . . . 3.1499999999999999 112.858 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.57 -147.93 16.32 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 125.411 1.482 . . . . 0.90000000000000002 111.327 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.05 123.2 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.169 1.788 . . . . 0.93999999999999995 111.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.32 -137.8 9.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.748 1.642 . . . . 1.5700000000000001 112.021 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -90.31 170.11 10.53 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.258 -0.554 . . . . 2.0499999999999998 110.049 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 t -105.95 157.66 17.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.991 0.9 . . . . 1.25 112.201 162.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.95 0.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.715 2.806 . . . . 2.8799999999999999 112.822 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 147.25 6.21 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.571 2.034 . . . . 0.83999999999999997 111.914 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 p -88.08 -177.44 5.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.297 -1.001 . . . . 0.76000000000000001 108.297 159.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 47.6 t -128.3 134.28 65.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.554 -1.276 . . . . 0.47999999999999998 107.554 149.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.2 p -82.95 127.09 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.596 -0.52 . . . . 0.81999999999999995 109.596 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.67 HD11 HD21 ' A' ' 125' ' ' LEU . 16.8 mt -103.88 130.64 54.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.219 -1.03 . . . . 1.22 108.219 169.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.41 112.12 8.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.656 1.182 . . . . 2.1499999999999999 109.131 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -77.77 144.49 37.11 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.773 -0.579 . . . . 3.3199999999999998 111.157 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 t -148.24 178.13 8.83 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.356 -0.979 . . . . 1.3200000000000001 108.356 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -70.36 -14.95 62.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.162 0.585 . . . . 3.3900000000000001 112.176 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.41 12.9 67.47 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.22 1.391 . . . . 1.0 114.845 163.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.98 -155.89 22.15 Favored Glycine 0 N--CA 1.467 0.741 0 C-N-CA 127.492 2.473 . . . . 0.79000000000000004 117.224 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -71.63 101.99 2.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.664 0.785 . . . . 0.59999999999999998 111.87 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -71.29 117.3 12.65 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.841 1.256 . . . . 2.2599999999999998 109.163 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -95.88 127.52 41.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.027 1.731 . . . . 0.95999999999999996 108.162 174.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.414 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 19.9 m -129.62 105.03 17.27 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 119.916 1.235 . . . . 0.59999999999999998 107.972 167.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.75 164.87 29.58 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.112 2.541 . . . . 0.54000000000000004 110.066 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -155.42 43.66 0.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 122.356 1.074 . . . . 1.3600000000000001 109.251 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.15 134.83 44.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.891 1.276 . . . . 1.01 112.089 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.637 ' H ' ' HE3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -104.63 164.47 11.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.962 2.505 . . . . 3.2599999999999998 109.056 168.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.57 16.06 0.38 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.778 2.431 . . . . 1.5600000000000001 114.195 163.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.36 160.5 36.93 Favored Pre-proline 0 CA--C 1.511 -0.545 0 O-C-N 121.871 -0.518 . . . . 1.8100000000000001 110.42 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.8 128.45 23.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 O-C-N 123.451 1.237 . . . . 1.1100000000000001 110.307 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -85.8 31.31 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 125.101 3.867 . . . . 1.1599999999999999 113.471 -147.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.08 -122.18 4.29 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 126.399 1.952 . . . . 1.1799999999999999 113.124 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.84 138.21 35.57 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.095 2.158 . . . . 2.5099999999999998 108.386 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -137.88 123.0 19.19 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 123.683 0.793 . . . . 1.3400000000000001 112.942 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.15 149.26 7.56 Favored Glycine 0 CA--C 1.54 1.656 0 O-C-N 121.336 -0.852 . . . . 0.69999999999999996 112.307 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.7 t80 -124.96 115.4 20.51 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.802 1.301 . . . . 2.0099999999999998 107.5 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -115.03 162.31 17.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.724 1.379 . . . . 0.97999999999999998 114.724 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.2 mt -107.75 143.6 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.765 2.026 . . . . 0.62 107.388 155.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -118.41 161.09 20.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.504 1.122 . . . . 0.91000000000000003 112.03 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.62 73.22 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.558 1.318 . . . . 0.73999999999999999 114.558 -163.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -101.92 177.77 4.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.69 1.196 . . . . 1.6399999999999999 111.61 164.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.49 90.2 0.55 Allowed Glycine 0 N--CA 1.469 0.856 0 C-N-CA 124.621 1.105 . . . . 0.83999999999999997 112.003 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -166.4 99.03 0.6 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.356 1.078 . . . . 2.0800000000000001 113.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.7 m -71.48 45.52 0.11 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.942 2.097 . . . . 1.6399999999999999 113.802 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.55 148.41 42.85 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.172 -1.58 . . . . 3.6099999999999999 111.452 -171.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.51 165.02 9.37 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.473 3.449 . . . . 1.3 112.139 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.65 148.96 40.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.425 1.09 . . . . 1.95 110.013 166.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.45 134.43 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.323 1.449 . . . . 2.2000000000000002 108.091 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -162.9 143.6 9.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.305 1.442 . . . . 5.5800000000000001 109.21 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t0 53.21 41.38 32.14 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.358 0.981 . . . . 4.0199999999999996 113.471 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 14.45 73.14 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.936 -0.925 . . . . 2.6400000000000001 115.086 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.38 156.79 44.39 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.446 1.623 . . . . 3.2400000000000002 111.717 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.09 138.98 44.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.377 0.88 . . . . 1.8 113.377 -170.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.83 134.06 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.265 1.426 . . . . 3.2799999999999998 109.037 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.52 -48.47 10.19 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.263 1.579 . . . . 2.3900000000000001 115.263 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.61 122.45 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 130.578 3.551 . . . . 2.71 107.412 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -154.45 -8.31 0.14 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.43 1.092 . . . . 6.79 113.849 -164.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.53 62.47 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 121.088 1.767 . . . . 1.52 113.048 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.0 -8.36 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.167 1.787 . . . . 1.01 114.708 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.4 -165.3 38.93 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 121.344 1.884 . . . . 2.5800000000000001 113.035 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.69 179.35 53.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.27 0.938 . . . . 1.2 112.358 165.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . 0.291 0.2 OUTLIER -77.57 54.03 1.14 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.335 1.054 . . . . 2.6699999999999999 113.655 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.9 tp 54.87 69.19 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.921 2.488 . . . . 1.71 111.484 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.45 65.52 11.76 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 129.0 2.92 . . . . 4.5899999999999999 113.009 -162.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.88 -58.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.382 2.721 . . . . 2.1099999999999999 113.436 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -137.7 125.96 23.15 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.29 1.036 . . . . 4.1699999999999999 109.51 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -174.89 -95.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.553 1.541 . . . . 6.0300000000000002 112.096 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 t 171.19 -23.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 128.713 2.805 . . . . 3.4399999999999999 112.604 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.78 -34.17 4.47 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 125.892 1.71 . . . . 2.79 111.646 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -52.25 144.64 12.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.409 1.1 . . . . 6.79 111.912 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -96.26 147.86 23.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.371 1.868 . . . . 2.0299999999999998 111.326 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.1 131.6 45.72 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.529 -0.915 . . . . 4.3899999999999997 108.529 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.19 -145.38 5.2 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.548 -1.14 . . . . 2.9700000000000002 114.108 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.47 -18.89 22.46 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.302 2.668 . . . . 3.23 114.265 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -165.29 146.81 7.52 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.863 1.265 . . . . 5.5099999999999998 110.834 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.88 -135.79 13.13 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.262 0.934 . . . . 3.8599999999999999 111.917 -171.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -165.71 157.89 14.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.435 1.494 . . . . 6.1500000000000004 109.451 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.18 -126.61 0.83 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.199 0.839 . . . . 2.6600000000000001 115.199 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 145.4 25.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.47 1.508 . . . . 3.79 111.985 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.58 -11.31 57.5 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.16 1.17 . . . . 2.0600000000000001 114.16 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.01 32.2 4.72 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.216 1.389 . . . . 1.04 114.858 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.97 131.64 56.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.008 1.323 . . . . 1.6699999999999999 111.16 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.464 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 3.4 mp -142.32 159.46 58.12 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 125.646 1.579 . . . . 2.0600000000000001 111.079 -162.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.11 152.0 56.08 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.942 2.428 . . . . 0.85999999999999999 113.083 -169.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.32 130.95 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.343 1.457 . . . . 2.3599999999999999 112.758 -162.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.33 88.43 2.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.019 2.928 . . . . 1.7 109.87 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.67 136.06 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.03 0.932 . . . . 0.80000000000000004 110.587 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.87 138.99 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 127.418 2.287 . . . . 1.5900000000000001 106.295 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.19 161.28 30.12 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.263 -0.898 . . . . 2.3500000000000001 111.276 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -19.2 0.85 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.731 2.123 . . . . 2.6299999999999999 116.731 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.84 1.89 55.4 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.487 2.315 . . . . 2.73 112.812 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.15 23.21 41.75 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 125.258 1.408 . . . . 0.85999999999999999 114.462 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -123.49 131.8 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.334 1.054 . . . . 1.1000000000000001 111.044 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.02 140.17 44.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.009 1.724 . . . . 0.92000000000000004 111.604 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -140.91 -2.9 1.28 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.745 1.757 . . . . 1.5700000000000001 115.745 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.3 111.85 3.71 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 114.791 1.404 . . . . 3.2799999999999998 114.791 -165.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.23 101.89 1.18 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.014 2.476 . . . . 2.48 110.079 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.0 178.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.145 1.778 . . . . 2.2999999999999998 110.203 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.0 m -146.92 142.48 27.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.675 0.79 . . . . 1.1000000000000001 110.621 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.88 106.97 56.45 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.494 1.118 . . . . 0.83999999999999997 110.422 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.61 7.44 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.663 2.909 . . . . 1.04 113.218 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -17.98 63.32 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.229 1.412 . . . . 5.5999999999999996 113.425 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mp -152.82 155.77 37.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.862 3.265 . . . . 2.2200000000000002 108.09 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.304 0.0 OUTLIER -147.94 43.35 1.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.545 2.054 . . . . 5.0599999999999996 116.545 -173.271 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -175.99 147.36 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.638 1.975 . . . . 2.0 110.161 167.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.75 -28.42 68.69 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 1.6499999999999999 111.717 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.16 -19.23 19.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.123 1.369 . . . . 3.3599999999999999 114.301 173.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.72 -7.94 59.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.565 1.146 . . . . 2.0600000000000001 112.496 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.27 0.78 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 114.912 1.449 . . . . 1.27 114.912 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -72.23 20.22 0.07 Allowed 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.682 2.105 . . . . 3.6299999999999999 116.682 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -142.47 15.8 2.01 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.454 1.901 . . . . 3.0099999999999998 111.322 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -128.91 175.84 8.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.581 1.552 . . . . 2.5800000000000001 112.748 -164.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.15 149.11 39.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.563 1.145 . . . . 0.68000000000000005 112.04 166.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 24' ' ' ILE . 44.2 mt -82.22 155.35 24.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.303 1.441 . . . . 2.1800000000000002 109.056 158.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.4 ttm -149.45 122.88 9.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.395 . . . . 1.45 111.97 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -94.32 109.25 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.779 1.232 . . . . 0.71999999999999997 108.658 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.4 147.9 22.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.415 2.286 . . . . 2.3700000000000001 113.218 -167.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 t -67.88 -38.54 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.049 -1.032 . . . . 1.5900000000000001 112.332 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.51 155.92 17.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.632 0.634 . . . . 1.22 111.619 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.71 165.6 28.69 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.374 0.988 . . . . 1.3899999999999999 111.758 157.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -122.65 23.5 9.51 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.189 1.181 . . . . 2.6400000000000001 114.189 -136.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -93.72 4.25 54.22 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 116.397 1.999 . . . . 2.8799999999999999 116.397 -167.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -131.88 151.27 51.81 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.677 1.732 . . . . 3.8799999999999999 115.677 -168.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.0 p -140.27 11.12 2.35 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.666 2.386 . . . . 3.1600000000000001 112.89 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -118.65 14.7 13.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.219 1.408 . . . . 4.7699999999999996 112.436 -145.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -121.31 163.17 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.758 2.823 . . . . 3.23 107.969 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.02 -10.12 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.828 2.352 . . . . 2.23 114.441 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.13 133.03 22.58 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.321 1.449 . . . . 5.5899999999999999 109.757 165.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 165.9 31.35 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.64 2.893 . . . . 3.71 113.175 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.92 25.48 14.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.293 1.837 . . . . 5.0800000000000001 111.647 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.59 13.72 59.14 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.989 -1.069 . . . . 2.8199999999999998 114.04 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 106.14 -7.7 41.05 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.619 1.58 . . . . 1.77 113.984 -168.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.19 22.08 0.63 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 126.303 1.906 . . . . 1.55 115.887 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.86 74.68 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.364 1.459 . . . . 1.6499999999999999 114.294 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.2 p -73.24 163.31 28.29 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.5 1.52 . . . . 1.6499999999999999 110.921 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 145.02 30.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.768 1.227 . . . . 5.25 111.555 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -92.16 -34.02 14.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.996 0.919 . . . . 2.8199999999999998 112.436 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.83 154.57 42.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.956 0.902 . . . . 0.59999999999999998 113.116 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.3 t -138.9 153.71 48.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.405 2.282 . . . . 1.4299999999999999 109.769 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.99 114.64 0.62 Allowed Glycine 0 N--CA 1.467 0.706 0 C-N-CA 124.088 0.851 . . . . 0.75 113.051 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.88 130.75 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.915 1.286 . . . . 1.8200000000000001 110.514 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mp -76.4 132.81 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 1.28 109.54 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 118.492 -0.766 . . . . 4.6699999999999999 112.954 -176.339 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 119.479 -0.296 . . . . 2.2599999999999998 110.414 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -131.79 140.34 49.17 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.603 1.705 . . . . 1.23 115.603 -137.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.89 136.87 34.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.144 0.973 . . . . 2.5600000000000001 111.569 161.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 98.16 11.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.624 1.17 . . . . 4.5999999999999996 111.36 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.03 118.55 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 120.8 -1.188 . . . . 1.1499999999999999 109.614 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.42 111.31 3.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.478 1.513 . . . . 1.1499999999999999 112.013 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 mmt -84.24 124.52 31.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.772 1.229 . . . . 1.5700000000000001 112.518 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -113.03 149.29 33.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.487 0.661 . . . . 2.3500000000000001 111.008 164.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -56.99 140.13 49.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.431 1.092 . . . . 1.28 109.635 171.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.36 147.28 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.43 0.559 . . . . 1.6000000000000001 111.479 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -167.97 49.51 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.822 0.849 . . . . 2.5699999999999998 112.67 -168.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.42 -31.75 0.23 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.046 2.138 . . . . 1.6299999999999999 114.316 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -2.37 10.74 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.34 0.973 . . . . 2.5899999999999999 111.619 160.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.93 -140.01 16.71 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.671 1.129 . . . . 1.6000000000000001 111.03 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.05 122.34 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.723 1.609 . . . . 1.1899999999999999 111.165 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.57 -134.99 8.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 126.176 1.846 . . . . 1.74 113.25 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.84 146.24 35.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.16 1.384 . . . . 2.02 110.984 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 t -83.89 142.9 30.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 1.28 110.878 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.8 -0.24 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.617 1.34 . . . . 3.6299999999999999 114.617 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.21 167.49 14.4 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.673 1.13 . . . . 0.82999999999999996 111.843 -171.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 p -103.3 176.14 5.25 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.569 -0.9 . . . . 1.04 108.569 161.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -119.19 131.36 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.718 -1.586 . . . . 0.70999999999999996 106.718 148.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -84.88 123.97 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.921 -0.4 . . . . 1.28 109.921 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.437 HD11 HD21 ' A' ' 125' ' ' LEU . 20.5 mt -98.32 117.91 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.177 -1.046 . . . . 1.3700000000000001 108.177 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -119.43 107.96 13.97 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.514 1.526 . . . . 1.9299999999999999 109.717 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.65 147.7 31.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.578 0.955 . . . . 3.9300000000000002 113.578 -172.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -179.58 7.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.719 0.808 . . . . 1.5800000000000001 110.96 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.16 -28.2 69.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.302 1.041 . . . . 3.7799999999999998 111.842 174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.9 10.34 60.48 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.448 1.023 . . . . 1.03 114.657 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.7 -145.74 23.97 Favored Glycine 0 N--CA 1.461 0.342 0 C-N-CA 129.15 3.262 . . . . 0.84999999999999998 114.895 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.6 95.19 7.09 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.916 0.886 . . . . 0.66000000000000003 110.488 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -71.66 107.18 4.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.108 0.963 . . . . 2.5099999999999998 109.856 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 t80 -99.9 105.46 17.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 117.254 -1.355 . . . . 0.57999999999999996 108.716 -167.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.4 m -116.05 109.07 45.21 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.789 1.632 . . . . 0.96999999999999997 109.216 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.63 151.76 17.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.888 3.059 . . . . 0.60999999999999999 111.654 -176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -141.53 23.68 2.12 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.555 0.693 . . . . 1.45 112.599 171.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -80.11 157.7 26.58 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 126.644 1.978 . . . . 0.80000000000000004 113.872 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.29 170.31 16.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.661 -1.609 . . . . 3.1899999999999999 109.831 165.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.81 22.93 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.607 2.763 . . . . 1.4199999999999999 112.92 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -99.85 160.82 26.25 Favored Pre-proline 0 CA--C 1.51 -0.591 0 C-N-CA 123.472 0.709 . . . . 1.6200000000000001 111.56 176.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 34.0 Cg_endo -63.15 127.44 20.22 Favored 'Trans proline' 0 N--CA 1.426 -2.456 0 O-C-N 123.531 1.28 . . . . 0.91000000000000003 110.482 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 4.8 Cg_endo -88.8 31.78 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.51 3.474 . . . . 1.4399999999999999 112.654 -144.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.37 -120.94 4.84 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 126.22 1.866 . . . . 1.8700000000000001 113.405 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.32 145.07 48.26 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.971 2.108 . . . . 2.4399999999999999 109.643 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.58 144.01 41.8 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.052 0.941 . . . . 0.93000000000000005 111.409 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.95 165.57 37.86 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.136 -0.978 . . . . 0.84999999999999998 111.215 168.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -146.55 126.9 13.97 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.358 -1.349 . . . . 2.1200000000000001 107.358 169.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -122.81 167.23 13.78 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.466 1.284 . . . . 1.1299999999999999 114.466 163.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.441 ' CG2' HD12 ' A' ' 74' ' ' LEU . 62.7 mt -85.24 148.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.132 0.973 . . . . 0.90000000000000002 108.836 151.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.38 153.74 41.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.822 2.049 . . . . 1.03 108.318 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.72 72.67 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.97 1.841 . . . . 1.23 115.97 -159.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.23 -179.59 5.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.43 1.892 . . . . 1.7 112.035 -170.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.41 125.78 7.13 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.548 -1.14 . . . . 2.0899999999999999 111.497 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 m 142.73 101.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 130.569 3.548 . . . . 2.2400000000000002 112.526 164.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 61.1 m -63.82 23.18 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 127.56 2.344 . . . . 1.3 115.709 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.08 130.18 33.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.528 -1.982 . . . . 3.27 110.737 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.29 157.9 14.88 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.225 3.283 . . . . 0.95999999999999996 111.544 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.57 174.49 7.73 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 1.6299999999999999 111.399 159.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.72 138.43 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.134 1.374 . . . . 2.4199999999999999 107.967 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.29 -124.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.182 0.593 . . . . 7.04 111.378 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.87 -31.32 66.59 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.901 1.68 . . . . 5.0599999999999996 115.353 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 44.17 0.02 OUTLIER Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.135 0.874 . . . . 2.8799999999999999 112.164 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 172.71 158.41 0.11 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.306 2.642 . . . . 3.7200000000000002 109.281 -164.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.6 141.89 47.17 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.131 1.16 . . . . 1.5600000000000001 114.131 -161.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.18 61.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.58 1.552 . . . . 1.8200000000000001 111.651 -167.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.99 -72.2 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 127.431 2.292 . . . . 1.72 115.498 166.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.93 106.6 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 1 C-N-CA 132.906 4.482 . . . . 1.6399999999999999 105.575 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -115.54 -46.49 2.86 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.378 1.071 . . . . 3.96 113.62 -155.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.62 -13.51 62.14 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.2 1.185 . . . . 1.3799999999999999 114.2 -171.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -12.74 61.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.729 2.012 . . . . 1.22 113.664 167.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.33 169.4 44.23 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.789 -1.194 . . . . 2.9500000000000002 112.638 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.69 -161.93 8.84 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.941 -0.864 . . . . 1.5900000000000001 110.941 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -42.81 141.33 1.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.601 -0.518 . . . . 2.4700000000000002 109.601 160.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -65.11 74.61 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.546 1.538 . . . . 3.04 112.529 -170.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -132.73 58.81 38.66 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 126.717 2.007 . . . . 4.0599999999999996 112.681 -160.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.51 -37.56 29.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.062 1.841 . . . . 2.8399999999999999 110.411 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -149.0 146.93 28.01 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.62 2.768 . . . . 4.29 105.805 162.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 p30 166.34 -47.42 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.115 2.166 . . . . 4.3799999999999999 114.327 168.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 t 172.74 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.428 2.691 . . . . 2.8700000000000001 111.425 -167.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.47 22.19 51.74 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 123.782 0.706 . . . . 2.21 114.135 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -160.29 -116.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.963 1.305 . . . . 4.3799999999999999 113.438 -167.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.468 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 2.8 t60 -160.05 145.24 15.09 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 119.833 -1.792 . . . . 1.8500000000000001 114.988 -170.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.65 -129.83 0.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.555 1.542 . . . . 4.29 111.164 170.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.55 -88.75 0.4 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.627 1.584 . . . . 3.1400000000000001 110.964 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -33.56 6.47 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.186 2.591 . . . . 4.0300000000000002 112.636 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.23 129.48 31.64 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.284 1.434 . . . . 5.5599999999999996 107.95 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.41 64.04 2.91 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 125.249 1.404 . . . . 2.8799999999999999 115.641 -158.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.09 98.71 11.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.996 0.918 . . . . 4.8799999999999999 112.92 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.99 -72.3 2.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 116.025 1.17 . . . . 4.0199999999999996 116.025 155.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.955 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 13.5 t-160 -75.09 93.24 2.73 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.314 1.057 . . . . 4.6600000000000001 113.132 -164.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.78 64.03 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.926 1.454 . . . . 3.23 114.926 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.7 -0.13 89.85 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.965 1.269 . . . . 1.6699999999999999 114.644 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.955 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 37.7 m-20 -67.03 134.25 51.54 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 118.297 1.048 . . . . 2.8100000000000001 108.651 161.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.28 168.25 11.66 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.096 0.958 . . . . 2.2799999999999998 111.515 -149.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.12 165.23 28.39 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.279 2.653 . . . . 1.1599999999999999 112.682 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -85.63 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 122.824 1.297 . . . . 2.0 112.983 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.59 97.3 2.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.309 3.444 . . . . 1.76 109.832 172.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.36 139.15 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.333 1.053 . . . . 1.6100000000000001 111.37 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.44 140.86 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.039 2.135 . . . . 1.5600000000000001 107.453 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -82.93 160.94 21.98 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.364 -0.835 . . . . 2.9100000000000001 112.024 174.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -20.38 4.44 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 115.539 1.681 . . . . 2.8599999999999999 115.539 -174.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -85.25 4.48 34.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.361 1.864 . . . . 3.3399999999999999 113.528 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.85 56.69 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 124.588 1.09 . . . . 0.90000000000000002 114.19 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.57 135.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.288 1.835 . . . . 1.1799999999999999 109.513 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 149.58 24.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.698 1.199 . . . . 0.98999999999999999 110.953 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.8 t -159.55 -34.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.672 0.989 . . . . 1.3400000000000001 113.672 -166.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.69 122.33 85.46 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.111 1.364 . . . . 3.77 111.64 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.18 136.72 16.43 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.91 2.406 . . . . 1.4199999999999999 111.441 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.27 74.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 122.976 1.37 . . . . 2.29 112.096 -167.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.2 m -57.07 137.67 55.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.538 2.335 . . . . 1.1599999999999999 113.022 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.56 98.04 22.36 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.757 1.223 . . . . 0.75 111.34 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.63 3.68 5.21 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.29 3.326 . . . . 1.1200000000000001 113.938 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -76.99 -16.27 59.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.287 1.435 . . . . 4.1399999999999997 112.383 -176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.46 -179.52 4.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.985 2.114 . . . . 2.1400000000000001 107.704 166.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -53.77 2.68 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.32 -0.862 . . . . 3.9100000000000001 111.673 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -127.37 163.44 24.0 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.175 1.546 . . . . 2.1699999999999999 115.175 -149.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tp -74.22 -34.99 63.85 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.595 -1.316 . . . . 2.1499999999999999 111.977 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.42 -35.86 65.85 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.123 1.369 . . . . 3.4100000000000001 113.698 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.33 -3.13 38.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.405 1.261 . . . . 1.6299999999999999 114.405 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.48 7.94 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.483 1.038 . . . . 0.91000000000000003 113.447 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.07 -10.67 4.56 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.278 1.955 . . . . 2.98 116.278 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -147.03 18.9 1.25 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.614 1.965 . . . . 3.52 111.537 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -101.45 -160.36 0.79 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.405 1.482 . . . . 1.55 112.274 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.47 160.71 39.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.081 1.352 . . . . 0.79000000000000004 112.332 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 24' ' ' ILE . 19.8 mt -113.62 149.69 34.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.3 2.64 . . . . 1.8999999999999999 108.093 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.5 mtt -137.59 128.13 26.67 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.524 1.056 . . . . 1.48 111.264 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.82 108.53 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.794 -1.187 . . . . 0.88 107.794 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -86.93 144.21 27.05 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.881 1.672 . . . . 2.29 113.142 -165.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.57 -43.6 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.099 -1.0 . . . . 1.26 112.035 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.38 172.0 25.98 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.914 -0.874 . . . . 1.0800000000000001 110.914 162.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.53 160.85 6.13 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.063 1.316 . . . . 1.4199999999999999 112.587 165.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -40.38 94.98 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.76 1.224 . . . . 3.46 114.14 -169.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.27 36.96 0.16 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 117.586 2.439 . . . . 2.8500000000000001 117.586 -151.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -108.46 148.19 30.56 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.562 1.545 . . . . 2.6400000000000001 112.372 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -149.48 -141.01 0.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.115 0.966 . . . . 3.5099999999999998 111.125 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.36 111.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.677 2.391 . . . . 5.5599999999999996 114.954 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -154.3 160.99 30.35 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.706 2.002 . . . . 3.29 109.461 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.78 12.51 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 124.522 3.482 . . . . 4.0800000000000001 114.747 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -132.36 140.81 39.11 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.519 1.528 . . . . 5.4400000000000004 110.151 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.47 151.61 82.0 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.983 3.122 . . . . 5.5300000000000002 112.955 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.63 21.19 6.97 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.956 1.702 . . . . 4.9900000000000002 113.415 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.93 80.81 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.531 1.062 . . . . 3.6699999999999999 113.62 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.97 -48.66 3.05 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.454 1.502 . . . . 2.0499999999999998 113.029 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.37 18.84 5.12 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.189 1.852 . . . . 1.71 114.956 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.28 -19.82 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.995 1.283 . . . . 1.6000000000000001 114.098 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.7 p -66.31 145.41 55.76 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.683 1.593 . . . . 1.4399999999999999 111.714 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.17 136.81 48.62 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.309 1.444 . . . . 4.6900000000000004 110.276 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 27.1 t80 -75.63 -37.06 60.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 2.1499999999999999 110.411 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.31 152.21 41.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.497 1.119 . . . . 0.73999999999999999 112.861 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 52.1 t -121.42 147.79 45.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.792 2.037 . . . . 1.6299999999999999 109.866 171.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -138.93 91.38 0.2 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.01 1.767 . . . . 0.82999999999999996 111.704 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.29 135.13 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.918 1.287 . . . . 2.77 111.587 166.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mt -97.03 151.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 1.6200000000000001 109.93 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 11.3 mmpt? . . . . . 0 N--CA 1.471 0.581 0 O-C-N 121.382 -0.824 . . . . 5.0 110.708 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.138 -0.69 . . . . 1.8799999999999999 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 m -114.79 131.02 56.94 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.221 1.373 . . . . 1.3 112.897 -153.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.76 141.53 48.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.624 2.37 . . . . 2.96 107.191 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -120.47 86.3 2.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.937 -1.102 . . . . 3.3199999999999998 110.82 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.11 118.68 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 121.6 -0.687 . . . . 1.02 109.672 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.92 104.01 1.02 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.142 1.354 . . . . 0.75 109.953 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 mtp -97.84 137.92 35.97 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.154 0.982 . . . . 1.3500000000000001 110.735 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -129.38 147.35 51.19 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.922 0.889 . . . . 3.02 112.092 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.14 142.93 56.35 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.127 1.371 . . . . 1.48 109.58 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 m -142.13 161.44 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.316 1.046 . . . . 1.4299999999999999 112.851 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t 155.65 124.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.756 2.822 . . . . 3.0699999999999998 111.423 144.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.57 -37.69 0.38 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.439 2.696 . . . . 1.97 115.516 164.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -7.87 56.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.585 1.554 . . . . 4.2999999999999998 111.367 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -149.48 18.1 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 125.478 1.513 . . . . 1.4399999999999999 112.386 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.05 130.79 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.65 1.58 . . . . 1.53 110.558 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.8 -134.48 8.54 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 125.68 1.609 . . . . 2.3300000000000001 113.351 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.83 153.49 24.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.162 2.185 . . . . 2.75 112.153 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -94.49 139.01 31.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.419 0.628 . . . . 1.3200000000000001 112.02 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.7 10.63 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.764 1.626 . . . . 2.9399999999999999 112.385 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 154.18 146.69 4.46 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.722 1.63 . . . . 0.62 111.265 -166.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.5 p -88.87 174.52 7.9 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.184 -1.043 . . . . 0.96999999999999997 108.184 158.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.5 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 99.0 t -127.42 129.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.622 -1.251 . . . . 0.69999999999999996 107.622 165.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.4 p -82.83 129.25 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.534 0.683 . . . . 1.0800000000000001 109.824 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.46 109.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.501 -1.666 . . . . 1.3500000000000001 106.501 169.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -116.0 108.28 16.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 123.098 1.427 . . . . 2.5299999999999998 110.741 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.06 142.83 56.36 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 127.476 2.31 . . . . 4.1399999999999997 111.707 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -154.7 177.01 11.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.535 1.16 . . . . 1.2 111.392 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.55 -25.24 66.01 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.991 0.916 . . . . 4.25 110.661 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.18 14.89 61.04 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.426 1.489 . . . . 0.97999999999999998 115.949 166.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.03 -164.39 51.46 Favored Glycine 0 N--CA 1.47 0.929 0 C-N-CA 129.74 3.543 . . . . 0.89000000000000001 115.095 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.35 104.56 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.445 1.498 . . . . 0.65000000000000002 112.145 -168.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -82.37 104.16 12.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.159 0.983 . . . . 1.8300000000000001 109.805 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.5 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 11.1 t80 -91.8 110.02 21.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.017 2.127 . . . . 0.72999999999999998 109.567 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.407 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 12.0 m -122.32 115.04 30.21 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.836 1.198 . . . . 0.88 108.563 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.93 164.44 27.5 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.101 2.534 . . . . 0.57999999999999996 110.867 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -160.03 51.39 0.32 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.316 1.055 . . . . 2.1600000000000001 111.288 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 150.86 32.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.069 1.348 . . . . 0.73999999999999999 112.013 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.27 38.39 3.13 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.221 1.934 . . . . 2.1099999999999999 116.221 -160.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.76 12.0 0.59 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.483 2.031 . . . . 1.6000000000000001 116.483 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.94 160.71 25.37 Favored Pre-proline 0 N--CA 1.477 0.896 0 N-CA-C 114.186 1.18 . . . . 1.3500000000000001 114.186 -169.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.93 130.87 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.328 1.352 . . . . 0.81999999999999995 112.708 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.66 48.08 2.07 Favored 'Trans proline' 0 C--N 1.35 0.653 1 C-N-CA 126.957 5.105 . . . . 0.96999999999999997 112.755 -158.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.94 -140.09 7.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.414 1.563 . . . . 1.23 113.287 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.04 134.51 53.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.821 1.648 . . . . 2.8399999999999999 108.534 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -139.88 125.21 18.94 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 125.157 1.383 . . . . 1.27 111.017 -162.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.79 154.78 9.11 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.642 -1.286 . . . . 0.52000000000000002 112.457 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.38 127.51 29.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.958 1.303 . . . . 1.9299999999999999 107.719 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.408 ' CD2' ' HA ' ' A' ' 93' ' ' ASP . 50.3 m170 -121.92 169.77 10.47 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 117.027 2.232 . . . . 1.04 117.027 168.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.16 138.79 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.508 1.923 . . . . 0.73999999999999999 109.254 152.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.14 164.94 16.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.217 2.607 . . . . 0.98999999999999999 110.602 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.86 -62.79 1.42 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.697 1.369 . . . . 1.47 114.697 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 -97.6 146.93 24.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.652 0.612 . . . . 1.5900000000000001 112.652 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.74 62.83 2.38 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.634 1.111 . . . . 0.88 112.322 168.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -149.73 77.73 1.34 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.72 1.208 . . . . 2.6600000000000001 112.589 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.0 m -64.16 9.42 0.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 116.331 1.974 . . . . 1.3200000000000001 116.331 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -72.44 151.71 91.87 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 119.743 -1.848 . . . . 3.6899999999999999 112.53 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.0 152.15 67.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.257 2.638 . . . . 1.77 111.316 171.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.68 147.79 22.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.546 0.738 . . . . 3.2000000000000002 110.914 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mm -86.45 104.64 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.528 -0.916 . . . . 4.71 108.528 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -162.34 138.96 7.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.265 1.026 . . . . 7.6699999999999999 109.909 -157.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t0 51.27 35.79 14.48 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 6.4500000000000002 113.85 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.61 11.0 85.88 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.527 -1.151 . . . . 3.9100000000000001 115.323 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -150.31 169.3 21.71 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.07 1.935 . . . . 3.0699999999999998 113.24 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.77 94.95 8.81 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.838 0.855 . . . . 2.2999999999999998 109.873 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.54 88.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.746 0.818 . . . . 2.9300000000000002 111.593 -170.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 55.69 -86.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.245 2.618 . . . . 2.0600000000000001 115.025 159.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.73 99.04 0.31 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.748 2.819 . . . . 2.7200000000000002 107.253 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -149.34 -17.46 0.28 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.284 1.216 . . . . 7.0199999999999996 114.284 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.04 -9.22 4.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.661 1.184 . . . . 1.72 113.55 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 2.65 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.185 2.194 . . . . 0.92000000000000004 113.671 164.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 16.29 26.93 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.563 1.554 . . . . 3.04 114.255 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -114.6 4.86 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.248 -1.541 . . . . 3.23 109.248 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -97.35 -101.67 0.19 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.983 1.313 . . . . 3.8599999999999999 107.652 158.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.9 tp -160.95 79.45 0.61 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.228 2.211 . . . . 1.96 106.759 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.74 68.97 63.07 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.772 -1.104 . . . . 4.9800000000000004 111.111 -152.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.04 -44.93 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.821 2.347 . . . . 2.02 113.6 -168.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -154.87 -151.71 0.37 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.287 1.835 . . . . 4.6500000000000004 108.916 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 75.23 -60.82 0.5 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.551 2.74 . . . . 4.4299999999999997 112.84 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 177.29 -19.45 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.927 2.491 . . . . 2.5699999999999998 113.328 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.73 49.17 76.46 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.039 1.29 . . . . 2.8799999999999999 114.896 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -143.96 18.29 1.78 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.662 1.727 . . . . 4.6600000000000001 115.662 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.8 t60 90.05 173.24 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.52 2.328 . . . . 2.73 112.871 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -162.1 51.91 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.897 1.279 . . . . 4.8799999999999999 110.136 -161.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.01 -47.95 1.29 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-O 117.973 -1.459 . . . . 2.8100000000000001 114.997 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -103.43 -23.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.179 3.253 . . . . 4.2699999999999996 113.831 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.97 172.99 1.57 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.793 2.437 . . . . 5.75 108.758 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.19 -159.05 32.13 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.064 0.84 . . . . 3.8900000000000001 113.516 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -153.52 28.71 0.49 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 6.4699999999999998 112.245 -168.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.18 16.65 60.87 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.105 -2.497 . . . . 3.5299999999999998 117.698 -165.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.708 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 2.6 t-160 170.06 99.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 128.396 2.678 . . . . 5.0499999999999998 111.059 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.49 2.79 2.78 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.578 1.696 . . . . 2.02 115.578 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.531 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -102.42 3.97 50.83 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.322 1.439 . . . . 0.81000000000000005 113.459 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.708 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 64.3 m-20 -71.93 137.09 47.12 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.525 1.162 . . . . 1.6599999999999999 109.619 165.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.86 169.04 11.06 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.762 1.225 . . . . 1.8799999999999999 109.915 -144.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.52 157.8 55.36 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.714 2.276 . . . . 1.03 111.866 -172.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.8 125.23 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.227 1.011 . . . . 2.4199999999999999 109.85 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.39 114.34 3.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 128.365 2.666 . . . . 2.54 109.872 168.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.87 143.32 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 120.966 -1.083 . . . . 0.92000000000000004 108.628 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -123.2 124.61 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 106.261 -1.755 . . . . 1.7 106.261 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.7 152.91 41.21 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.06 0.845 . . . . 1.8899999999999999 111.933 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -4.24 0.05 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 117.539 2.422 . . . . 2.23 117.539 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.06 4.42 10.89 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.793 1.637 . . . . 3.0299999999999998 114.016 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.52 16.51 17.68 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 116.226 1.25 . . . . 0.73999999999999999 116.226 166.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.65 134.08 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.128 1.371 . . . . 1.1100000000000001 107.932 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.22 120.68 40.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.331 0.652 . . . . 0.68999999999999995 109.352 168.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -132.21 2.81 3.94 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.135 1.774 . . . . 1.22 112.745 172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -82.89 117.76 69.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.687 1.995 . . . . 5.0999999999999996 111.983 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.33 147.27 18.05 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.475 2.783 . . . . 1.25 113.473 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.29 176.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.515 1.926 . . . . 1.1699999999999999 109.83 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.8 m -139.73 140.83 36.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.069 0.947 . . . . 0.66000000000000003 110.142 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.72 91.48 6.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.24 1.016 . . . . 0.72999999999999998 110.56 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.29 -8.92 24.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.818 3.012 . . . . 1.46 115.006 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -58.96 -29.17 66.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.178 1.391 . . . . 4.1600000000000001 113.751 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.52 164.98 11.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.131 1.772 . . . . 2.29 110.389 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.95 24.6 0.5 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.596 1.558 . . . . 4.1299999999999999 114.109 -170.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -178.57 148.5 0.45 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.441 2.296 . . . . 1.8100000000000001 112.507 170.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.75 -27.5 69.32 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.53 -1.356 . . . . 1.5800000000000001 111.269 166.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.44 -16.14 0.32 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.299 2.24 . . . . 2.8199999999999998 114.062 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -9.24 40.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.366 1.466 . . . . 1.9299999999999999 113.733 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.5 m -130.19 11.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.552 1.541 . . . . 1.0700000000000001 113.134 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -62.59 -3.36 1.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.494 2.405 . . . . 2.54 117.494 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.27 29.93 0.78 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.358 1.863 . . . . 2.9700000000000002 110.726 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -121.82 175.02 6.5 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.825 1.65 . . . . 1.4199999999999999 113.038 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.01 149.2 43.03 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.501 1.12 . . . . 0.56000000000000005 111.782 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.43 170.42 16.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.041 1.336 . . . . 2.3599999999999999 109.241 158.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 44.9 ttm -151.19 124.96 9.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.37 -0.831 . . . . 2.3100000000000001 111.454 163.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.5 120.98 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.164 -1.05 . . . . 0.91000000000000003 108.164 167.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -105.13 148.49 26.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.869 2.068 . . . . 1.8999999999999999 112.007 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.35 -25.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.718 -1.239 . . . . 1.1899999999999999 113.209 -162.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -129.28 162.55 22.64 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.135 0.874 . . . . 1.05 111.55 168.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.82 144.94 47.56 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.357 0.98 . . . . 1.5800000000000001 113.081 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -97.95 -8.86 27.19 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.992 1.849 . . . . 2.6600000000000001 115.992 -147.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -59.96 -25.61 65.34 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.939 1.296 . . . . 3.8700000000000001 113.407 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 76.4 mtm -82.11 61.64 5.47 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 3.3900000000000001 113.899 -167.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.6 p -91.82 -147.47 0.22 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.655 -1.278 . . . . 3.3999999999999999 110.846 156.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t0 58.35 42.25 21.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.456 1.502 . . . . 4.5599999999999996 112.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.92 156.51 5.96 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.509 1.924 . . . . 3.4900000000000002 109.64 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.25 -19.2 22.73 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.116 2.544 . . . . 2.7799999999999998 114.327 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.59 119.91 76.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.216 1.371 . . . . 7.9699999999999998 109.903 167.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.85 118.8 5.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.504 2.136 . . . . 4.4500000000000002 110.179 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 56.64 27.12 12.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.182 1.393 . . . . 4.0999999999999996 112.186 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.07 17.52 63.56 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 121.042 -1.036 . . . . 3.5099999999999998 113.333 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.07 3.78 75.7 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.6 1.571 . . . . 2.98 114.367 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.28 -5.91 75.35 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.252 1.526 . . . . 2.02 114.845 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.43 -12.0 80.04 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.235 1.398 . . . . 1.6799999999999999 115.326 -170.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.67 161.6 5.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.069 1.348 . . . . 1.6399999999999999 110.152 164.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 136.15 40.31 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 4.5700000000000003 112.65 -169.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -101.04 -25.63 13.99 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.261 1.424 . . . . 2.46 113.294 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.73 144.09 22.31 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.466 2.024 . . . . 0.70999999999999996 116.466 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.76 170.29 14.92 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.209 3.403 . . . . 2.8799999999999999 112.186 165.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 179.94 83.15 0.06 OUTLIER Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.884 1.706 . . . . 0.70999999999999996 112.41 166.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.94 130.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 118.026 0.913 . . . . 1.4299999999999999 110.704 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 27.3 mt -102.9 140.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.52 1.528 . . . . 1.3100000000000001 111.377 -169.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 mptt . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 124.774 1.23 . . . . 3.4100000000000001 108.733 161.581 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 119.424 -0.322 . . . . 2.2000000000000002 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.73 154.39 33.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 118.984 -2.323 . . . . 1.1599999999999999 116.995 -141.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.07 138.97 18.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.68 -1.6 . . . . 3.4300000000000002 111.328 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.81 113.82 27.08 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.803 -1.186 . . . . 4.5800000000000001 112.03 176.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.8 t -88.63 118.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.551 -0.537 . . . . 1.1699999999999999 109.551 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.34 103.09 2.36 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.152 1.358 . . . . 1.1100000000000001 110.323 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 41.8 mtt -81.85 148.83 28.62 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.439 0.904 . . . . 1.21 113.439 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -114.23 151.52 32.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 2.4700000000000002 110.134 167.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 mt -64.49 144.44 57.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.853 0.861 . . . . 1.1699999999999999 109.112 171.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 m -133.69 149.32 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.2 0.6 . . . . 1.05 111.36 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -174.55 53.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.143 0.977 . . . . 2.3700000000000001 112.53 -168.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.49 -14.21 0.42 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.051 1.74 . . . . 1.1299999999999999 115.094 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.15 -9.9 58.97 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.363 -0.836 . . . . 3.2999999999999998 110.994 160.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -129.69 9.39 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.517 -1.433 . . . . 1.03 109.517 -163.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.7 t -74.33 126.9 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.925 1.69 . . . . 0.81000000000000005 111.299 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.34 -135.53 8.93 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.066 1.793 . . . . 1.45 112.554 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.93 164.11 12.86 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.983 -0.716 . . . . 1.78 111.784 173.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.0 t -100.1 152.0 20.74 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.309 1.044 . . . . 0.94999999999999996 112.757 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.428 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 1.4 pp -144.21 4.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 128.178 2.591 . . . . 2.8599999999999999 113.495 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.53 170.69 27.71 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.205 1.383 . . . . 0.68000000000000005 114.266 172.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -109.74 177.66 4.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.989 1.316 . . . . 0.87 109.889 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.83 131.84 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.736 -1.209 . . . . 0.40999999999999998 107.736 158.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 9.0 p -85.89 123.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 123.579 0.549 . . . . 0.87 110.377 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mt -105.38 126.08 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 125.858 1.663 . . . . 1.3999999999999999 107.884 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -135.5 107.62 7.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.413 1.085 . . . . 2.0800000000000001 109.958 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -74.07 144.08 45.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.613 0.765 . . . . 3.6000000000000001 112.043 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -159.94 -174.58 4.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.708 1.203 . . . . 1.28 109.751 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.34 -26.51 65.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.627 1.571 . . . . 3.1699999999999999 112.75 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.94 13.86 65.81 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 124.851 1.215 . . . . 0.92000000000000004 114.754 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.95 -147.02 32.94 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 127.396 2.427 . . . . 0.73999999999999999 114.399 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.4 mt -76.26 99.46 4.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.986 0.915 . . . . 0.58999999999999997 112.017 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -77.69 114.16 16.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.13 1.372 . . . . 2.1299999999999999 110.397 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.73 116.79 32.63 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.485 2.314 . . . . 0.63 109.896 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.9 m -122.49 115.17 29.93 Favored Pre-proline 0 N--CA 1.477 0.875 0 CA-C-O 118.278 -0.868 . . . . 0.56999999999999995 108.755 176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.22 162.86 4.67 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.91 3.073 . . . . 0.40999999999999998 112.007 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -151.32 33.31 0.57 Allowed 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.12 0.962 . . . . 1.4299999999999999 112.606 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -95.75 150.05 20.82 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.911 1.684 . . . . 0.72999999999999998 113.903 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.5 162.37 24.13 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.516 1.526 . . . . 3.0899999999999999 109.217 174.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.28 21.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.933 2.893 . . . . 1.8600000000000001 113.789 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -106.57 155.87 38.1 Favored Pre-proline 0 CA--C 1.51 -0.576 0 C-N-CA 123.857 0.863 . . . . 2.0600000000000001 112.442 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.56 140.36 47.28 Favored 'Trans proline' 0 N--CA 1.427 -2.385 0 O-C-N 123.269 1.142 . . . . 1.1399999999999999 111.625 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 99' ' ' VAL . 12.2 Cg_endo -88.26 32.01 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.839 2.359 . . . . 1.3400000000000001 114.568 -148.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 99' ' ' VAL . . . -106.89 -147.35 14.02 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.532 1.073 . . . . 1.1899999999999999 113.912 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -81.57 131.51 35.28 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.964 -1.315 . . . . 2.5299999999999998 110.592 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -102.66 135.53 44.14 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.243 -1.021 . . . . 1.76 108.243 164.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.55 161.7 21.58 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.852 -0.899 . . . . 0.82999999999999996 110.852 166.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -146.84 122.34 10.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.915 -1.143 . . . . 2.04 107.915 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -126.8 167.65 15.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.207 1.188 . . . . 0.95999999999999996 114.207 159.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.32 145.66 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.08 1.352 . . . . 1.45 107.721 152.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -123.92 158.64 31.51 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.202 1.401 . . . . 0.84999999999999998 110.969 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.42 69.03 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.465 1.654 . . . . 0.66000000000000003 115.465 -163.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -126.48 -174.58 3.16 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.357 1.463 . . . . 1.1499999999999999 112.195 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.97 30.52 5.03 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 117.776 1.87 . . . . 1.27 117.776 -156.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.6 m -159.06 114.4 2.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 121.692 2.746 . . . . 2.4700000000000002 115.0 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.3 m -68.83 76.93 0.31 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.385 1.564 . . . . 2.7400000000000002 112.644 167.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -116.56 134.38 22.89 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 124.981 1.312 . . . . 3.8199999999999998 109.134 167.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.11 144.63 21.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.293 2.662 . . . . 1.1399999999999999 110.18 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.91 131.51 42.31 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.08 -0.711 . . . . 1.49 109.08 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.4 mm -99.15 110.0 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.952 -1.129 . . . . 3.5099999999999998 107.952 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -166.81 154.51 9.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 6.6500000000000004 111.003 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t70 41.31 54.86 3.45 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.527 1.531 . . . . 4.2000000000000002 114.853 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.11 87.75 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.722 -1.599 . . . . 2.6899999999999999 115.653 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -153.67 171.89 18.12 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.462 2.131 . . . . 2.7000000000000002 114.161 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 114.59 26.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.215 1.406 . . . . 2.1200000000000001 109.565 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.33 74.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.482 1.113 . . . . 1.9299999999999999 111.02 -172.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.7 -73.51 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.257 2.623 . . . . 2.1699999999999999 116.328 161.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.78 69.23 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 130.801 3.64 . . . . 1.8400000000000001 107.308 -165.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.26 -42.51 14.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.302 1.441 . . . . 4.5 112.236 -165.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.17 5.99 1.46 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.866 1.432 . . . . 1.3100000000000001 114.866 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.74 66.1 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.362 1.065 . . . . 1.02 112.526 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.23 -175.42 51.28 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 119.497 1.044 . . . . 2.3599999999999999 113.066 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.2 170.43 37.95 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.805 1.193 . . . . 1.3200000000000001 113.298 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -78.22 38.67 0.29 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.036 2.134 . . . . 3.2799999999999998 112.385 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.4 tp 56.73 72.59 0.5 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.132 2.573 . . . . 1.6399999999999999 110.213 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 39.2 p-10 -153.14 5.95 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 118.17 2.656 . . . . 4.54 118.17 -140.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 68.3 Cg_endo -70.39 -26.72 24.3 Favored 'Trans proline' 0 C--N 1.358 1.063 0 CA-C-N 123.906 2.431 . . . . 3.1800000000000002 116.151 -162.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.67 138.14 19.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.4 1.454 . . . . 2.9300000000000002 111.043 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 p30 161.61 -159.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 129.676 3.19 . . . . 4.7300000000000004 109.381 -161.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 t -72.74 -14.12 61.48 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.625 1.342 . . . . 4.6200000000000001 114.625 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.83 -58.38 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.946 1.26 . . . . 3.5800000000000001 113.124 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttt -69.32 163.89 24.09 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.963 1.381 . . . . 6.25 113.754 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.34 137.31 55.94 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.201 -0.937 . . . . 1.53 111.252 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -76.17 156.04 34.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.153 0.581 . . . . 3.5 112.064 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.2 -157.15 27.13 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.178 1.371 . . . . 2.6000000000000001 112.149 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.14 -23.8 28.67 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.169 2.58 . . . . 4.29 111.938 172.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -153.59 176.43 12.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.873 2.069 . . . . 7.9100000000000001 108.626 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.43 -126.63 7.97 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.074 -1.21 . . . . 3.3799999999999999 110.074 -165.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -165.95 157.16 13.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.006 0.903 . . . . 4.75 110.133 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.533 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . 166.31 -137.13 4.49 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.833 2.635 . . . . 2.6899999999999999 110.669 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -90.9 136.03 33.34 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.781 -0.835 . . . . 4.3899999999999997 112.378 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.53 -33.25 75.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.44 -0.788 . . . . 1.8700000000000001 113.064 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.52 6.13 83.02 Favored Glycine 0 N--CA 1.474 1.18 0 N-CA-C 115.717 1.047 . . . . 0.79000000000000004 115.717 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -67.98 130.18 42.17 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 118.772 1.286 . . . . 1.8 109.075 161.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.82 161.93 40.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.477 1.511 . . . . 1.8899999999999999 110.327 -151.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.31 144.86 20.92 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.427 2.751 . . . . 0.98999999999999999 111.63 -168.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.18 132.45 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.612 1.196 . . . . 1.47 113.533 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.87 81.76 1.65 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.807 2.443 . . . . 1.6699999999999999 109.37 169.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.87 131.78 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.421 -0.799 . . . . 1.1599999999999999 109.657 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.6 HG23 ' HA ' ' A' ' 42' ' ' PRO . 19.1 m -111.51 153.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.253 1.021 . . . . 2.04 108.48 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.7 p30 -69.04 159.36 33.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.732 -0.605 . . . . 2.04 111.93 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -49.09 -19.32 0.41 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.173 2.189 . . . . 3.8799999999999999 115.865 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.12 8.1 32.02 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 127.83 2.452 . . . . 4.5800000000000001 112.117 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.48 23.81 15.51 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 117.582 1.793 . . . . 1.1599999999999999 117.582 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -139.55 134.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.961 1.305 . . . . 1.21 111.29 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.85 118.65 26.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.306 2.242 . . . . 0.76000000000000001 110.786 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 t -146.94 -3.88 0.57 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.266 1.209 . . . . 1.3999999999999999 114.266 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.73 118.61 72.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.335 1.454 . . . . 3.29 112.219 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.79 125.82 11.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.262 3.308 . . . . 1.1100000000000001 110.227 170.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 175.11 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.581 1.552 . . . . 1.22 109.946 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 m -148.4 140.04 23.65 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.303 0.956 . . . . 0.69999999999999996 110.049 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.23 96.12 29.09 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.55 1.14 . . . . 0.72999999999999998 111.636 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.32 7.87 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.254 3.303 . . . . 1.1499999999999999 114.391 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -81.72 -23.65 36.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.32 1.448 . . . . 4.1200000000000001 111.6 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.81 139.32 48.85 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.881 1.673 . . . . 2.4700000000000002 107.863 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -107.1 -21.29 13.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 115.204 1.557 . . . . 3.7400000000000002 115.204 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.5 t -152.96 155.07 36.27 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.942 1.246 . . . . 1.8999999999999999 114.005 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -57.39 -32.3 66.68 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.131 0.572 . . . . 1.5700000000000001 112.433 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -64.08 -14.66 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.03 1.493 . . . . 3.2599999999999998 115.03 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -72.49 -20.28 61.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.217 0.917 . . . . 2.1099999999999999 112.252 167.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.43 10.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.223 1.409 . . . . 0.81000000000000005 113.96 -163.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -46.39 -20.84 0.13 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.02 2.928 . . . . 4.29 116.578 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -117.92 9.11 12.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.201 2.6 . . . . 4.5800000000000001 113.221 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.5 168.14 12.97 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.493 1.294 . . . . 1.2 114.493 -160.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.82 158.31 24.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.997 1.319 . . . . 1.04 111.565 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.08 150.86 39.29 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.664 1.586 . . . . 1.76 108.967 172.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.28 139.64 50.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.063 0.764 . . . . 2.2400000000000002 113.063 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.75 104.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.936 -1.505 . . . . 0.90000000000000002 106.936 159.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.93 150.05 34.1 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.929 2.091 . . . . 1.8500000000000001 111.65 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.67 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.859 -1.151 . . . . 1.71 112.648 -163.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.7 170.97 14.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.119 1.342 . . . . 1.5900000000000001 111.187 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.49 151.03 50.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.576 1.084 . . . . 1.79 113.072 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.16 -21.43 11.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.094 1.516 . . . . 3.2000000000000002 115.094 -152.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -75.44 8.52 2.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.468 1.655 . . . . 3.2999999999999998 115.468 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -81.22 55.54 2.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.976 1.311 . . . . 3.2200000000000002 111.197 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -81.79 33.98 0.39 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.962 2.505 . . . . 3.9399999999999999 115.211 -163.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.19 19.37 7.61 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.665 1.586 . . . . 5.9100000000000001 113.033 -163.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -147.47 154.61 45.29 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.927 1.691 . . . . 3.5 110.525 -167.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.09 7.29 2.14 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.046 3.164 . . . . 2.6200000000000001 114.241 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.419 ' HA ' ' HE2' ' A' ' 139' ' ' LYS . 8.7 mmpt? -107.12 99.77 28.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.021 1.328 . . . . 5.29 108.666 169.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.92 166.69 26.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.234 2.623 . . . . 3.1899999999999999 111.949 -170.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt 64.83 27.18 12.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.269 1.428 . . . . 3.71 111.878 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.7 1.62 31.91 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.741 1.639 . . . . 3.3900000000000001 114.7 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.49 -15.18 60.76 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.778 1.18 . . . . 2.27 113.063 -162.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.96 24.8 3.23 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.198 1.856 . . . . 1.6599999999999999 113.678 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.62 -15.98 73.69 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.116 1.341 . . . . 1.4199999999999999 115.246 -169.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 p -69.01 147.39 51.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.554 1.177 . . . . 1.6200000000000001 110.035 167.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 131.93 47.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 4.4100000000000001 109.818 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -81.94 -44.13 17.17 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.214 0.605 . . . . 2.3100000000000001 109.554 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.29 155.76 45.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.294 1.038 . . . . 0.67000000000000004 112.717 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 41.0 t -143.52 151.23 40.01 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.136 2.175 . . . . 1.29 111.331 -174.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.68 149.59 18.31 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.739 1.161 . . . . 1.02 113.842 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.98 149.09 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.1 1.76 . . . . 2.5099999999999998 112.36 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.33 147.11 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.492 1.917 . . . . 0.95999999999999996 111.923 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.744 0 C-N-CA 126.455 1.902 . . . . 4.3399999999999999 109.683 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 109.115 -0.698 . . . . 1.96 109.115 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -122.38 143.21 49.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.593 1.542 . . . . 1.25 114.454 -148.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -154.76 147.55 24.4 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.493 . . . . 3.04 109.584 168.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.43 77.16 1.77 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.679 1.592 . . . . 5.1399999999999997 112.671 -160.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.17 112.19 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 120.55 -1.344 . . . . 1.1299999999999999 111.377 -162.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.32 101.58 0.52 Allowed Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.878 2.18 . . . . 0.68999999999999995 111.476 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.2 mmm -79.93 126.15 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.833 1.253 . . . . 1.3899999999999999 111.133 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -105.56 149.26 26.42 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.786 1.279 . . . . 2.6000000000000001 112.973 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.71 65.66 1.37 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.371 2.268 . . . . 1.3799999999999999 111.619 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 15' ' ' VAL . 1.5 m -73.12 141.82 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.767 0.827 . . . . 1.21 111.005 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -148.72 -159.57 1.05 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.889 -1.05 . . . . 2.6800000000000002 109.049 171.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.06 -3.0 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.491 1.516 . . . . 1.72 112.382 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -98.12 8.92 44.07 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.965 1.706 . . . . 3.0699999999999998 111.633 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 -164.69 26.73 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 125.047 1.308 . . . . 1.4299999999999999 112.835 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.416 ' HA ' HG12 ' A' ' 10' ' ' VAL . 99.0 t -65.94 126.51 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.629 1.171 . . . . 1.1299999999999999 110.774 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.87 -137.23 9.45 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 125.577 1.56 . . . . 1.8300000000000001 113.355 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.32 150.91 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.685 1.594 . . . . 2.3500000000000001 112.546 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -79.45 145.76 33.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.469 0.708 . . . . 1.26 110.222 161.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.37 3.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.313 1.845 . . . . 3.1099999999999999 114.091 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.77 163.85 14.66 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.808 1.671 . . . . 0.71999999999999997 112.717 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -96.24 158.87 15.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.142 -0.688 . . . . 0.95999999999999996 109.142 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.4 t -105.15 132.46 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.352 -1.351 . . . . 0.47999999999999998 107.352 152.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 12.2 p -87.3 128.22 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.311 0.577 . . . . 0.87 110.536 172.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 126.46 1.904 . . . . 1.4099999999999999 107.714 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -131.83 112.57 12.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.048 0.928 . . . . 1.9099999999999999 111.198 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 137.49 57.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 128.25 2.62 . . . . 4.1900000000000004 112.463 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 29' ' ' GLY 0.312 14.8 t -151.2 161.84 41.98 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 124.543 2.116 . . . . 1.2 111.064 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -21.23 -41.19 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.573 -2.558 . . . . 3.6299999999999999 115.266 146.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 27' ' ' THR . . . -100.5 12.05 59.76 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 126.035 1.779 . . . . 0.84999999999999998 117.012 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.36 -152.0 23.94 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 130.225 3.774 . . . . 0.71999999999999997 114.708 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.51 102.59 4.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.281 -1.129 . . . . 0.58999999999999997 111.45 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -76.43 115.96 16.66 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.313 -0.867 . . . . 1.6899999999999999 109.882 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -105.69 110.54 22.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.477 2.311 . . . . 0.51000000000000001 109.623 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.408 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 11.8 m -114.47 110.27 47.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 119.79 1.177 . . . . 0.58999999999999997 108.095 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.61 152.68 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.382 2.722 . . . . 0.69999999999999996 110.89 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 40.4 0.77 Allowed 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.168 1.461 . . . . 2.3500000000000001 111.231 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mp -103.54 141.7 35.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.539 1.936 . . . . 0.92000000000000004 112.977 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' H ' ' HE3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -103.33 160.08 15.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.451 -1.249 . . . . 3.3500000000000001 109.805 170.074 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 97.69 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.521 2.728 . . . . 1.4199999999999999 115.099 160.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -98.75 156.24 35.81 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 118.886 0.766 . . . . 1.5900000000000001 111.86 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.82 136.45 57.53 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.915 1.744 . . . . 0.98999999999999999 110.589 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 99' ' ' VAL . 21.8 Cg_endo -86.97 34.58 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.564 2.843 . . . . 1.1699999999999999 114.736 -151.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.62 -140.84 11.62 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.729 1.157 . . . . 1.25 114.072 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -120.3 153.93 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.795 -0.826 . . . . 3.1800000000000002 110.414 165.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -138.23 133.69 33.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.615 0.766 . . . . 0.91000000000000003 110.203 -163.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 163.44 23.77 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 111.015 -0.834 . . . . 0.68000000000000005 111.015 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' CE1' HD13 ' A' ' 94' ' ' LEU . 4.6 t80 -135.95 132.25 36.17 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 106.086 -1.82 . . . . 1.8600000000000001 106.086 172.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.61 ' HA ' HD12 ' A' ' 94' ' ' LEU . 5.3 m170 -137.85 158.24 44.76 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.149 -0.97 . . . . 0.90000000000000002 112.815 168.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.54 142.85 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 127.42 2.288 . . . . 0.85999999999999999 108.006 163.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -123.28 156.38 35.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.077 1.351 . . . . 0.82999999999999996 110.663 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.75 78.73 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.974 1.842 . . . . 0.63 115.974 -159.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -116.33 -177.66 3.23 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.576 1.55 . . . . 1.0700000000000001 111.483 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.81 97.49 0.31 Allowed Glycine 0 N--CA 1.47 0.902 0 O-C-N 120.769 -1.207 . . . . 0.93000000000000005 113.441 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 t 173.87 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.605 2.362 . . . . 2.1699999999999999 109.638 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.5 m -70.11 31.15 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 115.976 1.843 . . . . 1.3100000000000001 115.976 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -84.54 124.91 72.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 119.724 -1.86 . . . . 4.0800000000000001 111.158 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.07 144.27 13.29 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.307 2.671 . . . . 0.95999999999999996 111.253 173.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.2 153.75 29.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.997 0.519 . . . . 1.5700000000000001 110.583 164.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.03 132.25 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.984 -1.072 . . . . 2.21 111.07 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.21 172.95 11.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.275 2.63 . . . . 4.8899999999999997 110.055 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -47.4 114.06 0.81 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.663 1.185 . . . . 5.1500000000000004 112.406 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.13 6.47 53.38 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.986 -1.452 . . . . 3.9500000000000002 115.715 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.93 129.14 10.48 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.809 2.304 . . . . 3.6299999999999999 114.378 -167.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.86 117.56 30.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.984 0.914 . . . . 1.52 108.826 165.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.37 74.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.224 1.81 . . . . 1.97 111.172 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.43 -73.58 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.863 2.865 . . . . 2.5 115.864 164.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.48 38.09 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 130.023 3.329 . . . . 2.46 109.332 -166.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.6 -25.49 62.69 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.293 1.22 . . . . 4.0999999999999996 114.293 -167.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -13.09 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.034 1.288 . . . . 1.3 113.908 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.82 -4.24 57.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.63 1.572 . . . . 1.25 113.02 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 -179.98 53.11 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.787 -1.196 . . . . 2.5699999999999998 114.22 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.89 -179.3 48.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.99 0.805 . . . . 1.1499999999999999 111.631 166.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.402 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 24.1 m170 -53.67 137.79 36.47 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 118.585 -0.721 . . . . 2.1899999999999999 109.812 172.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.402 HD13 ' HE2' ' A' ' 123' ' ' LYS . 59.8 tp -59.76 116.46 4.08 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.818 0.736 . . . . 1.5900000000000001 111.642 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -149.32 101.79 3.33 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.81 2.044 . . . . 4.1100000000000003 109.207 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.36 -46.43 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.639 1.559 . . . . 3.3100000000000001 111.111 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -164.16 13.91 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.794 2.038 . . . . 3.29 113.083 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -56.87 -39.62 74.67 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.2 -1.562 . . . . 3.3300000000000001 113.543 -170.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t 146.11 -28.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 1 C-N-CA 132.069 4.148 . . . . 3.1000000000000001 111.201 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.73 58.14 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 117.016 1.566 . . . . 2.27 117.016 162.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.85 -67.31 0.79 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.536 1.668 . . . . 7.7300000000000004 112.449 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 t60 171.69 157.54 0.09 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.811 2.844 . . . . 1.6799999999999999 111.549 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.65 133.28 32.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.743 1.217 . . . . 4.2300000000000004 108.69 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.51 -95.29 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 109.404 -1.478 . . . . 2.9300000000000002 109.404 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.76 29.46 0.41 Allowed 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 124.589 3.526 . . . . 3.21 112.631 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -146.23 -179.63 6.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.433 1.893 . . . . 5.5499999999999998 109.457 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.15 107.21 0.7 Allowed Glycine 0 N--CA 1.472 1.061 0 N-CA-C 109.095 -1.602 . . . . 3.7200000000000002 109.095 164.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -168.84 -5.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.059 1.503 . . . . 5.8399999999999999 115.059 -149.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -34.98 0.02 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 118.105 2.002 . . . . 3.1299999999999999 118.105 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.49 115.22 3.39 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.201 2.0 . . . . 3.6899999999999999 110.831 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.02 -11.35 7.95 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.479 1.659 . . . . 2.02 115.479 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.01 -0.16 89.23 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.963 -1.465 . . . . 0.81999999999999995 116.094 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.402 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 67.7 m-20 -85.09 134.86 34.18 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 120.5 2.15 . . . . 1.5 112.673 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 48' ' ' HIS . 1.8 mt -123.95 160.78 50.27 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.596 1.558 . . . . 2.6600000000000001 112.065 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.06 162.23 43.37 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.749 2.966 . . . . 1.01 112.247 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 132' ' ' ASP . 27.4 m -79.08 127.88 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 123.355 1.55 . . . . 1.48 114.56 -162.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.07 82.25 5.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.87 2.868 . . . . 1.97 109.492 174.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.26 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.071 -1.018 . . . . 1.4199999999999999 109.29 171.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 42' ' ' PRO . 25.4 m -125.89 157.96 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.347 1.059 . . . . 2.0 110.077 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -79.16 159.46 27.41 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.895 1.072 . . . . 2.2599999999999998 113.895 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -49.67 -20.57 0.83 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 127.502 2.321 . . . . 4.0999999999999996 117.148 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.13 0.92 27.89 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.211 1.559 . . . . 3.9700000000000002 115.211 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.99 42.25 2.67 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 116.0 1.16 . . . . 1.01 116.0 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.89 135.46 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.878 1.271 . . . . 1.05 109.522 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.32 118.1 31.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.572 1.949 . . . . 0.68999999999999995 109.238 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -156.54 21.61 0.34 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.737 1.384 . . . . 1.8300000000000001 114.737 -167.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -134.83 143.48 46.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.149 1.779 . . . . 4.3700000000000001 108.785 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -85.13 162.48 11.54 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.191 3.261 . . . . 1.47 114.362 -170.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.45 172.17 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 126.315 1.846 . . . . 1.26 109.722 166.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -141.39 146.5 36.68 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 119.925 1.239 . . . . 0.88 111.097 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.72 87.06 3.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.832 1.253 . . . . 0.85999999999999999 113.961 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.5 2.1 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.481 2.787 . . . . 1.3200000000000001 114.732 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -76.86 -11.27 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.695 1.134 . . . . 5.2699999999999996 111.673 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.31 164.87 13.88 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.005 2.122 . . . . 2.3300000000000001 110.711 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -152.08 11.09 0.54 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.528 1.931 . . . . 4.21 114.187 173.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -159.18 149.3 19.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.324 -1.485 . . . . 1.78 113.716 163.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -57.49 -24.53 56.39 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.084 -1.01 . . . . 1.73 111.38 162.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -52.03 -31.74 31.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.212 1.005 . . . . 3.0099999999999998 112.768 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.032 1.333 . . . . 2.3700000000000001 112.399 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.04 11.27 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.086 1.354 . . . . 0.96999999999999997 113.539 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.3 pttt -61.54 7.14 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.984 2.587 . . . . 2.7400000000000002 117.984 -171.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -156.33 22.19 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.48 1.912 . . . . 3.5 111.748 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HE2' HD13 ' A' ' 74' ' ' LEU . 57.9 mttp -113.34 170.53 8.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.846 1.259 . . . . 1.1699999999999999 114.31 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.08 150.3 23.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.609 1.164 . . . . 0.56999999999999995 112.372 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.4 145.27 40.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.864 2.066 . . . . 1.5600000000000001 107.585 165.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -130.65 136.56 48.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.824 0.738 . . . . 2.04 112.179 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 88.3 mt -94.26 124.37 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.518 -1.29 . . . . 0.81000000000000005 107.518 167.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -120.29 143.1 48.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.319 1.048 . . . . 1.8500000000000001 112.485 -156.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.25 -37.59 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.898 -1.126 . . . . 1.1799999999999999 112.983 -153.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.9 141.06 16.63 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.78 0.705 . . . . 1.1200000000000001 112.141 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -47.43 134.45 14.05 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 126.01 1.767 . . . . 2.1499999999999999 112.109 164.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.43 ' H ' HG12 ' A' ' 96' ' ' VAL . 4.4 t70 -76.11 1.72 14.88 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.22 1.408 . . . . 2.8999999999999999 113.001 -167.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -66.29 -1.47 3.41 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 119.727 -1.858 . . . . 4.7699999999999996 114.24 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 ptp -93.07 10.35 31.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.288 1.835 . . . . 3.6699999999999999 114.149 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.4 p -47.83 -21.96 0.49 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.812 2.152 . . . . 4.3499999999999996 116.812 -171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.44 -10.42 59.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.089 2.956 . . . . 7.9900000000000002 115.618 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -53.01 148.64 13.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 114.276 1.213 . . . . 4.2000000000000002 114.276 -166.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.36 30.59 0.34 Allowed 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.361 3.374 . . . . 3.1200000000000001 112.234 170.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 140.32 35.26 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.544 1.538 . . . . 4.4699999999999998 109.19 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.71 162.26 32.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.416 2.744 . . . . 3.4500000000000002 112.965 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 71.6 mt 64.39 16.08 9.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.778 1.631 . . . . 4.9299999999999997 114.033 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.03 12.08 58.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.065 1.317 . . . . 4.7800000000000002 114.955 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.33 -64.35 3.79 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.889 1.345 . . . . 2.9700000000000002 112.992 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.17 0.45 31.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.906 1.241 . . . . 2.0899999999999999 114.949 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.1 9.44 12.37 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.703 2.097 . . . . 2.1299999999999999 116.071 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.0 p -69.04 146.95 52.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.744 1.772 . . . . 1.96 108.996 161.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 143.18 27.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.036 -1.04 . . . . 5.5199999999999996 112.942 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.412 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 23.8 t80 -102.2 -26.54 13.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.196 0.598 . . . . 2.1899999999999999 111.849 158.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.96 149.18 28.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.653 -0.654 . . . . 0.52000000000000002 112.664 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.2 t -120.32 144.07 48.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.097 2.159 . . . . 1.46 109.714 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -139.43 104.51 0.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 126.341 1.924 . . . . 0.66000000000000003 111.18 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -83.0 130.37 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.339 1.069 . . . . 1.72 110.334 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.74 133.45 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.144 1.378 . . . . 0.91000000000000003 110.677 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 125.863 1.665 . . . . 4.5499999999999998 108.576 176.466 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.187 -0.301 . . . . 2.2200000000000002 110.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.78 159.63 40.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.786 1.773 . . . . 1.49 115.786 -151.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -148.37 136.95 21.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.476 1.511 . . . . 2.9500000000000002 109.459 159.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -83.41 103.63 12.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.429 1.092 . . . . 3.6099999999999999 112.031 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.8 t -79.02 114.36 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.253 -0.904 . . . . 1.1399999999999999 109.079 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.44 105.57 1.81 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.25 1.405 . . . . 0.72999999999999998 111.425 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.7 mmm -84.13 122.42 28.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.712 1.205 . . . . 1.71 111.365 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.16 151.79 23.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.756 0.789 . . . . 2.4399999999999999 111.185 166.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.52 136.31 57.97 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.083 0.953 . . . . 1.3300000000000001 109.706 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.53 140.59 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.393 -0.965 . . . . 1.24 108.393 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 t -151.44 17.61 0.72 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.597 0.759 . . . . 2.7599999999999998 111.85 -165.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.61 -21.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.538 2.335 . . . . 1.3300000000000001 113.371 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -71.8 28.18 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 119.879 1.218 . . . . 4.0099999999999998 111.985 163.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -174.78 52.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.562 2.029 . . . . 1.24 113.201 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.67 119.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.178 0.991 . . . . 1.45 108.608 153.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.04 -69.37 1.02 Allowed Glycine 0 N--CA 1.466 0.638 0 CA-C-O 122.159 0.866 . . . . 1.53 114.129 -170.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 153.88 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.106 1.363 . . . . 2.3799999999999999 109.537 -165.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -89.59 152.61 21.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.271 1.428 . . . . 1.2 112.983 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.42 -2.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 115.196 1.554 . . . . 3.71 115.196 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.77 175.05 20.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.561 2.029 . . . . 0.69999999999999996 111.792 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -104.71 175.21 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.583 -0.951 . . . . 0.81999999999999995 109.378 167.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.74 131.25 73.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.663 -1.606 . . . . 0.53000000000000003 106.663 152.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.4 p -80.89 122.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.667 -0.494 . . . . 0.91000000000000003 109.667 172.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.4 mt -94.48 127.31 46.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 107.374 -1.343 . . . . 1.45 107.374 165.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.38 123.56 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.17 1.388 . . . . 1.98 108.701 171.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 151.0 33.17 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 121.026 -0.269 . . . . 3.23 111.049 172.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -161.29 -173.82 4.01 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.405 0.682 . . . . 1.4299999999999999 109.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -59.73 -25.64 65.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.857 1.263 . . . . 5.5800000000000001 113.353 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.36 16.45 61.04 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.558 1.075 . . . . 1.0900000000000001 114.66 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.7 -140.44 24.23 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 125.334 1.445 . . . . 0.66000000000000003 114.002 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.19 98.38 4.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.194 0.998 . . . . 0.75 112.105 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.95 111.22 14.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.2 1.4 . . . . 2.2000000000000002 110.785 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.71 117.58 29.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.255 2.222 . . . . 0.57999999999999996 108.835 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.41 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.8 m -123.95 110.69 29.27 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-N 119.796 1.18 . . . . 0.62 108.986 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.74 158.34 10.47 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.974 3.116 . . . . 0.41999999999999998 111.341 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -149.06 29.32 0.81 Allowed 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.794 0.807 . . . . 1.28 113.058 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.77 148.77 21.94 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.542 1.537 . . . . 0.79000000000000004 111.915 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.52 23.38 6.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.853 2.168 . . . . 1.96 116.853 -164.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.73 69.2 0.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.888 0.875 . . . . 1.6599999999999999 111.351 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.13 160.94 66.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.88 0.872 . . . . 1.46 112.007 170.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.28 127.68 18.79 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.052 1.168 . . . . 0.94999999999999996 110.343 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -83.58 33.39 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.901 1 C-N-CA 126.053 4.502 . . . . 1.05 113.152 -159.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.72 -131.6 4.46 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 123.411 1.562 . . . . 1.1799999999999999 112.131 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.0 147.27 52.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.667 1.587 . . . . 3.8900000000000001 109.548 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.7 122.64 15.52 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.72 0.808 . . . . 1.3700000000000001 112.25 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.73 155.05 1.67 Allowed Glycine 0 CA--C 1.543 1.794 0 C-N-CA 123.936 0.779 . . . . 1.0 113.057 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.93 112.5 11.31 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.206 -1.405 . . . . 1.8999999999999999 107.206 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -116.33 158.79 22.89 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.249 1.203 . . . . 0.93999999999999995 114.249 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.471 ' CG2' HD12 ' A' ' 74' ' ' LEU . 63.2 mt -99.23 151.27 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.236 1.414 . . . . 0.68999999999999995 107.88 154.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.23 153.45 47.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.174 1.79 . . . . 0.91000000000000003 107.648 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.83 71.68 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.909 1.448 . . . . 0.87 114.909 -163.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -119.22 161.21 20.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.19 1.796 . . . . 1.54 112.371 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.13 86.02 0.56 Allowed Glycine 0 N--CA 1.467 0.715 0 C-N-CA 124.682 1.134 . . . . 0.85999999999999999 112.773 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 t -171.11 94.15 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.718 1.207 . . . . 1.9199999999999999 113.011 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 68.3 m -65.92 14.55 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 117.097 2.258 . . . . 1.3600000000000001 117.097 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -101.96 147.85 34.49 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 119.787 -1.821 . . . . 3.7799999999999998 113.965 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.37 161.42 11.19 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.723 3.615 . . . . 1.1499999999999999 112.602 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.31 14.13 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.605 0.762 . . . . 1.8999999999999999 111.213 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.23 115.34 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.345 1.058 . . . . 3.3700000000000001 109.643 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -146.34 147.06 30.94 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.85 1.66 . . . . 5.6900000000000004 110.704 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t0 53.13 32.18 12.68 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.617 1.34 . . . . 4.4500000000000002 114.617 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.1 6.48 87.54 Favored Glycine 0 CA--C 1.535 1.343 0 O-C-N 121.105 -0.997 . . . . 3.9900000000000002 114.771 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -141.58 -161.79 1.28 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.57 1.548 . . . . 3.9399999999999999 110.509 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.14 138.64 49.56 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.919 -1.113 . . . . 1.8999999999999999 113.027 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 t -82.24 60.75 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.838 1.655 . . . . 2.3199999999999998 111.029 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 47.17 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.154 2.582 . . . . 1.76 115.874 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.93 84.38 0.81 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.411 2.684 . . . . 1.47 107.556 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -84.72 -46.71 11.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.237 1.415 . . . . 3.98 112.03 -167.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -12.34 57.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.321 1.23 . . . . 1.1200000000000001 114.321 -164.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.74 -22.82 59.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.562 1.545 . . . . 0.79000000000000004 113.897 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.55 -174.97 17.77 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 120.398 1.454 . . . . 2.3900000000000001 114.278 -176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 -155.57 22.44 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.129 1.347 . . . . 1.1699999999999999 110.832 164.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -71.36 34.41 0.05 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 118.957 1.379 . . . . 2.4100000000000001 113.783 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.471 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER 64.11 46.04 3.85 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.452 1.501 . . . . 2.5299999999999998 109.536 -178.22 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -128.32 44.95 1.47 Allowed Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 116.3 1.963 . . . . 4.4000000000000004 116.3 -148.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.39 -20.81 31.38 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.834 2.356 . . . . 3.04 113.722 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -166.65 143.32 4.77 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.82 1.648 . . . . 3.8399999999999999 110.5 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 164.75 -23.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 129.501 3.12 . . . . 3.8399999999999999 113.435 170.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 t 139.18 -2.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 1 C-N-CA 131.829 4.052 . . . . 3.5299999999999998 112.855 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.26 2.73 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.549 1.38 . . . . 2.4399999999999999 116.549 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -86.71 172.5 10.14 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.43 1.615 . . . . 4.5499999999999998 113.73 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -107.68 143.92 35.51 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.068 1.347 . . . . 1.48 112.921 -173.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -152.86 -173.19 4.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.222 1.409 . . . . 3.8300000000000001 109.967 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.38 -52.1 0.01 OUTLIER Glycine 0 CA--C 1.544 1.854 0 CA-C-O 116.977 -2.013 . . . . 4.1500000000000004 115.022 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -105.0 -20.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.875 2.383 . . . . 5.2999999999999998 116.939 -164.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 177.27 17.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.44 1.496 . . . . 8.0500000000000007 114.369 -165.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.83 -150.05 21.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.494 1.521 . . . . 2.77 112.25 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -135.92 135.9 40.03 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.741 -1.207 . . . . 5.7800000000000002 107.741 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.75 -157.72 30.02 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.419 0.554 . . . . 2.9500000000000002 114.434 -173.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 136.75 58.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.286 0.634 . . . . 3.8199999999999998 112.665 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -11.9 60.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.681 0.993 . . . . 2.52 113.681 169.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.08 14.77 36.75 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.794 -1.559 . . . . 1.0700000000000001 115.439 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -106.99 131.93 53.5 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 119.614 1.707 . . . . 1.5700000000000001 112.267 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 3.9 mp -131.37 170.51 11.1 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.067 2.147 . . . . 2.0099999999999998 110.418 -168.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 94' ' ' LEU . 88.7 Cg_endo -80.22 152.9 21.29 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.403 2.068 . . . . 0.82999999999999996 111.868 -172.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.85 128.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.795 1.238 . . . . 2.2200000000000002 112.95 -168.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.38 82.17 1.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.151 2.18 . . . . 1.6799999999999999 108.894 168.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.49 141.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.51 1.124 . . . . 1.3799999999999999 109.161 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.93 150.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.419 1.888 . . . . 1.9099999999999999 108.866 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 143.49 26.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.057 0.844 . . . . 1.8799999999999999 112.683 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -19.83 -45.19 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.353 4.661 . . . . 3.3300000000000001 117.463 174.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.23 -29.37 65.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.943 1.297 . . . . 3.7000000000000002 112.633 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.11 20.72 6.2 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.807 1.67 . . . . 0.85999999999999999 113.463 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.6 mt -121.71 133.99 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.98999999999999999 109.888 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.63 131.01 49.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.615 1.166 . . . . 0.58999999999999997 110.322 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 t -152.37 4.18 0.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.427 2.01 . . . . 1.1000000000000001 116.427 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -100.98 136.96 19.64 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.877 1.217 . . . . 3.8500000000000001 111.334 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.14 146.8 47.08 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.526 3.484 . . . . 1.04 112.178 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.11 161.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.448 1.499 . . . . 1.1399999999999999 109.442 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -139.25 134.87 33.25 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.341 0.973 . . . . 0.72999999999999998 110.747 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.8 105.32 49.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.957 0.903 . . . . 0.93000000000000005 112.609 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.84 13.05 0.63 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.372 3.382 . . . . 1.1499999999999999 113.299 167.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -64.27 -41.26 97.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.096 1.758 . . . . 4.3899999999999997 110.737 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -111.41 151.73 28.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 2.3999999999999999 107.258 166.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -97.04 -22.07 17.02 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.586 0.958 . . . . 4.71 113.586 -174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.16 160.86 43.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.039 1.745 . . . . 1.5900000000000001 115.344 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.43 -30.68 68.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.457 1.503 . . . . 1.75 111.889 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -67.27 -2.75 6.42 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.807 2.043 . . . . 2.6099999999999999 113.313 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -96.86 -13.13 22.72 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.195 1.798 . . . . 1.8100000000000001 113.277 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.18 7.83 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.631 1.105 . . . . 1.0600000000000001 113.898 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -60.38 -12.6 9.76 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.854 2.168 . . . . 2.8799999999999999 116.854 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.39 16.75 13.87 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.55 1.94 . . . . 4.5800000000000001 114.08 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -121.2 -173.91 2.72 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.956 1.465 . . . . 1.4199999999999999 114.956 -165.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.5 156.56 47.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.508 1.523 . . . . 0.58999999999999997 111.555 169.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mp -118.3 130.0 55.78 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.525 1.93 . . . . 1.6499999999999999 108.489 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.2 mtt -116.98 128.72 55.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.46 0.573 . . . . 1.4199999999999999 111.772 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.02 103.51 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.61 -1.256 . . . . 0.80000000000000004 107.61 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -87.02 146.1 26.24 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.187 1.795 . . . . 2.3799999999999999 113.034 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.2 t -64.65 -30.32 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.983 -1.073 . . . . 1.6000000000000001 113.409 -164.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.14 149.66 18.07 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.316 0.96 . . . . 1.29 112.63 172.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.27 150.48 11.1 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.104 1.811 . . . . 1.5900000000000001 112.952 162.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.01 0.55 38.32 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.2 1.185 . . . . 2.4900000000000002 114.2 -141.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -81.55 -7.27 59.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.356 1.613 . . . . 3.02 115.356 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 65.9 mtm -84.45 109.75 18.12 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.74 1.216 . . . . 2.52 110.486 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -137.01 -45.35 0.57 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.17 0.988 . . . . 2.9100000000000001 112.759 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.41 80.64 8.53 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.123 -0.986 . . . . 3.8599999999999999 110.715 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 175.88 147.49 0.26 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 128.491 2.716 . . . . 3.48 110.272 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.33 -27.59 47.66 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 2.1299999999999999 114.029 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -109.91 87.75 6.07 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.802 0.841 . . . . 6.5 109.125 165.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.67 169.16 16.54 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.914 2.41 . . . . 4.5700000000000003 111.307 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt 66.3 6.04 4.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.523 1.929 . . . . 4.96 113.416 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.2 26.92 74.23 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 119.154 0.888 . . . . 3.9100000000000001 113.2 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.57 -9.35 77.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.778 1.18 . . . . 2.5600000000000001 113.186 -166.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 22.43 0.57 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.884 2.183 . . . . 1.6299999999999999 115.851 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.75 75.35 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 118.455 1.128 . . . . 1.73 112.337 166.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.7 p -65.21 156.86 30.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.454 1.502 . . . . 1.6499999999999999 110.896 162.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.25 137.67 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.761 1.224 . . . . 4.9500000000000002 110.582 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -82.37 -37.47 25.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.185 0.994 . . . . 2.3100000000000001 111.697 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.1 149.38 32.93 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.038 0.935 . . . . 0.53000000000000003 111.814 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.27 146.71 50.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.975 1.71 . . . . 1.5700000000000001 110.783 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -131.66 90.43 0.28 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.463 2.459 . . . . 0.70999999999999996 111.352 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.28 140.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.589 1.156 . . . . 2.6699999999999999 112.47 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.72 151.45 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.728 1.611 . . . . 1.1899999999999999 111.246 -170.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 O-C-N 120.912 -1.117 . . . . 4.3499999999999996 112.43 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 109.437 -0.579 . . . . 1.97 109.437 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.55 154.11 26.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.732 1.213 . . . . 1.1599999999999999 109.859 -172.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -149.17 125.77 11.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.921 1.343 . . . . 2.9300000000000002 110.27 170.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -83.83 109.89 17.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.064 1.746 . . . . 2.9900000000000002 110.528 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.66 124.47 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 120.089 1.313 . . . . 1.1499999999999999 110.482 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -76.25 110.95 3.17 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 125.669 1.604 . . . . 0.81000000000000005 110.752 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.5 mtp -96.74 131.7 43.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.253 1.021 . . . . 1.4199999999999999 111.121 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.65 142.91 45.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.066 1.346 . . . . 2.6899999999999999 111.524 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.7 mt -65.68 137.65 57.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.858 0.863 . . . . 1.3400000000000001 108.862 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.33 144.44 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.688 0.795 . . . . 1.05 111.432 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.1 t -163.79 72.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.677 0.791 . . . . 2.2400000000000002 112.473 -169.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 72.0 -33.47 0.27 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.029 2.531 . . . . 1.4299999999999999 115.44 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -33.78 68.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.353 1.461 . . . . 3.4700000000000002 110.082 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.39 -158.67 24.53 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 125.909 1.718 . . . . 1.3200000000000001 112.023 -169.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.84 126.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.391 1.476 . . . . 1.0800000000000001 110.899 171.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.91 -136.78 9.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.492 1.52 . . . . 1.99 111.504 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.34 165.64 12.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.411 -1.052 . . . . 1.8799999999999999 112.555 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -104.06 162.18 13.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.863 1.315 . . . . 1.3999999999999999 114.443 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pp -147.48 4.53 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 130.431 3.492 . . . . 2.8900000000000001 113.262 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.49 148.09 5.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.959 1.742 . . . . 0.81000000000000005 112.856 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.449 HG22 ' HA2' ' A' ' 6' ' ' GLY . 30.8 p -99.46 -179.9 4.36 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.184 -1.043 . . . . 0.84999999999999998 108.184 163.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 61.5 t -132.2 134.52 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.211 -1.033 . . . . 0.67000000000000004 108.211 163.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.5 p -81.54 122.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.49 -0.559 . . . . 0.96999999999999997 109.49 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -107.42 133.14 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.557 -0.905 . . . . 1.8899999999999999 108.557 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.22 124.91 18.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.547 1.539 . . . . 2.1600000000000001 107.498 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.34 128.66 47.4 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.515 0.726 . . . . 3.5600000000000001 109.703 -168.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -151.5 -174.53 4.86 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.633 0.235 . . . . 1.1699999999999999 111.633 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.17 -24.97 68.13 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.933 -1.105 . . . . 4.25 112.619 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.99 9.95 64.55 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 124.834 1.207 . . . . 0.96999999999999997 114.609 167.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.29 -140.19 23.43 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 126.668 2.08 . . . . 0.68999999999999995 112.988 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.87 93.47 5.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.9 0.88 . . . . 0.54000000000000004 110.49 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -72.69 131.57 42.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.483 1.913 . . . . 3.0299999999999998 109.22 166.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 19.3 t80 -127.93 106.72 9.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.99 2.116 . . . . 0.65000000000000002 108.176 -168.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.448 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 25.4 m -105.4 107.1 58.36 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.834 1.197 . . . . 0.79000000000000004 108.027 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.05 156.11 30.09 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.028 2.486 . . . . 0.71999999999999997 110.496 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.0 39.65 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.687 1.232 . . . . 2.3700000000000001 110.359 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.54 150.02 20.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 126.794 2.038 . . . . 1.01 111.733 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -132.5 162.34 31.45 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.339 -1.301 . . . . 3.1299999999999999 109.494 170.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.21 23.64 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.484 3.114 . . . . 1.6799999999999999 112.66 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.18 152.51 57.19 Favored Pre-proline 0 CA--C 1.487 -1.46 0 C-N-CA 125.249 1.42 . . . . 1.97 112.56 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -76.0 142.7 25.2 Favored 'Trans proline' 0 N--CA 1.413 -3.218 0 C-N-CA 116.599 -1.801 . . . . 1.52 111.286 -165.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -80.97 31.3 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.626 1 C-N-CA 127.89 5.727 . . . . 1.47 114.127 -155.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.86 -127.98 6.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 123.567 1.648 . . . . 1.6899999999999999 110.958 174.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -120.51 145.93 46.79 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 127.567 2.347 . . . . 3.0699999999999998 110.383 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.436 ' CD2' HG21 ' A' ' 99' ' ' VAL . 71.2 m-70 -139.9 125.11 18.8 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 124.158 0.983 . . . . 0.95999999999999996 112.404 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.31 149.79 9.41 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.607 -0.683 . . . . 0.55000000000000004 111.778 169.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -135.97 127.52 28.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.951 1.7 . . . . 1.8400000000000001 106.503 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -130.06 167.85 17.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.4 2.37 . . . . 1.01 117.4 166.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.0 mt -101.0 146.43 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.637 1.975 . . . . 0.77000000000000002 108.929 155.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -124.08 155.72 37.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.179 1.792 . . . . 1.49 110.541 -170.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.91 -37.91 70.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.948 1.462 . . . . 0.68999999999999995 114.948 -162.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -116.64 -179.34 3.65 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.335 1.454 . . . . 1.0800000000000001 111.033 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.98 51.05 0.86 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 116.646 1.419 . . . . 0.96999999999999997 116.646 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -153.22 123.93 7.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.661 1.731 . . . . 2.1299999999999999 112.45 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.1 m -68.77 -2.88 10.42 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.603 1.705 . . . . 2.0299999999999998 115.603 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.8 136.6 38.85 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 120.25 -1.531 . . . . 3.3700000000000001 112.02 -162.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -96.88 160.81 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.184 3.256 . . . . 1.3799999999999999 113.384 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.76 177.3 4.88 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.103 1.361 . . . . 2.3500000000000001 110.915 156.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.25 124.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.579 1.152 . . . . 2.5600000000000001 108.773 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -104.54 -178.86 3.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.579 1.952 . . . . 4.3700000000000001 109.911 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.33 104.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.529 0.937 . . . . 4.5599999999999996 113.529 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.06 18.03 70.45 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.262 -1.299 . . . . 4.1399999999999997 115.367 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -158.15 134.49 9.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.377 2.089 . . . . 4.7400000000000002 114.818 -169.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.6 130.33 35.01 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.107 -0.996 . . . . 1.9399999999999999 110.312 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -81.36 49.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.396 . . . . 2.9100000000000001 111.675 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.57 -57.47 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 130.608 3.563 . . . . 2.3399999999999999 117.817 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 163.38 85.35 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 1 C-N-CA 134.228 5.011 . . . . 1.6200000000000001 105.17 -167.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.85 -50.53 7.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.103 0.961 . . . . 5.2599999999999998 111.91 -155.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.56 15.02 0.11 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.12 1.156 . . . . 1.6499999999999999 114.12 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.65 -15.04 35.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.431 1.892 . . . . 0.87 112.7 165.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.08 9.68 85.38 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.737 1.455 . . . . 2.7799999999999998 116.737 168.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.04 -166.37 52.8 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.133 1.466 . . . . 1.46 112.277 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.603 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 39.4 m170 -61.97 149.87 39.47 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.707 0.753 . . . . 2.3700000000000001 111.22 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 123' ' ' LYS . 36.4 tp -67.98 110.18 3.79 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.904 -0.497 . . . . 1.8400000000000001 111.122 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.81 159.93 2.42 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 130.46 3.504 . . . . 3.3799999999999999 109.006 164.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -90.09 -18.6 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.328 2.019 . . . . 2.8399999999999999 115.712 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 178.55 -3.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.613 2.079 . . . . 4.9800000000000004 116.613 -163.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -58.92 -48.53 81.13 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.096 1.517 . . . . 3.73 115.096 -147.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 161.61 170.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.952 3.301 . . . . 3.54 109.467 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.93 -15.62 78.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.318 0.961 . . . . 3.6200000000000001 113.779 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.92 145.38 55.99 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.104 1.452 . . . . 4.6799999999999997 110.348 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -117.46 143.87 45.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.234 1.013 . . . . 1.53 112.299 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.74 117.56 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 3.7599999999999998 111.852 -161.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.05 171.53 35.7 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.004 1.288 . . . . 2.7799999999999998 111.958 171.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.74 -3.33 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.907 3.738 . . . . 4.04 115.876 -168.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -160.69 29.22 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.584 2.354 . . . . 8.0600000000000005 110.675 171.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.76 -141.15 7.76 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.098 2.285 . . . . 3.0099999999999998 112.224 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -151.97 148.07 27.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.336 1.068 . . . . 4.7800000000000002 112.055 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.12 -91.59 0.08 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.433 1.968 . . . . 2.23 112.524 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -134.76 134.25 40.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.136 1.375 . . . . 3.8700000000000001 110.285 -169.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -67.06 -21.63 65.89 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.63 1.344 . . . . 2.0899999999999999 114.63 -170.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.68 -2.65 76.64 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.707 1.146 . . . . 0.85999999999999999 115.128 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.603 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 71.8 m-20 -72.71 133.58 44.64 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.796 1.298 . . . . 1.5700000000000001 109.949 169.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.92 163.9 26.35 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.993 1.317 . . . . 1.73 110.645 -150.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.3 145.79 34.87 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.514 2.809 . . . . 0.89000000000000001 111.899 -167.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.16 130.35 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.587 1.184 . . . . 2.6600000000000001 110.446 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 125.31 31.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 131.128 3.771 . . . . 2.25 110.446 -172.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -97.06 140.18 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.336 1.055 . . . . 1.24 111.88 -172.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 45' ' ' HIS . 2.3 t -130.16 141.07 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.539 1.936 . . . . 1.6399999999999999 108.248 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -103.47 157.5 17.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.693 1.197 . . . . 2.73 112.53 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.74 50.08 0.43 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.673 2.389 . . . . 2.8599999999999999 115.649 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -128.34 1.49 5.7 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.402 -1.726 . . . . 3.7200000000000002 111.221 150.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.29 27.47 13.33 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.441 1.972 . . . . 0.80000000000000004 113.883 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.29 138.53 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.533 1.533 . . . . 1.1699999999999999 110.255 -165.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.15 127.72 53.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.354 0.979 . . . . 1.05 109.925 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 t -149.03 9.18 0.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.845 1.424 . . . . 1.05 114.845 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -100.73 130.77 24.68 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.922 1.289 . . . . 3.5699999999999998 110.306 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.14 140.56 17.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.078 2.519 . . . . 1.0700000000000001 112.252 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.63 160.64 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.04 1.736 . . . . 1.1699999999999999 109.499 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.0 m -144.73 132.55 21.23 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.384 0.993 . . . . 0.81000000000000005 111.423 -167.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.84 97.25 27.94 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.744 1.218 . . . . 0.67000000000000004 112.916 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.0 -2.52 12.77 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.582 3.521 . . . . 1.1799999999999999 115.905 -177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -88.15 -2.44 58.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.548 1.139 . . . . 3.71 113.361 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.55 169.72 9.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.976 2.51 . . . . 2.3399999999999999 107.834 164.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -152.67 5.74 0.39 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 117.038 2.236 . . . . 3.98 117.038 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 m -158.1 167.95 28.42 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.987 1.267 . . . . 1.74 113.291 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.81 -20.06 63.46 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.957 -1.09 . . . . 1.3400000000000001 111.863 163.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.52 -35.86 78.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.587 1.155 . . . . 3.54 113.657 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -68.51 -13.11 62.1 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.366 1.247 . . . . 3.1800000000000002 114.366 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.16 17.58 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.747 1.219 . . . . 0.97999999999999998 113.539 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -67.44 19.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 128.308 2.643 . . . . 2.3900000000000001 116.977 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -165.96 26.28 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.788 2.435 . . . . 2.9500000000000002 110.94 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' ' 74' ' ' LEU . 59.4 mttp -134.6 170.64 15.49 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.952 -1.092 . . . . 1.29 113.629 -167.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.5 157.09 25.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.03 1.332 . . . . 0.77000000000000002 112.543 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.35 135.04 51.06 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.871 2.068 . . . . 1.6499999999999999 107.294 168.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.09 138.19 54.3 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.383 0.673 . . . . 2.5 111.444 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.33 133.48 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.443 1.116 . . . . 1.48 110.278 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.22 135.5 51.67 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.324 1.85 . . . . 1.96 110.828 -155.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -73.53 -15.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.791 1.404 . . . . 2.5600000000000001 114.791 -151.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.03 169.53 24.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.401 1.477 . . . . 1.53 109.891 162.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.2 147.84 34.16 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 117.88 0.84 . . . . 1.8400000000000001 111.786 165.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.64 -22.04 0.89 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.352 1.242 . . . . 3.7599999999999998 114.352 -138.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.6 47.43 0.17 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.85 2.46 . . . . 4.0899999999999999 115.422 -172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 41.4 mtm -105.99 133.32 50.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.918 1.687 . . . . 2.23 112.493 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.9 p -99.18 -36.19 9.74 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.129 1.772 . . . . 3.3599999999999999 114.768 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.39 2.9 54.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.538 1.31 . . . . 4.1500000000000004 114.538 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.62 144.09 32.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.887 0.875 . . . . 3.9700000000000002 110.669 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -41.47 9.06 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.311 2.674 . . . . 2.1600000000000001 112.59 -173.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -83.15 136.94 43.13 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.729 -0.653 . . . . 4.7300000000000004 109.943 158.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.88 167.37 26.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.171 2.581 . . . . 2.98 111.034 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt 66.33 31.11 8.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.971 1.308 . . . . 3.75 110.953 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.22 11.2 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.059 1.314 . . . . 2.8199999999999998 114.223 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.6 -20.76 29.5 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.098 1.808 . . . . 2.8900000000000001 114.392 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.42 -3.31 47.35 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.387 1.47 . . . . 4.1299999999999999 114.617 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.9 46.77 1.8 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.587 1.565 . . . . 3.3399999999999999 115.59 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.2 m -58.79 158.03 8.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.382 1.873 . . . . 2.0 110.338 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.45 150.5 28.29 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.281 -1.512 . . . . 5.7800000000000002 113.042 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.489 ' CE2' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -100.73 -32.83 10.52 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 118.817 -0.611 . . . . 8.4399999999999995 111.251 153.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.29 152.47 37.17 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 116.482 2.03 . . . . 0.84999999999999998 116.482 -172.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.0 t -99.2 -177.69 3.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 129.26 3.024 . . . . 1.5900000000000001 110.368 164.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 176.09 91.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 127.427 2.442 . . . . 0.72999999999999998 111.456 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.07 133.62 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 1.45 110.024 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.16 128.1 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.468 1.107 . . . . 1.0700000000000001 110.962 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 82.9 mttt . . . . . 0 N--CA 1.472 0.662 0 C-N-CA 123.992 0.917 . . . . 4.3099999999999996 111.214 -173.063 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 108.99 -0.744 . . . . 1.6599999999999999 108.99 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.7 148.06 23.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.228 1.011 . . . . 2.1299999999999999 113.568 -167.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -153.23 116.99 4.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 2.6000000000000001 109.248 165.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -97.35 108.36 21.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.747 -1.22 . . . . 3.4300000000000002 109.439 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.61 125.92 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.386 0.539 . . . . 1.1200000000000001 109.886 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.0 114.17 4.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.958 1.266 . . . . 0.71999999999999997 110.171 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.4 mtt -98.09 129.78 44.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.963 0.905 . . . . 1.1499999999999999 111.726 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -107.44 147.83 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.135 1.374 . . . . 2.6400000000000001 110.717 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.5 mt -65.28 139.96 58.66 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.19 1.396 . . . . 1.1599999999999999 109.382 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.0 m -135.27 155.6 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 119.233 0.924 . . . . 1.28 111.683 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.1 55.74 0.1 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.127 0.788 . . . . 2.3399999999999999 113.127 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.86 -36.72 0.37 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 127.196 2.199 . . . . 2.27 113.849 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -22.01 57.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 4.6100000000000003 112.283 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.63 -159.81 24.61 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 124.933 1.254 . . . . 1.1000000000000001 112.91 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 t -80.71 130.08 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.512 1.925 . . . . 1.27 110.996 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.22 -135.33 8.07 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.4 1.476 . . . . 1.8600000000000001 112.49 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -104.86 172.29 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.942 0.897 . . . . 2.3799999999999999 111.315 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -109.43 141.13 42.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.77 0.828 . . . . 1.1499999999999999 112.473 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 19' ' ' ILE . 36.4 mm -118.73 23.85 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 127.068 2.147 . . . . 5.6399999999999997 110.937 164.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.2 173.04 33.37 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.32 -0.863 . . . . 0.60999999999999999 114.83 160.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -102.06 -179.49 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.28 1.032 . . . . 0.88 109.542 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 53.2 t -132.55 135.27 57.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.769 -1.197 . . . . 0.64000000000000001 107.769 160.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -88.33 128.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.065 0.228 . . . . 0.82999999999999996 110.626 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.54 133.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.824 -0.806 . . . . 1.52 108.824 161.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.21 128.16 53.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.547 0.739 . . . . 1.96 110.417 156.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 122.27 17.97 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.831 0.852 . . . . 4.0499999999999998 109.25 164.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -135.96 -178.51 5.17 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.33 -0.248 . . . . 1.6899999999999999 110.33 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -54.3 -46.34 72.77 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.866 -1.147 . . . . 5.3600000000000003 110.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.6 17.85 9.93 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.092 1.33 . . . . 1.1399999999999999 115.774 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.84 -144.08 20.13 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 126.698 2.094 . . . . 0.78000000000000003 114.071 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.72 99.52 5.89 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.996 0.903 . . . . 0.62 111.224 -170.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 108.16 5.11 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.195 1.798 . . . . 4.5 110.177 169.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 4.4 t80 -101.33 107.42 18.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.353 1.861 . . . . 0.58999999999999997 109.888 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.3 m -117.14 111.58 40.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 119.247 0.93 . . . . 0.68000000000000005 109.064 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -84.01 166.37 12.98 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.032 3.155 . . . . 0.69999999999999996 111.415 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -150.2 18.71 0.86 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.761 1.393 . . . . 1.6799999999999999 114.761 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.58 140.89 35.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.208 1.003 . . . . 0.95999999999999996 111.857 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 9.2 ptpt -116.52 35.92 4.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.731 1.752 . . . . 2.1699999999999999 115.731 -166.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 19' ' ' ILE . . . -162.77 49.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.651 0.78 . . . . 1.22 112.165 -165.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 157.54 70.86 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 1.29 112.578 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.0 141.64 40.62 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 O-C-N 122.985 0.992 . . . . 1.1100000000000001 111.233 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 2.1 Cg_endo -86.92 39.59 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 125.282 3.988 . . . . 1.1699999999999999 113.647 -156.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.83 -159.94 12.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.921 1.248 . . . . 1.1399999999999999 114.056 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -89.22 137.46 32.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.662 1.985 . . . . 2.8900000000000001 111.391 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -140.43 143.18 35.46 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.978 0.911 . . . . 1.3300000000000001 109.62 -173.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.06 161.97 46.82 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 119.029 0.831 . . . . 0.53000000000000003 112.112 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.402 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.9 t80 -144.51 124.86 13.83 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.326 -1.731 . . . . 1.8799999999999999 106.326 166.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.57 166.01 24.21 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.962 1.467 . . . . 0.94999999999999996 114.962 165.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CG2' HD12 ' A' ' 74' ' ' LEU . 20.6 mt -91.06 148.4 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.922 1.689 . . . . 0.63 109.341 159.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -126.42 160.49 30.32 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.355 1.462 . . . . 0.88 109.872 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.3 -20.2 65.58 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 116.609 2.077 . . . . 0.76000000000000001 116.609 -162.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -134.9 166.54 22.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.061 1.744 . . . . 1.1399999999999999 112.883 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 83.91 0.34 Allowed Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.151 1.358 . . . . 1.04 112.433 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.8 m -171.5 90.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.595 1.558 . . . . 2.3399999999999999 110.202 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 59.0 m -64.86 45.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 127.0 2.12 . . . . 1.3600000000000001 114.98 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -118.59 136.69 24.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 119.579 -1.95 . . . . 3.6099999999999999 110.786 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.61 168.74 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.185 3.256 . . . . 1.1799999999999999 111.686 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.18 144.98 25.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.016 -0.538 . . . . 1.52 109.772 155.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -109.92 117.35 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.118 1.367 . . . . 2.7000000000000002 108.34 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -166.41 146.4 6.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.962 1.305 . . . . 4.4900000000000002 110.6 -163.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 63.22 18.39 10.94 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.085 -1.009 . . . . 3.27 113.686 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.8 13.46 81.33 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.595 -1.315 . . . . 2.5299999999999998 114.217 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.82 174.54 10.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.643 1.577 . . . . 2.5499999999999998 110.793 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.6 151.04 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.371 -0.831 . . . . 1.6399999999999999 111.89 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.23 95.26 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.148 1.379 . . . . 1.8200000000000001 109.977 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 15.41 -85.41 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 129.396 3.079 . . . . 2.0 116.091 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 130.62 12.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.619 1.968 . . . . 1.6499999999999999 106.818 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -116.66 -46.0 2.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.512 1.925 . . . . 4.0 110.864 -165.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.5 -9.85 38.69 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.896 1.073 . . . . 1.1499999999999999 113.896 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.48 59.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.683 1.593 . . . . 0.81000000000000005 113.185 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.1 173.5 48.7 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 119.487 1.039 . . . . 2.4100000000000001 112.948 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.56 -177.89 42.15 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.78 0.705 . . . . 1.26 112.444 165.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -49.01 140.15 9.44 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.252 0.526 . . . . 2.1000000000000001 110.306 168.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.93 101.73 0.88 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.416 0.895 . . . . 2.8500000000000001 113.416 -170.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -150.45 130.33 6.71 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 128.009 2.524 . . . . 5.2999999999999998 108.547 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.14 -39.35 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.337 2.025 . . . . 2.48 113.918 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.67 31.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.463 1.905 . . . . 4.5199999999999996 114.548 -169.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -73.25 -44.15 59.89 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.115 -1.616 . . . . 4.3799999999999999 110.855 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.6 t 177.07 -37.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.277 1.831 . . . . 2.6800000000000002 113.378 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 5.91 79.13 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 117.853 -1.526 . . . . 2.1200000000000001 116.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.255 19.2 ptmt -102.39 17.71 22.86 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 117.712 2.486 . . . . 4.8499999999999996 117.712 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 t60 83.54 168.85 0.1 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 127.126 2.17 . . . . 2.1400000000000001 114.753 164.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -25.04 0.1 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.671 2.1 . . . . 5.1299999999999999 116.671 -154.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.6 -46.14 7.13 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 118.334 2.093 . . . . 2.5899999999999999 118.334 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -90.02 -12.63 2.77 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.192 2.496 . . . . 3.79 113.859 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -147.29 -104.17 0.09 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 6.0499999999999998 108.817 -161.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.68 98.73 0.14 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 119.17 0.896 . . . . 3.0499999999999998 114.23 170.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -159.79 44.76 0.23 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.578 1.151 . . . . 4.8700000000000001 109.741 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.43 -129.68 1.14 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 115.868 1.107 . . . . 2.6600000000000001 115.868 -166.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -95.36 146.2 24.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.236 1.014 . . . . 3.25 113.663 -154.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -24.61 33.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.683 0.994 . . . . 2.96 113.683 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.27 11.28 69.16 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.347 0.975 . . . . 1.28 114.91 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.8 149.79 32.5 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 117.95 0.875 . . . . 2.46 110.716 163.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.85 166.35 16.53 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.233 1.013 . . . . 1.8799999999999999 110.256 -141.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.37 157.01 50.13 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.605 2.87 . . . . 1.1100000000000001 111.654 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -73.21 128.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.647 1.213 . . . . 1.4299999999999999 112.34 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.09 63.37 5.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.773 2.829 . . . . 2.8799999999999999 110.792 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.87 144.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.088 -1.007 . . . . 1.4399999999999999 110.748 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 135.39 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.684 -0.858 . . . . 3.02 108.684 162.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 159.34 25.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.131 1.772 . . . . 3.71 112.52 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 6.8 p-10 -48.79 -8.68 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 119.867 3.284 . . . . 2.4900000000000002 119.867 -161.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -95.94 -36.3 11.12 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.883 1.673 . . . . 2.8500000000000001 114.589 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 115.01 14.39 8.53 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.922 1.529 . . . . 1.0800000000000001 116.922 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.9 mt -105.82 116.99 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.937 1.369 . . . . 1.6599999999999999 109.883 165.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.09 122.58 21.2 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.921 0.489 . . . . 0.70999999999999996 109.951 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -149.23 17.5 0.95 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.351 . . . . 1.0600000000000001 112.733 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -87.29 112.19 46.3 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.134 1.374 . . . . 3.0 111.526 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.9 107.09 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.89 2.393 . . . . 1.1599999999999999 109.973 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.67 145.93 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.501 1.12 . . . . 1.3400000000000001 109.582 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -127.36 131.97 50.28 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.016 0.825 . . . . 0.93999999999999995 111.014 -168.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.23 96.67 40.11 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.976 0.91 . . . . 0.73999999999999999 112.326 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.12 6.66 1.35 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.93 3.086 . . . . 1.01 113.293 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.08 -29.01 67.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.041 1.337 . . . . 5.1600000000000001 112.965 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.6 153.84 32.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.033 2.133 . . . . 1.9399999999999999 108.118 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 10.71 6.75 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.805 1.242 . . . . 5.0099999999999998 112.581 -174.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -167.13 150.72 6.58 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.974 -1.079 . . . . 1.6699999999999999 112.99 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -71.52 -33.6 69.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.561 0.744 . . . . 2.1200000000000001 110.655 162.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.02 -26.57 67.71 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.278 1.214 . . . . 3.3399999999999999 114.278 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -84.58 -0.57 53.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.075 1.35 . . . . 1.8799999999999999 113.395 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.81 12.96 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.581 1.152 . . . . 0.83999999999999997 113.922 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -69.93 17.45 0.05 Allowed 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 116.719 2.118 . . . . 2.3399999999999999 116.719 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -156.18 29.7 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.534 1.933 . . . . 2.8399999999999999 110.624 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -139.62 157.74 45.28 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.168 1.387 . . . . 1.5800000000000001 114.12 -167.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.96 149.09 22.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.99 1.316 . . . . 0.53000000000000003 112.998 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.55 131.21 55.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.019 2.528 . . . . 1.6299999999999999 106.521 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.3 mtm -125.75 136.68 53.42 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.468 1.031 . . . . 1.5900000000000001 113.036 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.25 112.35 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.928 1.291 . . . . 0.85999999999999999 108.227 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.1 134.72 34.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.699 1.6 . . . . 2.3599999999999999 111.661 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.67 -39.92 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.233 0.827 . . . . 1.23 113.233 -158.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.35 163.55 12.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.341 0.972 . . . . 1.1399999999999999 110.685 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.75 109.26 1.34 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.481 -1.048 . . . . 1.74 110.481 166.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.81 26.58 0.09 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.883 2.873 . . . . 4.9400000000000004 112.969 -167.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.72 21.6 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.045 1.868 . . . . 3.3300000000000001 116.045 -158.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.5 mtm -98.68 152.91 19.13 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.394 1.257 . . . . 2.48 114.394 -160.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.3 p -140.15 150.32 44.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.324 1.85 . . . . 3.79 110.463 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.9 t0 58.39 84.27 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.247 2.219 . . . . 4.6600000000000001 114.448 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.1 156.95 11.56 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.936 1.694 . . . . 3.5499999999999998 109.698 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.76 25.38 0.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.93 3.086 . . . . 3.3399999999999999 114.059 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -134.25 129.36 19.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.206 1.002 . . . . 4.7999999999999998 109.941 163.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.88 138.7 45.27 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.889 2.393 . . . . 2.9700000000000002 111.085 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 60.45 22.48 12.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.809 1.643 . . . . 3.6299999999999999 112.117 -171.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.45 0.13 29.02 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.004 1.288 . . . . 2.7799999999999998 114.554 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.37 -9.46 24.4 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.925 2.202 . . . . 1.76 113.957 -166.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.95 1.11 56.29 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.449 1.625 . . . . 1.45 116.324 -171.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.84 62.23 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 118.995 1.398 . . . . 1.46 116.485 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -79.31 155.96 28.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.014 1.725 . . . . 1.4399999999999999 110.771 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 136.01 49.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 5.0499999999999998 111.457 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -82.4 -32.61 29.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.518 1.127 . . . . 2.25 111.349 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.91 42.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.431 1.092 . . . . 0.51000000000000001 113.066 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.56 151.72 48.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.031 2.132 . . . . 1.46 110.479 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.07 125.15 1.78 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.301 1.429 . . . . 0.67000000000000004 111.873 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.6 132.45 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.835 1.254 . . . . 1.8200000000000001 110.87 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.06 131.4 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.032 1.333 . . . . 0.81999999999999995 110.533 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.4 mttt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 123.526 0.73 . . . . 3.8700000000000001 111.874 179.398 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.202 -0.666 . . . . 2.2000000000000002 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.39 143.1 45.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.196 1.362 . . . . 1.3500000000000001 113.974 -147.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -155.19 132.67 11.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.06 1.344 . . . . 2.52 110.454 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.38 97.07 7.19 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.842 -1.161 . . . . 4.1299999999999999 113.029 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.4 t -77.54 122.79 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 1.03 109.799 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.75 105.1 1.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.212 1.387 . . . . 0.68000000000000005 110.638 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.4 mtp -91.57 108.56 19.99 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.925 0.713 . . . . 1.1699999999999999 112.925 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -69.4 141.95 54.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.938 0.895 . . . . 2.8399999999999999 111.31 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.29 134.83 52.33 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.633 -0.877 . . . . 1.3700000000000001 108.633 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.69 159.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.091 0.556 . . . . 0.98999999999999999 111.578 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -155.23 -152.32 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.375 1.47 . . . . 2.7200000000000002 109.927 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -18.07 44.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.429 1.492 . . . . 1.26 113.429 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.84 -3.32 47.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.655 1.182 . . . . 2.6600000000000001 111.543 164.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 -133.41 11.78 Favored Glycine 0 CA--C 1.525 0.684 0 O-C-N 120.812 -1.18 . . . . 1.23 110.464 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.42 130.12 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.249 1.42 . . . . 1.0900000000000001 111.657 -165.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.54 -100.07 2.16 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.645 1.593 . . . . 1.23 112.291 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -151.06 152.43 33.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.134 1.774 . . . . 3.6400000000000001 109.065 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.5 t -87.99 155.1 20.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.22 1.01 . . . . 1.1899999999999999 112.308 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -135.37 2.9 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 2.7799999999999998 112.438 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.78 142.83 3.63 Favored Glycine 0 CA--C 1.524 0.62 0 O-C-N 121.468 -0.77 . . . . 0.77000000000000002 112.72 -162.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -97.88 175.82 6.01 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.367 -0.975 . . . . 0.81000000000000005 108.367 166.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 33' ' ' PHE . 23.0 t -127.52 129.07 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.594 -0.891 . . . . 0.68000000000000005 108.594 160.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.7 p -87.38 121.26 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 O-C-N 123.574 0.546 . . . . 0.96999999999999997 110.995 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.52 128.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.303 1.841 . . . . 1.1299999999999999 107.284 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.56 111.71 13.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.497 1.142 . . . . 2.27 111.118 164.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -86.31 145.78 26.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.418 2.287 . . . . 5.3700000000000001 113.447 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.302 8.5 t -163.16 160.5 24.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 125.179 2.418 . . . . 1.5900000000000001 110.775 -158.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -23.18 -53.18 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 110.712 -2.949 . . . . 3.7799999999999998 113.387 148.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.12 12.2 65.04 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 125.225 1.393 . . . . 1.03 116.179 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.66 -172.38 35.9 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 130.499 3.904 . . . . 1.48 115.272 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.1 mt -51.59 99.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.798 2.039 . . . . 0.78000000000000003 113.86 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -81.01 104.48 11.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.788 1.235 . . . . 1.79 110.849 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 47' ' ' PHE . 1.3 t80 -94.33 120.88 35.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.175 2.19 . . . . 0.62 110.265 -173.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.407 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.5 m -127.65 115.92 21.01 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.036 -0.983 . . . . 0.68999999999999995 109.286 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -85.03 154.92 11.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.455 2.77 . . . . 0.57999999999999996 113.562 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . 0.282 1.8 p80 -147.06 62.25 1.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.3 1.047 . . . . 1.24 111.873 168.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.449 ' HB2' HD21 ' A' ' 40' ' ' LEU . 1.2 mp -121.68 146.21 47.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.404 1.481 . . . . 0.68000000000000005 112.05 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -133.57 25.4 4.07 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 117.483 2.401 . . . . 2.3199999999999998 117.483 -158.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.54 25.02 0.4 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.817 1.414 . . . . 1.6299999999999999 114.817 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -89.92 162.91 34.21 Favored Pre-proline 0 N--CA 1.474 0.773 0 O-C-N 120.907 -1.121 . . . . 1.72 111.297 -174.177 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.27 128.12 25.24 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 N-CA-C 109.36 -1.054 . . . . 0.96999999999999997 109.36 162.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -87.45 20.17 1.24 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 124.399 3.399 . . . . 1.01 113.78 -149.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.18 150.2 18.2 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.576 . . . . 2.5099999999999998 109.447 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -44.15 143.23 1.23 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 127.365 2.266 . . . . 2.8900000000000001 115.852 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -126.74 125.98 42.69 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 125.679 1.592 . . . . 1.1499999999999999 113.408 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.32 159.99 7.92 Favored Glycine 0 CA--C 1.54 1.62 0 O-C-N 120.863 -1.148 . . . . 0.57999999999999996 112.581 171.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.659 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -137.15 126.4 24.72 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.617 -0.931 . . . . 2.29 108.832 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -120.85 159.3 25.77 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.558 1.318 . . . . 0.95999999999999996 114.558 166.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.3 mt -103.18 139.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.558 1.943 . . . . 0.62 107.371 157.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -113.59 166.26 11.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.223 . . . . 0.98999999999999999 111.137 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.56 64.78 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.494 1.294 . . . . 0.69999999999999996 114.494 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -110.84 -158.22 0.64 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.939 1.296 . . . . 1.3500000000000001 111.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.42 0.19 8.05 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 119.46 2.544 . . . . 1.29 119.46 -147.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 t -155.78 138.76 15.41 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.816 3.308 . . . . 3.1200000000000001 117.271 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.7 m -68.44 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 130.199 3.399 . . . . 1.3500000000000001 115.112 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.18 118.82 48.64 Favored Pre-proline 0 N--CA 1.475 0.788 0 O-C-N 119.446 -2.034 . . . . 3.1499999999999999 111.746 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.66 146.3 16.77 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.662 2.908 . . . . 1.3700000000000001 111.711 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.24 138.88 32.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.63 -0.714 . . . . 1.74 110.291 154.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.57 106.54 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.792 -1.188 . . . . 2.8100000000000001 107.792 160.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -151.98 136.54 16.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.578 1.551 . . . . 5.5 110.246 -161.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.4 t0 50.46 45.51 26.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.85 1.26 . . . . 4.1600000000000001 112.83 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 -19.49 48.97 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.065 1.793 . . . . 2.77 115.389 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.66 163.6 34.36 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.352 1.576 . . . . 3.2200000000000002 113.379 -156.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.57 121.83 26.81 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.497 -1.377 . . . . 1.9399999999999999 111.175 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -76.61 20.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 114.656 1.354 . . . . 2.8599999999999999 114.656 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.99 -56.96 0.57 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.146 2.578 . . . . 1.78 114.685 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.44 118.76 0.55 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.252 2.221 . . . . 1.8799999999999999 108.911 172.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.11 -43.8 7.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.581 0.752 . . . . 4.96 110.677 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.2 -2.38 7.99 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.221 1.193 . . . . 1.4399999999999999 114.221 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.13 -24.25 23.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.018 1.327 . . . . 0.84999999999999998 112.474 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.68 -176.94 41.87 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.713 1.142 . . . . 2.3900000000000001 112.878 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.62 -176.57 29.65 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.906 -0.761 . . . . 1.1699999999999999 112.834 171.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -55.59 150.38 12.36 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.936 -0.744 . . . . 2.23 109.487 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.493 HD13 ' HE2' ' A' ' 123' ' ' LYS . 53.8 tp -64.99 100.35 0.41 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.911 0.778 . . . . 1.54 112.002 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -163.78 123.15 1.32 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 129.279 3.032 . . . . 4.9699999999999998 108.926 165.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -92.16 -16.64 1.05 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.04 2.493 . . . . 1.95 114.283 173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -169.88 -14.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.437 2.384 . . . . 3.5800000000000001 117.437 -166.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -59.09 -36.62 75.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.957 1.708 . . . . 4.1100000000000003 112.742 -170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -172.93 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.182 0.993 . . . . 2.46 113.225 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 -17.48 8.06 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.29 -1.283 . . . . 1.98 113.834 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -78.08 154.49 31.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.175 1.988 . . . . 5.5800000000000001 112.077 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -79.68 150.52 30.89 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.012 -1.055 . . . . 1.3700000000000001 112.589 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.39 -166.01 0.88 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.598 0.759 . . . . 3.27 110.076 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.45 -140.5 6.43 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 120.746 -1.221 . . . . 2.21 111.79 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.15 -9.82 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.458 2.772 . . . . 3.29 114.23 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.98 174.41 5.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.817 2.047 . . . . 5.5499999999999998 109.164 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.98 -138.4 16.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.663 0.649 . . . . 3.2599999999999998 111.497 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.08 135.81 3.91 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.511 1.524 . . . . 6.6900000000000004 107.597 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.87 -135.28 3.22 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.258 1.409 . . . . 2.6600000000000001 113.397 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -75.7 136.25 40.37 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.145 -0.62 . . . . 3.5099999999999998 110.542 169.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.528 HD13 ' H ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -71.2 -12.84 61.69 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 2.4399999999999999 113.586 170.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.09 18.51 13.0 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.874 1.702 . . . . 0.95999999999999996 115.999 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -108.9 133.11 53.35 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.155 1.478 . . . . 1.47 110.585 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.659 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 4.8 mp -134.11 154.23 80.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.035 1.334 . . . . 2.1699999999999999 110.654 -163.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.75 163.9 37.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.41 2.74 . . . . 0.80000000000000004 112.987 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.14 119.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 114.975 -1.012 . . . . 2.1600000000000001 112.101 -160.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 87.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.112 2.965 . . . . 1.73 109.685 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.25 147.55 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.452 -0.78 . . . . 1.04 110.086 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.55 150.16 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 127.635 2.374 . . . . 1.6000000000000001 106.108 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.52 160.21 27.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.575 0.625 . . . . 2.4399999999999999 111.147 168.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -14.79 0.86 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 116.63 2.085 . . . . 2.4500000000000002 116.63 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.93 -5.78 37.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.359 2.264 . . . . 2.6299999999999999 113.395 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.5 52.01 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.674 1.131 . . . . 0.71999999999999997 115.184 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.6 mt -111.89 132.5 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.432 1.493 . . . . 1.1799999999999999 110.191 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.7 144.63 32.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.522 1.529 . . . . 1.02 112.198 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -151.31 -5.73 0.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.346 1.858 . . . . 1.3500000000000001 113.806 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -70.18 118.53 64.77 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.226 1.81 . . . . 4.5199999999999996 111.493 -174.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.15 146.73 32.46 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.884 2.389 . . . . 1.28 111.479 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.16 175.17 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.911 1.684 . . . . 1.22 109.627 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 m -150.57 133.19 15.75 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.305 0.957 . . . . 0.94999999999999996 110.449 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.579 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -106.3 105.41 54.03 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-O 118.745 -0.645 . . . . 0.91000000000000003 112.043 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.67 -16.16 21.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.233 2.622 . . . . 1.1899999999999999 115.631 -171.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -66.77 -43.25 84.53 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.252 0.834 . . . . 4.8200000000000003 113.252 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.95 151.25 38.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 2.0299999999999998 110.336 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -144.27 46.4 1.42 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.819 1.248 . . . . 4.0599999999999996 113.265 -169.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 m 151.22 142.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 130.874 3.67 . . . . 1.6799999999999999 113.554 166.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.19 -33.63 53.54 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.826 -1.171 . . . . 1.6299999999999999 111.636 164.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -20.92 5.72 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.794 1.775 . . . . 3.1699999999999999 115.794 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -92.25 -16.98 25.43 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.607 1.549 . . . . 3.0600000000000001 113.709 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.67 -1.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.993 1.479 . . . . 0.85999999999999999 114.993 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -8.4 13.24 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 117.121 2.267 . . . . 2.6699999999999999 117.121 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -104.97 -8.12 18.8 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.207 1.403 . . . . 2.8700000000000001 113.395 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HE2' HD13 ' A' ' 74' ' ' LEU . 20.9 mttt -96.16 168.56 10.52 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.932 1.293 . . . . 1.5600000000000001 114.338 -167.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.9 156.84 17.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.125 1.37 . . . . 0.78000000000000003 112.41 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 pp -131.96 155.0 48.73 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.924 1.69 . . . . 2.6000000000000001 111.193 169.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 67.9 mtt -136.28 139.74 42.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.607 0.763 . . . . 1.51 112.587 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.03 121.62 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.293 1.437 . . . . 0.65000000000000002 107.779 166.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -114.01 145.75 41.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.448 1.499 . . . . 2.0299999999999998 112.654 -161.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.0 -32.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 126.119 1.768 . . . . 1.1499999999999999 113.762 -159.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.68 167.37 20.04 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.782 1.182 . . . . 1.1100000000000001 111.703 168.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.97 163.68 50.43 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.241 1.401 . . . . 1.3500000000000001 112.759 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.51 11.93 14.97 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.199 1.555 . . . . 2.4500000000000002 115.199 -142.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -70.95 -10.47 59.74 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.441 -1.412 . . . . 3.04 114.638 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.2 mtm -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.664 1.586 . . . . 2.29 113.403 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 t -84.77 -175.39 5.75 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.61 -0.681 . . . . 3.2999999999999998 112.27 161.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 61.31 -16.05 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 129.053 2.941 . . . . 4.79 117.316 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -67.67 147.27 98.67 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.098 1.359 . . . . 3.3599999999999999 111.851 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.95 -25.0 32.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.612 2.875 . . . . 2.1099999999999999 112.718 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -104.65 84.98 1.05 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.43 -0.952 . . . . 3.8999999999999999 108.43 157.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.58 154.25 73.05 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.753 2.302 . . . . 3.2200000000000002 111.041 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 65.58 5.48 3.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.684 1.994 . . . . 4.2400000000000002 112.946 -169.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.42 14.52 54.48 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.718 1.151 . . . . 3.3100000000000001 114.429 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.45 44.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.972 1.272 . . . . 2.3700000000000001 114.035 -167.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.1 -16.65 66.92 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.209 1.385 . . . . 1.9299999999999999 113.164 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.68 0.08 29.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.149 1.357 . . . . 1.9099999999999999 114.628 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.0 p -71.75 160.66 32.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.127 1.463 . . . . 1.76 109.924 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.51 150.72 20.21 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.762 1.225 . . . . 5.7599999999999998 114.001 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -109.24 -37.92 5.65 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.317 0.647 . . . . 2.4399999999999999 110.793 154.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.75 155.04 47.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.79 0.836 . . . . 0.52000000000000002 112.69 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.1 t -139.09 147.51 42.07 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.223 2.209 . . . . 1.4099999999999999 109.821 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 123.99 1.72 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.978 1.275 . . . . 0.71999999999999997 112.624 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.22 126.19 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.792 1.237 . . . . 1.55 110.144 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 36.8 mt -80.87 142.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.642 1.177 . . . . 0.88 109.184 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 10.5 mmpt? . . . . . 0 CA--C 1.542 0.672 0 O-C-N 120.726 -1.234 . . . . 3.1600000000000001 111.811 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.107 -0.331 . . . . 2.1099999999999999 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -132.49 146.23 51.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.011 1.485 . . . . 1.0 115.011 -133.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -156.04 135.51 12.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.287 1.518 . . . . 2.7999999999999998 111.603 164.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -108.51 87.5 2.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.229 2.212 . . . . 3.0 110.974 -165.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.23 125.4 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.21 1.189 . . . . 2.0899999999999999 114.21 -171.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.0 100.68 0.59 Allowed Glycine 0 C--N 1.339 0.709 0 C-N-CA 125.191 1.377 . . . . 0.89000000000000001 110.525 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.28 128.92 34.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.653 0.74 . . . . 1.4399999999999999 111.931 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -111.09 143.4 41.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.904 2.081 . . . . 2.8700000000000001 111.658 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.2 mt -80.83 56.26 2.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.599 1.16 . . . . 1.7 112.904 -169.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.1 153.45 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 122.262 1.029 . . . . 1.1699999999999999 113.603 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -160.06 -156.26 0.48 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 125.728 1.611 . . . . 3.0099999999999998 109.051 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.14 8.88 0.49 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.37 1.868 . . . . 1.25 114.075 -172.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -108.46 -7.52 15.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.815 1.646 . . . . 2.6499999999999999 111.114 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.81 -142.63 17.14 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.644 -0.983 . . . . 0.96999999999999997 110.644 -160.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -92.53 136.3 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.159 1.783 . . . . 0.82999999999999996 110.907 -167.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.47 -68.26 0.28 Allowed Glycine 0 N--CA 1.473 1.146 0 C-N-CA 124.421 1.01 . . . . 1.6200000000000001 115.316 -166.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.3 154.98 10.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.207 1.803 . . . . 1.8500000000000001 110.8 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -129.82 122.42 28.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.9 -1.125 . . . . 1.6000000000000001 112.273 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.65 25.97 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.458 1.503 . . . . 5.5999999999999996 110.842 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.87 38.12 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.756 -0.59 . . . . 0.60999999999999999 114.32 161.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 p -99.24 -179.28 4.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.963 0.905 . . . . 0.90000000000000002 110.392 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 42.4 t -129.53 132.58 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.929 -1.137 . . . . 0.5 107.929 150.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.8 p -85.84 120.7 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.963 0.411 . . . . 0.81000000000000005 110.761 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.58 138.93 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 124.917 1.287 . . . . 1.3600000000000001 107.881 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.94 104.95 3.49 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.16 1.384 . . . . 2.2799999999999998 109.56 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 151.08 44.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.032 -0.531 . . . . 2.8199999999999998 111.558 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -158.38 -177.49 6.58 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.854 0.862 . . . . 1.3 110.547 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.5 -9.4 48.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.487 1.915 . . . . 3.7400000000000002 113.001 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.45 16.27 41.37 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.854 1.693 . . . . 1.1699999999999999 114.424 163.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.88 -151.42 23.86 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 127.235 2.35 . . . . 1.0 116.635 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.54 96.66 4.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.227 1.011 . . . . 0.80000000000000004 111.728 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -70.77 143.32 51.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.086 0.954 . . . . 2.1800000000000002 109.755 166.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.538 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 20.0 t80 -142.65 118.88 10.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.105 1.762 . . . . 0.53000000000000003 109.363 -167.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.8 m -123.44 109.5 30.89 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.173 -0.918 . . . . 0.62 108.831 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.4 164.31 19.11 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.818 3.012 . . . . 0.52000000000000002 110.929 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -158.63 33.78 0.23 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.314 0.857 . . . . 1.3600000000000001 113.314 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 mp -91.77 136.06 33.43 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.378 -1.451 . . . . 0.93000000000000005 112.018 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 14.98 21.63 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.499 2.037 . . . . 2.1099999999999999 116.499 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.59 88.07 1.19 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.664 -0.648 . . . . 1.8300000000000001 112.059 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 163.32 26.9 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.264 1.425 . . . . 1.48 111.298 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.51 124.31 13.09 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.013 1.809 . . . . 0.88 110.556 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -84.47 45.17 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 127.203 5.269 . . . . 1.1299999999999999 112.268 -163.381 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.13 -130.46 7.02 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 123.184 1.436 . . . . 1.45 111.866 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -147.56 127.95 13.99 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.253 1.421 . . . . 2.6400000000000001 109.264 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -130.19 154.48 47.49 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.578 0.955 . . . . 1.0800000000000001 113.578 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.35 155.87 51.75 Favored Glycine 0 CA--C 1.541 1.657 0 O-C-N 121.184 -0.948 . . . . 0.57999999999999996 112.192 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.528 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 1.4 t80 -130.85 122.57 27.31 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.054 -1.462 . . . . 2.0600000000000001 107.054 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 7.7 m170 -122.53 157.92 31.0 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.723 1.601 . . . . 1.03 114.43 165.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.6 mt -94.24 154.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 128.27 2.628 . . . . 0.73999999999999999 108.22 158.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -139.04 145.13 39.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.002 0.921 . . . . 0.96999999999999997 111.181 -170.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.57 67.0 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.242 1.941 . . . . 0.79000000000000004 116.242 -163.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.43 -179.27 5.06 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.415 1.086 . . . . 1.0700000000000001 113.211 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.0 32.76 4.47 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.597 1.57 . . . . 1.3799999999999999 116.675 -163.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -138.69 104.12 5.02 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.224 1.512 . . . . 2.4300000000000002 111.705 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -70.2 13.09 0.18 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 116.701 2.111 . . . . 1.4199999999999999 116.701 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -84.45 131.52 49.96 Favored Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 119.694 -1.879 . . . . 3.0699999999999998 112.115 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.71 149.16 29.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.524 2.816 . . . . 1.01 112.418 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.74 150.36 26.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.003 -0.544 . . . . 1.4199999999999999 110.38 156.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.0 mm -117.14 136.76 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.829 1.652 . . . . 2.4199999999999999 107.697 173.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -14.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.678 2.103 . . . . 5.5099999999999998 116.678 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.36 46.7 0.28 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.795 1.18 . . . . 3.3300000000000001 113.611 -163.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.1 22.3 68.75 Favored Glycine 0 N--CA 1.475 1.255 0 O-C-N 120.662 -1.274 . . . . 3.2799999999999998 113.295 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -163.32 155.22 17.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.293 1.837 . . . . 2.9100000000000001 110.501 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.0 138.51 46.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.243 1.417 . . . . 2.1299999999999999 111.749 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.82 39.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.969 1.308 . . . . 2.3999999999999999 111.377 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.4 -66.38 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.628 2.771 . . . . 2.25 116.207 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.91 107.13 0.96 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.074 2.55 . . . . 1.98 108.057 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -76.48 -54.1 7.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.484 0.714 . . . . 6.0599999999999996 110.059 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.1 20.64 0.37 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.045 0.938 . . . . 1.8700000000000001 113.325 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.4 -11.99 38.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.226 1.411 . . . . 0.82999999999999996 112.08 157.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.18 -70.3 3.18 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 120.229 -1.544 . . . . 2.96 114.051 171.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.02 179.23 32.75 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.522 1.534 . . . . 1.4199999999999999 112.909 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -61.28 -7.31 2.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.663 2.097 . . . . 2.5699999999999998 116.663 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 tt 78.51 98.73 0.06 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.957 2.103 . . . . 2.25 110.027 169.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -168.55 55.01 0.27 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 115.714 1.746 . . . . 3.5099999999999998 115.714 -148.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.39 -48.06 2.7 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.765 2.31 . . . . 2.6299999999999999 113.218 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -137.41 79.04 1.72 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.459 1.103 . . . . 4.21 110.058 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.96 -77.67 0.58 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.601 1.16 . . . . 3.9300000000000002 109.769 166.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -178.6 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.894 2.077 . . . . 2.3799999999999999 111.414 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.55 -9.3 58.82 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.245 0.926 . . . . 1.76 114.679 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.92 -14.35 61.9 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 116.052 1.871 . . . . 5.1299999999999999 116.052 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.9 t60 70.74 164.19 0.27 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.308 1.843 . . . . 1.55 111.5 -166.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -157.28 -152.38 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.886 -1.134 . . . . 3.9500000000000002 112.216 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.27 -40.18 0.16 Allowed Glycine 0 CA--C 1.543 1.805 0 C-N-CA 127.938 2.685 . . . . 2.3599999999999999 113.213 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -112.34 -1.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.617 2.878 . . . . 3.3199999999999998 115.606 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.08 -7.19 0.82 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.116 1.895 . . . . 6.3600000000000003 116.116 -159.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.36 -23.03 5.71 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 119.712 -1.867 . . . . 3.7400000000000002 114.322 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.71 64.26 2.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.089 2.156 . . . . 4.9199999999999999 113.451 -168.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 -93.39 0.11 Allowed Glycine 0 N--CA 1.469 0.899 0 O-C-N 120.457 -1.402 . . . . 2.48 113.655 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -138.15 156.03 48.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.23 2.212 . . . . 3.6299999999999999 108.279 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -84.96 -21.72 29.46 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.523 1.056 . . . . 1.99 113.131 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.63 19.84 22.15 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 117.806 -1.552 . . . . 0.96999999999999997 116.068 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -95.2 138.12 33.33 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 120.636 2.218 . . . . 1.49 111.065 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.528 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 5.2 mp -129.49 155.66 79.82 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.945 1.698 . . . . 2.2200000000000002 110.391 -169.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.02 162.04 43.01 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.417 2.744 . . . . 0.98999999999999999 111.787 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.0 127.24 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.902 1.334 . . . . 1.5600000000000001 113.237 -160.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 85.04 3.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 129.438 3.095 . . . . 2.48 108.57 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.12 149.55 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 0.92000000000000004 109.152 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.27 133.6 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.663 1.185 . . . . 1.6899999999999999 110.281 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.45 141.99 58.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.754 1.02 . . . . 1.8200000000000001 113.754 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -46.42 -23.92 0.43 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 129.016 2.927 . . . . 2.54 117.581 -170.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.58 -19.31 45.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.139 1.775 . . . . 3.0499999999999998 112.482 -168.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.69 30.95 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.43 1.491 . . . . 0.92000000000000004 113.483 -170.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.24 127.66 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.008 1.723 . . . . 1.1100000000000001 108.492 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.76 136.54 33.06 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.131 0.972 . . . . 0.81999999999999995 110.547 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.3 t -153.11 -2.43 0.22 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.918 1.687 . . . . 1.1100000000000001 113.052 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -80.43 118.96 74.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 128.387 2.675 . . . . 5.0300000000000002 112.283 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.09 149.43 28.52 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.931 3.087 . . . . 1.45 112.971 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.03 166.62 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.98 1.712 . . . . 1.28 110.591 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -138.99 137.1 36.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.9 1.28 . . . . 0.84999999999999998 109.553 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -112.42 110.17 53.23 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.338 0.655 . . . . 1.0 112.758 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.51 -0.95 11.13 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.879 3.052 . . . . 1.3400000000000001 114.692 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -73.87 -11.12 60.27 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.951 1.25 . . . . 4.6200000000000001 113.238 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.78 141.98 33.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.865 2.066 . . . . 2.4199999999999999 108.417 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 18.79 2.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.931 1.826 . . . . 6.9500000000000002 115.931 -160.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 85.9 p -153.24 164.72 37.58 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.821 1.248 . . . . 2.5899999999999999 108.329 167.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.0 tp -84.4 -34.61 23.5 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.676 -0.64 . . . . 2.2799999999999998 109.657 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.65 -41.36 42.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 2.8900000000000001 113.078 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -72.92 -5.09 36.16 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.231 1.197 . . . . 1.9099999999999999 114.231 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.03 13.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.024 1.329 . . . . 0.80000000000000004 113.541 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -59.7 -5.07 0.79 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 117.361 2.356 . . . . 2.23 117.361 -172.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.66 22.11 2.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.055 1.342 . . . . 3.5099999999999998 112.807 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -104.47 151.81 23.1 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.297 -0.877 . . . . 2.5800000000000001 112.866 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.47 148.42 27.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.836 -0.62 . . . . 0.70999999999999996 110.182 157.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.2 145.62 42.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.349 -0.982 . . . . 1.54 108.349 156.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.9 150.86 52.12 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.201 0.815 . . . . 2.48 113.201 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.5 mt -99.06 132.9 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.098 1.759 . . . . 0.71999999999999997 108.146 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -123.19 143.39 50.05 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.098 1.359 . . . . 2.77 112.197 -164.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 37.9 t -67.1 -35.4 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.922 -1.111 . . . . 1.3899999999999999 112.982 -160.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -108.19 150.74 17.0 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.182 0.896 . . . . 1.1200000000000001 111.937 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.89 147.81 40.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.634 1.111 . . . . 1.5800000000000001 111.376 159.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.404 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 25.3 t0 -103.4 -15.07 16.02 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.471 1.656 . . . . 2.9500000000000002 115.471 -138.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.24 51.98 0.57 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.415 1.635 . . . . 2.8999999999999999 115.415 -168.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.94 131.51 25.47 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.703 -1.248 . . . . 2.48 112.316 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -138.06 -54.93 0.65 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.717 0.807 . . . . 3.23 112.671 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.95 39.46 0.23 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.978 2.111 . . . . 4.2800000000000002 113.881 -164.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -124.18 163.58 35.03 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.155 2.582 . . . . 3.7000000000000002 109.773 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.84 -19.36 64.19 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.291 2.661 . . . . 2.4700000000000002 113.755 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -127.81 136.47 29.03 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 118.856 0.753 . . . . 4.5199999999999996 109.944 148.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.52 162.37 41.11 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.919 2.413 . . . . 3.75 110.176 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 mp 60.07 9.1 1.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.01 1.724 . . . . 3.8700000000000001 112.868 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 10.64 57.29 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.716 -1.24 . . . . 3.2999999999999998 114.139 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.7 83.07 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.434 1.016 . . . . 2.0800000000000001 113.891 -166.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.55 10.5 50.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.718 1.627 . . . . 1.7 115.006 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.83 -4.13 70.28 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.128 1.347 . . . . 1.45 114.537 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 p -62.71 157.99 19.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.048 1.339 . . . . 1.45 110.319 164.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.68 150.11 27.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.043 1.337 . . . . 6.7199999999999998 113.381 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -107.52 -19.82 13.44 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.436 0.902 . . . . 2.3799999999999999 113.436 162.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.24 156.32 23.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.205 0.911 . . . . 0.5 112.851 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.23 163.61 15.42 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.393 1.477 . . . . 2.2799999999999998 110.114 157.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -151.96 134.44 4.58 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.821 1.676 . . . . 0.68999999999999995 110.371 159.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.52 129.65 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.482 1.113 . . . . 1.53 109.873 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.4 mt -64.88 124.52 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.628 1.171 . . . . 1.1699999999999999 112.052 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 113.168 0.803 . . . . 3.4500000000000002 113.168 177.559 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.72 0.295 . . . . 2.77 110.484 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -150.84 155.78 39.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.206 1.402 . . . . 1.3799999999999999 109.194 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -154.59 121.51 5.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.113 1.365 . . . . 2.6000000000000001 109.601 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -86.58 102.43 14.14 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.638 -1.289 . . . . 3.5299999999999998 108.834 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.1 121.28 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 119.882 1.219 . . . . 1.05 110.586 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.6 104.13 2.26 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.644 1.593 . . . . 0.98999999999999999 110.983 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt -88.33 145.33 25.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.346 1.069 . . . . 1.4099999999999999 113.504 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -120.35 149.13 42.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.238 1.815 . . . . 2.8599999999999999 111.706 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.34 65.72 2.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.168 1.787 . . . . 1.45 111.139 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -74.39 157.84 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.705 1.202 . . . . 1.46 112.836 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -159.97 -156.78 0.51 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.309 1.444 . . . . 3.21 109.722 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.32 60.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.324 2.25 . . . . 1.21 113.587 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -87.33 -15.74 37.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.172 1.789 . . . . 3.02 112.198 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.24 -139.62 14.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.724 1.154 . . . . 1.0700000000000001 110.717 -161.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.94 139.13 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 126.766 2.026 . . . . 1.5600000000000001 113.284 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.67 -104.03 2.25 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.595 2.045 . . . . 1.6000000000000001 113.26 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.12 149.57 42.0 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 127.264 2.226 . . . . 2.3399999999999999 113.482 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -96.47 140.87 30.47 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.742 -1.224 . . . . 1.5700000000000001 112.053 166.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.64 5.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 125.351 1.46 . . . . 2.73 113.947 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.99 168.26 21.71 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.075 0.845 . . . . 0.93999999999999995 112.639 -168.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 p -116.86 -175.76 2.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.337 1.055 . . . . 0.87 109.162 170.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.482 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 44.7 t -129.08 135.65 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.441 -1.318 . . . . 0.70999999999999996 107.441 157.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.88 124.78 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.398 0.437 . . . . 1.03 110.203 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.7 127.67 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.371 1.068 . . . . 2.0 108.971 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -143.08 134.66 26.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.211 1.404 . . . . 2.04 110.452 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 117' ' ' LEU . 41.7 mt-10 -92.69 138.1 31.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.387 -1.733 . . . . 3.8199999999999998 112.087 -162.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 -175.51 4.99 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.577 -0.849 . . . . 1.52 112.276 168.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -70.97 -6.97 42.81 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.956 1.095 . . . . 3.8799999999999999 113.956 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.67 12.15 53.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.764 1.649 . . . . 1.25 113.913 162.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -152.7 21.65 Favored Glycine 0 N--CA 1.462 0.418 0 C-N-CA 128.083 2.754 . . . . 0.93000000000000005 116.225 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.3 mt -71.64 103.68 3.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.999 . . . . 0.88 111.259 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -76.63 116.41 17.28 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.239 1.016 . . . . 2.3599999999999999 109.081 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.482 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 25.4 t80 -113.56 113.03 24.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.239 2.216 . . . . 0.82999999999999996 109.19 -170.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.8 m -120.8 107.19 38.46 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 108.124 -1.065 . . . . 0.71999999999999997 108.124 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.65 164.31 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.505 2.803 . . . . 0.41999999999999998 110.685 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -152.67 30.63 0.52 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.133 0.968 . . . . 1.3100000000000001 112.669 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -89.78 132.76 35.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.919 -1.113 . . . . 0.81000000000000005 110.911 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -107.9 18.64 21.04 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.36 1.985 . . . . 2.5800000000000001 116.36 -159.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.62 75.69 0.56 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.14 0.976 . . . . 1.5900000000000001 111.992 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.11 158.43 69.46 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.791 1.237 . . . . 1.5700000000000001 110.871 173.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 37.4 Cg_endo -63.6 131.19 30.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.484 1.456 . . . . 1.1100000000000001 110.879 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 5.2 Cg_endo -87.2 34.76 0.43 Allowed 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 126.141 4.561 . . . . 1.0600000000000001 113.203 -150.18 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.84 -135.07 8.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.99 1.757 . . . . 1.26 114.072 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.51 131.53 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.919 1.688 . . . . 2.3999999999999999 108.417 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -132.73 147.21 52.32 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 124.561 1.144 . . . . 1.1799999999999999 112.392 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.44 149.31 51.34 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.943 -1.098 . . . . 0.81000000000000005 111.458 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -124.75 111.4 15.51 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.492 -1.67 . . . . 1.9299999999999999 106.492 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -116.24 157.43 24.91 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.633 -1.292 . . . . 1.1100000000000001 113.697 171.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.28 152.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.594 1.557 . . . . 1.1499999999999999 107.518 157.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.68 146.9 46.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.526 1.13 . . . . 1.0800000000000001 108.768 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.12 70.28 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.388 1.625 . . . . 0.72999999999999998 115.388 -153.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -125.42 155.24 40.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.481 1.113 . . . . 1.75 112.644 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.79 82.08 1.42 Allowed Glycine 0 N--CA 1.469 0.834 0 O-C-N 120.702 -1.249 . . . . 0.84999999999999998 112.795 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -166.54 95.52 0.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.55 0.74 . . . . 1.98 112.778 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.9 m -67.67 45.69 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.389 2.275 . . . . 1.45 113.635 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -121.05 127.12 26.35 Favored Pre-proline 0 CA--C 1.553 1.063 0 O-C-N 119.783 -1.823 . . . . 3.6400000000000001 111.113 -167.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -81.72 179.33 5.78 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.273 3.315 . . . . 1.0900000000000001 114.562 -168.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.19 173.13 12.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.799 2.04 . . . . 1.46 109.669 160.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.97 134.5 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.909 1.283 . . . . 3.21 108.194 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -150.78 143.05 24.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.642 1.577 . . . . 4.7400000000000002 110.14 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.61 25.96 13.86 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.204 1.187 . . . . 5.6299999999999999 114.204 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.77 17.54 65.51 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.414 1.006 . . . . 4.3600000000000003 115.001 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.16 162.56 39.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.173 1.487 . . . . 5.0099999999999998 112.903 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.2 129.05 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.436 1.095 . . . . 2.1899999999999999 111.384 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.41 -15.58 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.866 1.266 . . . . 2.5499999999999998 113.549 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 70.69 -49.26 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 128.482 2.713 . . . . 2.3300000000000001 113.574 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.67 106.69 3.71 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.24 1.016 . . . . 1.5800000000000001 109.991 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -95.32 -43.5 8.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.483 1.113 . . . . 4.7000000000000002 110.533 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.68 -9.03 31.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.256 1.022 . . . . 1.3500000000000001 113.545 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.76 -15.63 60.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.334 1.235 . . . . 0.87 114.334 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.91 -173.67 55.32 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 120.572 -1.33 . . . . 2.1200000000000001 114.228 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.51 -171.05 25.75 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 124.73 1.157 . . . . 1.3 113.131 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.471 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 1.8 m170 -64.87 8.91 0.1 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.898 2.079 . . . . 2.5699999999999998 114.649 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.1 tp 60.74 83.83 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.344 1.858 . . . . 1.6000000000000001 107.672 -164.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.435 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 54.4 p-10 -160.4 19.24 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 117.408 2.373 . . . . 4.3300000000000001 117.408 -143.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 71.6 Cg_endo -69.58 -31.77 20.67 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.232 1.955 . . . . 2.4399999999999999 115.498 -159.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -140.28 8.9 2.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.646 1.112 . . . . 3.1000000000000001 113.286 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.49 -41.99 19.04 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.05 -1.031 . . . . 3.7799999999999998 113.305 -164.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t 154.65 158.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 1 C-N-CA 132.237 4.215 . . . . 2.9300000000000002 107.414 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.07 -38.6 9.08 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 123.408 0.528 . . . . 2.6400000000000001 114.051 -171.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -77.77 176.25 9.2 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.362 1.065 . . . . 4.1600000000000001 113.734 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -124.29 158.9 31.47 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.29 1.036 . . . . 2.52 112.105 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.636 ' CD ' ' H ' ' A' ' 84' ' ' GLY 0.286 2.7 pp20? -150.56 -116.71 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.066 1.136 . . . . 3.96 114.066 -174.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.636 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 148.2 -55.5 0.5 Allowed Glycine 0 CA--C 1.547 2.086 0 C-N-CA 129.122 3.248 . . . . 3.1499999999999999 112.174 -171.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -97.95 -10.34 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.315 2.676 . . . . 3.7000000000000002 116.714 -166.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 -15.4 0.5 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.241 2.312 . . . . 6.0800000000000001 117.241 -162.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 -8.22 32.02 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.738 1.855 . . . . 3.1499999999999999 117.738 166.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -72.69 56.55 0.4 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.527 2.163 . . . . 5.29 113.252 170.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.82 110.17 0.27 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 120.717 -1.24 . . . . 3.1200000000000001 115.473 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.7 m170 59.99 -145.2 0.5 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.008 0.923 . . . . 4.0499999999999998 111.804 162.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.35 -28.43 0.54 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.791 1.034 . . . . 2.0 113.791 153.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.14 29.16 2.82 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 125.0 1.286 . . . . 1.1399999999999999 116.286 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 44.8 m-20 -99.2 134.72 41.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.969 1.307 . . . . 1.5600000000000001 110.232 171.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -131.37 152.25 80.19 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.167 1.387 . . . . 2.54 109.763 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.89 155.25 71.58 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.85 3.033 . . . . 1.28 111.418 -171.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.5 m -58.53 131.37 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 123.026 1.393 . . . . 1.51 113.08 -166.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.54 87.87 0.67 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.521 1.928 . . . . 2.54 108.137 167.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.94 138.35 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.115 0.966 . . . . 0.83999999999999997 108.796 170.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -118.67 135.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 126.021 1.728 . . . . 1.5600000000000001 107.111 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 149.11 50.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.773 0.715 . . . . 1.8200000000000001 111.673 175.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -53.58 -15.22 1.06 Allowed 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 116.198 1.925 . . . . 2.1699999999999999 116.198 -175.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -91.1 -8.92 47.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.391 1.876 . . . . 2.8700000000000001 113.118 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 21.39 16.16 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 124.567 1.079 . . . . 0.96999999999999997 114.782 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.2 mp -125.12 126.52 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.592 1.557 . . . . 1.3400000000000001 107.582 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.87 112.68 22.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.397 -0.964 . . . . 0.71999999999999997 108.397 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.0 t -131.79 -2.92 3.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.65 1.58 . . . . 1.0 112.715 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -72.64 115.08 36.01 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 128.041 2.537 . . . . 4.9699999999999998 111.078 -173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.54 138.33 24.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.73 2.287 . . . . 1.22 110.965 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.88 165.17 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.857 1.263 . . . . 1.28 109.916 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.3 m -133.53 139.07 46.39 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.363 0.665 . . . . 0.87 109.77 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.3 87.03 15.47 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.785 0.834 . . . . 1.03 112.424 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 5.38 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.279 3.32 . . . . 1.46 115.31 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -77.36 -31.73 54.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.705 1.139 . . . . 5.3600000000000003 111.246 170.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.91 127.44 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.909 1.684 . . . . 2.6899999999999999 107.948 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 1.74 10.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.947 1.091 . . . . 5.0599999999999996 113.947 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -154.08 165.69 35.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.077 1.751 . . . . 1.9199999999999999 112.208 158.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.537 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.4 mm? -64.17 -29.95 71.03 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.405 -0.81 . . . . 1.9299999999999999 111.081 162.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.12 -46.65 5.91 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.048 2.139 . . . . 2.9900000000000002 114.383 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -76.59 -2.54 33.05 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.728 1.381 . . . . 2.3100000000000001 114.728 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.08 13.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.087 1.355 . . . . 1.1000000000000001 112.096 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -57.6 -16.56 10.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.083 1.753 . . . . 2.0899999999999999 115.387 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.85 5.03 18.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 130.0 3.32 . . . . 4.7699999999999996 113.508 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.02 173.26 7.0 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.051 1.871 . . . . 1.21 116.051 -158.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.77 144.13 33.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.15 1.38 . . . . 0.72999999999999998 111.63 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.05 131.8 52.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.761 1.624 . . . . 1.6799999999999999 107.581 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.1 mtt -132.79 124.27 27.73 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.24 0.83 . . . . 1.3200000000000001 113.24 -170.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.26 114.87 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.842 1.257 . . . . 0.82999999999999996 108.43 171.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -99.31 147.36 25.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.48 1.912 . . . . 2.2400000000000002 112.29 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.74 -50.42 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.816 -0.611 . . . . 1.3999999999999999 110.05 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.23 152.64 47.07 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.76 -0.536 . . . . 2.1000000000000001 111.76 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.61 -163.88 21.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.725 2.107 . . . . 2.2999999999999998 114.022 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -155.88 98.72 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.282 1.033 . . . . 3.2000000000000002 110.32 -170.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -176.83 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.103 1.761 . . . . 3.0899999999999999 113.908 -167.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.3 ptp -127.97 76.68 1.7 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.555 -1.341 . . . . 3.7799999999999998 113.264 -146.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 p -72.2 109.88 6.27 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.747 -1.22 . . . . 4.79 112.18 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 97.2 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 129.961 3.304 . . . . 3.8300000000000001 112.834 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.49 144.37 10.32 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.174 0.989 . . . . 7.5 112.073 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.64 -52.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.876 3.051 . . . . 2.3900000000000001 110.929 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -67.82 115.93 32.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.977 -1.12 . . . . 4.0 107.977 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.79 164.77 34.65 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.886 2.391 . . . . 3.6099999999999999 113.29 -160.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.9 tp 71.13 -13.22 0.53 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.939 2.096 . . . . 4.9299999999999997 115.244 164.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 125.26 -2.19 8.3 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.309 1.909 . . . . 3.9700000000000002 115.014 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.31 -25.6 0.87 Allowed Glycine 0 CA--C 1.54 1.61 0 N-CA-C 117.249 1.66 . . . . 2.5600000000000001 117.249 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -112.11 60.21 0.34 Allowed Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.322 1.915 . . . . 2.3300000000000001 112.168 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.4 -1.89 88.91 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.497 1.523 . . . . 2.4300000000000002 114.797 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -63.11 146.8 52.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.524 1.162 . . . . 2.4199999999999999 109.771 166.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -106.11 153.28 22.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.585 1.154 . . . . 4.6699999999999999 110.025 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -98.2 -21.88 16.47 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.138 -0.458 . . . . 2.7400000000000002 111.974 155.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.81 161.87 36.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.588 1.329 . . . . 0.62 114.588 174.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.0 t -142.42 152.09 42.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.256 2.222 . . . . 1.3 109.798 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.26 133.82 4.28 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.794 1.188 . . . . 0.84999999999999998 111.666 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 67.7 t -92.11 132.03 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.167 0.987 . . . . 1.51 109.467 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -71.04 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.52 1.128 . . . . 1.02 110.129 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt . . . . . 0 C--O 1.239 0.524 0 O-C-N 121.221 -0.925 . . . . 3.5600000000000001 109.03 179.011 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.057 -0.72 . . . . 2.04 109.057 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.3 154.9 43.53 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.183 1.179 . . . . 1.0800000000000001 114.183 -148.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -153.31 135.82 15.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.178 1.466 . . . . 3.6699999999999999 111.699 161.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -89.43 111.27 22.11 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.368 1.867 . . . . 3.29 109.981 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.84 129.19 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 118.49 0.587 . . . . 1.1899999999999999 110.306 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.71 112.55 3.52 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.184 1.373 . . . . 0.83999999999999997 110.295 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.8 mtp -91.35 85.53 5.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.464 0.65 . . . . 1.6899999999999999 110.61 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -68.36 139.77 55.85 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.979 0.912 . . . . 2.7799999999999998 111.969 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.31 135.09 55.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.296 -0.631 . . . . 1.3400000000000001 109.296 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.1 156.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.689 1.196 . . . . 0.95999999999999996 110.378 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 t -169.52 48.04 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.027 0.931 . . . . 2.2200000000000002 112.058 -169.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.22 -17.38 0.27 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.303 1.841 . . . . 1.47 115.181 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.37 -4.37 59.14 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.111 1.364 . . . . 2.6499999999999999 112.035 171.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -159.11 14.91 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.8 1.667 . . . . 1.1200000000000001 112.331 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.6 t -67.17 128.2 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.577 1.551 . . . . 0.93000000000000005 111.07 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.49 -88.57 1.69 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.058 1.313 . . . . 1.4299999999999999 112.726 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.37 161.46 9.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.661 2.385 . . . . 2.8799999999999999 108.112 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 t -112.56 143.03 44.41 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.734 -1.229 . . . . 1.9099999999999999 114.128 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.481 HG22 ' HD2' ' A' ' 38' ' ' LYS . 39.6 mm -108.5 37.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.579 1.552 . . . . 5.3099999999999996 110.937 167.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.32 -154.15 25.3 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.661 -0.649 . . . . 1.1799999999999999 113.738 161.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.4 p -140.06 179.53 6.57 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.009 1.324 . . . . 0.98999999999999999 109.368 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.412 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 58.0 t -128.57 135.39 62.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.785 -1.191 . . . . 0.65000000000000002 107.785 160.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.8 p -88.39 127.27 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.348 0.405 . . . . 0.83999999999999997 110.697 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.12 134.4 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.737 0.815 . . . . 1.3400000000000001 109.013 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -138.46 134.83 34.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.716 1.606 . . . . 2.0099999999999998 108.45 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 157.87 18.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.935 1.087 . . . . 3.54 113.935 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 t -152.26 173.78 14.59 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.668 1.187 . . . . 1.3899999999999999 108.427 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.38 -13.13 62.01 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.286 -0.884 . . . . 4.7400000000000002 112.058 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.41 18.53 57.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.885 1.707 . . . . 1.3500000000000001 113.96 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 -143.02 21.17 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 127.692 2.568 . . . . 0.89000000000000001 116.882 166.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.67 103.35 14.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.761 0.824 . . . . 0.63 111.519 -162.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -80.38 110.61 15.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.183 1.793 . . . . 2.5099999999999998 110.286 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.412 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 5.7 t80 -99.52 119.63 38.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.649 2.779 . . . . 0.70999999999999996 109.188 -176.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 21.6 m -129.41 110.45 17.79 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 119.858 1.208 . . . . 0.57999999999999996 108.538 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -85.4 166.65 10.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.451 2.767 . . . . 0.46999999999999997 111.426 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -152.36 18.26 0.64 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.258 1.207 . . . . 1.8200000000000001 114.258 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.16 143.29 32.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.626 -1.296 . . . . 0.91000000000000003 111.324 -174.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HD2' HG22 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -109.44 12.26 24.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.298 1.592 . . . . 2.6299999999999999 115.298 -171.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.31 72.17 1.24 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.884 -1.053 . . . . 1.6499999999999999 112.101 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.05 162.97 49.37 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 124.02 0.928 . . . . 1.47 112.561 168.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 25.6 Cg_endo -62.77 126.9 19.17 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.167 1.245 . . . . 1.3600000000000001 111.243 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER -88.56 33.98 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 125.938 4.425 . . . . 1.22 113.285 -147.578 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.1 -133.09 6.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 123.48 1.6 . . . . 1.24 113.247 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -124.16 135.83 53.77 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.576 1.55 . . . . 2.7599999999999998 109.387 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.37 149.39 52.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.641 1.719 . . . . 1.47 115.641 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 138.7 49.26 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 110.19 -1.164 . . . . 0.70999999999999996 110.19 160.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.16 107.26 6.03 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 105.738 -1.949 . . . . 2.02 105.738 168.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -118.55 166.16 13.05 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.248 1.573 . . . . 1.6000000000000001 115.248 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.435 HG22 HD13 ' A' ' 74' ' ' LEU . 77.0 mt -96.17 139.87 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.565 1.946 . . . . 0.81000000000000005 109.026 162.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -137.68 152.51 49.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.795 2.438 . . . . 2.23 110.42 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.89 -10.87 59.45 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 117.633 2.457 . . . . 1.0800000000000001 117.633 -157.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -137.73 135.24 36.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.935 1.698 . . . . 1.1599999999999999 112.434 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 59.53 4.35 Favored Glycine 0 N--CA 1.471 0.982 0 C-N-CA 125.572 1.558 . . . . 1.05 114.119 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.68 116.37 4.14 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.787 1.294 . . . . 2.8599999999999999 114.073 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.3 m -89.7 9.38 27.31 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.822 2.049 . . . . 1.3 113.474 -175.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -68.92 129.25 92.44 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.641 1.577 . . . . 3.5 111.855 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -97.7 166.73 0.82 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.652 3.568 . . . . 1.3200000000000001 113.513 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.96 169.62 8.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 2.3300000000000001 111.91 162.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mm -119.68 117.71 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.19 1.396 . . . . 3.1299999999999999 109.747 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -152.75 157.42 40.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.173 1.389 . . . . 4.4800000000000004 111.466 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.29 27.41 9.81 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 115.788 1.773 . . . . 3.6200000000000001 115.788 156.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.21 20.12 65.42 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.865 -1.147 . . . . 3.25 115.023 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -160.76 -172.35 3.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.798 1.639 . . . . 2.6299999999999999 111.634 -169.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.22 139.82 35.7 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.9 -1.125 . . . . 1.5 110.533 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.97 43.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.574 1.15 . . . . 2.1600000000000001 112.431 -159.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.15 -65.97 0.06 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 129.007 2.923 . . . . 1.74 116.053 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 176.48 95.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 1 C-N-CA 132.267 4.227 . . . . 1.49 105.457 -175.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.85 -38.31 9.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.494 1.917 . . . . 4.7800000000000002 112.449 -158.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.76 31.73 0.09 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.324 1.449 . . . . 1.1899999999999999 114.26 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.13 -11.78 21.1 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.088 1.755 . . . . 1.6799999999999999 115.299 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 20.93 44.99 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.724 1.449 . . . . 3.7000000000000002 116.724 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.84 -99.94 1.81 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.231 1.516 . . . . 2.5 111.829 174.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -118.68 -117.79 0.32 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.445 1.898 . . . . 3.3999999999999999 106.981 164.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 49' ' ' ILE . 7.1 tt -174.41 92.73 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.011 2.125 . . . . 2.1600000000000001 107.794 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 173.26 146.7 0.2 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 127.917 2.487 . . . . 3.4199999999999999 111.826 -162.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.96 -38.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.258 2.639 . . . . 3.3399999999999999 113.877 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.23 26.0 0.2 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.876 1.216 . . . . 3.8100000000000001 113.736 -174.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.83 19.18 0.41 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.444 -1.41 . . . . 3.3599999999999999 114.541 -167.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.69 -30.22 0.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 128.825 2.85 . . . . 2.6800000000000002 114.17 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.18 -11.27 61.04 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.026 -1.43 . . . . 2.6699999999999999 115.83 167.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -61.21 -19.68 61.91 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.795 1.798 . . . . 4.4500000000000002 114.698 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.0 t60 98.9 167.0 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.758 2.823 . . . . 1.8 112.269 154.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -65.77 145.74 55.61 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.125 1.157 . . . . 5.1900000000000004 114.125 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.23 -155.42 7.64 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.127 1.822 . . . . 3.2400000000000002 112.15 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.78 -43.04 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.65 2.233 . . . . 4.0999999999999996 111.72 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.03 -3.32 9.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.618 1.567 . . . . 5.8799999999999999 112.869 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.29 167.07 22.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.871 1.7 . . . . 4.4500000000000002 114.553 -170.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -158.03 177.38 11.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.372 1.869 . . . . 7.8700000000000001 108.931 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.76 -20.81 0.02 OUTLIER Glycine 0 N--CA 1.465 0.594 0 CA-C-O 118.114 -1.381 . . . . 2.6000000000000001 115.946 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.964 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 7.0 p-80 -159.87 153.97 23.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.563 1.681 . . . . 5.2800000000000002 113.246 169.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.93 -18.89 63.4 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.236 -0.915 . . . . 2.3500000000000001 113.318 -175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -89.42 5.75 83.75 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.46 1.505 . . . . 1.0 114.587 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.964 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 12.8 m-20 -65.12 133.32 51.33 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 119.551 1.675 . . . . 2.3500000000000001 107.742 160.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.29 159.8 36.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.722 1.209 . . . . 1.9099999999999999 110.148 -153.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.21 154.18 56.76 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.558 2.839 . . . . 0.88 111.652 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 m -73.95 137.2 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 122.972 1.367 . . . . 1.4399999999999999 114.046 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.2 98.54 4.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.965 2.506 . . . . 1.8700000000000001 110.191 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.8 t -72.74 131.64 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.639 0.776 . . . . 0.93000000000000005 110.143 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.48 138.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.722 2.409 . . . . 1.8899999999999999 106.308 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 154.47 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.178 -0.951 . . . . 2.29 111.514 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -52.16 -12.31 0.23 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 116.987 2.217 . . . . 2.3399999999999999 116.987 -176.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.85 -21.58 26.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.13 2.172 . . . . 2.9399999999999999 113.098 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.62 9.52 23.03 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.327 1.441 . . . . 0.73999999999999999 115.251 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mt -116.35 135.91 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.104 1.362 . . . . 1.0900000000000001 110.207 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.22 128.41 54.69 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.919 0.888 . . . . 0.72999999999999998 110.801 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -145.37 14.12 1.42 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.512 1.301 . . . . 1.27 114.512 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -86.74 118.72 70.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.276 1.03 . . . . 2.9700000000000002 111.159 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.07 133.11 16.1 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.134 3.223 . . . . 1.3500000000000001 112.185 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.03 168.37 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 126.543 1.937 . . . . 1.55 110.5 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.7 m -140.63 143.57 35.27 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.704 1.138 . . . . 0.94999999999999996 112.052 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.46 99.36 51.16 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.978 1.311 . . . . 0.64000000000000001 113.123 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.53 18.59 0.94 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 125.201 3.934 . . . . 1.0700000000000001 114.873 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -73.05 -35.1 66.65 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.3 -0.875 . . . . 4.8200000000000003 111.634 171.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.35 165.12 11.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.287 2.235 . . . . 2.27 109.133 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.08 2.64 3.64 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.994 1.109 . . . . 4.1900000000000004 113.994 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.7 p -152.14 166.91 30.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.204 1.802 . . . . 2.0499999999999998 110.438 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.7 tp -85.42 -44.62 12.6 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.458 -0.776 . . . . 1.79 111.058 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.27 -23.81 62.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.212 1.405 . . . . 4.4500000000000002 113.853 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -12.32 60.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.842 1.053 . . . . 1.8100000000000001 113.842 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.93 15.86 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.931 1.292 . . . . 1.1499999999999999 113.29 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -51.15 -18.5 0.89 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 117.104 2.261 . . . . 2.75 117.104 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -121.92 11.47 10.34 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.586 1.955 . . . . 4.4100000000000001 113.595 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -102.73 169.87 8.35 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.324 1.231 . . . . 1.72 114.324 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.62 44.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.646 0.779 . . . . 0.93999999999999995 111.285 173.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.91 133.95 34.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.313 -1.736 . . . . 1.8300000000000001 106.313 156.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.12 131.16 34.4 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.539 1.063 . . . . 1.5800000000000001 112.171 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.93 114.35 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 107.074 -1.454 . . . . 0.93000000000000005 107.074 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -87.0 146.89 25.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.544 1.137 . . . . 2.6000000000000001 111.449 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.0 t -68.25 -37.61 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.193 0.597 . . . . 1.6899999999999999 110.474 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.39 -163.32 6.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.064 0.84 . . . . 2.0099999999999998 113.676 172.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.82 -146.32 10.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 127.466 2.46 . . . . 2.5899999999999999 109.298 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -157.11 149.54 23.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.702 0.801 . . . . 3.5600000000000001 110.967 161.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 56.3 t30 110.01 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 1 C-N-CA 131.703 4.001 . . . . 4.3200000000000003 109.453 -161.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.6 ptp -165.05 69.26 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 123.062 1.41 . . . . 3.8700000000000001 111.52 -162.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.6 p -97.76 0.09 46.27 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.253 2.221 . . . . 3.4100000000000001 115.357 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -164.05 63.95 0.15 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.753 -1.217 . . . . 3.3500000000000001 112.428 -163.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -130.31 149.78 74.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.072 1.349 . . . . 4.4000000000000004 108.466 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.19 -35.68 84.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.402 2.735 . . . . 2.04 112.437 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -94.56 113.76 61.81 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.717 -1.216 . . . . 6.9400000000000004 107.717 148.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.2 163.15 38.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.921 2.414 . . . . 3.9199999999999999 111.104 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt 60.71 28.47 18.19 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.733 0.813 . . . . 4.25 110.435 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.86 3.14 7.47 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.413 1.483 . . . . 2.6000000000000001 115.154 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.74 87.5 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 118.919 1.359 . . . . 2.29 114.052 -166.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.39 33.23 4.17 Favored Glycine 0 N--CA 1.474 1.189 0 C-N-CA 125.707 1.622 . . . . 1.8799999999999999 114.594 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.19 -4.42 90.49 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.052 1.786 . . . . 1.9099999999999999 115.039 -174.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 p -65.12 152.56 43.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.003 1.401 . . . . 2.27 110.752 165.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.35 132.48 54.08 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.486 1.114 . . . . 5.5300000000000002 109.103 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -74.65 -33.44 62.52 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.69 0.677 . . . . 2.5299999999999998 110.307 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.18 145.13 29.4 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.898 1.444 . . . . 0.78000000000000003 114.898 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.5 t -68.69 -174.02 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 129.165 2.986 . . . . 2.6099999999999999 111.548 164.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 164.54 62.06 0.02 OUTLIER Glycine 0 N--CA 1.465 0.626 0 C-N-CA 125.241 1.4 . . . . 0.73999999999999999 112.99 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.9 p -61.69 125.87 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.53 0.732 . . . . 2.48 110.844 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.32 132.09 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.728 0.811 . . . . 0.90000000000000002 108.816 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 CA--C 1.539 0.551 0 O-C-N 121.223 -0.923 . . . . 3.8399999999999999 110.831 176.988 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.994 -0.373 . . . . 2.2400000000000002 109.994 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -163.22 144.2 9.41 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.751 1.159 . . . . 1.3100000000000001 108.32 -169.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -149.0 130.25 14.6 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.978 1.37 . . . . 3.3999999999999999 111.118 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -80.99 106.99 13.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.842 1.657 . . . . 3.3100000000000001 109.407 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.19 122.09 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.605 0.639 . . . . 1.0900000000000001 111.025 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.613 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -72.91 104.91 1.63 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.059 1.79 . . . . 0.70999999999999996 111.954 170.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.6 mmm -88.8 132.93 34.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.412 1.485 . . . . 1.6699999999999999 111.359 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -106.53 145.42 31.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.642 1.177 . . . . 2.2799999999999998 110.934 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 mt -61.11 142.42 56.7 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.549 1.14 . . . . 1.0900000000000001 110.003 169.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.13 163.8 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.094 0.957 . . . . 1.3400000000000001 110.738 175.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t 177.29 69.52 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.253 2.221 . . . . 2.71 110.763 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 67.02 -29.89 0.15 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.372 2.269 . . . . 1.79 115.932 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -17.35 64.86 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.666 1.586 . . . . 3.3199999999999998 111.346 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.72 -160.53 17.18 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.368 1.937 . . . . 1.3100000000000001 111.35 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.23 128.89 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.552 1.141 . . . . 1.1499999999999999 109.74 169.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.81 -95.18 1.14 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 125.686 1.612 . . . . 1.5 113.26 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.58 166.18 34.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.217 1.407 . . . . 1.8100000000000001 110.8 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 t -93.13 151.32 19.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.421 1.488 . . . . 1.1000000000000001 114.341 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 15.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 127.192 2.197 . . . . 3.2200000000000002 113.587 -173.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.49 175.89 15.39 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.441 1.02 . . . . 0.65000000000000002 112.246 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.613 HG22 ' HA2' ' A' ' 6' ' ' GLY . 64.5 p -122.16 173.6 7.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.384 1.074 . . . . 0.92000000000000004 109.273 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.16 132.18 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.489 -1.301 . . . . 0.58999999999999997 107.489 162.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -86.35 124.84 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.774 0.321 . . . . 1.05 110.591 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.95 128.48 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.768 -1.197 . . . . 1.29 107.768 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -137.74 112.64 9.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.518 1.151 . . . . 2.3500000000000001 110.483 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -70.31 111.44 5.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.437 2.295 . . . . 3.2200000000000002 112.064 -167.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 159.73 15.35 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.084 -1.08 . . . . 2.5899999999999999 108.084 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.93 -19.34 64.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.471 0.708 . . . . 4.4800000000000004 111.868 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.83 30.8 9.66 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.012 1.768 . . . . 1.8100000000000001 113.959 165.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.37 -135.31 9.84 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 119.921 2.728 . . . . 2.04 119.921 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.38 113.27 21.15 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.955 1.302 . . . . 0.70999999999999996 110.147 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.77 109.42 15.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.164 0.986 . . . . 1.98 109.733 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t80 -92.05 121.08 33.27 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.19 1.796 . . . . 0.87 108.492 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.5 m -128.36 113.54 19.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 119.29 0.95 . . . . 1.0 108.694 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.15 157.12 13.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.491 2.794 . . . . 0.70999999999999996 110.98 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.27 40.86 0.42 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.561 1.172 . . . . 2.3599999999999999 111.613 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -101.39 140.46 35.66 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.48 1.512 . . . . 0.59999999999999998 112.314 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 31.37 6.74 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.394 1.628 . . . . 2.0600000000000001 115.394 -167.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.27 65.17 0.69 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.075 0.95 . . . . 1.3999999999999999 111.972 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.86 157.58 32.55 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 113.896 1.073 . . . . 1.3200000000000001 113.896 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.05 139.24 13.4 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 O-C-N 123.555 1.292 . . . . 1.52 112.083 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -77.97 31.14 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.867 1 C-N-CA 128.948 6.432 . . . . 1.8500000000000001 114.164 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.77 -135.96 6.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-O 123.58 1.655 . . . . 1.47 110.195 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -136.3 133.57 37.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.717 1.607 . . . . 2.8100000000000001 107.949 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -127.36 137.57 52.8 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.688 1.195 . . . . 0.97999999999999998 109.58 -169.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 156.15 49.21 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 119.664 1.12 . . . . 0.60999999999999999 111.743 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.6 t80 -129.42 118.87 22.87 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.322 -1.362 . . . . 1.8999999999999999 107.322 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -118.09 157.69 26.41 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.427 2.01 . . . . 0.91000000000000003 116.427 163.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -98.54 142.05 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.375 1.47 . . . . 0.71999999999999997 108.488 158.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -128.38 141.82 51.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.508 1.923 . . . . 0.93999999999999995 110.256 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.82 70.79 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.819 2.155 . . . . 0.75 116.819 -158.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -120.63 154.48 35.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.194 1.398 . . . . 1.28 111.746 171.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.43 84.17 1.58 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 120.844 -1.16 . . . . 0.81999999999999995 113.301 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 t -166.76 95.71 0.52 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.745 1.017 . . . . 2.2599999999999998 113.745 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 16.0 m -62.31 10.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.001 1.852 . . . . 1.48 116.001 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -87.6 129.33 51.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 119.953 -1.717 . . . . 3.3700000000000001 110.031 -166.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.1 155.14 33.35 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.387 2.058 . . . . 1.3400000000000001 110.618 166.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.24 145.32 51.45 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.684 -0.635 . . . . 1.6299999999999999 110.218 158.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 mm -96.75 123.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.968 1.307 . . . . 3.3799999999999999 108.561 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -169.47 157.82 7.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.244 1.418 . . . . 5.1799999999999997 111.775 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.78 27.34 14.62 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.251 1.021 . . . . 4.5199999999999996 112.317 167.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.11 84.64 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 126.381 1.943 . . . . 3.6800000000000002 114.914 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.59 -152.64 0.41 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.451 1.501 . . . . 3.9399999999999999 109.902 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.04 146.02 21.32 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.161 -0.962 . . . . 1.8799999999999999 113.042 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.69 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.563 1.545 . . . . 1.8899999999999999 113.16 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 67.81 -61.23 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 127.969 2.508 . . . . 2.0 116.584 168.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 166.35 99.83 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 C-N-CA 132.536 4.335 . . . . 1.8600000000000001 106.583 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -123.52 -45.97 2.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 3.6600000000000001 113.162 -157.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.07 -19.58 20.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.043 1.337 . . . . 1.48 113.391 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.13 -12.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.146 2.578 . . . . 0.82999999999999996 114.809 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.38 16.8 58.32 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.333 1.424 . . . . 3.21 115.022 163.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.17 -173.98 41.75 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.246 1.023 . . . . 1.21 112.339 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -63.49 141.29 58.82 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.737 -0.861 . . . . 2.27 109.937 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.31 111.8 3.18 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.129 -0.357 . . . . 1.6899999999999999 110.248 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.5 t0 169.7 126.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 128.762 2.825 . . . . 5.6600000000000001 111.645 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.04 -36.51 1.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.104 1.869 . . . . 2.3900000000000001 113.65 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -165.57 8.41 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.804 2.52 . . . . 4.4000000000000004 117.804 -156.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.99 -27.08 65.06 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.815 2.098 . . . . 4.8700000000000001 114.616 -170.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 165.89 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.967 3.307 . . . . 3.96 110.832 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.74 -18.51 38.6 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.863 1.221 . . . . 2.8399999999999999 114.63 169.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -69.87 -7.73 42.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.558 1.688 . . . . 7.3799999999999999 115.558 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.513 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 76.9 t60 68.56 157.13 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.825 2.45 . . . . 1.53 112.774 -172.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 84' ' ' GLY . 2.6 pp20? -140.41 -136.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.586 0.755 . . . . 4.4900000000000002 112.315 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.565 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 144.33 -46.02 0.83 Allowed Glycine 0 CA--C 1.538 1.518 0 C-N-CA 130.401 3.857 . . . . 4.0300000000000002 110.483 -172.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -108.02 -10.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.663 2.909 . . . . 4.0999999999999996 115.633 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -139.26 -3.19 1.57 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.453 2.019 . . . . 5.2400000000000002 116.453 -159.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.1 -31.04 1.57 Allowed Glycine 0 N--CA 1.472 1.09 0 O-C-N 120.45 -1.406 . . . . 4.7300000000000004 114.874 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -72.77 71.65 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.444 1.498 . . . . 5.1200000000000001 112.213 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.19 -91.61 0.09 OUTLIER Glycine 0 CA--C 1.523 0.579 0 C-N-CA 125.322 1.439 . . . . 2.1899999999999999 111.584 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -133.83 151.17 51.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.012 1.725 . . . . 3.6200000000000001 109.603 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.49 -28.71 68.79 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.219 0.918 . . . . 1.9199999999999999 113.169 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.15 16.37 55.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.863 1.697 . . . . 0.76000000000000001 115.357 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.513 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 89.1 m-20 -89.96 122.38 32.93 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.941 1.371 . . . . 2.21 109.867 168.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.478 HD12 ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -116.43 158.93 41.91 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.527 1.531 . . . . 1.77 109.795 -178.42 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.97 171.42 18.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.429 2.753 . . . . 1.6799999999999999 111.759 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.42 131.71 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.7 1.37 . . . . 1.3899999999999999 114.7 -163.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.65 94.52 0.59 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.221 2.608 . . . . 1.74 108.307 164.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.22 140.15 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.969 0.908 . . . . 0.93000000000000005 109.672 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.18 131.8 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.71 1.204 . . . . 1.77 108.866 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.0 140.04 40.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.763 0.792 . . . . 2.0699999999999998 111.793 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.23 60.46 0.43 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.715 2.006 . . . . 4.6299999999999999 113.509 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.51 6.93 0.29 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.432 2.293 . . . . 3.9199999999999999 112.314 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.53 3.94 43.46 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 126.297 1.904 . . . . 1.73 115.406 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.65 132.21 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.301 1.05 . . . . 1.73 110.291 -167.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 126.51 33.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.837 -0.539 . . . . 0.68000000000000005 110.089 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 t -141.39 -0.95 1.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.715 1.376 . . . . 1.0800000000000001 114.715 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -87.26 123.29 70.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.955 1.302 . . . . 3.1600000000000001 110.895 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.93 149.45 42.16 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.037 3.158 . . . . 1.6100000000000001 112.466 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.93 158.05 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.812 1.245 . . . . 1.4199999999999999 109.691 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.4 m -112.86 143.61 43.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.45 0.7 . . . . 1.3400000000000001 109.157 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -103.36 84.37 0.73 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.64 1.576 . . . . 0.91000000000000003 110.671 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.89 1.54 7.56 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.845 3.03 . . . . 1.6000000000000001 113.707 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.477 HH11 ' HG3' ' A' ' 113' ' ' ARG . 6.5 ttm-85 -76.92 -25.12 52.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.037 0.935 . . . . 5.29 112.404 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.09 178.86 4.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.691 1.996 . . . . 2.4300000000000002 109.607 165.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -16.81 2.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.552 1.316 . . . . 4.0199999999999996 114.552 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -154.84 166.55 33.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.103 1.32 . . . . 1.5700000000000001 112.734 -169.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.65 -29.44 16.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.866 0.866 . . . . 2.2999999999999998 111.244 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -28.98 70.14 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.86 -1.15 . . . . 3.3500000000000001 113.247 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.6 -17.47 63.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.471 0.708 . . . . 2.5800000000000001 112.89 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.73 13.91 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.485 0.92 . . . . 0.81999999999999995 113.485 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -59.68 -21.34 60.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.141 1.534 . . . . 2.6000000000000001 115.141 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -134.03 105.54 6.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.561 1.544 . . . . 3.5099999999999998 107.983 160.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -158.84 163.32 36.75 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.969 2.908 . . . . 1.53 109.329 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.62 158.45 16.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.493 0.663 . . . . 0.85999999999999999 110.676 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -130.69 117.0 18.81 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.295 2.238 . . . . 1.6899999999999999 106.876 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.8 mtt -117.67 122.01 42.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.731 0.696 . . . . 1.49 111.172 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.97 115.93 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.909 -1.515 . . . . 0.81000000000000005 106.909 166.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -98.58 151.12 21.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.298 1.839 . . . . 2.1699999999999999 112.267 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.3 m -63.17 -29.52 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 114.641 1.349 . . . . 2.6000000000000001 114.641 -160.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.17 168.28 24.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.457 1.503 . . . . 1.27 110.852 167.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.58 136.82 22.22 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.082 1.801 . . . . 1.49 114.08 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.02 114.84 29.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.801 1.64 . . . . 3.5499999999999998 109.932 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -167.47 36.18 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.177 0.991 . . . . 3.5299999999999998 112.514 -172.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.6 mtm -140.48 110.51 6.54 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.339 1.056 . . . . 2.3300000000000001 112.985 -165.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.7 m -93.08 156.78 16.66 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 2.77 111.971 168.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.06 32.45 2.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.061 2.144 . . . . 6.1399999999999997 116.12 165.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -115.86 146.51 37.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.113 1.365 . . . . 3.5299999999999998 110.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.1 17.77 0.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.54 3.493 . . . . 3.3500000000000001 114.069 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -98.53 113.38 64.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 121.107 -0.996 . . . . 7.5300000000000002 108.884 173.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.58 153.66 73.62 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.158 2.572 . . . . 5.0499999999999998 113.781 -156.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 tp 72.68 -1.14 3.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.66 1.984 . . . . 5.79 113.721 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' A' ' 82' ' ' HIS . . . 106.26 38.11 2.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.137 1.351 . . . . 6.3300000000000001 113.224 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.02 -41.15 2.95 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.22 1.391 . . . . 3.8700000000000001 113.556 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.07 -19.48 65.95 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 118.389 1.095 . . . . 3.1200000000000001 115.407 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 46.53 -110.69 0.55 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.65 1.595 . . . . 2.0 115.457 161.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 m -69.17 151.77 45.94 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.318 1.447 . . . . 2.6299999999999999 111.126 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.95 132.15 45.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.566 1.547 . . . . 4.71 108.238 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -83.11 -42.8 16.96 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 120.092 1.314 . . . . 2.9700000000000002 110.373 169.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.03 151.82 33.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.053 0.941 . . . . 0.55000000000000004 112.645 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.0 t -127.36 148.37 50.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.873 2.069 . . . . 1.3999999999999999 111.09 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -145.44 155.67 26.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.592 2.52 . . . . 1.23 111.701 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.46 1.104 . . . . 1.53 111.442 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.517 HD12 ' H ' ' A' ' 153' ' ' ILE . 3.4 mp -82.47 149.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.342 1.857 . . . . 1.3200000000000001 110.145 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.796 0 O-C-N 120.051 -1.655 . . . . 4.8399999999999999 110.938 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.244 0.068 . . . . 1.6599999999999999 110.948 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.5 148.16 22.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 1.24 109.201 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -151.15 127.2 10.44 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 123.191 1.472 . . . . 2.3799999999999999 110.943 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -105.19 97.36 7.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.019 1.728 . . . . 3.46 111.663 -167.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.52 131.17 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 115.17 1.544 . . . . 2.0299999999999998 115.17 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.6 103.01 1.19 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.499 1.047 . . . . 0.81999999999999995 110.79 167.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.5 mtp -85.34 131.16 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.503 0.721 . . . . 1.1599999999999999 110.406 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -110.7 145.38 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.115 1.366 . . . . 3.2000000000000002 113.108 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.4 mt -77.93 62.5 2.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.153 1.381 . . . . 1.7 111.673 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 m -55.07 130.79 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.246 1.418 . . . . 0.95999999999999996 112.02 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -158.63 72.18 0.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.007 1.484 . . . . 2.6400000000000001 115.007 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.51 -40.46 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.744 2.418 . . . . 1.49 113.767 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.96 6.46 4.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.552 1.541 . . . . 2.52 111.546 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.89 -159.14 31.24 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 126.079 1.8 . . . . 1.1599999999999999 112.769 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -42.11 126.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.405 1.482 . . . . 0.97999999999999998 110.725 159.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.27 -60.26 0.26 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.067 1.318 . . . . 1.97 114.429 -170.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -174.79 160.2 2.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.499 1.92 . . . . 2.75 110.738 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -152.69 148.64 27.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.163 1.542 . . . . 1.8600000000000001 115.163 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.62 56.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 130.149 3.38 . . . . 6.21 108.838 173.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.48 -177.94 39.92 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 113.226 -1.806 . . . . 0.64000000000000001 114.316 146.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.3 p -115.61 177.74 4.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.633 1.173 . . . . 0.77000000000000002 110.928 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.04 133.31 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.336 -0.987 . . . . 0.47999999999999998 108.336 156.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.3 p -87.49 119.49 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.65 0.593 . . . . 0.93999999999999995 110.337 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.15 117.73 47.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.191 -1.411 . . . . 1.3999999999999999 107.191 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -119.76 125.35 48.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.288 1.435 . . . . 2.3999999999999999 108.563 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.22 130.99 34.34 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.371 -0.603 . . . . 3.3399999999999999 109.371 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.6 t -148.86 -179.62 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.166 0.439 . . . . 1.29 110.378 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.22 -4.27 40.95 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.918 1.081 . . . . 3.71 113.918 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.3 9.57 67.28 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 124.159 0.885 . . . . 1.1799999999999999 114.18 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.1 -146.47 21.97 Favored Glycine 0 N--CA 1.463 0.448 0 C-N-CA 128.417 2.913 . . . . 0.93000000000000005 115.536 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.9 104.65 7.51 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.3 0.64 . . . . 0.87 111.107 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -84.6 115.18 22.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.791 2.036 . . . . 3.7999999999999998 109.988 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.26 104.65 14.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.776 1.63 . . . . 1.03 109.58 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.0 m -110.27 109.21 58.69 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.519 1.054 . . . . 0.75 108.346 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.1 159.36 18.0 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.586 2.858 . . . . 0.64000000000000001 111.127 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -146.41 27.23 1.14 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 121.418 0.628 . . . . 1.3400000000000001 112.479 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.85 140.86 30.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.805 -1.184 . . . . 0.68999999999999995 111.308 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 26.69 8.01 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.452 1.649 . . . . 2.21 115.452 -170.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.18 81.14 1.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.717 0.807 . . . . 1.55 110.933 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.72 163.36 41.29 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.839 1.256 . . . . 1.3500000000000001 110.407 168.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.29 128.97 24.02 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 121.006 1.137 . . . . 0.80000000000000004 110.619 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -79.8 25.23 0.6 Allowed 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 126.563 4.842 . . . . 0.93000000000000005 113.047 -162.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.6 -124.7 1.48 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 126.725 2.107 . . . . 1.3700000000000001 112.571 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -151.28 138.71 19.49 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.77 1.228 . . . . 2.8999999999999999 110.842 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -136.69 142.73 43.15 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.081 0.771 . . . . 1.1100000000000001 113.081 -163.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.07 153.77 51.63 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 111.28 -0.728 . . . . 0.77000000000000002 111.28 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -131.79 115.54 16.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.49 1.116 . . . . 1.98 108.161 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.424 ' HA ' HD22 ' A' ' 94' ' ' LEU . 16.9 m170 -115.97 165.67 12.85 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 117.121 2.267 . . . . 1.01 117.121 167.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.0 mt -108.05 148.34 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 128.414 2.686 . . . . 0.77000000000000002 108.045 154.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -126.16 163.39 23.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.94 1.296 . . . . 1.1699999999999999 110.425 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.4 75.91 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.586 1.699 . . . . 0.98999999999999999 115.586 -163.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.74 169.08 14.24 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.144 1.378 . . . . 1.8400000000000001 113.144 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.9 93.91 1.53 Allowed Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.005 1.288 . . . . 1.21 113.087 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -151.58 57.05 0.87 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.816 1.413 . . . . 3.6299999999999999 114.816 -165.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.6 m -64.72 37.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 116.505 2.039 . . . . 1.5 116.505 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -137.1 143.66 42.92 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 119.606 -1.934 . . . . 3.77 110.889 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.12 148.77 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.234 2.623 . . . . 1.02 113.432 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.3 137.1 40.92 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.489 -0.778 . . . . 1.3799999999999999 109.669 157.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.73 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.993 -1.114 . . . . 2.8199999999999998 107.993 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -147.21 133.66 19.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.15 0.98 . . . . 4.1500000000000004 111.042 -160.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.21 19.22 5.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.181 1.393 . . . . 3.7200000000000002 113.151 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.05 63.15 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.086 1.327 . . . . 2.71 115.313 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -137.27 -177.76 4.91 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.685 1.243 . . . . 3.0899999999999999 111.714 169.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.85 115.59 26.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.186 0.994 . . . . 1.6499999999999999 112.456 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -87.2 79.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.106 1.362 . . . . 1.77 110.47 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 19.89 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.33 3.452 . . . . 2.2999999999999998 117.991 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.44 41.64 0.88 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.557 1.943 . . . . 2.04 110.766 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -54.76 -37.19 65.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.144 -0.973 . . . . 4.0300000000000002 113.582 -169.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -4.48 17.98 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.54 1.311 . . . . 2.0600000000000001 114.54 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.1 -7.45 58.9 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.085 -1.009 . . . . 1.49 113.706 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 -179.35 32.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.807 -1.183 . . . . 2.0499999999999998 113.882 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.26 175.51 50.96 Favored Glycine 0 N--CA 1.474 1.222 0 N-CA-C 110.998 -0.841 . . . . 1.8999999999999999 110.998 161.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.44 36.06 0.19 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.608 1.204 . . . . 2.9399999999999999 113.561 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.5 tp 65.07 78.62 0.28 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.705 2.002 . . . . 1.79 112.349 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 90' ' ' HIS . 44.5 t0 -156.15 124.68 2.94 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 126.543 1.937 . . . . 5.6200000000000001 111.152 166.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.25 -22.52 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.216 2.611 . . . . 2.3599999999999999 113.838 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -145.7 -31.11 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.255 1.946 . . . . 4.6500000000000004 116.255 -157.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -60.63 -42.33 96.68 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 121.111 1.778 . . . . 4.5700000000000003 111.561 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 179.52 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.909 2.484 . . . . 2.1800000000000002 112.419 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 -15.91 4.18 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.541 -1.349 . . . . 2.3599999999999999 114.331 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -58.79 -82.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.614 1.965 . . . . 4.7800000000000002 113.39 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.68 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 81.1 t60 153.32 128.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 129.754 3.221 . . . . 1.4399999999999999 110.479 -174.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -130.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.365 1.066 . . . . 3.71 111.94 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.24 -51.1 0.85 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.498 1.999 . . . . 2.7799999999999998 111.761 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -104.14 -22.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.692 2.261 . . . . 3.1099999999999999 114.877 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -157.25 28.61 0.3 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.302 1.41 . . . . 5.2400000000000002 114.539 -160.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.05 -12.07 5.64 Favored Glycine 0 N--CA 1.477 1.43 0 O-C-N 119.662 -1.899 . . . . 3.9399999999999999 116.425 166.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.89 83.56 3.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.152 1.381 . . . . 4.4100000000000001 112.491 -170.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.51 116.02 4.16 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 124.424 1.012 . . . . 3.0899999999999999 112.806 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 22.1 m170 90.52 123.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.978 2.511 . . . . 3.1400000000000001 110.973 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.38 -12.51 24.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.005 0.522 . . . . 2.29 111.692 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.17 22.56 18.54 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.144 1.354 . . . . 1.05 113.985 165.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.68 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 79.3 m-20 -101.26 124.85 47.6 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.374 1.587 . . . . 2.6600000000000001 109.71 164.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -117.52 164.15 20.7 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.825 1.65 . . . . 1.8 109.316 -174.417 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.11 161.84 35.0 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.121 2.547 . . . . 1.0600000000000001 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.63 131.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 122.608 1.194 . . . . 1.6699999999999999 113.696 -165.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.85 86.25 4.09 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.439 2.696 . . . . 1.8200000000000001 108.814 176.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 142.55 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.583 0.753 . . . . 1.45 109.1 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -122.77 150.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.702 2.001 . . . . 1.74 107.832 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -94.39 150.88 19.85 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.762 0.652 . . . . 2.2799999999999998 112.762 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -42.77 -3.47 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 131.616 3.966 . . . . 3.52 118.518 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 -16.46 20.85 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 119.625 -1.922 . . . . 2.9399999999999999 112.507 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.9 27.49 7.01 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.718 1.628 . . . . 0.71999999999999997 112.796 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.2 mt -121.89 127.13 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.72 1.208 . . . . 1.6599999999999999 111.172 -171.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.84 123.95 29.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.932 0.893 . . . . 1.1699999999999999 108.926 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -139.0 -15.27 1.14 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.88 2.178 . . . . 2.6800000000000002 116.88 -167.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.48 127.91 74.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 121.413 1.915 . . . . 5.2699999999999996 112.812 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.14 85.69 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.258 3.305 . . . . 1.9099999999999999 110.06 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.01 122.16 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.826 0.851 . . . . 2.0800000000000001 110.045 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -120.03 126.93 52.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.529 0.732 . . . . 1.1399999999999999 110.54 -164.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.45 113.64 45.5 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.39 -0.814 . . . . 1.1899999999999999 112.626 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.79 8.59 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.96 3.107 . . . . 1.3100000000000001 113.447 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -71.78 -22.02 61.64 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.462 -0.774 . . . . 4.25 112.177 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.9 mt -139.52 160.16 40.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 130.155 3.382 . . . . 2.5699999999999998 106.532 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.414 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -148.26 10.23 0.87 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.948 2.203 . . . . 6.3799999999999999 116.948 -175.329 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 p -156.25 157.0 35.05 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.694 -0.629 . . . . 2.21 110.934 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.97 -24.15 52.31 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.015 -1.053 . . . . 1.47 112.653 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -54.31 -37.4 64.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.236 1.415 . . . . 3.8500000000000001 113.788 -176.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.19 -5.41 49.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.015 2.126 . . . . 1.6100000000000001 114.256 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 4.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.033 1.333 . . . . 1.75 113.135 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -66.07 7.08 0.32 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.832 2.16 . . . . 2.0299999999999998 116.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.31 14.0 3.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.386 2.274 . . . . 3.54 111.163 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.53 159.0 43.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.136 1.532 . . . . 1.2 115.136 -157.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.79 157.29 16.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.212 1.405 . . . . 0.62 112.828 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 mt -120.41 136.2 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.533 2.733 . . . . 1.5600000000000001 107.6 173.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -125.94 128.27 47.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.908 0.776 . . . . 2.1699999999999999 112.122 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.08 122.92 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.799 -1.186 . . . . 0.87 107.799 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -115.34 141.42 48.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.109 1.763 . . . . 2.0699999999999998 111.918 -160.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.81 -13.82 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 116.041 1.867 . . . . 2.5600000000000001 116.041 -156.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.36 160.32 25.47 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.309 -1.116 . . . . 1.0700000000000001 110.309 162.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.36 121.1 15.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.648 -1.381 . . . . 1.8500000000000001 109.648 163.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.63 1.28 14.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.984 0.914 . . . . 3.6699999999999999 112.945 -158.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -66.2 28.81 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 129.922 3.289 . . . . 3.46 115.867 -172.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.1 mtm -114.22 105.21 12.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.531 1.932 . . . . 2.9100000000000001 110.219 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 p -77.3 14.62 0.9 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.043 2.137 . . . . 3.0 113.952 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.72 4.73 0.77 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.787 1.773 . . . . 4.5599999999999996 115.787 -155.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -96.35 143.02 25.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.114 0.965 . . . . 4.54 110.328 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.2 -27.1 29.52 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.735 2.957 . . . . 3.0 113.192 -173.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -87.01 107.74 15.66 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.706 -1.22 . . . . 4.1299999999999999 107.706 148.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.95 175.08 7.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.791 2.327 . . . . 3.1899999999999999 110.925 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 61.16 34.97 18.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.161 0.984 . . . . 3.1600000000000001 109.175 -170.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.99 5.9 8.57 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.95 1.262 . . . . 3.2200000000000002 115.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.52 63.11 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-N 119.297 1.549 . . . . 2.3199999999999998 113.99 -165.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.15 16.29 59.44 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.967 2.223 . . . . 1.74 113.97 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.76 -6.02 62.24 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.311 1.434 . . . . 1.55 116.574 -170.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.3 m -66.98 162.53 21.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.369 1.585 . . . . 2.5699999999999998 110.401 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.84 139.0 31.11 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.405 2.282 . . . . 7.79 114.375 -177.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.82 -27.52 9.25 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 118.921 0.782 . . . . 2.7000000000000002 112.654 154.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -154.6 155.37 34.6 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.658 1.117 . . . . 0.56999999999999995 113.637 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.42 147.86 50.53 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.426 1.891 . . . . 1.5600000000000001 110.499 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.41 134.14 4.4 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.791 1.186 . . . . 0.72999999999999998 112.515 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.12 133.91 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.139 1.375 . . . . 1.77 109.009 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 mt -70.65 118.11 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 122.269 1.033 . . . . 0.97999999999999998 111.032 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 123.669 0.787 . . . . 7.5499999999999998 111.819 -177.715 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.253 -0.277 . . . . 2.9399999999999999 110.253 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -163.69 132.67 3.88 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.207 -1.558 . . . . 1.45 107.394 -163.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -144.79 120.88 10.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.123 1.44 . . . . 3.8199999999999998 113.409 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.11 74.3 6.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.839 1.655 . . . . 3.6200000000000001 110.824 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 t -70.59 122.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.286 -0.884 . . . . 1.23 111.881 -158.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.606 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -70.51 90.29 0.37 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 128.708 3.052 . . . . 1.0600000000000001 112.11 175.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 mtt -82.69 148.53 27.86 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.601 1.161 . . . . 1.4199999999999999 111.311 170.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -115.95 158.32 23.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.475 1.131 . . . . 2.4100000000000001 110.915 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.09 124.8 26.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.958 1.303 . . . . 1.0800000000000001 107.496 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.9 m -143.51 151.21 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.385 1.074 . . . . 1.1299999999999999 110.813 -174.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 t 171.27 121.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.044 2.538 . . . . 3.2799999999999998 110.387 163.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.59 -38.26 0.27 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.515 2.726 . . . . 1.3600000000000001 116.724 167.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -9.11 49.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.204 1.402 . . . . 2.9199999999999999 111.871 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.24 -156.19 19.95 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 125.277 1.418 . . . . 0.93999999999999995 113.385 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 10' ' ' VAL . 90.2 t -63.92 110.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.209 1.403 . . . . 0.79000000000000004 110.301 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.67 -86.06 1.16 Allowed Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.226 1.393 . . . . 1.46 112.255 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.24 164.56 37.86 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.382 1.473 . . . . 1.6499999999999999 109.392 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -104.52 170.32 7.96 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.363 1.065 . . . . 1.1399999999999999 113.339 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 pt -151.77 8.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 127.636 2.374 . . . . 2.77 112.372 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.14 173.02 20.68 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.011 0.815 . . . . 0.65000000000000002 113.809 -166.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.606 HG22 ' HA2' ' A' ' 6' ' ' GLY . 77.1 p -131.44 173.97 10.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.558 1.943 . . . . 1.1499999999999999 108.472 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.37 129.78 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 107.906 -1.146 . . . . 0.58999999999999997 107.906 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -78.38 109.95 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.612 0.642 . . . . 1.01 109.788 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 24' ' ' ILE . 34.1 mt -89.79 125.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.539 -1.282 . . . . 1.1399999999999999 107.539 160.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.504 0.668 . . . . 2.3700000000000001 110.312 166.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.29 130.7 37.54 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.084 1.754 . . . . 3.5299999999999998 109.539 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -149.21 -179.77 7.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.039 0.447 . . . . 1.6399999999999999 110.272 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.06 -29.6 69.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.809 1.244 . . . . 3.5299999999999998 111.751 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.28 66.16 Favored Glycine 0 N--CA 1.471 1.009 0 C-N-CA 124.696 1.141 . . . . 1.3999999999999999 114.885 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 -140.31 18.37 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 127.685 2.564 . . . . 1.1299999999999999 114.734 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.28 93.79 7.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.201 1.0 . . . . 0.70999999999999996 110.15 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.4 tttp -76.19 108.78 9.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.364 1.466 . . . . 2.2999999999999998 108.869 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.1 t80 -97.78 110.37 22.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.024 2.53 . . . . 0.51000000000000001 109.309 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 5.6 m -124.19 115.09 27.53 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.889 1.222 . . . . 0.71999999999999997 109.635 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.25 155.96 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.12 2.546 . . . . 0.48999999999999999 111.42 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -149.93 54.12 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.566 1.174 . . . . 1.8 111.007 166.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -107.24 134.56 50.15 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.921 1.288 . . . . 0.72999999999999998 111.232 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -109.25 21.15 17.48 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.265 1.95 . . . . 2.25 116.265 -160.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.96 65.51 0.19 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.128 0.971 . . . . 1.3500000000000001 113.567 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.53 161.28 49.07 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 124.519 1.128 . . . . 1.49 111.968 174.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.03 128.72 21.28 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.675 1.583 . . . . 0.90000000000000002 109.904 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 5.0 Cg_endo -85.74 41.75 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 1 C-N-CA 126.345 4.696 . . . . 1.03 112.553 -157.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.79 -132.83 7.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.974 1.749 . . . . 1.45 113.37 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -139.32 134.96 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.95 1.7 . . . . 2.8599999999999999 110.065 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -137.13 118.79 14.98 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.163 0.985 . . . . 1.0600000000000001 111.754 -165.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.05 130.04 36.12 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.158 -1.177 . . . . 1.0900000000000001 110.158 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -108.87 124.4 50.58 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.962 -1.496 . . . . 2.0 106.962 175.514 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -123.41 171.52 9.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.924 1.453 . . . . 1.0900000000000001 114.924 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mt -108.79 137.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.342 1.457 . . . . 0.68999999999999995 109.297 158.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -109.62 175.32 5.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.074 1.75 . . . . 1.21 113.156 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.87 67.27 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.414 1.635 . . . . 1.28 115.414 -164.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -116.95 -167.18 1.26 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.082 1.353 . . . . 1.2 111.152 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.46 86.39 0.18 Allowed Glycine 0 N--CA 1.472 1.05 0 O-C-N 120.794 -1.191 . . . . 0.93999999999999995 114.117 -173.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -177.98 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.746 2.018 . . . . 2.27 110.452 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.04 35.31 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.745 2.418 . . . . 1.27 116.632 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -115.13 134.19 22.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 120.207 -1.558 . . . . 3.9500000000000002 111.91 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -86.75 156.24 8.87 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.211 3.274 . . . . 1.3400000000000001 112.861 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.78 139.4 30.58 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.131 -0.94 . . . . 2.04 109.676 156.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mm -86.11 115.96 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.749 -1.204 . . . . 2.6699999999999999 107.749 167.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -171.34 135.75 0.97 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.052 1.341 . . . . 5.2699999999999996 109.469 -149.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 t70 52.27 41.49 30.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.648 1.579 . . . . 4.1399999999999997 114.488 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.55 79.4 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.059 -1.026 . . . . 2.9199999999999999 114.578 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -152.34 -164.94 2.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.526 1.531 . . . . 3.1899999999999999 110.074 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.28 122.31 40.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.191 -0.943 . . . . 1.75 110.857 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.7 t -79.4 79.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.254 -0.647 . . . . 2.6400000000000001 109.254 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 12.19 -68.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 131.298 3.839 . . . . 2.04 117.677 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.04 74.92 1.0 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.752 1.621 . . . . 2.2400000000000002 109.81 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.51 -37.52 75.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.649 0.78 . . . . 4.9100000000000001 112.17 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.21 -3.52 52.58 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.251 1.204 . . . . 1.55 114.251 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.92 18.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.53 1.132 . . . . 1.1399999999999999 112.601 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.09 -177.87 50.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.266 1.266 . . . . 2.6400000000000001 116.266 162.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.42 -166.02 14.36 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.73 1.157 . . . . 1.1899999999999999 113.288 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -59.69 145.45 44.84 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 109.189 -0.671 . . . . 3.0699999999999998 109.189 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.5 tp -74.97 87.53 2.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.976 -1.077 . . . . 1.6699999999999999 110.783 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.64 110.11 0.96 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.449 1.5 . . . . 3.3199999999999998 112.632 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.46 -50.84 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.024 2.483 . . . . 2.3300000000000001 110.998 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -127.52 126.58 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.029 1.332 . . . . 3.3100000000000001 109.921 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.356 12.2 p30 162.52 -108.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.887 3.675 . . . . 3.7400000000000002 110.768 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -155.0 -40.35 0.09 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.485 1.514 . . . . 2.8599999999999999 112.609 -167.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.43 -49.59 4.21 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.079 0.847 . . . . 3.7400000000000002 114.658 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 20.7 ptmt -49.68 -51.33 39.08 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.446 1.647 . . . . 4.7300000000000004 115.446 -151.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.448 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 161.26 136.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 129.42 3.088 . . . . 2.1600000000000001 113.022 157.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.27 -57.52 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.199 1.185 . . . . 4.1699999999999999 114.199 -163.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.34 -108.91 0.19 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.019 1.771 . . . . 3.3199999999999998 114.901 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.23 -33.43 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.502 2.135 . . . . 4.5199999999999996 113.462 -174.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -137.35 2.79 2.53 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.249 1.574 . . . . 6.29 115.249 -161.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.64 58.4 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.131 -1.606 . . . . 3.0 116.455 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -77.63 63.86 2.82 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.14 1.47 . . . . 6.2999999999999998 112.345 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.47 -144.55 4.86 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 116.645 1.418 . . . . 2.1499999999999999 116.645 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.948 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 14.2 p-80 -145.93 156.3 43.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.994 1.318 . . . . 4.8700000000000001 112.278 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.18 -22.47 64.76 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.644 1.35 . . . . 2.0499999999999998 114.644 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.47 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -96.13 4.66 65.25 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.595 2.045 . . . . 0.82999999999999996 114.957 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.948 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 8.6 m-20 -62.23 143.16 57.19 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.256 1.528 . . . . 2.3399999999999999 107.255 153.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.4 -174.58 0.43 Allowed Pre-proline 0 CA--C 1.56 1.352 0 O-C-N 120.844 -1.16 . . . . 1.8700000000000001 109.893 -155.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.99 169.94 14.23 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.632 2.222 . . . . 1.0700000000000001 112.722 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.94 126.99 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.878 0.871 . . . . 1.8400000000000001 110.975 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 81.8 1.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.869 2.068 . . . . 1.8500000000000001 108.552 164.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.97 142.17 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.128 -1.064 . . . . 1.0900000000000001 108.128 168.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.65 138.31 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.254 1.422 . . . . 1.7 109.475 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 142.53 56.74 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 112.827 0.676 . . . . 1.74 112.827 174.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -50.07 -17.91 0.48 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.881 2.472 . . . . 2.1499999999999999 117.542 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -93.77 -12.4 29.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.245 1.418 . . . . 2.75 113.266 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 21.63 16.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.228 0.918 . . . . 0.79000000000000004 114.847 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.27 125.53 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.418 -1.327 . . . . 1.23 107.418 169.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.5 125.96 34.11 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.492 -0.559 . . . . 0.65000000000000002 109.492 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -139.97 -6.51 1.26 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.193 2.197 . . . . 0.98999999999999999 112.953 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -73.22 113.83 25.65 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 128.0 2.52 . . . . 5.1299999999999999 111.827 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.01 142.94 28.43 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.333 2.689 . . . . 1.1799999999999999 111.907 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.84 168.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.469 1.508 . . . . 1.1200000000000001 109.574 167.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -140.74 141.02 34.93 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 119.242 0.928 . . . . 0.76000000000000001 110.459 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.95 95.15 16.39 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.374 1.07 . . . . 0.81000000000000005 111.122 172.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.25 6.49 4.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.568 3.512 . . . . 1.5600000000000001 114.431 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -85.92 -5.17 59.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.33 1.052 . . . . 4.1299999999999999 112.026 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.75 160.81 25.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.452 2.701 . . . . 2.3300000000000001 107.345 169.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.75 -7.21 1.1 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.008 1.485 . . . . 4.54 115.008 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.8 m -133.81 130.27 37.71 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.099 0.96 . . . . 2.0299999999999998 110.413 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -26.24 66.84 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.753 -1.217 . . . . 2.3700000000000001 111.019 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.74 -19.27 5.95 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.907 1.447 . . . . 3.5099999999999998 114.907 165.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.35 -13.55 60.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.94 1.246 . . . . 2.0899999999999999 112.067 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.42 2.34 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 114.263 1.209 . . . . 1.1100000000000001 114.263 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -62.54 8.72 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 118.057 2.614 . . . . 2.5600000000000001 118.057 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.72 17.64 1.28 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.219 1.408 . . . . 3.23 112.193 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -144.24 169.74 17.32 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.758 1.623 . . . . 1.6799999999999999 112.212 -168.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.98 139.55 35.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.784 1.234 . . . . 0.68999999999999995 113.439 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.3 mt -80.39 146.8 31.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.831 1.652 . . . . 1.98 108.359 158.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.02 126.89 22.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.03 0.832 . . . . 1.4199999999999999 111.686 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.4 mt -88.62 111.55 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.374 -1.343 . . . . 0.75 107.374 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.9 150.29 21.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.194 2.198 . . . . 2.5899999999999999 111.933 -175.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.29 -46.98 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.261 -0.899 . . . . 1.9199999999999999 111.363 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.28 139.62 16.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.491 0.587 . . . . 1.76 112.996 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.06 143.21 41.0 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.592 2.044 . . . . 1.96 113.348 170.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -80.3 97.01 6.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.694 1.198 . . . . 3.4199999999999999 111.037 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -177.68 -36.78 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.566 2.746 . . . . 4.4500000000000002 109.73 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.9 mtm -61.46 130.48 46.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.95 -1.094 . . . . 2.3500000000000001 112.964 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 t -157.77 -169.36 2.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.239 1.816 . . . . 3.0899999999999999 109.803 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 64.73 -35.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 129.598 3.159 . . . . 3.7799999999999998 116.405 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 155.64 14.32 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 127.029 2.132 . . . . 4.5599999999999996 110.771 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.06 -6.18 18.64 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.711 2.941 . . . . 2.1800000000000002 114.135 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -122.29 138.57 29.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.196 0.907 . . . . 3.98 110.359 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.69 144.37 77.85 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.298 2.666 . . . . 3.5899999999999999 111.167 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.84 29.31 15.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.85 1.26 . . . . 5.9299999999999997 111.357 -171.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.65 0.94 57.04 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.891 1.234 . . . . 3.0899999999999999 114.276 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.46 -13.2 15.77 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.432 1.491 . . . . 1.74 112.848 -162.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 28.98 0.7 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.247 1.879 . . . . 1.4199999999999999 114.455 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.31 -20.0 77.89 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.751 1.643 . . . . 1.6499999999999999 113.089 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.5 p -60.94 155.39 19.99 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.613 1.565 . . . . 1.7 111.754 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mmt-85 -111.55 159.69 17.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.366 1.466 . . . . 4.6200000000000001 111.214 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -107.27 -29.49 9.28 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.666 0.617 . . . . 2.5299999999999998 112.666 152.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.48 38.3 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.141 -0.975 . . . . 0.66000000000000003 113.571 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 50.4 t -135.36 151.59 50.63 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.272 2.229 . . . . 1.6299999999999999 108.947 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -155.1 123.87 1.42 Allowed Glycine 0 N--CA 1.468 0.782 0 C-N-CA 123.966 0.793 . . . . 0.69999999999999996 113.096 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.9 127.87 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.039 1.335 . . . . 1.7 109.492 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mt -79.14 125.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.257 1.027 . . . . 0.85999999999999999 110.983 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt . . . . . 0 C--O 1.238 0.489 0 C-N-CA 127.212 2.205 . . . . 3.8500000000000001 109.417 173.665 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.745 -0.465 . . . . 2.3900000000000001 109.745 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -153.28 136.12 15.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.155 -1.054 . . . . 1.28 108.155 -162.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.67 129.88 8.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.517 1.151 . . . . 2.6400000000000001 112.836 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -88.2 94.79 9.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.751 1.22 . . . . 3.98 109.393 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.52 123.84 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.833 -0.542 . . . . 1.0600000000000001 110.224 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.12 107.47 2.2 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.518 1.532 . . . . 0.80000000000000004 110.835 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 13.9 mmt -81.62 101.04 9.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.8 1.24 . . . . 1.3799999999999999 110.65 172.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.66 137.79 36.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.411 -0.959 . . . . 2.6600000000000001 108.411 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.07 138.88 58.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.422 -0.955 . . . . 1.3799999999999999 108.422 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -136.36 163.48 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.829 0.852 . . . . 1.1499999999999999 112.328 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -167.78 -148.2 0.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.677 1.991 . . . . 2.8500000000000001 108.404 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.96 17.38 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.941 3.697 . . . . 1.5800000000000001 115.686 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.84 -6.02 5.07 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.007 -1.683 . . . . 3.8999999999999999 111.739 171.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.14 -141.72 31.85 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.224 -1.551 . . . . 2.1400000000000001 109.224 -158.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -39.22 113.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.752 1.621 . . . . 1.6499999999999999 112.531 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.52 -77.05 1.16 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.16 1.838 . . . . 1.45 112.335 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.67 153.77 25.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.492 0.717 . . . . 1.72 112.351 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -97.2 132.96 42.45 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.531 1.308 . . . . 1.0600000000000001 114.531 -170.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mm -122.19 -17.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.606 1.562 . . . . 4.54 115.212 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.53 28.81 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 121.055 -1.028 . . . . 0.72999999999999998 113.306 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -95.52 176.45 6.17 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.162 -0.681 . . . . 0.77000000000000002 109.162 164.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 33' ' ' PHE . 23.2 t -135.49 129.99 49.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.001 -1.481 . . . . 0.48999999999999999 107.001 160.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -97.57 119.25 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.307 0.575 . . . . 0.84999999999999998 111.674 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.27 135.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.728 1.211 . . . . 1.46 108.837 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -139.25 100.8 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.819 1.648 . . . . 2.5 108.791 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.7 132.9 38.38 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 128.039 2.536 . . . . 3.1699999999999999 109.709 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -154.63 -168.89 3.05 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.475 0.31 . . . . 1.21 111.662 -166.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -57.36 -31.92 66.23 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.948 1.299 . . . . 5.1200000000000001 113.34 -176.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.5 22.84 38.13 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.856 1.693 . . . . 0.98999999999999999 114.386 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.14 -144.82 23.96 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.686 1.136 . . . . 0.73999999999999999 114.355 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.3 mt -80.36 104.38 10.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.836 0.854 . . . . 0.64000000000000001 111.924 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -83.2 111.81 19.27 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.373 -0.829 . . . . 1.8700000000000001 110.696 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 22' ' ' VAL . 0.8 OUTLIER -97.52 125.51 42.27 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.105 1.762 . . . . 0.91000000000000003 110.151 -177.24 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 m -127.84 110.82 20.38 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 117.993 -1.003 . . . . 0.63 109.458 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -91.85 158.16 3.4 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.461 2.774 . . . . 0.51000000000000001 112.542 -169.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -148.23 36.47 0.83 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 121.741 0.781 . . . . 1.4299999999999999 112.485 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -92.67 160.49 14.97 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.709 -1.869 . . . . 0.80000000000000004 113.001 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 18.38 1.87 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.486 2.402 . . . . 2.3199999999999998 117.486 -167.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.58 70.89 0.61 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.002 0.921 . . . . 1.3100000000000001 110.198 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.714 HD12 HG11 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -124.18 168.56 12.57 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.187 0.995 . . . . 1.73 109.325 170.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -52.8 137.17 60.29 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.987 1.792 . . . . 1.1799999999999999 110.825 159.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -89.57 26.42 0.54 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.85 2.367 . . . . 1.4099999999999999 114.243 -151.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.53 -149.23 8.64 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 123.387 1.548 . . . . 1.3400000000000001 115.677 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.38 139.97 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.268 2.227 . . . . 3.2599999999999998 111.511 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -131.47 131.63 43.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.522 0.729 . . . . 1.3300000000000001 110.911 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.38 152.76 47.01 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-N 118.782 0.719 . . . . 0.73999999999999999 111.646 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.417 ' CE1' ' CE2' ' A' ' 33' ' ' PHE . 5.2 t80 -128.36 108.92 10.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.054 -1.462 . . . . 1.8799999999999999 107.054 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -112.43 165.57 12.09 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.829 1.418 . . . . 0.70999999999999996 114.829 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.69 138.08 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.997 1.719 . . . . 1.1899999999999999 108.251 158.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -118.31 155.01 31.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.258 1.823 . . . . 0.95999999999999996 108.985 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.11 73.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.625 1.713 . . . . 0.77000000000000002 115.625 -157.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -132.21 163.63 28.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.283 1.033 . . . . 1.3700000000000001 112.816 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.47 84.58 1.16 Allowed Glycine 0 N--CA 1.469 0.85 0 O-C-N 120.822 -1.174 . . . . 0.94999999999999996 113.55 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -160.11 89.58 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.152 0.977 . . . . 2.3100000000000001 113.127 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.7 m -67.53 48.72 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.136 2.574 . . . . 1.45 113.759 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -131.61 139.79 36.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.215 1.406 . . . . 3.3500000000000001 112.663 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.38 166.19 4.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.887 3.058 . . . . 0.89000000000000001 112.848 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.67 144.32 42.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.073 0.949 . . . . 1.5 110.098 164.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.4 59.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.224 1.01 . . . . 3.0099999999999998 109.742 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 152.65 42.8 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.774 -0.579 . . . . 4.25 110.226 165.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t0 54.75 18.91 2.3 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.916 1.686 . . . . 3.75 114.131 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.18 77.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.075 1.321 . . . . 2.9199999999999999 114.644 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.23 146.43 40.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.702 1.251 . . . . 3.3500000000000001 111.18 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.64 18.57 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.899 -1.125 . . . . 1.7 113.383 -165.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.08 92.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.545 1.138 . . . . 1.9399999999999999 109.645 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -24.95 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 130.193 3.397 . . . . 2.02 118.61 -166.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.501 ' HB3' HH21 ' A' ' 147' ' ' ARG . . . -151.21 124.01 8.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.861 0.755 . . . . 1.8999999999999999 109.905 158.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.61 -48.7 4.24 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.846 0.858 . . . . 4.2400000000000002 110.252 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.28 -14.96 59.09 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.59 1.33 . . . . 1.3300000000000001 114.59 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.09 -7.9 10.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.931 1.292 . . . . 0.90000000000000002 114.227 169.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.3 -28.09 11.81 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 120.58 -1.325 . . . . 3.1800000000000002 115.046 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.4 -170.93 20.82 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.396 1.474 . . . . 1.3799999999999999 111.774 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -60.85 148.69 38.52 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.077 0.938 . . . . 3.0299999999999998 110.149 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.5 tp -78.06 73.08 4.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.758 1.223 . . . . 1.97 111.919 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.48 104.15 28.49 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.65 1.18 . . . . 3.8300000000000001 110.606 158.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.5 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.236 2.624 . . . . 1.98 110.96 159.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -166.39 3.22 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.617 1.34 . . . . 4.2599999999999998 114.617 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -68.45 -27.3 66.05 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.311 -1.493 . . . . 3.96 114.27 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 81' ' ' LYS . 18.9 m 114.47 139.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 1 C-N-CA 132.05 4.14 . . . . 4.8300000000000001 107.138 -161.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.16 -12.97 56.93 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.093 1.33 . . . . 2.1000000000000001 114.42 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.427 ' H ' HG22 ' A' ' 79' ' ' THR . 52.3 mttp -64.15 -6.0 5.84 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.441 2.015 . . . . 5.3899999999999997 116.441 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.2 t60 83.22 144.8 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.207 2.203 . . . . 1.6799999999999999 114.571 166.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -81.92 150.14 27.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.238 1.815 . . . . 3.6099999999999999 110.982 -173.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.04 -112.95 0.39 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.659 -1.079 . . . . 2.4700000000000002 114.619 171.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.63 -18.95 25.0 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.329 2.686 . . . . 3.3900000000000001 112.453 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -123.11 155.96 35.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.89 2.076 . . . . 4.9299999999999997 107.424 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.53 120.23 6.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.838 0.732 . . . . 3.0 111.61 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.69 21.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.107 2.163 . . . . 4.4400000000000004 113.496 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.18 -151.8 13.33 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 123.208 1.449 . . . . 3.0699999999999998 115.177 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -74.87 139.95 43.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.041 -1.079 . . . . 3.2400000000000002 111.352 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -62.5 -21.65 65.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.342 0.497 . . . . 2.3599999999999999 112.342 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.94 26.32 6.15 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.669 1.604 . . . . 1.04 115.425 172.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -111.17 131.68 54.91 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.778 1.789 . . . . 1.5 110.566 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.26 160.81 60.61 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.703 1.601 . . . . 2.2000000000000002 110.452 -163.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.49 159.69 32.28 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.607 2.871 . . . . 0.90000000000000002 112.526 -170.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 m -69.55 132.08 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 123.251 1.5 . . . . 1.6200000000000001 114.81 -163.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.97 75.11 4.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.5 3.12 . . . . 1.6799999999999999 109.072 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.06 136.09 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.046 -1.034 . . . . 1.0900000000000001 111.398 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 40' ' ' LEU . 3.3 m -114.17 162.92 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.094 0.958 . . . . 2.0600000000000001 110.151 161.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -88.96 171.0 10.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.101 0.56 . . . . 2.6000000000000001 112.255 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -16.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 128.003 2.521 . . . . 2.9100000000000001 117.804 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -96.66 -7.39 34.26 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.052 2.141 . . . . 2.8999999999999999 113.381 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.46 21.0 30.51 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 119.135 0.879 . . . . 1.0600000000000001 114.755 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.25 129.09 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.428 1.114 . . . . 1.54 111.961 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.686 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -99.42 126.85 45.39 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.29 2.236 . . . . 0.80000000000000004 111.159 -172.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -157.19 18.2 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.962 1.097 . . . . 1.25 113.962 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -89.35 113.34 56.07 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.47 1.108 . . . . 3.2799999999999998 109.372 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.54 138.91 19.92 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.191 3.261 . . . . 1.0700000000000001 111.365 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.84 167.41 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.454 1.101 . . . . 1.1599999999999999 111.464 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -136.5 134.09 37.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.256 1.022 . . . . 0.89000000000000001 110.59 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.22 93.49 39.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.315 1.046 . . . . 0.71999999999999997 112.674 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -77.65 94.77 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.361 2.707 . . . . 3.1800000000000002 108.452 160.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -50.7 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.967 1.707 . . . . 5.2000000000000002 109.11 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.12 162.57 25.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.078 1.351 . . . . 2.29 108.103 141.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -121.22 -24.67 5.43 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.219 1.192 . . . . 4.4900000000000002 114.219 162.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 m -124.16 150.43 45.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.607 1.094 . . . . 2.3700000000000001 113.922 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -37.2 86.57 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.208 -0.932 . . . . 2.2999999999999998 110.842 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.93 -16.92 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.231 1.567 . . . . 3.8900000000000001 115.231 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -83.53 -6.87 59.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 2.1699999999999999 112.313 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.05 11.92 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.522 1.129 . . . . 0.80000000000000004 113.417 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -65.66 13.25 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 117.756 2.502 . . . . 2.79 117.756 -172.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.73 23.14 0.69 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.423 1.889 . . . . 3.1299999999999999 112.018 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -121.02 174.87 6.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.292 1.219 . . . . 1.24 114.292 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.28 140.48 44.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.722 1.209 . . . . 0.54000000000000004 111.249 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.87 141.42 28.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 1.78 107.056 161.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.4 mtt -133.34 131.51 40.2 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.408 1.004 . . . . 1.23 112.173 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.3 110.37 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.64 1.176 . . . . 0.66000000000000003 108.298 170.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.83 142.99 29.36 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.876 2.071 . . . . 2.3500000000000001 111.737 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -58.95 -38.51 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 112.974 0.731 . . . . 1.54 112.974 -164.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.17 169.92 14.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.722 1.153 . . . . 1.5600000000000001 111.473 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.26 166.78 24.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.458 1.028 . . . . 1.8500000000000001 112.559 161.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.6 6.18 1.84 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.217 1.192 . . . . 2.7799999999999998 114.217 -134.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.005 2.122 . . . . 3.9900000000000002 114.759 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.5 mtm -138.71 63.44 1.52 Allowed 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.402 -1.436 . . . . 2.5099999999999998 113.375 -161.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -64.69 -34.28 77.94 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.337 1.236 . . . . 3.0899999999999999 114.337 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.38 67.34 9.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.965 1.098 . . . . 3.7999999999999998 113.965 -162.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.61 154.81 25.97 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.703 1.601 . . . . 3.23 110.989 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.37 -23.15 38.49 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.466 2.777 . . . . 2.7000000000000002 112.426 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.98 90.22 1.49 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.002 -1.11 . . . . 3.9100000000000001 108.002 154.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.0 169.28 18.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.077 2.518 . . . . 3.8500000000000001 111.445 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt 70.47 16.52 7.04 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.381 1.872 . . . . 3.8100000000000001 110.602 -167.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 3.48 24.38 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.208 1.385 . . . . 2.8399999999999999 113.839 -164.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.79 -1.34 52.23 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.785 1.659 . . . . 1.8899999999999999 114.036 -165.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.3 43.41 1.28 Allowed Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.53 2.014 . . . . 1.6599999999999999 115.239 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.58 -16.93 77.7 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.835 1.207 . . . . 1.8300000000000001 115.055 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 p -76.52 146.71 38.25 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.532 1.533 . . . . 1.47 112.742 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.501 HH21 ' HB3' ' A' ' 67' ' ' ALA . 1.1 mpp_? -105.23 138.98 40.57 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.83 1.652 . . . . 4.4400000000000004 110.39 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -91.55 -28.82 17.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.625 0.37 . . . . 2.6400000000000001 111.266 164.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.72 159.68 44.15 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.608 0.966 . . . . 0.48999999999999999 113.608 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 32.7 t -140.92 146.7 37.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.965 2.106 . . . . 1.4099999999999999 110.316 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -141.98 100.44 0.26 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.079 1.799 . . . . 0.72999999999999998 111.633 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.75 135.86 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.013 1.325 . . . . 2.3500000000000001 111.729 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.56 150.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.37 1.468 . . . . 1.47 110.712 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.476 0.844 0 O-C-N 121.599 -0.688 . . . . 3.9199999999999999 112.644 -177.404 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.549 0.214 . . . . 1.8899999999999999 111.55 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -153.61 152.68 31.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.853 1.261 . . . . 1.27 109.549 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.2 132.4 11.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 123.071 1.415 . . . . 2.3100000000000001 110.065 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -90.01 124.8 35.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 4.1900000000000004 111.241 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.01 101.06 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 120.859 -1.15 . . . . 1.48 108.282 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 109.36 2.81 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.272 1.415 . . . . 1.0800000000000001 109.907 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 77.6 mmm -87.35 149.35 24.56 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.925 0.89 . . . . 1.8799999999999999 110.685 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.62 145.73 50.02 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.823 1.649 . . . . 2.5600000000000001 109.954 168.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.79 140.43 58.87 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.617 -0.677 . . . . 1.6000000000000001 109.572 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.79 152.61 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.693 0.759 . . . . 1.02 110.821 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -151.87 -165.08 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.794 1.638 . . . . 2.6400000000000001 107.599 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.4 -0.15 1.22 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.233 2.213 . . . . 1.7 113.326 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -109.71 -9.98 14.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.502 1.921 . . . . 2.71 111.875 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.53 -161.85 21.39 Favored Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.014 1.292 . . . . 1.1100000000000001 113.85 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.71 127.32 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.392 1.877 . . . . 0.90000000000000002 111.693 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.69 -86.09 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.643 1.592 . . . . 1.47 114.262 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.49 170.5 22.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.784 2.434 . . . . 2.0299999999999998 109.199 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -106.22 159.47 16.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.76 8.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 128.899 2.879 . . . . 3.2200000000000002 113.034 -169.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.13 168.67 15.47 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.694 1.14 . . . . 0.84999999999999998 113.4 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 p -115.19 -177.27 3.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.534 1.534 . . . . 0.85999999999999999 109.335 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.45 138.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.821 -1.548 . . . . 0.68999999999999995 106.821 158.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 p -91.78 131.87 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.077 0.398 . . . . 0.93000000000000005 110.556 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -107.63 131.66 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.343 1.057 . . . . 1.4399999999999999 109.218 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.51 145.18 50.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.92 0.888 . . . . 1.9199999999999999 111.036 170.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.354 8.4 tm-20 -101.38 107.23 18.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.741 2.816 . . . . 3.79 108.129 -162.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -130.7 175.6 8.89 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.839 1.199 . . . . 2.8399999999999999 112.128 -167.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.82 -8.41 57.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.436 1.094 . . . . 5.6299999999999999 112.794 172.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.71 14.63 58.94 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.035 1.302 . . . . 1.1399999999999999 113.27 159.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.27 -151.05 32.57 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 128.299 2.857 . . . . 0.79000000000000004 115.592 174.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -69.68 112.76 6.37 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.758 -0.848 . . . . 0.94999999999999996 112.963 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -88.86 106.77 18.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.938 2.095 . . . . 2.0499999999999998 110.787 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -92.8 117.09 29.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.574 2.35 . . . . 0.62 108.912 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -125.77 114.93 24.69 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-N 120.478 1.49 . . . . 0.68999999999999995 109.327 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.1 163.4 5.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.323 2.682 . . . . 0.55000000000000004 112.379 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -151.86 20.37 0.69 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.703 1.001 . . . . 1.51 113.703 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.74 145.21 28.04 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.011 -1.055 . . . . 0.81000000000000005 111.749 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -119.2 19.91 12.74 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.869 1.803 . . . . 2.7400000000000002 115.869 -164.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.86 54.81 0.66 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.794 0.838 . . . . 1.51 112.174 -165.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.95 160.34 69.03 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.997 0.919 . . . . 1.5600000000000001 112.553 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 37.5 Cg_endo -62.59 132.73 39.17 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.871 1.714 . . . . 1.27 110.711 174.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.407 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 15.7 Cg_endo -89.04 25.39 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.679 2.253 . . . . 1.29 114.259 -143.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.34 -152.85 12.49 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 116.908 1.523 . . . . 1.25 116.908 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.96 147.04 23.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.95 2.1 . . . . 2.4700000000000002 109.851 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -149.2 148.15 29.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.087 0.955 . . . . 1.1899999999999999 112.842 -165.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.53 156.63 53.51 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.191 -0.943 . . . . 0.56000000000000005 110.936 162.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.34 121.59 11.56 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 106.134 -1.802 . . . . 1.9299999999999999 106.134 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -126.99 170.69 12.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.685 1.735 . . . . 0.97999999999999998 115.685 175.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -101.56 143.06 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.281 1.832 . . . . 0.68000000000000005 109.492 160.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -129.57 141.09 51.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.712 2.005 . . . . 1.0900000000000001 109.641 -172.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -28.49 66.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.059 2.244 . . . . 0.71999999999999997 117.059 -158.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -127.29 152.17 47.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.443 1.019 . . . . 1.1799999999999999 112.739 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.81 78.79 1.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.358 0.98 . . . . 0.95999999999999996 111.785 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -164.54 72.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.103 0.954 . . . . 2.1400000000000001 113.316 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.4 m -68.16 8.84 0.38 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.83 2.159 . . . . 1.6000000000000001 116.83 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.17 138.79 52.55 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.089 -1.632 . . . . 3.7200000000000002 110.771 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.28 165.67 6.77 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.217 3.278 . . . . 1.4199999999999999 111.341 172.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.56 -172.08 2.58 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.54 0.686 . . . . 2.5699999999999998 109.808 150.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.1 mm -96.64 146.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.728 1.211 . . . . 3.5899999999999999 109.402 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.0 138.95 3.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.504 2.322 . . . . 5.4800000000000004 108.866 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.84 32.0 16.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.233 1.413 . . . . 5.9000000000000004 112.621 -173.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.89 3.53 87.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.186 1.374 . . . . 3.3999999999999999 115.605 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.98 157.91 45.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.077 1.438 . . . . 4.6799999999999997 112.563 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.51 131.52 34.63 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.886 -1.134 . . . . 2.1699999999999999 112.269 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.0 33.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.382 0.882 . . . . 2.1400000000000001 113.382 -172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.61 -6.38 0.12 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 119.184 3.031 . . . . 2.6299999999999999 119.184 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 131.93 101.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 1 C-N-CA 133.005 4.522 . . . . 1.45 106.506 -173.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.41 -59.41 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.203 1.001 . . . . 4.7000000000000002 111.872 -154.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.31 -17.86 59.84 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.156 0.798 . . . . 1.6000000000000001 113.156 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.96 0.68 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.031 2.132 . . . . 0.81999999999999995 115.634 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.69 25.29 9.99 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 116.272 1.269 . . . . 2.9300000000000002 116.272 159.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 -119.83 5.12 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 110.452 -1.059 . . . . 2.7799999999999998 110.452 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -97.47 -102.47 0.19 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.144 -1.058 . . . . 3.54 108.144 149.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.5 tp -174.24 93.32 0.08 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.494 2.318 . . . . 1.8700000000000001 108.672 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -159.64 124.52 2.19 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 125.651 1.581 . . . . 4.2400000000000002 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.03 -31.56 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.478 2.785 . . . . 2.27 114.568 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -160.2 -7.91 0.05 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.328 1.422 . . . . 3.6899999999999999 114.388 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -76.01 -48.89 19.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.244 1.018 . . . . 3.2799999999999998 112.61 -160.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -163.34 -41.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.473 1.286 . . . . 2.9100000000000001 114.473 -174.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.52 -19.98 2.32 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.047 -1.418 . . . . 2.3199999999999998 114.538 -167.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -72.0 -80.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.212 2.006 . . . . 4.1900000000000004 113.289 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.8 t60 160.69 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 130.27 3.428 . . . . 1.52 111.027 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.411 ' CG ' ' H ' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -71.75 -154.29 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.345 1.458 . . . . 3.1600000000000001 111.939 173.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 83' ' ' GLU . . . 113.76 -80.1 0.28 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.801 1.667 . . . . 3.0800000000000001 112.259 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.49 -7.77 5.6 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.849 3.033 . . . . 4.8099999999999996 113.668 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -153.45 145.18 23.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.607 1.563 . . . . 5.2400000000000002 110.457 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.35 84.25 1.42 Allowed Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.986 1.279 . . . . 2.7000000000000002 112.068 -173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.72 13.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.526 1.53 . . . . 4.5 113.011 -162.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.3 -161.68 37.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.489 1.519 . . . . 2.2799999999999998 115.223 -168.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -74.58 133.68 42.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.924 -0.638 . . . . 3.7999999999999998 109.65 173.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.93 2.66 3.26 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.085 1.883 . . . . 2.7200000000000002 116.085 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.87 0.32 51.97 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.892 1.711 . . . . 1.25 115.129 168.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -79.0 147.02 33.04 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.956 1.378 . . . . 1.6799999999999999 111.673 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.92 159.05 27.33 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.812 0.845 . . . . 1.8100000000000001 110.282 -144.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.04 149.33 64.96 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.359 2.706 . . . . 1.05 112.419 -171.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.37 128.23 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.438 1.113 . . . . 1.76 112.983 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.0 tp -82.51 132.09 35.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.513 2.725 . . . . 2.3799999999999999 110.315 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.69 137.67 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.84 -1.162 . . . . 0.95999999999999996 109.662 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.49 151.97 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 107.434 -1.321 . . . . 2.2200000000000002 107.434 161.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.06 157.5 26.7 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.384 0.513 . . . . 2.1699999999999999 112.384 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 10.1 p30 -58.96 -10.11 2.3 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.724 1.75 . . . . 2.6499999999999999 115.724 -174.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.79 -12.59 41.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 2.4399999999999999 113.597 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.63 17.04 11.66 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.081 1.324 . . . . 0.72999999999999998 116.037 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.46 134.96 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.541 1.171 . . . . 1.8899999999999999 110.707 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.14 135.6 33.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.891 1.676 . . . . 0.85999999999999999 111.379 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -158.83 -19.79 0.07 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.271 1.582 . . . . 1.0 115.271 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.37 122.33 82.58 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.403 1.002 . . . . 3.6800000000000002 110.097 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.71 163.22 18.75 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.511 2.807 . . . . 1.5700000000000001 111.989 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 m -141.26 160.51 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.157 1.383 . . . . 1.3 110.267 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 138.41 52.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.948 0.899 . . . . 0.89000000000000001 109.743 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.97 88.23 6.65 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.522 1.129 . . . . 0.73999999999999999 112.051 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.76 5.41 1.71 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.041 3.16 . . . . 1.3300000000000001 115.974 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -15.47 52.44 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.531 1.06 . . . . 8.5199999999999996 112.633 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.93 136.65 20.52 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.04 0.936 . . . . 3.2000000000000002 111.754 -170.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 9.36 1.44 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.235 1.939 . . . . 5.6100000000000003 116.235 -154.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -147.54 128.19 14.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.538 -0.541 . . . . 2.1699999999999999 109.538 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.77 -29.85 67.1 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.725 1.148 . . . . 1.8600000000000001 112.436 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.49 -24.23 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.291 1.837 . . . . 3.04 114.284 171.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.61 -4.46 58.95 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 120.093 1.315 . . . . 2.0699999999999998 114.25 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.03 12.96 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.586 1.154 . . . . 0.91000000000000003 113.874 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.38 17.16 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.197 2.295 . . . . 2.6200000000000001 117.197 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -150.09 11.6 0.73 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.503 1.921 . . . . 3.0 112.383 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -100.84 172.06 7.28 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.63 -1.294 . . . . 1.5900000000000001 113.418 -171.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.14 144.28 35.75 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.883 0.873 . . . . 0.53000000000000003 110.212 161.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.9 141.09 36.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.779 1.632 . . . . 1.95 106.673 164.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.5 mtt -137.32 130.56 30.94 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.946 -1.096 . . . . 1.3 111.975 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.4 mt -83.85 131.68 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.092 -1.077 . . . . 0.83999999999999997 108.092 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.2 149.1 42.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.611 1.564 . . . . 2.3500000000000001 112.125 -168.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.5 -52.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.655 -0.653 . . . . 1.27 110.005 -168.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.85 169.17 29.51 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.127 0.87 . . . . 1.1899999999999999 111.769 169.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.22 -164.49 5.98 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.967 2.699 . . . . 2.6299999999999999 115.913 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.39 84.01 2.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.018 2.127 . . . . 3.4199999999999999 106.676 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -160.39 -8.06 0.05 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.254 1.576 . . . . 3.6899999999999999 115.254 -165.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.5 ptp -148.31 142.06 25.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.242 1.383 . . . . 2.8900000000000001 113.945 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 p -156.82 12.89 0.26 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.146 1.165 . . . . 2.98 114.146 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.51 -40.38 14.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.138 1.775 . . . . 4.5999999999999996 113.845 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.51 143.35 79.09 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.94 0.896 . . . . 3.3700000000000001 112.036 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.81 -31.84 24.28 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.148 2.565 . . . . 1.95 114.751 -165.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -73.81 115.45 42.2 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.289 1.404 . . . . 4.0499999999999998 108.731 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.23 144.84 64.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.014 2.476 . . . . 2.6400000000000001 112.716 -159.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 58.98 19.32 7.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.103 1.761 . . . . 3.2999999999999998 112.638 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.97 56.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.813 -0.993 . . . . 2.7999999999999998 113.755 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.89 -8.35 73.52 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.964 1.745 . . . . 1.8 114.418 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.01 -8.84 79.22 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.14 1.47 . . . . 1.3899999999999999 116.097 -169.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.83 2.29 25.73 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.921 1.248 . . . . 1.55 115.5 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 p -69.42 151.38 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.924 1.69 . . . . 1.49 110.789 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.31 150.16 22.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.318 1.447 . . . . 5.0300000000000002 110.268 -172.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -110.43 -34.77 6.23 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.31 0.485 . . . . 2.5499999999999998 112.31 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.8 144.74 24.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.776 1.028 . . . . 0.96999999999999997 113.776 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.9 t -104.82 139.61 39.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.93 2.492 . . . . 2.1200000000000001 110.903 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.27 87.67 0.25 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.978 2.704 . . . . 1.1399999999999999 111.052 173.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.98 135.53 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.84 . . . . 1.53 109.246 166.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.42 137.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.626 1.17 . . . . 2.0099999999999998 111.359 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 11.2 mmpt? . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.183 . . . . 3.8399999999999999 113.504 -175.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 121.752 0.787 . . . . 1.6299999999999999 111.38 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -169.12 151.77 4.84 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.551 1.54 . . . . 1.4299999999999999 108.143 -154.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.9 124.07 5.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 123.05 1.405 . . . . 2.6299999999999999 111.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -84.15 89.52 7.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.928 2.091 . . . . 3.4700000000000002 110.796 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -87.28 116.44 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.475 -0.765 . . . . 1.05 110.239 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.34 109.0 2.66 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.238 1.399 . . . . 0.72999999999999998 110.009 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.8 mtp -94.02 140.42 29.74 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.558 0.743 . . . . 1.1699999999999999 112.778 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -121.24 150.4 41.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.8 1.64 . . . . 2.6299999999999999 112.994 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.7 mt -71.6 73.42 0.77 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.207 2.603 . . . . 1.28 110.974 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.65 124.4 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.338 -0.851 . . . . 1.6000000000000001 109.947 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.5 t -160.28 74.49 0.55 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.963 1.098 . . . . 2.4199999999999999 113.963 -166.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.66 -42.62 0.52 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.167 2.187 . . . . 1.4399999999999999 114.561 163.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -6.7 50.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.947 1.299 . . . . 2.4500000000000002 112.071 169.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.47 -164.53 13.93 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.029 2.252 . . . . 1.4099999999999999 111.496 -173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.56 129.8 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.054 . . . . 1.27 110.255 161.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.64 -140.62 11.27 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.904 1.24 . . . . 2.0699999999999998 113.881 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.93 167.08 14.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.675 1.19 . . . . 1.9199999999999999 111.087 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -103.22 172.94 6.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.813 1.645 . . . . 1.3700000000000001 113.183 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.03 1.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 128.188 2.595 . . . . 3.48 113.138 -165.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.17 -177.44 20.29 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.148 1.356 . . . . 0.56000000000000005 112.714 -166.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.87 165.43 18.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.075 0.95 . . . . 1.04 109.411 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 40.9 t -110.67 129.32 66.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.558 -1.275 . . . . 0.56999999999999995 107.558 157.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.18 130.63 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 122.011 0.91 . . . . 2.6299999999999999 110.204 166.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -99.39 139.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.9 -1.148 . . . . 1.2 107.9 167.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -135.52 127.06 28.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.908 1.283 . . . . 2.3199999999999998 109.935 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.03 140.0 29.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.207 0.603 . . . . 3.5699999999999998 111.059 -171.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t -154.54 -178.99 7.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.5 0.72 . . . . 1.49 110.433 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -64.38 -23.8 67.41 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.659 1.584 . . . . 3.7999999999999998 113.546 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.07 16.68 59.02 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.283 1.42 . . . . 1.3600000000000001 113.848 166.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 115' ' ' LYS . . . 75.44 -144.49 31.81 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 129.241 3.305 . . . . 1.0 114.859 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.2 mt -71.71 109.17 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.291 0.636 . . . . 0.81999999999999995 111.088 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -80.58 107.34 13.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.268 1.427 . . . . 1.95 109.594 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -91.75 116.52 28.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.035 1.734 . . . . 0.70999999999999996 109.713 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.8 m -128.87 106.52 18.35 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.877 -0.582 . . . . 0.84999999999999998 110.332 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.09 154.72 14.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.897 3.065 . . . . 0.47999999999999998 112.405 -171.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -146.01 48.88 1.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.664 0.745 . . . . 1.6200000000000001 112.626 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.47 150.95 24.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.84999999999999998 112.228 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 22.0 5.52 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.393 1.627 . . . . 2.0699999999999998 115.393 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.24 83.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.112 0.965 . . . . 2.0699999999999998 110.706 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 164.68 31.62 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 124.803 1.241 . . . . 1.3899999999999999 110.535 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.48 138.46 85.92 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.13 1.22 . . . . 1.1899999999999999 110.07 169.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -90.81 24.67 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.333 2.022 . . . . 1.3100000000000001 114.428 -151.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.5 -154.62 20.58 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.181 1.372 . . . . 1.3 115.28 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 152.29 19.07 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.064 -1.256 . . . . 2.6699999999999999 110.539 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -149.41 122.78 9.03 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.674 1.59 . . . . 1.3400000000000001 111.291 -162.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.56 150.29 3.54 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 120.307 1.412 . . . . 0.59999999999999998 112.175 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.448 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -135.97 125.58 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.248 -1.39 . . . . 2.0600000000000001 107.248 173.157 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -124.28 172.31 9.19 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.118 1.525 . . . . 1.1100000000000001 115.118 167.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.38 141.66 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.747 1.619 . . . . 0.81000000000000005 109.168 159.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.27 154.3 46.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.986 2.114 . . . . 0.97999999999999998 110.583 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.93 60.63 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 117.362 2.356 . . . . 1.04 117.362 -150.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -137.69 148.86 46.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.122 1.328 . . . . 1.54 113.325 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.57 74.18 2.14 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.581 1.086 . . . . 1.1899999999999999 114.151 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 t -164.79 76.9 0.31 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.058 0.932 . . . . 2.3199999999999998 113.346 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.9 m -70.02 28.43 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.951 2.1 . . . . 1.8300000000000001 115.74 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -92.22 135.44 26.95 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.514 -1.366 . . . . 3.29 110.943 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.17 157.2 11.21 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.274 3.316 . . . . 1.3400000000000001 113.231 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.77 144.53 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.104 0.962 . . . . 1.8400000000000001 110.08 161.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mm -97.76 48.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.316 1.047 . . . . 3.7000000000000002 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -61.89 137.83 58.29 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.761 -1.212 . . . . 5.5700000000000003 111.313 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.94 26.35 9.73 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.182 0.993 . . . . 4.0800000000000001 112.921 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.71 83.34 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.96 -1.087 . . . . 2.7400000000000002 114.723 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.91 144.46 48.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.264 1.532 . . . . 3.2000000000000002 111.178 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.3 105.8 12.78 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.835 -1.165 . . . . 1.48 111.776 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 t -77.98 62.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.402 1.481 . . . . 2.6299999999999999 111.688 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.2 -63.15 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.852 3.261 . . . . 2.0099999999999998 116.756 169.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.4 119.8 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 131.555 3.942 . . . . 2.3799999999999999 108.648 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -100.46 -47.75 4.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.693 1.133 . . . . 4.8399999999999999 111.561 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.8 2.92 4.68 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 115.21 1.559 . . . . 1.53 115.21 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.52 -3.84 48.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.119 2.168 . . . . 1.3700000000000001 114.674 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 -13.83 55.01 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.037 1.575 . . . . 3.7400000000000002 117.037 165.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.09 -168.78 15.18 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.043 1.306 . . . . 1.3899999999999999 114.697 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 12.64 1.63 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.196 2.199 . . . . 2.3100000000000001 114.107 -175.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.8 tp 61.25 56.2 2.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.15 1.78 . . . . 1.5 109.15 -169.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -122.74 62.94 18.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.901 2.08 . . . . 4.2199999999999998 112.414 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.43 -38.43 26.05 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.83 2.353 . . . . 2.0 112.689 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -168.4 139.22 2.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.631 1.972 . . . . 3.5499999999999998 107.664 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 p30 157.69 -162.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 130.348 3.459 . . . . 4.2999999999999998 110.337 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -74.49 -11.83 60.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.265 2.626 . . . . 3.1299999999999999 116.048 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.65 -32.17 1.66 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.977 1.275 . . . . 2.2200000000000002 116.081 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -64.91 -9.84 24.23 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.151 2.278 . . . . 5.3099999999999996 117.151 -167.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.4 t60 75.08 153.52 0.14 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.427 2.291 . . . . 1.5600000000000001 112.238 -171.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -152.13 148.51 27.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.287 1.835 . . . . 4.9299999999999997 109.874 -169.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.35 -82.39 1.07 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.055 -1.414 . . . . 3.3399999999999999 109.882 163.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.01 -26.12 3.1 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.898 3.065 . . . . 4.54 115.942 -166.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.54 -157.55 0.62 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 120.091 1.314 . . . . 5.2999999999999998 111.383 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.98 13.59 37.7 Favored Glycine 0 N--CA 1.475 1.287 0 C-N-CA 124.979 1.276 . . . . 3.8799999999999999 115.195 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -100.25 51.76 0.89 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.052 1.426 . . . . 5.1200000000000001 112.301 -169.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.61 -143.71 4.9 Favored Glycine 0 N--CA 1.473 1.101 0 O-C-N 120.921 -1.112 . . . . 2.6699999999999999 115.608 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.06 147.73 22.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.705 1.202 . . . . 3.96 112.405 -168.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.88 -20.97 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.682 1.364 . . . . 2.0299999999999998 114.682 -174.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.06 -2.06 86.4 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.297 0.951 . . . . 0.85999999999999999 114.796 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.98 136.63 33.98 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.517 1.127 . . . . 1.77 111.99 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.42 167.61 14.17 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 126.092 1.757 . . . . 1.9099999999999999 109.861 -143.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.82 173.95 11.53 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.281 3.321 . . . . 1.0600000000000001 113.792 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.37 125.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.638 1.175 . . . . 2.0499999999999998 112.186 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 90.31 2.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.58 2.752 . . . . 1.8600000000000001 109.854 166.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.9 t -68.28 126.44 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.018 -1.051 . . . . 0.81999999999999995 109.092 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.97 162.67 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.931 1.292 . . . . 2.1200000000000001 108.411 167.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.47 160.47 16.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.759 1.022 . . . . 2.21 113.759 -176.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -15.68 0.29 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 127.957 2.503 . . . . 2.4700000000000002 117.438 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.09 -0.93 38.06 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.907 1.683 . . . . 3.2000000000000002 113.089 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.8 25.66 22.01 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.93 1.252 . . . . 0.88 114.432 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.9 mt -129.64 140.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 1.1200000000000001 109.955 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.4 129.0 56.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.349 1.86 . . . . 0.87 111.607 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 t -153.31 0.74 0.25 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.784 1.772 . . . . 1.3400000000000001 115.784 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -86.03 126.77 64.4 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.585 1.154 . . . . 3.3799999999999999 110.542 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.05 156.3 26.41 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.095 2.53 . . . . 1.3100000000000001 112.16 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.92 167.06 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 126.358 1.863 . . . . 1.3 109.591 167.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 m -140.06 140.48 36.14 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 1.23 111.053 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.63 114.24 15.54 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.482 1.113 . . . . 1.3300000000000001 112.691 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.14 5.15 6.2 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.26 3.307 . . . . 1.25 115.213 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -77.36 -19.17 56.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.566 0.951 . . . . 4.4699999999999998 113.566 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.56 144.99 46.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.423 1.889 . . . . 2.5 106.946 169.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.8 mtpt -131.06 -9.37 3.84 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.455 1.28 . . . . 4.0499999999999998 114.455 -160.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -157.98 142.2 15.98 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.929 1.292 . . . . 2.02 111.781 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.081 -1.012 . . . . 2.3900000000000001 113.172 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.97 -15.65 45.37 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 119.533 1.06 . . . . 3.1299999999999999 113.168 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.11 -22.29 63.98 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.47 -0.769 . . . . 1.97 112.793 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.02 20.97 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.655 1.582 . . . . 0.95999999999999996 112.689 -167.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -68.86 27.47 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.215 2.206 . . . . 2.0299999999999998 116.012 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.96 3.02 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.529 2.732 . . . . 3.21 113.024 173.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -108.19 172.15 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 1.4299999999999999 113.149 -166.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.0 150.06 39.23 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.247 1.019 . . . . 0.75 113.195 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.3 mt -89.66 152.29 21.44 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.169 1.788 . . . . 2.2599999999999998 109.01 161.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.8 mtt -141.31 127.8 20.06 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.597 0.635 . . . . 1.26 112.185 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.45 130.73 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.957 1.303 . . . . 0.68000000000000005 107.577 166.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.28 137.59 53.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.218 2.207 . . . . 1.8500000000000001 111.236 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -64.85 -42.83 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.326 1.05 . . . . 1.3300000000000001 112.781 -161.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -88.0 -106.01 0.95 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.1 1.333 . . . . 2.6600000000000001 112.041 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.48 -166.99 29.39 Favored Glycine 0 N--CA 1.462 0.404 0 O-C-N 121.233 -1.157 . . . . 1.78 111.75 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -162.9 145.97 10.82 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.622 1.169 . . . . 3.25 109.911 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 114.27 55.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 130.294 3.438 . . . . 4.3399999999999999 108.121 -154.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.3 ptp -169.63 37.02 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.044 1.338 . . . . 2.6400000000000001 113.455 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.61 61.31 2.31 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.078 -1.639 . . . . 3.4900000000000002 114.911 -169.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -140.25 -45.54 0.42 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 116.613 2.079 . . . . 4.2999999999999998 116.613 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.43 148.32 44.12 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.753 1.39 . . . . 3.8900000000000001 114.753 -156.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.44 -9.19 24.78 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.312 3.341 . . . . 1.97 115.555 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -101.43 78.34 0.21 Allowed Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.587 -0.894 . . . . 4.5999999999999996 108.587 154.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.73 152.38 82.21 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.758 2.972 . . . . 3.1299999999999999 112.355 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 mt 69.08 27.98 5.17 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.641 1.577 . . . . 4.0700000000000003 110.296 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.42 13.52 58.46 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.318 1.437 . . . . 3.0899999999999999 114.626 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.94 -6.9 46.32 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 118.676 1.238 . . . . 2.1299999999999999 114.375 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.87 5.94 56.73 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.488 1.994 . . . . 2.0899999999999999 114.089 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.8 2.56 7.91 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 118.613 1.206 . . . . 1.97 115.022 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 p -64.26 144.64 56.99 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.359 1.463 . . . . 1.54 109.655 169.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.92 137.58 36.92 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.001 0.92 . . . . 5.6500000000000004 112.605 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -91.46 -27.85 18.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.284 0.634 . . . . 2.2999999999999998 111.281 158.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.24 153.11 28.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.174 0.805 . . . . 0.57999999999999996 113.174 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.54 165.52 16.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.382 1.473 . . . . 1.47 110.755 165.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -160.82 136.43 4.46 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.658 1.123 . . . . 0.66000000000000003 112.797 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.11 133.45 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.657 1.183 . . . . 1.8999999999999999 110.603 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.0 141.2 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.503 1.121 . . . . 1.6499999999999999 111.068 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 123.981 0.913 . . . . 4.2800000000000002 112.769 -174.637 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.413 -0.217 . . . . 1.72 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -135.87 150.04 49.23 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.394 -1.441 . . . . 0.97999999999999998 114.763 -141.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -155.72 123.85 5.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.675 1.59 . . . . 2.3599999999999999 108.703 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.93 108.29 18.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.714 1.605 . . . . 4.8600000000000003 110.512 -171.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.15 126.38 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.339 0.656 . . . . 1.0600000000000001 110.14 -165.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.94 113.34 4.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.277 1.417 . . . . 0.77000000000000002 110.549 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.4 mmt -97.33 113.16 24.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.448 1.499 . . . . 1.54 110.586 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -102.2 149.55 24.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.287 1.035 . . . . 3.1699999999999999 112.108 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.31 61.98 1.25 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.395 1.078 . . . . 1.73 112.645 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.43 147.48 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.342 1.057 . . . . 1.22 112.489 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -177.44 134.85 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.798 1.639 . . . . 2.3199999999999998 111.338 163.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.67 -44.16 0.25 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.03 2.932 . . . . 1.1299999999999999 117.062 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 11.11 33.75 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.148 1.779 . . . . 3.0 110.844 172.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -133.23 11.69 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.996 1.284 . . . . 0.95999999999999996 110.684 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.19 134.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.862 1.665 . . . . 1.5900000000000001 111.031 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.53 -82.47 1.42 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.837 1.208 . . . . 2.3199999999999998 111.924 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.2 158.29 18.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.078 1.351 . . . . 2.0499999999999998 111.355 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.0 t -97.92 145.47 26.43 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.728 1.211 . . . . 1.7 112.977 -169.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.3 pt -142.85 3.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 114.837 1.421 . . . . 2.98 114.837 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.73 178.35 35.58 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 120.895 -1.128 . . . . 0.75 114.023 -170.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -131.14 178.41 6.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.352 1.061 . . . . 0.96999999999999997 109.054 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 38.3 t -131.05 133.99 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.095 -1.076 . . . . 0.45000000000000001 108.095 162.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 8.7 p -90.65 127.8 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.604 0.362 . . . . 0.81999999999999995 110.721 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.8 136.65 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.289 1.036 . . . . 1.75 108.825 169.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -141.91 113.5 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.215 1.406 . . . . 1.8500000000000001 110.744 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.77 153.55 39.94 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.733 0.813 . . . . 3.1200000000000001 112.063 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 t -167.68 -177.68 3.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.542 1.937 . . . . 1.23 109.149 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -53.1 -40.75 64.37 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.257 1.423 . . . . 3.8199999999999998 112.497 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 15.16 56.71 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.22 1.39 . . . . 0.84999999999999998 114.44 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 -152.78 42.48 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 127.36 2.41 . . . . 0.75 115.334 173.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.401 HD12 HD23 ' A' ' 114' ' ' LEU . 54.3 mt -65.53 104.34 0.99 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.701 0.801 . . . . 0.52000000000000002 113.135 -169.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -80.12 110.42 15.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.008 1.723 . . . . 2.5600000000000001 109.964 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 6.6 t80 -100.85 114.87 29.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.457 2.703 . . . . 0.66000000000000003 108.928 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.433 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.6 m -122.73 111.18 31.34 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 119.776 1.171 . . . . 0.56000000000000005 108.948 175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -84.08 158.55 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.525 2.817 . . . . 0.40999999999999998 111.66 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . 0.263 1.7 p80 -152.52 65.06 0.81 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 122.5 1.143 . . . . 1.23 111.664 172.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.59 151.26 45.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.35 1.86 . . . . 0.65000000000000002 111.535 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 37.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 117.509 2.411 . . . . 2.4500000000000002 117.509 -159.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.45 13.03 1.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.978 1.473 . . . . 2.4100000000000001 114.978 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.33 161.82 50.56 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 119.124 -0.465 . . . . 1.8200000000000001 111.359 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -60.96 129.78 30.18 Favored 'Trans proline' 0 N--CA 1.431 -2.157 0 O-C-N 123.241 1.127 . . . . 1.0600000000000001 109.756 162.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -86.45 22.86 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.665 3.577 . . . . 1.1000000000000001 113.269 -150.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.52 153.04 17.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 126.167 1.842 . . . . 1.9399999999999999 110.49 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -45.28 137.03 4.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.005 2.522 . . . . 3.2999999999999998 113.72 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -126.93 129.42 48.13 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 125.533 1.533 . . . . 0.94999999999999996 111.704 -172.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.14 158.18 1.72 Allowed Glycine 0 CA--C 1.543 1.843 0 CA-C-N 119.276 0.944 . . . . 0.66000000000000003 114.016 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.3 t80 -145.39 116.3 7.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.147 1.779 . . . . 1.8999999999999999 106.65 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -126.12 168.75 13.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.388 1.995 . . . . 0.75 116.388 165.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -99.08 135.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.391 1.876 . . . . 0.96999999999999997 110.09 154.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -105.6 176.14 5.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.822 1.649 . . . . 0.97999999999999998 111.963 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.9 62.59 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 116.744 2.127 . . . . 1.1899999999999999 116.744 -166.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -126.06 -159.68 0.93 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.6 1.56 . . . . 1.3100000000000001 111.277 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.87 66.73 0.37 Allowed Glycine 0 N--CA 1.476 1.323 0 N-CA-C 116.677 1.431 . . . . 1.01 116.677 -162.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -174.69 116.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.236 1.814 . . . . 2.5899999999999999 111.974 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -67.62 33.0 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 128.043 2.537 . . . . 1.46 115.183 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -104.89 126.61 30.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 119.996 -1.69 . . . . 3.0299999999999998 111.379 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.52 150.97 13.24 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.073 3.182 . . . . 1.3200000000000001 112.889 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 169.08 8.94 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.179 0.992 . . . . 1.9399999999999999 110.196 154.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 mm -97.9 124.1 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.948 -1.13 . . . . 2.8199999999999998 107.948 162.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -139.54 109.22 6.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.278 1.431 . . . . 5.0099999999999998 109.179 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t0 60.43 63.04 1.43 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.161 1.785 . . . . 4.2000000000000002 112.747 -166.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.39 13.33 54.34 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 115.711 1.045 . . . . 2.96 115.711 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -147.48 150.11 33.95 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.027 1.731 . . . . 3.3799999999999999 110.209 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.05 34.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.998 0.519 . . . . 1.45 111.896 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.5 t -67.94 -3.98 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.188 1.795 . . . . 2.9300000000000002 113.466 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.47 -50.56 0.69 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.499 2.72 . . . . 2.1600000000000001 112.575 -174.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.51 111.25 2.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.178 1.791 . . . . 1.72 109.682 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.89 -39.7 12.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.239 0.616 . . . . 5.0700000000000003 110.691 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.01 -4.2 30.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.114 1.153 . . . . 1.73 114.114 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.0 -18.9 27.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.178 1.391 . . . . 1.0800000000000001 112.631 168.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.31 178.1 31.53 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 122.319 0.955 . . . . 2.8500000000000001 113.516 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.69 -163.65 39.31 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.531 1.062 . . . . 1.3700000000000001 112.894 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -56.31 128.29 35.09 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.763 0.825 . . . . 3.04 109.591 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.32 66.72 0.18 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.681 1.993 . . . . 2.1299999999999999 112.34 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -111.21 113.55 54.2 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 4.6699999999999999 108.989 164.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -84.68 -31.27 0.46 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.288 1.992 . . . . 2.0800000000000001 113.302 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 176.9 29.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.869 2.068 . . . . 3.0699999999999998 111.289 -165.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -119.07 -21.19 7.76 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.56 -1.209 . . . . 3.8500000000000001 113.261 -164.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t 155.16 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 130.607 3.563 . . . . 2.1899999999999999 111.172 158.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.33 -11.29 61.69 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.8 1.191 . . . . 2.2000000000000002 115.494 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -73.79 1.78 9.76 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 116.019 1.859 . . . . 4.54 116.019 -173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.6 t60 87.75 135.16 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 129.045 2.938 . . . . 1.8100000000000001 114.151 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.65 19.33 14.61 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.981 1.712 . . . . 4.8399999999999999 114.385 -152.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.78 -35.68 31.04 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-O 117.642 -1.643 . . . . 2.4500000000000002 114.735 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -111.83 -2.39 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 124.316 3.344 . . . . 3.5 114.153 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -143.82 145.93 32.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.875 1.67 . . . . 5.2400000000000002 108.457 -172.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.12 6.5 35.09 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.586 1.394 . . . . 3.1499999999999999 116.586 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.81 130.34 15.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.051 1.426 . . . . 5.0599999999999996 109.721 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.69 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-O 115.709 -2.717 . . . . 3.3300000000000001 118.22 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.794 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 0.3 OUTLIER 152.99 118.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 129.145 2.978 . . . . 5.1900000000000004 110.924 -175.598 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.3 tt -67.03 -28.43 68.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.47 1.108 . . . . 2.6499999999999999 113.369 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -88.18 15.7 55.04 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.416 1.484 . . . . 0.83999999999999997 115.179 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.794 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 78.7 m-20 -76.11 147.65 38.43 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.2 1.5 . . . . 1.55 110.751 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.17 166.03 17.38 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.607 0.763 . . . . 1.79 110.368 -146.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.06 148.53 19.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.877 3.051 . . . . 1.1399999999999999 112.271 -171.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.89 135.16 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 122.108 0.956 . . . . 1.74 111.38 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 108.83 19.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.026 2.53 . . . . 2.48 110.428 -172.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.4 t -78.24 131.35 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.365 -0.835 . . . . 1.8300000000000001 111.935 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.68 141.31 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.67 2.388 . . . . 1.5900000000000001 106.423 166.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.51 164.3 22.07 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.134 0.424 . . . . 1.95 111.484 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -16.67 0.29 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 127.421 2.289 . . . . 2.23 116.89 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.62 -1.41 43.81 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.181 1.792 . . . . 2.4100000000000001 113.434 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.29 53.84 Favored Glycine 0 N--CA 1.473 1.119 0 O-C-N 121.185 -0.947 . . . . 0.93000000000000005 114.851 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.8 mt -106.14 121.97 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.217 1.007 . . . . 1.46 110.806 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.4 122.56 33.38 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.342 1.057 . . . . 0.63 109.092 168.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -155.48 8.68 0.27 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.135 1.161 . . . . 1.3200000000000001 114.135 -167.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.62 123.61 49.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.868 1.267 . . . . 3.3599999999999999 110.473 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.75 134.75 26.56 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.189 3.259 . . . . 1.3799999999999999 111.963 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.0 163.77 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 126.342 1.857 . . . . 1.6100000000000001 109.261 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 m -144.14 141.0 29.71 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.993 1.269 . . . . 0.81999999999999995 112.112 -167.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -121.17 106.05 39.01 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.554 1.142 . . . . 0.82999999999999996 113.381 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.1 7.42 1.74 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.727 3.618 . . . . 1.1100000000000001 114.637 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -75.4 -25.7 57.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.812 1.645 . . . . 6.9100000000000001 112.735 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.449 ' N ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -123.99 135.59 53.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.313 -1.736 . . . . 2.4700000000000002 106.313 168.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -113.05 -2.65 14.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 4.1799999999999997 113.579 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.4 t -141.11 174.06 10.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.353 0.979 . . . . 2.02 111.752 158.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.43 -24.27 64.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.165 -0.959 . . . . 1.48 111.09 157.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -60.01 -28.62 67.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.352 1.461 . . . . 2.8300000000000001 114.639 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -78.91 -16.1 57.45 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.199 1.185 . . . . 2.3599999999999999 114.199 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.1 m -124.42 16.35 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 125.195 1.398 . . . . 1.25 113.291 -172.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -65.44 8.64 0.15 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 128.242 2.617 . . . . 2.5 117.579 -171.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 41.76 0.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.273 1.429 . . . . 3.7000000000000002 112.171 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -134.49 168.28 19.23 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.937 1.295 . . . . 1.45 113.685 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.7 146.69 26.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.503 1.521 . . . . 0.53000000000000003 114.259 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.37 145.39 30.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.921 2.489 . . . . 1.6000000000000001 107.809 167.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 52.3 mtt -140.65 143.4 35.13 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.294 -0.879 . . . . 1.4099999999999999 112.427 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mt -99.75 123.6 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.772 1.629 . . . . 0.65000000000000002 108.444 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -109.02 143.29 38.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.293 1.837 . . . . 2.79 111.39 -165.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.12 -37.78 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.865 -1.147 . . . . 1.4099999999999999 111.914 -169.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.93 153.34 20.06 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.913 0.768 . . . . 0.96999999999999997 112.125 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.35 -178.9 25.6 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.891 1.71 . . . . 1.3100000000000001 113.128 163.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -137.01 14.87 3.07 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.027 1.491 . . . . 3.29 115.027 -126.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -105.16 21.82 16.44 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.709 1.374 . . . . 2.54 114.709 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtm -96.55 129.65 43.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.859 -1.151 . . . . 2.7000000000000002 112.363 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.2 p -126.7 4.93 6.71 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.766 1.395 . . . . 3.3399999999999999 114.766 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -157.09 124.61 5.33 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.887 -1.133 . . . . 3.5299999999999998 109.464 -169.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -174.09 142.25 0.85 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 117.926 -1.035 . . . . 3.6899999999999999 109.558 -167.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.11 -15.12 29.0 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.08 2.52 . . . . 2.7200000000000002 113.762 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -129.23 133.85 25.62 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.811 1.645 . . . . 4.6699999999999999 108.955 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.9 124.82 15.7 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.215 2.61 . . . . 3.3100000000000001 111.783 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp 58.88 5.2 0.48 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.689 1.996 . . . . 3.3100000000000001 114.007 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.87 9.08 44.8 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.883 -1.136 . . . . 3.8199999999999998 114.574 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.92 -0.27 33.85 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.411 1.482 . . . . 2.6800000000000002 114.345 -167.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.87 7.34 5.5 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.342 1.449 . . . . 1.75 115.646 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.24 -6.03 78.63 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.873 1.337 . . . . 2.1299999999999999 112.921 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 p -70.07 134.06 47.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.356 1.862 . . . . 2.0699999999999998 110.693 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.43 147.27 45.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.355 1.462 . . . . 5.2400000000000002 112.02 -172.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -106.3 -17.16 14.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.249 -0.881 . . . . 2.3700000000000001 112.93 169.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.85 33.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.856 1.428 . . . . 0.54000000000000004 114.856 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -135.74 149.12 49.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.198 2.199 . . . . 1.3200000000000001 110.238 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.5 1.71 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.342 1.925 . . . . 0.66000000000000003 112.474 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.63 141.71 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.569 1.148 . . . . 2.4199999999999999 112.592 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -77.14 141.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.57 1.148 . . . . 1.02 110.868 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 124.332 1.053 . . . . 4.2699999999999996 110.977 171.366 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.988 -0.745 . . . . 2.1200000000000001 108.988 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -128.71 133.53 48.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.899 -1.751 . . . . 1.26 112.504 -137.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -146.69 127.68 14.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 123.226 1.489 . . . . 2.5 112.711 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -109.86 90.94 3.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.251 1.42 . . . . 3.6299999999999999 110.216 -162.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.5 t -90.04 120.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.89 0.476 . . . . 1.0 110.299 -163.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.48 105.4 1.78 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.972 1.272 . . . . 0.79000000000000004 110.639 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 mmt -85.13 110.49 19.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.999 1.32 . . . . 1.54 110.57 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -98.25 143.78 28.38 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.95 0.9 . . . . 2.7999999999999998 111.452 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.3 63.01 3.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.895 1.278 . . . . 1.27 111.55 -175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.35 136.79 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.551 0.74 . . . . 1.23 111.205 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -157.96 139.87 14.03 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.597 0.359 . . . . 2.54 111.514 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' H ' ' NH2' ' A' ' 147' ' ' ARG . . . 26.76 -42.99 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.884 1 C-N-CA 134.638 5.175 . . . . 1.21 120.763 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -80.17 -23.26 41.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.825 1.25 . . . . 3.0800000000000001 111.791 166.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.5 -141.08 13.02 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.846 1.212 . . . . 0.95999999999999996 111.541 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.5 t -54.81 128.79 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.117 1.367 . . . . 1.1599999999999999 111.78 -174.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.26 -111.0 3.54 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.151 1.834 . . . . 1.22 111.701 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.68 169.35 15.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.515 1.126 . . . . 1.6599999999999999 110.945 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.9 t -109.44 156.81 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.058 -1.026 . . . . 1.05 111.994 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 pt -147.33 9.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.733 2.013 . . . . 2.7400000000000002 113.114 -172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.57 162.78 10.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.642 1.115 . . . . 0.68999999999999995 112.743 -167.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -104.45 -177.99 3.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.23 1.012 . . . . 0.79000000000000004 109.316 168.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.4 t -124.43 130.87 73.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 106.848 -1.538 . . . . 0.41999999999999998 106.848 151.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG12 ' HB ' ' A' ' 34' ' ' THR . 8.7 p -87.72 123.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.727 -0.471 . . . . 0.89000000000000001 109.727 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.86 119.98 45.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.04 -1.096 . . . . 1.5 108.04 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -118.47 111.33 18.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.835 0.854 . . . . 1.9399999999999999 110.848 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 130.47 46.57 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 127.124 2.17 . . . . 3.9100000000000001 111.165 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 t -161.18 -172.0 3.25 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.705 1.002 . . . . 2.0600000000000001 113.705 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.32 -31.29 43.49 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.523 1.529 . . . . 6.75 112.721 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.57 17.9 57.56 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 124.962 1.267 . . . . 1.8899999999999999 115.179 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.29 -140.43 28.4 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.22 1.39 . . . . 0.93000000000000005 111.372 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.59 107.89 7.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.284 0.634 . . . . 0.66000000000000003 111.13 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -87.83 107.51 18.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.771 1.228 . . . . 1.8700000000000001 111.263 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.34 104.61 16.02 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.596 1.958 . . . . 0.57999999999999996 109.763 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' HG12 ' A' ' 23' ' ' VAL . 4.2 m -113.69 106.66 53.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 107.256 -1.387 . . . . 0.56000000000000005 107.256 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.1 162.06 17.98 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.371 3.38 . . . . 0.46999999999999997 109.928 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -153.02 34.7 0.47 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.982 0.896 . . . . 1.22 112.346 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -97.26 142.85 28.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.703 1.201 . . . . 0.63 111.21 -174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.38 23.1 9.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.154 1.909 . . . . 2.25 116.154 -166.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.51 57.51 0.63 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.672 0.789 . . . . 1.3300000000000001 112.806 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.03 15.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.115 0.966 . . . . 1.4199999999999999 111.57 172.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 35.3 Cg_endo -62.73 134.36 46.77 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 122.058 1.839 . . . . 0.93999999999999995 110.973 166.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 18.6 Cg_endo -84.18 27.31 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.706 1 C-N-CA 126.692 4.928 . . . . 1.01 114.825 -152.673 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.79 -134.79 8.16 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.398 1.475 . . . . 1.25 115.091 -172.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -120.17 136.5 54.6 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.647 1.579 . . . . 2.29 108.588 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -124.87 143.64 50.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.18 0.992 . . . . 1.0800000000000001 112.631 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.9 153.68 52.32 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.917 -0.873 . . . . 0.54000000000000004 110.917 169.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -124.07 118.41 26.88 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.277 -1.379 . . . . 2.0600000000000001 107.277 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -116.5 160.95 19.86 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.068 1.507 . . . . 0.87 115.068 168.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.13 148.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.521 2.329 . . . . 1.01 108.332 158.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -134.62 145.37 48.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.91000000000000003 111.001 -174.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.46 87.58 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.784 1.772 . . . . 0.75 115.784 -159.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -116.76 148.63 40.97 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.658 1.183 . . . . 1.0800000000000001 112.989 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.69 72.57 2.81 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.769 1.176 . . . . 0.87 113.803 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -164.36 96.06 0.76 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.174 0.987 . . . . 1.8999999999999999 113.422 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -65.39 22.73 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.155 2.182 . . . . 1.3100000000000001 116.44 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -86.18 129.34 54.13 Favored Pre-proline 0 CA--C 1.55 0.957 0 O-C-N 119.802 -1.811 . . . . 3.0899999999999999 112.446 -166.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -95.62 173.26 1.11 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.897 3.731 . . . . 1.4099999999999999 111.99 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.5 154.07 45.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.12 1.368 . . . . 2.2000000000000002 110.956 165.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -85.05 113.55 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.205 -1.405 . . . . 3.8100000000000001 107.205 157.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -138.47 121.37 16.59 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.716 1.206 . . . . 4.5700000000000003 108.547 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 57.69 40.01 26.86 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.755 1.222 . . . . 4.2199999999999998 112.548 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.37 9.92 86.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.579 1.085 . . . . 3.27 115.34 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.02 154.09 48.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.001 1.401 . . . . 3.3799999999999999 110.727 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.56 113.13 24.79 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.51 -0.744 . . . . 2.5600000000000001 111.717 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.35 33.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 116.054 1.872 . . . . 2.6899999999999999 116.054 -163.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.68 -63.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.365 2.666 . . . . 2.1400000000000001 114.105 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.75 108.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 131.581 3.952 . . . . 1.6899999999999999 107.6 -176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -110.54 -39.2 4.98 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.141 0.976 . . . . 3.9900000000000002 111.817 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -19.73 62.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.538 0.94 . . . . 1.29 113.538 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -9.14 53.84 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.299 1.84 . . . . 0.78000000000000003 113.61 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.55 54.65 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.602 -1.312 . . . . 2.1600000000000001 112.629 -174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 179.47 51.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.897 0.76 . . . . 1.48 112.993 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.44 31.12 0.06 Allowed 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 114.197 1.184 . . . . 2.8300000000000001 114.197 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.6 tp 64.92 88.85 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.041 2.137 . . . . 1.77 112.654 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -166.37 121.49 0.91 Allowed Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.136 2.174 . . . . 4.9500000000000002 110.619 163.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -90.57 -14.16 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.255 2.636 . . . . 2.1000000000000001 114.118 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -154.33 -37.05 0.1 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.306 1.965 . . . . 5.04 116.306 -159.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -60.33 -32.92 71.7 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.478 1.49 . . . . 4.1399999999999997 113.669 -163.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 t 171.78 -26.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.792 2.837 . . . . 2.6899999999999999 111.551 163.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 5.12 82.76 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.048 -1.033 . . . . 2.1000000000000001 115.287 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -74.44 -25.95 59.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 115.17 1.544 . . . . 6.4500000000000002 115.17 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.6 t60 99.03 145.79 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 129.35 3.06 . . . . 1.95 111.79 -168.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -119.58 -153.59 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 3.8599999999999999 112.85 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.81 -138.32 6.71 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 117.659 -1.634 . . . . 2.5800000000000001 109.37 -155.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.08 -27.2 65.48 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.016 2.477 . . . . 3.04 113.96 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.66 -9.44 58.25 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.976 1.102 . . . . 5.9100000000000001 113.976 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.01 19.98 70.4 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 116.812 1.485 . . . . 3.02 116.812 167.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.98 100.52 3.95 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.595 1.197 . . . . 4.9299999999999997 111.0 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.94 -34.92 0.13 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-O 117.193 -1.893 . . . . 3.2400000000000002 116.128 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -161.83 128.34 3.77 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.756 2.022 . . . . 3.6400000000000001 110.719 157.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 91' ' ' LEU . 0.7 OUTLIER -66.66 -21.42 66.11 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.132 1.16 . . . . 2.6899999999999999 114.132 178.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.66 23.0 9.41 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.801 1.191 . . . . 0.85999999999999999 114.91 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.15 134.3 41.4 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.075 1.437 . . . . 1.5800000000000001 110.444 165.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.28 161.08 62.49 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.385 1.874 . . . . 1.98 110.335 -168.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.89 167.84 25.52 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.572 2.848 . . . . 1.3500000000000001 112.317 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 132' ' ' ASP . 2.9 m -75.79 147.17 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.845 1.307 . . . . 1.75 113.89 -164.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.94 97.09 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 130.557 3.543 . . . . 2.2599999999999998 108.397 -175.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 t -83.09 147.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.986 1.315 . . . . 0.82999999999999996 111.797 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.77 142.41 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.331 2.252 . . . . 1.54 107.93 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -71.71 160.25 32.95 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.406 0.548 . . . . 2.2599999999999998 111.688 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -57.57 -4.17 0.24 Allowed 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 116.91 2.189 . . . . 2.75 116.91 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -111.8 -11.23 13.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.263 1.425 . . . . 3.0 114.562 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.19 32.61 3.2 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 116.627 1.411 . . . . 0.71999999999999997 116.627 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.0 mt -121.3 135.89 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.543 1.537 . . . . 1.0800000000000001 108.62 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.24 130.14 55.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.247 1.019 . . . . 0.62 110.14 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -148.98 10.06 0.79 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.811 2.152 . . . . 1.1100000000000001 116.811 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.58 130.59 40.74 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 120.349 1.431 . . . . 6.04 114.167 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.12 87.33 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.908 3.072 . . . . 2.04 111.742 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.2 t -72.31 160.3 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.295 1.438 . . . . 1.8400000000000001 108.993 172.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.5 m -142.82 131.88 23.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.653 -1.279 . . . . 1.3899999999999999 111.505 -171.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.02 91.23 49.71 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.205 1.002 . . . . 0.81000000000000005 113.4 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.34 2.46 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.227 3.285 . . . . 1.3 115.201 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -72.06 -26.33 62.14 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.025 0.83 . . . . 3.7999999999999998 111.555 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.86 151.51 26.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.673 2.389 . . . . 2.0299999999999998 108.822 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -138.21 12.81 2.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.989 1.315 . . . . 4.96 114.044 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.6 t -160.76 152.24 19.36 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.98 -1.075 . . . . 2.2200000000000002 112.269 161.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.94 -28.55 62.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.204 -0.427 . . . . 1.6299999999999999 111.635 161.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -54.79 -28.73 51.26 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.105 0.962 . . . . 2.7999999999999998 112.813 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.17 -12.61 60.63 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.874 0.87 . . . . 1.8899999999999999 112.766 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.08 12.44 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.417 1.487 . . . . 0.73999999999999999 113.028 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -63.79 -1.71 1.49 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 117.224 2.305 . . . . 2.2599999999999998 117.224 -169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -146.15 19.97 1.4 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.249 1.82 . . . . 3.1499999999999999 111.941 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -104.8 -176.51 3.1 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.026 1.73 . . . . 1.45 112.974 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.21 160.42 22.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.526 1.13 . . . . 0.77000000000000002 112.368 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 mt -126.63 141.4 51.86 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 129.136 2.974 . . . . 1.77 106.038 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.26 138.8 48.02 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.129 0.877 . . . . 1.3 112.561 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -99.53 116.11 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.46 1.504 . . . . 0.76000000000000001 107.871 170.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -110.82 145.45 38.16 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.963 1.305 . . . . 1.8899999999999999 113.266 -162.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.53 -34.7 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.392 1.077 . . . . 1.1599999999999999 113.436 -154.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.2 151.87 18.3 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.978 -0.849 . . . . 1.1799999999999999 110.978 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -56.06 148.93 27.47 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.062 0.839 . . . . 1.8500000000000001 111.006 162.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.438 ' H ' HG12 ' A' ' 96' ' ' VAL . 38.4 t0 -127.05 133.9 50.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.359 1.076 . . . . 3.3300000000000001 113.232 -159.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -156.48 10.02 0.24 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.794 2.437 . . . . 3.3500000000000001 111.637 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -83.76 66.71 9.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.007 1.114 . . . . 3.2200000000000002 114.007 -157.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.5 p -75.23 30.91 0.1 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.075 1.139 . . . . 3.2000000000000002 114.075 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -165.62 147.15 7.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.745 2.018 . . . . 4.04 111.077 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 155.42 153.35 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 130.489 3.516 . . . . 4.3200000000000003 111.767 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -86.72 -17.15 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.26 3.307 . . . . 2.3500000000000001 112.863 163.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -91.33 144.02 29.12 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.878 1.271 . . . . 4.0 110.339 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -73.5 160.01 45.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.178 2.586 . . . . 4.9199999999999999 113.228 -166.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.31 2.48 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.606 1.963 . . . . 5.4000000000000004 114.756 170.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.83 3.67 80.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.733 1.159 . . . . 3.4500000000000002 114.159 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.96 -65.65 4.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.279 1.418 . . . . 1.9099999999999999 112.958 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.47 64.33 Favored Glycine 0 N--CA 1.476 1.367 0 C-N-CA 124.278 0.942 . . . . 1.6599999999999999 115.233 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.72 10.72 16.91 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.909 1.718 . . . . 2.02 115.582 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 p -71.39 156.05 39.92 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.581 1.691 . . . . 1.77 109.547 162.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.421 ' NH2' ' H ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.97 143.26 30.39 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.931 1.086 . . . . 6.1200000000000001 113.931 -173.154 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -99.63 -23.69 14.97 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.239 0.616 . . . . 2.46 111.402 153.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.89 158.31 43.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.251 0.932 . . . . 0.54000000000000004 113.453 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.46 150.07 51.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.383 1.873 . . . . 1.6200000000000001 110.05 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 107.84 0.37 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.049 1.785 . . . . 0.72999999999999998 112.007 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.04 139.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.595 1.158 . . . . 2.5 110.722 165.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.69 117.82 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.788 -0.57 . . . . 1.1399999999999999 110.202 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 125.629 1.572 . . . . 5.1500000000000004 110.222 179.386 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 119.276 -0.392 . . . . 1.8 110.627 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -155.47 140.6 17.46 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 119.625 -1.922 . . . . 1.3300000000000001 111.847 -172.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.33 146.4 21.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.542 1.163 . . . . 3.0600000000000001 111.881 166.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -109.55 116.94 32.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.571 1.549 . . . . 4.3499999999999996 113.423 -176.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -103.79 120.97 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.852 -1.155 . . . . 1.1699999999999999 110.822 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.8 108.63 2.99 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.557 2.027 . . . . 0.68999999999999995 112.159 178.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 35.0 mtt -90.43 139.17 30.93 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.953 1.834 . . . . 1.3200000000000001 115.953 -176.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -115.5 146.39 41.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.812 2.045 . . . . 3.0800000000000001 113.504 -174.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.98 63.08 4.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.555 1.542 . . . . 1.5700000000000001 113.066 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.8 105.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 120.929 -1.107 . . . . 1.4399999999999999 113.006 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.3 t -132.3 73.29 1.52 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.017 0.927 . . . . 2.5899999999999999 112.424 -173.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 71.19 -47.3 0.66 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.839 2.456 . . . . 1.3600000000000001 114.032 172.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.64 -12.58 61.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.819 1.248 . . . . 2.7799999999999998 112.085 174.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.67 -165.49 12.65 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.679 1.609 . . . . 1.24 113.542 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.57 134.35 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.856 1.663 . . . . 1.2 110.547 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.34 -83.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.214 1.388 . . . . 1.98 113.732 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -100.49 130.87 46.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.003 1.721 . . . . 2.2799999999999998 111.941 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -108.14 138.07 45.04 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.109 -0.994 . . . . 1.2 109.857 175.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mm -125.16 -16.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.86 1.43 . . . . 4.0300000000000002 114.86 -170.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.46 158.35 27.63 Favored Glycine 0 CA--C 1.521 0.467 0 O-C-N 121.518 -0.739 . . . . 1.04 111.907 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 p -88.34 173.98 8.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.062 0.934 . . . . 0.97999999999999998 109.219 163.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.1 132.91 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.896 -1.52 . . . . 0.58999999999999997 106.896 148.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.47 128.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 123.551 0.532 . . . . 0.87 110.174 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.48 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 125.283 1.433 . . . . 1.6599999999999999 108.208 -173.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.61 117.07 34.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 123.067 1.413 . . . . 1.8400000000000001 110.189 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.259 0.8 OUTLIER -81.95 122.03 27.25 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.205 3.402 . . . . 2.96 109.895 -169.481 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.0 t -144.2 178.44 7.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.17 0.986 . . . . 1.2 111.12 -173.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -28.98 68.06 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.491 1.916 . . . . 4.71 110.357 -176.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 13.7 60.59 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.563 1.554 . . . . 1.02 115.289 163.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.62 -151.17 21.15 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 127.627 2.537 . . . . 0.76000000000000001 116.552 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.54 101.2 4.8 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.869 . . . . 0.76000000000000001 111.53 -175.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.5 105.2 10.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.622 1.169 . . . . 1.79 110.833 173.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -93.86 116.64 29.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.575 2.35 . . . . 0.64000000000000001 109.975 -172.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -123.36 112.55 29.65 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 119.824 1.193 . . . . 0.56000000000000005 108.824 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.53 159.45 10.86 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.169 3.246 . . . . 0.54000000000000004 111.996 -173.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -150.06 39.61 0.77 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.24 0.543 . . . . 1.3600000000000001 112.287 171.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.48 142.34 28.68 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.032 -1.668 . . . . 0.88 112.828 -172.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 91.83 3.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.119 1.368 . . . . 2.1499999999999999 113.436 -171.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.534 ' C ' HD22 ' A' ' 40' ' ' LEU . . . 133.1 103.47 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 130.404 3.481 . . . . 2.0 107.227 -171.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.61 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -160.84 160.01 25.18 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 131.603 3.961 . . . . 2.6299999999999999 106.67 167.103 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -63.48 140.27 75.01 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 O-C-N 122.64 0.81 . . . . 1.3600000000000001 110.094 157.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -86.67 31.48 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.554 2.836 . . . . 1.49 113.513 -152.035 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.33 -177.44 14.99 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.154 1.359 . . . . 2.1499999999999999 113.527 -175.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -64.77 129.93 41.62 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 125.336 1.454 . . . . 3.3599999999999999 112.605 -168.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -125.57 131.34 52.75 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.594 1.158 . . . . 0.93999999999999995 110.209 -176.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.0 169.52 50.78 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 119.368 0.986 . . . . 0.64000000000000001 112.753 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 4.1 t80 -137.9 114.71 10.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.969 1.308 . . . . 1.9199999999999999 108.827 174.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -118.61 163.27 17.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.987 1.477 . . . . 0.70999999999999996 114.987 163.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.17 144.46 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.825 1.65 . . . . 0.68999999999999995 108.311 155.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -119.02 157.16 28.33 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.276 1.03 . . . . 0.82999999999999996 111.761 173.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -20.48 66.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 117.197 2.295 . . . . 0.69999999999999996 117.197 -162.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -132.43 -174.8 3.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.067 1.747 . . . . 1.1299999999999999 111.8 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 50.93 0.87 Allowed Glycine 0 N--CA 1.471 1.026 0 N-CA-C 116.316 1.286 . . . . 0.89000000000000001 116.316 -160.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 t -157.89 110.95 2.44 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.513 1.656 . . . . 2.3999999999999999 112.595 167.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.99 5.19 0.1 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.588 2.355 . . . . 1.3700000000000001 116.945 -173.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -83.84 140.56 40.6 Favored Pre-proline 0 CA--C 1.546 0.821 0 O-C-N 120.461 -1.399 . . . . 3.79 112.72 -167.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.84 148.84 12.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.04 3.16 . . . . 1.22 112.215 173.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.38 21.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.757 0.823 . . . . 1.5800000000000001 111.204 156.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.1 mm -114.48 103.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.852 1.261 . . . . 2.6000000000000001 109.428 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HE2' ' OD2' ' A' ' 61' ' ' ASP . 16.5 mtpt -101.63 149.13 24.44 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.393 1.477 . . . . 5.2999999999999998 110.051 168.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' OD2' ' HE2' ' A' ' 60' ' ' LYS . 12.8 m-20 46.59 39.02 6.25 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.276 1.213 . . . . 4.25 114.276 161.392 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.6 25.38 75.27 Favored Glycine 0 CA--C 1.537 1.406 0 CA-C-O 118.291 -1.283 . . . . 2.9100000000000001 115.556 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -156.07 158.25 37.46 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.395 2.098 . . . . 3.04 112.98 -177.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.14 139.73 31.88 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.354 -0.841 . . . . 1.55 113.0 -173.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 m -85.36 13.8 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 114.862 1.43 . . . . 2.8500000000000001 114.862 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.81 -51.41 0.7 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.849 2.46 . . . . 1.53 113.792 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.81 141.53 4.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.061 1.744 . . . . 2.1699999999999999 109.419 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.32 -50.99 1.99 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.969 0.508 . . . . 4.8700000000000001 111.424 173.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.3 1.24 6.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.549 1.314 . . . . 1.5900000000000001 114.549 -177.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 -18.7 35.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.277 1.431 . . . . 0.91000000000000003 112.522 166.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 -177.22 53.79 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 122.565 1.092 . . . . 2.23 114.764 176.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.86 179.9 37.35 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.941 1.258 . . . . 1.3700000000000001 113.669 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -69.51 5.06 1.49 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.042 1.867 . . . . 2.6299999999999999 116.042 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.3 tp 63.48 89.54 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.9 2.08 . . . . 1.6200000000000001 109.697 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -159.96 23.1 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 117.473 2.397 . . . . 3.4500000000000002 117.473 -156.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -61.37 -26.01 80.91 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.336 2.691 . . . . 2.0800000000000001 116.552 -152.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -131.4 22.75 4.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.197 0.999 . . . . 3.7000000000000002 111.62 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -89.94 -58.98 2.32 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.815 -1.178 . . . . 3.4100000000000001 113.294 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 159.84 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.294 3.037 . . . . 2.2400000000000002 111.293 -175.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.07 61.88 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.087 -1.396 . . . . 1.8300000000000001 115.336 176.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -72.14 -30.33 64.93 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.462 2.131 . . . . 5.3300000000000001 114.348 -175.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.46 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 58.9 t60 86.67 155.03 0.07 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 129.003 2.921 . . . . 1.6499999999999999 111.651 -166.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.74 -130.59 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.773 1.229 . . . . 3.8599999999999999 111.861 -173.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 145.11 -44.82 0.86 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 127.883 2.659 . . . . 2.8599999999999999 112.601 -174.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -111.39 -11.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.42 2.747 . . . . 3.2000000000000002 116.317 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -145.61 0.86 0.89 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.883 1.674 . . . . 4.5800000000000001 115.233 -153.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.99 -12.91 21.88 Favored Glycine 0 N--CA 1.476 1.345 0 O-C-N 120.462 -1.399 . . . . 3.2599999999999998 114.5 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.48 38.43 0.19 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.679 2.392 . . . . 6.5899999999999999 114.294 -166.375 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.94 -87.29 0.06 OUTLIER Glycine 0 C--N 1.342 0.902 0 O-C-N 120.427 -1.421 . . . . 2.5 114.911 -170.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -142.96 143.73 32.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.438 1.895 . . . . 3.5899999999999999 110.357 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -77.09 -14.43 59.81 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.829 1.195 . . . . 2.8700000000000001 114.013 170.171 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.63 3.37 79.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.296 -1.28 . . . . 0.84999999999999998 115.802 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.46 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 78.9 m-20 -94.2 129.25 40.88 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 119.424 1.612 . . . . 2.6200000000000001 112.08 -177.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 1.1 mm? -117.26 168.7 8.54 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.871 2.068 . . . . 1.9299999999999999 110.221 -177.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 94' ' ' LEU . 67.7 Cg_endo -81.44 167.4 17.3 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.066 2.51 . . . . 1.28 111.859 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.64 137.87 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 115.829 1.788 . . . . 1.6000000000000001 115.829 -163.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.22 95.19 4.26 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 130.845 3.658 . . . . 1.5600000000000001 110.059 170.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.34 131.26 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.919 -1.113 . . . . 1.01 111.759 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -118.03 149.5 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 127.328 2.251 . . . . 2.5099999999999998 109.082 167.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.87 166.36 19.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.723 1.009 . . . . 2.6899999999999999 113.723 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -13.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 119.389 3.107 . . . . 2.3199999999999998 119.389 -178.224 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -119.77 -4.4 10.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.639 1.576 . . . . 4.1100000000000003 114.355 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.09 38.77 2.25 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 116.785 1.474 . . . . 1.1200000000000001 116.785 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mm -126.6 130.84 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-N 119.507 1.653 . . . . 2.21 111.903 166.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.46 132.64 37.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.931 1.292 . . . . 0.79000000000000004 111.17 174.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 t -151.66 -14.2 0.2 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.992 1.849 . . . . 1.1200000000000001 115.992 -170.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.33 133.02 43.31 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 120.398 1.454 . . . . 3.5899999999999999 112.117 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.73 146.74 24.04 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.862 3.042 . . . . 1.04 112.372 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.25 170.72 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.356 1.863 . . . . 1.1399999999999999 110.005 172.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 m -135.68 140.76 44.71 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.152 0.887 . . . . 0.83999999999999997 110.971 -175.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.56 87.3 41.22 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.096 1.358 . . . . 0.81999999999999995 112.305 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.82 -7.98 14.5 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.408 3.405 . . . . 1.6799999999999999 114.95 176.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -65.23 -27.27 68.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.426 -0.796 . . . . 4.0999999999999996 110.921 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.33 142.8 50.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.796 2.039 . . . . 2.3599999999999999 109.265 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 32.46 0.54 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.074 1.35 . . . . 6.1600000000000001 113.239 -166.417 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.6 m -179.81 136.21 0.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.134 2.574 . . . . 1.78 109.867 162.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -32.67 63.34 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 118.946 0.794 . . . . 1.3700000000000001 111.321 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.8 -27.47 29.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.617 1.567 . . . . 3.2999999999999998 113.65 174.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.37 -28.98 68.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.184 0.902 . . . . 1.78 112.41 173.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.93 11.96 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.799 1.64 . . . . 0.96999999999999997 113.063 -161.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.08 -26.39 15.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.307 1.843 . . . . 2.1000000000000001 115.322 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -10.46 55.52 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.809 2.044 . . . . 3.77 114.587 177.347 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.24 168.84 9.95 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.986 1.476 . . . . 1.45 114.986 -154.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.56 151.5 31.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.337 1.455 . . . . 0.60999999999999999 112.053 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.22 143.77 39.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.488 1.915 . . . . 1.75 107.854 171.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.0 mtt -137.64 139.5 40.32 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.85 0.75 . . . . 1.1899999999999999 111.946 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.7 mt -100.41 126.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.569 1.548 . . . . 0.79000000000000004 108.346 171.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -105.85 149.26 26.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.995 1.318 . . . . 3.0699999999999998 113.43 -162.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.06 -43.0 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.924 0.89 . . . . 1.21 111.827 -167.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.89 171.3 27.15 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.857 -0.897 . . . . 0.96999999999999997 110.857 158.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.45 -147.88 0.02 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.328 2.871 . . . . 2.2000000000000002 114.573 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.52 54.03 0.48 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 123.746 1.736 . . . . 3.25 112.114 -150.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -160.94 27.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.511 -1.677 . . . . 3.3999999999999999 111.655 -162.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 70.5 mtm -132.86 116.25 16.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.529 1.132 . . . . 3.0099999999999998 111.355 -162.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 t -158.44 176.91 11.83 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.597 1.159 . . . . 3.1899999999999999 110.738 175.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 68.45 25.59 6.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.634 1.974 . . . . 3.77 114.012 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.94 153.27 78.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.498 1.119 . . . . 4.0599999999999996 111.774 178.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 -13.85 31.6 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.781 2.987 . . . . 1.9199999999999999 114.478 -170.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -100.07 87.11 0.68 Allowed Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 117.818 -1.087 . . . . 4.6500000000000004 108.596 157.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.77 151.95 60.38 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.933 2.422 . . . . 3.1600000000000001 111.562 -174.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mp 67.38 22.48 9.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 3.6200000000000001 110.301 -168.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.02 -7.58 4.26 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.569 1.557 . . . . 2.6899999999999999 114.612 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.81 1.35 87.2 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.096 1.332 . . . . 1.71 114.011 -163.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.7 67.05 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-N 118.982 1.391 . . . . 1.6000000000000001 114.878 -175.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.59 12.58 7.77 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.564 1.554 . . . . 1.6000000000000001 116.704 -169.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.4 p -75.18 169.1 18.71 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.341 1.57 . . . . 1.74 110.196 169.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 137.82 51.15 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.5 1.12 . . . . 5.1299999999999999 111.97 -173.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 3.5 t80 -85.26 -26.21 26.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.686 0.676 . . . . 2.21 111.881 162.035 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.01 157.78 36.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.236 0.828 . . . . 0.55000000000000004 113.236 173.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.8 t -136.68 148.56 47.45 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.646 1.978 . . . . 1.5 110.768 175.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -148.69 121.8 1.38 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.042 1.306 . . . . 0.66000000000000003 113.038 178.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.02 135.43 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.851 1.66 . . . . 1.6200000000000001 110.911 175.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.6 mt -79.21 155.02 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.068 1.347 . . . . 0.85999999999999999 111.036 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? . . . . . 0 CA--C 1.544 0.718 0 O-C-N 119.997 -1.689 . . . . 3.4500000000000002 110.949 169.783 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.609 -0.886 . . . . 1.99 108.609 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -142.54 150.01 39.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.88 1.437 . . . . 1.28 114.88 -133.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.04 141.25 17.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.468 1.128 . . . . 2.9500000000000002 109.825 167.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -90.67 135.39 33.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.617 -0.72 . . . . 2.8700000000000001 111.384 176.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.7 t -121.96 125.13 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.276 -0.89 . . . . 1.1499999999999999 111.108 177.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.13 115.17 4.14 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.836 1.207 . . . . 1.02 110.168 172.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.4 mtp -96.57 107.51 19.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.711 1.204 . . . . 1.71 109.695 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -93.98 146.21 24.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.813 0.671 . . . . 3.21 112.813 -169.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.4 62.75 1.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.378 1.071 . . . . 1.74 113.243 -175.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.6 m -58.54 131.84 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.507 -0.745 . . . . 1.4199999999999999 111.121 171.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -150.2 48.31 0.91 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.243 1.021 . . . . 2.5800000000000001 110.943 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.04 -36.7 0.32 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 128.703 2.801 . . . . 1.1399999999999999 112.004 -178.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.295 0.0 OUTLIER -78.28 41.84 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.248 1.419 . . . . 3.2200000000000002 114.1 174.205 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.17 -155.97 41.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.855 1.217 . . . . 1.54 112.362 175.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.82 125.28 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.158 -1.053 . . . . 1.1699999999999999 108.158 163.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.35 -82.06 1.55 Allowed Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.995 0.807 . . . . 2.1099999999999999 112.113 -166.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -158.37 164.83 35.95 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 122.389 1.09 . . . . 1.6399999999999999 112.579 167.355 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 t -103.16 146.76 27.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.758 1.623 . . . . 1.29 112.373 -176.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 pt -148.72 10.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.623 1.569 . . . . 2.77 113.516 -164.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.02 177.68 19.12 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.78 1.181 . . . . 0.83999999999999997 112.364 -165.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 p -129.47 -176.92 4.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.275 1.03 . . . . 1.01 109.984 170.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 54.6 t -126.52 136.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 124.273 1.029 . . . . 0.56000000000000005 108.367 159.438 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.56 133.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 123.198 0.312 . . . . 0.83999999999999997 110.325 171.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mt -108.77 133.78 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.871 -0.789 . . . . 1.6899999999999999 108.871 168.289 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -139.04 96.6 3.14 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.343 1.857 . . . . 2.2000000000000002 110.068 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 141.65 57.36 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 127.301 2.24 . . . . 4.3399999999999999 111.597 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -156.39 177.52 11.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.745 0.783 . . . . 1.3500000000000001 111.286 175.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.54 -18.51 62.17 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 3.96 112.012 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 7.26 81.13 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.927 1.251 . . . . 1.04 115.355 166.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.78 -169.66 42.93 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 129.458 3.409 . . . . 0.89000000000000001 116.145 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.24 105.45 0.34 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.353 1.461 . . . . 0.63 112.03 -175.531 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -84.75 113.4 21.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 2.1000000000000001 109.115 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 4.6 t80 -95.01 127.77 41.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.735 2.014 . . . . 0.72999999999999998 108.999 -177.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -137.64 109.77 8.69 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.501 1.501 . . . . 0.63 109.715 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.9 162.99 18.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.775 2.983 . . . . 0.60999999999999999 111.335 -175.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -150.11 30.7 0.7 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.051 0.76 . . . . 1.47 113.051 174.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.06 140.82 29.47 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.672 -1.267 . . . . 0.77000000000000002 112.425 -173.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 26.74 9.82 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.082 1.882 . . . . 2.0099999999999998 116.082 -168.381 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.65 65.26 0.67 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.131 0.572 . . . . 1.4399999999999999 112.127 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.2 159.39 69.92 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 121.731 -0.606 . . . . 1.3799999999999999 111.934 170.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -63.79 129.5 24.99 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 120.933 1.089 . . . . 0.81000000000000005 111.286 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.46 37.53 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.583 1 C-N-CA 126.752 4.968 . . . . 1.0700000000000001 113.251 -153.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.21 -135.4 7.31 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 123.52 1.622 . . . . 1.4299999999999999 112.165 -177.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -116.28 139.27 50.55 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.011 1.325 . . . . 2.5299999999999998 109.431 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -143.54 144.14 31.83 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.041 0.936 . . . . 1.3799999999999999 110.568 -168.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.95 160.85 52.21 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 110.262 -1.135 . . . . 0.94999999999999996 110.262 174.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 128.31 22.79 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 106.801 -1.555 . . . . 1.8400000000000001 106.801 166.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 93' ' ' ASP . 65.6 m170 -127.99 167.82 16.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.436 2.013 . . . . 1.02 116.436 173.712 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.7 146.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.716 1.606 . . . . 0.88 109.679 151.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.89 161.27 32.23 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.677 2.791 . . . . 0.94999999999999996 108.849 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -26.44 67.32 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.118 2.266 . . . . 0.85999999999999999 117.118 -157.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -140.36 165.65 26.85 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.184 1.394 . . . . 1.6799999999999999 113.271 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.13 104.11 2.68 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 120.806 -1.184 . . . . 0.98999999999999999 114.801 -172.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m 177.56 -173.56 0.12 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.773 3.229 . . . . 3.4500000000000002 109.443 171.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.8 m -120.03 -23.84 6.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.1 1.36 . . . . 2.4100000000000001 113.843 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -76.23 142.51 71.89 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.14 1.163 . . . . 3.02 114.14 -158.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.64 160.2 21.97 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.35 3.367 . . . . 1.1799999999999999 112.41 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.84 154.61 19.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.432 0.693 . . . . 1.77 109.954 158.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.72 123.7 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.206 1.002 . . . . 2.3700000000000001 108.86 -178.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -169.12 159.76 9.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.498 1.919 . . . . 5.5700000000000003 109.379 -175.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 t70 58.39 27.82 15.94 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.862 -1.149 . . . . 4.3600000000000003 113.234 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.03 14.52 82.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.991 1.281 . . . . 2.6699999999999999 115.032 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -152.65 164.02 38.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.391 1.595 . . . . 2.96 113.683 -168.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.71 113.75 26.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 1.74 111.109 -178.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.76 57.25 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.785 2.034 . . . . 2.1899999999999999 110.932 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.48 -68.13 0.12 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.964 2.505 . . . . 2.52 116.391 160.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -175.77 47.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.834 2.453 . . . . 2.3599999999999999 113.024 -167.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -59.48 -21.36 59.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.134 -1.604 . . . . 4.5099999999999998 113.658 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.38 -19.94 62.21 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 119.669 -1.894 . . . . 1.96 112.874 170.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 -9.27 26.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.199 1.8 . . . . 1.1599999999999999 113.606 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.63 165.21 32.65 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.018 -1.051 . . . . 2.9199999999999999 113.355 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.98 -173.09 23.98 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.855 -0.791 . . . . 1.45 112.752 168.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -44.66 138.92 3.14 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.515 0.726 . . . . 2.73 109.275 163.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 66.13 1.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.263 1.825 . . . . 2.9100000000000001 112.796 -165.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -110.06 83.79 3.2 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 129.002 2.921 . . . . 4.1299999999999999 108.226 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.36 -21.53 37.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.775 2.984 . . . . 3.2400000000000002 114.733 -176.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 6.26 0.24 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.293 0.849 . . . . 8.3300000000000001 113.293 153.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.71 -38.94 67.34 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.365 -1.46 . . . . 4.2599999999999998 114.828 -144.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t 169.26 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.267 2.227 . . . . 3.8399999999999999 112.078 -170.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.27 43.84 4.85 Favored Glycine 0 N--CA 1.47 0.931 0 CA-C-O 118.955 -0.914 . . . . 3.1499999999999999 113.077 176.199 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.316 12.9 ptmt -143.4 -101.08 0.12 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.912 1.449 . . . . 4.0999999999999996 114.912 -176.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.452 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -163.88 144.2 8.43 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 117.355 2.354 . . . . 2.0800000000000001 117.355 -157.533 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.64 -130.6 0.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.202 2.201 . . . . 4.0800000000000001 107.738 160.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.49 -89.59 0.56 Allowed Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.761 1.648 . . . . 2.8500000000000001 111.868 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -98.33 -21.0 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.297 2.665 . . . . 3.1299999999999999 114.993 -172.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 157.77 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.684 3.194 . . . . 5.4199999999999999 110.427 -161.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.76 -151.6 28.1 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.532 1.539 . . . . 3.4700000000000002 114.592 -172.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.78 13.18 0.27 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.43 2.011 . . . . 7.6799999999999997 116.43 -160.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.08 -178.55 38.42 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 120.251 1.387 . . . . 2.7599999999999998 113.071 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.773 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 19.3 t-160 57.32 96.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.246 1.818 . . . . 5.1299999999999999 115.007 170.214 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 65.37 6.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.693 -1.254 . . . . 2.9500000000000002 110.938 169.676 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.03 7.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.789 -1.562 . . . . 1.26 116.472 -176.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.773 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 3.2 m-20 -74.66 147.28 41.67 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.15 1.475 . . . . 1.8999999999999999 108.85 157.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.48 171.85 6.9 Favored Pre-proline 0 CA--C 1.555 1.151 0 O-C-N 121.314 -0.866 . . . . 1.8300000000000001 110.521 -142.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.89 133.21 19.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.326 2.018 . . . . 1.78 110.403 -174.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.01 132.39 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 123.362 1.554 . . . . 1.6799999999999999 112.766 -175.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -68.43 91.93 0.42 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.46 2.304 . . . . 2.46 110.253 168.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.14 131.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.028 -1.045 . . . . 1.04 109.133 166.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.77 133.55 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.407 1.883 . . . . 1.6200000000000001 106.915 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.41 154.57 22.73 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.808 0.731 . . . . 1.76 112.359 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -24.17 0.4 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.924 2.565 . . . . 2.5499999999999998 117.924 -167.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -93.22 -6.36 47.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.51 1.524 . . . . 2.9900000000000002 114.103 -176.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.25 20.71 8.48 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 125.072 1.32 . . . . 0.85999999999999999 115.487 175.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.71 127.81 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 118.161 0.98 . . . . 1.1799999999999999 109.984 -176.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.68 118.94 31.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 0.90000000000000002 109.291 169.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.1 t -135.48 4.45 3.13 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.963 1.305 . . . . 1.3 113.695 -178.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.01 119.74 69.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.856 1.662 . . . . 3.3500000000000001 112.982 -165.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.88 136.38 16.64 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.632 2.888 . . . . 1.21 112.402 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.97 173.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 126.557 1.943 . . . . 1.48 109.848 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 m -145.5 140.26 27.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.537 1.062 . . . . 0.72999999999999998 110.971 -174.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.34 90.64 5.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.609 1.163 . . . . 0.63 111.858 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.82 -2.61 11.21 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.09 3.193 . . . . 1.1699999999999999 115.293 -176.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.68 -15.95 61.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.379 1.472 . . . . 4.9299999999999997 112.396 176.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.09 145.31 49.99 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.67 1.988 . . . . 2.5699999999999998 107.684 175.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -147.44 32.9 0.88 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.603 2.361 . . . . 4.8300000000000001 111.625 -175.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -163.86 141.8 7.35 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.082 1.353 . . . . 1.6499999999999999 111.503 156.017 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.0 tp -65.96 -23.71 66.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.084 -1.01 . . . . 1.8200000000000001 110.685 175.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.07 -24.99 60.68 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.514 1.126 . . . . 2.6600000000000001 113.098 169.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -68.19 -15.87 63.75 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.641 1.11 . . . . 2.2999999999999998 112.392 174.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.93 8.08 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 114.192 1.182 . . . . 0.85999999999999999 114.192 -172.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -69.93 5.28 1.62 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 116.274 1.953 . . . . 3.1600000000000001 116.274 -171.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.46 9.09 3.98 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.137 2.175 . . . . 2.6899999999999999 112.195 177.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -110.45 -178.34 3.47 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.115 1.366 . . . . 1.6799999999999999 114.311 -168.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.51 149.88 41.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.988 1.315 . . . . 0.68000000000000005 111.8 172.016 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.07 154.24 17.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.669 1.988 . . . . 1.7 107.828 165.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.5 mtt -142.09 141.17 32.71 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.367 -0.833 . . . . 1.3 113.067 170.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.9 mt -88.34 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 108.18 -1.045 . . . . 0.94999999999999996 108.18 165.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.21 152.64 47.12 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.205 1.557 . . . . 2.02 115.205 -165.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.06 -53.53 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.727 1.611 . . . . 1.4099999999999999 112.762 -159.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.56 179.39 52.44 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.573 -1.411 . . . . 1.1699999999999999 109.573 158.107 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.82 -143.87 0.03 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 127.236 2.351 . . . . 2.29 112.553 168.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -151.53 59.92 0.88 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.185 1.18 . . . . 3.5899999999999999 114.185 -169.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -149.31 21.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.219 1.008 . . . . 3.0 113.564 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.06 142.71 52.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.017 1.327 . . . . 4.7199999999999998 112.672 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.4 p -85.04 166.49 16.65 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.88 1.272 . . . . 5.7800000000000002 112.864 172.523 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.92 142.43 51.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.814 0.846 . . . . 6.71 112.172 177.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.87 156.76 34.4 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.816 1.246 . . . . 4.5899999999999999 109.581 -160.349 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.03 -0.06 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.019 3.146 . . . . 2.6000000000000001 114.169 174.103 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -116.79 132.85 23.19 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.169 0.988 . . . . 6.3099999999999996 108.557 159.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.86 164.68 32.58 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.791 2.327 . . . . 3.5699999999999998 112.286 -173.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt 69.55 4.84 4.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.814 2.046 . . . . 4.4500000000000002 113.729 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.57 15.16 77.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.103 0.859 . . . . 2.96 113.359 -175.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.46 -51.52 3.34 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.537 1.541 . . . . 1.8600000000000001 113.757 -178.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.46 -10.5 73.62 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.333 1.444 . . . . 1.78 115.044 -176.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.49 42.44 1.97 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.653 1.597 . . . . 2.9399999999999999 113.937 -178.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.7 p -119.39 163.64 16.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 128.473 2.709 . . . . 3.6899999999999999 109.84 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.47 140.17 29.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.667 2.099 . . . . 6.0899999999999999 116.667 -166.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -98.99 -20.77 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.103 1.361 . . . . 2.8199999999999998 112.195 155.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.69 153.39 29.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.169 0.895 . . . . 0.73999999999999999 113.151 173.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 19.0 p -84.66 -149.86 0.12 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.723 1.609 . . . . 2.98 111.88 171.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.17 81.11 0.03 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.28 0.943 . . . . 0.82999999999999996 113.806 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.69 120.1 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.386 1.075 . . . . 2.1600000000000001 111.568 176.003 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 71.2 mt -79.76 138.72 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.147 -0.686 . . . . 0.93999999999999995 109.147 173.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.549 0.939 0 O-C-N 120.503 -1.373 . . . . 3.8900000000000001 111.335 -176.33 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.379 -0.6 . . . . 1.99 109.379 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -138.38 158.46 44.24 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.832 -1.167 . . . . 0.97999999999999998 114.089 -145.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -160.41 116.65 2.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.518 1.527 . . . . 3.4700000000000002 108.118 -175.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -90.46 143.14 27.04 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.884 -1.135 . . . . 3.9100000000000001 110.475 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' C ' HG23 ' A' ' 21' ' ' THR . 58.8 t -134.64 85.59 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 122.424 1.107 . . . . 1.05 111.707 177.064 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -32.07 114.52 0.08 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 127.252 2.358 . . . . 1.02 113.131 147.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.8 mtt -101.9 148.41 25.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 113.79 -1.205 . . . . 1.3700000000000001 113.365 171.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.22 148.38 35.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 2.2999999999999998 110.647 168.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.1 mt -61.18 135.93 57.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.512 -0.922 . . . . 1.1599999999999999 108.512 166.29 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.5 143.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.423 1.089 . . . . 1.03 108.912 173.098 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -171.68 91.87 0.13 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.512 -0.921 . . . . 2.4399999999999999 108.512 -174.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.85 -62.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.943 2.097 . . . . 1.6499999999999999 113.507 -177.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.265 0.1 OUTLIER -80.76 12.62 3.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.91 1.684 . . . . 5.3700000000000001 114.859 -173.212 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.14 -151.02 32.77 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.221 0.915 . . . . 1.02 112.049 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.98 110.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.452 1.901 . . . . 0.82999999999999996 111.835 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.58 -72.3 1.11 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.901 1.239 . . . . 1.7 113.636 -175.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.92 153.44 16.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.645 1.178 . . . . 1.8999999999999999 111.649 -175.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -92.97 145.22 24.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.014 1.726 . . . . 1.3899999999999999 114.523 -165.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 5.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 115.949 1.833 . . . . 3.5800000000000001 115.949 -177.193 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.74 175.54 20.58 Favored Glycine 0 N--CA 1.467 0.704 0 O-C-N 121.197 -0.94 . . . . 0.63 113.86 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 5' ' ' VAL . 64.4 m -115.34 156.51 25.36 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.975 1.31 . . . . 2.6499999999999999 108.859 172.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.49 133.43 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.889 -1.152 . . . . 0.52000000000000002 107.889 152.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -91.61 129.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 117.872 0.305 . . . . 0.93999999999999995 110.911 175.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mt -100.42 129.87 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.406 -0.961 . . . . 1.6899999999999999 108.406 170.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -133.21 123.55 25.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.272 1.029 . . . . 2.0600000000000001 109.279 167.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -78.56 157.98 28.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 112.252 0.464 . . . . 3.48 112.252 -177.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 t -156.36 178.49 10.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.906 0.86 . . . . 1.45 109.834 168.016 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -63.83 -13.42 44.47 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.419 2.288 . . . . 3.8599999999999999 113.137 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.22 8.73 53.47 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.104 1.812 . . . . 1.28 115.437 165.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.68 -162.85 28.08 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 130.643 3.973 . . . . 0.92000000000000004 117.638 171.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.55 108.02 2.28 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.357 1.063 . . . . 0.69999999999999996 111.738 -172.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -85.98 109.75 18.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.41 1.084 . . . . 1.8999999999999999 110.209 173.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.8 t80 -94.29 112.81 24.63 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.375 2.27 . . . . 0.55000000000000004 108.835 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 m -120.1 112.31 34.84 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 120.003 1.274 . . . . 0.69999999999999996 108.58 -176.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.58 150.6 7.57 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.011 2.474 . . . . 0.54000000000000004 113.156 -171.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' NE2' ' HB ' ' A' ' 21' ' ' THR . 7.9 p80 -147.51 41.98 1.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.356 1.074 . . . . 1.51 112.547 171.443 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.19 156.51 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.707 1.603 . . . . 0.82999999999999996 113.845 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 167.0 18.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.131 -1.85 . . . . 3.3300000000000001 109.211 176.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.55 19.42 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.14 2.576 . . . . 1.51 113.566 172.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.616 HD12 HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -91.33 164.75 23.56 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 121.678 -0.639 . . . . 1.79 110.231 174.324 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.29 145.3 96.05 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 120.296 0.664 . . . . 0.82999999999999996 111.578 165.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 10.2 Cg_endo -85.39 25.61 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 125.111 3.874 . . . . 1.0600000000000001 114.253 -153.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.84 -141.1 6.7 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 125.216 1.389 . . . . 1.28 116.012 -174.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.3 141.92 29.06 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.67 2.388 . . . . 2.3999999999999999 110.451 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -136.18 137.66 41.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.463 1.105 . . . . 1.6299999999999999 111.449 -172.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 157.38 52.34 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.899 -1.126 . . . . 0.78000000000000003 111.631 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 8.4 t80 -130.98 112.92 13.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.155 -1.424 . . . . 1.96 107.155 173.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -118.48 162.21 18.72 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.127 -0.983 . . . . 1.02 113.518 165.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.41 135.08 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.429 1.492 . . . . 0.81000000000000005 107.281 159.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -115.06 159.08 21.25 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.602 0.761 . . . . 0.94999999999999996 109.659 170.013 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.13 79.59 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.827 1.788 . . . . 1.01 115.827 -160.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.97 143.64 48.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.398 1.079 . . . . 1.1299999999999999 113.019 -173.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.55 62.18 2.75 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.512 1.53 . . . . 1.0600000000000001 114.941 -176.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -162.73 89.88 0.68 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.408 1.604 . . . . 2.0699999999999998 115.225 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.0 m -74.15 74.25 1.76 Allowed 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.041 -1.662 . . . . 2.7400000000000002 111.8 166.069 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -122.27 144.95 43.0 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.239 1.016 . . . . 3.2200000000000002 110.365 174.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.05 162.43 10.2 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.971 2.447 . . . . 1.1399999999999999 113.831 -167.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.51 128.78 55.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.387 1.075 . . . . 1.8200000000000001 108.935 161.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mm -90.71 38.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.456 1.122 . . . . 3.2799999999999998 110.009 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -66.72 130.34 42.84 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.929 1.291 . . . . 4.1699999999999999 110.976 -167.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t70 57.65 21.76 7.58 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.148 1.166 . . . . 3.7200000000000002 114.148 -176.309 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.05 76.01 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.148 0.88 . . . . 2.5699999999999998 114.495 177.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.75 134.88 52.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.401 1.601 . . . . 2.8799999999999999 110.71 172.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.74 95.11 9.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.319 -0.863 . . . . 1.8700000000000001 112.104 -169.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.73 95.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.596 1.558 . . . . 2.3900000000000001 108.594 173.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.4 -25.88 0.47 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 119.797 3.258 . . . . 2.8700000000000001 119.797 -156.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.67 38.06 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 120.128 1.331 . . . . 1.5800000000000001 114.267 -168.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.26 -34.12 73.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.224 1.01 . . . . 4.7699999999999996 113.076 -177.453 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.68 0.55 1.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.036 1.495 . . . . 1.4399999999999999 115.036 -175.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.57 -10.84 59.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.217 1.407 . . . . 1.0 113.856 175.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.33 32.89 12.58 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 116.796 1.479 . . . . 3.1800000000000002 116.796 164.016 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.57 -178.58 31.54 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 119.452 1.626 . . . . 1.0900000000000001 114.457 174.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -76.2 22.58 0.16 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.197 1.554 . . . . 2.27 115.197 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.254 31.1 tp 64.41 36.16 9.12 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.143 1.377 . . . . 1.7 111.508 172.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -123.17 49.55 2.54 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 116.371 1.989 . . . . 3.6099999999999999 116.371 -161.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.33 -29.14 46.44 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.51 2.14 . . . . 2.4199999999999999 113.028 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -127.16 34.88 4.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.649 1.18 . . . . 4.4699999999999998 111.905 -168.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -119.84 -153.6 0.55 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.834 1.254 . . . . 3.3700000000000001 110.882 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.6 p -88.99 -25.17 22.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.271 1.428 . . . . 3.0800000000000001 113.174 175.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.31 88.78 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.392 0.996 . . . . 2.0 114.74 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -98.05 7.94 45.53 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 116.116 1.895 . . . . 4.8399999999999999 116.116 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.7 t60 68.61 168.04 0.27 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.961 1.704 . . . . 2.0499999999999998 112.768 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -150.17 155.25 39.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.793 1.405 . . . . 3.6000000000000001 114.793 -149.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.33 -155.06 6.89 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 126.291 1.9 . . . . 2.6000000000000001 112.873 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.26 -9.79 24.83 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.861 3.041 . . . . 3.79 113.041 173.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.31 162.56 32.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.48 1.912 . . . . 6.3499999999999996 109.159 166.486 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.42 -159.71 23.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.28 0.943 . . . . 4.54 112.84 -172.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.95 137.21 3.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.393 2.277 . . . . 4.6900000000000004 105.876 168.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.7 -72.87 0.02 OUTLIER Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.195 0.902 . . . . 2.77 114.282 -172.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -150.85 125.75 9.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.596 1.959 . . . . 4.0300000000000002 110.801 -173.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -62.45 -20.38 64.47 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.223 1.194 . . . . 2.7200000000000002 114.223 175.108 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.39 8.22 59.03 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.631 2.062 . . . . 1.1799999999999999 116.031 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.39 139.75 30.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.995 1.397 . . . . 1.6499999999999999 111.154 167.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.61 163.63 49.75 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 126.784 2.034 . . . . 2.0600000000000001 110.077 -172.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.77 162.43 26.91 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.141 2.561 . . . . 1.0700000000000001 112.304 -172.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.12 141.92 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.699 1.37 . . . . 1.52 114.699 -164.092 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.12 107.09 18.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 130.675 3.59 . . . . 1.76 108.682 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.34 137.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.907 -1.121 . . . . 0.93000000000000005 110.575 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 40' ' ' LEU . 10.9 m -109.09 161.2 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.356 0.662 . . . . 2.1800000000000002 109.962 164.027 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.91 165.07 16.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.864 0.466 . . . . 2.0299999999999998 110.927 175.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -62.72 4.79 0.14 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 117.568 2.433 . . . . 2.9399999999999999 117.568 -161.443 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -104.17 -11.08 17.48 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.27 2.628 . . . . 3.4500000000000002 113.395 176.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.49 24.48 12.26 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 121.365 -0.834 . . . . 0.81999999999999995 114.675 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.5 mt -126.05 129.84 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.629 1.172 . . . . 1.46 110.92 -176.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -89.22 147.66 24.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.099 2.16 . . . . 1.1499999999999999 112.075 -172.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.97 -21.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.89 1.276 . . . . 1.22 114.057 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.53 116.95 50.61 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.457 1.103 . . . . 3.0600000000000001 110.447 176.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -85.07 163.13 11.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.592 2.862 . . . . 1.3400000000000001 112.349 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.85 161.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.723 1.209 . . . . 1.26 110.577 170.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 m -124.04 139.81 53.58 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.327 1.051 . . . . 0.87 110.041 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.58 97.85 29.71 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.21 1.004 . . . . 0.83999999999999997 110.79 174.137 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.88 -0.8 10.36 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.925 3.083 . . . . 1.3600000000000001 114.333 -176.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -86.94 -2.76 58.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.627 1.571 . . . . 4.0599999999999996 112.696 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.1 mt -141.53 123.86 15.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.52 2.328 . . . . 2.3599999999999999 106.242 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -116.18 5.66 13.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.857 1.263 . . . . 4.71 114.158 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.7 t -149.38 150.05 31.83 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.441 0.904 . . . . 1.8999999999999999 113.441 175.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.78 -28.68 70.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.377 -0.827 . . . . 1.6200000000000001 112.569 170.117 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.01 -18.57 65.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.065 1.302 . . . . 3.6699999999999999 113.58 -177.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.03 -19.49 61.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.338 1.055 . . . . 1.73 112.121 172.557 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.47 7.26 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.656 1.182 . . . . 0.80000000000000004 113.941 -170.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -63.68 5.67 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.263 2.32 . . . . 2.46 117.263 -174.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.54 0.43 2.49 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.713 2.005 . . . . 3.0 112.607 -178.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -95.81 171.71 8.48 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.457 1.503 . . . . 1.48 113.577 -168.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.73 150.28 27.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.511 1.124 . . . . 0.51000000000000001 111.984 165.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 mt -122.4 140.29 52.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.41 2.284 . . . . 1.7 107.803 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.485 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -143.23 146.81 33.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.418 1.008 . . . . 2.5499999999999998 113.599 177.937 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.8 119.14 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.274 1.43 . . . . 1.1399999999999999 108.301 166.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' A' ' 126' ' ' MET . 74.6 m80 -98.57 148.44 23.78 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.672 1.589 . . . . 3.0600000000000001 112.013 -168.5 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.8 -46.37 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.173 0.589 . . . . 1.75 112.144 -158.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.35 169.71 13.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.79 1.186 . . . . 1.79 111.14 164.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.28 -174.6 4.68 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.216 1.865 . . . . 1.77 113.433 170.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -159.91 166.22 30.58 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.787 0.835 . . . . 3.5299999999999998 111.914 -166.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.0 p30 159.04 23.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 132.721 4.408 . . . . 3.0699999999999998 111.625 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 72.9 mtm -92.37 106.84 18.76 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.897 -1.127 . . . . 3.2999999999999998 112.504 -165.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 p -93.05 158.86 15.56 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.656 -1.277 . . . . 3.5600000000000001 113.903 169.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.2 t0 65.58 17.96 11.08 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.417 2.006 . . . . 5.4100000000000001 116.417 155.04 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.9 157.08 49.17 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 120.699 -1.251 . . . . 6.8799999999999999 113.675 -172.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.36 -21.75 3.52 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.667 2.911 . . . . 3.04 114.134 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -102.92 95.74 6.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.088 -1.007 . . . . 7.2699999999999996 108.382 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.65 143.78 75.99 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.566 2.177 . . . . 3.4700000000000002 111.504 -164.346 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 77.06 -10.74 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.472 2.709 . . . . 4.0599999999999996 113.013 -174.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 62.58 15.41 53.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 2.6400000000000001 115.66 170.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.1 -21.8 32.45 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.912 1.244 . . . . 2.6499999999999999 113.631 -170.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.89 -8.18 52.21 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.403 1.478 . . . . 2.4900000000000002 114.009 176.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.69 -5.14 83.01 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.025 1.298 . . . . 2.0699999999999998 114.514 170.201 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.6 p -75.78 132.28 40.33 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.894 1.347 . . . . 1.8 110.174 175.104 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -97.84 135.08 40.11 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.167 0.987 . . . . 5.9699999999999998 110.192 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 26.7 t80 -91.0 -40.04 11.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.047 0.385 . . . . 2.2400000000000002 110.326 164.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.52 29.26 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.909 0.884 . . . . 1.1399999999999999 111.931 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.2 m -114.73 145.03 42.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.891 2.076 . . . . 2.8700000000000001 111.233 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.74 167.65 26.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.919 1.723 . . . . 1.3700000000000001 113.225 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.9 t -135.54 141.91 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.738 1.215 . . . . 1.53 109.734 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.2 mt -89.06 143.47 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.738 1.215 . . . . 0.82999999999999996 110.774 -176.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 4.6200000000000001 111.287 -177.27 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.238 0.542 . . . . 1.73 110.659 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -148.43 149.78 32.32 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.856 0.862 . . . . 0.97999999999999998 110.362 -172.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.04 132.05 16.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.657 1.217 . . . . 2.23 110.053 171.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -88.56 109.79 20.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.179 0.992 . . . . 3.7200000000000002 111.559 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -87.02 105.51 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.609 -1.307 . . . . 1.47 108.885 -169.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -59.38 108.81 1.8 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.651 1.596 . . . . 1.3600000000000001 109.953 169.426 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.7 mtt -109.41 154.03 23.16 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.275 1.43 . . . . 1.23 112.508 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -145.9 149.68 34.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.56 1.544 . . . . 3.0600000000000001 112.003 -169.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.41 66.1 3.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.953 1.301 . . . . 1.6000000000000001 111.435 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.25 144.83 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.698 0.799 . . . . 0.88 111.599 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.4 t -172.69 72.19 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.451 1.1 . . . . 2.0499999999999998 111.152 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.11 -19.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.866 2.066 . . . . 1.3 114.834 173.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -28.86 66.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.479 1.912 . . . . 2.9100000000000001 110.006 164.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.47 -159.23 24.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.182 1.372 . . . . 1.1399999999999999 111.067 -154.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -46.15 127.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.411 1.884 . . . . 1.1399999999999999 111.122 165.709 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.79 -68.02 0.18 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.607 1.575 . . . . 1.6599999999999999 114.039 -173.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.156 1.382 . . . . 1.8500000000000001 110.543 171.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -109.25 172.23 6.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.737 -1.227 . . . . 1.3400000000000001 112.571 178.106 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.7 pt -151.19 5.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 128.98 2.912 . . . . 3.0800000000000001 112.479 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.53 159.37 9.08 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 121.137 -0.977 . . . . 0.92000000000000004 113.751 -161.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 6' ' ' GLY . 72.9 p -125.99 -178.5 4.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.683 1.993 . . . . 1.6899999999999999 106.74 173.25 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 61.0 t -133.52 125.83 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.359 -0.978 . . . . 0.60999999999999999 108.359 169.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.0 p -74.77 124.69 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 117.978 0.354 . . . . 0.93999999999999995 110.599 170.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HD21 ' A' ' 125' ' ' LEU . 8.4 mt -98.41 131.43 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 108.298 -1.001 . . . . 1.5600000000000001 108.298 163.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -140.05 121.47 15.05 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.132 1.373 . . . . 1.8100000000000001 108.572 178.154 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.74 150.26 21.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.801 0.667 . . . . 3.0499999999999998 112.801 -169.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.6 178.9 9.57 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.108 0.563 . . . . 1.1799999999999999 110.546 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -60.53 -30.81 69.98 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.676 1.19 . . . . 3.6099999999999999 110.958 175.019 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.6 13.96 53.54 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.164 1.364 . . . . 0.89000000000000001 114.953 168.253 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.31 -148.49 20.71 Favored Glycine 0 N--CA 1.468 0.782 0 C-N-CA 127.167 2.318 . . . . 0.68999999999999995 116.268 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.2 mt -79.18 101.54 8.0 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.169 -0.606 . . . . 0.59999999999999998 110.862 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -75.73 112.37 12.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 2.3300000000000001 109.587 171.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 3.2 t80 -98.79 109.07 21.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 128.02 2.528 . . . . 0.52000000000000002 108.14 -178.355 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.422 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.5 m -111.13 105.64 57.11 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.335 -1.357 . . . . 0.64000000000000001 107.335 176.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.31 153.23 24.17 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.316 2.677 . . . . 0.75 110.846 -171.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.97 63.37 0.65 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.177 0.989 . . . . 2.79 111.013 178.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.25 141.78 51.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.057 2.143 . . . . 0.87 111.528 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -129.32 20.82 5.71 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 118.029 2.603 . . . . 2.7000000000000002 118.029 -158.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.43 19.58 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 115.581 1.697 . . . . 1.8999999999999999 115.581 -173.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.78 165.35 19.12 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 121.492 -0.755 . . . . 1.75 110.856 -171.419 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 59.9 Cg_endo -65.95 131.26 26.65 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 N-CA-C 109.806 -0.882 . . . . 1.1399999999999999 109.806 163.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 6.0 Cg_endo -88.88 34.2 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.272 3.315 . . . . 1.1299999999999999 112.402 -148.175 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.44 -122.54 4.8 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 123.821 1.79 . . . . 1.51 113.616 -178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -134.88 142.41 46.58 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 126.372 1.869 . . . . 3.1000000000000001 109.747 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -134.59 145.87 49.07 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.572 1.149 . . . . 1.1200000000000001 111.707 -173.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.82 157.16 26.72 Favored Glycine 0 CA--C 1.542 1.758 0 O-C-N 121.024 -1.048 . . . . 0.63 111.951 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -145.56 120.51 10.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.791 1.237 . . . . 2.0499999999999998 108.086 168.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.12 165.16 24.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.702 1.742 . . . . 0.85999999999999999 115.702 164.077 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.0 mt -89.96 144.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.398 1.479 . . . . 0.78000000000000003 109.143 160.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -127.44 170.19 12.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.885 2.074 . . . . 1.1100000000000001 111.361 -178.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.98 52.74 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.99 2.218 . . . . 1.02 116.99 -160.078 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -110.51 -157.41 0.61 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.752 1.221 . . . . 2.3100000000000001 111.477 -175.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.12 -27.63 8.67 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 117.65 1.82 . . . . 1.9399999999999999 117.65 -155.413 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 175.8 140.12 0.06 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.963 2.382 . . . . 3.3799999999999999 113.877 -173.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.58 67.08 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 117.354 2.353 . . . . 3.5800000000000001 117.354 -176.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -94.09 152.04 40.09 Favored Pre-proline 0 CA--C 1.55 0.963 0 O-C-N 121.053 -1.029 . . . . 3.3199999999999998 110.689 160.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -90.22 177.63 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.207 3.272 . . . . 1.49 112.673 -168.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.67 147.21 37.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.995 1.318 . . . . 1.4099999999999999 110.624 172.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.87 126.94 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.915 0.886 . . . . 2.46 110.989 -174.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.86 156.47 22.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.706 2.402 . . . . 5.79 110.73 173.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 52.09 37.33 21.23 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.078 1.51 . . . . 4.1799999999999997 115.078 167.028 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.88 79.38 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.003 -1.061 . . . . 2.52 114.351 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.07 156.04 42.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.857 1.328 . . . . 4.2800000000000002 113.528 -176.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.77 121.78 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.647 0.779 . . . . 1.6699999999999999 108.909 164.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.41 132.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.719 1.208 . . . . 3.0 108.567 171.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.3 -37.75 17.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.808 1.243 . . . . 1.8999999999999999 114.148 -172.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -179.98 123.74 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.465 2.706 . . . . 1.8400000000000001 110.307 175.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -121.49 -29.07 4.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.905 1.282 . . . . 4.2199999999999998 112.547 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.96 -0.29 8.98 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.202 -1.561 . . . . 1.8600000000000001 114.071 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.56 -17.46 33.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.734 1.614 . . . . 1.23 113.273 164.092 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.59 179.61 52.81 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.642 1.591 . . . . 2.5099999999999998 114.439 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.5 -172.8 25.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.946 0.784 . . . . 1.1699999999999999 112.864 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.94 24.07 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.047 1.739 . . . . 2.1499999999999999 115.627 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.9 tp 52.29 49.04 21.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.211 1.405 . . . . 1.8300000000000001 110.493 176.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -151.49 110.8 2.98 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.433 -0.803 . . . . 4.29 112.634 -171.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -91.72 -18.96 0.84 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.012 2.475 . . . . 2.9199999999999999 113.766 174.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -159.25 -22.56 0.07 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.938 1.829 . . . . 3.6600000000000001 115.938 -163.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -64.76 -35.86 82.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.751 1.614 . . . . 3.5800000000000001 112.366 -171.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -165.91 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.991 2.517 . . . . 3.9300000000000002 111.263 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.18 11.14 70.12 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.515 1.531 . . . . 2.3900000000000001 112.73 -177.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -167.16 -105.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.245 1.818 . . . . 5.6799999999999997 113.033 -166.142 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.433 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 4.2 t60 -161.43 141.57 10.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.727 1.751 . . . . 2.4700000000000002 115.727 -161.538 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.43 149.83 36.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.092 0.957 . . . . 4.0 113.293 174.171 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.52 -145.63 17.88 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 110.316 -1.114 . . . . 2.8100000000000001 110.316 156.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.39 17.56 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.996 3.131 . . . . 3.48 114.253 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.63 -11.08 8.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.691 1.596 . . . . 4.7800000000000002 114.429 -157.524 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.14 -7.68 81.58 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 116.955 1.542 . . . . 3.5600000000000001 116.955 169.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -78.02 83.16 4.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 1.585 . . . . 5.3300000000000001 109.383 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.8 -177.1 14.89 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 123.936 0.779 . . . . 3.2999999999999998 114.812 -168.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.998 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 5.4 p-80 -92.04 157.92 16.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.693 0.797 . . . . 5.75 111.274 169.312 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -63.05 -10.12 12.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.118 1.525 . . . . 3.1800000000000002 115.118 -179.151 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.617 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -115.24 19.9 14.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.798 2.142 . . . . 1.5800000000000001 113.753 173.349 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.998 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 69.0 m-20 -73.86 135.12 43.36 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.42 1.11 . . . . 2.5099999999999998 109.491 164.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.01 160.48 31.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.16 1.384 . . . . 1.8300000000000001 110.294 -147.521 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.11 168.77 20.07 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.216 3.277 . . . . 1.1100000000000001 111.633 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 m -82.0 142.89 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 122.894 1.33 . . . . 1.4399999999999999 113.374 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.76 92.73 3.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 129.061 2.944 . . . . 1.8 109.204 172.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 95.9 t -74.75 137.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.875 0.87 . . . . 1.1100000000000001 110.366 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.99 143.22 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.427 2.291 . . . . 1.49 106.305 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.8 164.49 12.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.858 0.754 . . . . 2.0499999999999998 111.701 174.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.64 -23.82 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 129.597 3.159 . . . . 2.8500000000000001 118.112 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.88 -23.5 52.61 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.935 1.694 . . . . 3.9700000000000002 112.463 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.46 17.73 32.91 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.948 1.737 . . . . 0.88 112.941 -161.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.1 mt -111.81 119.99 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.962 1.305 . . . . 1.05 110.966 -176.105 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.84 127.52 39.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.775 1.23 . . . . 0.87 109.732 168.179 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -156.2 4.49 0.17 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.233 1.568 . . . . 1.3600000000000001 115.233 -175.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.22 135.9 26.39 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 119.81 1.186 . . . . 3.5299999999999998 110.638 172.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.0 141.72 49.14 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.017 3.145 . . . . 1.1399999999999999 112.189 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.09 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.823 2.049 . . . . 1.6599999999999999 108.151 173.019 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.4 m -145.96 139.64 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.931 1.241 . . . . 0.68000000000000005 111.707 -178.584 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.01 94.06 5.05 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.26 1.024 . . . . 0.72999999999999998 112.462 169.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.79 -5.07 16.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.133 3.222 . . . . 1.3500000000000001 113.933 172.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -73.11 -7.92 53.45 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.146 1.778 . . . . 4.96 111.863 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.6 mt -124.28 177.16 6.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.735 2.414 . . . . 2.2599999999999998 109.821 170.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -144.39 -20.69 0.54 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.012 1.856 . . . . 4.0800000000000001 116.012 -172.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -144.03 163.25 34.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.847 1.203 . . . . 1.48 112.399 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.23 61.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.285 -0.884 . . . . 1.5900000000000001 110.297 174.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.95 -27.68 69.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.378 1.071 . . . . 3.1299999999999999 113.503 -166.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 119' ' ' GLU . 9.1 pt-20 -71.48 -20.36 62.09 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.753 1.621 . . . . 1.8300000000000001 113.869 175.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.33 8.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.374 1.47 . . . . 1.0800000000000001 112.984 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -62.08 -4.41 1.67 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.107 1.891 . . . . 2.3300000000000001 116.107 -175.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -137.67 24.26 2.88 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.318 2.247 . . . . 3.0099999999999998 110.814 -160.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -130.68 158.44 40.06 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.332 1.453 . . . . 1.28 113.931 -168.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.76 150.65 20.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.097 1.759 . . . . 0.93000000000000005 112.987 168.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 24' ' ' ILE . 7.4 mp -127.36 121.01 29.82 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.043 2.137 . . . . 3.0499999999999998 109.86 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -103.06 131.65 49.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.786 0.835 . . . . 2.3500000000000001 111.405 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.6 mt -93.52 123.38 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 107.818 -1.179 . . . . 0.68000000000000005 107.818 160.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -112.89 140.86 47.33 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.427 1.491 . . . . 1.8600000000000001 112.262 -159.024 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.03 -41.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.555 -0.716 . . . . 1.24 111.585 -168.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.23 163.57 15.0 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.493 0.568 . . . . 1.23 112.135 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.22 87.72 1.49 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.08 -1.208 . . . . 1.8500000000000001 110.08 173.349 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -61.78 122.61 15.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.797 0.839 . . . . 4.2999999999999998 111.645 178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 171.81 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.239 2.616 . . . . 3.4900000000000002 109.662 -157.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.9 ptp -74.15 60.42 0.79 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.345 1.458 . . . . 3.3300000000000001 112.192 171.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 t -74.08 -20.38 60.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.186 1.794 . . . . 3.77 115.111 -165.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -81.87 76.18 8.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 3.3599999999999999 112.269 -173.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -169.56 156.69 6.42 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.08 1.352 . . . . 3.9199999999999999 111.78 -179.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.89 -9.65 18.15 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.711 2.941 . . . . 2.8900000000000001 113.64 176.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -93.2 106.12 18.45 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 119.229 0.922 . . . . 4.3799999999999999 109.0 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.46 160.22 47.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.104 2.536 . . . . 3.2000000000000002 113.274 -158.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.58 32.22 21.92 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.834 1.654 . . . . 3.7799999999999998 111.501 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.34 67.45 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.668 1.128 . . . . 2.6800000000000002 114.333 -177.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.94 -17.0 18.34 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.156 1.36 . . . . 1.7 113.242 -164.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.92 8.24 60.6 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.006 1.765 . . . . 1.4199999999999999 114.844 -176.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.49 68.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.302 1.43 . . . . 1.4099999999999999 115.801 -170.193 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -58.47 154.46 13.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.181 1.49 . . . . 1.51 110.482 168.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 mmt-85 -96.39 138.47 33.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.388 1.075 . . . . 3.8700000000000001 109.453 -176.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.86 -18.8 16.22 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.955 0.798 . . . . 3.3199999999999998 111.774 154.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.31 168.79 25.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.537 1.135 . . . . 0.88 111.409 164.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -152.98 153.26 32.58 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.057 1.343 . . . . 1.8700000000000001 110.697 172.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -153.17 178.67 30.1 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.181 1.372 . . . . 1.6899999999999999 114.305 -175.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 139.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.05 1.34 . . . . 2.4500000000000002 111.302 -171.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 76.2 mt -92.86 143.03 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.44 1.096 . . . . 1.1699999999999999 109.613 171.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt . . . . . 0 N--CA 1.471 0.62 0 O-C-N 120.67 -1.269 . . . . 3.7400000000000002 112.508 177.128 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.717 -0.846 . . . . 1.5800000000000001 108.717 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.22 156.12 47.32 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.167 1.349 . . . . 1.03 114.187 -148.161 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.68 127.54 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.897 1.679 . . . . 2.3199999999999998 108.872 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -103.31 98.82 8.68 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.684 1.993 . . . . 3.8199999999999998 109.708 -174.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -87.77 129.45 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 114.177 1.177 . . . . 2.1400000000000001 114.177 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.47 103.78 0.73 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.672 1.129 . . . . 1.0 111.057 167.222 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.31 110.97 13.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.942 1.297 . . . . 1.49 109.971 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -108.66 147.15 32.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 2.4399999999999999 111.4 -170.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.21 61.18 2.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.981 -1.075 . . . . 1.3999999999999999 113.192 -171.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -70.87 154.86 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.281 1.432 . . . . 1.4099999999999999 113.211 -177.347 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -169.97 -152.97 0.1 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.602 1.561 . . . . 3.3300000000000001 109.295 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -11.82 2.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 129.03 2.932 . . . . 1.1200000000000001 116.06 -175.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.82 0.49 32.74 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.953 1.301 . . . . 4.1900000000000004 112.057 174.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.67 -147.15 21.08 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.695 1.14 . . . . 1.29 110.458 -165.072 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 10' ' ' VAL . 11.6 t -54.23 134.89 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.732 2.013 . . . . 1.04 112.808 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.28 -112.29 3.66 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.757 1.646 . . . . 1.2 112.803 -175.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.89 166.97 20.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.834 0.817 . . . . 1.9399999999999999 111.555 168.29 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.6 t -93.33 148.98 21.57 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.264 1.026 . . . . 1.48 113.192 -174.018 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 pt -142.1 2.23 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.296 1.438 . . . . 2.8199999999999998 113.915 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.33 170.25 22.8 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.042 -1.036 . . . . 0.68999999999999995 112.703 -173.42 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 p -107.66 178.73 4.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.023 0.929 . . . . 0.90000000000000002 110.332 171.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 33' ' ' PHE . 46.6 t -128.56 132.54 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.526 -1.287 . . . . 0.40999999999999998 107.526 152.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.419 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.9 p -85.09 119.92 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.72 0.638 . . . . 0.92000000000000004 109.77 174.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -102.65 130.23 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.227 -1.397 . . . . 1.3799999999999999 107.227 174.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -136.78 120.5 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.725 0.81 . . . . 2.3199999999999998 111.232 176.376 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.41 140.73 48.53 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.247 0.619 . . . . 3.6899999999999999 111.58 178.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -143.57 -179.92 6.73 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.387 1.075 . . . . 1.5900000000000001 108.649 164.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -68.03 -28.29 67.27 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.675 2.39 . . . . 5.21 111.812 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.45 17.87 54.41 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.016 1.769 . . . . 1.5 114.639 162.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.88 -159.01 26.38 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 127.365 2.412 . . . . 0.85999999999999999 118.411 164.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.97 104.08 8.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.736 0.815 . . . . 0.62 111.371 -168.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -79.94 110.43 15.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.763 1.625 . . . . 1.99 110.217 174.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 22' ' ' VAL . 4.0 t80 -99.06 118.73 36.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.294 2.238 . . . . 0.48999999999999999 109.475 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.419 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 78.7 m -124.82 111.98 27.24 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-N 119.292 0.951 . . . . 0.60999999999999999 109.103 176.315 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.83 165.21 17.8 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.6 2.867 . . . . 0.62 111.008 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -151.0 25.89 0.72 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.495 0.718 . . . . 1.3100000000000001 112.099 173.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.87 148.23 25.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.498 1.119 . . . . 0.90000000000000002 113.33 -170.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 144.5 49.47 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.974 1.31 . . . . 2.3999999999999999 108.56 168.315 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.93 45.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 128.203 2.601 . . . . 1.3600000000000001 112.514 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.76 160.98 40.25 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.433 1.093 . . . . 1.6899999999999999 110.537 169.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.26 125.55 14.22 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 121.124 1.216 . . . . 1.0700000000000001 110.375 169.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -80.47 74.5 5.51 Favored 'Trans proline' 0 N--CA 1.451 -1.015 1 C-N-CA 125.413 4.075 . . . . 1.76 109.925 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.88 -173.76 13.2 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 116.343 -2.837 . . . . 1.6699999999999999 111.932 132.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -56.81 140.61 47.37 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.003 1.321 . . . . 2.75 111.668 175.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -136.83 125.47 23.77 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.902 1.281 . . . . 1.1299999999999999 112.746 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.04 149.91 3.26 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.325 0.964 . . . . 0.67000000000000004 113.229 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.403 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.2 t80 -132.4 132.03 42.41 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.598 1.559 . . . . 1.99 106.82 176.081 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -136.1 168.63 19.02 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 114.867 1.432 . . . . 0.94999999999999996 114.867 170.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.6 139.51 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.664 1.586 . . . . 0.92000000000000004 109.545 158.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.55 165.24 13.79 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.962 2.105 . . . . 0.87 111.358 177.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.86 64.43 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.141 1.534 . . . . 0.77000000000000002 115.141 -159.541 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -123.73 152.44 42.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.929 0.892 . . . . 1.3799999999999999 113.074 178.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.95 79.81 1.82 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 125.596 1.57 . . . . 0.97999999999999998 110.975 174.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -166.53 59.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.46 0.704 . . . . 3.6099999999999999 112.523 -165.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.8 m -67.2 66.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.284 1.834 . . . . 1.8600000000000001 113.115 173.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -130.53 156.53 79.52 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.219 2.208 . . . . 3.5499999999999998 108.315 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.16 133.88 15.35 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.005 1.803 . . . . 1.1899999999999999 110.216 176.071 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 176.38 6.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.058 -0.974 . . . . 2.8399999999999999 109.917 161.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -103.2 128.62 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.887 -0.783 . . . . 5.6299999999999999 108.887 165.013 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -94.45 -71.31 0.67 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 118.644 -0.694 . . . . 7.6699999999999999 109.244 161.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.75 106.66 9.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.209 1.403 . . . . 4.1299999999999999 109.124 169.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.73 -44.9 0.65 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.501 2.0 . . . . 5.1600000000000001 116.852 174.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.14 158.41 18.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.222 1.409 . . . . 2.8900000000000001 114.026 -161.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.93 95.98 4.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.961 1.704 . . . . 1.8700000000000001 111.867 -171.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.92 80.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.93 0.872 . . . . 2.9700000000000002 112.159 -177.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 46.28 -104.7 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.869 2.467 . . . . 2.02 114.928 163.109 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.15 25.13 9.74 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.401 1.48 . . . . 1.9299999999999999 111.979 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -81.67 11.49 4.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.519 1.127 . . . . 8.5500000000000007 113.501 -174.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.64 -6.61 57.47 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.143 -0.973 . . . . 2.2200000000000002 112.677 158.072 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.21 23.8 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.684 1.594 . . . . 1.24 114.311 175.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.15 4.0 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.5 1.524 . . . . 3.6499999999999999 115.646 167.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.14 -176.85 30.26 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.791 1.186 . . . . 1.3500000000000001 112.486 -171.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -81.33 62.29 5.17 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 2.1600000000000001 110.532 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.8 tp 25.21 65.6 0.05 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.627 2.371 . . . . 1.6100000000000001 112.537 -174.563 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -127.14 60.65 43.57 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.038 2.135 . . . . 4.8300000000000001 112.057 -158.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.47 -41.16 9.25 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.387 2.058 . . . . 2.27 109.994 169.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -152.9 165.64 34.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.283 1.833 . . . . 4.5 110.03 167.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 140.88 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 1 C-N-CA 132.706 4.402 . . . . 3.75 113.209 163.101 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t 150.99 -56.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 130.726 3.61 . . . . 2.6099999999999999 110.785 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.09 -11.26 69.51 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.342 1.449 . . . . 1.97 115.093 -178.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.48 -25.04 61.86 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.749 1.775 . . . . 4.25 115.243 -176.275 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.605 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 24.7 t60 75.44 126.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.393 2.677 . . . . 2.6800000000000002 113.354 176.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 -57.13 2.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.824 0.849 . . . . 7.4500000000000002 112.873 165.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.62 -85.13 0.38 Allowed Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.291 -1.283 . . . . 4.9100000000000001 110.208 -156.133 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.38 -128.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.857 3.705 . . . . 6.7599999999999998 111.863 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.73 51.25 1.34 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.498 -1.376 . . . . 10.800000000000001 114.693 -159.061 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.14 -107.55 0.5 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.443 1.021 . . . . 2.6000000000000001 111.198 167.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -16.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.259 1.024 . . . . 5.0099999999999998 113.505 171.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.11 92.39 1.15 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.378 0.99 . . . . 3.8599999999999999 111.897 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.42 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 9.1 t-160 71.42 97.84 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.896 2.078 . . . . 5.2199999999999998 113.711 162.244 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -16.61 64.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.506 1.669 . . . . 3.2599999999999998 115.506 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.84 8.55 79.31 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.81 1.671 . . . . 1.29 113.979 175.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.605 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 72.8 m-20 -80.57 155.05 27.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 3.3799999999999999 109.93 153.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.54 154.54 21.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 121.029 -1.044 . . . . 1.6399999999999999 111.609 -133.158 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.04 143.1 64.29 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.705 2.937 . . . . 1.04 111.89 -171.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.45 133.49 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.724 0.81 . . . . 1.8500000000000001 111.473 -163.046 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.84 99.41 2.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.832 2.053 . . . . 1.8500000000000001 109.044 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.0 t -78.23 121.6 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.496 -0.753 . . . . 0.98999999999999999 109.811 177.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.81 131.41 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.654 1.982 . . . . 1.73 108.361 175.208 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -81.05 148.24 29.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.643 0.656 . . . . 3.3100000000000001 112.275 175.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -40.03 -25.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.338 3.055 . . . . 2.5800000000000001 117.035 -172.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.01 -19.76 62.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.608 1.963 . . . . 4.1100000000000003 113.444 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 31.8 6.24 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.309 1.433 . . . . 0.85999999999999999 112.852 -172.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.98 145.02 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.954 1.702 . . . . 1.0 108.581 -168.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -124.82 114.85 19.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.059 1.343 . . . . 0.68000000000000005 110.968 -177.109 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -125.94 -9.75 6.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.437 1.273 . . . . 1.3600000000000001 114.437 172.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.8 120.04 79.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.833 0.742 . . . . 3.1400000000000001 110.744 -167.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -85.62 153.8 10.33 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.716 2.944 . . . . 1.1200000000000001 112.632 -174.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.08 164.39 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.975 1.71 . . . . 1.1200000000000001 110.146 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.9 m -137.23 136.39 38.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.648 1.113 . . . . 0.82999999999999996 110.316 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.34 99.79 13.85 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.964 0.906 . . . . 0.79000000000000004 112.159 175.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.21 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.249 3.299 . . . . 1.0900000000000001 114.79 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.89 5.74 13.01 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.379 0.991 . . . . 4.8700000000000001 112.648 174.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.4 mt -140.92 171.94 13.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 129.244 3.018 . . . . 2.1899999999999999 107.571 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.34 2.35 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.612 1.708 . . . . 6.7699999999999996 115.612 -174.24 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -147.38 156.15 42.63 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.092 -1.005 . . . . 2.02 112.203 176.217 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.42 -26.03 63.48 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.204 -0.935 . . . . 1.5 111.336 161.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.18 -44.31 79.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.508 1.123 . . . . 4.0099999999999998 113.032 -173.183 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.68 -8.39 34.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.336 1.454 . . . . 1.8500000000000001 113.446 177.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.52 20.51 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.897 1.279 . . . . 0.89000000000000001 113.591 -177.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -68.09 -6.17 21.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.945 2.202 . . . . 2.4300000000000002 116.945 -172.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.72 39.37 1.67 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.897 1.679 . . . . 3.4399999999999999 110.668 178.04 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -117.55 149.1 41.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.453 1.101 . . . . 1.1699999999999999 112.853 -175.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.72 133.12 33.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.409 1.084 . . . . 0.80000000000000004 111.23 166.482 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.14 136.06 46.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.06 -1.089 . . . . 3.0699999999999998 108.06 165.492 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.0 mtt -132.1 133.42 44.3 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.217 0.607 . . . . 1.1899999999999999 111.984 -167.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.31 132.95 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.909 1.283 . . . . 0.64000000000000001 108.294 168.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 142.41 50.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.738 2.015 . . . . 2.2200000000000002 110.387 -159.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.73 -46.86 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.209 -0.932 . . . . 1.6599999999999999 111.732 -168.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.11 138.68 20.98 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 118.467 0.576 . . . . 1.25 111.859 175.112 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.06 146.94 49.11 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.773 1.654 . . . . 1.45 111.85 167.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -95.4 76.04 3.35 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.379 0.881 . . . . 2.9300000000000002 113.379 -156.268 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -163.66 56.23 0.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.182 0.993 . . . . 3.79 112.025 -171.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.28 119.31 5.42 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.91 -1.119 . . . . 2.2200000000000002 113.27 -171.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 t -146.5 -170.23 3.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.46 1.904 . . . . 3.3300000000000001 110.538 -178.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 71.35 -41.24 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 129.147 2.979 . . . . 3.6699999999999999 114.636 169.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -60.57 150.44 74.63 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 4.2400000000000002 111.707 173.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.01 -21.09 72.98 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.204 2.603 . . . . 2.1400000000000001 112.739 176.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -101.02 89.4 1.27 Allowed Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.836 0.854 . . . . 4.7599999999999998 109.923 158.172 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.9 161.16 43.57 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.484 . . . . 3.6699999999999999 110.243 172.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 60.53 9.45 2.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.956 1.302 . . . . 3.2799999999999998 111.953 -164.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 68.36 3.85 34.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.635 1.112 . . . . 3.1200000000000001 113.69 -167.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.12 3.27 58.99 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.322 1.439 . . . . 2.0699999999999998 114.036 -164.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.79 42.37 1.3 Allowed Glycine 0 N--CA 1.476 1.341 0 C-N-CA 127.148 2.309 . . . . 1.74 116.04 -173.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.1 71.36 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.34 0.972 . . . . 2.1699999999999999 113.437 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 p -61.4 136.81 58.16 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.591 1.956 . . . . 2.0499999999999998 112.075 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -99.29 162.29 13.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.858 1.663 . . . . 4.6799999999999997 110.974 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -118.68 -19.36 8.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.153 0.797 . . . . 2.4199999999999999 113.153 151.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.34 163.05 30.99 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.885 1.221 . . . . 0.55000000000000004 114.05 173.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.2 t -132.27 144.02 50.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 1.6299999999999999 110.786 164.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -132.17 101.43 0.46 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.872 2.177 . . . . 1.1899999999999999 109.571 168.059 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.25 130.12 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.565 1.146 . . . . 1.78 108.789 172.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 15.2 mt -60.4 127.7 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.404 0.681 . . . . 1.21 111.625 -178.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 10.9 mmpt? . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 113.148 0.795 . . . . 3.3700000000000001 113.148 178.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.624 0.249 . . . . 3.4399999999999999 110.616 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -151.82 130.92 12.66 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.67 -1.233 . . . . 2.2200000000000002 107.67 174.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -126.21 111.13 14.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.173 0.989 . . . . 3.46 110.722 -171.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 23' ' ' VAL 0.284 0.1 OUTLIER -79.41 77.32 5.97 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.122 -0.986 . . . . 3.9199999999999999 111.214 174.47 . . . . . . . . 4 4 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.1 120.62 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.501 -0.75 . . . . 1.0 110.133 -169.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.56 99.32 0.9 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.446 1.498 . . . . 0.81000000000000005 111.088 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.3 mmm -75.34 97.68 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.719 1.208 . . . . 1.4099999999999999 110.197 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.57 141.55 41.1 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.653 -0.654 . . . . 2.5499999999999998 110.717 174.712 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.95 131.17 44.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.878 0.871 . . . . 1.1699999999999999 109.208 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 m -143.43 160.71 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 113.498 0.925 . . . . 1.03 113.498 -175.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -172.76 -159.06 0.11 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.369 2.668 . . . . 3.0899999999999999 107.886 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.84 62.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.539 1.936 . . . . 1.3999999999999999 113.822 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -72.31 -9.43 58.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 3.8199999999999998 112.531 171.207 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.37 -135.27 13.05 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.54 1.064 . . . . 1.1200000000000001 111.192 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.65 132.33 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 1.0900000000000001 110.702 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.13 -104.51 2.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.747 1.642 . . . . 1.23 112.84 -175.131 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.73 168.69 19.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.569 1.147 . . . . 2.1200000000000001 110.372 170.494 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.7 t -98.14 137.91 36.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.832 -1.168 . . . . 1.1299999999999999 111.576 178.029 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.92 5.1 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.092 1.357 . . . . 2.8399999999999999 113.935 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.08 172.44 32.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.777 2.608 . . . . 0.77000000000000002 112.395 166.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 p -96.91 175.69 6.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.322 0.649 . . . . 0.79000000000000004 110.084 169.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.75 130.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.795 -1.187 . . . . 0.60999999999999999 107.795 151.295 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 4' ' ' LYS 0.258 9.2 p -84.97 113.26 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.352 0.596 . . . . 0.90000000000000002 111.447 178.004 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 125' ' ' LEU . 50.9 mt -87.26 127.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.542 -1.208 . . . . 1.0900000000000001 108.012 169.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -132.22 124.89 29.85 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.71 1.204 . . . . 1.8799999999999999 109.329 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -83.11 142.65 31.1 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.865 0.466 . . . . 4.1699999999999999 111.624 -174.226 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -157.82 -179.19 7.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.7 0.8 . . . . 1.4299999999999999 110.411 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.61 -15.73 63.62 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.136 -0.977 . . . . 3.7599999999999998 112.543 177.036 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.81 6.61 79.61 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.57 1.081 . . . . 1.1599999999999999 115.153 163.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.04 -141.09 18.25 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 127.183 2.325 . . . . 1.1599999999999999 114.82 174.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.49 96.22 3.44 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.553 1.141 . . . . 0.85999999999999999 111.659 -175.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -76.38 111.46 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.675 1.19 . . . . 1.8600000000000001 109.483 172.587 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.02 116.96 29.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.305 2.242 . . . . 0.54000000000000004 109.867 -175.388 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -130.81 114.12 16.52 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 120.257 1.389 . . . . 0.70999999999999996 110.674 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.95 162.53 7.43 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.089 2.526 . . . . 0.91000000000000003 113.099 -171.239 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -151.43 29.88 0.62 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.955 0.902 . . . . 1.3899999999999999 112.798 171.157 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -92.91 150.46 20.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.963 1.305 . . . . 0.98999999999999999 112.658 -171.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.18 27.09 4.84 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.008 1.855 . . . . 2.2200000000000002 116.008 -168.346 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.52 79.9 0.73 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.868 0.867 . . . . 1.6000000000000001 112.387 174.774 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.36 161.44 47.44 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 124.2 1.0 . . . . 1.4299999999999999 112.479 173.884 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.6 134.7 45.54 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.267 1.311 . . . . 1.1000000000000001 111.806 175.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -88.01 23.19 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.921 2.414 . . . . 1.04 115.126 -144.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.78 -153.05 11.48 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.874 1.226 . . . . 1.27 115.974 -172.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -78.47 150.97 32.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.463 2.305 . . . . 2.8900000000000001 111.157 171.579 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -149.13 141.23 23.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.923 0.889 . . . . 1.5800000000000001 112.221 -173.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 153.16 51.67 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 109.561 -1.416 . . . . 0.62 109.561 164.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.14 102.51 3.38 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.101 -1.444 . . . . 2.04 107.101 169.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -106.82 171.07 7.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.076 1.51 . . . . 0.94999999999999996 115.076 178.581 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -101.33 131.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.511 1.524 . . . . 0.69999999999999996 108.689 160.587 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -108.23 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.802 1.241 . . . . 2.0800000000000001 110.669 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.09 63.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.144 1.535 . . . . 0.81000000000000005 115.144 -161.455 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -127.23 151.32 48.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.648 1.179 . . . . 1.6000000000000001 111.919 173.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.1 81.76 1.69 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.581 1.086 . . . . 0.92000000000000004 113.193 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 t -170.24 138.59 1.64 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.146 0.978 . . . . 2.21 113.227 173.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.1 m -79.11 -5.15 53.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.038 1.735 . . . . 1.9399999999999999 114.217 172.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -78.58 132.89 64.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 O-C-N 120.081 -1.637 . . . . 3.5 113.159 -160.039 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -79.39 170.03 17.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.514 2.809 . . . . 1.4099999999999999 111.684 172.347 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 65' ' ' VAL . . . -119.16 165.24 14.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.482 1.513 . . . . 1.7 110.196 167.188 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.66 134.34 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.259 1.023 . . . . 2.5800000000000001 111.207 -167.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -156.54 134.56 11.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.62 1.568 . . . . 5.79 108.704 173.668 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.4 t0 55.05 46.72 23.58 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.841 0.856 . . . . 5.0999999999999996 112.19 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.68 7.27 58.17 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.884 1.113 . . . . 3.7200000000000002 115.884 173.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.75 162.26 33.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.855 1.327 . . . . 3.5499999999999998 111.764 -176.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.42 125.93 53.74 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.229 1.012 . . . . 1.9099999999999999 112.254 -167.38 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 58' ' ' ALA . 18.1 m -75.01 24.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 116.512 2.041 . . . . 2.9199999999999999 116.512 -164.569 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.5 8.23 2.14 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 117.015 2.228 . . . . 2.2200000000000002 117.015 170.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.579 ' HB3' HH12 ' A' ' 147' ' ' ARG . . . 137.26 115.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 1 C-N-CA 132.278 4.231 . . . . 2.0699999999999998 110.081 165.784 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.78 -37.76 4.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.564 1.145 . . . . 4.0899999999999999 110.32 172.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.18 -6.6 6.93 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.252 1.204 . . . . 1.2 114.252 177.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.32 -14.99 62.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.811 1.245 . . . . 1.25 113.292 168.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.8 51.63 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.805 -1.184 . . . . 3.1200000000000001 115.111 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.09 -172.55 55.26 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.699 1.142 . . . . 1.1799999999999999 112.25 -169.573 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.543 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 26.8 m170 -65.31 138.85 58.45 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.277 -1.131 . . . . 2.4300000000000002 111.387 174.513 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.69 119.87 13.78 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.28 0.632 . . . . 1.9399999999999999 112.067 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.97 125.87 5.06 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.02 2.128 . . . . 4.7599999999999998 110.97 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.04 -19.98 3.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.455 2.77 . . . . 3.7000000000000002 115.218 178.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 155.6 14.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 128.249 2.62 . . . . 4.0700000000000003 114.608 -170.134 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.2 -38.78 71.47 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.317 -1.489 . . . . 3.0899999999999999 112.401 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 81' ' ' LYS . 7.2 t 157.01 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 131.204 3.802 . . . . 2.79 110.621 177.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.45 1.77 66.11 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.416 1.008 . . . . 2.0099999999999998 114.248 179.429 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 79' ' ' THR . 18.0 ptmt -73.25 -30.42 63.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.097 1.448 . . . . 3.9199999999999999 114.72 -174.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.2 t60 117.2 148.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 130.853 3.661 . . . . 1.8700000000000001 112.806 -171.071 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -143.56 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.035 1.734 . . . . 3.9399999999999999 110.052 173.047 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.91 -132.56 9.93 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.244 -1.309 . . . . 2.4700000000000002 113.168 167.293 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.83 -17.45 22.74 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.934 3.09 . . . . 3.7400000000000002 114.885 -167.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -171.75 149.15 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.439 1.895 . . . . 5.6500000000000004 109.682 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.01 -145.2 16.92 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.375 0.988 . . . . 3.5299999999999998 113.242 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.16 145.52 4.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.353 2.661 . . . . 5.8099999999999996 106.324 -179.278 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.34 -20.81 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 CA-C-O 117.057 -1.968 . . . . 3.1400000000000001 116.627 173.774 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -152.22 118.57 5.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.346 1.573 . . . . 3.8199999999999998 110.199 160.472 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.25 -12.42 41.04 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.306 1.595 . . . . 2.6800000000000002 115.306 177.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.56 -4.92 90.15 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.995 1.283 . . . . 1.0600000000000001 115.067 173.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.543 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 66.5 m-20 -74.91 153.98 38.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.756 0.823 . . . . 1.6299999999999999 110.828 168.596 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.37 161.6 29.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.86 1.264 . . . . 1.8300000000000001 109.733 -149.563 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.56 157.78 57.81 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.489 2.792 . . . . 1.1699999999999999 111.86 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.72 143.13 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.223 1.011 . . . . 1.5700000000000001 113.22 -173.076 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -88.97 123.07 32.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.998 2.119 . . . . 2.27 110.057 172.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.76 136.34 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.437 0.695 . . . . 1.1399999999999999 109.833 172.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.2 158.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.459 -1.312 . . . . 2.27 107.459 160.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.74 159.56 17.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.64 0.978 . . . . 2.1299999999999999 113.64 -174.488 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -41.94 -17.91 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 129.79 3.236 . . . . 2.29 117.726 177.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -97.24 -13.52 21.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.62 1.568 . . . . 2.5099999999999998 113.928 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.55 22.95 8.64 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.121 1.343 . . . . 0.75 115.291 177.534 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.06 135.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.496 1.518 . . . . 1.1899999999999999 110.228 -178.232 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.08 120.39 34.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.315 1.446 . . . . 0.81000000000000005 110.686 -179.374 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t -150.45 16.04 0.8 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.452 1.101 . . . . 1.72 113.962 -169.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -113.05 130.18 23.81 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.966 0.906 . . . . 3.8900000000000001 110.998 177.029 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.13 158.35 52.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.619 2.879 . . . . 1.3899999999999999 110.885 175.05 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.46 166.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.38 1.872 . . . . 2.3100000000000001 107.557 169.587 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.1 m -140.15 136.58 33.65 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.223 0.92 . . . . 0.79000000000000004 108.982 171.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.94 87.96 9.36 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.388 1.075 . . . . 1.01 111.192 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.48 23.63 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.931 3.754 . . . . 1.0600000000000001 114.146 -179.01 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 -94.01 -20.68 19.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.95 1.3 . . . . 3.7400000000000002 112.045 174.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.11 135.47 53.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.838 2.055 . . . . 2.7799999999999998 107.155 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -92.38 -38.68 11.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.521 0.728 . . . . 5.0300000000000002 111.775 -177.101 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.31 154.32 51.57 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.393 1.627 . . . . 2.6200000000000001 115.393 -172.556 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.38 -42.73 70.68 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.379 1.071 . . . . 1.72 110.891 170.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.17 -21.89 3.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.266 1.826 . . . . 4.4199999999999999 113.478 177.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.43 -13.06 38.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.262 1.025 . . . . 2.5899999999999999 113.061 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 m -120.74 7.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.025 1.73 . . . . 1.05 113.484 -178.813 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -43.64 -15.08 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.804 3.241 . . . . 3.2799999999999998 117.643 171.569 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -128.24 3.37 5.76 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.117 2.567 . . . . 5.1200000000000001 113.378 -167.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -127.07 174.37 8.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.834 1.254 . . . . 1.8200000000000001 113.719 -168.36 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.89 143.07 47.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.227 1.011 . . . . 0.68000000000000005 112.454 179.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.633 HD21 HD11 ' A' ' 24' ' ' ILE . 16.0 mt -73.46 155.37 39.32 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.451 1.5 . . . . 2.2799999999999998 108.437 156.22 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 19.2 ttm -147.05 122.58 10.42 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.75 -0.594 . . . . 2.02 110.677 158.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.3 mt -80.25 122.55 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.513 -1.291 . . . . 0.73999999999999999 107.513 171.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -100.81 147.47 26.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.134 2.174 . . . . 2.1600000000000001 111.763 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.25 -54.78 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.302 -0.874 . . . . 1.6799999999999999 110.129 -171.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.8 164.41 39.2 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.547 -0.621 . . . . 0.96999999999999997 111.547 166.128 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.1 -144.05 0.03 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 129.162 3.268 . . . . 2.27 115.036 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -162.95 69.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.682 1.993 . . . . 2.9700000000000002 107.663 -170.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -157.45 14.92 0.25 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.295 -1.32 . . . . 3.8100000000000001 113.958 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.8 149.58 16.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.924 1.29 . . . . 4.5700000000000003 112.185 174.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.9 m -128.99 -170.58 2.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.907 1.283 . . . . 4.0899999999999999 111.834 -168.467 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.41 -26.48 0.18 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 128.452 2.701 . . . . 4.8499999999999996 115.955 158.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -70.01 146.41 95.04 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.23 1.812 . . . . 4.3799999999999999 111.195 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.41 -32.16 50.54 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.352 2.702 . . . . 2.52 113.281 -171.271 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -80.38 115.19 53.2 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.23 0.923 . . . . 4.1500000000000004 108.906 160.101 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.75 152.14 82.46 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.23 2.62 . . . . 2.8399999999999999 112.336 -172.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp 59.52 22.51 11.1 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.852 1.661 . . . . 4.25 111.444 -169.588 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.83 14.85 66.03 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 120.958 -1.089 . . . . 3.0600000000000001 113.508 -172.378 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 108.49 -7.93 34.61 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.722 1.63 . . . . 2.0800000000000001 114.037 -168.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.83 10.75 1.07 Allowed Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.358 1.579 . . . . 1.73 116.178 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 -12.41 73.56 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.207 1.504 . . . . 1.48 114.426 175.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.8 p -74.88 147.84 40.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.293 1.837 . . . . 2.0 112.555 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.579 HH12 ' HB3' ' A' ' 67' ' ' ALA . 3.2 mmt85 -110.17 150.07 29.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.563 1.545 . . . . 4.3399999999999999 111.076 -172.625 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -106.93 -39.16 5.84 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.241 0.46 . . . . 2.6600000000000001 112.241 160.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.36 144.73 24.03 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.382 1.623 . . . . 0.68999999999999995 115.382 -175.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.5 t -100.51 137.99 38.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.968 2.507 . . . . 1.5 111.307 173.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -133.46 87.11 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.56 1.553 . . . . 0.88 112.124 175.582 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.17 130.41 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.808 1.804 . . . . 1.52 110.656 173.458 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 mt -100.64 154.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 126.468 1.907 . . . . 1.3300000000000001 110.279 -172.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.52 0 C-N-CA 126.108 1.763 . . . . 4.7999999999999998 110.408 174.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.381 -0.599 . . . . 3.04 109.381 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.23 152.04 28.83 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.257 -0.902 . . . . 1.6499999999999999 109.086 -175.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -144.57 116.19 8.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.332 1.539 . . . . 2.48 112.825 176.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -78.8 82.95 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 127.606 2.362 . . . . 2.9900000000000002 110.569 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -75.79 110.99 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.057 -1.027 . . . . 1.8899999999999999 112.28 -177.228 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.6 100.48 0.49 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.404 1.954 . . . . 1.1899999999999999 110.81 177.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 mmt -72.85 125.52 27.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.849 1.66 . . . . 1.54 112.399 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -101.62 153.61 19.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.786 0.803 . . . . 2.4300000000000002 110.923 157.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.9 mt -58.48 143.57 45.23 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.347 1.459 . . . . 1.3600000000000001 109.18 163.756 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 m -141.6 166.1 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.065 0.946 . . . . 1.25 111.535 172.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 t -172.38 -161.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.616 2.366 . . . . 3.2200000000000002 108.176 -177.529 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.93 14.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.449 2.7 . . . . 1.8799999999999999 114.507 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.06 -12.5 10.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.058 1.343 . . . . 3.2200000000000002 111.349 172.655 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 -146.25 19.8 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 119.197 0.908 . . . . 1.6599999999999999 110.893 -167.506 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 82.0 t -62.28 126.38 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.228 1.811 . . . . 1.05 112.423 -177.07 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.28 -133.19 6.44 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.539 2.019 . . . . 1.4099999999999999 113.17 177.325 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.09 145.64 46.34 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 124.52 1.128 . . . . 2.0800000000000001 110.811 176.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.7 t -75.19 133.58 41.4 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.713 -0.617 . . . . 1.9299999999999999 109.438 164.576 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 tt -116.36 -37.05 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 127.908 2.483 . . . . 4.0800000000000001 111.546 -174.786 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.29 -178.83 38.08 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.39 -0.909 . . . . 1.46 113.443 -145.523 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 171.06 12.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 148.657 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.453 HG11 ' CG ' ' A' ' 33' ' ' PHE . 59.4 t -120.58 132.01 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 106.471 -1.677 . . . . 0.63 106.471 144.283 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 17.7 m -83.99 129.51 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 C-N-CA 119.744 -0.782 . . . . 3.1600000000000001 109.803 172.304 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.45 125.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.623 -0.881 . . . . 1.3700000000000001 108.623 175.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.68 126.9 30.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.736 1.214 . . . . 2.4700000000000002 109.96 178.506 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.78 141.79 29.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.797 0.839 . . . . 3.8399999999999999 112.946 -172.216 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -149.63 -176.61 5.47 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.897 0.879 . . . . 1.21 109.684 174.662 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -75.54 -11.98 60.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.272 -0.892 . . . . 4.1600000000000001 112.488 174.739 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.41 7.04 69.78 Favored Glycine 0 N--CA 1.477 1.411 0 O-C-N 120.758 -1.214 . . . . 0.95999999999999996 114.312 157.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.62 -145.58 26.42 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 127.819 2.628 . . . . 0.78000000000000003 114.598 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.4 109.46 7.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.187 0.595 . . . . 0.66000000000000003 110.704 -173.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -82.78 106.68 14.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.348 1.059 . . . . 1.78 110.397 174.071 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -85.85 110.11 19.16 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.044 1.338 . . . . 0.73999999999999999 108.345 175.614 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 23' ' ' VAL . 33.4 m -114.6 98.78 50.28 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 119.718 1.144 . . . . 1.29 108.792 178.066 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -85.73 153.51 10.16 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.244 3.296 . . . . 0.73999999999999999 111.497 -172.145 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -150.66 41.22 0.77 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.998 0.904 . . . . 1.3600000000000001 112.725 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mp -93.02 148.95 21.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.273 1.829 . . . . 0.84999999999999998 112.193 -176.295 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.86 40.25 2.16 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.24 1.57 . . . . 2.02 115.24 -169.265 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.33 48.53 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 1.3899999999999999 112.207 -175.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.04 161.0 47.07 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 121.261 -0.9 . . . . 1.3400000000000001 112.466 176.585 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.26 131.09 36.92 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.595 1.53 . . . . 1.23 110.18 171.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.411 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -90.46 30.64 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.722 1 C-N-CA 126.567 4.845 . . . . 1.29 112.176 -151.976 . . . . . . . . 4 4 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.79 166.68 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 125.582 1.563 . . . . 2.1400000000000001 109.762 173.325 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -67.44 143.8 56.06 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.889 0.875 . . . . 2.8799999999999999 112.814 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -129.69 150.83 50.84 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.076 1.35 . . . . 1.1899999999999999 111.614 -172.154 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.84 163.5 24.23 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.519 0.6 . . . . 0.66000000000000003 113.486 168.755 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.603 ' CE1' HD12 ' A' ' 125' ' ' LEU . 9.4 t80 -140.76 119.86 12.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.15 1.38 . . . . 2.1600000000000001 108.398 176.523 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -134.76 149.12 50.38 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.433 -0.792 . . . . 0.87 112.521 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.3 136.61 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.607 1.963 . . . . 0.95999999999999996 107.792 165.155 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -132.8 133.84 43.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.201 1.0 . . . . 1.1899999999999999 110.652 -163.326 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.19 65.67 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.628 2.084 . . . . 0.73999999999999999 116.628 -155.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -118.97 152.3 36.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.988 0.915 . . . . 1.4399999999999999 112.688 167.248 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.98 59.75 4.48 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.647 1.118 . . . . 0.95999999999999996 112.45 170.739 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 m -148.73 63.9 1.06 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.818 1.044 . . . . 3.21 113.818 -157.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.8 m -65.39 26.66 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 116.452 2.019 . . . . 1.74 116.452 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -78.14 139.13 60.53 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 119.919 -1.738 . . . . 3.8900000000000001 110.788 175.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.31 143.19 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.753 2.302 . . . . 1.3899999999999999 111.211 174.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 128.87 35.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.914 0.486 . . . . 2.21 110.461 172.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.44 125.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.215 1.006 . . . . 2.3900000000000001 110.694 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -166.09 128.17 1.92 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.386 0.674 . . . . 4.8799999999999999 112.74 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 57.77 52.88 7.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.655 1.582 . . . . 4.8099999999999996 114.1 169.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.78 77.48 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.082 -1.011 . . . . 3.4500000000000002 114.544 175.112 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.94 -164.08 1.35 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.41 1.884 . . . . 4.2000000000000002 109.178 -177.198 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.34 144.71 23.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.222 -0.924 . . . . 1.5800000000000001 112.651 -177.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 t -80.82 98.78 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.97 0.908 . . . . 2.54 109.934 -172.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.97 97.59 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.392 2.277 . . . . 3.4300000000000002 115.105 -170.2 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.45 30.73 17.29 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.524 1.93 . . . . 1.99 114.27 174.379 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.65 -32.36 73.82 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.271 0.841 . . . . 5.3799999999999999 113.271 -178.45 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.48 -15.62 50.96 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.898 1.073 . . . . 2.0800000000000001 113.898 -175.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -3.46 13.9 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.312 1.445 . . . . 1.1599999999999999 113.585 172.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.22 -171.32 32.34 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.943 1.247 . . . . 2.4900000000000002 113.53 175.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.57 -167.0 39.74 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.74 1.162 . . . . 1.9099999999999999 112.189 165.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.442 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 33.1 m170 -74.13 40.06 0.12 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.551 1.94 . . . . 3.29 112.833 -178.483 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp 49.82 61.45 3.16 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.904 1.682 . . . . 1.76 109.854 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -121.65 51.02 2.53 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.299 1.839 . . . . 3.9300000000000002 114.419 -163.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.2 -18.91 39.42 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.862 3.041 . . . . 1.8999999999999999 115.865 -166.074 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.0 31.79 0.06 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.35 0.977 . . . . 4.0599999999999996 112.46 -171.057 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.03 -60.41 1.68 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.655 0.983 . . . . 3.73 113.655 -163.391 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 t 167.99 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.317 2.647 . . . . 3.3399999999999999 108.54 -162.26 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.95 -30.93 8.93 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.857 0.741 . . . . 2.3900000000000001 113.03 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 11.7 ptmt -88.74 -177.89 5.64 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 117.88 0.84 . . . . 4.25 112.138 173.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -124.88 164.89 19.07 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.888 1.07 . . . . 2.1299999999999999 113.888 -155.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -138.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.449 1.1 . . . . 4.5700000000000003 111.478 -179.072 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.51 -138.09 18.48 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 109.067 -1.613 . . . . 2.73 109.067 -158.662 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.08 -32.08 64.52 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.344 2.03 . . . . 3.46 113.456 -171.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.03 -1.54 57.17 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 6.0099999999999998 113.43 -176.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.43 -12.56 0.93 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 118.316 2.086 . . . . 2.8700000000000001 118.316 167.001 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -84.33 44.85 1.06 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.182 1.491 . . . . 5.2999999999999998 114.393 -163.825 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.63 -147.67 6.33 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 117.477 1.751 . . . . 2.8300000000000001 117.477 -168.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -118.15 154.49 32.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.827 1.651 . . . . 3.8199999999999998 112.297 -157.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.16 -27.22 65.34 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.475 0.917 . . . . 2.1200000000000001 113.475 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.4 21.6 16.74 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.58 -1.122 . . . . 0.90000000000000002 114.581 176.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.442 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 75.7 m-20 -97.35 136.07 38.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.874 1.337 . . . . 1.79 111.063 169.34 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.496 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 3.8 mp -136.6 165.9 31.7 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 125.676 1.59 . . . . 1.78 109.345 -172.355 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.99 161.08 13.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.026 2.484 . . . . 1.0900000000000001 111.387 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.18 133.82 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.334 1.54 . . . . 1.4299999999999999 115.044 -164.478 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 87.01 2.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.096 2.558 . . . . 1.6599999999999999 109.319 170.232 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.99 133.01 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.139 0.576 . . . . 0.83999999999999997 110.809 175.107 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.7 136.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.956 2.102 . . . . 1.74 106.408 173.288 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.49 162.99 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.425 -0.321 . . . . 2.3700000000000001 111.834 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -44.69 -22.52 0.08 Allowed 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 117.899 2.555 . . . . 2.5699999999999998 117.899 -177.947 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -7.67 52.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.462 1.905 . . . . 2.6499999999999999 113.45 -176.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.22 30.39 11.04 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 124.274 0.94 . . . . 0.80000000000000004 114.197 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.0 mt -124.29 133.57 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.17 1.388 . . . . 1.03 110.165 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.6 139.03 40.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.958 1.703 . . . . 0.73999999999999999 111.205 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -151.15 -11.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.588 2.44 . . . . 1.98 117.588 -166.386 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.83 117.97 53.39 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 121.459 1.936 . . . . 4.2000000000000002 113.619 -172.446 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.01 78.01 2.63 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.951 3.1 . . . . 2.5699999999999998 110.216 171.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.57 148.78 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.747 1.619 . . . . 3.5299999999999998 109.908 175.288 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.36 139.18 52.53 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.956 -0.757 . . . . 1.46 108.956 160.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -124.87 99.73 34.73 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.646 0.779 . . . . 0.90000000000000002 111.922 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.31 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.184 3.256 . . . . 1.22 113.761 178.451 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -31.47 72.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.909 0.884 . . . . 4.9100000000000001 111.134 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.17 151.86 37.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.548 2.739 . . . . 2.2200000000000002 106.868 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -135.35 11.98 3.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.301 1.223 . . . . 4.5099999999999998 114.301 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -150.25 169.09 22.16 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.999 -1.688 . . . . 2.1200000000000001 111.011 160.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.05 -43.32 11.79 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.104 -0.997 . . . . 1.8100000000000001 112.104 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -64.85 -19.55 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.897 1.073 . . . . 2.5299999999999998 113.897 -176.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -16.21 63.98 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.626 0.973 . . . . 2.3199999999999998 113.626 171.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.2 24.07 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.942 1.697 . . . . 1.2 112.802 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -53.95 -9.14 0.22 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.654 2.465 . . . . 3.3399999999999999 117.654 178.235 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.68 50.33 1.37 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.668 1.587 . . . . 2.8999999999999999 109.875 -169.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -142.62 150.22 40.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.7 1.6 . . . . 2.2200000000000002 112.347 -169.775 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.68 137.5 32.27 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.834 -0.541 . . . . 0.90000000000000002 111.367 167.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.603 HD12 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -97.97 122.09 40.67 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.829 -0.804 . . . . 3.96 108.829 154.855 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 31.1 mtt -122.62 124.26 43.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.386 0.674 . . . . 1.29 111.073 -173.301 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.0 mt -77.17 114.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 107.685 -1.228 . . . . 0.68999999999999995 107.685 171.149 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.78 137.8 40.51 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.232 1.413 . . . . 2.5800000000000001 112.629 -162.028 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.28 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.332 -0.855 . . . . 1.49 111.349 -165.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.76 133.42 11.79 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 118.306 0.503 . . . . 1.6799999999999999 112.258 172.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.53 154.36 21.57 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.517 1.532 . . . . 1.4199999999999999 112.183 156.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -112.34 36.59 3.33 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.53 0.937 . . . . 3.4199999999999999 113.53 -128.75 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.2 5.97 40.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.961 1.304 . . . . 3.6099999999999999 113.851 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.6 tpp -98.16 132.88 43.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.954 1.464 . . . . 3.0299999999999998 114.954 -157.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.8 p -176.66 171.19 2.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.554 2.341 . . . . 3.4199999999999999 111.1 159.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t70 92.44 65.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.176 2.99 . . . . 4.4000000000000004 111.61 -177.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -151.8 159.68 32.77 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.307 1.843 . . . . 4.0800000000000001 109.467 -173.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 -9.17 21.44 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.237 3.291 . . . . 3.4900000000000002 114.417 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -125.13 142.33 41.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.725 1.21 . . . . 4.3099999999999996 109.241 166.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.33 134.92 54.66 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.314 2.01 . . . . 3.5499999999999998 111.089 -175.671 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.5 mt 63.41 17.97 10.69 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.49 1.516 . . . . 3.8999999999999999 112.527 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.39 7.43 60.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.763 1.173 . . . . 4.04 113.941 -174.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.16 -8.28 75.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.17 1.367 . . . . 2.8799999999999999 113.953 -168.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.36 0.18 42.5 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 119.378 1.589 . . . . 2.0299999999999998 115.043 -176.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.84 5.71 45.8 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.984 1.754 . . . . 1.71 115.171 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 p -70.38 159.9 33.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.885 1.342 . . . . 2.0499999999999998 110.864 173.158 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -112.84 136.1 52.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.489 1.516 . . . . 5.6200000000000001 109.894 -172.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -90.83 -35.98 14.49 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.157 0.89 . . . . 2.3700000000000001 112.129 166.29 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.36 150.14 31.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.519 0.727 . . . . 0.83999999999999997 112.456 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 t -127.07 131.43 50.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.343 1.857 . . . . 1.77 111.505 -178.329 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -126.37 97.03 0.48 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.784 2.135 . . . . 1.3100000000000001 110.465 166.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.76 125.26 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.587 1.155 . . . . 1.6699999999999999 109.218 172.074 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.5 mt -58.3 117.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.742 0.782 . . . . 1.27 109.668 176.373 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 116.059 -0.518 . . . . 4.5800000000000001 111.602 177.382 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.658 -0.497 . . . . 1.6899999999999999 109.658 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.07 152.85 42.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.572 1.323 . . . . 1.1499999999999999 114.572 -145.9 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 132.49 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 123.152 1.453 . . . . 2.9700000000000002 112.057 159.329 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -94.71 71.46 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.154 1.382 . . . . 3.3399999999999999 111.213 -166.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.17 119.29 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.211 -0.931 . . . . 1.5 110.738 -156.174 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.02 97.25 1.38 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 126.189 1.852 . . . . 1.01 110.185 -173.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 29.8 mtt -80.22 131.38 35.68 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.574 0.749 . . . . 1.1399999999999999 112.158 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.0 150.54 22.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.721 0.808 . . . . 2.7799999999999998 109.878 172.657 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.1 mt -64.31 140.87 58.91 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.363 -0.977 . . . . 1.3700000000000001 108.363 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.16 158.11 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 118.511 0.596 . . . . 1.1100000000000001 112.202 -177.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -171.44 -150.36 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.921 2.089 . . . . 2.6000000000000001 108.252 173.219 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.02 -8.35 3.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 128.473 2.709 . . . . 1.6799999999999999 114.837 -178.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.19 -14.7 32.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.903 0.881 . . . . 4.2800000000000002 112.065 169.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.451 ' CA ' ' HD3' ' A' ' 57' ' ' PRO . . . 82.85 -142.47 21.65 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.134 0.873 . . . . 1.24 110.968 -162.557 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.31 120.96 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.555 1.542 . . . . 1.1899999999999999 111.757 176.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.97 -133.22 7.13 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 125.993 1.759 . . . . 1.9299999999999999 111.705 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.83 171.48 7.3 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.717 -0.872 . . . . 3.4900000000000002 110.845 170.247 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -109.26 137.66 46.8 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.006 1.323 . . . . 1.3100000000000001 113.502 -176.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.94 4.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.325 1.85 . . . . 2.8199999999999998 112.887 177.186 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.33 153.18 7.63 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.489 -0.757 . . . . 0.57999999999999996 113.903 -168.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.5 p -90.33 175.2 7.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.917 -0.771 . . . . 0.89000000000000001 108.917 161.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.68 129.45 75.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 106.218 -1.771 . . . . 0.40000000000000002 106.218 148.27 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.95 118.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.374 -0.602 . . . . 0.82999999999999996 109.374 178.554 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.7 mt -99.0 126.7 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.147 -1.427 . . . . 1.5700000000000001 107.147 175.369 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -128.24 122.06 30.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.164 0.983 . . . . 2.5899999999999999 111.27 169.274 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 124.58 23.19 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.501 1.92 . . . . 3.2799999999999998 109.52 171.295 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.6 p -138.25 174.56 10.43 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.341 0.591 . . . . 2.6000000000000001 111.416 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.44 -23.86 64.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.267 -0.896 . . . . 3.5600000000000001 112.496 172.345 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.38 13.84 66.49 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.794 1.188 . . . . 1.3500000000000001 114.65 170.029 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.77 -158.03 31.7 Favored Glycine 0 N--CA 1.469 0.877 0 C-N-CA 126.732 2.11 . . . . 0.96999999999999997 114.559 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.51 96.72 2.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.958 0.903 . . . . 0.81999999999999995 111.738 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -72.81 116.59 13.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.72 2.008 . . . . 2.6600000000000001 109.975 172.11 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -109.12 111.48 23.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.309 2.244 . . . . 0.56999999999999995 109.768 -174.327 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.9 m -119.85 114.29 34.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-O 118.275 -0.869 . . . . 0.53000000000000003 108.986 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.45 160.74 9.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.048 2.498 . . . . 0.41999999999999998 112.781 -174.45 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -150.51 26.39 0.76 Allowed 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.546 0.943 . . . . 1.3799999999999999 113.546 172.348 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.91 143.53 31.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.66000000000000003 112.83 -176.366 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' H ' ' HE3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -125.18 128.28 48.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 117.575 -1.202 . . . . 2.3700000000000001 110.673 174.661 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 131.12 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 129.838 3.255 . . . . 1.97 115.971 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -95.92 159.66 31.82 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.115 0.966 . . . . 1.54 112.215 -172.27 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -59.77 133.39 50.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.511 2.141 . . . . 0.80000000000000004 111.408 171.219 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.601 ' HA ' HG23 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -92.97 43.08 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.019 2.48 . . . . 0.88 112.589 -150.266 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.25 -158.01 10.05 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 122.895 1.275 . . . . 1.1599999999999999 115.724 -175.506 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -81.11 145.0 31.29 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.668 2.387 . . . . 2.8199999999999998 111.735 173.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -152.39 138.05 17.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.783 1.633 . . . . 1.1200000000000001 110.018 -174.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.77 165.28 54.81 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 120.398 1.454 . . . . 0.62 114.194 169.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -130.36 121.98 27.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.551 1.541 . . . . 2.1000000000000001 107.22 177.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -121.74 156.34 33.34 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.179 1.354 . . . . 1.28 112.677 173.325 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.13 141.05 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.914 1.686 . . . . 0.95999999999999996 108.839 158.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -119.86 -179.09 3.8 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.767 1.627 . . . . 1.1899999999999999 110.254 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.69 56.24 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.807 2.151 . . . . 1.0900000000000001 116.807 -166.105 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -132.84 159.9 38.47 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.954 1.252 . . . . 1.3500000000000001 114.015 178.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.63 65.79 4.0 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.972 1.749 . . . . 1.03 113.14 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -146.06 76.15 1.44 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.482 0.919 . . . . 2.27 113.482 -168.449 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.1 m -60.54 38.49 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 129.303 3.041 . . . . 1.6100000000000001 117.636 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -120.15 168.9 9.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 119.789 -1.819 . . . . 3.4700000000000002 112.042 -166.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 92.5 Cg_endo -80.22 145.94 17.46 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.566 2.177 . . . . 1.4199999999999999 111.085 168.583 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.06 153.23 18.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.621 -0.718 . . . . 2.77 109.353 159.144 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.81 116.22 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.083 -1.451 . . . . 4.2599999999999998 107.083 163.005 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -79.51 -47.1 16.16 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.706 0.765 . . . . 7.6600000000000001 110.418 178.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -176.09 118.76 0.15 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.358 3.063 . . . . 5.8200000000000003 106.511 171.141 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.44 -4.46 0.95 Allowed Glycine 0 CA--C 1.54 1.65 0 N-CA-C 117.556 1.782 . . . . 3.6800000000000002 117.556 175.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -159.99 157.39 28.71 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.74 1.77 . . . . 3.2999999999999998 111.71 -171.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.49 133.98 34.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.4 1.08 . . . . 1.6000000000000001 112.221 -173.207 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.4 t -115.3 103.57 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.031 1.333 . . . . 3.0800000000000001 109.001 171.102 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.98 110.72 4.03 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.342 1.457 . . . . 3.1400000000000001 112.194 -177.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 122.1 -24.65 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 131.136 3.774 . . . . 2.8500000000000001 113.876 171.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.85 -11.28 58.29 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.412 1.46 . . . . 6.29 114.246 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.782 -1.199 . . . . 2.6200000000000001 112.785 168.034 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.65 3.44 16.37 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.355 1.062 . . . . 1.2 113.133 173.71 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.1 178.75 38.81 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.366 0.984 . . . . 2.21 113.564 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.2 -167.81 10.19 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.374 0.988 . . . . 1.3899999999999999 112.952 171.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -72.29 52.34 0.26 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.222 1.809 . . . . 2.3999999999999999 111.501 174.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.6 tp 37.3 58.67 1.23 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.71 2.004 . . . . 1.9199999999999999 111.465 178.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 85.02 55.57 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.216 1.806 . . . . 4.8200000000000003 112.273 -150.305 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.81 -63.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.648 2.899 . . . . 1.8600000000000001 111.672 175.144 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -143.43 129.38 19.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.473 -1.677 . . . . 5.46 106.473 173.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 p30 174.73 -97.65 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.532 1.933 . . . . 4.5700000000000003 112.196 179.092 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t 174.97 -45.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.991 2.516 . . . . 3.1200000000000001 109.739 -166.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.14 -39.8 3.1 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 126.141 1.829 . . . . 3.9399999999999999 116.374 149.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -43.26 -51.41 6.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.831 1.653 . . . . 3.96 113.546 -170.516 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.443 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 162.48 150.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.605 3.162 . . . . 2.4300000000000002 112.564 168.067 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -82.85 167.26 18.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.267 0.556 . . . . 3.4399999999999999 112.057 171.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.88 -109.97 0.78 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.595 -1.669 . . . . 5.4100000000000001 110.95 -167.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.02 -27.03 36.68 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.768 2.979 . . . . 7.5800000000000001 114.711 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.75 10.55 3.39 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.931 1.293 . . . . 9.6300000000000008 112.454 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.62 73.23 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.025 -0.875 . . . . 4.1299999999999999 114.807 171.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -82.94 51.14 1.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.265 1.532 . . . . 6.5300000000000002 113.839 -166.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.81 -171.66 42.13 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 117.249 1.66 . . . . 2.1400000000000001 117.249 -167.509 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.947 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 16.6 p-80 -139.74 157.13 46.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.922 1.689 . . . . 5.0 110.848 171.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.413 ' H ' HD23 ' A' ' 91' ' ' LEU . 2.5 pt? -69.36 24.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.582 1.553 . . . . 2.3999999999999999 115.186 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -153.56 23.46 0.74 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 128.572 2.987 . . . . 0.88 113.042 178.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.947 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 10.5 m-20 -80.53 138.62 36.53 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 106.75 -1.574 . . . . 2.1299999999999999 106.75 154.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 111' ' ' ALA . 3.7 mp -143.59 147.8 40.81 Favored Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 121.744 2.065 . . . . 2.3100000000000001 112.577 -171.404 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.94 157.94 54.13 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.124 3.216 . . . . 0.91000000000000003 113.254 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.67 125.97 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 115.429 1.64 . . . . 1.6399999999999999 115.429 -156.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 67.93 0.8 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.912 2.885 . . . . 1.53 110.313 170.835 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.8 134.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.508 -0.745 . . . . 1.05 109.429 174.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.601 HG23 ' HA ' ' A' ' 42' ' ' PRO . 6.4 m -115.0 152.14 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.006 0.922 . . . . 2.04 108.9 175.115 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -70.56 157.07 38.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.531 0.567 . . . . 2.7400000000000002 112.531 -176.293 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -50.56 -22.55 2.04 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 126.935 2.094 . . . . 2.1899999999999999 115.527 179.121 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -88.88 3.56 50.87 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.888 2.475 . . . . 3.7599999999999998 113.892 -178.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 30.08 21.19 Favored Glycine 0 N--CA 1.475 1.277 0 O-C-N 121.135 -0.978 . . . . 0.67000000000000004 115.283 173.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.8 131.56 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.252 1.421 . . . . 0.98999999999999999 109.535 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.83 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.651 1.18 . . . . 0.93000000000000005 109.969 176.516 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 t -149.4 -33.75 0.2 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.106 1.362 . . . . 1.6699999999999999 113.183 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -66.13 121.52 76.73 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.848 0.859 . . . . 3.1099999999999999 111.048 -178.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.65 152.31 22.66 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.149 3.233 . . . . 1.3600000000000001 112.354 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.27 175.99 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.456 1.503 . . . . 1.26 110.22 170.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.6 m -146.39 143.81 29.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.587 1.155 . . . . 0.98999999999999999 109.994 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -105.17 101.63 31.66 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.7 1.2 . . . . 1.3100000000000001 111.766 175.365 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.38 -5.81 10.12 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.981 2.454 . . . . 1.6499999999999999 116.195 -166.294 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -77.43 -17.13 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.553 1.524 . . . . 9.6699999999999999 113.188 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.15 153.55 19.16 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.92 1.688 . . . . 2.9100000000000001 109.421 -177.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 28.63 1.21 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.878 1.671 . . . . 4.3700000000000001 111.333 170.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.7 m -163.29 133.54 4.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.344 1.857 . . . . 2.1000000000000001 110.819 171.53 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.42 -27.47 67.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.271 1.428 . . . . 2.0 110.488 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.42 -26.88 5.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.396 1.878 . . . . 3.6000000000000001 113.687 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -65.84 -11.67 48.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.461 1.105 . . . . 2.5800000000000001 113.486 176.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.52 15.49 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.162 1.171 . . . . 0.70999999999999996 114.162 -172.245 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -69.06 9.24 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 118.1 2.63 . . . . 2.1200000000000001 118.1 -169.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -151.72 29.71 0.6 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.765 1.626 . . . . 3.3700000000000001 111.676 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -116.47 155.22 28.97 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.788 -1.195 . . . . 2.8999999999999999 112.222 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.97 141.26 28.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.296 0.638 . . . . 0.65000000000000002 110.46 166.309 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 141.67 43.82 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.175 -0.676 . . . . 1.6000000000000001 109.175 160.374 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.0 mtt -134.24 135.29 42.83 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.375 0.67 . . . . 1.3600000000000001 112.594 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.5 mt -82.13 105.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.609 1.163 . . . . 0.68000000000000005 108.65 172.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.11 139.75 30.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.106 1.762 . . . . 2.3300000000000001 110.979 -176.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.54 -39.08 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.871 -1.143 . . . . 1.6899999999999999 112.443 -162.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -94.99 144.12 17.0 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.205 0.907 . . . . 1.29 112.043 176.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.39 156.64 25.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 127.014 2.245 . . . . 1.72 115.053 175.446 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.66 53.26 0.7 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.517 1.151 . . . . 3.2000000000000002 113.268 -147.3 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -141.64 2.35 1.6 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.634 1.574 . . . . 2.5299999999999998 113.423 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.2 mtm -92.6 126.47 37.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.121 0.968 . . . . 2.2799999999999998 111.683 -171.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 -158.3 0.82 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.536 1.134 . . . . 3.27 110.921 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.24 -38.51 0.41 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 129.911 3.284 . . . . 3.6499999999999999 114.135 -176.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -67.65 146.26 98.46 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.724 2.01 . . . . 3.3100000000000001 113.42 -166.058 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.89 -40.44 44.16 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.521 3.481 . . . . 2.3500000000000001 112.204 -172.393 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.23 101.42 11.23 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 105.889 -1.893 . . . . 4.3600000000000003 105.889 162.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -75.77 179.44 6.25 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.429 2.753 . . . . 3.1299999999999999 113.338 -162.139 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.1 mt 66.53 1.08 2.0 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.887 2.075 . . . . 3.8300000000000001 113.987 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.74 27.12 67.83 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.698 1.135 . . . . 2.8900000000000001 112.388 -175.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.6 -8.88 79.12 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.018 1.294 . . . . 1.95 114.354 -171.198 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.78 22.09 0.57 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.349 1.928 . . . . 2.1899999999999999 115.86 -177.566 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.16 -15.26 65.04 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.936 1.255 . . . . 1.47 113.147 167.446 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.4 p -74.27 151.58 39.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.639 1.22 . . . . 1.71 110.013 172.329 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.93 142.31 30.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.472 1.109 . . . . 5.5499999999999998 112.581 -171.59 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.34 -33.88 12.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.555 0.742 . . . . 2.77 112.235 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.89 155.99 41.66 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.259 1.024 . . . . 0.62 113.038 -176.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.43 151.67 45.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.932 2.093 . . . . 1.4299999999999999 111.334 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.28 126.76 2.89 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.99 1.281 . . . . 0.66000000000000003 112.545 173.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.48 123.45 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.955 1.302 . . . . 1.53 109.972 171.238 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.69 113.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.719 -0.845 . . . . 1.01 108.719 170.455 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt . . . . . 0 CA--C 1.54 0.585 0 O-C-N 121.745 -0.597 . . . . 3.75 111.121 -174.757 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.528 -0.545 . . . . 1.6499999999999999 109.528 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -131.78 135.19 46.59 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.65 -1.281 . . . . 1.6699999999999999 113.788 -137.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -144.7 148.8 34.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.134 1.373 . . . . 2.8999999999999999 108.587 173.202 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -126.5 99.95 6.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.778 1.231 . . . . 4.3300000000000001 110.866 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -90.29 122.24 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 121.861 -0.524 . . . . 1.05 109.985 -173.167 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.2 104.7 2.06 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.905 1.717 . . . . 0.68999999999999995 110.752 174.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 mmm -86.93 89.45 7.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.422 1.489 . . . . 1.5800000000000001 110.655 -175.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -75.39 148.37 39.24 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.231 -0.918 . . . . 2.7599999999999998 111.04 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.13 140.72 58.24 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.53 -0.732 . . . . 1.3300000000000001 109.796 174.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.7 138.82 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.892 0.877 . . . . 1.1399999999999999 110.316 177.318 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -171.85 69.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.979 0.912 . . . . 2.6800000000000002 111.909 -170.122 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 74.37 -42.46 0.5 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.592 2.357 . . . . 1.4199999999999999 114.285 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.39 -9.22 58.23 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.486 1.039 . . . . 3.0699999999999998 112.163 174.072 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.91 -147.82 17.99 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 125.909 1.719 . . . . 1.0700000000000001 111.455 -173.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.8 t -58.85 127.04 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.795 1.638 . . . . 0.87 110.212 174.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.78 -97.71 2.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.32 0.962 . . . . 1.48 113.694 -168.464 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.29 127.93 12.41 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.707 1.203 . . . . 2.3799999999999999 109.864 -170.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 t -90.98 149.95 21.66 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.056 1.132 . . . . 1.1499999999999999 114.056 -160.556 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -143.07 -6.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 115.289 1.589 . . . . 2.7400000000000002 115.289 -173.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.5 153.73 13.31 Favored Glycine 0 N--CA 1.469 0.861 0 O-C-N 120.625 -1.297 . . . . 0.59999999999999998 114.556 -175.276 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 p -107.19 176.16 5.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.434 -0.95 . . . . 0.83999999999999997 108.434 163.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.08 134.03 66.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.44 -0.948 . . . . 0.76000000000000001 108.44 158.509 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.417 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.5 p -88.48 130.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.7 0.625 . . . . 1.0600000000000001 110.296 173.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.26 114.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.064 2.146 . . . . 1.51 108.399 -173.991 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.08 105.93 11.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.74 0.816 . . . . 2.1200000000000001 111.348 175.642 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 133.76 55.24 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.107 2.563 . . . . 3.7000000000000002 111.176 172.457 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 t -164.02 -172.02 2.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.209 0.604 . . . . 1.9299999999999999 111.089 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.54 -38.25 66.38 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.674 1.189 . . . . 3.6400000000000001 111.685 178.352 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.74 12.36 41.89 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.867 1.222 . . . . 1.28 115.297 173.058 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 -145.82 32.65 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 127.824 2.63 . . . . 0.97999999999999998 112.042 -177.407 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.89 102.21 6.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.997 0.919 . . . . 1.02 111.614 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.59 109.97 12.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.093 0.957 . . . . 2.1899999999999999 110.556 175.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.95 105.77 17.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.875 2.47 . . . . 0.96999999999999997 110.191 -169.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.417 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.0 m -110.7 108.99 57.99 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 107.84 -1.17 . . . . 1.25 107.84 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.43 157.11 22.27 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.807 2.338 . . . . 0.83999999999999997 111.211 -177.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -142.78 37.09 1.44 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.911 0.862 . . . . 1.53 111.253 169.01 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -91.49 158.67 16.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 123.123 1.439 . . . . 0.78000000000000003 113.841 -174.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HE3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -144.01 159.32 42.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.032 2.133 . . . . 2.96 108.38 174.525 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.52 23.66 0.08 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.465 2.706 . . . . 1.4399999999999999 113.381 171.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.467 HD12 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -92.89 161.75 30.74 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 121.484 -0.76 . . . . 1.72 110.773 174.158 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.63 135.33 52.2 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 O-C-N 122.655 0.818 . . . . 0.96999999999999997 110.068 164.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -92.65 24.05 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.968 3.112 . . . . 1.0800000000000001 112.942 -149.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.7 158.11 15.1 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.003 -1.239 . . . . 2.2400000000000002 110.003 167.141 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -51.2 130.9 27.38 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 128.302 2.641 . . . . 3.1600000000000001 114.915 -175.53 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -103.83 138.36 40.53 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.832 1.253 . . . . 1.5600000000000001 112.577 -171.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.63 150.66 50.91 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.926 -0.87 . . . . 0.72999999999999998 110.926 166.371 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.92 119.85 28.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.099 -1.445 . . . . 2.02 107.099 175.198 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -115.25 153.64 30.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.922 0.889 . . . . 0.96999999999999997 113.27 171.165 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.483 ' CG2' HD12 ' A' ' 74' ' ' LEU . 71.7 mt -94.75 144.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.396 1.078 . . . . 0.83999999999999997 109.03 150.612 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -118.74 156.85 28.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.15 1.78 . . . . 0.93000000000000005 110.214 176.409 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.1 62.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 117.101 2.26 . . . . 1.1100000000000001 117.101 -159.368 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -134.75 -179.2 5.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.8 2.04 . . . . 1.3400000000000001 110.44 175.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.84 100.55 0.54 Allowed Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.576 -1.327 . . . . 1.25 113.629 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.4 t 175.71 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.079 2.152 . . . . 2.0099999999999998 110.987 173.268 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.2 m -71.4 43.43 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 126.902 2.081 . . . . 1.5800000000000001 115.019 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -106.95 127.95 27.03 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.308 -1.495 . . . . 3.2799999999999998 111.276 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.84 162.34 29.63 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.824 3.016 . . . . 1.1000000000000001 112.305 173.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.12 145.76 40.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.125 0.97 . . . . 1.52 109.467 160.111 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mm -102.07 22.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.669 1.188 . . . . 3.3999999999999999 111.321 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.14 129.46 27.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.131 1.373 . . . . 4.4699999999999998 112.2 -175.332 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 t0 69.83 25.87 4.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.678 1.591 . . . . 3.3500000000000001 112.737 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.64 28.07 44.55 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.722 1.153 . . . . 2.3700000000000001 113.541 172.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -158.26 132.54 8.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.009 0.904 . . . . 2.7000000000000002 110.773 -166.488 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.8 104.0 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.394 -0.816 . . . . 1.8799999999999999 111.277 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.61 41.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.674 1.589 . . . . 2.1600000000000001 112.414 -175.066 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.46 -63.15 0.26 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.991 2.916 . . . . 1.75 115.563 172.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.77 128.31 2.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.074 2.55 . . . . 1.6399999999999999 108.315 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -116.48 -46.71 2.76 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.435 1.094 . . . . 4.9000000000000004 111.72 -177.455 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.54 -18.73 64.42 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.712 1.004 . . . . 1.4099999999999999 113.712 -174.617 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.1 -8.39 56.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.161 1.384 . . . . 1.05 113.45 168.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.64 174.4 49.27 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 120.608 -1.307 . . . . 2.6299999999999999 112.699 -172.744 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.37 -160.52 19.5 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 122.156 -0.614 . . . . 1.25 111.768 168.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -48.4 144.0 4.39 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.466 -0.568 . . . . 2.7999999999999998 109.466 165.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -71.3 61.01 0.3 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.515 1.526 . . . . 2.5 112.152 179.614 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -118.85 -1.21 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 120.724 3.602 . . . . 4.0499999999999998 120.724 -147.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.66 -56.84 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 123.505 2.288 . . . . 2.9399999999999999 114.885 -151.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -92.76 54.85 2.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.632 1.173 . . . . 3.3100000000000001 111.236 -177.168 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -123.94 -75.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.324 1.05 . . . . 3.3900000000000001 111.651 174.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t 168.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 130.02 3.328 . . . . 2.5699999999999998 111.257 -175.578 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.48 0.19 73.4 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 115.408 0.923 . . . . 1.9199999999999999 115.408 164.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -84.22 3.87 33.33 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.604 1.705 . . . . 5.0800000000000001 115.604 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 45.2 t60 62.25 -174.25 0.14 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.911 1.284 . . . . 1.8 111.662 -169.143 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.27 -155.14 0.47 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.558 -1.339 . . . . 3.98 111.467 -172.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.43 -101.56 0.64 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.041 -1.422 . . . . 2.8300000000000001 111.007 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.9 -15.38 32.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.501 2.8 . . . . 4.0 113.357 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.59 157.37 12.39 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.77 2.828 . . . . 6.8700000000000001 108.333 179.215 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.5 179.75 29.55 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.223 0.902 . . . . 4.0199999999999996 114.857 177.177 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -156.13 35.64 0.34 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.935 2.094 . . . . 5.8099999999999996 109.426 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.61 4.56 63.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 116.822 -2.099 . . . . 3.2999999999999998 116.703 -172.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.569 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 10.5 t-160 -177.12 99.5 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.358 1.863 . . . . 4.6100000000000003 111.561 171.551 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -14.19 62.78 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.104 1.89 . . . . 3.0 116.104 -176.297 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 25.37 28.22 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 127.273 2.368 . . . . 1.5800000000000001 115.537 -170.088 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD2' ' ND1' ' A' ' 90' ' ' HIS . 46.4 m-20 -93.14 151.73 19.67 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.205 1.402 . . . . 3.0499999999999998 110.384 167.226 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.63 157.91 76.23 Favored Pre-proline 0 CA--C 1.556 1.198 0 O-C-N 120.95 -1.094 . . . . 2.21 111.706 -161.745 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.7 162.38 41.41 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.96 3.106 . . . . 0.93000000000000005 112.509 -171.414 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -83.19 128.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 123.431 1.586 . . . . 1.6299999999999999 112.977 -161.072 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.03 83.22 6.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.556 2.742 . . . . 2.4100000000000001 110.033 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.53 143.62 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 125.598 1.559 . . . . 1.0 111.105 176.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.42 157.25 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 127.598 2.359 . . . . 1.73 107.913 170.159 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.7 p30 -81.35 163.26 23.0 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 118.743 -0.646 . . . . 2.0099999999999998 111.852 170.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -19.35 2.2 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.312 1.967 . . . . 3.5299999999999998 116.312 -174.028 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -94.37 -2.33 52.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.658 1.583 . . . . 3.8599999999999999 114.578 177.351 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.12 31.44 8.49 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.149 0.886 . . . . 1.0 115.174 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -116.53 133.78 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.768 1.627 . . . . 1.04 109.449 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.18 108.81 19.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.441 1.496 . . . . 0.68999999999999995 109.546 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 t -131.43 24.59 4.8 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.079 1.752 . . . . 1.3999999999999999 111.291 172.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.79 108.54 43.72 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.917 1.687 . . . . 3.04 108.933 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 129.87 14.65 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.791 2.327 . . . . 1.3 110.378 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.29 172.17 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.163 1.385 . . . . 1.5 108.972 175.544 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.3 m -151.22 145.59 25.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.226 0.921 . . . . 1.21 109.954 -171.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -112.45 89.64 12.99 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 112.992 0.738 . . . . 1.01 112.992 176.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 -4.91 12.86 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.856 3.038 . . . . 1.47 114.307 172.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -73.72 -18.92 60.94 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.751 2.02 . . . . 3.9399999999999999 112.046 176.129 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.38 164.02 13.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.379 2.272 . . . . 2.6699999999999999 108.405 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -154.37 6.11 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.295 1.591 . . . . 4.4299999999999997 115.295 -172.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 t -168.95 130.41 1.2 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.338 -1.476 . . . . 1.9299999999999999 113.099 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.35 -26.94 61.78 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.583 -1.323 . . . . 1.51 111.946 174.442 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.13 -16.69 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.676 1.361 . . . . 3.0899999999999999 114.676 175.506 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.68 -12.89 52.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.385 1.448 . . . . 2.04 113.056 171.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.41 3.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.353 1.461 . . . . 0.90000000000000002 114.587 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -62.35 -2.56 1.05 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.057 2.243 . . . . 2.3599999999999999 117.057 -175.374 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -148.85 29.38 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.036 1.735 . . . . 3.2999999999999998 110.826 174.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -111.87 -179.53 3.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.83 1.652 . . . . 1.54 111.578 178.338 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.31 151.74 48.95 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.003 -1.061 . . . . 0.59999999999999998 111.124 168.739 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.74 153.48 33.34 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.441 1.097 . . . . 2.3700000000000001 110.696 164.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.3 mtt -136.97 130.98 32.32 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.329 0.652 . . . . 1.23 110.94 -170.871 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.0 mt -84.74 109.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.76000000000000001 107.131 168.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -91.95 147.03 23.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.002 2.121 . . . . 2.1200000000000001 111.191 -175.029 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.71 -37.58 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.876 -1.14 . . . . 1.5900000000000001 113.397 -162.081 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.16 170.92 15.16 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 124.506 1.05 . . . . 1.5800000000000001 111.774 170.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.46 169.34 37.19 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 1.45 113.884 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -125.96 11.64 7.73 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.896 1.813 . . . . 2.46 115.896 -141.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.21 9.21 0.46 Allowed 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.126 -1.609 . . . . 2.8700000000000001 115.229 -177.448 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.1 mtm -81.19 79.29 7.87 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.527 1.531 . . . . 3.04 112.31 -172.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -81.68 -5.09 57.77 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.957 0.903 . . . . 2.98 113.352 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -149.3 145.05 26.86 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.152 -1.592 . . . . 3.8700000000000001 111.566 -173.393 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 151.27 153.88 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.091 1 C-N-CA 132.049 4.139 . . . . 4.0999999999999996 110.166 173.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.71 -12.1 22.11 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.306 2.671 . . . . 2.1499999999999999 114.382 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -77.93 116.0 54.99 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 119.76 1.164 . . . . 4.9699999999999998 108.927 165.284 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.84 173.33 12.09 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.161 2.574 . . . . 4.3499999999999996 112.948 -168.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.8 mt 67.04 11.21 8.26 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.355 1.862 . . . . 6.7599999999999998 113.904 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.28 6.62 59.91 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.437 1.494 . . . . 4.7699999999999996 114.481 177.04 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.93 -50.67 2.67 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.127 1.463 . . . . 3.1800000000000002 114.581 175.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.31 45.14 1.73 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 126.58 2.038 . . . . 2.0800000000000001 114.602 -175.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.74 -15.12 68.49 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.674 1.13 . . . . 1.8400000000000001 114.657 -175.014 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.8 p -67.68 125.09 25.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.216 1.406 . . . . 1.9399999999999999 112.244 -175.291 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 -91.01 150.41 21.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.011 1.724 . . . . 4.5999999999999996 110.098 176.19 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 11.0 t80 -112.49 -42.04 3.74 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.795 0.725 . . . . 2.0899999999999999 112.265 161.5 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.99 142.79 32.97 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.316 0.646 . . . . 0.68999999999999995 112.607 177.504 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.02 143.44 44.31 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.503 1.521 . . . . 1.3200000000000001 111.113 176.324 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.57 81.66 0.3 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 128.083 2.754 . . . . 0.77000000000000002 110.962 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.76 135.66 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 118.091 0.945 . . . . 2.2799999999999998 110.949 166.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.2 mt -107.54 140.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.045 1.338 . . . . 1.1399999999999999 110.341 -167.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 3.8599999999999999 109.822 177.493 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.568 -0.253 . . . . 3.2599999999999998 110.989 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -155.67 152.45 28.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.095 1.358 . . . . 1.96 110.121 -170.848 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.84 122.73 5.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.055 0.931 . . . . 2.6899999999999999 112.669 173.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.76 82.41 5.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.994 -1.066 . . . . 3.25 113.225 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.69 116.05 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.22 -0.925 . . . . 1.52 111.778 -169.265 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.09 90.38 1.2 Allowed Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.462 1.982 . . . . 1.1599999999999999 112.319 -177.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mmt -72.81 120.8 18.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.95 . . . . 1.78 113.13 -175.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -104.44 144.37 31.75 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.074 1.75 . . . . 3.52 112.033 -178.529 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.64 66.53 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.42 1.088 . . . . 1.8600000000000001 111.105 175.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 m -67.46 138.88 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.552 1.141 . . . . 0.95999999999999996 110.304 174.106 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -165.81 61.1 0.11 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.745 0.784 . . . . 2.21 112.317 -171.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.61 -26.79 0.17 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.965 2.506 . . . . 1.1599999999999999 115.265 171.212 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -17.44 61.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.301 2.24 . . . . 2.5800000000000001 112.117 173.7 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.8 -168.04 13.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.545 2.022 . . . . 1.6499999999999999 109.963 -160.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.2 t -56.64 139.5 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.327 0.651 . . . . 1.04 110.19 155.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.74 -128.2 4.7 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.927 1.727 . . . . 1.3799999999999999 112.065 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.67 162.75 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.755 1.622 . . . . 4.4000000000000004 111.009 178.224 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -128.45 156.5 43.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.083 0.953 . . . . 1.23 112.745 -164.746 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.74 7.53 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 125.005 1.322 . . . . 2.98 114.388 -162.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.84 173.82 24.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.063 1.315 . . . . 0.57999999999999996 112.975 -179.477 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 p -105.18 174.34 5.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.78 0.832 . . . . 0.94999999999999996 109.817 168.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 t -123.46 126.67 73.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.962 -1.496 . . . . 0.85999999999999999 106.962 151.59 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.55 119.7 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 123.279 0.362 . . . . 0.95999999999999996 111.408 -177.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.33 126.74 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.847 1.259 . . . . 1.1799999999999999 108.545 174.198 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -130.34 127.16 38.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.917 0.887 . . . . 2.3300000000000001 109.896 170.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 117' ' ' LEU . 12.8 tt0 -77.05 136.67 38.68 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.516 1.927 . . . . 3.3700000000000001 112.302 -171.261 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.58 -175.53 5.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.254 0.934 . . . . 1.23 111.361 175.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.24 -30.62 70.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.013 0.925 . . . . 4.0499999999999998 112.037 -179.383 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.11 11.77 41.07 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.892 0.758 . . . . 1.1000000000000001 113.762 166.197 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.36 -141.16 21.92 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 127.441 2.448 . . . . 0.83999999999999997 114.742 176.289 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.11 101.9 9.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.057 0.943 . . . . 0.63 111.296 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -78.06 108.24 11.21 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.983 1.313 . . . . 1.8500000000000001 110.594 175.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -102.69 117.1 33.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.458 2.303 . . . . 0.62 110.269 -171.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -127.58 112.36 20.9 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 117.765 -1.112 . . . . 0.68999999999999995 109.716 -172.473 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -88.62 159.43 6.42 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.188 2.592 . . . . 0.46999999999999997 112.224 -173.233 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.08 25.31 0.72 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.446 0.906 . . . . 1.3100000000000001 113.446 173.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.31 136.58 33.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.814 0.846 . . . . 0.66000000000000003 112.822 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.09 156.98 18.99 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.677 -0.692 . . . . 2.6000000000000001 111.198 161.551 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.15 20.39 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.806 2.442 . . . . 1.79 114.675 156.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.89 154.29 41.13 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 1.4199999999999999 112.458 176.252 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.07 137.68 45.1 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 O-C-N 122.953 0.975 . . . . 1.6000000000000001 110.911 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 9.7 Cg_endo -85.24 51.74 3.12 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.489 3.459 . . . . 1.73 112.283 -162.881 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 -162.42 13.99 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 114.868 -1.06 . . . . 1.1899999999999999 114.047 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.46 140.28 32.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.256 1.822 . . . . 2.6899999999999999 110.214 171.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.87 136.55 30.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 1.4199999999999999 109.683 -177.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.72 169.61 29.71 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.629 0.65 . . . . 0.72999999999999998 112.347 167.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.39 132.68 10.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.209 1.404 . . . . 2.04 108.566 171.112 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 15.6 m170 -129.79 170.49 13.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.231 1.567 . . . . 0.70999999999999996 115.231 168.633 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 74' ' ' LEU . 44.3 mt -99.01 147.1 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.629 1.572 . . . . 0.60999999999999999 109.151 153.201 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.59 152.34 40.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.168 1.787 . . . . 0.81999999999999995 110.503 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.35 -31.44 72.57 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.435 2.013 . . . . 0.92000000000000004 116.435 -160.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -113.73 169.8 8.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.858 1.663 . . . . 1.2 112.528 177.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.02 67.41 0.22 Allowed Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.948 1.139 . . . . 0.81000000000000005 115.948 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -166.88 120.5 1.02 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 119.459 1.629 . . . . 2.0699999999999998 114.572 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.4 m -69.93 -6.34 32.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.34 1.856 . . . . 1.4299999999999999 115.157 176.017 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -63.96 145.02 98.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 O-C-N 120.993 -1.067 . . . . 3.2000000000000002 111.825 -168.825 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.23 150.2 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.978 2.452 . . . . 1.28 111.752 179.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.25 140.96 34.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.517 0.727 . . . . 1.6799999999999999 109.723 161.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.92 126.75 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.13 -1.063 . . . . 2.7000000000000002 108.13 169.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -167.32 144.91 4.65 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.731 1.612 . . . . 5.25 109.971 -163.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 59.88 -104.73 0.2 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.072 1.349 . . . . 4.1399999999999997 108.003 -163.315 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.68 25.4 3.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.934 1.73 . . . . 2.6499999999999999 113.501 170.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.88 179.62 9.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.094 1.447 . . . . 4.5199999999999996 113.318 -167.059 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.57 108.53 20.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.812 1.245 . . . . 1.6599999999999999 112.679 -171.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.25 91.43 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.829 1.252 . . . . 2.0499999999999998 109.937 -179.06 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.15 114.7 2.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.567 1.547 . . . . 2.98 112.859 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.26 39.18 7.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.54 1.536 . . . . 1.8100000000000001 113.395 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.84 -43.0 90.64 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.409 0.684 . . . . 4.4199999999999999 109.896 158.431 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.78 78.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.664 1.186 . . . . 1.8 113.002 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -16.36 8.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.816 2.046 . . . . 0.87 115.416 179.161 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.89 176.25 45.35 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 120.072 1.305 . . . . 2.3100000000000001 112.561 -172.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.24 -175.92 22.72 Favored Glycine 0 N--CA 1.474 1.181 0 N-CA-C 111.732 -0.547 . . . . 1.3999999999999999 111.732 163.416 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -70.17 35.88 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.907 1.447 . . . . 3.0899999999999999 114.907 -176.325 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.489 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER 71.81 89.73 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.2 1.8 . . . . 3.0699999999999998 109.691 175.317 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.25 102.47 1.24 Allowed Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 127.287 2.235 . . . . 3.8700000000000001 110.03 -172.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.42 -54.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.259 2.64 . . . . 1.9299999999999999 111.561 173.557 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -132.37 15.2 4.55 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.052 1.296 . . . . 4.1699999999999999 113.651 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.91 -47.17 63.52 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.427 -1.421 . . . . 3.6099999999999999 111.388 -171.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t 178.16 -65.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.287 2.235 . . . . 2.8500000000000001 111.855 175.299 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.29 -21.14 6.13 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.825 1.203 . . . . 1.9199999999999999 114.502 -170.269 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -82.62 168.61 17.14 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.117 1.959 . . . . 4.3200000000000003 113.83 170.296 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -84.52 146.09 27.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.336 1.054 . . . . 1.5800000000000001 112.875 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 84' ' ' GLY . 7.1 tt0 -106.87 -156.81 0.59 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.505 1.122 . . . . 3.54 112.56 -178.323 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' A' ' 83' ' ' GLU . . . -160.47 -128.34 0.95 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 127.23 2.348 . . . . 3.1299999999999999 110.478 179.081 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.95 -27.22 12.38 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.363 2.709 . . . . 5.5499999999999998 113.353 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -174.18 164.85 4.07 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.664 2.386 . . . . 8.8699999999999992 109.979 171.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.22 -135.36 7.72 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 125.796 1.665 . . . . 2.6200000000000001 109.977 -174.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -142.67 116.13 9.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.289 1.044 . . . . 4.8099999999999996 112.079 166.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.58 -139.44 3.24 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 127.474 2.464 . . . . 2.1400000000000001 109.179 166.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -75.49 139.7 42.37 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 117.806 0.803 . . . . 3.7000000000000002 112.674 176.184 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.5 -15.84 62.84 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.711 1.375 . . . . 1.98 114.711 177.4 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.03 9.79 76.15 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 118.496 -1.169 . . . . 0.85999999999999999 114.892 175.161 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -82.84 136.09 34.74 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.87 1.335 . . . . 1.6499999999999999 111.497 171.405 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 171.2 7.26 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.983 0.913 . . . . 1.9099999999999999 111.066 -138.24 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.46 159.52 32.45 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.372 2.715 . . . . 1.22 112.45 -169.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -85.26 126.51 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 122.908 1.337 . . . . 1.46 113.423 -173.223 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.17 68.64 5.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.972 2.909 . . . . 1.6399999999999999 110.878 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.53 144.76 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.73 0.812 . . . . 1.1000000000000001 110.749 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.91 135.61 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 3.2000000000000002 109.478 169.548 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.12 154.22 42.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.843 1.257 . . . . 3.21 113.876 178.015 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 3.5 p-10 -33.34 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 131.188 3.795 . . . . 3.1600000000000001 118.953 179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -78.72 -21.52 47.94 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.567 1.547 . . . . 3.54 113.319 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.2 34.48 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 124.338 0.971 . . . . 1.3100000000000001 114.852 178.323 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mt -124.32 117.13 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.037 1.335 . . . . 1.3400000000000001 109.413 178.214 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 125.63 28.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.194 0.998 . . . . 0.60999999999999999 111.152 -177.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 t -142.7 -7.14 0.86 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.592 1.557 . . . . 1.2 113.502 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.0 117.38 64.66 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.038 -1.038 . . . . 3.27 111.193 -175.624 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 136.57 14.64 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.446 2.764 . . . . 1.0700000000000001 111.281 176.519 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 m -139.97 155.82 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.785 1.234 . . . . 1.1699999999999999 110.336 176.716 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.3 m -135.48 138.91 43.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.712 0.687 . . . . 0.78000000000000003 110.915 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.29 99.77 50.25 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.237 1.015 . . . . 0.70999999999999996 112.885 -174.848 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.22 -1.29 11.29 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.58 3.52 . . . . 1.28 115.384 -178.346 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -71.71 -25.32 62.03 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.158 0.89 . . . . 4.0599999999999996 111.855 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.79 133.04 56.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.003 2.521 . . . . 2.0899999999999999 106.802 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 12.29 1.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.756 1.021 . . . . 6.7400000000000002 113.756 -164.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.4 p -132.45 164.09 27.32 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.054 -0.721 . . . . 2.8900000000000001 109.054 146.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.8 -26.68 22.73 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.649 -0.657 . . . . 2.6400000000000001 110.547 168.187 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.28 -44.89 44.39 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.391 1.476 . . . . 3.1499999999999999 113.055 168.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.7 -2.34 14.23 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.877 1.066 . . . . 2.25 113.877 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 18.02 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.304 1.441 . . . . 0.91000000000000003 113.806 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -64.99 -4.27 4.42 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 118.135 2.642 . . . . 2.1699999999999999 118.135 -170.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.3 58.76 0.9 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.05 1.74 . . . . 4.3399999999999999 109.9 169.472 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -114.58 147.93 38.77 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.081 1.352 . . . . 1.45 110.751 173.292 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.38 140.47 31.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.813 0.845 . . . . 0.80000000000000004 110.354 164.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.41 149.12 36.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.558 1.943 . . . . 2.8599999999999999 107.534 170.174 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.6 mtt -132.97 137.73 46.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.813 0.279 . . . . 1.53 111.728 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.53 124.36 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.967 -1.494 . . . . 0.66000000000000003 106.967 165.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.32 137.97 51.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.289 1.036 . . . . 1.8200000000000001 112.17 -162.25 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.69 -32.96 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.486 1.291 . . . . 2.7000000000000002 114.486 -154.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.02 152.61 19.74 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.003 1.287 . . . . 1.3200000000000001 111.55 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.9 140.35 16.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.907 1.717 . . . . 1.76 113.644 175.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.404 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 15.5 t0 -83.28 -0.02 47.75 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.284 1.587 . . . . 2.4199999999999999 115.284 -152.394 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -77.2 -16.59 59.02 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.939 1.696 . . . . 3.46 114.977 -168.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.4 ptp -78.59 45.4 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.518 1.527 . . . . 3.1099999999999999 113.829 -171.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 m -83.2 -33.76 26.08 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 117.902 2.556 . . . . 4.3399999999999999 117.902 -146.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -92.95 21.77 5.45 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.296 1.039 . . . . 4.4400000000000004 113.466 -162.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -75.22 146.43 81.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.546 1.138 . . . . 3.9300000000000002 112.454 -172.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.07 -14.54 41.16 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.619 2.879 . . . . 1.9199999999999999 112.913 173.298 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -83.58 101.77 1.55 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.695 -0.854 . . . . 4.0300000000000002 108.695 151.504 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.24 146.28 93.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.387 2.058 . . . . 3.0699999999999998 110.422 -177.202 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 71.15 -3.25 2.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.783 2.033 . . . . 3.9399999999999999 112.927 -173.654 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.88 40.02 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.817 1.675 . . . . 2.6000000000000001 115.839 168.252 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.5 -38.45 3.01 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.309 1.433 . . . . 2.21 112.678 -167.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.31 -25.74 63.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.961 1.267 . . . . 1.75 114.349 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.43 2.7 14.05 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.88 1.228 . . . . 1.9099999999999999 115.312 172.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.9 m -66.2 152.27 45.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.761 1.28 . . . . 2.04 108.885 164.331 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.66 133.24 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.276 1.03 . . . . 4.7199999999999998 110.513 -169.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -98.09 -16.64 19.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.176 0.59 . . . . 2.3599999999999999 111.366 156.094 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.49 160.73 35.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.137 0.88 . . . . 0.69999999999999996 112.977 164.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.6 t -133.04 150.72 52.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.423 1.889 . . . . 1.54 109.825 167.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.21 136.34 4.38 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.393 1.473 . . . . 0.89000000000000001 111.701 -178.454 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.96 139.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.119 0.968 . . . . 2.0800000000000001 111.502 -174.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.03 149.55 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.172 1.389 . . . . 1.25 111.862 174.524 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 C--O 1.238 0.491 0 C-N-CA 125.311 1.444 . . . . 3.5800000000000001 111.38 -176.411 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 119.544 -0.265 . . . . 1.8300000000000001 110.756 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.78 152.62 35.5 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.763 -1.211 . . . . 1.04 113.228 -164.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -147.59 130.96 16.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.138 1.775 . . . . 2.2200000000000002 109.599 174.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.44 96.66 10.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 4.8799999999999999 111.117 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 t -90.15 112.32 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 120.597 -1.314 . . . . 1.22 109.147 -169.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.28 109.55 2.81 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.781 1.181 . . . . 0.95999999999999996 110.363 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.2 mtp -96.52 131.12 43.45 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.453 0.701 . . . . 1.1399999999999999 111.486 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -105.06 155.61 18.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.465 1.126 . . . . 2.6699999999999999 110.534 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.84 145.29 54.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.412 1.485 . . . . 1.49 109.451 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.4 m -140.07 140.46 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.507 0.723 . . . . 0.89000000000000001 111.085 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.08 57.9 0.1 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.788 0.662 . . . . 2.3500000000000001 112.788 -167.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 77.34 -21.48 0.33 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.949 2.1 . . . . 1.04 114.073 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -19.99 28.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.251 1.02 . . . . 3.1499999999999999 112.858 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.57 -147.93 16.32 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 125.411 1.482 . . . . 0.90000000000000002 111.327 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.05 123.2 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.169 1.788 . . . . 0.93999999999999995 111.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.32 -137.8 9.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.748 1.642 . . . . 1.5700000000000001 112.021 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -90.31 170.11 10.53 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.258 -0.554 . . . . 2.0499999999999998 110.049 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 t -105.95 157.66 17.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.991 0.9 . . . . 1.25 112.201 162.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.95 0.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.715 2.806 . . . . 2.8799999999999999 112.822 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 147.25 6.21 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.571 2.034 . . . . 0.83999999999999997 111.914 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 p -88.08 -177.44 5.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.297 -1.001 . . . . 0.76000000000000001 108.297 159.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 47.6 t -128.3 134.28 65.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.554 -1.276 . . . . 0.47999999999999998 107.554 149.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.2 p -82.95 127.09 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.596 -0.52 . . . . 0.81999999999999995 109.596 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.67 HD11 HD21 ' A' ' 125' ' ' LEU . 16.8 mt -103.88 130.64 54.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.219 -1.03 . . . . 1.22 108.219 169.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.41 112.12 8.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.656 1.182 . . . . 2.1499999999999999 109.131 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -77.77 144.49 37.11 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.773 -0.579 . . . . 3.3199999999999998 111.157 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 t -148.24 178.13 8.83 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.356 -0.979 . . . . 1.3200000000000001 108.356 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -70.36 -14.95 62.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.162 0.585 . . . . 3.3900000000000001 112.176 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.41 12.9 67.47 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.22 1.391 . . . . 1.0 114.845 163.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.98 -155.89 22.15 Favored Glycine 0 N--CA 1.467 0.741 0 C-N-CA 127.492 2.473 . . . . 0.79000000000000004 117.224 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -71.63 101.99 2.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.664 0.785 . . . . 0.59999999999999998 111.87 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -71.29 117.3 12.65 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.841 1.256 . . . . 2.2599999999999998 109.163 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -95.88 127.52 41.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.027 1.731 . . . . 0.95999999999999996 108.162 174.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.414 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 19.9 m -129.62 105.03 17.27 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 119.916 1.235 . . . . 0.59999999999999998 107.972 167.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.75 164.87 29.58 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.112 2.541 . . . . 0.54000000000000004 110.066 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -155.42 43.66 0.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 122.356 1.074 . . . . 1.3600000000000001 109.251 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.15 134.83 44.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.891 1.276 . . . . 1.01 112.089 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.637 ' H ' ' HE3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -104.63 164.47 11.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.962 2.505 . . . . 3.2599999999999998 109.056 168.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.57 16.06 0.38 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.778 2.431 . . . . 1.5600000000000001 114.195 163.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.36 160.5 36.93 Favored Pre-proline 0 CA--C 1.511 -0.545 0 O-C-N 121.871 -0.518 . . . . 1.8100000000000001 110.42 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.8 128.45 23.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 O-C-N 123.451 1.237 . . . . 1.1100000000000001 110.307 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -85.8 31.31 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 125.101 3.867 . . . . 1.1599999999999999 113.471 -147.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.08 -122.18 4.29 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 126.399 1.952 . . . . 1.1799999999999999 113.124 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.84 138.21 35.57 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.095 2.158 . . . . 2.5099999999999998 108.386 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -137.88 123.0 19.19 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 123.683 0.793 . . . . 1.3400000000000001 112.942 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.15 149.26 7.56 Favored Glycine 0 CA--C 1.54 1.656 0 O-C-N 121.336 -0.852 . . . . 0.69999999999999996 112.307 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.7 t80 -124.96 115.4 20.51 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.802 1.301 . . . . 2.0099999999999998 107.5 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -115.03 162.31 17.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.724 1.379 . . . . 0.97999999999999998 114.724 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.2 mt -107.75 143.6 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.765 2.026 . . . . 0.62 107.388 155.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -118.41 161.09 20.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.504 1.122 . . . . 0.91000000000000003 112.03 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.62 73.22 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.558 1.318 . . . . 0.73999999999999999 114.558 -163.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -101.92 177.77 4.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.69 1.196 . . . . 1.6399999999999999 111.61 164.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.49 90.2 0.55 Allowed Glycine 0 N--CA 1.469 0.856 0 C-N-CA 124.621 1.105 . . . . 0.83999999999999997 112.003 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -166.4 99.03 0.6 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.356 1.078 . . . . 2.0800000000000001 113.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.7 m -71.48 45.52 0.11 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.942 2.097 . . . . 1.6399999999999999 113.802 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.55 148.41 42.85 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.172 -1.58 . . . . 3.6099999999999999 111.452 -171.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.51 165.02 9.37 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.473 3.449 . . . . 1.3 112.139 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.65 148.96 40.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.425 1.09 . . . . 1.95 110.013 166.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.45 134.43 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.323 1.449 . . . . 2.2000000000000002 108.091 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -162.9 143.6 9.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.305 1.442 . . . . 5.5800000000000001 109.21 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t0 53.21 41.38 32.14 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.358 0.981 . . . . 4.0199999999999996 113.471 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 14.45 73.14 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.936 -0.925 . . . . 2.6400000000000001 115.086 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.38 156.79 44.39 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.446 1.623 . . . . 3.2400000000000002 111.717 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.09 138.98 44.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.377 0.88 . . . . 1.8 113.377 -170.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.83 134.06 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.265 1.426 . . . . 3.2799999999999998 109.037 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.52 -48.47 10.19 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.263 1.579 . . . . 2.3900000000000001 115.263 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.61 122.45 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 130.578 3.551 . . . . 2.71 107.412 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -154.45 -8.31 0.14 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.43 1.092 . . . . 6.79 113.849 -164.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.53 62.47 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 121.088 1.767 . . . . 1.52 113.048 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.0 -8.36 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.167 1.787 . . . . 1.01 114.708 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.4 -165.3 38.93 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 121.344 1.884 . . . . 2.5800000000000001 113.035 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.69 179.35 53.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.27 0.938 . . . . 1.2 112.358 165.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . 0.291 0.2 OUTLIER -77.57 54.03 1.14 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.335 1.054 . . . . 2.6699999999999999 113.655 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.9 tp 54.87 69.19 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.921 2.488 . . . . 1.71 111.484 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.45 65.52 11.76 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 129.0 2.92 . . . . 4.5899999999999999 113.009 -162.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.88 -58.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.382 2.721 . . . . 2.1099999999999999 113.436 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -137.7 125.96 23.15 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.29 1.036 . . . . 4.1699999999999999 109.51 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -174.89 -95.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.553 1.541 . . . . 6.0300000000000002 112.096 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 t 171.19 -23.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 128.713 2.805 . . . . 3.4399999999999999 112.604 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.78 -34.17 4.47 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 125.892 1.71 . . . . 2.79 111.646 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -52.25 144.64 12.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.409 1.1 . . . . 6.79 111.912 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -96.26 147.86 23.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.371 1.868 . . . . 2.0299999999999998 111.326 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.1 131.6 45.72 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.529 -0.915 . . . . 4.3899999999999997 108.529 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.19 -145.38 5.2 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.548 -1.14 . . . . 2.9700000000000002 114.108 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.47 -18.89 22.46 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.302 2.668 . . . . 3.23 114.265 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -165.29 146.81 7.52 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.863 1.265 . . . . 5.5099999999999998 110.834 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.88 -135.79 13.13 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.262 0.934 . . . . 3.8599999999999999 111.917 -171.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -165.71 157.89 14.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.435 1.494 . . . . 6.1500000000000004 109.451 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.18 -126.61 0.83 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.199 0.839 . . . . 2.6600000000000001 115.199 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 145.4 25.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.47 1.508 . . . . 3.79 111.985 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.58 -11.31 57.5 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.16 1.17 . . . . 2.0600000000000001 114.16 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.01 32.2 4.72 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.216 1.389 . . . . 1.04 114.858 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.97 131.64 56.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.008 1.323 . . . . 1.6699999999999999 111.16 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.464 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 3.4 mp -142.32 159.46 58.12 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 125.646 1.579 . . . . 2.0600000000000001 111.079 -162.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.11 152.0 56.08 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.942 2.428 . . . . 0.85999999999999999 113.083 -169.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.32 130.95 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.343 1.457 . . . . 2.3599999999999999 112.758 -162.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.33 88.43 2.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.019 2.928 . . . . 1.7 109.87 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.67 136.06 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.03 0.932 . . . . 0.80000000000000004 110.587 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.87 138.99 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 127.418 2.287 . . . . 1.5900000000000001 106.295 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.19 161.28 30.12 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.263 -0.898 . . . . 2.3500000000000001 111.276 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -19.2 0.85 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.731 2.123 . . . . 2.6299999999999999 116.731 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.84 1.89 55.4 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.487 2.315 . . . . 2.73 112.812 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.15 23.21 41.75 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 125.258 1.408 . . . . 0.85999999999999999 114.462 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -123.49 131.8 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.334 1.054 . . . . 1.1000000000000001 111.044 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.02 140.17 44.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.009 1.724 . . . . 0.92000000000000004 111.604 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -140.91 -2.9 1.28 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.745 1.757 . . . . 1.5700000000000001 115.745 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.3 111.85 3.71 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 114.791 1.404 . . . . 3.2799999999999998 114.791 -165.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.23 101.89 1.18 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.014 2.476 . . . . 2.48 110.079 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.0 178.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.145 1.778 . . . . 2.2999999999999998 110.203 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.0 m -146.92 142.48 27.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.675 0.79 . . . . 1.1000000000000001 110.621 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.88 106.97 56.45 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.494 1.118 . . . . 0.83999999999999997 110.422 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.61 7.44 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.663 2.909 . . . . 1.04 113.218 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -17.98 63.32 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.229 1.412 . . . . 5.5999999999999996 113.425 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mp -152.82 155.77 37.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.862 3.265 . . . . 2.2200000000000002 108.09 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.304 0.0 OUTLIER -147.94 43.35 1.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.545 2.054 . . . . 5.0599999999999996 116.545 -173.271 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -175.99 147.36 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.638 1.975 . . . . 2.0 110.161 167.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.75 -28.42 68.69 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 1.6499999999999999 111.717 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.16 -19.23 19.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.123 1.369 . . . . 3.3599999999999999 114.301 173.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.72 -7.94 59.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.565 1.146 . . . . 2.0600000000000001 112.496 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.27 0.78 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 114.912 1.449 . . . . 1.27 114.912 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -72.23 20.22 0.07 Allowed 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.682 2.105 . . . . 3.6299999999999999 116.682 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -142.47 15.8 2.01 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.454 1.901 . . . . 3.0099999999999998 111.322 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -128.91 175.84 8.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.581 1.552 . . . . 2.5800000000000001 112.748 -164.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.15 149.11 39.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.563 1.145 . . . . 0.68000000000000005 112.04 166.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 24' ' ' ILE . 44.2 mt -82.22 155.35 24.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.303 1.441 . . . . 2.1800000000000002 109.056 158.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.4 ttm -149.45 122.88 9.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.395 . . . . 1.45 111.97 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -94.32 109.25 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.779 1.232 . . . . 0.71999999999999997 108.658 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.4 147.9 22.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.415 2.286 . . . . 2.3700000000000001 113.218 -167.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 t -67.88 -38.54 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.049 -1.032 . . . . 1.5900000000000001 112.332 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.51 155.92 17.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.632 0.634 . . . . 1.22 111.619 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.71 165.6 28.69 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.374 0.988 . . . . 1.3899999999999999 111.758 157.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -122.65 23.5 9.51 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.189 1.181 . . . . 2.6400000000000001 114.189 -136.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -93.72 4.25 54.22 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 116.397 1.999 . . . . 2.8799999999999999 116.397 -167.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -131.88 151.27 51.81 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.677 1.732 . . . . 3.8799999999999999 115.677 -168.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.0 p -140.27 11.12 2.35 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.666 2.386 . . . . 3.1600000000000001 112.89 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -118.65 14.7 13.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.219 1.408 . . . . 4.7699999999999996 112.436 -145.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -121.31 163.17 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.758 2.823 . . . . 3.23 107.969 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.02 -10.12 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.828 2.352 . . . . 2.23 114.441 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.13 133.03 22.58 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.321 1.449 . . . . 5.5899999999999999 109.757 165.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 165.9 31.35 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.64 2.893 . . . . 3.71 113.175 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.92 25.48 14.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.293 1.837 . . . . 5.0800000000000001 111.647 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.59 13.72 59.14 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.989 -1.069 . . . . 2.8199999999999998 114.04 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 106.14 -7.7 41.05 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.619 1.58 . . . . 1.77 113.984 -168.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.19 22.08 0.63 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 126.303 1.906 . . . . 1.55 115.887 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.86 74.68 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.364 1.459 . . . . 1.6499999999999999 114.294 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.2 p -73.24 163.31 28.29 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.5 1.52 . . . . 1.6499999999999999 110.921 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 145.02 30.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.768 1.227 . . . . 5.25 111.555 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -92.16 -34.02 14.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.996 0.919 . . . . 2.8199999999999998 112.436 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.83 154.57 42.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.956 0.902 . . . . 0.59999999999999998 113.116 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.3 t -138.9 153.71 48.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.405 2.282 . . . . 1.4299999999999999 109.769 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.99 114.64 0.62 Allowed Glycine 0 N--CA 1.467 0.706 0 C-N-CA 124.088 0.851 . . . . 0.75 113.051 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.88 130.75 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.915 1.286 . . . . 1.8200000000000001 110.514 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mp -76.4 132.81 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 1.28 109.54 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 118.492 -0.766 . . . . 4.6699999999999999 112.954 -176.339 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 119.479 -0.296 . . . . 2.2599999999999998 110.414 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -131.79 140.34 49.17 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.603 1.705 . . . . 1.23 115.603 -137.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.89 136.87 34.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.144 0.973 . . . . 2.5600000000000001 111.569 161.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 98.16 11.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.624 1.17 . . . . 4.5999999999999996 111.36 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.03 118.55 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 120.8 -1.188 . . . . 1.1499999999999999 109.614 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.42 111.31 3.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.478 1.513 . . . . 1.1499999999999999 112.013 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 mmt -84.24 124.52 31.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.772 1.229 . . . . 1.5700000000000001 112.518 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -113.03 149.29 33.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.487 0.661 . . . . 2.3500000000000001 111.008 164.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -56.99 140.13 49.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.431 1.092 . . . . 1.28 109.635 171.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.36 147.28 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.43 0.559 . . . . 1.6000000000000001 111.479 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -167.97 49.51 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.822 0.849 . . . . 2.5699999999999998 112.67 -168.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.42 -31.75 0.23 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.046 2.138 . . . . 1.6299999999999999 114.316 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -2.37 10.74 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.34 0.973 . . . . 2.5899999999999999 111.619 160.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.93 -140.01 16.71 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.671 1.129 . . . . 1.6000000000000001 111.03 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.05 122.34 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.723 1.609 . . . . 1.1899999999999999 111.165 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.57 -134.99 8.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 126.176 1.846 . . . . 1.74 113.25 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.84 146.24 35.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.16 1.384 . . . . 2.02 110.984 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 t -83.89 142.9 30.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 1.28 110.878 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.8 -0.24 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.617 1.34 . . . . 3.6299999999999999 114.617 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.21 167.49 14.4 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.673 1.13 . . . . 0.82999999999999996 111.843 -171.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 p -103.3 176.14 5.25 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.569 -0.9 . . . . 1.04 108.569 161.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -119.19 131.36 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.718 -1.586 . . . . 0.70999999999999996 106.718 148.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -84.88 123.97 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.921 -0.4 . . . . 1.28 109.921 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.437 HD11 HD21 ' A' ' 125' ' ' LEU . 20.5 mt -98.32 117.91 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.177 -1.046 . . . . 1.3700000000000001 108.177 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -119.43 107.96 13.97 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.514 1.526 . . . . 1.9299999999999999 109.717 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.65 147.7 31.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.578 0.955 . . . . 3.9300000000000002 113.578 -172.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -179.58 7.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.719 0.808 . . . . 1.5800000000000001 110.96 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.16 -28.2 69.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.302 1.041 . . . . 3.7799999999999998 111.842 174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.9 10.34 60.48 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.448 1.023 . . . . 1.03 114.657 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.7 -145.74 23.97 Favored Glycine 0 N--CA 1.461 0.342 0 C-N-CA 129.15 3.262 . . . . 0.84999999999999998 114.895 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.6 95.19 7.09 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.916 0.886 . . . . 0.66000000000000003 110.488 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -71.66 107.18 4.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.108 0.963 . . . . 2.5099999999999998 109.856 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 t80 -99.9 105.46 17.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 117.254 -1.355 . . . . 0.57999999999999996 108.716 -167.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.4 m -116.05 109.07 45.21 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.789 1.632 . . . . 0.96999999999999997 109.216 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.63 151.76 17.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.888 3.059 . . . . 0.60999999999999999 111.654 -176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -141.53 23.68 2.12 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.555 0.693 . . . . 1.45 112.599 171.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -80.11 157.7 26.58 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 126.644 1.978 . . . . 0.80000000000000004 113.872 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.29 170.31 16.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.661 -1.609 . . . . 3.1899999999999999 109.831 165.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.81 22.93 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.607 2.763 . . . . 1.4199999999999999 112.92 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -99.85 160.82 26.25 Favored Pre-proline 0 CA--C 1.51 -0.591 0 C-N-CA 123.472 0.709 . . . . 1.6200000000000001 111.56 176.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 34.0 Cg_endo -63.15 127.44 20.22 Favored 'Trans proline' 0 N--CA 1.426 -2.456 0 O-C-N 123.531 1.28 . . . . 0.91000000000000003 110.482 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 4.8 Cg_endo -88.8 31.78 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.51 3.474 . . . . 1.4399999999999999 112.654 -144.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.37 -120.94 4.84 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 126.22 1.866 . . . . 1.8700000000000001 113.405 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.32 145.07 48.26 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.971 2.108 . . . . 2.4399999999999999 109.643 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.58 144.01 41.8 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.052 0.941 . . . . 0.93000000000000005 111.409 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.95 165.57 37.86 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.136 -0.978 . . . . 0.84999999999999998 111.215 168.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -146.55 126.9 13.97 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.358 -1.349 . . . . 2.1200000000000001 107.358 169.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -122.81 167.23 13.78 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.466 1.284 . . . . 1.1299999999999999 114.466 163.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.441 ' CG2' HD12 ' A' ' 74' ' ' LEU . 62.7 mt -85.24 148.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.132 0.973 . . . . 0.90000000000000002 108.836 151.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.38 153.74 41.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.822 2.049 . . . . 1.03 108.318 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.72 72.67 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.97 1.841 . . . . 1.23 115.97 -159.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.23 -179.59 5.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.43 1.892 . . . . 1.7 112.035 -170.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.41 125.78 7.13 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.548 -1.14 . . . . 2.0899999999999999 111.497 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 m 142.73 101.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 130.569 3.548 . . . . 2.2400000000000002 112.526 164.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 61.1 m -63.82 23.18 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 127.56 2.344 . . . . 1.3 115.709 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.08 130.18 33.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.528 -1.982 . . . . 3.27 110.737 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.29 157.9 14.88 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.225 3.283 . . . . 0.95999999999999996 111.544 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.57 174.49 7.73 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 1.6299999999999999 111.399 159.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.72 138.43 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.134 1.374 . . . . 2.4199999999999999 107.967 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.29 -124.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.182 0.593 . . . . 7.04 111.378 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.87 -31.32 66.59 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.901 1.68 . . . . 5.0599999999999996 115.353 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 44.17 0.02 OUTLIER Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.135 0.874 . . . . 2.8799999999999999 112.164 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 172.71 158.41 0.11 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.306 2.642 . . . . 3.7200000000000002 109.281 -164.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.6 141.89 47.17 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.131 1.16 . . . . 1.5600000000000001 114.131 -161.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.18 61.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.58 1.552 . . . . 1.8200000000000001 111.651 -167.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.99 -72.2 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 127.431 2.292 . . . . 1.72 115.498 166.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.93 106.6 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 1 C-N-CA 132.906 4.482 . . . . 1.6399999999999999 105.575 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -115.54 -46.49 2.86 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.378 1.071 . . . . 3.96 113.62 -155.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.62 -13.51 62.14 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.2 1.185 . . . . 1.3799999999999999 114.2 -171.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -12.74 61.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.729 2.012 . . . . 1.22 113.664 167.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.33 169.4 44.23 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.789 -1.194 . . . . 2.9500000000000002 112.638 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.69 -161.93 8.84 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.941 -0.864 . . . . 1.5900000000000001 110.941 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -42.81 141.33 1.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.601 -0.518 . . . . 2.4700000000000002 109.601 160.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -65.11 74.61 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.546 1.538 . . . . 3.04 112.529 -170.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -132.73 58.81 38.66 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 126.717 2.007 . . . . 4.0599999999999996 112.681 -160.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.51 -37.56 29.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.062 1.841 . . . . 2.8399999999999999 110.411 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -149.0 146.93 28.01 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.62 2.768 . . . . 4.29 105.805 162.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 p30 166.34 -47.42 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.115 2.166 . . . . 4.3799999999999999 114.327 168.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 t 172.74 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.428 2.691 . . . . 2.8700000000000001 111.425 -167.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.47 22.19 51.74 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 123.782 0.706 . . . . 2.21 114.135 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -160.29 -116.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.963 1.305 . . . . 4.3799999999999999 113.438 -167.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.456 ' CE1' ' CG ' ' A' ' 93' ' ' ASP . 2.8 t60 -160.05 145.24 15.09 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 119.833 -1.792 . . . . 1.8500000000000001 114.988 -170.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.65 -129.83 0.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.555 1.542 . . . . 4.29 111.164 170.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.55 -88.75 0.4 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.627 1.584 . . . . 3.1400000000000001 110.964 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -33.56 6.47 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.186 2.591 . . . . 4.0300000000000002 112.636 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.23 129.48 31.64 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.284 1.434 . . . . 5.5599999999999996 107.95 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.41 64.04 2.91 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 125.249 1.404 . . . . 2.8799999999999999 115.641 -158.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.09 98.71 11.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.996 0.918 . . . . 4.8799999999999999 112.92 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.99 -72.3 2.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 116.025 1.17 . . . . 4.0199999999999996 116.025 155.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -75.09 93.24 2.73 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.314 1.057 . . . . 4.6600000000000001 113.132 -164.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.78 64.03 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.926 1.454 . . . . 3.23 114.926 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.7 -0.13 89.85 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.965 1.269 . . . . 1.6699999999999999 114.644 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' CG ' ' CE1' ' A' ' 82' ' ' HIS . 37.7 m-20 -67.03 134.25 51.54 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 118.297 1.048 . . . . 2.8100000000000001 108.651 161.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.28 168.25 11.66 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.096 0.958 . . . . 2.2799999999999998 111.515 -149.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.12 165.23 28.39 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.279 2.653 . . . . 1.1599999999999999 112.682 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -85.63 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 122.824 1.297 . . . . 2.0 112.983 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.59 97.3 2.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.309 3.444 . . . . 1.76 109.832 172.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.36 139.15 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.333 1.053 . . . . 1.6100000000000001 111.37 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.44 140.86 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.039 2.135 . . . . 1.5600000000000001 107.453 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -82.93 160.94 21.98 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.364 -0.835 . . . . 2.9100000000000001 112.024 174.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -20.38 4.44 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 115.539 1.681 . . . . 2.8599999999999999 115.539 -174.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -85.25 4.48 34.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.361 1.864 . . . . 3.3399999999999999 113.528 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.85 56.69 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 124.588 1.09 . . . . 0.90000000000000002 114.19 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.57 135.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.288 1.835 . . . . 1.1799999999999999 109.513 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 149.58 24.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.698 1.199 . . . . 0.98999999999999999 110.953 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.8 t -159.55 -34.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.672 0.989 . . . . 1.3400000000000001 113.672 -166.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.69 122.33 85.46 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.111 1.364 . . . . 3.77 111.64 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.18 136.72 16.43 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.91 2.406 . . . . 1.4199999999999999 111.441 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.27 74.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 122.976 1.37 . . . . 2.29 112.096 -167.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.2 m -57.07 137.67 55.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.538 2.335 . . . . 1.1599999999999999 113.022 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.56 98.04 22.36 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.757 1.223 . . . . 0.75 111.34 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.63 3.68 5.21 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.29 3.326 . . . . 1.1200000000000001 113.938 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -76.99 -16.27 59.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.287 1.435 . . . . 4.1399999999999997 112.383 -176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.46 -179.52 4.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.985 2.114 . . . . 2.1400000000000001 107.704 166.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -53.77 2.68 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.32 -0.862 . . . . 3.9100000000000001 111.673 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -127.37 163.44 24.0 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.175 1.546 . . . . 2.1699999999999999 115.175 -149.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tp -74.22 -34.99 63.85 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.595 -1.316 . . . . 2.1499999999999999 111.977 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.42 -35.86 65.85 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.123 1.369 . . . . 3.4100000000000001 113.698 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.33 -3.13 38.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.405 1.261 . . . . 1.6299999999999999 114.405 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.48 7.94 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.483 1.038 . . . . 0.91000000000000003 113.447 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.07 -10.67 4.56 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.278 1.955 . . . . 2.98 116.278 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -147.03 18.9 1.25 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.614 1.965 . . . . 3.52 111.537 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -101.45 -160.36 0.79 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.405 1.482 . . . . 1.55 112.274 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.47 160.71 39.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.081 1.352 . . . . 0.79000000000000004 112.332 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 24' ' ' ILE . 19.8 mt -113.62 149.69 34.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.3 2.64 . . . . 1.8999999999999999 108.093 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.5 mtt -137.59 128.13 26.67 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.524 1.056 . . . . 1.48 111.264 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.82 108.53 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.794 -1.187 . . . . 0.88 107.794 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -86.93 144.21 27.05 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.881 1.672 . . . . 2.29 113.142 -165.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.57 -43.6 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.099 -1.0 . . . . 1.26 112.035 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.38 172.0 25.98 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.914 -0.874 . . . . 1.0800000000000001 110.914 162.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.53 160.85 6.13 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.063 1.316 . . . . 1.4199999999999999 112.587 165.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -40.38 94.98 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.76 1.224 . . . . 3.46 114.14 -169.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.27 36.96 0.16 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 117.586 2.439 . . . . 2.8500000000000001 117.586 -151.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -108.46 148.19 30.56 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.562 1.545 . . . . 2.6400000000000001 112.372 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -149.48 -141.01 0.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.115 0.966 . . . . 3.5099999999999998 111.125 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.36 111.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.677 2.391 . . . . 5.5599999999999996 114.954 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -154.3 160.99 30.35 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.706 2.002 . . . . 3.29 109.461 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.78 12.51 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 124.522 3.482 . . . . 4.0800000000000001 114.747 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -132.36 140.81 39.11 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.519 1.528 . . . . 5.4400000000000004 110.151 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.47 151.61 82.0 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.983 3.122 . . . . 5.5300000000000002 112.955 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.63 21.19 6.97 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.956 1.702 . . . . 4.9900000000000002 113.415 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.93 80.81 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.531 1.062 . . . . 3.6699999999999999 113.62 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.97 -48.66 3.05 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.454 1.502 . . . . 2.0499999999999998 113.029 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.37 18.84 5.12 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.189 1.852 . . . . 1.71 114.956 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.28 -19.82 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.995 1.283 . . . . 1.6000000000000001 114.098 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.7 p -66.31 145.41 55.76 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.683 1.593 . . . . 1.4399999999999999 111.714 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.17 136.81 48.62 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.309 1.444 . . . . 4.6900000000000004 110.276 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 27.1 t80 -75.63 -37.06 60.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 2.1499999999999999 110.411 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.31 152.21 41.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.497 1.119 . . . . 0.73999999999999999 112.861 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 52.1 t -121.42 147.79 45.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.792 2.037 . . . . 1.6299999999999999 109.866 171.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -138.93 91.38 0.2 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.01 1.767 . . . . 0.82999999999999996 111.704 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.29 135.13 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.918 1.287 . . . . 2.77 111.587 166.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mt -97.03 151.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 1.6200000000000001 109.93 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 11.3 mmpt? . . . . . 0 N--CA 1.471 0.581 0 O-C-N 121.382 -0.824 . . . . 5.0 110.708 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.138 -0.69 . . . . 1.8799999999999999 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 m -114.79 131.02 56.94 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.221 1.373 . . . . 1.3 112.897 -153.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.76 141.53 48.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.624 2.37 . . . . 2.96 107.191 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -120.47 86.3 2.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.937 -1.102 . . . . 3.3199999999999998 110.82 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.11 118.68 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 121.6 -0.687 . . . . 1.02 109.672 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.92 104.01 1.02 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.142 1.354 . . . . 0.75 109.953 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 mtp -97.84 137.92 35.97 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.154 0.982 . . . . 1.3500000000000001 110.735 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -129.38 147.35 51.19 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.922 0.889 . . . . 3.02 112.092 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.14 142.93 56.35 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.127 1.371 . . . . 1.48 109.58 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 m -142.13 161.44 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.316 1.046 . . . . 1.4299999999999999 112.851 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t 155.65 124.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.756 2.822 . . . . 3.0699999999999998 111.423 144.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.57 -37.69 0.38 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.439 2.696 . . . . 1.97 115.516 164.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -7.87 56.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.585 1.554 . . . . 4.2999999999999998 111.367 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -149.48 18.1 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 125.478 1.513 . . . . 1.4399999999999999 112.386 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.05 130.79 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.65 1.58 . . . . 1.53 110.558 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.8 -134.48 8.54 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 125.68 1.609 . . . . 2.3300000000000001 113.351 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.83 153.49 24.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.162 2.185 . . . . 2.75 112.153 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -94.49 139.01 31.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.419 0.628 . . . . 1.3200000000000001 112.02 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.7 10.63 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.764 1.626 . . . . 2.9399999999999999 112.385 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 154.18 146.69 4.46 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.722 1.63 . . . . 0.62 111.265 -166.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.5 p -88.87 174.52 7.9 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.184 -1.043 . . . . 0.96999999999999997 108.184 158.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.5 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 99.0 t -127.42 129.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.622 -1.251 . . . . 0.69999999999999996 107.622 165.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.4 p -82.83 129.25 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.534 0.683 . . . . 1.0800000000000001 109.824 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.46 109.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.501 -1.666 . . . . 1.3500000000000001 106.501 169.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -116.0 108.28 16.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 123.098 1.427 . . . . 2.5299999999999998 110.741 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.06 142.83 56.36 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 127.476 2.31 . . . . 4.1399999999999997 111.707 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -154.7 177.01 11.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.535 1.16 . . . . 1.2 111.392 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.55 -25.24 66.01 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.991 0.916 . . . . 4.25 110.661 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.18 14.89 61.04 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.426 1.489 . . . . 0.97999999999999998 115.949 166.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.03 -164.39 51.46 Favored Glycine 0 N--CA 1.47 0.929 0 C-N-CA 129.74 3.543 . . . . 0.89000000000000001 115.095 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.35 104.56 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.445 1.498 . . . . 0.65000000000000002 112.145 -168.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -82.37 104.16 12.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.159 0.983 . . . . 1.8300000000000001 109.805 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.5 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 11.1 t80 -91.8 110.02 21.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.017 2.127 . . . . 0.72999999999999998 109.567 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.407 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 12.0 m -122.32 115.04 30.21 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.836 1.198 . . . . 0.88 108.563 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.93 164.44 27.5 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.101 2.534 . . . . 0.57999999999999996 110.867 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -160.03 51.39 0.32 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.316 1.055 . . . . 2.1600000000000001 111.288 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 150.86 32.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.069 1.348 . . . . 0.73999999999999999 112.013 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.27 38.39 3.13 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.221 1.934 . . . . 2.1099999999999999 116.221 -160.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.76 12.0 0.59 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.483 2.031 . . . . 1.6000000000000001 116.483 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.94 160.71 25.37 Favored Pre-proline 0 N--CA 1.477 0.896 0 N-CA-C 114.186 1.18 . . . . 1.3500000000000001 114.186 -169.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.93 130.87 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.328 1.352 . . . . 0.81999999999999995 112.708 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.66 48.08 2.07 Favored 'Trans proline' 0 C--N 1.35 0.653 1 C-N-CA 126.957 5.105 . . . . 0.96999999999999997 112.755 -158.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.94 -140.09 7.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.414 1.563 . . . . 1.23 113.287 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.04 134.51 53.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.821 1.648 . . . . 2.8399999999999999 108.534 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -139.88 125.21 18.94 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 125.157 1.383 . . . . 1.27 111.017 -162.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.79 154.78 9.11 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.642 -1.286 . . . . 0.52000000000000002 112.457 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.38 127.51 29.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.958 1.303 . . . . 1.9299999999999999 107.719 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.442 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 50.3 m170 -121.92 169.77 10.47 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 117.027 2.232 . . . . 1.04 117.027 168.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.16 138.79 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.508 1.923 . . . . 0.73999999999999999 109.254 152.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.14 164.94 16.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.217 2.607 . . . . 0.98999999999999999 110.602 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.86 -62.79 1.42 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.697 1.369 . . . . 1.47 114.697 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 -97.6 146.93 24.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.652 0.612 . . . . 1.5900000000000001 112.652 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.74 62.83 2.38 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.634 1.111 . . . . 0.88 112.322 168.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -149.73 77.73 1.34 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.72 1.208 . . . . 2.6600000000000001 112.589 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.0 m -64.16 9.42 0.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 116.331 1.974 . . . . 1.3200000000000001 116.331 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -72.44 151.71 91.87 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 119.743 -1.848 . . . . 3.6899999999999999 112.53 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.0 152.15 67.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.257 2.638 . . . . 1.77 111.316 171.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.68 147.79 22.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.546 0.738 . . . . 3.2000000000000002 110.914 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mm -86.45 104.64 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.528 -0.916 . . . . 4.71 108.528 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -162.34 138.96 7.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.265 1.026 . . . . 7.6699999999999999 109.909 -157.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t0 51.27 35.79 14.48 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 6.4500000000000002 113.85 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.61 11.0 85.88 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.527 -1.151 . . . . 3.9100000000000001 115.323 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -150.31 169.3 21.71 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.07 1.935 . . . . 3.0699999999999998 113.24 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.77 94.95 8.81 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.838 0.855 . . . . 2.2999999999999998 109.873 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.54 88.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.746 0.818 . . . . 2.9300000000000002 111.593 -170.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 55.69 -86.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.245 2.618 . . . . 2.0600000000000001 115.025 159.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.73 99.04 0.31 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.748 2.819 . . . . 2.7200000000000002 107.253 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -149.34 -17.46 0.28 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.284 1.216 . . . . 7.0199999999999996 114.284 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.04 -9.22 4.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.661 1.184 . . . . 1.72 113.55 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 2.65 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.185 2.194 . . . . 0.92000000000000004 113.671 164.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 16.29 26.93 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.563 1.554 . . . . 3.04 114.255 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -114.6 4.86 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.248 -1.541 . . . . 3.23 109.248 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -97.35 -101.67 0.19 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.983 1.313 . . . . 3.8599999999999999 107.652 158.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.9 tp -160.95 79.45 0.61 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.228 2.211 . . . . 1.96 106.759 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.74 68.97 63.07 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.772 -1.104 . . . . 4.9800000000000004 111.111 -152.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.04 -44.93 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.821 2.347 . . . . 2.02 113.6 -168.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -154.87 -151.71 0.37 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.287 1.835 . . . . 4.6500000000000004 108.916 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 75.23 -60.82 0.5 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.551 2.74 . . . . 4.4299999999999997 112.84 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 177.29 -19.45 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.927 2.491 . . . . 2.5699999999999998 113.328 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.73 49.17 76.46 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.039 1.29 . . . . 2.8799999999999999 114.896 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -143.96 18.29 1.78 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.662 1.727 . . . . 4.6600000000000001 115.662 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.8 t60 90.05 173.24 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.52 2.328 . . . . 2.73 112.871 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -162.1 51.91 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.897 1.279 . . . . 4.8799999999999999 110.136 -161.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.01 -47.95 1.29 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-O 117.973 -1.459 . . . . 2.8100000000000001 114.997 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -103.43 -23.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.179 3.253 . . . . 4.2699999999999996 113.831 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.97 172.99 1.57 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.793 2.437 . . . . 5.75 108.758 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.19 -159.05 32.13 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.064 0.84 . . . . 3.8900000000000001 113.516 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -153.52 28.71 0.49 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 6.4699999999999998 112.245 -168.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.18 16.65 60.87 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.105 -2.497 . . . . 3.5299999999999998 117.698 -165.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.531 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 2.6 t-160 170.06 99.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 128.396 2.678 . . . . 5.0499999999999998 111.059 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.49 2.79 2.78 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.578 1.696 . . . . 2.02 115.578 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.531 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -102.42 3.97 50.83 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.322 1.439 . . . . 0.81000000000000005 113.459 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' OD1' ' CE1' ' A' ' 90' ' ' HIS . 64.3 m-20 -71.93 137.09 47.12 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.525 1.162 . . . . 1.6599999999999999 109.619 165.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.86 169.04 11.06 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.762 1.225 . . . . 1.8799999999999999 109.915 -144.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.52 157.8 55.36 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.714 2.276 . . . . 1.03 111.866 -172.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.8 125.23 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.227 1.011 . . . . 2.4199999999999999 109.85 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.39 114.34 3.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 128.365 2.666 . . . . 2.54 109.872 168.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.87 143.32 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 120.966 -1.083 . . . . 0.92000000000000004 108.628 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -123.2 124.61 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 106.261 -1.755 . . . . 1.7 106.261 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.7 152.91 41.21 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.06 0.845 . . . . 1.8899999999999999 111.933 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -4.24 0.05 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 117.539 2.422 . . . . 2.23 117.539 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.06 4.42 10.89 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.793 1.637 . . . . 3.0299999999999998 114.016 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.52 16.51 17.68 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 116.226 1.25 . . . . 0.73999999999999999 116.226 166.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.65 134.08 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.128 1.371 . . . . 1.1100000000000001 107.932 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.22 120.68 40.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.331 0.652 . . . . 0.68999999999999995 109.352 168.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -132.21 2.81 3.94 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.135 1.774 . . . . 1.22 112.745 172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -82.89 117.76 69.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.687 1.995 . . . . 5.0999999999999996 111.983 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.33 147.27 18.05 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.475 2.783 . . . . 1.25 113.473 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.29 176.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.515 1.926 . . . . 1.1699999999999999 109.83 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.8 m -139.73 140.83 36.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.069 0.947 . . . . 0.66000000000000003 110.142 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.72 91.48 6.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.24 1.016 . . . . 0.72999999999999998 110.56 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.29 -8.92 24.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.818 3.012 . . . . 1.46 115.006 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -58.96 -29.17 66.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.178 1.391 . . . . 4.1600000000000001 113.751 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.52 164.98 11.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.131 1.772 . . . . 2.29 110.389 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.95 24.6 0.5 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.596 1.558 . . . . 4.1299999999999999 114.109 -170.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -178.57 148.5 0.45 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.441 2.296 . . . . 1.8100000000000001 112.507 170.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.75 -27.5 69.32 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.53 -1.356 . . . . 1.5800000000000001 111.269 166.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.44 -16.14 0.32 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.299 2.24 . . . . 2.8199999999999998 114.062 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -9.24 40.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.366 1.466 . . . . 1.9299999999999999 113.733 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.5 m -130.19 11.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.552 1.541 . . . . 1.0700000000000001 113.134 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -62.59 -3.36 1.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.494 2.405 . . . . 2.54 117.494 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.27 29.93 0.78 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.358 1.863 . . . . 2.9700000000000002 110.726 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -121.82 175.02 6.5 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.825 1.65 . . . . 1.4199999999999999 113.038 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.01 149.2 43.03 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.501 1.12 . . . . 0.56000000000000005 111.782 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.43 170.42 16.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.041 1.336 . . . . 2.3599999999999999 109.241 158.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 44.9 ttm -151.19 124.96 9.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.37 -0.831 . . . . 2.3100000000000001 111.454 163.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.5 120.98 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.164 -1.05 . . . . 0.91000000000000003 108.164 167.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -105.13 148.49 26.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.869 2.068 . . . . 1.8999999999999999 112.007 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.35 -25.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.718 -1.239 . . . . 1.1899999999999999 113.209 -162.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -129.28 162.55 22.64 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.135 0.874 . . . . 1.05 111.55 168.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.82 144.94 47.56 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.357 0.98 . . . . 1.5800000000000001 113.081 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.442 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 37.6 t70 -97.95 -8.86 27.19 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.992 1.849 . . . . 2.6600000000000001 115.992 -147.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -59.96 -25.61 65.34 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.939 1.296 . . . . 3.8700000000000001 113.407 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 76.4 mtm -82.11 61.64 5.47 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 3.3900000000000001 113.899 -167.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.6 p -91.82 -147.47 0.22 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.655 -1.278 . . . . 3.3999999999999999 110.846 156.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t0 58.35 42.25 21.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.456 1.502 . . . . 4.5599999999999996 112.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.92 156.51 5.96 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.509 1.924 . . . . 3.4900000000000002 109.64 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.25 -19.2 22.73 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.116 2.544 . . . . 2.7799999999999998 114.327 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.59 119.91 76.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.216 1.371 . . . . 7.9699999999999998 109.903 167.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.85 118.8 5.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.504 2.136 . . . . 4.4500000000000002 110.179 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 56.64 27.12 12.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.182 1.393 . . . . 4.0999999999999996 112.186 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.07 17.52 63.56 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 121.042 -1.036 . . . . 3.5099999999999998 113.333 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.07 3.78 75.7 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.6 1.571 . . . . 2.98 114.367 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.28 -5.91 75.35 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.252 1.526 . . . . 2.02 114.845 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.43 -12.0 80.04 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.235 1.398 . . . . 1.6799999999999999 115.326 -170.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.67 161.6 5.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.069 1.348 . . . . 1.6399999999999999 110.152 164.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 136.15 40.31 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 4.5700000000000003 112.65 -169.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -101.04 -25.63 13.99 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.261 1.424 . . . . 2.46 113.294 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.73 144.09 22.31 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.466 2.024 . . . . 0.70999999999999996 116.466 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.76 170.29 14.92 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.209 3.403 . . . . 2.8799999999999999 112.186 165.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 179.94 83.15 0.06 OUTLIER Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.884 1.706 . . . . 0.70999999999999996 112.41 166.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.94 130.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 118.026 0.913 . . . . 1.4299999999999999 110.704 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 27.3 mt -102.9 140.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.52 1.528 . . . . 1.3100000000000001 111.377 -169.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 mptt . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 124.774 1.23 . . . . 3.4100000000000001 108.733 161.581 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 119.424 -0.322 . . . . 2.2000000000000002 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.73 154.39 33.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 118.984 -2.323 . . . . 1.1599999999999999 116.995 -141.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.07 138.97 18.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.68 -1.6 . . . . 3.4300000000000002 111.328 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.81 113.82 27.08 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.803 -1.186 . . . . 4.5800000000000001 112.03 176.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.8 t -88.63 118.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.551 -0.537 . . . . 1.1699999999999999 109.551 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.34 103.09 2.36 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.152 1.358 . . . . 1.1100000000000001 110.323 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 41.8 mtt -81.85 148.83 28.62 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.439 0.904 . . . . 1.21 113.439 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -114.23 151.52 32.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 2.4700000000000002 110.134 167.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 mt -64.49 144.44 57.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.853 0.861 . . . . 1.1699999999999999 109.112 171.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 m -133.69 149.32 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.2 0.6 . . . . 1.05 111.36 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -174.55 53.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.143 0.977 . . . . 2.3700000000000001 112.53 -168.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.49 -14.21 0.42 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.051 1.74 . . . . 1.1299999999999999 115.094 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.15 -9.9 58.97 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.363 -0.836 . . . . 3.2999999999999998 110.994 160.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -129.69 9.39 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.517 -1.433 . . . . 1.03 109.517 -163.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.7 t -74.33 126.9 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.925 1.69 . . . . 0.81000000000000005 111.299 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.34 -135.53 8.93 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.066 1.793 . . . . 1.45 112.554 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.93 164.11 12.86 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.983 -0.716 . . . . 1.78 111.784 173.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.0 t -100.1 152.0 20.74 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.309 1.044 . . . . 0.94999999999999996 112.757 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.428 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 1.4 pp -144.21 4.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 128.178 2.591 . . . . 2.8599999999999999 113.495 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.53 170.69 27.71 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.205 1.383 . . . . 0.68000000000000005 114.266 172.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -109.74 177.66 4.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.989 1.316 . . . . 0.87 109.889 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.83 131.84 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.736 -1.209 . . . . 0.40999999999999998 107.736 158.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 9.0 p -85.89 123.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 123.579 0.549 . . . . 0.87 110.377 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mt -105.38 126.08 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 125.858 1.663 . . . . 1.3999999999999999 107.884 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -135.5 107.62 7.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.413 1.085 . . . . 2.0800000000000001 109.958 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -74.07 144.08 45.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.613 0.765 . . . . 3.6000000000000001 112.043 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -159.94 -174.58 4.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.708 1.203 . . . . 1.28 109.751 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.34 -26.51 65.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.627 1.571 . . . . 3.1699999999999999 112.75 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.94 13.86 65.81 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 124.851 1.215 . . . . 0.92000000000000004 114.754 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.95 -147.02 32.94 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 127.396 2.427 . . . . 0.73999999999999999 114.399 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.4 mt -76.26 99.46 4.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.986 0.915 . . . . 0.58999999999999997 112.017 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -77.69 114.16 16.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.13 1.372 . . . . 2.1299999999999999 110.397 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.73 116.79 32.63 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.485 2.314 . . . . 0.63 109.896 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.9 m -122.49 115.17 29.93 Favored Pre-proline 0 N--CA 1.477 0.875 0 CA-C-O 118.278 -0.868 . . . . 0.56999999999999995 108.755 176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.22 162.86 4.67 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.91 3.073 . . . . 0.40999999999999998 112.007 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -151.32 33.31 0.57 Allowed 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.12 0.962 . . . . 1.4299999999999999 112.606 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -95.75 150.05 20.82 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.911 1.684 . . . . 0.72999999999999998 113.903 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.5 162.37 24.13 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.516 1.526 . . . . 3.0899999999999999 109.217 174.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.28 21.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.933 2.893 . . . . 1.8600000000000001 113.789 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -106.57 155.87 38.1 Favored Pre-proline 0 CA--C 1.51 -0.576 0 C-N-CA 123.857 0.863 . . . . 2.0600000000000001 112.442 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.56 140.36 47.28 Favored 'Trans proline' 0 N--CA 1.427 -2.385 0 O-C-N 123.269 1.142 . . . . 1.1399999999999999 111.625 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 99' ' ' VAL . 12.2 Cg_endo -88.26 32.01 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.839 2.359 . . . . 1.3400000000000001 114.568 -148.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 99' ' ' VAL . . . -106.89 -147.35 14.02 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.532 1.073 . . . . 1.1899999999999999 113.912 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -81.57 131.51 35.28 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.964 -1.315 . . . . 2.5299999999999998 110.592 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -102.66 135.53 44.14 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.243 -1.021 . . . . 1.76 108.243 164.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.55 161.7 21.58 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.852 -0.899 . . . . 0.82999999999999996 110.852 166.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -146.84 122.34 10.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.915 -1.143 . . . . 2.04 107.915 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -126.8 167.65 15.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.207 1.188 . . . . 0.95999999999999996 114.207 159.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.32 145.66 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.08 1.352 . . . . 1.45 107.721 152.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -123.92 158.64 31.51 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.202 1.401 . . . . 0.84999999999999998 110.969 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.42 69.03 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.465 1.654 . . . . 0.66000000000000003 115.465 -163.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -126.48 -174.58 3.16 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.357 1.463 . . . . 1.1499999999999999 112.195 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.97 30.52 5.03 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 117.776 1.87 . . . . 1.27 117.776 -156.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.6 m -159.06 114.4 2.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 121.692 2.746 . . . . 2.4700000000000002 115.0 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.3 m -68.83 76.93 0.31 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.385 1.564 . . . . 2.7400000000000002 112.644 167.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -116.56 134.38 22.89 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 124.981 1.312 . . . . 3.8199999999999998 109.134 167.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.11 144.63 21.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.293 2.662 . . . . 1.1399999999999999 110.18 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.91 131.51 42.31 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.08 -0.711 . . . . 1.49 109.08 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.4 mm -99.15 110.0 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.952 -1.129 . . . . 3.5099999999999998 107.952 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -166.81 154.51 9.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 6.6500000000000004 111.003 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t70 41.31 54.86 3.45 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.527 1.531 . . . . 4.2000000000000002 114.853 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.11 87.75 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.722 -1.599 . . . . 2.6899999999999999 115.653 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -153.67 171.89 18.12 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.462 2.131 . . . . 2.7000000000000002 114.161 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 114.59 26.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.215 1.406 . . . . 2.1200000000000001 109.565 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.33 74.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.482 1.113 . . . . 1.9299999999999999 111.02 -172.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.7 -73.51 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.257 2.623 . . . . 2.1699999999999999 116.328 161.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.78 69.23 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 130.801 3.64 . . . . 1.8400000000000001 107.308 -165.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.26 -42.51 14.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.302 1.441 . . . . 4.5 112.236 -165.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.17 5.99 1.46 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.866 1.432 . . . . 1.3100000000000001 114.866 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.74 66.1 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.362 1.065 . . . . 1.02 112.526 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.23 -175.42 51.28 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 119.497 1.044 . . . . 2.3599999999999999 113.066 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.2 170.43 37.95 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.805 1.193 . . . . 1.3200000000000001 113.298 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.618 ' CD2' ' H ' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -78.22 38.67 0.29 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.036 2.134 . . . . 3.2799999999999998 112.385 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.4 tp 56.73 72.59 0.5 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.132 2.573 . . . . 1.6399999999999999 110.213 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 39.2 p-10 -153.14 5.95 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 118.17 2.656 . . . . 4.54 118.17 -140.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 68.3 Cg_endo -70.39 -26.72 24.3 Favored 'Trans proline' 0 C--N 1.358 1.063 0 CA-C-N 123.906 2.431 . . . . 3.1800000000000002 116.151 -162.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.67 138.14 19.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.4 1.454 . . . . 2.9300000000000002 111.043 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 p30 161.61 -159.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 129.676 3.19 . . . . 4.7300000000000004 109.381 -161.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 t -72.74 -14.12 61.48 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.625 1.342 . . . . 4.6200000000000001 114.625 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.83 -58.38 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.946 1.26 . . . . 3.5800000000000001 113.124 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttt -69.32 163.89 24.09 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.963 1.381 . . . . 6.25 113.754 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.34 137.31 55.94 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.201 -0.937 . . . . 1.53 111.252 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -76.17 156.04 34.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.153 0.581 . . . . 3.5 112.064 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.2 -157.15 27.13 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.178 1.371 . . . . 2.6000000000000001 112.149 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.14 -23.8 28.67 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.169 2.58 . . . . 4.29 111.938 172.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -153.59 176.43 12.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.873 2.069 . . . . 7.9100000000000001 108.626 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.43 -126.63 7.97 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.074 -1.21 . . . . 3.3799999999999999 110.074 -165.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -165.95 157.16 13.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.006 0.903 . . . . 4.75 110.133 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . 166.31 -137.13 4.49 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.833 2.635 . . . . 2.6899999999999999 110.669 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -90.9 136.03 33.34 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.781 -0.835 . . . . 4.3899999999999997 112.378 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.53 -33.25 75.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.44 -0.788 . . . . 1.8700000000000001 113.064 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.52 6.13 83.02 Favored Glycine 0 N--CA 1.474 1.18 0 N-CA-C 115.717 1.047 . . . . 0.79000000000000004 115.717 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -67.98 130.18 42.17 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 118.772 1.286 . . . . 1.8 109.075 161.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.82 161.93 40.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.477 1.511 . . . . 1.8899999999999999 110.327 -151.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.31 144.86 20.92 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.427 2.751 . . . . 0.98999999999999999 111.63 -168.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.18 132.45 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.612 1.196 . . . . 1.47 113.533 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.87 81.76 1.65 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.807 2.443 . . . . 1.6699999999999999 109.37 169.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.87 131.78 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.421 -0.799 . . . . 1.1599999999999999 109.657 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.6 HG23 ' HA ' ' A' ' 42' ' ' PRO . 19.1 m -111.51 153.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.253 1.021 . . . . 2.04 108.48 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.7 p30 -69.04 159.36 33.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.732 -0.605 . . . . 2.04 111.93 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -49.09 -19.32 0.41 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.173 2.189 . . . . 3.8799999999999999 115.865 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.12 8.1 32.02 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 127.83 2.452 . . . . 4.5800000000000001 112.117 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.48 23.81 15.51 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 117.582 1.793 . . . . 1.1599999999999999 117.582 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -139.55 134.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.961 1.305 . . . . 1.21 111.29 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.85 118.65 26.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.306 2.242 . . . . 0.76000000000000001 110.786 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 t -146.94 -3.88 0.57 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.266 1.209 . . . . 1.3999999999999999 114.266 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.73 118.61 72.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.335 1.454 . . . . 3.29 112.219 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.79 125.82 11.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.262 3.308 . . . . 1.1100000000000001 110.227 170.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 175.11 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.581 1.552 . . . . 1.22 109.946 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 m -148.4 140.04 23.65 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.303 0.956 . . . . 0.69999999999999996 110.049 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.23 96.12 29.09 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.55 1.14 . . . . 0.72999999999999998 111.636 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.32 7.87 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.254 3.303 . . . . 1.1499999999999999 114.391 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -81.72 -23.65 36.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.32 1.448 . . . . 4.1200000000000001 111.6 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.81 139.32 48.85 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.881 1.673 . . . . 2.4700000000000002 107.863 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -107.1 -21.29 13.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 115.204 1.557 . . . . 3.7400000000000002 115.204 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.5 t -152.96 155.07 36.27 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.942 1.246 . . . . 1.8999999999999999 114.005 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -57.39 -32.3 66.68 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.131 0.572 . . . . 1.5700000000000001 112.433 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -64.08 -14.66 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.03 1.493 . . . . 3.2599999999999998 115.03 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -72.49 -20.28 61.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.217 0.917 . . . . 2.1099999999999999 112.252 167.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.43 10.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.223 1.409 . . . . 0.81000000000000005 113.96 -163.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -46.39 -20.84 0.13 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.02 2.928 . . . . 4.29 116.578 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -117.92 9.11 12.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.201 2.6 . . . . 4.5800000000000001 113.221 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.5 168.14 12.97 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.493 1.294 . . . . 1.2 114.493 -160.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.82 158.31 24.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.997 1.319 . . . . 1.04 111.565 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.08 150.86 39.29 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.664 1.586 . . . . 1.76 108.967 172.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.28 139.64 50.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.063 0.764 . . . . 2.2400000000000002 113.063 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.75 104.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.936 -1.505 . . . . 0.90000000000000002 106.936 159.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.93 150.05 34.1 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.929 2.091 . . . . 1.8500000000000001 111.65 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.67 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.859 -1.151 . . . . 1.71 112.648 -163.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.7 170.97 14.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.119 1.342 . . . . 1.5900000000000001 111.187 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.49 151.03 50.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.576 1.084 . . . . 1.79 113.072 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.16 -21.43 11.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.094 1.516 . . . . 3.2000000000000002 115.094 -152.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -75.44 8.52 2.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.468 1.655 . . . . 3.2999999999999998 115.468 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -81.22 55.54 2.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.976 1.311 . . . . 3.2200000000000002 111.197 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -81.79 33.98 0.39 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.962 2.505 . . . . 3.9399999999999999 115.211 -163.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.19 19.37 7.61 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.665 1.586 . . . . 5.9100000000000001 113.033 -163.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -147.47 154.61 45.29 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.927 1.691 . . . . 3.5 110.525 -167.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.09 7.29 2.14 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.046 3.164 . . . . 2.6200000000000001 114.241 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.419 ' HA ' ' HE2' ' A' ' 139' ' ' LYS . 8.7 mmpt? -107.12 99.77 28.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.021 1.328 . . . . 5.29 108.666 169.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.92 166.69 26.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.234 2.623 . . . . 3.1899999999999999 111.949 -170.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt 64.83 27.18 12.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.269 1.428 . . . . 3.71 111.878 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.7 1.62 31.91 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.741 1.639 . . . . 3.3900000000000001 114.7 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.49 -15.18 60.76 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.778 1.18 . . . . 2.27 113.063 -162.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.96 24.8 3.23 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.198 1.856 . . . . 1.6599999999999999 113.678 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.62 -15.98 73.69 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.116 1.341 . . . . 1.4199999999999999 115.246 -169.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 p -69.01 147.39 51.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.554 1.177 . . . . 1.6200000000000001 110.035 167.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 131.93 47.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 4.4100000000000001 109.818 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -81.94 -44.13 17.17 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.214 0.605 . . . . 2.3100000000000001 109.554 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.29 155.76 45.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.294 1.038 . . . . 0.67000000000000004 112.717 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 41.0 t -143.52 151.23 40.01 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.136 2.175 . . . . 1.29 111.331 -174.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.68 149.59 18.31 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.739 1.161 . . . . 1.02 113.842 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.98 149.09 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.1 1.76 . . . . 2.5099999999999998 112.36 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.33 147.11 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.492 1.917 . . . . 0.95999999999999996 111.923 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.744 0 C-N-CA 126.455 1.902 . . . . 4.3399999999999999 109.683 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 109.115 -0.698 . . . . 1.96 109.115 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -122.38 143.21 49.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.593 1.542 . . . . 1.25 114.454 -148.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -154.76 147.55 24.4 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.493 . . . . 3.04 109.584 168.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.43 77.16 1.77 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.679 1.592 . . . . 5.1399999999999997 112.671 -160.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.17 112.19 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 120.55 -1.344 . . . . 1.1299999999999999 111.377 -162.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.32 101.58 0.52 Allowed Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.878 2.18 . . . . 0.68999999999999995 111.476 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.2 mmm -79.93 126.15 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.833 1.253 . . . . 1.3899999999999999 111.133 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -105.56 149.26 26.42 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.786 1.279 . . . . 2.6000000000000001 112.973 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.71 65.66 1.37 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.371 2.268 . . . . 1.3799999999999999 111.619 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 15' ' ' VAL . 1.5 m -73.12 141.82 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.767 0.827 . . . . 1.21 111.005 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -148.72 -159.57 1.05 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.889 -1.05 . . . . 2.6800000000000002 109.049 171.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.06 -3.0 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.491 1.516 . . . . 1.72 112.382 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -98.12 8.92 44.07 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.965 1.706 . . . . 3.0699999999999998 111.633 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 -164.69 26.73 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 125.047 1.308 . . . . 1.4299999999999999 112.835 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.416 ' HA ' HG12 ' A' ' 10' ' ' VAL . 99.0 t -65.94 126.51 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.629 1.171 . . . . 1.1299999999999999 110.774 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.87 -137.23 9.45 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 125.577 1.56 . . . . 1.8300000000000001 113.355 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.32 150.91 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.685 1.594 . . . . 2.3500000000000001 112.546 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -79.45 145.76 33.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.469 0.708 . . . . 1.26 110.222 161.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.37 3.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.313 1.845 . . . . 3.1099999999999999 114.091 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.77 163.85 14.66 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.808 1.671 . . . . 0.71999999999999997 112.717 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -96.24 158.87 15.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.142 -0.688 . . . . 0.95999999999999996 109.142 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.4 t -105.15 132.46 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.352 -1.351 . . . . 0.47999999999999998 107.352 152.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 12.2 p -87.3 128.22 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.311 0.577 . . . . 0.87 110.536 172.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 126.46 1.904 . . . . 1.4099999999999999 107.714 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -131.83 112.57 12.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.048 0.928 . . . . 1.9099999999999999 111.198 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 137.49 57.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 128.25 2.62 . . . . 4.1900000000000004 112.463 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 29' ' ' GLY 0.312 14.8 t -151.2 161.84 41.98 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 124.543 2.116 . . . . 1.2 111.064 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -21.23 -41.19 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.573 -2.558 . . . . 3.6299999999999999 115.266 146.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 27' ' ' THR . . . -100.5 12.05 59.76 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 126.035 1.779 . . . . 0.84999999999999998 117.012 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.36 -152.0 23.94 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 130.225 3.774 . . . . 0.71999999999999997 114.708 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.51 102.59 4.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.281 -1.129 . . . . 0.58999999999999997 111.45 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -76.43 115.96 16.66 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.313 -0.867 . . . . 1.6899999999999999 109.882 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -105.69 110.54 22.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.477 2.311 . . . . 0.51000000000000001 109.623 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.408 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 11.8 m -114.47 110.27 47.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 119.79 1.177 . . . . 0.58999999999999997 108.095 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.61 152.68 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.382 2.722 . . . . 0.69999999999999996 110.89 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 40.4 0.77 Allowed 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.168 1.461 . . . . 2.3500000000000001 111.231 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mp -103.54 141.7 35.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.539 1.936 . . . . 0.92000000000000004 112.977 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' H ' ' HE3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -103.33 160.08 15.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.451 -1.249 . . . . 3.3500000000000001 109.805 170.074 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 97.69 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.521 2.728 . . . . 1.4199999999999999 115.099 160.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -98.75 156.24 35.81 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 118.886 0.766 . . . . 1.5900000000000001 111.86 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.82 136.45 57.53 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.915 1.744 . . . . 0.98999999999999999 110.589 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 99' ' ' VAL . 21.8 Cg_endo -86.97 34.58 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.564 2.843 . . . . 1.1699999999999999 114.736 -151.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.62 -140.84 11.62 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.729 1.157 . . . . 1.25 114.072 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -120.3 153.93 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.795 -0.826 . . . . 3.1800000000000002 110.414 165.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -138.23 133.69 33.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.615 0.766 . . . . 0.91000000000000003 110.203 -163.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 163.44 23.77 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 111.015 -0.834 . . . . 0.68000000000000005 111.015 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' CE1' HD13 ' A' ' 94' ' ' LEU . 4.6 t80 -135.95 132.25 36.17 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 106.086 -1.82 . . . . 1.8600000000000001 106.086 172.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.61 ' HA ' HD12 ' A' ' 94' ' ' LEU . 5.3 m170 -137.85 158.24 44.76 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.149 -0.97 . . . . 0.90000000000000002 112.815 168.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.54 142.85 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 127.42 2.288 . . . . 0.85999999999999999 108.006 163.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -123.28 156.38 35.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.077 1.351 . . . . 0.82999999999999996 110.663 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.75 78.73 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.974 1.842 . . . . 0.63 115.974 -159.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -116.33 -177.66 3.23 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.576 1.55 . . . . 1.0700000000000001 111.483 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.81 97.49 0.31 Allowed Glycine 0 N--CA 1.47 0.902 0 O-C-N 120.769 -1.207 . . . . 0.93000000000000005 113.441 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 t 173.87 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.605 2.362 . . . . 2.1699999999999999 109.638 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.5 m -70.11 31.15 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 115.976 1.843 . . . . 1.3100000000000001 115.976 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -84.54 124.91 72.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 119.724 -1.86 . . . . 4.0800000000000001 111.158 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.07 144.27 13.29 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.307 2.671 . . . . 0.95999999999999996 111.253 173.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.2 153.75 29.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.997 0.519 . . . . 1.5700000000000001 110.583 164.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.03 132.25 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.984 -1.072 . . . . 2.21 111.07 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.21 172.95 11.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.275 2.63 . . . . 4.8899999999999997 110.055 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -47.4 114.06 0.81 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.663 1.185 . . . . 5.1500000000000004 112.406 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.13 6.47 53.38 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.986 -1.452 . . . . 3.9500000000000002 115.715 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.93 129.14 10.48 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.809 2.304 . . . . 3.6299999999999999 114.378 -167.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.86 117.56 30.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.984 0.914 . . . . 1.52 108.826 165.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.37 74.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.224 1.81 . . . . 1.97 111.172 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.43 -73.58 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.863 2.865 . . . . 2.5 115.864 164.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.48 38.09 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 130.023 3.329 . . . . 2.46 109.332 -166.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.6 -25.49 62.69 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.293 1.22 . . . . 4.0999999999999996 114.293 -167.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -13.09 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.034 1.288 . . . . 1.3 113.908 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.82 -4.24 57.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.63 1.572 . . . . 1.25 113.02 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 -179.98 53.11 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.787 -1.196 . . . . 2.5699999999999998 114.22 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.89 -179.3 48.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.99 0.805 . . . . 1.1499999999999999 111.631 166.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -53.67 137.79 36.47 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 118.585 -0.721 . . . . 2.1899999999999999 109.812 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.402 HD13 ' HE2' ' A' ' 123' ' ' LYS . 59.8 tp -59.76 116.46 4.08 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.818 0.736 . . . . 1.5900000000000001 111.642 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -149.32 101.79 3.33 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.81 2.044 . . . . 4.1100000000000003 109.207 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.36 -46.43 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.639 1.559 . . . . 3.3100000000000001 111.111 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -164.16 13.91 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.794 2.038 . . . . 3.29 113.083 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -56.87 -39.62 74.67 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.2 -1.562 . . . . 3.3300000000000001 113.543 -170.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t 146.11 -28.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 1 C-N-CA 132.069 4.148 . . . . 3.1000000000000001 111.201 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.73 58.14 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 117.016 1.566 . . . . 2.27 117.016 162.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.85 -67.31 0.79 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.536 1.668 . . . . 7.7300000000000004 112.449 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 t60 171.69 157.54 0.09 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.811 2.844 . . . . 1.6799999999999999 111.549 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.65 133.28 32.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.743 1.217 . . . . 4.2300000000000004 108.69 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.51 -95.29 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 109.404 -1.478 . . . . 2.9300000000000002 109.404 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.76 29.46 0.41 Allowed 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 124.589 3.526 . . . . 3.21 112.631 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -146.23 -179.63 6.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.433 1.893 . . . . 5.5499999999999998 109.457 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.15 107.21 0.7 Allowed Glycine 0 N--CA 1.472 1.061 0 N-CA-C 109.095 -1.602 . . . . 3.7200000000000002 109.095 164.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -168.84 -5.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.059 1.503 . . . . 5.8399999999999999 115.059 -149.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -34.98 0.02 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 118.105 2.002 . . . . 3.1299999999999999 118.105 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.49 115.22 3.39 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.201 2.0 . . . . 3.6899999999999999 110.831 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.02 -11.35 7.95 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.479 1.659 . . . . 2.02 115.479 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.01 -0.16 89.23 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.963 -1.465 . . . . 0.81999999999999995 116.094 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -85.09 134.86 34.18 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 120.5 2.15 . . . . 1.5 112.673 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 48' ' ' HIS . 1.8 mt -123.95 160.78 50.27 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.596 1.558 . . . . 2.6600000000000001 112.065 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.06 162.23 43.37 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.749 2.966 . . . . 1.01 112.247 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 132' ' ' ASP . 27.4 m -79.08 127.88 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 123.355 1.55 . . . . 1.48 114.56 -162.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.07 82.25 5.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.87 2.868 . . . . 1.97 109.492 174.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.26 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.071 -1.018 . . . . 1.4199999999999999 109.29 171.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 42' ' ' PRO . 25.4 m -125.89 157.96 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.347 1.059 . . . . 2.0 110.077 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -79.16 159.46 27.41 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.895 1.072 . . . . 2.2599999999999998 113.895 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -49.67 -20.57 0.83 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 127.502 2.321 . . . . 4.0999999999999996 117.148 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.13 0.92 27.89 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.211 1.559 . . . . 3.9700000000000002 115.211 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.99 42.25 2.67 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 116.0 1.16 . . . . 1.01 116.0 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.89 135.46 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.878 1.271 . . . . 1.05 109.522 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.32 118.1 31.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.572 1.949 . . . . 0.68999999999999995 109.238 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -156.54 21.61 0.34 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.737 1.384 . . . . 1.8300000000000001 114.737 -167.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -134.83 143.48 46.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.149 1.779 . . . . 4.3700000000000001 108.785 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -85.13 162.48 11.54 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.191 3.261 . . . . 1.47 114.362 -170.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.45 172.17 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 126.315 1.846 . . . . 1.26 109.722 166.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -141.39 146.5 36.68 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 119.925 1.239 . . . . 0.88 111.097 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.72 87.06 3.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.832 1.253 . . . . 0.85999999999999999 113.961 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.5 2.1 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.481 2.787 . . . . 1.3200000000000001 114.732 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -76.86 -11.27 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.695 1.134 . . . . 5.2699999999999996 111.673 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.31 164.87 13.88 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.005 2.122 . . . . 2.3300000000000001 110.711 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -152.08 11.09 0.54 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.528 1.931 . . . . 4.21 114.187 173.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -159.18 149.3 19.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.324 -1.485 . . . . 1.78 113.716 163.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -57.49 -24.53 56.39 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.084 -1.01 . . . . 1.73 111.38 162.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -52.03 -31.74 31.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.212 1.005 . . . . 3.0099999999999998 112.768 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.032 1.333 . . . . 2.3700000000000001 112.399 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.04 11.27 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.086 1.354 . . . . 0.96999999999999997 113.539 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.3 pttt -61.54 7.14 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.984 2.587 . . . . 2.7400000000000002 117.984 -171.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -156.33 22.19 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.48 1.912 . . . . 3.5 111.748 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HE2' HD13 ' A' ' 74' ' ' LEU . 57.9 mttp -113.34 170.53 8.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.846 1.259 . . . . 1.1699999999999999 114.31 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.08 150.3 23.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.609 1.164 . . . . 0.56999999999999995 112.372 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.4 145.27 40.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.864 2.066 . . . . 1.5600000000000001 107.585 165.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -130.65 136.56 48.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.824 0.738 . . . . 2.04 112.179 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 88.3 mt -94.26 124.37 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.518 -1.29 . . . . 0.81000000000000005 107.518 167.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -120.29 143.1 48.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.319 1.048 . . . . 1.8500000000000001 112.485 -156.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.25 -37.59 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.898 -1.126 . . . . 1.1799999999999999 112.983 -153.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.9 141.06 16.63 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.78 0.705 . . . . 1.1200000000000001 112.141 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -47.43 134.45 14.05 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 126.01 1.767 . . . . 2.1499999999999999 112.109 164.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.43 ' H ' HG12 ' A' ' 96' ' ' VAL . 4.4 t70 -76.11 1.72 14.88 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.22 1.408 . . . . 2.8999999999999999 113.001 -167.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -66.29 -1.47 3.41 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 119.727 -1.858 . . . . 4.7699999999999996 114.24 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 ptp -93.07 10.35 31.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.288 1.835 . . . . 3.6699999999999999 114.149 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.4 p -47.83 -21.96 0.49 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.812 2.152 . . . . 4.3499999999999996 116.812 -171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.44 -10.42 59.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.089 2.956 . . . . 7.9900000000000002 115.618 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -53.01 148.64 13.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 114.276 1.213 . . . . 4.2000000000000002 114.276 -166.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.36 30.59 0.34 Allowed 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.361 3.374 . . . . 3.1200000000000001 112.234 170.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 140.32 35.26 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.544 1.538 . . . . 4.4699999999999998 109.19 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.71 162.26 32.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.416 2.744 . . . . 3.4500000000000002 112.965 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 71.6 mt 64.39 16.08 9.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.778 1.631 . . . . 4.9299999999999997 114.033 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.03 12.08 58.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.065 1.317 . . . . 4.7800000000000002 114.955 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.33 -64.35 3.79 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.889 1.345 . . . . 2.9700000000000002 112.992 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.17 0.45 31.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.906 1.241 . . . . 2.0899999999999999 114.949 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.1 9.44 12.37 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.703 2.097 . . . . 2.1299999999999999 116.071 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.0 p -69.04 146.95 52.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.744 1.772 . . . . 1.96 108.996 161.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 143.18 27.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.036 -1.04 . . . . 5.5199999999999996 112.942 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.412 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 23.8 t80 -102.2 -26.54 13.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.196 0.598 . . . . 2.1899999999999999 111.849 158.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.96 149.18 28.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.653 -0.654 . . . . 0.52000000000000002 112.664 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.2 t -120.32 144.07 48.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.097 2.159 . . . . 1.46 109.714 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -139.43 104.51 0.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 126.341 1.924 . . . . 0.66000000000000003 111.18 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -83.0 130.37 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.339 1.069 . . . . 1.72 110.334 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.74 133.45 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.144 1.378 . . . . 0.91000000000000003 110.677 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 125.863 1.665 . . . . 4.5499999999999998 108.576 176.466 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.187 -0.301 . . . . 2.2200000000000002 110.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.78 159.63 40.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.786 1.773 . . . . 1.49 115.786 -151.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -148.37 136.95 21.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.476 1.511 . . . . 2.9500000000000002 109.459 159.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -83.41 103.63 12.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.429 1.092 . . . . 3.6099999999999999 112.031 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.8 t -79.02 114.36 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.253 -0.904 . . . . 1.1399999999999999 109.079 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.44 105.57 1.81 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.25 1.405 . . . . 0.72999999999999998 111.425 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.7 mmm -84.13 122.42 28.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.712 1.205 . . . . 1.71 111.365 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.16 151.79 23.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.756 0.789 . . . . 2.4399999999999999 111.185 166.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.52 136.31 57.97 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.083 0.953 . . . . 1.3300000000000001 109.706 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.53 140.59 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.393 -0.965 . . . . 1.24 108.393 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 t -151.44 17.61 0.72 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.597 0.759 . . . . 2.7599999999999998 111.85 -165.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.61 -21.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.538 2.335 . . . . 1.3300000000000001 113.371 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -71.8 28.18 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 119.879 1.218 . . . . 4.0099999999999998 111.985 163.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -174.78 52.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.562 2.029 . . . . 1.24 113.201 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.67 119.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.178 0.991 . . . . 1.45 108.608 153.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.04 -69.37 1.02 Allowed Glycine 0 N--CA 1.466 0.638 0 CA-C-O 122.159 0.866 . . . . 1.53 114.129 -170.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 153.88 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.106 1.363 . . . . 2.3799999999999999 109.537 -165.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -89.59 152.61 21.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.271 1.428 . . . . 1.2 112.983 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.42 -2.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 115.196 1.554 . . . . 3.71 115.196 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.77 175.05 20.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.561 2.029 . . . . 0.69999999999999996 111.792 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -104.71 175.21 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.583 -0.951 . . . . 0.81999999999999995 109.378 167.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.74 131.25 73.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.663 -1.606 . . . . 0.53000000000000003 106.663 152.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.4 p -80.89 122.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.667 -0.494 . . . . 0.91000000000000003 109.667 172.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.4 mt -94.48 127.31 46.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 107.374 -1.343 . . . . 1.45 107.374 165.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.38 123.56 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.17 1.388 . . . . 1.98 108.701 171.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 151.0 33.17 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 121.026 -0.269 . . . . 3.23 111.049 172.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -161.29 -173.82 4.01 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.405 0.682 . . . . 1.4299999999999999 109.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -59.73 -25.64 65.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.857 1.263 . . . . 5.5800000000000001 113.353 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.36 16.45 61.04 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.558 1.075 . . . . 1.0900000000000001 114.66 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.7 -140.44 24.23 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 125.334 1.445 . . . . 0.66000000000000003 114.002 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.19 98.38 4.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.194 0.998 . . . . 0.75 112.105 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.95 111.22 14.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.2 1.4 . . . . 2.2000000000000002 110.785 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.71 117.58 29.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.255 2.222 . . . . 0.57999999999999996 108.835 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.41 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.8 m -123.95 110.69 29.27 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-N 119.796 1.18 . . . . 0.62 108.986 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.74 158.34 10.47 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.974 3.116 . . . . 0.41999999999999998 111.341 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -149.06 29.32 0.81 Allowed 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.794 0.807 . . . . 1.28 113.058 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.77 148.77 21.94 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.542 1.537 . . . . 0.79000000000000004 111.915 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.52 23.38 6.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.853 2.168 . . . . 1.96 116.853 -164.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.73 69.2 0.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.888 0.875 . . . . 1.6599999999999999 111.351 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.13 160.94 66.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.88 0.872 . . . . 1.46 112.007 170.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.28 127.68 18.79 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.052 1.168 . . . . 0.94999999999999996 110.343 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -83.58 33.39 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.901 1 C-N-CA 126.053 4.502 . . . . 1.05 113.152 -159.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.72 -131.6 4.46 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 123.411 1.562 . . . . 1.1799999999999999 112.131 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.0 147.27 52.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.667 1.587 . . . . 3.8900000000000001 109.548 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.7 122.64 15.52 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.72 0.808 . . . . 1.3700000000000001 112.25 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.73 155.05 1.67 Allowed Glycine 0 CA--C 1.543 1.794 0 C-N-CA 123.936 0.779 . . . . 1.0 113.057 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.93 112.5 11.31 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.206 -1.405 . . . . 1.8999999999999999 107.206 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -116.33 158.79 22.89 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.249 1.203 . . . . 0.93999999999999995 114.249 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.471 ' CG2' HD12 ' A' ' 74' ' ' LEU . 63.2 mt -99.23 151.27 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.236 1.414 . . . . 0.68999999999999995 107.88 154.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.23 153.45 47.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.174 1.79 . . . . 0.91000000000000003 107.648 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.83 71.68 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.909 1.448 . . . . 0.87 114.909 -163.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -119.22 161.21 20.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.19 1.796 . . . . 1.54 112.371 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.13 86.02 0.56 Allowed Glycine 0 N--CA 1.467 0.715 0 C-N-CA 124.682 1.134 . . . . 0.85999999999999999 112.773 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 t -171.11 94.15 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.718 1.207 . . . . 1.9199999999999999 113.011 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 68.3 m -65.92 14.55 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 117.097 2.258 . . . . 1.3600000000000001 117.097 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -101.96 147.85 34.49 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 119.787 -1.821 . . . . 3.7799999999999998 113.965 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.37 161.42 11.19 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.723 3.615 . . . . 1.1499999999999999 112.602 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.31 14.13 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.605 0.762 . . . . 1.8999999999999999 111.213 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.23 115.34 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.345 1.058 . . . . 3.3700000000000001 109.643 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -146.34 147.06 30.94 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.85 1.66 . . . . 5.6900000000000004 110.704 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t0 53.13 32.18 12.68 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.617 1.34 . . . . 4.4500000000000002 114.617 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.1 6.48 87.54 Favored Glycine 0 CA--C 1.535 1.343 0 O-C-N 121.105 -0.997 . . . . 3.9900000000000002 114.771 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -141.58 -161.79 1.28 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.57 1.548 . . . . 3.9399999999999999 110.509 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.14 138.64 49.56 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.919 -1.113 . . . . 1.8999999999999999 113.027 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 t -82.24 60.75 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.838 1.655 . . . . 2.3199999999999998 111.029 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 47.17 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.154 2.582 . . . . 1.76 115.874 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.93 84.38 0.81 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.411 2.684 . . . . 1.47 107.556 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -84.72 -46.71 11.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.237 1.415 . . . . 3.98 112.03 -167.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -12.34 57.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.321 1.23 . . . . 1.1200000000000001 114.321 -164.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.74 -22.82 59.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.562 1.545 . . . . 0.79000000000000004 113.897 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.55 -174.97 17.77 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 120.398 1.454 . . . . 2.3900000000000001 114.278 -176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 -155.57 22.44 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.129 1.347 . . . . 1.1699999999999999 110.832 164.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -71.36 34.41 0.05 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 118.957 1.379 . . . . 2.4100000000000001 113.783 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.471 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER 64.11 46.04 3.85 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.452 1.501 . . . . 2.5299999999999998 109.536 -178.22 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -128.32 44.95 1.47 Allowed Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 116.3 1.963 . . . . 4.4000000000000004 116.3 -148.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.39 -20.81 31.38 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.834 2.356 . . . . 3.04 113.722 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -166.65 143.32 4.77 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.82 1.648 . . . . 3.8399999999999999 110.5 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 164.75 -23.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 129.501 3.12 . . . . 3.8399999999999999 113.435 170.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 t 139.18 -2.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 1 C-N-CA 131.829 4.052 . . . . 3.5299999999999998 112.855 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.26 2.73 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.549 1.38 . . . . 2.4399999999999999 116.549 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -86.71 172.5 10.14 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.43 1.615 . . . . 4.5499999999999998 113.73 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -107.68 143.92 35.51 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.068 1.347 . . . . 1.48 112.921 -173.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -152.86 -173.19 4.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.222 1.409 . . . . 3.8300000000000001 109.967 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.38 -52.1 0.01 OUTLIER Glycine 0 CA--C 1.544 1.854 0 CA-C-O 116.977 -2.013 . . . . 4.1500000000000004 115.022 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -105.0 -20.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.875 2.383 . . . . 5.2999999999999998 116.939 -164.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 177.27 17.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.44 1.496 . . . . 8.0500000000000007 114.369 -165.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.83 -150.05 21.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.494 1.521 . . . . 2.77 112.25 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -135.92 135.9 40.03 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.741 -1.207 . . . . 5.7800000000000002 107.741 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.75 -157.72 30.02 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.419 0.554 . . . . 2.9500000000000002 114.434 -173.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 136.75 58.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.286 0.634 . . . . 3.8199999999999998 112.665 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -11.9 60.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.681 0.993 . . . . 2.52 113.681 169.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.08 14.77 36.75 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.794 -1.559 . . . . 1.0700000000000001 115.439 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -106.99 131.93 53.5 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 119.614 1.707 . . . . 1.5700000000000001 112.267 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 3.9 mp -131.37 170.51 11.1 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.067 2.147 . . . . 2.0099999999999998 110.418 -168.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 94' ' ' LEU . 88.7 Cg_endo -80.22 152.9 21.29 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.403 2.068 . . . . 0.82999999999999996 111.868 -172.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.85 128.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.795 1.238 . . . . 2.2200000000000002 112.95 -168.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.38 82.17 1.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.151 2.18 . . . . 1.6799999999999999 108.894 168.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.49 141.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.51 1.124 . . . . 1.3799999999999999 109.161 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.93 150.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.419 1.888 . . . . 1.9099999999999999 108.866 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 143.49 26.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.057 0.844 . . . . 1.8799999999999999 112.683 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -19.83 -45.19 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.353 4.661 . . . . 3.3300000000000001 117.463 174.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.23 -29.37 65.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.943 1.297 . . . . 3.7000000000000002 112.633 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.11 20.72 6.2 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.807 1.67 . . . . 0.85999999999999999 113.463 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.6 mt -121.71 133.99 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.98999999999999999 109.888 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.63 131.01 49.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.615 1.166 . . . . 0.58999999999999997 110.322 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 t -152.37 4.18 0.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.427 2.01 . . . . 1.1000000000000001 116.427 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -100.98 136.96 19.64 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.877 1.217 . . . . 3.8500000000000001 111.334 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.14 146.8 47.08 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.526 3.484 . . . . 1.04 112.178 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.11 161.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.448 1.499 . . . . 1.1399999999999999 109.442 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -139.25 134.87 33.25 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.341 0.973 . . . . 0.72999999999999998 110.747 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.8 105.32 49.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.957 0.903 . . . . 0.93000000000000005 112.609 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.84 13.05 0.63 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.372 3.382 . . . . 1.1499999999999999 113.299 167.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -64.27 -41.26 97.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.096 1.758 . . . . 4.3899999999999997 110.737 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -111.41 151.73 28.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 2.3999999999999999 107.258 166.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -97.04 -22.07 17.02 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.586 0.958 . . . . 4.71 113.586 -174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.16 160.86 43.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.039 1.745 . . . . 1.5900000000000001 115.344 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.43 -30.68 68.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.457 1.503 . . . . 1.75 111.889 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -67.27 -2.75 6.42 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.807 2.043 . . . . 2.6099999999999999 113.313 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -96.86 -13.13 22.72 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.195 1.798 . . . . 1.8100000000000001 113.277 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.18 7.83 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.631 1.105 . . . . 1.0600000000000001 113.898 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -60.38 -12.6 9.76 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.854 2.168 . . . . 2.8799999999999999 116.854 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.39 16.75 13.87 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.55 1.94 . . . . 4.5800000000000001 114.08 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -121.2 -173.91 2.72 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.956 1.465 . . . . 1.4199999999999999 114.956 -165.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.5 156.56 47.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.508 1.523 . . . . 0.58999999999999997 111.555 169.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mp -118.3 130.0 55.78 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.525 1.93 . . . . 1.6499999999999999 108.489 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.2 mtt -116.98 128.72 55.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.46 0.573 . . . . 1.4199999999999999 111.772 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.02 103.51 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.61 -1.256 . . . . 0.80000000000000004 107.61 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -87.02 146.1 26.24 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.187 1.795 . . . . 2.3799999999999999 113.034 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.2 t -64.65 -30.32 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.983 -1.073 . . . . 1.6000000000000001 113.409 -164.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.14 149.66 18.07 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.316 0.96 . . . . 1.29 112.63 172.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.27 150.48 11.1 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.104 1.811 . . . . 1.5900000000000001 112.952 162.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.01 0.55 38.32 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.2 1.185 . . . . 2.4900000000000002 114.2 -141.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -81.55 -7.27 59.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.356 1.613 . . . . 3.02 115.356 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 65.9 mtm -84.45 109.75 18.12 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.74 1.216 . . . . 2.52 110.486 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -137.01 -45.35 0.57 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.17 0.988 . . . . 2.9100000000000001 112.759 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.41 80.64 8.53 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.123 -0.986 . . . . 3.8599999999999999 110.715 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 175.88 147.49 0.26 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 128.491 2.716 . . . . 3.48 110.272 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.33 -27.59 47.66 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 2.1299999999999999 114.029 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -109.91 87.75 6.07 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.802 0.841 . . . . 6.5 109.125 165.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.67 169.16 16.54 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.914 2.41 . . . . 4.5700000000000003 111.307 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt 66.3 6.04 4.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.523 1.929 . . . . 4.96 113.416 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.2 26.92 74.23 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 119.154 0.888 . . . . 3.9100000000000001 113.2 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.57 -9.35 77.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.778 1.18 . . . . 2.5600000000000001 113.186 -166.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 22.43 0.57 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.884 2.183 . . . . 1.6299999999999999 115.851 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.75 75.35 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 118.455 1.128 . . . . 1.73 112.337 166.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.7 p -65.21 156.86 30.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.454 1.502 . . . . 1.6499999999999999 110.896 162.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.25 137.67 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.761 1.224 . . . . 4.9500000000000002 110.582 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -82.37 -37.47 25.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.185 0.994 . . . . 2.3100000000000001 111.697 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.1 149.38 32.93 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.038 0.935 . . . . 0.53000000000000003 111.814 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.27 146.71 50.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.975 1.71 . . . . 1.5700000000000001 110.783 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -131.66 90.43 0.28 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.463 2.459 . . . . 0.70999999999999996 111.352 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.28 140.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.589 1.156 . . . . 2.6699999999999999 112.47 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.72 151.45 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.728 1.611 . . . . 1.1899999999999999 111.246 -170.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 O-C-N 120.912 -1.117 . . . . 4.3499999999999996 112.43 171.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 109.437 -0.579 . . . . 1.97 109.437 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.55 154.11 26.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.732 1.213 . . . . 1.1599999999999999 109.859 -172.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -149.17 125.77 11.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.921 1.343 . . . . 2.9300000000000002 110.27 170.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -83.83 109.89 17.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.064 1.746 . . . . 2.9900000000000002 110.528 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.66 124.47 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 120.089 1.313 . . . . 1.1499999999999999 110.482 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -76.25 110.95 3.17 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 125.669 1.604 . . . . 0.81000000000000005 110.752 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.5 mtp -96.74 131.7 43.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.253 1.021 . . . . 1.4199999999999999 111.121 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.65 142.91 45.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.066 1.346 . . . . 2.6899999999999999 111.524 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.7 mt -65.68 137.65 57.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.858 0.863 . . . . 1.3400000000000001 108.862 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.33 144.44 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.688 0.795 . . . . 1.05 111.432 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.1 t -163.79 72.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.677 0.791 . . . . 2.2400000000000002 112.473 -169.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 72.0 -33.47 0.27 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.029 2.531 . . . . 1.4299999999999999 115.44 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -33.78 68.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.353 1.461 . . . . 3.4700000000000002 110.082 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.39 -158.67 24.53 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 125.909 1.718 . . . . 1.3200000000000001 112.023 -169.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.84 126.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.391 1.476 . . . . 1.0800000000000001 110.899 171.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.91 -136.78 9.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.492 1.52 . . . . 1.99 111.504 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.34 165.64 12.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.411 -1.052 . . . . 1.8799999999999999 112.555 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -104.06 162.18 13.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.863 1.315 . . . . 1.3999999999999999 114.443 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pp -147.48 4.53 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 130.431 3.492 . . . . 2.8900000000000001 113.262 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.49 148.09 5.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.959 1.742 . . . . 0.81000000000000005 112.856 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.449 HG22 ' HA2' ' A' ' 6' ' ' GLY . 30.8 p -99.46 -179.9 4.36 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.184 -1.043 . . . . 0.84999999999999998 108.184 163.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 61.5 t -132.2 134.52 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.211 -1.033 . . . . 0.67000000000000004 108.211 163.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.5 p -81.54 122.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.49 -0.559 . . . . 0.96999999999999997 109.49 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -107.42 133.14 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.557 -0.905 . . . . 1.8899999999999999 108.557 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.22 124.91 18.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.547 1.539 . . . . 2.1600000000000001 107.498 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.34 128.66 47.4 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.515 0.726 . . . . 3.5600000000000001 109.703 -168.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -151.5 -174.53 4.86 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.633 0.235 . . . . 1.1699999999999999 111.633 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.17 -24.97 68.13 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.933 -1.105 . . . . 4.25 112.619 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.99 9.95 64.55 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 124.834 1.207 . . . . 0.96999999999999997 114.609 167.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.29 -140.19 23.43 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 126.668 2.08 . . . . 0.68999999999999995 112.988 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.87 93.47 5.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.9 0.88 . . . . 0.54000000000000004 110.49 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -72.69 131.57 42.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.483 1.913 . . . . 3.0299999999999998 109.22 166.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 19.3 t80 -127.93 106.72 9.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.99 2.116 . . . . 0.65000000000000002 108.176 -168.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.448 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 25.4 m -105.4 107.1 58.36 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.834 1.197 . . . . 0.79000000000000004 108.027 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.05 156.11 30.09 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.028 2.486 . . . . 0.71999999999999997 110.496 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.0 39.65 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.687 1.232 . . . . 2.3700000000000001 110.359 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.54 150.02 20.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 126.794 2.038 . . . . 1.01 111.733 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -132.5 162.34 31.45 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.339 -1.301 . . . . 3.1299999999999999 109.494 170.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.21 23.64 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.484 3.114 . . . . 1.6799999999999999 112.66 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.18 152.51 57.19 Favored Pre-proline 0 CA--C 1.487 -1.46 0 C-N-CA 125.249 1.42 . . . . 1.97 112.56 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -76.0 142.7 25.2 Favored 'Trans proline' 0 N--CA 1.413 -3.218 0 C-N-CA 116.599 -1.801 . . . . 1.52 111.286 -165.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -80.97 31.3 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.626 1 C-N-CA 127.89 5.727 . . . . 1.47 114.127 -155.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.86 -127.98 6.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 123.567 1.648 . . . . 1.6899999999999999 110.958 174.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -120.51 145.93 46.79 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 127.567 2.347 . . . . 3.0699999999999998 110.383 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.436 ' CD2' HG21 ' A' ' 99' ' ' VAL . 71.2 m-70 -139.9 125.11 18.8 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 124.158 0.983 . . . . 0.95999999999999996 112.404 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.31 149.79 9.41 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.607 -0.683 . . . . 0.55000000000000004 111.778 169.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -135.97 127.52 28.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.951 1.7 . . . . 1.8400000000000001 106.503 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -130.06 167.85 17.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.4 2.37 . . . . 1.01 117.4 166.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.0 mt -101.0 146.43 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.637 1.975 . . . . 0.77000000000000002 108.929 155.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -124.08 155.72 37.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.179 1.792 . . . . 1.49 110.541 -170.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.91 -37.91 70.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.948 1.462 . . . . 0.68999999999999995 114.948 -162.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -116.64 -179.34 3.65 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.335 1.454 . . . . 1.0800000000000001 111.033 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.98 51.05 0.86 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 116.646 1.419 . . . . 0.96999999999999997 116.646 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -153.22 123.93 7.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.661 1.731 . . . . 2.1299999999999999 112.45 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.1 m -68.77 -2.88 10.42 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.603 1.705 . . . . 2.0299999999999998 115.603 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.8 136.6 38.85 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 120.25 -1.531 . . . . 3.3700000000000001 112.02 -162.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -96.88 160.81 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.184 3.256 . . . . 1.3799999999999999 113.384 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.76 177.3 4.88 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.103 1.361 . . . . 2.3500000000000001 110.915 156.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.25 124.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.579 1.152 . . . . 2.5600000000000001 108.773 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -104.54 -178.86 3.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.579 1.952 . . . . 4.3700000000000001 109.911 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.33 104.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.529 0.937 . . . . 4.5599999999999996 113.529 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.06 18.03 70.45 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.262 -1.299 . . . . 4.1399999999999997 115.367 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -158.15 134.49 9.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.377 2.089 . . . . 4.7400000000000002 114.818 -169.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.6 130.33 35.01 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.107 -0.996 . . . . 1.9399999999999999 110.312 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -81.36 49.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.396 . . . . 2.9100000000000001 111.675 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.57 -57.47 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 130.608 3.563 . . . . 2.3399999999999999 117.817 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 163.38 85.35 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 1 C-N-CA 134.228 5.011 . . . . 1.6200000000000001 105.17 -167.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.85 -50.53 7.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.103 0.961 . . . . 5.2599999999999998 111.91 -155.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.56 15.02 0.11 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.12 1.156 . . . . 1.6499999999999999 114.12 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.65 -15.04 35.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.431 1.892 . . . . 0.87 112.7 165.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.08 9.68 85.38 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.737 1.455 . . . . 2.7799999999999998 116.737 168.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.04 -166.37 52.8 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.133 1.466 . . . . 1.46 112.277 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -61.97 149.87 39.47 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.707 0.753 . . . . 2.3700000000000001 111.22 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 123' ' ' LYS . 36.4 tp -67.98 110.18 3.79 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.904 -0.497 . . . . 1.8400000000000001 111.122 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.81 159.93 2.42 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 130.46 3.504 . . . . 3.3799999999999999 109.006 164.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -90.09 -18.6 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.328 2.019 . . . . 2.8399999999999999 115.712 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 178.55 -3.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.613 2.079 . . . . 4.9800000000000004 116.613 -163.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -58.92 -48.53 81.13 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.096 1.517 . . . . 3.73 115.096 -147.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 161.61 170.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.952 3.301 . . . . 3.54 109.467 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.93 -15.62 78.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.318 0.961 . . . . 3.6200000000000001 113.779 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.92 145.38 55.99 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.104 1.452 . . . . 4.6799999999999997 110.348 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -117.46 143.87 45.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.234 1.013 . . . . 1.53 112.299 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.74 117.56 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 3.7599999999999998 111.852 -161.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.05 171.53 35.7 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.004 1.288 . . . . 2.7799999999999998 111.958 171.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.74 -3.33 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.907 3.738 . . . . 4.04 115.876 -168.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -160.69 29.22 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.584 2.354 . . . . 8.0600000000000005 110.675 171.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.76 -141.15 7.76 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.098 2.285 . . . . 3.0099999999999998 112.224 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -151.97 148.07 27.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.336 1.068 . . . . 4.7800000000000002 112.055 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.12 -91.59 0.08 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.433 1.968 . . . . 2.23 112.524 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -134.76 134.25 40.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.136 1.375 . . . . 3.8700000000000001 110.285 -169.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -67.06 -21.63 65.89 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.63 1.344 . . . . 2.0899999999999999 114.63 -170.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.68 -2.65 76.64 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.707 1.146 . . . . 0.85999999999999999 115.128 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -72.71 133.58 44.64 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.796 1.298 . . . . 1.5700000000000001 109.949 169.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.92 163.9 26.35 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.993 1.317 . . . . 1.73 110.645 -150.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.3 145.79 34.87 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.514 2.809 . . . . 0.89000000000000001 111.899 -167.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.16 130.35 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.587 1.184 . . . . 2.6600000000000001 110.446 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 125.31 31.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 131.128 3.771 . . . . 2.25 110.446 -172.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -97.06 140.18 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.336 1.055 . . . . 1.24 111.88 -172.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 45' ' ' HIS . 2.3 t -130.16 141.07 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.539 1.936 . . . . 1.6399999999999999 108.248 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -103.47 157.5 17.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.693 1.197 . . . . 2.73 112.53 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.74 50.08 0.43 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.673 2.389 . . . . 2.8599999999999999 115.649 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -128.34 1.49 5.7 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.402 -1.726 . . . . 3.7200000000000002 111.221 150.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.29 27.47 13.33 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.441 1.972 . . . . 0.80000000000000004 113.883 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.29 138.53 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.533 1.533 . . . . 1.1699999999999999 110.255 -165.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.15 127.72 53.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.354 0.979 . . . . 1.05 109.925 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 t -149.03 9.18 0.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.845 1.424 . . . . 1.05 114.845 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -100.73 130.77 24.68 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.922 1.289 . . . . 3.5699999999999998 110.306 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.14 140.56 17.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.078 2.519 . . . . 1.0700000000000001 112.252 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.63 160.64 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.04 1.736 . . . . 1.1699999999999999 109.499 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.0 m -144.73 132.55 21.23 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.384 0.993 . . . . 0.81000000000000005 111.423 -167.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.84 97.25 27.94 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.744 1.218 . . . . 0.67000000000000004 112.916 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.0 -2.52 12.77 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.582 3.521 . . . . 1.1799999999999999 115.905 -177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -88.15 -2.44 58.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.548 1.139 . . . . 3.71 113.361 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.55 169.72 9.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.976 2.51 . . . . 2.3399999999999999 107.834 164.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -152.67 5.74 0.39 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 117.038 2.236 . . . . 3.98 117.038 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 m -158.1 167.95 28.42 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.987 1.267 . . . . 1.74 113.291 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.81 -20.06 63.46 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.957 -1.09 . . . . 1.3400000000000001 111.863 163.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.52 -35.86 78.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.587 1.155 . . . . 3.54 113.657 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -68.51 -13.11 62.1 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.366 1.247 . . . . 3.1800000000000002 114.366 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.16 17.58 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.747 1.219 . . . . 0.97999999999999998 113.539 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -67.44 19.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 128.308 2.643 . . . . 2.3900000000000001 116.977 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -165.96 26.28 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.788 2.435 . . . . 2.9500000000000002 110.94 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' ' 74' ' ' LEU . 59.4 mttp -134.6 170.64 15.49 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.952 -1.092 . . . . 1.29 113.629 -167.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.5 157.09 25.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.03 1.332 . . . . 0.77000000000000002 112.543 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.35 135.04 51.06 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.871 2.068 . . . . 1.6499999999999999 107.294 168.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.09 138.19 54.3 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.383 0.673 . . . . 2.5 111.444 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.33 133.48 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.443 1.116 . . . . 1.48 110.278 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.22 135.5 51.67 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.324 1.85 . . . . 1.96 110.828 -155.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -73.53 -15.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.791 1.404 . . . . 2.5600000000000001 114.791 -151.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.03 169.53 24.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.401 1.477 . . . . 1.53 109.891 162.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.2 147.84 34.16 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 117.88 0.84 . . . . 1.8400000000000001 111.786 165.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.64 -22.04 0.89 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.352 1.242 . . . . 3.7599999999999998 114.352 -138.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.6 47.43 0.17 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.85 2.46 . . . . 4.0899999999999999 115.422 -172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 41.4 mtm -105.99 133.32 50.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.918 1.687 . . . . 2.23 112.493 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.9 p -99.18 -36.19 9.74 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.129 1.772 . . . . 3.3599999999999999 114.768 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.39 2.9 54.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.538 1.31 . . . . 4.1500000000000004 114.538 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.62 144.09 32.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.887 0.875 . . . . 3.9700000000000002 110.669 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -41.47 9.06 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.311 2.674 . . . . 2.1600000000000001 112.59 -173.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -83.15 136.94 43.13 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.729 -0.653 . . . . 4.7300000000000004 109.943 158.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.88 167.37 26.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.171 2.581 . . . . 2.98 111.034 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt 66.33 31.11 8.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.971 1.308 . . . . 3.75 110.953 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.22 11.2 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.059 1.314 . . . . 2.8199999999999998 114.223 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.6 -20.76 29.5 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.098 1.808 . . . . 2.8900000000000001 114.392 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.42 -3.31 47.35 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.387 1.47 . . . . 4.1299999999999999 114.617 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.9 46.77 1.8 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.587 1.565 . . . . 3.3399999999999999 115.59 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.2 m -58.79 158.03 8.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.382 1.873 . . . . 2.0 110.338 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.45 150.5 28.29 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.281 -1.512 . . . . 5.7800000000000002 113.042 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.489 ' CE2' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -100.73 -32.83 10.52 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 118.817 -0.611 . . . . 8.4399999999999995 111.251 153.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.29 152.47 37.17 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 116.482 2.03 . . . . 0.84999999999999998 116.482 -172.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.0 t -99.2 -177.69 3.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 129.26 3.024 . . . . 1.5900000000000001 110.368 164.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 176.09 91.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 127.427 2.442 . . . . 0.72999999999999998 111.456 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.07 133.62 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 1.45 110.024 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.16 128.1 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.468 1.107 . . . . 1.0700000000000001 110.962 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 82.9 mttt . . . . . 0 N--CA 1.472 0.662 0 C-N-CA 123.992 0.917 . . . . 4.3099999999999996 111.214 -173.063 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 108.99 -0.744 . . . . 1.6599999999999999 108.99 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.7 148.06 23.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.228 1.011 . . . . 2.1299999999999999 113.568 -167.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -153.23 116.99 4.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 2.6000000000000001 109.248 165.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -97.35 108.36 21.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.747 -1.22 . . . . 3.4300000000000002 109.439 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.61 125.92 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.386 0.539 . . . . 1.1200000000000001 109.886 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.0 114.17 4.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.958 1.266 . . . . 0.71999999999999997 110.171 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.4 mtt -98.09 129.78 44.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.963 0.905 . . . . 1.1499999999999999 111.726 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -107.44 147.83 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.135 1.374 . . . . 2.6400000000000001 110.717 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.5 mt -65.28 139.96 58.66 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.19 1.396 . . . . 1.1599999999999999 109.382 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.0 m -135.27 155.6 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 119.233 0.924 . . . . 1.28 111.683 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.1 55.74 0.1 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.127 0.788 . . . . 2.3399999999999999 113.127 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.86 -36.72 0.37 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 127.196 2.199 . . . . 2.27 113.849 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -22.01 57.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 4.6100000000000003 112.283 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.63 -159.81 24.61 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 124.933 1.254 . . . . 1.1000000000000001 112.91 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 t -80.71 130.08 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.512 1.925 . . . . 1.27 110.996 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.22 -135.33 8.07 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.4 1.476 . . . . 1.8600000000000001 112.49 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -104.86 172.29 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.942 0.897 . . . . 2.3799999999999999 111.315 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -109.43 141.13 42.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.77 0.828 . . . . 1.1499999999999999 112.473 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 19' ' ' ILE . 36.4 mm -118.73 23.85 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 127.068 2.147 . . . . 5.6399999999999997 110.937 164.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.2 173.04 33.37 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.32 -0.863 . . . . 0.60999999999999999 114.83 160.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -102.06 -179.49 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.28 1.032 . . . . 0.88 109.542 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 53.2 t -132.55 135.27 57.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.769 -1.197 . . . . 0.64000000000000001 107.769 160.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -88.33 128.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.065 0.228 . . . . 0.82999999999999996 110.626 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.54 133.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.824 -0.806 . . . . 1.52 108.824 161.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.21 128.16 53.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.547 0.739 . . . . 1.96 110.417 156.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 122.27 17.97 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.831 0.852 . . . . 4.0499999999999998 109.25 164.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -135.96 -178.51 5.17 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.33 -0.248 . . . . 1.6899999999999999 110.33 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -54.3 -46.34 72.77 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.866 -1.147 . . . . 5.3600000000000003 110.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.6 17.85 9.93 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.092 1.33 . . . . 1.1399999999999999 115.774 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.84 -144.08 20.13 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 126.698 2.094 . . . . 0.78000000000000003 114.071 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.72 99.52 5.89 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.996 0.903 . . . . 0.62 111.224 -170.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 108.16 5.11 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.195 1.798 . . . . 4.5 110.177 169.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 4.4 t80 -101.33 107.42 18.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.353 1.861 . . . . 0.58999999999999997 109.888 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.3 m -117.14 111.58 40.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 119.247 0.93 . . . . 0.68000000000000005 109.064 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -84.01 166.37 12.98 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.032 3.155 . . . . 0.69999999999999996 111.415 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -150.2 18.71 0.86 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.761 1.393 . . . . 1.6799999999999999 114.761 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.58 140.89 35.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.208 1.003 . . . . 0.95999999999999996 111.857 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 9.2 ptpt -116.52 35.92 4.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.731 1.752 . . . . 2.1699999999999999 115.731 -166.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 19' ' ' ILE . . . -162.77 49.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.651 0.78 . . . . 1.22 112.165 -165.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 157.54 70.86 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 1.29 112.578 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.0 141.64 40.62 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 O-C-N 122.985 0.992 . . . . 1.1100000000000001 111.233 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 2.1 Cg_endo -86.92 39.59 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 125.282 3.988 . . . . 1.1699999999999999 113.647 -156.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.83 -159.94 12.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.921 1.248 . . . . 1.1399999999999999 114.056 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -89.22 137.46 32.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.662 1.985 . . . . 2.8900000000000001 111.391 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -140.43 143.18 35.46 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.978 0.911 . . . . 1.3300000000000001 109.62 -173.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.06 161.97 46.82 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 119.029 0.831 . . . . 0.53000000000000003 112.112 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.402 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.9 t80 -144.51 124.86 13.83 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.326 -1.731 . . . . 1.8799999999999999 106.326 166.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.57 166.01 24.21 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.962 1.467 . . . . 0.94999999999999996 114.962 165.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CG2' HD12 ' A' ' 74' ' ' LEU . 20.6 mt -91.06 148.4 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.922 1.689 . . . . 0.63 109.341 159.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -126.42 160.49 30.32 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.355 1.462 . . . . 0.88 109.872 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.3 -20.2 65.58 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 116.609 2.077 . . . . 0.76000000000000001 116.609 -162.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -134.9 166.54 22.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.061 1.744 . . . . 1.1399999999999999 112.883 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 83.91 0.34 Allowed Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.151 1.358 . . . . 1.04 112.433 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.8 m -171.5 90.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.595 1.558 . . . . 2.3399999999999999 110.202 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 59.0 m -64.86 45.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 127.0 2.12 . . . . 1.3600000000000001 114.98 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -118.59 136.69 24.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 119.579 -1.95 . . . . 3.6099999999999999 110.786 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.61 168.74 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.185 3.256 . . . . 1.1799999999999999 111.686 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.18 144.98 25.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.016 -0.538 . . . . 1.52 109.772 155.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -109.92 117.35 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.118 1.367 . . . . 2.7000000000000002 108.34 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -166.41 146.4 6.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.962 1.305 . . . . 4.4900000000000002 110.6 -163.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 63.22 18.39 10.94 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.085 -1.009 . . . . 3.27 113.686 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.8 13.46 81.33 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.595 -1.315 . . . . 2.5299999999999998 114.217 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.82 174.54 10.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.643 1.577 . . . . 2.5499999999999998 110.793 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.6 151.04 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.371 -0.831 . . . . 1.6399999999999999 111.89 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.23 95.26 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.148 1.379 . . . . 1.8200000000000001 109.977 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 15.41 -85.41 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 129.396 3.079 . . . . 2.0 116.091 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 130.62 12.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.619 1.968 . . . . 1.6499999999999999 106.818 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -116.66 -46.0 2.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.512 1.925 . . . . 4.0 110.864 -165.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.5 -9.85 38.69 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.896 1.073 . . . . 1.1499999999999999 113.896 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.48 59.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.683 1.593 . . . . 0.81000000000000005 113.185 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.1 173.5 48.7 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 119.487 1.039 . . . . 2.4100000000000001 112.948 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.56 -177.89 42.15 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.78 0.705 . . . . 1.26 112.444 165.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -49.01 140.15 9.44 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.252 0.526 . . . . 2.1000000000000001 110.306 168.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.93 101.73 0.88 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.416 0.895 . . . . 2.8500000000000001 113.416 -170.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -150.45 130.33 6.71 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 128.009 2.524 . . . . 5.2999999999999998 108.547 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.14 -39.35 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.337 2.025 . . . . 2.48 113.918 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.67 31.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.463 1.905 . . . . 4.5199999999999996 114.548 -169.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -73.25 -44.15 59.89 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.115 -1.616 . . . . 4.3799999999999999 110.855 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.6 t 177.07 -37.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.277 1.831 . . . . 2.6800000000000002 113.378 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 5.91 79.13 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 117.853 -1.526 . . . . 2.1200000000000001 116.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.255 19.2 ptmt -102.39 17.71 22.86 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 117.712 2.486 . . . . 4.8499999999999996 117.712 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 t60 83.54 168.85 0.1 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 127.126 2.17 . . . . 2.1400000000000001 114.753 164.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -25.04 0.1 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.671 2.1 . . . . 5.1299999999999999 116.671 -154.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.6 -46.14 7.13 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 118.334 2.093 . . . . 2.5899999999999999 118.334 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -90.02 -12.63 2.77 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.192 2.496 . . . . 3.79 113.859 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -147.29 -104.17 0.09 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 6.0499999999999998 108.817 -161.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.68 98.73 0.14 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 119.17 0.896 . . . . 3.0499999999999998 114.23 170.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -159.79 44.76 0.23 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.578 1.151 . . . . 4.8700000000000001 109.741 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.43 -129.68 1.14 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 115.868 1.107 . . . . 2.6600000000000001 115.868 -166.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -95.36 146.2 24.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.236 1.014 . . . . 3.25 113.663 -154.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -24.61 33.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.683 0.994 . . . . 2.96 113.683 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.27 11.28 69.16 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.347 0.975 . . . . 1.28 114.91 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.8 149.79 32.5 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 117.95 0.875 . . . . 2.46 110.716 163.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.85 166.35 16.53 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.233 1.013 . . . . 1.8799999999999999 110.256 -141.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.37 157.01 50.13 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.605 2.87 . . . . 1.1100000000000001 111.654 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -73.21 128.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.647 1.213 . . . . 1.4299999999999999 112.34 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.09 63.37 5.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.773 2.829 . . . . 2.8799999999999999 110.792 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.87 144.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.088 -1.007 . . . . 1.4399999999999999 110.748 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 135.39 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.684 -0.858 . . . . 3.02 108.684 162.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 159.34 25.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.131 1.772 . . . . 3.71 112.52 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 6.8 p-10 -48.79 -8.68 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 119.867 3.284 . . . . 2.4900000000000002 119.867 -161.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -95.94 -36.3 11.12 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.883 1.673 . . . . 2.8500000000000001 114.589 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 115.01 14.39 8.53 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.922 1.529 . . . . 1.0800000000000001 116.922 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.9 mt -105.82 116.99 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.937 1.369 . . . . 1.6599999999999999 109.883 165.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.09 122.58 21.2 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.921 0.489 . . . . 0.70999999999999996 109.951 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -149.23 17.5 0.95 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.351 . . . . 1.0600000000000001 112.733 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -87.29 112.19 46.3 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.134 1.374 . . . . 3.0 111.526 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.9 107.09 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.89 2.393 . . . . 1.1599999999999999 109.973 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.67 145.93 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.501 1.12 . . . . 1.3400000000000001 109.582 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -127.36 131.97 50.28 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.016 0.825 . . . . 0.93999999999999995 111.014 -168.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.23 96.67 40.11 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.976 0.91 . . . . 0.73999999999999999 112.326 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.12 6.66 1.35 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.93 3.086 . . . . 1.01 113.293 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.08 -29.01 67.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.041 1.337 . . . . 5.1600000000000001 112.965 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.6 153.84 32.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.033 2.133 . . . . 1.9399999999999999 108.118 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 10.71 6.75 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.805 1.242 . . . . 5.0099999999999998 112.581 -174.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -167.13 150.72 6.58 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.974 -1.079 . . . . 1.6699999999999999 112.99 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -71.52 -33.6 69.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.561 0.744 . . . . 2.1200000000000001 110.655 162.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.02 -26.57 67.71 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.278 1.214 . . . . 3.3399999999999999 114.278 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -84.58 -0.57 53.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.075 1.35 . . . . 1.8799999999999999 113.395 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.81 12.96 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.581 1.152 . . . . 0.83999999999999997 113.922 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -69.93 17.45 0.05 Allowed 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 116.719 2.118 . . . . 2.3399999999999999 116.719 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -156.18 29.7 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.534 1.933 . . . . 2.8399999999999999 110.624 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -139.62 157.74 45.28 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.168 1.387 . . . . 1.5800000000000001 114.12 -167.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.96 149.09 22.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.99 1.316 . . . . 0.53000000000000003 112.998 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.55 131.21 55.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.019 2.528 . . . . 1.6299999999999999 106.521 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.3 mtm -125.75 136.68 53.42 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.468 1.031 . . . . 1.5900000000000001 113.036 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.25 112.35 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.928 1.291 . . . . 0.85999999999999999 108.227 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.1 134.72 34.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.699 1.6 . . . . 2.3599999999999999 111.661 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.67 -39.92 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.233 0.827 . . . . 1.23 113.233 -158.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.35 163.55 12.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.341 0.972 . . . . 1.1399999999999999 110.685 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.75 109.26 1.34 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.481 -1.048 . . . . 1.74 110.481 166.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.81 26.58 0.09 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.883 2.873 . . . . 4.9400000000000004 112.969 -167.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.72 21.6 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.045 1.868 . . . . 3.3300000000000001 116.045 -158.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.5 mtm -98.68 152.91 19.13 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.394 1.257 . . . . 2.48 114.394 -160.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.3 p -140.15 150.32 44.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.324 1.85 . . . . 3.79 110.463 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.9 t0 58.39 84.27 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.247 2.219 . . . . 4.6600000000000001 114.448 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.1 156.95 11.56 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.936 1.694 . . . . 3.5499999999999998 109.698 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.76 25.38 0.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.93 3.086 . . . . 3.3399999999999999 114.059 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -134.25 129.36 19.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.206 1.002 . . . . 4.7999999999999998 109.941 163.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.88 138.7 45.27 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.889 2.393 . . . . 2.9700000000000002 111.085 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 60.45 22.48 12.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.809 1.643 . . . . 3.6299999999999999 112.117 -171.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.45 0.13 29.02 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.004 1.288 . . . . 2.7799999999999998 114.554 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.37 -9.46 24.4 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.925 2.202 . . . . 1.76 113.957 -166.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.95 1.11 56.29 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.449 1.625 . . . . 1.45 116.324 -171.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.84 62.23 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 118.995 1.398 . . . . 1.46 116.485 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -79.31 155.96 28.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.014 1.725 . . . . 1.4399999999999999 110.771 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 136.01 49.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 5.0499999999999998 111.457 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -82.4 -32.61 29.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.518 1.127 . . . . 2.25 111.349 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.91 42.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.431 1.092 . . . . 0.51000000000000001 113.066 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.56 151.72 48.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.031 2.132 . . . . 1.46 110.479 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.07 125.15 1.78 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.301 1.429 . . . . 0.67000000000000004 111.873 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.6 132.45 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.835 1.254 . . . . 1.8200000000000001 110.87 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.06 131.4 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.032 1.333 . . . . 0.81999999999999995 110.533 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.4 mttt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 123.526 0.73 . . . . 3.8700000000000001 111.874 179.398 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.202 -0.666 . . . . 2.2000000000000002 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.39 143.1 45.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.196 1.362 . . . . 1.3500000000000001 113.974 -147.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -155.19 132.67 11.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.06 1.344 . . . . 2.52 110.454 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.38 97.07 7.19 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.842 -1.161 . . . . 4.1299999999999999 113.029 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.4 t -77.54 122.79 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 1.03 109.799 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.75 105.1 1.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.212 1.387 . . . . 0.68000000000000005 110.638 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.4 mtp -91.57 108.56 19.99 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.925 0.713 . . . . 1.1699999999999999 112.925 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -69.4 141.95 54.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.938 0.895 . . . . 2.8399999999999999 111.31 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.29 134.83 52.33 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.633 -0.877 . . . . 1.3700000000000001 108.633 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.69 159.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.091 0.556 . . . . 0.98999999999999999 111.578 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -155.23 -152.32 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.375 1.47 . . . . 2.7200000000000002 109.927 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -18.07 44.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.429 1.492 . . . . 1.26 113.429 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.84 -3.32 47.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.655 1.182 . . . . 2.6600000000000001 111.543 164.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 -133.41 11.78 Favored Glycine 0 CA--C 1.525 0.684 0 O-C-N 120.812 -1.18 . . . . 1.23 110.464 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.42 130.12 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.249 1.42 . . . . 1.0900000000000001 111.657 -165.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.54 -100.07 2.16 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.645 1.593 . . . . 1.23 112.291 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -151.06 152.43 33.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.134 1.774 . . . . 3.6400000000000001 109.065 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.5 t -87.99 155.1 20.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.22 1.01 . . . . 1.1899999999999999 112.308 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -135.37 2.9 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 2.7799999999999998 112.438 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.78 142.83 3.63 Favored Glycine 0 CA--C 1.524 0.62 0 O-C-N 121.468 -0.77 . . . . 0.77000000000000002 112.72 -162.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -97.88 175.82 6.01 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.367 -0.975 . . . . 0.81000000000000005 108.367 166.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 33' ' ' PHE . 23.0 t -127.52 129.07 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.594 -0.891 . . . . 0.68000000000000005 108.594 160.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.7 p -87.38 121.26 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 O-C-N 123.574 0.546 . . . . 0.96999999999999997 110.995 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.52 128.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.303 1.841 . . . . 1.1299999999999999 107.284 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.56 111.71 13.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.497 1.142 . . . . 2.27 111.118 164.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -86.31 145.78 26.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.418 2.287 . . . . 5.3700000000000001 113.447 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.302 8.5 t -163.16 160.5 24.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 125.179 2.418 . . . . 1.5900000000000001 110.775 -158.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -23.18 -53.18 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 110.712 -2.949 . . . . 3.7799999999999998 113.387 148.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.12 12.2 65.04 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 125.225 1.393 . . . . 1.03 116.179 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.66 -172.38 35.9 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 130.499 3.904 . . . . 1.48 115.272 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.1 mt -51.59 99.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.798 2.039 . . . . 0.78000000000000003 113.86 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -81.01 104.48 11.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.788 1.235 . . . . 1.79 110.849 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 47' ' ' PHE . 1.3 t80 -94.33 120.88 35.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.175 2.19 . . . . 0.62 110.265 -173.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.407 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.5 m -127.65 115.92 21.01 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.036 -0.983 . . . . 0.68999999999999995 109.286 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -85.03 154.92 11.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.455 2.77 . . . . 0.57999999999999996 113.562 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . 0.282 1.8 p80 -147.06 62.25 1.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.3 1.047 . . . . 1.24 111.873 168.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.449 ' HB2' HD21 ' A' ' 40' ' ' LEU . 1.2 mp -121.68 146.21 47.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.404 1.481 . . . . 0.68000000000000005 112.05 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -133.57 25.4 4.07 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 117.483 2.401 . . . . 2.3199999999999998 117.483 -158.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.54 25.02 0.4 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.817 1.414 . . . . 1.6299999999999999 114.817 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -89.92 162.91 34.21 Favored Pre-proline 0 N--CA 1.474 0.773 0 O-C-N 120.907 -1.121 . . . . 1.72 111.297 -174.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.27 128.12 25.24 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 N-CA-C 109.36 -1.054 . . . . 0.96999999999999997 109.36 162.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -87.45 20.17 1.24 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 124.399 3.399 . . . . 1.01 113.78 -149.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.18 150.2 18.2 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.576 . . . . 2.5099999999999998 109.447 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -44.15 143.23 1.23 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 127.365 2.266 . . . . 2.8900000000000001 115.852 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -126.74 125.98 42.69 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 125.679 1.592 . . . . 1.1499999999999999 113.408 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.32 159.99 7.92 Favored Glycine 0 CA--C 1.54 1.62 0 O-C-N 120.863 -1.148 . . . . 0.57999999999999996 112.581 171.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.659 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -137.15 126.4 24.72 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.617 -0.931 . . . . 2.29 108.832 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -120.85 159.3 25.77 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.558 1.318 . . . . 0.95999999999999996 114.558 166.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.3 mt -103.18 139.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.558 1.943 . . . . 0.62 107.371 157.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -113.59 166.26 11.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.223 . . . . 0.98999999999999999 111.137 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.56 64.78 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.494 1.294 . . . . 0.69999999999999996 114.494 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -110.84 -158.22 0.64 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.939 1.296 . . . . 1.3500000000000001 111.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.42 0.19 8.05 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 119.46 2.544 . . . . 1.29 119.46 -147.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 t -155.78 138.76 15.41 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.816 3.308 . . . . 3.1200000000000001 117.271 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.7 m -68.44 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 130.199 3.399 . . . . 1.3500000000000001 115.112 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.18 118.82 48.64 Favored Pre-proline 0 N--CA 1.475 0.788 0 O-C-N 119.446 -2.034 . . . . 3.1499999999999999 111.746 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.66 146.3 16.77 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.662 2.908 . . . . 1.3700000000000001 111.711 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.24 138.88 32.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.63 -0.714 . . . . 1.74 110.291 154.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.57 106.54 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.792 -1.188 . . . . 2.8100000000000001 107.792 160.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -151.98 136.54 16.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.578 1.551 . . . . 5.5 110.246 -161.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.4 t0 50.46 45.51 26.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.85 1.26 . . . . 4.1600000000000001 112.83 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 -19.49 48.97 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.065 1.793 . . . . 2.77 115.389 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.66 163.6 34.36 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.352 1.576 . . . . 3.2200000000000002 113.379 -156.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.57 121.83 26.81 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.497 -1.377 . . . . 1.9399999999999999 111.175 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -76.61 20.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 114.656 1.354 . . . . 2.8599999999999999 114.656 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.99 -56.96 0.57 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.146 2.578 . . . . 1.78 114.685 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.44 118.76 0.55 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.252 2.221 . . . . 1.8799999999999999 108.911 172.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.11 -43.8 7.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.581 0.752 . . . . 4.96 110.677 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.2 -2.38 7.99 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.221 1.193 . . . . 1.4399999999999999 114.221 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.13 -24.25 23.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.018 1.327 . . . . 0.84999999999999998 112.474 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.68 -176.94 41.87 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.713 1.142 . . . . 2.3900000000000001 112.878 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.62 -176.57 29.65 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.906 -0.761 . . . . 1.1699999999999999 112.834 171.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -55.59 150.38 12.36 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.936 -0.744 . . . . 2.23 109.487 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD13 ' HE2' ' A' ' 123' ' ' LYS . 53.8 tp -64.99 100.35 0.41 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.911 0.778 . . . . 1.54 112.002 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -163.78 123.15 1.32 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 129.279 3.032 . . . . 4.9699999999999998 108.926 165.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -92.16 -16.64 1.05 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.04 2.493 . . . . 1.95 114.283 173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -169.88 -14.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.437 2.384 . . . . 3.5800000000000001 117.437 -166.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -59.09 -36.62 75.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.957 1.708 . . . . 4.1100000000000003 112.742 -170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -172.93 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.182 0.993 . . . . 2.46 113.225 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 -17.48 8.06 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.29 -1.283 . . . . 1.98 113.834 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -78.08 154.49 31.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.175 1.988 . . . . 5.5800000000000001 112.077 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -79.68 150.52 30.89 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.012 -1.055 . . . . 1.3700000000000001 112.589 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.39 -166.01 0.88 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.598 0.759 . . . . 3.27 110.076 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.45 -140.5 6.43 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 120.746 -1.221 . . . . 2.21 111.79 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.15 -9.82 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.458 2.772 . . . . 3.29 114.23 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.98 174.41 5.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.817 2.047 . . . . 5.5499999999999998 109.164 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.98 -138.4 16.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.663 0.649 . . . . 3.2599999999999998 111.497 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.08 135.81 3.91 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.511 1.524 . . . . 6.6900000000000004 107.597 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.87 -135.28 3.22 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.258 1.409 . . . . 2.6600000000000001 113.397 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -75.7 136.25 40.37 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.145 -0.62 . . . . 3.5099999999999998 110.542 169.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.528 HD13 ' H ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -71.2 -12.84 61.69 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 2.4399999999999999 113.586 170.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.09 18.51 13.0 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.874 1.702 . . . . 0.95999999999999996 115.999 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -108.9 133.11 53.35 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.155 1.478 . . . . 1.47 110.585 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.659 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 4.8 mp -134.11 154.23 80.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.035 1.334 . . . . 2.1699999999999999 110.654 -163.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.75 163.9 37.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.41 2.74 . . . . 0.80000000000000004 112.987 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.14 119.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 114.975 -1.012 . . . . 2.1600000000000001 112.101 -160.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 87.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.112 2.965 . . . . 1.73 109.685 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.25 147.55 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.452 -0.78 . . . . 1.04 110.086 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.55 150.16 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 127.635 2.374 . . . . 1.6000000000000001 106.108 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.52 160.21 27.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.575 0.625 . . . . 2.4399999999999999 111.147 168.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -14.79 0.86 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 116.63 2.085 . . . . 2.4500000000000002 116.63 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.93 -5.78 37.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.359 2.264 . . . . 2.6299999999999999 113.395 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.5 52.01 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.674 1.131 . . . . 0.71999999999999997 115.184 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.6 mt -111.89 132.5 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.432 1.493 . . . . 1.1799999999999999 110.191 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.7 144.63 32.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.522 1.529 . . . . 1.02 112.198 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -151.31 -5.73 0.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.346 1.858 . . . . 1.3500000000000001 113.806 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -70.18 118.53 64.77 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.226 1.81 . . . . 4.5199999999999996 111.493 -174.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.15 146.73 32.46 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.884 2.389 . . . . 1.28 111.479 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.16 175.17 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.911 1.684 . . . . 1.22 109.627 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 m -150.57 133.19 15.75 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.305 0.957 . . . . 0.94999999999999996 110.449 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.579 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -106.3 105.41 54.03 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-O 118.745 -0.645 . . . . 0.91000000000000003 112.043 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.67 -16.16 21.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.233 2.622 . . . . 1.1899999999999999 115.631 -171.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -66.77 -43.25 84.53 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.252 0.834 . . . . 4.8200000000000003 113.252 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.95 151.25 38.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 2.0299999999999998 110.336 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -144.27 46.4 1.42 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.819 1.248 . . . . 4.0599999999999996 113.265 -169.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 m 151.22 142.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 130.874 3.67 . . . . 1.6799999999999999 113.554 166.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.19 -33.63 53.54 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.826 -1.171 . . . . 1.6299999999999999 111.636 164.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -20.92 5.72 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.794 1.775 . . . . 3.1699999999999999 115.794 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -92.25 -16.98 25.43 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.607 1.549 . . . . 3.0600000000000001 113.709 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.67 -1.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.993 1.479 . . . . 0.85999999999999999 114.993 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -8.4 13.24 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 117.121 2.267 . . . . 2.6699999999999999 117.121 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -104.97 -8.12 18.8 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.207 1.403 . . . . 2.8700000000000001 113.395 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HE2' HD13 ' A' ' 74' ' ' LEU . 20.9 mttt -96.16 168.56 10.52 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.932 1.293 . . . . 1.5600000000000001 114.338 -167.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.9 156.84 17.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.125 1.37 . . . . 0.78000000000000003 112.41 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 pp -131.96 155.0 48.73 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.924 1.69 . . . . 2.6000000000000001 111.193 169.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 67.9 mtt -136.28 139.74 42.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.607 0.763 . . . . 1.51 112.587 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.03 121.62 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.293 1.437 . . . . 0.65000000000000002 107.779 166.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -114.01 145.75 41.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.448 1.499 . . . . 2.0299999999999998 112.654 -161.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.0 -32.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 126.119 1.768 . . . . 1.1499999999999999 113.762 -159.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.68 167.37 20.04 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.782 1.182 . . . . 1.1100000000000001 111.703 168.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.97 163.68 50.43 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.241 1.401 . . . . 1.3500000000000001 112.759 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.51 11.93 14.97 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.199 1.555 . . . . 2.4500000000000002 115.199 -142.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -70.95 -10.47 59.74 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.441 -1.412 . . . . 3.04 114.638 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.2 mtm -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.664 1.586 . . . . 2.29 113.403 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 t -84.77 -175.39 5.75 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.61 -0.681 . . . . 3.2999999999999998 112.27 161.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 61.31 -16.05 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 129.053 2.941 . . . . 4.79 117.316 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -67.67 147.27 98.67 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.098 1.359 . . . . 3.3599999999999999 111.851 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.95 -25.0 32.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.612 2.875 . . . . 2.1099999999999999 112.718 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -104.65 84.98 1.05 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.43 -0.952 . . . . 3.8999999999999999 108.43 157.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.58 154.25 73.05 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.753 2.302 . . . . 3.2200000000000002 111.041 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 65.58 5.48 3.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.684 1.994 . . . . 4.2400000000000002 112.946 -169.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.42 14.52 54.48 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.718 1.151 . . . . 3.3100000000000001 114.429 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.45 44.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.972 1.272 . . . . 2.3700000000000001 114.035 -167.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.1 -16.65 66.92 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.209 1.385 . . . . 1.9299999999999999 113.164 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.68 0.08 29.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.149 1.357 . . . . 1.9099999999999999 114.628 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.0 p -71.75 160.66 32.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.127 1.463 . . . . 1.76 109.924 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.51 150.72 20.21 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.762 1.225 . . . . 5.7599999999999998 114.001 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -109.24 -37.92 5.65 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.317 0.647 . . . . 2.4399999999999999 110.793 154.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.75 155.04 47.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.79 0.836 . . . . 0.52000000000000002 112.69 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.1 t -139.09 147.51 42.07 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.223 2.209 . . . . 1.4099999999999999 109.821 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 123.99 1.72 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.978 1.275 . . . . 0.71999999999999997 112.624 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.22 126.19 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.792 1.237 . . . . 1.55 110.144 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 36.8 mt -80.87 142.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.642 1.177 . . . . 0.88 109.184 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 10.5 mmpt? . . . . . 0 CA--C 1.542 0.672 0 O-C-N 120.726 -1.234 . . . . 3.1600000000000001 111.811 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.107 -0.331 . . . . 2.1099999999999999 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -132.49 146.23 51.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.011 1.485 . . . . 1.0 115.011 -133.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -156.04 135.51 12.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.287 1.518 . . . . 2.7999999999999998 111.603 164.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -108.51 87.5 2.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.229 2.212 . . . . 3.0 110.974 -165.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.23 125.4 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.21 1.189 . . . . 2.0899999999999999 114.21 -171.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.0 100.68 0.59 Allowed Glycine 0 C--N 1.339 0.709 0 C-N-CA 125.191 1.377 . . . . 0.89000000000000001 110.525 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.28 128.92 34.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.653 0.74 . . . . 1.4399999999999999 111.931 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -111.09 143.4 41.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.904 2.081 . . . . 2.8700000000000001 111.658 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.2 mt -80.83 56.26 2.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.599 1.16 . . . . 1.7 112.904 -169.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.1 153.45 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 122.262 1.029 . . . . 1.1699999999999999 113.603 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -160.06 -156.26 0.48 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 125.728 1.611 . . . . 3.0099999999999998 109.051 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.14 8.88 0.49 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.37 1.868 . . . . 1.25 114.075 -172.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -108.46 -7.52 15.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.815 1.646 . . . . 2.6499999999999999 111.114 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.81 -142.63 17.14 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.644 -0.983 . . . . 0.96999999999999997 110.644 -160.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -92.53 136.3 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.159 1.783 . . . . 0.82999999999999996 110.907 -167.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.47 -68.26 0.28 Allowed Glycine 0 N--CA 1.473 1.146 0 C-N-CA 124.421 1.01 . . . . 1.6200000000000001 115.316 -166.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.3 154.98 10.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.207 1.803 . . . . 1.8500000000000001 110.8 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -129.82 122.42 28.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.9 -1.125 . . . . 1.6000000000000001 112.273 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.65 25.97 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.458 1.503 . . . . 5.5999999999999996 110.842 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.87 38.12 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.756 -0.59 . . . . 0.60999999999999999 114.32 161.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 p -99.24 -179.28 4.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.963 0.905 . . . . 0.90000000000000002 110.392 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 42.4 t -129.53 132.58 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.929 -1.137 . . . . 0.5 107.929 150.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.8 p -85.84 120.7 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.963 0.411 . . . . 0.81000000000000005 110.761 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.58 138.93 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 124.917 1.287 . . . . 1.3600000000000001 107.881 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.94 104.95 3.49 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.16 1.384 . . . . 2.2799999999999998 109.56 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 151.08 44.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.032 -0.531 . . . . 2.8199999999999998 111.558 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -158.38 -177.49 6.58 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.854 0.862 . . . . 1.3 110.547 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.5 -9.4 48.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.487 1.915 . . . . 3.7400000000000002 113.001 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.45 16.27 41.37 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.854 1.693 . . . . 1.1699999999999999 114.424 163.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.88 -151.42 23.86 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 127.235 2.35 . . . . 1.0 116.635 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.54 96.66 4.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.227 1.011 . . . . 0.80000000000000004 111.728 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -70.77 143.32 51.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.086 0.954 . . . . 2.1800000000000002 109.755 166.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.538 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 20.0 t80 -142.65 118.88 10.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.105 1.762 . . . . 0.53000000000000003 109.363 -167.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.8 m -123.44 109.5 30.89 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.173 -0.918 . . . . 0.62 108.831 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.4 164.31 19.11 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.818 3.012 . . . . 0.52000000000000002 110.929 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -158.63 33.78 0.23 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.314 0.857 . . . . 1.3600000000000001 113.314 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 mp -91.77 136.06 33.43 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.378 -1.451 . . . . 0.93000000000000005 112.018 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 14.98 21.63 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.499 2.037 . . . . 2.1099999999999999 116.499 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.59 88.07 1.19 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.664 -0.648 . . . . 1.8300000000000001 112.059 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 163.32 26.9 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.264 1.425 . . . . 1.48 111.298 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.51 124.31 13.09 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.013 1.809 . . . . 0.88 110.556 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -84.47 45.17 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 127.203 5.269 . . . . 1.1299999999999999 112.268 -163.381 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.13 -130.46 7.02 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 123.184 1.436 . . . . 1.45 111.866 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -147.56 127.95 13.99 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.253 1.421 . . . . 2.6400000000000001 109.264 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -130.19 154.48 47.49 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.578 0.955 . . . . 1.0800000000000001 113.578 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.35 155.87 51.75 Favored Glycine 0 CA--C 1.541 1.657 0 O-C-N 121.184 -0.948 . . . . 0.57999999999999996 112.192 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.528 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 1.4 t80 -130.85 122.57 27.31 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.054 -1.462 . . . . 2.0600000000000001 107.054 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 7.7 m170 -122.53 157.92 31.0 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.723 1.601 . . . . 1.03 114.43 165.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.6 mt -94.24 154.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 128.27 2.628 . . . . 0.73999999999999999 108.22 158.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -139.04 145.13 39.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.002 0.921 . . . . 0.96999999999999997 111.181 -170.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.57 67.0 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.242 1.941 . . . . 0.79000000000000004 116.242 -163.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.43 -179.27 5.06 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.415 1.086 . . . . 1.0700000000000001 113.211 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.0 32.76 4.47 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.597 1.57 . . . . 1.3799999999999999 116.675 -163.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -138.69 104.12 5.02 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.224 1.512 . . . . 2.4300000000000002 111.705 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -70.2 13.09 0.18 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 116.701 2.111 . . . . 1.4199999999999999 116.701 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -84.45 131.52 49.96 Favored Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 119.694 -1.879 . . . . 3.0699999999999998 112.115 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.71 149.16 29.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.524 2.816 . . . . 1.01 112.418 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.74 150.36 26.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.003 -0.544 . . . . 1.4199999999999999 110.38 156.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.0 mm -117.14 136.76 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.829 1.652 . . . . 2.4199999999999999 107.697 173.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -14.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.678 2.103 . . . . 5.5099999999999998 116.678 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.36 46.7 0.28 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.795 1.18 . . . . 3.3300000000000001 113.611 -163.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.1 22.3 68.75 Favored Glycine 0 N--CA 1.475 1.255 0 O-C-N 120.662 -1.274 . . . . 3.2799999999999998 113.295 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -163.32 155.22 17.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.293 1.837 . . . . 2.9100000000000001 110.501 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.0 138.51 46.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.243 1.417 . . . . 2.1299999999999999 111.749 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.82 39.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.969 1.308 . . . . 2.3999999999999999 111.377 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.4 -66.38 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.628 2.771 . . . . 2.25 116.207 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.91 107.13 0.96 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.074 2.55 . . . . 1.98 108.057 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -76.48 -54.1 7.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.484 0.714 . . . . 6.0599999999999996 110.059 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.1 20.64 0.37 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.045 0.938 . . . . 1.8700000000000001 113.325 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.4 -11.99 38.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.226 1.411 . . . . 0.82999999999999996 112.08 157.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.18 -70.3 3.18 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 120.229 -1.544 . . . . 2.96 114.051 171.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.02 179.23 32.75 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.522 1.534 . . . . 1.4199999999999999 112.909 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -61.28 -7.31 2.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.663 2.097 . . . . 2.5699999999999998 116.663 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 tt 78.51 98.73 0.06 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.957 2.103 . . . . 2.25 110.027 169.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -168.55 55.01 0.27 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 115.714 1.746 . . . . 3.5099999999999998 115.714 -148.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.39 -48.06 2.7 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.765 2.31 . . . . 2.6299999999999999 113.218 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -137.41 79.04 1.72 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.459 1.103 . . . . 4.21 110.058 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.96 -77.67 0.58 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.601 1.16 . . . . 3.9300000000000002 109.769 166.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -178.6 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.894 2.077 . . . . 2.3799999999999999 111.414 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.55 -9.3 58.82 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.245 0.926 . . . . 1.76 114.679 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.92 -14.35 61.9 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 116.052 1.871 . . . . 5.1299999999999999 116.052 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.9 t60 70.74 164.19 0.27 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.308 1.843 . . . . 1.55 111.5 -166.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -157.28 -152.38 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.886 -1.134 . . . . 3.9500000000000002 112.216 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.27 -40.18 0.16 Allowed Glycine 0 CA--C 1.543 1.805 0 C-N-CA 127.938 2.685 . . . . 2.3599999999999999 113.213 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -112.34 -1.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.617 2.878 . . . . 3.3199999999999998 115.606 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.08 -7.19 0.82 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.116 1.895 . . . . 6.3600000000000003 116.116 -159.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.36 -23.03 5.71 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 119.712 -1.867 . . . . 3.7400000000000002 114.322 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.71 64.26 2.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.089 2.156 . . . . 4.9199999999999999 113.451 -168.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 -93.39 0.11 Allowed Glycine 0 N--CA 1.469 0.899 0 O-C-N 120.457 -1.402 . . . . 2.48 113.655 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -138.15 156.03 48.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.23 2.212 . . . . 3.6299999999999999 108.279 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -84.96 -21.72 29.46 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.523 1.056 . . . . 1.99 113.131 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.63 19.84 22.15 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 117.806 -1.552 . . . . 0.96999999999999997 116.068 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -95.2 138.12 33.33 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 120.636 2.218 . . . . 1.49 111.065 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.528 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 5.2 mp -129.49 155.66 79.82 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.945 1.698 . . . . 2.2200000000000002 110.391 -169.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.02 162.04 43.01 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.417 2.744 . . . . 0.98999999999999999 111.787 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.0 127.24 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.902 1.334 . . . . 1.5600000000000001 113.237 -160.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 85.04 3.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 129.438 3.095 . . . . 2.48 108.57 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.12 149.55 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 0.92000000000000004 109.152 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.27 133.6 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.663 1.185 . . . . 1.6899999999999999 110.281 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.45 141.99 58.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.754 1.02 . . . . 1.8200000000000001 113.754 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -46.42 -23.92 0.43 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 129.016 2.927 . . . . 2.54 117.581 -170.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.58 -19.31 45.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.139 1.775 . . . . 3.0499999999999998 112.482 -168.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.69 30.95 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.43 1.491 . . . . 0.92000000000000004 113.483 -170.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.24 127.66 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.008 1.723 . . . . 1.1100000000000001 108.492 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.76 136.54 33.06 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.131 0.972 . . . . 0.81999999999999995 110.547 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.3 t -153.11 -2.43 0.22 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.918 1.687 . . . . 1.1100000000000001 113.052 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -80.43 118.96 74.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 128.387 2.675 . . . . 5.0300000000000002 112.283 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.09 149.43 28.52 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.931 3.087 . . . . 1.45 112.971 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.03 166.62 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.98 1.712 . . . . 1.28 110.591 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -138.99 137.1 36.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.9 1.28 . . . . 0.84999999999999998 109.553 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -112.42 110.17 53.23 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.338 0.655 . . . . 1.0 112.758 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.51 -0.95 11.13 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.879 3.052 . . . . 1.3400000000000001 114.692 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -73.87 -11.12 60.27 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.951 1.25 . . . . 4.6200000000000001 113.238 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.78 141.98 33.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.865 2.066 . . . . 2.4199999999999999 108.417 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 18.79 2.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.931 1.826 . . . . 6.9500000000000002 115.931 -160.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 85.9 p -153.24 164.72 37.58 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.821 1.248 . . . . 2.5899999999999999 108.329 167.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.0 tp -84.4 -34.61 23.5 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.676 -0.64 . . . . 2.2799999999999998 109.657 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.65 -41.36 42.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 2.8900000000000001 113.078 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -72.92 -5.09 36.16 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.231 1.197 . . . . 1.9099999999999999 114.231 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.03 13.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.024 1.329 . . . . 0.80000000000000004 113.541 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -59.7 -5.07 0.79 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 117.361 2.356 . . . . 2.23 117.361 -172.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.66 22.11 2.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.055 1.342 . . . . 3.5099999999999998 112.807 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -104.47 151.81 23.1 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.297 -0.877 . . . . 2.5800000000000001 112.866 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.47 148.42 27.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.836 -0.62 . . . . 0.70999999999999996 110.182 157.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.2 145.62 42.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.349 -0.982 . . . . 1.54 108.349 156.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.9 150.86 52.12 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.201 0.815 . . . . 2.48 113.201 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.5 mt -99.06 132.9 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.098 1.759 . . . . 0.71999999999999997 108.146 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -123.19 143.39 50.05 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.098 1.359 . . . . 2.77 112.197 -164.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 37.9 t -67.1 -35.4 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.922 -1.111 . . . . 1.3899999999999999 112.982 -160.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -108.19 150.74 17.0 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.182 0.896 . . . . 1.1200000000000001 111.937 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.89 147.81 40.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.634 1.111 . . . . 1.5800000000000001 111.376 159.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.404 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 25.3 t0 -103.4 -15.07 16.02 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.471 1.656 . . . . 2.9500000000000002 115.471 -138.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.24 51.98 0.57 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.415 1.635 . . . . 2.8999999999999999 115.415 -168.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.94 131.51 25.47 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.703 -1.248 . . . . 2.48 112.316 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -138.06 -54.93 0.65 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.717 0.807 . . . . 3.23 112.671 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.95 39.46 0.23 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.978 2.111 . . . . 4.2800000000000002 113.881 -164.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -124.18 163.58 35.03 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.155 2.582 . . . . 3.7000000000000002 109.773 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.84 -19.36 64.19 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.291 2.661 . . . . 2.4700000000000002 113.755 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -127.81 136.47 29.03 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 118.856 0.753 . . . . 4.5199999999999996 109.944 148.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.52 162.37 41.11 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.919 2.413 . . . . 3.75 110.176 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 mp 60.07 9.1 1.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.01 1.724 . . . . 3.8700000000000001 112.868 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 10.64 57.29 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.716 -1.24 . . . . 3.2999999999999998 114.139 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.7 83.07 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.434 1.016 . . . . 2.0800000000000001 113.891 -166.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.55 10.5 50.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.718 1.627 . . . . 1.7 115.006 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.83 -4.13 70.28 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.128 1.347 . . . . 1.45 114.537 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 p -62.71 157.99 19.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.048 1.339 . . . . 1.45 110.319 164.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.68 150.11 27.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.043 1.337 . . . . 6.7199999999999998 113.381 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -107.52 -19.82 13.44 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.436 0.902 . . . . 2.3799999999999999 113.436 162.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.24 156.32 23.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.205 0.911 . . . . 0.5 112.851 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.23 163.61 15.42 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.393 1.477 . . . . 2.2799999999999998 110.114 157.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -151.96 134.44 4.58 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.821 1.676 . . . . 0.68999999999999995 110.371 159.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.52 129.65 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.482 1.113 . . . . 1.53 109.873 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.4 mt -64.88 124.52 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.628 1.171 . . . . 1.1699999999999999 112.052 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 113.168 0.803 . . . . 3.4500000000000002 113.168 177.559 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.72 0.295 . . . . 2.77 110.484 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -150.84 155.78 39.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.206 1.402 . . . . 1.3799999999999999 109.194 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -154.59 121.51 5.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.113 1.365 . . . . 2.6000000000000001 109.601 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -86.58 102.43 14.14 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.638 -1.289 . . . . 3.5299999999999998 108.834 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.1 121.28 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 119.882 1.219 . . . . 1.05 110.586 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.6 104.13 2.26 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.644 1.593 . . . . 0.98999999999999999 110.983 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt -88.33 145.33 25.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.346 1.069 . . . . 1.4099999999999999 113.504 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -120.35 149.13 42.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.238 1.815 . . . . 2.8599999999999999 111.706 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.34 65.72 2.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.168 1.787 . . . . 1.45 111.139 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -74.39 157.84 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.705 1.202 . . . . 1.46 112.836 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -159.97 -156.78 0.51 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.309 1.444 . . . . 3.21 109.722 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.32 60.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.324 2.25 . . . . 1.21 113.587 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -87.33 -15.74 37.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.172 1.789 . . . . 3.02 112.198 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.24 -139.62 14.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.724 1.154 . . . . 1.0700000000000001 110.717 -161.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.94 139.13 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 126.766 2.026 . . . . 1.5600000000000001 113.284 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.67 -104.03 2.25 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.595 2.045 . . . . 1.6000000000000001 113.26 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.12 149.57 42.0 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 127.264 2.226 . . . . 2.3399999999999999 113.482 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -96.47 140.87 30.47 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.742 -1.224 . . . . 1.5700000000000001 112.053 166.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.64 5.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 125.351 1.46 . . . . 2.73 113.947 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.99 168.26 21.71 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.075 0.845 . . . . 0.93999999999999995 112.639 -168.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 p -116.86 -175.76 2.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.337 1.055 . . . . 0.87 109.162 170.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.482 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 44.7 t -129.08 135.65 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.441 -1.318 . . . . 0.70999999999999996 107.441 157.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.88 124.78 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.398 0.437 . . . . 1.03 110.203 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.7 127.67 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.371 1.068 . . . . 2.0 108.971 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -143.08 134.66 26.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.211 1.404 . . . . 2.04 110.452 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 117' ' ' LEU . 41.7 mt-10 -92.69 138.1 31.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.387 -1.733 . . . . 3.8199999999999998 112.087 -162.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 -175.51 4.99 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.577 -0.849 . . . . 1.52 112.276 168.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -70.97 -6.97 42.81 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.956 1.095 . . . . 3.8799999999999999 113.956 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.67 12.15 53.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.764 1.649 . . . . 1.25 113.913 162.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -152.7 21.65 Favored Glycine 0 N--CA 1.462 0.418 0 C-N-CA 128.083 2.754 . . . . 0.93000000000000005 116.225 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.3 mt -71.64 103.68 3.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.999 . . . . 0.88 111.259 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -76.63 116.41 17.28 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.239 1.016 . . . . 2.3599999999999999 109.081 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.482 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 25.4 t80 -113.56 113.03 24.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.239 2.216 . . . . 0.82999999999999996 109.19 -170.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.8 m -120.8 107.19 38.46 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 108.124 -1.065 . . . . 0.71999999999999997 108.124 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.65 164.31 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.505 2.803 . . . . 0.41999999999999998 110.685 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -152.67 30.63 0.52 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.133 0.968 . . . . 1.3100000000000001 112.669 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -89.78 132.76 35.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.919 -1.113 . . . . 0.81000000000000005 110.911 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -107.9 18.64 21.04 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.36 1.985 . . . . 2.5800000000000001 116.36 -159.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.62 75.69 0.56 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.14 0.976 . . . . 1.5900000000000001 111.992 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.11 158.43 69.46 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.791 1.237 . . . . 1.5700000000000001 110.871 173.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 37.4 Cg_endo -63.6 131.19 30.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.484 1.456 . . . . 1.1100000000000001 110.879 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 5.2 Cg_endo -87.2 34.76 0.43 Allowed 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 126.141 4.561 . . . . 1.0600000000000001 113.203 -150.18 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.84 -135.07 8.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.99 1.757 . . . . 1.26 114.072 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.51 131.53 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.919 1.688 . . . . 2.3999999999999999 108.417 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -132.73 147.21 52.32 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 124.561 1.144 . . . . 1.1799999999999999 112.392 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.44 149.31 51.34 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.943 -1.098 . . . . 0.81000000000000005 111.458 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -124.75 111.4 15.51 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.492 -1.67 . . . . 1.9299999999999999 106.492 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -116.24 157.43 24.91 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.633 -1.292 . . . . 1.1100000000000001 113.697 171.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.28 152.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.594 1.557 . . . . 1.1499999999999999 107.518 157.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.68 146.9 46.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.526 1.13 . . . . 1.0800000000000001 108.768 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.12 70.28 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.388 1.625 . . . . 0.72999999999999998 115.388 -153.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -125.42 155.24 40.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.481 1.113 . . . . 1.75 112.644 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.79 82.08 1.42 Allowed Glycine 0 N--CA 1.469 0.834 0 O-C-N 120.702 -1.249 . . . . 0.84999999999999998 112.795 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -166.54 95.52 0.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.55 0.74 . . . . 1.98 112.778 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.9 m -67.67 45.69 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.389 2.275 . . . . 1.45 113.635 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -121.05 127.12 26.35 Favored Pre-proline 0 CA--C 1.553 1.063 0 O-C-N 119.783 -1.823 . . . . 3.6400000000000001 111.113 -167.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -81.72 179.33 5.78 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.273 3.315 . . . . 1.0900000000000001 114.562 -168.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.19 173.13 12.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.799 2.04 . . . . 1.46 109.669 160.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.97 134.5 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.909 1.283 . . . . 3.21 108.194 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -150.78 143.05 24.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.642 1.577 . . . . 4.7400000000000002 110.14 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.61 25.96 13.86 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.204 1.187 . . . . 5.6299999999999999 114.204 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.77 17.54 65.51 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.414 1.006 . . . . 4.3600000000000003 115.001 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.16 162.56 39.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.173 1.487 . . . . 5.0099999999999998 112.903 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.2 129.05 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.436 1.095 . . . . 2.1899999999999999 111.384 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.41 -15.58 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.866 1.266 . . . . 2.5499999999999998 113.549 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 70.69 -49.26 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 128.482 2.713 . . . . 2.3300000000000001 113.574 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.67 106.69 3.71 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.24 1.016 . . . . 1.5800000000000001 109.991 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -95.32 -43.5 8.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.483 1.113 . . . . 4.7000000000000002 110.533 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.68 -9.03 31.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.256 1.022 . . . . 1.3500000000000001 113.545 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.76 -15.63 60.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.334 1.235 . . . . 0.87 114.334 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.91 -173.67 55.32 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 120.572 -1.33 . . . . 2.1200000000000001 114.228 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.51 -171.05 25.75 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 124.73 1.157 . . . . 1.3 113.131 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -64.87 8.91 0.1 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.898 2.079 . . . . 2.5699999999999998 114.649 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.1 tp 60.74 83.83 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.344 1.858 . . . . 1.6000000000000001 107.672 -164.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.435 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 54.4 p-10 -160.4 19.24 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 117.408 2.373 . . . . 4.3300000000000001 117.408 -143.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 71.6 Cg_endo -69.58 -31.77 20.67 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.232 1.955 . . . . 2.4399999999999999 115.498 -159.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -140.28 8.9 2.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.646 1.112 . . . . 3.1000000000000001 113.286 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.49 -41.99 19.04 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.05 -1.031 . . . . 3.7799999999999998 113.305 -164.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t 154.65 158.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 1 C-N-CA 132.237 4.215 . . . . 2.9300000000000002 107.414 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.07 -38.6 9.08 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 123.408 0.528 . . . . 2.6400000000000001 114.051 -171.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -77.77 176.25 9.2 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.362 1.065 . . . . 4.1600000000000001 113.734 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -124.29 158.9 31.47 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.29 1.036 . . . . 2.52 112.105 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.636 ' CD ' ' H ' ' A' ' 84' ' ' GLY 0.286 2.7 pp20? -150.56 -116.71 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.066 1.136 . . . . 3.96 114.066 -174.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.636 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 148.2 -55.5 0.5 Allowed Glycine 0 CA--C 1.547 2.086 0 C-N-CA 129.122 3.248 . . . . 3.1499999999999999 112.174 -171.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -97.95 -10.34 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.315 2.676 . . . . 3.7000000000000002 116.714 -166.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 -15.4 0.5 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.241 2.312 . . . . 6.0800000000000001 117.241 -162.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 -8.22 32.02 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.738 1.855 . . . . 3.1499999999999999 117.738 166.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -72.69 56.55 0.4 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.527 2.163 . . . . 5.29 113.252 170.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.82 110.17 0.27 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 120.717 -1.24 . . . . 3.1200000000000001 115.473 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.7 m170 59.99 -145.2 0.5 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.008 0.923 . . . . 4.0499999999999998 111.804 162.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.35 -28.43 0.54 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.791 1.034 . . . . 2.0 113.791 153.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.14 29.16 2.82 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 125.0 1.286 . . . . 1.1399999999999999 116.286 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -99.2 134.72 41.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.969 1.307 . . . . 1.5600000000000001 110.232 171.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -131.37 152.25 80.19 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.167 1.387 . . . . 2.54 109.763 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.89 155.25 71.58 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.85 3.033 . . . . 1.28 111.418 -171.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.5 m -58.53 131.37 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 123.026 1.393 . . . . 1.51 113.08 -166.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.54 87.87 0.67 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.521 1.928 . . . . 2.54 108.137 167.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.94 138.35 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.115 0.966 . . . . 0.83999999999999997 108.796 170.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -118.67 135.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 126.021 1.728 . . . . 1.5600000000000001 107.111 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 149.11 50.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.773 0.715 . . . . 1.8200000000000001 111.673 175.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -53.58 -15.22 1.06 Allowed 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 116.198 1.925 . . . . 2.1699999999999999 116.198 -175.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -91.1 -8.92 47.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.391 1.876 . . . . 2.8700000000000001 113.118 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 21.39 16.16 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 124.567 1.079 . . . . 0.96999999999999997 114.782 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.2 mp -125.12 126.52 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.592 1.557 . . . . 1.3400000000000001 107.582 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.87 112.68 22.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.397 -0.964 . . . . 0.71999999999999997 108.397 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.0 t -131.79 -2.92 3.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.65 1.58 . . . . 1.0 112.715 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -72.64 115.08 36.01 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 128.041 2.537 . . . . 4.9699999999999998 111.078 -173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.54 138.33 24.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.73 2.287 . . . . 1.22 110.965 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.88 165.17 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.857 1.263 . . . . 1.28 109.916 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.3 m -133.53 139.07 46.39 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.363 0.665 . . . . 0.87 109.77 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.3 87.03 15.47 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.785 0.834 . . . . 1.03 112.424 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 5.38 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.279 3.32 . . . . 1.46 115.31 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -77.36 -31.73 54.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.705 1.139 . . . . 5.3600000000000003 111.246 170.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.91 127.44 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.909 1.684 . . . . 2.6899999999999999 107.948 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 1.74 10.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.947 1.091 . . . . 5.0599999999999996 113.947 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -154.08 165.69 35.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.077 1.751 . . . . 1.9199999999999999 112.208 158.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.537 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.4 mm? -64.17 -29.95 71.03 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.405 -0.81 . . . . 1.9299999999999999 111.081 162.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.12 -46.65 5.91 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.048 2.139 . . . . 2.9900000000000002 114.383 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -76.59 -2.54 33.05 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.728 1.381 . . . . 2.3100000000000001 114.728 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.08 13.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.087 1.355 . . . . 1.1000000000000001 112.096 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -57.6 -16.56 10.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.083 1.753 . . . . 2.0899999999999999 115.387 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.85 5.03 18.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 130.0 3.32 . . . . 4.7699999999999996 113.508 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.02 173.26 7.0 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.051 1.871 . . . . 1.21 116.051 -158.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.77 144.13 33.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.15 1.38 . . . . 0.72999999999999998 111.63 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.05 131.8 52.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.761 1.624 . . . . 1.6799999999999999 107.581 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.1 mtt -132.79 124.27 27.73 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.24 0.83 . . . . 1.3200000000000001 113.24 -170.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.26 114.87 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.842 1.257 . . . . 0.82999999999999996 108.43 171.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -99.31 147.36 25.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.48 1.912 . . . . 2.2400000000000002 112.29 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.74 -50.42 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.816 -0.611 . . . . 1.3999999999999999 110.05 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.23 152.64 47.07 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.76 -0.536 . . . . 2.1000000000000001 111.76 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.61 -163.88 21.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.725 2.107 . . . . 2.2999999999999998 114.022 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -155.88 98.72 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.282 1.033 . . . . 3.2000000000000002 110.32 -170.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -176.83 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.103 1.761 . . . . 3.0899999999999999 113.908 -167.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.3 ptp -127.97 76.68 1.7 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.555 -1.341 . . . . 3.7799999999999998 113.264 -146.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 p -72.2 109.88 6.27 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.747 -1.22 . . . . 4.79 112.18 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 97.2 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 129.961 3.304 . . . . 3.8300000000000001 112.834 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.49 144.37 10.32 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.174 0.989 . . . . 7.5 112.073 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.64 -52.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.876 3.051 . . . . 2.3900000000000001 110.929 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -67.82 115.93 32.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.977 -1.12 . . . . 4.0 107.977 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.79 164.77 34.65 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.886 2.391 . . . . 3.6099999999999999 113.29 -160.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.9 tp 71.13 -13.22 0.53 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.939 2.096 . . . . 4.9299999999999997 115.244 164.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 125.26 -2.19 8.3 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.309 1.909 . . . . 3.9700000000000002 115.014 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.31 -25.6 0.87 Allowed Glycine 0 CA--C 1.54 1.61 0 N-CA-C 117.249 1.66 . . . . 2.5600000000000001 117.249 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -112.11 60.21 0.34 Allowed Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.322 1.915 . . . . 2.3300000000000001 112.168 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.4 -1.89 88.91 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.497 1.523 . . . . 2.4300000000000002 114.797 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -63.11 146.8 52.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.524 1.162 . . . . 2.4199999999999999 109.771 166.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -106.11 153.28 22.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.585 1.154 . . . . 4.6699999999999999 110.025 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -98.2 -21.88 16.47 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.138 -0.458 . . . . 2.7400000000000002 111.974 155.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.81 161.87 36.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.588 1.329 . . . . 0.62 114.588 174.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.0 t -142.42 152.09 42.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.256 2.222 . . . . 1.3 109.798 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.26 133.82 4.28 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.794 1.188 . . . . 0.84999999999999998 111.666 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 67.7 t -92.11 132.03 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.167 0.987 . . . . 1.51 109.467 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -71.04 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.52 1.128 . . . . 1.02 110.129 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt . . . . . 0 C--O 1.239 0.524 0 O-C-N 121.221 -0.925 . . . . 3.5600000000000001 109.03 179.011 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.057 -0.72 . . . . 2.04 109.057 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.3 154.9 43.53 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.183 1.179 . . . . 1.0800000000000001 114.183 -148.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -153.31 135.82 15.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.178 1.466 . . . . 3.6699999999999999 111.699 161.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -89.43 111.27 22.11 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.368 1.867 . . . . 3.29 109.981 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.84 129.19 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 118.49 0.587 . . . . 1.1899999999999999 110.306 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.71 112.55 3.52 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.184 1.373 . . . . 0.83999999999999997 110.295 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.8 mtp -91.35 85.53 5.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.464 0.65 . . . . 1.6899999999999999 110.61 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -68.36 139.77 55.85 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.979 0.912 . . . . 2.7799999999999998 111.969 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.31 135.09 55.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.296 -0.631 . . . . 1.3400000000000001 109.296 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.1 156.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.689 1.196 . . . . 0.95999999999999996 110.378 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 t -169.52 48.04 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.027 0.931 . . . . 2.2200000000000002 112.058 -169.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.22 -17.38 0.27 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.303 1.841 . . . . 1.47 115.181 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.37 -4.37 59.14 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.111 1.364 . . . . 2.6499999999999999 112.035 171.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -159.11 14.91 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.8 1.667 . . . . 1.1200000000000001 112.331 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.6 t -67.17 128.2 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.577 1.551 . . . . 0.93000000000000005 111.07 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.49 -88.57 1.69 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.058 1.313 . . . . 1.4299999999999999 112.726 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.37 161.46 9.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.661 2.385 . . . . 2.8799999999999999 108.112 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 t -112.56 143.03 44.41 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.734 -1.229 . . . . 1.9099999999999999 114.128 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.481 HG22 ' HD2' ' A' ' 38' ' ' LYS . 39.6 mm -108.5 37.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.579 1.552 . . . . 5.3099999999999996 110.937 167.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.32 -154.15 25.3 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.661 -0.649 . . . . 1.1799999999999999 113.738 161.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.4 p -140.06 179.53 6.57 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.009 1.324 . . . . 0.98999999999999999 109.368 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.412 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 58.0 t -128.57 135.39 62.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.785 -1.191 . . . . 0.65000000000000002 107.785 160.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.8 p -88.39 127.27 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.348 0.405 . . . . 0.83999999999999997 110.697 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.12 134.4 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.737 0.815 . . . . 1.3400000000000001 109.013 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -138.46 134.83 34.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.716 1.606 . . . . 2.0099999999999998 108.45 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 157.87 18.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.935 1.087 . . . . 3.54 113.935 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 t -152.26 173.78 14.59 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.668 1.187 . . . . 1.3899999999999999 108.427 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.38 -13.13 62.01 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.286 -0.884 . . . . 4.7400000000000002 112.058 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.41 18.53 57.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.885 1.707 . . . . 1.3500000000000001 113.96 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 -143.02 21.17 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 127.692 2.568 . . . . 0.89000000000000001 116.882 166.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.67 103.35 14.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.761 0.824 . . . . 0.63 111.519 -162.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -80.38 110.61 15.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.183 1.793 . . . . 2.5099999999999998 110.286 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.412 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 5.7 t80 -99.52 119.63 38.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.649 2.779 . . . . 0.70999999999999996 109.188 -176.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 21.6 m -129.41 110.45 17.79 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 119.858 1.208 . . . . 0.57999999999999996 108.538 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -85.4 166.65 10.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.451 2.767 . . . . 0.46999999999999997 111.426 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -152.36 18.26 0.64 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.258 1.207 . . . . 1.8200000000000001 114.258 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.16 143.29 32.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.626 -1.296 . . . . 0.91000000000000003 111.324 -174.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HD2' HG22 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -109.44 12.26 24.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.298 1.592 . . . . 2.6299999999999999 115.298 -171.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.31 72.17 1.24 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.884 -1.053 . . . . 1.6499999999999999 112.101 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.05 162.97 49.37 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 124.02 0.928 . . . . 1.47 112.561 168.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 25.6 Cg_endo -62.77 126.9 19.17 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.167 1.245 . . . . 1.3600000000000001 111.243 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER -88.56 33.98 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 125.938 4.425 . . . . 1.22 113.285 -147.578 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.1 -133.09 6.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 123.48 1.6 . . . . 1.24 113.247 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -124.16 135.83 53.77 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.576 1.55 . . . . 2.7599999999999998 109.387 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.37 149.39 52.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.641 1.719 . . . . 1.47 115.641 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 138.7 49.26 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 110.19 -1.164 . . . . 0.70999999999999996 110.19 160.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.16 107.26 6.03 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 105.738 -1.949 . . . . 2.02 105.738 168.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -118.55 166.16 13.05 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.248 1.573 . . . . 1.6000000000000001 115.248 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.435 HG22 HD13 ' A' ' 74' ' ' LEU . 77.0 mt -96.17 139.87 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.565 1.946 . . . . 0.81000000000000005 109.026 162.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -137.68 152.51 49.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.795 2.438 . . . . 2.23 110.42 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.89 -10.87 59.45 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 117.633 2.457 . . . . 1.0800000000000001 117.633 -157.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -137.73 135.24 36.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.935 1.698 . . . . 1.1599999999999999 112.434 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 59.53 4.35 Favored Glycine 0 N--CA 1.471 0.982 0 C-N-CA 125.572 1.558 . . . . 1.05 114.119 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.68 116.37 4.14 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.787 1.294 . . . . 2.8599999999999999 114.073 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.3 m -89.7 9.38 27.31 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.822 2.049 . . . . 1.3 113.474 -175.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -68.92 129.25 92.44 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.641 1.577 . . . . 3.5 111.855 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -97.7 166.73 0.82 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.652 3.568 . . . . 1.3200000000000001 113.513 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.96 169.62 8.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 2.3300000000000001 111.91 162.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mm -119.68 117.71 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.19 1.396 . . . . 3.1299999999999999 109.747 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -152.75 157.42 40.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.173 1.389 . . . . 4.4800000000000004 111.466 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.29 27.41 9.81 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 115.788 1.773 . . . . 3.6200000000000001 115.788 156.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.21 20.12 65.42 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.865 -1.147 . . . . 3.25 115.023 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -160.76 -172.35 3.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.798 1.639 . . . . 2.6299999999999999 111.634 -169.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.22 139.82 35.7 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.9 -1.125 . . . . 1.5 110.533 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.97 43.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.574 1.15 . . . . 2.1600000000000001 112.431 -159.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.15 -65.97 0.06 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 129.007 2.923 . . . . 1.74 116.053 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 176.48 95.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 1 C-N-CA 132.267 4.227 . . . . 1.49 105.457 -175.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.85 -38.31 9.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.494 1.917 . . . . 4.7800000000000002 112.449 -158.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.76 31.73 0.09 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.324 1.449 . . . . 1.1899999999999999 114.26 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.13 -11.78 21.1 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.088 1.755 . . . . 1.6799999999999999 115.299 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 20.93 44.99 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.724 1.449 . . . . 3.7000000000000002 116.724 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.84 -99.94 1.81 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.231 1.516 . . . . 2.5 111.829 174.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -118.68 -117.79 0.32 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.445 1.898 . . . . 3.3999999999999999 106.981 164.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 49' ' ' ILE . 7.1 tt -174.41 92.73 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.011 2.125 . . . . 2.1600000000000001 107.794 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 173.26 146.7 0.2 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 127.917 2.487 . . . . 3.4199999999999999 111.826 -162.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.96 -38.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.258 2.639 . . . . 3.3399999999999999 113.877 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.23 26.0 0.2 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.876 1.216 . . . . 3.8100000000000001 113.736 -174.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.83 19.18 0.41 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.444 -1.41 . . . . 3.3599999999999999 114.541 -167.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.69 -30.22 0.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 128.825 2.85 . . . . 2.6800000000000002 114.17 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.18 -11.27 61.04 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.026 -1.43 . . . . 2.6699999999999999 115.83 167.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -61.21 -19.68 61.91 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.795 1.798 . . . . 4.4500000000000002 114.698 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.0 t60 98.9 167.0 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.758 2.823 . . . . 1.8 112.269 154.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -65.77 145.74 55.61 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.125 1.157 . . . . 5.1900000000000004 114.125 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.23 -155.42 7.64 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.127 1.822 . . . . 3.2400000000000002 112.15 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.78 -43.04 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.65 2.233 . . . . 4.0999999999999996 111.72 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.03 -3.32 9.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.618 1.567 . . . . 5.8799999999999999 112.869 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.29 167.07 22.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.871 1.7 . . . . 4.4500000000000002 114.553 -170.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -158.03 177.38 11.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.372 1.869 . . . . 7.8700000000000001 108.931 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.76 -20.81 0.02 OUTLIER Glycine 0 N--CA 1.465 0.594 0 CA-C-O 118.114 -1.381 . . . . 2.6000000000000001 115.946 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.424 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 7.0 p-80 -159.87 153.97 23.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.563 1.681 . . . . 5.2800000000000002 113.246 169.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.93 -18.89 63.4 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.236 -0.915 . . . . 2.3500000000000001 113.318 -175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -89.42 5.75 83.75 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.46 1.505 . . . . 1.0 114.587 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -65.12 133.32 51.33 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 119.551 1.675 . . . . 2.3500000000000001 107.742 160.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.29 159.8 36.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.722 1.209 . . . . 1.9099999999999999 110.148 -153.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.21 154.18 56.76 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.558 2.839 . . . . 0.88 111.652 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 m -73.95 137.2 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 122.972 1.367 . . . . 1.4399999999999999 114.046 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.2 98.54 4.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.965 2.506 . . . . 1.8700000000000001 110.191 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.8 t -72.74 131.64 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.639 0.776 . . . . 0.93000000000000005 110.143 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.48 138.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.722 2.409 . . . . 1.8899999999999999 106.308 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 154.47 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.178 -0.951 . . . . 2.29 111.514 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -52.16 -12.31 0.23 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 116.987 2.217 . . . . 2.3399999999999999 116.987 -176.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.85 -21.58 26.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.13 2.172 . . . . 2.9399999999999999 113.098 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.62 9.52 23.03 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.327 1.441 . . . . 0.73999999999999999 115.251 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mt -116.35 135.91 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.104 1.362 . . . . 1.0900000000000001 110.207 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.22 128.41 54.69 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.919 0.888 . . . . 0.72999999999999998 110.801 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -145.37 14.12 1.42 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.512 1.301 . . . . 1.27 114.512 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -86.74 118.72 70.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.276 1.03 . . . . 2.9700000000000002 111.159 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.07 133.11 16.1 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.134 3.223 . . . . 1.3500000000000001 112.185 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.03 168.37 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 126.543 1.937 . . . . 1.55 110.5 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.7 m -140.63 143.57 35.27 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.704 1.138 . . . . 0.94999999999999996 112.052 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.46 99.36 51.16 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.978 1.311 . . . . 0.64000000000000001 113.123 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.53 18.59 0.94 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 125.201 3.934 . . . . 1.0700000000000001 114.873 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -73.05 -35.1 66.65 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.3 -0.875 . . . . 4.8200000000000003 111.634 171.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.35 165.12 11.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.287 2.235 . . . . 2.27 109.133 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.08 2.64 3.64 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.994 1.109 . . . . 4.1900000000000004 113.994 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.7 p -152.14 166.91 30.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.204 1.802 . . . . 2.0499999999999998 110.438 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.7 tp -85.42 -44.62 12.6 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.458 -0.776 . . . . 1.79 111.058 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.27 -23.81 62.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.212 1.405 . . . . 4.4500000000000002 113.853 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -12.32 60.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.842 1.053 . . . . 1.8100000000000001 113.842 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.93 15.86 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.931 1.292 . . . . 1.1499999999999999 113.29 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -51.15 -18.5 0.89 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 117.104 2.261 . . . . 2.75 117.104 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -121.92 11.47 10.34 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.586 1.955 . . . . 4.4100000000000001 113.595 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -102.73 169.87 8.35 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.324 1.231 . . . . 1.72 114.324 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.62 44.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.646 0.779 . . . . 0.93999999999999995 111.285 173.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.91 133.95 34.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.313 -1.736 . . . . 1.8300000000000001 106.313 156.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.12 131.16 34.4 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.539 1.063 . . . . 1.5800000000000001 112.171 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.93 114.35 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 107.074 -1.454 . . . . 0.93000000000000005 107.074 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -87.0 146.89 25.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.544 1.137 . . . . 2.6000000000000001 111.449 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.0 t -68.25 -37.61 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.193 0.597 . . . . 1.6899999999999999 110.474 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.39 -163.32 6.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.064 0.84 . . . . 2.0099999999999998 113.676 172.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.82 -146.32 10.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 127.466 2.46 . . . . 2.5899999999999999 109.298 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -157.11 149.54 23.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.702 0.801 . . . . 3.5600000000000001 110.967 161.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 56.3 t30 110.01 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 1 C-N-CA 131.703 4.001 . . . . 4.3200000000000003 109.453 -161.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.6 ptp -165.05 69.26 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 123.062 1.41 . . . . 3.8700000000000001 111.52 -162.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.6 p -97.76 0.09 46.27 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.253 2.221 . . . . 3.4100000000000001 115.357 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -164.05 63.95 0.15 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.753 -1.217 . . . . 3.3500000000000001 112.428 -163.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -130.31 149.78 74.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.072 1.349 . . . . 4.4000000000000004 108.466 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.19 -35.68 84.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.402 2.735 . . . . 2.04 112.437 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -94.56 113.76 61.81 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.717 -1.216 . . . . 6.9400000000000004 107.717 148.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.2 163.15 38.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.921 2.414 . . . . 3.9199999999999999 111.104 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt 60.71 28.47 18.19 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.733 0.813 . . . . 4.25 110.435 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.86 3.14 7.47 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.413 1.483 . . . . 2.6000000000000001 115.154 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.74 87.5 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 118.919 1.359 . . . . 2.29 114.052 -166.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.39 33.23 4.17 Favored Glycine 0 N--CA 1.474 1.189 0 C-N-CA 125.707 1.622 . . . . 1.8799999999999999 114.594 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.19 -4.42 90.49 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.052 1.786 . . . . 1.9099999999999999 115.039 -174.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 p -65.12 152.56 43.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.003 1.401 . . . . 2.27 110.752 165.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.35 132.48 54.08 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.486 1.114 . . . . 5.5300000000000002 109.103 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -74.65 -33.44 62.52 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.69 0.677 . . . . 2.5299999999999998 110.307 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.18 145.13 29.4 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.898 1.444 . . . . 0.78000000000000003 114.898 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.5 t -68.69 -174.02 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 129.165 2.986 . . . . 2.6099999999999999 111.548 164.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 164.54 62.06 0.02 OUTLIER Glycine 0 N--CA 1.465 0.626 0 C-N-CA 125.241 1.4 . . . . 0.73999999999999999 112.99 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.9 p -61.69 125.87 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.53 0.732 . . . . 2.48 110.844 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.32 132.09 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.728 0.811 . . . . 0.90000000000000002 108.816 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 CA--C 1.539 0.551 0 O-C-N 121.223 -0.923 . . . . 3.8399999999999999 110.831 176.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.994 -0.373 . . . . 2.2400000000000002 109.994 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -163.22 144.2 9.41 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.751 1.159 . . . . 1.3100000000000001 108.32 -169.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -149.0 130.25 14.6 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.978 1.37 . . . . 3.3999999999999999 111.118 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -80.99 106.99 13.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.842 1.657 . . . . 3.3100000000000001 109.407 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.19 122.09 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.605 0.639 . . . . 1.0900000000000001 111.025 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.613 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -72.91 104.91 1.63 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.059 1.79 . . . . 0.70999999999999996 111.954 170.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.6 mmm -88.8 132.93 34.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.412 1.485 . . . . 1.6699999999999999 111.359 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -106.53 145.42 31.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.642 1.177 . . . . 2.2799999999999998 110.934 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 mt -61.11 142.42 56.7 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.549 1.14 . . . . 1.0900000000000001 110.003 169.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.13 163.8 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.094 0.957 . . . . 1.3400000000000001 110.738 175.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t 177.29 69.52 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.253 2.221 . . . . 2.71 110.763 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 67.02 -29.89 0.15 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.372 2.269 . . . . 1.79 115.932 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -17.35 64.86 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.666 1.586 . . . . 3.3199999999999998 111.346 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.72 -160.53 17.18 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.368 1.937 . . . . 1.3100000000000001 111.35 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.23 128.89 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.552 1.141 . . . . 1.1499999999999999 109.74 169.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.81 -95.18 1.14 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 125.686 1.612 . . . . 1.5 113.26 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.58 166.18 34.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.217 1.407 . . . . 1.8100000000000001 110.8 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 t -93.13 151.32 19.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.421 1.488 . . . . 1.1000000000000001 114.341 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 15.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 127.192 2.197 . . . . 3.2200000000000002 113.587 -173.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.49 175.89 15.39 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.441 1.02 . . . . 0.65000000000000002 112.246 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.613 HG22 ' HA2' ' A' ' 6' ' ' GLY . 64.5 p -122.16 173.6 7.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.384 1.074 . . . . 0.92000000000000004 109.273 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.16 132.18 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.489 -1.301 . . . . 0.58999999999999997 107.489 162.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -86.35 124.84 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.774 0.321 . . . . 1.05 110.591 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.95 128.48 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.768 -1.197 . . . . 1.29 107.768 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -137.74 112.64 9.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.518 1.151 . . . . 2.3500000000000001 110.483 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -70.31 111.44 5.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.437 2.295 . . . . 3.2200000000000002 112.064 -167.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 159.73 15.35 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.084 -1.08 . . . . 2.5899999999999999 108.084 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.93 -19.34 64.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.471 0.708 . . . . 4.4800000000000004 111.868 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.83 30.8 9.66 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.012 1.768 . . . . 1.8100000000000001 113.959 165.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.37 -135.31 9.84 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 119.921 2.728 . . . . 2.04 119.921 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.38 113.27 21.15 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.955 1.302 . . . . 0.70999999999999996 110.147 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.77 109.42 15.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.164 0.986 . . . . 1.98 109.733 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t80 -92.05 121.08 33.27 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.19 1.796 . . . . 0.87 108.492 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.5 m -128.36 113.54 19.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 119.29 0.95 . . . . 1.0 108.694 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.15 157.12 13.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.491 2.794 . . . . 0.70999999999999996 110.98 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.27 40.86 0.42 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.561 1.172 . . . . 2.3599999999999999 111.613 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -101.39 140.46 35.66 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.48 1.512 . . . . 0.59999999999999998 112.314 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 31.37 6.74 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.394 1.628 . . . . 2.0600000000000001 115.394 -167.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.27 65.17 0.69 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.075 0.95 . . . . 1.3999999999999999 111.972 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.86 157.58 32.55 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 113.896 1.073 . . . . 1.3200000000000001 113.896 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.05 139.24 13.4 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 O-C-N 123.555 1.292 . . . . 1.52 112.083 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -77.97 31.14 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.867 1 C-N-CA 128.948 6.432 . . . . 1.8500000000000001 114.164 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.77 -135.96 6.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-O 123.58 1.655 . . . . 1.47 110.195 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -136.3 133.57 37.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.717 1.607 . . . . 2.8100000000000001 107.949 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -127.36 137.57 52.8 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.688 1.195 . . . . 0.97999999999999998 109.58 -169.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 156.15 49.21 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 119.664 1.12 . . . . 0.60999999999999999 111.743 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.6 t80 -129.42 118.87 22.87 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.322 -1.362 . . . . 1.8999999999999999 107.322 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -118.09 157.69 26.41 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.427 2.01 . . . . 0.91000000000000003 116.427 163.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -98.54 142.05 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.375 1.47 . . . . 0.71999999999999997 108.488 158.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -128.38 141.82 51.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.508 1.923 . . . . 0.93999999999999995 110.256 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.82 70.79 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.819 2.155 . . . . 0.75 116.819 -158.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -120.63 154.48 35.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.194 1.398 . . . . 1.28 111.746 171.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.43 84.17 1.58 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 120.844 -1.16 . . . . 0.81999999999999995 113.301 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 t -166.76 95.71 0.52 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.745 1.017 . . . . 2.2599999999999998 113.745 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 16.0 m -62.31 10.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.001 1.852 . . . . 1.48 116.001 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -87.6 129.33 51.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 119.953 -1.717 . . . . 3.3700000000000001 110.031 -166.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.1 155.14 33.35 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.387 2.058 . . . . 1.3400000000000001 110.618 166.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.24 145.32 51.45 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.684 -0.635 . . . . 1.6299999999999999 110.218 158.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 mm -96.75 123.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.968 1.307 . . . . 3.3799999999999999 108.561 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -169.47 157.82 7.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.244 1.418 . . . . 5.1799999999999997 111.775 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.78 27.34 14.62 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.251 1.021 . . . . 4.5199999999999996 112.317 167.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.11 84.64 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 126.381 1.943 . . . . 3.6800000000000002 114.914 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.59 -152.64 0.41 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.451 1.501 . . . . 3.9399999999999999 109.902 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.04 146.02 21.32 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.161 -0.962 . . . . 1.8799999999999999 113.042 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.69 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.563 1.545 . . . . 1.8899999999999999 113.16 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 67.81 -61.23 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 127.969 2.508 . . . . 2.0 116.584 168.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 166.35 99.83 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 C-N-CA 132.536 4.335 . . . . 1.8600000000000001 106.583 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -123.52 -45.97 2.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 3.6600000000000001 113.162 -157.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.07 -19.58 20.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.043 1.337 . . . . 1.48 113.391 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.13 -12.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.146 2.578 . . . . 0.82999999999999996 114.809 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.38 16.8 58.32 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.333 1.424 . . . . 3.21 115.022 163.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.17 -173.98 41.75 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.246 1.023 . . . . 1.21 112.339 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -63.49 141.29 58.82 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.737 -0.861 . . . . 2.27 109.937 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.31 111.8 3.18 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.129 -0.357 . . . . 1.6899999999999999 110.248 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.5 t0 169.7 126.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 128.762 2.825 . . . . 5.6600000000000001 111.645 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.04 -36.51 1.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.104 1.869 . . . . 2.3900000000000001 113.65 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -165.57 8.41 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.804 2.52 . . . . 4.4000000000000004 117.804 -156.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.99 -27.08 65.06 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.815 2.098 . . . . 4.8700000000000001 114.616 -170.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 165.89 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.967 3.307 . . . . 3.96 110.832 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.74 -18.51 38.6 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.863 1.221 . . . . 2.8399999999999999 114.63 169.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -69.87 -7.73 42.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.558 1.688 . . . . 7.3799999999999999 115.558 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.406 ' CD2' ' HA3' ' A' ' 142' ' ' GLY . 76.9 t60 68.56 157.13 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.825 2.45 . . . . 1.53 112.774 -172.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 84' ' ' GLY . 2.6 pp20? -140.41 -136.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.586 0.755 . . . . 4.4900000000000002 112.315 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.565 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 144.33 -46.02 0.83 Allowed Glycine 0 CA--C 1.538 1.518 0 C-N-CA 130.401 3.857 . . . . 4.0300000000000002 110.483 -172.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -108.02 -10.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.663 2.909 . . . . 4.0999999999999996 115.633 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -139.26 -3.19 1.57 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.453 2.019 . . . . 5.2400000000000002 116.453 -159.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.1 -31.04 1.57 Allowed Glycine 0 N--CA 1.472 1.09 0 O-C-N 120.45 -1.406 . . . . 4.7300000000000004 114.874 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -72.77 71.65 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.444 1.498 . . . . 5.1200000000000001 112.213 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.19 -91.61 0.09 OUTLIER Glycine 0 CA--C 1.523 0.579 0 C-N-CA 125.322 1.439 . . . . 2.1899999999999999 111.584 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -133.83 151.17 51.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.012 1.725 . . . . 3.6200000000000001 109.603 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.49 -28.71 68.79 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.219 0.918 . . . . 1.9199999999999999 113.169 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.15 16.37 55.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.863 1.697 . . . . 0.76000000000000001 115.357 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -89.96 122.38 32.93 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.941 1.371 . . . . 2.21 109.867 168.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.478 HD12 ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -116.43 158.93 41.91 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.527 1.531 . . . . 1.77 109.795 -178.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.97 171.42 18.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.429 2.753 . . . . 1.6799999999999999 111.759 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.42 131.71 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.7 1.37 . . . . 1.3899999999999999 114.7 -163.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.65 94.52 0.59 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.221 2.608 . . . . 1.74 108.307 164.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.22 140.15 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.969 0.908 . . . . 0.93000000000000005 109.672 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.18 131.8 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.71 1.204 . . . . 1.77 108.866 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.0 140.04 40.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.763 0.792 . . . . 2.0699999999999998 111.793 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.23 60.46 0.43 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.715 2.006 . . . . 4.6299999999999999 113.509 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.51 6.93 0.29 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.432 2.293 . . . . 3.9199999999999999 112.314 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.53 3.94 43.46 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 126.297 1.904 . . . . 1.73 115.406 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.65 132.21 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.301 1.05 . . . . 1.73 110.291 -167.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 126.51 33.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.837 -0.539 . . . . 0.68000000000000005 110.089 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 t -141.39 -0.95 1.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.715 1.376 . . . . 1.0800000000000001 114.715 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -87.26 123.29 70.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.955 1.302 . . . . 3.1600000000000001 110.895 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.93 149.45 42.16 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.037 3.158 . . . . 1.6100000000000001 112.466 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.93 158.05 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.812 1.245 . . . . 1.4199999999999999 109.691 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.4 m -112.86 143.61 43.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.45 0.7 . . . . 1.3400000000000001 109.157 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -103.36 84.37 0.73 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.64 1.576 . . . . 0.91000000000000003 110.671 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.89 1.54 7.56 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.845 3.03 . . . . 1.6000000000000001 113.707 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.477 HH11 ' HG3' ' A' ' 113' ' ' ARG . 6.5 ttm-85 -76.92 -25.12 52.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.037 0.935 . . . . 5.29 112.404 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.09 178.86 4.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.691 1.996 . . . . 2.4300000000000002 109.607 165.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -16.81 2.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.552 1.316 . . . . 4.0199999999999996 114.552 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -154.84 166.55 33.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.103 1.32 . . . . 1.5700000000000001 112.734 -169.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.65 -29.44 16.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.866 0.866 . . . . 2.2999999999999998 111.244 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -28.98 70.14 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.86 -1.15 . . . . 3.3500000000000001 113.247 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.6 -17.47 63.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.471 0.708 . . . . 2.5800000000000001 112.89 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.73 13.91 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.485 0.92 . . . . 0.81999999999999995 113.485 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -59.68 -21.34 60.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.141 1.534 . . . . 2.6000000000000001 115.141 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -134.03 105.54 6.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.561 1.544 . . . . 3.5099999999999998 107.983 160.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -158.84 163.32 36.75 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.969 2.908 . . . . 1.53 109.329 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.62 158.45 16.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.493 0.663 . . . . 0.85999999999999999 110.676 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -130.69 117.0 18.81 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.295 2.238 . . . . 1.6899999999999999 106.876 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.8 mtt -117.67 122.01 42.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.731 0.696 . . . . 1.49 111.172 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.97 115.93 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.909 -1.515 . . . . 0.81000000000000005 106.909 166.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -98.58 151.12 21.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.298 1.839 . . . . 2.1699999999999999 112.267 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.3 m -63.17 -29.52 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 114.641 1.349 . . . . 2.6000000000000001 114.641 -160.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.17 168.28 24.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.457 1.503 . . . . 1.27 110.852 167.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.58 136.82 22.22 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.082 1.801 . . . . 1.49 114.08 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.02 114.84 29.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.801 1.64 . . . . 3.5499999999999998 109.932 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -167.47 36.18 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.177 0.991 . . . . 3.5299999999999998 112.514 -172.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.6 mtm -140.48 110.51 6.54 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.339 1.056 . . . . 2.3300000000000001 112.985 -165.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.7 m -93.08 156.78 16.66 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 2.77 111.971 168.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.06 32.45 2.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.061 2.144 . . . . 6.1399999999999997 116.12 165.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -115.86 146.51 37.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.113 1.365 . . . . 3.5299999999999998 110.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.1 17.77 0.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.54 3.493 . . . . 3.3500000000000001 114.069 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -98.53 113.38 64.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 121.107 -0.996 . . . . 7.5300000000000002 108.884 173.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.58 153.66 73.62 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.158 2.572 . . . . 5.0499999999999998 113.781 -156.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 tp 72.68 -1.14 3.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.66 1.984 . . . . 5.79 113.721 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' A' ' 82' ' ' HIS . . . 106.26 38.11 2.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.137 1.351 . . . . 6.3300000000000001 113.224 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.02 -41.15 2.95 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.22 1.391 . . . . 3.8700000000000001 113.556 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.07 -19.48 65.95 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 118.389 1.095 . . . . 3.1200000000000001 115.407 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 46.53 -110.69 0.55 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.65 1.595 . . . . 2.0 115.457 161.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 m -69.17 151.77 45.94 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.318 1.447 . . . . 2.6299999999999999 111.126 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.95 132.15 45.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.566 1.547 . . . . 4.71 108.238 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -83.11 -42.8 16.96 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 120.092 1.314 . . . . 2.9700000000000002 110.373 169.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.03 151.82 33.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.053 0.941 . . . . 0.55000000000000004 112.645 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.0 t -127.36 148.37 50.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.873 2.069 . . . . 1.3999999999999999 111.09 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -145.44 155.67 26.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.592 2.52 . . . . 1.23 111.701 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.46 1.104 . . . . 1.53 111.442 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.517 HD12 ' H ' ' A' ' 153' ' ' ILE . 3.4 mp -82.47 149.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.342 1.857 . . . . 1.3200000000000001 110.145 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.796 0 O-C-N 120.051 -1.655 . . . . 4.8399999999999999 110.938 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.244 0.068 . . . . 1.6599999999999999 110.948 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.5 148.16 22.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 1.24 109.201 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -151.15 127.2 10.44 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 123.191 1.472 . . . . 2.3799999999999999 110.943 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -105.19 97.36 7.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.019 1.728 . . . . 3.46 111.663 -167.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.52 131.17 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 115.17 1.544 . . . . 2.0299999999999998 115.17 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.6 103.01 1.19 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.499 1.047 . . . . 0.81999999999999995 110.79 167.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.5 mtp -85.34 131.16 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.503 0.721 . . . . 1.1599999999999999 110.406 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -110.7 145.38 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.115 1.366 . . . . 3.2000000000000002 113.108 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.4 mt -77.93 62.5 2.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.153 1.381 . . . . 1.7 111.673 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 m -55.07 130.79 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.246 1.418 . . . . 0.95999999999999996 112.02 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -158.63 72.18 0.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.007 1.484 . . . . 2.6400000000000001 115.007 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.51 -40.46 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.744 2.418 . . . . 1.49 113.767 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.96 6.46 4.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.552 1.541 . . . . 2.52 111.546 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.89 -159.14 31.24 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 126.079 1.8 . . . . 1.1599999999999999 112.769 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -42.11 126.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.405 1.482 . . . . 0.97999999999999998 110.725 159.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.27 -60.26 0.26 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.067 1.318 . . . . 1.97 114.429 -170.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -174.79 160.2 2.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.499 1.92 . . . . 2.75 110.738 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -152.69 148.64 27.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.163 1.542 . . . . 1.8600000000000001 115.163 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.62 56.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 130.149 3.38 . . . . 6.21 108.838 173.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.48 -177.94 39.92 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 113.226 -1.806 . . . . 0.64000000000000001 114.316 146.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.3 p -115.61 177.74 4.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.633 1.173 . . . . 0.77000000000000002 110.928 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.04 133.31 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.336 -0.987 . . . . 0.47999999999999998 108.336 156.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.3 p -87.49 119.49 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.65 0.593 . . . . 0.93999999999999995 110.337 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.15 117.73 47.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.191 -1.411 . . . . 1.3999999999999999 107.191 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -119.76 125.35 48.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.288 1.435 . . . . 2.3999999999999999 108.563 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.22 130.99 34.34 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.371 -0.603 . . . . 3.3399999999999999 109.371 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.6 t -148.86 -179.62 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.166 0.439 . . . . 1.29 110.378 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.22 -4.27 40.95 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.918 1.081 . . . . 3.71 113.918 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.3 9.57 67.28 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 124.159 0.885 . . . . 1.1799999999999999 114.18 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.1 -146.47 21.97 Favored Glycine 0 N--CA 1.463 0.448 0 C-N-CA 128.417 2.913 . . . . 0.93000000000000005 115.536 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.9 104.65 7.51 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.3 0.64 . . . . 0.87 111.107 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -84.6 115.18 22.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.791 2.036 . . . . 3.7999999999999998 109.988 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.26 104.65 14.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.776 1.63 . . . . 1.03 109.58 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.0 m -110.27 109.21 58.69 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.519 1.054 . . . . 0.75 108.346 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.1 159.36 18.0 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.586 2.858 . . . . 0.64000000000000001 111.127 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -146.41 27.23 1.14 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 121.418 0.628 . . . . 1.3400000000000001 112.479 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.85 140.86 30.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.805 -1.184 . . . . 0.68999999999999995 111.308 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 26.69 8.01 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.452 1.649 . . . . 2.21 115.452 -170.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.18 81.14 1.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.717 0.807 . . . . 1.55 110.933 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.72 163.36 41.29 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.839 1.256 . . . . 1.3500000000000001 110.407 168.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.29 128.97 24.02 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 121.006 1.137 . . . . 0.80000000000000004 110.619 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -79.8 25.23 0.6 Allowed 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 126.563 4.842 . . . . 0.93000000000000005 113.047 -162.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.6 -124.7 1.48 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 126.725 2.107 . . . . 1.3700000000000001 112.571 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -151.28 138.71 19.49 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.77 1.228 . . . . 2.8999999999999999 110.842 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -136.69 142.73 43.15 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.081 0.771 . . . . 1.1100000000000001 113.081 -163.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.07 153.77 51.63 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 111.28 -0.728 . . . . 0.77000000000000002 111.28 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -131.79 115.54 16.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.49 1.116 . . . . 1.98 108.161 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.424 ' HA ' HD22 ' A' ' 94' ' ' LEU . 16.9 m170 -115.97 165.67 12.85 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 117.121 2.267 . . . . 1.01 117.121 167.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.0 mt -108.05 148.34 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 128.414 2.686 . . . . 0.77000000000000002 108.045 154.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -126.16 163.39 23.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.94 1.296 . . . . 1.1699999999999999 110.425 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.4 75.91 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.586 1.699 . . . . 0.98999999999999999 115.586 -163.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.74 169.08 14.24 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.144 1.378 . . . . 1.8400000000000001 113.144 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.9 93.91 1.53 Allowed Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.005 1.288 . . . . 1.21 113.087 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -151.58 57.05 0.87 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.816 1.413 . . . . 3.6299999999999999 114.816 -165.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.6 m -64.72 37.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 116.505 2.039 . . . . 1.5 116.505 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -137.1 143.66 42.92 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 119.606 -1.934 . . . . 3.77 110.889 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.12 148.77 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.234 2.623 . . . . 1.02 113.432 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.3 137.1 40.92 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.489 -0.778 . . . . 1.3799999999999999 109.669 157.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.73 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.993 -1.114 . . . . 2.8199999999999998 107.993 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -147.21 133.66 19.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.15 0.98 . . . . 4.1500000000000004 111.042 -160.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.21 19.22 5.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.181 1.393 . . . . 3.7200000000000002 113.151 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.05 63.15 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.086 1.327 . . . . 2.71 115.313 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -137.27 -177.76 4.91 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.685 1.243 . . . . 3.0899999999999999 111.714 169.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.85 115.59 26.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.186 0.994 . . . . 1.6499999999999999 112.456 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -87.2 79.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.106 1.362 . . . . 1.77 110.47 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 19.89 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.33 3.452 . . . . 2.2999999999999998 117.991 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.44 41.64 0.88 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.557 1.943 . . . . 2.04 110.766 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -54.76 -37.19 65.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.144 -0.973 . . . . 4.0300000000000002 113.582 -169.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -4.48 17.98 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.54 1.311 . . . . 2.0600000000000001 114.54 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.1 -7.45 58.9 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.085 -1.009 . . . . 1.49 113.706 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 -179.35 32.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.807 -1.183 . . . . 2.0499999999999998 113.882 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.26 175.51 50.96 Favored Glycine 0 N--CA 1.474 1.222 0 N-CA-C 110.998 -0.841 . . . . 1.8999999999999999 110.998 161.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.44 36.06 0.19 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.608 1.204 . . . . 2.9399999999999999 113.561 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.5 tp 65.07 78.62 0.28 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.705 2.002 . . . . 1.79 112.349 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 90' ' ' HIS . 44.5 t0 -156.15 124.68 2.94 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 126.543 1.937 . . . . 5.6200000000000001 111.152 166.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.25 -22.52 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.216 2.611 . . . . 2.3599999999999999 113.838 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -145.7 -31.11 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.255 1.946 . . . . 4.6500000000000004 116.255 -157.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -60.63 -42.33 96.68 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 121.111 1.778 . . . . 4.5700000000000003 111.561 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 179.52 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.909 2.484 . . . . 2.1800000000000002 112.419 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 -15.91 4.18 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.541 -1.349 . . . . 2.3599999999999999 114.331 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -58.79 -82.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.614 1.965 . . . . 4.7800000000000002 113.39 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 81.1 t60 153.32 128.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 129.754 3.221 . . . . 1.4399999999999999 110.479 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -130.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.365 1.066 . . . . 3.71 111.94 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.24 -51.1 0.85 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.498 1.999 . . . . 2.7799999999999998 111.761 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -104.14 -22.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.692 2.261 . . . . 3.1099999999999999 114.877 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -157.25 28.61 0.3 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.302 1.41 . . . . 5.2400000000000002 114.539 -160.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.05 -12.07 5.64 Favored Glycine 0 N--CA 1.477 1.43 0 O-C-N 119.662 -1.899 . . . . 3.9399999999999999 116.425 166.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.89 83.56 3.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.152 1.381 . . . . 4.4100000000000001 112.491 -170.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.51 116.02 4.16 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 124.424 1.012 . . . . 3.0899999999999999 112.806 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 22.1 m170 90.52 123.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.978 2.511 . . . . 3.1400000000000001 110.973 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.38 -12.51 24.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.005 0.522 . . . . 2.29 111.692 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.17 22.56 18.54 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.144 1.354 . . . . 1.05 113.985 165.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -101.26 124.85 47.6 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.374 1.587 . . . . 2.6600000000000001 109.71 164.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -117.52 164.15 20.7 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.825 1.65 . . . . 1.8 109.316 -174.417 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.11 161.84 35.0 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.121 2.547 . . . . 1.0600000000000001 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.63 131.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 122.608 1.194 . . . . 1.6699999999999999 113.696 -165.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.85 86.25 4.09 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.439 2.696 . . . . 1.8200000000000001 108.814 176.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 142.55 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.583 0.753 . . . . 1.45 109.1 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -122.77 150.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.702 2.001 . . . . 1.74 107.832 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -94.39 150.88 19.85 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.762 0.652 . . . . 2.2799999999999998 112.762 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -42.77 -3.47 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 131.616 3.966 . . . . 3.52 118.518 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 -16.46 20.85 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 119.625 -1.922 . . . . 2.9399999999999999 112.507 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.9 27.49 7.01 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.718 1.628 . . . . 0.71999999999999997 112.796 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.2 mt -121.89 127.13 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.72 1.208 . . . . 1.6599999999999999 111.172 -171.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.84 123.95 29.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.932 0.893 . . . . 1.1699999999999999 108.926 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -139.0 -15.27 1.14 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.88 2.178 . . . . 2.6800000000000002 116.88 -167.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.48 127.91 74.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 121.413 1.915 . . . . 5.2699999999999996 112.812 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.14 85.69 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.258 3.305 . . . . 1.9099999999999999 110.06 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.01 122.16 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.826 0.851 . . . . 2.0800000000000001 110.045 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -120.03 126.93 52.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.529 0.732 . . . . 1.1399999999999999 110.54 -164.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.45 113.64 45.5 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.39 -0.814 . . . . 1.1899999999999999 112.626 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.79 8.59 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.96 3.107 . . . . 1.3100000000000001 113.447 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -71.78 -22.02 61.64 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.462 -0.774 . . . . 4.25 112.177 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.9 mt -139.52 160.16 40.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 130.155 3.382 . . . . 2.5699999999999998 106.532 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.414 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -148.26 10.23 0.87 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.948 2.203 . . . . 6.3799999999999999 116.948 -175.329 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 p -156.25 157.0 35.05 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.694 -0.629 . . . . 2.21 110.934 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.97 -24.15 52.31 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.015 -1.053 . . . . 1.47 112.653 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -54.31 -37.4 64.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.236 1.415 . . . . 3.8500000000000001 113.788 -176.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.19 -5.41 49.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.015 2.126 . . . . 1.6100000000000001 114.256 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 4.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.033 1.333 . . . . 1.75 113.135 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -66.07 7.08 0.32 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.832 2.16 . . . . 2.0299999999999998 116.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.31 14.0 3.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.386 2.274 . . . . 3.54 111.163 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.53 159.0 43.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.136 1.532 . . . . 1.2 115.136 -157.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.79 157.29 16.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.212 1.405 . . . . 0.62 112.828 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 mt -120.41 136.2 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.533 2.733 . . . . 1.5600000000000001 107.6 173.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -125.94 128.27 47.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.908 0.776 . . . . 2.1699999999999999 112.122 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.08 122.92 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.799 -1.186 . . . . 0.87 107.799 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -115.34 141.42 48.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.109 1.763 . . . . 2.0699999999999998 111.918 -160.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.81 -13.82 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 116.041 1.867 . . . . 2.5600000000000001 116.041 -156.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.36 160.32 25.47 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.309 -1.116 . . . . 1.0700000000000001 110.309 162.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.36 121.1 15.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.648 -1.381 . . . . 1.8500000000000001 109.648 163.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.63 1.28 14.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.984 0.914 . . . . 3.6699999999999999 112.945 -158.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -66.2 28.81 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 129.922 3.289 . . . . 3.46 115.867 -172.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.1 mtm -114.22 105.21 12.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.531 1.932 . . . . 2.9100000000000001 110.219 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 p -77.3 14.62 0.9 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.043 2.137 . . . . 3.0 113.952 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.72 4.73 0.77 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.787 1.773 . . . . 4.5599999999999996 115.787 -155.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -96.35 143.02 25.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.114 0.965 . . . . 4.54 110.328 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.2 -27.1 29.52 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.735 2.957 . . . . 3.0 113.192 -173.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -87.01 107.74 15.66 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.706 -1.22 . . . . 4.1299999999999999 107.706 148.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.95 175.08 7.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.791 2.327 . . . . 3.1899999999999999 110.925 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 61.16 34.97 18.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.161 0.984 . . . . 3.1600000000000001 109.175 -170.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.99 5.9 8.57 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.95 1.262 . . . . 3.2200000000000002 115.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.52 63.11 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-N 119.297 1.549 . . . . 2.3199999999999998 113.99 -165.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.15 16.29 59.44 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.967 2.223 . . . . 1.74 113.97 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.76 -6.02 62.24 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.311 1.434 . . . . 1.55 116.574 -170.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.3 m -66.98 162.53 21.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.369 1.585 . . . . 2.5699999999999998 110.401 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.84 139.0 31.11 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.405 2.282 . . . . 7.79 114.375 -177.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.82 -27.52 9.25 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 118.921 0.782 . . . . 2.7000000000000002 112.654 154.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -154.6 155.37 34.6 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.658 1.117 . . . . 0.56999999999999995 113.637 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.42 147.86 50.53 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.426 1.891 . . . . 1.5600000000000001 110.499 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.41 134.14 4.4 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.791 1.186 . . . . 0.72999999999999998 112.515 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.12 133.91 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.139 1.375 . . . . 1.77 109.009 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 mt -70.65 118.11 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 122.269 1.033 . . . . 0.97999999999999998 111.032 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 123.669 0.787 . . . . 7.5499999999999998 111.819 -177.715 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.253 -0.277 . . . . 2.9399999999999999 110.253 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -163.69 132.67 3.88 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.207 -1.558 . . . . 1.45 107.394 -163.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -144.79 120.88 10.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.123 1.44 . . . . 3.8199999999999998 113.409 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.11 74.3 6.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.839 1.655 . . . . 3.6200000000000001 110.824 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 t -70.59 122.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.286 -0.884 . . . . 1.23 111.881 -158.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.606 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -70.51 90.29 0.37 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 128.708 3.052 . . . . 1.0600000000000001 112.11 175.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 mtt -82.69 148.53 27.86 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.601 1.161 . . . . 1.4199999999999999 111.311 170.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -115.95 158.32 23.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.475 1.131 . . . . 2.4100000000000001 110.915 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.09 124.8 26.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.958 1.303 . . . . 1.0800000000000001 107.496 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.9 m -143.51 151.21 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.385 1.074 . . . . 1.1299999999999999 110.813 -174.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 t 171.27 121.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.044 2.538 . . . . 3.2799999999999998 110.387 163.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.59 -38.26 0.27 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.515 2.726 . . . . 1.3600000000000001 116.724 167.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -9.11 49.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.204 1.402 . . . . 2.9199999999999999 111.871 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.24 -156.19 19.95 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 125.277 1.418 . . . . 0.93999999999999995 113.385 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 10' ' ' VAL . 90.2 t -63.92 110.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.209 1.403 . . . . 0.79000000000000004 110.301 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.67 -86.06 1.16 Allowed Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.226 1.393 . . . . 1.46 112.255 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.24 164.56 37.86 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.382 1.473 . . . . 1.6499999999999999 109.392 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -104.52 170.32 7.96 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.363 1.065 . . . . 1.1399999999999999 113.339 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 pt -151.77 8.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 127.636 2.374 . . . . 2.77 112.372 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.14 173.02 20.68 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.011 0.815 . . . . 0.65000000000000002 113.809 -166.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.606 HG22 ' HA2' ' A' ' 6' ' ' GLY . 77.1 p -131.44 173.97 10.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.558 1.943 . . . . 1.1499999999999999 108.472 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.37 129.78 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 107.906 -1.146 . . . . 0.58999999999999997 107.906 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -78.38 109.95 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.612 0.642 . . . . 1.01 109.788 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 24' ' ' ILE . 34.1 mt -89.79 125.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.539 -1.282 . . . . 1.1399999999999999 107.539 160.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.504 0.668 . . . . 2.3700000000000001 110.312 166.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.29 130.7 37.54 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.084 1.754 . . . . 3.5299999999999998 109.539 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -149.21 -179.77 7.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.039 0.447 . . . . 1.6399999999999999 110.272 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.06 -29.6 69.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.809 1.244 . . . . 3.5299999999999998 111.751 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.28 66.16 Favored Glycine 0 N--CA 1.471 1.009 0 C-N-CA 124.696 1.141 . . . . 1.3999999999999999 114.885 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 -140.31 18.37 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 127.685 2.564 . . . . 1.1299999999999999 114.734 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.28 93.79 7.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.201 1.0 . . . . 0.70999999999999996 110.15 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.4 tttp -76.19 108.78 9.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.364 1.466 . . . . 2.2999999999999998 108.869 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.1 t80 -97.78 110.37 22.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.024 2.53 . . . . 0.51000000000000001 109.309 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 5.6 m -124.19 115.09 27.53 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.889 1.222 . . . . 0.71999999999999997 109.635 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.25 155.96 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.12 2.546 . . . . 0.48999999999999999 111.42 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -149.93 54.12 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.566 1.174 . . . . 1.8 111.007 166.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -107.24 134.56 50.15 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.921 1.288 . . . . 0.72999999999999998 111.232 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -109.25 21.15 17.48 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.265 1.95 . . . . 2.25 116.265 -160.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.96 65.51 0.19 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.128 0.971 . . . . 1.3500000000000001 113.567 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.53 161.28 49.07 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 124.519 1.128 . . . . 1.49 111.968 174.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.03 128.72 21.28 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.675 1.583 . . . . 0.90000000000000002 109.904 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 5.0 Cg_endo -85.74 41.75 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 1 C-N-CA 126.345 4.696 . . . . 1.03 112.553 -157.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.79 -132.83 7.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.974 1.749 . . . . 1.45 113.37 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -139.32 134.96 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.95 1.7 . . . . 2.8599999999999999 110.065 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -137.13 118.79 14.98 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.163 0.985 . . . . 1.0600000000000001 111.754 -165.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.05 130.04 36.12 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.158 -1.177 . . . . 1.0900000000000001 110.158 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -108.87 124.4 50.58 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.962 -1.496 . . . . 2.0 106.962 175.514 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -123.41 171.52 9.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.924 1.453 . . . . 1.0900000000000001 114.924 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mt -108.79 137.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.342 1.457 . . . . 0.68999999999999995 109.297 158.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -109.62 175.32 5.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.074 1.75 . . . . 1.21 113.156 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.87 67.27 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.414 1.635 . . . . 1.28 115.414 -164.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -116.95 -167.18 1.26 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.082 1.353 . . . . 1.2 111.152 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.46 86.39 0.18 Allowed Glycine 0 N--CA 1.472 1.05 0 O-C-N 120.794 -1.191 . . . . 0.93999999999999995 114.117 -173.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -177.98 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.746 2.018 . . . . 2.27 110.452 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.04 35.31 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.745 2.418 . . . . 1.27 116.632 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -115.13 134.19 22.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 120.207 -1.558 . . . . 3.9500000000000002 111.91 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -86.75 156.24 8.87 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.211 3.274 . . . . 1.3400000000000001 112.861 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.78 139.4 30.58 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.131 -0.94 . . . . 2.04 109.676 156.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mm -86.11 115.96 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.749 -1.204 . . . . 2.6699999999999999 107.749 167.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -171.34 135.75 0.97 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.052 1.341 . . . . 5.2699999999999996 109.469 -149.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 t70 52.27 41.49 30.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.648 1.579 . . . . 4.1399999999999997 114.488 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.55 79.4 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.059 -1.026 . . . . 2.9199999999999999 114.578 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -152.34 -164.94 2.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.526 1.531 . . . . 3.1899999999999999 110.074 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.28 122.31 40.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.191 -0.943 . . . . 1.75 110.857 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.7 t -79.4 79.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.254 -0.647 . . . . 2.6400000000000001 109.254 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 12.19 -68.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 131.298 3.839 . . . . 2.04 117.677 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.04 74.92 1.0 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.752 1.621 . . . . 2.2400000000000002 109.81 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.51 -37.52 75.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.649 0.78 . . . . 4.9100000000000001 112.17 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.21 -3.52 52.58 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.251 1.204 . . . . 1.55 114.251 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.92 18.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.53 1.132 . . . . 1.1399999999999999 112.601 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.09 -177.87 50.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.266 1.266 . . . . 2.6400000000000001 116.266 162.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.42 -166.02 14.36 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.73 1.157 . . . . 1.1899999999999999 113.288 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -59.69 145.45 44.84 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 109.189 -0.671 . . . . 3.0699999999999998 109.189 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.5 tp -74.97 87.53 2.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.976 -1.077 . . . . 1.6699999999999999 110.783 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.64 110.11 0.96 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.449 1.5 . . . . 3.3199999999999998 112.632 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.46 -50.84 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.024 2.483 . . . . 2.3300000000000001 110.998 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -127.52 126.58 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.029 1.332 . . . . 3.3100000000000001 109.921 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.356 12.2 p30 162.52 -108.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.887 3.675 . . . . 3.7400000000000002 110.768 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -155.0 -40.35 0.09 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.485 1.514 . . . . 2.8599999999999999 112.609 -167.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.43 -49.59 4.21 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.079 0.847 . . . . 3.7400000000000002 114.658 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 20.7 ptmt -49.68 -51.33 39.08 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.446 1.647 . . . . 4.7300000000000004 115.446 -151.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.448 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 161.26 136.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 129.42 3.088 . . . . 2.1600000000000001 113.022 157.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.27 -57.52 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.199 1.185 . . . . 4.1699999999999999 114.199 -163.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.34 -108.91 0.19 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.019 1.771 . . . . 3.3199999999999998 114.901 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.23 -33.43 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.502 2.135 . . . . 4.5199999999999996 113.462 -174.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -137.35 2.79 2.53 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.249 1.574 . . . . 6.29 115.249 -161.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.64 58.4 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.131 -1.606 . . . . 3.0 116.455 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -77.63 63.86 2.82 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.14 1.47 . . . . 6.2999999999999998 112.345 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.47 -144.55 4.86 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 116.645 1.418 . . . . 2.1499999999999999 116.645 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.47 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 14.2 p-80 -145.93 156.3 43.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.994 1.318 . . . . 4.8700000000000001 112.278 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.18 -22.47 64.76 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.644 1.35 . . . . 2.0499999999999998 114.644 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.47 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -96.13 4.66 65.25 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.595 2.045 . . . . 0.82999999999999996 114.957 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' OD1' ' CE1' ' A' ' 82' ' ' HIS . 8.6 m-20 -62.23 143.16 57.19 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.256 1.528 . . . . 2.3399999999999999 107.255 153.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.4 -174.58 0.43 Allowed Pre-proline 0 CA--C 1.56 1.352 0 O-C-N 120.844 -1.16 . . . . 1.8700000000000001 109.893 -155.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.99 169.94 14.23 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.632 2.222 . . . . 1.0700000000000001 112.722 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.94 126.99 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.878 0.871 . . . . 1.8400000000000001 110.975 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 81.8 1.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.869 2.068 . . . . 1.8500000000000001 108.552 164.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.97 142.17 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.128 -1.064 . . . . 1.0900000000000001 108.128 168.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.65 138.31 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.254 1.422 . . . . 1.7 109.475 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 142.53 56.74 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 112.827 0.676 . . . . 1.74 112.827 174.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -50.07 -17.91 0.48 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.881 2.472 . . . . 2.1499999999999999 117.542 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -93.77 -12.4 29.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.245 1.418 . . . . 2.75 113.266 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 21.63 16.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.228 0.918 . . . . 0.79000000000000004 114.847 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.27 125.53 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.418 -1.327 . . . . 1.23 107.418 169.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.5 125.96 34.11 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.492 -0.559 . . . . 0.65000000000000002 109.492 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -139.97 -6.51 1.26 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.193 2.197 . . . . 0.98999999999999999 112.953 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -73.22 113.83 25.65 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 128.0 2.52 . . . . 5.1299999999999999 111.827 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.01 142.94 28.43 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.333 2.689 . . . . 1.1799999999999999 111.907 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.84 168.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.469 1.508 . . . . 1.1200000000000001 109.574 167.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -140.74 141.02 34.93 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 119.242 0.928 . . . . 0.76000000000000001 110.459 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.95 95.15 16.39 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.374 1.07 . . . . 0.81000000000000005 111.122 172.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.25 6.49 4.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.568 3.512 . . . . 1.5600000000000001 114.431 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -85.92 -5.17 59.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.33 1.052 . . . . 4.1299999999999999 112.026 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.75 160.81 25.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.452 2.701 . . . . 2.3300000000000001 107.345 169.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.75 -7.21 1.1 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.008 1.485 . . . . 4.54 115.008 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.8 m -133.81 130.27 37.71 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.099 0.96 . . . . 2.0299999999999998 110.413 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -26.24 66.84 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.753 -1.217 . . . . 2.3700000000000001 111.019 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.74 -19.27 5.95 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.907 1.447 . . . . 3.5099999999999998 114.907 165.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.35 -13.55 60.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.94 1.246 . . . . 2.0899999999999999 112.067 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.42 2.34 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 114.263 1.209 . . . . 1.1100000000000001 114.263 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -62.54 8.72 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 118.057 2.614 . . . . 2.5600000000000001 118.057 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.72 17.64 1.28 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.219 1.408 . . . . 3.23 112.193 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -144.24 169.74 17.32 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.758 1.623 . . . . 1.6799999999999999 112.212 -168.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.98 139.55 35.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.784 1.234 . . . . 0.68999999999999995 113.439 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.3 mt -80.39 146.8 31.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.831 1.652 . . . . 1.98 108.359 158.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.02 126.89 22.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.03 0.832 . . . . 1.4199999999999999 111.686 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.4 mt -88.62 111.55 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.374 -1.343 . . . . 0.75 107.374 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.9 150.29 21.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.194 2.198 . . . . 2.5899999999999999 111.933 -175.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.29 -46.98 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.261 -0.899 . . . . 1.9199999999999999 111.363 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.28 139.62 16.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.491 0.587 . . . . 1.76 112.996 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.06 143.21 41.0 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.592 2.044 . . . . 1.96 113.348 170.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -80.3 97.01 6.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.694 1.198 . . . . 3.4199999999999999 111.037 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -177.68 -36.78 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.566 2.746 . . . . 4.4500000000000002 109.73 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.9 mtm -61.46 130.48 46.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.95 -1.094 . . . . 2.3500000000000001 112.964 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 t -157.77 -169.36 2.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.239 1.816 . . . . 3.0899999999999999 109.803 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 64.73 -35.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 129.598 3.159 . . . . 3.7799999999999998 116.405 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 155.64 14.32 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 127.029 2.132 . . . . 4.5599999999999996 110.771 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.06 -6.18 18.64 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.711 2.941 . . . . 2.1800000000000002 114.135 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -122.29 138.57 29.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.196 0.907 . . . . 3.98 110.359 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.69 144.37 77.85 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.298 2.666 . . . . 3.5899999999999999 111.167 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.84 29.31 15.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.85 1.26 . . . . 5.9299999999999997 111.357 -171.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.65 0.94 57.04 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.891 1.234 . . . . 3.0899999999999999 114.276 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.46 -13.2 15.77 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.432 1.491 . . . . 1.74 112.848 -162.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 28.98 0.7 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.247 1.879 . . . . 1.4199999999999999 114.455 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.31 -20.0 77.89 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.751 1.643 . . . . 1.6499999999999999 113.089 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.5 p -60.94 155.39 19.99 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.613 1.565 . . . . 1.7 111.754 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mmt-85 -111.55 159.69 17.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.366 1.466 . . . . 4.6200000000000001 111.214 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -107.27 -29.49 9.28 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.666 0.617 . . . . 2.5299999999999998 112.666 152.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.48 38.3 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.141 -0.975 . . . . 0.66000000000000003 113.571 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 50.4 t -135.36 151.59 50.63 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.272 2.229 . . . . 1.6299999999999999 108.947 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -155.1 123.87 1.42 Allowed Glycine 0 N--CA 1.468 0.782 0 C-N-CA 123.966 0.793 . . . . 0.69999999999999996 113.096 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.9 127.87 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.039 1.335 . . . . 1.7 109.492 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mt -79.14 125.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.257 1.027 . . . . 0.85999999999999999 110.983 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt . . . . . 0 C--O 1.238 0.489 0 C-N-CA 127.212 2.205 . . . . 3.8500000000000001 109.417 173.665 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.745 -0.465 . . . . 2.3900000000000001 109.745 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -153.28 136.12 15.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.155 -1.054 . . . . 1.28 108.155 -162.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.67 129.88 8.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.517 1.151 . . . . 2.6400000000000001 112.836 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -88.2 94.79 9.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.751 1.22 . . . . 3.98 109.393 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.52 123.84 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.833 -0.542 . . . . 1.0600000000000001 110.224 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.12 107.47 2.2 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.518 1.532 . . . . 0.80000000000000004 110.835 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 13.9 mmt -81.62 101.04 9.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.8 1.24 . . . . 1.3799999999999999 110.65 172.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.66 137.79 36.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.411 -0.959 . . . . 2.6600000000000001 108.411 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.07 138.88 58.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.422 -0.955 . . . . 1.3799999999999999 108.422 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -136.36 163.48 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.829 0.852 . . . . 1.1499999999999999 112.328 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -167.78 -148.2 0.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.677 1.991 . . . . 2.8500000000000001 108.404 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.96 17.38 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.941 3.697 . . . . 1.5800000000000001 115.686 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.84 -6.02 5.07 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.007 -1.683 . . . . 3.8999999999999999 111.739 171.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.14 -141.72 31.85 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.224 -1.551 . . . . 2.1400000000000001 109.224 -158.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -39.22 113.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.752 1.621 . . . . 1.6499999999999999 112.531 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.52 -77.05 1.16 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.16 1.838 . . . . 1.45 112.335 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.67 153.77 25.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.492 0.717 . . . . 1.72 112.351 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -97.2 132.96 42.45 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.531 1.308 . . . . 1.0600000000000001 114.531 -170.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mm -122.19 -17.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.606 1.562 . . . . 4.54 115.212 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.53 28.81 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 121.055 -1.028 . . . . 0.72999999999999998 113.306 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -95.52 176.45 6.17 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.162 -0.681 . . . . 0.77000000000000002 109.162 164.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 33' ' ' PHE . 23.2 t -135.49 129.99 49.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.001 -1.481 . . . . 0.48999999999999999 107.001 160.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -97.57 119.25 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.307 0.575 . . . . 0.84999999999999998 111.674 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.27 135.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.728 1.211 . . . . 1.46 108.837 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -139.25 100.8 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.819 1.648 . . . . 2.5 108.791 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.7 132.9 38.38 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 128.039 2.536 . . . . 3.1699999999999999 109.709 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -154.63 -168.89 3.05 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.475 0.31 . . . . 1.21 111.662 -166.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -57.36 -31.92 66.23 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.948 1.299 . . . . 5.1200000000000001 113.34 -176.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.5 22.84 38.13 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.856 1.693 . . . . 0.98999999999999999 114.386 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.14 -144.82 23.96 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.686 1.136 . . . . 0.73999999999999999 114.355 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.3 mt -80.36 104.38 10.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.836 0.854 . . . . 0.64000000000000001 111.924 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -83.2 111.81 19.27 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.373 -0.829 . . . . 1.8700000000000001 110.696 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 22' ' ' VAL . 0.8 OUTLIER -97.52 125.51 42.27 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.105 1.762 . . . . 0.91000000000000003 110.151 -177.24 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 m -127.84 110.82 20.38 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 117.993 -1.003 . . . . 0.63 109.458 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -91.85 158.16 3.4 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.461 2.774 . . . . 0.51000000000000001 112.542 -169.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -148.23 36.47 0.83 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 121.741 0.781 . . . . 1.4299999999999999 112.485 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -92.67 160.49 14.97 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.709 -1.869 . . . . 0.80000000000000004 113.001 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 18.38 1.87 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.486 2.402 . . . . 2.3199999999999998 117.486 -167.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.58 70.89 0.61 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.002 0.921 . . . . 1.3100000000000001 110.198 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.714 HD12 HG11 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -124.18 168.56 12.57 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.187 0.995 . . . . 1.73 109.325 170.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -52.8 137.17 60.29 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.987 1.792 . . . . 1.1799999999999999 110.825 159.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -89.57 26.42 0.54 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.85 2.367 . . . . 1.4099999999999999 114.243 -151.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.53 -149.23 8.64 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 123.387 1.548 . . . . 1.3400000000000001 115.677 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.38 139.97 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.268 2.227 . . . . 3.2599999999999998 111.511 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -131.47 131.63 43.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.522 0.729 . . . . 1.3300000000000001 110.911 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.38 152.76 47.01 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-N 118.782 0.719 . . . . 0.73999999999999999 111.646 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.417 ' CE1' ' CE2' ' A' ' 33' ' ' PHE . 5.2 t80 -128.36 108.92 10.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.054 -1.462 . . . . 1.8799999999999999 107.054 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -112.43 165.57 12.09 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.829 1.418 . . . . 0.70999999999999996 114.829 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.69 138.08 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.997 1.719 . . . . 1.1899999999999999 108.251 158.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -118.31 155.01 31.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.258 1.823 . . . . 0.95999999999999996 108.985 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.11 73.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.625 1.713 . . . . 0.77000000000000002 115.625 -157.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -132.21 163.63 28.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.283 1.033 . . . . 1.3700000000000001 112.816 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.47 84.58 1.16 Allowed Glycine 0 N--CA 1.469 0.85 0 O-C-N 120.822 -1.174 . . . . 0.94999999999999996 113.55 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -160.11 89.58 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.152 0.977 . . . . 2.3100000000000001 113.127 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.7 m -67.53 48.72 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.136 2.574 . . . . 1.45 113.759 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -131.61 139.79 36.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.215 1.406 . . . . 3.3500000000000001 112.663 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.38 166.19 4.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.887 3.058 . . . . 0.89000000000000001 112.848 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.67 144.32 42.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.073 0.949 . . . . 1.5 110.098 164.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.4 59.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.224 1.01 . . . . 3.0099999999999998 109.742 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 152.65 42.8 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.774 -0.579 . . . . 4.25 110.226 165.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t0 54.75 18.91 2.3 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.916 1.686 . . . . 3.75 114.131 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.18 77.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.075 1.321 . . . . 2.9199999999999999 114.644 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.23 146.43 40.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.702 1.251 . . . . 3.3500000000000001 111.18 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.64 18.57 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.899 -1.125 . . . . 1.7 113.383 -165.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.08 92.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.545 1.138 . . . . 1.9399999999999999 109.645 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -24.95 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 130.193 3.397 . . . . 2.02 118.61 -166.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.501 ' HB3' HH21 ' A' ' 147' ' ' ARG . . . -151.21 124.01 8.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.861 0.755 . . . . 1.8999999999999999 109.905 158.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.61 -48.7 4.24 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.846 0.858 . . . . 4.2400000000000002 110.252 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.28 -14.96 59.09 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.59 1.33 . . . . 1.3300000000000001 114.59 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.09 -7.9 10.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.931 1.292 . . . . 0.90000000000000002 114.227 169.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.3 -28.09 11.81 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 120.58 -1.325 . . . . 3.1800000000000002 115.046 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.4 -170.93 20.82 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.396 1.474 . . . . 1.3799999999999999 111.774 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -60.85 148.69 38.52 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.077 0.938 . . . . 3.0299999999999998 110.149 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.5 tp -78.06 73.08 4.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.758 1.223 . . . . 1.97 111.919 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.48 104.15 28.49 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.65 1.18 . . . . 3.8300000000000001 110.606 158.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.5 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.236 2.624 . . . . 1.98 110.96 159.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -166.39 3.22 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.617 1.34 . . . . 4.2599999999999998 114.617 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -68.45 -27.3 66.05 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.311 -1.493 . . . . 3.96 114.27 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 81' ' ' LYS . 18.9 m 114.47 139.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 1 C-N-CA 132.05 4.14 . . . . 4.8300000000000001 107.138 -161.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.16 -12.97 56.93 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.093 1.33 . . . . 2.1000000000000001 114.42 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.427 ' H ' HG22 ' A' ' 79' ' ' THR . 52.3 mttp -64.15 -6.0 5.84 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.441 2.015 . . . . 5.3899999999999997 116.441 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.2 t60 83.22 144.8 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.207 2.203 . . . . 1.6799999999999999 114.571 166.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -81.92 150.14 27.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.238 1.815 . . . . 3.6099999999999999 110.982 -173.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.04 -112.95 0.39 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.659 -1.079 . . . . 2.4700000000000002 114.619 171.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.63 -18.95 25.0 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.329 2.686 . . . . 3.3900000000000001 112.453 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -123.11 155.96 35.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.89 2.076 . . . . 4.9299999999999997 107.424 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.53 120.23 6.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.838 0.732 . . . . 3.0 111.61 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.69 21.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.107 2.163 . . . . 4.4400000000000004 113.496 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.18 -151.8 13.33 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 123.208 1.449 . . . . 3.0699999999999998 115.177 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -74.87 139.95 43.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.041 -1.079 . . . . 3.2400000000000002 111.352 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -62.5 -21.65 65.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.342 0.497 . . . . 2.3599999999999999 112.342 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.94 26.32 6.15 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.669 1.604 . . . . 1.04 115.425 172.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -111.17 131.68 54.91 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.778 1.789 . . . . 1.5 110.566 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.26 160.81 60.61 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.703 1.601 . . . . 2.2000000000000002 110.452 -163.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.49 159.69 32.28 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.607 2.871 . . . . 0.90000000000000002 112.526 -170.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 m -69.55 132.08 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 123.251 1.5 . . . . 1.6200000000000001 114.81 -163.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.97 75.11 4.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.5 3.12 . . . . 1.6799999999999999 109.072 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.06 136.09 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.046 -1.034 . . . . 1.0900000000000001 111.398 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 40' ' ' LEU . 3.3 m -114.17 162.92 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.094 0.958 . . . . 2.0600000000000001 110.151 161.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -88.96 171.0 10.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.101 0.56 . . . . 2.6000000000000001 112.255 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -16.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 128.003 2.521 . . . . 2.9100000000000001 117.804 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -96.66 -7.39 34.26 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.052 2.141 . . . . 2.8999999999999999 113.381 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.46 21.0 30.51 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 119.135 0.879 . . . . 1.0600000000000001 114.755 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.25 129.09 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.428 1.114 . . . . 1.54 111.961 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.686 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -99.42 126.85 45.39 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.29 2.236 . . . . 0.80000000000000004 111.159 -172.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -157.19 18.2 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.962 1.097 . . . . 1.25 113.962 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -89.35 113.34 56.07 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.47 1.108 . . . . 3.2799999999999998 109.372 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.54 138.91 19.92 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.191 3.261 . . . . 1.0700000000000001 111.365 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.84 167.41 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.454 1.101 . . . . 1.1599999999999999 111.464 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -136.5 134.09 37.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.256 1.022 . . . . 0.89000000000000001 110.59 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.22 93.49 39.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.315 1.046 . . . . 0.71999999999999997 112.674 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -77.65 94.77 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.361 2.707 . . . . 3.1800000000000002 108.452 160.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -50.7 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.967 1.707 . . . . 5.2000000000000002 109.11 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.12 162.57 25.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.078 1.351 . . . . 2.29 108.103 141.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -121.22 -24.67 5.43 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.219 1.192 . . . . 4.4900000000000002 114.219 162.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 m -124.16 150.43 45.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.607 1.094 . . . . 2.3700000000000001 113.922 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -37.2 86.57 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.208 -0.932 . . . . 2.2999999999999998 110.842 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.93 -16.92 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.231 1.567 . . . . 3.8900000000000001 115.231 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -83.53 -6.87 59.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 2.1699999999999999 112.313 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.05 11.92 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.522 1.129 . . . . 0.80000000000000004 113.417 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -65.66 13.25 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 117.756 2.502 . . . . 2.79 117.756 -172.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.73 23.14 0.69 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.423 1.889 . . . . 3.1299999999999999 112.018 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -121.02 174.87 6.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.292 1.219 . . . . 1.24 114.292 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.28 140.48 44.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.722 1.209 . . . . 0.54000000000000004 111.249 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.87 141.42 28.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 1.78 107.056 161.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.4 mtt -133.34 131.51 40.2 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.408 1.004 . . . . 1.23 112.173 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.3 110.37 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.64 1.176 . . . . 0.66000000000000003 108.298 170.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.83 142.99 29.36 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.876 2.071 . . . . 2.3500000000000001 111.737 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -58.95 -38.51 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 112.974 0.731 . . . . 1.54 112.974 -164.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.17 169.92 14.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.722 1.153 . . . . 1.5600000000000001 111.473 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.26 166.78 24.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.458 1.028 . . . . 1.8500000000000001 112.559 161.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.6 6.18 1.84 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.217 1.192 . . . . 2.7799999999999998 114.217 -134.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.005 2.122 . . . . 3.9900000000000002 114.759 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.5 mtm -138.71 63.44 1.52 Allowed 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.402 -1.436 . . . . 2.5099999999999998 113.375 -161.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -64.69 -34.28 77.94 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.337 1.236 . . . . 3.0899999999999999 114.337 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.38 67.34 9.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.965 1.098 . . . . 3.7999999999999998 113.965 -162.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.61 154.81 25.97 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.703 1.601 . . . . 3.23 110.989 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.37 -23.15 38.49 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.466 2.777 . . . . 2.7000000000000002 112.426 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.98 90.22 1.49 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.002 -1.11 . . . . 3.9100000000000001 108.002 154.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.0 169.28 18.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.077 2.518 . . . . 3.8500000000000001 111.445 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt 70.47 16.52 7.04 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.381 1.872 . . . . 3.8100000000000001 110.602 -167.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 3.48 24.38 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.208 1.385 . . . . 2.8399999999999999 113.839 -164.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.79 -1.34 52.23 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.785 1.659 . . . . 1.8899999999999999 114.036 -165.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.3 43.41 1.28 Allowed Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.53 2.014 . . . . 1.6599999999999999 115.239 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.58 -16.93 77.7 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.835 1.207 . . . . 1.8300000000000001 115.055 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 p -76.52 146.71 38.25 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.532 1.533 . . . . 1.47 112.742 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.501 HH21 ' HB3' ' A' ' 67' ' ' ALA . 1.1 mpp_? -105.23 138.98 40.57 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.83 1.652 . . . . 4.4400000000000004 110.39 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -91.55 -28.82 17.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.625 0.37 . . . . 2.6400000000000001 111.266 164.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.72 159.68 44.15 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.608 0.966 . . . . 0.48999999999999999 113.608 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 32.7 t -140.92 146.7 37.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.965 2.106 . . . . 1.4099999999999999 110.316 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -141.98 100.44 0.26 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.079 1.799 . . . . 0.72999999999999998 111.633 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.75 135.86 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.013 1.325 . . . . 2.3500000000000001 111.729 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.56 150.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.37 1.468 . . . . 1.47 110.712 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.476 0.844 0 O-C-N 121.599 -0.688 . . . . 3.9199999999999999 112.644 -177.404 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.549 0.214 . . . . 1.8899999999999999 111.55 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -153.61 152.68 31.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.853 1.261 . . . . 1.27 109.549 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.2 132.4 11.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 123.071 1.415 . . . . 2.3100000000000001 110.065 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -90.01 124.8 35.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 4.1900000000000004 111.241 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.01 101.06 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 120.859 -1.15 . . . . 1.48 108.282 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 109.36 2.81 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.272 1.415 . . . . 1.0800000000000001 109.907 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 77.6 mmm -87.35 149.35 24.56 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.925 0.89 . . . . 1.8799999999999999 110.685 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.62 145.73 50.02 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.823 1.649 . . . . 2.5600000000000001 109.954 168.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.79 140.43 58.87 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.617 -0.677 . . . . 1.6000000000000001 109.572 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.79 152.61 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.693 0.759 . . . . 1.02 110.821 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -151.87 -165.08 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.794 1.638 . . . . 2.6400000000000001 107.599 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.4 -0.15 1.22 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.233 2.213 . . . . 1.7 113.326 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -109.71 -9.98 14.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.502 1.921 . . . . 2.71 111.875 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.53 -161.85 21.39 Favored Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.014 1.292 . . . . 1.1100000000000001 113.85 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.71 127.32 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.392 1.877 . . . . 0.90000000000000002 111.693 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.69 -86.09 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.643 1.592 . . . . 1.47 114.262 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.49 170.5 22.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.784 2.434 . . . . 2.0299999999999998 109.199 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -106.22 159.47 16.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.76 8.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 128.899 2.879 . . . . 3.2200000000000002 113.034 -169.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.13 168.67 15.47 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.694 1.14 . . . . 0.84999999999999998 113.4 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 p -115.19 -177.27 3.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.534 1.534 . . . . 0.85999999999999999 109.335 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.45 138.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.821 -1.548 . . . . 0.68999999999999995 106.821 158.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 p -91.78 131.87 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.077 0.398 . . . . 0.93000000000000005 110.556 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -107.63 131.66 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.343 1.057 . . . . 1.4399999999999999 109.218 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.51 145.18 50.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.92 0.888 . . . . 1.9199999999999999 111.036 170.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.354 8.4 tm-20 -101.38 107.23 18.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.741 2.816 . . . . 3.79 108.129 -162.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -130.7 175.6 8.89 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.839 1.199 . . . . 2.8399999999999999 112.128 -167.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.82 -8.41 57.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.436 1.094 . . . . 5.6299999999999999 112.794 172.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.71 14.63 58.94 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.035 1.302 . . . . 1.1399999999999999 113.27 159.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.27 -151.05 32.57 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 128.299 2.857 . . . . 0.79000000000000004 115.592 174.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -69.68 112.76 6.37 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.758 -0.848 . . . . 0.94999999999999996 112.963 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -88.86 106.77 18.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.938 2.095 . . . . 2.0499999999999998 110.787 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -92.8 117.09 29.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.574 2.35 . . . . 0.62 108.912 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -125.77 114.93 24.69 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-N 120.478 1.49 . . . . 0.68999999999999995 109.327 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.1 163.4 5.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.323 2.682 . . . . 0.55000000000000004 112.379 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -151.86 20.37 0.69 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.703 1.001 . . . . 1.51 113.703 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.74 145.21 28.04 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.011 -1.055 . . . . 0.81000000000000005 111.749 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -119.2 19.91 12.74 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.869 1.803 . . . . 2.7400000000000002 115.869 -164.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.86 54.81 0.66 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.794 0.838 . . . . 1.51 112.174 -165.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.95 160.34 69.03 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.997 0.919 . . . . 1.5600000000000001 112.553 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 37.5 Cg_endo -62.59 132.73 39.17 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.871 1.714 . . . . 1.27 110.711 174.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.407 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 15.7 Cg_endo -89.04 25.39 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.679 2.253 . . . . 1.29 114.259 -143.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.34 -152.85 12.49 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 116.908 1.523 . . . . 1.25 116.908 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.96 147.04 23.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.95 2.1 . . . . 2.4700000000000002 109.851 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -149.2 148.15 29.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.087 0.955 . . . . 1.1899999999999999 112.842 -165.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.53 156.63 53.51 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.191 -0.943 . . . . 0.56000000000000005 110.936 162.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.34 121.59 11.56 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 106.134 -1.802 . . . . 1.9299999999999999 106.134 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -126.99 170.69 12.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.685 1.735 . . . . 0.97999999999999998 115.685 175.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -101.56 143.06 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.281 1.832 . . . . 0.68000000000000005 109.492 160.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -129.57 141.09 51.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.712 2.005 . . . . 1.0900000000000001 109.641 -172.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -28.49 66.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.059 2.244 . . . . 0.71999999999999997 117.059 -158.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -127.29 152.17 47.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.443 1.019 . . . . 1.1799999999999999 112.739 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.81 78.79 1.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.358 0.98 . . . . 0.95999999999999996 111.785 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -164.54 72.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.103 0.954 . . . . 2.1400000000000001 113.316 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.4 m -68.16 8.84 0.38 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.83 2.159 . . . . 1.6000000000000001 116.83 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.17 138.79 52.55 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.089 -1.632 . . . . 3.7200000000000002 110.771 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.28 165.67 6.77 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.217 3.278 . . . . 1.4199999999999999 111.341 172.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.56 -172.08 2.58 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.54 0.686 . . . . 2.5699999999999998 109.808 150.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.1 mm -96.64 146.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.728 1.211 . . . . 3.5899999999999999 109.402 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.0 138.95 3.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.504 2.322 . . . . 5.4800000000000004 108.866 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.84 32.0 16.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.233 1.413 . . . . 5.9000000000000004 112.621 -173.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.89 3.53 87.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.186 1.374 . . . . 3.3999999999999999 115.605 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.98 157.91 45.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.077 1.438 . . . . 4.6799999999999997 112.563 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.51 131.52 34.63 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.886 -1.134 . . . . 2.1699999999999999 112.269 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.0 33.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.382 0.882 . . . . 2.1400000000000001 113.382 -172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.61 -6.38 0.12 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 119.184 3.031 . . . . 2.6299999999999999 119.184 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 131.93 101.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 1 C-N-CA 133.005 4.522 . . . . 1.45 106.506 -173.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.41 -59.41 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.203 1.001 . . . . 4.7000000000000002 111.872 -154.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.31 -17.86 59.84 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.156 0.798 . . . . 1.6000000000000001 113.156 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.96 0.68 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.031 2.132 . . . . 0.81999999999999995 115.634 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.69 25.29 9.99 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 116.272 1.269 . . . . 2.9300000000000002 116.272 159.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 -119.83 5.12 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 110.452 -1.059 . . . . 2.7799999999999998 110.452 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -97.47 -102.47 0.19 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.144 -1.058 . . . . 3.54 108.144 149.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.5 tp -174.24 93.32 0.08 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.494 2.318 . . . . 1.8700000000000001 108.672 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -159.64 124.52 2.19 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 125.651 1.581 . . . . 4.2400000000000002 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.03 -31.56 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.478 2.785 . . . . 2.27 114.568 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -160.2 -7.91 0.05 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.328 1.422 . . . . 3.6899999999999999 114.388 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -76.01 -48.89 19.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.244 1.018 . . . . 3.2799999999999998 112.61 -160.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -163.34 -41.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.473 1.286 . . . . 2.9100000000000001 114.473 -174.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.52 -19.98 2.32 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.047 -1.418 . . . . 2.3199999999999998 114.538 -167.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -72.0 -80.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.212 2.006 . . . . 4.1900000000000004 113.289 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.8 t60 160.69 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 130.27 3.428 . . . . 1.52 111.027 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.411 ' CG ' ' H ' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -71.75 -154.29 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.345 1.458 . . . . 3.1600000000000001 111.939 173.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 83' ' ' GLU . . . 113.76 -80.1 0.28 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.801 1.667 . . . . 3.0800000000000001 112.259 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.49 -7.77 5.6 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.849 3.033 . . . . 4.8099999999999996 113.668 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -153.45 145.18 23.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.607 1.563 . . . . 5.2400000000000002 110.457 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.35 84.25 1.42 Allowed Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.986 1.279 . . . . 2.7000000000000002 112.068 -173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.72 13.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.526 1.53 . . . . 4.5 113.011 -162.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.3 -161.68 37.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.489 1.519 . . . . 2.2799999999999998 115.223 -168.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -74.58 133.68 42.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.924 -0.638 . . . . 3.7999999999999998 109.65 173.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.93 2.66 3.26 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.085 1.883 . . . . 2.7200000000000002 116.085 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.87 0.32 51.97 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.892 1.711 . . . . 1.25 115.129 168.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -79.0 147.02 33.04 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.956 1.378 . . . . 1.6799999999999999 111.673 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.92 159.05 27.33 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.812 0.845 . . . . 1.8100000000000001 110.282 -144.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.04 149.33 64.96 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.359 2.706 . . . . 1.05 112.419 -171.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.37 128.23 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.438 1.113 . . . . 1.76 112.983 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.0 tp -82.51 132.09 35.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.513 2.725 . . . . 2.3799999999999999 110.315 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.69 137.67 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.84 -1.162 . . . . 0.95999999999999996 109.662 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.49 151.97 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 107.434 -1.321 . . . . 2.2200000000000002 107.434 161.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.06 157.5 26.7 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.384 0.513 . . . . 2.1699999999999999 112.384 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 10.1 p30 -58.96 -10.11 2.3 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.724 1.75 . . . . 2.6499999999999999 115.724 -174.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.79 -12.59 41.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 2.4399999999999999 113.597 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.63 17.04 11.66 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.081 1.324 . . . . 0.72999999999999998 116.037 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.46 134.96 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.541 1.171 . . . . 1.8899999999999999 110.707 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.14 135.6 33.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.891 1.676 . . . . 0.85999999999999999 111.379 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -158.83 -19.79 0.07 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.271 1.582 . . . . 1.0 115.271 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.37 122.33 82.58 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.403 1.002 . . . . 3.6800000000000002 110.097 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.71 163.22 18.75 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.511 2.807 . . . . 1.5700000000000001 111.989 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 m -141.26 160.51 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.157 1.383 . . . . 1.3 110.267 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 138.41 52.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.948 0.899 . . . . 0.89000000000000001 109.743 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.97 88.23 6.65 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.522 1.129 . . . . 0.73999999999999999 112.051 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.76 5.41 1.71 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.041 3.16 . . . . 1.3300000000000001 115.974 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -15.47 52.44 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.531 1.06 . . . . 8.5199999999999996 112.633 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.93 136.65 20.52 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.04 0.936 . . . . 3.2000000000000002 111.754 -170.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 9.36 1.44 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.235 1.939 . . . . 5.6100000000000003 116.235 -154.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -147.54 128.19 14.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.538 -0.541 . . . . 2.1699999999999999 109.538 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.77 -29.85 67.1 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.725 1.148 . . . . 1.8600000000000001 112.436 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.49 -24.23 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.291 1.837 . . . . 3.04 114.284 171.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.61 -4.46 58.95 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 120.093 1.315 . . . . 2.0699999999999998 114.25 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.03 12.96 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.586 1.154 . . . . 0.91000000000000003 113.874 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.38 17.16 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.197 2.295 . . . . 2.6200000000000001 117.197 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -150.09 11.6 0.73 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.503 1.921 . . . . 3.0 112.383 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -100.84 172.06 7.28 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.63 -1.294 . . . . 1.5900000000000001 113.418 -171.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.14 144.28 35.75 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.883 0.873 . . . . 0.53000000000000003 110.212 161.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.9 141.09 36.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.779 1.632 . . . . 1.95 106.673 164.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.5 mtt -137.32 130.56 30.94 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.946 -1.096 . . . . 1.3 111.975 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.4 mt -83.85 131.68 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.092 -1.077 . . . . 0.83999999999999997 108.092 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.2 149.1 42.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.611 1.564 . . . . 2.3500000000000001 112.125 -168.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.5 -52.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.655 -0.653 . . . . 1.27 110.005 -168.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.85 169.17 29.51 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.127 0.87 . . . . 1.1899999999999999 111.769 169.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.22 -164.49 5.98 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.967 2.699 . . . . 2.6299999999999999 115.913 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.39 84.01 2.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.018 2.127 . . . . 3.4199999999999999 106.676 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -160.39 -8.06 0.05 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.254 1.576 . . . . 3.6899999999999999 115.254 -165.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.5 ptp -148.31 142.06 25.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.242 1.383 . . . . 2.8900000000000001 113.945 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 p -156.82 12.89 0.26 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.146 1.165 . . . . 2.98 114.146 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.51 -40.38 14.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.138 1.775 . . . . 4.5999999999999996 113.845 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.51 143.35 79.09 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.94 0.896 . . . . 3.3700000000000001 112.036 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.81 -31.84 24.28 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.148 2.565 . . . . 1.95 114.751 -165.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -73.81 115.45 42.2 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.289 1.404 . . . . 4.0499999999999998 108.731 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.23 144.84 64.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.014 2.476 . . . . 2.6400000000000001 112.716 -159.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 58.98 19.32 7.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.103 1.761 . . . . 3.2999999999999998 112.638 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.97 56.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.813 -0.993 . . . . 2.7999999999999998 113.755 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.89 -8.35 73.52 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.964 1.745 . . . . 1.8 114.418 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.01 -8.84 79.22 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.14 1.47 . . . . 1.3899999999999999 116.097 -169.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.83 2.29 25.73 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.921 1.248 . . . . 1.55 115.5 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 p -69.42 151.38 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.924 1.69 . . . . 1.49 110.789 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.31 150.16 22.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.318 1.447 . . . . 5.0300000000000002 110.268 -172.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -110.43 -34.77 6.23 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.31 0.485 . . . . 2.5499999999999998 112.31 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.8 144.74 24.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.776 1.028 . . . . 0.96999999999999997 113.776 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.9 t -104.82 139.61 39.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.93 2.492 . . . . 2.1200000000000001 110.903 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.27 87.67 0.25 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.978 2.704 . . . . 1.1399999999999999 111.052 173.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.98 135.53 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.84 . . . . 1.53 109.246 166.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.42 137.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.626 1.17 . . . . 2.0099999999999998 111.359 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 11.2 mmpt? . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.183 . . . . 3.8399999999999999 113.504 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 121.752 0.787 . . . . 1.6299999999999999 111.38 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -169.12 151.77 4.84 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.551 1.54 . . . . 1.4299999999999999 108.143 -154.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.9 124.07 5.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 123.05 1.405 . . . . 2.6299999999999999 111.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -84.15 89.52 7.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.928 2.091 . . . . 3.4700000000000002 110.796 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -87.28 116.44 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.475 -0.765 . . . . 1.05 110.239 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.34 109.0 2.66 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.238 1.399 . . . . 0.72999999999999998 110.009 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.8 mtp -94.02 140.42 29.74 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.558 0.743 . . . . 1.1699999999999999 112.778 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -121.24 150.4 41.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.8 1.64 . . . . 2.6299999999999999 112.994 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.7 mt -71.6 73.42 0.77 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.207 2.603 . . . . 1.28 110.974 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.65 124.4 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.338 -0.851 . . . . 1.6000000000000001 109.947 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.5 t -160.28 74.49 0.55 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.963 1.098 . . . . 2.4199999999999999 113.963 -166.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.66 -42.62 0.52 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.167 2.187 . . . . 1.4399999999999999 114.561 163.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -6.7 50.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.947 1.299 . . . . 2.4500000000000002 112.071 169.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.47 -164.53 13.93 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.029 2.252 . . . . 1.4099999999999999 111.496 -173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.56 129.8 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.054 . . . . 1.27 110.255 161.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.64 -140.62 11.27 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.904 1.24 . . . . 2.0699999999999998 113.881 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.93 167.08 14.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.675 1.19 . . . . 1.9199999999999999 111.087 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -103.22 172.94 6.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.813 1.645 . . . . 1.3700000000000001 113.183 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.03 1.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 128.188 2.595 . . . . 3.48 113.138 -165.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.17 -177.44 20.29 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.148 1.356 . . . . 0.56000000000000005 112.714 -166.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.87 165.43 18.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.075 0.95 . . . . 1.04 109.411 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 40.9 t -110.67 129.32 66.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.558 -1.275 . . . . 0.56999999999999995 107.558 157.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.18 130.63 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 122.011 0.91 . . . . 2.6299999999999999 110.204 166.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -99.39 139.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.9 -1.148 . . . . 1.2 107.9 167.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -135.52 127.06 28.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.908 1.283 . . . . 2.3199999999999998 109.935 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.03 140.0 29.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.207 0.603 . . . . 3.5699999999999998 111.059 -171.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t -154.54 -178.99 7.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.5 0.72 . . . . 1.49 110.433 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -64.38 -23.8 67.41 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.659 1.584 . . . . 3.7999999999999998 113.546 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.07 16.68 59.02 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.283 1.42 . . . . 1.3600000000000001 113.848 166.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 115' ' ' LYS . . . 75.44 -144.49 31.81 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 129.241 3.305 . . . . 1.0 114.859 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.2 mt -71.71 109.17 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.291 0.636 . . . . 0.81999999999999995 111.088 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -80.58 107.34 13.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.268 1.427 . . . . 1.95 109.594 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -91.75 116.52 28.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.035 1.734 . . . . 0.70999999999999996 109.713 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.8 m -128.87 106.52 18.35 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.877 -0.582 . . . . 0.84999999999999998 110.332 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.09 154.72 14.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.897 3.065 . . . . 0.47999999999999998 112.405 -171.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -146.01 48.88 1.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.664 0.745 . . . . 1.6200000000000001 112.626 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.47 150.95 24.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.84999999999999998 112.228 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 22.0 5.52 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.393 1.627 . . . . 2.0699999999999998 115.393 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.24 83.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.112 0.965 . . . . 2.0699999999999998 110.706 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 164.68 31.62 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 124.803 1.241 . . . . 1.3899999999999999 110.535 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.48 138.46 85.92 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.13 1.22 . . . . 1.1899999999999999 110.07 169.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -90.81 24.67 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.333 2.022 . . . . 1.3100000000000001 114.428 -151.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.5 -154.62 20.58 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.181 1.372 . . . . 1.3 115.28 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 152.29 19.07 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.064 -1.256 . . . . 2.6699999999999999 110.539 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -149.41 122.78 9.03 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.674 1.59 . . . . 1.3400000000000001 111.291 -162.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.56 150.29 3.54 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 120.307 1.412 . . . . 0.59999999999999998 112.175 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.448 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -135.97 125.58 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.248 -1.39 . . . . 2.0600000000000001 107.248 173.157 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -124.28 172.31 9.19 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.118 1.525 . . . . 1.1100000000000001 115.118 167.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.38 141.66 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.747 1.619 . . . . 0.81000000000000005 109.168 159.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.27 154.3 46.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.986 2.114 . . . . 0.97999999999999998 110.583 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.93 60.63 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 117.362 2.356 . . . . 1.04 117.362 -150.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -137.69 148.86 46.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.122 1.328 . . . . 1.54 113.325 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.57 74.18 2.14 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.581 1.086 . . . . 1.1899999999999999 114.151 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 t -164.79 76.9 0.31 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.058 0.932 . . . . 2.3199999999999998 113.346 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.9 m -70.02 28.43 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.951 2.1 . . . . 1.8300000000000001 115.74 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -92.22 135.44 26.95 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.514 -1.366 . . . . 3.29 110.943 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.17 157.2 11.21 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.274 3.316 . . . . 1.3400000000000001 113.231 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.77 144.53 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.104 0.962 . . . . 1.8400000000000001 110.08 161.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mm -97.76 48.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.316 1.047 . . . . 3.7000000000000002 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -61.89 137.83 58.29 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.761 -1.212 . . . . 5.5700000000000003 111.313 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.94 26.35 9.73 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.182 0.993 . . . . 4.0800000000000001 112.921 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.71 83.34 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.96 -1.087 . . . . 2.7400000000000002 114.723 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.91 144.46 48.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.264 1.532 . . . . 3.2000000000000002 111.178 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.3 105.8 12.78 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.835 -1.165 . . . . 1.48 111.776 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 t -77.98 62.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.402 1.481 . . . . 2.6299999999999999 111.688 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.2 -63.15 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.852 3.261 . . . . 2.0099999999999998 116.756 169.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.4 119.8 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 131.555 3.942 . . . . 2.3799999999999999 108.648 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -100.46 -47.75 4.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.693 1.133 . . . . 4.8399999999999999 111.561 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.8 2.92 4.68 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 115.21 1.559 . . . . 1.53 115.21 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.52 -3.84 48.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.119 2.168 . . . . 1.3700000000000001 114.674 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 -13.83 55.01 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.037 1.575 . . . . 3.7400000000000002 117.037 165.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.09 -168.78 15.18 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.043 1.306 . . . . 1.3899999999999999 114.697 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 12.64 1.63 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.196 2.199 . . . . 2.3100000000000001 114.107 -175.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.8 tp 61.25 56.2 2.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.15 1.78 . . . . 1.5 109.15 -169.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -122.74 62.94 18.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.901 2.08 . . . . 4.2199999999999998 112.414 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.43 -38.43 26.05 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.83 2.353 . . . . 2.0 112.689 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -168.4 139.22 2.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.631 1.972 . . . . 3.5499999999999998 107.664 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 p30 157.69 -162.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 130.348 3.459 . . . . 4.2999999999999998 110.337 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -74.49 -11.83 60.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.265 2.626 . . . . 3.1299999999999999 116.048 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.65 -32.17 1.66 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.977 1.275 . . . . 2.2200000000000002 116.081 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -64.91 -9.84 24.23 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.151 2.278 . . . . 5.3099999999999996 117.151 -167.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.4 t60 75.08 153.52 0.14 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.427 2.291 . . . . 1.5600000000000001 112.238 -171.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -152.13 148.51 27.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.287 1.835 . . . . 4.9299999999999997 109.874 -169.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.35 -82.39 1.07 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.055 -1.414 . . . . 3.3399999999999999 109.882 163.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.01 -26.12 3.1 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.898 3.065 . . . . 4.54 115.942 -166.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.54 -157.55 0.62 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 120.091 1.314 . . . . 5.2999999999999998 111.383 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.98 13.59 37.7 Favored Glycine 0 N--CA 1.475 1.287 0 C-N-CA 124.979 1.276 . . . . 3.8799999999999999 115.195 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -100.25 51.76 0.89 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.052 1.426 . . . . 5.1200000000000001 112.301 -169.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.61 -143.71 4.9 Favored Glycine 0 N--CA 1.473 1.101 0 O-C-N 120.921 -1.112 . . . . 2.6699999999999999 115.608 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.06 147.73 22.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.705 1.202 . . . . 3.96 112.405 -168.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.88 -20.97 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.682 1.364 . . . . 2.0299999999999998 114.682 -174.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.06 -2.06 86.4 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.297 0.951 . . . . 0.85999999999999999 114.796 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.98 136.63 33.98 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.517 1.127 . . . . 1.77 111.99 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.42 167.61 14.17 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 126.092 1.757 . . . . 1.9099999999999999 109.861 -143.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.82 173.95 11.53 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.281 3.321 . . . . 1.0600000000000001 113.792 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.37 125.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.638 1.175 . . . . 2.0499999999999998 112.186 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 90.31 2.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.58 2.752 . . . . 1.8600000000000001 109.854 166.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.9 t -68.28 126.44 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.018 -1.051 . . . . 0.81999999999999995 109.092 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.97 162.67 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.931 1.292 . . . . 2.1200000000000001 108.411 167.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.47 160.47 16.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.759 1.022 . . . . 2.21 113.759 -176.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -15.68 0.29 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 127.957 2.503 . . . . 2.4700000000000002 117.438 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.09 -0.93 38.06 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.907 1.683 . . . . 3.2000000000000002 113.089 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.8 25.66 22.01 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.93 1.252 . . . . 0.88 114.432 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.9 mt -129.64 140.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 1.1200000000000001 109.955 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.4 129.0 56.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.349 1.86 . . . . 0.87 111.607 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 t -153.31 0.74 0.25 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.784 1.772 . . . . 1.3400000000000001 115.784 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -86.03 126.77 64.4 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.585 1.154 . . . . 3.3799999999999999 110.542 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.05 156.3 26.41 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.095 2.53 . . . . 1.3100000000000001 112.16 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.92 167.06 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 126.358 1.863 . . . . 1.3 109.591 167.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 m -140.06 140.48 36.14 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 1.23 111.053 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.63 114.24 15.54 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.482 1.113 . . . . 1.3300000000000001 112.691 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.14 5.15 6.2 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.26 3.307 . . . . 1.25 115.213 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -77.36 -19.17 56.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.566 0.951 . . . . 4.4699999999999998 113.566 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.56 144.99 46.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.423 1.889 . . . . 2.5 106.946 169.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.8 mtpt -131.06 -9.37 3.84 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.455 1.28 . . . . 4.0499999999999998 114.455 -160.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -157.98 142.2 15.98 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.929 1.292 . . . . 2.02 111.781 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.081 -1.012 . . . . 2.3900000000000001 113.172 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.97 -15.65 45.37 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 119.533 1.06 . . . . 3.1299999999999999 113.168 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.11 -22.29 63.98 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.47 -0.769 . . . . 1.97 112.793 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.02 20.97 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.655 1.582 . . . . 0.95999999999999996 112.689 -167.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -68.86 27.47 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.215 2.206 . . . . 2.0299999999999998 116.012 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.96 3.02 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.529 2.732 . . . . 3.21 113.024 173.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -108.19 172.15 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 1.4299999999999999 113.149 -166.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.0 150.06 39.23 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.247 1.019 . . . . 0.75 113.195 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.3 mt -89.66 152.29 21.44 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.169 1.788 . . . . 2.2599999999999998 109.01 161.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.8 mtt -141.31 127.8 20.06 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.597 0.635 . . . . 1.26 112.185 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.45 130.73 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.957 1.303 . . . . 0.68000000000000005 107.577 166.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.28 137.59 53.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.218 2.207 . . . . 1.8500000000000001 111.236 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -64.85 -42.83 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.326 1.05 . . . . 1.3300000000000001 112.781 -161.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -88.0 -106.01 0.95 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.1 1.333 . . . . 2.6600000000000001 112.041 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.48 -166.99 29.39 Favored Glycine 0 N--CA 1.462 0.404 0 O-C-N 121.233 -1.157 . . . . 1.78 111.75 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -162.9 145.97 10.82 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.622 1.169 . . . . 3.25 109.911 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 114.27 55.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 130.294 3.438 . . . . 4.3399999999999999 108.121 -154.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.3 ptp -169.63 37.02 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.044 1.338 . . . . 2.6400000000000001 113.455 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.61 61.31 2.31 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.078 -1.639 . . . . 3.4900000000000002 114.911 -169.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -140.25 -45.54 0.42 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 116.613 2.079 . . . . 4.2999999999999998 116.613 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.43 148.32 44.12 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.753 1.39 . . . . 3.8900000000000001 114.753 -156.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.44 -9.19 24.78 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.312 3.341 . . . . 1.97 115.555 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -101.43 78.34 0.21 Allowed Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.587 -0.894 . . . . 4.5999999999999996 108.587 154.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.73 152.38 82.21 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.758 2.972 . . . . 3.1299999999999999 112.355 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 mt 69.08 27.98 5.17 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.641 1.577 . . . . 4.0700000000000003 110.296 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.42 13.52 58.46 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.318 1.437 . . . . 3.0899999999999999 114.626 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.94 -6.9 46.32 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 118.676 1.238 . . . . 2.1299999999999999 114.375 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.87 5.94 56.73 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.488 1.994 . . . . 2.0899999999999999 114.089 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.8 2.56 7.91 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 118.613 1.206 . . . . 1.97 115.022 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 p -64.26 144.64 56.99 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.359 1.463 . . . . 1.54 109.655 169.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.92 137.58 36.92 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.001 0.92 . . . . 5.6500000000000004 112.605 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -91.46 -27.85 18.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.284 0.634 . . . . 2.2999999999999998 111.281 158.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.24 153.11 28.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.174 0.805 . . . . 0.57999999999999996 113.174 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.54 165.52 16.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.382 1.473 . . . . 1.47 110.755 165.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -160.82 136.43 4.46 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.658 1.123 . . . . 0.66000000000000003 112.797 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.11 133.45 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.657 1.183 . . . . 1.8999999999999999 110.603 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.0 141.2 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.503 1.121 . . . . 1.6499999999999999 111.068 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 123.981 0.913 . . . . 4.2800000000000002 112.769 -174.637 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.413 -0.217 . . . . 1.72 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -135.87 150.04 49.23 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.394 -1.441 . . . . 0.97999999999999998 114.763 -141.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -155.72 123.85 5.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.675 1.59 . . . . 2.3599999999999999 108.703 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.93 108.29 18.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.714 1.605 . . . . 4.8600000000000003 110.512 -171.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.15 126.38 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.339 0.656 . . . . 1.0600000000000001 110.14 -165.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.94 113.34 4.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.277 1.417 . . . . 0.77000000000000002 110.549 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.4 mmt -97.33 113.16 24.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.448 1.499 . . . . 1.54 110.586 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -102.2 149.55 24.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.287 1.035 . . . . 3.1699999999999999 112.108 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.31 61.98 1.25 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.395 1.078 . . . . 1.73 112.645 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.43 147.48 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.342 1.057 . . . . 1.22 112.489 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -177.44 134.85 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.798 1.639 . . . . 2.3199999999999998 111.338 163.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.67 -44.16 0.25 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.03 2.932 . . . . 1.1299999999999999 117.062 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 11.11 33.75 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.148 1.779 . . . . 3.0 110.844 172.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -133.23 11.69 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.996 1.284 . . . . 0.95999999999999996 110.684 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.19 134.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.862 1.665 . . . . 1.5900000000000001 111.031 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.53 -82.47 1.42 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.837 1.208 . . . . 2.3199999999999998 111.924 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.2 158.29 18.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.078 1.351 . . . . 2.0499999999999998 111.355 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.0 t -97.92 145.47 26.43 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.728 1.211 . . . . 1.7 112.977 -169.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.3 pt -142.85 3.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 114.837 1.421 . . . . 2.98 114.837 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.73 178.35 35.58 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 120.895 -1.128 . . . . 0.75 114.023 -170.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -131.14 178.41 6.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.352 1.061 . . . . 0.96999999999999997 109.054 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 38.3 t -131.05 133.99 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.095 -1.076 . . . . 0.45000000000000001 108.095 162.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 8.7 p -90.65 127.8 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.604 0.362 . . . . 0.81999999999999995 110.721 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.8 136.65 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.289 1.036 . . . . 1.75 108.825 169.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -141.91 113.5 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.215 1.406 . . . . 1.8500000000000001 110.744 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.77 153.55 39.94 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.733 0.813 . . . . 3.1200000000000001 112.063 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 t -167.68 -177.68 3.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.542 1.937 . . . . 1.23 109.149 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -53.1 -40.75 64.37 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.257 1.423 . . . . 3.8199999999999998 112.497 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 15.16 56.71 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.22 1.39 . . . . 0.84999999999999998 114.44 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 -152.78 42.48 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 127.36 2.41 . . . . 0.75 115.334 173.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.401 HD12 HD23 ' A' ' 114' ' ' LEU . 54.3 mt -65.53 104.34 0.99 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.701 0.801 . . . . 0.52000000000000002 113.135 -169.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -80.12 110.42 15.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.008 1.723 . . . . 2.5600000000000001 109.964 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 6.6 t80 -100.85 114.87 29.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.457 2.703 . . . . 0.66000000000000003 108.928 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.433 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.6 m -122.73 111.18 31.34 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 119.776 1.171 . . . . 0.56000000000000005 108.948 175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -84.08 158.55 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.525 2.817 . . . . 0.40999999999999998 111.66 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . 0.263 1.7 p80 -152.52 65.06 0.81 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 122.5 1.143 . . . . 1.23 111.664 172.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.59 151.26 45.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.35 1.86 . . . . 0.65000000000000002 111.535 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 37.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 117.509 2.411 . . . . 2.4500000000000002 117.509 -159.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.45 13.03 1.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.978 1.473 . . . . 2.4100000000000001 114.978 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.33 161.82 50.56 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 119.124 -0.465 . . . . 1.8200000000000001 111.359 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -60.96 129.78 30.18 Favored 'Trans proline' 0 N--CA 1.431 -2.157 0 O-C-N 123.241 1.127 . . . . 1.0600000000000001 109.756 162.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -86.45 22.86 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.665 3.577 . . . . 1.1000000000000001 113.269 -150.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.52 153.04 17.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 126.167 1.842 . . . . 1.9399999999999999 110.49 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -45.28 137.03 4.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.005 2.522 . . . . 3.2999999999999998 113.72 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -126.93 129.42 48.13 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 125.533 1.533 . . . . 0.94999999999999996 111.704 -172.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.14 158.18 1.72 Allowed Glycine 0 CA--C 1.543 1.843 0 CA-C-N 119.276 0.944 . . . . 0.66000000000000003 114.016 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.3 t80 -145.39 116.3 7.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.147 1.779 . . . . 1.8999999999999999 106.65 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -126.12 168.75 13.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.388 1.995 . . . . 0.75 116.388 165.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -99.08 135.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.391 1.876 . . . . 0.96999999999999997 110.09 154.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -105.6 176.14 5.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.822 1.649 . . . . 0.97999999999999998 111.963 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.9 62.59 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 116.744 2.127 . . . . 1.1899999999999999 116.744 -166.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -126.06 -159.68 0.93 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.6 1.56 . . . . 1.3100000000000001 111.277 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.87 66.73 0.37 Allowed Glycine 0 N--CA 1.476 1.323 0 N-CA-C 116.677 1.431 . . . . 1.01 116.677 -162.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -174.69 116.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.236 1.814 . . . . 2.5899999999999999 111.974 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -67.62 33.0 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 128.043 2.537 . . . . 1.46 115.183 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -104.89 126.61 30.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 119.996 -1.69 . . . . 3.0299999999999998 111.379 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.52 150.97 13.24 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.073 3.182 . . . . 1.3200000000000001 112.889 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 169.08 8.94 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.179 0.992 . . . . 1.9399999999999999 110.196 154.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 mm -97.9 124.1 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.948 -1.13 . . . . 2.8199999999999998 107.948 162.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -139.54 109.22 6.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.278 1.431 . . . . 5.0099999999999998 109.179 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t0 60.43 63.04 1.43 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.161 1.785 . . . . 4.2000000000000002 112.747 -166.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.39 13.33 54.34 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 115.711 1.045 . . . . 2.96 115.711 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -147.48 150.11 33.95 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.027 1.731 . . . . 3.3799999999999999 110.209 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.05 34.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.998 0.519 . . . . 1.45 111.896 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.5 t -67.94 -3.98 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.188 1.795 . . . . 2.9300000000000002 113.466 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.47 -50.56 0.69 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.499 2.72 . . . . 2.1600000000000001 112.575 -174.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.51 111.25 2.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.178 1.791 . . . . 1.72 109.682 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.89 -39.7 12.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.239 0.616 . . . . 5.0700000000000003 110.691 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.01 -4.2 30.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.114 1.153 . . . . 1.73 114.114 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.0 -18.9 27.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.178 1.391 . . . . 1.0800000000000001 112.631 168.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.31 178.1 31.53 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 122.319 0.955 . . . . 2.8500000000000001 113.516 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.69 -163.65 39.31 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.531 1.062 . . . . 1.3700000000000001 112.894 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -56.31 128.29 35.09 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.763 0.825 . . . . 3.04 109.591 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.32 66.72 0.18 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.681 1.993 . . . . 2.1299999999999999 112.34 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -111.21 113.55 54.2 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 4.6699999999999999 108.989 164.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -84.68 -31.27 0.46 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.288 1.992 . . . . 2.0800000000000001 113.302 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 176.9 29.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.869 2.068 . . . . 3.0699999999999998 111.289 -165.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -119.07 -21.19 7.76 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.56 -1.209 . . . . 3.8500000000000001 113.261 -164.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t 155.16 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 130.607 3.563 . . . . 2.1899999999999999 111.172 158.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.33 -11.29 61.69 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.8 1.191 . . . . 2.2000000000000002 115.494 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -73.79 1.78 9.76 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 116.019 1.859 . . . . 4.54 116.019 -173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.6 t60 87.75 135.16 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 129.045 2.938 . . . . 1.8100000000000001 114.151 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.65 19.33 14.61 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.981 1.712 . . . . 4.8399999999999999 114.385 -152.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.78 -35.68 31.04 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-O 117.642 -1.643 . . . . 2.4500000000000002 114.735 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -111.83 -2.39 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 124.316 3.344 . . . . 3.5 114.153 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -143.82 145.93 32.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.875 1.67 . . . . 5.2400000000000002 108.457 -172.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.12 6.5 35.09 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.586 1.394 . . . . 3.1499999999999999 116.586 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.81 130.34 15.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.051 1.426 . . . . 5.0599999999999996 109.721 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.69 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-O 115.709 -2.717 . . . . 3.3300000000000001 118.22 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.467 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 0.3 OUTLIER 152.99 118.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 129.145 2.978 . . . . 5.1900000000000004 110.924 -175.598 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.3 tt -67.03 -28.43 68.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.47 1.108 . . . . 2.6499999999999999 113.369 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -88.18 15.7 55.04 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.416 1.484 . . . . 0.83999999999999997 115.179 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.441 ' OD1' ' CE1' ' A' ' 90' ' ' HIS . 78.7 m-20 -76.11 147.65 38.43 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.2 1.5 . . . . 1.55 110.751 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.17 166.03 17.38 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.607 0.763 . . . . 1.79 110.368 -146.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.06 148.53 19.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.877 3.051 . . . . 1.1399999999999999 112.271 -171.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.89 135.16 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 122.108 0.956 . . . . 1.74 111.38 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 108.83 19.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.026 2.53 . . . . 2.48 110.428 -172.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.4 t -78.24 131.35 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.365 -0.835 . . . . 1.8300000000000001 111.935 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.68 141.31 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.67 2.388 . . . . 1.5900000000000001 106.423 166.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.51 164.3 22.07 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.134 0.424 . . . . 1.95 111.484 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -16.67 0.29 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 127.421 2.289 . . . . 2.23 116.89 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.62 -1.41 43.81 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.181 1.792 . . . . 2.4100000000000001 113.434 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.29 53.84 Favored Glycine 0 N--CA 1.473 1.119 0 O-C-N 121.185 -0.947 . . . . 0.93000000000000005 114.851 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.8 mt -106.14 121.97 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.217 1.007 . . . . 1.46 110.806 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.4 122.56 33.38 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.342 1.057 . . . . 0.63 109.092 168.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -155.48 8.68 0.27 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.135 1.161 . . . . 1.3200000000000001 114.135 -167.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.62 123.61 49.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.868 1.267 . . . . 3.3599999999999999 110.473 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.75 134.75 26.56 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.189 3.259 . . . . 1.3799999999999999 111.963 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.0 163.77 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 126.342 1.857 . . . . 1.6100000000000001 109.261 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 m -144.14 141.0 29.71 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.993 1.269 . . . . 0.81999999999999995 112.112 -167.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -121.17 106.05 39.01 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.554 1.142 . . . . 0.82999999999999996 113.381 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.1 7.42 1.74 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.727 3.618 . . . . 1.1100000000000001 114.637 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -75.4 -25.7 57.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.812 1.645 . . . . 6.9100000000000001 112.735 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.449 ' N ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -123.99 135.59 53.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.313 -1.736 . . . . 2.4700000000000002 106.313 168.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -113.05 -2.65 14.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 4.1799999999999997 113.579 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.4 t -141.11 174.06 10.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.353 0.979 . . . . 2.02 111.752 158.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.43 -24.27 64.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.165 -0.959 . . . . 1.48 111.09 157.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -60.01 -28.62 67.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.352 1.461 . . . . 2.8300000000000001 114.639 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -78.91 -16.1 57.45 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.199 1.185 . . . . 2.3599999999999999 114.199 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.1 m -124.42 16.35 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 125.195 1.398 . . . . 1.25 113.291 -172.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -65.44 8.64 0.15 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 128.242 2.617 . . . . 2.5 117.579 -171.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 41.76 0.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.273 1.429 . . . . 3.7000000000000002 112.171 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -134.49 168.28 19.23 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.937 1.295 . . . . 1.45 113.685 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.7 146.69 26.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.503 1.521 . . . . 0.53000000000000003 114.259 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.37 145.39 30.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.921 2.489 . . . . 1.6000000000000001 107.809 167.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 52.3 mtt -140.65 143.4 35.13 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.294 -0.879 . . . . 1.4099999999999999 112.427 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mt -99.75 123.6 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.772 1.629 . . . . 0.65000000000000002 108.444 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -109.02 143.29 38.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.293 1.837 . . . . 2.79 111.39 -165.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.12 -37.78 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.865 -1.147 . . . . 1.4099999999999999 111.914 -169.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.93 153.34 20.06 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.913 0.768 . . . . 0.96999999999999997 112.125 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.35 -178.9 25.6 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.891 1.71 . . . . 1.3100000000000001 113.128 163.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -137.01 14.87 3.07 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.027 1.491 . . . . 3.29 115.027 -126.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -105.16 21.82 16.44 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.709 1.374 . . . . 2.54 114.709 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtm -96.55 129.65 43.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.859 -1.151 . . . . 2.7000000000000002 112.363 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.2 p -126.7 4.93 6.71 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.766 1.395 . . . . 3.3399999999999999 114.766 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -157.09 124.61 5.33 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.887 -1.133 . . . . 3.5299999999999998 109.464 -169.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -174.09 142.25 0.85 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 117.926 -1.035 . . . . 3.6899999999999999 109.558 -167.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.11 -15.12 29.0 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.08 2.52 . . . . 2.7200000000000002 113.762 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -129.23 133.85 25.62 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.811 1.645 . . . . 4.6699999999999999 108.955 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.9 124.82 15.7 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.215 2.61 . . . . 3.3100000000000001 111.783 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp 58.88 5.2 0.48 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.689 1.996 . . . . 3.3100000000000001 114.007 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.87 9.08 44.8 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.883 -1.136 . . . . 3.8199999999999998 114.574 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.92 -0.27 33.85 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.411 1.482 . . . . 2.6800000000000002 114.345 -167.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.87 7.34 5.5 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.342 1.449 . . . . 1.75 115.646 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.24 -6.03 78.63 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.873 1.337 . . . . 2.1299999999999999 112.921 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 p -70.07 134.06 47.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.356 1.862 . . . . 2.0699999999999998 110.693 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.43 147.27 45.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.355 1.462 . . . . 5.2400000000000002 112.02 -172.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -106.3 -17.16 14.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.249 -0.881 . . . . 2.3700000000000001 112.93 169.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.85 33.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.856 1.428 . . . . 0.54000000000000004 114.856 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -135.74 149.12 49.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.198 2.199 . . . . 1.3200000000000001 110.238 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.5 1.71 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.342 1.925 . . . . 0.66000000000000003 112.474 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.63 141.71 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.569 1.148 . . . . 2.4199999999999999 112.592 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -77.14 141.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.57 1.148 . . . . 1.02 110.868 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 124.332 1.053 . . . . 4.2699999999999996 110.977 171.366 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.988 -0.745 . . . . 2.1200000000000001 108.988 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -128.71 133.53 48.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.899 -1.751 . . . . 1.26 112.504 -137.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -146.69 127.68 14.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 123.226 1.489 . . . . 2.5 112.711 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -109.86 90.94 3.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.251 1.42 . . . . 3.6299999999999999 110.216 -162.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.5 t -90.04 120.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.89 0.476 . . . . 1.0 110.299 -163.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.48 105.4 1.78 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.972 1.272 . . . . 0.79000000000000004 110.639 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 mmt -85.13 110.49 19.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.999 1.32 . . . . 1.54 110.57 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -98.25 143.78 28.38 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.95 0.9 . . . . 2.7999999999999998 111.452 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.3 63.01 3.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.895 1.278 . . . . 1.27 111.55 -175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.35 136.79 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.551 0.74 . . . . 1.23 111.205 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -157.96 139.87 14.03 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.597 0.359 . . . . 2.54 111.514 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' H ' ' NH2' ' A' ' 147' ' ' ARG . . . 26.76 -42.99 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.884 1 C-N-CA 134.638 5.175 . . . . 1.21 120.763 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -80.17 -23.26 41.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.825 1.25 . . . . 3.0800000000000001 111.791 166.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.5 -141.08 13.02 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.846 1.212 . . . . 0.95999999999999996 111.541 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.5 t -54.81 128.79 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.117 1.367 . . . . 1.1599999999999999 111.78 -174.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.26 -111.0 3.54 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.151 1.834 . . . . 1.22 111.701 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.68 169.35 15.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.515 1.126 . . . . 1.6599999999999999 110.945 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.9 t -109.44 156.81 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.058 -1.026 . . . . 1.05 111.994 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 pt -147.33 9.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.733 2.013 . . . . 2.7400000000000002 113.114 -172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.57 162.78 10.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.642 1.115 . . . . 0.68999999999999995 112.743 -167.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -104.45 -177.99 3.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.23 1.012 . . . . 0.79000000000000004 109.316 168.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.4 t -124.43 130.87 73.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 106.848 -1.538 . . . . 0.41999999999999998 106.848 151.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG12 ' HB ' ' A' ' 34' ' ' THR . 8.7 p -87.72 123.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.727 -0.471 . . . . 0.89000000000000001 109.727 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.86 119.98 45.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.04 -1.096 . . . . 1.5 108.04 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -118.47 111.33 18.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.835 0.854 . . . . 1.9399999999999999 110.848 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 130.47 46.57 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 127.124 2.17 . . . . 3.9100000000000001 111.165 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 t -161.18 -172.0 3.25 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.705 1.002 . . . . 2.0600000000000001 113.705 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.32 -31.29 43.49 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.523 1.529 . . . . 6.75 112.721 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.57 17.9 57.56 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 124.962 1.267 . . . . 1.8899999999999999 115.179 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.29 -140.43 28.4 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.22 1.39 . . . . 0.93000000000000005 111.372 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.59 107.89 7.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.284 0.634 . . . . 0.66000000000000003 111.13 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -87.83 107.51 18.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.771 1.228 . . . . 1.8700000000000001 111.263 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.34 104.61 16.02 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.596 1.958 . . . . 0.57999999999999996 109.763 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' HG12 ' A' ' 23' ' ' VAL . 4.2 m -113.69 106.66 53.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 107.256 -1.387 . . . . 0.56000000000000005 107.256 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.1 162.06 17.98 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.371 3.38 . . . . 0.46999999999999997 109.928 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -153.02 34.7 0.47 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.982 0.896 . . . . 1.22 112.346 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -97.26 142.85 28.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.703 1.201 . . . . 0.63 111.21 -174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.38 23.1 9.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.154 1.909 . . . . 2.25 116.154 -166.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.51 57.51 0.63 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.672 0.789 . . . . 1.3300000000000001 112.806 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.03 15.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.115 0.966 . . . . 1.4199999999999999 111.57 172.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 35.3 Cg_endo -62.73 134.36 46.77 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 122.058 1.839 . . . . 0.93999999999999995 110.973 166.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 18.6 Cg_endo -84.18 27.31 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.706 1 C-N-CA 126.692 4.928 . . . . 1.01 114.825 -152.673 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.79 -134.79 8.16 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.398 1.475 . . . . 1.25 115.091 -172.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -120.17 136.5 54.6 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.647 1.579 . . . . 2.29 108.588 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -124.87 143.64 50.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.18 0.992 . . . . 1.0800000000000001 112.631 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.9 153.68 52.32 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.917 -0.873 . . . . 0.54000000000000004 110.917 169.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -124.07 118.41 26.88 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.277 -1.379 . . . . 2.0600000000000001 107.277 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -116.5 160.95 19.86 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.068 1.507 . . . . 0.87 115.068 168.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.13 148.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.521 2.329 . . . . 1.01 108.332 158.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -134.62 145.37 48.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.91000000000000003 111.001 -174.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.46 87.58 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.784 1.772 . . . . 0.75 115.784 -159.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -116.76 148.63 40.97 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.658 1.183 . . . . 1.0800000000000001 112.989 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.69 72.57 2.81 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.769 1.176 . . . . 0.87 113.803 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -164.36 96.06 0.76 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.174 0.987 . . . . 1.8999999999999999 113.422 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -65.39 22.73 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.155 2.182 . . . . 1.3100000000000001 116.44 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -86.18 129.34 54.13 Favored Pre-proline 0 CA--C 1.55 0.957 0 O-C-N 119.802 -1.811 . . . . 3.0899999999999999 112.446 -166.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -95.62 173.26 1.11 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.897 3.731 . . . . 1.4099999999999999 111.99 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.5 154.07 45.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.12 1.368 . . . . 2.2000000000000002 110.956 165.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -85.05 113.55 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.205 -1.405 . . . . 3.8100000000000001 107.205 157.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -138.47 121.37 16.59 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.716 1.206 . . . . 4.5700000000000003 108.547 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 57.69 40.01 26.86 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.755 1.222 . . . . 4.2199999999999998 112.548 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.37 9.92 86.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.579 1.085 . . . . 3.27 115.34 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.02 154.09 48.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.001 1.401 . . . . 3.3799999999999999 110.727 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.56 113.13 24.79 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.51 -0.744 . . . . 2.5600000000000001 111.717 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.35 33.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 116.054 1.872 . . . . 2.6899999999999999 116.054 -163.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.68 -63.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.365 2.666 . . . . 2.1400000000000001 114.105 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.75 108.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 131.581 3.952 . . . . 1.6899999999999999 107.6 -176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -110.54 -39.2 4.98 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.141 0.976 . . . . 3.9900000000000002 111.817 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -19.73 62.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.538 0.94 . . . . 1.29 113.538 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -9.14 53.84 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.299 1.84 . . . . 0.78000000000000003 113.61 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.55 54.65 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.602 -1.312 . . . . 2.1600000000000001 112.629 -174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 179.47 51.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.897 0.76 . . . . 1.48 112.993 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.44 31.12 0.06 Allowed 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 114.197 1.184 . . . . 2.8300000000000001 114.197 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.6 tp 64.92 88.85 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.041 2.137 . . . . 1.77 112.654 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -166.37 121.49 0.91 Allowed Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.136 2.174 . . . . 4.9500000000000002 110.619 163.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -90.57 -14.16 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.255 2.636 . . . . 2.1000000000000001 114.118 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -154.33 -37.05 0.1 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.306 1.965 . . . . 5.04 116.306 -159.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -60.33 -32.92 71.7 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.478 1.49 . . . . 4.1399999999999997 113.669 -163.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 t 171.78 -26.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.792 2.837 . . . . 2.6899999999999999 111.551 163.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 5.12 82.76 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.048 -1.033 . . . . 2.1000000000000001 115.287 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -74.44 -25.95 59.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 115.17 1.544 . . . . 6.4500000000000002 115.17 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.6 t60 99.03 145.79 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 129.35 3.06 . . . . 1.95 111.79 -168.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -119.58 -153.59 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 3.8599999999999999 112.85 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.81 -138.32 6.71 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 117.659 -1.634 . . . . 2.5800000000000001 109.37 -155.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.08 -27.2 65.48 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.016 2.477 . . . . 3.04 113.96 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.66 -9.44 58.25 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.976 1.102 . . . . 5.9100000000000001 113.976 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.01 19.98 70.4 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 116.812 1.485 . . . . 3.02 116.812 167.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.98 100.52 3.95 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.595 1.197 . . . . 4.9299999999999997 111.0 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.94 -34.92 0.13 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-O 117.193 -1.893 . . . . 3.2400000000000002 116.128 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -161.83 128.34 3.77 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.756 2.022 . . . . 3.6400000000000001 110.719 157.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 91' ' ' LEU . 0.7 OUTLIER -66.66 -21.42 66.11 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.132 1.16 . . . . 2.6899999999999999 114.132 178.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.66 23.0 9.41 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.801 1.191 . . . . 0.85999999999999999 114.91 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.15 134.3 41.4 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.075 1.437 . . . . 1.5800000000000001 110.444 165.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.28 161.08 62.49 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.385 1.874 . . . . 1.98 110.335 -168.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.89 167.84 25.52 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.572 2.848 . . . . 1.3500000000000001 112.317 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 132' ' ' ASP . 2.9 m -75.79 147.17 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.845 1.307 . . . . 1.75 113.89 -164.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.94 97.09 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 130.557 3.543 . . . . 2.2599999999999998 108.397 -175.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 t -83.09 147.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.986 1.315 . . . . 0.82999999999999996 111.797 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.77 142.41 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.331 2.252 . . . . 1.54 107.93 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -71.71 160.25 32.95 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.406 0.548 . . . . 2.2599999999999998 111.688 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -57.57 -4.17 0.24 Allowed 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 116.91 2.189 . . . . 2.75 116.91 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -111.8 -11.23 13.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.263 1.425 . . . . 3.0 114.562 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.19 32.61 3.2 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 116.627 1.411 . . . . 0.71999999999999997 116.627 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.0 mt -121.3 135.89 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.543 1.537 . . . . 1.0800000000000001 108.62 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.24 130.14 55.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.247 1.019 . . . . 0.62 110.14 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -148.98 10.06 0.79 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.811 2.152 . . . . 1.1100000000000001 116.811 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.58 130.59 40.74 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 120.349 1.431 . . . . 6.04 114.167 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.12 87.33 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.908 3.072 . . . . 2.04 111.742 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.2 t -72.31 160.3 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.295 1.438 . . . . 1.8400000000000001 108.993 172.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.5 m -142.82 131.88 23.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.653 -1.279 . . . . 1.3899999999999999 111.505 -171.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.02 91.23 49.71 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.205 1.002 . . . . 0.81000000000000005 113.4 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.34 2.46 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.227 3.285 . . . . 1.3 115.201 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -72.06 -26.33 62.14 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.025 0.83 . . . . 3.7999999999999998 111.555 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.86 151.51 26.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.673 2.389 . . . . 2.0299999999999998 108.822 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -138.21 12.81 2.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.989 1.315 . . . . 4.96 114.044 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.6 t -160.76 152.24 19.36 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.98 -1.075 . . . . 2.2200000000000002 112.269 161.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.94 -28.55 62.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.204 -0.427 . . . . 1.6299999999999999 111.635 161.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -54.79 -28.73 51.26 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.105 0.962 . . . . 2.7999999999999998 112.813 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.17 -12.61 60.63 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.874 0.87 . . . . 1.8899999999999999 112.766 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.08 12.44 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.417 1.487 . . . . 0.73999999999999999 113.028 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -63.79 -1.71 1.49 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 117.224 2.305 . . . . 2.2599999999999998 117.224 -169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -146.15 19.97 1.4 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.249 1.82 . . . . 3.1499999999999999 111.941 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -104.8 -176.51 3.1 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.026 1.73 . . . . 1.45 112.974 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.21 160.42 22.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.526 1.13 . . . . 0.77000000000000002 112.368 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 mt -126.63 141.4 51.86 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 129.136 2.974 . . . . 1.77 106.038 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.26 138.8 48.02 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.129 0.877 . . . . 1.3 112.561 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -99.53 116.11 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.46 1.504 . . . . 0.76000000000000001 107.871 170.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -110.82 145.45 38.16 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.963 1.305 . . . . 1.8899999999999999 113.266 -162.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.53 -34.7 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.392 1.077 . . . . 1.1599999999999999 113.436 -154.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.2 151.87 18.3 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.978 -0.849 . . . . 1.1799999999999999 110.978 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -56.06 148.93 27.47 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.062 0.839 . . . . 1.8500000000000001 111.006 162.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.438 ' H ' HG12 ' A' ' 96' ' ' VAL . 38.4 t0 -127.05 133.9 50.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.359 1.076 . . . . 3.3300000000000001 113.232 -159.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -156.48 10.02 0.24 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.794 2.437 . . . . 3.3500000000000001 111.637 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -83.76 66.71 9.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.007 1.114 . . . . 3.2200000000000002 114.007 -157.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.5 p -75.23 30.91 0.1 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.075 1.139 . . . . 3.2000000000000002 114.075 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -165.62 147.15 7.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.745 2.018 . . . . 4.04 111.077 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 155.42 153.35 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 130.489 3.516 . . . . 4.3200000000000003 111.767 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -86.72 -17.15 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.26 3.307 . . . . 2.3500000000000001 112.863 163.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -91.33 144.02 29.12 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.878 1.271 . . . . 4.0 110.339 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -73.5 160.01 45.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.178 2.586 . . . . 4.9199999999999999 113.228 -166.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.31 2.48 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.606 1.963 . . . . 5.4000000000000004 114.756 170.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.83 3.67 80.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.733 1.159 . . . . 3.4500000000000002 114.159 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.96 -65.65 4.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.279 1.418 . . . . 1.9099999999999999 112.958 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.47 64.33 Favored Glycine 0 N--CA 1.476 1.367 0 C-N-CA 124.278 0.942 . . . . 1.6599999999999999 115.233 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.72 10.72 16.91 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.909 1.718 . . . . 2.02 115.582 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 p -71.39 156.05 39.92 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.581 1.691 . . . . 1.77 109.547 162.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.421 ' NH2' ' H ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.97 143.26 30.39 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.931 1.086 . . . . 6.1200000000000001 113.931 -173.154 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -99.63 -23.69 14.97 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.239 0.616 . . . . 2.46 111.402 153.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.89 158.31 43.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.251 0.932 . . . . 0.54000000000000004 113.453 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.46 150.07 51.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.383 1.873 . . . . 1.6200000000000001 110.05 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 107.84 0.37 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.049 1.785 . . . . 0.72999999999999998 112.007 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.04 139.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.595 1.158 . . . . 2.5 110.722 165.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.69 117.82 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.788 -0.57 . . . . 1.1399999999999999 110.202 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 125.629 1.572 . . . . 5.1500000000000004 110.222 179.386 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 119.276 -0.392 . . . . 1.8 110.627 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -155.47 140.6 17.46 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 119.625 -1.922 . . . . 1.3300000000000001 111.847 -172.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.33 146.4 21.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.542 1.163 . . . . 3.0600000000000001 111.881 166.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -109.55 116.94 32.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.571 1.549 . . . . 4.3499999999999996 113.423 -176.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -103.79 120.97 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.852 -1.155 . . . . 1.1699999999999999 110.822 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.8 108.63 2.99 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.557 2.027 . . . . 0.68999999999999995 112.159 178.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 35.0 mtt -90.43 139.17 30.93 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.953 1.834 . . . . 1.3200000000000001 115.953 -176.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -115.5 146.39 41.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.812 2.045 . . . . 3.0800000000000001 113.504 -174.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.98 63.08 4.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.555 1.542 . . . . 1.5700000000000001 113.066 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.8 105.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 120.929 -1.107 . . . . 1.4399999999999999 113.006 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.3 t -132.3 73.29 1.52 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.017 0.927 . . . . 2.5899999999999999 112.424 -173.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 71.19 -47.3 0.66 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.839 2.456 . . . . 1.3600000000000001 114.032 172.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.64 -12.58 61.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.819 1.248 . . . . 2.7799999999999998 112.085 174.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.67 -165.49 12.65 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.679 1.609 . . . . 1.24 113.542 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.57 134.35 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.856 1.663 . . . . 1.2 110.547 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.34 -83.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.214 1.388 . . . . 1.98 113.732 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -100.49 130.87 46.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.003 1.721 . . . . 2.2799999999999998 111.941 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -108.14 138.07 45.04 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.109 -0.994 . . . . 1.2 109.857 175.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mm -125.16 -16.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.86 1.43 . . . . 4.0300000000000002 114.86 -170.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.46 158.35 27.63 Favored Glycine 0 CA--C 1.521 0.467 0 O-C-N 121.518 -0.739 . . . . 1.04 111.907 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 p -88.34 173.98 8.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.062 0.934 . . . . 0.97999999999999998 109.219 163.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.1 132.91 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.896 -1.52 . . . . 0.58999999999999997 106.896 148.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.47 128.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 123.551 0.532 . . . . 0.87 110.174 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.48 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 125.283 1.433 . . . . 1.6599999999999999 108.208 -173.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.61 117.07 34.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 123.067 1.413 . . . . 1.8400000000000001 110.189 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.259 0.8 OUTLIER -81.95 122.03 27.25 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.205 3.402 . . . . 2.96 109.895 -169.481 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.0 t -144.2 178.44 7.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.17 0.986 . . . . 1.2 111.12 -173.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -28.98 68.06 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.491 1.916 . . . . 4.71 110.357 -176.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 13.7 60.59 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.563 1.554 . . . . 1.02 115.289 163.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.62 -151.17 21.15 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 127.627 2.537 . . . . 0.76000000000000001 116.552 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.54 101.2 4.8 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.869 . . . . 0.76000000000000001 111.53 -175.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.5 105.2 10.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.622 1.169 . . . . 1.79 110.833 173.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -93.86 116.64 29.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.575 2.35 . . . . 0.64000000000000001 109.975 -172.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -123.36 112.55 29.65 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 119.824 1.193 . . . . 0.56000000000000005 108.824 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.53 159.45 10.86 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.169 3.246 . . . . 0.54000000000000004 111.996 -173.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -150.06 39.61 0.77 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.24 0.543 . . . . 1.3600000000000001 112.287 171.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.48 142.34 28.68 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.032 -1.668 . . . . 0.88 112.828 -172.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 91.83 3.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.119 1.368 . . . . 2.1499999999999999 113.436 -171.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' C ' HD22 ' A' ' 40' ' ' LEU . . . 133.1 103.47 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 130.404 3.481 . . . . 2.0 107.227 -171.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.61 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -160.84 160.01 25.18 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 131.603 3.961 . . . . 2.6299999999999999 106.67 167.103 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -63.48 140.27 75.01 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 O-C-N 122.64 0.81 . . . . 1.3600000000000001 110.094 157.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -86.67 31.48 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.554 2.836 . . . . 1.49 113.513 -152.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.33 -177.44 14.99 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.154 1.359 . . . . 2.1499999999999999 113.527 -175.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -64.77 129.93 41.62 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 125.336 1.454 . . . . 3.3599999999999999 112.605 -168.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -125.57 131.34 52.75 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.594 1.158 . . . . 0.93999999999999995 110.209 -176.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.0 169.52 50.78 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 119.368 0.986 . . . . 0.64000000000000001 112.753 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 4.1 t80 -137.9 114.71 10.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.969 1.308 . . . . 1.9199999999999999 108.827 174.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -118.61 163.27 17.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.987 1.477 . . . . 0.70999999999999996 114.987 163.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.17 144.46 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.825 1.65 . . . . 0.68999999999999995 108.311 155.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -119.02 157.16 28.33 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.276 1.03 . . . . 0.82999999999999996 111.761 173.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -20.48 66.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 117.197 2.295 . . . . 0.69999999999999996 117.197 -162.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -132.43 -174.8 3.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.067 1.747 . . . . 1.1299999999999999 111.8 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 50.93 0.87 Allowed Glycine 0 N--CA 1.471 1.026 0 N-CA-C 116.316 1.286 . . . . 0.89000000000000001 116.316 -160.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 t -157.89 110.95 2.44 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.513 1.656 . . . . 2.3999999999999999 112.595 167.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.99 5.19 0.1 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.588 2.355 . . . . 1.3700000000000001 116.945 -173.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -83.84 140.56 40.6 Favored Pre-proline 0 CA--C 1.546 0.821 0 O-C-N 120.461 -1.399 . . . . 3.79 112.72 -167.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.84 148.84 12.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.04 3.16 . . . . 1.22 112.215 173.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.38 21.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.757 0.823 . . . . 1.5800000000000001 111.204 156.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.1 mm -114.48 103.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.852 1.261 . . . . 2.6000000000000001 109.428 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HE2' ' OD2' ' A' ' 61' ' ' ASP . 16.5 mtpt -101.63 149.13 24.44 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.393 1.477 . . . . 5.2999999999999998 110.051 168.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' OD2' ' HE2' ' A' ' 60' ' ' LYS . 12.8 m-20 46.59 39.02 6.25 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.276 1.213 . . . . 4.25 114.276 161.392 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.6 25.38 75.27 Favored Glycine 0 CA--C 1.537 1.406 0 CA-C-O 118.291 -1.283 . . . . 2.9100000000000001 115.556 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -156.07 158.25 37.46 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.395 2.098 . . . . 3.04 112.98 -177.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.14 139.73 31.88 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.354 -0.841 . . . . 1.55 113.0 -173.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 m -85.36 13.8 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 114.862 1.43 . . . . 2.8500000000000001 114.862 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.81 -51.41 0.7 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.849 2.46 . . . . 1.53 113.792 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.81 141.53 4.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.061 1.744 . . . . 2.1699999999999999 109.419 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.32 -50.99 1.99 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.969 0.508 . . . . 4.8700000000000001 111.424 173.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.3 1.24 6.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.549 1.314 . . . . 1.5900000000000001 114.549 -177.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 -18.7 35.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.277 1.431 . . . . 0.91000000000000003 112.522 166.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 -177.22 53.79 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 122.565 1.092 . . . . 2.23 114.764 176.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.86 179.9 37.35 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.941 1.258 . . . . 1.3700000000000001 113.669 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -69.51 5.06 1.49 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.042 1.867 . . . . 2.6299999999999999 116.042 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.3 tp 63.48 89.54 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.9 2.08 . . . . 1.6200000000000001 109.697 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -159.96 23.1 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 117.473 2.397 . . . . 3.4500000000000002 117.473 -156.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -61.37 -26.01 80.91 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.336 2.691 . . . . 2.0800000000000001 116.552 -152.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -131.4 22.75 4.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.197 0.999 . . . . 3.7000000000000002 111.62 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -89.94 -58.98 2.32 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.815 -1.178 . . . . 3.4100000000000001 113.294 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 159.84 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.294 3.037 . . . . 2.2400000000000002 111.293 -175.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.07 61.88 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.087 -1.396 . . . . 1.8300000000000001 115.336 176.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -72.14 -30.33 64.93 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.462 2.131 . . . . 5.3300000000000001 114.348 -175.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.9 t60 86.67 155.03 0.07 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 129.003 2.921 . . . . 1.6499999999999999 111.651 -166.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.74 -130.59 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.773 1.229 . . . . 3.8599999999999999 111.861 -173.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 145.11 -44.82 0.86 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 127.883 2.659 . . . . 2.8599999999999999 112.601 -174.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -111.39 -11.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.42 2.747 . . . . 3.2000000000000002 116.317 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -145.61 0.86 0.89 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.883 1.674 . . . . 4.5800000000000001 115.233 -153.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.99 -12.91 21.88 Favored Glycine 0 N--CA 1.476 1.345 0 O-C-N 120.462 -1.399 . . . . 3.2599999999999998 114.5 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.48 38.43 0.19 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.679 2.392 . . . . 6.5899999999999999 114.294 -166.375 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.94 -87.29 0.06 OUTLIER Glycine 0 C--N 1.342 0.902 0 O-C-N 120.427 -1.421 . . . . 2.5 114.911 -170.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -142.96 143.73 32.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.438 1.895 . . . . 3.5899999999999999 110.357 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -77.09 -14.43 59.81 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.829 1.195 . . . . 2.8700000000000001 114.013 170.171 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.63 3.37 79.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.296 -1.28 . . . . 0.84999999999999998 115.802 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -94.2 129.25 40.88 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 119.424 1.612 . . . . 2.6200000000000001 112.08 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 1.1 mm? -117.26 168.7 8.54 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.871 2.068 . . . . 1.9299999999999999 110.221 -177.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 94' ' ' LEU . 67.7 Cg_endo -81.44 167.4 17.3 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.066 2.51 . . . . 1.28 111.859 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.64 137.87 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 115.829 1.788 . . . . 1.6000000000000001 115.829 -163.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.22 95.19 4.26 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 130.845 3.658 . . . . 1.5600000000000001 110.059 170.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.34 131.26 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.919 -1.113 . . . . 1.01 111.759 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -118.03 149.5 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 127.328 2.251 . . . . 2.5099999999999998 109.082 167.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.87 166.36 19.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.723 1.009 . . . . 2.6899999999999999 113.723 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -13.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 119.389 3.107 . . . . 2.3199999999999998 119.389 -178.224 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -119.77 -4.4 10.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.639 1.576 . . . . 4.1100000000000003 114.355 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.09 38.77 2.25 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 116.785 1.474 . . . . 1.1200000000000001 116.785 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mm -126.6 130.84 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-N 119.507 1.653 . . . . 2.21 111.903 166.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.46 132.64 37.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.931 1.292 . . . . 0.79000000000000004 111.17 174.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 t -151.66 -14.2 0.2 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.992 1.849 . . . . 1.1200000000000001 115.992 -170.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.33 133.02 43.31 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 120.398 1.454 . . . . 3.5899999999999999 112.117 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.73 146.74 24.04 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.862 3.042 . . . . 1.04 112.372 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.25 170.72 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.356 1.863 . . . . 1.1399999999999999 110.005 172.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 m -135.68 140.76 44.71 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.152 0.887 . . . . 0.83999999999999997 110.971 -175.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.56 87.3 41.22 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.096 1.358 . . . . 0.81999999999999995 112.305 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.82 -7.98 14.5 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.408 3.405 . . . . 1.6799999999999999 114.95 176.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -65.23 -27.27 68.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.426 -0.796 . . . . 4.0999999999999996 110.921 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.33 142.8 50.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.796 2.039 . . . . 2.3599999999999999 109.265 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 32.46 0.54 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.074 1.35 . . . . 6.1600000000000001 113.239 -166.417 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.6 m -179.81 136.21 0.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.134 2.574 . . . . 1.78 109.867 162.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -32.67 63.34 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 118.946 0.794 . . . . 1.3700000000000001 111.321 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.8 -27.47 29.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.617 1.567 . . . . 3.2999999999999998 113.65 174.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.37 -28.98 68.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.184 0.902 . . . . 1.78 112.41 173.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.93 11.96 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.799 1.64 . . . . 0.96999999999999997 113.063 -161.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.08 -26.39 15.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.307 1.843 . . . . 2.1000000000000001 115.322 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -10.46 55.52 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.809 2.044 . . . . 3.77 114.587 177.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.24 168.84 9.95 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.986 1.476 . . . . 1.45 114.986 -154.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.56 151.5 31.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.337 1.455 . . . . 0.60999999999999999 112.053 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.22 143.77 39.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.488 1.915 . . . . 1.75 107.854 171.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.0 mtt -137.64 139.5 40.32 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.85 0.75 . . . . 1.1899999999999999 111.946 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.7 mt -100.41 126.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.569 1.548 . . . . 0.79000000000000004 108.346 171.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -105.85 149.26 26.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.995 1.318 . . . . 3.0699999999999998 113.43 -162.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.06 -43.0 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.924 0.89 . . . . 1.21 111.827 -167.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.89 171.3 27.15 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.857 -0.897 . . . . 0.96999999999999997 110.857 158.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.45 -147.88 0.02 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.328 2.871 . . . . 2.2000000000000002 114.573 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.52 54.03 0.48 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 123.746 1.736 . . . . 3.25 112.114 -150.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -160.94 27.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.511 -1.677 . . . . 3.3999999999999999 111.655 -162.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 70.5 mtm -132.86 116.25 16.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.529 1.132 . . . . 3.0099999999999998 111.355 -162.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 t -158.44 176.91 11.83 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.597 1.159 . . . . 3.1899999999999999 110.738 175.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 68.45 25.59 6.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.634 1.974 . . . . 3.77 114.012 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.94 153.27 78.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.498 1.119 . . . . 4.0599999999999996 111.774 178.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 -13.85 31.6 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.781 2.987 . . . . 1.9199999999999999 114.478 -170.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -100.07 87.11 0.68 Allowed Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 117.818 -1.087 . . . . 4.6500000000000004 108.596 157.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.77 151.95 60.38 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.933 2.422 . . . . 3.1600000000000001 111.562 -174.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mp 67.38 22.48 9.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 3.6200000000000001 110.301 -168.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.02 -7.58 4.26 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.569 1.557 . . . . 2.6899999999999999 114.612 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.81 1.35 87.2 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.096 1.332 . . . . 1.71 114.011 -163.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.7 67.05 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-N 118.982 1.391 . . . . 1.6000000000000001 114.878 -175.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.59 12.58 7.77 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.564 1.554 . . . . 1.6000000000000001 116.704 -169.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.4 p -75.18 169.1 18.71 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.341 1.57 . . . . 1.74 110.196 169.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 137.82 51.15 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.5 1.12 . . . . 5.1299999999999999 111.97 -173.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 3.5 t80 -85.26 -26.21 26.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.686 0.676 . . . . 2.21 111.881 162.035 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.01 157.78 36.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.236 0.828 . . . . 0.55000000000000004 113.236 173.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.8 t -136.68 148.56 47.45 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.646 1.978 . . . . 1.5 110.768 175.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -148.69 121.8 1.38 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.042 1.306 . . . . 0.66000000000000003 113.038 178.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.02 135.43 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.851 1.66 . . . . 1.6200000000000001 110.911 175.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.6 mt -79.21 155.02 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.068 1.347 . . . . 0.85999999999999999 111.036 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? . . . . . 0 CA--C 1.544 0.718 0 O-C-N 119.997 -1.689 . . . . 3.4500000000000002 110.949 169.783 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.609 -0.886 . . . . 1.99 108.609 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -142.54 150.01 39.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.88 1.437 . . . . 1.28 114.88 -133.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.04 141.25 17.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.468 1.128 . . . . 2.9500000000000002 109.825 167.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -90.67 135.39 33.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.617 -0.72 . . . . 2.8700000000000001 111.384 176.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.7 t -121.96 125.13 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.276 -0.89 . . . . 1.1499999999999999 111.108 177.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.13 115.17 4.14 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.836 1.207 . . . . 1.02 110.168 172.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.4 mtp -96.57 107.51 19.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.711 1.204 . . . . 1.71 109.695 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -93.98 146.21 24.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.813 0.671 . . . . 3.21 112.813 -169.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.4 62.75 1.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.378 1.071 . . . . 1.74 113.243 -175.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.6 m -58.54 131.84 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.507 -0.745 . . . . 1.4199999999999999 111.121 171.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -150.2 48.31 0.91 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.243 1.021 . . . . 2.5800000000000001 110.943 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.04 -36.7 0.32 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 128.703 2.801 . . . . 1.1399999999999999 112.004 -178.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.295 0.0 OUTLIER -78.28 41.84 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.248 1.419 . . . . 3.2200000000000002 114.1 174.205 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.17 -155.97 41.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.855 1.217 . . . . 1.54 112.362 175.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.82 125.28 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.158 -1.053 . . . . 1.1699999999999999 108.158 163.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.35 -82.06 1.55 Allowed Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.995 0.807 . . . . 2.1099999999999999 112.113 -166.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -158.37 164.83 35.95 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 122.389 1.09 . . . . 1.6399999999999999 112.579 167.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 t -103.16 146.76 27.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.758 1.623 . . . . 1.29 112.373 -176.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 pt -148.72 10.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.623 1.569 . . . . 2.77 113.516 -164.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.02 177.68 19.12 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.78 1.181 . . . . 0.83999999999999997 112.364 -165.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 p -129.47 -176.92 4.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.275 1.03 . . . . 1.01 109.984 170.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 54.6 t -126.52 136.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 124.273 1.029 . . . . 0.56000000000000005 108.367 159.438 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.56 133.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 123.198 0.312 . . . . 0.83999999999999997 110.325 171.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mt -108.77 133.78 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.871 -0.789 . . . . 1.6899999999999999 108.871 168.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -139.04 96.6 3.14 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.343 1.857 . . . . 2.2000000000000002 110.068 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 141.65 57.36 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 127.301 2.24 . . . . 4.3399999999999999 111.597 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -156.39 177.52 11.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.745 0.783 . . . . 1.3500000000000001 111.286 175.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.54 -18.51 62.17 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 3.96 112.012 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 7.26 81.13 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.927 1.251 . . . . 1.04 115.355 166.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.78 -169.66 42.93 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 129.458 3.409 . . . . 0.89000000000000001 116.145 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.24 105.45 0.34 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.353 1.461 . . . . 0.63 112.03 -175.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -84.75 113.4 21.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 2.1000000000000001 109.115 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 4.6 t80 -95.01 127.77 41.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.735 2.014 . . . . 0.72999999999999998 108.999 -177.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -137.64 109.77 8.69 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.501 1.501 . . . . 0.63 109.715 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.9 162.99 18.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.775 2.983 . . . . 0.60999999999999999 111.335 -175.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -150.11 30.7 0.7 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.051 0.76 . . . . 1.47 113.051 174.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.06 140.82 29.47 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.672 -1.267 . . . . 0.77000000000000002 112.425 -173.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 26.74 9.82 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.082 1.882 . . . . 2.0099999999999998 116.082 -168.381 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.65 65.26 0.67 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.131 0.572 . . . . 1.4399999999999999 112.127 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.2 159.39 69.92 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 121.731 -0.606 . . . . 1.3799999999999999 111.934 170.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -63.79 129.5 24.99 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 120.933 1.089 . . . . 0.81000000000000005 111.286 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.46 37.53 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.583 1 C-N-CA 126.752 4.968 . . . . 1.0700000000000001 113.251 -153.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.21 -135.4 7.31 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 123.52 1.622 . . . . 1.4299999999999999 112.165 -177.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -116.28 139.27 50.55 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.011 1.325 . . . . 2.5299999999999998 109.431 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -143.54 144.14 31.83 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.041 0.936 . . . . 1.3799999999999999 110.568 -168.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.95 160.85 52.21 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 110.262 -1.135 . . . . 0.94999999999999996 110.262 174.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 128.31 22.79 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 106.801 -1.555 . . . . 1.8400000000000001 106.801 166.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 93' ' ' ASP . 65.6 m170 -127.99 167.82 16.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.436 2.013 . . . . 1.02 116.436 173.712 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.7 146.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.716 1.606 . . . . 0.88 109.679 151.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.89 161.27 32.23 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.677 2.791 . . . . 0.94999999999999996 108.849 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -26.44 67.32 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.118 2.266 . . . . 0.85999999999999999 117.118 -157.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -140.36 165.65 26.85 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.184 1.394 . . . . 1.6799999999999999 113.271 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.13 104.11 2.68 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 120.806 -1.184 . . . . 0.98999999999999999 114.801 -172.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m 177.56 -173.56 0.12 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.773 3.229 . . . . 3.4500000000000002 109.443 171.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.8 m -120.03 -23.84 6.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.1 1.36 . . . . 2.4100000000000001 113.843 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -76.23 142.51 71.89 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.14 1.163 . . . . 3.02 114.14 -158.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.64 160.2 21.97 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.35 3.367 . . . . 1.1799999999999999 112.41 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.84 154.61 19.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.432 0.693 . . . . 1.77 109.954 158.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.72 123.7 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.206 1.002 . . . . 2.3700000000000001 108.86 -178.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -169.12 159.76 9.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.498 1.919 . . . . 5.5700000000000003 109.379 -175.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 t70 58.39 27.82 15.94 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.862 -1.149 . . . . 4.3600000000000003 113.234 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.03 14.52 82.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.991 1.281 . . . . 2.6699999999999999 115.032 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -152.65 164.02 38.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.391 1.595 . . . . 2.96 113.683 -168.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.71 113.75 26.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 1.74 111.109 -178.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.76 57.25 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.785 2.034 . . . . 2.1899999999999999 110.932 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.48 -68.13 0.12 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.964 2.505 . . . . 2.52 116.391 160.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -175.77 47.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.834 2.453 . . . . 2.3599999999999999 113.024 -167.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -59.48 -21.36 59.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.134 -1.604 . . . . 4.5099999999999998 113.658 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.38 -19.94 62.21 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 119.669 -1.894 . . . . 1.96 112.874 170.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 -9.27 26.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.199 1.8 . . . . 1.1599999999999999 113.606 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.63 165.21 32.65 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.018 -1.051 . . . . 2.9199999999999999 113.355 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.98 -173.09 23.98 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.855 -0.791 . . . . 1.45 112.752 168.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -44.66 138.92 3.14 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.515 0.726 . . . . 2.73 109.275 163.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 66.13 1.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.263 1.825 . . . . 2.9100000000000001 112.796 -165.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -110.06 83.79 3.2 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 129.002 2.921 . . . . 4.1299999999999999 108.226 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.36 -21.53 37.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.775 2.984 . . . . 3.2400000000000002 114.733 -176.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 6.26 0.24 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.293 0.849 . . . . 8.3300000000000001 113.293 153.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.71 -38.94 67.34 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.365 -1.46 . . . . 4.2599999999999998 114.828 -144.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t 169.26 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.267 2.227 . . . . 3.8399999999999999 112.078 -170.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.27 43.84 4.85 Favored Glycine 0 N--CA 1.47 0.931 0 CA-C-O 118.955 -0.914 . . . . 3.1499999999999999 113.077 176.199 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.316 12.9 ptmt -143.4 -101.08 0.12 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.912 1.449 . . . . 4.0999999999999996 114.912 -176.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.427 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -163.88 144.2 8.43 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 117.355 2.354 . . . . 2.0800000000000001 117.355 -157.533 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.64 -130.6 0.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.202 2.201 . . . . 4.0800000000000001 107.738 160.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.49 -89.59 0.56 Allowed Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.761 1.648 . . . . 2.8500000000000001 111.868 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -98.33 -21.0 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.297 2.665 . . . . 3.1299999999999999 114.993 -172.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 157.77 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.684 3.194 . . . . 5.4199999999999999 110.427 -161.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.76 -151.6 28.1 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.532 1.539 . . . . 3.4700000000000002 114.592 -172.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.78 13.18 0.27 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.43 2.011 . . . . 7.6799999999999997 116.43 -160.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.08 -178.55 38.42 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 120.251 1.387 . . . . 2.7599999999999998 113.071 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 57.32 96.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.246 1.818 . . . . 5.1299999999999999 115.007 170.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 65.37 6.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.693 -1.254 . . . . 2.9500000000000002 110.938 169.676 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.03 7.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.789 -1.562 . . . . 1.26 116.472 -176.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' ' CE1' ' A' ' 82' ' ' HIS . 3.2 m-20 -74.66 147.28 41.67 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.15 1.475 . . . . 1.8999999999999999 108.85 157.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.48 171.85 6.9 Favored Pre-proline 0 CA--C 1.555 1.151 0 O-C-N 121.314 -0.866 . . . . 1.8300000000000001 110.521 -142.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.89 133.21 19.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.326 2.018 . . . . 1.78 110.403 -174.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.01 132.39 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 123.362 1.554 . . . . 1.6799999999999999 112.766 -175.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -68.43 91.93 0.42 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.46 2.304 . . . . 2.46 110.253 168.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.14 131.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.028 -1.045 . . . . 1.04 109.133 166.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.77 133.55 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.407 1.883 . . . . 1.6200000000000001 106.915 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.41 154.57 22.73 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.808 0.731 . . . . 1.76 112.359 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -24.17 0.4 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.924 2.565 . . . . 2.5499999999999998 117.924 -167.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -93.22 -6.36 47.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.51 1.524 . . . . 2.9900000000000002 114.103 -176.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.25 20.71 8.48 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 125.072 1.32 . . . . 0.85999999999999999 115.487 175.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.71 127.81 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 118.161 0.98 . . . . 1.1799999999999999 109.984 -176.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.68 118.94 31.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 0.90000000000000002 109.291 169.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.1 t -135.48 4.45 3.13 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.963 1.305 . . . . 1.3 113.695 -178.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.01 119.74 69.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.856 1.662 . . . . 3.3500000000000001 112.982 -165.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.88 136.38 16.64 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.632 2.888 . . . . 1.21 112.402 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.97 173.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 126.557 1.943 . . . . 1.48 109.848 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 m -145.5 140.26 27.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.537 1.062 . . . . 0.72999999999999998 110.971 -174.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.34 90.64 5.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.609 1.163 . . . . 0.63 111.858 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.82 -2.61 11.21 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.09 3.193 . . . . 1.1699999999999999 115.293 -176.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.68 -15.95 61.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.379 1.472 . . . . 4.9299999999999997 112.396 176.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.09 145.31 49.99 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.67 1.988 . . . . 2.5699999999999998 107.684 175.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -147.44 32.9 0.88 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.603 2.361 . . . . 4.8300000000000001 111.625 -175.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -163.86 141.8 7.35 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.082 1.353 . . . . 1.6499999999999999 111.503 156.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.0 tp -65.96 -23.71 66.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.084 -1.01 . . . . 1.8200000000000001 110.685 175.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.07 -24.99 60.68 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.514 1.126 . . . . 2.6600000000000001 113.098 169.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -68.19 -15.87 63.75 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.641 1.11 . . . . 2.2999999999999998 112.392 174.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.93 8.08 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 114.192 1.182 . . . . 0.85999999999999999 114.192 -172.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -69.93 5.28 1.62 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 116.274 1.953 . . . . 3.1600000000000001 116.274 -171.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.46 9.09 3.98 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.137 2.175 . . . . 2.6899999999999999 112.195 177.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -110.45 -178.34 3.47 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.115 1.366 . . . . 1.6799999999999999 114.311 -168.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.51 149.88 41.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.988 1.315 . . . . 0.68000000000000005 111.8 172.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.07 154.24 17.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.669 1.988 . . . . 1.7 107.828 165.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.5 mtt -142.09 141.17 32.71 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.367 -0.833 . . . . 1.3 113.067 170.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.9 mt -88.34 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 108.18 -1.045 . . . . 0.94999999999999996 108.18 165.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.21 152.64 47.12 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.205 1.557 . . . . 2.02 115.205 -165.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.06 -53.53 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.727 1.611 . . . . 1.4099999999999999 112.762 -159.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.56 179.39 52.44 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.573 -1.411 . . . . 1.1699999999999999 109.573 158.107 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.82 -143.87 0.03 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 127.236 2.351 . . . . 2.29 112.553 168.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -151.53 59.92 0.88 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.185 1.18 . . . . 3.5899999999999999 114.185 -169.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -149.31 21.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.219 1.008 . . . . 3.0 113.564 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.06 142.71 52.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.017 1.327 . . . . 4.7199999999999998 112.672 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.4 p -85.04 166.49 16.65 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.88 1.272 . . . . 5.7800000000000002 112.864 172.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.92 142.43 51.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.814 0.846 . . . . 6.71 112.172 177.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.87 156.76 34.4 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.816 1.246 . . . . 4.5899999999999999 109.581 -160.349 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.03 -0.06 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.019 3.146 . . . . 2.6000000000000001 114.169 174.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -116.79 132.85 23.19 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.169 0.988 . . . . 6.3099999999999996 108.557 159.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.86 164.68 32.58 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.791 2.327 . . . . 3.5699999999999998 112.286 -173.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt 69.55 4.84 4.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.814 2.046 . . . . 4.4500000000000002 113.729 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.57 15.16 77.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.103 0.859 . . . . 2.96 113.359 -175.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.46 -51.52 3.34 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.537 1.541 . . . . 1.8600000000000001 113.757 -178.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.46 -10.5 73.62 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.333 1.444 . . . . 1.78 115.044 -176.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.49 42.44 1.97 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.653 1.597 . . . . 2.9399999999999999 113.937 -178.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.7 p -119.39 163.64 16.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 128.473 2.709 . . . . 3.6899999999999999 109.84 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.47 140.17 29.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.667 2.099 . . . . 6.0899999999999999 116.667 -166.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -98.99 -20.77 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.103 1.361 . . . . 2.8199999999999998 112.195 155.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.69 153.39 29.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.169 0.895 . . . . 0.73999999999999999 113.151 173.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 19.0 p -84.66 -149.86 0.12 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.723 1.609 . . . . 2.98 111.88 171.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.17 81.11 0.03 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.28 0.943 . . . . 0.82999999999999996 113.806 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.69 120.1 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.386 1.075 . . . . 2.1600000000000001 111.568 176.003 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 71.2 mt -79.76 138.72 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.147 -0.686 . . . . 0.93999999999999995 109.147 173.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.549 0.939 0 O-C-N 120.503 -1.373 . . . . 3.8900000000000001 111.335 -176.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.379 -0.6 . . . . 1.99 109.379 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -138.38 158.46 44.24 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.832 -1.167 . . . . 0.97999999999999998 114.089 -145.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -160.41 116.65 2.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.518 1.527 . . . . 3.4700000000000002 108.118 -175.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -90.46 143.14 27.04 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.884 -1.135 . . . . 3.9100000000000001 110.475 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' C ' HG23 ' A' ' 21' ' ' THR . 58.8 t -134.64 85.59 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 122.424 1.107 . . . . 1.05 111.707 177.064 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -32.07 114.52 0.08 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 127.252 2.358 . . . . 1.02 113.131 147.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.8 mtt -101.9 148.41 25.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 113.79 -1.205 . . . . 1.3700000000000001 113.365 171.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.22 148.38 35.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 2.2999999999999998 110.647 168.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.1 mt -61.18 135.93 57.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.512 -0.922 . . . . 1.1599999999999999 108.512 166.29 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.5 143.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.423 1.089 . . . . 1.03 108.912 173.098 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -171.68 91.87 0.13 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.512 -0.921 . . . . 2.4399999999999999 108.512 -174.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.85 -62.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.943 2.097 . . . . 1.6499999999999999 113.507 -177.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.265 0.1 OUTLIER -80.76 12.62 3.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.91 1.684 . . . . 5.3700000000000001 114.859 -173.212 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.14 -151.02 32.77 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.221 0.915 . . . . 1.02 112.049 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.98 110.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.452 1.901 . . . . 0.82999999999999996 111.835 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.58 -72.3 1.11 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.901 1.239 . . . . 1.7 113.636 -175.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.92 153.44 16.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.645 1.178 . . . . 1.8999999999999999 111.649 -175.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -92.97 145.22 24.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.014 1.726 . . . . 1.3899999999999999 114.523 -165.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 5.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 115.949 1.833 . . . . 3.5800000000000001 115.949 -177.193 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.74 175.54 20.58 Favored Glycine 0 N--CA 1.467 0.704 0 O-C-N 121.197 -0.94 . . . . 0.63 113.86 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 5' ' ' VAL . 64.4 m -115.34 156.51 25.36 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.975 1.31 . . . . 2.6499999999999999 108.859 172.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.49 133.43 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.889 -1.152 . . . . 0.52000000000000002 107.889 152.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -91.61 129.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 117.872 0.305 . . . . 0.93999999999999995 110.911 175.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mt -100.42 129.87 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.406 -0.961 . . . . 1.6899999999999999 108.406 170.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -133.21 123.55 25.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.272 1.029 . . . . 2.0600000000000001 109.279 167.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -78.56 157.98 28.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 112.252 0.464 . . . . 3.48 112.252 -177.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 t -156.36 178.49 10.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.906 0.86 . . . . 1.45 109.834 168.016 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -63.83 -13.42 44.47 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.419 2.288 . . . . 3.8599999999999999 113.137 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.22 8.73 53.47 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.104 1.812 . . . . 1.28 115.437 165.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.68 -162.85 28.08 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 130.643 3.973 . . . . 0.92000000000000004 117.638 171.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.55 108.02 2.28 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.357 1.063 . . . . 0.69999999999999996 111.738 -172.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -85.98 109.75 18.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.41 1.084 . . . . 1.8999999999999999 110.209 173.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.8 t80 -94.29 112.81 24.63 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.375 2.27 . . . . 0.55000000000000004 108.835 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 m -120.1 112.31 34.84 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 120.003 1.274 . . . . 0.69999999999999996 108.58 -176.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.58 150.6 7.57 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.011 2.474 . . . . 0.54000000000000004 113.156 -171.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' NE2' ' HB ' ' A' ' 21' ' ' THR . 7.9 p80 -147.51 41.98 1.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.356 1.074 . . . . 1.51 112.547 171.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.19 156.51 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.707 1.603 . . . . 0.82999999999999996 113.845 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 167.0 18.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.131 -1.85 . . . . 3.3300000000000001 109.211 176.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.55 19.42 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.14 2.576 . . . . 1.51 113.566 172.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.616 HD12 HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -91.33 164.75 23.56 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 121.678 -0.639 . . . . 1.79 110.231 174.324 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.29 145.3 96.05 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 120.296 0.664 . . . . 0.82999999999999996 111.578 165.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 10.2 Cg_endo -85.39 25.61 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 125.111 3.874 . . . . 1.0600000000000001 114.253 -153.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.84 -141.1 6.7 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 125.216 1.389 . . . . 1.28 116.012 -174.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.3 141.92 29.06 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.67 2.388 . . . . 2.3999999999999999 110.451 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -136.18 137.66 41.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.463 1.105 . . . . 1.6299999999999999 111.449 -172.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 157.38 52.34 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.899 -1.126 . . . . 0.78000000000000003 111.631 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 8.4 t80 -130.98 112.92 13.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.155 -1.424 . . . . 1.96 107.155 173.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -118.48 162.21 18.72 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.127 -0.983 . . . . 1.02 113.518 165.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.41 135.08 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.429 1.492 . . . . 0.81000000000000005 107.281 159.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -115.06 159.08 21.25 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.602 0.761 . . . . 0.94999999999999996 109.659 170.013 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.13 79.59 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.827 1.788 . . . . 1.01 115.827 -160.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.97 143.64 48.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.398 1.079 . . . . 1.1299999999999999 113.019 -173.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.55 62.18 2.75 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.512 1.53 . . . . 1.0600000000000001 114.941 -176.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -162.73 89.88 0.68 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.408 1.604 . . . . 2.0699999999999998 115.225 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.0 m -74.15 74.25 1.76 Allowed 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.041 -1.662 . . . . 2.7400000000000002 111.8 166.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -122.27 144.95 43.0 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.239 1.016 . . . . 3.2200000000000002 110.365 174.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.05 162.43 10.2 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.971 2.447 . . . . 1.1399999999999999 113.831 -167.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.51 128.78 55.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.387 1.075 . . . . 1.8200000000000001 108.935 161.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mm -90.71 38.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.456 1.122 . . . . 3.2799999999999998 110.009 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -66.72 130.34 42.84 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.929 1.291 . . . . 4.1699999999999999 110.976 -167.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t70 57.65 21.76 7.58 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.148 1.166 . . . . 3.7200000000000002 114.148 -176.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.05 76.01 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.148 0.88 . . . . 2.5699999999999998 114.495 177.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.75 134.88 52.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.401 1.601 . . . . 2.8799999999999999 110.71 172.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.74 95.11 9.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.319 -0.863 . . . . 1.8700000000000001 112.104 -169.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.73 95.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.596 1.558 . . . . 2.3900000000000001 108.594 173.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.4 -25.88 0.47 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 119.797 3.258 . . . . 2.8700000000000001 119.797 -156.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.67 38.06 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 120.128 1.331 . . . . 1.5800000000000001 114.267 -168.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.26 -34.12 73.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.224 1.01 . . . . 4.7699999999999996 113.076 -177.453 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.68 0.55 1.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.036 1.495 . . . . 1.4399999999999999 115.036 -175.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.57 -10.84 59.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.217 1.407 . . . . 1.0 113.856 175.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.33 32.89 12.58 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 116.796 1.479 . . . . 3.1800000000000002 116.796 164.016 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.57 -178.58 31.54 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 119.452 1.626 . . . . 1.0900000000000001 114.457 174.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -76.2 22.58 0.16 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.197 1.554 . . . . 2.27 115.197 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.254 31.1 tp 64.41 36.16 9.12 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.143 1.377 . . . . 1.7 111.508 172.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -123.17 49.55 2.54 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 116.371 1.989 . . . . 3.6099999999999999 116.371 -161.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.33 -29.14 46.44 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.51 2.14 . . . . 2.4199999999999999 113.028 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -127.16 34.88 4.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.649 1.18 . . . . 4.4699999999999998 111.905 -168.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -119.84 -153.6 0.55 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.834 1.254 . . . . 3.3700000000000001 110.882 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.6 p -88.99 -25.17 22.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.271 1.428 . . . . 3.0800000000000001 113.174 175.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.31 88.78 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.392 0.996 . . . . 2.0 114.74 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -98.05 7.94 45.53 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 116.116 1.895 . . . . 4.8399999999999999 116.116 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.7 t60 68.61 168.04 0.27 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.961 1.704 . . . . 2.0499999999999998 112.768 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -150.17 155.25 39.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.793 1.405 . . . . 3.6000000000000001 114.793 -149.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.33 -155.06 6.89 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 126.291 1.9 . . . . 2.6000000000000001 112.873 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.26 -9.79 24.83 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.861 3.041 . . . . 3.79 113.041 173.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.31 162.56 32.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.48 1.912 . . . . 6.3499999999999996 109.159 166.486 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.42 -159.71 23.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.28 0.943 . . . . 4.54 112.84 -172.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.95 137.21 3.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.393 2.277 . . . . 4.6900000000000004 105.876 168.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.7 -72.87 0.02 OUTLIER Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.195 0.902 . . . . 2.77 114.282 -172.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -150.85 125.75 9.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.596 1.959 . . . . 4.0300000000000002 110.801 -173.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -62.45 -20.38 64.47 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.223 1.194 . . . . 2.7200000000000002 114.223 175.108 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.39 8.22 59.03 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.631 2.062 . . . . 1.1799999999999999 116.031 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.39 139.75 30.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.995 1.397 . . . . 1.6499999999999999 111.154 167.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.61 163.63 49.75 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 126.784 2.034 . . . . 2.0600000000000001 110.077 -172.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.77 162.43 26.91 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.141 2.561 . . . . 1.0700000000000001 112.304 -172.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.12 141.92 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.699 1.37 . . . . 1.52 114.699 -164.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.12 107.09 18.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 130.675 3.59 . . . . 1.76 108.682 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.34 137.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.907 -1.121 . . . . 0.93000000000000005 110.575 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 40' ' ' LEU . 10.9 m -109.09 161.2 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.356 0.662 . . . . 2.1800000000000002 109.962 164.027 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.91 165.07 16.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.864 0.466 . . . . 2.0299999999999998 110.927 175.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -62.72 4.79 0.14 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 117.568 2.433 . . . . 2.9399999999999999 117.568 -161.443 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -104.17 -11.08 17.48 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.27 2.628 . . . . 3.4500000000000002 113.395 176.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.49 24.48 12.26 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 121.365 -0.834 . . . . 0.81999999999999995 114.675 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.5 mt -126.05 129.84 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.629 1.172 . . . . 1.46 110.92 -176.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -89.22 147.66 24.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.099 2.16 . . . . 1.1499999999999999 112.075 -172.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.97 -21.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.89 1.276 . . . . 1.22 114.057 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.53 116.95 50.61 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.457 1.103 . . . . 3.0600000000000001 110.447 176.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -85.07 163.13 11.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.592 2.862 . . . . 1.3400000000000001 112.349 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.85 161.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.723 1.209 . . . . 1.26 110.577 170.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 m -124.04 139.81 53.58 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.327 1.051 . . . . 0.87 110.041 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.58 97.85 29.71 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.21 1.004 . . . . 0.83999999999999997 110.79 174.137 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.88 -0.8 10.36 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.925 3.083 . . . . 1.3600000000000001 114.333 -176.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -86.94 -2.76 58.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.627 1.571 . . . . 4.0599999999999996 112.696 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.1 mt -141.53 123.86 15.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.52 2.328 . . . . 2.3599999999999999 106.242 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -116.18 5.66 13.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.857 1.263 . . . . 4.71 114.158 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.7 t -149.38 150.05 31.83 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.441 0.904 . . . . 1.8999999999999999 113.441 175.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.78 -28.68 70.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.377 -0.827 . . . . 1.6200000000000001 112.569 170.117 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.01 -18.57 65.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.065 1.302 . . . . 3.6699999999999999 113.58 -177.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.03 -19.49 61.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.338 1.055 . . . . 1.73 112.121 172.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.47 7.26 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.656 1.182 . . . . 0.80000000000000004 113.941 -170.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -63.68 5.67 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.263 2.32 . . . . 2.46 117.263 -174.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.54 0.43 2.49 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.713 2.005 . . . . 3.0 112.607 -178.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -95.81 171.71 8.48 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.457 1.503 . . . . 1.48 113.577 -168.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.73 150.28 27.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.511 1.124 . . . . 0.51000000000000001 111.984 165.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 mt -122.4 140.29 52.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.41 2.284 . . . . 1.7 107.803 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.485 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -143.23 146.81 33.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.418 1.008 . . . . 2.5499999999999998 113.599 177.937 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.8 119.14 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.274 1.43 . . . . 1.1399999999999999 108.301 166.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' A' ' 126' ' ' MET . 74.6 m80 -98.57 148.44 23.78 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.672 1.589 . . . . 3.0600000000000001 112.013 -168.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.8 -46.37 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.173 0.589 . . . . 1.75 112.144 -158.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.35 169.71 13.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.79 1.186 . . . . 1.79 111.14 164.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.28 -174.6 4.68 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.216 1.865 . . . . 1.77 113.433 170.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -159.91 166.22 30.58 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.787 0.835 . . . . 3.5299999999999998 111.914 -166.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.0 p30 159.04 23.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 132.721 4.408 . . . . 3.0699999999999998 111.625 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 72.9 mtm -92.37 106.84 18.76 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.897 -1.127 . . . . 3.2999999999999998 112.504 -165.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 p -93.05 158.86 15.56 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.656 -1.277 . . . . 3.5600000000000001 113.903 169.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.2 t0 65.58 17.96 11.08 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.417 2.006 . . . . 5.4100000000000001 116.417 155.04 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.9 157.08 49.17 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 120.699 -1.251 . . . . 6.8799999999999999 113.675 -172.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.36 -21.75 3.52 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.667 2.911 . . . . 3.04 114.134 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -102.92 95.74 6.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.088 -1.007 . . . . 7.2699999999999996 108.382 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.65 143.78 75.99 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.566 2.177 . . . . 3.4700000000000002 111.504 -164.346 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 77.06 -10.74 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.472 2.709 . . . . 4.0599999999999996 113.013 -174.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 62.58 15.41 53.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 2.6400000000000001 115.66 170.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.1 -21.8 32.45 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.912 1.244 . . . . 2.6499999999999999 113.631 -170.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.89 -8.18 52.21 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.403 1.478 . . . . 2.4900000000000002 114.009 176.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.69 -5.14 83.01 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.025 1.298 . . . . 2.0699999999999998 114.514 170.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.6 p -75.78 132.28 40.33 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.894 1.347 . . . . 1.8 110.174 175.104 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -97.84 135.08 40.11 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.167 0.987 . . . . 5.9699999999999998 110.192 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 26.7 t80 -91.0 -40.04 11.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.047 0.385 . . . . 2.2400000000000002 110.326 164.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.52 29.26 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.909 0.884 . . . . 1.1399999999999999 111.931 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.2 m -114.73 145.03 42.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.891 2.076 . . . . 2.8700000000000001 111.233 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.74 167.65 26.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.919 1.723 . . . . 1.3700000000000001 113.225 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.9 t -135.54 141.91 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.738 1.215 . . . . 1.53 109.734 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.2 mt -89.06 143.47 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.738 1.215 . . . . 0.82999999999999996 110.774 -176.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 4.6200000000000001 111.287 -177.27 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.238 0.542 . . . . 1.73 110.659 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -148.43 149.78 32.32 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.856 0.862 . . . . 0.97999999999999998 110.362 -172.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.04 132.05 16.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.657 1.217 . . . . 2.23 110.053 171.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -88.56 109.79 20.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.179 0.992 . . . . 3.7200000000000002 111.559 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -87.02 105.51 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.609 -1.307 . . . . 1.47 108.885 -169.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -59.38 108.81 1.8 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.651 1.596 . . . . 1.3600000000000001 109.953 169.426 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.7 mtt -109.41 154.03 23.16 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.275 1.43 . . . . 1.23 112.508 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -145.9 149.68 34.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.56 1.544 . . . . 3.0600000000000001 112.003 -169.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.41 66.1 3.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.953 1.301 . . . . 1.6000000000000001 111.435 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.25 144.83 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.698 0.799 . . . . 0.88 111.599 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.4 t -172.69 72.19 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.451 1.1 . . . . 2.0499999999999998 111.152 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.11 -19.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.866 2.066 . . . . 1.3 114.834 173.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -28.86 66.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.479 1.912 . . . . 2.9100000000000001 110.006 164.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.47 -159.23 24.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.182 1.372 . . . . 1.1399999999999999 111.067 -154.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -46.15 127.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.411 1.884 . . . . 1.1399999999999999 111.122 165.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.79 -68.02 0.18 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.607 1.575 . . . . 1.6599999999999999 114.039 -173.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.156 1.382 . . . . 1.8500000000000001 110.543 171.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -109.25 172.23 6.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.737 -1.227 . . . . 1.3400000000000001 112.571 178.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.7 pt -151.19 5.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 128.98 2.912 . . . . 3.0800000000000001 112.479 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.53 159.37 9.08 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 121.137 -0.977 . . . . 0.92000000000000004 113.751 -161.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 6' ' ' GLY . 72.9 p -125.99 -178.5 4.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.683 1.993 . . . . 1.6899999999999999 106.74 173.25 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 61.0 t -133.52 125.83 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.359 -0.978 . . . . 0.60999999999999999 108.359 169.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.0 p -74.77 124.69 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 117.978 0.354 . . . . 0.93999999999999995 110.599 170.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HD21 ' A' ' 125' ' ' LEU . 8.4 mt -98.41 131.43 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 108.298 -1.001 . . . . 1.5600000000000001 108.298 163.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -140.05 121.47 15.05 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.132 1.373 . . . . 1.8100000000000001 108.572 178.154 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.74 150.26 21.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.801 0.667 . . . . 3.0499999999999998 112.801 -169.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.6 178.9 9.57 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.108 0.563 . . . . 1.1799999999999999 110.546 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -60.53 -30.81 69.98 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.676 1.19 . . . . 3.6099999999999999 110.958 175.019 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.6 13.96 53.54 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.164 1.364 . . . . 0.89000000000000001 114.953 168.253 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.31 -148.49 20.71 Favored Glycine 0 N--CA 1.468 0.782 0 C-N-CA 127.167 2.318 . . . . 0.68999999999999995 116.268 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.2 mt -79.18 101.54 8.0 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.169 -0.606 . . . . 0.59999999999999998 110.862 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -75.73 112.37 12.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 2.3300000000000001 109.587 171.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 3.2 t80 -98.79 109.07 21.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 128.02 2.528 . . . . 0.52000000000000002 108.14 -178.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.422 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.5 m -111.13 105.64 57.11 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.335 -1.357 . . . . 0.64000000000000001 107.335 176.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.31 153.23 24.17 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.316 2.677 . . . . 0.75 110.846 -171.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.97 63.37 0.65 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.177 0.989 . . . . 2.79 111.013 178.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.25 141.78 51.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.057 2.143 . . . . 0.87 111.528 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -129.32 20.82 5.71 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 118.029 2.603 . . . . 2.7000000000000002 118.029 -158.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.43 19.58 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 115.581 1.697 . . . . 1.8999999999999999 115.581 -173.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.78 165.35 19.12 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 121.492 -0.755 . . . . 1.75 110.856 -171.419 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 59.9 Cg_endo -65.95 131.26 26.65 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 N-CA-C 109.806 -0.882 . . . . 1.1399999999999999 109.806 163.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 6.0 Cg_endo -88.88 34.2 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.272 3.315 . . . . 1.1299999999999999 112.402 -148.175 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.44 -122.54 4.8 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 123.821 1.79 . . . . 1.51 113.616 -178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -134.88 142.41 46.58 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 126.372 1.869 . . . . 3.1000000000000001 109.747 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -134.59 145.87 49.07 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.572 1.149 . . . . 1.1200000000000001 111.707 -173.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.82 157.16 26.72 Favored Glycine 0 CA--C 1.542 1.758 0 O-C-N 121.024 -1.048 . . . . 0.63 111.951 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -145.56 120.51 10.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.791 1.237 . . . . 2.0499999999999998 108.086 168.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.12 165.16 24.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.702 1.742 . . . . 0.85999999999999999 115.702 164.077 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.0 mt -89.96 144.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.398 1.479 . . . . 0.78000000000000003 109.143 160.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -127.44 170.19 12.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.885 2.074 . . . . 1.1100000000000001 111.361 -178.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.98 52.74 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.99 2.218 . . . . 1.02 116.99 -160.078 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -110.51 -157.41 0.61 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.752 1.221 . . . . 2.3100000000000001 111.477 -175.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.12 -27.63 8.67 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 117.65 1.82 . . . . 1.9399999999999999 117.65 -155.413 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 175.8 140.12 0.06 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.963 2.382 . . . . 3.3799999999999999 113.877 -173.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.58 67.08 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 117.354 2.353 . . . . 3.5800000000000001 117.354 -176.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -94.09 152.04 40.09 Favored Pre-proline 0 CA--C 1.55 0.963 0 O-C-N 121.053 -1.029 . . . . 3.3199999999999998 110.689 160.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -90.22 177.63 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.207 3.272 . . . . 1.49 112.673 -168.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.67 147.21 37.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.995 1.318 . . . . 1.4099999999999999 110.624 172.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.87 126.94 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.915 0.886 . . . . 2.46 110.989 -174.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.86 156.47 22.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.706 2.402 . . . . 5.79 110.73 173.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 52.09 37.33 21.23 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.078 1.51 . . . . 4.1799999999999997 115.078 167.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.88 79.38 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.003 -1.061 . . . . 2.52 114.351 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.07 156.04 42.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.857 1.328 . . . . 4.2800000000000002 113.528 -176.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.77 121.78 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.647 0.779 . . . . 1.6699999999999999 108.909 164.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.41 132.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.719 1.208 . . . . 3.0 108.567 171.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.3 -37.75 17.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.808 1.243 . . . . 1.8999999999999999 114.148 -172.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -179.98 123.74 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.465 2.706 . . . . 1.8400000000000001 110.307 175.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -121.49 -29.07 4.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.905 1.282 . . . . 4.2199999999999998 112.547 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.96 -0.29 8.98 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.202 -1.561 . . . . 1.8600000000000001 114.071 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.56 -17.46 33.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.734 1.614 . . . . 1.23 113.273 164.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.59 179.61 52.81 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.642 1.591 . . . . 2.5099999999999998 114.439 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.5 -172.8 25.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.946 0.784 . . . . 1.1699999999999999 112.864 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.94 24.07 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.047 1.739 . . . . 2.1499999999999999 115.627 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.9 tp 52.29 49.04 21.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.211 1.405 . . . . 1.8300000000000001 110.493 176.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -151.49 110.8 2.98 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.433 -0.803 . . . . 4.29 112.634 -171.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -91.72 -18.96 0.84 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.012 2.475 . . . . 2.9199999999999999 113.766 174.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -159.25 -22.56 0.07 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.938 1.829 . . . . 3.6600000000000001 115.938 -163.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -64.76 -35.86 82.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.751 1.614 . . . . 3.5800000000000001 112.366 -171.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -165.91 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.991 2.517 . . . . 3.9300000000000002 111.263 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.18 11.14 70.12 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.515 1.531 . . . . 2.3900000000000001 112.73 -177.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -167.16 -105.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.245 1.818 . . . . 5.6799999999999997 113.033 -166.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -161.43 141.57 10.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.727 1.751 . . . . 2.4700000000000002 115.727 -161.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.43 149.83 36.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.092 0.957 . . . . 4.0 113.293 174.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.52 -145.63 17.88 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 110.316 -1.114 . . . . 2.8100000000000001 110.316 156.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.39 17.56 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.996 3.131 . . . . 3.48 114.253 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.63 -11.08 8.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.691 1.596 . . . . 4.7800000000000002 114.429 -157.524 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.14 -7.68 81.58 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 116.955 1.542 . . . . 3.5600000000000001 116.955 169.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -78.02 83.16 4.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 1.585 . . . . 5.3300000000000001 109.383 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.8 -177.1 14.89 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 123.936 0.779 . . . . 3.2999999999999998 114.812 -168.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.617 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 5.4 p-80 -92.04 157.92 16.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.693 0.797 . . . . 5.75 111.274 169.312 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -63.05 -10.12 12.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.118 1.525 . . . . 3.1800000000000002 115.118 -179.151 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.617 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -115.24 19.9 14.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.798 2.142 . . . . 1.5800000000000001 113.753 173.349 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -73.86 135.12 43.36 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.42 1.11 . . . . 2.5099999999999998 109.491 164.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.01 160.48 31.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.16 1.384 . . . . 1.8300000000000001 110.294 -147.521 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.11 168.77 20.07 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.216 3.277 . . . . 1.1100000000000001 111.633 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 m -82.0 142.89 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 122.894 1.33 . . . . 1.4399999999999999 113.374 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.76 92.73 3.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 129.061 2.944 . . . . 1.8 109.204 172.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 95.9 t -74.75 137.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.875 0.87 . . . . 1.1100000000000001 110.366 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.99 143.22 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.427 2.291 . . . . 1.49 106.305 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.8 164.49 12.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.858 0.754 . . . . 2.0499999999999998 111.701 174.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.64 -23.82 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 129.597 3.159 . . . . 2.8500000000000001 118.112 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.88 -23.5 52.61 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.935 1.694 . . . . 3.9700000000000002 112.463 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.46 17.73 32.91 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.948 1.737 . . . . 0.88 112.941 -161.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.1 mt -111.81 119.99 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.962 1.305 . . . . 1.05 110.966 -176.105 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.84 127.52 39.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.775 1.23 . . . . 0.87 109.732 168.179 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -156.2 4.49 0.17 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.233 1.568 . . . . 1.3600000000000001 115.233 -175.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.22 135.9 26.39 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 119.81 1.186 . . . . 3.5299999999999998 110.638 172.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.0 141.72 49.14 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.017 3.145 . . . . 1.1399999999999999 112.189 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.09 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.823 2.049 . . . . 1.6599999999999999 108.151 173.019 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.4 m -145.96 139.64 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.931 1.241 . . . . 0.68000000000000005 111.707 -178.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.01 94.06 5.05 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.26 1.024 . . . . 0.72999999999999998 112.462 169.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.79 -5.07 16.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.133 3.222 . . . . 1.3500000000000001 113.933 172.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -73.11 -7.92 53.45 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.146 1.778 . . . . 4.96 111.863 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.6 mt -124.28 177.16 6.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.735 2.414 . . . . 2.2599999999999998 109.821 170.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -144.39 -20.69 0.54 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.012 1.856 . . . . 4.0800000000000001 116.012 -172.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -144.03 163.25 34.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.847 1.203 . . . . 1.48 112.399 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.23 61.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.285 -0.884 . . . . 1.5900000000000001 110.297 174.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.95 -27.68 69.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.378 1.071 . . . . 3.1299999999999999 113.503 -166.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 119' ' ' GLU . 9.1 pt-20 -71.48 -20.36 62.09 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.753 1.621 . . . . 1.8300000000000001 113.869 175.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.33 8.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.374 1.47 . . . . 1.0800000000000001 112.984 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -62.08 -4.41 1.67 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.107 1.891 . . . . 2.3300000000000001 116.107 -175.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -137.67 24.26 2.88 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.318 2.247 . . . . 3.0099999999999998 110.814 -160.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -130.68 158.44 40.06 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.332 1.453 . . . . 1.28 113.931 -168.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.76 150.65 20.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.097 1.759 . . . . 0.93000000000000005 112.987 168.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 24' ' ' ILE . 7.4 mp -127.36 121.01 29.82 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.043 2.137 . . . . 3.0499999999999998 109.86 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -103.06 131.65 49.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.786 0.835 . . . . 2.3500000000000001 111.405 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.6 mt -93.52 123.38 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 107.818 -1.179 . . . . 0.68000000000000005 107.818 160.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -112.89 140.86 47.33 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.427 1.491 . . . . 1.8600000000000001 112.262 -159.024 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.03 -41.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.555 -0.716 . . . . 1.24 111.585 -168.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.23 163.57 15.0 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.493 0.568 . . . . 1.23 112.135 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.22 87.72 1.49 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.08 -1.208 . . . . 1.8500000000000001 110.08 173.349 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -61.78 122.61 15.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.797 0.839 . . . . 4.2999999999999998 111.645 178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 171.81 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.239 2.616 . . . . 3.4900000000000002 109.662 -157.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.9 ptp -74.15 60.42 0.79 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.345 1.458 . . . . 3.3300000000000001 112.192 171.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 t -74.08 -20.38 60.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.186 1.794 . . . . 3.77 115.111 -165.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -81.87 76.18 8.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 3.3599999999999999 112.269 -173.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -169.56 156.69 6.42 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.08 1.352 . . . . 3.9199999999999999 111.78 -179.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.89 -9.65 18.15 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.711 2.941 . . . . 2.8900000000000001 113.64 176.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -93.2 106.12 18.45 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 119.229 0.922 . . . . 4.3799999999999999 109.0 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.46 160.22 47.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.104 2.536 . . . . 3.2000000000000002 113.274 -158.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.58 32.22 21.92 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.834 1.654 . . . . 3.7799999999999998 111.501 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.34 67.45 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.668 1.128 . . . . 2.6800000000000002 114.333 -177.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.94 -17.0 18.34 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.156 1.36 . . . . 1.7 113.242 -164.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.92 8.24 60.6 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.006 1.765 . . . . 1.4199999999999999 114.844 -176.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.49 68.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.302 1.43 . . . . 1.4099999999999999 115.801 -170.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -58.47 154.46 13.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.181 1.49 . . . . 1.51 110.482 168.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 mmt-85 -96.39 138.47 33.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.388 1.075 . . . . 3.8700000000000001 109.453 -176.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.86 -18.8 16.22 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.955 0.798 . . . . 3.3199999999999998 111.774 154.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.31 168.79 25.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.537 1.135 . . . . 0.88 111.409 164.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -152.98 153.26 32.58 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.057 1.343 . . . . 1.8700000000000001 110.697 172.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -153.17 178.67 30.1 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.181 1.372 . . . . 1.6899999999999999 114.305 -175.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 139.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.05 1.34 . . . . 2.4500000000000002 111.302 -171.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 76.2 mt -92.86 143.03 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.44 1.096 . . . . 1.1699999999999999 109.613 171.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt . . . . . 0 N--CA 1.471 0.62 0 O-C-N 120.67 -1.269 . . . . 3.7400000000000002 112.508 177.128 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.717 -0.846 . . . . 1.5800000000000001 108.717 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.22 156.12 47.32 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.167 1.349 . . . . 1.03 114.187 -148.161 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.68 127.54 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.897 1.679 . . . . 2.3199999999999998 108.872 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -103.31 98.82 8.68 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.684 1.993 . . . . 3.8199999999999998 109.708 -174.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -87.77 129.45 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 114.177 1.177 . . . . 2.1400000000000001 114.177 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.47 103.78 0.73 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.672 1.129 . . . . 1.0 111.057 167.222 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.31 110.97 13.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.942 1.297 . . . . 1.49 109.971 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -108.66 147.15 32.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 2.4399999999999999 111.4 -170.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.21 61.18 2.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.981 -1.075 . . . . 1.3999999999999999 113.192 -171.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -70.87 154.86 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.281 1.432 . . . . 1.4099999999999999 113.211 -177.347 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -169.97 -152.97 0.1 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.602 1.561 . . . . 3.3300000000000001 109.295 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -11.82 2.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 129.03 2.932 . . . . 1.1200000000000001 116.06 -175.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.82 0.49 32.74 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.953 1.301 . . . . 4.1900000000000004 112.057 174.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.67 -147.15 21.08 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.695 1.14 . . . . 1.29 110.458 -165.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 10' ' ' VAL . 11.6 t -54.23 134.89 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.732 2.013 . . . . 1.04 112.808 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.28 -112.29 3.66 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.757 1.646 . . . . 1.2 112.803 -175.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.89 166.97 20.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.834 0.817 . . . . 1.9399999999999999 111.555 168.29 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.6 t -93.33 148.98 21.57 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.264 1.026 . . . . 1.48 113.192 -174.018 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 pt -142.1 2.23 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.296 1.438 . . . . 2.8199999999999998 113.915 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.33 170.25 22.8 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.042 -1.036 . . . . 0.68999999999999995 112.703 -173.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 p -107.66 178.73 4.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.023 0.929 . . . . 0.90000000000000002 110.332 171.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 33' ' ' PHE . 46.6 t -128.56 132.54 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.526 -1.287 . . . . 0.40999999999999998 107.526 152.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.419 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.9 p -85.09 119.92 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.72 0.638 . . . . 0.92000000000000004 109.77 174.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -102.65 130.23 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.227 -1.397 . . . . 1.3799999999999999 107.227 174.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -136.78 120.5 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.725 0.81 . . . . 2.3199999999999998 111.232 176.376 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.41 140.73 48.53 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.247 0.619 . . . . 3.6899999999999999 111.58 178.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -143.57 -179.92 6.73 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.387 1.075 . . . . 1.5900000000000001 108.649 164.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -68.03 -28.29 67.27 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.675 2.39 . . . . 5.21 111.812 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.45 17.87 54.41 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.016 1.769 . . . . 1.5 114.639 162.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.88 -159.01 26.38 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 127.365 2.412 . . . . 0.85999999999999999 118.411 164.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.97 104.08 8.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.736 0.815 . . . . 0.62 111.371 -168.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -79.94 110.43 15.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.763 1.625 . . . . 1.99 110.217 174.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 22' ' ' VAL . 4.0 t80 -99.06 118.73 36.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.294 2.238 . . . . 0.48999999999999999 109.475 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.419 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 78.7 m -124.82 111.98 27.24 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-N 119.292 0.951 . . . . 0.60999999999999999 109.103 176.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.83 165.21 17.8 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.6 2.867 . . . . 0.62 111.008 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -151.0 25.89 0.72 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.495 0.718 . . . . 1.3100000000000001 112.099 173.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.87 148.23 25.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.498 1.119 . . . . 0.90000000000000002 113.33 -170.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 144.5 49.47 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.974 1.31 . . . . 2.3999999999999999 108.56 168.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.93 45.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 128.203 2.601 . . . . 1.3600000000000001 112.514 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.76 160.98 40.25 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.433 1.093 . . . . 1.6899999999999999 110.537 169.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.26 125.55 14.22 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 121.124 1.216 . . . . 1.0700000000000001 110.375 169.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -80.47 74.5 5.51 Favored 'Trans proline' 0 N--CA 1.451 -1.015 1 C-N-CA 125.413 4.075 . . . . 1.76 109.925 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.88 -173.76 13.2 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 116.343 -2.837 . . . . 1.6699999999999999 111.932 132.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -56.81 140.61 47.37 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.003 1.321 . . . . 2.75 111.668 175.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -136.83 125.47 23.77 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.902 1.281 . . . . 1.1299999999999999 112.746 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.04 149.91 3.26 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.325 0.964 . . . . 0.67000000000000004 113.229 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.403 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.2 t80 -132.4 132.03 42.41 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.598 1.559 . . . . 1.99 106.82 176.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -136.1 168.63 19.02 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 114.867 1.432 . . . . 0.94999999999999996 114.867 170.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.6 139.51 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.664 1.586 . . . . 0.92000000000000004 109.545 158.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.55 165.24 13.79 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.962 2.105 . . . . 0.87 111.358 177.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.86 64.43 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.141 1.534 . . . . 0.77000000000000002 115.141 -159.541 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -123.73 152.44 42.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.929 0.892 . . . . 1.3799999999999999 113.074 178.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.95 79.81 1.82 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 125.596 1.57 . . . . 0.97999999999999998 110.975 174.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -166.53 59.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.46 0.704 . . . . 3.6099999999999999 112.523 -165.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.8 m -67.2 66.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.284 1.834 . . . . 1.8600000000000001 113.115 173.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -130.53 156.53 79.52 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.219 2.208 . . . . 3.5499999999999998 108.315 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.16 133.88 15.35 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.005 1.803 . . . . 1.1899999999999999 110.216 176.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 176.38 6.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.058 -0.974 . . . . 2.8399999999999999 109.917 161.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -103.2 128.62 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.887 -0.783 . . . . 5.6299999999999999 108.887 165.013 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -94.45 -71.31 0.67 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 118.644 -0.694 . . . . 7.6699999999999999 109.244 161.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.75 106.66 9.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.209 1.403 . . . . 4.1299999999999999 109.124 169.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.73 -44.9 0.65 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.501 2.0 . . . . 5.1600000000000001 116.852 174.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.14 158.41 18.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.222 1.409 . . . . 2.8900000000000001 114.026 -161.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.93 95.98 4.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.961 1.704 . . . . 1.8700000000000001 111.867 -171.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.92 80.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.93 0.872 . . . . 2.9700000000000002 112.159 -177.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 46.28 -104.7 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.869 2.467 . . . . 2.02 114.928 163.109 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.15 25.13 9.74 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.401 1.48 . . . . 1.9299999999999999 111.979 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -81.67 11.49 4.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.519 1.127 . . . . 8.5500000000000007 113.501 -174.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.64 -6.61 57.47 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.143 -0.973 . . . . 2.2200000000000002 112.677 158.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.21 23.8 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.684 1.594 . . . . 1.24 114.311 175.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.15 4.0 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.5 1.524 . . . . 3.6499999999999999 115.646 167.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.14 -176.85 30.26 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.791 1.186 . . . . 1.3500000000000001 112.486 -171.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -81.33 62.29 5.17 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 2.1600000000000001 110.532 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.8 tp 25.21 65.6 0.05 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.627 2.371 . . . . 1.6100000000000001 112.537 -174.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -127.14 60.65 43.57 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.038 2.135 . . . . 4.8300000000000001 112.057 -158.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.47 -41.16 9.25 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.387 2.058 . . . . 2.27 109.994 169.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -152.9 165.64 34.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.283 1.833 . . . . 4.5 110.03 167.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 140.88 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 1 C-N-CA 132.706 4.402 . . . . 3.75 113.209 163.101 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t 150.99 -56.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 130.726 3.61 . . . . 2.6099999999999999 110.785 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.09 -11.26 69.51 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.342 1.449 . . . . 1.97 115.093 -178.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.48 -25.04 61.86 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.749 1.775 . . . . 4.25 115.243 -176.275 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.416 ' CE1' ' CG ' ' A' ' 93' ' ' ASP . 24.7 t60 75.44 126.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.393 2.677 . . . . 2.6800000000000002 113.354 176.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 -57.13 2.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.824 0.849 . . . . 7.4500000000000002 112.873 165.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.62 -85.13 0.38 Allowed Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.291 -1.283 . . . . 4.9100000000000001 110.208 -156.133 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.38 -128.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.857 3.705 . . . . 6.7599999999999998 111.863 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.73 51.25 1.34 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.498 -1.376 . . . . 10.800000000000001 114.693 -159.061 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.14 -107.55 0.5 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.443 1.021 . . . . 2.6000000000000001 111.198 167.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -16.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.259 1.024 . . . . 5.0099999999999998 113.505 171.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.11 92.39 1.15 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.378 0.99 . . . . 3.8599999999999999 111.897 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 71.42 97.84 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.896 2.078 . . . . 5.2199999999999998 113.711 162.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -16.61 64.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.506 1.669 . . . . 3.2599999999999998 115.506 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.84 8.55 79.31 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.81 1.671 . . . . 1.29 113.979 175.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' CG ' ' CE1' ' A' ' 82' ' ' HIS . 72.8 m-20 -80.57 155.05 27.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 3.3799999999999999 109.93 153.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.54 154.54 21.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 121.029 -1.044 . . . . 1.6399999999999999 111.609 -133.158 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.04 143.1 64.29 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.705 2.937 . . . . 1.04 111.89 -171.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.45 133.49 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.724 0.81 . . . . 1.8500000000000001 111.473 -163.046 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.84 99.41 2.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.832 2.053 . . . . 1.8500000000000001 109.044 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.0 t -78.23 121.6 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.496 -0.753 . . . . 0.98999999999999999 109.811 177.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.81 131.41 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.654 1.982 . . . . 1.73 108.361 175.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -81.05 148.24 29.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.643 0.656 . . . . 3.3100000000000001 112.275 175.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -40.03 -25.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.338 3.055 . . . . 2.5800000000000001 117.035 -172.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.01 -19.76 62.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.608 1.963 . . . . 4.1100000000000003 113.444 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 31.8 6.24 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.309 1.433 . . . . 0.85999999999999999 112.852 -172.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.98 145.02 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.954 1.702 . . . . 1.0 108.581 -168.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -124.82 114.85 19.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.059 1.343 . . . . 0.68000000000000005 110.968 -177.109 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -125.94 -9.75 6.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.437 1.273 . . . . 1.3600000000000001 114.437 172.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.8 120.04 79.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.833 0.742 . . . . 3.1400000000000001 110.744 -167.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -85.62 153.8 10.33 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.716 2.944 . . . . 1.1200000000000001 112.632 -174.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.08 164.39 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.975 1.71 . . . . 1.1200000000000001 110.146 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.9 m -137.23 136.39 38.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.648 1.113 . . . . 0.82999999999999996 110.316 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.34 99.79 13.85 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.964 0.906 . . . . 0.79000000000000004 112.159 175.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.21 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.249 3.299 . . . . 1.0900000000000001 114.79 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.89 5.74 13.01 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.379 0.991 . . . . 4.8700000000000001 112.648 174.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.4 mt -140.92 171.94 13.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 129.244 3.018 . . . . 2.1899999999999999 107.571 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.34 2.35 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.612 1.708 . . . . 6.7699999999999996 115.612 -174.24 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -147.38 156.15 42.63 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.092 -1.005 . . . . 2.02 112.203 176.217 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.42 -26.03 63.48 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.204 -0.935 . . . . 1.5 111.336 161.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.18 -44.31 79.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.508 1.123 . . . . 4.0099999999999998 113.032 -173.183 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.68 -8.39 34.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.336 1.454 . . . . 1.8500000000000001 113.446 177.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.52 20.51 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.897 1.279 . . . . 0.89000000000000001 113.591 -177.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -68.09 -6.17 21.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.945 2.202 . . . . 2.4300000000000002 116.945 -172.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.72 39.37 1.67 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.897 1.679 . . . . 3.4399999999999999 110.668 178.04 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -117.55 149.1 41.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.453 1.101 . . . . 1.1699999999999999 112.853 -175.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.72 133.12 33.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.409 1.084 . . . . 0.80000000000000004 111.23 166.482 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.14 136.06 46.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.06 -1.089 . . . . 3.0699999999999998 108.06 165.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.0 mtt -132.1 133.42 44.3 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.217 0.607 . . . . 1.1899999999999999 111.984 -167.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.31 132.95 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.909 1.283 . . . . 0.64000000000000001 108.294 168.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 142.41 50.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.738 2.015 . . . . 2.2200000000000002 110.387 -159.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.73 -46.86 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.209 -0.932 . . . . 1.6599999999999999 111.732 -168.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.11 138.68 20.98 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 118.467 0.576 . . . . 1.25 111.859 175.112 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.06 146.94 49.11 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.773 1.654 . . . . 1.45 111.85 167.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -95.4 76.04 3.35 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.379 0.881 . . . . 2.9300000000000002 113.379 -156.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -163.66 56.23 0.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.182 0.993 . . . . 3.79 112.025 -171.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.28 119.31 5.42 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.91 -1.119 . . . . 2.2200000000000002 113.27 -171.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 t -146.5 -170.23 3.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.46 1.904 . . . . 3.3300000000000001 110.538 -178.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 71.35 -41.24 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 129.147 2.979 . . . . 3.6699999999999999 114.636 169.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -60.57 150.44 74.63 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 4.2400000000000002 111.707 173.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.01 -21.09 72.98 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.204 2.603 . . . . 2.1400000000000001 112.739 176.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -101.02 89.4 1.27 Allowed Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.836 0.854 . . . . 4.7599999999999998 109.923 158.172 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.9 161.16 43.57 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.484 . . . . 3.6699999999999999 110.243 172.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 60.53 9.45 2.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.956 1.302 . . . . 3.2799999999999998 111.953 -164.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 68.36 3.85 34.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.635 1.112 . . . . 3.1200000000000001 113.69 -167.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.12 3.27 58.99 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.322 1.439 . . . . 2.0699999999999998 114.036 -164.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.79 42.37 1.3 Allowed Glycine 0 N--CA 1.476 1.341 0 C-N-CA 127.148 2.309 . . . . 1.74 116.04 -173.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.1 71.36 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.34 0.972 . . . . 2.1699999999999999 113.437 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 p -61.4 136.81 58.16 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.591 1.956 . . . . 2.0499999999999998 112.075 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -99.29 162.29 13.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.858 1.663 . . . . 4.6799999999999997 110.974 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -118.68 -19.36 8.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.153 0.797 . . . . 2.4199999999999999 113.153 151.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.34 163.05 30.99 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.885 1.221 . . . . 0.55000000000000004 114.05 173.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.2 t -132.27 144.02 50.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 1.6299999999999999 110.786 164.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -132.17 101.43 0.46 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.872 2.177 . . . . 1.1899999999999999 109.571 168.059 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.25 130.12 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.565 1.146 . . . . 1.78 108.789 172.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 15.2 mt -60.4 127.7 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.404 0.681 . . . . 1.21 111.625 -178.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 10.9 mmpt? . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 113.148 0.795 . . . . 3.3700000000000001 113.148 178.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.624 0.249 . . . . 3.4399999999999999 110.616 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -151.82 130.92 12.66 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.67 -1.233 . . . . 2.2200000000000002 107.67 174.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -126.21 111.13 14.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.173 0.989 . . . . 3.46 110.722 -171.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 23' ' ' VAL 0.284 0.1 OUTLIER -79.41 77.32 5.97 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.122 -0.986 . . . . 3.9199999999999999 111.214 174.47 . . . . . . . . 4 4 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.1 120.62 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.501 -0.75 . . . . 1.0 110.133 -169.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.56 99.32 0.9 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.446 1.498 . . . . 0.81000000000000005 111.088 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.3 mmm -75.34 97.68 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.719 1.208 . . . . 1.4099999999999999 110.197 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.57 141.55 41.1 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.653 -0.654 . . . . 2.5499999999999998 110.717 174.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.95 131.17 44.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.878 0.871 . . . . 1.1699999999999999 109.208 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 m -143.43 160.71 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 113.498 0.925 . . . . 1.03 113.498 -175.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -172.76 -159.06 0.11 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.369 2.668 . . . . 3.0899999999999999 107.886 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.84 62.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.539 1.936 . . . . 1.3999999999999999 113.822 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -72.31 -9.43 58.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 3.8199999999999998 112.531 171.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.37 -135.27 13.05 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.54 1.064 . . . . 1.1200000000000001 111.192 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.65 132.33 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 1.0900000000000001 110.702 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.13 -104.51 2.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.747 1.642 . . . . 1.23 112.84 -175.131 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.73 168.69 19.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.569 1.147 . . . . 2.1200000000000001 110.372 170.494 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.7 t -98.14 137.91 36.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.832 -1.168 . . . . 1.1299999999999999 111.576 178.029 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.92 5.1 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.092 1.357 . . . . 2.8399999999999999 113.935 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.08 172.44 32.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.777 2.608 . . . . 0.77000000000000002 112.395 166.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 p -96.91 175.69 6.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.322 0.649 . . . . 0.79000000000000004 110.084 169.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.75 130.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.795 -1.187 . . . . 0.60999999999999999 107.795 151.295 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 4' ' ' LYS 0.258 9.2 p -84.97 113.26 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.352 0.596 . . . . 0.90000000000000002 111.447 178.004 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 125' ' ' LEU . 50.9 mt -87.26 127.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.542 -1.208 . . . . 1.0900000000000001 108.012 169.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -132.22 124.89 29.85 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.71 1.204 . . . . 1.8799999999999999 109.329 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -83.11 142.65 31.1 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.865 0.466 . . . . 4.1699999999999999 111.624 -174.226 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -157.82 -179.19 7.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.7 0.8 . . . . 1.4299999999999999 110.411 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.61 -15.73 63.62 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.136 -0.977 . . . . 3.7599999999999998 112.543 177.036 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.81 6.61 79.61 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.57 1.081 . . . . 1.1599999999999999 115.153 163.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.04 -141.09 18.25 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 127.183 2.325 . . . . 1.1599999999999999 114.82 174.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.49 96.22 3.44 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.553 1.141 . . . . 0.85999999999999999 111.659 -175.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -76.38 111.46 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.675 1.19 . . . . 1.8600000000000001 109.483 172.587 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.02 116.96 29.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.305 2.242 . . . . 0.54000000000000004 109.867 -175.388 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -130.81 114.12 16.52 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 120.257 1.389 . . . . 0.70999999999999996 110.674 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.95 162.53 7.43 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.089 2.526 . . . . 0.91000000000000003 113.099 -171.239 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -151.43 29.88 0.62 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.955 0.902 . . . . 1.3899999999999999 112.798 171.157 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -92.91 150.46 20.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.963 1.305 . . . . 0.98999999999999999 112.658 -171.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.18 27.09 4.84 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.008 1.855 . . . . 2.2200000000000002 116.008 -168.346 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.52 79.9 0.73 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.868 0.867 . . . . 1.6000000000000001 112.387 174.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.36 161.44 47.44 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 124.2 1.0 . . . . 1.4299999999999999 112.479 173.884 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.6 134.7 45.54 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.267 1.311 . . . . 1.1000000000000001 111.806 175.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -88.01 23.19 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.921 2.414 . . . . 1.04 115.126 -144.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.78 -153.05 11.48 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.874 1.226 . . . . 1.27 115.974 -172.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -78.47 150.97 32.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.463 2.305 . . . . 2.8900000000000001 111.157 171.579 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -149.13 141.23 23.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.923 0.889 . . . . 1.5800000000000001 112.221 -173.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 153.16 51.67 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 109.561 -1.416 . . . . 0.62 109.561 164.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.14 102.51 3.38 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.101 -1.444 . . . . 2.04 107.101 169.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -106.82 171.07 7.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.076 1.51 . . . . 0.94999999999999996 115.076 178.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -101.33 131.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.511 1.524 . . . . 0.69999999999999996 108.689 160.587 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -108.23 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.802 1.241 . . . . 2.0800000000000001 110.669 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.09 63.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.144 1.535 . . . . 0.81000000000000005 115.144 -161.455 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -127.23 151.32 48.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.648 1.179 . . . . 1.6000000000000001 111.919 173.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.1 81.76 1.69 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.581 1.086 . . . . 0.92000000000000004 113.193 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 t -170.24 138.59 1.64 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.146 0.978 . . . . 2.21 113.227 173.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.1 m -79.11 -5.15 53.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.038 1.735 . . . . 1.9399999999999999 114.217 172.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -78.58 132.89 64.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 O-C-N 120.081 -1.637 . . . . 3.5 113.159 -160.039 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -79.39 170.03 17.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.514 2.809 . . . . 1.4099999999999999 111.684 172.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 65' ' ' VAL . . . -119.16 165.24 14.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.482 1.513 . . . . 1.7 110.196 167.188 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.66 134.34 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.259 1.023 . . . . 2.5800000000000001 111.207 -167.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -156.54 134.56 11.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.62 1.568 . . . . 5.79 108.704 173.668 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.4 t0 55.05 46.72 23.58 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.841 0.856 . . . . 5.0999999999999996 112.19 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.68 7.27 58.17 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.884 1.113 . . . . 3.7200000000000002 115.884 173.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.75 162.26 33.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.855 1.327 . . . . 3.5499999999999998 111.764 -176.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.42 125.93 53.74 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.229 1.012 . . . . 1.9099999999999999 112.254 -167.38 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 58' ' ' ALA . 18.1 m -75.01 24.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 116.512 2.041 . . . . 2.9199999999999999 116.512 -164.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.5 8.23 2.14 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 117.015 2.228 . . . . 2.2200000000000002 117.015 170.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.579 ' HB3' HH12 ' A' ' 147' ' ' ARG . . . 137.26 115.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 1 C-N-CA 132.278 4.231 . . . . 2.0699999999999998 110.081 165.784 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.78 -37.76 4.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.564 1.145 . . . . 4.0899999999999999 110.32 172.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.18 -6.6 6.93 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.252 1.204 . . . . 1.2 114.252 177.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.32 -14.99 62.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.811 1.245 . . . . 1.25 113.292 168.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.8 51.63 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.805 -1.184 . . . . 3.1200000000000001 115.111 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.09 -172.55 55.26 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.699 1.142 . . . . 1.1799999999999999 112.25 -169.573 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -65.31 138.85 58.45 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.277 -1.131 . . . . 2.4300000000000002 111.387 174.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.69 119.87 13.78 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.28 0.632 . . . . 1.9399999999999999 112.067 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.97 125.87 5.06 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.02 2.128 . . . . 4.7599999999999998 110.97 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.04 -19.98 3.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.455 2.77 . . . . 3.7000000000000002 115.218 178.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 155.6 14.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 128.249 2.62 . . . . 4.0700000000000003 114.608 -170.134 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.2 -38.78 71.47 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.317 -1.489 . . . . 3.0899999999999999 112.401 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 81' ' ' LYS . 7.2 t 157.01 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 131.204 3.802 . . . . 2.79 110.621 177.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.45 1.77 66.11 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.416 1.008 . . . . 2.0099999999999998 114.248 179.429 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 79' ' ' THR . 18.0 ptmt -73.25 -30.42 63.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.097 1.448 . . . . 3.9199999999999999 114.72 -174.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.2 t60 117.2 148.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 130.853 3.661 . . . . 1.8700000000000001 112.806 -171.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -143.56 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.035 1.734 . . . . 3.9399999999999999 110.052 173.047 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.91 -132.56 9.93 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.244 -1.309 . . . . 2.4700000000000002 113.168 167.293 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.83 -17.45 22.74 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.934 3.09 . . . . 3.7400000000000002 114.885 -167.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -171.75 149.15 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.439 1.895 . . . . 5.6500000000000004 109.682 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.01 -145.2 16.92 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.375 0.988 . . . . 3.5299999999999998 113.242 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.16 145.52 4.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.353 2.661 . . . . 5.8099999999999996 106.324 -179.278 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.34 -20.81 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 CA-C-O 117.057 -1.968 . . . . 3.1400000000000001 116.627 173.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -152.22 118.57 5.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.346 1.573 . . . . 3.8199999999999998 110.199 160.472 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.25 -12.42 41.04 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.306 1.595 . . . . 2.6800000000000002 115.306 177.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.56 -4.92 90.15 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.995 1.283 . . . . 1.0600000000000001 115.067 173.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -74.91 153.98 38.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.756 0.823 . . . . 1.6299999999999999 110.828 168.596 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.37 161.6 29.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.86 1.264 . . . . 1.8300000000000001 109.733 -149.563 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.56 157.78 57.81 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.489 2.792 . . . . 1.1699999999999999 111.86 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.72 143.13 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.223 1.011 . . . . 1.5700000000000001 113.22 -173.076 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -88.97 123.07 32.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.998 2.119 . . . . 2.27 110.057 172.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.76 136.34 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.437 0.695 . . . . 1.1399999999999999 109.833 172.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.2 158.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.459 -1.312 . . . . 2.27 107.459 160.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.74 159.56 17.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.64 0.978 . . . . 2.1299999999999999 113.64 -174.488 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -41.94 -17.91 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 129.79 3.236 . . . . 2.29 117.726 177.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -97.24 -13.52 21.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.62 1.568 . . . . 2.5099999999999998 113.928 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.55 22.95 8.64 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.121 1.343 . . . . 0.75 115.291 177.534 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.06 135.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.496 1.518 . . . . 1.1899999999999999 110.228 -178.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.08 120.39 34.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.315 1.446 . . . . 0.81000000000000005 110.686 -179.374 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t -150.45 16.04 0.8 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.452 1.101 . . . . 1.72 113.962 -169.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -113.05 130.18 23.81 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.966 0.906 . . . . 3.8900000000000001 110.998 177.029 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.13 158.35 52.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.619 2.879 . . . . 1.3899999999999999 110.885 175.05 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.46 166.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.38 1.872 . . . . 2.3100000000000001 107.557 169.587 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.1 m -140.15 136.58 33.65 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.223 0.92 . . . . 0.79000000000000004 108.982 171.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.94 87.96 9.36 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.388 1.075 . . . . 1.01 111.192 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.48 23.63 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.931 3.754 . . . . 1.0600000000000001 114.146 -179.01 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 -94.01 -20.68 19.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.95 1.3 . . . . 3.7400000000000002 112.045 174.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.11 135.47 53.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.838 2.055 . . . . 2.7799999999999998 107.155 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -92.38 -38.68 11.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.521 0.728 . . . . 5.0300000000000002 111.775 -177.101 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.31 154.32 51.57 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.393 1.627 . . . . 2.6200000000000001 115.393 -172.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.38 -42.73 70.68 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.379 1.071 . . . . 1.72 110.891 170.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.17 -21.89 3.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.266 1.826 . . . . 4.4199999999999999 113.478 177.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.43 -13.06 38.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.262 1.025 . . . . 2.5899999999999999 113.061 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 m -120.74 7.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.025 1.73 . . . . 1.05 113.484 -178.813 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -43.64 -15.08 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.804 3.241 . . . . 3.2799999999999998 117.643 171.569 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -128.24 3.37 5.76 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.117 2.567 . . . . 5.1200000000000001 113.378 -167.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -127.07 174.37 8.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.834 1.254 . . . . 1.8200000000000001 113.719 -168.36 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.89 143.07 47.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.227 1.011 . . . . 0.68000000000000005 112.454 179.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.633 HD21 HD11 ' A' ' 24' ' ' ILE . 16.0 mt -73.46 155.37 39.32 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.451 1.5 . . . . 2.2799999999999998 108.437 156.22 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 19.2 ttm -147.05 122.58 10.42 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.75 -0.594 . . . . 2.02 110.677 158.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.3 mt -80.25 122.55 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.513 -1.291 . . . . 0.73999999999999999 107.513 171.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -100.81 147.47 26.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.134 2.174 . . . . 2.1600000000000001 111.763 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.25 -54.78 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.302 -0.874 . . . . 1.6799999999999999 110.129 -171.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.8 164.41 39.2 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.547 -0.621 . . . . 0.96999999999999997 111.547 166.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.1 -144.05 0.03 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 129.162 3.268 . . . . 2.27 115.036 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -162.95 69.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.682 1.993 . . . . 2.9700000000000002 107.663 -170.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -157.45 14.92 0.25 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.295 -1.32 . . . . 3.8100000000000001 113.958 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.8 149.58 16.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.924 1.29 . . . . 4.5700000000000003 112.185 174.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.9 m -128.99 -170.58 2.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.907 1.283 . . . . 4.0899999999999999 111.834 -168.467 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.41 -26.48 0.18 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 128.452 2.701 . . . . 4.8499999999999996 115.955 158.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -70.01 146.41 95.04 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.23 1.812 . . . . 4.3799999999999999 111.195 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.41 -32.16 50.54 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.352 2.702 . . . . 2.52 113.281 -171.271 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -80.38 115.19 53.2 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.23 0.923 . . . . 4.1500000000000004 108.906 160.101 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.75 152.14 82.46 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.23 2.62 . . . . 2.8399999999999999 112.336 -172.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp 59.52 22.51 11.1 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.852 1.661 . . . . 4.25 111.444 -169.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.83 14.85 66.03 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 120.958 -1.089 . . . . 3.0600000000000001 113.508 -172.378 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 108.49 -7.93 34.61 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.722 1.63 . . . . 2.0800000000000001 114.037 -168.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.83 10.75 1.07 Allowed Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.358 1.579 . . . . 1.73 116.178 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 -12.41 73.56 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.207 1.504 . . . . 1.48 114.426 175.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.8 p -74.88 147.84 40.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.293 1.837 . . . . 2.0 112.555 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.579 HH12 ' HB3' ' A' ' 67' ' ' ALA . 3.2 mmt85 -110.17 150.07 29.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.563 1.545 . . . . 4.3399999999999999 111.076 -172.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -106.93 -39.16 5.84 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.241 0.46 . . . . 2.6600000000000001 112.241 160.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.36 144.73 24.03 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.382 1.623 . . . . 0.68999999999999995 115.382 -175.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.5 t -100.51 137.99 38.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.968 2.507 . . . . 1.5 111.307 173.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -133.46 87.11 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.56 1.553 . . . . 0.88 112.124 175.582 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.17 130.41 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.808 1.804 . . . . 1.52 110.656 173.458 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 mt -100.64 154.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 126.468 1.907 . . . . 1.3300000000000001 110.279 -172.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.52 0 C-N-CA 126.108 1.763 . . . . 4.7999999999999998 110.408 174.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.381 -0.599 . . . . 3.04 109.381 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.23 152.04 28.83 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.257 -0.902 . . . . 1.6499999999999999 109.086 -175.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -144.57 116.19 8.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.332 1.539 . . . . 2.48 112.825 176.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -78.8 82.95 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 127.606 2.362 . . . . 2.9900000000000002 110.569 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -75.79 110.99 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.057 -1.027 . . . . 1.8899999999999999 112.28 -177.228 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.6 100.48 0.49 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.404 1.954 . . . . 1.1899999999999999 110.81 177.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 mmt -72.85 125.52 27.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.849 1.66 . . . . 1.54 112.399 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -101.62 153.61 19.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.786 0.803 . . . . 2.4300000000000002 110.923 157.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.9 mt -58.48 143.57 45.23 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.347 1.459 . . . . 1.3600000000000001 109.18 163.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 m -141.6 166.1 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.065 0.946 . . . . 1.25 111.535 172.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 t -172.38 -161.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.616 2.366 . . . . 3.2200000000000002 108.176 -177.529 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.93 14.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.449 2.7 . . . . 1.8799999999999999 114.507 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.06 -12.5 10.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.058 1.343 . . . . 3.2200000000000002 111.349 172.655 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 -146.25 19.8 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 119.197 0.908 . . . . 1.6599999999999999 110.893 -167.506 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 82.0 t -62.28 126.38 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.228 1.811 . . . . 1.05 112.423 -177.07 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.28 -133.19 6.44 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.539 2.019 . . . . 1.4099999999999999 113.17 177.325 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.09 145.64 46.34 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 124.52 1.128 . . . . 2.0800000000000001 110.811 176.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.7 t -75.19 133.58 41.4 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.713 -0.617 . . . . 1.9299999999999999 109.438 164.576 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 tt -116.36 -37.05 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 127.908 2.483 . . . . 4.0800000000000001 111.546 -174.786 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.29 -178.83 38.08 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.39 -0.909 . . . . 1.46 113.443 -145.523 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 171.06 12.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 148.657 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.453 HG11 ' CG ' ' A' ' 33' ' ' PHE . 59.4 t -120.58 132.01 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 106.471 -1.677 . . . . 0.63 106.471 144.283 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 17.7 m -83.99 129.51 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 C-N-CA 119.744 -0.782 . . . . 3.1600000000000001 109.803 172.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.45 125.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.623 -0.881 . . . . 1.3700000000000001 108.623 175.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.68 126.9 30.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.736 1.214 . . . . 2.4700000000000002 109.96 178.506 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.78 141.79 29.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.797 0.839 . . . . 3.8399999999999999 112.946 -172.216 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -149.63 -176.61 5.47 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.897 0.879 . . . . 1.21 109.684 174.662 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -75.54 -11.98 60.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.272 -0.892 . . . . 4.1600000000000001 112.488 174.739 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.41 7.04 69.78 Favored Glycine 0 N--CA 1.477 1.411 0 O-C-N 120.758 -1.214 . . . . 0.95999999999999996 114.312 157.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.62 -145.58 26.42 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 127.819 2.628 . . . . 0.78000000000000003 114.598 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.4 109.46 7.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.187 0.595 . . . . 0.66000000000000003 110.704 -173.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -82.78 106.68 14.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.348 1.059 . . . . 1.78 110.397 174.071 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -85.85 110.11 19.16 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.044 1.338 . . . . 0.73999999999999999 108.345 175.614 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 23' ' ' VAL . 33.4 m -114.6 98.78 50.28 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 119.718 1.144 . . . . 1.29 108.792 178.066 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -85.73 153.51 10.16 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.244 3.296 . . . . 0.73999999999999999 111.497 -172.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -150.66 41.22 0.77 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.998 0.904 . . . . 1.3600000000000001 112.725 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mp -93.02 148.95 21.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.273 1.829 . . . . 0.84999999999999998 112.193 -176.295 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.86 40.25 2.16 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.24 1.57 . . . . 2.02 115.24 -169.265 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.33 48.53 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 1.3899999999999999 112.207 -175.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.04 161.0 47.07 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 121.261 -0.9 . . . . 1.3400000000000001 112.466 176.585 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.26 131.09 36.92 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.595 1.53 . . . . 1.23 110.18 171.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.411 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -90.46 30.64 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.722 1 C-N-CA 126.567 4.845 . . . . 1.29 112.176 -151.976 . . . . . . . . 4 4 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.79 166.68 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 125.582 1.563 . . . . 2.1400000000000001 109.762 173.325 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -67.44 143.8 56.06 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.889 0.875 . . . . 2.8799999999999999 112.814 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -129.69 150.83 50.84 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.076 1.35 . . . . 1.1899999999999999 111.614 -172.154 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.84 163.5 24.23 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.519 0.6 . . . . 0.66000000000000003 113.486 168.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.603 ' CE1' HD12 ' A' ' 125' ' ' LEU . 9.4 t80 -140.76 119.86 12.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.15 1.38 . . . . 2.1600000000000001 108.398 176.523 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -134.76 149.12 50.38 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.433 -0.792 . . . . 0.87 112.521 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.3 136.61 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.607 1.963 . . . . 0.95999999999999996 107.792 165.155 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -132.8 133.84 43.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.201 1.0 . . . . 1.1899999999999999 110.652 -163.326 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.19 65.67 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.628 2.084 . . . . 0.73999999999999999 116.628 -155.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -118.97 152.3 36.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.988 0.915 . . . . 1.4399999999999999 112.688 167.248 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.98 59.75 4.48 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.647 1.118 . . . . 0.95999999999999996 112.45 170.739 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 m -148.73 63.9 1.06 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.818 1.044 . . . . 3.21 113.818 -157.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.8 m -65.39 26.66 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 116.452 2.019 . . . . 1.74 116.452 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -78.14 139.13 60.53 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 119.919 -1.738 . . . . 3.8900000000000001 110.788 175.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.31 143.19 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.753 2.302 . . . . 1.3899999999999999 111.211 174.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 128.87 35.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.914 0.486 . . . . 2.21 110.461 172.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.44 125.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.215 1.006 . . . . 2.3900000000000001 110.694 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -166.09 128.17 1.92 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.386 0.674 . . . . 4.8799999999999999 112.74 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 57.77 52.88 7.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.655 1.582 . . . . 4.8099999999999996 114.1 169.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.78 77.48 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.082 -1.011 . . . . 3.4500000000000002 114.544 175.112 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.94 -164.08 1.35 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.41 1.884 . . . . 4.2000000000000002 109.178 -177.198 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.34 144.71 23.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.222 -0.924 . . . . 1.5800000000000001 112.651 -177.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 t -80.82 98.78 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.97 0.908 . . . . 2.54 109.934 -172.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.97 97.59 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.392 2.277 . . . . 3.4300000000000002 115.105 -170.2 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.45 30.73 17.29 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.524 1.93 . . . . 1.99 114.27 174.379 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.65 -32.36 73.82 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.271 0.841 . . . . 5.3799999999999999 113.271 -178.45 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.48 -15.62 50.96 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.898 1.073 . . . . 2.0800000000000001 113.898 -175.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -3.46 13.9 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.312 1.445 . . . . 1.1599999999999999 113.585 172.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.22 -171.32 32.34 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.943 1.247 . . . . 2.4900000000000002 113.53 175.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.57 -167.0 39.74 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.74 1.162 . . . . 1.9099999999999999 112.189 165.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -74.13 40.06 0.12 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.551 1.94 . . . . 3.29 112.833 -178.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp 49.82 61.45 3.16 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.904 1.682 . . . . 1.76 109.854 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -121.65 51.02 2.53 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.299 1.839 . . . . 3.9300000000000002 114.419 -163.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.2 -18.91 39.42 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.862 3.041 . . . . 1.8999999999999999 115.865 -166.074 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.0 31.79 0.06 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.35 0.977 . . . . 4.0599999999999996 112.46 -171.057 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.03 -60.41 1.68 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.655 0.983 . . . . 3.73 113.655 -163.391 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 t 167.99 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.317 2.647 . . . . 3.3399999999999999 108.54 -162.26 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.95 -30.93 8.93 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.857 0.741 . . . . 2.3900000000000001 113.03 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 11.7 ptmt -88.74 -177.89 5.64 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 117.88 0.84 . . . . 4.25 112.138 173.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -124.88 164.89 19.07 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.888 1.07 . . . . 2.1299999999999999 113.888 -155.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -138.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.449 1.1 . . . . 4.5700000000000003 111.478 -179.072 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.51 -138.09 18.48 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 109.067 -1.613 . . . . 2.73 109.067 -158.662 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.08 -32.08 64.52 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.344 2.03 . . . . 3.46 113.456 -171.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.03 -1.54 57.17 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 6.0099999999999998 113.43 -176.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.43 -12.56 0.93 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 118.316 2.086 . . . . 2.8700000000000001 118.316 167.001 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -84.33 44.85 1.06 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.182 1.491 . . . . 5.2999999999999998 114.393 -163.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.63 -147.67 6.33 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 117.477 1.751 . . . . 2.8300000000000001 117.477 -168.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -118.15 154.49 32.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.827 1.651 . . . . 3.8199999999999998 112.297 -157.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.16 -27.22 65.34 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.475 0.917 . . . . 2.1200000000000001 113.475 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.4 21.6 16.74 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.58 -1.122 . . . . 0.90000000000000002 114.581 176.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -97.35 136.07 38.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.874 1.337 . . . . 1.79 111.063 169.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.496 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 3.8 mp -136.6 165.9 31.7 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 125.676 1.59 . . . . 1.78 109.345 -172.355 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.99 161.08 13.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.026 2.484 . . . . 1.0900000000000001 111.387 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.18 133.82 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.334 1.54 . . . . 1.4299999999999999 115.044 -164.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 87.01 2.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.096 2.558 . . . . 1.6599999999999999 109.319 170.232 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.99 133.01 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.139 0.576 . . . . 0.83999999999999997 110.809 175.107 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.7 136.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.956 2.102 . . . . 1.74 106.408 173.288 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.49 162.99 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.425 -0.321 . . . . 2.3700000000000001 111.834 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -44.69 -22.52 0.08 Allowed 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 117.899 2.555 . . . . 2.5699999999999998 117.899 -177.947 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -7.67 52.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.462 1.905 . . . . 2.6499999999999999 113.45 -176.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.22 30.39 11.04 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 124.274 0.94 . . . . 0.80000000000000004 114.197 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.0 mt -124.29 133.57 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.17 1.388 . . . . 1.03 110.165 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.6 139.03 40.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.958 1.703 . . . . 0.73999999999999999 111.205 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -151.15 -11.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.588 2.44 . . . . 1.98 117.588 -166.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.83 117.97 53.39 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 121.459 1.936 . . . . 4.2000000000000002 113.619 -172.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.01 78.01 2.63 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.951 3.1 . . . . 2.5699999999999998 110.216 171.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.57 148.78 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.747 1.619 . . . . 3.5299999999999998 109.908 175.288 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.36 139.18 52.53 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.956 -0.757 . . . . 1.46 108.956 160.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -124.87 99.73 34.73 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.646 0.779 . . . . 0.90000000000000002 111.922 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.31 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.184 3.256 . . . . 1.22 113.761 178.451 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -31.47 72.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.909 0.884 . . . . 4.9100000000000001 111.134 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.17 151.86 37.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.548 2.739 . . . . 2.2200000000000002 106.868 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -135.35 11.98 3.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.301 1.223 . . . . 4.5099999999999998 114.301 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -150.25 169.09 22.16 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.999 -1.688 . . . . 2.1200000000000001 111.011 160.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.05 -43.32 11.79 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.104 -0.997 . . . . 1.8100000000000001 112.104 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -64.85 -19.55 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.897 1.073 . . . . 2.5299999999999998 113.897 -176.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -16.21 63.98 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.626 0.973 . . . . 2.3199999999999998 113.626 171.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.2 24.07 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.942 1.697 . . . . 1.2 112.802 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -53.95 -9.14 0.22 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.654 2.465 . . . . 3.3399999999999999 117.654 178.235 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.68 50.33 1.37 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.668 1.587 . . . . 2.8999999999999999 109.875 -169.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -142.62 150.22 40.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.7 1.6 . . . . 2.2200000000000002 112.347 -169.775 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.68 137.5 32.27 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.834 -0.541 . . . . 0.90000000000000002 111.367 167.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.603 HD12 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -97.97 122.09 40.67 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.829 -0.804 . . . . 3.96 108.829 154.855 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 31.1 mtt -122.62 124.26 43.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.386 0.674 . . . . 1.29 111.073 -173.301 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.0 mt -77.17 114.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 107.685 -1.228 . . . . 0.68999999999999995 107.685 171.149 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.78 137.8 40.51 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.232 1.413 . . . . 2.5800000000000001 112.629 -162.028 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.28 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.332 -0.855 . . . . 1.49 111.349 -165.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.76 133.42 11.79 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 118.306 0.503 . . . . 1.6799999999999999 112.258 172.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.53 154.36 21.57 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.517 1.532 . . . . 1.4199999999999999 112.183 156.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -112.34 36.59 3.33 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.53 0.937 . . . . 3.4199999999999999 113.53 -128.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.2 5.97 40.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.961 1.304 . . . . 3.6099999999999999 113.851 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.6 tpp -98.16 132.88 43.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.954 1.464 . . . . 3.0299999999999998 114.954 -157.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.8 p -176.66 171.19 2.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.554 2.341 . . . . 3.4199999999999999 111.1 159.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t70 92.44 65.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.176 2.99 . . . . 4.4000000000000004 111.61 -177.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -151.8 159.68 32.77 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.307 1.843 . . . . 4.0800000000000001 109.467 -173.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 -9.17 21.44 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.237 3.291 . . . . 3.4900000000000002 114.417 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -125.13 142.33 41.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.725 1.21 . . . . 4.3099999999999996 109.241 166.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.33 134.92 54.66 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.314 2.01 . . . . 3.5499999999999998 111.089 -175.671 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.5 mt 63.41 17.97 10.69 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.49 1.516 . . . . 3.8999999999999999 112.527 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.39 7.43 60.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.763 1.173 . . . . 4.04 113.941 -174.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.16 -8.28 75.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.17 1.367 . . . . 2.8799999999999999 113.953 -168.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.36 0.18 42.5 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 119.378 1.589 . . . . 2.0299999999999998 115.043 -176.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.84 5.71 45.8 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.984 1.754 . . . . 1.71 115.171 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 p -70.38 159.9 33.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.885 1.342 . . . . 2.0499999999999998 110.864 173.158 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -112.84 136.1 52.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.489 1.516 . . . . 5.6200000000000001 109.894 -172.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -90.83 -35.98 14.49 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.157 0.89 . . . . 2.3700000000000001 112.129 166.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.36 150.14 31.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.519 0.727 . . . . 0.83999999999999997 112.456 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 t -127.07 131.43 50.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.343 1.857 . . . . 1.77 111.505 -178.329 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -126.37 97.03 0.48 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.784 2.135 . . . . 1.3100000000000001 110.465 166.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.76 125.26 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.587 1.155 . . . . 1.6699999999999999 109.218 172.074 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.5 mt -58.3 117.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.742 0.782 . . . . 1.27 109.668 176.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 116.059 -0.518 . . . . 4.5800000000000001 111.602 177.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.658 -0.497 . . . . 1.6899999999999999 109.658 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.07 152.85 42.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.572 1.323 . . . . 1.1499999999999999 114.572 -145.9 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 132.49 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 123.152 1.453 . . . . 2.9700000000000002 112.057 159.329 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -94.71 71.46 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.154 1.382 . . . . 3.3399999999999999 111.213 -166.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.17 119.29 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.211 -0.931 . . . . 1.5 110.738 -156.174 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.02 97.25 1.38 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 126.189 1.852 . . . . 1.01 110.185 -173.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 29.8 mtt -80.22 131.38 35.68 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.574 0.749 . . . . 1.1399999999999999 112.158 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.0 150.54 22.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.721 0.808 . . . . 2.7799999999999998 109.878 172.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.1 mt -64.31 140.87 58.91 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.363 -0.977 . . . . 1.3700000000000001 108.363 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.16 158.11 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 118.511 0.596 . . . . 1.1100000000000001 112.202 -177.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -171.44 -150.36 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.921 2.089 . . . . 2.6000000000000001 108.252 173.219 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.02 -8.35 3.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 128.473 2.709 . . . . 1.6799999999999999 114.837 -178.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.19 -14.7 32.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.903 0.881 . . . . 4.2800000000000002 112.065 169.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.451 ' CA ' ' HD3' ' A' ' 57' ' ' PRO . . . 82.85 -142.47 21.65 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.134 0.873 . . . . 1.24 110.968 -162.557 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.31 120.96 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.555 1.542 . . . . 1.1899999999999999 111.757 176.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.97 -133.22 7.13 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 125.993 1.759 . . . . 1.9299999999999999 111.705 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.83 171.48 7.3 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.717 -0.872 . . . . 3.4900000000000002 110.845 170.247 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -109.26 137.66 46.8 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.006 1.323 . . . . 1.3100000000000001 113.502 -176.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.94 4.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.325 1.85 . . . . 2.8199999999999998 112.887 177.186 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.33 153.18 7.63 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.489 -0.757 . . . . 0.57999999999999996 113.903 -168.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.5 p -90.33 175.2 7.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.917 -0.771 . . . . 0.89000000000000001 108.917 161.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.68 129.45 75.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 106.218 -1.771 . . . . 0.40000000000000002 106.218 148.27 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.95 118.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.374 -0.602 . . . . 0.82999999999999996 109.374 178.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.7 mt -99.0 126.7 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.147 -1.427 . . . . 1.5700000000000001 107.147 175.369 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -128.24 122.06 30.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.164 0.983 . . . . 2.5899999999999999 111.27 169.274 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 124.58 23.19 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.501 1.92 . . . . 3.2799999999999998 109.52 171.295 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.6 p -138.25 174.56 10.43 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.341 0.591 . . . . 2.6000000000000001 111.416 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.44 -23.86 64.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.267 -0.896 . . . . 3.5600000000000001 112.496 172.345 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.38 13.84 66.49 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.794 1.188 . . . . 1.3500000000000001 114.65 170.029 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.77 -158.03 31.7 Favored Glycine 0 N--CA 1.469 0.877 0 C-N-CA 126.732 2.11 . . . . 0.96999999999999997 114.559 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.51 96.72 2.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.958 0.903 . . . . 0.81999999999999995 111.738 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -72.81 116.59 13.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.72 2.008 . . . . 2.6600000000000001 109.975 172.11 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -109.12 111.48 23.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.309 2.244 . . . . 0.56999999999999995 109.768 -174.327 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.9 m -119.85 114.29 34.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-O 118.275 -0.869 . . . . 0.53000000000000003 108.986 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.45 160.74 9.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.048 2.498 . . . . 0.41999999999999998 112.781 -174.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -150.51 26.39 0.76 Allowed 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.546 0.943 . . . . 1.3799999999999999 113.546 172.348 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.91 143.53 31.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.66000000000000003 112.83 -176.366 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' H ' ' HE3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -125.18 128.28 48.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 117.575 -1.202 . . . . 2.3700000000000001 110.673 174.661 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 131.12 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 129.838 3.255 . . . . 1.97 115.971 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -95.92 159.66 31.82 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.115 0.966 . . . . 1.54 112.215 -172.27 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -59.77 133.39 50.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.511 2.141 . . . . 0.80000000000000004 111.408 171.219 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.601 ' HA ' HG23 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -92.97 43.08 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.019 2.48 . . . . 0.88 112.589 -150.266 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.25 -158.01 10.05 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 122.895 1.275 . . . . 1.1599999999999999 115.724 -175.506 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -81.11 145.0 31.29 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.668 2.387 . . . . 2.8199999999999998 111.735 173.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -152.39 138.05 17.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.783 1.633 . . . . 1.1200000000000001 110.018 -174.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.77 165.28 54.81 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 120.398 1.454 . . . . 0.62 114.194 169.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -130.36 121.98 27.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.551 1.541 . . . . 2.1000000000000001 107.22 177.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -121.74 156.34 33.34 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.179 1.354 . . . . 1.28 112.677 173.325 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.13 141.05 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.914 1.686 . . . . 0.95999999999999996 108.839 158.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -119.86 -179.09 3.8 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.767 1.627 . . . . 1.1899999999999999 110.254 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.69 56.24 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.807 2.151 . . . . 1.0900000000000001 116.807 -166.105 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -132.84 159.9 38.47 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.954 1.252 . . . . 1.3500000000000001 114.015 178.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.63 65.79 4.0 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.972 1.749 . . . . 1.03 113.14 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -146.06 76.15 1.44 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.482 0.919 . . . . 2.27 113.482 -168.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.1 m -60.54 38.49 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 129.303 3.041 . . . . 1.6100000000000001 117.636 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -120.15 168.9 9.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 119.789 -1.819 . . . . 3.4700000000000002 112.042 -166.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 92.5 Cg_endo -80.22 145.94 17.46 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.566 2.177 . . . . 1.4199999999999999 111.085 168.583 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.06 153.23 18.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.621 -0.718 . . . . 2.77 109.353 159.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.81 116.22 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.083 -1.451 . . . . 4.2599999999999998 107.083 163.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -79.51 -47.1 16.16 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.706 0.765 . . . . 7.6600000000000001 110.418 178.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -176.09 118.76 0.15 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.358 3.063 . . . . 5.8200000000000003 106.511 171.141 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.44 -4.46 0.95 Allowed Glycine 0 CA--C 1.54 1.65 0 N-CA-C 117.556 1.782 . . . . 3.6800000000000002 117.556 175.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -159.99 157.39 28.71 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.74 1.77 . . . . 3.2999999999999998 111.71 -171.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.49 133.98 34.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.4 1.08 . . . . 1.6000000000000001 112.221 -173.207 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.4 t -115.3 103.57 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.031 1.333 . . . . 3.0800000000000001 109.001 171.102 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.98 110.72 4.03 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.342 1.457 . . . . 3.1400000000000001 112.194 -177.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 122.1 -24.65 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 131.136 3.774 . . . . 2.8500000000000001 113.876 171.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.85 -11.28 58.29 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.412 1.46 . . . . 6.29 114.246 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.782 -1.199 . . . . 2.6200000000000001 112.785 168.034 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.65 3.44 16.37 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.355 1.062 . . . . 1.2 113.133 173.71 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.1 178.75 38.81 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.366 0.984 . . . . 2.21 113.564 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.2 -167.81 10.19 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.374 0.988 . . . . 1.3899999999999999 112.952 171.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -72.29 52.34 0.26 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.222 1.809 . . . . 2.3999999999999999 111.501 174.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.6 tp 37.3 58.67 1.23 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.71 2.004 . . . . 1.9199999999999999 111.465 178.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 85.02 55.57 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.216 1.806 . . . . 4.8200000000000003 112.273 -150.305 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.81 -63.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.648 2.899 . . . . 1.8600000000000001 111.672 175.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -143.43 129.38 19.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.473 -1.677 . . . . 5.46 106.473 173.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 p30 174.73 -97.65 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.532 1.933 . . . . 4.5700000000000003 112.196 179.092 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t 174.97 -45.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.991 2.516 . . . . 3.1200000000000001 109.739 -166.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.14 -39.8 3.1 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 126.141 1.829 . . . . 3.9399999999999999 116.374 149.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -43.26 -51.41 6.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.831 1.653 . . . . 3.96 113.546 -170.516 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 162.48 150.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.605 3.162 . . . . 2.4300000000000002 112.564 168.067 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -82.85 167.26 18.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.267 0.556 . . . . 3.4399999999999999 112.057 171.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.88 -109.97 0.78 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.595 -1.669 . . . . 5.4100000000000001 110.95 -167.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.02 -27.03 36.68 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.768 2.979 . . . . 7.5800000000000001 114.711 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.75 10.55 3.39 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.931 1.293 . . . . 9.6300000000000008 112.454 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.62 73.23 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.025 -0.875 . . . . 4.1299999999999999 114.807 171.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -82.94 51.14 1.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.265 1.532 . . . . 6.5300000000000002 113.839 -166.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.81 -171.66 42.13 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 117.249 1.66 . . . . 2.1400000000000001 117.249 -167.509 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -139.74 157.13 46.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.922 1.689 . . . . 5.0 110.848 171.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.413 ' H ' HD23 ' A' ' 91' ' ' LEU . 2.5 pt? -69.36 24.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.582 1.553 . . . . 2.3999999999999999 115.186 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -153.56 23.46 0.74 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 128.572 2.987 . . . . 0.88 113.042 178.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' CE1' ' A' ' 82' ' ' HIS . 10.5 m-20 -80.53 138.62 36.53 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 106.75 -1.574 . . . . 2.1299999999999999 106.75 154.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 111' ' ' ALA . 3.7 mp -143.59 147.8 40.81 Favored Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 121.744 2.065 . . . . 2.3100000000000001 112.577 -171.404 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.94 157.94 54.13 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.124 3.216 . . . . 0.91000000000000003 113.254 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.67 125.97 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 115.429 1.64 . . . . 1.6399999999999999 115.429 -156.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 67.93 0.8 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.912 2.885 . . . . 1.53 110.313 170.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.8 134.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.508 -0.745 . . . . 1.05 109.429 174.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.601 HG23 ' HA ' ' A' ' 42' ' ' PRO . 6.4 m -115.0 152.14 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.006 0.922 . . . . 2.04 108.9 175.115 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -70.56 157.07 38.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.531 0.567 . . . . 2.7400000000000002 112.531 -176.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -50.56 -22.55 2.04 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 126.935 2.094 . . . . 2.1899999999999999 115.527 179.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -88.88 3.56 50.87 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.888 2.475 . . . . 3.7599999999999998 113.892 -178.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 30.08 21.19 Favored Glycine 0 N--CA 1.475 1.277 0 O-C-N 121.135 -0.978 . . . . 0.67000000000000004 115.283 173.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.8 131.56 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.252 1.421 . . . . 0.98999999999999999 109.535 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.83 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.651 1.18 . . . . 0.93000000000000005 109.969 176.516 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 t -149.4 -33.75 0.2 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.106 1.362 . . . . 1.6699999999999999 113.183 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -66.13 121.52 76.73 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.848 0.859 . . . . 3.1099999999999999 111.048 -178.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.65 152.31 22.66 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.149 3.233 . . . . 1.3600000000000001 112.354 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.27 175.99 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.456 1.503 . . . . 1.26 110.22 170.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.6 m -146.39 143.81 29.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.587 1.155 . . . . 0.98999999999999999 109.994 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -105.17 101.63 31.66 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.7 1.2 . . . . 1.3100000000000001 111.766 175.365 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.38 -5.81 10.12 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.981 2.454 . . . . 1.6499999999999999 116.195 -166.294 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -77.43 -17.13 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.553 1.524 . . . . 9.6699999999999999 113.188 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.15 153.55 19.16 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.92 1.688 . . . . 2.9100000000000001 109.421 -177.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 28.63 1.21 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.878 1.671 . . . . 4.3700000000000001 111.333 170.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.7 m -163.29 133.54 4.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.344 1.857 . . . . 2.1000000000000001 110.819 171.53 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.42 -27.47 67.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.271 1.428 . . . . 2.0 110.488 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.42 -26.88 5.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.396 1.878 . . . . 3.6000000000000001 113.687 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -65.84 -11.67 48.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.461 1.105 . . . . 2.5800000000000001 113.486 176.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.52 15.49 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.162 1.171 . . . . 0.70999999999999996 114.162 -172.245 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -69.06 9.24 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 118.1 2.63 . . . . 2.1200000000000001 118.1 -169.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -151.72 29.71 0.6 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.765 1.626 . . . . 3.3700000000000001 111.676 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -116.47 155.22 28.97 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.788 -1.195 . . . . 2.8999999999999999 112.222 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.97 141.26 28.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.296 0.638 . . . . 0.65000000000000002 110.46 166.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 141.67 43.82 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.175 -0.676 . . . . 1.6000000000000001 109.175 160.374 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.0 mtt -134.24 135.29 42.83 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.375 0.67 . . . . 1.3600000000000001 112.594 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.5 mt -82.13 105.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.609 1.163 . . . . 0.68000000000000005 108.65 172.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.11 139.75 30.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.106 1.762 . . . . 2.3300000000000001 110.979 -176.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.54 -39.08 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.871 -1.143 . . . . 1.6899999999999999 112.443 -162.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -94.99 144.12 17.0 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.205 0.907 . . . . 1.29 112.043 176.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.39 156.64 25.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 127.014 2.245 . . . . 1.72 115.053 175.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.66 53.26 0.7 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.517 1.151 . . . . 3.2000000000000002 113.268 -147.3 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -141.64 2.35 1.6 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.634 1.574 . . . . 2.5299999999999998 113.423 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.2 mtm -92.6 126.47 37.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.121 0.968 . . . . 2.2799999999999998 111.683 -171.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 -158.3 0.82 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.536 1.134 . . . . 3.27 110.921 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.24 -38.51 0.41 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 129.911 3.284 . . . . 3.6499999999999999 114.135 -176.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -67.65 146.26 98.46 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.724 2.01 . . . . 3.3100000000000001 113.42 -166.058 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.89 -40.44 44.16 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.521 3.481 . . . . 2.3500000000000001 112.204 -172.393 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.23 101.42 11.23 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 105.889 -1.893 . . . . 4.3600000000000003 105.889 162.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -75.77 179.44 6.25 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.429 2.753 . . . . 3.1299999999999999 113.338 -162.139 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.1 mt 66.53 1.08 2.0 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.887 2.075 . . . . 3.8300000000000001 113.987 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.74 27.12 67.83 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.698 1.135 . . . . 2.8900000000000001 112.388 -175.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.6 -8.88 79.12 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.018 1.294 . . . . 1.95 114.354 -171.198 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.78 22.09 0.57 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.349 1.928 . . . . 2.1899999999999999 115.86 -177.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.16 -15.26 65.04 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.936 1.255 . . . . 1.47 113.147 167.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.4 p -74.27 151.58 39.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.639 1.22 . . . . 1.71 110.013 172.329 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.93 142.31 30.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.472 1.109 . . . . 5.5499999999999998 112.581 -171.59 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.34 -33.88 12.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.555 0.742 . . . . 2.77 112.235 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.89 155.99 41.66 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.259 1.024 . . . . 0.62 113.038 -176.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.43 151.67 45.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.932 2.093 . . . . 1.4299999999999999 111.334 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.28 126.76 2.89 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.99 1.281 . . . . 0.66000000000000003 112.545 173.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.48 123.45 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.955 1.302 . . . . 1.53 109.972 171.238 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.69 113.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.719 -0.845 . . . . 1.01 108.719 170.455 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt . . . . . 0 CA--C 1.54 0.585 0 O-C-N 121.745 -0.597 . . . . 3.75 111.121 -174.757 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.528 -0.545 . . . . 1.6499999999999999 109.528 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -131.78 135.19 46.59 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.65 -1.281 . . . . 1.6699999999999999 113.788 -137.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -144.7 148.8 34.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.134 1.373 . . . . 2.8999999999999999 108.587 173.202 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -126.5 99.95 6.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.778 1.231 . . . . 4.3300000000000001 110.866 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -90.29 122.24 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 121.861 -0.524 . . . . 1.05 109.985 -173.167 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.2 104.7 2.06 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.905 1.717 . . . . 0.68999999999999995 110.752 174.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 mmm -86.93 89.45 7.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.422 1.489 . . . . 1.5800000000000001 110.655 -175.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -75.39 148.37 39.24 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.231 -0.918 . . . . 2.7599999999999998 111.04 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.13 140.72 58.24 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.53 -0.732 . . . . 1.3300000000000001 109.796 174.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.7 138.82 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.892 0.877 . . . . 1.1399999999999999 110.316 177.318 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -171.85 69.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.979 0.912 . . . . 2.6800000000000002 111.909 -170.122 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 74.37 -42.46 0.5 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.592 2.357 . . . . 1.4199999999999999 114.285 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.39 -9.22 58.23 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.486 1.039 . . . . 3.0699999999999998 112.163 174.072 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.91 -147.82 17.99 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 125.909 1.719 . . . . 1.0700000000000001 111.455 -173.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.8 t -58.85 127.04 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.795 1.638 . . . . 0.87 110.212 174.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.78 -97.71 2.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.32 0.962 . . . . 1.48 113.694 -168.464 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.29 127.93 12.41 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.707 1.203 . . . . 2.3799999999999999 109.864 -170.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 t -90.98 149.95 21.66 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.056 1.132 . . . . 1.1499999999999999 114.056 -160.556 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -143.07 -6.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 115.289 1.589 . . . . 2.7400000000000002 115.289 -173.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.5 153.73 13.31 Favored Glycine 0 N--CA 1.469 0.861 0 O-C-N 120.625 -1.297 . . . . 0.59999999999999998 114.556 -175.276 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 p -107.19 176.16 5.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.434 -0.95 . . . . 0.83999999999999997 108.434 163.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.08 134.03 66.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.44 -0.948 . . . . 0.76000000000000001 108.44 158.509 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.417 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.5 p -88.48 130.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.7 0.625 . . . . 1.0600000000000001 110.296 173.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.26 114.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.064 2.146 . . . . 1.51 108.399 -173.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.08 105.93 11.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.74 0.816 . . . . 2.1200000000000001 111.348 175.642 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 133.76 55.24 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.107 2.563 . . . . 3.7000000000000002 111.176 172.457 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 t -164.02 -172.02 2.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.209 0.604 . . . . 1.9299999999999999 111.089 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.54 -38.25 66.38 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.674 1.189 . . . . 3.6400000000000001 111.685 178.352 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.74 12.36 41.89 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.867 1.222 . . . . 1.28 115.297 173.058 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 -145.82 32.65 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 127.824 2.63 . . . . 0.97999999999999998 112.042 -177.407 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.89 102.21 6.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.997 0.919 . . . . 1.02 111.614 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.59 109.97 12.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.093 0.957 . . . . 2.1899999999999999 110.556 175.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.95 105.77 17.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.875 2.47 . . . . 0.96999999999999997 110.191 -169.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.417 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.0 m -110.7 108.99 57.99 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 107.84 -1.17 . . . . 1.25 107.84 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.43 157.11 22.27 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.807 2.338 . . . . 0.83999999999999997 111.211 -177.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -142.78 37.09 1.44 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.911 0.862 . . . . 1.53 111.253 169.01 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -91.49 158.67 16.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 123.123 1.439 . . . . 0.78000000000000003 113.841 -174.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HE3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -144.01 159.32 42.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.032 2.133 . . . . 2.96 108.38 174.525 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.52 23.66 0.08 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.465 2.706 . . . . 1.4399999999999999 113.381 171.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.467 HD12 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -92.89 161.75 30.74 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 121.484 -0.76 . . . . 1.72 110.773 174.158 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.63 135.33 52.2 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 O-C-N 122.655 0.818 . . . . 0.96999999999999997 110.068 164.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -92.65 24.05 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.968 3.112 . . . . 1.0800000000000001 112.942 -149.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.7 158.11 15.1 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.003 -1.239 . . . . 2.2400000000000002 110.003 167.141 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -51.2 130.9 27.38 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 128.302 2.641 . . . . 3.1600000000000001 114.915 -175.53 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -103.83 138.36 40.53 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.832 1.253 . . . . 1.5600000000000001 112.577 -171.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.63 150.66 50.91 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.926 -0.87 . . . . 0.72999999999999998 110.926 166.371 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.92 119.85 28.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.099 -1.445 . . . . 2.02 107.099 175.198 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -115.25 153.64 30.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.922 0.889 . . . . 0.96999999999999997 113.27 171.165 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.483 ' CG2' HD12 ' A' ' 74' ' ' LEU . 71.7 mt -94.75 144.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.396 1.078 . . . . 0.83999999999999997 109.03 150.612 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -118.74 156.85 28.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.15 1.78 . . . . 0.93000000000000005 110.214 176.409 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.1 62.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 117.101 2.26 . . . . 1.1100000000000001 117.101 -159.368 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -134.75 -179.2 5.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.8 2.04 . . . . 1.3400000000000001 110.44 175.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.84 100.55 0.54 Allowed Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.576 -1.327 . . . . 1.25 113.629 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.4 t 175.71 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.079 2.152 . . . . 2.0099999999999998 110.987 173.268 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.2 m -71.4 43.43 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 126.902 2.081 . . . . 1.5800000000000001 115.019 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -106.95 127.95 27.03 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.308 -1.495 . . . . 3.2799999999999998 111.276 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.84 162.34 29.63 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.824 3.016 . . . . 1.1000000000000001 112.305 173.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.12 145.76 40.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.125 0.97 . . . . 1.52 109.467 160.111 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mm -102.07 22.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.669 1.188 . . . . 3.3999999999999999 111.321 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.14 129.46 27.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.131 1.373 . . . . 4.4699999999999998 112.2 -175.332 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 t0 69.83 25.87 4.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.678 1.591 . . . . 3.3500000000000001 112.737 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.64 28.07 44.55 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.722 1.153 . . . . 2.3700000000000001 113.541 172.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -158.26 132.54 8.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.009 0.904 . . . . 2.7000000000000002 110.773 -166.488 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.8 104.0 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.394 -0.816 . . . . 1.8799999999999999 111.277 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.61 41.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.674 1.589 . . . . 2.1600000000000001 112.414 -175.066 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.46 -63.15 0.26 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.991 2.916 . . . . 1.75 115.563 172.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.77 128.31 2.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.074 2.55 . . . . 1.6399999999999999 108.315 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -116.48 -46.71 2.76 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.435 1.094 . . . . 4.9000000000000004 111.72 -177.455 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.54 -18.73 64.42 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.712 1.004 . . . . 1.4099999999999999 113.712 -174.617 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.1 -8.39 56.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.161 1.384 . . . . 1.05 113.45 168.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.64 174.4 49.27 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 120.608 -1.307 . . . . 2.6299999999999999 112.699 -172.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.37 -160.52 19.5 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 122.156 -0.614 . . . . 1.25 111.768 168.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -48.4 144.0 4.39 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.466 -0.568 . . . . 2.7999999999999998 109.466 165.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -71.3 61.01 0.3 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.515 1.526 . . . . 2.5 112.152 179.614 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -118.85 -1.21 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 120.724 3.602 . . . . 4.0499999999999998 120.724 -147.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.66 -56.84 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 123.505 2.288 . . . . 2.9399999999999999 114.885 -151.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -92.76 54.85 2.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.632 1.173 . . . . 3.3100000000000001 111.236 -177.168 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -123.94 -75.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.324 1.05 . . . . 3.3900000000000001 111.651 174.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t 168.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 130.02 3.328 . . . . 2.5699999999999998 111.257 -175.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.48 0.19 73.4 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 115.408 0.923 . . . . 1.9199999999999999 115.408 164.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -84.22 3.87 33.33 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.604 1.705 . . . . 5.0800000000000001 115.604 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 45.2 t60 62.25 -174.25 0.14 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.911 1.284 . . . . 1.8 111.662 -169.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.27 -155.14 0.47 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.558 -1.339 . . . . 3.98 111.467 -172.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.43 -101.56 0.64 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.041 -1.422 . . . . 2.8300000000000001 111.007 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.9 -15.38 32.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.501 2.8 . . . . 4.0 113.357 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.59 157.37 12.39 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.77 2.828 . . . . 6.8700000000000001 108.333 179.215 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.5 179.75 29.55 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.223 0.902 . . . . 4.0199999999999996 114.857 177.177 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -156.13 35.64 0.34 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.935 2.094 . . . . 5.8099999999999996 109.426 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.61 4.56 63.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 116.822 -2.099 . . . . 3.2999999999999998 116.703 -172.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -177.12 99.5 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.358 1.863 . . . . 4.6100000000000003 111.561 171.551 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -14.19 62.78 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.104 1.89 . . . . 3.0 116.104 -176.297 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 25.37 28.22 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 127.273 2.368 . . . . 1.5800000000000001 115.537 -170.088 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -93.14 151.73 19.67 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.205 1.402 . . . . 3.0499999999999998 110.384 167.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.63 157.91 76.23 Favored Pre-proline 0 CA--C 1.556 1.198 0 O-C-N 120.95 -1.094 . . . . 2.21 111.706 -161.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.7 162.38 41.41 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.96 3.106 . . . . 0.93000000000000005 112.509 -171.414 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -83.19 128.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 123.431 1.586 . . . . 1.6299999999999999 112.977 -161.072 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.03 83.22 6.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.556 2.742 . . . . 2.4100000000000001 110.033 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.53 143.62 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 125.598 1.559 . . . . 1.0 111.105 176.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.42 157.25 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 127.598 2.359 . . . . 1.73 107.913 170.159 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.7 p30 -81.35 163.26 23.0 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 118.743 -0.646 . . . . 2.0099999999999998 111.852 170.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -19.35 2.2 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.312 1.967 . . . . 3.5299999999999998 116.312 -174.028 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -94.37 -2.33 52.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.658 1.583 . . . . 3.8599999999999999 114.578 177.351 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.12 31.44 8.49 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.149 0.886 . . . . 1.0 115.174 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -116.53 133.78 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.768 1.627 . . . . 1.04 109.449 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.18 108.81 19.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.441 1.496 . . . . 0.68999999999999995 109.546 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 t -131.43 24.59 4.8 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.079 1.752 . . . . 1.3999999999999999 111.291 172.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.79 108.54 43.72 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.917 1.687 . . . . 3.04 108.933 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 129.87 14.65 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.791 2.327 . . . . 1.3 110.378 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.29 172.17 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.163 1.385 . . . . 1.5 108.972 175.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.3 m -151.22 145.59 25.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.226 0.921 . . . . 1.21 109.954 -171.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -112.45 89.64 12.99 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 112.992 0.738 . . . . 1.01 112.992 176.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 -4.91 12.86 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.856 3.038 . . . . 1.47 114.307 172.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -73.72 -18.92 60.94 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.751 2.02 . . . . 3.9399999999999999 112.046 176.129 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.38 164.02 13.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.379 2.272 . . . . 2.6699999999999999 108.405 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -154.37 6.11 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.295 1.591 . . . . 4.4299999999999997 115.295 -172.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 t -168.95 130.41 1.2 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.338 -1.476 . . . . 1.9299999999999999 113.099 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.35 -26.94 61.78 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.583 -1.323 . . . . 1.51 111.946 174.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.13 -16.69 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.676 1.361 . . . . 3.0899999999999999 114.676 175.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.68 -12.89 52.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.385 1.448 . . . . 2.04 113.056 171.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.41 3.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.353 1.461 . . . . 0.90000000000000002 114.587 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -62.35 -2.56 1.05 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.057 2.243 . . . . 2.3599999999999999 117.057 -175.374 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -148.85 29.38 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.036 1.735 . . . . 3.2999999999999998 110.826 174.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -111.87 -179.53 3.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.83 1.652 . . . . 1.54 111.578 178.338 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.31 151.74 48.95 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.003 -1.061 . . . . 0.59999999999999998 111.124 168.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.74 153.48 33.34 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.441 1.097 . . . . 2.3700000000000001 110.696 164.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.3 mtt -136.97 130.98 32.32 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.329 0.652 . . . . 1.23 110.94 -170.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.0 mt -84.74 109.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.76000000000000001 107.131 168.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -91.95 147.03 23.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.002 2.121 . . . . 2.1200000000000001 111.191 -175.029 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.71 -37.58 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.876 -1.14 . . . . 1.5900000000000001 113.397 -162.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.16 170.92 15.16 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 124.506 1.05 . . . . 1.5800000000000001 111.774 170.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.46 169.34 37.19 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 1.45 113.884 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -125.96 11.64 7.73 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.896 1.813 . . . . 2.46 115.896 -141.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.21 9.21 0.46 Allowed 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.126 -1.609 . . . . 2.8700000000000001 115.229 -177.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.1 mtm -81.19 79.29 7.87 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.527 1.531 . . . . 3.04 112.31 -172.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -81.68 -5.09 57.77 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.957 0.903 . . . . 2.98 113.352 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -149.3 145.05 26.86 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.152 -1.592 . . . . 3.8700000000000001 111.566 -173.393 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 151.27 153.88 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.091 1 C-N-CA 132.049 4.139 . . . . 4.0999999999999996 110.166 173.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.71 -12.1 22.11 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.306 2.671 . . . . 2.1499999999999999 114.382 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -77.93 116.0 54.99 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 119.76 1.164 . . . . 4.9699999999999998 108.927 165.284 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.84 173.33 12.09 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.161 2.574 . . . . 4.3499999999999996 112.948 -168.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.8 mt 67.04 11.21 8.26 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.355 1.862 . . . . 6.7599999999999998 113.904 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.28 6.62 59.91 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.437 1.494 . . . . 4.7699999999999996 114.481 177.04 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.93 -50.67 2.67 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.127 1.463 . . . . 3.1800000000000002 114.581 175.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.31 45.14 1.73 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 126.58 2.038 . . . . 2.0800000000000001 114.602 -175.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.74 -15.12 68.49 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.674 1.13 . . . . 1.8400000000000001 114.657 -175.014 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.8 p -67.68 125.09 25.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.216 1.406 . . . . 1.9399999999999999 112.244 -175.291 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 -91.01 150.41 21.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.011 1.724 . . . . 4.5999999999999996 110.098 176.19 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 11.0 t80 -112.49 -42.04 3.74 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.795 0.725 . . . . 2.0899999999999999 112.265 161.5 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.99 142.79 32.97 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.316 0.646 . . . . 0.68999999999999995 112.607 177.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.02 143.44 44.31 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.503 1.521 . . . . 1.3200000000000001 111.113 176.324 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.57 81.66 0.3 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 128.083 2.754 . . . . 0.77000000000000002 110.962 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.76 135.66 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 118.091 0.945 . . . . 2.2799999999999998 110.949 166.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.2 mt -107.54 140.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.045 1.338 . . . . 1.1399999999999999 110.341 -167.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 3.8599999999999999 109.822 177.493 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.568 -0.253 . . . . 3.2599999999999998 110.989 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -155.67 152.45 28.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.095 1.358 . . . . 1.96 110.121 -170.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.84 122.73 5.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.055 0.931 . . . . 2.6899999999999999 112.669 173.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.76 82.41 5.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.994 -1.066 . . . . 3.25 113.225 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.69 116.05 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.22 -0.925 . . . . 1.52 111.778 -169.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.09 90.38 1.2 Allowed Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.462 1.982 . . . . 1.1599999999999999 112.319 -177.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mmt -72.81 120.8 18.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.95 . . . . 1.78 113.13 -175.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -104.44 144.37 31.75 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.074 1.75 . . . . 3.52 112.033 -178.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.64 66.53 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.42 1.088 . . . . 1.8600000000000001 111.105 175.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 m -67.46 138.88 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.552 1.141 . . . . 0.95999999999999996 110.304 174.106 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -165.81 61.1 0.11 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.745 0.784 . . . . 2.21 112.317 -171.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.61 -26.79 0.17 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.965 2.506 . . . . 1.1599999999999999 115.265 171.212 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -17.44 61.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.301 2.24 . . . . 2.5800000000000001 112.117 173.7 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.8 -168.04 13.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.545 2.022 . . . . 1.6499999999999999 109.963 -160.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.2 t -56.64 139.5 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.327 0.651 . . . . 1.04 110.19 155.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.74 -128.2 4.7 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.927 1.727 . . . . 1.3799999999999999 112.065 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.67 162.75 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.755 1.622 . . . . 4.4000000000000004 111.009 178.224 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -128.45 156.5 43.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.083 0.953 . . . . 1.23 112.745 -164.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.74 7.53 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 125.005 1.322 . . . . 2.98 114.388 -162.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.84 173.82 24.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.063 1.315 . . . . 0.57999999999999996 112.975 -179.477 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 p -105.18 174.34 5.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.78 0.832 . . . . 0.94999999999999996 109.817 168.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 t -123.46 126.67 73.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.962 -1.496 . . . . 0.85999999999999999 106.962 151.59 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.55 119.7 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 123.279 0.362 . . . . 0.95999999999999996 111.408 -177.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.33 126.74 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.847 1.259 . . . . 1.1799999999999999 108.545 174.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -130.34 127.16 38.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.917 0.887 . . . . 2.3300000000000001 109.896 170.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 117' ' ' LEU . 12.8 tt0 -77.05 136.67 38.68 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.516 1.927 . . . . 3.3700000000000001 112.302 -171.261 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.58 -175.53 5.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.254 0.934 . . . . 1.23 111.361 175.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.24 -30.62 70.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.013 0.925 . . . . 4.0499999999999998 112.037 -179.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.11 11.77 41.07 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.892 0.758 . . . . 1.1000000000000001 113.762 166.197 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.36 -141.16 21.92 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 127.441 2.448 . . . . 0.83999999999999997 114.742 176.289 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.11 101.9 9.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.057 0.943 . . . . 0.63 111.296 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -78.06 108.24 11.21 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.983 1.313 . . . . 1.8500000000000001 110.594 175.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -102.69 117.1 33.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.458 2.303 . . . . 0.62 110.269 -171.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -127.58 112.36 20.9 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 117.765 -1.112 . . . . 0.68999999999999995 109.716 -172.473 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -88.62 159.43 6.42 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.188 2.592 . . . . 0.46999999999999997 112.224 -173.233 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.08 25.31 0.72 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.446 0.906 . . . . 1.3100000000000001 113.446 173.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.31 136.58 33.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.814 0.846 . . . . 0.66000000000000003 112.822 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.09 156.98 18.99 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.677 -0.692 . . . . 2.6000000000000001 111.198 161.551 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.15 20.39 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.806 2.442 . . . . 1.79 114.675 156.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.89 154.29 41.13 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 1.4199999999999999 112.458 176.252 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.07 137.68 45.1 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 O-C-N 122.953 0.975 . . . . 1.6000000000000001 110.911 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 9.7 Cg_endo -85.24 51.74 3.12 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.489 3.459 . . . . 1.73 112.283 -162.881 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 -162.42 13.99 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 114.868 -1.06 . . . . 1.1899999999999999 114.047 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.46 140.28 32.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.256 1.822 . . . . 2.6899999999999999 110.214 171.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.87 136.55 30.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 1.4199999999999999 109.683 -177.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.72 169.61 29.71 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.629 0.65 . . . . 0.72999999999999998 112.347 167.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.39 132.68 10.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.209 1.404 . . . . 2.04 108.566 171.112 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 15.6 m170 -129.79 170.49 13.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.231 1.567 . . . . 0.70999999999999996 115.231 168.633 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 74' ' ' LEU . 44.3 mt -99.01 147.1 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.629 1.572 . . . . 0.60999999999999999 109.151 153.201 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.59 152.34 40.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.168 1.787 . . . . 0.81999999999999995 110.503 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.35 -31.44 72.57 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.435 2.013 . . . . 0.92000000000000004 116.435 -160.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -113.73 169.8 8.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.858 1.663 . . . . 1.2 112.528 177.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.02 67.41 0.22 Allowed Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.948 1.139 . . . . 0.81000000000000005 115.948 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -166.88 120.5 1.02 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 119.459 1.629 . . . . 2.0699999999999998 114.572 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.4 m -69.93 -6.34 32.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.34 1.856 . . . . 1.4299999999999999 115.157 176.017 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -63.96 145.02 98.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 O-C-N 120.993 -1.067 . . . . 3.2000000000000002 111.825 -168.825 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.23 150.2 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.978 2.452 . . . . 1.28 111.752 179.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.25 140.96 34.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.517 0.727 . . . . 1.6799999999999999 109.723 161.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.92 126.75 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.13 -1.063 . . . . 2.7000000000000002 108.13 169.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -167.32 144.91 4.65 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.731 1.612 . . . . 5.25 109.971 -163.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 59.88 -104.73 0.2 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.072 1.349 . . . . 4.1399999999999997 108.003 -163.315 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.68 25.4 3.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.934 1.73 . . . . 2.6499999999999999 113.501 170.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.88 179.62 9.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.094 1.447 . . . . 4.5199999999999996 113.318 -167.059 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.57 108.53 20.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.812 1.245 . . . . 1.6599999999999999 112.679 -171.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.25 91.43 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.829 1.252 . . . . 2.0499999999999998 109.937 -179.06 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.15 114.7 2.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.567 1.547 . . . . 2.98 112.859 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.26 39.18 7.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.54 1.536 . . . . 1.8100000000000001 113.395 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.84 -43.0 90.64 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.409 0.684 . . . . 4.4199999999999999 109.896 158.431 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.78 78.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.664 1.186 . . . . 1.8 113.002 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -16.36 8.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.816 2.046 . . . . 0.87 115.416 179.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.89 176.25 45.35 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 120.072 1.305 . . . . 2.3100000000000001 112.561 -172.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.24 -175.92 22.72 Favored Glycine 0 N--CA 1.474 1.181 0 N-CA-C 111.732 -0.547 . . . . 1.3999999999999999 111.732 163.416 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -70.17 35.88 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.907 1.447 . . . . 3.0899999999999999 114.907 -176.325 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.489 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER 71.81 89.73 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.2 1.8 . . . . 3.0699999999999998 109.691 175.317 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.25 102.47 1.24 Allowed Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 127.287 2.235 . . . . 3.8700000000000001 110.03 -172.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.42 -54.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.259 2.64 . . . . 1.9299999999999999 111.561 173.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -132.37 15.2 4.55 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.052 1.296 . . . . 4.1699999999999999 113.651 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.91 -47.17 63.52 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.427 -1.421 . . . . 3.6099999999999999 111.388 -171.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t 178.16 -65.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.287 2.235 . . . . 2.8500000000000001 111.855 175.299 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.29 -21.14 6.13 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.825 1.203 . . . . 1.9199999999999999 114.502 -170.269 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -82.62 168.61 17.14 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.117 1.959 . . . . 4.3200000000000003 113.83 170.296 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -84.52 146.09 27.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.336 1.054 . . . . 1.5800000000000001 112.875 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 84' ' ' GLY . 7.1 tt0 -106.87 -156.81 0.59 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.505 1.122 . . . . 3.54 112.56 -178.323 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' A' ' 83' ' ' GLU . . . -160.47 -128.34 0.95 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 127.23 2.348 . . . . 3.1299999999999999 110.478 179.081 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.95 -27.22 12.38 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.363 2.709 . . . . 5.5499999999999998 113.353 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -174.18 164.85 4.07 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.664 2.386 . . . . 8.8699999999999992 109.979 171.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.22 -135.36 7.72 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 125.796 1.665 . . . . 2.6200000000000001 109.977 -174.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -142.67 116.13 9.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.289 1.044 . . . . 4.8099999999999996 112.079 166.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.58 -139.44 3.24 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 127.474 2.464 . . . . 2.1400000000000001 109.179 166.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -75.49 139.7 42.37 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 117.806 0.803 . . . . 3.7000000000000002 112.674 176.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.5 -15.84 62.84 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.711 1.375 . . . . 1.98 114.711 177.4 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.03 9.79 76.15 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 118.496 -1.169 . . . . 0.85999999999999999 114.892 175.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -82.84 136.09 34.74 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.87 1.335 . . . . 1.6499999999999999 111.497 171.405 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 171.2 7.26 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.983 0.913 . . . . 1.9099999999999999 111.066 -138.24 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.46 159.52 32.45 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.372 2.715 . . . . 1.22 112.45 -169.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -85.26 126.51 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 122.908 1.337 . . . . 1.46 113.423 -173.223 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.17 68.64 5.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.972 2.909 . . . . 1.6399999999999999 110.878 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.53 144.76 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.73 0.812 . . . . 1.1000000000000001 110.749 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.91 135.61 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 3.2000000000000002 109.478 169.548 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.12 154.22 42.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.843 1.257 . . . . 3.21 113.876 178.015 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 3.5 p-10 -33.34 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 131.188 3.795 . . . . 3.1600000000000001 118.953 179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -78.72 -21.52 47.94 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.567 1.547 . . . . 3.54 113.319 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.2 34.48 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 124.338 0.971 . . . . 1.3100000000000001 114.852 178.323 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mt -124.32 117.13 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.037 1.335 . . . . 1.3400000000000001 109.413 178.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 125.63 28.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.194 0.998 . . . . 0.60999999999999999 111.152 -177.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 t -142.7 -7.14 0.86 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.592 1.557 . . . . 1.2 113.502 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.0 117.38 64.66 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.038 -1.038 . . . . 3.27 111.193 -175.624 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 136.57 14.64 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.446 2.764 . . . . 1.0700000000000001 111.281 176.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 m -139.97 155.82 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.785 1.234 . . . . 1.1699999999999999 110.336 176.716 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.3 m -135.48 138.91 43.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.712 0.687 . . . . 0.78000000000000003 110.915 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.29 99.77 50.25 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.237 1.015 . . . . 0.70999999999999996 112.885 -174.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.22 -1.29 11.29 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.58 3.52 . . . . 1.28 115.384 -178.346 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -71.71 -25.32 62.03 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.158 0.89 . . . . 4.0599999999999996 111.855 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.79 133.04 56.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.003 2.521 . . . . 2.0899999999999999 106.802 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 12.29 1.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.756 1.021 . . . . 6.7400000000000002 113.756 -164.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.4 p -132.45 164.09 27.32 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.054 -0.721 . . . . 2.8900000000000001 109.054 146.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.8 -26.68 22.73 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.649 -0.657 . . . . 2.6400000000000001 110.547 168.187 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.28 -44.89 44.39 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.391 1.476 . . . . 3.1499999999999999 113.055 168.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.7 -2.34 14.23 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.877 1.066 . . . . 2.25 113.877 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 18.02 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.304 1.441 . . . . 0.91000000000000003 113.806 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -64.99 -4.27 4.42 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 118.135 2.642 . . . . 2.1699999999999999 118.135 -170.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.3 58.76 0.9 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.05 1.74 . . . . 4.3399999999999999 109.9 169.472 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -114.58 147.93 38.77 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.081 1.352 . . . . 1.45 110.751 173.292 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.38 140.47 31.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.813 0.845 . . . . 0.80000000000000004 110.354 164.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.41 149.12 36.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.558 1.943 . . . . 2.8599999999999999 107.534 170.174 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.6 mtt -132.97 137.73 46.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.813 0.279 . . . . 1.53 111.728 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.53 124.36 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.967 -1.494 . . . . 0.66000000000000003 106.967 165.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.32 137.97 51.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.289 1.036 . . . . 1.8200000000000001 112.17 -162.25 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.69 -32.96 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.486 1.291 . . . . 2.7000000000000002 114.486 -154.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.02 152.61 19.74 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.003 1.287 . . . . 1.3200000000000001 111.55 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.9 140.35 16.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.907 1.717 . . . . 1.76 113.644 175.279 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.404 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 15.5 t0 -83.28 -0.02 47.75 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.284 1.587 . . . . 2.4199999999999999 115.284 -152.394 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -77.2 -16.59 59.02 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.939 1.696 . . . . 3.46 114.977 -168.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.4 ptp -78.59 45.4 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.518 1.527 . . . . 3.1099999999999999 113.829 -171.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 m -83.2 -33.76 26.08 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 117.902 2.556 . . . . 4.3399999999999999 117.902 -146.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -92.95 21.77 5.45 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.296 1.039 . . . . 4.4400000000000004 113.466 -162.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -75.22 146.43 81.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.546 1.138 . . . . 3.9300000000000002 112.454 -172.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.07 -14.54 41.16 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.619 2.879 . . . . 1.9199999999999999 112.913 173.298 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -83.58 101.77 1.55 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.695 -0.854 . . . . 4.0300000000000002 108.695 151.504 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.24 146.28 93.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.387 2.058 . . . . 3.0699999999999998 110.422 -177.202 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 71.15 -3.25 2.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.783 2.033 . . . . 3.9399999999999999 112.927 -173.654 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.88 40.02 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.817 1.675 . . . . 2.6000000000000001 115.839 168.252 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.5 -38.45 3.01 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.309 1.433 . . . . 2.21 112.678 -167.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.31 -25.74 63.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.961 1.267 . . . . 1.75 114.349 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.43 2.7 14.05 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.88 1.228 . . . . 1.9099999999999999 115.312 172.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.9 m -66.2 152.27 45.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.761 1.28 . . . . 2.04 108.885 164.331 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.66 133.24 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.276 1.03 . . . . 4.7199999999999998 110.513 -169.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -98.09 -16.64 19.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.176 0.59 . . . . 2.3599999999999999 111.366 156.094 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.49 160.73 35.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.137 0.88 . . . . 0.69999999999999996 112.977 164.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.6 t -133.04 150.72 52.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.423 1.889 . . . . 1.54 109.825 167.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.21 136.34 4.38 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.393 1.473 . . . . 0.89000000000000001 111.701 -178.454 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.96 139.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.119 0.968 . . . . 2.0800000000000001 111.502 -174.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.03 149.55 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.172 1.389 . . . . 1.25 111.862 174.524 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 C--O 1.238 0.491 0 C-N-CA 125.311 1.444 . . . . 3.5800000000000001 111.38 -176.411 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 119.544 -0.265 . . . . 1.83 110.756 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.78 152.62 35.5 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.763 -1.211 . . . . 1.04 113.228 -164.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -147.59 130.96 16.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.138 1.775 . . . . 2.22 109.599 174.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.44 96.66 10.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 4.88 111.117 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 t -90.15 112.32 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 120.597 -1.314 . . . . 1.22 109.147 -169.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.28 109.55 2.81 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.781 1.181 . . . . 0.96 110.363 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.2 mtp -96.52 131.12 43.45 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.453 0.701 . . . . 1.14 111.486 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -105.06 155.61 18.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.465 1.126 . . . . 2.67 110.534 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.84 145.29 54.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.412 1.485 . . . . 1.49 109.451 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.4 m -140.07 140.46 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.507 0.723 . . . . 0.89 111.085 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.08 57.9 0.1 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.788 0.662 . . . . 2.35 112.788 -167.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 77.34 -21.48 0.33 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.949 2.1 . . . . 1.04 114.073 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -19.99 28.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.251 1.02 . . . . 3.15 112.858 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.57 -147.93 16.32 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 125.411 1.482 . . . . 0.9 111.327 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.05 123.2 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.169 1.788 . . . . 0.94 111.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.32 -137.8 9.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.748 1.642 . . . . 1.57 112.021 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -90.31 170.11 10.53 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.258 -0.554 . . . . 2.05 110.049 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 t -105.95 157.66 17.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.991 0.9 . . . . 1.25 112.201 162.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.95 0.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.715 2.806 . . . . 2.88 112.822 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 147.25 6.21 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.571 2.034 . . . . 0.84 111.914 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 p -88.08 -177.44 5.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.297 -1.001 . . . . 0.76 108.297 159.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 47.6 t -128.3 134.28 65.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.554 -1.276 . . . . 0.48 107.554 149.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.2 p -82.95 127.09 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.596 -0.52 . . . . 0.82 109.596 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.67 HD11 HD21 ' A' ' 125' ' ' LEU . 16.8 mt -103.88 130.64 54.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.219 -1.03 . . . . 1.22 108.219 169.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.41 112.12 8.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.656 1.182 . . . . 2.15 109.131 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -77.77 144.49 37.11 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.773 -0.579 . . . . 3.32 111.157 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 t -148.24 178.13 8.83 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.356 -0.979 . . . . 1.32 108.356 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -70.36 -14.95 62.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.162 0.585 . . . . 3.39 112.176 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.41 12.9 67.47 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.22 1.391 . . . . 1.0 114.845 163.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.98 -155.89 22.15 Favored Glycine 0 N--CA 1.467 0.741 0 C-N-CA 127.492 2.473 . . . . 0.79 117.224 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -71.63 101.99 2.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.664 0.785 . . . . 0.6 111.87 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -71.29 117.3 12.65 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.841 1.256 . . . . 2.26 109.163 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -95.88 127.52 41.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.027 1.731 . . . . 0.96 108.162 174.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.414 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 19.9 m -129.62 105.03 17.27 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 119.916 1.235 . . . . 0.6 107.972 167.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.75 164.87 29.58 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.112 2.541 . . . . 0.54 110.066 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -155.42 43.66 0.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 122.356 1.074 . . . . 1.36 109.251 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.15 134.83 44.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.891 1.276 . . . . 1.01 112.089 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.637 ' HE3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -104.63 164.47 11.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.962 2.505 . . . . 3.26 109.056 168.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.57 16.06 0.38 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.778 2.431 . . . . 1.56 114.195 163.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.36 160.5 36.93 Favored Pre-proline 0 CA--C 1.511 -0.545 0 O-C-N 121.871 -0.518 . . . . 1.81 110.42 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.8 128.45 23.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 O-C-N 123.451 1.237 . . . . 1.11 110.307 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -85.8 31.31 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 125.101 3.867 . . . . 1.16 113.471 -147.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.08 -122.18 4.29 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 126.399 1.952 . . . . 1.18 113.124 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.84 138.21 35.57 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.095 2.158 . . . . 2.51 108.386 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -137.88 123.0 19.19 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 123.683 0.793 . . . . 1.34 112.942 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.15 149.26 7.56 Favored Glycine 0 CA--C 1.54 1.656 0 O-C-N 121.336 -0.852 . . . . 0.7 112.307 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.7 t80 -124.96 115.4 20.51 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.802 1.301 . . . . 2.01 107.5 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -115.03 162.31 17.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.724 1.379 . . . . 0.98 114.724 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.2 mt -107.75 143.6 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.765 2.026 . . . . 0.62 107.388 155.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -118.41 161.09 20.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.504 1.122 . . . . 0.91 112.03 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.62 73.22 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.558 1.318 . . . . 0.74 114.558 -163.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -101.92 177.77 4.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.69 1.196 . . . . 1.64 111.61 164.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.49 90.2 0.55 Allowed Glycine 0 N--CA 1.469 0.856 0 C-N-CA 124.621 1.105 . . . . 0.84 112.003 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -166.4 99.03 0.6 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.356 1.078 . . . . 2.08 113.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.7 m -71.48 45.52 0.11 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.942 2.097 . . . . 1.64 113.802 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.55 148.41 42.85 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.172 -1.58 . . . . 3.61 111.452 -171.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.51 165.02 9.37 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.473 3.449 . . . . 1.3 112.139 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.65 148.96 40.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.425 1.09 . . . . 1.95 110.013 166.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.45 134.43 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.323 1.449 . . . . 2.2 108.091 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -162.9 143.6 9.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.305 1.442 . . . . 5.58 109.21 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t0 53.21 41.38 32.14 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.358 0.981 . . . . 4.02 113.471 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 14.45 73.14 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.936 -0.925 . . . . 2.64 115.086 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.38 156.79 44.39 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.446 1.623 . . . . 3.24 111.717 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.09 138.98 44.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.377 0.88 . . . . 1.8 113.377 -170.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.83 134.06 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.265 1.426 . . . . 3.28 109.037 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.52 -48.47 10.19 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.263 1.579 . . . . 2.39 115.263 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.61 122.45 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 130.578 3.551 . . . . 2.71 107.412 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -154.45 -8.31 0.14 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.43 1.092 . . . . 6.79 113.849 -164.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.53 62.47 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 121.088 1.767 . . . . 1.52 113.048 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.0 -8.36 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.167 1.787 . . . . 1.01 114.708 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.4 -165.3 38.93 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 121.344 1.884 . . . . 2.58 113.035 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.69 179.35 53.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.27 0.938 . . . . 1.2 112.358 165.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . 0.291 0.2 OUTLIER -77.57 54.03 1.14 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.335 1.054 . . . . 2.67 113.655 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.9 tp 54.87 69.19 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.921 2.488 . . . . 1.71 111.484 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.45 65.52 11.76 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 129.0 2.92 . . . . 4.59 113.009 -162.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.88 -58.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.382 2.721 . . . . 2.11 113.436 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -137.7 125.96 23.15 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.29 1.036 . . . . 4.17 109.51 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -174.89 -95.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.553 1.541 . . . . 6.03 112.096 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 t 171.19 -23.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 128.713 2.805 . . . . 3.44 112.604 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.78 -34.17 4.47 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 125.892 1.71 . . . . 2.79 111.646 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -52.25 144.64 12.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.409 1.1 . . . . 6.79 111.912 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -96.26 147.86 23.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.371 1.868 . . . . 2.03 111.326 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.1 131.6 45.72 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.529 -0.915 . . . . 4.39 108.529 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.19 -145.38 5.2 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.548 -1.14 . . . . 2.97 114.108 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.47 -18.89 22.46 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.302 2.668 . . . . 3.23 114.265 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -165.29 146.81 7.52 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.863 1.265 . . . . 5.51 110.834 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.88 -135.79 13.13 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.262 0.934 . . . . 3.86 111.917 -171.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -165.71 157.89 14.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.435 1.494 . . . . 6.15 109.451 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.18 -126.61 0.83 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.199 0.839 . . . . 2.66 115.199 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 145.4 25.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.47 1.508 . . . . 3.79 111.985 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.58 -11.31 57.5 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.16 1.17 . . . . 2.06 114.16 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.01 32.2 4.72 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.216 1.389 . . . . 1.04 114.858 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.97 131.64 56.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.008 1.323 . . . . 1.67 111.16 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.464 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 3.4 mp -142.32 159.46 58.12 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 125.646 1.579 . . . . 2.06 111.079 -162.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.11 152.0 56.08 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.942 2.428 . . . . 0.86 113.083 -169.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.32 130.95 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.343 1.457 . . . . 2.36 112.758 -162.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.33 88.43 2.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.019 2.928 . . . . 1.7 109.87 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.67 136.06 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.03 0.932 . . . . 0.8 110.587 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.87 138.99 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 127.418 2.287 . . . . 1.59 106.295 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.19 161.28 30.12 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.263 -0.898 . . . . 2.35 111.276 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -19.2 0.85 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.731 2.123 . . . . 2.63 116.731 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.84 1.89 55.4 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.487 2.315 . . . . 2.73 112.812 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.15 23.21 41.75 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 125.258 1.408 . . . . 0.86 114.462 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -123.49 131.8 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.334 1.054 . . . . 1.1 111.044 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.02 140.17 44.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.009 1.724 . . . . 0.92 111.604 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -140.91 -2.9 1.28 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.745 1.757 . . . . 1.57 115.745 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.3 111.85 3.71 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 114.791 1.404 . . . . 3.28 114.791 -165.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.23 101.89 1.18 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.014 2.476 . . . . 2.48 110.079 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.0 178.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.145 1.778 . . . . 2.3 110.203 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.0 m -146.92 142.48 27.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.675 0.79 . . . . 1.1 110.621 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.88 106.97 56.45 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.494 1.118 . . . . 0.84 110.422 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.61 7.44 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.663 2.909 . . . . 1.04 113.218 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -17.98 63.32 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.229 1.412 . . . . 5.6 113.425 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mp -152.82 155.77 37.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.862 3.265 . . . . 2.22 108.09 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.304 0.0 OUTLIER -147.94 43.35 1.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.545 2.054 . . . . 5.06 116.545 -173.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -175.99 147.36 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.638 1.975 . . . . 2.0 110.161 167.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.75 -28.42 68.69 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 1.65 111.717 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.16 -19.23 19.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.123 1.369 . . . . 3.36 114.301 173.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.72 -7.94 59.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.565 1.146 . . . . 2.06 112.496 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.27 0.78 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 114.912 1.449 . . . . 1.27 114.912 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -72.23 20.22 0.07 Allowed 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.682 2.105 . . . . 3.63 116.682 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -142.47 15.8 2.01 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.454 1.901 . . . . 3.01 111.322 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -128.91 175.84 8.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.581 1.552 . . . . 2.58 112.748 -164.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.15 149.11 39.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.563 1.145 . . . . 0.68 112.04 166.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 24' ' ' ILE . 44.2 mt -82.22 155.35 24.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.303 1.441 . . . . 2.18 109.056 158.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.4 ttm -149.45 122.88 9.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.395 . . . . 1.45 111.97 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -94.32 109.25 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.779 1.232 . . . . 0.72 108.658 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.4 147.9 22.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.415 2.286 . . . . 2.37 113.218 -167.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 t -67.88 -38.54 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.049 -1.032 . . . . 1.59 112.332 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.51 155.92 17.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.632 0.634 . . . . 1.22 111.619 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.71 165.6 28.69 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.374 0.988 . . . . 1.39 111.758 157.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -122.65 23.5 9.51 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.189 1.181 . . . . 2.64 114.189 -136.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -93.72 4.25 54.22 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 116.397 1.999 . . . . 2.88 116.397 -167.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -131.88 151.27 51.81 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.677 1.732 . . . . 3.88 115.677 -168.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.0 p -140.27 11.12 2.35 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.666 2.386 . . . . 3.16 112.89 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -118.65 14.7 13.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.219 1.408 . . . . 4.77 112.436 -145.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -121.31 163.17 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.758 2.823 . . . . 3.23 107.969 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.02 -10.12 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.828 2.352 . . . . 2.23 114.441 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.13 133.03 22.58 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.321 1.449 . . . . 5.59 109.757 165.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 165.9 31.35 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.64 2.893 . . . . 3.71 113.175 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.92 25.48 14.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.293 1.837 . . . . 5.08 111.647 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.59 13.72 59.14 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.989 -1.069 . . . . 2.82 114.04 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 106.14 -7.7 41.05 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.619 1.58 . . . . 1.77 113.984 -168.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.19 22.08 0.63 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 126.303 1.906 . . . . 1.55 115.887 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.86 74.68 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.364 1.459 . . . . 1.65 114.294 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.2 p -73.24 163.31 28.29 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.5 1.52 . . . . 1.65 110.921 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 145.02 30.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.768 1.227 . . . . 5.25 111.555 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -92.16 -34.02 14.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.996 0.919 . . . . 2.82 112.436 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.83 154.57 42.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.956 0.902 . . . . 0.6 113.116 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.3 t -138.9 153.71 48.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.405 2.282 . . . . 1.43 109.769 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.99 114.64 0.62 Allowed Glycine 0 N--CA 1.467 0.706 0 C-N-CA 124.088 0.851 . . . . 0.75 113.051 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.88 130.75 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.915 1.286 . . . . 1.82 110.514 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mp -76.4 132.81 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 1.28 109.54 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 118.492 -0.766 . . . . 4.67 112.954 -176.339 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 119.479 -0.296 . . . . 2.26 110.414 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -131.79 140.34 49.17 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.603 1.705 . . . . 1.23 115.603 -137.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.89 136.87 34.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.144 0.973 . . . . 2.56 111.569 161.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 98.16 11.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.624 1.17 . . . . 4.6 111.36 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.03 118.55 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 120.8 -1.188 . . . . 1.15 109.614 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.42 111.31 3.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.478 1.513 . . . . 1.15 112.013 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 mmt -84.24 124.52 31.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.772 1.229 . . . . 1.57 112.518 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -113.03 149.29 33.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.487 0.661 . . . . 2.35 111.008 164.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -56.99 140.13 49.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.431 1.092 . . . . 1.28 109.635 171.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.36 147.28 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.43 0.559 . . . . 1.6 111.479 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -167.97 49.51 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.822 0.849 . . . . 2.57 112.67 -168.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.42 -31.75 0.23 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.046 2.138 . . . . 1.63 114.316 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -2.37 10.74 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.34 0.973 . . . . 2.59 111.619 160.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.93 -140.01 16.71 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.671 1.129 . . . . 1.6 111.03 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.05 122.34 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.723 1.609 . . . . 1.19 111.165 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.57 -134.99 8.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 126.176 1.846 . . . . 1.74 113.25 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.84 146.24 35.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.16 1.384 . . . . 2.02 110.984 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 t -83.89 142.9 30.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 1.28 110.878 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.8 -0.24 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.617 1.34 . . . . 3.63 114.617 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.21 167.49 14.4 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.673 1.13 . . . . 0.83 111.843 -171.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 p -103.3 176.14 5.25 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.569 -0.9 . . . . 1.04 108.569 161.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -119.19 131.36 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.718 -1.586 . . . . 0.71 106.718 148.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -84.88 123.97 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.921 -0.4 . . . . 1.28 109.921 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.437 HD11 HD21 ' A' ' 125' ' ' LEU . 20.5 mt -98.32 117.91 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.177 -1.046 . . . . 1.37 108.177 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -119.43 107.96 13.97 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.514 1.526 . . . . 1.93 109.717 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.65 147.7 31.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.578 0.955 . . . . 3.93 113.578 -172.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -179.58 7.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.719 0.808 . . . . 1.58 110.96 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.16 -28.2 69.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.302 1.041 . . . . 3.78 111.842 174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.9 10.34 60.48 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.448 1.023 . . . . 1.03 114.657 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.7 -145.74 23.97 Favored Glycine 0 N--CA 1.461 0.342 0 C-N-CA 129.15 3.262 . . . . 0.85 114.895 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.6 95.19 7.09 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.916 0.886 . . . . 0.66 110.488 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -71.66 107.18 4.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.108 0.963 . . . . 2.51 109.856 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 t80 -99.9 105.46 17.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 117.254 -1.355 . . . . 0.58 108.716 -167.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.4 m -116.05 109.07 45.21 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.789 1.632 . . . . 0.97 109.216 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.63 151.76 17.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.888 3.059 . . . . 0.61 111.654 -176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -141.53 23.68 2.12 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.555 0.693 . . . . 1.45 112.599 171.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -80.11 157.7 26.58 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 126.644 1.978 . . . . 0.8 113.872 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.29 170.31 16.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.661 -1.609 . . . . 3.19 109.831 165.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.81 22.93 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.607 2.763 . . . . 1.42 112.92 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -99.85 160.82 26.25 Favored Pre-proline 0 CA--C 1.51 -0.591 0 C-N-CA 123.472 0.709 . . . . 1.62 111.56 176.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 34.0 Cg_endo -63.15 127.44 20.22 Favored 'Trans proline' 0 N--CA 1.426 -2.456 0 O-C-N 123.531 1.28 . . . . 0.91 110.482 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 4.8 Cg_endo -88.8 31.78 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.51 3.474 . . . . 1.44 112.654 -144.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.37 -120.94 4.84 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 126.22 1.866 . . . . 1.87 113.405 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.32 145.07 48.26 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.971 2.108 . . . . 2.44 109.643 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.58 144.01 41.8 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.052 0.941 . . . . 0.93 111.409 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.95 165.57 37.86 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.136 -0.978 . . . . 0.85 111.215 168.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -146.55 126.9 13.97 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.358 -1.349 . . . . 2.12 107.358 169.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -122.81 167.23 13.78 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.466 1.284 . . . . 1.13 114.466 163.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.441 ' CG2' HD12 ' A' ' 74' ' ' LEU . 62.7 mt -85.24 148.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.132 0.973 . . . . 0.9 108.836 151.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.38 153.74 41.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.822 2.049 . . . . 1.03 108.318 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.72 72.67 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.97 1.841 . . . . 1.23 115.97 -159.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.23 -179.59 5.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.43 1.892 . . . . 1.7 112.035 -170.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.41 125.78 7.13 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.548 -1.14 . . . . 2.09 111.497 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 m 142.73 101.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 130.569 3.548 . . . . 2.24 112.526 164.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 61.1 m -63.82 23.18 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 127.56 2.344 . . . . 1.3 115.709 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.08 130.18 33.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.528 -1.982 . . . . 3.27 110.737 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.29 157.9 14.88 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.225 3.283 . . . . 0.96 111.544 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.57 174.49 7.73 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 1.63 111.399 159.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.72 138.43 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.134 1.374 . . . . 2.42 107.967 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.29 -124.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.182 0.593 . . . . 7.04 111.378 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.87 -31.32 66.59 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.901 1.68 . . . . 5.06 115.353 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 44.17 0.02 OUTLIER Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.135 0.874 . . . . 2.88 112.164 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 172.71 158.41 0.11 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.306 2.642 . . . . 3.72 109.281 -164.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.6 141.89 47.17 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.131 1.16 . . . . 1.56 114.131 -161.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.18 61.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.58 1.552 . . . . 1.82 111.651 -167.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.99 -72.2 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 127.431 2.292 . . . . 1.72 115.498 166.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.93 106.6 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 1 C-N-CA 132.906 4.482 . . . . 1.64 105.575 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -115.54 -46.49 2.86 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.378 1.071 . . . . 3.96 113.62 -155.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.62 -13.51 62.14 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.2 1.185 . . . . 1.38 114.2 -171.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -12.74 61.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.729 2.012 . . . . 1.22 113.664 167.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.33 169.4 44.23 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.789 -1.194 . . . . 2.95 112.638 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.69 -161.93 8.84 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.941 -0.864 . . . . 1.59 110.941 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -42.81 141.33 1.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.601 -0.518 . . . . 2.47 109.601 160.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -65.11 74.61 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.546 1.538 . . . . 3.04 112.529 -170.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -132.73 58.81 38.66 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 126.717 2.007 . . . . 4.06 112.681 -160.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.51 -37.56 29.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.062 1.841 . . . . 2.84 110.411 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -149.0 146.93 28.01 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.62 2.768 . . . . 4.29 105.805 162.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 p30 166.34 -47.42 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.115 2.166 . . . . 4.38 114.327 168.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 t 172.74 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.428 2.691 . . . . 2.87 111.425 -167.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.47 22.19 51.74 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 123.782 0.706 . . . . 2.21 114.135 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -160.29 -116.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.963 1.305 . . . . 4.38 113.438 -167.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.468 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 2.8 t60 -160.05 145.24 15.09 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 119.833 -1.792 . . . . 1.85 114.988 -170.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.65 -129.83 0.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.555 1.542 . . . . 4.29 111.164 170.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.55 -88.75 0.4 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.627 1.584 . . . . 3.14 110.964 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -33.56 6.47 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.186 2.591 . . . . 4.03 112.636 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.23 129.48 31.64 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.284 1.434 . . . . 5.56 107.95 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.41 64.04 2.91 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 125.249 1.404 . . . . 2.88 115.641 -158.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.09 98.71 11.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.996 0.918 . . . . 4.88 112.92 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.99 -72.3 2.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 116.025 1.17 . . . . 4.02 116.025 155.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.955 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 13.5 t-160 -75.09 93.24 2.73 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.314 1.057 . . . . 4.66 113.132 -164.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.78 64.03 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.926 1.454 . . . . 3.23 114.926 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.7 -0.13 89.85 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.965 1.269 . . . . 1.67 114.644 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.955 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 37.7 m-20 -67.03 134.25 51.54 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 118.297 1.048 . . . . 2.81 108.651 161.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.28 168.25 11.66 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.096 0.958 . . . . 2.28 111.515 -149.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.12 165.23 28.39 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.279 2.653 . . . . 1.16 112.682 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -85.63 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 122.824 1.297 . . . . 2.0 112.983 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.59 97.3 2.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.309 3.444 . . . . 1.76 109.832 172.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.36 139.15 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.333 1.053 . . . . 1.61 111.37 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.44 140.86 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.039 2.135 . . . . 1.56 107.453 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.93 160.94 21.98 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.364 -0.835 . . . . 2.91 112.024 174.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -20.38 4.44 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 115.539 1.681 . . . . 2.86 115.539 -174.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -85.25 4.48 34.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.361 1.864 . . . . 3.34 113.528 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.85 56.69 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 124.588 1.09 . . . . 0.9 114.19 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.57 135.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.288 1.835 . . . . 1.18 109.513 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 149.58 24.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.698 1.199 . . . . 0.99 110.953 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.8 t -159.55 -34.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.672 0.989 . . . . 1.34 113.672 -166.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.69 122.33 85.46 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.111 1.364 . . . . 3.77 111.64 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.18 136.72 16.43 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.91 2.406 . . . . 1.42 111.441 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.27 74.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 122.976 1.37 . . . . 2.29 112.096 -167.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.2 m -57.07 137.67 55.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.538 2.335 . . . . 1.16 113.022 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.56 98.04 22.36 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.757 1.223 . . . . 0.75 111.34 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.63 3.68 5.21 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.29 3.326 . . . . 1.12 113.938 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -76.99 -16.27 59.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.287 1.435 . . . . 4.14 112.383 -176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.46 -179.52 4.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.985 2.114 . . . . 2.14 107.704 166.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -53.77 2.68 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.32 -0.862 . . . . 3.91 111.673 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -127.37 163.44 24.0 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.175 1.546 . . . . 2.17 115.175 -149.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tp -74.22 -34.99 63.85 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.595 -1.316 . . . . 2.15 111.977 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.42 -35.86 65.85 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.123 1.369 . . . . 3.41 113.698 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.33 -3.13 38.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.405 1.261 . . . . 1.63 114.405 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.48 7.94 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.483 1.038 . . . . 0.91 113.447 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.07 -10.67 4.56 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.278 1.955 . . . . 2.98 116.278 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -147.03 18.9 1.25 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.614 1.965 . . . . 3.52 111.537 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -101.45 -160.36 0.79 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.405 1.482 . . . . 1.55 112.274 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.47 160.71 39.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.081 1.352 . . . . 0.79 112.332 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 24' ' ' ILE . 19.8 mt -113.62 149.69 34.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.3 2.64 . . . . 1.9 108.093 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.5 mtt -137.59 128.13 26.67 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.524 1.056 . . . . 1.48 111.264 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.82 108.53 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.794 -1.187 . . . . 0.88 107.794 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -86.93 144.21 27.05 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.881 1.672 . . . . 2.29 113.142 -165.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.57 -43.6 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.099 -1.0 . . . . 1.26 112.035 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.38 172.0 25.98 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.914 -0.874 . . . . 1.08 110.914 162.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.53 160.85 6.13 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.063 1.316 . . . . 1.42 112.587 165.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -40.38 94.98 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.76 1.224 . . . . 3.46 114.14 -169.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.27 36.96 0.16 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 117.586 2.439 . . . . 2.85 117.586 -151.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -108.46 148.19 30.56 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.562 1.545 . . . . 2.64 112.372 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -149.48 -141.01 0.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.115 0.966 . . . . 3.51 111.125 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.36 111.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.677 2.391 . . . . 5.56 114.954 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -154.3 160.99 30.35 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.706 2.002 . . . . 3.29 109.461 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.78 12.51 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 124.522 3.482 . . . . 4.08 114.747 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -132.36 140.81 39.11 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.519 1.528 . . . . 5.44 110.151 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.47 151.61 82.0 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.983 3.122 . . . . 5.53 112.955 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.63 21.19 6.97 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.956 1.702 . . . . 4.99 113.415 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.93 80.81 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.531 1.062 . . . . 3.67 113.62 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.97 -48.66 3.05 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.454 1.502 . . . . 2.05 113.029 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.37 18.84 5.12 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.189 1.852 . . . . 1.71 114.956 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.28 -19.82 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.995 1.283 . . . . 1.6 114.098 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.7 p -66.31 145.41 55.76 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.683 1.593 . . . . 1.44 111.714 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.17 136.81 48.62 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.309 1.444 . . . . 4.69 110.276 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 27.1 t80 -75.63 -37.06 60.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 2.15 110.411 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.31 152.21 41.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.497 1.119 . . . . 0.74 112.861 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 52.1 t -121.42 147.79 45.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.792 2.037 . . . . 1.63 109.866 171.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -138.93 91.38 0.2 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.01 1.767 . . . . 0.83 111.704 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.29 135.13 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.918 1.287 . . . . 2.77 111.587 166.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mt -97.03 151.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 1.62 109.93 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 11.3 mmpt? . . . . . 0 N--CA 1.471 0.581 0 O-C-N 121.382 -0.824 . . . . 5.0 110.708 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.138 -0.69 . . . . 1.88 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 m -114.79 131.02 56.94 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.221 1.373 . . . . 1.3 112.897 -153.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.76 141.53 48.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.624 2.37 . . . . 2.96 107.191 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -120.47 86.3 2.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.937 -1.102 . . . . 3.32 110.82 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.11 118.68 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 121.6 -0.687 . . . . 1.02 109.672 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.92 104.01 1.02 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.142 1.354 . . . . 0.75 109.953 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 mtp -97.84 137.92 35.97 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.154 0.982 . . . . 1.35 110.735 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -129.38 147.35 51.19 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.922 0.889 . . . . 3.02 112.092 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.14 142.93 56.35 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.127 1.371 . . . . 1.48 109.58 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 m -142.13 161.44 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.316 1.046 . . . . 1.43 112.851 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t 155.65 124.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.756 2.822 . . . . 3.07 111.423 144.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.57 -37.69 0.38 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.439 2.696 . . . . 1.97 115.516 164.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -7.87 56.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.585 1.554 . . . . 4.3 111.367 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -149.48 18.1 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 125.478 1.513 . . . . 1.44 112.386 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.05 130.79 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.65 1.58 . . . . 1.53 110.558 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.8 -134.48 8.54 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 125.68 1.609 . . . . 2.33 113.351 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.83 153.49 24.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.162 2.185 . . . . 2.75 112.153 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -94.49 139.01 31.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.419 0.628 . . . . 1.32 112.02 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.7 10.63 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.764 1.626 . . . . 2.94 112.385 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 154.18 146.69 4.46 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.722 1.63 . . . . 0.62 111.265 -166.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.5 p -88.87 174.52 7.9 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.184 -1.043 . . . . 0.97 108.184 158.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.5 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 99.0 t -127.42 129.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.622 -1.251 . . . . 0.7 107.622 165.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.4 p -82.83 129.25 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.534 0.683 . . . . 1.08 109.824 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.46 109.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.501 -1.666 . . . . 1.35 106.501 169.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -116.0 108.28 16.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 123.098 1.427 . . . . 2.53 110.741 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.06 142.83 56.36 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 127.476 2.31 . . . . 4.14 111.707 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -154.7 177.01 11.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.535 1.16 . . . . 1.2 111.392 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.55 -25.24 66.01 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.991 0.916 . . . . 4.25 110.661 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.18 14.89 61.04 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.426 1.489 . . . . 0.98 115.949 166.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.03 -164.39 51.46 Favored Glycine 0 N--CA 1.47 0.929 0 C-N-CA 129.74 3.543 . . . . 0.89 115.095 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.35 104.56 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.445 1.498 . . . . 0.65 112.145 -168.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -82.37 104.16 12.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.159 0.983 . . . . 1.83 109.805 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.5 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 11.1 t80 -91.8 110.02 21.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.017 2.127 . . . . 0.73 109.567 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.407 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 12.0 m -122.32 115.04 30.21 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.836 1.198 . . . . 0.88 108.563 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.93 164.44 27.5 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.101 2.534 . . . . 0.58 110.867 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -160.03 51.39 0.32 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.316 1.055 . . . . 2.16 111.288 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 150.86 32.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.069 1.348 . . . . 0.74 112.013 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.27 38.39 3.13 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.221 1.934 . . . . 2.11 116.221 -160.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.76 12.0 0.59 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.483 2.031 . . . . 1.6 116.483 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.94 160.71 25.37 Favored Pre-proline 0 N--CA 1.477 0.896 0 N-CA-C 114.186 1.18 . . . . 1.35 114.186 -169.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.93 130.87 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.328 1.352 . . . . 0.82 112.708 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.66 48.08 2.07 Favored 'Trans proline' 0 C--N 1.35 0.653 1 C-N-CA 126.957 5.105 . . . . 0.97 112.755 -158.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.94 -140.09 7.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.414 1.563 . . . . 1.23 113.287 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.04 134.51 53.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.821 1.648 . . . . 2.84 108.534 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -139.88 125.21 18.94 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 125.157 1.383 . . . . 1.27 111.017 -162.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.79 154.78 9.11 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.642 -1.286 . . . . 0.52 112.457 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.38 127.51 29.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.958 1.303 . . . . 1.93 107.719 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.408 ' CD2' ' HA ' ' A' ' 93' ' ' ASP . 50.3 m170 -121.92 169.77 10.47 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 117.027 2.232 . . . . 1.04 117.027 168.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.16 138.79 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.508 1.923 . . . . 0.74 109.254 152.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.14 164.94 16.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.217 2.607 . . . . 0.99 110.602 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.86 -62.79 1.42 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.697 1.369 . . . . 1.47 114.697 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 -97.6 146.93 24.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.652 0.612 . . . . 1.59 112.652 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.74 62.83 2.38 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.634 1.111 . . . . 0.88 112.322 168.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -149.73 77.73 1.34 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.72 1.208 . . . . 2.66 112.589 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.0 m -64.16 9.42 0.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 116.331 1.974 . . . . 1.32 116.331 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -72.44 151.71 91.87 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 119.743 -1.848 . . . . 3.69 112.53 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.0 152.15 67.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.257 2.638 . . . . 1.77 111.316 171.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.68 147.79 22.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.546 0.738 . . . . 3.2 110.914 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mm -86.45 104.64 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.528 -0.916 . . . . 4.71 108.528 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -162.34 138.96 7.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.265 1.026 . . . . 7.67 109.909 -157.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t0 51.27 35.79 14.48 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 6.45 113.85 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.61 11.0 85.88 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.527 -1.151 . . . . 3.91 115.323 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -150.31 169.3 21.71 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.07 1.935 . . . . 3.07 113.24 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.77 94.95 8.81 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.838 0.855 . . . . 2.3 109.873 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.54 88.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.746 0.818 . . . . 2.93 111.593 -170.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 55.69 -86.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.245 2.618 . . . . 2.06 115.025 159.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.73 99.04 0.31 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.748 2.819 . . . . 2.72 107.253 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -149.34 -17.46 0.28 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.284 1.216 . . . . 7.02 114.284 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.04 -9.22 4.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.661 1.184 . . . . 1.72 113.55 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 2.65 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.185 2.194 . . . . 0.92 113.671 164.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 16.29 26.93 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.563 1.554 . . . . 3.04 114.255 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -114.6 4.86 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.248 -1.541 . . . . 3.23 109.248 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -97.35 -101.67 0.19 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.983 1.313 . . . . 3.86 107.652 158.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.9 tp -160.95 79.45 0.61 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.228 2.211 . . . . 1.96 106.759 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.74 68.97 63.07 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.772 -1.104 . . . . 4.98 111.111 -152.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.04 -44.93 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.821 2.347 . . . . 2.02 113.6 -168.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -154.87 -151.71 0.37 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.287 1.835 . . . . 4.65 108.916 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 75.23 -60.82 0.5 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.551 2.74 . . . . 4.43 112.84 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 177.29 -19.45 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.927 2.491 . . . . 2.57 113.328 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.73 49.17 76.46 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.039 1.29 . . . . 2.88 114.896 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -143.96 18.29 1.78 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.662 1.727 . . . . 4.66 115.662 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.8 t60 90.05 173.24 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.52 2.328 . . . . 2.73 112.871 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -162.1 51.91 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.897 1.279 . . . . 4.88 110.136 -161.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.01 -47.95 1.29 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-O 117.973 -1.459 . . . . 2.81 114.997 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -103.43 -23.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.179 3.253 . . . . 4.27 113.831 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.97 172.99 1.57 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.793 2.437 . . . . 5.75 108.758 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.19 -159.05 32.13 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.064 0.84 . . . . 3.89 113.516 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -153.52 28.71 0.49 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 6.47 112.245 -168.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.18 16.65 60.87 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.105 -2.497 . . . . 3.53 117.698 -165.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.708 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 2.6 t-160 170.06 99.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 128.396 2.678 . . . . 5.05 111.059 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.49 2.79 2.78 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.578 1.696 . . . . 2.02 115.578 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.531 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -102.42 3.97 50.83 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.322 1.439 . . . . 0.81 113.459 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.708 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 64.3 m-20 -71.93 137.09 47.12 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.525 1.162 . . . . 1.66 109.619 165.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.86 169.04 11.06 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.762 1.225 . . . . 1.88 109.915 -144.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.52 157.8 55.36 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.714 2.276 . . . . 1.03 111.866 -172.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.8 125.23 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.227 1.011 . . . . 2.42 109.85 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.39 114.34 3.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 128.365 2.666 . . . . 2.54 109.872 168.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.87 143.32 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 120.966 -1.083 . . . . 0.92 108.628 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -123.2 124.61 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 106.261 -1.755 . . . . 1.7 106.261 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.7 152.91 41.21 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.06 0.845 . . . . 1.89 111.933 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -4.24 0.05 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 117.539 2.422 . . . . 2.23 117.539 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.06 4.42 10.89 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.793 1.637 . . . . 3.03 114.016 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.52 16.51 17.68 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 116.226 1.25 . . . . 0.74 116.226 166.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.65 134.08 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.128 1.371 . . . . 1.11 107.932 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.22 120.68 40.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.331 0.652 . . . . 0.69 109.352 168.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -132.21 2.81 3.94 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.135 1.774 . . . . 1.22 112.745 172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -82.89 117.76 69.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.687 1.995 . . . . 5.1 111.983 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.33 147.27 18.05 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.475 2.783 . . . . 1.25 113.473 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.29 176.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.515 1.926 . . . . 1.17 109.83 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.8 m -139.73 140.83 36.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.069 0.947 . . . . 0.66 110.142 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.72 91.48 6.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.24 1.016 . . . . 0.73 110.56 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.29 -8.92 24.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.818 3.012 . . . . 1.46 115.006 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -58.96 -29.17 66.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.178 1.391 . . . . 4.16 113.751 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.52 164.98 11.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.131 1.772 . . . . 2.29 110.389 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.95 24.6 0.5 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.596 1.558 . . . . 4.13 114.109 -170.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -178.57 148.5 0.45 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.441 2.296 . . . . 1.81 112.507 170.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.75 -27.5 69.32 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.53 -1.356 . . . . 1.58 111.269 166.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.44 -16.14 0.32 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.299 2.24 . . . . 2.82 114.062 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -9.24 40.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.366 1.466 . . . . 1.93 113.733 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.5 m -130.19 11.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.552 1.541 . . . . 1.07 113.134 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -62.59 -3.36 1.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.494 2.405 . . . . 2.54 117.494 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.27 29.93 0.78 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.358 1.863 . . . . 2.97 110.726 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -121.82 175.02 6.5 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.825 1.65 . . . . 1.42 113.038 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.01 149.2 43.03 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.501 1.12 . . . . 0.56 111.782 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.43 170.42 16.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.041 1.336 . . . . 2.36 109.241 158.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 44.9 ttm -151.19 124.96 9.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.37 -0.831 . . . . 2.31 111.454 163.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.5 120.98 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.164 -1.05 . . . . 0.91 108.164 167.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -105.13 148.49 26.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.869 2.068 . . . . 1.9 112.007 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.35 -25.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.718 -1.239 . . . . 1.19 113.209 -162.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -129.28 162.55 22.64 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.135 0.874 . . . . 1.05 111.55 168.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.82 144.94 47.56 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.357 0.98 . . . . 1.58 113.081 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -97.95 -8.86 27.19 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.992 1.849 . . . . 2.66 115.992 -147.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -59.96 -25.61 65.34 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.939 1.296 . . . . 3.87 113.407 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 76.4 mtm -82.11 61.64 5.47 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 3.39 113.899 -167.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.6 p -91.82 -147.47 0.22 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.655 -1.278 . . . . 3.4 110.846 156.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t0 58.35 42.25 21.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.456 1.502 . . . . 4.56 112.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.92 156.51 5.96 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.509 1.924 . . . . 3.49 109.64 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.25 -19.2 22.73 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.116 2.544 . . . . 2.78 114.327 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.59 119.91 76.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.216 1.371 . . . . 7.97 109.903 167.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.85 118.8 5.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.504 2.136 . . . . 4.45 110.179 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 56.64 27.12 12.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.182 1.393 . . . . 4.1 112.186 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.07 17.52 63.56 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 121.042 -1.036 . . . . 3.51 113.333 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.07 3.78 75.7 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.6 1.571 . . . . 2.98 114.367 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.28 -5.91 75.35 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.252 1.526 . . . . 2.02 114.845 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.43 -12.0 80.04 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.235 1.398 . . . . 1.68 115.326 -170.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.67 161.6 5.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.069 1.348 . . . . 1.64 110.152 164.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 136.15 40.31 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 4.57 112.65 -169.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -101.04 -25.63 13.99 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.261 1.424 . . . . 2.46 113.294 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.73 144.09 22.31 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.466 2.024 . . . . 0.71 116.466 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.76 170.29 14.92 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.209 3.403 . . . . 2.88 112.186 165.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 179.94 83.15 0.06 OUTLIER Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.884 1.706 . . . . 0.71 112.41 166.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.94 130.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 118.026 0.913 . . . . 1.43 110.704 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 27.3 mt -102.9 140.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.52 1.528 . . . . 1.31 111.377 -169.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 mptt . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 124.774 1.23 . . . . 3.41 108.733 161.581 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 119.424 -0.322 . . . . 2.2 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.73 154.39 33.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 118.984 -2.323 . . . . 1.16 116.995 -141.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.07 138.97 18.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.68 -1.6 . . . . 3.43 111.328 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.81 113.82 27.08 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.803 -1.186 . . . . 4.58 112.03 176.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.8 t -88.63 118.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.551 -0.537 . . . . 1.17 109.551 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.34 103.09 2.36 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.152 1.358 . . . . 1.11 110.323 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 41.8 mtt -81.85 148.83 28.62 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.439 0.904 . . . . 1.21 113.439 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -114.23 151.52 32.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 2.47 110.134 167.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 mt -64.49 144.44 57.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.853 0.861 . . . . 1.17 109.112 171.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 m -133.69 149.32 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.2 0.6 . . . . 1.05 111.36 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -174.55 53.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.143 0.977 . . . . 2.37 112.53 -168.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.49 -14.21 0.42 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.051 1.74 . . . . 1.13 115.094 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.15 -9.9 58.97 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.363 -0.836 . . . . 3.3 110.994 160.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -129.69 9.39 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.517 -1.433 . . . . 1.03 109.517 -163.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.7 t -74.33 126.9 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.925 1.69 . . . . 0.81 111.299 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.34 -135.53 8.93 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.066 1.793 . . . . 1.45 112.554 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.93 164.11 12.86 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.983 -0.716 . . . . 1.78 111.784 173.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.0 t -100.1 152.0 20.74 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.309 1.044 . . . . 0.95 112.757 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.428 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 1.4 pp -144.21 4.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 128.178 2.591 . . . . 2.86 113.495 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.53 170.69 27.71 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.205 1.383 . . . . 0.68 114.266 172.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -109.74 177.66 4.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.989 1.316 . . . . 0.87 109.889 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.83 131.84 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.736 -1.209 . . . . 0.41 107.736 158.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 9.0 p -85.89 123.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 123.579 0.549 . . . . 0.87 110.377 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mt -105.38 126.08 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 125.858 1.663 . . . . 1.4 107.884 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -135.5 107.62 7.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.413 1.085 . . . . 2.08 109.958 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -74.07 144.08 45.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.613 0.765 . . . . 3.6 112.043 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -159.94 -174.58 4.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.708 1.203 . . . . 1.28 109.751 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.34 -26.51 65.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.627 1.571 . . . . 3.17 112.75 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.94 13.86 65.81 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 124.851 1.215 . . . . 0.92 114.754 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.95 -147.02 32.94 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 127.396 2.427 . . . . 0.74 114.399 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.4 mt -76.26 99.46 4.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.986 0.915 . . . . 0.59 112.017 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -77.69 114.16 16.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.13 1.372 . . . . 2.13 110.397 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.73 116.79 32.63 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.485 2.314 . . . . 0.63 109.896 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.9 m -122.49 115.17 29.93 Favored Pre-proline 0 N--CA 1.477 0.875 0 CA-C-O 118.278 -0.868 . . . . 0.57 108.755 176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.22 162.86 4.67 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.91 3.073 . . . . 0.41 112.007 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -151.32 33.31 0.57 Allowed 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.12 0.962 . . . . 1.43 112.606 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -95.75 150.05 20.82 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.911 1.684 . . . . 0.73 113.903 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.5 162.37 24.13 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.516 1.526 . . . . 3.09 109.217 174.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.28 21.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.933 2.893 . . . . 1.86 113.789 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -106.57 155.87 38.1 Favored Pre-proline 0 CA--C 1.51 -0.576 0 C-N-CA 123.857 0.863 . . . . 2.06 112.442 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.56 140.36 47.28 Favored 'Trans proline' 0 N--CA 1.427 -2.385 0 O-C-N 123.269 1.142 . . . . 1.14 111.625 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 99' ' ' VAL . 12.2 Cg_endo -88.26 32.01 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.839 2.359 . . . . 1.34 114.568 -148.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 99' ' ' VAL . . . -106.89 -147.35 14.02 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.532 1.073 . . . . 1.19 113.912 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -81.57 131.51 35.28 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.964 -1.315 . . . . 2.53 110.592 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -102.66 135.53 44.14 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.243 -1.021 . . . . 1.76 108.243 164.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.55 161.7 21.58 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.852 -0.899 . . . . 0.83 110.852 166.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -146.84 122.34 10.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.915 -1.143 . . . . 2.04 107.915 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -126.8 167.65 15.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.207 1.188 . . . . 0.96 114.207 159.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.32 145.66 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.08 1.352 . . . . 1.45 107.721 152.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -123.92 158.64 31.51 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.202 1.401 . . . . 0.85 110.969 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.42 69.03 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.465 1.654 . . . . 0.66 115.465 -163.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -126.48 -174.58 3.16 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.357 1.463 . . . . 1.15 112.195 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.97 30.52 5.03 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 117.776 1.87 . . . . 1.27 117.776 -156.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.6 m -159.06 114.4 2.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 121.692 2.746 . . . . 2.47 115.0 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.3 m -68.83 76.93 0.31 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.385 1.564 . . . . 2.74 112.644 167.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -116.56 134.38 22.89 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 124.981 1.312 . . . . 3.82 109.134 167.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.11 144.63 21.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.293 2.662 . . . . 1.14 110.18 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.91 131.51 42.31 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.08 -0.711 . . . . 1.49 109.08 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.4 mm -99.15 110.0 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.952 -1.129 . . . . 3.51 107.952 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -166.81 154.51 9.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 6.65 111.003 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t70 41.31 54.86 3.45 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.527 1.531 . . . . 4.2 114.853 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.11 87.75 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.722 -1.599 . . . . 2.69 115.653 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -153.67 171.89 18.12 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.462 2.131 . . . . 2.7 114.161 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 114.59 26.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.215 1.406 . . . . 2.12 109.565 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.33 74.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.482 1.113 . . . . 1.93 111.02 -172.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.7 -73.51 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.257 2.623 . . . . 2.17 116.328 161.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.78 69.23 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 130.801 3.64 . . . . 1.84 107.308 -165.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.26 -42.51 14.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.302 1.441 . . . . 4.5 112.236 -165.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.17 5.99 1.46 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.866 1.432 . . . . 1.31 114.866 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.74 66.1 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.362 1.065 . . . . 1.02 112.526 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.23 -175.42 51.28 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 119.497 1.044 . . . . 2.36 113.066 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.2 170.43 37.95 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.805 1.193 . . . . 1.32 113.298 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.618 ' CD2' ' H ' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -78.22 38.67 0.29 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.036 2.134 . . . . 3.28 112.385 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.4 tp 56.73 72.59 0.5 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.132 2.573 . . . . 1.64 110.213 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 39.2 p-10 -153.14 5.95 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 118.17 2.656 . . . . 4.54 118.17 -140.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 68.3 Cg_endo -70.39 -26.72 24.3 Favored 'Trans proline' 0 C--N 1.358 1.063 0 CA-C-N 123.906 2.431 . . . . 3.18 116.151 -162.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.67 138.14 19.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.4 1.454 . . . . 2.93 111.043 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 p30 161.61 -159.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 129.676 3.19 . . . . 4.73 109.381 -161.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 t -72.74 -14.12 61.48 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.625 1.342 . . . . 4.62 114.625 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.83 -58.38 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.946 1.26 . . . . 3.58 113.124 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttt -69.32 163.89 24.09 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.963 1.381 . . . . 6.25 113.754 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.34 137.31 55.94 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.201 -0.937 . . . . 1.53 111.252 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -76.17 156.04 34.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.153 0.581 . . . . 3.5 112.064 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.2 -157.15 27.13 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.178 1.371 . . . . 2.6 112.149 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.14 -23.8 28.67 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.169 2.58 . . . . 4.29 111.938 172.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -153.59 176.43 12.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.873 2.069 . . . . 7.91 108.626 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.43 -126.63 7.97 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.074 -1.21 . . . . 3.38 110.074 -165.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -165.95 157.16 13.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.006 0.903 . . . . 4.75 110.133 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.533 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . 166.31 -137.13 4.49 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.833 2.635 . . . . 2.69 110.669 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -90.9 136.03 33.34 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.781 -0.835 . . . . 4.39 112.378 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.53 -33.25 75.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.44 -0.788 . . . . 1.87 113.064 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.52 6.13 83.02 Favored Glycine 0 N--CA 1.474 1.18 0 N-CA-C 115.717 1.047 . . . . 0.79 115.717 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -67.98 130.18 42.17 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 118.772 1.286 . . . . 1.8 109.075 161.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.82 161.93 40.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.477 1.511 . . . . 1.89 110.327 -151.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.31 144.86 20.92 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.427 2.751 . . . . 0.99 111.63 -168.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.18 132.45 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.612 1.196 . . . . 1.47 113.533 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.87 81.76 1.65 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.807 2.443 . . . . 1.67 109.37 169.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.87 131.78 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.421 -0.799 . . . . 1.16 109.657 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.6 HG23 ' HA ' ' A' ' 42' ' ' PRO . 19.1 m -111.51 153.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.253 1.021 . . . . 2.04 108.48 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.04 159.36 33.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.732 -0.605 . . . . 2.04 111.93 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -49.09 -19.32 0.41 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.173 2.189 . . . . 3.88 115.865 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.12 8.1 32.02 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 127.83 2.452 . . . . 4.58 112.117 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.48 23.81 15.51 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 117.582 1.793 . . . . 1.16 117.582 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -139.55 134.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.961 1.305 . . . . 1.21 111.29 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.85 118.65 26.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.306 2.242 . . . . 0.76 110.786 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 t -146.94 -3.88 0.57 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.266 1.209 . . . . 1.4 114.266 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.73 118.61 72.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.335 1.454 . . . . 3.29 112.219 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.79 125.82 11.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.262 3.308 . . . . 1.11 110.227 170.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 175.11 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.581 1.552 . . . . 1.22 109.946 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 m -148.4 140.04 23.65 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.303 0.956 . . . . 0.7 110.049 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.23 96.12 29.09 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.55 1.14 . . . . 0.73 111.636 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.32 7.87 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.254 3.303 . . . . 1.15 114.391 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -81.72 -23.65 36.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.32 1.448 . . . . 4.12 111.6 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.81 139.32 48.85 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.881 1.673 . . . . 2.47 107.863 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -107.1 -21.29 13.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 115.204 1.557 . . . . 3.74 115.204 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.5 t -152.96 155.07 36.27 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.942 1.246 . . . . 1.9 114.005 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -57.39 -32.3 66.68 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.131 0.572 . . . . 1.57 112.433 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -64.08 -14.66 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.03 1.493 . . . . 3.26 115.03 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -72.49 -20.28 61.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.217 0.917 . . . . 2.11 112.252 167.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.43 10.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.223 1.409 . . . . 0.81 113.96 -163.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -46.39 -20.84 0.13 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.02 2.928 . . . . 4.29 116.578 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -117.92 9.11 12.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.201 2.6 . . . . 4.58 113.221 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.5 168.14 12.97 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.493 1.294 . . . . 1.2 114.493 -160.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.82 158.31 24.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.997 1.319 . . . . 1.04 111.565 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.08 150.86 39.29 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.664 1.586 . . . . 1.76 108.967 172.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.28 139.64 50.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.063 0.764 . . . . 2.24 113.063 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.75 104.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.936 -1.505 . . . . 0.9 106.936 159.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.93 150.05 34.1 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.929 2.091 . . . . 1.85 111.65 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.67 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.859 -1.151 . . . . 1.71 112.648 -163.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.7 170.97 14.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.119 1.342 . . . . 1.59 111.187 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.49 151.03 50.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.576 1.084 . . . . 1.79 113.072 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.16 -21.43 11.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.094 1.516 . . . . 3.2 115.094 -152.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -75.44 8.52 2.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.468 1.655 . . . . 3.3 115.468 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -81.22 55.54 2.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.976 1.311 . . . . 3.22 111.197 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -81.79 33.98 0.39 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.962 2.505 . . . . 3.94 115.211 -163.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.19 19.37 7.61 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.665 1.586 . . . . 5.91 113.033 -163.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -147.47 154.61 45.29 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.927 1.691 . . . . 3.5 110.525 -167.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.09 7.29 2.14 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.046 3.164 . . . . 2.62 114.241 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 139' ' ' LYS . 8.7 mmpt? -107.12 99.77 28.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.021 1.328 . . . . 5.29 108.666 169.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.92 166.69 26.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.234 2.623 . . . . 3.19 111.949 -170.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt 64.83 27.18 12.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.269 1.428 . . . . 3.71 111.878 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.7 1.62 31.91 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.741 1.639 . . . . 3.39 114.7 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.49 -15.18 60.76 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.778 1.18 . . . . 2.27 113.063 -162.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.96 24.8 3.23 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.198 1.856 . . . . 1.66 113.678 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.62 -15.98 73.69 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.116 1.341 . . . . 1.42 115.246 -169.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 p -69.01 147.39 51.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.554 1.177 . . . . 1.62 110.035 167.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 131.93 47.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 4.41 109.818 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -81.94 -44.13 17.17 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.214 0.605 . . . . 2.31 109.554 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.29 155.76 45.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.294 1.038 . . . . 0.67 112.717 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 41.0 t -143.52 151.23 40.01 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.136 2.175 . . . . 1.29 111.331 -174.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.68 149.59 18.31 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.739 1.161 . . . . 1.02 113.842 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.98 149.09 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.1 1.76 . . . . 2.51 112.36 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.33 147.11 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.492 1.917 . . . . 0.96 111.923 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.744 0 C-N-CA 126.455 1.902 . . . . 4.34 109.683 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 109.115 -0.698 . . . . 1.96 109.115 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -122.38 143.21 49.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.593 1.542 . . . . 1.25 114.454 -148.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -154.76 147.55 24.4 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.493 . . . . 3.04 109.584 168.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.43 77.16 1.77 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.679 1.592 . . . . 5.14 112.671 -160.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.17 112.19 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 120.55 -1.344 . . . . 1.13 111.377 -162.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.32 101.58 0.52 Allowed Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.878 2.18 . . . . 0.69 111.476 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.2 mmm -79.93 126.15 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.833 1.253 . . . . 1.39 111.133 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -105.56 149.26 26.42 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.786 1.279 . . . . 2.6 112.973 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.71 65.66 1.37 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.371 2.268 . . . . 1.38 111.619 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 15' ' ' VAL . 1.5 m -73.12 141.82 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.767 0.827 . . . . 1.21 111.005 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -148.72 -159.57 1.05 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.889 -1.05 . . . . 2.68 109.049 171.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.06 -3.0 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.491 1.516 . . . . 1.72 112.382 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 8.92 44.07 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.965 1.706 . . . . 3.07 111.633 171.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 -164.69 26.73 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 125.047 1.308 . . . . 1.43 112.835 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.416 ' HA ' HG12 ' A' ' 10' ' ' VAL . 99.0 t -65.94 126.51 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.629 1.171 . . . . 1.13 110.774 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.87 -137.23 9.45 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 125.577 1.56 . . . . 1.83 113.355 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.32 150.91 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.685 1.594 . . . . 2.35 112.546 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -79.45 145.76 33.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.469 0.708 . . . . 1.26 110.222 161.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.37 3.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.313 1.845 . . . . 3.11 114.091 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.77 163.85 14.66 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.808 1.671 . . . . 0.72 112.717 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -96.24 158.87 15.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.142 -0.688 . . . . 0.96 109.142 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.4 t -105.15 132.46 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.352 -1.351 . . . . 0.48 107.352 152.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 12.2 p -87.3 128.22 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.311 0.577 . . . . 0.87 110.536 172.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 126.46 1.904 . . . . 1.41 107.714 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -131.83 112.57 12.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.048 0.928 . . . . 1.91 111.198 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 137.49 57.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 128.25 2.62 . . . . 4.19 112.463 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 29' ' ' GLY 0.312 14.8 t -151.2 161.84 41.98 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 124.543 2.116 . . . . 1.2 111.064 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -21.23 -41.19 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.573 -2.558 . . . . 3.63 115.266 146.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 27' ' ' THR . . . -100.5 12.05 59.76 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 126.035 1.779 . . . . 0.85 117.012 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.36 -152.0 23.94 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 130.225 3.774 . . . . 0.72 114.708 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.51 102.59 4.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.281 -1.129 . . . . 0.59 111.45 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -76.43 115.96 16.66 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.313 -0.867 . . . . 1.69 109.882 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -105.69 110.54 22.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.477 2.311 . . . . 0.51 109.623 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.408 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 11.8 m -114.47 110.27 47.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 119.79 1.177 . . . . 0.59 108.095 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.61 152.68 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.382 2.722 . . . . 0.7 110.89 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 40.4 0.77 Allowed 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.168 1.461 . . . . 2.35 111.231 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mp -103.54 141.7 35.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.539 1.936 . . . . 0.92 112.977 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HE3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -103.33 160.08 15.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.451 -1.249 . . . . 3.35 109.805 170.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 97.69 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.521 2.728 . . . . 1.42 115.099 160.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -98.75 156.24 35.81 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 118.886 0.766 . . . . 1.59 111.86 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.82 136.45 57.53 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.915 1.744 . . . . 0.99 110.589 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 99' ' ' VAL . 21.8 Cg_endo -86.97 34.58 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.564 2.843 . . . . 1.17 114.736 -151.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.62 -140.84 11.62 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.729 1.157 . . . . 1.25 114.072 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -120.3 153.93 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.795 -0.826 . . . . 3.18 110.414 165.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -138.23 133.69 33.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.615 0.766 . . . . 0.91 110.203 -163.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 163.44 23.77 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 111.015 -0.834 . . . . 0.68 111.015 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' CE1' HD13 ' A' ' 94' ' ' LEU . 4.6 t80 -135.95 132.25 36.17 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 106.086 -1.82 . . . . 1.86 106.086 172.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.61 ' HA ' HD12 ' A' ' 94' ' ' LEU . 5.3 m170 -137.85 158.24 44.76 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.149 -0.97 . . . . 0.9 112.815 168.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.54 142.85 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 127.42 2.288 . . . . 0.86 108.006 163.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -123.28 156.38 35.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.077 1.351 . . . . 0.83 110.663 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.75 78.73 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.974 1.842 . . . . 0.63 115.974 -159.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -116.33 -177.66 3.23 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.576 1.55 . . . . 1.07 111.483 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.81 97.49 0.31 Allowed Glycine 0 N--CA 1.47 0.902 0 O-C-N 120.769 -1.207 . . . . 0.93 113.441 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 t 173.87 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.605 2.362 . . . . 2.17 109.638 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.5 m -70.11 31.15 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 115.976 1.843 . . . . 1.31 115.976 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -84.54 124.91 72.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 119.724 -1.86 . . . . 4.08 111.158 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.07 144.27 13.29 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.307 2.671 . . . . 0.96 111.253 173.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.2 153.75 29.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.997 0.519 . . . . 1.57 110.583 164.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.03 132.25 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.984 -1.072 . . . . 2.21 111.07 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.21 172.95 11.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.275 2.63 . . . . 4.89 110.055 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -47.4 114.06 0.81 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.663 1.185 . . . . 5.15 112.406 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.13 6.47 53.38 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.986 -1.452 . . . . 3.95 115.715 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.93 129.14 10.48 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.809 2.304 . . . . 3.63 114.378 -167.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.86 117.56 30.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.984 0.914 . . . . 1.52 108.826 165.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.37 74.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.224 1.81 . . . . 1.97 111.172 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.43 -73.58 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.863 2.865 . . . . 2.5 115.864 164.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.48 38.09 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 130.023 3.329 . . . . 2.46 109.332 -166.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.6 -25.49 62.69 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.293 1.22 . . . . 4.1 114.293 -167.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -13.09 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.034 1.288 . . . . 1.3 113.908 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.82 -4.24 57.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.63 1.572 . . . . 1.25 113.02 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 -179.98 53.11 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.787 -1.196 . . . . 2.57 114.22 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.89 -179.3 48.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.99 0.805 . . . . 1.15 111.631 166.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.402 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 24.1 m170 -53.67 137.79 36.47 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 118.585 -0.721 . . . . 2.19 109.812 172.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.402 HD13 ' HE2' ' A' ' 123' ' ' LYS . 59.8 tp -59.76 116.46 4.08 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.818 0.736 . . . . 1.59 111.642 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -149.32 101.79 3.33 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.81 2.044 . . . . 4.11 109.207 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.36 -46.43 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.639 1.559 . . . . 3.31 111.111 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -164.16 13.91 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.794 2.038 . . . . 3.29 113.083 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -56.87 -39.62 74.67 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.2 -1.562 . . . . 3.33 113.543 -170.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t 146.11 -28.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 1 C-N-CA 132.069 4.148 . . . . 3.1 111.201 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.73 58.14 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 117.016 1.566 . . . . 2.27 117.016 162.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.85 -67.31 0.79 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.536 1.668 . . . . 7.73 112.449 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 t60 171.69 157.54 0.09 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.811 2.844 . . . . 1.68 111.549 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.65 133.28 32.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.743 1.217 . . . . 4.23 108.69 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.51 -95.29 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 109.404 -1.478 . . . . 2.93 109.404 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.76 29.46 0.41 Allowed 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 124.589 3.526 . . . . 3.21 112.631 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -146.23 -179.63 6.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.433 1.893 . . . . 5.55 109.457 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.15 107.21 0.7 Allowed Glycine 0 N--CA 1.472 1.061 0 N-CA-C 109.095 -1.602 . . . . 3.72 109.095 164.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -168.84 -5.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.059 1.503 . . . . 5.84 115.059 -149.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -34.98 0.02 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 118.105 2.002 . . . . 3.13 118.105 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.49 115.22 3.39 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.201 2.0 . . . . 3.69 110.831 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.02 -11.35 7.95 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.479 1.659 . . . . 2.02 115.479 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.01 -0.16 89.23 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.963 -1.465 . . . . 0.82 116.094 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.402 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 67.7 m-20 -85.09 134.86 34.18 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 120.5 2.15 . . . . 1.5 112.673 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 48' ' ' HIS . 1.8 mt -123.95 160.78 50.27 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.596 1.558 . . . . 2.66 112.065 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.06 162.23 43.37 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.749 2.966 . . . . 1.01 112.247 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 132' ' ' ASP . 27.4 m -79.08 127.88 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 123.355 1.55 . . . . 1.48 114.56 -162.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.07 82.25 5.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.87 2.868 . . . . 1.97 109.492 174.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.26 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.071 -1.018 . . . . 1.42 109.29 171.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 42' ' ' PRO . 25.4 m -125.89 157.96 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.347 1.059 . . . . 2.0 110.077 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.16 159.46 27.41 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.895 1.072 . . . . 2.26 113.895 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -49.67 -20.57 0.83 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 127.502 2.321 . . . . 4.1 117.148 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.13 0.92 27.89 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.211 1.559 . . . . 3.97 115.211 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.99 42.25 2.67 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 116.0 1.16 . . . . 1.01 116.0 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.89 135.46 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.878 1.271 . . . . 1.05 109.522 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.32 118.1 31.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.572 1.949 . . . . 0.69 109.238 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -156.54 21.61 0.34 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.737 1.384 . . . . 1.83 114.737 -167.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -134.83 143.48 46.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.149 1.779 . . . . 4.37 108.785 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -85.13 162.48 11.54 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.191 3.261 . . . . 1.47 114.362 -170.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.45 172.17 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 126.315 1.846 . . . . 1.26 109.722 166.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -141.39 146.5 36.68 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 119.925 1.239 . . . . 0.88 111.097 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.72 87.06 3.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.832 1.253 . . . . 0.86 113.961 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.5 2.1 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.481 2.787 . . . . 1.32 114.732 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -76.86 -11.27 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.695 1.134 . . . . 5.27 111.673 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.31 164.87 13.88 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.005 2.122 . . . . 2.33 110.711 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -152.08 11.09 0.54 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.528 1.931 . . . . 4.21 114.187 173.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -159.18 149.3 19.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.324 -1.485 . . . . 1.78 113.716 163.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -57.49 -24.53 56.39 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.084 -1.01 . . . . 1.73 111.38 162.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -52.03 -31.74 31.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.212 1.005 . . . . 3.01 112.768 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.032 1.333 . . . . 2.37 112.399 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.04 11.27 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.086 1.354 . . . . 0.97 113.539 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.3 pttt -61.54 7.14 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.984 2.587 . . . . 2.74 117.984 -171.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -156.33 22.19 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.48 1.912 . . . . 3.5 111.748 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HE2' HD13 ' A' ' 74' ' ' LEU . 57.9 mttp -113.34 170.53 8.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.846 1.259 . . . . 1.17 114.31 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.08 150.3 23.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.609 1.164 . . . . 0.57 112.372 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.4 145.27 40.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.864 2.066 . . . . 1.56 107.585 165.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -130.65 136.56 48.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.824 0.738 . . . . 2.04 112.179 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 88.3 mt -94.26 124.37 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.518 -1.29 . . . . 0.81 107.518 167.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -120.29 143.1 48.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.319 1.048 . . . . 1.85 112.485 -156.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.25 -37.59 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.898 -1.126 . . . . 1.18 112.983 -153.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.9 141.06 16.63 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.78 0.705 . . . . 1.12 112.141 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -47.43 134.45 14.05 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 126.01 1.767 . . . . 2.15 112.109 164.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.43 ' H ' HG12 ' A' ' 96' ' ' VAL . 4.4 t70 -76.11 1.72 14.88 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.22 1.408 . . . . 2.9 113.001 -167.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -66.29 -1.47 3.41 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 119.727 -1.858 . . . . 4.77 114.24 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 ptp -93.07 10.35 31.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.288 1.835 . . . . 3.67 114.149 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.4 p -47.83 -21.96 0.49 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.812 2.152 . . . . 4.35 116.812 -171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.44 -10.42 59.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.089 2.956 . . . . 7.99 115.618 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -53.01 148.64 13.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 114.276 1.213 . . . . 4.2 114.276 -166.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.36 30.59 0.34 Allowed 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.361 3.374 . . . . 3.12 112.234 170.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 140.32 35.26 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.544 1.538 . . . . 4.47 109.19 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.71 162.26 32.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.416 2.744 . . . . 3.45 112.965 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 71.6 mt 64.39 16.08 9.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.778 1.631 . . . . 4.93 114.033 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.03 12.08 58.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.065 1.317 . . . . 4.78 114.955 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.33 -64.35 3.79 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.889 1.345 . . . . 2.97 112.992 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.17 0.45 31.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.906 1.241 . . . . 2.09 114.949 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.1 9.44 12.37 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.703 2.097 . . . . 2.13 116.071 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.0 p -69.04 146.95 52.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.744 1.772 . . . . 1.96 108.996 161.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 143.18 27.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.036 -1.04 . . . . 5.52 112.942 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.412 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 23.8 t80 -102.2 -26.54 13.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.196 0.598 . . . . 2.19 111.849 158.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.96 149.18 28.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.653 -0.654 . . . . 0.52 112.664 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.2 t -120.32 144.07 48.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.097 2.159 . . . . 1.46 109.714 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -139.43 104.51 0.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 126.341 1.924 . . . . 0.66 111.18 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -83.0 130.37 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.339 1.069 . . . . 1.72 110.334 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.74 133.45 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.144 1.378 . . . . 0.91 110.677 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 125.863 1.665 . . . . 4.55 108.576 176.466 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.187 -0.301 . . . . 2.22 110.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.78 159.63 40.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.786 1.773 . . . . 1.49 115.786 -151.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -148.37 136.95 21.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.476 1.511 . . . . 2.95 109.459 159.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -83.41 103.63 12.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.429 1.092 . . . . 3.61 112.031 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.8 t -79.02 114.36 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.253 -0.904 . . . . 1.14 109.079 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.44 105.57 1.81 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.25 1.405 . . . . 0.73 111.425 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.7 mmm -84.13 122.42 28.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.712 1.205 . . . . 1.71 111.365 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.16 151.79 23.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.756 0.789 . . . . 2.44 111.185 166.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.52 136.31 57.97 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.083 0.953 . . . . 1.33 109.706 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.53 140.59 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.393 -0.965 . . . . 1.24 108.393 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 t -151.44 17.61 0.72 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.597 0.759 . . . . 2.76 111.85 -165.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.61 -21.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.538 2.335 . . . . 1.33 113.371 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -71.8 28.18 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 119.879 1.218 . . . . 4.01 111.985 163.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -174.78 52.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.562 2.029 . . . . 1.24 113.201 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.67 119.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.178 0.991 . . . . 1.45 108.608 153.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.04 -69.37 1.02 Allowed Glycine 0 N--CA 1.466 0.638 0 CA-C-O 122.159 0.866 . . . . 1.53 114.129 -170.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 153.88 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.106 1.363 . . . . 2.38 109.537 -165.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -89.59 152.61 21.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.271 1.428 . . . . 1.2 112.983 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.42 -2.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 115.196 1.554 . . . . 3.71 115.196 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.77 175.05 20.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.561 2.029 . . . . 0.7 111.792 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -104.71 175.21 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.583 -0.951 . . . . 0.82 109.378 167.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.74 131.25 73.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.663 -1.606 . . . . 0.53 106.663 152.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.4 p -80.89 122.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.667 -0.494 . . . . 0.91 109.667 172.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.4 mt -94.48 127.31 46.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 107.374 -1.343 . . . . 1.45 107.374 165.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.38 123.56 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.17 1.388 . . . . 1.98 108.701 171.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 151.0 33.17 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 121.026 -0.269 . . . . 3.23 111.049 172.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -161.29 -173.82 4.01 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.405 0.682 . . . . 1.43 109.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -59.73 -25.64 65.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.857 1.263 . . . . 5.58 113.353 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.36 16.45 61.04 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.558 1.075 . . . . 1.09 114.66 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.7 -140.44 24.23 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 125.334 1.445 . . . . 0.66 114.002 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.19 98.38 4.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.194 0.998 . . . . 0.75 112.105 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.95 111.22 14.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.2 1.4 . . . . 2.2 110.785 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.71 117.58 29.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.255 2.222 . . . . 0.58 108.835 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.41 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.8 m -123.95 110.69 29.27 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-N 119.796 1.18 . . . . 0.62 108.986 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.74 158.34 10.47 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.974 3.116 . . . . 0.42 111.341 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -149.06 29.32 0.81 Allowed 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.794 0.807 . . . . 1.28 113.058 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.77 148.77 21.94 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.542 1.537 . . . . 0.79 111.915 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.52 23.38 6.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.853 2.168 . . . . 1.96 116.853 -164.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.73 69.2 0.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.888 0.875 . . . . 1.66 111.351 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.13 160.94 66.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.88 0.872 . . . . 1.46 112.007 170.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.28 127.68 18.79 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.052 1.168 . . . . 0.95 110.343 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -83.58 33.39 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.901 1 C-N-CA 126.053 4.502 . . . . 1.05 113.152 -159.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.72 -131.6 4.46 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 123.411 1.562 . . . . 1.18 112.131 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.0 147.27 52.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.667 1.587 . . . . 3.89 109.548 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.7 122.64 15.52 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.72 0.808 . . . . 1.37 112.25 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.73 155.05 1.67 Allowed Glycine 0 CA--C 1.543 1.794 0 C-N-CA 123.936 0.779 . . . . 1.0 113.057 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.93 112.5 11.31 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.206 -1.405 . . . . 1.9 107.206 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -116.33 158.79 22.89 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.249 1.203 . . . . 0.94 114.249 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.471 ' CG2' HD12 ' A' ' 74' ' ' LEU . 63.2 mt -99.23 151.27 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.236 1.414 . . . . 0.69 107.88 154.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.23 153.45 47.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.174 1.79 . . . . 0.91 107.648 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.83 71.68 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.909 1.448 . . . . 0.87 114.909 -163.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -119.22 161.21 20.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.19 1.796 . . . . 1.54 112.371 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.13 86.02 0.56 Allowed Glycine 0 N--CA 1.467 0.715 0 C-N-CA 124.682 1.134 . . . . 0.86 112.773 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 t -171.11 94.15 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.718 1.207 . . . . 1.92 113.011 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 68.3 m -65.92 14.55 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 117.097 2.258 . . . . 1.36 117.097 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -101.96 147.85 34.49 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 119.787 -1.821 . . . . 3.78 113.965 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.37 161.42 11.19 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.723 3.615 . . . . 1.15 112.602 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.31 14.13 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.605 0.762 . . . . 1.9 111.213 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.23 115.34 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.345 1.058 . . . . 3.37 109.643 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -146.34 147.06 30.94 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.85 1.66 . . . . 5.69 110.704 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t0 53.13 32.18 12.68 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.617 1.34 . . . . 4.45 114.617 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.1 6.48 87.54 Favored Glycine 0 CA--C 1.535 1.343 0 O-C-N 121.105 -0.997 . . . . 3.99 114.771 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -141.58 -161.79 1.28 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.57 1.548 . . . . 3.94 110.509 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.14 138.64 49.56 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.919 -1.113 . . . . 1.9 113.027 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 t -82.24 60.75 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.838 1.655 . . . . 2.32 111.029 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 47.17 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.154 2.582 . . . . 1.76 115.874 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.93 84.38 0.81 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.411 2.684 . . . . 1.47 107.556 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -84.72 -46.71 11.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.237 1.415 . . . . 3.98 112.03 -167.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -12.34 57.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.321 1.23 . . . . 1.12 114.321 -164.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.74 -22.82 59.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.562 1.545 . . . . 0.79 113.897 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.55 -174.97 17.77 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 120.398 1.454 . . . . 2.39 114.278 -176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 -155.57 22.44 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.129 1.347 . . . . 1.17 110.832 164.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -71.36 34.41 0.05 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 118.957 1.379 . . . . 2.41 113.783 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.471 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER 64.11 46.04 3.85 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.452 1.501 . . . . 2.53 109.536 -178.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -128.32 44.95 1.47 Allowed Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 116.3 1.963 . . . . 4.4 116.3 -148.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.39 -20.81 31.38 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.834 2.356 . . . . 3.04 113.722 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -166.65 143.32 4.77 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.82 1.648 . . . . 3.84 110.5 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 164.75 -23.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 129.501 3.12 . . . . 3.84 113.435 170.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 t 139.18 -2.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 1 C-N-CA 131.829 4.052 . . . . 3.53 112.855 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.26 2.73 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.549 1.38 . . . . 2.44 116.549 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -86.71 172.5 10.14 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.43 1.615 . . . . 4.55 113.73 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -107.68 143.92 35.51 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.068 1.347 . . . . 1.48 112.921 -173.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -152.86 -173.19 4.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.222 1.409 . . . . 3.83 109.967 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.38 -52.1 0.01 OUTLIER Glycine 0 CA--C 1.544 1.854 0 CA-C-O 116.977 -2.013 . . . . 4.15 115.022 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -105.0 -20.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.875 2.383 . . . . 5.3 116.939 -164.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 177.27 17.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.44 1.496 . . . . 8.05 114.369 -165.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.83 -150.05 21.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.494 1.521 . . . . 2.77 112.25 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -135.92 135.9 40.03 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.741 -1.207 . . . . 5.78 107.741 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.75 -157.72 30.02 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.419 0.554 . . . . 2.95 114.434 -173.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 136.75 58.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.286 0.634 . . . . 3.82 112.665 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -11.9 60.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.681 0.993 . . . . 2.52 113.681 169.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.08 14.77 36.75 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.794 -1.559 . . . . 1.07 115.439 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -106.99 131.93 53.5 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 119.614 1.707 . . . . 1.57 112.267 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 3.9 mp -131.37 170.51 11.1 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.067 2.147 . . . . 2.01 110.418 -168.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 94' ' ' LEU . 88.7 Cg_endo -80.22 152.9 21.29 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.403 2.068 . . . . 0.83 111.868 -172.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.85 128.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.795 1.238 . . . . 2.22 112.95 -168.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.38 82.17 1.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.151 2.18 . . . . 1.68 108.894 168.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.49 141.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.51 1.124 . . . . 1.38 109.161 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.93 150.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.419 1.888 . . . . 1.91 108.866 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 143.49 26.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.057 0.844 . . . . 1.88 112.683 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -19.83 -45.19 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.353 4.661 . . . . 3.33 117.463 174.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.23 -29.37 65.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.943 1.297 . . . . 3.7 112.633 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.11 20.72 6.2 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.807 1.67 . . . . 0.86 113.463 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.6 mt -121.71 133.99 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.99 109.888 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.63 131.01 49.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.615 1.166 . . . . 0.59 110.322 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 t -152.37 4.18 0.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.427 2.01 . . . . 1.1 116.427 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -100.98 136.96 19.64 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.877 1.217 . . . . 3.85 111.334 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.14 146.8 47.08 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.526 3.484 . . . . 1.04 112.178 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.11 161.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.448 1.499 . . . . 1.14 109.442 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -139.25 134.87 33.25 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.341 0.973 . . . . 0.73 110.747 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.8 105.32 49.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.957 0.903 . . . . 0.93 112.609 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.84 13.05 0.63 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.372 3.382 . . . . 1.15 113.299 167.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -64.27 -41.26 97.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.096 1.758 . . . . 4.39 110.737 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -111.41 151.73 28.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 2.4 107.258 166.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -97.04 -22.07 17.02 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.586 0.958 . . . . 4.71 113.586 -174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.16 160.86 43.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.039 1.745 . . . . 1.59 115.344 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.43 -30.68 68.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.457 1.503 . . . . 1.75 111.889 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -67.27 -2.75 6.42 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.807 2.043 . . . . 2.61 113.313 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -96.86 -13.13 22.72 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.195 1.798 . . . . 1.81 113.277 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.18 7.83 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.631 1.105 . . . . 1.06 113.898 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -60.38 -12.6 9.76 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.854 2.168 . . . . 2.88 116.854 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.39 16.75 13.87 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.55 1.94 . . . . 4.58 114.08 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -121.2 -173.91 2.72 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.956 1.465 . . . . 1.42 114.956 -165.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.5 156.56 47.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.508 1.523 . . . . 0.59 111.555 169.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mp -118.3 130.0 55.78 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.525 1.93 . . . . 1.65 108.489 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.2 mtt -116.98 128.72 55.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.46 0.573 . . . . 1.42 111.772 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.02 103.51 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.61 -1.256 . . . . 0.8 107.61 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -87.02 146.1 26.24 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.187 1.795 . . . . 2.38 113.034 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.2 t -64.65 -30.32 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.983 -1.073 . . . . 1.6 113.409 -164.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.14 149.66 18.07 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.316 0.96 . . . . 1.29 112.63 172.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.27 150.48 11.1 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.104 1.811 . . . . 1.59 112.952 162.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.01 0.55 38.32 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.2 1.185 . . . . 2.49 114.2 -141.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -81.55 -7.27 59.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.356 1.613 . . . . 3.02 115.356 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 65.9 mtm -84.45 109.75 18.12 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.74 1.216 . . . . 2.52 110.486 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -137.01 -45.35 0.57 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.17 0.988 . . . . 2.91 112.759 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.41 80.64 8.53 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.123 -0.986 . . . . 3.86 110.715 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 175.88 147.49 0.26 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 128.491 2.716 . . . . 3.48 110.272 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.33 -27.59 47.66 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 2.13 114.029 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -109.91 87.75 6.07 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.802 0.841 . . . . 6.5 109.125 165.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.67 169.16 16.54 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.914 2.41 . . . . 4.57 111.307 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt 66.3 6.04 4.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.523 1.929 . . . . 4.96 113.416 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.2 26.92 74.23 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 119.154 0.888 . . . . 3.91 113.2 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.57 -9.35 77.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.778 1.18 . . . . 2.56 113.186 -166.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 22.43 0.57 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.884 2.183 . . . . 1.63 115.851 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.75 75.35 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 118.455 1.128 . . . . 1.73 112.337 166.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.7 p -65.21 156.86 30.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.454 1.502 . . . . 1.65 110.896 162.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.25 137.67 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.761 1.224 . . . . 4.95 110.582 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -82.37 -37.47 25.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.185 0.994 . . . . 2.31 111.697 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.1 149.38 32.93 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.038 0.935 . . . . 0.53 111.814 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.27 146.71 50.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.975 1.71 . . . . 1.57 110.783 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -131.66 90.43 0.28 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.463 2.459 . . . . 0.71 111.352 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.28 140.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.589 1.156 . . . . 2.67 112.47 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.72 151.45 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.728 1.611 . . . . 1.19 111.246 -170.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 O-C-N 120.912 -1.117 . . . . 4.35 112.43 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 109.437 -0.579 . . . . 1.97 109.437 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.55 154.11 26.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.732 1.213 . . . . 1.16 109.859 -172.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -149.17 125.77 11.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.921 1.343 . . . . 2.93 110.27 170.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -83.83 109.89 17.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.064 1.746 . . . . 2.99 110.528 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.66 124.47 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 120.089 1.313 . . . . 1.15 110.482 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -76.25 110.95 3.17 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 125.669 1.604 . . . . 0.81 110.752 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.5 mtp -96.74 131.7 43.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.253 1.021 . . . . 1.42 111.121 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.65 142.91 45.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.066 1.346 . . . . 2.69 111.524 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.7 mt -65.68 137.65 57.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.858 0.863 . . . . 1.34 108.862 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.33 144.44 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.688 0.795 . . . . 1.05 111.432 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.1 t -163.79 72.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.677 0.791 . . . . 2.24 112.473 -169.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 72.0 -33.47 0.27 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.029 2.531 . . . . 1.43 115.44 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -33.78 68.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.353 1.461 . . . . 3.47 110.082 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.39 -158.67 24.53 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 125.909 1.718 . . . . 1.32 112.023 -169.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.84 126.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.391 1.476 . . . . 1.08 110.899 171.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.91 -136.78 9.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.492 1.52 . . . . 1.99 111.504 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.34 165.64 12.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.411 -1.052 . . . . 1.88 112.555 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -104.06 162.18 13.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.863 1.315 . . . . 1.4 114.443 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pp -147.48 4.53 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 130.431 3.492 . . . . 2.89 113.262 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.49 148.09 5.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.959 1.742 . . . . 0.81 112.856 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.449 HG22 ' HA2' ' A' ' 6' ' ' GLY . 30.8 p -99.46 -179.9 4.36 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.184 -1.043 . . . . 0.85 108.184 163.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 61.5 t -132.2 134.52 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.211 -1.033 . . . . 0.67 108.211 163.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.5 p -81.54 122.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.49 -0.559 . . . . 0.97 109.49 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -107.42 133.14 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.557 -0.905 . . . . 1.89 108.557 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.22 124.91 18.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.547 1.539 . . . . 2.16 107.498 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.34 128.66 47.4 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.515 0.726 . . . . 3.56 109.703 -168.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -151.5 -174.53 4.86 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.633 0.235 . . . . 1.17 111.633 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.17 -24.97 68.13 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.933 -1.105 . . . . 4.25 112.619 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.99 9.95 64.55 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 124.834 1.207 . . . . 0.97 114.609 167.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.29 -140.19 23.43 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 126.668 2.08 . . . . 0.69 112.988 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.87 93.47 5.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.9 0.88 . . . . 0.54 110.49 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -72.69 131.57 42.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.483 1.913 . . . . 3.03 109.22 166.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 19.3 t80 -127.93 106.72 9.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.99 2.116 . . . . 0.65 108.176 -168.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.448 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 25.4 m -105.4 107.1 58.36 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.834 1.197 . . . . 0.79 108.027 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.05 156.11 30.09 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.028 2.486 . . . . 0.72 110.496 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.0 39.65 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.687 1.232 . . . . 2.37 110.359 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.54 150.02 20.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 126.794 2.038 . . . . 1.01 111.733 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HE2' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -132.5 162.34 31.45 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.339 -1.301 . . . . 3.13 109.494 170.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.21 23.64 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.484 3.114 . . . . 1.68 112.66 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.18 152.51 57.19 Favored Pre-proline 0 CA--C 1.487 -1.46 0 C-N-CA 125.249 1.42 . . . . 1.97 112.56 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -76.0 142.7 25.2 Favored 'Trans proline' 0 N--CA 1.413 -3.218 0 C-N-CA 116.599 -1.801 . . . . 1.52 111.286 -165.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -80.97 31.3 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.626 1 C-N-CA 127.89 5.727 . . . . 1.47 114.127 -155.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.86 -127.98 6.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 123.567 1.648 . . . . 1.69 110.958 174.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -120.51 145.93 46.79 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 127.567 2.347 . . . . 3.07 110.383 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.436 ' CD2' HG21 ' A' ' 99' ' ' VAL . 71.2 m-70 -139.9 125.11 18.8 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 124.158 0.983 . . . . 0.96 112.404 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.31 149.79 9.41 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.607 -0.683 . . . . 0.55 111.778 169.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -135.97 127.52 28.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.951 1.7 . . . . 1.84 106.503 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -130.06 167.85 17.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.4 2.37 . . . . 1.01 117.4 166.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.0 mt -101.0 146.43 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.637 1.975 . . . . 0.77 108.929 155.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -124.08 155.72 37.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.179 1.792 . . . . 1.49 110.541 -170.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.91 -37.91 70.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.948 1.462 . . . . 0.69 114.948 -162.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.42 HD22 ' HA3' ' A' ' 71' ' ' GLY . 66.9 m-80 -116.64 -179.34 3.65 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.335 1.454 . . . . 1.08 111.033 173.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.98 51.05 0.86 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 116.646 1.419 . . . . 0.97 116.646 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -153.22 123.93 7.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.661 1.731 . . . . 2.13 112.45 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.1 m -68.77 -2.88 10.42 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.603 1.705 . . . . 2.03 115.603 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.8 136.6 38.85 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 120.25 -1.531 . . . . 3.37 112.02 -162.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -96.88 160.81 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.184 3.256 . . . . 1.38 113.384 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.76 177.3 4.88 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.103 1.361 . . . . 2.35 110.915 156.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.25 124.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.579 1.152 . . . . 2.56 108.773 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -104.54 -178.86 3.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.579 1.952 . . . . 4.37 109.911 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.33 104.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.529 0.937 . . . . 4.56 113.529 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.06 18.03 70.45 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.262 -1.299 . . . . 4.14 115.367 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -158.15 134.49 9.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.377 2.089 . . . . 4.74 114.818 -169.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.6 130.33 35.01 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.107 -0.996 . . . . 1.94 110.312 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -81.36 49.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.396 . . . . 2.91 111.675 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.57 -57.47 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 130.608 3.563 . . . . 2.34 117.817 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 163.38 85.35 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 1 C-N-CA 134.228 5.011 . . . . 1.62 105.17 -167.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.85 -50.53 7.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.103 0.961 . . . . 5.26 111.91 -155.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.56 15.02 0.11 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.12 1.156 . . . . 1.65 114.12 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.65 -15.04 35.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.431 1.892 . . . . 0.87 112.7 165.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' HD22 ' A' ' 52' ' ' ASN . . . 76.08 9.68 85.38 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.737 1.455 . . . . 2.78 116.737 168.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.04 -166.37 52.8 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.133 1.466 . . . . 1.46 112.277 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.603 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 39.4 m170 -61.97 149.87 39.47 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.707 0.753 . . . . 2.37 111.22 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 123' ' ' LYS . 36.4 tp -67.98 110.18 3.79 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.904 -0.497 . . . . 1.84 111.122 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.81 159.93 2.42 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 130.46 3.504 . . . . 3.38 109.006 164.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -90.09 -18.6 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.328 2.019 . . . . 2.84 115.712 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 178.55 -3.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.613 2.079 . . . . 4.98 116.613 -163.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -58.92 -48.53 81.13 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.096 1.517 . . . . 3.73 115.096 -147.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 161.61 170.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.952 3.301 . . . . 3.54 109.467 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.93 -15.62 78.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.318 0.961 . . . . 3.62 113.779 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.92 145.38 55.99 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.104 1.452 . . . . 4.68 110.348 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -117.46 143.87 45.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.234 1.013 . . . . 1.53 112.299 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.74 117.56 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 3.76 111.852 -161.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.05 171.53 35.7 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.004 1.288 . . . . 2.78 111.958 171.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.74 -3.33 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.907 3.738 . . . . 4.04 115.876 -168.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -160.69 29.22 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.584 2.354 . . . . 8.06 110.675 171.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.76 -141.15 7.76 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.098 2.285 . . . . 3.01 112.224 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -151.97 148.07 27.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.336 1.068 . . . . 4.78 112.055 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.12 -91.59 0.08 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.433 1.968 . . . . 2.23 112.524 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -134.76 134.25 40.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.136 1.375 . . . . 3.87 110.285 -169.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -67.06 -21.63 65.89 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.63 1.344 . . . . 2.09 114.63 -170.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.68 -2.65 76.64 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.707 1.146 . . . . 0.86 115.128 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.603 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 71.8 m-20 -72.71 133.58 44.64 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.796 1.298 . . . . 1.57 109.949 169.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.92 163.9 26.35 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.993 1.317 . . . . 1.73 110.645 -150.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.3 145.79 34.87 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.514 2.809 . . . . 0.89 111.899 -167.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.16 130.35 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.587 1.184 . . . . 2.66 110.446 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 125.31 31.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 131.128 3.771 . . . . 2.25 110.446 -172.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -97.06 140.18 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.336 1.055 . . . . 1.24 111.88 -172.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 45' ' ' HIS . 2.3 t -130.16 141.07 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.539 1.936 . . . . 1.64 108.248 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -103.47 157.5 17.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.693 1.197 . . . . 2.73 112.53 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.74 50.08 0.43 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.673 2.389 . . . . 2.86 115.649 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -128.34 1.49 5.7 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.402 -1.726 . . . . 3.72 111.221 150.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.29 27.47 13.33 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.441 1.972 . . . . 0.8 113.883 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.29 138.53 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.533 1.533 . . . . 1.17 110.255 -165.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.15 127.72 53.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.354 0.979 . . . . 1.05 109.925 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 t -149.03 9.18 0.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.845 1.424 . . . . 1.05 114.845 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -100.73 130.77 24.68 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.922 1.289 . . . . 3.57 110.306 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.14 140.56 17.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.078 2.519 . . . . 1.07 112.252 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.63 160.64 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.04 1.736 . . . . 1.17 109.499 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.0 m -144.73 132.55 21.23 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.384 0.993 . . . . 0.81 111.423 -167.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.84 97.25 27.94 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.744 1.218 . . . . 0.67 112.916 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.0 -2.52 12.77 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.582 3.521 . . . . 1.18 115.905 -177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -88.15 -2.44 58.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.548 1.139 . . . . 3.71 113.361 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.55 169.72 9.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.976 2.51 . . . . 2.34 107.834 164.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -152.67 5.74 0.39 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 117.038 2.236 . . . . 3.98 117.038 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 m -158.1 167.95 28.42 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.987 1.267 . . . . 1.74 113.291 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.81 -20.06 63.46 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.957 -1.09 . . . . 1.34 111.863 163.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.52 -35.86 78.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.587 1.155 . . . . 3.54 113.657 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -68.51 -13.11 62.1 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.366 1.247 . . . . 3.18 114.366 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.16 17.58 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.747 1.219 . . . . 0.98 113.539 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -67.44 19.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 128.308 2.643 . . . . 2.39 116.977 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -165.96 26.28 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.788 2.435 . . . . 2.95 110.94 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' ' 74' ' ' LEU . 59.4 mttp -134.6 170.64 15.49 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.952 -1.092 . . . . 1.29 113.629 -167.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.5 157.09 25.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.03 1.332 . . . . 0.77 112.543 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.35 135.04 51.06 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.871 2.068 . . . . 1.65 107.294 168.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.09 138.19 54.3 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.383 0.673 . . . . 2.5 111.444 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.33 133.48 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.443 1.116 . . . . 1.48 110.278 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.22 135.5 51.67 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.324 1.85 . . . . 1.96 110.828 -155.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -73.53 -15.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.791 1.404 . . . . 2.56 114.791 -151.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.03 169.53 24.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.401 1.477 . . . . 1.53 109.891 162.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.2 147.84 34.16 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 117.88 0.84 . . . . 1.84 111.786 165.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.64 -22.04 0.89 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.352 1.242 . . . . 3.76 114.352 -138.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.6 47.43 0.17 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.85 2.46 . . . . 4.09 115.422 -172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 41.4 mtm -105.99 133.32 50.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.918 1.687 . . . . 2.23 112.493 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.9 p -99.18 -36.19 9.74 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.129 1.772 . . . . 3.36 114.768 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.39 2.9 54.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.538 1.31 . . . . 4.15 114.538 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.62 144.09 32.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.887 0.875 . . . . 3.97 110.669 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -41.47 9.06 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.311 2.674 . . . . 2.16 112.59 -173.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -83.15 136.94 43.13 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.729 -0.653 . . . . 4.73 109.943 158.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.88 167.37 26.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.171 2.581 . . . . 2.98 111.034 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt 66.33 31.11 8.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.971 1.308 . . . . 3.75 110.953 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.22 11.2 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.059 1.314 . . . . 2.82 114.223 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.6 -20.76 29.5 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.098 1.808 . . . . 2.89 114.392 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.42 -3.31 47.35 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.387 1.47 . . . . 4.13 114.617 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.9 46.77 1.8 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.587 1.565 . . . . 3.34 115.59 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.2 m -58.79 158.03 8.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.382 1.873 . . . . 2.0 110.338 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.45 150.5 28.29 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.281 -1.512 . . . . 5.78 113.042 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.489 ' CE2' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -100.73 -32.83 10.52 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 118.817 -0.611 . . . . 8.44 111.251 153.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.29 152.47 37.17 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 116.482 2.03 . . . . 0.85 116.482 -172.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.0 t -99.2 -177.69 3.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 129.26 3.024 . . . . 1.59 110.368 164.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 176.09 91.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 127.427 2.442 . . . . 0.73 111.456 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.07 133.62 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 1.45 110.024 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.16 128.1 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.468 1.107 . . . . 1.07 110.962 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 82.9 mttt . . . . . 0 N--CA 1.472 0.662 0 C-N-CA 123.992 0.917 . . . . 4.31 111.214 -173.063 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 108.99 -0.744 . . . . 1.66 108.99 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.7 148.06 23.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.228 1.011 . . . . 2.13 113.568 -167.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -153.23 116.99 4.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 2.6 109.248 165.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -97.35 108.36 21.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.747 -1.22 . . . . 3.43 109.439 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.61 125.92 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.386 0.539 . . . . 1.12 109.886 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.0 114.17 4.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.958 1.266 . . . . 0.72 110.171 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.4 mtt -98.09 129.78 44.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.963 0.905 . . . . 1.15 111.726 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -107.44 147.83 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.135 1.374 . . . . 2.64 110.717 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.5 mt -65.28 139.96 58.66 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.19 1.396 . . . . 1.16 109.382 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.0 m -135.27 155.6 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 119.233 0.924 . . . . 1.28 111.683 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.1 55.74 0.1 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.127 0.788 . . . . 2.34 113.127 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.86 -36.72 0.37 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 127.196 2.199 . . . . 2.27 113.849 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -22.01 57.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 4.61 112.283 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.63 -159.81 24.61 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 124.933 1.254 . . . . 1.1 112.91 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 t -80.71 130.08 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.512 1.925 . . . . 1.27 110.996 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.22 -135.33 8.07 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.4 1.476 . . . . 1.86 112.49 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -104.86 172.29 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.942 0.897 . . . . 2.38 111.315 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -109.43 141.13 42.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.77 0.828 . . . . 1.15 112.473 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 19' ' ' ILE . 36.4 mm -118.73 23.85 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 127.068 2.147 . . . . 5.64 110.937 164.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.2 173.04 33.37 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.32 -0.863 . . . . 0.61 114.83 160.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -102.06 -179.49 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.28 1.032 . . . . 0.88 109.542 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 53.2 t -132.55 135.27 57.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.769 -1.197 . . . . 0.64 107.769 160.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -88.33 128.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.065 0.228 . . . . 0.83 110.626 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.54 133.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.824 -0.806 . . . . 1.52 108.824 161.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.21 128.16 53.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.547 0.739 . . . . 1.96 110.417 156.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 122.27 17.97 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.831 0.852 . . . . 4.05 109.25 164.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -135.96 -178.51 5.17 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.33 -0.248 . . . . 1.69 110.33 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -54.3 -46.34 72.77 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.866 -1.147 . . . . 5.36 110.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.6 17.85 9.93 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.092 1.33 . . . . 1.14 115.774 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.84 -144.08 20.13 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 126.698 2.094 . . . . 0.78 114.071 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.72 99.52 5.89 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.996 0.903 . . . . 0.62 111.224 -170.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 108.16 5.11 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.195 1.798 . . . . 4.5 110.177 169.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 4.4 t80 -101.33 107.42 18.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.353 1.861 . . . . 0.59 109.888 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.3 m -117.14 111.58 40.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 119.247 0.93 . . . . 0.68 109.064 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -84.01 166.37 12.98 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.032 3.155 . . . . 0.7 111.415 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -150.2 18.71 0.86 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.761 1.393 . . . . 1.68 114.761 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.58 140.89 35.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.208 1.003 . . . . 0.96 111.857 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 9.2 ptpt -116.52 35.92 4.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.731 1.752 . . . . 2.17 115.731 -166.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 19' ' ' ILE . . . -162.77 49.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.651 0.78 . . . . 1.22 112.165 -165.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 157.54 70.86 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 1.29 112.578 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.0 141.64 40.62 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 O-C-N 122.985 0.992 . . . . 1.11 111.233 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 2.1 Cg_endo -86.92 39.59 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 125.282 3.988 . . . . 1.17 113.647 -156.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.83 -159.94 12.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.921 1.248 . . . . 1.14 114.056 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -89.22 137.46 32.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.662 1.985 . . . . 2.89 111.391 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -140.43 143.18 35.46 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.978 0.911 . . . . 1.33 109.62 -173.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.06 161.97 46.82 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 119.029 0.831 . . . . 0.53 112.112 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.402 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.9 t80 -144.51 124.86 13.83 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.326 -1.731 . . . . 1.88 106.326 166.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.57 166.01 24.21 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.962 1.467 . . . . 0.95 114.962 165.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CG2' HD12 ' A' ' 74' ' ' LEU . 20.6 mt -91.06 148.4 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.922 1.689 . . . . 0.63 109.341 159.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -126.42 160.49 30.32 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.355 1.462 . . . . 0.88 109.872 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.3 -20.2 65.58 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 116.609 2.077 . . . . 0.76 116.609 -162.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -134.9 166.54 22.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.061 1.744 . . . . 1.14 112.883 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 83.91 0.34 Allowed Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.151 1.358 . . . . 1.04 112.433 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.8 m -171.5 90.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.595 1.558 . . . . 2.34 110.202 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 59.0 m -64.86 45.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 127.0 2.12 . . . . 1.36 114.98 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -118.59 136.69 24.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 119.579 -1.95 . . . . 3.61 110.786 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.61 168.74 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.185 3.256 . . . . 1.18 111.686 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.18 144.98 25.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.016 -0.538 . . . . 1.52 109.772 155.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -109.92 117.35 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.118 1.367 . . . . 2.7 108.34 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -166.41 146.4 6.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.962 1.305 . . . . 4.49 110.6 -163.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 63.22 18.39 10.94 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.085 -1.009 . . . . 3.27 113.686 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.8 13.46 81.33 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.595 -1.315 . . . . 2.53 114.217 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.82 174.54 10.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.643 1.577 . . . . 2.55 110.793 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.6 151.04 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.371 -0.831 . . . . 1.64 111.89 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.23 95.26 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.148 1.379 . . . . 1.82 109.977 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 15.41 -85.41 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 129.396 3.079 . . . . 2.0 116.091 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 130.62 12.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.619 1.968 . . . . 1.65 106.818 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -116.66 -46.0 2.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.512 1.925 . . . . 4.0 110.864 -165.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.5 -9.85 38.69 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.896 1.073 . . . . 1.15 113.896 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.48 59.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.683 1.593 . . . . 0.81 113.185 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.1 173.5 48.7 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 119.487 1.039 . . . . 2.41 112.948 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.56 -177.89 42.15 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.78 0.705 . . . . 1.26 112.444 165.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -49.01 140.15 9.44 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.252 0.526 . . . . 2.1 110.306 168.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.93 101.73 0.88 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.416 0.895 . . . . 2.85 113.416 -170.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -150.45 130.33 6.71 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 128.009 2.524 . . . . 5.3 108.547 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.14 -39.35 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.337 2.025 . . . . 2.48 113.918 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.67 31.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.463 1.905 . . . . 4.52 114.548 -169.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -73.25 -44.15 59.89 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.115 -1.616 . . . . 4.38 110.855 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.6 t 177.07 -37.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.277 1.831 . . . . 2.68 113.378 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 5.91 79.13 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 117.853 -1.526 . . . . 2.12 116.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.255 19.2 ptmt -102.39 17.71 22.86 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 117.712 2.486 . . . . 4.85 117.712 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 t60 83.54 168.85 0.1 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 127.126 2.17 . . . . 2.14 114.753 164.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -25.04 0.1 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.671 2.1 . . . . 5.13 116.671 -154.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.6 -46.14 7.13 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 118.334 2.093 . . . . 2.59 118.334 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -90.02 -12.63 2.77 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.192 2.496 . . . . 3.79 113.859 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -147.29 -104.17 0.09 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 6.05 108.817 -161.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.68 98.73 0.14 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 119.17 0.896 . . . . 3.05 114.23 170.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -159.79 44.76 0.23 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.578 1.151 . . . . 4.87 109.741 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.43 -129.68 1.14 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 115.868 1.107 . . . . 2.66 115.868 -166.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -95.36 146.2 24.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.236 1.014 . . . . 3.25 113.663 -154.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -24.61 33.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.683 0.994 . . . . 2.96 113.683 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.27 11.28 69.16 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.347 0.975 . . . . 1.28 114.91 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.8 149.79 32.5 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 117.95 0.875 . . . . 2.46 110.716 163.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.85 166.35 16.53 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.233 1.013 . . . . 1.88 110.256 -141.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.37 157.01 50.13 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.605 2.87 . . . . 1.11 111.654 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -73.21 128.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.647 1.213 . . . . 1.43 112.34 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.09 63.37 5.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.773 2.829 . . . . 2.88 110.792 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.87 144.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.088 -1.007 . . . . 1.44 110.748 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 135.39 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.684 -0.858 . . . . 3.02 108.684 162.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 159.34 25.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.131 1.772 . . . . 3.71 112.52 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -48.79 -8.68 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 119.867 3.284 . . . . 2.49 119.867 -161.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -95.94 -36.3 11.12 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.883 1.673 . . . . 2.85 114.589 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 115.01 14.39 8.53 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.922 1.529 . . . . 1.08 116.922 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.9 mt -105.82 116.99 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.937 1.369 . . . . 1.66 109.883 165.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.09 122.58 21.2 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.921 0.489 . . . . 0.71 109.951 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -149.23 17.5 0.95 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.351 . . . . 1.06 112.733 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -87.29 112.19 46.3 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.134 1.374 . . . . 3.0 111.526 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.9 107.09 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.89 2.393 . . . . 1.16 109.973 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.67 145.93 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.501 1.12 . . . . 1.34 109.582 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -127.36 131.97 50.28 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.016 0.825 . . . . 0.94 111.014 -168.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.23 96.67 40.11 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.976 0.91 . . . . 0.74 112.326 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.12 6.66 1.35 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.93 3.086 . . . . 1.01 113.293 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.08 -29.01 67.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.041 1.337 . . . . 5.16 112.965 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.6 153.84 32.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.033 2.133 . . . . 1.94 108.118 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 10.71 6.75 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.805 1.242 . . . . 5.01 112.581 -174.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -167.13 150.72 6.58 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.974 -1.079 . . . . 1.67 112.99 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -71.52 -33.6 69.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.561 0.744 . . . . 2.12 110.655 162.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.02 -26.57 67.71 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.278 1.214 . . . . 3.34 114.278 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -84.58 -0.57 53.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.075 1.35 . . . . 1.88 113.395 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.81 12.96 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.581 1.152 . . . . 0.84 113.922 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -69.93 17.45 0.05 Allowed 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 116.719 2.118 . . . . 2.34 116.719 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -156.18 29.7 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.534 1.933 . . . . 2.84 110.624 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -139.62 157.74 45.28 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.168 1.387 . . . . 1.58 114.12 -167.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.96 149.09 22.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.99 1.316 . . . . 0.53 112.998 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.55 131.21 55.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.019 2.528 . . . . 1.63 106.521 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.3 mtm -125.75 136.68 53.42 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.468 1.031 . . . . 1.59 113.036 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.25 112.35 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.928 1.291 . . . . 0.86 108.227 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.1 134.72 34.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.699 1.6 . . . . 2.36 111.661 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.67 -39.92 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.233 0.827 . . . . 1.23 113.233 -158.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.35 163.55 12.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.341 0.972 . . . . 1.14 110.685 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.75 109.26 1.34 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.481 -1.048 . . . . 1.74 110.481 166.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.81 26.58 0.09 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.883 2.873 . . . . 4.94 112.969 -167.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.72 21.6 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.045 1.868 . . . . 3.33 116.045 -158.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.5 mtm -98.68 152.91 19.13 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.394 1.257 . . . . 2.48 114.394 -160.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.3 p -140.15 150.32 44.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.324 1.85 . . . . 3.79 110.463 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.9 t0 58.39 84.27 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.247 2.219 . . . . 4.66 114.448 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.1 156.95 11.56 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.936 1.694 . . . . 3.55 109.698 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.76 25.38 0.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.93 3.086 . . . . 3.34 114.059 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -134.25 129.36 19.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.206 1.002 . . . . 4.8 109.941 163.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.88 138.7 45.27 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.889 2.393 . . . . 2.97 111.085 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 60.45 22.48 12.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.809 1.643 . . . . 3.63 112.117 -171.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.45 0.13 29.02 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.004 1.288 . . . . 2.78 114.554 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.37 -9.46 24.4 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.925 2.202 . . . . 1.76 113.957 -166.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.95 1.11 56.29 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.449 1.625 . . . . 1.45 116.324 -171.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.84 62.23 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 118.995 1.398 . . . . 1.46 116.485 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -79.31 155.96 28.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.014 1.725 . . . . 1.44 110.771 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 136.01 49.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 5.05 111.457 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -82.4 -32.61 29.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.518 1.127 . . . . 2.25 111.349 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.91 42.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.431 1.092 . . . . 0.51 113.066 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.56 151.72 48.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.031 2.132 . . . . 1.46 110.479 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.07 125.15 1.78 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.301 1.429 . . . . 0.67 111.873 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.6 132.45 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.835 1.254 . . . . 1.82 110.87 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.06 131.4 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.032 1.333 . . . . 0.82 110.533 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.4 mttt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 123.526 0.73 . . . . 3.87 111.874 179.398 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.202 -0.666 . . . . 2.2 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.39 143.1 45.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.196 1.362 . . . . 1.35 113.974 -147.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -155.19 132.67 11.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.06 1.344 . . . . 2.52 110.454 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.38 97.07 7.19 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.842 -1.161 . . . . 4.13 113.029 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.4 t -77.54 122.79 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 1.03 109.799 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.75 105.1 1.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.212 1.387 . . . . 0.68 110.638 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.4 mtp -91.57 108.56 19.99 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.925 0.713 . . . . 1.17 112.925 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -69.4 141.95 54.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.938 0.895 . . . . 2.84 111.31 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.29 134.83 52.33 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.633 -0.877 . . . . 1.37 108.633 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.69 159.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.091 0.556 . . . . 0.99 111.578 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -155.23 -152.32 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.375 1.47 . . . . 2.72 109.927 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -18.07 44.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.429 1.492 . . . . 1.26 113.429 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.84 -3.32 47.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.655 1.182 . . . . 2.66 111.543 164.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 -133.41 11.78 Favored Glycine 0 CA--C 1.525 0.684 0 O-C-N 120.812 -1.18 . . . . 1.23 110.464 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.42 130.12 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.249 1.42 . . . . 1.09 111.657 -165.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.54 -100.07 2.16 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.645 1.593 . . . . 1.23 112.291 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -151.06 152.43 33.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.134 1.774 . . . . 3.64 109.065 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.5 t -87.99 155.1 20.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.22 1.01 . . . . 1.19 112.308 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -135.37 2.9 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 2.78 112.438 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.78 142.83 3.63 Favored Glycine 0 CA--C 1.524 0.62 0 O-C-N 121.468 -0.77 . . . . 0.77 112.72 -162.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -97.88 175.82 6.01 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.367 -0.975 . . . . 0.81 108.367 166.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 33' ' ' PHE . 23.0 t -127.52 129.07 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.594 -0.891 . . . . 0.68 108.594 160.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.7 p -87.38 121.26 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 O-C-N 123.574 0.546 . . . . 0.97 110.995 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.52 128.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.303 1.841 . . . . 1.13 107.284 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.56 111.71 13.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.497 1.142 . . . . 2.27 111.118 164.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -86.31 145.78 26.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.418 2.287 . . . . 5.37 113.447 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.302 8.5 t -163.16 160.5 24.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 125.179 2.418 . . . . 1.59 110.775 -158.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -23.18 -53.18 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 110.712 -2.949 . . . . 3.78 113.387 148.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.12 12.2 65.04 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 125.225 1.393 . . . . 1.03 116.179 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.66 -172.38 35.9 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 130.499 3.904 . . . . 1.48 115.272 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.1 mt -51.59 99.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.798 2.039 . . . . 0.78 113.86 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -81.01 104.48 11.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.788 1.235 . . . . 1.79 110.849 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 47' ' ' PHE . 1.3 t80 -94.33 120.88 35.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.175 2.19 . . . . 0.62 110.265 -173.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.407 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.5 m -127.65 115.92 21.01 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.036 -0.983 . . . . 0.69 109.286 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -85.03 154.92 11.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.455 2.77 . . . . 0.58 113.562 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . 0.282 1.8 p80 -147.06 62.25 1.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.3 1.047 . . . . 1.24 111.873 168.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.449 ' HB2' HD21 ' A' ' 40' ' ' LEU . 1.2 mp -121.68 146.21 47.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.404 1.481 . . . . 0.68 112.05 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -133.57 25.4 4.07 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 117.483 2.401 . . . . 2.32 117.483 -158.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.54 25.02 0.4 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.817 1.414 . . . . 1.63 114.817 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -89.92 162.91 34.21 Favored Pre-proline 0 N--CA 1.474 0.773 0 O-C-N 120.907 -1.121 . . . . 1.72 111.297 -174.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.27 128.12 25.24 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 N-CA-C 109.36 -1.054 . . . . 0.97 109.36 162.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -87.45 20.17 1.24 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 124.399 3.399 . . . . 1.01 113.78 -149.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.18 150.2 18.2 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.576 . . . . 2.51 109.447 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -44.15 143.23 1.23 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 127.365 2.266 . . . . 2.89 115.852 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -126.74 125.98 42.69 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 125.679 1.592 . . . . 1.15 113.408 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.32 159.99 7.92 Favored Glycine 0 CA--C 1.54 1.62 0 O-C-N 120.863 -1.148 . . . . 0.58 112.581 171.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.659 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -137.15 126.4 24.72 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.617 -0.931 . . . . 2.29 108.832 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -120.85 159.3 25.77 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.558 1.318 . . . . 0.96 114.558 166.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.3 mt -103.18 139.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.558 1.943 . . . . 0.62 107.371 157.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -113.59 166.26 11.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.223 . . . . 0.99 111.137 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.56 64.78 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.494 1.294 . . . . 0.7 114.494 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -110.84 -158.22 0.64 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.939 1.296 . . . . 1.35 111.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.42 0.19 8.05 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 119.46 2.544 . . . . 1.29 119.46 -147.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 t -155.78 138.76 15.41 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.816 3.308 . . . . 3.12 117.271 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.7 m -68.44 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 130.199 3.399 . . . . 1.35 115.112 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.18 118.82 48.64 Favored Pre-proline 0 N--CA 1.475 0.788 0 O-C-N 119.446 -2.034 . . . . 3.15 111.746 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.66 146.3 16.77 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.662 2.908 . . . . 1.37 111.711 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.24 138.88 32.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.63 -0.714 . . . . 1.74 110.291 154.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.57 106.54 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.792 -1.188 . . . . 2.81 107.792 160.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -151.98 136.54 16.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.578 1.551 . . . . 5.5 110.246 -161.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.4 t0 50.46 45.51 26.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.85 1.26 . . . . 4.16 112.83 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 -19.49 48.97 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.065 1.793 . . . . 2.77 115.389 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.66 163.6 34.36 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.352 1.576 . . . . 3.22 113.379 -156.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.57 121.83 26.81 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.497 -1.377 . . . . 1.94 111.175 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -76.61 20.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 114.656 1.354 . . . . 2.86 114.656 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.99 -56.96 0.57 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.146 2.578 . . . . 1.78 114.685 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.44 118.76 0.55 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.252 2.221 . . . . 1.88 108.911 172.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.11 -43.8 7.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.581 0.752 . . . . 4.96 110.677 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.2 -2.38 7.99 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.221 1.193 . . . . 1.44 114.221 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.13 -24.25 23.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.018 1.327 . . . . 0.85 112.474 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.68 -176.94 41.87 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.713 1.142 . . . . 2.39 112.878 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.62 -176.57 29.65 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.906 -0.761 . . . . 1.17 112.834 171.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -55.59 150.38 12.36 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.936 -0.744 . . . . 2.23 109.487 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.493 HD13 ' HE2' ' A' ' 123' ' ' LYS . 53.8 tp -64.99 100.35 0.41 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.911 0.778 . . . . 1.54 112.002 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -163.78 123.15 1.32 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 129.279 3.032 . . . . 4.97 108.926 165.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -92.16 -16.64 1.05 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.04 2.493 . . . . 1.95 114.283 173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -169.88 -14.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.437 2.384 . . . . 3.58 117.437 -166.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -59.09 -36.62 75.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.957 1.708 . . . . 4.11 112.742 -170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -172.93 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.182 0.993 . . . . 2.46 113.225 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 -17.48 8.06 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.29 -1.283 . . . . 1.98 113.834 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -78.08 154.49 31.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.175 1.988 . . . . 5.58 112.077 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -79.68 150.52 30.89 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.012 -1.055 . . . . 1.37 112.589 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.39 -166.01 0.88 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.598 0.759 . . . . 3.27 110.076 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.45 -140.5 6.43 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 120.746 -1.221 . . . . 2.21 111.79 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.15 -9.82 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.458 2.772 . . . . 3.29 114.23 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.98 174.41 5.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.817 2.047 . . . . 5.55 109.164 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.98 -138.4 16.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.663 0.649 . . . . 3.26 111.497 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.08 135.81 3.91 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.511 1.524 . . . . 6.69 107.597 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.87 -135.28 3.22 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.258 1.409 . . . . 2.66 113.397 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -75.7 136.25 40.37 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.145 -0.62 . . . . 3.51 110.542 169.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.528 HD13 ' H ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -71.2 -12.84 61.69 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 2.44 113.586 170.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.09 18.51 13.0 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.874 1.702 . . . . 0.96 115.999 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -108.9 133.11 53.35 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.155 1.478 . . . . 1.47 110.585 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.659 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 4.8 mp -134.11 154.23 80.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.035 1.334 . . . . 2.17 110.654 -163.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.75 163.9 37.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.41 2.74 . . . . 0.8 112.987 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.14 119.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 114.975 -1.012 . . . . 2.16 112.101 -160.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 87.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.112 2.965 . . . . 1.73 109.685 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.25 147.55 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.452 -0.78 . . . . 1.04 110.086 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.55 150.16 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 127.635 2.374 . . . . 1.6 106.108 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.52 160.21 27.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.575 0.625 . . . . 2.44 111.147 168.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -14.79 0.86 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 116.63 2.085 . . . . 2.45 116.63 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.93 -5.78 37.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.359 2.264 . . . . 2.63 113.395 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.5 52.01 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.674 1.131 . . . . 0.72 115.184 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.6 mt -111.89 132.5 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.432 1.493 . . . . 1.18 110.191 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.7 144.63 32.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.522 1.529 . . . . 1.02 112.198 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -151.31 -5.73 0.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.346 1.858 . . . . 1.35 113.806 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -70.18 118.53 64.77 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.226 1.81 . . . . 4.52 111.493 -174.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.15 146.73 32.46 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.884 2.389 . . . . 1.28 111.479 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.16 175.17 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.911 1.684 . . . . 1.22 109.627 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 m -150.57 133.19 15.75 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.305 0.957 . . . . 0.95 110.449 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.579 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -106.3 105.41 54.03 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-O 118.745 -0.645 . . . . 0.91 112.043 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.67 -16.16 21.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.233 2.622 . . . . 1.19 115.631 -171.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -66.77 -43.25 84.53 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.252 0.834 . . . . 4.82 113.252 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.95 151.25 38.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 2.03 110.336 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -144.27 46.4 1.42 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.819 1.248 . . . . 4.06 113.265 -169.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 m 151.22 142.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 130.874 3.67 . . . . 1.68 113.554 166.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.19 -33.63 53.54 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.826 -1.171 . . . . 1.63 111.636 164.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -20.92 5.72 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.794 1.775 . . . . 3.17 115.794 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -92.25 -16.98 25.43 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.607 1.549 . . . . 3.06 113.709 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.67 -1.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.993 1.479 . . . . 0.86 114.993 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -8.4 13.24 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 117.121 2.267 . . . . 2.67 117.121 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -104.97 -8.12 18.8 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.207 1.403 . . . . 2.87 113.395 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HE2' HD13 ' A' ' 74' ' ' LEU . 20.9 mttt -96.16 168.56 10.52 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.932 1.293 . . . . 1.56 114.338 -167.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.9 156.84 17.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.125 1.37 . . . . 0.78 112.41 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 pp -131.96 155.0 48.73 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.924 1.69 . . . . 2.6 111.193 169.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 67.9 mtt -136.28 139.74 42.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.607 0.763 . . . . 1.51 112.587 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.03 121.62 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.293 1.437 . . . . 0.65 107.779 166.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -114.01 145.75 41.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.448 1.499 . . . . 2.03 112.654 -161.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.0 -32.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 126.119 1.768 . . . . 1.15 113.762 -159.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.68 167.37 20.04 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.782 1.182 . . . . 1.11 111.703 168.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.97 163.68 50.43 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.241 1.401 . . . . 1.35 112.759 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.51 11.93 14.97 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.199 1.555 . . . . 2.45 115.199 -142.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -70.95 -10.47 59.74 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.441 -1.412 . . . . 3.04 114.638 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.2 mtm -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.664 1.586 . . . . 2.29 113.403 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 t -84.77 -175.39 5.75 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.61 -0.681 . . . . 3.3 112.27 161.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 61.31 -16.05 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 129.053 2.941 . . . . 4.79 117.316 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -67.67 147.27 98.67 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.098 1.359 . . . . 3.36 111.851 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.95 -25.0 32.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.612 2.875 . . . . 2.11 112.718 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -104.65 84.98 1.05 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.43 -0.952 . . . . 3.9 108.43 157.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.58 154.25 73.05 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.753 2.302 . . . . 3.22 111.041 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 65.58 5.48 3.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.684 1.994 . . . . 4.24 112.946 -169.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.42 14.52 54.48 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.718 1.151 . . . . 3.31 114.429 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.45 44.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.972 1.272 . . . . 2.37 114.035 -167.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.1 -16.65 66.92 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.209 1.385 . . . . 1.93 113.164 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.68 0.08 29.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.149 1.357 . . . . 1.91 114.628 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.0 p -71.75 160.66 32.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.127 1.463 . . . . 1.76 109.924 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.51 150.72 20.21 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.762 1.225 . . . . 5.76 114.001 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -109.24 -37.92 5.65 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.317 0.647 . . . . 2.44 110.793 154.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.75 155.04 47.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.79 0.836 . . . . 0.52 112.69 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.1 t -139.09 147.51 42.07 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.223 2.209 . . . . 1.41 109.821 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 123.99 1.72 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.978 1.275 . . . . 0.72 112.624 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.22 126.19 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.792 1.237 . . . . 1.55 110.144 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 36.8 mt -80.87 142.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.642 1.177 . . . . 0.88 109.184 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 10.5 mmpt? . . . . . 0 CA--C 1.542 0.672 0 O-C-N 120.726 -1.234 . . . . 3.16 111.811 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.107 -0.331 . . . . 2.11 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -132.49 146.23 51.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.011 1.485 . . . . 1.0 115.011 -133.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -156.04 135.51 12.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.287 1.518 . . . . 2.8 111.603 164.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -108.51 87.5 2.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.229 2.212 . . . . 3.0 110.974 -165.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.23 125.4 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.21 1.189 . . . . 2.09 114.21 -171.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.0 100.68 0.59 Allowed Glycine 0 C--N 1.339 0.709 0 C-N-CA 125.191 1.377 . . . . 0.89 110.525 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.28 128.92 34.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.653 0.74 . . . . 1.44 111.931 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -111.09 143.4 41.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.904 2.081 . . . . 2.87 111.658 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.2 mt -80.83 56.26 2.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.599 1.16 . . . . 1.7 112.904 -169.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.1 153.45 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 122.262 1.029 . . . . 1.17 113.603 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -160.06 -156.26 0.48 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 125.728 1.611 . . . . 3.01 109.051 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.14 8.88 0.49 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.37 1.868 . . . . 1.25 114.075 -172.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -108.46 -7.52 15.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.815 1.646 . . . . 2.65 111.114 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.81 -142.63 17.14 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.644 -0.983 . . . . 0.97 110.644 -160.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -92.53 136.3 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.159 1.783 . . . . 0.83 110.907 -167.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.47 -68.26 0.28 Allowed Glycine 0 N--CA 1.473 1.146 0 C-N-CA 124.421 1.01 . . . . 1.62 115.316 -166.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.3 154.98 10.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.207 1.803 . . . . 1.85 110.8 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -129.82 122.42 28.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.9 -1.125 . . . . 1.6 112.273 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.65 25.97 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.458 1.503 . . . . 5.6 110.842 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.87 38.12 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.756 -0.59 . . . . 0.61 114.32 161.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 p -99.24 -179.28 4.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.963 0.905 . . . . 0.9 110.392 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 42.4 t -129.53 132.58 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.929 -1.137 . . . . 0.5 107.929 150.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.8 p -85.84 120.7 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.963 0.411 . . . . 0.81 110.761 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.58 138.93 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 124.917 1.287 . . . . 1.36 107.881 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.94 104.95 3.49 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.16 1.384 . . . . 2.28 109.56 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 151.08 44.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.032 -0.531 . . . . 2.82 111.558 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -158.38 -177.49 6.58 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.854 0.862 . . . . 1.3 110.547 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.5 -9.4 48.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.487 1.915 . . . . 3.74 113.001 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.45 16.27 41.37 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.854 1.693 . . . . 1.17 114.424 163.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.88 -151.42 23.86 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 127.235 2.35 . . . . 1.0 116.635 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.54 96.66 4.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.227 1.011 . . . . 0.8 111.728 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -70.77 143.32 51.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.086 0.954 . . . . 2.18 109.755 166.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.538 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 20.0 t80 -142.65 118.88 10.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.105 1.762 . . . . 0.53 109.363 -167.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.8 m -123.44 109.5 30.89 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.173 -0.918 . . . . 0.62 108.831 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.4 164.31 19.11 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.818 3.012 . . . . 0.52 110.929 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -158.63 33.78 0.23 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.314 0.857 . . . . 1.36 113.314 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 mp -91.77 136.06 33.43 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.378 -1.451 . . . . 0.93 112.018 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 14.98 21.63 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.499 2.037 . . . . 2.11 116.499 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.59 88.07 1.19 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.664 -0.648 . . . . 1.83 112.059 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 163.32 26.9 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.264 1.425 . . . . 1.48 111.298 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.51 124.31 13.09 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.013 1.809 . . . . 0.88 110.556 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -84.47 45.17 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 127.203 5.269 . . . . 1.13 112.268 -163.381 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.13 -130.46 7.02 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 123.184 1.436 . . . . 1.45 111.866 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -147.56 127.95 13.99 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.253 1.421 . . . . 2.64 109.264 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -130.19 154.48 47.49 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.578 0.955 . . . . 1.08 113.578 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.35 155.87 51.75 Favored Glycine 0 CA--C 1.541 1.657 0 O-C-N 121.184 -0.948 . . . . 0.58 112.192 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.528 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 1.4 t80 -130.85 122.57 27.31 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.054 -1.462 . . . . 2.06 107.054 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 7.7 m170 -122.53 157.92 31.0 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.723 1.601 . . . . 1.03 114.43 165.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.6 mt -94.24 154.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 128.27 2.628 . . . . 0.74 108.22 158.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -139.04 145.13 39.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.002 0.921 . . . . 0.97 111.181 -170.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.57 67.0 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.242 1.941 . . . . 0.79 116.242 -163.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.43 -179.27 5.06 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.415 1.086 . . . . 1.07 113.211 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.0 32.76 4.47 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.597 1.57 . . . . 1.38 116.675 -163.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -138.69 104.12 5.02 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.224 1.512 . . . . 2.43 111.705 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -70.2 13.09 0.18 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 116.701 2.111 . . . . 1.42 116.701 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -84.45 131.52 49.96 Favored Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 119.694 -1.879 . . . . 3.07 112.115 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.71 149.16 29.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.524 2.816 . . . . 1.01 112.418 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.74 150.36 26.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.003 -0.544 . . . . 1.42 110.38 156.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.0 mm -117.14 136.76 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.829 1.652 . . . . 2.42 107.697 173.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -14.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.678 2.103 . . . . 5.51 116.678 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.36 46.7 0.28 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.795 1.18 . . . . 3.33 113.611 -163.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.1 22.3 68.75 Favored Glycine 0 N--CA 1.475 1.255 0 O-C-N 120.662 -1.274 . . . . 3.28 113.295 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -163.32 155.22 17.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.293 1.837 . . . . 2.91 110.501 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.0 138.51 46.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.243 1.417 . . . . 2.13 111.749 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.82 39.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.969 1.308 . . . . 2.4 111.377 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.4 -66.38 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.628 2.771 . . . . 2.25 116.207 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.91 107.13 0.96 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.074 2.55 . . . . 1.98 108.057 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -76.48 -54.1 7.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.484 0.714 . . . . 6.06 110.059 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.1 20.64 0.37 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.045 0.938 . . . . 1.87 113.325 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.4 -11.99 38.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.226 1.411 . . . . 0.83 112.08 157.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.18 -70.3 3.18 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 120.229 -1.544 . . . . 2.96 114.051 171.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.02 179.23 32.75 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.522 1.534 . . . . 1.42 112.909 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -61.28 -7.31 2.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.663 2.097 . . . . 2.57 116.663 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 tt 78.51 98.73 0.06 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.957 2.103 . . . . 2.25 110.027 169.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -168.55 55.01 0.27 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 115.714 1.746 . . . . 3.51 115.714 -148.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.39 -48.06 2.7 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.765 2.31 . . . . 2.63 113.218 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -137.41 79.04 1.72 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.459 1.103 . . . . 4.21 110.058 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.96 -77.67 0.58 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.601 1.16 . . . . 3.93 109.769 166.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -178.6 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.894 2.077 . . . . 2.38 111.414 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.55 -9.3 58.82 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.245 0.926 . . . . 1.76 114.679 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.92 -14.35 61.9 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 116.052 1.871 . . . . 5.13 116.052 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.9 t60 70.74 164.19 0.27 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.308 1.843 . . . . 1.55 111.5 -166.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -157.28 -152.38 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.886 -1.134 . . . . 3.95 112.216 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.27 -40.18 0.16 Allowed Glycine 0 CA--C 1.543 1.805 0 C-N-CA 127.938 2.685 . . . . 2.36 113.213 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -112.34 -1.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.617 2.878 . . . . 3.32 115.606 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.08 -7.19 0.82 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.116 1.895 . . . . 6.36 116.116 -159.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.36 -23.03 5.71 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 119.712 -1.867 . . . . 3.74 114.322 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.71 64.26 2.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.089 2.156 . . . . 4.92 113.451 -168.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 -93.39 0.11 Allowed Glycine 0 N--CA 1.469 0.899 0 O-C-N 120.457 -1.402 . . . . 2.48 113.655 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -138.15 156.03 48.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.23 2.212 . . . . 3.63 108.279 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -84.96 -21.72 29.46 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.523 1.056 . . . . 1.99 113.131 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.63 19.84 22.15 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 117.806 -1.552 . . . . 0.97 116.068 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -95.2 138.12 33.33 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 120.636 2.218 . . . . 1.49 111.065 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.528 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 5.2 mp -129.49 155.66 79.82 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.945 1.698 . . . . 2.22 110.391 -169.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.02 162.04 43.01 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.417 2.744 . . . . 0.99 111.787 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.0 127.24 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.902 1.334 . . . . 1.56 113.237 -160.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 85.04 3.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 129.438 3.095 . . . . 2.48 108.57 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.12 149.55 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 0.92 109.152 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.27 133.6 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.663 1.185 . . . . 1.69 110.281 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.45 141.99 58.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.754 1.02 . . . . 1.82 113.754 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -46.42 -23.92 0.43 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 129.016 2.927 . . . . 2.54 117.581 -170.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.58 -19.31 45.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.139 1.775 . . . . 3.05 112.482 -168.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.69 30.95 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.43 1.491 . . . . 0.92 113.483 -170.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.24 127.66 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.008 1.723 . . . . 1.11 108.492 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.76 136.54 33.06 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.131 0.972 . . . . 0.82 110.547 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.3 t -153.11 -2.43 0.22 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.918 1.687 . . . . 1.11 113.052 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -80.43 118.96 74.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 128.387 2.675 . . . . 5.03 112.283 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.09 149.43 28.52 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.931 3.087 . . . . 1.45 112.971 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.03 166.62 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.98 1.712 . . . . 1.28 110.591 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -138.99 137.1 36.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.9 1.28 . . . . 0.85 109.553 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -112.42 110.17 53.23 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.338 0.655 . . . . 1.0 112.758 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.51 -0.95 11.13 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.879 3.052 . . . . 1.34 114.692 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -73.87 -11.12 60.27 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.951 1.25 . . . . 4.62 113.238 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.78 141.98 33.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.865 2.066 . . . . 2.42 108.417 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 18.79 2.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.931 1.826 . . . . 6.95 115.931 -160.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 85.9 p -153.24 164.72 37.58 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.821 1.248 . . . . 2.59 108.329 167.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.0 tp -84.4 -34.61 23.5 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.676 -0.64 . . . . 2.28 109.657 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.65 -41.36 42.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 2.89 113.078 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -72.92 -5.09 36.16 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.231 1.197 . . . . 1.91 114.231 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.03 13.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.024 1.329 . . . . 0.8 113.541 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -59.7 -5.07 0.79 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 117.361 2.356 . . . . 2.23 117.361 -172.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.66 22.11 2.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.055 1.342 . . . . 3.51 112.807 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -104.47 151.81 23.1 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.297 -0.877 . . . . 2.58 112.866 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.47 148.42 27.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.836 -0.62 . . . . 0.71 110.182 157.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.2 145.62 42.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.349 -0.982 . . . . 1.54 108.349 156.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.9 150.86 52.12 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.201 0.815 . . . . 2.48 113.201 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.5 mt -99.06 132.9 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.098 1.759 . . . . 0.72 108.146 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -123.19 143.39 50.05 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.098 1.359 . . . . 2.77 112.197 -164.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 37.9 t -67.1 -35.4 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.922 -1.111 . . . . 1.39 112.982 -160.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -108.19 150.74 17.0 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.182 0.896 . . . . 1.12 111.937 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.89 147.81 40.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.634 1.111 . . . . 1.58 111.376 159.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.404 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 25.3 t0 -103.4 -15.07 16.02 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.471 1.656 . . . . 2.95 115.471 -138.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.24 51.98 0.57 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.415 1.635 . . . . 2.9 115.415 -168.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.94 131.51 25.47 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.703 -1.248 . . . . 2.48 112.316 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -138.06 -54.93 0.65 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.717 0.807 . . . . 3.23 112.671 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.95 39.46 0.23 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.978 2.111 . . . . 4.28 113.881 -164.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -124.18 163.58 35.03 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.155 2.582 . . . . 3.7 109.773 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.84 -19.36 64.19 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.291 2.661 . . . . 2.47 113.755 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -127.81 136.47 29.03 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 118.856 0.753 . . . . 4.52 109.944 148.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.52 162.37 41.11 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.919 2.413 . . . . 3.75 110.176 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 mp 60.07 9.1 1.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.01 1.724 . . . . 3.87 112.868 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 10.64 57.29 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.716 -1.24 . . . . 3.3 114.139 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.7 83.07 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.434 1.016 . . . . 2.08 113.891 -166.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.55 10.5 50.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.718 1.627 . . . . 1.7 115.006 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.83 -4.13 70.28 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.128 1.347 . . . . 1.45 114.537 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 p -62.71 157.99 19.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.048 1.339 . . . . 1.45 110.319 164.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.68 150.11 27.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.043 1.337 . . . . 6.72 113.381 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -107.52 -19.82 13.44 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.436 0.902 . . . . 2.38 113.436 162.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.24 156.32 23.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.205 0.911 . . . . 0.5 112.851 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.23 163.61 15.42 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.393 1.477 . . . . 2.28 110.114 157.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -151.96 134.44 4.58 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.821 1.676 . . . . 0.69 110.371 159.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.52 129.65 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.482 1.113 . . . . 1.53 109.873 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.4 mt -64.88 124.52 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.628 1.171 . . . . 1.17 112.052 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 113.168 0.803 . . . . 3.45 113.168 177.559 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.72 0.295 . . . . 2.77 110.484 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -150.84 155.78 39.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.206 1.402 . . . . 1.38 109.194 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -154.59 121.51 5.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.113 1.365 . . . . 2.6 109.601 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -86.58 102.43 14.14 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.638 -1.289 . . . . 3.53 108.834 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.1 121.28 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 119.882 1.219 . . . . 1.05 110.586 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.6 104.13 2.26 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.644 1.593 . . . . 0.99 110.983 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt -88.33 145.33 25.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.346 1.069 . . . . 1.41 113.504 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -120.35 149.13 42.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.238 1.815 . . . . 2.86 111.706 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.34 65.72 2.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.168 1.787 . . . . 1.45 111.139 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -74.39 157.84 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.705 1.202 . . . . 1.46 112.836 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -159.97 -156.78 0.51 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.309 1.444 . . . . 3.21 109.722 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.32 60.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.324 2.25 . . . . 1.21 113.587 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -87.33 -15.74 37.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.172 1.789 . . . . 3.02 112.198 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.24 -139.62 14.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.724 1.154 . . . . 1.07 110.717 -161.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.94 139.13 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 126.766 2.026 . . . . 1.56 113.284 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.67 -104.03 2.25 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.595 2.045 . . . . 1.6 113.26 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.12 149.57 42.0 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 127.264 2.226 . . . . 2.34 113.482 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -96.47 140.87 30.47 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.742 -1.224 . . . . 1.57 112.053 166.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.64 5.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 125.351 1.46 . . . . 2.73 113.947 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.99 168.26 21.71 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.075 0.845 . . . . 0.94 112.639 -168.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 p -116.86 -175.76 2.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.337 1.055 . . . . 0.87 109.162 170.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.482 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 44.7 t -129.08 135.65 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.441 -1.318 . . . . 0.71 107.441 157.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.88 124.78 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.398 0.437 . . . . 1.03 110.203 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.7 127.67 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.371 1.068 . . . . 2.0 108.971 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -143.08 134.66 26.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.211 1.404 . . . . 2.04 110.452 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 117' ' ' LEU . 41.7 mt-10 -92.69 138.1 31.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.387 -1.733 . . . . 3.82 112.087 -162.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 -175.51 4.99 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.577 -0.849 . . . . 1.52 112.276 168.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -70.97 -6.97 42.81 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.956 1.095 . . . . 3.88 113.956 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.67 12.15 53.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.764 1.649 . . . . 1.25 113.913 162.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -152.7 21.65 Favored Glycine 0 N--CA 1.462 0.418 0 C-N-CA 128.083 2.754 . . . . 0.93 116.225 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.3 mt -71.64 103.68 3.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.999 . . . . 0.88 111.259 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -76.63 116.41 17.28 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.239 1.016 . . . . 2.36 109.081 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.482 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 25.4 t80 -113.56 113.03 24.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.239 2.216 . . . . 0.83 109.19 -170.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.8 m -120.8 107.19 38.46 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 108.124 -1.065 . . . . 0.72 108.124 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.65 164.31 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.505 2.803 . . . . 0.42 110.685 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -152.67 30.63 0.52 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.133 0.968 . . . . 1.31 112.669 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -89.78 132.76 35.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.919 -1.113 . . . . 0.81 110.911 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -107.9 18.64 21.04 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.36 1.985 . . . . 2.58 116.36 -159.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.62 75.69 0.56 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.14 0.976 . . . . 1.59 111.992 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.11 158.43 69.46 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.791 1.237 . . . . 1.57 110.871 173.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 37.4 Cg_endo -63.6 131.19 30.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.484 1.456 . . . . 1.11 110.879 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 5.2 Cg_endo -87.2 34.76 0.43 Allowed 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 126.141 4.561 . . . . 1.06 113.203 -150.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.84 -135.07 8.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.99 1.757 . . . . 1.26 114.072 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.51 131.53 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.919 1.688 . . . . 2.4 108.417 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -132.73 147.21 52.32 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 124.561 1.144 . . . . 1.18 112.392 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.44 149.31 51.34 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.943 -1.098 . . . . 0.81 111.458 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -124.75 111.4 15.51 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.492 -1.67 . . . . 1.93 106.492 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -116.24 157.43 24.91 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.633 -1.292 . . . . 1.11 113.697 171.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.28 152.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.594 1.557 . . . . 1.15 107.518 157.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.68 146.9 46.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.526 1.13 . . . . 1.08 108.768 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.12 70.28 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.388 1.625 . . . . 0.73 115.388 -153.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -125.42 155.24 40.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.481 1.113 . . . . 1.75 112.644 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.79 82.08 1.42 Allowed Glycine 0 N--CA 1.469 0.834 0 O-C-N 120.702 -1.249 . . . . 0.85 112.795 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -166.54 95.52 0.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.55 0.74 . . . . 1.98 112.778 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.9 m -67.67 45.69 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.389 2.275 . . . . 1.45 113.635 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -121.05 127.12 26.35 Favored Pre-proline 0 CA--C 1.553 1.063 0 O-C-N 119.783 -1.823 . . . . 3.64 111.113 -167.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -81.72 179.33 5.78 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.273 3.315 . . . . 1.09 114.562 -168.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.19 173.13 12.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.799 2.04 . . . . 1.46 109.669 160.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.97 134.5 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.909 1.283 . . . . 3.21 108.194 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -150.78 143.05 24.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.642 1.577 . . . . 4.74 110.14 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.61 25.96 13.86 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.204 1.187 . . . . 5.63 114.204 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.77 17.54 65.51 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.414 1.006 . . . . 4.36 115.001 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.16 162.56 39.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.173 1.487 . . . . 5.01 112.903 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.2 129.05 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.436 1.095 . . . . 2.19 111.384 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.41 -15.58 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.866 1.266 . . . . 2.55 113.549 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 70.69 -49.26 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 128.482 2.713 . . . . 2.33 113.574 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.67 106.69 3.71 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.24 1.016 . . . . 1.58 109.991 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -95.32 -43.5 8.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.483 1.113 . . . . 4.7 110.533 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.68 -9.03 31.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.256 1.022 . . . . 1.35 113.545 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.76 -15.63 60.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.334 1.235 . . . . 0.87 114.334 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.91 -173.67 55.32 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 120.572 -1.33 . . . . 2.12 114.228 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.51 -171.05 25.75 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 124.73 1.157 . . . . 1.3 113.131 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.471 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 1.8 m170 -64.87 8.91 0.1 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.898 2.079 . . . . 2.57 114.649 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.1 tp 60.74 83.83 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.344 1.858 . . . . 1.6 107.672 -164.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.435 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 54.4 p-10 -160.4 19.24 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 117.408 2.373 . . . . 4.33 117.408 -143.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 71.6 Cg_endo -69.58 -31.77 20.67 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.232 1.955 . . . . 2.44 115.498 -159.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -140.28 8.9 2.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.646 1.112 . . . . 3.1 113.286 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.49 -41.99 19.04 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.05 -1.031 . . . . 3.78 113.305 -164.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t 154.65 158.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 1 C-N-CA 132.237 4.215 . . . . 2.93 107.414 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.07 -38.6 9.08 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 123.408 0.528 . . . . 2.64 114.051 -171.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -77.77 176.25 9.2 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.362 1.065 . . . . 4.16 113.734 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -124.29 158.9 31.47 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.29 1.036 . . . . 2.52 112.105 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.636 ' CD ' ' H ' ' A' ' 84' ' ' GLY 0.286 2.7 pp20? -150.56 -116.71 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.066 1.136 . . . . 3.96 114.066 -174.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.636 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 148.2 -55.5 0.5 Allowed Glycine 0 CA--C 1.547 2.086 0 C-N-CA 129.122 3.248 . . . . 3.15 112.174 -171.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -97.95 -10.34 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.315 2.676 . . . . 3.7 116.714 -166.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 -15.4 0.5 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.241 2.312 . . . . 6.08 117.241 -162.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 -8.22 32.02 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.738 1.855 . . . . 3.15 117.738 166.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -72.69 56.55 0.4 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.527 2.163 . . . . 5.29 113.252 170.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.82 110.17 0.27 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 120.717 -1.24 . . . . 3.12 115.473 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.7 m170 59.99 -145.2 0.5 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.008 0.923 . . . . 4.05 111.804 162.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.35 -28.43 0.54 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.791 1.034 . . . . 2.0 113.791 153.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.14 29.16 2.82 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 125.0 1.286 . . . . 1.14 116.286 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 44.8 m-20 -99.2 134.72 41.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.969 1.307 . . . . 1.56 110.232 171.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -131.37 152.25 80.19 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.167 1.387 . . . . 2.54 109.763 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.89 155.25 71.58 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.85 3.033 . . . . 1.28 111.418 -171.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.5 m -58.53 131.37 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 123.026 1.393 . . . . 1.51 113.08 -166.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.54 87.87 0.67 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.521 1.928 . . . . 2.54 108.137 167.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.94 138.35 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.115 0.966 . . . . 0.84 108.796 170.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -118.67 135.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 126.021 1.728 . . . . 1.56 107.111 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 149.11 50.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.773 0.715 . . . . 1.82 111.673 175.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -53.58 -15.22 1.06 Allowed 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 116.198 1.925 . . . . 2.17 116.198 -175.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -91.1 -8.92 47.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.391 1.876 . . . . 2.87 113.118 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 21.39 16.16 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 124.567 1.079 . . . . 0.97 114.782 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.2 mp -125.12 126.52 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.592 1.557 . . . . 1.34 107.582 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.87 112.68 22.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.397 -0.964 . . . . 0.72 108.397 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.0 t -131.79 -2.92 3.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.65 1.58 . . . . 1.0 112.715 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -72.64 115.08 36.01 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 128.041 2.537 . . . . 4.97 111.078 -173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.54 138.33 24.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.73 2.287 . . . . 1.22 110.965 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.88 165.17 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.857 1.263 . . . . 1.28 109.916 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.3 m -133.53 139.07 46.39 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.363 0.665 . . . . 0.87 109.77 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.3 87.03 15.47 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.785 0.834 . . . . 1.03 112.424 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 5.38 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.279 3.32 . . . . 1.46 115.31 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -77.36 -31.73 54.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.705 1.139 . . . . 5.36 111.246 170.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.91 127.44 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.909 1.684 . . . . 2.69 107.948 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 1.74 10.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.947 1.091 . . . . 5.06 113.947 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -154.08 165.69 35.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.077 1.751 . . . . 1.92 112.208 158.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.537 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.4 mm? -64.17 -29.95 71.03 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.405 -0.81 . . . . 1.93 111.081 162.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.12 -46.65 5.91 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.048 2.139 . . . . 2.99 114.383 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -76.59 -2.54 33.05 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.728 1.381 . . . . 2.31 114.728 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.08 13.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.087 1.355 . . . . 1.1 112.096 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -57.6 -16.56 10.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.083 1.753 . . . . 2.09 115.387 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.85 5.03 18.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 130.0 3.32 . . . . 4.77 113.508 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.02 173.26 7.0 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.051 1.871 . . . . 1.21 116.051 -158.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.77 144.13 33.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.15 1.38 . . . . 0.73 111.63 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.05 131.8 52.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.761 1.624 . . . . 1.68 107.581 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.1 mtt -132.79 124.27 27.73 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.24 0.83 . . . . 1.32 113.24 -170.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.26 114.87 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.842 1.257 . . . . 0.83 108.43 171.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -99.31 147.36 25.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.48 1.912 . . . . 2.24 112.29 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.74 -50.42 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.816 -0.611 . . . . 1.4 110.05 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.23 152.64 47.07 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.76 -0.536 . . . . 2.1 111.76 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.61 -163.88 21.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.725 2.107 . . . . 2.3 114.022 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -155.88 98.72 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.282 1.033 . . . . 3.2 110.32 -170.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -176.83 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.103 1.761 . . . . 3.09 113.908 -167.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.3 ptp -127.97 76.68 1.7 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.555 -1.341 . . . . 3.78 113.264 -146.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 p -72.2 109.88 6.27 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.747 -1.22 . . . . 4.79 112.18 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 97.2 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 129.961 3.304 . . . . 3.83 112.834 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.49 144.37 10.32 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.174 0.989 . . . . 7.5 112.073 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.64 -52.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.876 3.051 . . . . 2.39 110.929 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -67.82 115.93 32.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.977 -1.12 . . . . 4.0 107.977 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.79 164.77 34.65 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.886 2.391 . . . . 3.61 113.29 -160.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.9 tp 71.13 -13.22 0.53 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.939 2.096 . . . . 4.93 115.244 164.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 125.26 -2.19 8.3 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.309 1.909 . . . . 3.97 115.014 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.31 -25.6 0.87 Allowed Glycine 0 CA--C 1.54 1.61 0 N-CA-C 117.249 1.66 . . . . 2.56 117.249 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -112.11 60.21 0.34 Allowed Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.322 1.915 . . . . 2.33 112.168 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.4 -1.89 88.91 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.497 1.523 . . . . 2.43 114.797 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -63.11 146.8 52.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.524 1.162 . . . . 2.42 109.771 166.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -106.11 153.28 22.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.585 1.154 . . . . 4.67 110.025 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -98.2 -21.88 16.47 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.138 -0.458 . . . . 2.74 111.974 155.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.81 161.87 36.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.588 1.329 . . . . 0.62 114.588 174.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.0 t -142.42 152.09 42.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.256 2.222 . . . . 1.3 109.798 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.26 133.82 4.28 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.794 1.188 . . . . 0.85 111.666 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 67.7 t -92.11 132.03 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.167 0.987 . . . . 1.51 109.467 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -71.04 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.52 1.128 . . . . 1.02 110.129 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt . . . . . 0 C--O 1.239 0.524 0 O-C-N 121.221 -0.925 . . . . 3.56 109.03 179.011 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.057 -0.72 . . . . 2.04 109.057 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.3 154.9 43.53 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.183 1.179 . . . . 1.08 114.183 -148.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -153.31 135.82 15.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.178 1.466 . . . . 3.67 111.699 161.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -89.43 111.27 22.11 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.368 1.867 . . . . 3.29 109.981 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.84 129.19 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 118.49 0.587 . . . . 1.19 110.306 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.71 112.55 3.52 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.184 1.373 . . . . 0.84 110.295 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.8 mtp -91.35 85.53 5.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.464 0.65 . . . . 1.69 110.61 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -68.36 139.77 55.85 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.979 0.912 . . . . 2.78 111.969 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.31 135.09 55.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.296 -0.631 . . . . 1.34 109.296 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.1 156.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.689 1.196 . . . . 0.96 110.378 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 t -169.52 48.04 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.027 0.931 . . . . 2.22 112.058 -169.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.22 -17.38 0.27 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.303 1.841 . . . . 1.47 115.181 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.37 -4.37 59.14 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.111 1.364 . . . . 2.65 112.035 171.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -159.11 14.91 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.8 1.667 . . . . 1.12 112.331 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.6 t -67.17 128.2 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.577 1.551 . . . . 0.93 111.07 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.49 -88.57 1.69 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.058 1.313 . . . . 1.43 112.726 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.37 161.46 9.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.661 2.385 . . . . 2.88 108.112 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 t -112.56 143.03 44.41 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.734 -1.229 . . . . 1.91 114.128 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.481 HG22 ' HD2' ' A' ' 38' ' ' LYS . 39.6 mm -108.5 37.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.579 1.552 . . . . 5.31 110.937 167.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.32 -154.15 25.3 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.661 -0.649 . . . . 1.18 113.738 161.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.4 p -140.06 179.53 6.57 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.009 1.324 . . . . 0.99 109.368 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.412 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 58.0 t -128.57 135.39 62.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.785 -1.191 . . . . 0.65 107.785 160.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.8 p -88.39 127.27 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.348 0.405 . . . . 0.84 110.697 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.12 134.4 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.737 0.815 . . . . 1.34 109.013 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -138.46 134.83 34.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.716 1.606 . . . . 2.01 108.45 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 157.87 18.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.935 1.087 . . . . 3.54 113.935 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 t -152.26 173.78 14.59 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.668 1.187 . . . . 1.39 108.427 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.38 -13.13 62.01 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.286 -0.884 . . . . 4.74 112.058 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.41 18.53 57.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.885 1.707 . . . . 1.35 113.96 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 -143.02 21.17 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 127.692 2.568 . . . . 0.89 116.882 166.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.67 103.35 14.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.761 0.824 . . . . 0.63 111.519 -162.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -80.38 110.61 15.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.183 1.793 . . . . 2.51 110.286 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.412 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 5.7 t80 -99.52 119.63 38.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.649 2.779 . . . . 0.71 109.188 -176.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 21.6 m -129.41 110.45 17.79 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 119.858 1.208 . . . . 0.58 108.538 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -85.4 166.65 10.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.451 2.767 . . . . 0.47 111.426 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -152.36 18.26 0.64 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.258 1.207 . . . . 1.82 114.258 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.16 143.29 32.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.626 -1.296 . . . . 0.91 111.324 -174.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HD2' HG22 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -109.44 12.26 24.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.298 1.592 . . . . 2.63 115.298 -171.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.31 72.17 1.24 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.884 -1.053 . . . . 1.65 112.101 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.05 162.97 49.37 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 124.02 0.928 . . . . 1.47 112.561 168.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 25.6 Cg_endo -62.77 126.9 19.17 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.167 1.245 . . . . 1.36 111.243 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER -88.56 33.98 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 125.938 4.425 . . . . 1.22 113.285 -147.578 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.1 -133.09 6.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 123.48 1.6 . . . . 1.24 113.247 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -124.16 135.83 53.77 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.576 1.55 . . . . 2.76 109.387 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.37 149.39 52.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.641 1.719 . . . . 1.47 115.641 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 138.7 49.26 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 110.19 -1.164 . . . . 0.71 110.19 160.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.16 107.26 6.03 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 105.738 -1.949 . . . . 2.02 105.738 168.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -118.55 166.16 13.05 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.248 1.573 . . . . 1.6 115.248 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.435 HG22 HD13 ' A' ' 74' ' ' LEU . 77.0 mt -96.17 139.87 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.565 1.946 . . . . 0.81 109.026 162.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -137.68 152.51 49.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.795 2.438 . . . . 2.23 110.42 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.89 -10.87 59.45 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 117.633 2.457 . . . . 1.08 117.633 -157.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.73 135.24 36.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.935 1.698 . . . . 1.16 112.434 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 59.53 4.35 Favored Glycine 0 N--CA 1.471 0.982 0 C-N-CA 125.572 1.558 . . . . 1.05 114.119 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.68 116.37 4.14 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.787 1.294 . . . . 2.86 114.073 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.3 m -89.7 9.38 27.31 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.822 2.049 . . . . 1.3 113.474 -175.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -68.92 129.25 92.44 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.641 1.577 . . . . 3.5 111.855 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -97.7 166.73 0.82 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.652 3.568 . . . . 1.32 113.513 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.96 169.62 8.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 2.33 111.91 162.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mm -119.68 117.71 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.19 1.396 . . . . 3.13 109.747 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -152.75 157.42 40.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.173 1.389 . . . . 4.48 111.466 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.29 27.41 9.81 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 115.788 1.773 . . . . 3.62 115.788 156.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.21 20.12 65.42 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.865 -1.147 . . . . 3.25 115.023 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -160.76 -172.35 3.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.798 1.639 . . . . 2.63 111.634 -169.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.22 139.82 35.7 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.9 -1.125 . . . . 1.5 110.533 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.97 43.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.574 1.15 . . . . 2.16 112.431 -159.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.15 -65.97 0.06 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 129.007 2.923 . . . . 1.74 116.053 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 176.48 95.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 1 C-N-CA 132.267 4.227 . . . . 1.49 105.457 -175.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.85 -38.31 9.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.494 1.917 . . . . 4.78 112.449 -158.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.76 31.73 0.09 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.324 1.449 . . . . 1.19 114.26 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.13 -11.78 21.1 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.088 1.755 . . . . 1.68 115.299 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 20.93 44.99 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.724 1.449 . . . . 3.7 116.724 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.84 -99.94 1.81 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.231 1.516 . . . . 2.5 111.829 174.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -118.68 -117.79 0.32 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.445 1.898 . . . . 3.4 106.981 164.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 49' ' ' ILE . 7.1 tt -174.41 92.73 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.011 2.125 . . . . 2.16 107.794 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 173.26 146.7 0.2 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 127.917 2.487 . . . . 3.42 111.826 -162.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.96 -38.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.258 2.639 . . . . 3.34 113.877 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.23 26.0 0.2 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.876 1.216 . . . . 3.81 113.736 -174.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.83 19.18 0.41 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.444 -1.41 . . . . 3.36 114.541 -167.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.69 -30.22 0.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 128.825 2.85 . . . . 2.68 114.17 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.18 -11.27 61.04 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.026 -1.43 . . . . 2.67 115.83 167.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -61.21 -19.68 61.91 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.795 1.798 . . . . 4.45 114.698 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.0 t60 98.9 167.0 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.758 2.823 . . . . 1.8 112.269 154.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -65.77 145.74 55.61 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.125 1.157 . . . . 5.19 114.125 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.23 -155.42 7.64 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.127 1.822 . . . . 3.24 112.15 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.78 -43.04 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.65 2.233 . . . . 4.1 111.72 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.03 -3.32 9.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.618 1.567 . . . . 5.88 112.869 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.29 167.07 22.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.871 1.7 . . . . 4.45 114.553 -170.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -158.03 177.38 11.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.372 1.869 . . . . 7.87 108.931 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.76 -20.81 0.02 OUTLIER Glycine 0 N--CA 1.465 0.594 0 CA-C-O 118.114 -1.381 . . . . 2.6 115.946 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.964 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 7.0 p-80 -159.87 153.97 23.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.563 1.681 . . . . 5.28 113.246 169.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.93 -18.89 63.4 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.236 -0.915 . . . . 2.35 113.318 -175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -89.42 5.75 83.75 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.46 1.505 . . . . 1.0 114.587 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.964 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 12.8 m-20 -65.12 133.32 51.33 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 119.551 1.675 . . . . 2.35 107.742 160.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.29 159.8 36.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.722 1.209 . . . . 1.91 110.148 -153.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.21 154.18 56.76 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.558 2.839 . . . . 0.88 111.652 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 m -73.95 137.2 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 122.972 1.367 . . . . 1.44 114.046 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.2 98.54 4.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.965 2.506 . . . . 1.87 110.191 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.8 t -72.74 131.64 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.639 0.776 . . . . 0.93 110.143 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.48 138.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.722 2.409 . . . . 1.89 106.308 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 154.47 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.178 -0.951 . . . . 2.29 111.514 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -52.16 -12.31 0.23 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 116.987 2.217 . . . . 2.34 116.987 -176.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.85 -21.58 26.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.13 2.172 . . . . 2.94 113.098 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.62 9.52 23.03 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.327 1.441 . . . . 0.74 115.251 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mt -116.35 135.91 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.104 1.362 . . . . 1.09 110.207 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.22 128.41 54.69 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.919 0.888 . . . . 0.73 110.801 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -145.37 14.12 1.42 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.512 1.301 . . . . 1.27 114.512 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -86.74 118.72 70.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.276 1.03 . . . . 2.97 111.159 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.07 133.11 16.1 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.134 3.223 . . . . 1.35 112.185 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.03 168.37 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 126.543 1.937 . . . . 1.55 110.5 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.7 m -140.63 143.57 35.27 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.704 1.138 . . . . 0.95 112.052 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.46 99.36 51.16 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.978 1.311 . . . . 0.64 113.123 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.53 18.59 0.94 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 125.201 3.934 . . . . 1.07 114.873 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -73.05 -35.1 66.65 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.3 -0.875 . . . . 4.82 111.634 171.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.35 165.12 11.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.287 2.235 . . . . 2.27 109.133 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.08 2.64 3.64 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.994 1.109 . . . . 4.19 113.994 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.7 p -152.14 166.91 30.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.204 1.802 . . . . 2.05 110.438 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.7 tp -85.42 -44.62 12.6 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.458 -0.776 . . . . 1.79 111.058 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.27 -23.81 62.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.212 1.405 . . . . 4.45 113.853 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -12.32 60.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.842 1.053 . . . . 1.81 113.842 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.93 15.86 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.931 1.292 . . . . 1.15 113.29 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -51.15 -18.5 0.89 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 117.104 2.261 . . . . 2.75 117.104 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -121.92 11.47 10.34 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.586 1.955 . . . . 4.41 113.595 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -102.73 169.87 8.35 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.324 1.231 . . . . 1.72 114.324 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.62 44.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.646 0.779 . . . . 0.94 111.285 173.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.91 133.95 34.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.313 -1.736 . . . . 1.83 106.313 156.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.12 131.16 34.4 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.539 1.063 . . . . 1.58 112.171 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.93 114.35 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 107.074 -1.454 . . . . 0.93 107.074 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -87.0 146.89 25.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.544 1.137 . . . . 2.6 111.449 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.0 t -68.25 -37.61 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.193 0.597 . . . . 1.69 110.474 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.39 -163.32 6.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.064 0.84 . . . . 2.01 113.676 172.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.82 -146.32 10.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 127.466 2.46 . . . . 2.59 109.298 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -157.11 149.54 23.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.702 0.801 . . . . 3.56 110.967 161.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 56.3 t30 110.01 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 1 C-N-CA 131.703 4.001 . . . . 4.32 109.453 -161.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.6 ptp -165.05 69.26 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 123.062 1.41 . . . . 3.87 111.52 -162.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.6 p -97.76 0.09 46.27 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.253 2.221 . . . . 3.41 115.357 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -164.05 63.95 0.15 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.753 -1.217 . . . . 3.35 112.428 -163.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -130.31 149.78 74.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.072 1.349 . . . . 4.4 108.466 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.19 -35.68 84.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.402 2.735 . . . . 2.04 112.437 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -94.56 113.76 61.81 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.717 -1.216 . . . . 6.94 107.717 148.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.2 163.15 38.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.921 2.414 . . . . 3.92 111.104 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt 60.71 28.47 18.19 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.733 0.813 . . . . 4.25 110.435 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.86 3.14 7.47 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.413 1.483 . . . . 2.6 115.154 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.74 87.5 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 118.919 1.359 . . . . 2.29 114.052 -166.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.39 33.23 4.17 Favored Glycine 0 N--CA 1.474 1.189 0 C-N-CA 125.707 1.622 . . . . 1.88 114.594 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.19 -4.42 90.49 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.052 1.786 . . . . 1.91 115.039 -174.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 p -65.12 152.56 43.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.003 1.401 . . . . 2.27 110.752 165.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.35 132.48 54.08 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.486 1.114 . . . . 5.53 109.103 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -74.65 -33.44 62.52 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.69 0.677 . . . . 2.53 110.307 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.18 145.13 29.4 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.898 1.444 . . . . 0.78 114.898 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.5 t -68.69 -174.02 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 129.165 2.986 . . . . 2.61 111.548 164.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 164.54 62.06 0.02 OUTLIER Glycine 0 N--CA 1.465 0.626 0 C-N-CA 125.241 1.4 . . . . 0.74 112.99 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.9 p -61.69 125.87 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.53 0.732 . . . . 2.48 110.844 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.32 132.09 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.728 0.811 . . . . 0.9 108.816 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 CA--C 1.539 0.551 0 O-C-N 121.223 -0.923 . . . . 3.84 110.831 176.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.994 -0.373 . . . . 2.24 109.994 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -163.22 144.2 9.41 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.751 1.159 . . . . 1.31 108.32 -169.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -149.0 130.25 14.6 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.978 1.37 . . . . 3.4 111.118 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -80.99 106.99 13.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.842 1.657 . . . . 3.31 109.407 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.19 122.09 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.605 0.639 . . . . 1.09 111.025 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.613 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -72.91 104.91 1.63 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.059 1.79 . . . . 0.71 111.954 170.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.6 mmm -88.8 132.93 34.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.412 1.485 . . . . 1.67 111.359 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -106.53 145.42 31.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.642 1.177 . . . . 2.28 110.934 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 mt -61.11 142.42 56.7 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.549 1.14 . . . . 1.09 110.003 169.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.13 163.8 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.094 0.957 . . . . 1.34 110.738 175.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t 177.29 69.52 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.253 2.221 . . . . 2.71 110.763 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 67.02 -29.89 0.15 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.372 2.269 . . . . 1.79 115.932 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -17.35 64.86 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.666 1.586 . . . . 3.32 111.346 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.72 -160.53 17.18 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.368 1.937 . . . . 1.31 111.35 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.23 128.89 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.552 1.141 . . . . 1.15 109.74 169.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.81 -95.18 1.14 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 125.686 1.612 . . . . 1.5 113.26 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.58 166.18 34.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.217 1.407 . . . . 1.81 110.8 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 t -93.13 151.32 19.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.421 1.488 . . . . 1.1 114.341 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 15.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 127.192 2.197 . . . . 3.22 113.587 -173.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.49 175.89 15.39 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.441 1.02 . . . . 0.65 112.246 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.613 HG22 ' HA2' ' A' ' 6' ' ' GLY . 64.5 p -122.16 173.6 7.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.384 1.074 . . . . 0.92 109.273 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.16 132.18 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.489 -1.301 . . . . 0.59 107.489 162.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -86.35 124.84 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.774 0.321 . . . . 1.05 110.591 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.95 128.48 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.768 -1.197 . . . . 1.29 107.768 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -137.74 112.64 9.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.518 1.151 . . . . 2.35 110.483 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -70.31 111.44 5.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.437 2.295 . . . . 3.22 112.064 -167.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 159.73 15.35 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.084 -1.08 . . . . 2.59 108.084 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.93 -19.34 64.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.471 0.708 . . . . 4.48 111.868 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.83 30.8 9.66 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.012 1.768 . . . . 1.81 113.959 165.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.37 -135.31 9.84 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 119.921 2.728 . . . . 2.04 119.921 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.38 113.27 21.15 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.955 1.302 . . . . 0.71 110.147 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.77 109.42 15.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.164 0.986 . . . . 1.98 109.733 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t80 -92.05 121.08 33.27 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.19 1.796 . . . . 0.87 108.492 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.5 m -128.36 113.54 19.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 119.29 0.95 . . . . 1.0 108.694 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.15 157.12 13.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.491 2.794 . . . . 0.71 110.98 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.27 40.86 0.42 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.561 1.172 . . . . 2.36 111.613 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -101.39 140.46 35.66 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.48 1.512 . . . . 0.6 112.314 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 31.37 6.74 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.394 1.628 . . . . 2.06 115.394 -167.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.27 65.17 0.69 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.075 0.95 . . . . 1.4 111.972 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.86 157.58 32.55 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 113.896 1.073 . . . . 1.32 113.896 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.05 139.24 13.4 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 O-C-N 123.555 1.292 . . . . 1.52 112.083 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -77.97 31.14 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.867 1 C-N-CA 128.948 6.432 . . . . 1.85 114.164 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.77 -135.96 6.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-O 123.58 1.655 . . . . 1.47 110.195 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -136.3 133.57 37.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.717 1.607 . . . . 2.81 107.949 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -127.36 137.57 52.8 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.688 1.195 . . . . 0.98 109.58 -169.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 156.15 49.21 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 119.664 1.12 . . . . 0.61 111.743 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.6 t80 -129.42 118.87 22.87 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.322 -1.362 . . . . 1.9 107.322 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -118.09 157.69 26.41 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.427 2.01 . . . . 0.91 116.427 163.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -98.54 142.05 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.375 1.47 . . . . 0.72 108.488 158.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -128.38 141.82 51.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.508 1.923 . . . . 0.94 110.256 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.82 70.79 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.819 2.155 . . . . 0.75 116.819 -158.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -120.63 154.48 35.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.194 1.398 . . . . 1.28 111.746 171.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.43 84.17 1.58 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 120.844 -1.16 . . . . 0.82 113.301 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 t -166.76 95.71 0.52 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.745 1.017 . . . . 2.26 113.745 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 16.0 m -62.31 10.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.001 1.852 . . . . 1.48 116.001 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -87.6 129.33 51.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 119.953 -1.717 . . . . 3.37 110.031 -166.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.1 155.14 33.35 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.387 2.058 . . . . 1.34 110.618 166.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.24 145.32 51.45 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.684 -0.635 . . . . 1.63 110.218 158.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 mm -96.75 123.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.968 1.307 . . . . 3.38 108.561 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -169.47 157.82 7.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.244 1.418 . . . . 5.18 111.775 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.78 27.34 14.62 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.251 1.021 . . . . 4.52 112.317 167.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.11 84.64 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 126.381 1.943 . . . . 3.68 114.914 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.59 -152.64 0.41 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.451 1.501 . . . . 3.94 109.902 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.04 146.02 21.32 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.161 -0.962 . . . . 1.88 113.042 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.69 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.563 1.545 . . . . 1.89 113.16 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 67.81 -61.23 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 127.969 2.508 . . . . 2.0 116.584 168.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 166.35 99.83 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 C-N-CA 132.536 4.335 . . . . 1.86 106.583 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -123.52 -45.97 2.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 3.66 113.162 -157.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.07 -19.58 20.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.043 1.337 . . . . 1.48 113.391 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.13 -12.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.146 2.578 . . . . 0.83 114.809 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.38 16.8 58.32 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.333 1.424 . . . . 3.21 115.022 163.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.17 -173.98 41.75 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.246 1.023 . . . . 1.21 112.339 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -63.49 141.29 58.82 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.737 -0.861 . . . . 2.27 109.937 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.31 111.8 3.18 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.129 -0.357 . . . . 1.69 110.248 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.5 t0 169.7 126.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 128.762 2.825 . . . . 5.66 111.645 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.04 -36.51 1.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.104 1.869 . . . . 2.39 113.65 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -165.57 8.41 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.804 2.52 . . . . 4.4 117.804 -156.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.99 -27.08 65.06 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.815 2.098 . . . . 4.87 114.616 -170.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 165.89 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.967 3.307 . . . . 3.96 110.832 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.74 -18.51 38.6 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.863 1.221 . . . . 2.84 114.63 169.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -69.87 -7.73 42.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.558 1.688 . . . . 7.38 115.558 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.513 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 76.9 t60 68.56 157.13 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.825 2.45 . . . . 1.53 112.774 -172.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 84' ' ' GLY . 2.6 pp20? -140.41 -136.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.586 0.755 . . . . 4.49 112.315 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.565 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 144.33 -46.02 0.83 Allowed Glycine 0 CA--C 1.538 1.518 0 C-N-CA 130.401 3.857 . . . . 4.03 110.483 -172.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -108.02 -10.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.663 2.909 . . . . 4.1 115.633 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -139.26 -3.19 1.57 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.453 2.019 . . . . 5.24 116.453 -159.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.1 -31.04 1.57 Allowed Glycine 0 N--CA 1.472 1.09 0 O-C-N 120.45 -1.406 . . . . 4.73 114.874 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -72.77 71.65 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.444 1.498 . . . . 5.12 112.213 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.19 -91.61 0.09 OUTLIER Glycine 0 CA--C 1.523 0.579 0 C-N-CA 125.322 1.439 . . . . 2.19 111.584 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -133.83 151.17 51.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.012 1.725 . . . . 3.62 109.603 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.49 -28.71 68.79 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.219 0.918 . . . . 1.92 113.169 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.15 16.37 55.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.863 1.697 . . . . 0.76 115.357 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.513 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 89.1 m-20 -89.96 122.38 32.93 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.941 1.371 . . . . 2.21 109.867 168.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.478 HD12 ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -116.43 158.93 41.91 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.527 1.531 . . . . 1.77 109.795 -178.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.97 171.42 18.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.429 2.753 . . . . 1.68 111.759 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.42 131.71 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.7 1.37 . . . . 1.39 114.7 -163.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.65 94.52 0.59 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.221 2.608 . . . . 1.74 108.307 164.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.22 140.15 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.969 0.908 . . . . 0.93 109.672 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.18 131.8 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.71 1.204 . . . . 1.77 108.866 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.0 140.04 40.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.763 0.792 . . . . 2.07 111.793 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.23 60.46 0.43 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.715 2.006 . . . . 4.63 113.509 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.51 6.93 0.29 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.432 2.293 . . . . 3.92 112.314 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.53 3.94 43.46 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 126.297 1.904 . . . . 1.73 115.406 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.65 132.21 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.301 1.05 . . . . 1.73 110.291 -167.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 126.51 33.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.837 -0.539 . . . . 0.68 110.089 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 t -141.39 -0.95 1.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.715 1.376 . . . . 1.08 114.715 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -87.26 123.29 70.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.955 1.302 . . . . 3.16 110.895 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.93 149.45 42.16 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.037 3.158 . . . . 1.61 112.466 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.93 158.05 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.812 1.245 . . . . 1.42 109.691 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.4 m -112.86 143.61 43.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.45 0.7 . . . . 1.34 109.157 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -103.36 84.37 0.73 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.64 1.576 . . . . 0.91 110.671 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.89 1.54 7.56 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.845 3.03 . . . . 1.6 113.707 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.477 HH11 ' HG3' ' A' ' 113' ' ' ARG . 6.5 ttm-85 -76.92 -25.12 52.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.037 0.935 . . . . 5.29 112.404 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.09 178.86 4.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.691 1.996 . . . . 2.43 109.607 165.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -16.81 2.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.552 1.316 . . . . 4.02 114.552 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -154.84 166.55 33.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.103 1.32 . . . . 1.57 112.734 -169.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.65 -29.44 16.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.866 0.866 . . . . 2.3 111.244 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -28.98 70.14 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.86 -1.15 . . . . 3.35 113.247 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.6 -17.47 63.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.471 0.708 . . . . 2.58 112.89 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.73 13.91 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.485 0.92 . . . . 0.82 113.485 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -59.68 -21.34 60.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.141 1.534 . . . . 2.6 115.141 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -134.03 105.54 6.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.561 1.544 . . . . 3.51 107.983 160.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -158.84 163.32 36.75 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.969 2.908 . . . . 1.53 109.329 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.62 158.45 16.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.493 0.663 . . . . 0.86 110.676 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -130.69 117.0 18.81 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.295 2.238 . . . . 1.69 106.876 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.8 mtt -117.67 122.01 42.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.731 0.696 . . . . 1.49 111.172 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.97 115.93 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.909 -1.515 . . . . 0.81 106.909 166.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -98.58 151.12 21.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.298 1.839 . . . . 2.17 112.267 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.3 m -63.17 -29.52 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 114.641 1.349 . . . . 2.6 114.641 -160.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.17 168.28 24.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.457 1.503 . . . . 1.27 110.852 167.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.58 136.82 22.22 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.082 1.801 . . . . 1.49 114.08 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.02 114.84 29.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.801 1.64 . . . . 3.55 109.932 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -167.47 36.18 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.177 0.991 . . . . 3.53 112.514 -172.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.6 mtm -140.48 110.51 6.54 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.339 1.056 . . . . 2.33 112.985 -165.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.7 m -93.08 156.78 16.66 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 2.77 111.971 168.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.06 32.45 2.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.061 2.144 . . . . 6.14 116.12 165.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -115.86 146.51 37.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.113 1.365 . . . . 3.53 110.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.1 17.77 0.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.54 3.493 . . . . 3.35 114.069 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -98.53 113.38 64.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 121.107 -0.996 . . . . 7.53 108.884 173.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.58 153.66 73.62 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.158 2.572 . . . . 5.05 113.781 -156.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 tp 72.68 -1.14 3.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.66 1.984 . . . . 5.79 113.721 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' A' ' 82' ' ' HIS . . . 106.26 38.11 2.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.137 1.351 . . . . 6.33 113.224 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.02 -41.15 2.95 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.22 1.391 . . . . 3.87 113.556 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.07 -19.48 65.95 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 118.389 1.095 . . . . 3.12 115.407 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 46.53 -110.69 0.55 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.65 1.595 . . . . 2.0 115.457 161.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 m -69.17 151.77 45.94 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.318 1.447 . . . . 2.63 111.126 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.95 132.15 45.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.566 1.547 . . . . 4.71 108.238 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -83.11 -42.8 16.96 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 120.092 1.314 . . . . 2.97 110.373 169.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.03 151.82 33.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.053 0.941 . . . . 0.55 112.645 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.0 t -127.36 148.37 50.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.873 2.069 . . . . 1.4 111.09 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -145.44 155.67 26.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.592 2.52 . . . . 1.23 111.701 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.46 1.104 . . . . 1.53 111.442 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 153' ' ' ILE . 3.4 mp -82.47 149.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.342 1.857 . . . . 1.32 110.145 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.796 0 O-C-N 120.051 -1.655 . . . . 4.84 110.938 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.244 0.068 . . . . 1.66 110.948 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.5 148.16 22.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 1.24 109.201 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -151.15 127.2 10.44 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 123.191 1.472 . . . . 2.38 110.943 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -105.19 97.36 7.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.019 1.728 . . . . 3.46 111.663 -167.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.52 131.17 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 115.17 1.544 . . . . 2.03 115.17 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.6 103.01 1.19 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.499 1.047 . . . . 0.82 110.79 167.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.5 mtp -85.34 131.16 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.503 0.721 . . . . 1.16 110.406 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -110.7 145.38 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.115 1.366 . . . . 3.2 113.108 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.4 mt -77.93 62.5 2.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.153 1.381 . . . . 1.7 111.673 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 m -55.07 130.79 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.246 1.418 . . . . 0.96 112.02 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -158.63 72.18 0.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.007 1.484 . . . . 2.64 115.007 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.51 -40.46 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.744 2.418 . . . . 1.49 113.767 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.96 6.46 4.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.552 1.541 . . . . 2.52 111.546 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.89 -159.14 31.24 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 126.079 1.8 . . . . 1.16 112.769 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -42.11 126.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.405 1.482 . . . . 0.98 110.725 159.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.27 -60.26 0.26 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.067 1.318 . . . . 1.97 114.429 -170.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -174.79 160.2 2.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.499 1.92 . . . . 2.75 110.738 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -152.69 148.64 27.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.163 1.542 . . . . 1.86 115.163 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.62 56.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 130.149 3.38 . . . . 6.21 108.838 173.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.48 -177.94 39.92 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 113.226 -1.806 . . . . 0.64 114.316 146.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.3 p -115.61 177.74 4.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.633 1.173 . . . . 0.77 110.928 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.04 133.31 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.336 -0.987 . . . . 0.48 108.336 156.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.3 p -87.49 119.49 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.65 0.593 . . . . 0.94 110.337 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.15 117.73 47.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.191 -1.411 . . . . 1.4 107.191 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -119.76 125.35 48.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.288 1.435 . . . . 2.4 108.563 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.22 130.99 34.34 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.371 -0.603 . . . . 3.34 109.371 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.6 t -148.86 -179.62 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.166 0.439 . . . . 1.29 110.378 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.22 -4.27 40.95 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.918 1.081 . . . . 3.71 113.918 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.3 9.57 67.28 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 124.159 0.885 . . . . 1.18 114.18 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.1 -146.47 21.97 Favored Glycine 0 N--CA 1.463 0.448 0 C-N-CA 128.417 2.913 . . . . 0.93 115.536 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.9 104.65 7.51 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.3 0.64 . . . . 0.87 111.107 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -84.6 115.18 22.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.791 2.036 . . . . 3.8 109.988 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.26 104.65 14.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.776 1.63 . . . . 1.03 109.58 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.0 m -110.27 109.21 58.69 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.519 1.054 . . . . 0.75 108.346 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.1 159.36 18.0 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.586 2.858 . . . . 0.64 111.127 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -146.41 27.23 1.14 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 121.418 0.628 . . . . 1.34 112.479 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.85 140.86 30.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.805 -1.184 . . . . 0.69 111.308 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 26.69 8.01 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.452 1.649 . . . . 2.21 115.452 -170.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.18 81.14 1.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.717 0.807 . . . . 1.55 110.933 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.72 163.36 41.29 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.839 1.256 . . . . 1.35 110.407 168.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.29 128.97 24.02 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 121.006 1.137 . . . . 0.8 110.619 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -79.8 25.23 0.6 Allowed 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 126.563 4.842 . . . . 0.93 113.047 -162.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.6 -124.7 1.48 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 126.725 2.107 . . . . 1.37 112.571 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -151.28 138.71 19.49 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.77 1.228 . . . . 2.9 110.842 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -136.69 142.73 43.15 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.081 0.771 . . . . 1.11 113.081 -163.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.07 153.77 51.63 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 111.28 -0.728 . . . . 0.77 111.28 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -131.79 115.54 16.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.49 1.116 . . . . 1.98 108.161 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.424 ' HA ' HD22 ' A' ' 94' ' ' LEU . 16.9 m170 -115.97 165.67 12.85 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 117.121 2.267 . . . . 1.01 117.121 167.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.0 mt -108.05 148.34 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 128.414 2.686 . . . . 0.77 108.045 154.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -126.16 163.39 23.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.94 1.296 . . . . 1.17 110.425 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.4 75.91 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.586 1.699 . . . . 0.99 115.586 -163.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.74 169.08 14.24 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.144 1.378 . . . . 1.84 113.144 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.9 93.91 1.53 Allowed Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.005 1.288 . . . . 1.21 113.087 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -151.58 57.05 0.87 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.816 1.413 . . . . 3.63 114.816 -165.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.6 m -64.72 37.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 116.505 2.039 . . . . 1.5 116.505 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -137.1 143.66 42.92 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 119.606 -1.934 . . . . 3.77 110.889 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.12 148.77 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.234 2.623 . . . . 1.02 113.432 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.3 137.1 40.92 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.489 -0.778 . . . . 1.38 109.669 157.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.73 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.993 -1.114 . . . . 2.82 107.993 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -147.21 133.66 19.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.15 0.98 . . . . 4.15 111.042 -160.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.21 19.22 5.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.181 1.393 . . . . 3.72 113.151 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.05 63.15 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.086 1.327 . . . . 2.71 115.313 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -137.27 -177.76 4.91 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.685 1.243 . . . . 3.09 111.714 169.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.85 115.59 26.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.186 0.994 . . . . 1.65 112.456 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -87.2 79.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.106 1.362 . . . . 1.77 110.47 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 19.89 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.33 3.452 . . . . 2.3 117.991 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.44 41.64 0.88 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.557 1.943 . . . . 2.04 110.766 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -54.76 -37.19 65.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.144 -0.973 . . . . 4.03 113.582 -169.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -4.48 17.98 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.54 1.311 . . . . 2.06 114.54 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.1 -7.45 58.9 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.085 -1.009 . . . . 1.49 113.706 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 -179.35 32.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.807 -1.183 . . . . 2.05 113.882 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.26 175.51 50.96 Favored Glycine 0 N--CA 1.474 1.222 0 N-CA-C 110.998 -0.841 . . . . 1.9 110.998 161.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.44 36.06 0.19 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.608 1.204 . . . . 2.94 113.561 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.5 tp 65.07 78.62 0.28 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.705 2.002 . . . . 1.79 112.349 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 90' ' ' HIS . 44.5 t0 -156.15 124.68 2.94 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 126.543 1.937 . . . . 5.62 111.152 166.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.25 -22.52 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.216 2.611 . . . . 2.36 113.838 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -145.7 -31.11 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.255 1.946 . . . . 4.65 116.255 -157.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -60.63 -42.33 96.68 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 121.111 1.778 . . . . 4.57 111.561 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 179.52 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.909 2.484 . . . . 2.18 112.419 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 -15.91 4.18 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.541 -1.349 . . . . 2.36 114.331 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -58.79 -82.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.614 1.965 . . . . 4.78 113.39 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.68 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 81.1 t60 153.32 128.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 129.754 3.221 . . . . 1.44 110.479 -174.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -130.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.365 1.066 . . . . 3.71 111.94 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.24 -51.1 0.85 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.498 1.999 . . . . 2.78 111.761 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -104.14 -22.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.692 2.261 . . . . 3.11 114.877 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -157.25 28.61 0.3 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.302 1.41 . . . . 5.24 114.539 -160.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.05 -12.07 5.64 Favored Glycine 0 N--CA 1.477 1.43 0 O-C-N 119.662 -1.899 . . . . 3.94 116.425 166.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.89 83.56 3.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.152 1.381 . . . . 4.41 112.491 -170.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.51 116.02 4.16 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 124.424 1.012 . . . . 3.09 112.806 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 22.1 m170 90.52 123.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.978 2.511 . . . . 3.14 110.973 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.38 -12.51 24.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.005 0.522 . . . . 2.29 111.692 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.17 22.56 18.54 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.144 1.354 . . . . 1.05 113.985 165.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.68 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 79.3 m-20 -101.26 124.85 47.6 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.374 1.587 . . . . 2.66 109.71 164.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -117.52 164.15 20.7 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.825 1.65 . . . . 1.8 109.316 -174.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.11 161.84 35.0 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.121 2.547 . . . . 1.06 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.63 131.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 122.608 1.194 . . . . 1.67 113.696 -165.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.85 86.25 4.09 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.439 2.696 . . . . 1.82 108.814 176.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 142.55 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.583 0.753 . . . . 1.45 109.1 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -122.77 150.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.702 2.001 . . . . 1.74 107.832 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -94.39 150.88 19.85 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.762 0.652 . . . . 2.28 112.762 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -42.77 -3.47 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 131.616 3.966 . . . . 3.52 118.518 176.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 -16.46 20.85 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 119.625 -1.922 . . . . 2.94 112.507 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.9 27.49 7.01 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.718 1.628 . . . . 0.72 112.796 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.2 mt -121.89 127.13 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.72 1.208 . . . . 1.66 111.172 -171.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.84 123.95 29.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.932 0.893 . . . . 1.17 108.926 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -139.0 -15.27 1.14 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.88 2.178 . . . . 2.68 116.88 -167.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.48 127.91 74.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 121.413 1.915 . . . . 5.27 112.812 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.14 85.69 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.258 3.305 . . . . 1.91 110.06 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.01 122.16 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.826 0.851 . . . . 2.08 110.045 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -120.03 126.93 52.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.529 0.732 . . . . 1.14 110.54 -164.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.45 113.64 45.5 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.39 -0.814 . . . . 1.19 112.626 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.79 8.59 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.96 3.107 . . . . 1.31 113.447 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -71.78 -22.02 61.64 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.462 -0.774 . . . . 4.25 112.177 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.9 mt -139.52 160.16 40.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 130.155 3.382 . . . . 2.57 106.532 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.414 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -148.26 10.23 0.87 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.948 2.203 . . . . 6.38 116.948 -175.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 p -156.25 157.0 35.05 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.694 -0.629 . . . . 2.21 110.934 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.97 -24.15 52.31 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.015 -1.053 . . . . 1.47 112.653 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -54.31 -37.4 64.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.236 1.415 . . . . 3.85 113.788 -176.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.19 -5.41 49.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.015 2.126 . . . . 1.61 114.256 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 4.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.033 1.333 . . . . 1.75 113.135 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -66.07 7.08 0.32 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.832 2.16 . . . . 2.03 116.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.31 14.0 3.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.386 2.274 . . . . 3.54 111.163 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.53 159.0 43.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.136 1.532 . . . . 1.2 115.136 -157.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.79 157.29 16.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.212 1.405 . . . . 0.62 112.828 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 mt -120.41 136.2 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.533 2.733 . . . . 1.56 107.6 173.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -125.94 128.27 47.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.908 0.776 . . . . 2.17 112.122 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.08 122.92 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.799 -1.186 . . . . 0.87 107.799 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -115.34 141.42 48.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.109 1.763 . . . . 2.07 111.918 -160.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.81 -13.82 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 116.041 1.867 . . . . 2.56 116.041 -156.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.36 160.32 25.47 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.309 -1.116 . . . . 1.07 110.309 162.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.36 121.1 15.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.648 -1.381 . . . . 1.85 109.648 163.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.63 1.28 14.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.984 0.914 . . . . 3.67 112.945 -158.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -66.2 28.81 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 129.922 3.289 . . . . 3.46 115.867 -172.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.1 mtm -114.22 105.21 12.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.531 1.932 . . . . 2.91 110.219 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 p -77.3 14.62 0.9 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.043 2.137 . . . . 3.0 113.952 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.72 4.73 0.77 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.787 1.773 . . . . 4.56 115.787 -155.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -96.35 143.02 25.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.114 0.965 . . . . 4.54 110.328 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.2 -27.1 29.52 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.735 2.957 . . . . 3.0 113.192 -173.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -87.01 107.74 15.66 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.706 -1.22 . . . . 4.13 107.706 148.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.95 175.08 7.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.791 2.327 . . . . 3.19 110.925 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 61.16 34.97 18.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.161 0.984 . . . . 3.16 109.175 -170.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.99 5.9 8.57 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.95 1.262 . . . . 3.22 115.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.52 63.11 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-N 119.297 1.549 . . . . 2.32 113.99 -165.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.15 16.29 59.44 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.967 2.223 . . . . 1.74 113.97 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.76 -6.02 62.24 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.311 1.434 . . . . 1.55 116.574 -170.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.3 m -66.98 162.53 21.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.369 1.585 . . . . 2.57 110.401 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.84 139.0 31.11 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.405 2.282 . . . . 7.79 114.375 -177.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.82 -27.52 9.25 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 118.921 0.782 . . . . 2.7 112.654 154.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -154.6 155.37 34.6 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.658 1.117 . . . . 0.57 113.637 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.42 147.86 50.53 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.426 1.891 . . . . 1.56 110.499 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.41 134.14 4.4 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.791 1.186 . . . . 0.73 112.515 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.12 133.91 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.139 1.375 . . . . 1.77 109.009 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 mt -70.65 118.11 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 122.269 1.033 . . . . 0.98 111.032 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 123.669 0.787 . . . . 7.55 111.819 -177.715 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.253 -0.277 . . . . 2.94 110.253 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -163.69 132.67 3.88 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.207 -1.558 . . . . 1.45 107.394 -163.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -144.79 120.88 10.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.123 1.44 . . . . 3.82 113.409 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.11 74.3 6.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.839 1.655 . . . . 3.62 110.824 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 t -70.59 122.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.286 -0.884 . . . . 1.23 111.881 -158.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.606 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -70.51 90.29 0.37 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 128.708 3.052 . . . . 1.06 112.11 175.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 mtt -82.69 148.53 27.86 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.601 1.161 . . . . 1.42 111.311 170.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -115.95 158.32 23.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.475 1.131 . . . . 2.41 110.915 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.09 124.8 26.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.958 1.303 . . . . 1.08 107.496 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.9 m -143.51 151.21 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.385 1.074 . . . . 1.13 110.813 -174.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 t 171.27 121.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.044 2.538 . . . . 3.28 110.387 163.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.59 -38.26 0.27 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.515 2.726 . . . . 1.36 116.724 167.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -9.11 49.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.204 1.402 . . . . 2.92 111.871 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.24 -156.19 19.95 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 125.277 1.418 . . . . 0.94 113.385 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 10' ' ' VAL . 90.2 t -63.92 110.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.209 1.403 . . . . 0.79 110.301 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.67 -86.06 1.16 Allowed Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.226 1.393 . . . . 1.46 112.255 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.24 164.56 37.86 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.382 1.473 . . . . 1.65 109.392 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -104.52 170.32 7.96 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.363 1.065 . . . . 1.14 113.339 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 pt -151.77 8.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 127.636 2.374 . . . . 2.77 112.372 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.14 173.02 20.68 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.011 0.815 . . . . 0.65 113.809 -166.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.606 HG22 ' HA2' ' A' ' 6' ' ' GLY . 77.1 p -131.44 173.97 10.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.558 1.943 . . . . 1.15 108.472 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.37 129.78 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 107.906 -1.146 . . . . 0.59 107.906 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -78.38 109.95 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.612 0.642 . . . . 1.01 109.788 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 24' ' ' ILE . 34.1 mt -89.79 125.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.539 -1.282 . . . . 1.14 107.539 160.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.504 0.668 . . . . 2.37 110.312 166.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.29 130.7 37.54 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.084 1.754 . . . . 3.53 109.539 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -149.21 -179.77 7.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.039 0.447 . . . . 1.64 110.272 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.06 -29.6 69.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.809 1.244 . . . . 3.53 111.751 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.28 66.16 Favored Glycine 0 N--CA 1.471 1.009 0 C-N-CA 124.696 1.141 . . . . 1.4 114.885 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 -140.31 18.37 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 127.685 2.564 . . . . 1.13 114.734 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.28 93.79 7.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.201 1.0 . . . . 0.71 110.15 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.4 tttp -76.19 108.78 9.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.364 1.466 . . . . 2.3 108.869 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.1 t80 -97.78 110.37 22.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.024 2.53 . . . . 0.51 109.309 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 5.6 m -124.19 115.09 27.53 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.889 1.222 . . . . 0.72 109.635 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.25 155.96 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.12 2.546 . . . . 0.49 111.42 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -149.93 54.12 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.566 1.174 . . . . 1.8 111.007 166.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -107.24 134.56 50.15 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.921 1.288 . . . . 0.73 111.232 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -109.25 21.15 17.48 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.265 1.95 . . . . 2.25 116.265 -160.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.96 65.51 0.19 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.128 0.971 . . . . 1.35 113.567 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.53 161.28 49.07 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 124.519 1.128 . . . . 1.49 111.968 174.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.03 128.72 21.28 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.675 1.583 . . . . 0.9 109.904 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 5.0 Cg_endo -85.74 41.75 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 1 C-N-CA 126.345 4.696 . . . . 1.03 112.553 -157.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.79 -132.83 7.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.974 1.749 . . . . 1.45 113.37 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -139.32 134.96 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.95 1.7 . . . . 2.86 110.065 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -137.13 118.79 14.98 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.163 0.985 . . . . 1.06 111.754 -165.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.05 130.04 36.12 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.158 -1.177 . . . . 1.09 110.158 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -108.87 124.4 50.58 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.962 -1.496 . . . . 2.0 106.962 175.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -123.41 171.52 9.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.924 1.453 . . . . 1.09 114.924 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mt -108.79 137.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.342 1.457 . . . . 0.69 109.297 158.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -109.62 175.32 5.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.074 1.75 . . . . 1.21 113.156 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.87 67.27 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.414 1.635 . . . . 1.28 115.414 -164.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -116.95 -167.18 1.26 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.082 1.353 . . . . 1.2 111.152 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.46 86.39 0.18 Allowed Glycine 0 N--CA 1.472 1.05 0 O-C-N 120.794 -1.191 . . . . 0.94 114.117 -173.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -177.98 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.746 2.018 . . . . 2.27 110.452 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.04 35.31 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.745 2.418 . . . . 1.27 116.632 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -115.13 134.19 22.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 120.207 -1.558 . . . . 3.95 111.91 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -86.75 156.24 8.87 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.211 3.274 . . . . 1.34 112.861 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.78 139.4 30.58 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.131 -0.94 . . . . 2.04 109.676 156.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mm -86.11 115.96 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.749 -1.204 . . . . 2.67 107.749 167.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -171.34 135.75 0.97 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.052 1.341 . . . . 5.27 109.469 -149.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 t70 52.27 41.49 30.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.648 1.579 . . . . 4.14 114.488 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.55 79.4 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.059 -1.026 . . . . 2.92 114.578 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -152.34 -164.94 2.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.526 1.531 . . . . 3.19 110.074 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.28 122.31 40.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.191 -0.943 . . . . 1.75 110.857 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.7 t -79.4 79.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.254 -0.647 . . . . 2.64 109.254 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 12.19 -68.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 131.298 3.839 . . . . 2.04 117.677 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.04 74.92 1.0 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.752 1.621 . . . . 2.24 109.81 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.51 -37.52 75.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.649 0.78 . . . . 4.91 112.17 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.21 -3.52 52.58 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.251 1.204 . . . . 1.55 114.251 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.92 18.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.53 1.132 . . . . 1.14 112.601 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.09 -177.87 50.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.266 1.266 . . . . 2.64 116.266 162.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.42 -166.02 14.36 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.73 1.157 . . . . 1.19 113.288 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -59.69 145.45 44.84 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 109.189 -0.671 . . . . 3.07 109.189 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.5 tp -74.97 87.53 2.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.976 -1.077 . . . . 1.67 110.783 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.64 110.11 0.96 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.449 1.5 . . . . 3.32 112.632 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.46 -50.84 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.024 2.483 . . . . 2.33 110.998 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -127.52 126.58 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.029 1.332 . . . . 3.31 109.921 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.356 12.2 p30 162.52 -108.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.887 3.675 . . . . 3.74 110.768 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -155.0 -40.35 0.09 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.485 1.514 . . . . 2.86 112.609 -167.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.43 -49.59 4.21 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.079 0.847 . . . . 3.74 114.658 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 20.7 ptmt -49.68 -51.33 39.08 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.446 1.647 . . . . 4.73 115.446 -151.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.448 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 161.26 136.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 129.42 3.088 . . . . 2.16 113.022 157.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.27 -57.52 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.199 1.185 . . . . 4.17 114.199 -163.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.34 -108.91 0.19 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.019 1.771 . . . . 3.32 114.901 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.23 -33.43 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.502 2.135 . . . . 4.52 113.462 -174.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -137.35 2.79 2.53 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.249 1.574 . . . . 6.29 115.249 -161.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.64 58.4 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.131 -1.606 . . . . 3.0 116.455 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -77.63 63.86 2.82 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.14 1.47 . . . . 6.3 112.345 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.47 -144.55 4.86 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 116.645 1.418 . . . . 2.15 116.645 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.948 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 14.2 p-80 -145.93 156.3 43.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.994 1.318 . . . . 4.87 112.278 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.18 -22.47 64.76 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.644 1.35 . . . . 2.05 114.644 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.47 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -96.13 4.66 65.25 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.595 2.045 . . . . 0.83 114.957 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.948 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 8.6 m-20 -62.23 143.16 57.19 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.256 1.528 . . . . 2.34 107.255 153.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.4 -174.58 0.43 Allowed Pre-proline 0 CA--C 1.56 1.352 0 O-C-N 120.844 -1.16 . . . . 1.87 109.893 -155.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.99 169.94 14.23 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.632 2.222 . . . . 1.07 112.722 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.94 126.99 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.878 0.871 . . . . 1.84 110.975 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 81.8 1.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.869 2.068 . . . . 1.85 108.552 164.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.97 142.17 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.128 -1.064 . . . . 1.09 108.128 168.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.65 138.31 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.254 1.422 . . . . 1.7 109.475 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 142.53 56.74 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 112.827 0.676 . . . . 1.74 112.827 174.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -50.07 -17.91 0.48 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.881 2.472 . . . . 2.15 117.542 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -93.77 -12.4 29.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.245 1.418 . . . . 2.75 113.266 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 21.63 16.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.228 0.918 . . . . 0.79 114.847 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.27 125.53 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.418 -1.327 . . . . 1.23 107.418 169.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.5 125.96 34.11 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.492 -0.559 . . . . 0.65 109.492 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -139.97 -6.51 1.26 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.193 2.197 . . . . 0.99 112.953 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -73.22 113.83 25.65 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 128.0 2.52 . . . . 5.13 111.827 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.01 142.94 28.43 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.333 2.689 . . . . 1.18 111.907 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.84 168.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.469 1.508 . . . . 1.12 109.574 167.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -140.74 141.02 34.93 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 119.242 0.928 . . . . 0.76 110.459 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.95 95.15 16.39 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.374 1.07 . . . . 0.81 111.122 172.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.25 6.49 4.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.568 3.512 . . . . 1.56 114.431 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -85.92 -5.17 59.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.33 1.052 . . . . 4.13 112.026 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.75 160.81 25.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.452 2.701 . . . . 2.33 107.345 169.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.75 -7.21 1.1 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.008 1.485 . . . . 4.54 115.008 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.8 m -133.81 130.27 37.71 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.099 0.96 . . . . 2.03 110.413 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -26.24 66.84 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.753 -1.217 . . . . 2.37 111.019 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.74 -19.27 5.95 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.907 1.447 . . . . 3.51 114.907 165.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.35 -13.55 60.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.94 1.246 . . . . 2.09 112.067 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.42 2.34 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 114.263 1.209 . . . . 1.11 114.263 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -62.54 8.72 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 118.057 2.614 . . . . 2.56 118.057 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.72 17.64 1.28 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.219 1.408 . . . . 3.23 112.193 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -144.24 169.74 17.32 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.758 1.623 . . . . 1.68 112.212 -168.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.98 139.55 35.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.784 1.234 . . . . 0.69 113.439 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.3 mt -80.39 146.8 31.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.831 1.652 . . . . 1.98 108.359 158.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.02 126.89 22.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.03 0.832 . . . . 1.42 111.686 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.4 mt -88.62 111.55 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.374 -1.343 . . . . 0.75 107.374 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.9 150.29 21.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.194 2.198 . . . . 2.59 111.933 -175.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.29 -46.98 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.261 -0.899 . . . . 1.92 111.363 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.28 139.62 16.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.491 0.587 . . . . 1.76 112.996 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.06 143.21 41.0 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.592 2.044 . . . . 1.96 113.348 170.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -80.3 97.01 6.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.694 1.198 . . . . 3.42 111.037 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -177.68 -36.78 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.566 2.746 . . . . 4.45 109.73 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.9 mtm -61.46 130.48 46.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.95 -1.094 . . . . 2.35 112.964 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 t -157.77 -169.36 2.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.239 1.816 . . . . 3.09 109.803 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 64.73 -35.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 129.598 3.159 . . . . 3.78 116.405 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 155.64 14.32 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 127.029 2.132 . . . . 4.56 110.771 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.06 -6.18 18.64 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.711 2.941 . . . . 2.18 114.135 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -122.29 138.57 29.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.196 0.907 . . . . 3.98 110.359 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.69 144.37 77.85 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.298 2.666 . . . . 3.59 111.167 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.84 29.31 15.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.85 1.26 . . . . 5.93 111.357 -171.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.65 0.94 57.04 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.891 1.234 . . . . 3.09 114.276 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.46 -13.2 15.77 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.432 1.491 . . . . 1.74 112.848 -162.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 28.98 0.7 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.247 1.879 . . . . 1.42 114.455 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.31 -20.0 77.89 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.751 1.643 . . . . 1.65 113.089 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.5 p -60.94 155.39 19.99 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.613 1.565 . . . . 1.7 111.754 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mmt-85 -111.55 159.69 17.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.366 1.466 . . . . 4.62 111.214 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -107.27 -29.49 9.28 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.666 0.617 . . . . 2.53 112.666 152.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.48 38.3 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.141 -0.975 . . . . 0.66 113.571 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 50.4 t -135.36 151.59 50.63 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.272 2.229 . . . . 1.63 108.947 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -155.1 123.87 1.42 Allowed Glycine 0 N--CA 1.468 0.782 0 C-N-CA 123.966 0.793 . . . . 0.7 113.096 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.9 127.87 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.039 1.335 . . . . 1.7 109.492 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mt -79.14 125.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.257 1.027 . . . . 0.86 110.983 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt . . . . . 0 C--O 1.238 0.489 0 C-N-CA 127.212 2.205 . . . . 3.85 109.417 173.665 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.745 -0.465 . . . . 2.39 109.745 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -153.28 136.12 15.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.155 -1.054 . . . . 1.28 108.155 -162.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.67 129.88 8.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.517 1.151 . . . . 2.64 112.836 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -88.2 94.79 9.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.751 1.22 . . . . 3.98 109.393 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.52 123.84 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.833 -0.542 . . . . 1.06 110.224 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.12 107.47 2.2 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.518 1.532 . . . . 0.8 110.835 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 13.9 mmt -81.62 101.04 9.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.8 1.24 . . . . 1.38 110.65 172.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.66 137.79 36.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.411 -0.959 . . . . 2.66 108.411 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.07 138.88 58.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.422 -0.955 . . . . 1.38 108.422 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -136.36 163.48 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.829 0.852 . . . . 1.15 112.328 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -167.78 -148.2 0.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.677 1.991 . . . . 2.85 108.404 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.96 17.38 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.941 3.697 . . . . 1.58 115.686 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.84 -6.02 5.07 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.007 -1.683 . . . . 3.9 111.739 171.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.14 -141.72 31.85 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.224 -1.551 . . . . 2.14 109.224 -158.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -39.22 113.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.752 1.621 . . . . 1.65 112.531 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.52 -77.05 1.16 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.16 1.838 . . . . 1.45 112.335 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.67 153.77 25.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.492 0.717 . . . . 1.72 112.351 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -97.2 132.96 42.45 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.531 1.308 . . . . 1.06 114.531 -170.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mm -122.19 -17.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.606 1.562 . . . . 4.54 115.212 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.53 28.81 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 121.055 -1.028 . . . . 0.73 113.306 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -95.52 176.45 6.17 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.162 -0.681 . . . . 0.77 109.162 164.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 33' ' ' PHE . 23.2 t -135.49 129.99 49.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.001 -1.481 . . . . 0.49 107.001 160.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -97.57 119.25 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.307 0.575 . . . . 0.85 111.674 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.27 135.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.728 1.211 . . . . 1.46 108.837 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -139.25 100.8 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.819 1.648 . . . . 2.5 108.791 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.7 132.9 38.38 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 128.039 2.536 . . . . 3.17 109.709 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -154.63 -168.89 3.05 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.475 0.31 . . . . 1.21 111.662 -166.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -57.36 -31.92 66.23 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.948 1.299 . . . . 5.12 113.34 -176.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.5 22.84 38.13 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.856 1.693 . . . . 0.99 114.386 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.14 -144.82 23.96 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.686 1.136 . . . . 0.74 114.355 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.3 mt -80.36 104.38 10.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.836 0.854 . . . . 0.64 111.924 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -83.2 111.81 19.27 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.373 -0.829 . . . . 1.87 110.696 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 22' ' ' VAL . 0.8 OUTLIER -97.52 125.51 42.27 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.105 1.762 . . . . 0.91 110.151 -177.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 m -127.84 110.82 20.38 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 117.993 -1.003 . . . . 0.63 109.458 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -91.85 158.16 3.4 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.461 2.774 . . . . 0.51 112.542 -169.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -148.23 36.47 0.83 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 121.741 0.781 . . . . 1.43 112.485 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -92.67 160.49 14.97 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.709 -1.869 . . . . 0.8 113.001 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 18.38 1.87 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.486 2.402 . . . . 2.32 117.486 -167.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.58 70.89 0.61 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.002 0.921 . . . . 1.31 110.198 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.714 HD12 HG11 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -124.18 168.56 12.57 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.187 0.995 . . . . 1.73 109.325 170.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -52.8 137.17 60.29 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.987 1.792 . . . . 1.18 110.825 159.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -89.57 26.42 0.54 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.85 2.367 . . . . 1.41 114.243 -151.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.53 -149.23 8.64 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 123.387 1.548 . . . . 1.34 115.677 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.38 139.97 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.268 2.227 . . . . 3.26 111.511 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -131.47 131.63 43.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.522 0.729 . . . . 1.33 110.911 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.38 152.76 47.01 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-N 118.782 0.719 . . . . 0.74 111.646 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.417 ' CE1' ' CE2' ' A' ' 33' ' ' PHE . 5.2 t80 -128.36 108.92 10.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.054 -1.462 . . . . 1.88 107.054 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -112.43 165.57 12.09 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.829 1.418 . . . . 0.71 114.829 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.69 138.08 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.997 1.719 . . . . 1.19 108.251 158.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -118.31 155.01 31.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.258 1.823 . . . . 0.96 108.985 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.11 73.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.625 1.713 . . . . 0.77 115.625 -157.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -132.21 163.63 28.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.283 1.033 . . . . 1.37 112.816 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.47 84.58 1.16 Allowed Glycine 0 N--CA 1.469 0.85 0 O-C-N 120.822 -1.174 . . . . 0.95 113.55 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -160.11 89.58 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.152 0.977 . . . . 2.31 113.127 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.7 m -67.53 48.72 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.136 2.574 . . . . 1.45 113.759 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -131.61 139.79 36.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.215 1.406 . . . . 3.35 112.663 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.38 166.19 4.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.887 3.058 . . . . 0.89 112.848 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.67 144.32 42.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.073 0.949 . . . . 1.5 110.098 164.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.4 59.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.224 1.01 . . . . 3.01 109.742 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 152.65 42.8 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.774 -0.579 . . . . 4.25 110.226 165.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t0 54.75 18.91 2.3 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.916 1.686 . . . . 3.75 114.131 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.18 77.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.075 1.321 . . . . 2.92 114.644 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.23 146.43 40.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.702 1.251 . . . . 3.35 111.18 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.64 18.57 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.899 -1.125 . . . . 1.7 113.383 -165.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.08 92.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.545 1.138 . . . . 1.94 109.645 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -24.95 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 130.193 3.397 . . . . 2.02 118.61 -166.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.501 ' HB3' HH21 ' A' ' 147' ' ' ARG . . . -151.21 124.01 8.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.861 0.755 . . . . 1.9 109.905 158.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.61 -48.7 4.24 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.846 0.858 . . . . 4.24 110.252 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.28 -14.96 59.09 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.59 1.33 . . . . 1.33 114.59 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.09 -7.9 10.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.931 1.292 . . . . 0.9 114.227 169.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.3 -28.09 11.81 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 120.58 -1.325 . . . . 3.18 115.046 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.4 -170.93 20.82 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.396 1.474 . . . . 1.38 111.774 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -60.85 148.69 38.52 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.077 0.938 . . . . 3.03 110.149 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.5 tp -78.06 73.08 4.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.758 1.223 . . . . 1.97 111.919 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.48 104.15 28.49 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.65 1.18 . . . . 3.83 110.606 158.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.5 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.236 2.624 . . . . 1.98 110.96 159.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -166.39 3.22 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.617 1.34 . . . . 4.26 114.617 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -68.45 -27.3 66.05 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.311 -1.493 . . . . 3.96 114.27 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 81' ' ' LYS . 18.9 m 114.47 139.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 1 C-N-CA 132.05 4.14 . . . . 4.83 107.138 -161.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.16 -12.97 56.93 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.093 1.33 . . . . 2.1 114.42 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.427 ' H ' HG22 ' A' ' 79' ' ' THR . 52.3 mttp -64.15 -6.0 5.84 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.441 2.015 . . . . 5.39 116.441 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.2 t60 83.22 144.8 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.207 2.203 . . . . 1.68 114.571 166.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -81.92 150.14 27.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.238 1.815 . . . . 3.61 110.982 -173.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.04 -112.95 0.39 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.659 -1.079 . . . . 2.47 114.619 171.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.63 -18.95 25.0 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.329 2.686 . . . . 3.39 112.453 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -123.11 155.96 35.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.89 2.076 . . . . 4.93 107.424 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.53 120.23 6.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.838 0.732 . . . . 3.0 111.61 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.69 21.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.107 2.163 . . . . 4.44 113.496 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.18 -151.8 13.33 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 123.208 1.449 . . . . 3.07 115.177 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -74.87 139.95 43.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.041 -1.079 . . . . 3.24 111.352 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -62.5 -21.65 65.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.342 0.497 . . . . 2.36 112.342 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.94 26.32 6.15 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.669 1.604 . . . . 1.04 115.425 172.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -111.17 131.68 54.91 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.778 1.789 . . . . 1.5 110.566 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.26 160.81 60.61 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.703 1.601 . . . . 2.2 110.452 -163.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.49 159.69 32.28 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.607 2.871 . . . . 0.9 112.526 -170.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 m -69.55 132.08 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 123.251 1.5 . . . . 1.62 114.81 -163.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.97 75.11 4.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.5 3.12 . . . . 1.68 109.072 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.06 136.09 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.046 -1.034 . . . . 1.09 111.398 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 40' ' ' LEU . 3.3 m -114.17 162.92 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.094 0.958 . . . . 2.06 110.151 161.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -88.96 171.0 10.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.101 0.56 . . . . 2.6 112.255 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -16.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 128.003 2.521 . . . . 2.91 117.804 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -96.66 -7.39 34.26 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.052 2.141 . . . . 2.9 113.381 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.46 21.0 30.51 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 119.135 0.879 . . . . 1.06 114.755 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.25 129.09 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.428 1.114 . . . . 1.54 111.961 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.686 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -99.42 126.85 45.39 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.29 2.236 . . . . 0.8 111.159 -172.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -157.19 18.2 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.962 1.097 . . . . 1.25 113.962 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -89.35 113.34 56.07 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.47 1.108 . . . . 3.28 109.372 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.54 138.91 19.92 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.191 3.261 . . . . 1.07 111.365 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.84 167.41 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.454 1.101 . . . . 1.16 111.464 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -136.5 134.09 37.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.256 1.022 . . . . 0.89 110.59 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.22 93.49 39.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.315 1.046 . . . . 0.72 112.674 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -77.65 94.77 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.361 2.707 . . . . 3.18 108.452 160.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -50.7 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.967 1.707 . . . . 5.2 109.11 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.12 162.57 25.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.078 1.351 . . . . 2.29 108.103 141.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -121.22 -24.67 5.43 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.219 1.192 . . . . 4.49 114.219 162.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 m -124.16 150.43 45.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.607 1.094 . . . . 2.37 113.922 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -37.2 86.57 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.208 -0.932 . . . . 2.3 110.842 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.93 -16.92 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.231 1.567 . . . . 3.89 115.231 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -83.53 -6.87 59.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 2.17 112.313 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.05 11.92 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.522 1.129 . . . . 0.8 113.417 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -65.66 13.25 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 117.756 2.502 . . . . 2.79 117.756 -172.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.73 23.14 0.69 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.423 1.889 . . . . 3.13 112.018 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -121.02 174.87 6.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.292 1.219 . . . . 1.24 114.292 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.28 140.48 44.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.722 1.209 . . . . 0.54 111.249 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.87 141.42 28.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 1.78 107.056 161.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.4 mtt -133.34 131.51 40.2 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.408 1.004 . . . . 1.23 112.173 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.3 110.37 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.64 1.176 . . . . 0.66 108.298 170.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.83 142.99 29.36 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.876 2.071 . . . . 2.35 111.737 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -58.95 -38.51 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 112.974 0.731 . . . . 1.54 112.974 -164.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.17 169.92 14.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.722 1.153 . . . . 1.56 111.473 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.26 166.78 24.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.458 1.028 . . . . 1.85 112.559 161.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.6 6.18 1.84 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.217 1.192 . . . . 2.78 114.217 -134.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.005 2.122 . . . . 3.99 114.759 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.5 mtm -138.71 63.44 1.52 Allowed 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.402 -1.436 . . . . 2.51 113.375 -161.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -64.69 -34.28 77.94 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.337 1.236 . . . . 3.09 114.337 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.38 67.34 9.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.965 1.098 . . . . 3.8 113.965 -162.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.61 154.81 25.97 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.703 1.601 . . . . 3.23 110.989 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.37 -23.15 38.49 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.466 2.777 . . . . 2.7 112.426 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.98 90.22 1.49 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.002 -1.11 . . . . 3.91 108.002 154.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.0 169.28 18.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.077 2.518 . . . . 3.85 111.445 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt 70.47 16.52 7.04 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.381 1.872 . . . . 3.81 110.602 -167.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 3.48 24.38 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.208 1.385 . . . . 2.84 113.839 -164.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.79 -1.34 52.23 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.785 1.659 . . . . 1.89 114.036 -165.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.3 43.41 1.28 Allowed Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.53 2.014 . . . . 1.66 115.239 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.58 -16.93 77.7 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.835 1.207 . . . . 1.83 115.055 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 p -76.52 146.71 38.25 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.532 1.533 . . . . 1.47 112.742 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.501 HH21 ' HB3' ' A' ' 67' ' ' ALA . 1.1 mpp_? -105.23 138.98 40.57 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.83 1.652 . . . . 4.44 110.39 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -91.55 -28.82 17.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.625 0.37 . . . . 2.64 111.266 164.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.72 159.68 44.15 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.608 0.966 . . . . 0.49 113.608 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 32.7 t -140.92 146.7 37.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.965 2.106 . . . . 1.41 110.316 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -141.98 100.44 0.26 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.079 1.799 . . . . 0.73 111.633 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.75 135.86 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.013 1.325 . . . . 2.35 111.729 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.56 150.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.37 1.468 . . . . 1.47 110.712 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.476 0.844 0 O-C-N 121.599 -0.688 . . . . 3.92 112.644 -177.404 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.549 0.214 . . . . 1.89 111.55 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -153.61 152.68 31.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.853 1.261 . . . . 1.27 109.549 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.2 132.4 11.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 123.071 1.415 . . . . 2.31 110.065 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -90.01 124.8 35.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 4.19 111.241 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.01 101.06 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 120.859 -1.15 . . . . 1.48 108.282 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 109.36 2.81 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.272 1.415 . . . . 1.08 109.907 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 77.6 mmm -87.35 149.35 24.56 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.925 0.89 . . . . 1.88 110.685 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.62 145.73 50.02 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.823 1.649 . . . . 2.56 109.954 168.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.79 140.43 58.87 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.617 -0.677 . . . . 1.6 109.572 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.79 152.61 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.693 0.759 . . . . 1.02 110.821 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -151.87 -165.08 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.794 1.638 . . . . 2.64 107.599 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' C ' HE21 ' A' ' 13' ' ' GLN . . . -64.4 -0.15 1.22 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.233 2.213 . . . . 1.7 113.326 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.409 HE21 ' C ' ' A' ' 12' ' ' ALA . 2.3 mm-40 -109.71 -9.98 14.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.502 1.921 . . . . 2.71 111.875 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.53 -161.85 21.39 Favored Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.014 1.292 . . . . 1.11 113.85 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.71 127.32 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.392 1.877 . . . . 0.9 111.693 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.69 -86.09 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.643 1.592 . . . . 1.47 114.262 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.49 170.5 22.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.784 2.434 . . . . 2.03 109.199 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -106.22 159.47 16.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.76 8.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 128.899 2.879 . . . . 3.22 113.034 -169.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.13 168.67 15.47 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.694 1.14 . . . . 0.85 113.4 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 p -115.19 -177.27 3.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.534 1.534 . . . . 0.86 109.335 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.45 138.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.821 -1.548 . . . . 0.69 106.821 158.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 p -91.78 131.87 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.077 0.398 . . . . 0.93 110.556 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -107.63 131.66 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.343 1.057 . . . . 1.44 109.218 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.51 145.18 50.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.92 0.888 . . . . 1.92 111.036 170.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.354 8.4 tm-20 -101.38 107.23 18.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.741 2.816 . . . . 3.79 108.129 -162.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -130.7 175.6 8.89 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.839 1.199 . . . . 2.84 112.128 -167.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.82 -8.41 57.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.436 1.094 . . . . 5.63 112.794 172.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.71 14.63 58.94 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.035 1.302 . . . . 1.14 113.27 159.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.27 -151.05 32.57 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 128.299 2.857 . . . . 0.79 115.592 174.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -69.68 112.76 6.37 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.758 -0.848 . . . . 0.95 112.963 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -88.86 106.77 18.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.938 2.095 . . . . 2.05 110.787 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -92.8 117.09 29.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.574 2.35 . . . . 0.62 108.912 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -125.77 114.93 24.69 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-N 120.478 1.49 . . . . 0.69 109.327 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.1 163.4 5.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.323 2.682 . . . . 0.55 112.379 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -151.86 20.37 0.69 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.703 1.001 . . . . 1.51 113.703 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.74 145.21 28.04 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.011 -1.055 . . . . 0.81 111.749 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -119.2 19.91 12.74 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.869 1.803 . . . . 2.74 115.869 -164.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.86 54.81 0.66 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.794 0.838 . . . . 1.51 112.174 -165.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.95 160.34 69.03 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.997 0.919 . . . . 1.56 112.553 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 37.5 Cg_endo -62.59 132.73 39.17 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.871 1.714 . . . . 1.27 110.711 174.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.407 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 15.7 Cg_endo -89.04 25.39 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.679 2.253 . . . . 1.29 114.259 -143.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.34 -152.85 12.49 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 116.908 1.523 . . . . 1.25 116.908 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.96 147.04 23.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.95 2.1 . . . . 2.47 109.851 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -149.2 148.15 29.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.087 0.955 . . . . 1.19 112.842 -165.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.53 156.63 53.51 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.191 -0.943 . . . . 0.56 110.936 162.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.34 121.59 11.56 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 106.134 -1.802 . . . . 1.93 106.134 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -126.99 170.69 12.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.685 1.735 . . . . 0.98 115.685 175.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -101.56 143.06 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.281 1.832 . . . . 0.68 109.492 160.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -129.57 141.09 51.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.712 2.005 . . . . 1.09 109.641 -172.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -28.49 66.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.059 2.244 . . . . 0.72 117.059 -158.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -127.29 152.17 47.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.443 1.019 . . . . 1.18 112.739 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.81 78.79 1.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.358 0.98 . . . . 0.96 111.785 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -164.54 72.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.103 0.954 . . . . 2.14 113.316 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.4 m -68.16 8.84 0.38 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.83 2.159 . . . . 1.6 116.83 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.17 138.79 52.55 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.089 -1.632 . . . . 3.72 110.771 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.28 165.67 6.77 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.217 3.278 . . . . 1.42 111.341 172.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.56 -172.08 2.58 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.54 0.686 . . . . 2.57 109.808 150.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.1 mm -96.64 146.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.728 1.211 . . . . 3.59 109.402 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.0 138.95 3.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.504 2.322 . . . . 5.48 108.866 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.84 32.0 16.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.233 1.413 . . . . 5.9 112.621 -173.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.89 3.53 87.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.186 1.374 . . . . 3.4 115.605 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.98 157.91 45.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.077 1.438 . . . . 4.68 112.563 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.51 131.52 34.63 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.886 -1.134 . . . . 2.17 112.269 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.0 33.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.382 0.882 . . . . 2.14 113.382 -172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.61 -6.38 0.12 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 119.184 3.031 . . . . 2.63 119.184 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 131.93 101.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 1 C-N-CA 133.005 4.522 . . . . 1.45 106.506 -173.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.41 -59.41 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.203 1.001 . . . . 4.7 111.872 -154.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.31 -17.86 59.84 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.156 0.798 . . . . 1.6 113.156 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.96 0.68 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.031 2.132 . . . . 0.82 115.634 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.69 25.29 9.99 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 116.272 1.269 . . . . 2.93 116.272 159.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 -119.83 5.12 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 110.452 -1.059 . . . . 2.78 110.452 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -97.47 -102.47 0.19 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.144 -1.058 . . . . 3.54 108.144 149.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.5 tp -174.24 93.32 0.08 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.494 2.318 . . . . 1.87 108.672 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -159.64 124.52 2.19 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 125.651 1.581 . . . . 4.24 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.03 -31.56 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.478 2.785 . . . . 2.27 114.568 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -160.2 -7.91 0.05 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.328 1.422 . . . . 3.69 114.388 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -76.01 -48.89 19.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.244 1.018 . . . . 3.28 112.61 -160.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -163.34 -41.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.473 1.286 . . . . 2.91 114.473 -174.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.52 -19.98 2.32 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.047 -1.418 . . . . 2.32 114.538 -167.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -72.0 -80.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.212 2.006 . . . . 4.19 113.289 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.8 t60 160.69 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 130.27 3.428 . . . . 1.52 111.027 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.411 ' CG ' ' H ' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -71.75 -154.29 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.345 1.458 . . . . 3.16 111.939 173.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 83' ' ' GLU . . . 113.76 -80.1 0.28 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.801 1.667 . . . . 3.08 112.259 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.49 -7.77 5.6 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.849 3.033 . . . . 4.81 113.668 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -153.45 145.18 23.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.607 1.563 . . . . 5.24 110.457 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.35 84.25 1.42 Allowed Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.986 1.279 . . . . 2.7 112.068 -173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.72 13.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.526 1.53 . . . . 4.5 113.011 -162.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.3 -161.68 37.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.489 1.519 . . . . 2.28 115.223 -168.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -74.58 133.68 42.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.924 -0.638 . . . . 3.8 109.65 173.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.93 2.66 3.26 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.085 1.883 . . . . 2.72 116.085 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.87 0.32 51.97 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.892 1.711 . . . . 1.25 115.129 168.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -79.0 147.02 33.04 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.956 1.378 . . . . 1.68 111.673 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.92 159.05 27.33 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.812 0.845 . . . . 1.81 110.282 -144.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.04 149.33 64.96 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.359 2.706 . . . . 1.05 112.419 -171.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.37 128.23 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.438 1.113 . . . . 1.76 112.983 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.0 tp -82.51 132.09 35.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.513 2.725 . . . . 2.38 110.315 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.69 137.67 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.84 -1.162 . . . . 0.96 109.662 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.49 151.97 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 107.434 -1.321 . . . . 2.22 107.434 161.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.06 157.5 26.7 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.384 0.513 . . . . 2.17 112.384 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.9 OUTLIER -58.96 -10.11 2.3 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.724 1.75 . . . . 2.65 115.724 -174.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.79 -12.59 41.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 2.44 113.597 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.63 17.04 11.66 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.081 1.324 . . . . 0.73 116.037 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.46 134.96 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.541 1.171 . . . . 1.89 110.707 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.14 135.6 33.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.891 1.676 . . . . 0.86 111.379 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -158.83 -19.79 0.07 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.271 1.582 . . . . 1.0 115.271 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.37 122.33 82.58 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.403 1.002 . . . . 3.68 110.097 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.71 163.22 18.75 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.511 2.807 . . . . 1.57 111.989 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 m -141.26 160.51 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.157 1.383 . . . . 1.3 110.267 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 138.41 52.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.948 0.899 . . . . 0.89 109.743 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.97 88.23 6.65 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.522 1.129 . . . . 0.74 112.051 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.76 5.41 1.71 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.041 3.16 . . . . 1.33 115.974 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -15.47 52.44 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.531 1.06 . . . . 8.52 112.633 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.93 136.65 20.52 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.04 0.936 . . . . 3.2 111.754 -170.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 9.36 1.44 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.235 1.939 . . . . 5.61 116.235 -154.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -147.54 128.19 14.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.538 -0.541 . . . . 2.17 109.538 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.77 -29.85 67.1 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.725 1.148 . . . . 1.86 112.436 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.49 -24.23 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.291 1.837 . . . . 3.04 114.284 171.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.61 -4.46 58.95 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 120.093 1.315 . . . . 2.07 114.25 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.03 12.96 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.586 1.154 . . . . 0.91 113.874 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.38 17.16 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.197 2.295 . . . . 2.62 117.197 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -150.09 11.6 0.73 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.503 1.921 . . . . 3.0 112.383 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -100.84 172.06 7.28 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.63 -1.294 . . . . 1.59 113.418 -171.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.14 144.28 35.75 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.883 0.873 . . . . 0.53 110.212 161.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.9 141.09 36.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.779 1.632 . . . . 1.95 106.673 164.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.5 mtt -137.32 130.56 30.94 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.946 -1.096 . . . . 1.3 111.975 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.4 mt -83.85 131.68 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.092 -1.077 . . . . 0.84 108.092 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.2 149.1 42.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.611 1.564 . . . . 2.35 112.125 -168.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.5 -52.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.655 -0.653 . . . . 1.27 110.005 -168.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.85 169.17 29.51 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.127 0.87 . . . . 1.19 111.769 169.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.22 -164.49 5.98 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.967 2.699 . . . . 2.63 115.913 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.39 84.01 2.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.018 2.127 . . . . 3.42 106.676 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -160.39 -8.06 0.05 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.254 1.576 . . . . 3.69 115.254 -165.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.5 ptp -148.31 142.06 25.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.242 1.383 . . . . 2.89 113.945 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 p -156.82 12.89 0.26 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.146 1.165 . . . . 2.98 114.146 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.51 -40.38 14.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.138 1.775 . . . . 4.6 113.845 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.51 143.35 79.09 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.94 0.896 . . . . 3.37 112.036 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.81 -31.84 24.28 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.148 2.565 . . . . 1.95 114.751 -165.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -73.81 115.45 42.2 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.289 1.404 . . . . 4.05 108.731 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.23 144.84 64.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.014 2.476 . . . . 2.64 112.716 -159.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 58.98 19.32 7.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.103 1.761 . . . . 3.3 112.638 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.97 56.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.813 -0.993 . . . . 2.8 113.755 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.89 -8.35 73.52 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.964 1.745 . . . . 1.8 114.418 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.01 -8.84 79.22 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.14 1.47 . . . . 1.39 116.097 -169.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.83 2.29 25.73 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.921 1.248 . . . . 1.55 115.5 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 p -69.42 151.38 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.924 1.69 . . . . 1.49 110.789 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.31 150.16 22.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.318 1.447 . . . . 5.03 110.268 -172.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -110.43 -34.77 6.23 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.31 0.485 . . . . 2.55 112.31 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.8 144.74 24.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.776 1.028 . . . . 0.97 113.776 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.9 t -104.82 139.61 39.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.93 2.492 . . . . 2.12 110.903 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.27 87.67 0.25 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.978 2.704 . . . . 1.14 111.052 173.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.98 135.53 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.84 . . . . 1.53 109.246 166.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.42 137.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.626 1.17 . . . . 2.01 111.359 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 11.2 mmpt? . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.183 . . . . 3.84 113.504 -175.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 121.752 0.787 . . . . 1.63 111.38 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -169.12 151.77 4.84 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.551 1.54 . . . . 1.43 108.143 -154.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.9 124.07 5.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 123.05 1.405 . . . . 2.63 111.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -84.15 89.52 7.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.928 2.091 . . . . 3.47 110.796 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -87.28 116.44 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.475 -0.765 . . . . 1.05 110.239 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.34 109.0 2.66 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.238 1.399 . . . . 0.73 110.009 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.8 mtp -94.02 140.42 29.74 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.558 0.743 . . . . 1.17 112.778 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -121.24 150.4 41.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.8 1.64 . . . . 2.63 112.994 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.7 mt -71.6 73.42 0.77 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.207 2.603 . . . . 1.28 110.974 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.65 124.4 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.338 -0.851 . . . . 1.6 109.947 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.5 t -160.28 74.49 0.55 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.963 1.098 . . . . 2.42 113.963 -166.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.66 -42.62 0.52 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.167 2.187 . . . . 1.44 114.561 163.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -6.7 50.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.947 1.299 . . . . 2.45 112.071 169.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.47 -164.53 13.93 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.029 2.252 . . . . 1.41 111.496 -173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.56 129.8 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.054 . . . . 1.27 110.255 161.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.64 -140.62 11.27 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.904 1.24 . . . . 2.07 113.881 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.93 167.08 14.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.675 1.19 . . . . 1.92 111.087 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -103.22 172.94 6.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.813 1.645 . . . . 1.37 113.183 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.03 1.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 128.188 2.595 . . . . 3.48 113.138 -165.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.17 -177.44 20.29 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.148 1.356 . . . . 0.56 112.714 -166.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.87 165.43 18.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.075 0.95 . . . . 1.04 109.411 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 40.9 t -110.67 129.32 66.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.558 -1.275 . . . . 0.57 107.558 157.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.18 130.63 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 122.011 0.91 . . . . 2.63 110.204 166.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -99.39 139.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.9 -1.148 . . . . 1.2 107.9 167.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -135.52 127.06 28.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.908 1.283 . . . . 2.32 109.935 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.03 140.0 29.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.207 0.603 . . . . 3.57 111.059 -171.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t -154.54 -178.99 7.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.5 0.72 . . . . 1.49 110.433 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -64.38 -23.8 67.41 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.659 1.584 . . . . 3.8 113.546 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.07 16.68 59.02 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.283 1.42 . . . . 1.36 113.848 166.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 115' ' ' LYS . . . 75.44 -144.49 31.81 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 129.241 3.305 . . . . 1.0 114.859 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.2 mt -71.71 109.17 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.291 0.636 . . . . 0.82 111.088 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -80.58 107.34 13.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.268 1.427 . . . . 1.95 109.594 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -91.75 116.52 28.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.035 1.734 . . . . 0.71 109.713 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.8 m -128.87 106.52 18.35 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.877 -0.582 . . . . 0.85 110.332 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.09 154.72 14.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.897 3.065 . . . . 0.48 112.405 -171.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -146.01 48.88 1.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.664 0.745 . . . . 1.62 112.626 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.47 150.95 24.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.85 112.228 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 22.0 5.52 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.393 1.627 . . . . 2.07 115.393 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.24 83.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.112 0.965 . . . . 2.07 110.706 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 164.68 31.62 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 124.803 1.241 . . . . 1.39 110.535 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.48 138.46 85.92 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.13 1.22 . . . . 1.19 110.07 169.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -90.81 24.67 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.333 2.022 . . . . 1.31 114.428 -151.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.5 -154.62 20.58 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.181 1.372 . . . . 1.3 115.28 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 152.29 19.07 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.064 -1.256 . . . . 2.67 110.539 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -149.41 122.78 9.03 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.674 1.59 . . . . 1.34 111.291 -162.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.56 150.29 3.54 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 120.307 1.412 . . . . 0.6 112.175 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.448 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -135.97 125.58 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.248 -1.39 . . . . 2.06 107.248 173.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -124.28 172.31 9.19 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.118 1.525 . . . . 1.11 115.118 167.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.38 141.66 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.747 1.619 . . . . 0.81 109.168 159.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.27 154.3 46.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.986 2.114 . . . . 0.98 110.583 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.93 60.63 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 117.362 2.356 . . . . 1.04 117.362 -150.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.533 HD22 ' HA3' ' A' ' 71' ' ' GLY . 66.9 m-80 -137.69 148.86 46.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.122 1.328 . . . . 1.54 113.325 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.57 74.18 2.14 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.581 1.086 . . . . 1.19 114.151 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 t -164.79 76.9 0.31 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.058 0.932 . . . . 2.32 113.346 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.9 m -70.02 28.43 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.951 2.1 . . . . 1.83 115.74 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -92.22 135.44 26.95 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.514 -1.366 . . . . 3.29 110.943 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.17 157.2 11.21 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.274 3.316 . . . . 1.34 113.231 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.77 144.53 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.104 0.962 . . . . 1.84 110.08 161.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mm -97.76 48.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.316 1.047 . . . . 3.7 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -61.89 137.83 58.29 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.761 -1.212 . . . . 5.57 111.313 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.94 26.35 9.73 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.182 0.993 . . . . 4.08 112.921 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.71 83.34 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.96 -1.087 . . . . 2.74 114.723 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.91 144.46 48.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.264 1.532 . . . . 3.2 111.178 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.3 105.8 12.78 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.835 -1.165 . . . . 1.48 111.776 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 t -77.98 62.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.402 1.481 . . . . 2.63 111.688 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.2 -63.15 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.852 3.261 . . . . 2.01 116.756 169.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.4 119.8 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 131.555 3.942 . . . . 2.38 108.648 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -100.46 -47.75 4.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.693 1.133 . . . . 4.84 111.561 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.8 2.92 4.68 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 115.21 1.559 . . . . 1.53 115.21 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.52 -3.84 48.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.119 2.168 . . . . 1.37 114.674 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' HD22 ' A' ' 52' ' ' ASN . . . 85.88 -13.83 55.01 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.037 1.575 . . . . 3.74 117.037 165.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.09 -168.78 15.18 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.043 1.306 . . . . 1.39 114.697 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 12.64 1.63 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.196 2.199 . . . . 2.31 114.107 -175.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.8 tp 61.25 56.2 2.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.15 1.78 . . . . 1.5 109.15 -169.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -122.74 62.94 18.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.901 2.08 . . . . 4.22 112.414 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.43 -38.43 26.05 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.83 2.353 . . . . 2.0 112.689 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -168.4 139.22 2.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.631 1.972 . . . . 3.55 107.664 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 p30 157.69 -162.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 130.348 3.459 . . . . 4.3 110.337 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -74.49 -11.83 60.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.265 2.626 . . . . 3.13 116.048 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.65 -32.17 1.66 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.977 1.275 . . . . 2.22 116.081 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -64.91 -9.84 24.23 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.151 2.278 . . . . 5.31 117.151 -167.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.4 t60 75.08 153.52 0.14 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.427 2.291 . . . . 1.56 112.238 -171.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -152.13 148.51 27.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.287 1.835 . . . . 4.93 109.874 -169.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.35 -82.39 1.07 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.055 -1.414 . . . . 3.34 109.882 163.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.01 -26.12 3.1 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.898 3.065 . . . . 4.54 115.942 -166.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.54 -157.55 0.62 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 120.091 1.314 . . . . 5.3 111.383 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.98 13.59 37.7 Favored Glycine 0 N--CA 1.475 1.287 0 C-N-CA 124.979 1.276 . . . . 3.88 115.195 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -100.25 51.76 0.89 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.052 1.426 . . . . 5.12 112.301 -169.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.61 -143.71 4.9 Favored Glycine 0 N--CA 1.473 1.101 0 O-C-N 120.921 -1.112 . . . . 2.67 115.608 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.06 147.73 22.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.705 1.202 . . . . 3.96 112.405 -168.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.88 -20.97 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.682 1.364 . . . . 2.03 114.682 -174.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.06 -2.06 86.4 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.297 0.951 . . . . 0.86 114.796 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.98 136.63 33.98 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.517 1.127 . . . . 1.77 111.99 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.42 167.61 14.17 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 126.092 1.757 . . . . 1.91 109.861 -143.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.82 173.95 11.53 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.281 3.321 . . . . 1.06 113.792 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.37 125.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.638 1.175 . . . . 2.05 112.186 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 90.31 2.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.58 2.752 . . . . 1.86 109.854 166.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.9 t -68.28 126.44 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.018 -1.051 . . . . 0.82 109.092 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.97 162.67 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.931 1.292 . . . . 2.12 108.411 167.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.47 160.47 16.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.759 1.022 . . . . 2.21 113.759 -176.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -15.68 0.29 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 127.957 2.503 . . . . 2.47 117.438 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.09 -0.93 38.06 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.907 1.683 . . . . 3.2 113.089 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.8 25.66 22.01 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.93 1.252 . . . . 0.88 114.432 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.9 mt -129.64 140.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 1.12 109.955 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.4 129.0 56.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.349 1.86 . . . . 0.87 111.607 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 t -153.31 0.74 0.25 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.784 1.772 . . . . 1.34 115.784 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -86.03 126.77 64.4 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.585 1.154 . . . . 3.38 110.542 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.05 156.3 26.41 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.095 2.53 . . . . 1.31 112.16 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.92 167.06 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 126.358 1.863 . . . . 1.3 109.591 167.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 m -140.06 140.48 36.14 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 1.23 111.053 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.63 114.24 15.54 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.482 1.113 . . . . 1.33 112.691 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.14 5.15 6.2 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.26 3.307 . . . . 1.25 115.213 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -77.36 -19.17 56.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.566 0.951 . . . . 4.47 113.566 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.56 144.99 46.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.423 1.889 . . . . 2.5 106.946 169.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.8 mtpt -131.06 -9.37 3.84 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.455 1.28 . . . . 4.05 114.455 -160.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -157.98 142.2 15.98 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.929 1.292 . . . . 2.02 111.781 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.081 -1.012 . . . . 2.39 113.172 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.97 -15.65 45.37 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 119.533 1.06 . . . . 3.13 113.168 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.11 -22.29 63.98 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.47 -0.769 . . . . 1.97 112.793 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.02 20.97 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.655 1.582 . . . . 0.96 112.689 -167.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -68.86 27.47 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.215 2.206 . . . . 2.03 116.012 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.96 3.02 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.529 2.732 . . . . 3.21 113.024 173.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -108.19 172.15 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 1.43 113.149 -166.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.0 150.06 39.23 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.247 1.019 . . . . 0.75 113.195 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.3 mt -89.66 152.29 21.44 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.169 1.788 . . . . 2.26 109.01 161.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.8 mtt -141.31 127.8 20.06 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.597 0.635 . . . . 1.26 112.185 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.45 130.73 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.957 1.303 . . . . 0.68 107.577 166.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.28 137.59 53.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.218 2.207 . . . . 1.85 111.236 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -64.85 -42.83 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.326 1.05 . . . . 1.33 112.781 -161.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -88.0 -106.01 0.95 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.1 1.333 . . . . 2.66 112.041 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.48 -166.99 29.39 Favored Glycine 0 N--CA 1.462 0.404 0 O-C-N 121.233 -1.157 . . . . 1.78 111.75 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -162.9 145.97 10.82 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.622 1.169 . . . . 3.25 109.911 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 114.27 55.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 130.294 3.438 . . . . 4.34 108.121 -154.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.3 ptp -169.63 37.02 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.044 1.338 . . . . 2.64 113.455 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.61 61.31 2.31 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.078 -1.639 . . . . 3.49 114.911 -169.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -140.25 -45.54 0.42 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 116.613 2.079 . . . . 4.3 116.613 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.43 148.32 44.12 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.753 1.39 . . . . 3.89 114.753 -156.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.44 -9.19 24.78 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.312 3.341 . . . . 1.97 115.555 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -101.43 78.34 0.21 Allowed Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.587 -0.894 . . . . 4.6 108.587 154.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.73 152.38 82.21 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.758 2.972 . . . . 3.13 112.355 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 mt 69.08 27.98 5.17 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.641 1.577 . . . . 4.07 110.296 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.42 13.52 58.46 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.318 1.437 . . . . 3.09 114.626 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.94 -6.9 46.32 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 118.676 1.238 . . . . 2.13 114.375 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.87 5.94 56.73 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.488 1.994 . . . . 2.09 114.089 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.8 2.56 7.91 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 118.613 1.206 . . . . 1.97 115.022 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 p -64.26 144.64 56.99 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.359 1.463 . . . . 1.54 109.655 169.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.92 137.58 36.92 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.001 0.92 . . . . 5.65 112.605 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -91.46 -27.85 18.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.284 0.634 . . . . 2.3 111.281 158.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.24 153.11 28.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.174 0.805 . . . . 0.58 113.174 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.54 165.52 16.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.382 1.473 . . . . 1.47 110.755 165.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -160.82 136.43 4.46 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.658 1.123 . . . . 0.66 112.797 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.11 133.45 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.657 1.183 . . . . 1.9 110.603 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.0 141.2 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.503 1.121 . . . . 1.65 111.068 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 123.981 0.913 . . . . 4.28 112.769 -174.637 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.413 -0.217 . . . . 1.72 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -135.87 150.04 49.23 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.394 -1.441 . . . . 0.98 114.763 -141.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -155.72 123.85 5.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.675 1.59 . . . . 2.36 108.703 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.93 108.29 18.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.714 1.605 . . . . 4.86 110.512 -171.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.15 126.38 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.339 0.656 . . . . 1.06 110.14 -165.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.94 113.34 4.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.277 1.417 . . . . 0.77 110.549 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.4 mmt -97.33 113.16 24.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.448 1.499 . . . . 1.54 110.586 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -102.2 149.55 24.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.287 1.035 . . . . 3.17 112.108 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.31 61.98 1.25 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.395 1.078 . . . . 1.73 112.645 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.43 147.48 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.342 1.057 . . . . 1.22 112.489 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -177.44 134.85 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.798 1.639 . . . . 2.32 111.338 163.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.67 -44.16 0.25 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.03 2.932 . . . . 1.13 117.062 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 11.11 33.75 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.148 1.779 . . . . 3.0 110.844 172.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -133.23 11.69 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.996 1.284 . . . . 0.96 110.684 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.19 134.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.862 1.665 . . . . 1.59 111.031 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.53 -82.47 1.42 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.837 1.208 . . . . 2.32 111.924 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.2 158.29 18.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.078 1.351 . . . . 2.05 111.355 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.0 t -97.92 145.47 26.43 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.728 1.211 . . . . 1.7 112.977 -169.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.3 pt -142.85 3.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 114.837 1.421 . . . . 2.98 114.837 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.73 178.35 35.58 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 120.895 -1.128 . . . . 0.75 114.023 -170.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -131.14 178.41 6.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.352 1.061 . . . . 0.97 109.054 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 38.3 t -131.05 133.99 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.095 -1.076 . . . . 0.45 108.095 162.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 8.7 p -90.65 127.8 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.604 0.362 . . . . 0.82 110.721 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.8 136.65 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.289 1.036 . . . . 1.75 108.825 169.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -141.91 113.5 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.215 1.406 . . . . 1.85 110.744 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.77 153.55 39.94 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.733 0.813 . . . . 3.12 112.063 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 t -167.68 -177.68 3.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.542 1.937 . . . . 1.23 109.149 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -53.1 -40.75 64.37 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.257 1.423 . . . . 3.82 112.497 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 15.16 56.71 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.22 1.39 . . . . 0.85 114.44 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 -152.78 42.48 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 127.36 2.41 . . . . 0.75 115.334 173.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.401 HD12 HD23 ' A' ' 114' ' ' LEU . 54.3 mt -65.53 104.34 0.99 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.701 0.801 . . . . 0.52 113.135 -169.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -80.12 110.42 15.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.008 1.723 . . . . 2.56 109.964 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 6.6 t80 -100.85 114.87 29.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.457 2.703 . . . . 0.66 108.928 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.433 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.6 m -122.73 111.18 31.34 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 119.776 1.171 . . . . 0.56 108.948 175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -84.08 158.55 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.525 2.817 . . . . 0.41 111.66 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . 0.263 1.7 p80 -152.52 65.06 0.81 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 122.5 1.143 . . . . 1.23 111.664 172.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.59 151.26 45.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.35 1.86 . . . . 0.65 111.535 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 37.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 117.509 2.411 . . . . 2.45 117.509 -159.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.45 13.03 1.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.978 1.473 . . . . 2.41 114.978 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.33 161.82 50.56 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 119.124 -0.465 . . . . 1.82 111.359 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -60.96 129.78 30.18 Favored 'Trans proline' 0 N--CA 1.431 -2.157 0 O-C-N 123.241 1.127 . . . . 1.06 109.756 162.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -86.45 22.86 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.665 3.577 . . . . 1.1 113.269 -150.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.52 153.04 17.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 126.167 1.842 . . . . 1.94 110.49 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -45.28 137.03 4.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.005 2.522 . . . . 3.3 113.72 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -126.93 129.42 48.13 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 125.533 1.533 . . . . 0.95 111.704 -172.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.14 158.18 1.72 Allowed Glycine 0 CA--C 1.543 1.843 0 CA-C-N 119.276 0.944 . . . . 0.66 114.016 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.3 t80 -145.39 116.3 7.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.147 1.779 . . . . 1.9 106.65 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -126.12 168.75 13.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.388 1.995 . . . . 0.75 116.388 165.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -99.08 135.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.391 1.876 . . . . 0.97 110.09 154.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -105.6 176.14 5.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.822 1.649 . . . . 0.98 111.963 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.9 62.59 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 116.744 2.127 . . . . 1.19 116.744 -166.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -126.06 -159.68 0.93 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.6 1.56 . . . . 1.31 111.277 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.87 66.73 0.37 Allowed Glycine 0 N--CA 1.476 1.323 0 N-CA-C 116.677 1.431 . . . . 1.01 116.677 -162.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -174.69 116.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.236 1.814 . . . . 2.59 111.974 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -67.62 33.0 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 128.043 2.537 . . . . 1.46 115.183 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -104.89 126.61 30.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 119.996 -1.69 . . . . 3.03 111.379 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.52 150.97 13.24 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.073 3.182 . . . . 1.32 112.889 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 169.08 8.94 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.179 0.992 . . . . 1.94 110.196 154.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 mm -97.9 124.1 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.948 -1.13 . . . . 2.82 107.948 162.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -139.54 109.22 6.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.278 1.431 . . . . 5.01 109.179 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t0 60.43 63.04 1.43 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.161 1.785 . . . . 4.2 112.747 -166.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.39 13.33 54.34 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 115.711 1.045 . . . . 2.96 115.711 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -147.48 150.11 33.95 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.027 1.731 . . . . 3.38 110.209 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.05 34.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.998 0.519 . . . . 1.45 111.896 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.5 t -67.94 -3.98 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.188 1.795 . . . . 2.93 113.466 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.47 -50.56 0.69 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.499 2.72 . . . . 2.16 112.575 -174.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.51 111.25 2.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.178 1.791 . . . . 1.72 109.682 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.89 -39.7 12.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.239 0.616 . . . . 5.07 110.691 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.01 -4.2 30.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.114 1.153 . . . . 1.73 114.114 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.0 -18.9 27.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.178 1.391 . . . . 1.08 112.631 168.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.31 178.1 31.53 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 122.319 0.955 . . . . 2.85 113.516 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.69 -163.65 39.31 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.531 1.062 . . . . 1.37 112.894 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -56.31 128.29 35.09 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.763 0.825 . . . . 3.04 109.591 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.32 66.72 0.18 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.681 1.993 . . . . 2.13 112.34 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -111.21 113.55 54.2 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 4.67 108.989 164.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -84.68 -31.27 0.46 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.288 1.992 . . . . 2.08 113.302 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 176.9 29.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.869 2.068 . . . . 3.07 111.289 -165.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -119.07 -21.19 7.76 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.56 -1.209 . . . . 3.85 113.261 -164.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t 155.16 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 130.607 3.563 . . . . 2.19 111.172 158.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.33 -11.29 61.69 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.8 1.191 . . . . 2.2 115.494 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -73.79 1.78 9.76 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 116.019 1.859 . . . . 4.54 116.019 -173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.6 t60 87.75 135.16 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 129.045 2.938 . . . . 1.81 114.151 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.65 19.33 14.61 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.981 1.712 . . . . 4.84 114.385 -152.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.78 -35.68 31.04 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-O 117.642 -1.643 . . . . 2.45 114.735 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -111.83 -2.39 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 124.316 3.344 . . . . 3.5 114.153 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -143.82 145.93 32.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.875 1.67 . . . . 5.24 108.457 -172.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.12 6.5 35.09 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.586 1.394 . . . . 3.15 116.586 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.81 130.34 15.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.051 1.426 . . . . 5.06 109.721 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.69 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-O 115.709 -2.717 . . . . 3.33 118.22 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.794 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 0.3 OUTLIER 152.99 118.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 129.145 2.978 . . . . 5.19 110.924 -175.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.3 tt -67.03 -28.43 68.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.47 1.108 . . . . 2.65 113.369 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -88.18 15.7 55.04 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.416 1.484 . . . . 0.84 115.179 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.794 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 78.7 m-20 -76.11 147.65 38.43 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.2 1.5 . . . . 1.55 110.751 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.17 166.03 17.38 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.607 0.763 . . . . 1.79 110.368 -146.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.06 148.53 19.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.877 3.051 . . . . 1.14 112.271 -171.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.89 135.16 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 122.108 0.956 . . . . 1.74 111.38 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 108.83 19.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.026 2.53 . . . . 2.48 110.428 -172.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.4 t -78.24 131.35 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.365 -0.835 . . . . 1.83 111.935 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.68 141.31 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.67 2.388 . . . . 1.59 106.423 166.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.51 164.3 22.07 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.134 0.424 . . . . 1.95 111.484 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -16.67 0.29 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 127.421 2.289 . . . . 2.23 116.89 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.62 -1.41 43.81 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.181 1.792 . . . . 2.41 113.434 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.29 53.84 Favored Glycine 0 N--CA 1.473 1.119 0 O-C-N 121.185 -0.947 . . . . 0.93 114.851 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.8 mt -106.14 121.97 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.217 1.007 . . . . 1.46 110.806 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.4 122.56 33.38 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.342 1.057 . . . . 0.63 109.092 168.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -155.48 8.68 0.27 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.135 1.161 . . . . 1.32 114.135 -167.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.62 123.61 49.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.868 1.267 . . . . 3.36 110.473 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.75 134.75 26.56 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.189 3.259 . . . . 1.38 111.963 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.0 163.77 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 126.342 1.857 . . . . 1.61 109.261 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 m -144.14 141.0 29.71 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.993 1.269 . . . . 0.82 112.112 -167.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -121.17 106.05 39.01 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.554 1.142 . . . . 0.83 113.381 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.1 7.42 1.74 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.727 3.618 . . . . 1.11 114.637 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -75.4 -25.7 57.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.812 1.645 . . . . 6.91 112.735 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -123.99 135.59 53.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.313 -1.736 . . . . 2.47 106.313 168.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -113.05 -2.65 14.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 4.18 113.579 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.4 t -141.11 174.06 10.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.353 0.979 . . . . 2.02 111.752 158.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.43 -24.27 64.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.165 -0.959 . . . . 1.48 111.09 157.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -60.01 -28.62 67.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.352 1.461 . . . . 2.83 114.639 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -78.91 -16.1 57.45 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.199 1.185 . . . . 2.36 114.199 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.1 m -124.42 16.35 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 125.195 1.398 . . . . 1.25 113.291 -172.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -65.44 8.64 0.15 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 128.242 2.617 . . . . 2.5 117.579 -171.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 41.76 0.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.273 1.429 . . . . 3.7 112.171 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -134.49 168.28 19.23 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.937 1.295 . . . . 1.45 113.685 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.7 146.69 26.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.503 1.521 . . . . 0.53 114.259 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.37 145.39 30.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.921 2.489 . . . . 1.6 107.809 167.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 52.3 mtt -140.65 143.4 35.13 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.294 -0.879 . . . . 1.41 112.427 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mt -99.75 123.6 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.772 1.629 . . . . 0.65 108.444 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -109.02 143.29 38.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.293 1.837 . . . . 2.79 111.39 -165.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.12 -37.78 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.865 -1.147 . . . . 1.41 111.914 -169.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.93 153.34 20.06 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.913 0.768 . . . . 0.97 112.125 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.35 -178.9 25.6 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.891 1.71 . . . . 1.31 113.128 163.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -137.01 14.87 3.07 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.027 1.491 . . . . 3.29 115.027 -126.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -105.16 21.82 16.44 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.709 1.374 . . . . 2.54 114.709 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtm -96.55 129.65 43.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.859 -1.151 . . . . 2.7 112.363 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.2 p -126.7 4.93 6.71 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.766 1.395 . . . . 3.34 114.766 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -157.09 124.61 5.33 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.887 -1.133 . . . . 3.53 109.464 -169.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -174.09 142.25 0.85 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 117.926 -1.035 . . . . 3.69 109.558 -167.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.11 -15.12 29.0 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.08 2.52 . . . . 2.72 113.762 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -129.23 133.85 25.62 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.811 1.645 . . . . 4.67 108.955 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.9 124.82 15.7 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.215 2.61 . . . . 3.31 111.783 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp 58.88 5.2 0.48 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.689 1.996 . . . . 3.31 114.007 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.87 9.08 44.8 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.883 -1.136 . . . . 3.82 114.574 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.92 -0.27 33.85 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.411 1.482 . . . . 2.68 114.345 -167.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.87 7.34 5.5 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.342 1.449 . . . . 1.75 115.646 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.24 -6.03 78.63 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.873 1.337 . . . . 2.13 112.921 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 p -70.07 134.06 47.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.356 1.862 . . . . 2.07 110.693 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.43 147.27 45.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.355 1.462 . . . . 5.24 112.02 -172.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -106.3 -17.16 14.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.249 -0.881 . . . . 2.37 112.93 169.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.85 33.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.856 1.428 . . . . 0.54 114.856 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -135.74 149.12 49.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.198 2.199 . . . . 1.32 110.238 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.5 1.71 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.342 1.925 . . . . 0.66 112.474 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.63 141.71 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.569 1.148 . . . . 2.42 112.592 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -77.14 141.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.57 1.148 . . . . 1.02 110.868 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 124.332 1.053 . . . . 4.27 110.977 171.366 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.988 -0.745 . . . . 2.12 108.988 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -128.71 133.53 48.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.899 -1.751 . . . . 1.26 112.504 -137.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -146.69 127.68 14.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 123.226 1.489 . . . . 2.5 112.711 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -109.86 90.94 3.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.251 1.42 . . . . 3.63 110.216 -162.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.5 t -90.04 120.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.89 0.476 . . . . 1.0 110.299 -163.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.48 105.4 1.78 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.972 1.272 . . . . 0.79 110.639 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 mmt -85.13 110.49 19.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.999 1.32 . . . . 1.54 110.57 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -98.25 143.78 28.38 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.95 0.9 . . . . 2.8 111.452 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.3 63.01 3.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.895 1.278 . . . . 1.27 111.55 -175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.35 136.79 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.551 0.74 . . . . 1.23 111.205 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -157.96 139.87 14.03 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.597 0.359 . . . . 2.54 111.514 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' H ' ' NH2' ' A' ' 147' ' ' ARG . . . 26.76 -42.99 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.884 1 C-N-CA 134.638 5.175 . . . . 1.21 120.763 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -80.17 -23.26 41.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.825 1.25 . . . . 3.08 111.791 166.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.5 -141.08 13.02 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.846 1.212 . . . . 0.96 111.541 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.5 t -54.81 128.79 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.117 1.367 . . . . 1.16 111.78 -174.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.26 -111.0 3.54 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.151 1.834 . . . . 1.22 111.701 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.68 169.35 15.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.515 1.126 . . . . 1.66 110.945 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.9 t -109.44 156.81 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.058 -1.026 . . . . 1.05 111.994 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 pt -147.33 9.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.733 2.013 . . . . 2.74 113.114 -172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.57 162.78 10.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.642 1.115 . . . . 0.69 112.743 -167.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -104.45 -177.99 3.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.23 1.012 . . . . 0.79 109.316 168.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.4 t -124.43 130.87 73.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 106.848 -1.538 . . . . 0.42 106.848 151.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG12 ' HB ' ' A' ' 34' ' ' THR . 8.7 p -87.72 123.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.727 -0.471 . . . . 0.89 109.727 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.86 119.98 45.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.04 -1.096 . . . . 1.5 108.04 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -118.47 111.33 18.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.835 0.854 . . . . 1.94 110.848 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 130.47 46.57 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 127.124 2.17 . . . . 3.91 111.165 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 t -161.18 -172.0 3.25 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.705 1.002 . . . . 2.06 113.705 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.32 -31.29 43.49 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.523 1.529 . . . . 6.75 112.721 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.57 17.9 57.56 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 124.962 1.267 . . . . 1.89 115.179 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.29 -140.43 28.4 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.22 1.39 . . . . 0.93 111.372 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.59 107.89 7.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.284 0.634 . . . . 0.66 111.13 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -87.83 107.51 18.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.771 1.228 . . . . 1.87 111.263 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.34 104.61 16.02 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.596 1.958 . . . . 0.58 109.763 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' HG12 ' A' ' 23' ' ' VAL . 4.2 m -113.69 106.66 53.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 107.256 -1.387 . . . . 0.56 107.256 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.1 162.06 17.98 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.371 3.38 . . . . 0.47 109.928 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -153.02 34.7 0.47 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.982 0.896 . . . . 1.22 112.346 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -97.26 142.85 28.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.703 1.201 . . . . 0.63 111.21 -174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.38 23.1 9.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.154 1.909 . . . . 2.25 116.154 -166.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.51 57.51 0.63 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.672 0.789 . . . . 1.33 112.806 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.03 15.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.115 0.966 . . . . 1.42 111.57 172.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 35.3 Cg_endo -62.73 134.36 46.77 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 122.058 1.839 . . . . 0.94 110.973 166.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 18.6 Cg_endo -84.18 27.31 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.706 1 C-N-CA 126.692 4.928 . . . . 1.01 114.825 -152.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.79 -134.79 8.16 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.398 1.475 . . . . 1.25 115.091 -172.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -120.17 136.5 54.6 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.647 1.579 . . . . 2.29 108.588 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -124.87 143.64 50.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.18 0.992 . . . . 1.08 112.631 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.9 153.68 52.32 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.917 -0.873 . . . . 0.54 110.917 169.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -124.07 118.41 26.88 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.277 -1.379 . . . . 2.06 107.277 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -116.5 160.95 19.86 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.068 1.507 . . . . 0.87 115.068 168.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.13 148.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.521 2.329 . . . . 1.01 108.332 158.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -134.62 145.37 48.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.91 111.001 -174.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.46 87.58 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.784 1.772 . . . . 0.75 115.784 -159.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -116.76 148.63 40.97 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.658 1.183 . . . . 1.08 112.989 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.69 72.57 2.81 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.769 1.176 . . . . 0.87 113.803 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -164.36 96.06 0.76 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.174 0.987 . . . . 1.9 113.422 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -65.39 22.73 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.155 2.182 . . . . 1.31 116.44 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -86.18 129.34 54.13 Favored Pre-proline 0 CA--C 1.55 0.957 0 O-C-N 119.802 -1.811 . . . . 3.09 112.446 -166.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -95.62 173.26 1.11 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.897 3.731 . . . . 1.41 111.99 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.5 154.07 45.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.12 1.368 . . . . 2.2 110.956 165.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -85.05 113.55 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.205 -1.405 . . . . 3.81 107.205 157.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -138.47 121.37 16.59 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.716 1.206 . . . . 4.57 108.547 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 57.69 40.01 26.86 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.755 1.222 . . . . 4.22 112.548 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.37 9.92 86.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.579 1.085 . . . . 3.27 115.34 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.02 154.09 48.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.001 1.401 . . . . 3.38 110.727 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.56 113.13 24.79 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.51 -0.744 . . . . 2.56 111.717 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.35 33.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 116.054 1.872 . . . . 2.69 116.054 -163.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.68 -63.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.365 2.666 . . . . 2.14 114.105 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.75 108.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 131.581 3.952 . . . . 1.69 107.6 -176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -110.54 -39.2 4.98 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.141 0.976 . . . . 3.99 111.817 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -19.73 62.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.538 0.94 . . . . 1.29 113.538 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -9.14 53.84 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.299 1.84 . . . . 0.78 113.61 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.55 54.65 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.602 -1.312 . . . . 2.16 112.629 -174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 179.47 51.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.897 0.76 . . . . 1.48 112.993 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.44 31.12 0.06 Allowed 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 114.197 1.184 . . . . 2.83 114.197 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.6 tp 64.92 88.85 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.041 2.137 . . . . 1.77 112.654 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -166.37 121.49 0.91 Allowed Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.136 2.174 . . . . 4.95 110.619 163.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -90.57 -14.16 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.255 2.636 . . . . 2.1 114.118 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -154.33 -37.05 0.1 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.306 1.965 . . . . 5.04 116.306 -159.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -60.33 -32.92 71.7 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.478 1.49 . . . . 4.14 113.669 -163.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 t 171.78 -26.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.792 2.837 . . . . 2.69 111.551 163.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 5.12 82.76 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.048 -1.033 . . . . 2.1 115.287 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -74.44 -25.95 59.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 115.17 1.544 . . . . 6.45 115.17 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.6 t60 99.03 145.79 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 129.35 3.06 . . . . 1.95 111.79 -168.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -119.58 -153.59 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 3.86 112.85 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.81 -138.32 6.71 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 117.659 -1.634 . . . . 2.58 109.37 -155.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.08 -27.2 65.48 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.016 2.477 . . . . 3.04 113.96 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.66 -9.44 58.25 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.976 1.102 . . . . 5.91 113.976 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.01 19.98 70.4 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 116.812 1.485 . . . . 3.02 116.812 167.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.98 100.52 3.95 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.595 1.197 . . . . 4.93 111.0 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.94 -34.92 0.13 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-O 117.193 -1.893 . . . . 3.24 116.128 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -161.83 128.34 3.77 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.756 2.022 . . . . 3.64 110.719 157.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -66.66 -21.42 66.11 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.132 1.16 . . . . 2.69 114.132 178.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.66 23.0 9.41 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.801 1.191 . . . . 0.86 114.91 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.15 134.3 41.4 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.075 1.437 . . . . 1.58 110.444 165.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.28 161.08 62.49 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.385 1.874 . . . . 1.98 110.335 -168.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.89 167.84 25.52 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.572 2.848 . . . . 1.35 112.317 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 132' ' ' ASP . 2.9 m -75.79 147.17 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.845 1.307 . . . . 1.75 113.89 -164.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.94 97.09 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 130.557 3.543 . . . . 2.26 108.397 -175.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 t -83.09 147.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.986 1.315 . . . . 0.83 111.797 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.77 142.41 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.331 2.252 . . . . 1.54 107.93 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.436 ' C ' HD22 ' A' ' 100' ' ' ASN . 0.0 OUTLIER -71.71 160.25 32.95 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.406 0.548 . . . . 2.26 111.688 175.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -57.57 -4.17 0.24 Allowed 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 116.91 2.189 . . . . 2.75 116.91 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -111.8 -11.23 13.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.263 1.425 . . . . 3.0 114.562 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.19 32.61 3.2 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 116.627 1.411 . . . . 0.72 116.627 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.417 ' H ' ' ND2' ' A' ' 100' ' ' ASN . 13.0 mt -121.3 135.89 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.543 1.537 . . . . 1.08 108.62 175.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.24 130.14 55.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.247 1.019 . . . . 0.62 110.14 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -148.98 10.06 0.79 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.811 2.152 . . . . 1.11 116.811 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.58 130.59 40.74 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 120.349 1.431 . . . . 6.04 114.167 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.12 87.33 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.908 3.072 . . . . 2.04 111.742 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.2 t -72.31 160.3 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.295 1.438 . . . . 1.84 108.993 172.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.5 m -142.82 131.88 23.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.653 -1.279 . . . . 1.39 111.505 -171.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.02 91.23 49.71 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.205 1.002 . . . . 0.81 113.4 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.34 2.46 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.227 3.285 . . . . 1.3 115.201 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -72.06 -26.33 62.14 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.025 0.83 . . . . 3.8 111.555 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.86 151.51 26.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.673 2.389 . . . . 2.03 108.822 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -138.21 12.81 2.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.989 1.315 . . . . 4.96 114.044 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.6 t -160.76 152.24 19.36 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.98 -1.075 . . . . 2.22 112.269 161.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.94 -28.55 62.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.204 -0.427 . . . . 1.63 111.635 161.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -54.79 -28.73 51.26 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.105 0.962 . . . . 2.8 112.813 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.17 -12.61 60.63 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.874 0.87 . . . . 1.89 112.766 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.08 12.44 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.417 1.487 . . . . 0.74 113.028 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -63.79 -1.71 1.49 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 117.224 2.305 . . . . 2.26 117.224 -169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -146.15 19.97 1.4 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.249 1.82 . . . . 3.15 111.941 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -104.8 -176.51 3.1 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.026 1.73 . . . . 1.45 112.974 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.21 160.42 22.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.526 1.13 . . . . 0.77 112.368 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 mt -126.63 141.4 51.86 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 129.136 2.974 . . . . 1.77 106.038 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.26 138.8 48.02 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.129 0.877 . . . . 1.3 112.561 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -99.53 116.11 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.46 1.504 . . . . 0.76 107.871 170.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -110.82 145.45 38.16 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.963 1.305 . . . . 1.89 113.266 -162.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.53 -34.7 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.392 1.077 . . . . 1.16 113.436 -154.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.2 151.87 18.3 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.978 -0.849 . . . . 1.18 110.978 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -56.06 148.93 27.47 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.062 0.839 . . . . 1.85 111.006 162.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.438 ' H ' HG12 ' A' ' 96' ' ' VAL . 38.4 t0 -127.05 133.9 50.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.359 1.076 . . . . 3.33 113.232 -159.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -156.48 10.02 0.24 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.794 2.437 . . . . 3.35 111.637 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -83.76 66.71 9.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.007 1.114 . . . . 3.22 114.007 -157.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.5 p -75.23 30.91 0.1 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.075 1.139 . . . . 3.2 114.075 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -165.62 147.15 7.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.745 2.018 . . . . 4.04 111.077 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 155.42 153.35 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 130.489 3.516 . . . . 4.32 111.767 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -86.72 -17.15 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.26 3.307 . . . . 2.35 112.863 163.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -91.33 144.02 29.12 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.878 1.271 . . . . 4.0 110.339 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -73.5 160.01 45.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.178 2.586 . . . . 4.92 113.228 -166.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.31 2.48 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.606 1.963 . . . . 5.4 114.756 170.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.83 3.67 80.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.733 1.159 . . . . 3.45 114.159 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.96 -65.65 4.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.279 1.418 . . . . 1.91 112.958 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.47 64.33 Favored Glycine 0 N--CA 1.476 1.367 0 C-N-CA 124.278 0.942 . . . . 1.66 115.233 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.72 10.72 16.91 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.909 1.718 . . . . 2.02 115.582 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 p -71.39 156.05 39.92 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.581 1.691 . . . . 1.77 109.547 162.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.421 ' NH2' ' H ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.97 143.26 30.39 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.931 1.086 . . . . 6.12 113.931 -173.154 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -99.63 -23.69 14.97 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.239 0.616 . . . . 2.46 111.402 153.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.89 158.31 43.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.251 0.932 . . . . 0.54 113.453 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.46 150.07 51.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.383 1.873 . . . . 1.62 110.05 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 107.84 0.37 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.049 1.785 . . . . 0.73 112.007 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.04 139.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.595 1.158 . . . . 2.5 110.722 165.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.69 117.82 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.788 -0.57 . . . . 1.14 110.202 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 125.629 1.572 . . . . 5.15 110.222 179.386 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 119.276 -0.392 . . . . 1.8 110.627 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -155.47 140.6 17.46 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 119.625 -1.922 . . . . 1.33 111.847 -172.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.33 146.4 21.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.542 1.163 . . . . 3.06 111.881 166.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -109.55 116.94 32.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.571 1.549 . . . . 4.35 113.423 -176.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -103.79 120.97 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.852 -1.155 . . . . 1.17 110.822 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.8 108.63 2.99 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.557 2.027 . . . . 0.69 112.159 178.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 35.0 mtt -90.43 139.17 30.93 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.953 1.834 . . . . 1.32 115.953 -176.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -115.5 146.39 41.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.812 2.045 . . . . 3.08 113.504 -174.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.98 63.08 4.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.555 1.542 . . . . 1.57 113.066 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.8 105.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 120.929 -1.107 . . . . 1.44 113.006 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.3 t -132.3 73.29 1.52 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.017 0.927 . . . . 2.59 112.424 -173.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 71.19 -47.3 0.66 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.839 2.456 . . . . 1.36 114.032 172.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.64 -12.58 61.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.819 1.248 . . . . 2.78 112.085 174.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.67 -165.49 12.65 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.679 1.609 . . . . 1.24 113.542 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.57 134.35 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.856 1.663 . . . . 1.2 110.547 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.34 -83.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.214 1.388 . . . . 1.98 113.732 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -100.49 130.87 46.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.003 1.721 . . . . 2.28 111.941 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -108.14 138.07 45.04 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.109 -0.994 . . . . 1.2 109.857 175.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mm -125.16 -16.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.86 1.43 . . . . 4.03 114.86 -170.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.46 158.35 27.63 Favored Glycine 0 CA--C 1.521 0.467 0 O-C-N 121.518 -0.739 . . . . 1.04 111.907 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 p -88.34 173.98 8.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.062 0.934 . . . . 0.98 109.219 163.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.1 132.91 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.896 -1.52 . . . . 0.59 106.896 148.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.47 128.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 123.551 0.532 . . . . 0.87 110.174 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.48 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 125.283 1.433 . . . . 1.66 108.208 -173.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.61 117.07 34.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 123.067 1.413 . . . . 1.84 110.189 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.259 0.8 OUTLIER -81.95 122.03 27.25 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.205 3.402 . . . . 2.96 109.895 -169.481 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.0 t -144.2 178.44 7.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.17 0.986 . . . . 1.2 111.12 -173.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -28.98 68.06 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.491 1.916 . . . . 4.71 110.357 -176.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 13.7 60.59 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.563 1.554 . . . . 1.02 115.289 163.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.62 -151.17 21.15 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 127.627 2.537 . . . . 0.76 116.552 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.54 101.2 4.8 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.869 . . . . 0.76 111.53 -175.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.5 105.2 10.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.622 1.169 . . . . 1.79 110.833 173.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -93.86 116.64 29.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.575 2.35 . . . . 0.64 109.975 -172.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -123.36 112.55 29.65 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 119.824 1.193 . . . . 0.56 108.824 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.53 159.45 10.86 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.169 3.246 . . . . 0.54 111.996 -173.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -150.06 39.61 0.77 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.24 0.543 . . . . 1.36 112.287 171.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.48 142.34 28.68 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.032 -1.668 . . . . 0.88 112.828 -172.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 91.83 3.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.119 1.368 . . . . 2.15 113.436 -171.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.534 ' C ' HD22 ' A' ' 40' ' ' LEU . . . 133.1 103.47 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 130.404 3.481 . . . . 2.0 107.227 -171.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.61 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -160.84 160.01 25.18 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 131.603 3.961 . . . . 2.63 106.67 167.103 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -63.48 140.27 75.01 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 O-C-N 122.64 0.81 . . . . 1.36 110.094 157.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -86.67 31.48 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.554 2.836 . . . . 1.49 113.513 -152.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.33 -177.44 14.99 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.154 1.359 . . . . 2.15 113.527 -175.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -64.77 129.93 41.62 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 125.336 1.454 . . . . 3.36 112.605 -168.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -125.57 131.34 52.75 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.594 1.158 . . . . 0.94 110.209 -176.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.0 169.52 50.78 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 119.368 0.986 . . . . 0.64 112.753 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 4.1 t80 -137.9 114.71 10.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.969 1.308 . . . . 1.92 108.827 174.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -118.61 163.27 17.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.987 1.477 . . . . 0.71 114.987 163.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.17 144.46 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.825 1.65 . . . . 0.69 108.311 155.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -119.02 157.16 28.33 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.276 1.03 . . . . 0.83 111.761 173.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -20.48 66.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 117.197 2.295 . . . . 0.7 117.197 -162.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -132.43 -174.8 3.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.067 1.747 . . . . 1.13 111.8 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 50.93 0.87 Allowed Glycine 0 N--CA 1.471 1.026 0 N-CA-C 116.316 1.286 . . . . 0.89 116.316 -160.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 t -157.89 110.95 2.44 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.513 1.656 . . . . 2.4 112.595 167.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.99 5.19 0.1 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.588 2.355 . . . . 1.37 116.945 -173.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -83.84 140.56 40.6 Favored Pre-proline 0 CA--C 1.546 0.821 0 O-C-N 120.461 -1.399 . . . . 3.79 112.72 -167.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.84 148.84 12.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.04 3.16 . . . . 1.22 112.215 173.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.38 21.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.757 0.823 . . . . 1.58 111.204 156.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.1 mm -114.48 103.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.852 1.261 . . . . 2.6 109.428 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HE2' ' OD2' ' A' ' 61' ' ' ASP . 16.5 mtpt -101.63 149.13 24.44 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.393 1.477 . . . . 5.3 110.051 168.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' OD2' ' HE2' ' A' ' 60' ' ' LYS . 12.8 m-20 46.59 39.02 6.25 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.276 1.213 . . . . 4.25 114.276 161.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.6 25.38 75.27 Favored Glycine 0 CA--C 1.537 1.406 0 CA-C-O 118.291 -1.283 . . . . 2.91 115.556 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -156.07 158.25 37.46 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.395 2.098 . . . . 3.04 112.98 -177.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.14 139.73 31.88 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.354 -0.841 . . . . 1.55 113.0 -173.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 m -85.36 13.8 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 114.862 1.43 . . . . 2.85 114.862 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.81 -51.41 0.7 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.849 2.46 . . . . 1.53 113.792 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.81 141.53 4.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.061 1.744 . . . . 2.17 109.419 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.32 -50.99 1.99 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.969 0.508 . . . . 4.87 111.424 173.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.3 1.24 6.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.549 1.314 . . . . 1.59 114.549 -177.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 -18.7 35.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.277 1.431 . . . . 0.91 112.522 166.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 -177.22 53.79 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 122.565 1.092 . . . . 2.23 114.764 176.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.86 179.9 37.35 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.941 1.258 . . . . 1.37 113.669 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -69.51 5.06 1.49 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.042 1.867 . . . . 2.63 116.042 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.3 tp 63.48 89.54 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.9 2.08 . . . . 1.62 109.697 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -159.96 23.1 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 117.473 2.397 . . . . 3.45 117.473 -156.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -61.37 -26.01 80.91 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.336 2.691 . . . . 2.08 116.552 -152.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -131.4 22.75 4.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.197 0.999 . . . . 3.7 111.62 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -89.94 -58.98 2.32 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.815 -1.178 . . . . 3.41 113.294 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 159.84 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.294 3.037 . . . . 2.24 111.293 -175.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.07 61.88 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.087 -1.396 . . . . 1.83 115.336 176.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -72.14 -30.33 64.93 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.462 2.131 . . . . 5.33 114.348 -175.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.46 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 58.9 t60 86.67 155.03 0.07 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 129.003 2.921 . . . . 1.65 111.651 -166.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.74 -130.59 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.773 1.229 . . . . 3.86 111.861 -173.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 145.11 -44.82 0.86 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 127.883 2.659 . . . . 2.86 112.601 -174.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -111.39 -11.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.42 2.747 . . . . 3.2 116.317 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -145.61 0.86 0.89 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.883 1.674 . . . . 4.58 115.233 -153.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.99 -12.91 21.88 Favored Glycine 0 N--CA 1.476 1.345 0 O-C-N 120.462 -1.399 . . . . 3.26 114.5 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.48 38.43 0.19 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.679 2.392 . . . . 6.59 114.294 -166.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.94 -87.29 0.06 OUTLIER Glycine 0 C--N 1.342 0.902 0 O-C-N 120.427 -1.421 . . . . 2.5 114.911 -170.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -142.96 143.73 32.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.438 1.895 . . . . 3.59 110.357 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -77.09 -14.43 59.81 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.829 1.195 . . . . 2.87 114.013 170.171 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.63 3.37 79.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.296 -1.28 . . . . 0.85 115.802 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.46 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 78.9 m-20 -94.2 129.25 40.88 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 119.424 1.612 . . . . 2.62 112.08 -177.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 1.1 mm? -117.26 168.7 8.54 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.871 2.068 . . . . 1.93 110.221 -177.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 94' ' ' LEU . 67.7 Cg_endo -81.44 167.4 17.3 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.066 2.51 . . . . 1.28 111.859 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.64 137.87 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 115.829 1.788 . . . . 1.6 115.829 -163.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.22 95.19 4.26 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 130.845 3.658 . . . . 1.56 110.059 170.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.34 131.26 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.919 -1.113 . . . . 1.01 111.759 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -118.03 149.5 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 127.328 2.251 . . . . 2.51 109.082 167.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.87 166.36 19.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.723 1.009 . . . . 2.69 113.723 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -13.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 119.389 3.107 . . . . 2.32 119.389 -178.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -119.77 -4.4 10.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.639 1.576 . . . . 4.11 114.355 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.09 38.77 2.25 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 116.785 1.474 . . . . 1.12 116.785 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mm -126.6 130.84 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-N 119.507 1.653 . . . . 2.21 111.903 166.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.46 132.64 37.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.931 1.292 . . . . 0.79 111.17 174.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 t -151.66 -14.2 0.2 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.992 1.849 . . . . 1.12 115.992 -170.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.33 133.02 43.31 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 120.398 1.454 . . . . 3.59 112.117 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.73 146.74 24.04 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.862 3.042 . . . . 1.04 112.372 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.25 170.72 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.356 1.863 . . . . 1.14 110.005 172.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 m -135.68 140.76 44.71 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.152 0.887 . . . . 0.84 110.971 -175.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.56 87.3 41.22 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.096 1.358 . . . . 0.82 112.305 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.82 -7.98 14.5 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.408 3.405 . . . . 1.68 114.95 176.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -65.23 -27.27 68.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.426 -0.796 . . . . 4.1 110.921 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.33 142.8 50.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.796 2.039 . . . . 2.36 109.265 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 32.46 0.54 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.074 1.35 . . . . 6.16 113.239 -166.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.6 m -179.81 136.21 0.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.134 2.574 . . . . 1.78 109.867 162.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -32.67 63.34 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 118.946 0.794 . . . . 1.37 111.321 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.8 -27.47 29.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.617 1.567 . . . . 3.3 113.65 174.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.37 -28.98 68.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.184 0.902 . . . . 1.78 112.41 173.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.93 11.96 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.799 1.64 . . . . 0.97 113.063 -161.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.08 -26.39 15.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.307 1.843 . . . . 2.1 115.322 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -10.46 55.52 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.809 2.044 . . . . 3.77 114.587 177.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.24 168.84 9.95 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.986 1.476 . . . . 1.45 114.986 -154.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.56 151.5 31.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.337 1.455 . . . . 0.61 112.053 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.22 143.77 39.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.488 1.915 . . . . 1.75 107.854 171.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.0 mtt -137.64 139.5 40.32 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.85 0.75 . . . . 1.19 111.946 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.7 mt -100.41 126.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.569 1.548 . . . . 0.79 108.346 171.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -105.85 149.26 26.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.995 1.318 . . . . 3.07 113.43 -162.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.06 -43.0 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.924 0.89 . . . . 1.21 111.827 -167.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.89 171.3 27.15 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.857 -0.897 . . . . 0.97 110.857 158.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.45 -147.88 0.02 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.328 2.871 . . . . 2.2 114.573 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.52 54.03 0.48 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 123.746 1.736 . . . . 3.25 112.114 -150.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -160.94 27.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.511 -1.677 . . . . 3.4 111.655 -162.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 70.5 mtm -132.86 116.25 16.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.529 1.132 . . . . 3.01 111.355 -162.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 t -158.44 176.91 11.83 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.597 1.159 . . . . 3.19 110.738 175.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 68.45 25.59 6.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.634 1.974 . . . . 3.77 114.012 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.94 153.27 78.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.498 1.119 . . . . 4.06 111.774 178.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 -13.85 31.6 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.781 2.987 . . . . 1.92 114.478 -170.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -100.07 87.11 0.68 Allowed Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 117.818 -1.087 . . . . 4.65 108.596 157.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.77 151.95 60.38 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.933 2.422 . . . . 3.16 111.562 -174.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mp 67.38 22.48 9.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 3.62 110.301 -168.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.02 -7.58 4.26 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.569 1.557 . . . . 2.69 114.612 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.81 1.35 87.2 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.096 1.332 . . . . 1.71 114.011 -163.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.7 67.05 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-N 118.982 1.391 . . . . 1.6 114.878 -175.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.59 12.58 7.77 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.564 1.554 . . . . 1.6 116.704 -169.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.4 p -75.18 169.1 18.71 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.341 1.57 . . . . 1.74 110.196 169.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 137.82 51.15 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.5 1.12 . . . . 5.13 111.97 -173.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 3.5 t80 -85.26 -26.21 26.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.686 0.676 . . . . 2.21 111.881 162.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.01 157.78 36.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.236 0.828 . . . . 0.55 113.236 173.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.8 t -136.68 148.56 47.45 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.646 1.978 . . . . 1.5 110.768 175.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -148.69 121.8 1.38 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.042 1.306 . . . . 0.66 113.038 178.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.02 135.43 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.851 1.66 . . . . 1.62 110.911 175.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.6 mt -79.21 155.02 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.068 1.347 . . . . 0.86 111.036 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? . . . . . 0 CA--C 1.544 0.718 0 O-C-N 119.997 -1.689 . . . . 3.45 110.949 169.783 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.609 -0.886 . . . . 1.99 108.609 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -142.54 150.01 39.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.88 1.437 . . . . 1.28 114.88 -133.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.04 141.25 17.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.468 1.128 . . . . 2.95 109.825 167.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -90.67 135.39 33.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.617 -0.72 . . . . 2.87 111.384 176.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.7 t -121.96 125.13 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.276 -0.89 . . . . 1.15 111.108 177.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.13 115.17 4.14 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.836 1.207 . . . . 1.02 110.168 172.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.4 mtp -96.57 107.51 19.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.711 1.204 . . . . 1.71 109.695 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -93.98 146.21 24.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.813 0.671 . . . . 3.21 112.813 -169.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.4 62.75 1.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.378 1.071 . . . . 1.74 113.243 -175.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.6 m -58.54 131.84 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.507 -0.745 . . . . 1.42 111.121 171.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -150.2 48.31 0.91 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.243 1.021 . . . . 2.58 110.943 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.04 -36.7 0.32 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 128.703 2.801 . . . . 1.14 112.004 -178.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.295 0.0 OUTLIER -78.28 41.84 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.248 1.419 . . . . 3.22 114.1 174.205 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.17 -155.97 41.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.855 1.217 . . . . 1.54 112.362 175.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.82 125.28 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.158 -1.053 . . . . 1.17 108.158 163.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.35 -82.06 1.55 Allowed Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.995 0.807 . . . . 2.11 112.113 -166.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -158.37 164.83 35.95 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 122.389 1.09 . . . . 1.64 112.579 167.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 t -103.16 146.76 27.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.758 1.623 . . . . 1.29 112.373 -176.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 pt -148.72 10.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.623 1.569 . . . . 2.77 113.516 -164.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.02 177.68 19.12 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.78 1.181 . . . . 0.84 112.364 -165.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 p -129.47 -176.92 4.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.275 1.03 . . . . 1.01 109.984 170.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 54.6 t -126.52 136.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 124.273 1.029 . . . . 0.56 108.367 159.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.56 133.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 123.198 0.312 . . . . 0.84 110.325 171.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mt -108.77 133.78 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.871 -0.789 . . . . 1.69 108.871 168.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -139.04 96.6 3.14 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.343 1.857 . . . . 2.2 110.068 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 141.65 57.36 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 127.301 2.24 . . . . 4.34 111.597 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -156.39 177.52 11.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.745 0.783 . . . . 1.35 111.286 175.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.54 -18.51 62.17 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 3.96 112.012 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 7.26 81.13 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.927 1.251 . . . . 1.04 115.355 166.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.78 -169.66 42.93 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 129.458 3.409 . . . . 0.89 116.145 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.24 105.45 0.34 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.353 1.461 . . . . 0.63 112.03 -175.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -84.75 113.4 21.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 2.1 109.115 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 4.6 t80 -95.01 127.77 41.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.735 2.014 . . . . 0.73 108.999 -177.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -137.64 109.77 8.69 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.501 1.501 . . . . 0.63 109.715 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.9 162.99 18.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.775 2.983 . . . . 0.61 111.335 -175.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -150.11 30.7 0.7 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.051 0.76 . . . . 1.47 113.051 174.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.06 140.82 29.47 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.672 -1.267 . . . . 0.77 112.425 -173.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 26.74 9.82 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.082 1.882 . . . . 2.01 116.082 -168.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.65 65.26 0.67 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.131 0.572 . . . . 1.44 112.127 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.2 159.39 69.92 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 121.731 -0.606 . . . . 1.38 111.934 170.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -63.79 129.5 24.99 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 120.933 1.089 . . . . 0.81 111.286 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.46 37.53 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.583 1 C-N-CA 126.752 4.968 . . . . 1.07 113.251 -153.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.21 -135.4 7.31 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 123.52 1.622 . . . . 1.43 112.165 -177.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -116.28 139.27 50.55 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.011 1.325 . . . . 2.53 109.431 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -143.54 144.14 31.83 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.041 0.936 . . . . 1.38 110.568 -168.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.95 160.85 52.21 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 110.262 -1.135 . . . . 0.95 110.262 174.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 128.31 22.79 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 106.801 -1.555 . . . . 1.84 106.801 166.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 93' ' ' ASP . 65.6 m170 -127.99 167.82 16.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.436 2.013 . . . . 1.02 116.436 173.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.7 146.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.716 1.606 . . . . 0.88 109.679 151.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.89 161.27 32.23 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.677 2.791 . . . . 0.95 108.849 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -26.44 67.32 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.118 2.266 . . . . 0.86 117.118 -157.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -140.36 165.65 26.85 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.184 1.394 . . . . 1.68 113.271 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.13 104.11 2.68 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 120.806 -1.184 . . . . 0.99 114.801 -172.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m 177.56 -173.56 0.12 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.773 3.229 . . . . 3.45 109.443 171.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.8 m -120.03 -23.84 6.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.1 1.36 . . . . 2.41 113.843 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -76.23 142.51 71.89 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.14 1.163 . . . . 3.02 114.14 -158.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.64 160.2 21.97 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.35 3.367 . . . . 1.18 112.41 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.84 154.61 19.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.432 0.693 . . . . 1.77 109.954 158.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.72 123.7 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.206 1.002 . . . . 2.37 108.86 -178.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -169.12 159.76 9.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.498 1.919 . . . . 5.57 109.379 -175.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 t70 58.39 27.82 15.94 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.862 -1.149 . . . . 4.36 113.234 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.03 14.52 82.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.991 1.281 . . . . 2.67 115.032 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -152.65 164.02 38.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.391 1.595 . . . . 2.96 113.683 -168.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.71 113.75 26.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 1.74 111.109 -178.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.76 57.25 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.785 2.034 . . . . 2.19 110.932 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.48 -68.13 0.12 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.964 2.505 . . . . 2.52 116.391 160.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -175.77 47.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.834 2.453 . . . . 2.36 113.024 -167.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -59.48 -21.36 59.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.134 -1.604 . . . . 4.51 113.658 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.38 -19.94 62.21 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 119.669 -1.894 . . . . 1.96 112.874 170.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 -9.27 26.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.199 1.8 . . . . 1.16 113.606 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.63 165.21 32.65 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.018 -1.051 . . . . 2.92 113.355 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.98 -173.09 23.98 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.855 -0.791 . . . . 1.45 112.752 168.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -44.66 138.92 3.14 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.515 0.726 . . . . 2.73 109.275 163.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 66.13 1.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.263 1.825 . . . . 2.91 112.796 -165.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -110.06 83.79 3.2 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 129.002 2.921 . . . . 4.13 108.226 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.36 -21.53 37.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.775 2.984 . . . . 3.24 114.733 -176.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 6.26 0.24 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.293 0.849 . . . . 8.33 113.293 153.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.71 -38.94 67.34 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.365 -1.46 . . . . 4.26 114.828 -144.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t 169.26 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.267 2.227 . . . . 3.84 112.078 -170.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.27 43.84 4.85 Favored Glycine 0 N--CA 1.47 0.931 0 CA-C-O 118.955 -0.914 . . . . 3.15 113.077 176.199 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.316 12.9 ptmt -143.4 -101.08 0.12 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.912 1.449 . . . . 4.1 114.912 -176.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.452 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -163.88 144.2 8.43 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 117.355 2.354 . . . . 2.08 117.355 -157.533 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.64 -130.6 0.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.202 2.201 . . . . 4.08 107.738 160.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.49 -89.59 0.56 Allowed Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.761 1.648 . . . . 2.85 111.868 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -98.33 -21.0 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.297 2.665 . . . . 3.13 114.993 -172.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 157.77 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.684 3.194 . . . . 5.42 110.427 -161.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.76 -151.6 28.1 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.532 1.539 . . . . 3.47 114.592 -172.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.78 13.18 0.27 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.43 2.011 . . . . 7.68 116.43 -160.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.08 -178.55 38.42 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 120.251 1.387 . . . . 2.76 113.071 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.773 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 19.3 t-160 57.32 96.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.246 1.818 . . . . 5.13 115.007 170.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 65.37 6.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.693 -1.254 . . . . 2.95 110.938 169.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.03 7.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.789 -1.562 . . . . 1.26 116.472 -176.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.773 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 3.2 m-20 -74.66 147.28 41.67 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.15 1.475 . . . . 1.9 108.85 157.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.48 171.85 6.9 Favored Pre-proline 0 CA--C 1.555 1.151 0 O-C-N 121.314 -0.866 . . . . 1.83 110.521 -142.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.89 133.21 19.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.326 2.018 . . . . 1.78 110.403 -174.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.01 132.39 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 123.362 1.554 . . . . 1.68 112.766 -175.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -68.43 91.93 0.42 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.46 2.304 . . . . 2.46 110.253 168.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.14 131.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.028 -1.045 . . . . 1.04 109.133 166.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.77 133.55 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.407 1.883 . . . . 1.62 106.915 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.41 154.57 22.73 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.808 0.731 . . . . 1.76 112.359 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -24.17 0.4 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.924 2.565 . . . . 2.55 117.924 -167.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -93.22 -6.36 47.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.51 1.524 . . . . 2.99 114.103 -176.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.25 20.71 8.48 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 125.072 1.32 . . . . 0.86 115.487 175.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.71 127.81 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 118.161 0.98 . . . . 1.18 109.984 -176.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.68 118.94 31.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 0.9 109.291 169.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.1 t -135.48 4.45 3.13 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.963 1.305 . . . . 1.3 113.695 -178.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.01 119.74 69.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.856 1.662 . . . . 3.35 112.982 -165.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.88 136.38 16.64 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.632 2.888 . . . . 1.21 112.402 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.97 173.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 126.557 1.943 . . . . 1.48 109.848 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 m -145.5 140.26 27.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.537 1.062 . . . . 0.73 110.971 -174.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.34 90.64 5.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.609 1.163 . . . . 0.63 111.858 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.82 -2.61 11.21 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.09 3.193 . . . . 1.17 115.293 -176.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.68 -15.95 61.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.379 1.472 . . . . 4.93 112.396 176.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.09 145.31 49.99 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.67 1.988 . . . . 2.57 107.684 175.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -147.44 32.9 0.88 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.603 2.361 . . . . 4.83 111.625 -175.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -163.86 141.8 7.35 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.082 1.353 . . . . 1.65 111.503 156.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.0 tp -65.96 -23.71 66.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.084 -1.01 . . . . 1.82 110.685 175.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.07 -24.99 60.68 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.514 1.126 . . . . 2.66 113.098 169.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -68.19 -15.87 63.75 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.641 1.11 . . . . 2.3 112.392 174.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.93 8.08 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 114.192 1.182 . . . . 0.86 114.192 -172.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -69.93 5.28 1.62 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 116.274 1.953 . . . . 3.16 116.274 -171.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.46 9.09 3.98 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.137 2.175 . . . . 2.69 112.195 177.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -110.45 -178.34 3.47 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.115 1.366 . . . . 1.68 114.311 -168.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.51 149.88 41.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.988 1.315 . . . . 0.68 111.8 172.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.07 154.24 17.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.669 1.988 . . . . 1.7 107.828 165.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.5 mtt -142.09 141.17 32.71 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.367 -0.833 . . . . 1.3 113.067 170.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.9 mt -88.34 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 108.18 -1.045 . . . . 0.95 108.18 165.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.21 152.64 47.12 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.205 1.557 . . . . 2.02 115.205 -165.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.06 -53.53 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.727 1.611 . . . . 1.41 112.762 -159.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.56 179.39 52.44 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.573 -1.411 . . . . 1.17 109.573 158.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.82 -143.87 0.03 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 127.236 2.351 . . . . 2.29 112.553 168.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -151.53 59.92 0.88 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.185 1.18 . . . . 3.59 114.185 -169.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -149.31 21.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.219 1.008 . . . . 3.0 113.564 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.06 142.71 52.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.017 1.327 . . . . 4.72 112.672 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.4 p -85.04 166.49 16.65 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.88 1.272 . . . . 5.78 112.864 172.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.92 142.43 51.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.814 0.846 . . . . 6.71 112.172 177.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.87 156.76 34.4 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.816 1.246 . . . . 4.59 109.581 -160.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.03 -0.06 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.019 3.146 . . . . 2.6 114.169 174.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -116.79 132.85 23.19 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.169 0.988 . . . . 6.31 108.557 159.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.86 164.68 32.58 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.791 2.327 . . . . 3.57 112.286 -173.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt 69.55 4.84 4.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.814 2.046 . . . . 4.45 113.729 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.57 15.16 77.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.103 0.859 . . . . 2.96 113.359 -175.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.46 -51.52 3.34 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.537 1.541 . . . . 1.86 113.757 -178.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.46 -10.5 73.62 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.333 1.444 . . . . 1.78 115.044 -176.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.49 42.44 1.97 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.653 1.597 . . . . 2.94 113.937 -178.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.7 p -119.39 163.64 16.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 128.473 2.709 . . . . 3.69 109.84 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.47 140.17 29.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.667 2.099 . . . . 6.09 116.667 -166.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -98.99 -20.77 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.103 1.361 . . . . 2.82 112.195 155.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.69 153.39 29.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.169 0.895 . . . . 0.74 113.151 173.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 19.0 p -84.66 -149.86 0.12 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.723 1.609 . . . . 2.98 111.88 171.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.17 81.11 0.03 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.28 0.943 . . . . 0.83 113.806 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.69 120.1 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.386 1.075 . . . . 2.16 111.568 176.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 71.2 mt -79.76 138.72 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.147 -0.686 . . . . 0.94 109.147 173.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.549 0.939 0 O-C-N 120.503 -1.373 . . . . 3.89 111.335 -176.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.379 -0.6 . . . . 1.99 109.379 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -138.38 158.46 44.24 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.832 -1.167 . . . . 0.98 114.089 -145.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -160.41 116.65 2.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.518 1.527 . . . . 3.47 108.118 -175.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -90.46 143.14 27.04 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.884 -1.135 . . . . 3.91 110.475 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' C ' HG23 ' A' ' 21' ' ' THR . 58.8 t -134.64 85.59 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 122.424 1.107 . . . . 1.05 111.707 177.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -32.07 114.52 0.08 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 127.252 2.358 . . . . 1.02 113.131 147.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.8 mtt -101.9 148.41 25.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 113.79 -1.205 . . . . 1.37 113.365 171.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.22 148.38 35.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 2.3 110.647 168.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.1 mt -61.18 135.93 57.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.512 -0.922 . . . . 1.16 108.512 166.29 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.5 143.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.423 1.089 . . . . 1.03 108.912 173.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -171.68 91.87 0.13 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.512 -0.921 . . . . 2.44 108.512 -174.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.85 -62.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.943 2.097 . . . . 1.65 113.507 -177.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.265 0.1 OUTLIER -80.76 12.62 3.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.91 1.684 . . . . 5.37 114.859 -173.212 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.14 -151.02 32.77 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.221 0.915 . . . . 1.02 112.049 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.98 110.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.452 1.901 . . . . 0.83 111.835 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.58 -72.3 1.11 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.901 1.239 . . . . 1.7 113.636 -175.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.92 153.44 16.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.645 1.178 . . . . 1.9 111.649 -175.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -92.97 145.22 24.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.014 1.726 . . . . 1.39 114.523 -165.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 5.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 115.949 1.833 . . . . 3.58 115.949 -177.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.74 175.54 20.58 Favored Glycine 0 N--CA 1.467 0.704 0 O-C-N 121.197 -0.94 . . . . 0.63 113.86 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 5' ' ' VAL . 64.4 m -115.34 156.51 25.36 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.975 1.31 . . . . 2.65 108.859 172.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.49 133.43 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.889 -1.152 . . . . 0.52 107.889 152.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -91.61 129.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 117.872 0.305 . . . . 0.94 110.911 175.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mt -100.42 129.87 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.406 -0.961 . . . . 1.69 108.406 170.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -133.21 123.55 25.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.272 1.029 . . . . 2.06 109.279 167.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -78.56 157.98 28.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 112.252 0.464 . . . . 3.48 112.252 -177.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 t -156.36 178.49 10.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.906 0.86 . . . . 1.45 109.834 168.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -63.83 -13.42 44.47 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.419 2.288 . . . . 3.86 113.137 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.22 8.73 53.47 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.104 1.812 . . . . 1.28 115.437 165.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.68 -162.85 28.08 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 130.643 3.973 . . . . 0.92 117.638 171.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.55 108.02 2.28 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.357 1.063 . . . . 0.7 111.738 -172.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -85.98 109.75 18.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.41 1.084 . . . . 1.9 110.209 173.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.8 t80 -94.29 112.81 24.63 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.375 2.27 . . . . 0.55 108.835 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 m -120.1 112.31 34.84 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 120.003 1.274 . . . . 0.7 108.58 -176.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.58 150.6 7.57 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.011 2.474 . . . . 0.54 113.156 -171.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' NE2' ' HB ' ' A' ' 21' ' ' THR . 7.9 p80 -147.51 41.98 1.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.356 1.074 . . . . 1.51 112.547 171.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.19 156.51 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.707 1.603 . . . . 0.83 113.845 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 167.0 18.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.131 -1.85 . . . . 3.33 109.211 176.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.55 19.42 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.14 2.576 . . . . 1.51 113.566 172.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.616 HD12 HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -91.33 164.75 23.56 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 121.678 -0.639 . . . . 1.79 110.231 174.324 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.29 145.3 96.05 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 120.296 0.664 . . . . 0.83 111.578 165.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 10.2 Cg_endo -85.39 25.61 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 125.111 3.874 . . . . 1.06 114.253 -153.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.84 -141.1 6.7 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 125.216 1.389 . . . . 1.28 116.012 -174.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.3 141.92 29.06 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.67 2.388 . . . . 2.4 110.451 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -136.18 137.66 41.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.463 1.105 . . . . 1.63 111.449 -172.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 157.38 52.34 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.899 -1.126 . . . . 0.78 111.631 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 8.4 t80 -130.98 112.92 13.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.155 -1.424 . . . . 1.96 107.155 173.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -118.48 162.21 18.72 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.127 -0.983 . . . . 1.02 113.518 165.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.41 135.08 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.429 1.492 . . . . 0.81 107.281 159.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -115.06 159.08 21.25 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.602 0.761 . . . . 0.95 109.659 170.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.13 79.59 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.827 1.788 . . . . 1.01 115.827 -160.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.97 143.64 48.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.398 1.079 . . . . 1.13 113.019 -173.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.55 62.18 2.75 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.512 1.53 . . . . 1.06 114.941 -176.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -162.73 89.88 0.68 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.408 1.604 . . . . 2.07 115.225 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.0 m -74.15 74.25 1.76 Allowed 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.041 -1.662 . . . . 2.74 111.8 166.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -122.27 144.95 43.0 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.239 1.016 . . . . 3.22 110.365 174.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.05 162.43 10.2 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.971 2.447 . . . . 1.14 113.831 -167.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.51 128.78 55.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.387 1.075 . . . . 1.82 108.935 161.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mm -90.71 38.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.456 1.122 . . . . 3.28 110.009 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -66.72 130.34 42.84 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.929 1.291 . . . . 4.17 110.976 -167.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t70 57.65 21.76 7.58 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.148 1.166 . . . . 3.72 114.148 -176.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.05 76.01 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.148 0.88 . . . . 2.57 114.495 177.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.75 134.88 52.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.401 1.601 . . . . 2.88 110.71 172.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.74 95.11 9.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.319 -0.863 . . . . 1.87 112.104 -169.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.73 95.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.596 1.558 . . . . 2.39 108.594 173.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.4 -25.88 0.47 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 119.797 3.258 . . . . 2.87 119.797 -156.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.67 38.06 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 120.128 1.331 . . . . 1.58 114.267 -168.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.26 -34.12 73.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.224 1.01 . . . . 4.77 113.076 -177.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.68 0.55 1.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.036 1.495 . . . . 1.44 115.036 -175.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.57 -10.84 59.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.217 1.407 . . . . 1.0 113.856 175.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.33 32.89 12.58 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 116.796 1.479 . . . . 3.18 116.796 164.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.57 -178.58 31.54 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 119.452 1.626 . . . . 1.09 114.457 174.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -76.2 22.58 0.16 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.197 1.554 . . . . 2.27 115.197 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.254 31.1 tp 64.41 36.16 9.12 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.143 1.377 . . . . 1.7 111.508 172.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -123.17 49.55 2.54 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 116.371 1.989 . . . . 3.61 116.371 -161.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.33 -29.14 46.44 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.51 2.14 . . . . 2.42 113.028 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -127.16 34.88 4.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.649 1.18 . . . . 4.47 111.905 -168.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -119.84 -153.6 0.55 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.834 1.254 . . . . 3.37 110.882 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.6 p -88.99 -25.17 22.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.271 1.428 . . . . 3.08 113.174 175.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.31 88.78 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.392 0.996 . . . . 2.0 114.74 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -98.05 7.94 45.53 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 116.116 1.895 . . . . 4.84 116.116 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.7 t60 68.61 168.04 0.27 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.961 1.704 . . . . 2.05 112.768 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -150.17 155.25 39.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.793 1.405 . . . . 3.6 114.793 -149.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.33 -155.06 6.89 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 126.291 1.9 . . . . 2.6 112.873 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.26 -9.79 24.83 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.861 3.041 . . . . 3.79 113.041 173.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.31 162.56 32.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.48 1.912 . . . . 6.35 109.159 166.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.42 -159.71 23.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.28 0.943 . . . . 4.54 112.84 -172.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.95 137.21 3.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.393 2.277 . . . . 4.69 105.876 168.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.7 -72.87 0.02 OUTLIER Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.195 0.902 . . . . 2.77 114.282 -172.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -150.85 125.75 9.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.596 1.959 . . . . 4.03 110.801 -173.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -62.45 -20.38 64.47 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.223 1.194 . . . . 2.72 114.223 175.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.39 8.22 59.03 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.631 2.062 . . . . 1.18 116.031 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.39 139.75 30.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.995 1.397 . . . . 1.65 111.154 167.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.61 163.63 49.75 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 126.784 2.034 . . . . 2.06 110.077 -172.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.77 162.43 26.91 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.141 2.561 . . . . 1.07 112.304 -172.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.12 141.92 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.699 1.37 . . . . 1.52 114.699 -164.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.12 107.09 18.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 130.675 3.59 . . . . 1.76 108.682 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.34 137.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.907 -1.121 . . . . 0.93 110.575 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 40' ' ' LEU . 10.9 m -109.09 161.2 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.356 0.662 . . . . 2.18 109.962 164.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.91 165.07 16.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.864 0.466 . . . . 2.03 110.927 175.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -62.72 4.79 0.14 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 117.568 2.433 . . . . 2.94 117.568 -161.443 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -104.17 -11.08 17.48 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.27 2.628 . . . . 3.45 113.395 176.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.49 24.48 12.26 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 121.365 -0.834 . . . . 0.82 114.675 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.5 mt -126.05 129.84 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.629 1.172 . . . . 1.46 110.92 -176.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -89.22 147.66 24.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.099 2.16 . . . . 1.15 112.075 -172.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.97 -21.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.89 1.276 . . . . 1.22 114.057 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.53 116.95 50.61 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.457 1.103 . . . . 3.06 110.447 176.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -85.07 163.13 11.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.592 2.862 . . . . 1.34 112.349 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.85 161.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.723 1.209 . . . . 1.26 110.577 170.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 m -124.04 139.81 53.58 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.327 1.051 . . . . 0.87 110.041 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.58 97.85 29.71 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.21 1.004 . . . . 0.84 110.79 174.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.88 -0.8 10.36 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.925 3.083 . . . . 1.36 114.333 -176.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -86.94 -2.76 58.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.627 1.571 . . . . 4.06 112.696 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.1 mt -141.53 123.86 15.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.52 2.328 . . . . 2.36 106.242 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -116.18 5.66 13.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.857 1.263 . . . . 4.71 114.158 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.7 t -149.38 150.05 31.83 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.441 0.904 . . . . 1.9 113.441 175.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.78 -28.68 70.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.377 -0.827 . . . . 1.62 112.569 170.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.01 -18.57 65.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.065 1.302 . . . . 3.67 113.58 -177.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.03 -19.49 61.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.338 1.055 . . . . 1.73 112.121 172.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.47 7.26 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.656 1.182 . . . . 0.8 113.941 -170.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -63.68 5.67 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.263 2.32 . . . . 2.46 117.263 -174.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.54 0.43 2.49 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.713 2.005 . . . . 3.0 112.607 -178.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -95.81 171.71 8.48 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.457 1.503 . . . . 1.48 113.577 -168.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.73 150.28 27.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.511 1.124 . . . . 0.51 111.984 165.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 mt -122.4 140.29 52.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.41 2.284 . . . . 1.7 107.803 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.485 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -143.23 146.81 33.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.418 1.008 . . . . 2.55 113.599 177.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.8 119.14 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.274 1.43 . . . . 1.14 108.301 166.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' A' ' 126' ' ' MET . 74.6 m80 -98.57 148.44 23.78 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.672 1.589 . . . . 3.06 112.013 -168.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.8 -46.37 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.173 0.589 . . . . 1.75 112.144 -158.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.35 169.71 13.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.79 1.186 . . . . 1.79 111.14 164.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.28 -174.6 4.68 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.216 1.865 . . . . 1.77 113.433 170.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -159.91 166.22 30.58 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.787 0.835 . . . . 3.53 111.914 -166.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.0 p30 159.04 23.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 132.721 4.408 . . . . 3.07 111.625 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 72.9 mtm -92.37 106.84 18.76 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.897 -1.127 . . . . 3.3 112.504 -165.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 p -93.05 158.86 15.56 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.656 -1.277 . . . . 3.56 113.903 169.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.2 t0 65.58 17.96 11.08 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.417 2.006 . . . . 5.41 116.417 155.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.9 157.08 49.17 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 120.699 -1.251 . . . . 6.88 113.675 -172.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.36 -21.75 3.52 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.667 2.911 . . . . 3.04 114.134 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -102.92 95.74 6.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.088 -1.007 . . . . 7.27 108.382 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.65 143.78 75.99 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.566 2.177 . . . . 3.47 111.504 -164.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 77.06 -10.74 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.472 2.709 . . . . 4.06 113.013 -174.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 62.58 15.41 53.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 2.64 115.66 170.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.1 -21.8 32.45 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.912 1.244 . . . . 2.65 113.631 -170.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.89 -8.18 52.21 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.403 1.478 . . . . 2.49 114.009 176.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.69 -5.14 83.01 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.025 1.298 . . . . 2.07 114.514 170.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.6 p -75.78 132.28 40.33 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.894 1.347 . . . . 1.8 110.174 175.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -97.84 135.08 40.11 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.167 0.987 . . . . 5.97 110.192 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 26.7 t80 -91.0 -40.04 11.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.047 0.385 . . . . 2.24 110.326 164.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.52 29.26 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.909 0.884 . . . . 1.14 111.931 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.2 m -114.73 145.03 42.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.891 2.076 . . . . 2.87 111.233 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.74 167.65 26.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.919 1.723 . . . . 1.37 113.225 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.9 t -135.54 141.91 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.738 1.215 . . . . 1.53 109.734 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.2 mt -89.06 143.47 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.738 1.215 . . . . 0.83 110.774 -176.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 4.62 111.287 -177.27 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.238 0.542 . . . . 1.73 110.659 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -148.43 149.78 32.32 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.856 0.862 . . . . 0.98 110.362 -172.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.04 132.05 16.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.657 1.217 . . . . 2.23 110.053 171.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -88.56 109.79 20.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.179 0.992 . . . . 3.72 111.559 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -87.02 105.51 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.609 -1.307 . . . . 1.47 108.885 -169.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -59.38 108.81 1.8 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.651 1.596 . . . . 1.36 109.953 169.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.7 mtt -109.41 154.03 23.16 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.275 1.43 . . . . 1.23 112.508 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -145.9 149.68 34.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.56 1.544 . . . . 3.06 112.003 -169.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.41 66.1 3.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.953 1.301 . . . . 1.6 111.435 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.25 144.83 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.698 0.799 . . . . 0.88 111.599 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.4 t -172.69 72.19 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.451 1.1 . . . . 2.05 111.152 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.11 -19.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.866 2.066 . . . . 1.3 114.834 173.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -28.86 66.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.479 1.912 . . . . 2.91 110.006 164.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.47 -159.23 24.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.182 1.372 . . . . 1.14 111.067 -154.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -46.15 127.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.411 1.884 . . . . 1.14 111.122 165.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.79 -68.02 0.18 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.607 1.575 . . . . 1.66 114.039 -173.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.156 1.382 . . . . 1.85 110.543 171.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -109.25 172.23 6.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.737 -1.227 . . . . 1.34 112.571 178.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.7 pt -151.19 5.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 128.98 2.912 . . . . 3.08 112.479 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.53 159.37 9.08 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 121.137 -0.977 . . . . 0.92 113.751 -161.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 6' ' ' GLY . 72.9 p -125.99 -178.5 4.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.683 1.993 . . . . 1.69 106.74 173.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 61.0 t -133.52 125.83 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.359 -0.978 . . . . 0.61 108.359 169.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.0 p -74.77 124.69 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 117.978 0.354 . . . . 0.94 110.599 170.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HD21 ' A' ' 125' ' ' LEU . 8.4 mt -98.41 131.43 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 108.298 -1.001 . . . . 1.56 108.298 163.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -140.05 121.47 15.05 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.132 1.373 . . . . 1.81 108.572 178.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.74 150.26 21.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.801 0.667 . . . . 3.05 112.801 -169.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.6 178.9 9.57 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.108 0.563 . . . . 1.18 110.546 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -60.53 -30.81 69.98 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.676 1.19 . . . . 3.61 110.958 175.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.6 13.96 53.54 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.164 1.364 . . . . 0.89 114.953 168.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.31 -148.49 20.71 Favored Glycine 0 N--CA 1.468 0.782 0 C-N-CA 127.167 2.318 . . . . 0.69 116.268 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.2 mt -79.18 101.54 8.0 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.169 -0.606 . . . . 0.6 110.862 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -75.73 112.37 12.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 2.33 109.587 171.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 3.2 t80 -98.79 109.07 21.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 128.02 2.528 . . . . 0.52 108.14 -178.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.422 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.5 m -111.13 105.64 57.11 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.335 -1.357 . . . . 0.64 107.335 176.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.31 153.23 24.17 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.316 2.677 . . . . 0.75 110.846 -171.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.97 63.37 0.65 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.177 0.989 . . . . 2.79 111.013 178.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.25 141.78 51.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.057 2.143 . . . . 0.87 111.528 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -129.32 20.82 5.71 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 118.029 2.603 . . . . 2.7 118.029 -158.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.43 19.58 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 115.581 1.697 . . . . 1.9 115.581 -173.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.78 165.35 19.12 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 121.492 -0.755 . . . . 1.75 110.856 -171.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 59.9 Cg_endo -65.95 131.26 26.65 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 N-CA-C 109.806 -0.882 . . . . 1.14 109.806 163.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 6.0 Cg_endo -88.88 34.2 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.272 3.315 . . . . 1.13 112.402 -148.175 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.44 -122.54 4.8 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 123.821 1.79 . . . . 1.51 113.616 -178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -134.88 142.41 46.58 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 126.372 1.869 . . . . 3.1 109.747 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -134.59 145.87 49.07 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.572 1.149 . . . . 1.12 111.707 -173.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.82 157.16 26.72 Favored Glycine 0 CA--C 1.542 1.758 0 O-C-N 121.024 -1.048 . . . . 0.63 111.951 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -145.56 120.51 10.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.791 1.237 . . . . 2.05 108.086 168.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.12 165.16 24.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.702 1.742 . . . . 0.86 115.702 164.077 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.0 mt -89.96 144.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.398 1.479 . . . . 0.78 109.143 160.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -127.44 170.19 12.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.885 2.074 . . . . 1.11 111.361 -178.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.98 52.74 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.99 2.218 . . . . 1.02 116.99 -160.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -110.51 -157.41 0.61 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.752 1.221 . . . . 2.31 111.477 -175.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.12 -27.63 8.67 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 117.65 1.82 . . . . 1.94 117.65 -155.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 175.8 140.12 0.06 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.963 2.382 . . . . 3.38 113.877 -173.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.58 67.08 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 117.354 2.353 . . . . 3.58 117.354 -176.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -94.09 152.04 40.09 Favored Pre-proline 0 CA--C 1.55 0.963 0 O-C-N 121.053 -1.029 . . . . 3.32 110.689 160.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -90.22 177.63 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.207 3.272 . . . . 1.49 112.673 -168.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.67 147.21 37.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.995 1.318 . . . . 1.41 110.624 172.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.87 126.94 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.915 0.886 . . . . 2.46 110.989 -174.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.86 156.47 22.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.706 2.402 . . . . 5.79 110.73 173.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 52.09 37.33 21.23 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.078 1.51 . . . . 4.18 115.078 167.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.88 79.38 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.003 -1.061 . . . . 2.52 114.351 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.07 156.04 42.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.857 1.328 . . . . 4.28 113.528 -176.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.77 121.78 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.647 0.779 . . . . 1.67 108.909 164.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.41 132.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.719 1.208 . . . . 3.0 108.567 171.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.3 -37.75 17.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.808 1.243 . . . . 1.9 114.148 -172.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -179.98 123.74 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.465 2.706 . . . . 1.84 110.307 175.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -121.49 -29.07 4.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.905 1.282 . . . . 4.22 112.547 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.96 -0.29 8.98 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.202 -1.561 . . . . 1.86 114.071 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.56 -17.46 33.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.734 1.614 . . . . 1.23 113.273 164.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.59 179.61 52.81 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.642 1.591 . . . . 2.51 114.439 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.5 -172.8 25.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.946 0.784 . . . . 1.17 112.864 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.94 24.07 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.047 1.739 . . . . 2.15 115.627 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.9 tp 52.29 49.04 21.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.211 1.405 . . . . 1.83 110.493 176.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -151.49 110.8 2.98 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.433 -0.803 . . . . 4.29 112.634 -171.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -91.72 -18.96 0.84 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.012 2.475 . . . . 2.92 113.766 174.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -159.25 -22.56 0.07 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.938 1.829 . . . . 3.66 115.938 -163.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -64.76 -35.86 82.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.751 1.614 . . . . 3.58 112.366 -171.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -165.91 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.991 2.517 . . . . 3.93 111.263 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.18 11.14 70.12 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.515 1.531 . . . . 2.39 112.73 -177.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -167.16 -105.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.245 1.818 . . . . 5.68 113.033 -166.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.433 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 4.2 t60 -161.43 141.57 10.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.727 1.751 . . . . 2.47 115.727 -161.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.43 149.83 36.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.092 0.957 . . . . 4.0 113.293 174.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.52 -145.63 17.88 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 110.316 -1.114 . . . . 2.81 110.316 156.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.39 17.56 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.996 3.131 . . . . 3.48 114.253 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.63 -11.08 8.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.691 1.596 . . . . 4.78 114.429 -157.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.14 -7.68 81.58 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 116.955 1.542 . . . . 3.56 116.955 169.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -78.02 83.16 4.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 1.585 . . . . 5.33 109.383 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.8 -177.1 14.89 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 123.936 0.779 . . . . 3.3 114.812 -168.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.998 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 5.4 p-80 -92.04 157.92 16.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.693 0.797 . . . . 5.75 111.274 169.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -63.05 -10.12 12.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.118 1.525 . . . . 3.18 115.118 -179.151 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.617 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -115.24 19.9 14.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.798 2.142 . . . . 1.58 113.753 173.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.998 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 69.0 m-20 -73.86 135.12 43.36 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.42 1.11 . . . . 2.51 109.491 164.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.01 160.48 31.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.16 1.384 . . . . 1.83 110.294 -147.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.11 168.77 20.07 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.216 3.277 . . . . 1.11 111.633 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 m -82.0 142.89 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 122.894 1.33 . . . . 1.44 113.374 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.76 92.73 3.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 129.061 2.944 . . . . 1.8 109.204 172.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 95.9 t -74.75 137.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.875 0.87 . . . . 1.11 110.366 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.99 143.22 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.427 2.291 . . . . 1.49 106.305 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.8 164.49 12.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.858 0.754 . . . . 2.05 111.701 174.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.64 -23.82 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 129.597 3.159 . . . . 2.85 118.112 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.88 -23.5 52.61 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.935 1.694 . . . . 3.97 112.463 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.46 17.73 32.91 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.948 1.737 . . . . 0.88 112.941 -161.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.1 mt -111.81 119.99 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.962 1.305 . . . . 1.05 110.966 -176.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.84 127.52 39.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.775 1.23 . . . . 0.87 109.732 168.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -156.2 4.49 0.17 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.233 1.568 . . . . 1.36 115.233 -175.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.22 135.9 26.39 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 119.81 1.186 . . . . 3.53 110.638 172.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.0 141.72 49.14 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.017 3.145 . . . . 1.14 112.189 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.09 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.823 2.049 . . . . 1.66 108.151 173.019 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.4 m -145.96 139.64 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.931 1.241 . . . . 0.68 111.707 -178.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.01 94.06 5.05 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.26 1.024 . . . . 0.73 112.462 169.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.79 -5.07 16.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.133 3.222 . . . . 1.35 113.933 172.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -73.11 -7.92 53.45 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.146 1.778 . . . . 4.96 111.863 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.6 mt -124.28 177.16 6.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.735 2.414 . . . . 2.26 109.821 170.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -144.39 -20.69 0.54 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.012 1.856 . . . . 4.08 116.012 -172.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -144.03 163.25 34.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.847 1.203 . . . . 1.48 112.399 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.23 61.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.285 -0.884 . . . . 1.59 110.297 174.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.95 -27.68 69.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.378 1.071 . . . . 3.13 113.503 -166.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 119' ' ' GLU . 9.1 pt-20 -71.48 -20.36 62.09 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.753 1.621 . . . . 1.83 113.869 175.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.33 8.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.374 1.47 . . . . 1.08 112.984 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -62.08 -4.41 1.67 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.107 1.891 . . . . 2.33 116.107 -175.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -137.67 24.26 2.88 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.318 2.247 . . . . 3.01 110.814 -160.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -130.68 158.44 40.06 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.332 1.453 . . . . 1.28 113.931 -168.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.76 150.65 20.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.097 1.759 . . . . 0.93 112.987 168.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 24' ' ' ILE . 7.4 mp -127.36 121.01 29.82 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.043 2.137 . . . . 3.05 109.86 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -103.06 131.65 49.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.786 0.835 . . . . 2.35 111.405 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.6 mt -93.52 123.38 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 107.818 -1.179 . . . . 0.68 107.818 160.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -112.89 140.86 47.33 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.427 1.491 . . . . 1.86 112.262 -159.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.03 -41.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.555 -0.716 . . . . 1.24 111.585 -168.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.23 163.57 15.0 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.493 0.568 . . . . 1.23 112.135 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.22 87.72 1.49 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.08 -1.208 . . . . 1.85 110.08 173.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -61.78 122.61 15.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.797 0.839 . . . . 4.3 111.645 178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 171.81 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.239 2.616 . . . . 3.49 109.662 -157.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.9 ptp -74.15 60.42 0.79 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.345 1.458 . . . . 3.33 112.192 171.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 t -74.08 -20.38 60.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.186 1.794 . . . . 3.77 115.111 -165.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -81.87 76.18 8.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 3.36 112.269 -173.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -169.56 156.69 6.42 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.08 1.352 . . . . 3.92 111.78 -179.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.89 -9.65 18.15 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.711 2.941 . . . . 2.89 113.64 176.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -93.2 106.12 18.45 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 119.229 0.922 . . . . 4.38 109.0 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.46 160.22 47.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.104 2.536 . . . . 3.2 113.274 -158.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.58 32.22 21.92 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.834 1.654 . . . . 3.78 111.501 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.34 67.45 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.668 1.128 . . . . 2.68 114.333 -177.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.94 -17.0 18.34 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.156 1.36 . . . . 1.7 113.242 -164.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.92 8.24 60.6 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.006 1.765 . . . . 1.42 114.844 -176.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.49 68.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.302 1.43 . . . . 1.41 115.801 -170.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -58.47 154.46 13.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.181 1.49 . . . . 1.51 110.482 168.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 mmt-85 -96.39 138.47 33.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.388 1.075 . . . . 3.87 109.453 -176.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.86 -18.8 16.22 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.955 0.798 . . . . 3.32 111.774 154.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.31 168.79 25.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.537 1.135 . . . . 0.88 111.409 164.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -152.98 153.26 32.58 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.057 1.343 . . . . 1.87 110.697 172.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -153.17 178.67 30.1 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.181 1.372 . . . . 1.69 114.305 -175.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 139.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.05 1.34 . . . . 2.45 111.302 -171.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 76.2 mt -92.86 143.03 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.44 1.096 . . . . 1.17 109.613 171.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt . . . . . 0 N--CA 1.471 0.62 0 O-C-N 120.67 -1.269 . . . . 3.74 112.508 177.128 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.717 -0.846 . . . . 1.58 108.717 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.22 156.12 47.32 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.167 1.349 . . . . 1.03 114.187 -148.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.68 127.54 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.897 1.679 . . . . 2.32 108.872 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -103.31 98.82 8.68 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.684 1.993 . . . . 3.82 109.708 -174.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -87.77 129.45 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 114.177 1.177 . . . . 2.14 114.177 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.47 103.78 0.73 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.672 1.129 . . . . 1.0 111.057 167.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.31 110.97 13.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.942 1.297 . . . . 1.49 109.971 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -108.66 147.15 32.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 2.44 111.4 -170.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.21 61.18 2.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.981 -1.075 . . . . 1.4 113.192 -171.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -70.87 154.86 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.281 1.432 . . . . 1.41 113.211 -177.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -169.97 -152.97 0.1 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.602 1.561 . . . . 3.33 109.295 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -11.82 2.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 129.03 2.932 . . . . 1.12 116.06 -175.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.82 0.49 32.74 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.953 1.301 . . . . 4.19 112.057 174.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.67 -147.15 21.08 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.695 1.14 . . . . 1.29 110.458 -165.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 10' ' ' VAL . 11.6 t -54.23 134.89 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.732 2.013 . . . . 1.04 112.808 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.28 -112.29 3.66 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.757 1.646 . . . . 1.2 112.803 -175.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.89 166.97 20.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.834 0.817 . . . . 1.94 111.555 168.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.6 t -93.33 148.98 21.57 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.264 1.026 . . . . 1.48 113.192 -174.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 pt -142.1 2.23 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.296 1.438 . . . . 2.82 113.915 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.33 170.25 22.8 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.042 -1.036 . . . . 0.69 112.703 -173.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 p -107.66 178.73 4.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.023 0.929 . . . . 0.9 110.332 171.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 33' ' ' PHE . 46.6 t -128.56 132.54 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.526 -1.287 . . . . 0.41 107.526 152.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.419 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.9 p -85.09 119.92 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.72 0.638 . . . . 0.92 109.77 174.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -102.65 130.23 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.227 -1.397 . . . . 1.38 107.227 174.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -136.78 120.5 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.725 0.81 . . . . 2.32 111.232 176.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.41 140.73 48.53 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.247 0.619 . . . . 3.69 111.58 178.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -143.57 -179.92 6.73 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.387 1.075 . . . . 1.59 108.649 164.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -68.03 -28.29 67.27 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.675 2.39 . . . . 5.21 111.812 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.45 17.87 54.41 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.016 1.769 . . . . 1.5 114.639 162.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.88 -159.01 26.38 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 127.365 2.412 . . . . 0.86 118.411 164.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.97 104.08 8.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.736 0.815 . . . . 0.62 111.371 -168.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -79.94 110.43 15.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.763 1.625 . . . . 1.99 110.217 174.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 22' ' ' VAL . 4.0 t80 -99.06 118.73 36.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.294 2.238 . . . . 0.49 109.475 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.419 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 78.7 m -124.82 111.98 27.24 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-N 119.292 0.951 . . . . 0.61 109.103 176.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.83 165.21 17.8 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.6 2.867 . . . . 0.62 111.008 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -151.0 25.89 0.72 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.495 0.718 . . . . 1.31 112.099 173.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.87 148.23 25.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.498 1.119 . . . . 0.9 113.33 -170.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 144.5 49.47 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.974 1.31 . . . . 2.4 108.56 168.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.93 45.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 128.203 2.601 . . . . 1.36 112.514 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.76 160.98 40.25 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.433 1.093 . . . . 1.69 110.537 169.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.26 125.55 14.22 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 121.124 1.216 . . . . 1.07 110.375 169.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -80.47 74.5 5.51 Favored 'Trans proline' 0 N--CA 1.451 -1.015 1 C-N-CA 125.413 4.075 . . . . 1.76 109.925 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.88 -173.76 13.2 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 116.343 -2.837 . . . . 1.67 111.932 132.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -56.81 140.61 47.37 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.003 1.321 . . . . 2.75 111.668 175.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -136.83 125.47 23.77 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.902 1.281 . . . . 1.13 112.746 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.04 149.91 3.26 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.325 0.964 . . . . 0.67 113.229 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.403 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.2 t80 -132.4 132.03 42.41 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.598 1.559 . . . . 1.99 106.82 176.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -136.1 168.63 19.02 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 114.867 1.432 . . . . 0.95 114.867 170.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.6 139.51 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.664 1.586 . . . . 0.92 109.545 158.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.55 165.24 13.79 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.962 2.105 . . . . 0.87 111.358 177.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.86 64.43 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.141 1.534 . . . . 0.77 115.141 -159.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -123.73 152.44 42.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.929 0.892 . . . . 1.38 113.074 178.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.95 79.81 1.82 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 125.596 1.57 . . . . 0.98 110.975 174.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -166.53 59.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.46 0.704 . . . . 3.61 112.523 -165.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.8 m -67.2 66.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.284 1.834 . . . . 1.86 113.115 173.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -130.53 156.53 79.52 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.219 2.208 . . . . 3.55 108.315 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.16 133.88 15.35 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.005 1.803 . . . . 1.19 110.216 176.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 176.38 6.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.058 -0.974 . . . . 2.84 109.917 161.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -103.2 128.62 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.887 -0.783 . . . . 5.63 108.887 165.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -94.45 -71.31 0.67 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 118.644 -0.694 . . . . 7.67 109.244 161.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.75 106.66 9.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.209 1.403 . . . . 4.13 109.124 169.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.73 -44.9 0.65 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.501 2.0 . . . . 5.16 116.852 174.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.14 158.41 18.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.222 1.409 . . . . 2.89 114.026 -161.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.93 95.98 4.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.961 1.704 . . . . 1.87 111.867 -171.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.92 80.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.93 0.872 . . . . 2.97 112.159 -177.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 46.28 -104.7 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.869 2.467 . . . . 2.02 114.928 163.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.15 25.13 9.74 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.401 1.48 . . . . 1.93 111.979 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -81.67 11.49 4.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.519 1.127 . . . . 8.55 113.501 -174.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.64 -6.61 57.47 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.143 -0.973 . . . . 2.22 112.677 158.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.21 23.8 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.684 1.594 . . . . 1.24 114.311 175.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.15 4.0 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.5 1.524 . . . . 3.65 115.646 167.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.14 -176.85 30.26 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.791 1.186 . . . . 1.35 112.486 -171.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -81.33 62.29 5.17 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 2.16 110.532 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.8 tp 25.21 65.6 0.05 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.627 2.371 . . . . 1.61 112.537 -174.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -127.14 60.65 43.57 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.038 2.135 . . . . 4.83 112.057 -158.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.47 -41.16 9.25 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.387 2.058 . . . . 2.27 109.994 169.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -152.9 165.64 34.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.283 1.833 . . . . 4.5 110.03 167.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 140.88 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 1 C-N-CA 132.706 4.402 . . . . 3.75 113.209 163.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t 150.99 -56.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 130.726 3.61 . . . . 2.61 110.785 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.09 -11.26 69.51 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.342 1.449 . . . . 1.97 115.093 -178.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.48 -25.04 61.86 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.749 1.775 . . . . 4.25 115.243 -176.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.605 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 24.7 t60 75.44 126.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.393 2.677 . . . . 2.68 113.354 176.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 -57.13 2.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.824 0.849 . . . . 7.45 112.873 165.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.62 -85.13 0.38 Allowed Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.291 -1.283 . . . . 4.91 110.208 -156.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.38 -128.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.857 3.705 . . . . 6.76 111.863 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.73 51.25 1.34 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.498 -1.376 . . . . 10.8 114.693 -159.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.14 -107.55 0.5 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.443 1.021 . . . . 2.6 111.198 167.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -16.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.259 1.024 . . . . 5.01 113.505 171.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.11 92.39 1.15 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.378 0.99 . . . . 3.86 111.897 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.42 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 9.1 t-160 71.42 97.84 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.896 2.078 . . . . 5.22 113.711 162.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -16.61 64.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.506 1.669 . . . . 3.26 115.506 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.84 8.55 79.31 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.81 1.671 . . . . 1.29 113.979 175.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.605 ' OD2' ' ND1' ' A' ' 82' ' ' HIS . 72.8 m-20 -80.57 155.05 27.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 3.38 109.93 153.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.54 154.54 21.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 121.029 -1.044 . . . . 1.64 111.609 -133.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.04 143.1 64.29 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.705 2.937 . . . . 1.04 111.89 -171.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.45 133.49 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.724 0.81 . . . . 1.85 111.473 -163.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.84 99.41 2.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.832 2.053 . . . . 1.85 109.044 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.0 t -78.23 121.6 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.496 -0.753 . . . . 0.99 109.811 177.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.81 131.41 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.654 1.982 . . . . 1.73 108.361 175.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -81.05 148.24 29.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.643 0.656 . . . . 3.31 112.275 175.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -40.03 -25.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.338 3.055 . . . . 2.58 117.035 -172.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.01 -19.76 62.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.608 1.963 . . . . 4.11 113.444 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 31.8 6.24 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.309 1.433 . . . . 0.86 112.852 -172.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.98 145.02 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.954 1.702 . . . . 1.0 108.581 -168.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -124.82 114.85 19.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.059 1.343 . . . . 0.68 110.968 -177.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -125.94 -9.75 6.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.437 1.273 . . . . 1.36 114.437 172.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.8 120.04 79.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.833 0.742 . . . . 3.14 110.744 -167.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -85.62 153.8 10.33 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.716 2.944 . . . . 1.12 112.632 -174.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.08 164.39 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.975 1.71 . . . . 1.12 110.146 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.9 m -137.23 136.39 38.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.648 1.113 . . . . 0.83 110.316 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.34 99.79 13.85 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.964 0.906 . . . . 0.79 112.159 175.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.21 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.249 3.299 . . . . 1.09 114.79 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.89 5.74 13.01 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.379 0.991 . . . . 4.87 112.648 174.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.4 mt -140.92 171.94 13.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 129.244 3.018 . . . . 2.19 107.571 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.34 2.35 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.612 1.708 . . . . 6.77 115.612 -174.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -147.38 156.15 42.63 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.092 -1.005 . . . . 2.02 112.203 176.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.42 -26.03 63.48 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.204 -0.935 . . . . 1.5 111.336 161.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.18 -44.31 79.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.508 1.123 . . . . 4.01 113.032 -173.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.68 -8.39 34.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.336 1.454 . . . . 1.85 113.446 177.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.52 20.51 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.897 1.279 . . . . 0.89 113.591 -177.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -68.09 -6.17 21.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.945 2.202 . . . . 2.43 116.945 -172.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.72 39.37 1.67 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.897 1.679 . . . . 3.44 110.668 178.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -117.55 149.1 41.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.453 1.101 . . . . 1.17 112.853 -175.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.72 133.12 33.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.409 1.084 . . . . 0.8 111.23 166.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.14 136.06 46.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.06 -1.089 . . . . 3.07 108.06 165.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.0 mtt -132.1 133.42 44.3 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.217 0.607 . . . . 1.19 111.984 -167.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.31 132.95 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.909 1.283 . . . . 0.64 108.294 168.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 142.41 50.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.738 2.015 . . . . 2.22 110.387 -159.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.73 -46.86 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.209 -0.932 . . . . 1.66 111.732 -168.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.11 138.68 20.98 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 118.467 0.576 . . . . 1.25 111.859 175.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.06 146.94 49.11 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.773 1.654 . . . . 1.45 111.85 167.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -95.4 76.04 3.35 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.379 0.881 . . . . 2.93 113.379 -156.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -163.66 56.23 0.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.182 0.993 . . . . 3.79 112.025 -171.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.28 119.31 5.42 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.91 -1.119 . . . . 2.22 113.27 -171.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 t -146.5 -170.23 3.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.46 1.904 . . . . 3.33 110.538 -178.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 71.35 -41.24 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 129.147 2.979 . . . . 3.67 114.636 169.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -60.57 150.44 74.63 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 4.24 111.707 173.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.01 -21.09 72.98 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.204 2.603 . . . . 2.14 112.739 176.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -101.02 89.4 1.27 Allowed Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.836 0.854 . . . . 4.76 109.923 158.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.9 161.16 43.57 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.484 . . . . 3.67 110.243 172.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 60.53 9.45 2.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.956 1.302 . . . . 3.28 111.953 -164.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 68.36 3.85 34.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.635 1.112 . . . . 3.12 113.69 -167.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.12 3.27 58.99 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.322 1.439 . . . . 2.07 114.036 -164.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.79 42.37 1.3 Allowed Glycine 0 N--CA 1.476 1.341 0 C-N-CA 127.148 2.309 . . . . 1.74 116.04 -173.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.1 71.36 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.34 0.972 . . . . 2.17 113.437 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 p -61.4 136.81 58.16 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.591 1.956 . . . . 2.05 112.075 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -99.29 162.29 13.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.858 1.663 . . . . 4.68 110.974 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -118.68 -19.36 8.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.153 0.797 . . . . 2.42 113.153 151.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.34 163.05 30.99 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.885 1.221 . . . . 0.55 114.05 173.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.2 t -132.27 144.02 50.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 1.63 110.786 164.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -132.17 101.43 0.46 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.872 2.177 . . . . 1.19 109.571 168.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.25 130.12 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.565 1.146 . . . . 1.78 108.789 172.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 15.2 mt -60.4 127.7 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.404 0.681 . . . . 1.21 111.625 -178.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 10.9 mmpt? . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 113.148 0.795 . . . . 3.37 113.148 178.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.624 0.249 . . . . 3.44 110.616 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -151.82 130.92 12.66 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.67 -1.233 . . . . 2.22 107.67 174.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -126.21 111.13 14.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.173 0.989 . . . . 3.46 110.722 -171.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 23' ' ' VAL 0.284 0.1 OUTLIER -79.41 77.32 5.97 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.122 -0.986 . . . . 3.92 111.214 174.47 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.1 120.62 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.501 -0.75 . . . . 1.0 110.133 -169.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.56 99.32 0.9 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.446 1.498 . . . . 0.81 111.088 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.3 mmm -75.34 97.68 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.719 1.208 . . . . 1.41 110.197 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.57 141.55 41.1 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.653 -0.654 . . . . 2.55 110.717 174.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.95 131.17 44.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.878 0.871 . . . . 1.17 109.208 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 m -143.43 160.71 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 113.498 0.925 . . . . 1.03 113.498 -175.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -172.76 -159.06 0.11 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.369 2.668 . . . . 3.09 107.886 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.84 62.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.539 1.936 . . . . 1.4 113.822 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -72.31 -9.43 58.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 3.82 112.531 171.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.37 -135.27 13.05 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.54 1.064 . . . . 1.12 111.192 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.65 132.33 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 1.09 110.702 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.13 -104.51 2.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.747 1.642 . . . . 1.23 112.84 -175.131 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.73 168.69 19.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.569 1.147 . . . . 2.12 110.372 170.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.7 t -98.14 137.91 36.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.832 -1.168 . . . . 1.13 111.576 178.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.92 5.1 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.092 1.357 . . . . 2.84 113.935 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.08 172.44 32.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.777 2.608 . . . . 0.77 112.395 166.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 p -96.91 175.69 6.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.322 0.649 . . . . 0.79 110.084 169.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.75 130.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.795 -1.187 . . . . 0.61 107.795 151.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 4' ' ' LYS 0.258 9.2 p -84.97 113.26 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.352 0.596 . . . . 0.9 111.447 178.004 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 125' ' ' LEU . 50.9 mt -87.26 127.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.542 -1.208 . . . . 1.09 108.012 169.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -132.22 124.89 29.85 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.71 1.204 . . . . 1.88 109.329 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -83.11 142.65 31.1 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.865 0.466 . . . . 4.17 111.624 -174.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -157.82 -179.19 7.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.7 0.8 . . . . 1.43 110.411 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.61 -15.73 63.62 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.136 -0.977 . . . . 3.76 112.543 177.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.81 6.61 79.61 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.57 1.081 . . . . 1.16 115.153 163.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.04 -141.09 18.25 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 127.183 2.325 . . . . 1.16 114.82 174.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.49 96.22 3.44 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.553 1.141 . . . . 0.86 111.659 -175.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -76.38 111.46 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.675 1.19 . . . . 1.86 109.483 172.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.02 116.96 29.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.305 2.242 . . . . 0.54 109.867 -175.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -130.81 114.12 16.52 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 120.257 1.389 . . . . 0.71 110.674 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.95 162.53 7.43 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.089 2.526 . . . . 0.91 113.099 -171.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -151.43 29.88 0.62 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.955 0.902 . . . . 1.39 112.798 171.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -92.91 150.46 20.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.963 1.305 . . . . 0.99 112.658 -171.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.18 27.09 4.84 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.008 1.855 . . . . 2.22 116.008 -168.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.52 79.9 0.73 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.868 0.867 . . . . 1.6 112.387 174.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.36 161.44 47.44 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 124.2 1.0 . . . . 1.43 112.479 173.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.6 134.7 45.54 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.267 1.311 . . . . 1.1 111.806 175.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -88.01 23.19 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.921 2.414 . . . . 1.04 115.126 -144.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.78 -153.05 11.48 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.874 1.226 . . . . 1.27 115.974 -172.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -78.47 150.97 32.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.463 2.305 . . . . 2.89 111.157 171.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -149.13 141.23 23.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.923 0.889 . . . . 1.58 112.221 -173.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 153.16 51.67 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 109.561 -1.416 . . . . 0.62 109.561 164.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.14 102.51 3.38 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.101 -1.444 . . . . 2.04 107.101 169.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -106.82 171.07 7.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.076 1.51 . . . . 0.95 115.076 178.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -101.33 131.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.511 1.524 . . . . 0.7 108.689 160.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -108.23 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.802 1.241 . . . . 2.08 110.669 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.09 63.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.144 1.535 . . . . 0.81 115.144 -161.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -127.23 151.32 48.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.648 1.179 . . . . 1.6 111.919 173.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.1 81.76 1.69 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.581 1.086 . . . . 0.92 113.193 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 t -170.24 138.59 1.64 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.146 0.978 . . . . 2.21 113.227 173.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.1 m -79.11 -5.15 53.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.038 1.735 . . . . 1.94 114.217 172.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -78.58 132.89 64.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 O-C-N 120.081 -1.637 . . . . 3.5 113.159 -160.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -79.39 170.03 17.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.514 2.809 . . . . 1.41 111.684 172.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 65' ' ' VAL . . . -119.16 165.24 14.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.482 1.513 . . . . 1.7 110.196 167.188 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.66 134.34 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.259 1.023 . . . . 2.58 111.207 -167.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -156.54 134.56 11.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.62 1.568 . . . . 5.79 108.704 173.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.4 t0 55.05 46.72 23.58 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.841 0.856 . . . . 5.1 112.19 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.68 7.27 58.17 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.884 1.113 . . . . 3.72 115.884 173.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.75 162.26 33.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.855 1.327 . . . . 3.55 111.764 -176.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.42 125.93 53.74 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.229 1.012 . . . . 1.91 112.254 -167.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 58' ' ' ALA . 18.1 m -75.01 24.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 116.512 2.041 . . . . 2.92 116.512 -164.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.5 8.23 2.14 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 117.015 2.228 . . . . 2.22 117.015 170.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.579 ' HB3' HH12 ' A' ' 147' ' ' ARG . . . 137.26 115.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 1 C-N-CA 132.278 4.231 . . . . 2.07 110.081 165.784 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.78 -37.76 4.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.564 1.145 . . . . 4.09 110.32 172.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.18 -6.6 6.93 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.252 1.204 . . . . 1.2 114.252 177.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.32 -14.99 62.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.811 1.245 . . . . 1.25 113.292 168.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.8 51.63 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.805 -1.184 . . . . 3.12 115.111 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.09 -172.55 55.26 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.699 1.142 . . . . 1.18 112.25 -169.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.543 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 26.8 m170 -65.31 138.85 58.45 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.277 -1.131 . . . . 2.43 111.387 174.513 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.69 119.87 13.78 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.28 0.632 . . . . 1.94 112.067 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.97 125.87 5.06 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.02 2.128 . . . . 4.76 110.97 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.04 -19.98 3.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.455 2.77 . . . . 3.7 115.218 178.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 155.6 14.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 128.249 2.62 . . . . 4.07 114.608 -170.134 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.2 -38.78 71.47 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.317 -1.489 . . . . 3.09 112.401 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 81' ' ' LYS . 7.2 t 157.01 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 131.204 3.802 . . . . 2.79 110.621 177.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.45 1.77 66.11 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.416 1.008 . . . . 2.01 114.248 179.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 79' ' ' THR . 18.0 ptmt -73.25 -30.42 63.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.097 1.448 . . . . 3.92 114.72 -174.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.2 t60 117.2 148.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 130.853 3.661 . . . . 1.87 112.806 -171.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -143.56 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.035 1.734 . . . . 3.94 110.052 173.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.91 -132.56 9.93 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.244 -1.309 . . . . 2.47 113.168 167.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.83 -17.45 22.74 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.934 3.09 . . . . 3.74 114.885 -167.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -171.75 149.15 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.439 1.895 . . . . 5.65 109.682 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.01 -145.2 16.92 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.375 0.988 . . . . 3.53 113.242 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.16 145.52 4.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.353 2.661 . . . . 5.81 106.324 -179.278 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.34 -20.81 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 CA-C-O 117.057 -1.968 . . . . 3.14 116.627 173.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -152.22 118.57 5.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.346 1.573 . . . . 3.82 110.199 160.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.25 -12.42 41.04 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.306 1.595 . . . . 2.68 115.306 177.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.56 -4.92 90.15 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.995 1.283 . . . . 1.06 115.067 173.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.543 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 66.5 m-20 -74.91 153.98 38.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.756 0.823 . . . . 1.63 110.828 168.596 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.37 161.6 29.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.86 1.264 . . . . 1.83 109.733 -149.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.56 157.78 57.81 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.489 2.792 . . . . 1.17 111.86 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.72 143.13 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.223 1.011 . . . . 1.57 113.22 -173.076 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -88.97 123.07 32.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.998 2.119 . . . . 2.27 110.057 172.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.76 136.34 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.437 0.695 . . . . 1.14 109.833 172.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.2 158.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.459 -1.312 . . . . 2.27 107.459 160.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.74 159.56 17.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.64 0.978 . . . . 2.13 113.64 -174.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -41.94 -17.91 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 129.79 3.236 . . . . 2.29 117.726 177.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -97.24 -13.52 21.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.62 1.568 . . . . 2.51 113.928 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.55 22.95 8.64 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.121 1.343 . . . . 0.75 115.291 177.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.06 135.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.496 1.518 . . . . 1.19 110.228 -178.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.08 120.39 34.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.315 1.446 . . . . 0.81 110.686 -179.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t -150.45 16.04 0.8 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.452 1.101 . . . . 1.72 113.962 -169.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -113.05 130.18 23.81 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.966 0.906 . . . . 3.89 110.998 177.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.13 158.35 52.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.619 2.879 . . . . 1.39 110.885 175.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.46 166.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.38 1.872 . . . . 2.31 107.557 169.587 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.1 m -140.15 136.58 33.65 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.223 0.92 . . . . 0.79 108.982 171.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.94 87.96 9.36 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.388 1.075 . . . . 1.01 111.192 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.48 23.63 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.931 3.754 . . . . 1.06 114.146 -179.01 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 -94.01 -20.68 19.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.95 1.3 . . . . 3.74 112.045 174.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.11 135.47 53.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.838 2.055 . . . . 2.78 107.155 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -92.38 -38.68 11.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.521 0.728 . . . . 5.03 111.775 -177.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.31 154.32 51.57 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.393 1.627 . . . . 2.62 115.393 -172.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.38 -42.73 70.68 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.379 1.071 . . . . 1.72 110.891 170.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.17 -21.89 3.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.266 1.826 . . . . 4.42 113.478 177.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.43 -13.06 38.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.262 1.025 . . . . 2.59 113.061 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 m -120.74 7.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.025 1.73 . . . . 1.05 113.484 -178.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -43.64 -15.08 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.804 3.241 . . . . 3.28 117.643 171.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -128.24 3.37 5.76 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.117 2.567 . . . . 5.12 113.378 -167.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -127.07 174.37 8.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.834 1.254 . . . . 1.82 113.719 -168.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.89 143.07 47.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.227 1.011 . . . . 0.68 112.454 179.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.633 HD21 HD11 ' A' ' 24' ' ' ILE . 16.0 mt -73.46 155.37 39.32 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.451 1.5 . . . . 2.28 108.437 156.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 19.2 ttm -147.05 122.58 10.42 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.75 -0.594 . . . . 2.02 110.677 158.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.3 mt -80.25 122.55 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.513 -1.291 . . . . 0.74 107.513 171.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -100.81 147.47 26.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.134 2.174 . . . . 2.16 111.763 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.25 -54.78 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.302 -0.874 . . . . 1.68 110.129 -171.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.8 164.41 39.2 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.547 -0.621 . . . . 0.97 111.547 166.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.1 -144.05 0.03 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 129.162 3.268 . . . . 2.27 115.036 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -162.95 69.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.682 1.993 . . . . 2.97 107.663 -170.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -157.45 14.92 0.25 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.295 -1.32 . . . . 3.81 113.958 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.8 149.58 16.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.924 1.29 . . . . 4.57 112.185 174.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.9 m -128.99 -170.58 2.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.907 1.283 . . . . 4.09 111.834 -168.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.41 -26.48 0.18 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 128.452 2.701 . . . . 4.85 115.955 158.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -70.01 146.41 95.04 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.23 1.812 . . . . 4.38 111.195 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.41 -32.16 50.54 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.352 2.702 . . . . 2.52 113.281 -171.271 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -80.38 115.19 53.2 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.23 0.923 . . . . 4.15 108.906 160.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.75 152.14 82.46 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.23 2.62 . . . . 2.84 112.336 -172.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp 59.52 22.51 11.1 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.852 1.661 . . . . 4.25 111.444 -169.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.83 14.85 66.03 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 120.958 -1.089 . . . . 3.06 113.508 -172.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 108.49 -7.93 34.61 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.722 1.63 . . . . 2.08 114.037 -168.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.83 10.75 1.07 Allowed Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.358 1.579 . . . . 1.73 116.178 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 -12.41 73.56 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.207 1.504 . . . . 1.48 114.426 175.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.8 p -74.88 147.84 40.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.293 1.837 . . . . 2.0 112.555 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.579 HH12 ' HB3' ' A' ' 67' ' ' ALA . 3.2 mmt85 -110.17 150.07 29.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.563 1.545 . . . . 4.34 111.076 -172.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -106.93 -39.16 5.84 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.241 0.46 . . . . 2.66 112.241 160.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.36 144.73 24.03 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.382 1.623 . . . . 0.69 115.382 -175.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.5 t -100.51 137.99 38.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.968 2.507 . . . . 1.5 111.307 173.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -133.46 87.11 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.56 1.553 . . . . 0.88 112.124 175.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.17 130.41 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.808 1.804 . . . . 1.52 110.656 173.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 mt -100.64 154.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 126.468 1.907 . . . . 1.33 110.279 -172.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.52 0 C-N-CA 126.108 1.763 . . . . 4.8 110.408 174.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.381 -0.599 . . . . 3.04 109.381 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.23 152.04 28.83 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.257 -0.902 . . . . 1.65 109.086 -175.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -144.57 116.19 8.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.332 1.539 . . . . 2.48 112.825 176.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -78.8 82.95 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 127.606 2.362 . . . . 2.99 110.569 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -75.79 110.99 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.057 -1.027 . . . . 1.89 112.28 -177.228 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.6 100.48 0.49 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.404 1.954 . . . . 1.19 110.81 177.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 mmt -72.85 125.52 27.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.849 1.66 . . . . 1.54 112.399 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -101.62 153.61 19.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.786 0.803 . . . . 2.43 110.923 157.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.9 mt -58.48 143.57 45.23 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.347 1.459 . . . . 1.36 109.18 163.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 m -141.6 166.1 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.065 0.946 . . . . 1.25 111.535 172.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 t -172.38 -161.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.616 2.366 . . . . 3.22 108.176 -177.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.93 14.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.449 2.7 . . . . 1.88 114.507 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.06 -12.5 10.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.058 1.343 . . . . 3.22 111.349 172.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 -146.25 19.8 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 119.197 0.908 . . . . 1.66 110.893 -167.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 82.0 t -62.28 126.38 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.228 1.811 . . . . 1.05 112.423 -177.07 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.28 -133.19 6.44 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.539 2.019 . . . . 1.41 113.17 177.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.09 145.64 46.34 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 124.52 1.128 . . . . 2.08 110.811 176.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.7 t -75.19 133.58 41.4 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.713 -0.617 . . . . 1.93 109.438 164.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 tt -116.36 -37.05 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 127.908 2.483 . . . . 4.08 111.546 -174.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.29 -178.83 38.08 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.39 -0.909 . . . . 1.46 113.443 -145.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 171.06 12.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 148.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.453 HG11 ' CG ' ' A' ' 33' ' ' PHE . 59.4 t -120.58 132.01 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 106.471 -1.677 . . . . 0.63 106.471 144.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 17.7 m -83.99 129.51 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 C-N-CA 119.744 -0.782 . . . . 3.16 109.803 172.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.45 125.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.623 -0.881 . . . . 1.37 108.623 175.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.68 126.9 30.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.736 1.214 . . . . 2.47 109.96 178.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.78 141.79 29.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.797 0.839 . . . . 3.84 112.946 -172.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -149.63 -176.61 5.47 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.897 0.879 . . . . 1.21 109.684 174.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -75.54 -11.98 60.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.272 -0.892 . . . . 4.16 112.488 174.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.41 7.04 69.78 Favored Glycine 0 N--CA 1.477 1.411 0 O-C-N 120.758 -1.214 . . . . 0.96 114.312 157.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.62 -145.58 26.42 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 127.819 2.628 . . . . 0.78 114.598 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.4 109.46 7.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.187 0.595 . . . . 0.66 110.704 -173.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -82.78 106.68 14.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.348 1.059 . . . . 1.78 110.397 174.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -85.85 110.11 19.16 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.044 1.338 . . . . 0.74 108.345 175.614 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 23' ' ' VAL . 33.4 m -114.6 98.78 50.28 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 119.718 1.144 . . . . 1.29 108.792 178.066 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -85.73 153.51 10.16 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.244 3.296 . . . . 0.74 111.497 -172.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -150.66 41.22 0.77 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.998 0.904 . . . . 1.36 112.725 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mp -93.02 148.95 21.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.273 1.829 . . . . 0.85 112.193 -176.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.86 40.25 2.16 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.24 1.57 . . . . 2.02 115.24 -169.265 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.33 48.53 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 1.39 112.207 -175.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.04 161.0 47.07 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 121.261 -0.9 . . . . 1.34 112.466 176.585 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.26 131.09 36.92 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.595 1.53 . . . . 1.23 110.18 171.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.411 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -90.46 30.64 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.722 1 C-N-CA 126.567 4.845 . . . . 1.29 112.176 -151.976 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.79 166.68 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 125.582 1.563 . . . . 2.14 109.762 173.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -67.44 143.8 56.06 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.889 0.875 . . . . 2.88 112.814 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -129.69 150.83 50.84 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.076 1.35 . . . . 1.19 111.614 -172.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.84 163.5 24.23 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.519 0.6 . . . . 0.66 113.486 168.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.603 ' CE1' HD12 ' A' ' 125' ' ' LEU . 9.4 t80 -140.76 119.86 12.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.15 1.38 . . . . 2.16 108.398 176.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -134.76 149.12 50.38 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.433 -0.792 . . . . 0.87 112.521 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.3 136.61 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.607 1.963 . . . . 0.96 107.792 165.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -132.8 133.84 43.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.201 1.0 . . . . 1.19 110.652 -163.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.19 65.67 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.628 2.084 . . . . 0.74 116.628 -155.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -118.97 152.3 36.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.988 0.915 . . . . 1.44 112.688 167.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.98 59.75 4.48 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.647 1.118 . . . . 0.96 112.45 170.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 m -148.73 63.9 1.06 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.818 1.044 . . . . 3.21 113.818 -157.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.8 m -65.39 26.66 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 116.452 2.019 . . . . 1.74 116.452 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -78.14 139.13 60.53 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 119.919 -1.738 . . . . 3.89 110.788 175.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.31 143.19 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.753 2.302 . . . . 1.39 111.211 174.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 128.87 35.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.914 0.486 . . . . 2.21 110.461 172.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.44 125.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.215 1.006 . . . . 2.39 110.694 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -166.09 128.17 1.92 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.386 0.674 . . . . 4.88 112.74 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 57.77 52.88 7.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.655 1.582 . . . . 4.81 114.1 169.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.78 77.48 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.082 -1.011 . . . . 3.45 114.544 175.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.94 -164.08 1.35 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.41 1.884 . . . . 4.2 109.178 -177.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.34 144.71 23.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.222 -0.924 . . . . 1.58 112.651 -177.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 t -80.82 98.78 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.97 0.908 . . . . 2.54 109.934 -172.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.97 97.59 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.392 2.277 . . . . 3.43 115.105 -170.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.45 30.73 17.29 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.524 1.93 . . . . 1.99 114.27 174.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.65 -32.36 73.82 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.271 0.841 . . . . 5.38 113.271 -178.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.48 -15.62 50.96 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.898 1.073 . . . . 2.08 113.898 -175.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -3.46 13.9 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.312 1.445 . . . . 1.16 113.585 172.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.22 -171.32 32.34 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.943 1.247 . . . . 2.49 113.53 175.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.57 -167.0 39.74 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.74 1.162 . . . . 1.91 112.189 165.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.442 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 33.1 m170 -74.13 40.06 0.12 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.551 1.94 . . . . 3.29 112.833 -178.483 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp 49.82 61.45 3.16 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.904 1.682 . . . . 1.76 109.854 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -121.65 51.02 2.53 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.299 1.839 . . . . 3.93 114.419 -163.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.2 -18.91 39.42 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.862 3.041 . . . . 1.9 115.865 -166.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.0 31.79 0.06 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.35 0.977 . . . . 4.06 112.46 -171.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.03 -60.41 1.68 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.655 0.983 . . . . 3.73 113.655 -163.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 t 167.99 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.317 2.647 . . . . 3.34 108.54 -162.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.95 -30.93 8.93 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.857 0.741 . . . . 2.39 113.03 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 11.7 ptmt -88.74 -177.89 5.64 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 117.88 0.84 . . . . 4.25 112.138 173.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -124.88 164.89 19.07 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.888 1.07 . . . . 2.13 113.888 -155.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -138.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.449 1.1 . . . . 4.57 111.478 -179.072 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.51 -138.09 18.48 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 109.067 -1.613 . . . . 2.73 109.067 -158.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.08 -32.08 64.52 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.344 2.03 . . . . 3.46 113.456 -171.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.03 -1.54 57.17 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 6.01 113.43 -176.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.43 -12.56 0.93 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 118.316 2.086 . . . . 2.87 118.316 167.001 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -84.33 44.85 1.06 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.182 1.491 . . . . 5.3 114.393 -163.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.63 -147.67 6.33 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 117.477 1.751 . . . . 2.83 117.477 -168.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -118.15 154.49 32.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.827 1.651 . . . . 3.82 112.297 -157.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.16 -27.22 65.34 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.475 0.917 . . . . 2.12 113.475 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.4 21.6 16.74 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.58 -1.122 . . . . 0.9 114.581 176.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.442 ' OD1' ' ND1' ' A' ' 73' ' ' HIS . 75.7 m-20 -97.35 136.07 38.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.874 1.337 . . . . 1.79 111.063 169.34 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.496 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 3.8 mp -136.6 165.9 31.7 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 125.676 1.59 . . . . 1.78 109.345 -172.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.99 161.08 13.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.026 2.484 . . . . 1.09 111.387 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.18 133.82 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.334 1.54 . . . . 1.43 115.044 -164.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 87.01 2.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.096 2.558 . . . . 1.66 109.319 170.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.99 133.01 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.139 0.576 . . . . 0.84 110.809 175.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.7 136.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.956 2.102 . . . . 1.74 106.408 173.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.49 162.99 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.425 -0.321 . . . . 2.37 111.834 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -44.69 -22.52 0.08 Allowed 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 117.899 2.555 . . . . 2.57 117.899 -177.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -7.67 52.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.462 1.905 . . . . 2.65 113.45 -176.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.22 30.39 11.04 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 124.274 0.94 . . . . 0.8 114.197 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.0 mt -124.29 133.57 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.17 1.388 . . . . 1.03 110.165 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.6 139.03 40.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.958 1.703 . . . . 0.74 111.205 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -151.15 -11.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.588 2.44 . . . . 1.98 117.588 -166.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.83 117.97 53.39 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 121.459 1.936 . . . . 4.2 113.619 -172.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.01 78.01 2.63 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.951 3.1 . . . . 2.57 110.216 171.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.57 148.78 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.747 1.619 . . . . 3.53 109.908 175.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.36 139.18 52.53 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.956 -0.757 . . . . 1.46 108.956 160.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -124.87 99.73 34.73 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.646 0.779 . . . . 0.9 111.922 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.31 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.184 3.256 . . . . 1.22 113.761 178.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -31.47 72.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.909 0.884 . . . . 4.91 111.134 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.17 151.86 37.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.548 2.739 . . . . 2.22 106.868 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -135.35 11.98 3.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.301 1.223 . . . . 4.51 114.301 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -150.25 169.09 22.16 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.999 -1.688 . . . . 2.12 111.011 160.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.05 -43.32 11.79 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.104 -0.997 . . . . 1.81 112.104 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -64.85 -19.55 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.897 1.073 . . . . 2.53 113.897 -176.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -16.21 63.98 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.626 0.973 . . . . 2.32 113.626 171.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.2 24.07 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.942 1.697 . . . . 1.2 112.802 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -53.95 -9.14 0.22 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.654 2.465 . . . . 3.34 117.654 178.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.68 50.33 1.37 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.668 1.587 . . . . 2.9 109.875 -169.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -142.62 150.22 40.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.7 1.6 . . . . 2.22 112.347 -169.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.68 137.5 32.27 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.834 -0.541 . . . . 0.9 111.367 167.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.603 HD12 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -97.97 122.09 40.67 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.829 -0.804 . . . . 3.96 108.829 154.855 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 31.1 mtt -122.62 124.26 43.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.386 0.674 . . . . 1.29 111.073 -173.301 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.0 mt -77.17 114.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 107.685 -1.228 . . . . 0.69 107.685 171.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.78 137.8 40.51 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.232 1.413 . . . . 2.58 112.629 -162.028 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.28 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.332 -0.855 . . . . 1.49 111.349 -165.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.76 133.42 11.79 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 118.306 0.503 . . . . 1.68 112.258 172.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.53 154.36 21.57 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.517 1.532 . . . . 1.42 112.183 156.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -112.34 36.59 3.33 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.53 0.937 . . . . 3.42 113.53 -128.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.2 5.97 40.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.961 1.304 . . . . 3.61 113.851 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.6 tpp -98.16 132.88 43.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.954 1.464 . . . . 3.03 114.954 -157.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.8 p -176.66 171.19 2.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.554 2.341 . . . . 3.42 111.1 159.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t70 92.44 65.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.176 2.99 . . . . 4.4 111.61 -177.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -151.8 159.68 32.77 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.307 1.843 . . . . 4.08 109.467 -173.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 -9.17 21.44 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.237 3.291 . . . . 3.49 114.417 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -125.13 142.33 41.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.725 1.21 . . . . 4.31 109.241 166.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.33 134.92 54.66 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.314 2.01 . . . . 3.55 111.089 -175.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.5 mt 63.41 17.97 10.69 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.49 1.516 . . . . 3.9 112.527 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.39 7.43 60.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.763 1.173 . . . . 4.04 113.941 -174.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.16 -8.28 75.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.17 1.367 . . . . 2.88 113.953 -168.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.36 0.18 42.5 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 119.378 1.589 . . . . 2.03 115.043 -176.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.84 5.71 45.8 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.984 1.754 . . . . 1.71 115.171 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 p -70.38 159.9 33.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.885 1.342 . . . . 2.05 110.864 173.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -112.84 136.1 52.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.489 1.516 . . . . 5.62 109.894 -172.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -90.83 -35.98 14.49 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.157 0.89 . . . . 2.37 112.129 166.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.36 150.14 31.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.519 0.727 . . . . 0.84 112.456 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 t -127.07 131.43 50.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.343 1.857 . . . . 1.77 111.505 -178.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -126.37 97.03 0.48 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.784 2.135 . . . . 1.31 110.465 166.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.76 125.26 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.587 1.155 . . . . 1.67 109.218 172.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.5 mt -58.3 117.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.742 0.782 . . . . 1.27 109.668 176.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 116.059 -0.518 . . . . 4.58 111.602 177.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.658 -0.497 . . . . 1.69 109.658 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.07 152.85 42.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.572 1.323 . . . . 1.15 114.572 -145.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 132.49 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 123.152 1.453 . . . . 2.97 112.057 159.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -94.71 71.46 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.154 1.382 . . . . 3.34 111.213 -166.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.17 119.29 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.211 -0.931 . . . . 1.5 110.738 -156.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.02 97.25 1.38 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 126.189 1.852 . . . . 1.01 110.185 -173.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 29.8 mtt -80.22 131.38 35.68 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.574 0.749 . . . . 1.14 112.158 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.0 150.54 22.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.721 0.808 . . . . 2.78 109.878 172.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.1 mt -64.31 140.87 58.91 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.363 -0.977 . . . . 1.37 108.363 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.16 158.11 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 118.511 0.596 . . . . 1.11 112.202 -177.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -171.44 -150.36 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.921 2.089 . . . . 2.6 108.252 173.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.02 -8.35 3.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 128.473 2.709 . . . . 1.68 114.837 -178.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.19 -14.7 32.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.903 0.881 . . . . 4.28 112.065 169.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.451 ' CA ' ' HD3' ' A' ' 57' ' ' PRO . . . 82.85 -142.47 21.65 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.134 0.873 . . . . 1.24 110.968 -162.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.31 120.96 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.555 1.542 . . . . 1.19 111.757 176.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.97 -133.22 7.13 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 125.993 1.759 . . . . 1.93 111.705 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.83 171.48 7.3 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.717 -0.872 . . . . 3.49 110.845 170.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -109.26 137.66 46.8 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.006 1.323 . . . . 1.31 113.502 -176.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.94 4.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.325 1.85 . . . . 2.82 112.887 177.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.33 153.18 7.63 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.489 -0.757 . . . . 0.58 113.903 -168.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.5 p -90.33 175.2 7.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.917 -0.771 . . . . 0.89 108.917 161.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.68 129.45 75.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 106.218 -1.771 . . . . 0.4 106.218 148.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.95 118.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.374 -0.602 . . . . 0.83 109.374 178.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.7 mt -99.0 126.7 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.147 -1.427 . . . . 1.57 107.147 175.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -128.24 122.06 30.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.164 0.983 . . . . 2.59 111.27 169.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 124.58 23.19 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.501 1.92 . . . . 3.28 109.52 171.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.6 p -138.25 174.56 10.43 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.341 0.591 . . . . 2.6 111.416 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.44 -23.86 64.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.267 -0.896 . . . . 3.56 112.496 172.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.38 13.84 66.49 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.794 1.188 . . . . 1.35 114.65 170.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.77 -158.03 31.7 Favored Glycine 0 N--CA 1.469 0.877 0 C-N-CA 126.732 2.11 . . . . 0.97 114.559 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.51 96.72 2.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.958 0.903 . . . . 0.82 111.738 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -72.81 116.59 13.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.72 2.008 . . . . 2.66 109.975 172.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -109.12 111.48 23.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.309 2.244 . . . . 0.57 109.768 -174.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.9 m -119.85 114.29 34.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-O 118.275 -0.869 . . . . 0.53 108.986 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.45 160.74 9.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.048 2.498 . . . . 0.42 112.781 -174.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -150.51 26.39 0.76 Allowed 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.546 0.943 . . . . 1.38 113.546 172.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.91 143.53 31.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.66 112.83 -176.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HE3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -125.18 128.28 48.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 117.575 -1.202 . . . . 2.37 110.673 174.661 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 131.12 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 129.838 3.255 . . . . 1.97 115.971 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -95.92 159.66 31.82 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.115 0.966 . . . . 1.54 112.215 -172.27 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -59.77 133.39 50.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.511 2.141 . . . . 0.8 111.408 171.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.601 ' HA ' HG23 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -92.97 43.08 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.019 2.48 . . . . 0.88 112.589 -150.266 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.25 -158.01 10.05 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 122.895 1.275 . . . . 1.16 115.724 -175.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -81.11 145.0 31.29 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.668 2.387 . . . . 2.82 111.735 173.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -152.39 138.05 17.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.783 1.633 . . . . 1.12 110.018 -174.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.77 165.28 54.81 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 120.398 1.454 . . . . 0.62 114.194 169.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -130.36 121.98 27.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.551 1.541 . . . . 2.1 107.22 177.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -121.74 156.34 33.34 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.179 1.354 . . . . 1.28 112.677 173.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.13 141.05 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.914 1.686 . . . . 0.96 108.839 158.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -119.86 -179.09 3.8 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.767 1.627 . . . . 1.19 110.254 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.69 56.24 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.807 2.151 . . . . 1.09 116.807 -166.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -132.84 159.9 38.47 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.954 1.252 . . . . 1.35 114.015 178.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.63 65.79 4.0 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.972 1.749 . . . . 1.03 113.14 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -146.06 76.15 1.44 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.482 0.919 . . . . 2.27 113.482 -168.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.1 m -60.54 38.49 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 129.303 3.041 . . . . 1.61 117.636 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -120.15 168.9 9.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 119.789 -1.819 . . . . 3.47 112.042 -166.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 92.5 Cg_endo -80.22 145.94 17.46 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.566 2.177 . . . . 1.42 111.085 168.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.06 153.23 18.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.621 -0.718 . . . . 2.77 109.353 159.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.81 116.22 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.083 -1.451 . . . . 4.26 107.083 163.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -79.51 -47.1 16.16 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.706 0.765 . . . . 7.66 110.418 178.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -176.09 118.76 0.15 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.358 3.063 . . . . 5.82 106.511 171.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.44 -4.46 0.95 Allowed Glycine 0 CA--C 1.54 1.65 0 N-CA-C 117.556 1.782 . . . . 3.68 117.556 175.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -159.99 157.39 28.71 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.74 1.77 . . . . 3.3 111.71 -171.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.49 133.98 34.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.4 1.08 . . . . 1.6 112.221 -173.207 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.4 t -115.3 103.57 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.031 1.333 . . . . 3.08 109.001 171.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.98 110.72 4.03 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.342 1.457 . . . . 3.14 112.194 -177.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 122.1 -24.65 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 131.136 3.774 . . . . 2.85 113.876 171.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.85 -11.28 58.29 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.412 1.46 . . . . 6.29 114.246 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.782 -1.199 . . . . 2.62 112.785 168.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.65 3.44 16.37 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.355 1.062 . . . . 1.2 113.133 173.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.1 178.75 38.81 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.366 0.984 . . . . 2.21 113.564 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.2 -167.81 10.19 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.374 0.988 . . . . 1.39 112.952 171.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -72.29 52.34 0.26 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.222 1.809 . . . . 2.4 111.501 174.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.6 tp 37.3 58.67 1.23 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.71 2.004 . . . . 1.92 111.465 178.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 85.02 55.57 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.216 1.806 . . . . 4.82 112.273 -150.305 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.81 -63.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.648 2.899 . . . . 1.86 111.672 175.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -143.43 129.38 19.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.473 -1.677 . . . . 5.46 106.473 173.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 p30 174.73 -97.65 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.532 1.933 . . . . 4.57 112.196 179.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t 174.97 -45.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.991 2.516 . . . . 3.12 109.739 -166.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.14 -39.8 3.1 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 126.141 1.829 . . . . 3.94 116.374 149.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -43.26 -51.41 6.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.831 1.653 . . . . 3.96 113.546 -170.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.443 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 162.48 150.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.605 3.162 . . . . 2.43 112.564 168.067 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -82.85 167.26 18.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.267 0.556 . . . . 3.44 112.057 171.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.88 -109.97 0.78 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.595 -1.669 . . . . 5.41 110.95 -167.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.02 -27.03 36.68 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.768 2.979 . . . . 7.58 114.711 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.75 10.55 3.39 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.931 1.293 . . . . 9.63 112.454 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.62 73.23 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.025 -0.875 . . . . 4.13 114.807 171.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -82.94 51.14 1.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.265 1.532 . . . . 6.53 113.839 -166.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.81 -171.66 42.13 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 117.249 1.66 . . . . 2.14 117.249 -167.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.947 ' ND1' ' OD1' ' A' ' 93' ' ' ASP . 16.6 p-80 -139.74 157.13 46.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.922 1.689 . . . . 5.0 110.848 171.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.413 ' H ' HD23 ' A' ' 91' ' ' LEU . 2.5 pt? -69.36 24.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.582 1.553 . . . . 2.4 115.186 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -153.56 23.46 0.74 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 128.572 2.987 . . . . 0.88 113.042 178.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.947 ' OD1' ' ND1' ' A' ' 90' ' ' HIS . 10.5 m-20 -80.53 138.62 36.53 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 106.75 -1.574 . . . . 2.13 106.75 154.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 111' ' ' ALA . 3.7 mp -143.59 147.8 40.81 Favored Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 121.744 2.065 . . . . 2.31 112.577 -171.404 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.94 157.94 54.13 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.124 3.216 . . . . 0.91 113.254 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.67 125.97 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 115.429 1.64 . . . . 1.64 115.429 -156.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 67.93 0.8 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.912 2.885 . . . . 1.53 110.313 170.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.8 134.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.508 -0.745 . . . . 1.05 109.429 174.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.601 HG23 ' HA ' ' A' ' 42' ' ' PRO . 6.4 m -115.0 152.14 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.006 0.922 . . . . 2.04 108.9 175.115 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 100' ' ' ASN . 0.1 OUTLIER -70.56 157.07 38.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.531 0.567 . . . . 2.74 112.531 -176.293 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -50.56 -22.55 2.04 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 126.935 2.094 . . . . 2.19 115.527 179.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -88.88 3.56 50.87 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.888 2.475 . . . . 3.76 113.892 -178.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 30.08 21.19 Favored Glycine 0 N--CA 1.475 1.277 0 O-C-N 121.135 -0.978 . . . . 0.67 115.283 173.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.8 131.56 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.252 1.421 . . . . 0.99 109.535 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.83 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.651 1.18 . . . . 0.93 109.969 176.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 t -149.4 -33.75 0.2 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.106 1.362 . . . . 1.67 113.183 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -66.13 121.52 76.73 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.848 0.859 . . . . 3.11 111.048 -178.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.65 152.31 22.66 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.149 3.233 . . . . 1.36 112.354 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.27 175.99 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.456 1.503 . . . . 1.26 110.22 170.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.6 m -146.39 143.81 29.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.587 1.155 . . . . 0.99 109.994 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -105.17 101.63 31.66 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.7 1.2 . . . . 1.31 111.766 175.365 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.38 -5.81 10.12 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.981 2.454 . . . . 1.65 116.195 -166.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -77.43 -17.13 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.553 1.524 . . . . 9.67 113.188 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.15 153.55 19.16 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.92 1.688 . . . . 2.91 109.421 -177.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 28.63 1.21 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.878 1.671 . . . . 4.37 111.333 170.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.7 m -163.29 133.54 4.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.344 1.857 . . . . 2.1 110.819 171.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.42 -27.47 67.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.271 1.428 . . . . 2.0 110.488 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.42 -26.88 5.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.396 1.878 . . . . 3.6 113.687 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -65.84 -11.67 48.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.461 1.105 . . . . 2.58 113.486 176.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.52 15.49 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.162 1.171 . . . . 0.71 114.162 -172.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -69.06 9.24 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 118.1 2.63 . . . . 2.12 118.1 -169.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -151.72 29.71 0.6 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.765 1.626 . . . . 3.37 111.676 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -116.47 155.22 28.97 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.788 -1.195 . . . . 2.9 112.222 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.97 141.26 28.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.296 0.638 . . . . 0.65 110.46 166.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 141.67 43.82 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.175 -0.676 . . . . 1.6 109.175 160.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.0 mtt -134.24 135.29 42.83 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.375 0.67 . . . . 1.36 112.594 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.5 mt -82.13 105.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.609 1.163 . . . . 0.68 108.65 172.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.11 139.75 30.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.106 1.762 . . . . 2.33 110.979 -176.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.54 -39.08 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.871 -1.143 . . . . 1.69 112.443 -162.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -94.99 144.12 17.0 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.205 0.907 . . . . 1.29 112.043 176.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.39 156.64 25.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 127.014 2.245 . . . . 1.72 115.053 175.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.66 53.26 0.7 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.517 1.151 . . . . 3.2 113.268 -147.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -141.64 2.35 1.6 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.634 1.574 . . . . 2.53 113.423 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.2 mtm -92.6 126.47 37.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.121 0.968 . . . . 2.28 111.683 -171.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 -158.3 0.82 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.536 1.134 . . . . 3.27 110.921 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.24 -38.51 0.41 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 129.911 3.284 . . . . 3.65 114.135 -176.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -67.65 146.26 98.46 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.724 2.01 . . . . 3.31 113.42 -166.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.89 -40.44 44.16 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.521 3.481 . . . . 2.35 112.204 -172.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.23 101.42 11.23 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 105.889 -1.893 . . . . 4.36 105.889 162.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -75.77 179.44 6.25 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.429 2.753 . . . . 3.13 113.338 -162.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.1 mt 66.53 1.08 2.0 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.887 2.075 . . . . 3.83 113.987 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.74 27.12 67.83 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.698 1.135 . . . . 2.89 112.388 -175.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.6 -8.88 79.12 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.018 1.294 . . . . 1.95 114.354 -171.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.78 22.09 0.57 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.349 1.928 . . . . 2.19 115.86 -177.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.16 -15.26 65.04 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.936 1.255 . . . . 1.47 113.147 167.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.4 p -74.27 151.58 39.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.639 1.22 . . . . 1.71 110.013 172.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.93 142.31 30.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.472 1.109 . . . . 5.55 112.581 -171.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.34 -33.88 12.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.555 0.742 . . . . 2.77 112.235 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.89 155.99 41.66 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.259 1.024 . . . . 0.62 113.038 -176.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.43 151.67 45.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.932 2.093 . . . . 1.43 111.334 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.28 126.76 2.89 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.99 1.281 . . . . 0.66 112.545 173.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.48 123.45 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.955 1.302 . . . . 1.53 109.972 171.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.69 113.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.719 -0.845 . . . . 1.01 108.719 170.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt . . . . . 0 CA--C 1.54 0.585 0 O-C-N 121.745 -0.597 . . . . 3.75 111.121 -174.757 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.528 -0.545 . . . . 1.65 109.528 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -131.78 135.19 46.59 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.65 -1.281 . . . . 1.67 113.788 -137.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -144.7 148.8 34.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.134 1.373 . . . . 2.9 108.587 173.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -126.5 99.95 6.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.778 1.231 . . . . 4.33 110.866 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -90.29 122.24 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 121.861 -0.524 . . . . 1.05 109.985 -173.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.2 104.7 2.06 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.905 1.717 . . . . 0.69 110.752 174.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 mmm -86.93 89.45 7.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.422 1.489 . . . . 1.58 110.655 -175.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -75.39 148.37 39.24 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.231 -0.918 . . . . 2.76 111.04 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.13 140.72 58.24 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.53 -0.732 . . . . 1.33 109.796 174.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.7 138.82 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.892 0.877 . . . . 1.14 110.316 177.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -171.85 69.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.979 0.912 . . . . 2.68 111.909 -170.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 74.37 -42.46 0.5 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.592 2.357 . . . . 1.42 114.285 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.39 -9.22 58.23 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.486 1.039 . . . . 3.07 112.163 174.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.91 -147.82 17.99 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 125.909 1.719 . . . . 1.07 111.455 -173.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.8 t -58.85 127.04 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.795 1.638 . . . . 0.87 110.212 174.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.78 -97.71 2.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.32 0.962 . . . . 1.48 113.694 -168.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.29 127.93 12.41 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.707 1.203 . . . . 2.38 109.864 -170.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 t -90.98 149.95 21.66 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.056 1.132 . . . . 1.15 114.056 -160.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -143.07 -6.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 115.289 1.589 . . . . 2.74 115.289 -173.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.5 153.73 13.31 Favored Glycine 0 N--CA 1.469 0.861 0 O-C-N 120.625 -1.297 . . . . 0.6 114.556 -175.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 p -107.19 176.16 5.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.434 -0.95 . . . . 0.84 108.434 163.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.08 134.03 66.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.44 -0.948 . . . . 0.76 108.44 158.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.417 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.5 p -88.48 130.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.7 0.625 . . . . 1.06 110.296 173.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.26 114.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.064 2.146 . . . . 1.51 108.399 -173.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.08 105.93 11.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.74 0.816 . . . . 2.12 111.348 175.642 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 133.76 55.24 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.107 2.563 . . . . 3.7 111.176 172.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 t -164.02 -172.02 2.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.209 0.604 . . . . 1.93 111.089 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.54 -38.25 66.38 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.674 1.189 . . . . 3.64 111.685 178.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.74 12.36 41.89 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.867 1.222 . . . . 1.28 115.297 173.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 -145.82 32.65 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 127.824 2.63 . . . . 0.98 112.042 -177.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.89 102.21 6.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.997 0.919 . . . . 1.02 111.614 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.59 109.97 12.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.093 0.957 . . . . 2.19 110.556 175.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.95 105.77 17.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.875 2.47 . . . . 0.97 110.191 -169.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.417 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.0 m -110.7 108.99 57.99 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 107.84 -1.17 . . . . 1.25 107.84 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.43 157.11 22.27 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.807 2.338 . . . . 0.84 111.211 -177.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -142.78 37.09 1.44 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.911 0.862 . . . . 1.53 111.253 169.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -91.49 158.67 16.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 123.123 1.439 . . . . 0.78 113.841 -174.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' N ' ' HE3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -144.01 159.32 42.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.032 2.133 . . . . 2.96 108.38 174.525 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.52 23.66 0.08 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.465 2.706 . . . . 1.44 113.381 171.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.467 HD12 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -92.89 161.75 30.74 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 121.484 -0.76 . . . . 1.72 110.773 174.158 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.63 135.33 52.2 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 O-C-N 122.655 0.818 . . . . 0.97 110.068 164.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -92.65 24.05 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.968 3.112 . . . . 1.08 112.942 -149.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.7 158.11 15.1 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.003 -1.239 . . . . 2.24 110.003 167.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -51.2 130.9 27.38 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 128.302 2.641 . . . . 3.16 114.915 -175.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -103.83 138.36 40.53 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.832 1.253 . . . . 1.56 112.577 -171.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.63 150.66 50.91 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.926 -0.87 . . . . 0.73 110.926 166.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.92 119.85 28.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.099 -1.445 . . . . 2.02 107.099 175.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -115.25 153.64 30.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.922 0.889 . . . . 0.97 113.27 171.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.483 ' CG2' HD12 ' A' ' 74' ' ' LEU . 71.7 mt -94.75 144.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.396 1.078 . . . . 0.84 109.03 150.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -118.74 156.85 28.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.15 1.78 . . . . 0.93 110.214 176.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.1 62.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 117.101 2.26 . . . . 1.11 117.101 -159.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -134.75 -179.2 5.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.8 2.04 . . . . 1.34 110.44 175.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.84 100.55 0.54 Allowed Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.576 -1.327 . . . . 1.25 113.629 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.4 t 175.71 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.079 2.152 . . . . 2.01 110.987 173.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.2 m -71.4 43.43 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 126.902 2.081 . . . . 1.58 115.019 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -106.95 127.95 27.03 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.308 -1.495 . . . . 3.28 111.276 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.84 162.34 29.63 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.824 3.016 . . . . 1.1 112.305 173.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.12 145.76 40.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.125 0.97 . . . . 1.52 109.467 160.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mm -102.07 22.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.669 1.188 . . . . 3.4 111.321 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.14 129.46 27.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.131 1.373 . . . . 4.47 112.2 -175.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 t0 69.83 25.87 4.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.678 1.591 . . . . 3.35 112.737 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.64 28.07 44.55 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.722 1.153 . . . . 2.37 113.541 172.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -158.26 132.54 8.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.009 0.904 . . . . 2.7 110.773 -166.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.8 104.0 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.394 -0.816 . . . . 1.88 111.277 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.61 41.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.674 1.589 . . . . 2.16 112.414 -175.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.46 -63.15 0.26 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.991 2.916 . . . . 1.75 115.563 172.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.77 128.31 2.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.074 2.55 . . . . 1.64 108.315 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -116.48 -46.71 2.76 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.435 1.094 . . . . 4.9 111.72 -177.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.54 -18.73 64.42 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.712 1.004 . . . . 1.41 113.712 -174.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.1 -8.39 56.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.161 1.384 . . . . 1.05 113.45 168.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.64 174.4 49.27 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 120.608 -1.307 . . . . 2.63 112.699 -172.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.37 -160.52 19.5 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 122.156 -0.614 . . . . 1.25 111.768 168.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -48.4 144.0 4.39 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.466 -0.568 . . . . 2.8 109.466 165.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -71.3 61.01 0.3 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.515 1.526 . . . . 2.5 112.152 179.614 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -118.85 -1.21 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 120.724 3.602 . . . . 4.05 120.724 -147.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.66 -56.84 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 123.505 2.288 . . . . 2.94 114.885 -151.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -92.76 54.85 2.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.632 1.173 . . . . 3.31 111.236 -177.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -123.94 -75.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.324 1.05 . . . . 3.39 111.651 174.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t 168.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 130.02 3.328 . . . . 2.57 111.257 -175.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.48 0.19 73.4 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 115.408 0.923 . . . . 1.92 115.408 164.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -84.22 3.87 33.33 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.604 1.705 . . . . 5.08 115.604 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 45.2 t60 62.25 -174.25 0.14 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.911 1.284 . . . . 1.8 111.662 -169.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.27 -155.14 0.47 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.558 -1.339 . . . . 3.98 111.467 -172.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.43 -101.56 0.64 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.041 -1.422 . . . . 2.83 111.007 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.9 -15.38 32.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.501 2.8 . . . . 4.0 113.357 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.59 157.37 12.39 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.77 2.828 . . . . 6.87 108.333 179.215 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.5 179.75 29.55 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.223 0.902 . . . . 4.02 114.857 177.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -156.13 35.64 0.34 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.935 2.094 . . . . 5.81 109.426 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.61 4.56 63.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 116.822 -2.099 . . . . 3.3 116.703 -172.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.569 ' ND1' ' OD2' ' A' ' 93' ' ' ASP . 10.5 t-160 -177.12 99.5 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.358 1.863 . . . . 4.61 111.561 171.551 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -14.19 62.78 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.104 1.89 . . . . 3.0 116.104 -176.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 25.37 28.22 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 127.273 2.368 . . . . 1.58 115.537 -170.088 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD2' ' ND1' ' A' ' 90' ' ' HIS . 46.4 m-20 -93.14 151.73 19.67 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.205 1.402 . . . . 3.05 110.384 167.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.63 157.91 76.23 Favored Pre-proline 0 CA--C 1.556 1.198 0 O-C-N 120.95 -1.094 . . . . 2.21 111.706 -161.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.7 162.38 41.41 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.96 3.106 . . . . 0.93 112.509 -171.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -83.19 128.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 123.431 1.586 . . . . 1.63 112.977 -161.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.03 83.22 6.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.556 2.742 . . . . 2.41 110.033 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.53 143.62 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 125.598 1.559 . . . . 1.0 111.105 176.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.42 157.25 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 127.598 2.359 . . . . 1.73 107.913 170.159 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 163.26 23.0 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 118.743 -0.646 . . . . 2.01 111.852 170.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -19.35 2.2 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.312 1.967 . . . . 3.53 116.312 -174.028 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -94.37 -2.33 52.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.658 1.583 . . . . 3.86 114.578 177.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.12 31.44 8.49 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.149 0.886 . . . . 1.0 115.174 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -116.53 133.78 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.768 1.627 . . . . 1.04 109.449 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.18 108.81 19.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.441 1.496 . . . . 0.69 109.546 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 t -131.43 24.59 4.8 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.079 1.752 . . . . 1.4 111.291 172.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.79 108.54 43.72 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.917 1.687 . . . . 3.04 108.933 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 129.87 14.65 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.791 2.327 . . . . 1.3 110.378 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.29 172.17 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.163 1.385 . . . . 1.5 108.972 175.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.3 m -151.22 145.59 25.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.226 0.921 . . . . 1.21 109.954 -171.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -112.45 89.64 12.99 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 112.992 0.738 . . . . 1.01 112.992 176.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 -4.91 12.86 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.856 3.038 . . . . 1.47 114.307 172.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -73.72 -18.92 60.94 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.751 2.02 . . . . 3.94 112.046 176.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.38 164.02 13.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.379 2.272 . . . . 2.67 108.405 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -154.37 6.11 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.295 1.591 . . . . 4.43 115.295 -172.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 t -168.95 130.41 1.2 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.338 -1.476 . . . . 1.93 113.099 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.35 -26.94 61.78 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.583 -1.323 . . . . 1.51 111.946 174.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.13 -16.69 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.676 1.361 . . . . 3.09 114.676 175.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.68 -12.89 52.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.385 1.448 . . . . 2.04 113.056 171.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.41 3.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.353 1.461 . . . . 0.9 114.587 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -62.35 -2.56 1.05 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.057 2.243 . . . . 2.36 117.057 -175.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -148.85 29.38 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.036 1.735 . . . . 3.3 110.826 174.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -111.87 -179.53 3.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.83 1.652 . . . . 1.54 111.578 178.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.31 151.74 48.95 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.003 -1.061 . . . . 0.6 111.124 168.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.74 153.48 33.34 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.441 1.097 . . . . 2.37 110.696 164.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.3 mtt -136.97 130.98 32.32 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.329 0.652 . . . . 1.23 110.94 -170.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.0 mt -84.74 109.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.76 107.131 168.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -91.95 147.03 23.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.002 2.121 . . . . 2.12 111.191 -175.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.71 -37.58 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.876 -1.14 . . . . 1.59 113.397 -162.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.16 170.92 15.16 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 124.506 1.05 . . . . 1.58 111.774 170.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.46 169.34 37.19 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 1.45 113.884 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -125.96 11.64 7.73 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.896 1.813 . . . . 2.46 115.896 -141.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.21 9.21 0.46 Allowed 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.126 -1.609 . . . . 2.87 115.229 -177.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.1 mtm -81.19 79.29 7.87 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.527 1.531 . . . . 3.04 112.31 -172.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -81.68 -5.09 57.77 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.957 0.903 . . . . 2.98 113.352 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -149.3 145.05 26.86 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.152 -1.592 . . . . 3.87 111.566 -173.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 151.27 153.88 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.091 1 C-N-CA 132.049 4.139 . . . . 4.1 110.166 173.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.71 -12.1 22.11 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.306 2.671 . . . . 2.15 114.382 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -77.93 116.0 54.99 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 119.76 1.164 . . . . 4.97 108.927 165.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.84 173.33 12.09 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.161 2.574 . . . . 4.35 112.948 -168.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.8 mt 67.04 11.21 8.26 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.355 1.862 . . . . 6.76 113.904 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.28 6.62 59.91 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.437 1.494 . . . . 4.77 114.481 177.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.93 -50.67 2.67 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.127 1.463 . . . . 3.18 114.581 175.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.31 45.14 1.73 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 126.58 2.038 . . . . 2.08 114.602 -175.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.74 -15.12 68.49 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.674 1.13 . . . . 1.84 114.657 -175.014 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.8 p -67.68 125.09 25.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.216 1.406 . . . . 1.94 112.244 -175.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 -91.01 150.41 21.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.011 1.724 . . . . 4.6 110.098 176.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 11.0 t80 -112.49 -42.04 3.74 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.795 0.725 . . . . 2.09 112.265 161.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.99 142.79 32.97 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.316 0.646 . . . . 0.69 112.607 177.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.02 143.44 44.31 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.503 1.521 . . . . 1.32 111.113 176.324 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.57 81.66 0.3 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 128.083 2.754 . . . . 0.77 110.962 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.76 135.66 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 118.091 0.945 . . . . 2.28 110.949 166.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.2 mt -107.54 140.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.045 1.338 . . . . 1.14 110.341 -167.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 3.86 109.822 177.493 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.568 -0.253 . . . . 3.26 110.989 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -155.67 152.45 28.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.095 1.358 . . . . 1.96 110.121 -170.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.84 122.73 5.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.055 0.931 . . . . 2.69 112.669 173.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.76 82.41 5.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.994 -1.066 . . . . 3.25 113.225 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.69 116.05 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.22 -0.925 . . . . 1.52 111.778 -169.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.09 90.38 1.2 Allowed Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.462 1.982 . . . . 1.16 112.319 -177.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mmt -72.81 120.8 18.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.95 . . . . 1.78 113.13 -175.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -104.44 144.37 31.75 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.074 1.75 . . . . 3.52 112.033 -178.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.64 66.53 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.42 1.088 . . . . 1.86 111.105 175.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 m -67.46 138.88 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.552 1.141 . . . . 0.96 110.304 174.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -165.81 61.1 0.11 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.745 0.784 . . . . 2.21 112.317 -171.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.61 -26.79 0.17 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.965 2.506 . . . . 1.16 115.265 171.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -17.44 61.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.301 2.24 . . . . 2.58 112.117 173.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.8 -168.04 13.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.545 2.022 . . . . 1.65 109.963 -160.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.2 t -56.64 139.5 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.327 0.651 . . . . 1.04 110.19 155.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.74 -128.2 4.7 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.927 1.727 . . . . 1.38 112.065 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -116.67 162.75 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.755 1.622 . . . . 4.4 111.009 178.224 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -128.45 156.5 43.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.083 0.953 . . . . 1.23 112.745 -164.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.74 7.53 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 125.005 1.322 . . . . 2.98 114.388 -162.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.84 173.82 24.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.063 1.315 . . . . 0.58 112.975 -179.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 p -105.18 174.34 5.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.78 0.832 . . . . 0.95 109.817 168.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 t -123.46 126.67 73.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.962 -1.496 . . . . 0.86 106.962 151.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.55 119.7 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 123.279 0.362 . . . . 0.96 111.408 -177.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.33 126.74 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.847 1.259 . . . . 1.18 108.545 174.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -130.34 127.16 38.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.917 0.887 . . . . 2.33 109.896 170.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 117' ' ' LEU . 12.8 tt0 -77.05 136.67 38.68 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.516 1.927 . . . . 3.37 112.302 -171.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.58 -175.53 5.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.254 0.934 . . . . 1.23 111.361 175.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.24 -30.62 70.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.013 0.925 . . . . 4.05 112.037 -179.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.11 11.77 41.07 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.892 0.758 . . . . 1.1 113.762 166.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.36 -141.16 21.92 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 127.441 2.448 . . . . 0.84 114.742 176.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.11 101.9 9.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.057 0.943 . . . . 0.63 111.296 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -78.06 108.24 11.21 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.983 1.313 . . . . 1.85 110.594 175.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -102.69 117.1 33.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.458 2.303 . . . . 0.62 110.269 -171.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -127.58 112.36 20.9 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 117.765 -1.112 . . . . 0.69 109.716 -172.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -88.62 159.43 6.42 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.188 2.592 . . . . 0.47 112.224 -173.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.08 25.31 0.72 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.446 0.906 . . . . 1.31 113.446 173.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.31 136.58 33.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.814 0.846 . . . . 0.66 112.822 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.09 156.98 18.99 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.677 -0.692 . . . . 2.6 111.198 161.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.15 20.39 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.806 2.442 . . . . 1.79 114.675 156.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.89 154.29 41.13 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 1.42 112.458 176.252 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.07 137.68 45.1 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 O-C-N 122.953 0.975 . . . . 1.6 110.911 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 9.7 Cg_endo -85.24 51.74 3.12 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.489 3.459 . . . . 1.73 112.283 -162.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 -162.42 13.99 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 114.868 -1.06 . . . . 1.19 114.047 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.46 140.28 32.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.256 1.822 . . . . 2.69 110.214 171.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.87 136.55 30.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 1.42 109.683 -177.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.72 169.61 29.71 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.629 0.65 . . . . 0.73 112.347 167.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.39 132.68 10.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.209 1.404 . . . . 2.04 108.566 171.112 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 15.6 m170 -129.79 170.49 13.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.231 1.567 . . . . 0.71 115.231 168.633 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 74' ' ' LEU . 44.3 mt -99.01 147.1 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.629 1.572 . . . . 0.61 109.151 153.201 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.59 152.34 40.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.168 1.787 . . . . 0.82 110.503 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.35 -31.44 72.57 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.435 2.013 . . . . 0.92 116.435 -160.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -113.73 169.8 8.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.858 1.663 . . . . 1.2 112.528 177.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.02 67.41 0.22 Allowed Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.948 1.139 . . . . 0.81 115.948 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -166.88 120.5 1.02 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 119.459 1.629 . . . . 2.07 114.572 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.4 m -69.93 -6.34 32.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.34 1.856 . . . . 1.43 115.157 176.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -63.96 145.02 98.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 O-C-N 120.993 -1.067 . . . . 3.2 111.825 -168.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.23 150.2 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.978 2.452 . . . . 1.28 111.752 179.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.25 140.96 34.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.517 0.727 . . . . 1.68 109.723 161.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.92 126.75 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.13 -1.063 . . . . 2.7 108.13 169.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -167.32 144.91 4.65 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.731 1.612 . . . . 5.25 109.971 -163.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 59.88 -104.73 0.2 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.072 1.349 . . . . 4.14 108.003 -163.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.68 25.4 3.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.934 1.73 . . . . 2.65 113.501 170.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.88 179.62 9.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.094 1.447 . . . . 4.52 113.318 -167.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.57 108.53 20.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.812 1.245 . . . . 1.66 112.679 -171.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.25 91.43 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.829 1.252 . . . . 2.05 109.937 -179.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.15 114.7 2.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.567 1.547 . . . . 2.98 112.859 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.26 39.18 7.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.54 1.536 . . . . 1.81 113.395 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.84 -43.0 90.64 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.409 0.684 . . . . 4.42 109.896 158.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.78 78.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.664 1.186 . . . . 1.8 113.002 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -16.36 8.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.816 2.046 . . . . 0.87 115.416 179.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.89 176.25 45.35 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 120.072 1.305 . . . . 2.31 112.561 -172.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.24 -175.92 22.72 Favored Glycine 0 N--CA 1.474 1.181 0 N-CA-C 111.732 -0.547 . . . . 1.4 111.732 163.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -70.17 35.88 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.907 1.447 . . . . 3.09 114.907 -176.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.489 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER 71.81 89.73 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.2 1.8 . . . . 3.07 109.691 175.317 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.25 102.47 1.24 Allowed Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 127.287 2.235 . . . . 3.87 110.03 -172.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.42 -54.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.259 2.64 . . . . 1.93 111.561 173.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -132.37 15.2 4.55 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.052 1.296 . . . . 4.17 113.651 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.91 -47.17 63.52 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.427 -1.421 . . . . 3.61 111.388 -171.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t 178.16 -65.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.287 2.235 . . . . 2.85 111.855 175.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.29 -21.14 6.13 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.825 1.203 . . . . 1.92 114.502 -170.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -82.62 168.61 17.14 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.117 1.959 . . . . 4.32 113.83 170.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -84.52 146.09 27.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.336 1.054 . . . . 1.58 112.875 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 84' ' ' GLY . 7.1 tt0 -106.87 -156.81 0.59 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.505 1.122 . . . . 3.54 112.56 -178.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' A' ' 83' ' ' GLU . . . -160.47 -128.34 0.95 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 127.23 2.348 . . . . 3.13 110.478 179.081 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.95 -27.22 12.38 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.363 2.709 . . . . 5.55 113.353 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -174.18 164.85 4.07 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.664 2.386 . . . . 8.87 109.979 171.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.22 -135.36 7.72 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 125.796 1.665 . . . . 2.62 109.977 -174.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -142.67 116.13 9.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.289 1.044 . . . . 4.81 112.079 166.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.58 -139.44 3.24 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 127.474 2.464 . . . . 2.14 109.179 166.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -75.49 139.7 42.37 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 117.806 0.803 . . . . 3.7 112.674 176.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.5 -15.84 62.84 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.711 1.375 . . . . 1.98 114.711 177.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.03 9.79 76.15 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 118.496 -1.169 . . . . 0.86 114.892 175.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -82.84 136.09 34.74 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.87 1.335 . . . . 1.65 111.497 171.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 171.2 7.26 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.983 0.913 . . . . 1.91 111.066 -138.24 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.46 159.52 32.45 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.372 2.715 . . . . 1.22 112.45 -169.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -85.26 126.51 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 122.908 1.337 . . . . 1.46 113.423 -173.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.17 68.64 5.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.972 2.909 . . . . 1.64 110.878 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.53 144.76 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.73 0.812 . . . . 1.1 110.749 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.91 135.61 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 3.2 109.478 169.548 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.12 154.22 42.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.843 1.257 . . . . 3.21 113.876 178.015 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 6.3 p30 -33.34 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 131.188 3.795 . . . . 3.16 118.953 179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -78.72 -21.52 47.94 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.567 1.547 . . . . 3.54 113.319 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.2 34.48 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 124.338 0.971 . . . . 1.31 114.852 178.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mt -124.32 117.13 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.037 1.335 . . . . 1.34 109.413 178.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 125.63 28.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.194 0.998 . . . . 0.61 111.152 -177.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 t -142.7 -7.14 0.86 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.592 1.557 . . . . 1.2 113.502 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.0 117.38 64.66 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.038 -1.038 . . . . 3.27 111.193 -175.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 136.57 14.64 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.446 2.764 . . . . 1.07 111.281 176.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 m -139.97 155.82 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.785 1.234 . . . . 1.17 110.336 176.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.3 m -135.48 138.91 43.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.712 0.687 . . . . 0.78 110.915 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.29 99.77 50.25 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.237 1.015 . . . . 0.71 112.885 -174.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.22 -1.29 11.29 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.58 3.52 . . . . 1.28 115.384 -178.346 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -71.71 -25.32 62.03 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.158 0.89 . . . . 4.06 111.855 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.79 133.04 56.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.003 2.521 . . . . 2.09 106.802 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 12.29 1.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.756 1.021 . . . . 6.74 113.756 -164.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.4 p -132.45 164.09 27.32 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.054 -0.721 . . . . 2.89 109.054 146.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.8 -26.68 22.73 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.649 -0.657 . . . . 2.64 110.547 168.187 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.28 -44.89 44.39 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.391 1.476 . . . . 3.15 113.055 168.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.7 -2.34 14.23 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.877 1.066 . . . . 2.25 113.877 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 18.02 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.304 1.441 . . . . 0.91 113.806 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -64.99 -4.27 4.42 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 118.135 2.642 . . . . 2.17 118.135 -170.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.3 58.76 0.9 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.05 1.74 . . . . 4.34 109.9 169.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -114.58 147.93 38.77 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.081 1.352 . . . . 1.45 110.751 173.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.38 140.47 31.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.813 0.845 . . . . 0.8 110.354 164.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.41 149.12 36.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.558 1.943 . . . . 2.86 107.534 170.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.6 mtt -132.97 137.73 46.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.813 0.279 . . . . 1.53 111.728 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.53 124.36 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.967 -1.494 . . . . 0.66 106.967 165.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.32 137.97 51.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.289 1.036 . . . . 1.82 112.17 -162.25 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.69 -32.96 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.486 1.291 . . . . 2.7 114.486 -154.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.02 152.61 19.74 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.003 1.287 . . . . 1.32 111.55 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.9 140.35 16.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.907 1.717 . . . . 1.76 113.644 175.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.404 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 15.5 t0 -83.28 -0.02 47.75 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.284 1.587 . . . . 2.42 115.284 -152.394 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -77.2 -16.59 59.02 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.939 1.696 . . . . 3.46 114.977 -168.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.4 ptp -78.59 45.4 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.518 1.527 . . . . 3.11 113.829 -171.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 m -83.2 -33.76 26.08 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 117.902 2.556 . . . . 4.34 117.902 -146.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -92.95 21.77 5.45 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.296 1.039 . . . . 4.44 113.466 -162.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -75.22 146.43 81.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.546 1.138 . . . . 3.93 112.454 -172.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.07 -14.54 41.16 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.619 2.879 . . . . 1.92 112.913 173.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -83.58 101.77 1.55 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.695 -0.854 . . . . 4.03 108.695 151.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.24 146.28 93.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.387 2.058 . . . . 3.07 110.422 -177.202 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 71.15 -3.25 2.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.783 2.033 . . . . 3.94 112.927 -173.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.88 40.02 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.817 1.675 . . . . 2.6 115.839 168.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.5 -38.45 3.01 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.309 1.433 . . . . 2.21 112.678 -167.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.31 -25.74 63.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.961 1.267 . . . . 1.75 114.349 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.43 2.7 14.05 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.88 1.228 . . . . 1.91 115.312 172.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.9 m -66.2 152.27 45.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.761 1.28 . . . . 2.04 108.885 164.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.66 133.24 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.276 1.03 . . . . 4.72 110.513 -169.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -98.09 -16.64 19.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.176 0.59 . . . . 2.36 111.366 156.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.49 160.73 35.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.137 0.88 . . . . 0.7 112.977 164.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.6 t -133.04 150.72 52.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.423 1.889 . . . . 1.54 109.825 167.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.21 136.34 4.38 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.393 1.473 . . . . 0.89 111.701 -178.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.96 139.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.119 0.968 . . . . 2.08 111.502 -174.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.03 149.55 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.172 1.389 . . . . 1.25 111.862 174.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 C--O 1.238 0.491 0 C-N-CA 125.311 1.444 . . . . 3.58 111.38 -176.411 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 119.544 -0.265 . . . . 1.83 110.756 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.78 152.62 35.5 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.763 -1.211 . . . . 1.04 113.228 -164.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -147.59 130.96 16.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.138 1.775 . . . . 2.22 109.599 174.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.44 96.66 10.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 4.88 111.117 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 t -90.15 112.32 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 120.597 -1.314 . . . . 1.22 109.147 -169.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.28 109.55 2.81 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.781 1.181 . . . . 0.96 110.363 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.2 mtp -96.52 131.12 43.45 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.453 0.701 . . . . 1.14 111.486 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -105.06 155.61 18.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.465 1.126 . . . . 2.67 110.534 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.84 145.29 54.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.412 1.485 . . . . 1.49 109.451 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.4 m -140.07 140.46 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.507 0.723 . . . . 0.89 111.085 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.08 57.9 0.1 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.788 0.662 . . . . 2.35 112.788 -167.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 77.34 -21.48 0.33 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.949 2.1 . . . . 1.04 114.073 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -19.99 28.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.251 1.02 . . . . 3.15 112.858 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.57 -147.93 16.32 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 125.411 1.482 . . . . 0.9 111.327 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.05 123.2 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.169 1.788 . . . . 0.94 111.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.32 -137.8 9.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.748 1.642 . . . . 1.57 112.021 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -90.31 170.11 10.53 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.258 -0.554 . . . . 2.05 110.049 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 t -105.95 157.66 17.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.991 0.9 . . . . 1.25 112.201 162.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.95 0.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.715 2.806 . . . . 2.88 112.822 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 147.25 6.21 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.571 2.034 . . . . 0.84 111.914 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 p -88.08 -177.44 5.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.297 -1.001 . . . . 0.76 108.297 159.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 47.6 t -128.3 134.28 65.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.554 -1.276 . . . . 0.48 107.554 149.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.2 p -82.95 127.09 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.596 -0.52 . . . . 0.82 109.596 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.67 HD11 HD21 ' A' ' 125' ' ' LEU . 16.8 mt -103.88 130.64 54.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.219 -1.03 . . . . 1.22 108.219 169.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.41 112.12 8.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.656 1.182 . . . . 2.15 109.131 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -77.77 144.49 37.11 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.773 -0.579 . . . . 3.32 111.157 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 t -148.24 178.13 8.83 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.356 -0.979 . . . . 1.32 108.356 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -70.36 -14.95 62.79 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.162 0.585 . . . . 3.39 112.176 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.41 12.9 67.47 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.22 1.391 . . . . 1.0 114.845 163.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.98 -155.89 22.15 Favored Glycine 0 N--CA 1.467 0.741 0 C-N-CA 127.492 2.473 . . . . 0.79 117.224 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -71.63 101.99 2.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.664 0.785 . . . . 0.6 111.87 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -71.29 117.3 12.65 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.841 1.256 . . . . 2.26 109.163 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -95.88 127.52 41.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.027 1.731 . . . . 0.96 108.162 174.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.414 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 19.9 m -129.62 105.03 17.27 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 119.916 1.235 . . . . 0.6 107.972 167.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.75 164.87 29.58 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.112 2.541 . . . . 0.54 110.066 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -155.42 43.66 0.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 122.356 1.074 . . . . 1.36 109.251 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.15 134.83 44.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.891 1.276 . . . . 1.01 112.089 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.637 ' HE3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -104.63 164.47 11.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.962 2.505 . . . . 3.26 109.056 168.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.57 16.06 0.38 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.778 2.431 . . . . 1.56 114.195 163.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.36 160.5 36.93 Favored Pre-proline 0 CA--C 1.511 -0.545 0 O-C-N 121.871 -0.518 . . . . 1.81 110.42 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.8 128.45 23.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 O-C-N 123.451 1.237 . . . . 1.11 110.307 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -85.8 31.31 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 125.101 3.867 . . . . 1.16 113.471 -147.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.08 -122.18 4.29 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 126.399 1.952 . . . . 1.18 113.124 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.84 138.21 35.57 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.095 2.158 . . . . 2.51 108.386 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -137.88 123.0 19.19 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 123.683 0.793 . . . . 1.34 112.942 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.15 149.26 7.56 Favored Glycine 0 CA--C 1.54 1.656 0 O-C-N 121.336 -0.852 . . . . 0.7 112.307 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.7 t80 -124.96 115.4 20.51 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.802 1.301 . . . . 2.01 107.5 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -115.03 162.31 17.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.724 1.379 . . . . 0.98 114.724 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.2 mt -107.75 143.6 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.765 2.026 . . . . 0.62 107.388 155.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -118.41 161.09 20.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.504 1.122 . . . . 0.91 112.03 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.62 73.22 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.558 1.318 . . . . 0.74 114.558 -163.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -101.92 177.77 4.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.69 1.196 . . . . 1.64 111.61 164.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.49 90.2 0.55 Allowed Glycine 0 N--CA 1.469 0.856 0 C-N-CA 124.621 1.105 . . . . 0.84 112.003 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -166.4 99.03 0.6 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.356 1.078 . . . . 2.08 113.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.7 m -71.48 45.52 0.11 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.942 2.097 . . . . 1.64 113.802 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.55 148.41 42.85 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 120.172 -1.58 . . . . 3.61 111.452 -171.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.51 165.02 9.37 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.473 3.449 . . . . 1.3 112.139 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.65 148.96 40.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.425 1.09 . . . . 1.95 110.013 166.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.45 134.43 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.323 1.449 . . . . 2.2 108.091 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -162.9 143.6 9.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.305 1.442 . . . . 5.58 109.21 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t0 53.21 41.38 32.14 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.358 0.981 . . . . 4.02 113.471 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 14.45 73.14 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.936 -0.925 . . . . 2.64 115.086 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.38 156.79 44.39 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.446 1.623 . . . . 3.24 111.717 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.09 138.98 44.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.377 0.88 . . . . 1.8 113.377 -170.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.83 134.06 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.265 1.426 . . . . 3.28 109.037 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.52 -48.47 10.19 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.263 1.579 . . . . 2.39 115.263 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.61 122.45 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 130.578 3.551 . . . . 2.71 107.412 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -154.45 -8.31 0.14 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.43 1.092 . . . . 6.79 113.849 -164.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.53 62.47 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 121.088 1.767 . . . . 1.52 113.048 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.0 -8.36 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.167 1.787 . . . . 1.01 114.708 167.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.4 -165.3 38.93 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 121.344 1.884 . . . . 2.58 113.035 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.69 179.35 53.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.27 0.938 . . . . 1.2 112.358 165.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . 0.291 0.2 OUTLIER -77.57 54.03 1.14 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.335 1.054 . . . . 2.67 113.655 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.9 tp 54.87 69.19 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.921 2.488 . . . . 1.71 111.484 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.45 65.52 11.76 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 129.0 2.92 . . . . 4.59 113.009 -162.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.88 -58.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.382 2.721 . . . . 2.11 113.436 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -137.7 125.96 23.15 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.29 1.036 . . . . 4.17 109.51 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -174.89 -95.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.553 1.541 . . . . 6.03 112.096 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 t 171.19 -23.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 128.713 2.805 . . . . 3.44 112.604 -169.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.78 -34.17 4.47 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 125.892 1.71 . . . . 2.79 111.646 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -52.25 144.64 12.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.409 1.1 . . . . 6.79 111.912 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -96.26 147.86 23.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.371 1.868 . . . . 2.03 111.326 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.1 131.6 45.72 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.529 -0.915 . . . . 4.39 108.529 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.19 -145.38 5.2 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.548 -1.14 . . . . 2.97 114.108 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.47 -18.89 22.46 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.302 2.668 . . . . 3.23 114.265 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -165.29 146.81 7.52 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.863 1.265 . . . . 5.51 110.834 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.88 -135.79 13.13 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.262 0.934 . . . . 3.86 111.917 -171.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -165.71 157.89 14.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.435 1.494 . . . . 6.15 109.451 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.18 -126.61 0.83 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.199 0.839 . . . . 2.66 115.199 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 145.4 25.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.47 1.508 . . . . 3.79 111.985 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.58 -11.31 57.5 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.16 1.17 . . . . 2.06 114.16 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.01 32.2 4.72 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.216 1.389 . . . . 1.04 114.858 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.97 131.64 56.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.008 1.323 . . . . 1.67 111.16 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.464 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 3.4 mp -142.32 159.46 58.12 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 125.646 1.579 . . . . 2.06 111.079 -162.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.11 152.0 56.08 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.942 2.428 . . . . 0.86 113.083 -169.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.32 130.95 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.343 1.457 . . . . 2.36 112.758 -162.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.33 88.43 2.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.019 2.928 . . . . 1.7 109.87 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.67 136.06 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.03 0.932 . . . . 0.8 110.587 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.87 138.99 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 127.418 2.287 . . . . 1.59 106.295 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.19 161.28 30.12 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.263 -0.898 . . . . 2.35 111.276 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -19.2 0.85 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.731 2.123 . . . . 2.63 116.731 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.84 1.89 55.4 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.487 2.315 . . . . 2.73 112.812 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.15 23.21 41.75 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 125.258 1.408 . . . . 0.86 114.462 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -123.49 131.8 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.334 1.054 . . . . 1.1 111.044 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.02 140.17 44.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.009 1.724 . . . . 0.92 111.604 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -140.91 -2.9 1.28 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.745 1.757 . . . . 1.57 115.745 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.3 111.85 3.71 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 114.791 1.404 . . . . 3.28 114.791 -165.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.23 101.89 1.18 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.014 2.476 . . . . 2.48 110.079 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.0 178.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.145 1.778 . . . . 2.3 110.203 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.0 m -146.92 142.48 27.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.675 0.79 . . . . 1.1 110.621 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.88 106.97 56.45 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.494 1.118 . . . . 0.84 110.422 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.61 7.44 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.663 2.909 . . . . 1.04 113.218 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -17.98 63.32 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.229 1.412 . . . . 5.6 113.425 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mp -152.82 155.77 37.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.862 3.265 . . . . 2.22 108.09 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.304 0.0 OUTLIER -147.94 43.35 1.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.545 2.054 . . . . 5.06 116.545 -173.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -175.99 147.36 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.638 1.975 . . . . 2.0 110.161 167.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.75 -28.42 68.69 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 1.65 111.717 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.16 -19.23 19.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.123 1.369 . . . . 3.36 114.301 173.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.72 -7.94 59.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.565 1.146 . . . . 2.06 112.496 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.27 0.78 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 114.912 1.449 . . . . 1.27 114.912 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -72.23 20.22 0.07 Allowed 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.682 2.105 . . . . 3.63 116.682 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -142.47 15.8 2.01 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.454 1.901 . . . . 3.01 111.322 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -128.91 175.84 8.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.581 1.552 . . . . 2.58 112.748 -164.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.15 149.11 39.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.563 1.145 . . . . 0.68 112.04 166.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 24' ' ' ILE . 44.2 mt -82.22 155.35 24.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.303 1.441 . . . . 2.18 109.056 158.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 30.4 ttm -149.45 122.88 9.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.395 . . . . 1.45 111.97 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -94.32 109.25 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.779 1.232 . . . . 0.72 108.658 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.4 147.9 22.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.415 2.286 . . . . 2.37 113.218 -167.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 t -67.88 -38.54 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.049 -1.032 . . . . 1.59 112.332 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.51 155.92 17.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.632 0.634 . . . . 1.22 111.619 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.71 165.6 28.69 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.374 0.988 . . . . 1.39 111.758 157.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -122.65 23.5 9.51 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.189 1.181 . . . . 2.64 114.189 -136.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -93.72 4.25 54.22 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 116.397 1.999 . . . . 2.88 116.397 -167.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -131.88 151.27 51.81 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.677 1.732 . . . . 3.88 115.677 -168.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.0 p -140.27 11.12 2.35 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.666 2.386 . . . . 3.16 112.89 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -118.65 14.7 13.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.219 1.408 . . . . 4.77 112.436 -145.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -121.31 163.17 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.758 2.823 . . . . 3.23 107.969 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.02 -10.12 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.828 2.352 . . . . 2.23 114.441 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.13 133.03 22.58 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.321 1.449 . . . . 5.59 109.757 165.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 165.9 31.35 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.64 2.893 . . . . 3.71 113.175 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 59.92 25.48 14.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.293 1.837 . . . . 5.08 111.647 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.59 13.72 59.14 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.989 -1.069 . . . . 2.82 114.04 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 106.14 -7.7 41.05 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.619 1.58 . . . . 1.77 113.984 -168.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.19 22.08 0.63 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 126.303 1.906 . . . . 1.55 115.887 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.86 74.68 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.364 1.459 . . . . 1.65 114.294 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.2 p -73.24 163.31 28.29 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.5 1.52 . . . . 1.65 110.921 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 145.02 30.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.768 1.227 . . . . 5.25 111.555 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -92.16 -34.02 14.49 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.996 0.919 . . . . 2.82 112.436 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.83 154.57 42.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.956 0.902 . . . . 0.6 113.116 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.3 t -138.9 153.71 48.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.405 2.282 . . . . 1.43 109.769 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.99 114.64 0.62 Allowed Glycine 0 N--CA 1.467 0.706 0 C-N-CA 124.088 0.851 . . . . 0.75 113.051 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.88 130.75 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.915 1.286 . . . . 1.82 110.514 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mp -76.4 132.81 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 1.28 109.54 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 118.492 -0.766 . . . . 4.67 112.954 -176.339 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 119.479 -0.296 . . . . 2.26 110.414 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -131.79 140.34 49.17 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.603 1.705 . . . . 1.23 115.603 -137.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.89 136.87 34.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.144 0.973 . . . . 2.56 111.569 161.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 98.16 11.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.624 1.17 . . . . 4.6 111.36 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.03 118.55 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 120.8 -1.188 . . . . 1.15 109.614 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.42 111.31 3.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.478 1.513 . . . . 1.15 112.013 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 mmt -84.24 124.52 31.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.772 1.229 . . . . 1.57 112.518 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -113.03 149.29 33.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.487 0.661 . . . . 2.35 111.008 164.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -56.99 140.13 49.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.431 1.092 . . . . 1.28 109.635 171.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.36 147.28 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.43 0.559 . . . . 1.6 111.479 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -167.97 49.51 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.822 0.849 . . . . 2.57 112.67 -168.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.42 -31.75 0.23 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.046 2.138 . . . . 1.63 114.316 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -2.37 10.74 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.34 0.973 . . . . 2.59 111.619 160.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.93 -140.01 16.71 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.671 1.129 . . . . 1.6 111.03 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.05 122.34 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.723 1.609 . . . . 1.19 111.165 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.57 -134.99 8.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 126.176 1.846 . . . . 1.74 113.25 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.84 146.24 35.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.16 1.384 . . . . 2.02 110.984 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 t -83.89 142.9 30.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 1.28 110.878 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.8 -0.24 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 114.617 1.34 . . . . 3.63 114.617 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.21 167.49 14.4 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.673 1.13 . . . . 0.83 111.843 -171.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 p -103.3 176.14 5.25 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.569 -0.9 . . . . 1.04 108.569 161.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -119.19 131.36 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.718 -1.586 . . . . 0.71 106.718 148.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -84.88 123.97 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.921 -0.4 . . . . 1.28 109.921 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.437 HD11 HD21 ' A' ' 125' ' ' LEU . 20.5 mt -98.32 117.91 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.177 -1.046 . . . . 1.37 108.177 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -119.43 107.96 13.97 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.514 1.526 . . . . 1.93 109.717 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.65 147.7 31.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.578 0.955 . . . . 3.93 113.578 -172.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -179.58 7.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.719 0.808 . . . . 1.58 110.96 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.16 -28.2 69.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.302 1.041 . . . . 3.78 111.842 174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.9 10.34 60.48 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.448 1.023 . . . . 1.03 114.657 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.7 -145.74 23.97 Favored Glycine 0 N--CA 1.461 0.342 0 C-N-CA 129.15 3.262 . . . . 0.85 114.895 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.6 95.19 7.09 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.916 0.886 . . . . 0.66 110.488 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -71.66 107.18 4.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.108 0.963 . . . . 2.51 109.856 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 t80 -99.9 105.46 17.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 117.254 -1.355 . . . . 0.58 108.716 -167.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.4 m -116.05 109.07 45.21 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.789 1.632 . . . . 0.97 109.216 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.63 151.76 17.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.888 3.059 . . . . 0.61 111.654 -176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -141.53 23.68 2.12 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.555 0.693 . . . . 1.45 112.599 171.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -80.11 157.7 26.58 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 126.644 1.978 . . . . 0.8 113.872 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.29 170.31 16.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.661 -1.609 . . . . 3.19 109.831 165.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.81 22.93 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.607 2.763 . . . . 1.42 112.92 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -99.85 160.82 26.25 Favored Pre-proline 0 CA--C 1.51 -0.591 0 C-N-CA 123.472 0.709 . . . . 1.62 111.56 176.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 34.0 Cg_endo -63.15 127.44 20.22 Favored 'Trans proline' 0 N--CA 1.426 -2.456 0 O-C-N 123.531 1.28 . . . . 0.91 110.482 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 4.8 Cg_endo -88.8 31.78 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.51 3.474 . . . . 1.44 112.654 -144.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.37 -120.94 4.84 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 126.22 1.866 . . . . 1.87 113.405 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.32 145.07 48.26 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.971 2.108 . . . . 2.44 109.643 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.58 144.01 41.8 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 124.052 0.941 . . . . 0.93 111.409 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.95 165.57 37.86 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.136 -0.978 . . . . 0.85 111.215 168.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -146.55 126.9 13.97 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.358 -1.349 . . . . 2.12 107.358 169.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -122.81 167.23 13.78 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.466 1.284 . . . . 1.13 114.466 163.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.441 ' CG2' HD12 ' A' ' 74' ' ' LEU . 62.7 mt -85.24 148.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.132 0.973 . . . . 0.9 108.836 151.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.38 153.74 41.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.822 2.049 . . . . 1.03 108.318 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.72 72.67 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.97 1.841 . . . . 1.23 115.97 -159.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.23 -179.59 5.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.43 1.892 . . . . 1.7 112.035 -170.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.41 125.78 7.13 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.548 -1.14 . . . . 2.09 111.497 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 m 142.73 101.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 130.569 3.548 . . . . 2.24 112.526 164.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 61.1 m -63.82 23.18 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 127.56 2.344 . . . . 1.3 115.709 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.08 130.18 33.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.528 -1.982 . . . . 3.27 110.737 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.29 157.9 14.88 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.225 3.283 . . . . 0.96 111.544 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.57 174.49 7.73 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 1.63 111.399 159.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.72 138.43 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.134 1.374 . . . . 2.42 107.967 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.29 -124.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.182 0.593 . . . . 7.04 111.378 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.87 -31.32 66.59 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.901 1.68 . . . . 5.06 115.353 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 44.17 0.02 OUTLIER Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.135 0.874 . . . . 2.88 112.164 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 172.71 158.41 0.11 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.306 2.642 . . . . 3.72 109.281 -164.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.6 141.89 47.17 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.131 1.16 . . . . 1.56 114.131 -161.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.18 61.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.58 1.552 . . . . 1.82 111.651 -167.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.99 -72.2 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 127.431 2.292 . . . . 1.72 115.498 166.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.93 106.6 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 1 C-N-CA 132.906 4.482 . . . . 1.64 105.575 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -115.54 -46.49 2.86 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.378 1.071 . . . . 3.96 113.62 -155.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.62 -13.51 62.14 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.2 1.185 . . . . 1.38 114.2 -171.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -12.74 61.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.729 2.012 . . . . 1.22 113.664 167.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.33 169.4 44.23 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.789 -1.194 . . . . 2.95 112.638 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.69 -161.93 8.84 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.941 -0.864 . . . . 1.59 110.941 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -42.81 141.33 1.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.601 -0.518 . . . . 2.47 109.601 160.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -65.11 74.61 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.546 1.538 . . . . 3.04 112.529 -170.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -132.73 58.81 38.66 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 126.717 2.007 . . . . 4.06 112.681 -160.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.51 -37.56 29.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.062 1.841 . . . . 2.84 110.411 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -149.0 146.93 28.01 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.62 2.768 . . . . 4.29 105.805 162.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 p30 166.34 -47.42 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.115 2.166 . . . . 4.38 114.327 168.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 t 172.74 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.428 2.691 . . . . 2.87 111.425 -167.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.47 22.19 51.74 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 123.782 0.706 . . . . 2.21 114.135 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -160.29 -116.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.963 1.305 . . . . 4.38 113.438 -167.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.456 ' CE1' ' CG ' ' A' ' 93' ' ' ASP . 2.8 t60 -160.05 145.24 15.09 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 119.833 -1.792 . . . . 1.85 114.988 -170.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.65 -129.83 0.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.555 1.542 . . . . 4.29 111.164 170.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.55 -88.75 0.4 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.627 1.584 . . . . 3.14 110.964 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -33.56 6.47 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.186 2.591 . . . . 4.03 112.636 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.23 129.48 31.64 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.284 1.434 . . . . 5.56 107.95 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.41 64.04 2.91 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 125.249 1.404 . . . . 2.88 115.641 -158.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.09 98.71 11.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.996 0.918 . . . . 4.88 112.92 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.99 -72.3 2.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 116.025 1.17 . . . . 4.02 116.025 155.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -75.09 93.24 2.73 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.314 1.057 . . . . 4.66 113.132 -164.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.78 64.03 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.926 1.454 . . . . 3.23 114.926 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.7 -0.13 89.85 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.965 1.269 . . . . 1.67 114.644 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' CG ' ' CE1' ' A' ' 82' ' ' HIS . 37.7 m-20 -67.03 134.25 51.54 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 118.297 1.048 . . . . 2.81 108.651 161.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.28 168.25 11.66 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.096 0.958 . . . . 2.28 111.515 -149.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.12 165.23 28.39 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.279 2.653 . . . . 1.16 112.682 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -85.63 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 122.824 1.297 . . . . 2.0 112.983 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.59 97.3 2.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.309 3.444 . . . . 1.76 109.832 172.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.36 139.15 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.333 1.053 . . . . 1.61 111.37 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.44 140.86 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.039 2.135 . . . . 1.56 107.453 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.93 160.94 21.98 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.364 -0.835 . . . . 2.91 112.024 174.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -20.38 4.44 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 115.539 1.681 . . . . 2.86 115.539 -174.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -85.25 4.48 34.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.361 1.864 . . . . 3.34 113.528 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.85 56.69 Favored Glycine 0 N--CA 1.47 0.93 0 C-N-CA 124.588 1.09 . . . . 0.9 114.19 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.57 135.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.288 1.835 . . . . 1.18 109.513 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 149.58 24.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.698 1.199 . . . . 0.99 110.953 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.8 t -159.55 -34.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.672 0.989 . . . . 1.34 113.672 -166.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.69 122.33 85.46 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.111 1.364 . . . . 3.77 111.64 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.18 136.72 16.43 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.91 2.406 . . . . 1.42 111.441 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.27 74.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 122.976 1.37 . . . . 2.29 112.096 -167.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.2 m -57.07 137.67 55.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.538 2.335 . . . . 1.16 113.022 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.56 98.04 22.36 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.757 1.223 . . . . 0.75 111.34 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.63 3.68 5.21 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.29 3.326 . . . . 1.12 113.938 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -76.99 -16.27 59.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.287 1.435 . . . . 4.14 112.383 -176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.46 -179.52 4.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.985 2.114 . . . . 2.14 107.704 166.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -53.77 2.68 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.32 -0.862 . . . . 3.91 111.673 167.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -127.37 163.44 24.0 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.175 1.546 . . . . 2.17 115.175 -149.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tp -74.22 -34.99 63.85 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.595 -1.316 . . . . 2.15 111.977 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.42 -35.86 65.85 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.123 1.369 . . . . 3.41 113.698 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.33 -3.13 38.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.405 1.261 . . . . 1.63 114.405 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.48 7.94 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.483 1.038 . . . . 0.91 113.447 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.07 -10.67 4.56 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.278 1.955 . . . . 2.98 116.278 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -147.03 18.9 1.25 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.614 1.965 . . . . 3.52 111.537 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -101.45 -160.36 0.79 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.405 1.482 . . . . 1.55 112.274 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.47 160.71 39.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.081 1.352 . . . . 0.79 112.332 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 24' ' ' ILE . 19.8 mt -113.62 149.69 34.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.3 2.64 . . . . 1.9 108.093 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.5 mtt -137.59 128.13 26.67 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.524 1.056 . . . . 1.48 111.264 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.82 108.53 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.794 -1.187 . . . . 0.88 107.794 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -86.93 144.21 27.05 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.881 1.672 . . . . 2.29 113.142 -165.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.57 -43.6 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.099 -1.0 . . . . 1.26 112.035 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.38 172.0 25.98 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.914 -0.874 . . . . 1.08 110.914 162.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.53 160.85 6.13 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.063 1.316 . . . . 1.42 112.587 165.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -40.38 94.98 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.76 1.224 . . . . 3.46 114.14 -169.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.27 36.96 0.16 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 117.586 2.439 . . . . 2.85 117.586 -151.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -108.46 148.19 30.56 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.562 1.545 . . . . 2.64 112.372 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -149.48 -141.01 0.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.115 0.966 . . . . 3.51 111.125 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.36 111.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.677 2.391 . . . . 5.56 114.954 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -154.3 160.99 30.35 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.706 2.002 . . . . 3.29 109.461 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.78 12.51 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 124.522 3.482 . . . . 4.08 114.747 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -132.36 140.81 39.11 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.519 1.528 . . . . 5.44 110.151 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.47 151.61 82.0 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.983 3.122 . . . . 5.53 112.955 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.63 21.19 6.97 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.956 1.702 . . . . 4.99 113.415 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.93 80.81 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.531 1.062 . . . . 3.67 113.62 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.97 -48.66 3.05 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.454 1.502 . . . . 2.05 113.029 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.37 18.84 5.12 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.189 1.852 . . . . 1.71 114.956 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.28 -19.82 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.995 1.283 . . . . 1.6 114.098 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.7 p -66.31 145.41 55.76 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.683 1.593 . . . . 1.44 111.714 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.17 136.81 48.62 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.309 1.444 . . . . 4.69 110.276 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 27.1 t80 -75.63 -37.06 60.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 2.15 110.411 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.31 152.21 41.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.497 1.119 . . . . 0.74 112.861 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 52.1 t -121.42 147.79 45.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.792 2.037 . . . . 1.63 109.866 171.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -138.93 91.38 0.2 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.01 1.767 . . . . 0.83 111.704 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.29 135.13 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.918 1.287 . . . . 2.77 111.587 166.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mt -97.03 151.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 1.62 109.93 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 11.3 mmpt? . . . . . 0 N--CA 1.471 0.581 0 O-C-N 121.382 -0.824 . . . . 5.0 110.708 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.138 -0.69 . . . . 1.88 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 m -114.79 131.02 56.94 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.221 1.373 . . . . 1.3 112.897 -153.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.76 141.53 48.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.624 2.37 . . . . 2.96 107.191 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -120.47 86.3 2.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.937 -1.102 . . . . 3.32 110.82 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.11 118.68 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 121.6 -0.687 . . . . 1.02 109.672 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.92 104.01 1.02 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.142 1.354 . . . . 0.75 109.953 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 mtp -97.84 137.92 35.97 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.154 0.982 . . . . 1.35 110.735 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -129.38 147.35 51.19 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.922 0.889 . . . . 3.02 112.092 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.14 142.93 56.35 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.127 1.371 . . . . 1.48 109.58 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 m -142.13 161.44 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.316 1.046 . . . . 1.43 112.851 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t 155.65 124.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.756 2.822 . . . . 3.07 111.423 144.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.57 -37.69 0.38 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.439 2.696 . . . . 1.97 115.516 164.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -7.87 56.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.585 1.554 . . . . 4.3 111.367 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -149.48 18.1 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 125.478 1.513 . . . . 1.44 112.386 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.05 130.79 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.65 1.58 . . . . 1.53 110.558 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.8 -134.48 8.54 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 125.68 1.609 . . . . 2.33 113.351 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.83 153.49 24.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.162 2.185 . . . . 2.75 112.153 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 t -94.49 139.01 31.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.419 0.628 . . . . 1.32 112.02 167.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.7 10.63 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.764 1.626 . . . . 2.94 112.385 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 154.18 146.69 4.46 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.722 1.63 . . . . 0.62 111.265 -166.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.5 p -88.87 174.52 7.9 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.184 -1.043 . . . . 0.97 108.184 158.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.5 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 99.0 t -127.42 129.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.622 -1.251 . . . . 0.7 107.622 165.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.4 p -82.83 129.25 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.534 0.683 . . . . 1.08 109.824 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.46 109.88 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.501 -1.666 . . . . 1.35 106.501 169.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -116.0 108.28 16.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 123.098 1.427 . . . . 2.53 110.741 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.06 142.83 56.36 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 127.476 2.31 . . . . 4.14 111.707 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -154.7 177.01 11.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.535 1.16 . . . . 1.2 111.392 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.55 -25.24 66.01 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.991 0.916 . . . . 4.25 110.661 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.18 14.89 61.04 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.426 1.489 . . . . 0.98 115.949 166.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.03 -164.39 51.46 Favored Glycine 0 N--CA 1.47 0.929 0 C-N-CA 129.74 3.543 . . . . 0.89 115.095 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.35 104.56 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.445 1.498 . . . . 0.65 112.145 -168.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -82.37 104.16 12.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.159 0.983 . . . . 1.83 109.805 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.5 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 11.1 t80 -91.8 110.02 21.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.017 2.127 . . . . 0.73 109.567 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.407 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 12.0 m -122.32 115.04 30.21 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.836 1.198 . . . . 0.88 108.563 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.93 164.44 27.5 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.101 2.534 . . . . 0.58 110.867 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -160.03 51.39 0.32 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.316 1.055 . . . . 2.16 111.288 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 150.86 32.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.069 1.348 . . . . 0.74 112.013 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.27 38.39 3.13 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.221 1.934 . . . . 2.11 116.221 -160.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.76 12.0 0.59 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 116.483 2.031 . . . . 1.6 116.483 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.94 160.71 25.37 Favored Pre-proline 0 N--CA 1.477 0.896 0 N-CA-C 114.186 1.18 . . . . 1.35 114.186 -169.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.93 130.87 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.328 1.352 . . . . 0.82 112.708 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.66 48.08 2.07 Favored 'Trans proline' 0 C--N 1.35 0.653 1 C-N-CA 126.957 5.105 . . . . 0.97 112.755 -158.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.94 -140.09 7.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.414 1.563 . . . . 1.23 113.287 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.04 134.51 53.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.821 1.648 . . . . 2.84 108.534 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -139.88 125.21 18.94 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 125.157 1.383 . . . . 1.27 111.017 -162.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.79 154.78 9.11 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.642 -1.286 . . . . 0.52 112.457 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.38 127.51 29.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.958 1.303 . . . . 1.93 107.719 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.442 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 50.3 m170 -121.92 169.77 10.47 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 117.027 2.232 . . . . 1.04 117.027 168.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.16 138.79 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.508 1.923 . . . . 0.74 109.254 152.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.14 164.94 16.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.217 2.607 . . . . 0.99 110.602 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.86 -62.79 1.42 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.697 1.369 . . . . 1.47 114.697 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 -97.6 146.93 24.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.652 0.612 . . . . 1.59 112.652 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.74 62.83 2.38 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.634 1.111 . . . . 0.88 112.322 168.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -149.73 77.73 1.34 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.72 1.208 . . . . 2.66 112.589 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.0 m -64.16 9.42 0.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 116.331 1.974 . . . . 1.32 116.331 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -72.44 151.71 91.87 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 119.743 -1.848 . . . . 3.69 112.53 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.0 152.15 67.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.257 2.638 . . . . 1.77 111.316 171.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.68 147.79 22.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.546 0.738 . . . . 3.2 110.914 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mm -86.45 104.64 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.528 -0.916 . . . . 4.71 108.528 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -162.34 138.96 7.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.265 1.026 . . . . 7.67 109.909 -157.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t0 51.27 35.79 14.48 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 6.45 113.85 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.61 11.0 85.88 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.527 -1.151 . . . . 3.91 115.323 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -150.31 169.3 21.71 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.07 1.935 . . . . 3.07 113.24 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.77 94.95 8.81 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.838 0.855 . . . . 2.3 109.873 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.54 88.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.746 0.818 . . . . 2.93 111.593 -170.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 55.69 -86.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.245 2.618 . . . . 2.06 115.025 159.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.73 99.04 0.31 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.748 2.819 . . . . 2.72 107.253 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -149.34 -17.46 0.28 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.284 1.216 . . . . 7.02 114.284 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.04 -9.22 4.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.661 1.184 . . . . 1.72 113.55 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 2.65 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.185 2.194 . . . . 0.92 113.671 164.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 16.29 26.93 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.563 1.554 . . . . 3.04 114.255 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -114.6 4.86 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.248 -1.541 . . . . 3.23 109.248 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -97.35 -101.67 0.19 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.983 1.313 . . . . 3.86 107.652 158.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.9 tp -160.95 79.45 0.61 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.228 2.211 . . . . 1.96 106.759 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.74 68.97 63.07 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.772 -1.104 . . . . 4.98 111.111 -152.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.04 -44.93 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.821 2.347 . . . . 2.02 113.6 -168.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -154.87 -151.71 0.37 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.287 1.835 . . . . 4.65 108.916 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 75.23 -60.82 0.5 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.551 2.74 . . . . 4.43 112.84 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 177.29 -19.45 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.927 2.491 . . . . 2.57 113.328 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.73 49.17 76.46 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.039 1.29 . . . . 2.88 114.896 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -143.96 18.29 1.78 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.662 1.727 . . . . 4.66 115.662 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.8 t60 90.05 173.24 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.52 2.328 . . . . 2.73 112.871 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -162.1 51.91 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.897 1.279 . . . . 4.88 110.136 -161.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.01 -47.95 1.29 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-O 117.973 -1.459 . . . . 2.81 114.997 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -103.43 -23.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.179 3.253 . . . . 4.27 113.831 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.97 172.99 1.57 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.793 2.437 . . . . 5.75 108.758 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.19 -159.05 32.13 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.064 0.84 . . . . 3.89 113.516 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -153.52 28.71 0.49 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 6.47 112.245 -168.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.18 16.65 60.87 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.105 -2.497 . . . . 3.53 117.698 -165.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.531 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 2.6 t-160 170.06 99.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 128.396 2.678 . . . . 5.05 111.059 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.49 2.79 2.78 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.578 1.696 . . . . 2.02 115.578 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.531 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -102.42 3.97 50.83 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.322 1.439 . . . . 0.81 113.459 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' OD1' ' CE1' ' A' ' 90' ' ' HIS . 64.3 m-20 -71.93 137.09 47.12 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.525 1.162 . . . . 1.66 109.619 165.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.86 169.04 11.06 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.762 1.225 . . . . 1.88 109.915 -144.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.52 157.8 55.36 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.714 2.276 . . . . 1.03 111.866 -172.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.8 125.23 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.227 1.011 . . . . 2.42 109.85 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.39 114.34 3.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 128.365 2.666 . . . . 2.54 109.872 168.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.87 143.32 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 120.966 -1.083 . . . . 0.92 108.628 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -123.2 124.61 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 106.261 -1.755 . . . . 1.7 106.261 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.7 152.91 41.21 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.06 0.845 . . . . 1.89 111.933 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -4.24 0.05 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 117.539 2.422 . . . . 2.23 117.539 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.06 4.42 10.89 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.793 1.637 . . . . 3.03 114.016 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.52 16.51 17.68 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 116.226 1.25 . . . . 0.74 116.226 166.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.65 134.08 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.128 1.371 . . . . 1.11 107.932 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.22 120.68 40.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.331 0.652 . . . . 0.69 109.352 168.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -132.21 2.81 3.94 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.135 1.774 . . . . 1.22 112.745 172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -82.89 117.76 69.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.687 1.995 . . . . 5.1 111.983 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.33 147.27 18.05 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.475 2.783 . . . . 1.25 113.473 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.29 176.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.515 1.926 . . . . 1.17 109.83 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.8 m -139.73 140.83 36.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.069 0.947 . . . . 0.66 110.142 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.72 91.48 6.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.24 1.016 . . . . 0.73 110.56 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.29 -8.92 24.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.818 3.012 . . . . 1.46 115.006 -174.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -58.96 -29.17 66.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.178 1.391 . . . . 4.16 113.751 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.52 164.98 11.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.131 1.772 . . . . 2.29 110.389 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.95 24.6 0.5 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.596 1.558 . . . . 4.13 114.109 -170.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -178.57 148.5 0.45 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.441 2.296 . . . . 1.81 112.507 170.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.75 -27.5 69.32 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.53 -1.356 . . . . 1.58 111.269 166.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.44 -16.14 0.32 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.299 2.24 . . . . 2.82 114.062 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -9.24 40.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.366 1.466 . . . . 1.93 113.733 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.5 m -130.19 11.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.552 1.541 . . . . 1.07 113.134 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -62.59 -3.36 1.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.494 2.405 . . . . 2.54 117.494 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.27 29.93 0.78 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.358 1.863 . . . . 2.97 110.726 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -121.82 175.02 6.5 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.825 1.65 . . . . 1.42 113.038 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.01 149.2 43.03 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.501 1.12 . . . . 0.56 111.782 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.43 170.42 16.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.041 1.336 . . . . 2.36 109.241 158.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 44.9 ttm -151.19 124.96 9.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.37 -0.831 . . . . 2.31 111.454 163.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.5 120.98 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.164 -1.05 . . . . 0.91 108.164 167.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -105.13 148.49 26.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.869 2.068 . . . . 1.9 112.007 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.35 -25.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.718 -1.239 . . . . 1.19 113.209 -162.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -129.28 162.55 22.64 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.135 0.874 . . . . 1.05 111.55 168.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.82 144.94 47.56 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.357 0.98 . . . . 1.58 113.081 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.442 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 37.6 t70 -97.95 -8.86 27.19 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.992 1.849 . . . . 2.66 115.992 -147.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -59.96 -25.61 65.34 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.939 1.296 . . . . 3.87 113.407 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 76.4 mtm -82.11 61.64 5.47 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 3.39 113.899 -167.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.6 p -91.82 -147.47 0.22 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.655 -1.278 . . . . 3.4 110.846 156.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t0 58.35 42.25 21.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.456 1.502 . . . . 4.56 112.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.92 156.51 5.96 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.509 1.924 . . . . 3.49 109.64 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.25 -19.2 22.73 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.116 2.544 . . . . 2.78 114.327 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.59 119.91 76.79 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.216 1.371 . . . . 7.97 109.903 167.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.85 118.8 5.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.504 2.136 . . . . 4.45 110.179 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 56.64 27.12 12.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.182 1.393 . . . . 4.1 112.186 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.07 17.52 63.56 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 121.042 -1.036 . . . . 3.51 113.333 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.07 3.78 75.7 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.6 1.571 . . . . 2.98 114.367 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.28 -5.91 75.35 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.252 1.526 . . . . 2.02 114.845 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.43 -12.0 80.04 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.235 1.398 . . . . 1.68 115.326 -170.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.67 161.6 5.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.069 1.348 . . . . 1.64 110.152 164.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 136.15 40.31 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 4.57 112.65 -169.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -101.04 -25.63 13.99 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.261 1.424 . . . . 2.46 113.294 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.73 144.09 22.31 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.466 2.024 . . . . 0.71 116.466 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.76 170.29 14.92 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.209 3.403 . . . . 2.88 112.186 165.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 179.94 83.15 0.06 OUTLIER Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.884 1.706 . . . . 0.71 112.41 166.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.94 130.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 118.026 0.913 . . . . 1.43 110.704 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 27.3 mt -102.9 140.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.52 1.528 . . . . 1.31 111.377 -169.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 mptt . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 124.774 1.23 . . . . 3.41 108.733 161.581 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 119.424 -0.322 . . . . 2.2 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.73 154.39 33.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 118.984 -2.323 . . . . 1.16 116.995 -141.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.07 138.97 18.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.68 -1.6 . . . . 3.43 111.328 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.81 113.82 27.08 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.803 -1.186 . . . . 4.58 112.03 176.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.8 t -88.63 118.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.551 -0.537 . . . . 1.17 109.551 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.34 103.09 2.36 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.152 1.358 . . . . 1.11 110.323 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 41.8 mtt -81.85 148.83 28.62 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.439 0.904 . . . . 1.21 113.439 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -114.23 151.52 32.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 2.47 110.134 167.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 mt -64.49 144.44 57.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.853 0.861 . . . . 1.17 109.112 171.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 m -133.69 149.32 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.2 0.6 . . . . 1.05 111.36 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -174.55 53.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.143 0.977 . . . . 2.37 112.53 -168.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.49 -14.21 0.42 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.051 1.74 . . . . 1.13 115.094 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.15 -9.9 58.97 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.363 -0.836 . . . . 3.3 110.994 160.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -129.69 9.39 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.517 -1.433 . . . . 1.03 109.517 -163.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.7 t -74.33 126.9 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.925 1.69 . . . . 0.81 111.299 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.34 -135.53 8.93 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.066 1.793 . . . . 1.45 112.554 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.93 164.11 12.86 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.983 -0.716 . . . . 1.78 111.784 173.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.0 t -100.1 152.0 20.74 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.309 1.044 . . . . 0.95 112.757 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.428 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 1.4 pp -144.21 4.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 128.178 2.591 . . . . 2.86 113.495 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.53 170.69 27.71 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.205 1.383 . . . . 0.68 114.266 172.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -109.74 177.66 4.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.989 1.316 . . . . 0.87 109.889 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.83 131.84 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.736 -1.209 . . . . 0.41 107.736 158.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 9.0 p -85.89 123.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 123.579 0.549 . . . . 0.87 110.377 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mt -105.38 126.08 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 125.858 1.663 . . . . 1.4 107.884 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -135.5 107.62 7.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.413 1.085 . . . . 2.08 109.958 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -74.07 144.08 45.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.613 0.765 . . . . 3.6 112.043 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -159.94 -174.58 4.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.708 1.203 . . . . 1.28 109.751 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.34 -26.51 65.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.627 1.571 . . . . 3.17 112.75 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.94 13.86 65.81 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 124.851 1.215 . . . . 0.92 114.754 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.95 -147.02 32.94 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 127.396 2.427 . . . . 0.74 114.399 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.4 mt -76.26 99.46 4.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.986 0.915 . . . . 0.59 112.017 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -77.69 114.16 16.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.13 1.372 . . . . 2.13 110.397 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.73 116.79 32.63 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.485 2.314 . . . . 0.63 109.896 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.9 m -122.49 115.17 29.93 Favored Pre-proline 0 N--CA 1.477 0.875 0 CA-C-O 118.278 -0.868 . . . . 0.57 108.755 176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.22 162.86 4.67 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.91 3.073 . . . . 0.41 112.007 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -151.32 33.31 0.57 Allowed 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.12 0.962 . . . . 1.43 112.606 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -95.75 150.05 20.82 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.911 1.684 . . . . 0.73 113.903 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.5 162.37 24.13 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.516 1.526 . . . . 3.09 109.217 174.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.28 21.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.933 2.893 . . . . 1.86 113.789 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -106.57 155.87 38.1 Favored Pre-proline 0 CA--C 1.51 -0.576 0 C-N-CA 123.857 0.863 . . . . 2.06 112.442 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.56 140.36 47.28 Favored 'Trans proline' 0 N--CA 1.427 -2.385 0 O-C-N 123.269 1.142 . . . . 1.14 111.625 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 99' ' ' VAL . 12.2 Cg_endo -88.26 32.01 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.839 2.359 . . . . 1.34 114.568 -148.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 99' ' ' VAL . . . -106.89 -147.35 14.02 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 122.532 1.073 . . . . 1.19 113.912 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -81.57 131.51 35.28 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.964 -1.315 . . . . 2.53 110.592 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -102.66 135.53 44.14 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.243 -1.021 . . . . 1.76 108.243 164.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.55 161.7 21.58 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.852 -0.899 . . . . 0.83 110.852 166.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -146.84 122.34 10.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.915 -1.143 . . . . 2.04 107.915 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -126.8 167.65 15.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.207 1.188 . . . . 0.96 114.207 159.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.32 145.66 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.08 1.352 . . . . 1.45 107.721 152.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -123.92 158.64 31.51 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.202 1.401 . . . . 0.85 110.969 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.42 69.03 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.465 1.654 . . . . 0.66 115.465 -163.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -126.48 -174.58 3.16 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.357 1.463 . . . . 1.15 112.195 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.97 30.52 5.03 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 117.776 1.87 . . . . 1.27 117.776 -156.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.6 m -159.06 114.4 2.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 121.692 2.746 . . . . 2.47 115.0 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.3 m -68.83 76.93 0.31 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.385 1.564 . . . . 2.74 112.644 167.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -116.56 134.38 22.89 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 124.981 1.312 . . . . 3.82 109.134 167.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.11 144.63 21.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.293 2.662 . . . . 1.14 110.18 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.91 131.51 42.31 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.08 -0.711 . . . . 1.49 109.08 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.4 mm -99.15 110.0 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.952 -1.129 . . . . 3.51 107.952 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -166.81 154.51 9.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 6.65 111.003 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t70 41.31 54.86 3.45 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.527 1.531 . . . . 4.2 114.853 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.11 87.75 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.722 -1.599 . . . . 2.69 115.653 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -153.67 171.89 18.12 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.462 2.131 . . . . 2.7 114.161 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 114.59 26.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.215 1.406 . . . . 2.12 109.565 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.33 74.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.482 1.113 . . . . 1.93 111.02 -172.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.7 -73.51 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.257 2.623 . . . . 2.17 116.328 161.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.78 69.23 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 130.801 3.64 . . . . 1.84 107.308 -165.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.26 -42.51 14.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.302 1.441 . . . . 4.5 112.236 -165.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.17 5.99 1.46 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.866 1.432 . . . . 1.31 114.866 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.74 66.1 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.362 1.065 . . . . 1.02 112.526 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.23 -175.42 51.28 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 119.497 1.044 . . . . 2.36 113.066 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.2 170.43 37.95 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.805 1.193 . . . . 1.32 113.298 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.618 ' CD2' ' H ' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -78.22 38.67 0.29 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.036 2.134 . . . . 3.28 112.385 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.4 tp 56.73 72.59 0.5 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.132 2.573 . . . . 1.64 110.213 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 39.2 p-10 -153.14 5.95 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 118.17 2.656 . . . . 4.54 118.17 -140.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 68.3 Cg_endo -70.39 -26.72 24.3 Favored 'Trans proline' 0 C--N 1.358 1.063 0 CA-C-N 123.906 2.431 . . . . 3.18 116.151 -162.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.67 138.14 19.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.4 1.454 . . . . 2.93 111.043 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 p30 161.61 -159.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 129.676 3.19 . . . . 4.73 109.381 -161.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 t -72.74 -14.12 61.48 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 114.625 1.342 . . . . 4.62 114.625 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.83 -58.38 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.946 1.26 . . . . 3.58 113.124 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttt -69.32 163.89 24.09 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.963 1.381 . . . . 6.25 113.754 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.34 137.31 55.94 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.201 -0.937 . . . . 1.53 111.252 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -76.17 156.04 34.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.153 0.581 . . . . 3.5 112.064 -170.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.2 -157.15 27.13 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.178 1.371 . . . . 2.6 112.149 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.14 -23.8 28.67 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.169 2.58 . . . . 4.29 111.938 172.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -153.59 176.43 12.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.873 2.069 . . . . 7.91 108.626 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.43 -126.63 7.97 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.074 -1.21 . . . . 3.38 110.074 -165.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -165.95 157.16 13.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.006 0.903 . . . . 4.75 110.133 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . 166.31 -137.13 4.49 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.833 2.635 . . . . 2.69 110.669 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -90.9 136.03 33.34 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.781 -0.835 . . . . 4.39 112.378 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.53 -33.25 75.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.44 -0.788 . . . . 1.87 113.064 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.52 6.13 83.02 Favored Glycine 0 N--CA 1.474 1.18 0 N-CA-C 115.717 1.047 . . . . 0.79 115.717 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -67.98 130.18 42.17 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 118.772 1.286 . . . . 1.8 109.075 161.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.82 161.93 40.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.477 1.511 . . . . 1.89 110.327 -151.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.31 144.86 20.92 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.427 2.751 . . . . 0.99 111.63 -168.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.18 132.45 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.612 1.196 . . . . 1.47 113.533 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.87 81.76 1.65 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.807 2.443 . . . . 1.67 109.37 169.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.87 131.78 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.421 -0.799 . . . . 1.16 109.657 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.6 HG23 ' HA ' ' A' ' 42' ' ' PRO . 19.1 m -111.51 153.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.253 1.021 . . . . 2.04 108.48 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.04 159.36 33.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.732 -0.605 . . . . 2.04 111.93 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -49.09 -19.32 0.41 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.173 2.189 . . . . 3.88 115.865 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.12 8.1 32.02 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 127.83 2.452 . . . . 4.58 112.117 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.48 23.81 15.51 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 117.582 1.793 . . . . 1.16 117.582 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -139.55 134.98 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.961 1.305 . . . . 1.21 111.29 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.85 118.65 26.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.306 2.242 . . . . 0.76 110.786 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 t -146.94 -3.88 0.57 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.266 1.209 . . . . 1.4 114.266 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -81.73 118.61 72.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.335 1.454 . . . . 3.29 112.219 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.79 125.82 11.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.262 3.308 . . . . 1.11 110.227 170.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 175.11 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.581 1.552 . . . . 1.22 109.946 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 m -148.4 140.04 23.65 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.303 0.956 . . . . 0.7 110.049 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.23 96.12 29.09 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.55 1.14 . . . . 0.73 111.636 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.32 7.87 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.254 3.303 . . . . 1.15 114.391 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -81.72 -23.65 36.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.32 1.448 . . . . 4.12 111.6 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.81 139.32 48.85 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.881 1.673 . . . . 2.47 107.863 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -107.1 -21.29 13.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 115.204 1.557 . . . . 3.74 115.204 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.5 t -152.96 155.07 36.27 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.942 1.246 . . . . 1.9 114.005 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -57.39 -32.3 66.68 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.131 0.572 . . . . 1.57 112.433 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -64.08 -14.66 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.03 1.493 . . . . 3.26 115.03 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -72.49 -20.28 61.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.217 0.917 . . . . 2.11 112.252 167.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.43 10.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.223 1.409 . . . . 0.81 113.96 -163.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -46.39 -20.84 0.13 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.02 2.928 . . . . 4.29 116.578 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -117.92 9.11 12.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.201 2.6 . . . . 4.58 113.221 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.5 168.14 12.97 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.493 1.294 . . . . 1.2 114.493 -160.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.82 158.31 24.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.997 1.319 . . . . 1.04 111.565 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.08 150.86 39.29 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.664 1.586 . . . . 1.76 108.967 172.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.28 139.64 50.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.063 0.764 . . . . 2.24 113.063 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.75 104.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.936 -1.505 . . . . 0.9 106.936 159.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.93 150.05 34.1 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.929 2.091 . . . . 1.85 111.65 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.67 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.859 -1.151 . . . . 1.71 112.648 -163.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.7 170.97 14.97 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.119 1.342 . . . . 1.59 111.187 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.49 151.03 50.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.576 1.084 . . . . 1.79 113.072 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.16 -21.43 11.93 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.094 1.516 . . . . 3.2 115.094 -152.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -75.44 8.52 2.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.468 1.655 . . . . 3.3 115.468 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.2 mtm -81.22 55.54 2.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.976 1.311 . . . . 3.22 111.197 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -81.79 33.98 0.39 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.962 2.505 . . . . 3.94 115.211 -163.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.19 19.37 7.61 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.665 1.586 . . . . 5.91 113.033 -163.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -147.47 154.61 45.29 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.927 1.691 . . . . 3.5 110.525 -167.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.09 7.29 2.14 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.046 3.164 . . . . 2.62 114.241 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 139' ' ' LYS . 8.7 mmpt? -107.12 99.77 28.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.021 1.328 . . . . 5.29 108.666 169.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.92 166.69 26.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.234 2.623 . . . . 3.19 111.949 -170.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt 64.83 27.18 12.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.269 1.428 . . . . 3.71 111.878 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.7 1.62 31.91 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.741 1.639 . . . . 3.39 114.7 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.49 -15.18 60.76 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.778 1.18 . . . . 2.27 113.063 -162.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.96 24.8 3.23 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.198 1.856 . . . . 1.66 113.678 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.62 -15.98 73.69 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.116 1.341 . . . . 1.42 115.246 -169.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 p -69.01 147.39 51.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.554 1.177 . . . . 1.62 110.035 167.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 131.93 47.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 4.41 109.818 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -81.94 -44.13 17.17 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.214 0.605 . . . . 2.31 109.554 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.29 155.76 45.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.294 1.038 . . . . 0.67 112.717 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 41.0 t -143.52 151.23 40.01 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.136 2.175 . . . . 1.29 111.331 -174.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.68 149.59 18.31 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.739 1.161 . . . . 1.02 113.842 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.98 149.09 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.1 1.76 . . . . 2.51 112.36 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.33 147.11 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.492 1.917 . . . . 0.96 111.923 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.744 0 C-N-CA 126.455 1.902 . . . . 4.34 109.683 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 109.115 -0.698 . . . . 1.96 109.115 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -122.38 143.21 49.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.593 1.542 . . . . 1.25 114.454 -148.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -154.76 147.55 24.4 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.493 . . . . 3.04 109.584 168.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.43 77.16 1.77 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.679 1.592 . . . . 5.14 112.671 -160.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -85.17 112.19 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 120.55 -1.344 . . . . 1.13 111.377 -162.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.32 101.58 0.52 Allowed Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.878 2.18 . . . . 0.69 111.476 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.2 mmm -79.93 126.15 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.833 1.253 . . . . 1.39 111.133 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -105.56 149.26 26.42 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.786 1.279 . . . . 2.6 112.973 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.71 65.66 1.37 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.371 2.268 . . . . 1.38 111.619 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 15' ' ' VAL . 1.5 m -73.12 141.82 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.767 0.827 . . . . 1.21 111.005 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -148.72 -159.57 1.05 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.889 -1.05 . . . . 2.68 109.049 171.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.06 -3.0 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.491 1.516 . . . . 1.72 112.382 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 8.92 44.07 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.965 1.706 . . . . 3.07 111.633 171.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 -164.69 26.73 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 125.047 1.308 . . . . 1.43 112.835 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.416 ' HA ' HG12 ' A' ' 10' ' ' VAL . 99.0 t -65.94 126.51 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.629 1.171 . . . . 1.13 110.774 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.87 -137.23 9.45 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 125.577 1.56 . . . . 1.83 113.355 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.32 150.91 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.685 1.594 . . . . 2.35 112.546 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -79.45 145.76 33.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.469 0.708 . . . . 1.26 110.222 161.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.37 3.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.313 1.845 . . . . 3.11 114.091 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.77 163.85 14.66 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.808 1.671 . . . . 0.72 112.717 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -96.24 158.87 15.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.142 -0.688 . . . . 0.96 109.142 166.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.4 t -105.15 132.46 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.352 -1.351 . . . . 0.48 107.352 152.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 12.2 p -87.3 128.22 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.311 0.577 . . . . 0.87 110.536 172.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 126.46 1.904 . . . . 1.41 107.714 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -131.83 112.57 12.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.048 0.928 . . . . 1.91 111.198 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 137.49 57.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 128.25 2.62 . . . . 4.19 112.463 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 29' ' ' GLY 0.312 14.8 t -151.2 161.84 41.98 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 124.543 2.116 . . . . 1.2 111.064 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -21.23 -41.19 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.573 -2.558 . . . . 3.63 115.266 146.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 27' ' ' THR . . . -100.5 12.05 59.76 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 126.035 1.779 . . . . 0.85 117.012 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.36 -152.0 23.94 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 130.225 3.774 . . . . 0.72 114.708 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.51 102.59 4.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.281 -1.129 . . . . 0.59 111.45 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -76.43 115.96 16.66 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.313 -0.867 . . . . 1.69 109.882 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -105.69 110.54 22.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.477 2.311 . . . . 0.51 109.623 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.408 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 11.8 m -114.47 110.27 47.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 119.79 1.177 . . . . 0.59 108.095 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.61 152.68 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.382 2.722 . . . . 0.7 110.89 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.38 40.4 0.77 Allowed 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.168 1.461 . . . . 2.35 111.231 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mp -103.54 141.7 35.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.539 1.936 . . . . 0.92 112.977 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HE3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -103.33 160.08 15.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.451 -1.249 . . . . 3.35 109.805 170.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 97.69 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.521 2.728 . . . . 1.42 115.099 160.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -98.75 156.24 35.81 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 118.886 0.766 . . . . 1.59 111.86 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.82 136.45 57.53 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.915 1.744 . . . . 0.99 110.589 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 99' ' ' VAL . 21.8 Cg_endo -86.97 34.58 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.564 2.843 . . . . 1.17 114.736 -151.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.62 -140.84 11.62 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.729 1.157 . . . . 1.25 114.072 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -120.3 153.93 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.795 -0.826 . . . . 3.18 110.414 165.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -138.23 133.69 33.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.615 0.766 . . . . 0.91 110.203 -163.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 163.44 23.77 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 111.015 -0.834 . . . . 0.68 111.015 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' CE1' HD13 ' A' ' 94' ' ' LEU . 4.6 t80 -135.95 132.25 36.17 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 106.086 -1.82 . . . . 1.86 106.086 172.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.61 ' HA ' HD12 ' A' ' 94' ' ' LEU . 5.3 m170 -137.85 158.24 44.76 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.149 -0.97 . . . . 0.9 112.815 168.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.54 142.85 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 127.42 2.288 . . . . 0.86 108.006 163.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -123.28 156.38 35.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.077 1.351 . . . . 0.83 110.663 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.75 78.73 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.974 1.842 . . . . 0.63 115.974 -159.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -116.33 -177.66 3.23 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.576 1.55 . . . . 1.07 111.483 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.81 97.49 0.31 Allowed Glycine 0 N--CA 1.47 0.902 0 O-C-N 120.769 -1.207 . . . . 0.93 113.441 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 t 173.87 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.605 2.362 . . . . 2.17 109.638 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.5 m -70.11 31.15 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 115.976 1.843 . . . . 1.31 115.976 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -84.54 124.91 72.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 O-C-N 119.724 -1.86 . . . . 4.08 111.158 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.07 144.27 13.29 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.307 2.671 . . . . 0.96 111.253 173.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.2 153.75 29.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.997 0.519 . . . . 1.57 110.583 164.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.03 132.25 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.984 -1.072 . . . . 2.21 111.07 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.21 172.95 11.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.275 2.63 . . . . 4.89 110.055 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -47.4 114.06 0.81 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.663 1.185 . . . . 5.15 112.406 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.13 6.47 53.38 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.986 -1.452 . . . . 3.95 115.715 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.93 129.14 10.48 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.809 2.304 . . . . 3.63 114.378 -167.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.86 117.56 30.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.984 0.914 . . . . 1.52 108.826 165.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.37 74.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.224 1.81 . . . . 1.97 111.172 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.43 -73.58 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.863 2.865 . . . . 2.5 115.864 164.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.48 38.09 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 130.023 3.329 . . . . 2.46 109.332 -166.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.6 -25.49 62.69 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.293 1.22 . . . . 4.1 114.293 -167.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -13.09 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.034 1.288 . . . . 1.3 113.908 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.82 -4.24 57.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.63 1.572 . . . . 1.25 113.02 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.93 -179.98 53.11 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.787 -1.196 . . . . 2.57 114.22 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.89 -179.3 48.07 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.99 0.805 . . . . 1.15 111.631 166.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -53.67 137.79 36.47 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 118.585 -0.721 . . . . 2.19 109.812 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.402 HD13 ' HE2' ' A' ' 123' ' ' LYS . 59.8 tp -59.76 116.46 4.08 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.818 0.736 . . . . 1.59 111.642 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -149.32 101.79 3.33 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.81 2.044 . . . . 4.11 109.207 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.36 -46.43 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.639 1.559 . . . . 3.31 111.111 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -164.16 13.91 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.794 2.038 . . . . 3.29 113.083 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -56.87 -39.62 74.67 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.2 -1.562 . . . . 3.33 113.543 -170.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t 146.11 -28.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 1 C-N-CA 132.069 4.148 . . . . 3.1 111.201 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.73 58.14 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 117.016 1.566 . . . . 2.27 117.016 162.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.85 -67.31 0.79 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.536 1.668 . . . . 7.73 112.449 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 t60 171.69 157.54 0.09 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.811 2.844 . . . . 1.68 111.549 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.65 133.28 32.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.743 1.217 . . . . 4.23 108.69 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.51 -95.29 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 109.404 -1.478 . . . . 2.93 109.404 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.76 29.46 0.41 Allowed 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 124.589 3.526 . . . . 3.21 112.631 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -146.23 -179.63 6.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.433 1.893 . . . . 5.55 109.457 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.15 107.21 0.7 Allowed Glycine 0 N--CA 1.472 1.061 0 N-CA-C 109.095 -1.602 . . . . 3.72 109.095 164.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -168.84 -5.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.059 1.503 . . . . 5.84 115.059 -149.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.9 -34.98 0.02 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 118.105 2.002 . . . . 3.13 118.105 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.49 115.22 3.39 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.201 2.0 . . . . 3.69 110.831 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.02 -11.35 7.95 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.479 1.659 . . . . 2.02 115.479 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.01 -0.16 89.23 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.963 -1.465 . . . . 0.82 116.094 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -85.09 134.86 34.18 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 120.5 2.15 . . . . 1.5 112.673 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 48' ' ' HIS . 1.8 mt -123.95 160.78 50.27 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.596 1.558 . . . . 2.66 112.065 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.06 162.23 43.37 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.749 2.966 . . . . 1.01 112.247 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 132' ' ' ASP . 27.4 m -79.08 127.88 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 123.355 1.55 . . . . 1.48 114.56 -162.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.07 82.25 5.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.87 2.868 . . . . 1.97 109.492 174.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.26 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.071 -1.018 . . . . 1.42 109.29 171.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 42' ' ' PRO . 25.4 m -125.89 157.96 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.347 1.059 . . . . 2.0 110.077 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.16 159.46 27.41 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.895 1.072 . . . . 2.26 113.895 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -49.67 -20.57 0.83 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 127.502 2.321 . . . . 4.1 117.148 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.13 0.92 27.89 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.211 1.559 . . . . 3.97 115.211 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.99 42.25 2.67 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 116.0 1.16 . . . . 1.01 116.0 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.89 135.46 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.878 1.271 . . . . 1.05 109.522 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.32 118.1 31.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.572 1.949 . . . . 0.69 109.238 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -156.54 21.61 0.34 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.737 1.384 . . . . 1.83 114.737 -167.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -134.83 143.48 46.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.149 1.779 . . . . 4.37 108.785 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -85.13 162.48 11.54 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.191 3.261 . . . . 1.47 114.362 -170.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.45 172.17 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 126.315 1.846 . . . . 1.26 109.722 166.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -141.39 146.5 36.68 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 119.925 1.239 . . . . 0.88 111.097 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.72 87.06 3.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.832 1.253 . . . . 0.86 113.961 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.5 2.1 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.481 2.787 . . . . 1.32 114.732 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -76.86 -11.27 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.695 1.134 . . . . 5.27 111.673 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.31 164.87 13.88 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.005 2.122 . . . . 2.33 110.711 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -152.08 11.09 0.54 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.528 1.931 . . . . 4.21 114.187 173.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -159.18 149.3 19.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.324 -1.485 . . . . 1.78 113.716 163.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -57.49 -24.53 56.39 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.084 -1.01 . . . . 1.73 111.38 162.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -52.03 -31.74 31.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.212 1.005 . . . . 3.01 112.768 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.032 1.333 . . . . 2.37 112.399 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.04 11.27 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.086 1.354 . . . . 0.97 113.539 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.3 pttt -61.54 7.14 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.984 2.587 . . . . 2.74 117.984 -171.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -156.33 22.19 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.48 1.912 . . . . 3.5 111.748 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HE2' HD13 ' A' ' 74' ' ' LEU . 57.9 mttp -113.34 170.53 8.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.846 1.259 . . . . 1.17 114.31 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.08 150.3 23.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.609 1.164 . . . . 0.57 112.372 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.4 145.27 40.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.864 2.066 . . . . 1.56 107.585 165.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -130.65 136.56 48.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.824 0.738 . . . . 2.04 112.179 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 88.3 mt -94.26 124.37 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.518 -1.29 . . . . 0.81 107.518 167.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -120.29 143.1 48.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.319 1.048 . . . . 1.85 112.485 -156.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.25 -37.59 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.898 -1.126 . . . . 1.18 112.983 -153.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.9 141.06 16.63 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.78 0.705 . . . . 1.12 112.141 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -47.43 134.45 14.05 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 126.01 1.767 . . . . 2.15 112.109 164.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.43 ' H ' HG12 ' A' ' 96' ' ' VAL . 4.4 t70 -76.11 1.72 14.88 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.22 1.408 . . . . 2.9 113.001 -167.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -66.29 -1.47 3.41 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 119.727 -1.858 . . . . 4.77 114.24 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 ptp -93.07 10.35 31.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.288 1.835 . . . . 3.67 114.149 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.4 p -47.83 -21.96 0.49 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.812 2.152 . . . . 4.35 116.812 -171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.44 -10.42 59.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.089 2.956 . . . . 7.99 115.618 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -53.01 148.64 13.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 114.276 1.213 . . . . 4.2 114.276 -166.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.36 30.59 0.34 Allowed 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.361 3.374 . . . . 3.12 112.234 170.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 140.32 35.26 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.544 1.538 . . . . 4.47 109.19 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.71 162.26 32.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.416 2.744 . . . . 3.45 112.965 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 71.6 mt 64.39 16.08 9.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.778 1.631 . . . . 4.93 114.033 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.03 12.08 58.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.065 1.317 . . . . 4.78 114.955 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.33 -64.35 3.79 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.889 1.345 . . . . 2.97 112.992 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.17 0.45 31.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.906 1.241 . . . . 2.09 114.949 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.1 9.44 12.37 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.703 2.097 . . . . 2.13 116.071 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.0 p -69.04 146.95 52.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.744 1.772 . . . . 1.96 108.996 161.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 143.18 27.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.036 -1.04 . . . . 5.52 112.942 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.412 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 23.8 t80 -102.2 -26.54 13.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.196 0.598 . . . . 2.19 111.849 158.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.96 149.18 28.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.653 -0.654 . . . . 0.52 112.664 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.2 t -120.32 144.07 48.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.097 2.159 . . . . 1.46 109.714 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -139.43 104.51 0.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 126.341 1.924 . . . . 0.66 111.18 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -83.0 130.37 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.339 1.069 . . . . 1.72 110.334 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.74 133.45 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.144 1.378 . . . . 0.91 110.677 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 125.863 1.665 . . . . 4.55 108.576 176.466 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.187 -0.301 . . . . 2.22 110.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.78 159.63 40.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.786 1.773 . . . . 1.49 115.786 -151.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -148.37 136.95 21.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.476 1.511 . . . . 2.95 109.459 159.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -83.41 103.63 12.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.429 1.092 . . . . 3.61 112.031 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.8 t -79.02 114.36 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.253 -0.904 . . . . 1.14 109.079 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.44 105.57 1.81 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.25 1.405 . . . . 0.73 111.425 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.7 mmm -84.13 122.42 28.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.712 1.205 . . . . 1.71 111.365 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.16 151.79 23.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.756 0.789 . . . . 2.44 111.185 166.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.52 136.31 57.97 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.083 0.953 . . . . 1.33 109.706 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.53 140.59 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.393 -0.965 . . . . 1.24 108.393 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 t -151.44 17.61 0.72 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.597 0.759 . . . . 2.76 111.85 -165.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.61 -21.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.538 2.335 . . . . 1.33 113.371 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -71.8 28.18 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 119.879 1.218 . . . . 4.01 111.985 163.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -174.78 52.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.562 2.029 . . . . 1.24 113.201 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.67 119.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.178 0.991 . . . . 1.45 108.608 153.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.04 -69.37 1.02 Allowed Glycine 0 N--CA 1.466 0.638 0 CA-C-O 122.159 0.866 . . . . 1.53 114.129 -170.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 153.88 9.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.106 1.363 . . . . 2.38 109.537 -165.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -89.59 152.61 21.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.271 1.428 . . . . 1.2 112.983 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.42 -2.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 115.196 1.554 . . . . 3.71 115.196 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.77 175.05 20.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.561 2.029 . . . . 0.7 111.792 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -104.71 175.21 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.583 -0.951 . . . . 0.82 109.378 167.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.74 131.25 73.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.663 -1.606 . . . . 0.53 106.663 152.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.4 p -80.89 122.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.667 -0.494 . . . . 0.91 109.667 172.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.4 mt -94.48 127.31 46.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 107.374 -1.343 . . . . 1.45 107.374 165.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.38 123.56 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.17 1.388 . . . . 1.98 108.701 171.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 151.0 33.17 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 121.026 -0.269 . . . . 3.23 111.049 172.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -161.29 -173.82 4.01 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.405 0.682 . . . . 1.43 109.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -59.73 -25.64 65.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.857 1.263 . . . . 5.58 113.353 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.36 16.45 61.04 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.558 1.075 . . . . 1.09 114.66 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.7 -140.44 24.23 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 125.334 1.445 . . . . 0.66 114.002 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.19 98.38 4.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.194 0.998 . . . . 0.75 112.105 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.95 111.22 14.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.2 1.4 . . . . 2.2 110.785 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.71 117.58 29.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.255 2.222 . . . . 0.58 108.835 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.41 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.8 m -123.95 110.69 29.27 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-N 119.796 1.18 . . . . 0.62 108.986 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.74 158.34 10.47 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.974 3.116 . . . . 0.42 111.341 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -149.06 29.32 0.81 Allowed 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.794 0.807 . . . . 1.28 113.058 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.77 148.77 21.94 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.542 1.537 . . . . 0.79 111.915 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.52 23.38 6.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.853 2.168 . . . . 1.96 116.853 -164.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.73 69.2 0.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.888 0.875 . . . . 1.66 111.351 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.13 160.94 66.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.88 0.872 . . . . 1.46 112.007 170.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.28 127.68 18.79 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.052 1.168 . . . . 0.95 110.343 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -83.58 33.39 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.901 1 C-N-CA 126.053 4.502 . . . . 1.05 113.152 -159.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.72 -131.6 4.46 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 123.411 1.562 . . . . 1.18 112.131 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.0 147.27 52.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.667 1.587 . . . . 3.89 109.548 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.7 122.64 15.52 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.72 0.808 . . . . 1.37 112.25 -173.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.73 155.05 1.67 Allowed Glycine 0 CA--C 1.543 1.794 0 C-N-CA 123.936 0.779 . . . . 1.0 113.057 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -133.93 112.5 11.31 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.206 -1.405 . . . . 1.9 107.206 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -116.33 158.79 22.89 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.249 1.203 . . . . 0.94 114.249 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.471 ' CG2' HD12 ' A' ' 74' ' ' LEU . 63.2 mt -99.23 151.27 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.236 1.414 . . . . 0.69 107.88 154.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.23 153.45 47.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.174 1.79 . . . . 0.91 107.648 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.83 71.68 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.909 1.448 . . . . 0.87 114.909 -163.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -119.22 161.21 20.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.19 1.796 . . . . 1.54 112.371 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.13 86.02 0.56 Allowed Glycine 0 N--CA 1.467 0.715 0 C-N-CA 124.682 1.134 . . . . 0.86 112.773 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 t -171.11 94.15 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.718 1.207 . . . . 1.92 113.011 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 68.3 m -65.92 14.55 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 117.097 2.258 . . . . 1.36 117.097 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -101.96 147.85 34.49 Favored Pre-proline 0 CA--C 1.549 0.926 0 O-C-N 119.787 -1.821 . . . . 3.78 113.965 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.37 161.42 11.19 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.723 3.615 . . . . 1.15 112.602 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.31 14.13 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.605 0.762 . . . . 1.9 111.213 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.23 115.34 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.345 1.058 . . . . 3.37 109.643 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -146.34 147.06 30.94 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.85 1.66 . . . . 5.69 110.704 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t0 53.13 32.18 12.68 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.617 1.34 . . . . 4.45 114.617 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.1 6.48 87.54 Favored Glycine 0 CA--C 1.535 1.343 0 O-C-N 121.105 -0.997 . . . . 3.99 114.771 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -141.58 -161.79 1.28 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.57 1.548 . . . . 3.94 110.509 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.14 138.64 49.56 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.919 -1.113 . . . . 1.9 113.027 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 t -82.24 60.75 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.838 1.655 . . . . 2.32 111.029 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 47.17 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.154 2.582 . . . . 1.76 115.874 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.93 84.38 0.81 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.411 2.684 . . . . 1.47 107.556 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -84.72 -46.71 11.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.237 1.415 . . . . 3.98 112.03 -167.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -12.34 57.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.321 1.23 . . . . 1.12 114.321 -164.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.74 -22.82 59.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.562 1.545 . . . . 0.79 113.897 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.55 -174.97 17.77 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 120.398 1.454 . . . . 2.39 114.278 -176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 -155.57 22.44 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.129 1.347 . . . . 1.17 110.832 164.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -71.36 34.41 0.05 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 118.957 1.379 . . . . 2.41 113.783 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.471 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER 64.11 46.04 3.85 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.452 1.501 . . . . 2.53 109.536 -178.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -128.32 44.95 1.47 Allowed Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 116.3 1.963 . . . . 4.4 116.3 -148.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.39 -20.81 31.38 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.834 2.356 . . . . 3.04 113.722 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -166.65 143.32 4.77 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.82 1.648 . . . . 3.84 110.5 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 164.75 -23.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 129.501 3.12 . . . . 3.84 113.435 170.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 t 139.18 -2.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 1 C-N-CA 131.829 4.052 . . . . 3.53 112.855 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.26 2.73 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.549 1.38 . . . . 2.44 116.549 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -86.71 172.5 10.14 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.43 1.615 . . . . 4.55 113.73 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -107.68 143.92 35.51 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.068 1.347 . . . . 1.48 112.921 -173.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -152.86 -173.19 4.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.222 1.409 . . . . 3.83 109.967 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.38 -52.1 0.01 OUTLIER Glycine 0 CA--C 1.544 1.854 0 CA-C-O 116.977 -2.013 . . . . 4.15 115.022 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -105.0 -20.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.875 2.383 . . . . 5.3 116.939 -164.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 177.27 17.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.44 1.496 . . . . 8.05 114.369 -165.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.83 -150.05 21.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.494 1.521 . . . . 2.77 112.25 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -135.92 135.9 40.03 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.741 -1.207 . . . . 5.78 107.741 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.75 -157.72 30.02 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.419 0.554 . . . . 2.95 114.434 -173.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 136.75 58.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.286 0.634 . . . . 3.82 112.665 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -11.9 60.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.681 0.993 . . . . 2.52 113.681 169.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.08 14.77 36.75 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.794 -1.559 . . . . 1.07 115.439 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -106.99 131.93 53.5 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 119.614 1.707 . . . . 1.57 112.267 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 3.9 mp -131.37 170.51 11.1 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.067 2.147 . . . . 2.01 110.418 -168.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 94' ' ' LEU . 88.7 Cg_endo -80.22 152.9 21.29 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.403 2.068 . . . . 0.83 111.868 -172.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.85 128.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.795 1.238 . . . . 2.22 112.95 -168.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.38 82.17 1.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.151 2.18 . . . . 1.68 108.894 168.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.49 141.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.51 1.124 . . . . 1.38 109.161 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.93 150.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.419 1.888 . . . . 1.91 108.866 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 143.49 26.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.057 0.844 . . . . 1.88 112.683 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -19.83 -45.19 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.353 4.661 . . . . 3.33 117.463 174.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.23 -29.37 65.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.943 1.297 . . . . 3.7 112.633 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.11 20.72 6.2 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.807 1.67 . . . . 0.86 113.463 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.6 mt -121.71 133.99 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.99 109.888 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.63 131.01 49.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.615 1.166 . . . . 0.59 110.322 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 t -152.37 4.18 0.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.427 2.01 . . . . 1.1 116.427 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -100.98 136.96 19.64 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.877 1.217 . . . . 3.85 111.334 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.14 146.8 47.08 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.526 3.484 . . . . 1.04 112.178 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.11 161.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.448 1.499 . . . . 1.14 109.442 165.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -139.25 134.87 33.25 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.341 0.973 . . . . 0.73 110.747 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.8 105.32 49.9 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.957 0.903 . . . . 0.93 112.609 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.84 13.05 0.63 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.372 3.382 . . . . 1.15 113.299 167.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -64.27 -41.26 97.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.096 1.758 . . . . 4.39 110.737 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -111.41 151.73 28.18 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 2.4 107.258 166.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -97.04 -22.07 17.02 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.586 0.958 . . . . 4.71 113.586 -174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.16 160.86 43.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.039 1.745 . . . . 1.59 115.344 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.43 -30.68 68.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.457 1.503 . . . . 1.75 111.889 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -67.27 -2.75 6.42 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.807 2.043 . . . . 2.61 113.313 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -96.86 -13.13 22.72 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.195 1.798 . . . . 1.81 113.277 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.18 7.83 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.631 1.105 . . . . 1.06 113.898 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -60.38 -12.6 9.76 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.854 2.168 . . . . 2.88 116.854 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.39 16.75 13.87 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.55 1.94 . . . . 4.58 114.08 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -121.2 -173.91 2.72 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.956 1.465 . . . . 1.42 114.956 -165.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.5 156.56 47.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.508 1.523 . . . . 0.59 111.555 169.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mp -118.3 130.0 55.78 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.525 1.93 . . . . 1.65 108.489 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.2 mtt -116.98 128.72 55.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.46 0.573 . . . . 1.42 111.772 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.02 103.51 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.61 -1.256 . . . . 0.8 107.61 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -87.02 146.1 26.24 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.187 1.795 . . . . 2.38 113.034 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.2 t -64.65 -30.32 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.983 -1.073 . . . . 1.6 113.409 -164.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.14 149.66 18.07 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.316 0.96 . . . . 1.29 112.63 172.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.27 150.48 11.1 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.104 1.811 . . . . 1.59 112.952 162.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.01 0.55 38.32 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.2 1.185 . . . . 2.49 114.2 -141.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -81.55 -7.27 59.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.356 1.613 . . . . 3.02 115.356 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 65.9 mtm -84.45 109.75 18.12 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.74 1.216 . . . . 2.52 110.486 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -137.01 -45.35 0.57 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.17 0.988 . . . . 2.91 112.759 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.41 80.64 8.53 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.123 -0.986 . . . . 3.86 110.715 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 175.88 147.49 0.26 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 128.491 2.716 . . . . 3.48 110.272 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.33 -27.59 47.66 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 2.13 114.029 -166.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -109.91 87.75 6.07 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.802 0.841 . . . . 6.5 109.125 165.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.67 169.16 16.54 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.914 2.41 . . . . 4.57 111.307 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt 66.3 6.04 4.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.523 1.929 . . . . 4.96 113.416 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.2 26.92 74.23 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 119.154 0.888 . . . . 3.91 113.2 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.57 -9.35 77.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.778 1.18 . . . . 2.56 113.186 -166.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 22.43 0.57 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.884 2.183 . . . . 1.63 115.851 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.75 75.35 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 118.455 1.128 . . . . 1.73 112.337 166.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.7 p -65.21 156.86 30.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.454 1.502 . . . . 1.65 110.896 162.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.25 137.67 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.761 1.224 . . . . 4.95 110.582 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -82.37 -37.47 25.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.185 0.994 . . . . 2.31 111.697 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.1 149.38 32.93 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.038 0.935 . . . . 0.53 111.814 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.27 146.71 50.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.975 1.71 . . . . 1.57 110.783 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -131.66 90.43 0.28 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.463 2.459 . . . . 0.71 111.352 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.28 140.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.589 1.156 . . . . 2.67 112.47 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.72 151.45 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.728 1.611 . . . . 1.19 111.246 -170.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 O-C-N 120.912 -1.117 . . . . 4.35 112.43 171.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 109.437 -0.579 . . . . 1.97 109.437 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.55 154.11 26.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.732 1.213 . . . . 1.16 109.859 -172.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -149.17 125.77 11.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.921 1.343 . . . . 2.93 110.27 170.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -83.83 109.89 17.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.064 1.746 . . . . 2.99 110.528 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.66 124.47 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 120.089 1.313 . . . . 1.15 110.482 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -76.25 110.95 3.17 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 125.669 1.604 . . . . 0.81 110.752 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.5 mtp -96.74 131.7 43.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.253 1.021 . . . . 1.42 111.121 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.65 142.91 45.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.066 1.346 . . . . 2.69 111.524 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.7 mt -65.68 137.65 57.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.858 0.863 . . . . 1.34 108.862 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.33 144.44 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.688 0.795 . . . . 1.05 111.432 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.1 t -163.79 72.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.677 0.791 . . . . 2.24 112.473 -169.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 72.0 -33.47 0.27 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.029 2.531 . . . . 1.43 115.44 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -33.78 68.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.353 1.461 . . . . 3.47 110.082 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.39 -158.67 24.53 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 125.909 1.718 . . . . 1.32 112.023 -169.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.84 126.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.391 1.476 . . . . 1.08 110.899 171.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.91 -136.78 9.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.492 1.52 . . . . 1.99 111.504 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.34 165.64 12.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.411 -1.052 . . . . 1.88 112.555 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -104.06 162.18 13.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.863 1.315 . . . . 1.4 114.443 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pp -147.48 4.53 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 130.431 3.492 . . . . 2.89 113.262 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.49 148.09 5.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.959 1.742 . . . . 0.81 112.856 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.449 HG22 ' HA2' ' A' ' 6' ' ' GLY . 30.8 p -99.46 -179.9 4.36 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.184 -1.043 . . . . 0.85 108.184 163.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 61.5 t -132.2 134.52 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.211 -1.033 . . . . 0.67 108.211 163.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 13.5 p -81.54 122.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.49 -0.559 . . . . 0.97 109.49 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -107.42 133.14 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.557 -0.905 . . . . 1.89 108.557 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.22 124.91 18.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.547 1.539 . . . . 2.16 107.498 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.34 128.66 47.4 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.515 0.726 . . . . 3.56 109.703 -168.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -151.5 -174.53 4.86 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.633 0.235 . . . . 1.17 111.633 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.17 -24.97 68.13 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.933 -1.105 . . . . 4.25 112.619 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.99 9.95 64.55 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 124.834 1.207 . . . . 0.97 114.609 167.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.29 -140.19 23.43 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 126.668 2.08 . . . . 0.69 112.988 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.87 93.47 5.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.9 0.88 . . . . 0.54 110.49 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -72.69 131.57 42.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.483 1.913 . . . . 3.03 109.22 166.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 19.3 t80 -127.93 106.72 9.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.99 2.116 . . . . 0.65 108.176 -168.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.448 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 25.4 m -105.4 107.1 58.36 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 119.834 1.197 . . . . 0.79 108.027 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.05 156.11 30.09 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.028 2.486 . . . . 0.72 110.496 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.0 39.65 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.687 1.232 . . . . 2.37 110.359 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.54 150.02 20.79 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 126.794 2.038 . . . . 1.01 111.733 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HE2' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -132.5 162.34 31.45 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.339 -1.301 . . . . 3.13 109.494 170.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 93.21 23.64 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 129.484 3.114 . . . . 1.68 112.66 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.18 152.51 57.19 Favored Pre-proline 0 CA--C 1.487 -1.46 0 C-N-CA 125.249 1.42 . . . . 1.97 112.56 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -76.0 142.7 25.2 Favored 'Trans proline' 0 N--CA 1.413 -3.218 0 C-N-CA 116.599 -1.801 . . . . 1.52 111.286 -165.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -80.97 31.3 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.626 1 C-N-CA 127.89 5.727 . . . . 1.47 114.127 -155.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.86 -127.98 6.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 123.567 1.648 . . . . 1.69 110.958 174.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -120.51 145.93 46.79 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 127.567 2.347 . . . . 3.07 110.383 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.436 ' CD2' HG21 ' A' ' 99' ' ' VAL . 71.2 m-70 -139.9 125.11 18.8 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 124.158 0.983 . . . . 0.96 112.404 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.31 149.79 9.41 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.607 -0.683 . . . . 0.55 111.778 169.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -135.97 127.52 28.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.951 1.7 . . . . 1.84 106.503 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -130.06 167.85 17.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.4 2.37 . . . . 1.01 117.4 166.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.0 mt -101.0 146.43 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.637 1.975 . . . . 0.77 108.929 155.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -124.08 155.72 37.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.179 1.792 . . . . 1.49 110.541 -170.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.91 -37.91 70.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.948 1.462 . . . . 0.69 114.948 -162.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.42 HD22 ' HA3' ' A' ' 71' ' ' GLY . 66.9 m-80 -116.64 -179.34 3.65 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.335 1.454 . . . . 1.08 111.033 173.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.98 51.05 0.86 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 116.646 1.419 . . . . 0.97 116.646 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -153.22 123.93 7.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.661 1.731 . . . . 2.13 112.45 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.1 m -68.77 -2.88 10.42 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.603 1.705 . . . . 2.03 115.603 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.8 136.6 38.85 Favored Pre-proline 0 CA--C 1.549 0.908 0 O-C-N 120.25 -1.531 . . . . 3.37 112.02 -162.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -96.88 160.81 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.184 3.256 . . . . 1.38 113.384 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.76 177.3 4.88 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.103 1.361 . . . . 2.35 110.915 156.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.25 124.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.579 1.152 . . . . 2.56 108.773 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -104.54 -178.86 3.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.579 1.952 . . . . 4.37 109.911 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.33 104.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.529 0.937 . . . . 4.56 113.529 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.06 18.03 70.45 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.262 -1.299 . . . . 4.14 115.367 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -158.15 134.49 9.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.377 2.089 . . . . 4.74 114.818 -169.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.6 130.33 35.01 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.107 -0.996 . . . . 1.94 110.312 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -81.36 49.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.396 . . . . 2.91 111.675 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.57 -57.47 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 130.608 3.563 . . . . 2.34 117.817 166.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 163.38 85.35 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 1 C-N-CA 134.228 5.011 . . . . 1.62 105.17 -167.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.85 -50.53 7.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.103 0.961 . . . . 5.26 111.91 -155.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.56 15.02 0.11 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.12 1.156 . . . . 1.65 114.12 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.65 -15.04 35.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.431 1.892 . . . . 0.87 112.7 165.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' HD22 ' A' ' 52' ' ' ASN . . . 76.08 9.68 85.38 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.737 1.455 . . . . 2.78 116.737 168.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.04 -166.37 52.8 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.133 1.466 . . . . 1.46 112.277 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -61.97 149.87 39.47 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.707 0.753 . . . . 2.37 111.22 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 123' ' ' LYS . 36.4 tp -67.98 110.18 3.79 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.904 -0.497 . . . . 1.84 111.122 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.81 159.93 2.42 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 130.46 3.504 . . . . 3.38 109.006 164.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -90.09 -18.6 1.37 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.328 2.019 . . . . 2.84 115.712 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 178.55 -3.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.613 2.079 . . . . 4.98 116.613 -163.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -58.92 -48.53 81.13 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.096 1.517 . . . . 3.73 115.096 -147.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 161.61 170.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.952 3.301 . . . . 3.54 109.467 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.93 -15.62 78.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.318 0.961 . . . . 3.62 113.779 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.92 145.38 55.99 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.104 1.452 . . . . 4.68 110.348 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -117.46 143.87 45.6 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.234 1.013 . . . . 1.53 112.299 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.74 117.56 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 3.76 111.852 -161.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.05 171.53 35.7 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.004 1.288 . . . . 2.78 111.958 171.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.74 -3.33 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.907 3.738 . . . . 4.04 115.876 -168.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -160.69 29.22 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.584 2.354 . . . . 8.06 110.675 171.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.76 -141.15 7.76 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.098 2.285 . . . . 3.01 112.224 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -151.97 148.07 27.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.336 1.068 . . . . 4.78 112.055 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.12 -91.59 0.08 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.433 1.968 . . . . 2.23 112.524 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -134.76 134.25 40.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.136 1.375 . . . . 3.87 110.285 -169.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -67.06 -21.63 65.89 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.63 1.344 . . . . 2.09 114.63 -170.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.68 -2.65 76.64 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.707 1.146 . . . . 0.86 115.128 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -72.71 133.58 44.64 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.796 1.298 . . . . 1.57 109.949 169.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.92 163.9 26.35 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.993 1.317 . . . . 1.73 110.645 -150.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.3 145.79 34.87 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.514 2.809 . . . . 0.89 111.899 -167.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.16 130.35 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.587 1.184 . . . . 2.66 110.446 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 125.31 31.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 131.128 3.771 . . . . 2.25 110.446 -172.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -97.06 140.18 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.336 1.055 . . . . 1.24 111.88 -172.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 45' ' ' HIS . 2.3 t -130.16 141.07 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.539 1.936 . . . . 1.64 108.248 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -103.47 157.5 17.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.693 1.197 . . . . 2.73 112.53 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.74 50.08 0.43 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.673 2.389 . . . . 2.86 115.649 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -128.34 1.49 5.7 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.402 -1.726 . . . . 3.72 111.221 150.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.29 27.47 13.33 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.441 1.972 . . . . 0.8 113.883 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.29 138.53 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.533 1.533 . . . . 1.17 110.255 -165.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.15 127.72 53.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.354 0.979 . . . . 1.05 109.925 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 t -149.03 9.18 0.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.845 1.424 . . . . 1.05 114.845 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -100.73 130.77 24.68 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.922 1.289 . . . . 3.57 110.306 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.14 140.56 17.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.078 2.519 . . . . 1.07 112.252 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.63 160.64 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.04 1.736 . . . . 1.17 109.499 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.0 m -144.73 132.55 21.23 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.384 0.993 . . . . 0.81 111.423 -167.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.84 97.25 27.94 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.744 1.218 . . . . 0.67 112.916 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.0 -2.52 12.77 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.582 3.521 . . . . 1.18 115.905 -177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -88.15 -2.44 58.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.548 1.139 . . . . 3.71 113.361 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.55 169.72 9.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.976 2.51 . . . . 2.34 107.834 164.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -152.67 5.74 0.39 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 117.038 2.236 . . . . 3.98 117.038 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 m -158.1 167.95 28.42 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.987 1.267 . . . . 1.74 113.291 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.81 -20.06 63.46 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.957 -1.09 . . . . 1.34 111.863 163.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.52 -35.86 78.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.587 1.155 . . . . 3.54 113.657 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -68.51 -13.11 62.1 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.366 1.247 . . . . 3.18 114.366 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.16 17.58 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.747 1.219 . . . . 0.98 113.539 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -67.44 19.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 128.308 2.643 . . . . 2.39 116.977 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -165.96 26.28 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.788 2.435 . . . . 2.95 110.94 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' ' 74' ' ' LEU . 59.4 mttp -134.6 170.64 15.49 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.952 -1.092 . . . . 1.29 113.629 -167.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.5 157.09 25.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.03 1.332 . . . . 0.77 112.543 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.35 135.04 51.06 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.871 2.068 . . . . 1.65 107.294 168.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.09 138.19 54.3 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.383 0.673 . . . . 2.5 111.444 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.33 133.48 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.443 1.116 . . . . 1.48 110.278 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.22 135.5 51.67 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.324 1.85 . . . . 1.96 110.828 -155.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -73.53 -15.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.791 1.404 . . . . 2.56 114.791 -151.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.03 169.53 24.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.401 1.477 . . . . 1.53 109.891 162.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.2 147.84 34.16 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 117.88 0.84 . . . . 1.84 111.786 165.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.64 -22.04 0.89 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.352 1.242 . . . . 3.76 114.352 -138.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.6 47.43 0.17 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.85 2.46 . . . . 4.09 115.422 -172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 41.4 mtm -105.99 133.32 50.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.918 1.687 . . . . 2.23 112.493 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.9 p -99.18 -36.19 9.74 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.129 1.772 . . . . 3.36 114.768 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.39 2.9 54.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.538 1.31 . . . . 4.15 114.538 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.62 144.09 32.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.887 0.875 . . . . 3.97 110.669 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -41.47 9.06 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.311 2.674 . . . . 2.16 112.59 -173.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -83.15 136.94 43.13 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.729 -0.653 . . . . 4.73 109.943 158.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.88 167.37 26.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.171 2.581 . . . . 2.98 111.034 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt 66.33 31.11 8.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.971 1.308 . . . . 3.75 110.953 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.22 11.2 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.059 1.314 . . . . 2.82 114.223 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.6 -20.76 29.5 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.098 1.808 . . . . 2.89 114.392 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.42 -3.31 47.35 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.387 1.47 . . . . 4.13 114.617 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.9 46.77 1.8 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.587 1.565 . . . . 3.34 115.59 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.2 m -58.79 158.03 8.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.382 1.873 . . . . 2.0 110.338 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.45 150.5 28.29 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.281 -1.512 . . . . 5.78 113.042 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.489 ' CE2' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -100.73 -32.83 10.52 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 118.817 -0.611 . . . . 8.44 111.251 153.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.29 152.47 37.17 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 116.482 2.03 . . . . 0.85 116.482 -172.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.0 t -99.2 -177.69 3.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 129.26 3.024 . . . . 1.59 110.368 164.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 176.09 91.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 127.427 2.442 . . . . 0.73 111.456 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.07 133.62 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 1.45 110.024 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.16 128.1 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.468 1.107 . . . . 1.07 110.962 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 82.9 mttt . . . . . 0 N--CA 1.472 0.662 0 C-N-CA 123.992 0.917 . . . . 4.31 111.214 -173.063 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 108.99 -0.744 . . . . 1.66 108.99 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.7 148.06 23.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.228 1.011 . . . . 2.13 113.568 -167.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -153.23 116.99 4.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 2.6 109.248 165.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -97.35 108.36 21.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.747 -1.22 . . . . 3.43 109.439 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.61 125.92 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.386 0.539 . . . . 1.12 109.886 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.0 114.17 4.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.958 1.266 . . . . 0.72 110.171 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.4 mtt -98.09 129.78 44.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.963 0.905 . . . . 1.15 111.726 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -107.44 147.83 29.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.135 1.374 . . . . 2.64 110.717 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.5 mt -65.28 139.96 58.66 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.19 1.396 . . . . 1.16 109.382 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.0 m -135.27 155.6 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 119.233 0.924 . . . . 1.28 111.683 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 t -166.1 55.74 0.1 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.127 0.788 . . . . 2.34 113.127 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.86 -36.72 0.37 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 127.196 2.199 . . . . 2.27 113.849 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -22.01 57.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 4.61 112.283 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.63 -159.81 24.61 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 124.933 1.254 . . . . 1.1 112.91 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 t -80.71 130.08 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.512 1.925 . . . . 1.27 110.996 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.22 -135.33 8.07 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.4 1.476 . . . . 1.86 112.49 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -104.86 172.29 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.942 0.897 . . . . 2.38 111.315 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -109.43 141.13 42.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.77 0.828 . . . . 1.15 112.473 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 19' ' ' ILE . 36.4 mm -118.73 23.85 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 127.068 2.147 . . . . 5.64 110.937 164.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.2 173.04 33.37 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.32 -0.863 . . . . 0.61 114.83 160.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -102.06 -179.49 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.28 1.032 . . . . 0.88 109.542 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 53.2 t -132.55 135.27 57.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.769 -1.197 . . . . 0.64 107.769 160.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -88.33 128.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.065 0.228 . . . . 0.83 110.626 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.54 133.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.824 -0.806 . . . . 1.52 108.824 161.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.21 128.16 53.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.547 0.739 . . . . 1.96 110.417 156.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 122.27 17.97 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.831 0.852 . . . . 4.05 109.25 164.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -135.96 -178.51 5.17 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.33 -0.248 . . . . 1.69 110.33 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -54.3 -46.34 72.77 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.866 -1.147 . . . . 5.36 110.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.6 17.85 9.93 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.092 1.33 . . . . 1.14 115.774 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.84 -144.08 20.13 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 126.698 2.094 . . . . 0.78 114.071 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.0 mt -77.72 99.52 5.89 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.996 0.903 . . . . 0.62 111.224 -170.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 108.16 5.11 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.195 1.798 . . . . 4.5 110.177 169.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 4.4 t80 -101.33 107.42 18.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.353 1.861 . . . . 0.59 109.888 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.3 m -117.14 111.58 40.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 119.247 0.93 . . . . 0.68 109.064 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -84.01 166.37 12.98 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.032 3.155 . . . . 0.7 111.415 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -150.2 18.71 0.86 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.761 1.393 . . . . 1.68 114.761 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.58 140.89 35.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.208 1.003 . . . . 0.96 111.857 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 9.2 ptpt -116.52 35.92 4.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.731 1.752 . . . . 2.17 115.731 -166.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 19' ' ' ILE . . . -162.77 49.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.651 0.78 . . . . 1.22 112.165 -165.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 157.54 70.86 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 1.29 112.578 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.0 141.64 40.62 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 O-C-N 122.985 0.992 . . . . 1.11 111.233 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 2.1 Cg_endo -86.92 39.59 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 125.282 3.988 . . . . 1.17 113.647 -156.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.83 -159.94 12.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.921 1.248 . . . . 1.14 114.056 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -89.22 137.46 32.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.662 1.985 . . . . 2.89 111.391 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -140.43 143.18 35.46 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.978 0.911 . . . . 1.33 109.62 -173.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.06 161.97 46.82 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 119.029 0.831 . . . . 0.53 112.112 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.402 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.9 t80 -144.51 124.86 13.83 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.326 -1.731 . . . . 1.88 106.326 166.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.57 166.01 24.21 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.962 1.467 . . . . 0.95 114.962 165.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CG2' HD12 ' A' ' 74' ' ' LEU . 20.6 mt -91.06 148.4 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.922 1.689 . . . . 0.63 109.341 159.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -126.42 160.49 30.32 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.355 1.462 . . . . 0.88 109.872 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.3 -20.2 65.58 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 116.609 2.077 . . . . 0.76 116.609 -162.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -134.9 166.54 22.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.061 1.744 . . . . 1.14 112.883 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 83.91 0.34 Allowed Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.151 1.358 . . . . 1.04 112.433 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.8 m -171.5 90.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.595 1.558 . . . . 2.34 110.202 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 59.0 m -64.86 45.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 127.0 2.12 . . . . 1.36 114.98 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -118.59 136.69 24.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 119.579 -1.95 . . . . 3.61 110.786 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.61 168.74 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.185 3.256 . . . . 1.18 111.686 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.18 144.98 25.03 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.016 -0.538 . . . . 1.52 109.772 155.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -109.92 117.35 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.118 1.367 . . . . 2.7 108.34 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -166.41 146.4 6.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.962 1.305 . . . . 4.49 110.6 -163.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 63.22 18.39 10.94 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.085 -1.009 . . . . 3.27 113.686 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.8 13.46 81.33 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.595 -1.315 . . . . 2.53 114.217 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.82 174.54 10.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.643 1.577 . . . . 2.55 110.793 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.6 151.04 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.371 -0.831 . . . . 1.64 111.89 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.23 95.26 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.148 1.379 . . . . 1.82 109.977 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 15.41 -85.41 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 129.396 3.079 . . . . 2.0 116.091 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 130.62 12.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.619 1.968 . . . . 1.65 106.818 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -116.66 -46.0 2.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.512 1.925 . . . . 4.0 110.864 -165.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.5 -9.85 38.69 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.896 1.073 . . . . 1.15 113.896 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.48 59.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.683 1.593 . . . . 0.81 113.185 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.1 173.5 48.7 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 119.487 1.039 . . . . 2.41 112.948 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.56 -177.89 42.15 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.78 0.705 . . . . 1.26 112.444 165.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -49.01 140.15 9.44 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.252 0.526 . . . . 2.1 110.306 168.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.93 101.73 0.88 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.416 0.895 . . . . 2.85 113.416 -170.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -150.45 130.33 6.71 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 128.009 2.524 . . . . 5.3 108.547 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.14 -39.35 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.337 2.025 . . . . 2.48 113.918 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.67 31.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.463 1.905 . . . . 4.52 114.548 -169.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -73.25 -44.15 59.89 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.115 -1.616 . . . . 4.38 110.855 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.6 t 177.07 -37.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.277 1.831 . . . . 2.68 113.378 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 5.91 79.13 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 117.853 -1.526 . . . . 2.12 116.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.255 19.2 ptmt -102.39 17.71 22.86 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 117.712 2.486 . . . . 4.85 117.712 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 t60 83.54 168.85 0.1 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 127.126 2.17 . . . . 2.14 114.753 164.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -25.04 0.1 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.671 2.1 . . . . 5.13 116.671 -154.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -43.6 -46.14 7.13 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 118.334 2.093 . . . . 2.59 118.334 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -90.02 -12.63 2.77 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 CA-C-N 121.192 2.496 . . . . 3.79 113.859 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -147.29 -104.17 0.09 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 6.05 108.817 -161.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.68 98.73 0.14 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 119.17 0.896 . . . . 3.05 114.23 170.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -159.79 44.76 0.23 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.578 1.151 . . . . 4.87 109.741 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.43 -129.68 1.14 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 115.868 1.107 . . . . 2.66 115.868 -166.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -95.36 146.2 24.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.236 1.014 . . . . 3.25 113.663 -154.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -24.61 33.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.683 0.994 . . . . 2.96 113.683 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.27 11.28 69.16 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.347 0.975 . . . . 1.28 114.91 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.8 149.79 32.5 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 117.95 0.875 . . . . 2.46 110.716 163.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.85 166.35 16.53 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.233 1.013 . . . . 1.88 110.256 -141.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.37 157.01 50.13 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.605 2.87 . . . . 1.11 111.654 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -73.21 128.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.647 1.213 . . . . 1.43 112.34 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.09 63.37 5.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.773 2.829 . . . . 2.88 110.792 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.87 144.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.088 -1.007 . . . . 1.44 110.748 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 135.39 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.684 -0.858 . . . . 3.02 108.684 162.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 159.34 25.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.131 1.772 . . . . 3.71 112.52 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -48.79 -8.68 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 119.867 3.284 . . . . 2.49 119.867 -161.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -95.94 -36.3 11.12 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.883 1.673 . . . . 2.85 114.589 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 115.01 14.39 8.53 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.922 1.529 . . . . 1.08 116.922 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.9 mt -105.82 116.99 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.937 1.369 . . . . 1.66 109.883 165.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.09 122.58 21.2 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.921 0.489 . . . . 0.71 109.951 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -149.23 17.5 0.95 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.351 . . . . 1.06 112.733 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -87.29 112.19 46.3 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.134 1.374 . . . . 3.0 111.526 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.9 107.09 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.89 2.393 . . . . 1.16 109.973 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.67 145.93 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.501 1.12 . . . . 1.34 109.582 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -127.36 131.97 50.28 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.016 0.825 . . . . 0.94 111.014 -168.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.23 96.67 40.11 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.976 0.91 . . . . 0.74 112.326 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.12 6.66 1.35 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.93 3.086 . . . . 1.01 113.293 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.08 -29.01 67.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.041 1.337 . . . . 5.16 112.965 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.6 153.84 32.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.033 2.133 . . . . 1.94 108.118 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 10.71 6.75 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.805 1.242 . . . . 5.01 112.581 -174.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -167.13 150.72 6.58 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.974 -1.079 . . . . 1.67 112.99 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -71.52 -33.6 69.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.561 0.744 . . . . 2.12 110.655 162.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.02 -26.57 67.71 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.278 1.214 . . . . 3.34 114.278 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -84.58 -0.57 53.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.075 1.35 . . . . 1.88 113.395 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.81 12.96 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.581 1.152 . . . . 0.84 113.922 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -69.93 17.45 0.05 Allowed 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 116.719 2.118 . . . . 2.34 116.719 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -156.18 29.7 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.534 1.933 . . . . 2.84 110.624 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -139.62 157.74 45.28 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.168 1.387 . . . . 1.58 114.12 -167.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.96 149.09 22.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.99 1.316 . . . . 0.53 112.998 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.55 131.21 55.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.019 2.528 . . . . 1.63 106.521 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.3 mtm -125.75 136.68 53.42 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.468 1.031 . . . . 1.59 113.036 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.25 112.35 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.928 1.291 . . . . 0.86 108.227 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.1 134.72 34.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.699 1.6 . . . . 2.36 111.661 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.67 -39.92 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 113.233 0.827 . . . . 1.23 113.233 -158.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.35 163.55 12.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.341 0.972 . . . . 1.14 110.685 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -55.75 109.26 1.34 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.481 -1.048 . . . . 1.74 110.481 166.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.81 26.58 0.09 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.883 2.873 . . . . 4.94 112.969 -167.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.72 21.6 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.045 1.868 . . . . 3.33 116.045 -158.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.5 mtm -98.68 152.91 19.13 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.394 1.257 . . . . 2.48 114.394 -160.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.3 p -140.15 150.32 44.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.324 1.85 . . . . 3.79 110.463 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.9 t0 58.39 84.27 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.247 2.219 . . . . 4.66 114.448 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.1 156.95 11.56 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.936 1.694 . . . . 3.55 109.698 166.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.76 25.38 0.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.93 3.086 . . . . 3.34 114.059 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -134.25 129.36 19.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.206 1.002 . . . . 4.8 109.941 163.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.88 138.7 45.27 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.889 2.393 . . . . 2.97 111.085 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 60.45 22.48 12.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.809 1.643 . . . . 3.63 112.117 -171.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.45 0.13 29.02 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.004 1.288 . . . . 2.78 114.554 -170.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.37 -9.46 24.4 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.925 2.202 . . . . 1.76 113.957 -166.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.95 1.11 56.29 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.449 1.625 . . . . 1.45 116.324 -171.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.84 62.23 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 118.995 1.398 . . . . 1.46 116.485 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -79.31 155.96 28.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.014 1.725 . . . . 1.44 110.771 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 136.01 49.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 5.05 111.457 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -82.4 -32.61 29.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.518 1.127 . . . . 2.25 111.349 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.91 42.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.431 1.092 . . . . 0.51 113.066 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.56 151.72 48.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.031 2.132 . . . . 1.46 110.479 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.07 125.15 1.78 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.301 1.429 . . . . 0.67 111.873 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -81.6 132.45 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.835 1.254 . . . . 1.82 110.87 174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.06 131.4 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.032 1.333 . . . . 0.82 110.533 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 71.4 mttt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 123.526 0.73 . . . . 3.87 111.874 179.398 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.202 -0.666 . . . . 2.2 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.39 143.1 45.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.196 1.362 . . . . 1.35 113.974 -147.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -155.19 132.67 11.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.06 1.344 . . . . 2.52 110.454 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.38 97.07 7.19 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.842 -1.161 . . . . 4.13 113.029 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.4 t -77.54 122.79 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 1.03 109.799 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.75 105.1 1.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.212 1.387 . . . . 0.68 110.638 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.4 mtp -91.57 108.56 19.99 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.925 0.713 . . . . 1.17 112.925 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -69.4 141.95 54.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.938 0.895 . . . . 2.84 111.31 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.29 134.83 52.33 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.633 -0.877 . . . . 1.37 108.633 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.69 159.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.091 0.556 . . . . 0.99 111.578 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -155.23 -152.32 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.375 1.47 . . . . 2.72 109.927 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -18.07 44.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.429 1.492 . . . . 1.26 113.429 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.84 -3.32 47.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.655 1.182 . . . . 2.66 111.543 164.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 -133.41 11.78 Favored Glycine 0 CA--C 1.525 0.684 0 O-C-N 120.812 -1.18 . . . . 1.23 110.464 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.42 130.12 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.249 1.42 . . . . 1.09 111.657 -165.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.54 -100.07 2.16 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.645 1.593 . . . . 1.23 112.291 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -151.06 152.43 33.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.134 1.774 . . . . 3.64 109.065 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.5 t -87.99 155.1 20.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.22 1.01 . . . . 1.19 112.308 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -135.37 2.9 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 2.78 112.438 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.78 142.83 3.63 Favored Glycine 0 CA--C 1.524 0.62 0 O-C-N 121.468 -0.77 . . . . 0.77 112.72 -162.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -97.88 175.82 6.01 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.367 -0.975 . . . . 0.81 108.367 166.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 33' ' ' PHE . 23.0 t -127.52 129.07 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.594 -0.891 . . . . 0.68 108.594 160.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.7 p -87.38 121.26 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 O-C-N 123.574 0.546 . . . . 0.97 110.995 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.52 128.81 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.303 1.841 . . . . 1.13 107.284 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.56 111.71 13.01 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.497 1.142 . . . . 2.27 111.118 164.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -86.31 145.78 26.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.418 2.287 . . . . 5.37 113.447 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.302 8.5 t -163.16 160.5 24.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 125.179 2.418 . . . . 1.59 110.775 -158.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -23.18 -53.18 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 110.712 -2.949 . . . . 3.78 113.387 148.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.12 12.2 65.04 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 125.225 1.393 . . . . 1.03 116.179 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.66 -172.38 35.9 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 130.499 3.904 . . . . 1.48 115.272 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.1 mt -51.59 99.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.798 2.039 . . . . 0.78 113.86 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -81.01 104.48 11.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.788 1.235 . . . . 1.79 110.849 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 47' ' ' PHE . 1.3 t80 -94.33 120.88 35.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.175 2.19 . . . . 0.62 110.265 -173.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.407 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.5 m -127.65 115.92 21.01 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.036 -0.983 . . . . 0.69 109.286 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -85.03 154.92 11.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.455 2.77 . . . . 0.58 113.562 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . 0.282 1.8 p80 -147.06 62.25 1.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.3 1.047 . . . . 1.24 111.873 168.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.449 ' HB2' HD21 ' A' ' 40' ' ' LEU . 1.2 mp -121.68 146.21 47.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.404 1.481 . . . . 0.68 112.05 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -133.57 25.4 4.07 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 117.483 2.401 . . . . 2.32 117.483 -158.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.54 25.02 0.4 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.817 1.414 . . . . 1.63 114.817 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -89.92 162.91 34.21 Favored Pre-proline 0 N--CA 1.474 0.773 0 O-C-N 120.907 -1.121 . . . . 1.72 111.297 -174.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.27 128.12 25.24 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 N-CA-C 109.36 -1.054 . . . . 0.97 109.36 162.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -87.45 20.17 1.24 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 124.399 3.399 . . . . 1.01 113.78 -149.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.18 150.2 18.2 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.61 1.576 . . . . 2.51 109.447 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -44.15 143.23 1.23 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 127.365 2.266 . . . . 2.89 115.852 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -126.74 125.98 42.69 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 125.679 1.592 . . . . 1.15 113.408 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.32 159.99 7.92 Favored Glycine 0 CA--C 1.54 1.62 0 O-C-N 120.863 -1.148 . . . . 0.58 112.581 171.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.659 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -137.15 126.4 24.72 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.617 -0.931 . . . . 2.29 108.832 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -120.85 159.3 25.77 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.558 1.318 . . . . 0.96 114.558 166.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.3 mt -103.18 139.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.558 1.943 . . . . 0.62 107.371 157.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -113.59 166.26 11.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.223 . . . . 0.99 111.137 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.56 64.78 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.494 1.294 . . . . 0.7 114.494 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -110.84 -158.22 0.64 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.939 1.296 . . . . 1.35 111.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.42 0.19 8.05 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 119.46 2.544 . . . . 1.29 119.46 -147.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 t -155.78 138.76 15.41 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.816 3.308 . . . . 3.12 117.271 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.7 m -68.44 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 130.199 3.399 . . . . 1.35 115.112 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.18 118.82 48.64 Favored Pre-proline 0 N--CA 1.475 0.788 0 O-C-N 119.446 -2.034 . . . . 3.15 111.746 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.66 146.3 16.77 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.662 2.908 . . . . 1.37 111.711 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.24 138.88 32.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.63 -0.714 . . . . 1.74 110.291 154.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.57 106.54 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.792 -1.188 . . . . 2.81 107.792 160.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -151.98 136.54 16.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.578 1.551 . . . . 5.5 110.246 -161.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.4 t0 50.46 45.51 26.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.85 1.26 . . . . 4.16 112.83 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 -19.49 48.97 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.065 1.793 . . . . 2.77 115.389 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.66 163.6 34.36 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.352 1.576 . . . . 3.22 113.379 -156.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.57 121.83 26.81 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.497 -1.377 . . . . 1.94 111.175 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -76.61 20.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 114.656 1.354 . . . . 2.86 114.656 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.99 -56.96 0.57 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.146 2.578 . . . . 1.78 114.685 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.44 118.76 0.55 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.252 2.221 . . . . 1.88 108.911 172.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.11 -43.8 7.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.581 0.752 . . . . 4.96 110.677 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.2 -2.38 7.99 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.221 1.193 . . . . 1.44 114.221 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.13 -24.25 23.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.018 1.327 . . . . 0.85 112.474 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.68 -176.94 41.87 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.713 1.142 . . . . 2.39 112.878 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.62 -176.57 29.65 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.906 -0.761 . . . . 1.17 112.834 171.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -55.59 150.38 12.36 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.936 -0.744 . . . . 2.23 109.487 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD13 ' HE2' ' A' ' 123' ' ' LYS . 53.8 tp -64.99 100.35 0.41 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.911 0.778 . . . . 1.54 112.002 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -163.78 123.15 1.32 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 129.279 3.032 . . . . 4.97 108.926 165.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -92.16 -16.64 1.05 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.04 2.493 . . . . 1.95 114.283 173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -169.88 -14.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.437 2.384 . . . . 3.58 117.437 -166.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -59.09 -36.62 75.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.957 1.708 . . . . 4.11 112.742 -170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -172.93 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.182 0.993 . . . . 2.46 113.225 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 -17.48 8.06 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.29 -1.283 . . . . 1.98 113.834 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -78.08 154.49 31.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.175 1.988 . . . . 5.58 112.077 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -79.68 150.52 30.89 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.012 -1.055 . . . . 1.37 112.589 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.39 -166.01 0.88 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.598 0.759 . . . . 3.27 110.076 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.45 -140.5 6.43 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 120.746 -1.221 . . . . 2.21 111.79 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.15 -9.82 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.458 2.772 . . . . 3.29 114.23 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.98 174.41 5.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.817 2.047 . . . . 5.55 109.164 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.98 -138.4 16.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.663 0.649 . . . . 3.26 111.497 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.08 135.81 3.91 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.511 1.524 . . . . 6.69 107.597 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.87 -135.28 3.22 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.258 1.409 . . . . 2.66 113.397 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -75.7 136.25 40.37 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.145 -0.62 . . . . 3.51 110.542 169.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.528 HD13 ' H ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -71.2 -12.84 61.69 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 2.44 113.586 170.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.09 18.51 13.0 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.874 1.702 . . . . 0.96 115.999 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -108.9 133.11 53.35 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.155 1.478 . . . . 1.47 110.585 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.659 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 4.8 mp -134.11 154.23 80.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.035 1.334 . . . . 2.17 110.654 -163.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.75 163.9 37.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.41 2.74 . . . . 0.8 112.987 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.14 119.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 114.975 -1.012 . . . . 2.16 112.101 -160.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 87.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.112 2.965 . . . . 1.73 109.685 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.25 147.55 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.452 -0.78 . . . . 1.04 110.086 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.55 150.16 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 127.635 2.374 . . . . 1.6 106.108 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.52 160.21 27.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.575 0.625 . . . . 2.44 111.147 168.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -14.79 0.86 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 116.63 2.085 . . . . 2.45 116.63 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.93 -5.78 37.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.359 2.264 . . . . 2.63 113.395 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.5 52.01 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.674 1.131 . . . . 0.72 115.184 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.6 mt -111.89 132.5 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.432 1.493 . . . . 1.18 110.191 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.7 144.63 32.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.522 1.529 . . . . 1.02 112.198 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -151.31 -5.73 0.27 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.346 1.858 . . . . 1.35 113.806 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -70.18 118.53 64.77 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.226 1.81 . . . . 4.52 111.493 -174.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.15 146.73 32.46 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.884 2.389 . . . . 1.28 111.479 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.16 175.17 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.911 1.684 . . . . 1.22 109.627 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 m -150.57 133.19 15.75 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.305 0.957 . . . . 0.95 110.449 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.579 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -106.3 105.41 54.03 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-O 118.745 -0.645 . . . . 0.91 112.043 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.67 -16.16 21.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.233 2.622 . . . . 1.19 115.631 -171.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -66.77 -43.25 84.53 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.252 0.834 . . . . 4.82 113.252 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.95 151.25 38.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 2.03 110.336 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -144.27 46.4 1.42 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.819 1.248 . . . . 4.06 113.265 -169.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 m 151.22 142.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 130.874 3.67 . . . . 1.68 113.554 166.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.19 -33.63 53.54 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.826 -1.171 . . . . 1.63 111.636 164.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -20.92 5.72 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.794 1.775 . . . . 3.17 115.794 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -92.25 -16.98 25.43 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.607 1.549 . . . . 3.06 113.709 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.67 -1.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.993 1.479 . . . . 0.86 114.993 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -8.4 13.24 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 117.121 2.267 . . . . 2.67 117.121 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -104.97 -8.12 18.8 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.207 1.403 . . . . 2.87 113.395 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HE2' HD13 ' A' ' 74' ' ' LEU . 20.9 mttt -96.16 168.56 10.52 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.932 1.293 . . . . 1.56 114.338 -167.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.9 156.84 17.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.125 1.37 . . . . 0.78 112.41 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 pp -131.96 155.0 48.73 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.924 1.69 . . . . 2.6 111.193 169.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 67.9 mtt -136.28 139.74 42.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.607 0.763 . . . . 1.51 112.587 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.03 121.62 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.293 1.437 . . . . 0.65 107.779 166.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -114.01 145.75 41.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.448 1.499 . . . . 2.03 112.654 -161.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.0 -32.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 126.119 1.768 . . . . 1.15 113.762 -159.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -127.68 167.37 20.04 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.782 1.182 . . . . 1.11 111.703 168.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.97 163.68 50.43 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.241 1.401 . . . . 1.35 112.759 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.51 11.93 14.97 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.199 1.555 . . . . 2.45 115.199 -142.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -70.95 -10.47 59.74 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.441 -1.412 . . . . 3.04 114.638 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.2 mtm -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.664 1.586 . . . . 2.29 113.403 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 t -84.77 -175.39 5.75 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.61 -0.681 . . . . 3.3 112.27 161.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 61.31 -16.05 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 129.053 2.941 . . . . 4.79 117.316 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -67.67 147.27 98.67 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.098 1.359 . . . . 3.36 111.851 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.95 -25.0 32.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.612 2.875 . . . . 2.11 112.718 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -104.65 84.98 1.05 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.43 -0.952 . . . . 3.9 108.43 157.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.58 154.25 73.05 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.753 2.302 . . . . 3.22 111.041 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 65.58 5.48 3.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.684 1.994 . . . . 4.24 112.946 -169.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.42 14.52 54.48 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.718 1.151 . . . . 3.31 114.429 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.45 44.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.972 1.272 . . . . 2.37 114.035 -167.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.1 -16.65 66.92 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.209 1.385 . . . . 1.93 113.164 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.68 0.08 29.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.149 1.357 . . . . 1.91 114.628 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.0 p -71.75 160.66 32.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.127 1.463 . . . . 1.76 109.924 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.51 150.72 20.21 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.762 1.225 . . . . 5.76 114.001 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -109.24 -37.92 5.65 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.317 0.647 . . . . 2.44 110.793 154.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.75 155.04 47.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.79 0.836 . . . . 0.52 112.69 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.1 t -139.09 147.51 42.07 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.223 2.209 . . . . 1.41 109.821 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 123.99 1.72 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.978 1.275 . . . . 0.72 112.624 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.22 126.19 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.792 1.237 . . . . 1.55 110.144 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 36.8 mt -80.87 142.79 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.642 1.177 . . . . 0.88 109.184 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 10.5 mmpt? . . . . . 0 CA--C 1.542 0.672 0 O-C-N 120.726 -1.234 . . . . 3.16 111.811 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.107 -0.331 . . . . 2.11 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -132.49 146.23 51.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.011 1.485 . . . . 1.0 115.011 -133.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -156.04 135.51 12.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.287 1.518 . . . . 2.8 111.603 164.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -108.51 87.5 2.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.229 2.212 . . . . 3.0 110.974 -165.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.23 125.4 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.21 1.189 . . . . 2.09 114.21 -171.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.0 100.68 0.59 Allowed Glycine 0 C--N 1.339 0.709 0 C-N-CA 125.191 1.377 . . . . 0.89 110.525 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.28 128.92 34.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.653 0.74 . . . . 1.44 111.931 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -111.09 143.4 41.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.904 2.081 . . . . 2.87 111.658 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.2 mt -80.83 56.26 2.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.599 1.16 . . . . 1.7 112.904 -169.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.1 153.45 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 122.262 1.029 . . . . 1.17 113.603 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -160.06 -156.26 0.48 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 125.728 1.611 . . . . 3.01 109.051 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.14 8.88 0.49 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.37 1.868 . . . . 1.25 114.075 -172.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -108.46 -7.52 15.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.815 1.646 . . . . 2.65 111.114 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.81 -142.63 17.14 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.644 -0.983 . . . . 0.97 110.644 -160.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -92.53 136.3 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.159 1.783 . . . . 0.83 110.907 -167.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.47 -68.26 0.28 Allowed Glycine 0 N--CA 1.473 1.146 0 C-N-CA 124.421 1.01 . . . . 1.62 115.316 -166.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.3 154.98 10.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.207 1.803 . . . . 1.85 110.8 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -129.82 122.42 28.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.9 -1.125 . . . . 1.6 112.273 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.65 25.97 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.458 1.503 . . . . 5.6 110.842 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.87 38.12 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.756 -0.59 . . . . 0.61 114.32 161.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 p -99.24 -179.28 4.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.963 0.905 . . . . 0.9 110.392 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 42.4 t -129.53 132.58 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.929 -1.137 . . . . 0.5 107.929 150.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.8 p -85.84 120.7 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.963 0.411 . . . . 0.81 110.761 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.58 138.93 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 124.917 1.287 . . . . 1.36 107.881 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.94 104.95 3.49 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.16 1.384 . . . . 2.28 109.56 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 151.08 44.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.032 -0.531 . . . . 2.82 111.558 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -158.38 -177.49 6.58 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.854 0.862 . . . . 1.3 110.547 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.5 -9.4 48.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.487 1.915 . . . . 3.74 113.001 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.45 16.27 41.37 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.854 1.693 . . . . 1.17 114.424 163.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.88 -151.42 23.86 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 127.235 2.35 . . . . 1.0 116.635 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.54 96.66 4.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.227 1.011 . . . . 0.8 111.728 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -70.77 143.32 51.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.086 0.954 . . . . 2.18 109.755 166.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.538 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 20.0 t80 -142.65 118.88 10.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.105 1.762 . . . . 0.53 109.363 -167.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 2.8 m -123.44 109.5 30.89 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.173 -0.918 . . . . 0.62 108.831 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.4 164.31 19.11 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.818 3.012 . . . . 0.52 110.929 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -158.63 33.78 0.23 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.314 0.857 . . . . 1.36 113.314 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 mp -91.77 136.06 33.43 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.378 -1.451 . . . . 0.93 112.018 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 14.98 21.63 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.499 2.037 . . . . 2.11 116.499 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.59 88.07 1.19 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.664 -0.648 . . . . 1.83 112.059 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 163.32 26.9 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.264 1.425 . . . . 1.48 111.298 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.51 124.31 13.09 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.013 1.809 . . . . 0.88 110.556 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.6 OUTLIER -84.47 45.17 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 127.203 5.269 . . . . 1.13 112.268 -163.381 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.13 -130.46 7.02 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 123.184 1.436 . . . . 1.45 111.866 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -147.56 127.95 13.99 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.253 1.421 . . . . 2.64 109.264 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -130.19 154.48 47.49 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.578 0.955 . . . . 1.08 113.578 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.35 155.87 51.75 Favored Glycine 0 CA--C 1.541 1.657 0 O-C-N 121.184 -0.948 . . . . 0.58 112.192 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.528 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 1.4 t80 -130.85 122.57 27.31 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.054 -1.462 . . . . 2.06 107.054 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 7.7 m170 -122.53 157.92 31.0 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.723 1.601 . . . . 1.03 114.43 165.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.6 mt -94.24 154.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 128.27 2.628 . . . . 0.74 108.22 158.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -139.04 145.13 39.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.002 0.921 . . . . 0.97 111.181 -170.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.57 67.0 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.242 1.941 . . . . 0.79 116.242 -163.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.43 -179.27 5.06 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.415 1.086 . . . . 1.07 113.211 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.0 32.76 4.47 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.597 1.57 . . . . 1.38 116.675 -163.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -138.69 104.12 5.02 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.224 1.512 . . . . 2.43 111.705 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -70.2 13.09 0.18 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 116.701 2.111 . . . . 1.42 116.701 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -84.45 131.52 49.96 Favored Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 119.694 -1.879 . . . . 3.07 112.115 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.71 149.16 29.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.524 2.816 . . . . 1.01 112.418 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.74 150.36 26.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.003 -0.544 . . . . 1.42 110.38 156.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.0 mm -117.14 136.76 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.829 1.652 . . . . 2.42 107.697 173.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -14.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.678 2.103 . . . . 5.51 116.678 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.36 46.7 0.28 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.795 1.18 . . . . 3.33 113.611 -163.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.1 22.3 68.75 Favored Glycine 0 N--CA 1.475 1.255 0 O-C-N 120.662 -1.274 . . . . 3.28 113.295 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -163.32 155.22 17.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.293 1.837 . . . . 2.91 110.501 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.0 138.51 46.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.243 1.417 . . . . 2.13 111.749 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.82 39.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.969 1.308 . . . . 2.4 111.377 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.4 -66.38 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.628 2.771 . . . . 2.25 116.207 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.91 107.13 0.96 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.074 2.55 . . . . 1.98 108.057 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -76.48 -54.1 7.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.484 0.714 . . . . 6.06 110.059 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.1 20.64 0.37 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.045 0.938 . . . . 1.87 113.325 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.4 -11.99 38.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.226 1.411 . . . . 0.83 112.08 157.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.18 -70.3 3.18 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 120.229 -1.544 . . . . 2.96 114.051 171.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.02 179.23 32.75 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.522 1.534 . . . . 1.42 112.909 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -61.28 -7.31 2.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.663 2.097 . . . . 2.57 116.663 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 tt 78.51 98.73 0.06 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.957 2.103 . . . . 2.25 110.027 169.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -168.55 55.01 0.27 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 115.714 1.746 . . . . 3.51 115.714 -148.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.39 -48.06 2.7 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.765 2.31 . . . . 2.63 113.218 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -137.41 79.04 1.72 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.459 1.103 . . . . 4.21 110.058 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.96 -77.67 0.58 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.601 1.16 . . . . 3.93 109.769 166.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -178.6 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.894 2.077 . . . . 2.38 111.414 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.55 -9.3 58.82 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.245 0.926 . . . . 1.76 114.679 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.92 -14.35 61.9 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 116.052 1.871 . . . . 5.13 116.052 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.9 t60 70.74 164.19 0.27 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.308 1.843 . . . . 1.55 111.5 -166.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -157.28 -152.38 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.886 -1.134 . . . . 3.95 112.216 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.27 -40.18 0.16 Allowed Glycine 0 CA--C 1.543 1.805 0 C-N-CA 127.938 2.685 . . . . 2.36 113.213 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -112.34 -1.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.617 2.878 . . . . 3.32 115.606 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.08 -7.19 0.82 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.116 1.895 . . . . 6.36 116.116 -159.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.36 -23.03 5.71 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 119.712 -1.867 . . . . 3.74 114.322 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.71 64.26 2.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.089 2.156 . . . . 4.92 113.451 -168.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 -93.39 0.11 Allowed Glycine 0 N--CA 1.469 0.899 0 O-C-N 120.457 -1.402 . . . . 2.48 113.655 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -138.15 156.03 48.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.23 2.212 . . . . 3.63 108.279 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -84.96 -21.72 29.46 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.523 1.056 . . . . 1.99 113.131 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.63 19.84 22.15 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 117.806 -1.552 . . . . 0.97 116.068 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -95.2 138.12 33.33 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 120.636 2.218 . . . . 1.49 111.065 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.528 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 5.2 mp -129.49 155.66 79.82 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.945 1.698 . . . . 2.22 110.391 -169.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.02 162.04 43.01 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.417 2.744 . . . . 0.99 111.787 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.0 127.24 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.902 1.334 . . . . 1.56 113.237 -160.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 85.04 3.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 129.438 3.095 . . . . 2.48 108.57 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.12 149.55 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 0.92 109.152 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.27 133.6 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.663 1.185 . . . . 1.69 110.281 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.45 141.99 58.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.754 1.02 . . . . 1.82 113.754 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -46.42 -23.92 0.43 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 129.016 2.927 . . . . 2.54 117.581 -170.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.58 -19.31 45.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.139 1.775 . . . . 3.05 112.482 -168.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.69 30.95 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.43 1.491 . . . . 0.92 113.483 -170.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.24 127.66 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.008 1.723 . . . . 1.11 108.492 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.76 136.54 33.06 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.131 0.972 . . . . 0.82 110.547 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.3 t -153.11 -2.43 0.22 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.918 1.687 . . . . 1.11 113.052 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -80.43 118.96 74.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 128.387 2.675 . . . . 5.03 112.283 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.09 149.43 28.52 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.931 3.087 . . . . 1.45 112.971 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.03 166.62 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.98 1.712 . . . . 1.28 110.591 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -138.99 137.1 36.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.9 1.28 . . . . 0.85 109.553 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -112.42 110.17 53.23 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.338 0.655 . . . . 1.0 112.758 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.51 -0.95 11.13 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.879 3.052 . . . . 1.34 114.692 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -73.87 -11.12 60.27 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.951 1.25 . . . . 4.62 113.238 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.78 141.98 33.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.865 2.066 . . . . 2.42 108.417 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 18.79 2.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.931 1.826 . . . . 6.95 115.931 -160.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 85.9 p -153.24 164.72 37.58 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.821 1.248 . . . . 2.59 108.329 167.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.0 tp -84.4 -34.61 23.5 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.676 -0.64 . . . . 2.28 109.657 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.65 -41.36 42.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 2.89 113.078 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -72.92 -5.09 36.16 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.231 1.197 . . . . 1.91 114.231 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.03 13.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.024 1.329 . . . . 0.8 113.541 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -59.7 -5.07 0.79 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 117.361 2.356 . . . . 2.23 117.361 -172.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.66 22.11 2.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.055 1.342 . . . . 3.51 112.807 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -104.47 151.81 23.1 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.297 -0.877 . . . . 2.58 112.866 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.47 148.42 27.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.836 -0.62 . . . . 0.71 110.182 157.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.2 145.62 42.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.349 -0.982 . . . . 1.54 108.349 156.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.9 150.86 52.12 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.201 0.815 . . . . 2.48 113.201 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.5 mt -99.06 132.9 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.098 1.759 . . . . 0.72 108.146 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -123.19 143.39 50.05 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.098 1.359 . . . . 2.77 112.197 -164.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 37.9 t -67.1 -35.4 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.922 -1.111 . . . . 1.39 112.982 -160.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -108.19 150.74 17.0 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.182 0.896 . . . . 1.12 111.937 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.89 147.81 40.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.634 1.111 . . . . 1.58 111.376 159.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.404 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 25.3 t0 -103.4 -15.07 16.02 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.471 1.656 . . . . 2.95 115.471 -138.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.24 51.98 0.57 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.415 1.635 . . . . 2.9 115.415 -168.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.94 131.51 25.47 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.703 -1.248 . . . . 2.48 112.316 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -138.06 -54.93 0.65 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.717 0.807 . . . . 3.23 112.671 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.95 39.46 0.23 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.978 2.111 . . . . 4.28 113.881 -164.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -124.18 163.58 35.03 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.155 2.582 . . . . 3.7 109.773 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.84 -19.36 64.19 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.291 2.661 . . . . 2.47 113.755 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -127.81 136.47 29.03 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 118.856 0.753 . . . . 4.52 109.944 148.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.52 162.37 41.11 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.919 2.413 . . . . 3.75 110.176 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 mp 60.07 9.1 1.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.01 1.724 . . . . 3.87 112.868 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 10.64 57.29 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.716 -1.24 . . . . 3.3 114.139 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.7 83.07 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.434 1.016 . . . . 2.08 113.891 -166.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.55 10.5 50.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.718 1.627 . . . . 1.7 115.006 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.83 -4.13 70.28 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.128 1.347 . . . . 1.45 114.537 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 p -62.71 157.99 19.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.048 1.339 . . . . 1.45 110.319 164.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.68 150.11 27.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.043 1.337 . . . . 6.72 113.381 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -107.52 -19.82 13.44 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.436 0.902 . . . . 2.38 113.436 162.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.24 156.32 23.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.205 0.911 . . . . 0.5 112.851 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.23 163.61 15.42 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.393 1.477 . . . . 2.28 110.114 157.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -151.96 134.44 4.58 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.821 1.676 . . . . 0.69 110.371 159.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.52 129.65 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.482 1.113 . . . . 1.53 109.873 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.4 mt -64.88 124.52 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.628 1.171 . . . . 1.17 112.052 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 113.168 0.803 . . . . 3.45 113.168 177.559 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.72 0.295 . . . . 2.77 110.484 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -150.84 155.78 39.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.206 1.402 . . . . 1.38 109.194 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -154.59 121.51 5.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.113 1.365 . . . . 2.6 109.601 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -86.58 102.43 14.14 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.638 -1.289 . . . . 3.53 108.834 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.1 121.28 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 119.882 1.219 . . . . 1.05 110.586 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.6 104.13 2.26 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.644 1.593 . . . . 0.99 110.983 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt -88.33 145.33 25.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.346 1.069 . . . . 1.41 113.504 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -120.35 149.13 42.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.238 1.815 . . . . 2.86 111.706 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.34 65.72 2.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.168 1.787 . . . . 1.45 111.139 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -74.39 157.84 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.705 1.202 . . . . 1.46 112.836 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -159.97 -156.78 0.51 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.309 1.444 . . . . 3.21 109.722 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.32 60.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.324 2.25 . . . . 1.21 113.587 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -87.33 -15.74 37.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.172 1.789 . . . . 3.02 112.198 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.24 -139.62 14.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.724 1.154 . . . . 1.07 110.717 -161.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.94 139.13 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 126.766 2.026 . . . . 1.56 113.284 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.67 -104.03 2.25 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.595 2.045 . . . . 1.6 113.26 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.12 149.57 42.0 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 127.264 2.226 . . . . 2.34 113.482 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -96.47 140.87 30.47 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.742 -1.224 . . . . 1.57 112.053 166.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.64 5.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 125.351 1.46 . . . . 2.73 113.947 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.99 168.26 21.71 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.075 0.845 . . . . 0.94 112.639 -168.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 p -116.86 -175.76 2.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.337 1.055 . . . . 0.87 109.162 170.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.482 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 44.7 t -129.08 135.65 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.441 -1.318 . . . . 0.71 107.441 157.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.88 124.78 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.398 0.437 . . . . 1.03 110.203 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.7 127.67 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.371 1.068 . . . . 2.0 108.971 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -143.08 134.66 26.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.211 1.404 . . . . 2.04 110.452 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 117' ' ' LEU . 41.7 mt-10 -92.69 138.1 31.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.387 -1.733 . . . . 3.82 112.087 -162.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 -175.51 4.99 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.577 -0.849 . . . . 1.52 112.276 168.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -70.97 -6.97 42.81 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.956 1.095 . . . . 3.88 113.956 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.67 12.15 53.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.764 1.649 . . . . 1.25 113.913 162.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -152.7 21.65 Favored Glycine 0 N--CA 1.462 0.418 0 C-N-CA 128.083 2.754 . . . . 0.93 116.225 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.3 mt -71.64 103.68 3.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.999 . . . . 0.88 111.259 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -76.63 116.41 17.28 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.239 1.016 . . . . 2.36 109.081 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.482 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 25.4 t80 -113.56 113.03 24.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.239 2.216 . . . . 0.83 109.19 -170.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.8 m -120.8 107.19 38.46 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 108.124 -1.065 . . . . 0.72 108.124 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.65 164.31 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.505 2.803 . . . . 0.42 110.685 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -152.67 30.63 0.52 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.133 0.968 . . . . 1.31 112.669 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -89.78 132.76 35.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.919 -1.113 . . . . 0.81 110.911 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -107.9 18.64 21.04 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 116.36 1.985 . . . . 2.58 116.36 -159.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.62 75.69 0.56 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.14 0.976 . . . . 1.59 111.992 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.11 158.43 69.46 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.791 1.237 . . . . 1.57 110.871 173.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 37.4 Cg_endo -63.6 131.19 30.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.484 1.456 . . . . 1.11 110.879 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 5.2 Cg_endo -87.2 34.76 0.43 Allowed 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 126.141 4.561 . . . . 1.06 113.203 -150.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.84 -135.07 8.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.99 1.757 . . . . 1.26 114.072 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.51 131.53 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.919 1.688 . . . . 2.4 108.417 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -132.73 147.21 52.32 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 124.561 1.144 . . . . 1.18 112.392 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.44 149.31 51.34 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 120.943 -1.098 . . . . 0.81 111.458 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -124.75 111.4 15.51 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.492 -1.67 . . . . 1.93 106.492 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -116.24 157.43 24.91 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.633 -1.292 . . . . 1.11 113.697 171.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.28 152.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.594 1.557 . . . . 1.15 107.518 157.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.68 146.9 46.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.526 1.13 . . . . 1.08 108.768 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.12 70.28 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.388 1.625 . . . . 0.73 115.388 -153.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -125.42 155.24 40.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.481 1.113 . . . . 1.75 112.644 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.79 82.08 1.42 Allowed Glycine 0 N--CA 1.469 0.834 0 O-C-N 120.702 -1.249 . . . . 0.85 112.795 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -166.54 95.52 0.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.55 0.74 . . . . 1.98 112.778 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.9 m -67.67 45.69 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.389 2.275 . . . . 1.45 113.635 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -121.05 127.12 26.35 Favored Pre-proline 0 CA--C 1.553 1.063 0 O-C-N 119.783 -1.823 . . . . 3.64 111.113 -167.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -81.72 179.33 5.78 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.273 3.315 . . . . 1.09 114.562 -168.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.19 173.13 12.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.799 2.04 . . . . 1.46 109.669 160.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.97 134.5 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.909 1.283 . . . . 3.21 108.194 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -150.78 143.05 24.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.642 1.577 . . . . 4.74 110.14 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.61 25.96 13.86 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.204 1.187 . . . . 5.63 114.204 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.77 17.54 65.51 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.414 1.006 . . . . 4.36 115.001 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.16 162.56 39.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.173 1.487 . . . . 5.01 112.903 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.2 129.05 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.436 1.095 . . . . 2.19 111.384 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.41 -15.58 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.866 1.266 . . . . 2.55 113.549 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 70.69 -49.26 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 128.482 2.713 . . . . 2.33 113.574 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.67 106.69 3.71 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.24 1.016 . . . . 1.58 109.991 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -95.32 -43.5 8.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.483 1.113 . . . . 4.7 110.533 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.68 -9.03 31.93 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.256 1.022 . . . . 1.35 113.545 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.76 -15.63 60.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.334 1.235 . . . . 0.87 114.334 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.91 -173.67 55.32 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 120.572 -1.33 . . . . 2.12 114.228 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.51 -171.05 25.75 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 124.73 1.157 . . . . 1.3 113.131 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -64.87 8.91 0.1 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.898 2.079 . . . . 2.57 114.649 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.1 tp 60.74 83.83 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.344 1.858 . . . . 1.6 107.672 -164.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.435 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 54.4 p-10 -160.4 19.24 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 117.408 2.373 . . . . 4.33 117.408 -143.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 71.6 Cg_endo -69.58 -31.77 20.67 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.232 1.955 . . . . 2.44 115.498 -159.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -140.28 8.9 2.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.646 1.112 . . . . 3.1 113.286 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.49 -41.99 19.04 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.05 -1.031 . . . . 3.78 113.305 -164.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t 154.65 158.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 1 C-N-CA 132.237 4.215 . . . . 2.93 107.414 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.07 -38.6 9.08 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 123.408 0.528 . . . . 2.64 114.051 -171.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -77.77 176.25 9.2 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.362 1.065 . . . . 4.16 113.734 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -124.29 158.9 31.47 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.29 1.036 . . . . 2.52 112.105 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.636 ' CD ' ' H ' ' A' ' 84' ' ' GLY 0.286 2.7 pp20? -150.56 -116.71 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.066 1.136 . . . . 3.96 114.066 -174.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.636 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 148.2 -55.5 0.5 Allowed Glycine 0 CA--C 1.547 2.086 0 C-N-CA 129.122 3.248 . . . . 3.15 112.174 -171.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -97.95 -10.34 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.315 2.676 . . . . 3.7 116.714 -166.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 -15.4 0.5 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.241 2.312 . . . . 6.08 117.241 -162.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 -8.22 32.02 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.738 1.855 . . . . 3.15 117.738 166.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -72.69 56.55 0.4 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.527 2.163 . . . . 5.29 113.252 170.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.82 110.17 0.27 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 120.717 -1.24 . . . . 3.12 115.473 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.7 m170 59.99 -145.2 0.5 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.008 0.923 . . . . 4.05 111.804 162.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -143.35 -28.43 0.54 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.791 1.034 . . . . 2.0 113.791 153.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.14 29.16 2.82 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 125.0 1.286 . . . . 1.14 116.286 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -99.2 134.72 41.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.969 1.307 . . . . 1.56 110.232 171.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -131.37 152.25 80.19 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.167 1.387 . . . . 2.54 109.763 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.89 155.25 71.58 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.85 3.033 . . . . 1.28 111.418 -171.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.5 m -58.53 131.37 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 123.026 1.393 . . . . 1.51 113.08 -166.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.54 87.87 0.67 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.521 1.928 . . . . 2.54 108.137 167.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.94 138.35 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.115 0.966 . . . . 0.84 108.796 170.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -118.67 135.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 126.021 1.728 . . . . 1.56 107.111 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 149.11 50.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.773 0.715 . . . . 1.82 111.673 175.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -53.58 -15.22 1.06 Allowed 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 116.198 1.925 . . . . 2.17 116.198 -175.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -91.1 -8.92 47.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.391 1.876 . . . . 2.87 113.118 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 21.39 16.16 Favored Glycine 0 N--CA 1.476 1.339 0 C-N-CA 124.567 1.079 . . . . 0.97 114.782 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.2 mp -125.12 126.52 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.592 1.557 . . . . 1.34 107.582 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.87 112.68 22.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.397 -0.964 . . . . 0.72 108.397 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.0 t -131.79 -2.92 3.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.65 1.58 . . . . 1.0 112.715 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -72.64 115.08 36.01 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 128.041 2.537 . . . . 4.97 111.078 -173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.54 138.33 24.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.73 2.287 . . . . 1.22 110.965 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.88 165.17 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.857 1.263 . . . . 1.28 109.916 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.3 m -133.53 139.07 46.39 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.363 0.665 . . . . 0.87 109.77 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.3 87.03 15.47 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.785 0.834 . . . . 1.03 112.424 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 5.38 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.279 3.32 . . . . 1.46 115.31 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -77.36 -31.73 54.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.705 1.139 . . . . 5.36 111.246 170.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.91 127.44 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.909 1.684 . . . . 2.69 107.948 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 1.74 10.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.947 1.091 . . . . 5.06 113.947 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -154.08 165.69 35.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.077 1.751 . . . . 1.92 112.208 158.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.537 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.4 mm? -64.17 -29.95 71.03 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.405 -0.81 . . . . 1.93 111.081 162.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.12 -46.65 5.91 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.048 2.139 . . . . 2.99 114.383 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -76.59 -2.54 33.05 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.728 1.381 . . . . 2.31 114.728 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.08 13.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.087 1.355 . . . . 1.1 112.096 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -57.6 -16.56 10.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.083 1.753 . . . . 2.09 115.387 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.85 5.03 18.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 130.0 3.32 . . . . 4.77 113.508 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.02 173.26 7.0 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.051 1.871 . . . . 1.21 116.051 -158.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.77 144.13 33.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.15 1.38 . . . . 0.73 111.63 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.05 131.8 52.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.761 1.624 . . . . 1.68 107.581 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.1 mtt -132.79 124.27 27.73 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.24 0.83 . . . . 1.32 113.24 -170.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.26 114.87 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.842 1.257 . . . . 0.83 108.43 171.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -99.31 147.36 25.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.48 1.912 . . . . 2.24 112.29 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.74 -50.42 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.816 -0.611 . . . . 1.4 110.05 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.23 152.64 47.07 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.76 -0.536 . . . . 2.1 111.76 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.61 -163.88 21.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.725 2.107 . . . . 2.3 114.022 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -155.88 98.72 1.93 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.282 1.033 . . . . 3.2 110.32 -170.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -176.83 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.103 1.761 . . . . 3.09 113.908 -167.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.3 ptp -127.97 76.68 1.7 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.555 -1.341 . . . . 3.78 113.264 -146.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 p -72.2 109.88 6.27 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.747 -1.22 . . . . 4.79 112.18 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 97.2 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 129.961 3.304 . . . . 3.83 112.834 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.49 144.37 10.32 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.174 0.989 . . . . 7.5 112.073 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.64 -52.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.876 3.051 . . . . 2.39 110.929 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -67.82 115.93 32.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.977 -1.12 . . . . 4.0 107.977 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.79 164.77 34.65 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.886 2.391 . . . . 3.61 113.29 -160.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.9 tp 71.13 -13.22 0.53 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.939 2.096 . . . . 4.93 115.244 164.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 125.26 -2.19 8.3 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.309 1.909 . . . . 3.97 115.014 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.31 -25.6 0.87 Allowed Glycine 0 CA--C 1.54 1.61 0 N-CA-C 117.249 1.66 . . . . 2.56 117.249 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -112.11 60.21 0.34 Allowed Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.322 1.915 . . . . 2.33 112.168 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.4 -1.89 88.91 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.497 1.523 . . . . 2.43 114.797 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -63.11 146.8 52.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.524 1.162 . . . . 2.42 109.771 166.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -106.11 153.28 22.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.585 1.154 . . . . 4.67 110.025 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -98.2 -21.88 16.47 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.138 -0.458 . . . . 2.74 111.974 155.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.81 161.87 36.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.588 1.329 . . . . 0.62 114.588 174.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.0 t -142.42 152.09 42.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.256 2.222 . . . . 1.3 109.798 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.26 133.82 4.28 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.794 1.188 . . . . 0.85 111.666 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 67.7 t -92.11 132.03 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.167 0.987 . . . . 1.51 109.467 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -71.04 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.52 1.128 . . . . 1.02 110.129 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt . . . . . 0 C--O 1.239 0.524 0 O-C-N 121.221 -0.925 . . . . 3.56 109.03 179.011 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.057 -0.72 . . . . 2.04 109.057 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.3 154.9 43.53 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.183 1.179 . . . . 1.08 114.183 -148.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -153.31 135.82 15.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.178 1.466 . . . . 3.67 111.699 161.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -89.43 111.27 22.11 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.368 1.867 . . . . 3.29 109.981 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.84 129.19 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 118.49 0.587 . . . . 1.19 110.306 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.71 112.55 3.52 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.184 1.373 . . . . 0.84 110.295 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.8 mtp -91.35 85.53 5.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.464 0.65 . . . . 1.69 110.61 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -68.36 139.77 55.85 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.979 0.912 . . . . 2.78 111.969 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.31 135.09 55.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.296 -0.631 . . . . 1.34 109.296 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.1 156.14 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.689 1.196 . . . . 0.96 110.378 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 t -169.52 48.04 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.027 0.931 . . . . 2.22 112.058 -169.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.22 -17.38 0.27 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.303 1.841 . . . . 1.47 115.181 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.37 -4.37 59.14 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.111 1.364 . . . . 2.65 112.035 171.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -159.11 14.91 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.8 1.667 . . . . 1.12 112.331 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.6 t -67.17 128.2 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.577 1.551 . . . . 0.93 111.07 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.49 -88.57 1.69 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.058 1.313 . . . . 1.43 112.726 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.37 161.46 9.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.661 2.385 . . . . 2.88 108.112 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 t -112.56 143.03 44.41 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.734 -1.229 . . . . 1.91 114.128 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.481 HG22 ' HD2' ' A' ' 38' ' ' LYS . 39.6 mm -108.5 37.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.579 1.552 . . . . 5.31 110.937 167.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.32 -154.15 25.3 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.661 -0.649 . . . . 1.18 113.738 161.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.4 p -140.06 179.53 6.57 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.009 1.324 . . . . 0.99 109.368 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.412 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 58.0 t -128.57 135.39 62.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.785 -1.191 . . . . 0.65 107.785 160.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.8 p -88.39 127.27 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.348 0.405 . . . . 0.84 110.697 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.12 134.4 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.737 0.815 . . . . 1.34 109.013 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -138.46 134.83 34.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.716 1.606 . . . . 2.01 108.45 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 157.87 18.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.935 1.087 . . . . 3.54 113.935 -175.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 t -152.26 173.78 14.59 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.668 1.187 . . . . 1.39 108.427 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.38 -13.13 62.01 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.286 -0.884 . . . . 4.74 112.058 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.41 18.53 57.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.885 1.707 . . . . 1.35 113.96 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 -143.02 21.17 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 127.692 2.568 . . . . 0.89 116.882 166.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.67 103.35 14.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.761 0.824 . . . . 0.63 111.519 -162.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -80.38 110.61 15.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.183 1.793 . . . . 2.51 110.286 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.412 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 5.7 t80 -99.52 119.63 38.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.649 2.779 . . . . 0.71 109.188 -176.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 21.6 m -129.41 110.45 17.79 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 119.858 1.208 . . . . 0.58 108.538 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -85.4 166.65 10.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.451 2.767 . . . . 0.47 111.426 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -152.36 18.26 0.64 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.258 1.207 . . . . 1.82 114.258 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.16 143.29 32.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.626 -1.296 . . . . 0.91 111.324 -174.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HD2' HG22 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -109.44 12.26 24.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.298 1.592 . . . . 2.63 115.298 -171.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.31 72.17 1.24 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.884 -1.053 . . . . 1.65 112.101 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.05 162.97 49.37 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 124.02 0.928 . . . . 1.47 112.561 168.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 25.6 Cg_endo -62.77 126.9 19.17 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.167 1.245 . . . . 1.36 111.243 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.5 OUTLIER -88.56 33.98 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.634 1 C-N-CA 125.938 4.425 . . . . 1.22 113.285 -147.578 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.1 -133.09 6.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 123.48 1.6 . . . . 1.24 113.247 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -124.16 135.83 53.77 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.576 1.55 . . . . 2.76 109.387 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.37 149.39 52.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.641 1.719 . . . . 1.47 115.641 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 138.7 49.26 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 110.19 -1.164 . . . . 0.71 110.19 160.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.16 107.26 6.03 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 105.738 -1.949 . . . . 2.02 105.738 168.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -118.55 166.16 13.05 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.248 1.573 . . . . 1.6 115.248 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.435 HG22 HD13 ' A' ' 74' ' ' LEU . 77.0 mt -96.17 139.87 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.565 1.946 . . . . 0.81 109.026 162.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -137.68 152.51 49.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.795 2.438 . . . . 2.23 110.42 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.89 -10.87 59.45 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 117.633 2.457 . . . . 1.08 117.633 -157.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.73 135.24 36.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.935 1.698 . . . . 1.16 112.434 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.38 59.53 4.35 Favored Glycine 0 N--CA 1.471 0.982 0 C-N-CA 125.572 1.558 . . . . 1.05 114.119 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.68 116.37 4.14 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.787 1.294 . . . . 2.86 114.073 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.3 m -89.7 9.38 27.31 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.822 2.049 . . . . 1.3 113.474 -175.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -68.92 129.25 92.44 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.641 1.577 . . . . 3.5 111.855 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -97.7 166.73 0.82 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.652 3.568 . . . . 1.32 113.513 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.96 169.62 8.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 2.33 111.91 162.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mm -119.68 117.71 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.19 1.396 . . . . 3.13 109.747 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -152.75 157.42 40.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.173 1.389 . . . . 4.48 111.466 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.29 27.41 9.81 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 115.788 1.773 . . . . 3.62 115.788 156.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.21 20.12 65.42 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.865 -1.147 . . . . 3.25 115.023 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -160.76 -172.35 3.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.798 1.639 . . . . 2.63 111.634 -169.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.22 139.82 35.7 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.9 -1.125 . . . . 1.5 110.533 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.97 43.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.574 1.15 . . . . 2.16 112.431 -159.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.15 -65.97 0.06 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 129.007 2.923 . . . . 1.74 116.053 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 176.48 95.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 1 C-N-CA 132.267 4.227 . . . . 1.49 105.457 -175.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.85 -38.31 9.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.494 1.917 . . . . 4.78 112.449 -158.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.76 31.73 0.09 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.324 1.449 . . . . 1.19 114.26 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.13 -11.78 21.1 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.088 1.755 . . . . 1.68 115.299 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 20.93 44.99 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.724 1.449 . . . . 3.7 116.724 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.84 -99.94 1.81 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.231 1.516 . . . . 2.5 111.829 174.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -118.68 -117.79 0.32 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.445 1.898 . . . . 3.4 106.981 164.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 49' ' ' ILE . 7.1 tt -174.41 92.73 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.011 2.125 . . . . 2.16 107.794 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 173.26 146.7 0.2 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 127.917 2.487 . . . . 3.42 111.826 -162.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.96 -38.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.258 2.639 . . . . 3.34 113.877 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.23 26.0 0.2 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.876 1.216 . . . . 3.81 113.736 -174.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.83 19.18 0.41 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.444 -1.41 . . . . 3.36 114.541 -167.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.69 -30.22 0.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 128.825 2.85 . . . . 2.68 114.17 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.18 -11.27 61.04 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.026 -1.43 . . . . 2.67 115.83 167.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -61.21 -19.68 61.91 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.795 1.798 . . . . 4.45 114.698 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.0 t60 98.9 167.0 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.758 2.823 . . . . 1.8 112.269 154.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -65.77 145.74 55.61 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.125 1.157 . . . . 5.19 114.125 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.23 -155.42 7.64 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.127 1.822 . . . . 3.24 112.15 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.78 -43.04 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.65 2.233 . . . . 4.1 111.72 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.03 -3.32 9.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.618 1.567 . . . . 5.88 112.869 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.29 167.07 22.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.871 1.7 . . . . 4.45 114.553 -170.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -158.03 177.38 11.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.372 1.869 . . . . 7.87 108.931 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.76 -20.81 0.02 OUTLIER Glycine 0 N--CA 1.465 0.594 0 CA-C-O 118.114 -1.381 . . . . 2.6 115.946 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.424 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 7.0 p-80 -159.87 153.97 23.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.563 1.681 . . . . 5.28 113.246 169.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.93 -18.89 63.4 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.236 -0.915 . . . . 2.35 113.318 -175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -89.42 5.75 83.75 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.46 1.505 . . . . 1.0 114.587 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -65.12 133.32 51.33 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 119.551 1.675 . . . . 2.35 107.742 160.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.29 159.8 36.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.722 1.209 . . . . 1.91 110.148 -153.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.21 154.18 56.76 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.558 2.839 . . . . 0.88 111.652 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 m -73.95 137.2 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 122.972 1.367 . . . . 1.44 114.046 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.2 98.54 4.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.965 2.506 . . . . 1.87 110.191 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.8 t -72.74 131.64 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.639 0.776 . . . . 0.93 110.143 173.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.48 138.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.722 2.409 . . . . 1.89 106.308 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 154.47 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.178 -0.951 . . . . 2.29 111.514 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -52.16 -12.31 0.23 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 116.987 2.217 . . . . 2.34 116.987 -176.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.85 -21.58 26.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.13 2.172 . . . . 2.94 113.098 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.62 9.52 23.03 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.327 1.441 . . . . 0.74 115.251 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 mt -116.35 135.91 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.104 1.362 . . . . 1.09 110.207 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.22 128.41 54.69 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.919 0.888 . . . . 0.73 110.801 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -145.37 14.12 1.42 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.512 1.301 . . . . 1.27 114.512 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -86.74 118.72 70.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.276 1.03 . . . . 2.97 111.159 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.07 133.11 16.1 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.134 3.223 . . . . 1.35 112.185 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.03 168.37 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 126.543 1.937 . . . . 1.55 110.5 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.7 m -140.63 143.57 35.27 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.704 1.138 . . . . 0.95 112.052 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.46 99.36 51.16 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.978 1.311 . . . . 0.64 113.123 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.53 18.59 0.94 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 125.201 3.934 . . . . 1.07 114.873 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -73.05 -35.1 66.65 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.3 -0.875 . . . . 4.82 111.634 171.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.35 165.12 11.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.287 2.235 . . . . 2.27 109.133 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.08 2.64 3.64 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.994 1.109 . . . . 4.19 113.994 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.7 p -152.14 166.91 30.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.204 1.802 . . . . 2.05 110.438 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.7 tp -85.42 -44.62 12.6 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.458 -0.776 . . . . 1.79 111.058 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.27 -23.81 62.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.212 1.405 . . . . 4.45 113.853 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.64 -12.32 60.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.842 1.053 . . . . 1.81 113.842 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.93 15.86 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.931 1.292 . . . . 1.15 113.29 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -51.15 -18.5 0.89 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 117.104 2.261 . . . . 2.75 117.104 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -121.92 11.47 10.34 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.586 1.955 . . . . 4.41 113.595 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -102.73 169.87 8.35 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.324 1.231 . . . . 1.72 114.324 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.62 44.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.646 0.779 . . . . 0.94 111.285 173.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.91 133.95 34.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.313 -1.736 . . . . 1.83 106.313 156.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.12 131.16 34.4 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.539 1.063 . . . . 1.58 112.171 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.93 114.35 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 107.074 -1.454 . . . . 0.93 107.074 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -87.0 146.89 25.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.544 1.137 . . . . 2.6 111.449 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.0 t -68.25 -37.61 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.193 0.597 . . . . 1.69 110.474 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.39 -163.32 6.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.064 0.84 . . . . 2.01 113.676 172.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.82 -146.32 10.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 127.466 2.46 . . . . 2.59 109.298 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -157.11 149.54 23.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.702 0.801 . . . . 3.56 110.967 161.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 56.3 t30 110.01 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 1 C-N-CA 131.703 4.001 . . . . 4.32 109.453 -161.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.6 ptp -165.05 69.26 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 123.062 1.41 . . . . 3.87 111.52 -162.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.6 p -97.76 0.09 46.27 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.253 2.221 . . . . 3.41 115.357 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -164.05 63.95 0.15 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.753 -1.217 . . . . 3.35 112.428 -163.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -130.31 149.78 74.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.072 1.349 . . . . 4.4 108.466 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.19 -35.68 84.34 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.402 2.735 . . . . 2.04 112.437 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -94.56 113.76 61.81 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.717 -1.216 . . . . 6.94 107.717 148.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.2 163.15 38.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.921 2.414 . . . . 3.92 111.104 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt 60.71 28.47 18.19 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.733 0.813 . . . . 4.25 110.435 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.86 3.14 7.47 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.413 1.483 . . . . 2.6 115.154 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.74 87.5 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 118.919 1.359 . . . . 2.29 114.052 -166.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.39 33.23 4.17 Favored Glycine 0 N--CA 1.474 1.189 0 C-N-CA 125.707 1.622 . . . . 1.88 114.594 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.19 -4.42 90.49 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.052 1.786 . . . . 1.91 115.039 -174.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.3 p -65.12 152.56 43.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.003 1.401 . . . . 2.27 110.752 165.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.35 132.48 54.08 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.486 1.114 . . . . 5.53 109.103 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -74.65 -33.44 62.52 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.69 0.677 . . . . 2.53 110.307 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.18 145.13 29.4 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.898 1.444 . . . . 0.78 114.898 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.5 t -68.69 -174.02 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 129.165 2.986 . . . . 2.61 111.548 164.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 164.54 62.06 0.02 OUTLIER Glycine 0 N--CA 1.465 0.626 0 C-N-CA 125.241 1.4 . . . . 0.74 112.99 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.9 p -61.69 125.87 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.53 0.732 . . . . 2.48 110.844 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.32 132.09 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.728 0.811 . . . . 0.9 108.816 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 CA--C 1.539 0.551 0 O-C-N 121.223 -0.923 . . . . 3.84 110.831 176.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.994 -0.373 . . . . 2.24 109.994 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -163.22 144.2 9.41 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.751 1.159 . . . . 1.31 108.32 -169.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -149.0 130.25 14.6 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.978 1.37 . . . . 3.4 111.118 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -80.99 106.99 13.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.842 1.657 . . . . 3.31 109.407 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.19 122.09 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.605 0.639 . . . . 1.09 111.025 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.613 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -72.91 104.91 1.63 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.059 1.79 . . . . 0.71 111.954 170.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.6 mmm -88.8 132.93 34.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.412 1.485 . . . . 1.67 111.359 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -106.53 145.42 31.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.642 1.177 . . . . 2.28 110.934 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 mt -61.11 142.42 56.7 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.549 1.14 . . . . 1.09 110.003 169.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.13 163.8 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.094 0.957 . . . . 1.34 110.738 175.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t 177.29 69.52 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.253 2.221 . . . . 2.71 110.763 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 67.02 -29.89 0.15 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.372 2.269 . . . . 1.79 115.932 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -17.35 64.86 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.666 1.586 . . . . 3.32 111.346 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.72 -160.53 17.18 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.368 1.937 . . . . 1.31 111.35 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.23 128.89 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.552 1.141 . . . . 1.15 109.74 169.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.81 -95.18 1.14 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 125.686 1.612 . . . . 1.5 113.26 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.58 166.18 34.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.217 1.407 . . . . 1.81 110.8 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 t -93.13 151.32 19.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.421 1.488 . . . . 1.1 114.341 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 15.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 127.192 2.197 . . . . 3.22 113.587 -173.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.49 175.89 15.39 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.441 1.02 . . . . 0.65 112.246 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.613 HG22 ' HA2' ' A' ' 6' ' ' GLY . 64.5 p -122.16 173.6 7.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.384 1.074 . . . . 0.92 109.273 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.16 132.18 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.489 -1.301 . . . . 0.59 107.489 162.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -86.35 124.84 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.774 0.321 . . . . 1.05 110.591 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.95 128.48 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.768 -1.197 . . . . 1.29 107.768 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -137.74 112.64 9.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.518 1.151 . . . . 2.35 110.483 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -70.31 111.44 5.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.437 2.295 . . . . 3.22 112.064 -167.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 159.73 15.35 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.084 -1.08 . . . . 2.59 108.084 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.93 -19.34 64.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.471 0.708 . . . . 4.48 111.868 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.83 30.8 9.66 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.012 1.768 . . . . 1.81 113.959 165.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.37 -135.31 9.84 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 119.921 2.728 . . . . 2.04 119.921 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.38 113.27 21.15 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.955 1.302 . . . . 0.71 110.147 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.77 109.42 15.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.164 0.986 . . . . 1.98 109.733 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t80 -92.05 121.08 33.27 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.19 1.796 . . . . 0.87 108.492 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.5 m -128.36 113.54 19.71 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 119.29 0.95 . . . . 1.0 108.694 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.15 157.12 13.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.491 2.794 . . . . 0.71 110.98 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.27 40.86 0.42 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.561 1.172 . . . . 2.36 111.613 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -101.39 140.46 35.66 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.48 1.512 . . . . 0.6 112.314 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 31.37 6.74 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.394 1.628 . . . . 2.06 115.394 -167.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.27 65.17 0.69 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.075 0.95 . . . . 1.4 111.972 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.86 157.58 32.55 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 113.896 1.073 . . . . 1.32 113.896 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.05 139.24 13.4 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 O-C-N 123.555 1.292 . . . . 1.52 112.083 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -77.97 31.14 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.867 1 C-N-CA 128.948 6.432 . . . . 1.85 114.164 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.77 -135.96 6.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-O 123.58 1.655 . . . . 1.47 110.195 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -136.3 133.57 37.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.717 1.607 . . . . 2.81 107.949 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -127.36 137.57 52.8 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.688 1.195 . . . . 0.98 109.58 -169.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 156.15 49.21 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 119.664 1.12 . . . . 0.61 111.743 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.6 t80 -129.42 118.87 22.87 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.322 -1.362 . . . . 1.9 107.322 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -118.09 157.69 26.41 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.427 2.01 . . . . 0.91 116.427 163.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -98.54 142.05 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.375 1.47 . . . . 0.72 108.488 158.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -128.38 141.82 51.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.508 1.923 . . . . 0.94 110.256 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.44 -29.82 70.79 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.819 2.155 . . . . 0.75 116.819 -158.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -120.63 154.48 35.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.194 1.398 . . . . 1.28 111.746 171.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.43 84.17 1.58 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 120.844 -1.16 . . . . 0.82 113.301 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 t -166.76 95.71 0.52 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.745 1.017 . . . . 2.26 113.745 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 16.0 m -62.31 10.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.001 1.852 . . . . 1.48 116.001 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -87.6 129.33 51.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 119.953 -1.717 . . . . 3.37 110.031 -166.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.1 155.14 33.35 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.387 2.058 . . . . 1.34 110.618 166.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.24 145.32 51.45 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.684 -0.635 . . . . 1.63 110.218 158.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 mm -96.75 123.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.968 1.307 . . . . 3.38 108.561 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -169.47 157.82 7.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.244 1.418 . . . . 5.18 111.775 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.78 27.34 14.62 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.251 1.021 . . . . 4.52 112.317 167.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.11 84.64 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 126.381 1.943 . . . . 3.68 114.914 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.59 -152.64 0.41 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.451 1.501 . . . . 3.94 109.902 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.04 146.02 21.32 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.161 -0.962 . . . . 1.88 113.042 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.69 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.563 1.545 . . . . 1.89 113.16 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 67.81 -61.23 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 127.969 2.508 . . . . 2.0 116.584 168.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 166.35 99.83 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 C-N-CA 132.536 4.335 . . . . 1.86 106.583 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -123.52 -45.97 2.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 3.66 113.162 -157.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.07 -19.58 20.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.043 1.337 . . . . 1.48 113.391 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.13 -12.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.146 2.578 . . . . 0.83 114.809 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.38 16.8 58.32 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.333 1.424 . . . . 3.21 115.022 163.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.17 -173.98 41.75 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.246 1.023 . . . . 1.21 112.339 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -63.49 141.29 58.82 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.737 -0.861 . . . . 2.27 109.937 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.31 111.8 3.18 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.129 -0.357 . . . . 1.69 110.248 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.5 t0 169.7 126.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 128.762 2.825 . . . . 5.66 111.645 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.04 -36.51 1.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.104 1.869 . . . . 2.39 113.65 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -165.57 8.41 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.804 2.52 . . . . 4.4 117.804 -156.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.99 -27.08 65.06 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.815 2.098 . . . . 4.87 114.616 -170.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 165.89 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.967 3.307 . . . . 3.96 110.832 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.74 -18.51 38.6 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.863 1.221 . . . . 2.84 114.63 169.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -69.87 -7.73 42.65 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.558 1.688 . . . . 7.38 115.558 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.406 ' CD2' ' HA3' ' A' ' 142' ' ' GLY . 76.9 t60 68.56 157.13 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.825 2.45 . . . . 1.53 112.774 -172.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 84' ' ' GLY . 2.6 pp20? -140.41 -136.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.586 0.755 . . . . 4.49 112.315 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.565 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 144.33 -46.02 0.83 Allowed Glycine 0 CA--C 1.538 1.518 0 C-N-CA 130.401 3.857 . . . . 4.03 110.483 -172.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -108.02 -10.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.663 2.909 . . . . 4.1 115.633 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -139.26 -3.19 1.57 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.453 2.019 . . . . 5.24 116.453 -159.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.1 -31.04 1.57 Allowed Glycine 0 N--CA 1.472 1.09 0 O-C-N 120.45 -1.406 . . . . 4.73 114.874 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -72.77 71.65 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.444 1.498 . . . . 5.12 112.213 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.19 -91.61 0.09 OUTLIER Glycine 0 CA--C 1.523 0.579 0 C-N-CA 125.322 1.439 . . . . 2.19 111.584 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -133.83 151.17 51.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.012 1.725 . . . . 3.62 109.603 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.49 -28.71 68.79 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.219 0.918 . . . . 1.92 113.169 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.15 16.37 55.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.863 1.697 . . . . 0.76 115.357 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -89.96 122.38 32.93 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.941 1.371 . . . . 2.21 109.867 168.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.478 HD12 ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -116.43 158.93 41.91 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.527 1.531 . . . . 1.77 109.795 -178.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.97 171.42 18.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.429 2.753 . . . . 1.68 111.759 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.42 131.71 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.7 1.37 . . . . 1.39 114.7 -163.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.65 94.52 0.59 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.221 2.608 . . . . 1.74 108.307 164.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.22 140.15 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.969 0.908 . . . . 0.93 109.672 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.18 131.8 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.71 1.204 . . . . 1.77 108.866 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.0 140.04 40.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.763 0.792 . . . . 2.07 111.793 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.23 60.46 0.43 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.715 2.006 . . . . 4.63 113.509 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.51 6.93 0.29 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.432 2.293 . . . . 3.92 112.314 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.53 3.94 43.46 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 126.297 1.904 . . . . 1.73 115.406 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.65 132.21 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.301 1.05 . . . . 1.73 110.291 -167.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 126.51 33.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.837 -0.539 . . . . 0.68 110.089 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 t -141.39 -0.95 1.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.715 1.376 . . . . 1.08 114.715 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -87.26 123.29 70.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.955 1.302 . . . . 3.16 110.895 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.93 149.45 42.16 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.037 3.158 . . . . 1.61 112.466 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.93 158.05 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.812 1.245 . . . . 1.42 109.691 164.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.4 m -112.86 143.61 43.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.45 0.7 . . . . 1.34 109.157 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -103.36 84.37 0.73 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.64 1.576 . . . . 0.91 110.671 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.89 1.54 7.56 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.845 3.03 . . . . 1.6 113.707 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.477 HH11 ' HG3' ' A' ' 113' ' ' ARG . 6.5 ttm-85 -76.92 -25.12 52.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.037 0.935 . . . . 5.29 112.404 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.09 178.86 4.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.691 1.996 . . . . 2.43 109.607 165.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -16.81 2.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.552 1.316 . . . . 4.02 114.552 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -154.84 166.55 33.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.103 1.32 . . . . 1.57 112.734 -169.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.65 -29.44 16.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.866 0.866 . . . . 2.3 111.244 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -28.98 70.14 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.86 -1.15 . . . . 3.35 113.247 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.6 -17.47 63.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.471 0.708 . . . . 2.58 112.89 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.73 13.91 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 113.485 0.92 . . . . 0.82 113.485 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -59.68 -21.34 60.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.141 1.534 . . . . 2.6 115.141 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -134.03 105.54 6.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.561 1.544 . . . . 3.51 107.983 160.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -158.84 163.32 36.75 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.969 2.908 . . . . 1.53 109.329 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.62 158.45 16.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.493 0.663 . . . . 0.86 110.676 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -130.69 117.0 18.81 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.295 2.238 . . . . 1.69 106.876 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.8 mtt -117.67 122.01 42.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.731 0.696 . . . . 1.49 111.172 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.6 mt -87.97 115.93 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.909 -1.515 . . . . 0.81 106.909 166.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -98.58 151.12 21.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.298 1.839 . . . . 2.17 112.267 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.3 m -63.17 -29.52 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 114.641 1.349 . . . . 2.6 114.641 -160.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.17 168.28 24.4 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.457 1.503 . . . . 1.27 110.852 167.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.58 136.82 22.22 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.082 1.801 . . . . 1.49 114.08 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.02 114.84 29.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.801 1.64 . . . . 3.55 109.932 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -167.47 36.18 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.177 0.991 . . . . 3.53 112.514 -172.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.6 mtm -140.48 110.51 6.54 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.339 1.056 . . . . 2.33 112.985 -165.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.7 m -93.08 156.78 16.66 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 2.77 111.971 168.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.06 32.45 2.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.061 2.144 . . . . 6.14 116.12 165.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -115.86 146.51 37.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.113 1.365 . . . . 3.53 110.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.1 17.77 0.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.54 3.493 . . . . 3.35 114.069 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -98.53 113.38 64.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 121.107 -0.996 . . . . 7.53 108.884 173.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.58 153.66 73.62 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.158 2.572 . . . . 5.05 113.781 -156.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 tp 72.68 -1.14 3.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.66 1.984 . . . . 5.79 113.721 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' A' ' 82' ' ' HIS . . . 106.26 38.11 2.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.137 1.351 . . . . 6.33 113.224 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.02 -41.15 2.95 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.22 1.391 . . . . 3.87 113.556 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.07 -19.48 65.95 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 118.389 1.095 . . . . 3.12 115.407 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 46.53 -110.69 0.55 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.65 1.595 . . . . 2.0 115.457 161.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 m -69.17 151.77 45.94 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.318 1.447 . . . . 2.63 111.126 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.95 132.15 45.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.566 1.547 . . . . 4.71 108.238 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -83.11 -42.8 16.96 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 120.092 1.314 . . . . 2.97 110.373 169.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.03 151.82 33.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.053 0.941 . . . . 0.55 112.645 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.0 t -127.36 148.37 50.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.873 2.069 . . . . 1.4 111.09 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -145.44 155.67 26.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.592 2.52 . . . . 1.23 111.701 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.46 1.104 . . . . 1.53 111.442 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 153' ' ' ILE . 3.4 mp -82.47 149.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.342 1.857 . . . . 1.32 110.145 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.796 0 O-C-N 120.051 -1.655 . . . . 4.84 110.938 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.244 0.068 . . . . 1.66 110.948 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.5 148.16 22.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.572 1.149 . . . . 1.24 109.201 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -151.15 127.2 10.44 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 123.191 1.472 . . . . 2.38 110.943 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -105.19 97.36 7.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.019 1.728 . . . . 3.46 111.663 -167.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.52 131.17 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 115.17 1.544 . . . . 2.03 115.17 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.6 103.01 1.19 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.499 1.047 . . . . 0.82 110.79 167.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.5 mtp -85.34 131.16 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.503 0.721 . . . . 1.16 110.406 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -110.7 145.38 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.115 1.366 . . . . 3.2 113.108 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.4 mt -77.93 62.5 2.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.153 1.381 . . . . 1.7 111.673 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 m -55.07 130.79 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.246 1.418 . . . . 0.96 112.02 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -158.63 72.18 0.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.007 1.484 . . . . 2.64 115.007 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.51 -40.46 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.744 2.418 . . . . 1.49 113.767 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.96 6.46 4.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.552 1.541 . . . . 2.52 111.546 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.89 -159.14 31.24 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 126.079 1.8 . . . . 1.16 112.769 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -42.11 126.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.405 1.482 . . . . 0.98 110.725 159.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.27 -60.26 0.26 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.067 1.318 . . . . 1.97 114.429 -170.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -174.79 160.2 2.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.499 1.92 . . . . 2.75 110.738 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -152.69 148.64 27.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.163 1.542 . . . . 1.86 115.163 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.62 56.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 130.149 3.38 . . . . 6.21 108.838 173.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.48 -177.94 39.92 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 113.226 -1.806 . . . . 0.64 114.316 146.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.3 p -115.61 177.74 4.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.633 1.173 . . . . 0.77 110.928 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.04 133.31 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.336 -0.987 . . . . 0.48 108.336 156.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 11.3 p -87.49 119.49 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.65 0.593 . . . . 0.94 110.337 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.15 117.73 47.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.191 -1.411 . . . . 1.4 107.191 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -119.76 125.35 48.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.288 1.435 . . . . 2.4 108.563 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.22 130.99 34.34 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.371 -0.603 . . . . 3.34 109.371 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.6 t -148.86 -179.62 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.166 0.439 . . . . 1.29 110.378 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.22 -4.27 40.95 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.918 1.081 . . . . 3.71 113.918 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.3 9.57 67.28 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 124.159 0.885 . . . . 1.18 114.18 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.1 -146.47 21.97 Favored Glycine 0 N--CA 1.463 0.448 0 C-N-CA 128.417 2.913 . . . . 0.93 115.536 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.9 104.65 7.51 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.3 0.64 . . . . 0.87 111.107 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -84.6 115.18 22.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.791 2.036 . . . . 3.8 109.988 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.26 104.65 14.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.776 1.63 . . . . 1.03 109.58 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 9.0 m -110.27 109.21 58.69 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.519 1.054 . . . . 0.75 108.346 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.1 159.36 18.0 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.586 2.858 . . . . 0.64 111.127 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -146.41 27.23 1.14 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 121.418 0.628 . . . . 1.34 112.479 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.85 140.86 30.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.805 -1.184 . . . . 0.69 111.308 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 26.69 8.01 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.452 1.649 . . . . 2.21 115.452 -170.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.18 81.14 1.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.717 0.807 . . . . 1.55 110.933 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.72 163.36 41.29 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.839 1.256 . . . . 1.35 110.407 168.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.29 128.97 24.02 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 121.006 1.137 . . . . 0.8 110.619 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -79.8 25.23 0.6 Allowed 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 126.563 4.842 . . . . 0.93 113.047 -162.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.6 -124.7 1.48 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 126.725 2.107 . . . . 1.37 112.571 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -151.28 138.71 19.49 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.77 1.228 . . . . 2.9 110.842 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -136.69 142.73 43.15 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.081 0.771 . . . . 1.11 113.081 -163.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.07 153.77 51.63 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 111.28 -0.728 . . . . 0.77 111.28 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -131.79 115.54 16.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.49 1.116 . . . . 1.98 108.161 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.424 ' HA ' HD22 ' A' ' 94' ' ' LEU . 16.9 m170 -115.97 165.67 12.85 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 117.121 2.267 . . . . 1.01 117.121 167.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.0 mt -108.05 148.34 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 128.414 2.686 . . . . 0.77 108.045 154.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -126.16 163.39 23.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.94 1.296 . . . . 1.17 110.425 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.4 75.91 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.586 1.699 . . . . 0.99 115.586 -163.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.74 169.08 14.24 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.144 1.378 . . . . 1.84 113.144 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.9 93.91 1.53 Allowed Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.005 1.288 . . . . 1.21 113.087 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -151.58 57.05 0.87 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.816 1.413 . . . . 3.63 114.816 -165.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 64.6 m -64.72 37.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 116.505 2.039 . . . . 1.5 116.505 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -137.1 143.66 42.92 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 119.606 -1.934 . . . . 3.77 110.889 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.12 148.77 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.234 2.623 . . . . 1.02 113.432 -168.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.3 137.1 40.92 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.489 -0.778 . . . . 1.38 109.669 157.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.73 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.993 -1.114 . . . . 2.82 107.993 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -147.21 133.66 19.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.15 0.98 . . . . 4.15 111.042 -160.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.21 19.22 5.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.181 1.393 . . . . 3.72 113.151 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.05 63.15 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.086 1.327 . . . . 2.71 115.313 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -137.27 -177.76 4.91 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.685 1.243 . . . . 3.09 111.714 169.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.85 115.59 26.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.186 0.994 . . . . 1.65 112.456 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -87.2 79.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.106 1.362 . . . . 1.77 110.47 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 19.89 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.33 3.452 . . . . 2.3 117.991 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.44 41.64 0.88 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.557 1.943 . . . . 2.04 110.766 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -54.76 -37.19 65.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.144 -0.973 . . . . 4.03 113.582 -169.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -4.48 17.98 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.54 1.311 . . . . 2.06 114.54 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.1 -7.45 58.9 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.085 -1.009 . . . . 1.49 113.706 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 -179.35 32.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.807 -1.183 . . . . 2.05 113.882 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.26 175.51 50.96 Favored Glycine 0 N--CA 1.474 1.222 0 N-CA-C 110.998 -0.841 . . . . 1.9 110.998 161.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.44 36.06 0.19 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.608 1.204 . . . . 2.94 113.561 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.5 tp 65.07 78.62 0.28 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.705 2.002 . . . . 1.79 112.349 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 90' ' ' HIS . 44.5 t0 -156.15 124.68 2.94 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 126.543 1.937 . . . . 5.62 111.152 166.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.25 -22.52 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.216 2.611 . . . . 2.36 113.838 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -145.7 -31.11 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.255 1.946 . . . . 4.65 116.255 -157.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -60.63 -42.33 96.68 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 121.111 1.778 . . . . 4.57 111.561 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t 179.52 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.909 2.484 . . . . 2.18 112.419 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 -15.91 4.18 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.541 -1.349 . . . . 2.36 114.331 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -58.79 -82.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.614 1.965 . . . . 4.78 113.39 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 81.1 t60 153.32 128.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 129.754 3.221 . . . . 1.44 110.479 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -130.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.365 1.066 . . . . 3.71 111.94 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.24 -51.1 0.85 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.498 1.999 . . . . 2.78 111.761 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -104.14 -22.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.692 2.261 . . . . 3.11 114.877 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -157.25 28.61 0.3 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.302 1.41 . . . . 5.24 114.539 -160.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.05 -12.07 5.64 Favored Glycine 0 N--CA 1.477 1.43 0 O-C-N 119.662 -1.899 . . . . 3.94 116.425 166.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.89 83.56 3.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.152 1.381 . . . . 4.41 112.491 -170.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.51 116.02 4.16 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 124.424 1.012 . . . . 3.09 112.806 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 22.1 m170 90.52 123.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.978 2.511 . . . . 3.14 110.973 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.38 -12.51 24.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.005 0.522 . . . . 2.29 111.692 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.17 22.56 18.54 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.144 1.354 . . . . 1.05 113.985 165.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -101.26 124.85 47.6 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.374 1.587 . . . . 2.66 109.71 164.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -117.52 164.15 20.7 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.825 1.65 . . . . 1.8 109.316 -174.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.11 161.84 35.0 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.121 2.547 . . . . 1.06 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.63 131.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 122.608 1.194 . . . . 1.67 113.696 -165.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.85 86.25 4.09 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.439 2.696 . . . . 1.82 108.814 176.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 142.55 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.583 0.753 . . . . 1.45 109.1 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -122.77 150.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.702 2.001 . . . . 1.74 107.832 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -94.39 150.88 19.85 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.762 0.652 . . . . 2.28 112.762 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -42.77 -3.47 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 131.616 3.966 . . . . 3.52 118.518 176.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 -16.46 20.85 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 119.625 -1.922 . . . . 2.94 112.507 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.9 27.49 7.01 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.718 1.628 . . . . 0.72 112.796 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.2 mt -121.89 127.13 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.72 1.208 . . . . 1.66 111.172 -171.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.84 123.95 29.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.932 0.893 . . . . 1.17 108.926 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -139.0 -15.27 1.14 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.88 2.178 . . . . 2.68 116.88 -167.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.48 127.91 74.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 121.413 1.915 . . . . 5.27 112.812 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.14 85.69 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.258 3.305 . . . . 1.91 110.06 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.01 122.16 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.826 0.851 . . . . 2.08 110.045 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -120.03 126.93 52.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.529 0.732 . . . . 1.14 110.54 -164.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.45 113.64 45.5 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.39 -0.814 . . . . 1.19 112.626 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.79 8.59 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.96 3.107 . . . . 1.31 113.447 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -71.78 -22.02 61.64 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.462 -0.774 . . . . 4.25 112.177 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.9 mt -139.52 160.16 40.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 130.155 3.382 . . . . 2.57 106.532 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.414 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -148.26 10.23 0.87 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.948 2.203 . . . . 6.38 116.948 -175.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 p -156.25 157.0 35.05 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.694 -0.629 . . . . 2.21 110.934 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.97 -24.15 52.31 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.015 -1.053 . . . . 1.47 112.653 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -54.31 -37.4 64.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.236 1.415 . . . . 3.85 113.788 -176.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.19 -5.41 49.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.015 2.126 . . . . 1.61 114.256 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 4.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.033 1.333 . . . . 1.75 113.135 -171.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -66.07 7.08 0.32 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.832 2.16 . . . . 2.03 116.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.31 14.0 3.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.386 2.274 . . . . 3.54 111.163 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.53 159.0 43.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.136 1.532 . . . . 1.2 115.136 -157.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.79 157.29 16.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.212 1.405 . . . . 0.62 112.828 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 mt -120.41 136.2 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.533 2.733 . . . . 1.56 107.6 173.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -125.94 128.27 47.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.908 0.776 . . . . 2.17 112.122 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.08 122.92 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.799 -1.186 . . . . 0.87 107.799 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -115.34 141.42 48.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.109 1.763 . . . . 2.07 111.918 -160.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.81 -13.82 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 116.041 1.867 . . . . 2.56 116.041 -156.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.36 160.32 25.47 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.309 -1.116 . . . . 1.07 110.309 162.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -53.36 121.1 15.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.648 -1.381 . . . . 1.85 109.648 163.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.63 1.28 14.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.984 0.914 . . . . 3.67 112.945 -158.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -66.2 28.81 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 129.922 3.289 . . . . 3.46 115.867 -172.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.1 mtm -114.22 105.21 12.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.531 1.932 . . . . 2.91 110.219 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 p -77.3 14.62 0.9 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.043 2.137 . . . . 3.0 113.952 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.72 4.73 0.77 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.787 1.773 . . . . 4.56 115.787 -155.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -96.35 143.02 25.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.114 0.965 . . . . 4.54 110.328 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.2 -27.1 29.52 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.735 2.957 . . . . 3.0 113.192 -173.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -87.01 107.74 15.66 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.706 -1.22 . . . . 4.13 107.706 148.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.95 175.08 7.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.791 2.327 . . . . 3.19 110.925 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 61.16 34.97 18.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.161 0.984 . . . . 3.16 109.175 -170.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.99 5.9 8.57 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.95 1.262 . . . . 3.22 115.636 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.52 63.11 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-N 119.297 1.549 . . . . 2.32 113.99 -165.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.15 16.29 59.44 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.967 2.223 . . . . 1.74 113.97 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.76 -6.02 62.24 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.311 1.434 . . . . 1.55 116.574 -170.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.3 m -66.98 162.53 21.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.369 1.585 . . . . 2.57 110.401 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.84 139.0 31.11 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.405 2.282 . . . . 7.79 114.375 -177.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.82 -27.52 9.25 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 118.921 0.782 . . . . 2.7 112.654 154.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -154.6 155.37 34.6 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.658 1.117 . . . . 0.57 113.637 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.42 147.86 50.53 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.426 1.891 . . . . 1.56 110.499 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -152.41 134.14 4.4 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.791 1.186 . . . . 0.73 112.515 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.12 133.91 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.139 1.375 . . . . 1.77 109.009 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 mt -70.65 118.11 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 122.269 1.033 . . . . 0.98 111.032 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 123.669 0.787 . . . . 7.55 111.819 -177.715 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.253 -0.277 . . . . 2.94 110.253 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -163.69 132.67 3.88 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.207 -1.558 . . . . 1.45 107.394 -163.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -144.79 120.88 10.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.123 1.44 . . . . 3.82 113.409 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -80.11 74.3 6.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.839 1.655 . . . . 3.62 110.824 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 t -70.59 122.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.286 -0.884 . . . . 1.23 111.881 -158.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.606 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -70.51 90.29 0.37 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 128.708 3.052 . . . . 1.06 112.11 175.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 mtt -82.69 148.53 27.86 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.601 1.161 . . . . 1.42 111.311 170.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -115.95 158.32 23.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.475 1.131 . . . . 2.41 110.915 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.09 124.8 26.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.958 1.303 . . . . 1.08 107.496 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.9 m -143.51 151.21 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.385 1.074 . . . . 1.13 110.813 -174.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 t 171.27 121.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.044 2.538 . . . . 3.28 110.387 163.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.59 -38.26 0.27 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.515 2.726 . . . . 1.36 116.724 167.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -9.11 49.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.204 1.402 . . . . 2.92 111.871 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.24 -156.19 19.95 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 125.277 1.418 . . . . 0.94 113.385 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 10' ' ' VAL . 90.2 t -63.92 110.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.209 1.403 . . . . 0.79 110.301 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.67 -86.06 1.16 Allowed Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.226 1.393 . . . . 1.46 112.255 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.24 164.56 37.86 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.382 1.473 . . . . 1.65 109.392 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -104.52 170.32 7.96 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.363 1.065 . . . . 1.14 113.339 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 pt -151.77 8.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 127.636 2.374 . . . . 2.77 112.372 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.14 173.02 20.68 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.011 0.815 . . . . 0.65 113.809 -166.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.606 HG22 ' HA2' ' A' ' 6' ' ' GLY . 77.1 p -131.44 173.97 10.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.558 1.943 . . . . 1.15 108.472 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.37 129.78 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 107.906 -1.146 . . . . 0.59 107.906 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.6 p -78.38 109.95 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.612 0.642 . . . . 1.01 109.788 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 24' ' ' ILE . 34.1 mt -89.79 125.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.539 -1.282 . . . . 1.14 107.539 160.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.504 0.668 . . . . 2.37 110.312 166.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.29 130.7 37.54 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.084 1.754 . . . . 3.53 109.539 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -149.21 -179.77 7.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.039 0.447 . . . . 1.64 110.272 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.06 -29.6 69.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.809 1.244 . . . . 3.53 111.751 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.28 66.16 Favored Glycine 0 N--CA 1.471 1.009 0 C-N-CA 124.696 1.141 . . . . 1.4 114.885 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 -140.31 18.37 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 127.685 2.564 . . . . 1.13 114.734 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.28 93.79 7.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.201 1.0 . . . . 0.71 110.15 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.4 tttp -76.19 108.78 9.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.364 1.466 . . . . 2.3 108.869 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 6.1 t80 -97.78 110.37 22.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.024 2.53 . . . . 0.51 109.309 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 5.6 m -124.19 115.09 27.53 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.889 1.222 . . . . 0.72 109.635 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.25 155.96 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.12 2.546 . . . . 0.49 111.42 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -149.93 54.12 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.566 1.174 . . . . 1.8 111.007 166.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -107.24 134.56 50.15 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.921 1.288 . . . . 0.73 111.232 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -109.25 21.15 17.48 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.265 1.95 . . . . 2.25 116.265 -160.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.96 65.51 0.19 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.128 0.971 . . . . 1.35 113.567 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.53 161.28 49.07 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 124.519 1.128 . . . . 1.49 111.968 174.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.03 128.72 21.28 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.675 1.583 . . . . 0.9 109.904 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 5.0 Cg_endo -85.74 41.75 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 1 C-N-CA 126.345 4.696 . . . . 1.03 112.553 -157.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.79 -132.83 7.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.974 1.749 . . . . 1.45 113.37 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -139.32 134.96 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.95 1.7 . . . . 2.86 110.065 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -137.13 118.79 14.98 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.163 0.985 . . . . 1.06 111.754 -165.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.05 130.04 36.12 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.158 -1.177 . . . . 1.09 110.158 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -108.87 124.4 50.58 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.962 -1.496 . . . . 2.0 106.962 175.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -123.41 171.52 9.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.924 1.453 . . . . 1.09 114.924 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mt -108.79 137.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.342 1.457 . . . . 0.69 109.297 158.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -109.62 175.32 5.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.074 1.75 . . . . 1.21 113.156 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.87 67.27 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.414 1.635 . . . . 1.28 115.414 -164.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -116.95 -167.18 1.26 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.082 1.353 . . . . 1.2 111.152 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.46 86.39 0.18 Allowed Glycine 0 N--CA 1.472 1.05 0 O-C-N 120.794 -1.191 . . . . 0.94 114.117 -173.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -177.98 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.746 2.018 . . . . 2.27 110.452 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.04 35.31 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.745 2.418 . . . . 1.27 116.632 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -115.13 134.19 22.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 120.207 -1.558 . . . . 3.95 111.91 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -86.75 156.24 8.87 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.211 3.274 . . . . 1.34 112.861 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.78 139.4 30.58 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.131 -0.94 . . . . 2.04 109.676 156.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mm -86.11 115.96 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.749 -1.204 . . . . 2.67 107.749 167.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -171.34 135.75 0.97 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.052 1.341 . . . . 5.27 109.469 -149.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 t70 52.27 41.49 30.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.648 1.579 . . . . 4.14 114.488 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.55 79.4 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.059 -1.026 . . . . 2.92 114.578 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -152.34 -164.94 2.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.526 1.531 . . . . 3.19 110.074 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.28 122.31 40.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.191 -0.943 . . . . 1.75 110.857 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.7 t -79.4 79.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.254 -0.647 . . . . 2.64 109.254 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 12.19 -68.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 131.298 3.839 . . . . 2.04 117.677 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.04 74.92 1.0 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.752 1.621 . . . . 2.24 109.81 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.51 -37.52 75.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.649 0.78 . . . . 4.91 112.17 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.21 -3.52 52.58 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.251 1.204 . . . . 1.55 114.251 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.92 18.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.53 1.132 . . . . 1.14 112.601 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.09 -177.87 50.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.266 1.266 . . . . 2.64 116.266 162.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.42 -166.02 14.36 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.73 1.157 . . . . 1.19 113.288 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -59.69 145.45 44.84 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 109.189 -0.671 . . . . 3.07 109.189 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.5 tp -74.97 87.53 2.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.976 -1.077 . . . . 1.67 110.783 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.64 110.11 0.96 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.449 1.5 . . . . 3.32 112.632 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.46 -50.84 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.024 2.483 . . . . 2.33 110.998 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -127.52 126.58 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.029 1.332 . . . . 3.31 109.921 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.356 12.2 p30 162.52 -108.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.887 3.675 . . . . 3.74 110.768 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -155.0 -40.35 0.09 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.485 1.514 . . . . 2.86 112.609 -167.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.43 -49.59 4.21 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.079 0.847 . . . . 3.74 114.658 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 20.7 ptmt -49.68 -51.33 39.08 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.446 1.647 . . . . 4.73 115.446 -151.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.448 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 161.26 136.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 129.42 3.088 . . . . 2.16 113.022 157.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.27 -57.52 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.199 1.185 . . . . 4.17 114.199 -163.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.34 -108.91 0.19 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.019 1.771 . . . . 3.32 114.901 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.23 -33.43 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.502 2.135 . . . . 4.52 113.462 -174.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -137.35 2.79 2.53 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.249 1.574 . . . . 6.29 115.249 -161.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.64 58.4 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.131 -1.606 . . . . 3.0 116.455 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -77.63 63.86 2.82 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.14 1.47 . . . . 6.3 112.345 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.47 -144.55 4.86 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 116.645 1.418 . . . . 2.15 116.645 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.47 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 14.2 p-80 -145.93 156.3 43.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.994 1.318 . . . . 4.87 112.278 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.18 -22.47 64.76 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.644 1.35 . . . . 2.05 114.644 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.47 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -96.13 4.66 65.25 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.595 2.045 . . . . 0.83 114.957 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' OD1' ' CE1' ' A' ' 82' ' ' HIS . 8.6 m-20 -62.23 143.16 57.19 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.256 1.528 . . . . 2.34 107.255 153.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.4 -174.58 0.43 Allowed Pre-proline 0 CA--C 1.56 1.352 0 O-C-N 120.844 -1.16 . . . . 1.87 109.893 -155.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.99 169.94 14.23 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.632 2.222 . . . . 1.07 112.722 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.94 126.99 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.878 0.871 . . . . 1.84 110.975 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 81.8 1.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.869 2.068 . . . . 1.85 108.552 164.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.97 142.17 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.128 -1.064 . . . . 1.09 108.128 168.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.65 138.31 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.254 1.422 . . . . 1.7 109.475 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 142.53 56.74 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 112.827 0.676 . . . . 1.74 112.827 174.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -50.07 -17.91 0.48 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.881 2.472 . . . . 2.15 117.542 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -93.77 -12.4 29.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.245 1.418 . . . . 2.75 113.266 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 21.63 16.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.228 0.918 . . . . 0.79 114.847 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.27 125.53 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.418 -1.327 . . . . 1.23 107.418 169.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.5 125.96 34.11 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.492 -0.559 . . . . 0.65 109.492 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -139.97 -6.51 1.26 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.193 2.197 . . . . 0.99 112.953 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -73.22 113.83 25.65 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 128.0 2.52 . . . . 5.13 111.827 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.01 142.94 28.43 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.333 2.689 . . . . 1.18 111.907 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.84 168.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.469 1.508 . . . . 1.12 109.574 167.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -140.74 141.02 34.93 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 119.242 0.928 . . . . 0.76 110.459 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.95 95.15 16.39 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.374 1.07 . . . . 0.81 111.122 172.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.25 6.49 4.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.568 3.512 . . . . 1.56 114.431 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -85.92 -5.17 59.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.33 1.052 . . . . 4.13 112.026 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.75 160.81 25.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.452 2.701 . . . . 2.33 107.345 169.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.75 -7.21 1.1 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.008 1.485 . . . . 4.54 115.008 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.8 m -133.81 130.27 37.71 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.099 0.96 . . . . 2.03 110.413 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -26.24 66.84 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.753 -1.217 . . . . 2.37 111.019 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.74 -19.27 5.95 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.907 1.447 . . . . 3.51 114.907 165.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.35 -13.55 60.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.94 1.246 . . . . 2.09 112.067 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.42 2.34 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 114.263 1.209 . . . . 1.11 114.263 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -62.54 8.72 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 118.057 2.614 . . . . 2.56 118.057 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.72 17.64 1.28 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.219 1.408 . . . . 3.23 112.193 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -144.24 169.74 17.32 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.758 1.623 . . . . 1.68 112.212 -168.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.98 139.55 35.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.784 1.234 . . . . 0.69 113.439 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.3 mt -80.39 146.8 31.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.831 1.652 . . . . 1.98 108.359 158.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.02 126.89 22.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.03 0.832 . . . . 1.42 111.686 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.4 mt -88.62 111.55 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.374 -1.343 . . . . 0.75 107.374 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.9 150.29 21.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.194 2.198 . . . . 2.59 111.933 -175.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.29 -46.98 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.261 -0.899 . . . . 1.92 111.363 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.28 139.62 16.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.491 0.587 . . . . 1.76 112.996 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.06 143.21 41.0 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.592 2.044 . . . . 1.96 113.348 170.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -80.3 97.01 6.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.694 1.198 . . . . 3.42 111.037 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -177.68 -36.78 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.566 2.746 . . . . 4.45 109.73 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.9 mtm -61.46 130.48 46.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.95 -1.094 . . . . 2.35 112.964 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 t -157.77 -169.36 2.82 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.239 1.816 . . . . 3.09 109.803 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 64.73 -35.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 129.598 3.159 . . . . 3.78 116.405 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 155.64 14.32 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 127.029 2.132 . . . . 4.56 110.771 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.06 -6.18 18.64 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.711 2.941 . . . . 2.18 114.135 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -122.29 138.57 29.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.196 0.907 . . . . 3.98 110.359 171.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.69 144.37 77.85 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.298 2.666 . . . . 3.59 111.167 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.84 29.31 15.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.85 1.26 . . . . 5.93 111.357 -171.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.65 0.94 57.04 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.891 1.234 . . . . 3.09 114.276 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.46 -13.2 15.77 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.432 1.491 . . . . 1.74 112.848 -162.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 28.98 0.7 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.247 1.879 . . . . 1.42 114.455 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.31 -20.0 77.89 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.751 1.643 . . . . 1.65 113.089 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.5 p -60.94 155.39 19.99 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.613 1.565 . . . . 1.7 111.754 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mmt-85 -111.55 159.69 17.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.366 1.466 . . . . 4.62 111.214 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -107.27 -29.49 9.28 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.666 0.617 . . . . 2.53 112.666 152.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.48 38.3 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.141 -0.975 . . . . 0.66 113.571 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 50.4 t -135.36 151.59 50.63 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.272 2.229 . . . . 1.63 108.947 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -155.1 123.87 1.42 Allowed Glycine 0 N--CA 1.468 0.782 0 C-N-CA 123.966 0.793 . . . . 0.7 113.096 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.9 127.87 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.039 1.335 . . . . 1.7 109.492 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mt -79.14 125.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.257 1.027 . . . . 0.86 110.983 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt . . . . . 0 C--O 1.238 0.489 0 C-N-CA 127.212 2.205 . . . . 3.85 109.417 173.665 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.745 -0.465 . . . . 2.39 109.745 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -153.28 136.12 15.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.155 -1.054 . . . . 1.28 108.155 -162.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.67 129.88 8.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.517 1.151 . . . . 2.64 112.836 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -88.2 94.79 9.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.751 1.22 . . . . 3.98 109.393 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.52 123.84 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.833 -0.542 . . . . 1.06 110.224 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.12 107.47 2.2 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.518 1.532 . . . . 0.8 110.835 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 13.9 mmt -81.62 101.04 9.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.8 1.24 . . . . 1.38 110.65 172.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.66 137.79 36.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.411 -0.959 . . . . 2.66 108.411 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.07 138.88 58.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.422 -0.955 . . . . 1.38 108.422 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -136.36 163.48 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.829 0.852 . . . . 1.15 112.328 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -167.78 -148.2 0.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.677 1.991 . . . . 2.85 108.404 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.96 17.38 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.941 3.697 . . . . 1.58 115.686 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.84 -6.02 5.07 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.007 -1.683 . . . . 3.9 111.739 171.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.14 -141.72 31.85 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.224 -1.551 . . . . 2.14 109.224 -158.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -39.22 113.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.752 1.621 . . . . 1.65 112.531 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.52 -77.05 1.16 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.16 1.838 . . . . 1.45 112.335 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.67 153.77 25.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.492 0.717 . . . . 1.72 112.351 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -97.2 132.96 42.45 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.531 1.308 . . . . 1.06 114.531 -170.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mm -122.19 -17.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.606 1.562 . . . . 4.54 115.212 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.53 28.81 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 121.055 -1.028 . . . . 0.73 113.306 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -95.52 176.45 6.17 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.162 -0.681 . . . . 0.77 109.162 164.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 33' ' ' PHE . 23.2 t -135.49 129.99 49.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.001 -1.481 . . . . 0.49 107.001 160.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -97.57 119.25 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.307 0.575 . . . . 0.85 111.674 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.27 135.44 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.728 1.211 . . . . 1.46 108.837 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -139.25 100.8 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.819 1.648 . . . . 2.5 108.791 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.7 132.9 38.38 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 128.039 2.536 . . . . 3.17 109.709 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -154.63 -168.89 3.05 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.475 0.31 . . . . 1.21 111.662 -166.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -57.36 -31.92 66.23 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.948 1.299 . . . . 5.12 113.34 -176.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.5 22.84 38.13 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.856 1.693 . . . . 0.99 114.386 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.14 -144.82 23.96 Favored Glycine 0 N--CA 1.466 0.664 0 C-N-CA 124.686 1.136 . . . . 0.74 114.355 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.3 mt -80.36 104.38 10.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.836 0.854 . . . . 0.64 111.924 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -83.2 111.81 19.27 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.373 -0.829 . . . . 1.87 110.696 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 22' ' ' VAL . 0.8 OUTLIER -97.52 125.51 42.27 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.105 1.762 . . . . 0.91 110.151 -177.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 m -127.84 110.82 20.38 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 117.993 -1.003 . . . . 0.63 109.458 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -91.85 158.16 3.4 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.461 2.774 . . . . 0.51 112.542 -169.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -148.23 36.47 0.83 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 121.741 0.781 . . . . 1.43 112.485 175.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -92.67 160.49 14.97 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.709 -1.869 . . . . 0.8 113.001 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 18.38 1.87 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.486 2.402 . . . . 2.32 117.486 -167.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.58 70.89 0.61 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.002 0.921 . . . . 1.31 110.198 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.714 HD12 HG11 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -124.18 168.56 12.57 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.187 0.995 . . . . 1.73 109.325 170.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -52.8 137.17 60.29 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.987 1.792 . . . . 1.18 110.825 159.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -89.57 26.42 0.54 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.85 2.367 . . . . 1.41 114.243 -151.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.53 -149.23 8.64 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 123.387 1.548 . . . . 1.34 115.677 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.38 139.97 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.268 2.227 . . . . 3.26 111.511 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -131.47 131.63 43.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.522 0.729 . . . . 1.33 110.911 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.38 152.76 47.01 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-N 118.782 0.719 . . . . 0.74 111.646 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.417 ' CE1' ' CE2' ' A' ' 33' ' ' PHE . 5.2 t80 -128.36 108.92 10.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.054 -1.462 . . . . 1.88 107.054 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -112.43 165.57 12.09 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.829 1.418 . . . . 0.71 114.829 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.69 138.08 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.997 1.719 . . . . 1.19 108.251 158.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -118.31 155.01 31.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.258 1.823 . . . . 0.96 108.985 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.11 73.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.625 1.713 . . . . 0.77 115.625 -157.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -132.21 163.63 28.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.283 1.033 . . . . 1.37 112.816 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.47 84.58 1.16 Allowed Glycine 0 N--CA 1.469 0.85 0 O-C-N 120.822 -1.174 . . . . 0.95 113.55 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -160.11 89.58 0.86 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.152 0.977 . . . . 2.31 113.127 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.7 m -67.53 48.72 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.136 2.574 . . . . 1.45 113.759 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -131.61 139.79 36.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.215 1.406 . . . . 3.35 112.663 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.38 166.19 4.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.887 3.058 . . . . 0.89 112.848 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.67 144.32 42.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.073 0.949 . . . . 1.5 110.098 164.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.4 59.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.224 1.01 . . . . 3.01 109.742 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 152.65 42.8 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.774 -0.579 . . . . 4.25 110.226 165.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t0 54.75 18.91 2.3 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.916 1.686 . . . . 3.75 114.131 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.28 20.18 77.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.075 1.321 . . . . 2.92 114.644 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.23 146.43 40.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.702 1.251 . . . . 3.35 111.18 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.64 18.57 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.899 -1.125 . . . . 1.7 113.383 -165.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.08 92.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.545 1.138 . . . . 1.94 109.645 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -24.95 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 130.193 3.397 . . . . 2.02 118.61 -166.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.501 ' HB3' HH21 ' A' ' 147' ' ' ARG . . . -151.21 124.01 8.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.861 0.755 . . . . 1.9 109.905 158.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.61 -48.7 4.24 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.846 0.858 . . . . 4.24 110.252 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.28 -14.96 59.09 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.59 1.33 . . . . 1.33 114.59 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.09 -7.9 10.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.931 1.292 . . . . 0.9 114.227 169.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.3 -28.09 11.81 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 120.58 -1.325 . . . . 3.18 115.046 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.4 -170.93 20.82 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.396 1.474 . . . . 1.38 111.774 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -60.85 148.69 38.52 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.077 0.938 . . . . 3.03 110.149 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.5 tp -78.06 73.08 4.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.758 1.223 . . . . 1.97 111.919 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.48 104.15 28.49 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.65 1.18 . . . . 3.83 110.606 158.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.5 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.236 2.624 . . . . 1.98 110.96 159.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -166.39 3.22 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.617 1.34 . . . . 4.26 114.617 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -68.45 -27.3 66.05 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.311 -1.493 . . . . 3.96 114.27 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 81' ' ' LYS . 18.9 m 114.47 139.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 1 C-N-CA 132.05 4.14 . . . . 4.83 107.138 -161.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.16 -12.97 56.93 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.093 1.33 . . . . 2.1 114.42 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.427 ' H ' HG22 ' A' ' 79' ' ' THR . 52.3 mttp -64.15 -6.0 5.84 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.441 2.015 . . . . 5.39 116.441 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.2 t60 83.22 144.8 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.207 2.203 . . . . 1.68 114.571 166.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -81.92 150.14 27.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.238 1.815 . . . . 3.61 110.982 -173.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.04 -112.95 0.39 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.659 -1.079 . . . . 2.47 114.619 171.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.63 -18.95 25.0 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.329 2.686 . . . . 3.39 112.453 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -123.11 155.96 35.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.89 2.076 . . . . 4.93 107.424 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.53 120.23 6.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.838 0.732 . . . . 3.0 111.61 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.69 21.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.107 2.163 . . . . 4.44 113.496 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.18 -151.8 13.33 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 123.208 1.449 . . . . 3.07 115.177 -174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -74.87 139.95 43.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.041 -1.079 . . . . 3.24 111.352 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 pp -62.5 -21.65 65.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.342 0.497 . . . . 2.36 112.342 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.94 26.32 6.15 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.669 1.604 . . . . 1.04 115.425 172.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -111.17 131.68 54.91 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.778 1.789 . . . . 1.5 110.566 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.26 160.81 60.61 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.703 1.601 . . . . 2.2 110.452 -163.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.49 159.69 32.28 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.607 2.871 . . . . 0.9 112.526 -170.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 m -69.55 132.08 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 123.251 1.5 . . . . 1.62 114.81 -163.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.97 75.11 4.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.5 3.12 . . . . 1.68 109.072 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.06 136.09 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.046 -1.034 . . . . 1.09 111.398 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 40' ' ' LEU . 3.3 m -114.17 162.92 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.094 0.958 . . . . 2.06 110.151 161.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -88.96 171.0 10.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.101 0.56 . . . . 2.6 112.255 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -16.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 128.003 2.521 . . . . 2.91 117.804 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -96.66 -7.39 34.26 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.052 2.141 . . . . 2.9 113.381 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.46 21.0 30.51 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 119.135 0.879 . . . . 1.06 114.755 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.25 129.09 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.428 1.114 . . . . 1.54 111.961 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.686 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -99.42 126.85 45.39 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.29 2.236 . . . . 0.8 111.159 -172.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -157.19 18.2 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.962 1.097 . . . . 1.25 113.962 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -89.35 113.34 56.07 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.47 1.108 . . . . 3.28 109.372 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.54 138.91 19.92 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.191 3.261 . . . . 1.07 111.365 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.84 167.41 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.454 1.101 . . . . 1.16 111.464 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -136.5 134.09 37.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.256 1.022 . . . . 0.89 110.59 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.22 93.49 39.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.315 1.046 . . . . 0.72 112.674 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -77.65 94.77 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.361 2.707 . . . . 3.18 108.452 160.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -50.7 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.967 1.707 . . . . 5.2 109.11 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.12 162.57 25.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.078 1.351 . . . . 2.29 108.103 141.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -121.22 -24.67 5.43 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.219 1.192 . . . . 4.49 114.219 162.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 m -124.16 150.43 45.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.607 1.094 . . . . 2.37 113.922 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -37.2 86.57 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.208 -0.932 . . . . 2.3 110.842 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.93 -16.92 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.231 1.567 . . . . 3.89 115.231 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -83.53 -6.87 59.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 2.17 112.313 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.05 11.92 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.522 1.129 . . . . 0.8 113.417 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -65.66 13.25 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 117.756 2.502 . . . . 2.79 117.756 -172.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.73 23.14 0.69 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.423 1.889 . . . . 3.13 112.018 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -121.02 174.87 6.37 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.292 1.219 . . . . 1.24 114.292 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.28 140.48 44.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.722 1.209 . . . . 0.54 111.249 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.87 141.42 28.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 1.78 107.056 161.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.4 mtt -133.34 131.51 40.2 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.408 1.004 . . . . 1.23 112.173 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.3 110.37 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.64 1.176 . . . . 0.66 108.298 170.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.83 142.99 29.36 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.876 2.071 . . . . 2.35 111.737 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -58.95 -38.51 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 112.974 0.731 . . . . 1.54 112.974 -164.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.17 169.92 14.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.722 1.153 . . . . 1.56 111.473 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.26 166.78 24.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.458 1.028 . . . . 1.85 112.559 161.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.6 6.18 1.84 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.217 1.192 . . . . 2.78 114.217 -134.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.005 2.122 . . . . 3.99 114.759 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.5 mtm -138.71 63.44 1.52 Allowed 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.402 -1.436 . . . . 2.51 113.375 -161.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -64.69 -34.28 77.94 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.337 1.236 . . . . 3.09 114.337 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.38 67.34 9.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.965 1.098 . . . . 3.8 113.965 -162.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.61 154.81 25.97 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.703 1.601 . . . . 3.23 110.989 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.37 -23.15 38.49 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.466 2.777 . . . . 2.7 112.426 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.98 90.22 1.49 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.002 -1.11 . . . . 3.91 108.002 154.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.0 169.28 18.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.077 2.518 . . . . 3.85 111.445 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt 70.47 16.52 7.04 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.381 1.872 . . . . 3.81 110.602 -167.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.19 3.48 24.38 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.208 1.385 . . . . 2.84 113.839 -164.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.79 -1.34 52.23 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.785 1.659 . . . . 1.89 114.036 -165.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.3 43.41 1.28 Allowed Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.53 2.014 . . . . 1.66 115.239 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.58 -16.93 77.7 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.835 1.207 . . . . 1.83 115.055 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 p -76.52 146.71 38.25 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.532 1.533 . . . . 1.47 112.742 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.501 HH21 ' HB3' ' A' ' 67' ' ' ALA . 1.1 mpp_? -105.23 138.98 40.57 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.83 1.652 . . . . 4.44 110.39 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -91.55 -28.82 17.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.625 0.37 . . . . 2.64 111.266 164.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.72 159.68 44.15 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.608 0.966 . . . . 0.49 113.608 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 32.7 t -140.92 146.7 37.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.965 2.106 . . . . 1.41 110.316 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -141.98 100.44 0.26 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.079 1.799 . . . . 0.73 111.633 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.75 135.86 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.013 1.325 . . . . 2.35 111.729 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.56 150.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.37 1.468 . . . . 1.47 110.712 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.476 0.844 0 O-C-N 121.599 -0.688 . . . . 3.92 112.644 -177.404 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.549 0.214 . . . . 1.89 111.55 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -153.61 152.68 31.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.853 1.261 . . . . 1.27 109.549 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.2 132.4 11.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 123.071 1.415 . . . . 2.31 110.065 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -90.01 124.8 35.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 4.19 111.241 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.01 101.06 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 120.859 -1.15 . . . . 1.48 108.282 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 109.36 2.81 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.272 1.415 . . . . 1.08 109.907 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 77.6 mmm -87.35 149.35 24.56 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.925 0.89 . . . . 1.88 110.685 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.62 145.73 50.02 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.823 1.649 . . . . 2.56 109.954 168.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.79 140.43 58.87 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.617 -0.677 . . . . 1.6 109.572 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.79 152.61 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.693 0.759 . . . . 1.02 110.821 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -151.87 -165.08 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.794 1.638 . . . . 2.64 107.599 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' C ' HE21 ' A' ' 13' ' ' GLN . . . -64.4 -0.15 1.22 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.233 2.213 . . . . 1.7 113.326 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.409 HE21 ' C ' ' A' ' 12' ' ' ALA . 2.3 mm-40 -109.71 -9.98 14.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.502 1.921 . . . . 2.71 111.875 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.53 -161.85 21.39 Favored Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.014 1.292 . . . . 1.11 113.85 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.71 127.32 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.392 1.877 . . . . 0.9 111.693 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.69 -86.09 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.643 1.592 . . . . 1.47 114.262 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.49 170.5 22.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.784 2.434 . . . . 2.03 109.199 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -106.22 159.47 16.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.76 8.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 128.899 2.879 . . . . 3.22 113.034 -169.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.13 168.67 15.47 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.694 1.14 . . . . 0.85 113.4 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 p -115.19 -177.27 3.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.534 1.534 . . . . 0.86 109.335 173.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.45 138.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.821 -1.548 . . . . 0.69 106.821 158.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 p -91.78 131.87 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.077 0.398 . . . . 0.93 110.556 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mt -107.63 131.66 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.343 1.057 . . . . 1.44 109.218 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.51 145.18 50.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.92 0.888 . . . . 1.92 111.036 170.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.354 8.4 tm-20 -101.38 107.23 18.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.741 2.816 . . . . 3.79 108.129 -162.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -130.7 175.6 8.89 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.839 1.199 . . . . 2.84 112.128 -167.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.82 -8.41 57.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.436 1.094 . . . . 5.63 112.794 172.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.71 14.63 58.94 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.035 1.302 . . . . 1.14 113.27 159.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.27 -151.05 32.57 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 128.299 2.857 . . . . 0.79 115.592 174.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -69.68 112.76 6.37 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.758 -0.848 . . . . 0.95 112.963 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -88.86 106.77 18.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.938 2.095 . . . . 2.05 110.787 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -92.8 117.09 29.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.574 2.35 . . . . 0.62 108.912 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -125.77 114.93 24.69 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-N 120.478 1.49 . . . . 0.69 109.327 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.1 163.4 5.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.323 2.682 . . . . 0.55 112.379 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -151.86 20.37 0.69 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.703 1.001 . . . . 1.51 113.703 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.74 145.21 28.04 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.011 -1.055 . . . . 0.81 111.749 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -119.2 19.91 12.74 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.869 1.803 . . . . 2.74 115.869 -164.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.86 54.81 0.66 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.794 0.838 . . . . 1.51 112.174 -165.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.95 160.34 69.03 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.997 0.919 . . . . 1.56 112.553 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 37.5 Cg_endo -62.59 132.73 39.17 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.871 1.714 . . . . 1.27 110.711 174.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.407 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 15.7 Cg_endo -89.04 25.39 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.679 2.253 . . . . 1.29 114.259 -143.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.34 -152.85 12.49 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 116.908 1.523 . . . . 1.25 116.908 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.96 147.04 23.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.95 2.1 . . . . 2.47 109.851 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -149.2 148.15 29.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.087 0.955 . . . . 1.19 112.842 -165.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.53 156.63 53.51 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.191 -0.943 . . . . 0.56 110.936 162.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.34 121.59 11.56 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 106.134 -1.802 . . . . 1.93 106.134 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -126.99 170.69 12.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.685 1.735 . . . . 0.98 115.685 175.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -101.56 143.06 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.281 1.832 . . . . 0.68 109.492 160.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -129.57 141.09 51.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.712 2.005 . . . . 1.09 109.641 -172.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -28.49 66.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.059 2.244 . . . . 0.72 117.059 -158.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -127.29 152.17 47.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.443 1.019 . . . . 1.18 112.739 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.81 78.79 1.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.358 0.98 . . . . 0.96 111.785 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -164.54 72.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.103 0.954 . . . . 2.14 113.316 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.4 m -68.16 8.84 0.38 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.83 2.159 . . . . 1.6 116.83 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.17 138.79 52.55 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.089 -1.632 . . . . 3.72 110.771 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.28 165.67 6.77 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.217 3.278 . . . . 1.42 111.341 172.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.56 -172.08 2.58 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.54 0.686 . . . . 2.57 109.808 150.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.1 mm -96.64 146.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.728 1.211 . . . . 3.59 109.402 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.0 138.95 3.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.504 2.322 . . . . 5.48 108.866 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.84 32.0 16.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.233 1.413 . . . . 5.9 112.621 -173.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.89 3.53 87.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.186 1.374 . . . . 3.4 115.605 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.98 157.91 45.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.077 1.438 . . . . 4.68 112.563 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.51 131.52 34.63 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.886 -1.134 . . . . 2.17 112.269 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.0 33.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.382 0.882 . . . . 2.14 113.382 -172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.61 -6.38 0.12 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 119.184 3.031 . . . . 2.63 119.184 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 131.93 101.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 1 C-N-CA 133.005 4.522 . . . . 1.45 106.506 -173.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.41 -59.41 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.203 1.001 . . . . 4.7 111.872 -154.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.31 -17.86 59.84 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.156 0.798 . . . . 1.6 113.156 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.96 0.68 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.031 2.132 . . . . 0.82 115.634 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.69 25.29 9.99 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 116.272 1.269 . . . . 2.93 116.272 159.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 -119.83 5.12 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 110.452 -1.059 . . . . 2.78 110.452 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -97.47 -102.47 0.19 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.144 -1.058 . . . . 3.54 108.144 149.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.5 tp -174.24 93.32 0.08 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.494 2.318 . . . . 1.87 108.672 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -159.64 124.52 2.19 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 125.651 1.581 . . . . 4.24 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.03 -31.56 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.478 2.785 . . . . 2.27 114.568 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -160.2 -7.91 0.05 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.328 1.422 . . . . 3.69 114.388 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -76.01 -48.89 19.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.244 1.018 . . . . 3.28 112.61 -160.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -163.34 -41.03 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.473 1.286 . . . . 2.91 114.473 -174.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.52 -19.98 2.32 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.047 -1.418 . . . . 2.32 114.538 -167.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -72.0 -80.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.212 2.006 . . . . 4.19 113.289 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.8 t60 160.69 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 130.27 3.428 . . . . 1.52 111.027 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.411 ' CG ' ' H ' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -71.75 -154.29 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.345 1.458 . . . . 3.16 111.939 173.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 83' ' ' GLU . . . 113.76 -80.1 0.28 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.801 1.667 . . . . 3.08 112.259 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.49 -7.77 5.6 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.849 3.033 . . . . 4.81 113.668 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -153.45 145.18 23.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.607 1.563 . . . . 5.24 110.457 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.35 84.25 1.42 Allowed Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.986 1.279 . . . . 2.7 112.068 -173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.72 13.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.526 1.53 . . . . 4.5 113.011 -162.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.3 -161.68 37.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.489 1.519 . . . . 2.28 115.223 -168.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -74.58 133.68 42.19 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.924 -0.638 . . . . 3.8 109.65 173.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.93 2.66 3.26 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.085 1.883 . . . . 2.72 116.085 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.87 0.32 51.97 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.892 1.711 . . . . 1.25 115.129 168.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -79.0 147.02 33.04 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.956 1.378 . . . . 1.68 111.673 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.92 159.05 27.33 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.812 0.845 . . . . 1.81 110.282 -144.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.04 149.33 64.96 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.359 2.706 . . . . 1.05 112.419 -171.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.37 128.23 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.438 1.113 . . . . 1.76 112.983 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.0 tp -82.51 132.09 35.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.513 2.725 . . . . 2.38 110.315 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.69 137.67 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.84 -1.162 . . . . 0.96 109.662 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.49 151.97 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 107.434 -1.321 . . . . 2.22 107.434 161.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.06 157.5 26.7 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.384 0.513 . . . . 2.17 112.384 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.9 OUTLIER -58.96 -10.11 2.3 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.724 1.75 . . . . 2.65 115.724 -174.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.79 -12.59 41.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 2.44 113.597 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.63 17.04 11.66 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.081 1.324 . . . . 0.73 116.037 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.46 134.96 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.541 1.171 . . . . 1.89 110.707 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.14 135.6 33.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.891 1.676 . . . . 0.86 111.379 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -158.83 -19.79 0.07 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.271 1.582 . . . . 1.0 115.271 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.37 122.33 82.58 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.403 1.002 . . . . 3.68 110.097 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.71 163.22 18.75 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.511 2.807 . . . . 1.57 111.989 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 m -141.26 160.51 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.157 1.383 . . . . 1.3 110.267 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 138.41 52.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.948 0.899 . . . . 0.89 109.743 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.97 88.23 6.65 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.522 1.129 . . . . 0.74 112.051 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.76 5.41 1.71 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.041 3.16 . . . . 1.33 115.974 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -15.47 52.44 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.531 1.06 . . . . 8.52 112.633 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.93 136.65 20.52 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.04 0.936 . . . . 3.2 111.754 -170.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 9.36 1.44 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.235 1.939 . . . . 5.61 116.235 -154.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 m -147.54 128.19 14.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.538 -0.541 . . . . 2.17 109.538 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.77 -29.85 67.1 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.725 1.148 . . . . 1.86 112.436 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.49 -24.23 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.291 1.837 . . . . 3.04 114.284 171.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.61 -4.46 58.95 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 120.093 1.315 . . . . 2.07 114.25 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.03 12.96 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.586 1.154 . . . . 0.91 113.874 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.38 17.16 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.197 2.295 . . . . 2.62 117.197 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -150.09 11.6 0.73 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.503 1.921 . . . . 3.0 112.383 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -100.84 172.06 7.28 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.63 -1.294 . . . . 1.59 113.418 -171.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.14 144.28 35.75 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.883 0.873 . . . . 0.53 110.212 161.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.9 141.09 36.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.779 1.632 . . . . 1.95 106.673 164.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.5 mtt -137.32 130.56 30.94 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.946 -1.096 . . . . 1.3 111.975 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.4 mt -83.85 131.68 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.092 -1.077 . . . . 0.84 108.092 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.2 149.1 42.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.611 1.564 . . . . 2.35 112.125 -168.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.5 -52.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.655 -0.653 . . . . 1.27 110.005 -168.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -93.85 169.17 29.51 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.127 0.87 . . . . 1.19 111.769 169.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.22 -164.49 5.98 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.967 2.699 . . . . 2.63 115.913 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.39 84.01 2.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.018 2.127 . . . . 3.42 106.676 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -160.39 -8.06 0.05 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.254 1.576 . . . . 3.69 115.254 -165.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.5 ptp -148.31 142.06 25.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.242 1.383 . . . . 2.89 113.945 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 p -156.82 12.89 0.26 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.146 1.165 . . . . 2.98 114.146 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.51 -40.38 14.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.138 1.775 . . . . 4.6 113.845 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.51 143.35 79.09 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.94 0.896 . . . . 3.37 112.036 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.81 -31.84 24.28 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.148 2.565 . . . . 1.95 114.751 -165.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -73.81 115.45 42.2 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.289 1.404 . . . . 4.05 108.731 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.23 144.84 64.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.014 2.476 . . . . 2.64 112.716 -159.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 58.98 19.32 7.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.103 1.761 . . . . 3.3 112.638 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.97 56.88 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.813 -0.993 . . . . 2.8 113.755 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.89 -8.35 73.52 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.964 1.745 . . . . 1.8 114.418 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.01 -8.84 79.22 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.14 1.47 . . . . 1.39 116.097 -169.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.83 2.29 25.73 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.921 1.248 . . . . 1.55 115.5 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 p -69.42 151.38 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.924 1.69 . . . . 1.49 110.789 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.31 150.16 22.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.318 1.447 . . . . 5.03 110.268 -172.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -110.43 -34.77 6.23 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.31 0.485 . . . . 2.55 112.31 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.8 144.74 24.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.776 1.028 . . . . 0.97 113.776 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.9 t -104.82 139.61 39.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.93 2.492 . . . . 2.12 110.903 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.27 87.67 0.25 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.978 2.704 . . . . 1.14 111.052 173.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.98 135.53 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.84 . . . . 1.53 109.246 166.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.42 137.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.626 1.17 . . . . 2.01 111.359 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 11.2 mmpt? . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.183 . . . . 3.84 113.504 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 121.752 0.787 . . . . 1.63 111.38 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -169.12 151.77 4.84 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.551 1.54 . . . . 1.43 108.143 -154.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -156.9 124.07 5.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 123.05 1.405 . . . . 2.63 111.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -84.15 89.52 7.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.928 2.091 . . . . 3.47 110.796 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -87.28 116.44 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.475 -0.765 . . . . 1.05 110.239 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.34 109.0 2.66 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.238 1.399 . . . . 0.73 110.009 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.8 mtp -94.02 140.42 29.74 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.558 0.743 . . . . 1.17 112.778 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -121.24 150.4 41.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.8 1.64 . . . . 2.63 112.994 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.7 mt -71.6 73.42 0.77 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.207 2.603 . . . . 1.28 110.974 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.65 124.4 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.338 -0.851 . . . . 1.6 109.947 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.5 t -160.28 74.49 0.55 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.963 1.098 . . . . 2.42 113.963 -166.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.66 -42.62 0.52 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.167 2.187 . . . . 1.44 114.561 163.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -6.7 50.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.947 1.299 . . . . 2.45 112.071 169.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.47 -164.53 13.93 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.029 2.252 . . . . 1.41 111.496 -173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.56 129.8 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.054 . . . . 1.27 110.255 161.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.64 -140.62 11.27 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.904 1.24 . . . . 2.07 113.881 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.93 167.08 14.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.675 1.19 . . . . 1.92 111.087 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -103.22 172.94 6.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.813 1.645 . . . . 1.37 113.183 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.03 1.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 128.188 2.595 . . . . 3.48 113.138 -165.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.17 -177.44 20.29 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.148 1.356 . . . . 0.56 112.714 -166.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.87 165.43 18.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.075 0.95 . . . . 1.04 109.411 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 40.9 t -110.67 129.32 66.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.558 -1.275 . . . . 0.57 107.558 157.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.18 130.63 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 122.011 0.91 . . . . 2.63 110.204 166.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -99.39 139.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.9 -1.148 . . . . 1.2 107.9 167.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -135.52 127.06 28.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.908 1.283 . . . . 2.32 109.935 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.03 140.0 29.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.207 0.603 . . . . 3.57 111.059 -171.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t -154.54 -178.99 7.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.5 0.72 . . . . 1.49 110.433 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -64.38 -23.8 67.41 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.659 1.584 . . . . 3.8 113.546 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.07 16.68 59.02 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.283 1.42 . . . . 1.36 113.848 166.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 115' ' ' LYS . . . 75.44 -144.49 31.81 Favored Glycine 0 N--CA 1.465 0.628 0 C-N-CA 129.241 3.305 . . . . 1.0 114.859 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.2 mt -71.71 109.17 5.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.291 0.636 . . . . 0.82 111.088 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -80.58 107.34 13.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.268 1.427 . . . . 1.95 109.594 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -91.75 116.52 28.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.035 1.734 . . . . 0.71 109.713 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.8 m -128.87 106.52 18.35 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.877 -0.582 . . . . 0.85 110.332 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.09 154.72 14.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.897 3.065 . . . . 0.48 112.405 -171.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -146.01 48.88 1.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.664 0.745 . . . . 1.62 112.626 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.47 150.95 24.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.85 112.228 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 22.0 5.52 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.393 1.627 . . . . 2.07 115.393 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.24 83.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.112 0.965 . . . . 2.07 110.706 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 164.68 31.62 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 124.803 1.241 . . . . 1.39 110.535 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.48 138.46 85.92 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.13 1.22 . . . . 1.19 110.07 169.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -90.81 24.67 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.333 2.022 . . . . 1.31 114.428 -151.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.5 -154.62 20.58 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.181 1.372 . . . . 1.3 115.28 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 152.29 19.07 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.064 -1.256 . . . . 2.67 110.539 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -149.41 122.78 9.03 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.674 1.59 . . . . 1.34 111.291 -162.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.56 150.29 3.54 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 120.307 1.412 . . . . 0.6 112.175 169.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.448 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -135.97 125.58 25.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.248 -1.39 . . . . 2.06 107.248 173.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -124.28 172.31 9.19 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.118 1.525 . . . . 1.11 115.118 167.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.38 141.66 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.747 1.619 . . . . 0.81 109.168 159.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.27 154.3 46.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.986 2.114 . . . . 0.98 110.583 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.93 60.63 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 117.362 2.356 . . . . 1.04 117.362 -150.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.533 HD22 ' HA3' ' A' ' 71' ' ' GLY . 66.9 m-80 -137.69 148.86 46.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.122 1.328 . . . . 1.54 113.325 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.57 74.18 2.14 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.581 1.086 . . . . 1.19 114.151 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 t -164.79 76.9 0.31 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.058 0.932 . . . . 2.32 113.346 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.9 m -70.02 28.43 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.951 2.1 . . . . 1.83 115.74 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -92.22 135.44 26.95 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.514 -1.366 . . . . 3.29 110.943 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.17 157.2 11.21 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.274 3.316 . . . . 1.34 113.231 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.77 144.53 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.104 0.962 . . . . 1.84 110.08 161.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mm -97.76 48.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.316 1.047 . . . . 3.7 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -61.89 137.83 58.29 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.761 -1.212 . . . . 5.57 111.313 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.94 26.35 9.73 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.182 0.993 . . . . 4.08 112.921 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.71 83.34 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.96 -1.087 . . . . 2.74 114.723 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.91 144.46 48.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.264 1.532 . . . . 3.2 111.178 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.3 105.8 12.78 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.835 -1.165 . . . . 1.48 111.776 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 t -77.98 62.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.402 1.481 . . . . 2.63 111.688 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.2 -63.15 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.852 3.261 . . . . 2.01 116.756 169.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.4 119.8 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 131.555 3.942 . . . . 2.38 108.648 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -100.46 -47.75 4.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.693 1.133 . . . . 4.84 111.561 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.8 2.92 4.68 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 115.21 1.559 . . . . 1.53 115.21 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.52 -3.84 48.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.119 2.168 . . . . 1.37 114.674 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' HD22 ' A' ' 52' ' ' ASN . . . 85.88 -13.83 55.01 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.037 1.575 . . . . 3.74 117.037 165.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.09 -168.78 15.18 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.043 1.306 . . . . 1.39 114.697 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 12.64 1.63 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.196 2.199 . . . . 2.31 114.107 -175.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.8 tp 61.25 56.2 2.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.15 1.78 . . . . 1.5 109.15 -169.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -122.74 62.94 18.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.901 2.08 . . . . 4.22 112.414 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.43 -38.43 26.05 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.83 2.353 . . . . 2.0 112.689 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -168.4 139.22 2.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.631 1.972 . . . . 3.55 107.664 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 p30 157.69 -162.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 130.348 3.459 . . . . 4.3 110.337 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -74.49 -11.83 60.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.265 2.626 . . . . 3.13 116.048 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.65 -32.17 1.66 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.977 1.275 . . . . 2.22 116.081 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -64.91 -9.84 24.23 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.151 2.278 . . . . 5.31 117.151 -167.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.4 t60 75.08 153.52 0.14 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.427 2.291 . . . . 1.56 112.238 -171.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -152.13 148.51 27.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.287 1.835 . . . . 4.93 109.874 -169.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.35 -82.39 1.07 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.055 -1.414 . . . . 3.34 109.882 163.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.01 -26.12 3.1 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.898 3.065 . . . . 4.54 115.942 -166.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.54 -157.55 0.62 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 120.091 1.314 . . . . 5.3 111.383 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.98 13.59 37.7 Favored Glycine 0 N--CA 1.475 1.287 0 C-N-CA 124.979 1.276 . . . . 3.88 115.195 -175.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -100.25 51.76 0.89 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.052 1.426 . . . . 5.12 112.301 -169.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.61 -143.71 4.9 Favored Glycine 0 N--CA 1.473 1.101 0 O-C-N 120.921 -1.112 . . . . 2.67 115.608 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.06 147.73 22.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.705 1.202 . . . . 3.96 112.405 -168.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.88 -20.97 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.682 1.364 . . . . 2.03 114.682 -174.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.06 -2.06 86.4 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.297 0.951 . . . . 0.86 114.796 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -83.98 136.63 33.98 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.517 1.127 . . . . 1.77 111.99 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.42 167.61 14.17 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 126.092 1.757 . . . . 1.91 109.861 -143.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.82 173.95 11.53 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.281 3.321 . . . . 1.06 113.792 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.37 125.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.638 1.175 . . . . 2.05 112.186 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 90.31 2.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.58 2.752 . . . . 1.86 109.854 166.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.9 t -68.28 126.44 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.018 -1.051 . . . . 0.82 109.092 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.97 162.67 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.931 1.292 . . . . 2.12 108.411 167.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.47 160.47 16.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.759 1.022 . . . . 2.21 113.759 -176.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -15.68 0.29 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 127.957 2.503 . . . . 2.47 117.438 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.09 -0.93 38.06 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.907 1.683 . . . . 3.2 113.089 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.8 25.66 22.01 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.93 1.252 . . . . 0.88 114.432 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.9 mt -129.64 140.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 1.12 109.955 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.4 129.0 56.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.349 1.86 . . . . 0.87 111.607 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 t -153.31 0.74 0.25 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.784 1.772 . . . . 1.34 115.784 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -86.03 126.77 64.4 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.585 1.154 . . . . 3.38 110.542 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.05 156.3 26.41 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.095 2.53 . . . . 1.31 112.16 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.1 m -141.92 167.06 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 126.358 1.863 . . . . 1.3 109.591 167.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 m -140.06 140.48 36.14 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 1.23 111.053 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.63 114.24 15.54 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.482 1.113 . . . . 1.33 112.691 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.14 5.15 6.2 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.26 3.307 . . . . 1.25 115.213 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -77.36 -19.17 56.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.566 0.951 . . . . 4.47 113.566 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.56 144.99 46.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.423 1.889 . . . . 2.5 106.946 169.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.8 mtpt -131.06 -9.37 3.84 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.455 1.28 . . . . 4.05 114.455 -160.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -157.98 142.2 15.98 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.929 1.292 . . . . 2.02 111.781 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.081 -1.012 . . . . 2.39 113.172 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.97 -15.65 45.37 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 119.533 1.06 . . . . 3.13 113.168 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.11 -22.29 63.98 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.47 -0.769 . . . . 1.97 112.793 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.02 20.97 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.655 1.582 . . . . 0.96 112.689 -167.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -68.86 27.47 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.215 2.206 . . . . 2.03 116.012 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.96 3.02 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 128.529 2.732 . . . . 3.21 113.024 173.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -108.19 172.15 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 1.43 113.149 -166.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.0 150.06 39.23 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.247 1.019 . . . . 0.75 113.195 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.3 mt -89.66 152.29 21.44 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.169 1.788 . . . . 2.26 109.01 161.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 50.8 mtt -141.31 127.8 20.06 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.597 0.635 . . . . 1.26 112.185 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.45 130.73 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.957 1.303 . . . . 0.68 107.577 166.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.28 137.59 53.57 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.218 2.207 . . . . 1.85 111.236 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -64.85 -42.83 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.326 1.05 . . . . 1.33 112.781 -161.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -88.0 -106.01 0.95 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.1 1.333 . . . . 2.66 112.041 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.48 -166.99 29.39 Favored Glycine 0 N--CA 1.462 0.404 0 O-C-N 121.233 -1.157 . . . . 1.78 111.75 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -162.9 145.97 10.82 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.622 1.169 . . . . 3.25 109.911 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 114.27 55.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 130.294 3.438 . . . . 4.34 108.121 -154.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.3 ptp -169.63 37.02 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.044 1.338 . . . . 2.64 113.455 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.61 61.31 2.31 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.078 -1.639 . . . . 3.49 114.911 -169.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -140.25 -45.54 0.42 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 116.613 2.079 . . . . 4.3 116.613 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.43 148.32 44.12 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.753 1.39 . . . . 3.89 114.753 -156.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.44 -9.19 24.78 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.312 3.341 . . . . 1.97 115.555 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -101.43 78.34 0.21 Allowed Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.587 -0.894 . . . . 4.6 108.587 154.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.73 152.38 82.21 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.758 2.972 . . . . 3.13 112.355 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 mt 69.08 27.98 5.17 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.641 1.577 . . . . 4.07 110.296 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.42 13.52 58.46 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.318 1.437 . . . . 3.09 114.626 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.94 -6.9 46.32 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 118.676 1.238 . . . . 2.13 114.375 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.87 5.94 56.73 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.488 1.994 . . . . 2.09 114.089 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.8 2.56 7.91 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 118.613 1.206 . . . . 1.97 115.022 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 p -64.26 144.64 56.99 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.359 1.463 . . . . 1.54 109.655 169.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.92 137.58 36.92 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.001 0.92 . . . . 5.65 112.605 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -91.46 -27.85 18.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.284 0.634 . . . . 2.3 111.281 158.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.24 153.11 28.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.174 0.805 . . . . 0.58 113.174 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.54 165.52 16.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.382 1.473 . . . . 1.47 110.755 165.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -160.82 136.43 4.46 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.658 1.123 . . . . 0.66 112.797 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.11 133.45 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.657 1.183 . . . . 1.9 110.603 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.0 141.2 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.503 1.121 . . . . 1.65 111.068 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 123.981 0.913 . . . . 4.28 112.769 -174.637 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.413 -0.217 . . . . 1.72 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -135.87 150.04 49.23 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.394 -1.441 . . . . 0.98 114.763 -141.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -155.72 123.85 5.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.675 1.59 . . . . 2.36 108.703 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.93 108.29 18.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.714 1.605 . . . . 4.86 110.512 -171.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.15 126.38 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.339 0.656 . . . . 1.06 110.14 -165.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.94 113.34 4.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.277 1.417 . . . . 0.77 110.549 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.4 mmt -97.33 113.16 24.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.448 1.499 . . . . 1.54 110.586 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -102.2 149.55 24.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.287 1.035 . . . . 3.17 112.108 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.31 61.98 1.25 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.395 1.078 . . . . 1.73 112.645 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.43 147.48 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.342 1.057 . . . . 1.22 112.489 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 t -177.44 134.85 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.798 1.639 . . . . 2.32 111.338 163.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.67 -44.16 0.25 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.03 2.932 . . . . 1.13 117.062 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 11.11 33.75 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.148 1.779 . . . . 3.0 110.844 172.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -133.23 11.69 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.996 1.284 . . . . 0.96 110.684 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.19 134.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.862 1.665 . . . . 1.59 111.031 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.53 -82.47 1.42 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.837 1.208 . . . . 2.32 111.924 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.2 158.29 18.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.078 1.351 . . . . 2.05 111.355 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.0 t -97.92 145.47 26.43 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.728 1.211 . . . . 1.7 112.977 -169.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.3 pt -142.85 3.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 114.837 1.421 . . . . 2.98 114.837 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.73 178.35 35.58 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 120.895 -1.128 . . . . 0.75 114.023 -170.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -131.14 178.41 6.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.352 1.061 . . . . 0.97 109.054 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 38.3 t -131.05 133.99 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.095 -1.076 . . . . 0.45 108.095 162.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 8.7 p -90.65 127.8 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.604 0.362 . . . . 0.82 110.721 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.8 136.65 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.289 1.036 . . . . 1.75 108.825 169.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -141.91 113.5 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.215 1.406 . . . . 1.85 110.744 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.77 153.55 39.94 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.733 0.813 . . . . 3.12 112.063 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 t -167.68 -177.68 3.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.542 1.937 . . . . 1.23 109.149 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -53.1 -40.75 64.37 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.257 1.423 . . . . 3.82 112.497 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 15.16 56.71 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.22 1.39 . . . . 0.85 114.44 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 -152.78 42.48 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 127.36 2.41 . . . . 0.75 115.334 173.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.401 HD12 HD23 ' A' ' 114' ' ' LEU . 54.3 mt -65.53 104.34 0.99 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.701 0.801 . . . . 0.52 113.135 -169.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -80.12 110.42 15.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.008 1.723 . . . . 2.56 109.964 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 6.6 t80 -100.85 114.87 29.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.457 2.703 . . . . 0.66 108.928 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.433 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.6 m -122.73 111.18 31.34 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 119.776 1.171 . . . . 0.56 108.948 175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -84.08 158.55 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.525 2.817 . . . . 0.41 111.66 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . 0.263 1.7 p80 -152.52 65.06 0.81 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 122.5 1.143 . . . . 1.23 111.664 172.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.59 151.26 45.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.35 1.86 . . . . 0.65 111.535 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 37.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 117.509 2.411 . . . . 2.45 117.509 -159.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.45 13.03 1.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.978 1.473 . . . . 2.41 114.978 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.33 161.82 50.56 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 119.124 -0.465 . . . . 1.82 111.359 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -60.96 129.78 30.18 Favored 'Trans proline' 0 N--CA 1.431 -2.157 0 O-C-N 123.241 1.127 . . . . 1.06 109.756 162.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -86.45 22.86 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.665 3.577 . . . . 1.1 113.269 -150.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.52 153.04 17.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 126.167 1.842 . . . . 1.94 110.49 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -45.28 137.03 4.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.005 2.522 . . . . 3.3 113.72 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -126.93 129.42 48.13 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 125.533 1.533 . . . . 0.95 111.704 -172.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.14 158.18 1.72 Allowed Glycine 0 CA--C 1.543 1.843 0 CA-C-N 119.276 0.944 . . . . 0.66 114.016 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 1.3 t80 -145.39 116.3 7.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.147 1.779 . . . . 1.9 106.65 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -126.12 168.75 13.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.388 1.995 . . . . 0.75 116.388 165.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -99.08 135.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.391 1.876 . . . . 0.97 110.09 154.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -105.6 176.14 5.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.822 1.649 . . . . 0.98 111.963 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.9 62.59 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 116.744 2.127 . . . . 1.19 116.744 -166.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -126.06 -159.68 0.93 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.6 1.56 . . . . 1.31 111.277 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.87 66.73 0.37 Allowed Glycine 0 N--CA 1.476 1.323 0 N-CA-C 116.677 1.431 . . . . 1.01 116.677 -162.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -174.69 116.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.236 1.814 . . . . 2.59 111.974 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.7 m -67.62 33.0 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 128.043 2.537 . . . . 1.46 115.183 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -104.89 126.61 30.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 119.996 -1.69 . . . . 3.03 111.379 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.52 150.97 13.24 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.073 3.182 . . . . 1.32 112.889 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 169.08 8.94 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.179 0.992 . . . . 1.94 110.196 154.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 mm -97.9 124.1 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.948 -1.13 . . . . 2.82 107.948 162.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -139.54 109.22 6.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.278 1.431 . . . . 5.01 109.179 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t0 60.43 63.04 1.43 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.161 1.785 . . . . 4.2 112.747 -166.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.39 13.33 54.34 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 115.711 1.045 . . . . 2.96 115.711 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -147.48 150.11 33.95 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.027 1.731 . . . . 3.38 110.209 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.05 34.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.998 0.519 . . . . 1.45 111.896 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.5 t -67.94 -3.98 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.188 1.795 . . . . 2.93 113.466 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.47 -50.56 0.69 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.499 2.72 . . . . 2.16 112.575 -174.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.51 111.25 2.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.178 1.791 . . . . 1.72 109.682 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.89 -39.7 12.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.239 0.616 . . . . 5.07 110.691 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.01 -4.2 30.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.114 1.153 . . . . 1.73 114.114 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.0 -18.9 27.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.178 1.391 . . . . 1.08 112.631 168.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.31 178.1 31.53 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 122.319 0.955 . . . . 2.85 113.516 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.69 -163.65 39.31 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.531 1.062 . . . . 1.37 112.894 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -56.31 128.29 35.09 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.763 0.825 . . . . 3.04 109.591 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.32 66.72 0.18 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.681 1.993 . . . . 2.13 112.34 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -111.21 113.55 54.2 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 4.67 108.989 164.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -84.68 -31.27 0.46 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.288 1.992 . . . . 2.08 113.302 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 176.9 29.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.869 2.068 . . . . 3.07 111.289 -165.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -119.07 -21.19 7.76 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.56 -1.209 . . . . 3.85 113.261 -164.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t 155.16 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 130.607 3.563 . . . . 2.19 111.172 158.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.33 -11.29 61.69 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.8 1.191 . . . . 2.2 115.494 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -73.79 1.78 9.76 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 116.019 1.859 . . . . 4.54 116.019 -173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.6 t60 87.75 135.16 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 129.045 2.938 . . . . 1.81 114.151 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.65 19.33 14.61 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.981 1.712 . . . . 4.84 114.385 -152.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.78 -35.68 31.04 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-O 117.642 -1.643 . . . . 2.45 114.735 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -111.83 -2.39 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 124.316 3.344 . . . . 3.5 114.153 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -143.82 145.93 32.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.875 1.67 . . . . 5.24 108.457 -172.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.12 6.5 35.09 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.586 1.394 . . . . 3.15 116.586 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.81 130.34 15.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.051 1.426 . . . . 5.06 109.721 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.69 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-O 115.709 -2.717 . . . . 3.33 118.22 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.467 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 0.3 OUTLIER 152.99 118.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 129.145 2.978 . . . . 5.19 110.924 -175.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.3 tt -67.03 -28.43 68.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.47 1.108 . . . . 2.65 113.369 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -88.18 15.7 55.04 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.416 1.484 . . . . 0.84 115.179 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.441 ' OD1' ' CE1' ' A' ' 90' ' ' HIS . 78.7 m-20 -76.11 147.65 38.43 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.2 1.5 . . . . 1.55 110.751 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.17 166.03 17.38 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.607 0.763 . . . . 1.79 110.368 -146.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.06 148.53 19.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.877 3.051 . . . . 1.14 112.271 -171.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.89 135.16 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 122.108 0.956 . . . . 1.74 111.38 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 108.83 19.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.026 2.53 . . . . 2.48 110.428 -172.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.4 t -78.24 131.35 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.365 -0.835 . . . . 1.83 111.935 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.68 141.31 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.67 2.388 . . . . 1.59 106.423 166.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.51 164.3 22.07 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.134 0.424 . . . . 1.95 111.484 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -16.67 0.29 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 127.421 2.289 . . . . 2.23 116.89 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.62 -1.41 43.81 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.181 1.792 . . . . 2.41 113.434 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.29 53.84 Favored Glycine 0 N--CA 1.473 1.119 0 O-C-N 121.185 -0.947 . . . . 0.93 114.851 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.8 mt -106.14 121.97 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.217 1.007 . . . . 1.46 110.806 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.4 122.56 33.38 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.342 1.057 . . . . 0.63 109.092 168.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -155.48 8.68 0.27 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.135 1.161 . . . . 1.32 114.135 -167.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.62 123.61 49.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.868 1.267 . . . . 3.36 110.473 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.75 134.75 26.56 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.189 3.259 . . . . 1.38 111.963 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.0 163.77 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 126.342 1.857 . . . . 1.61 109.261 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 m -144.14 141.0 29.71 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.993 1.269 . . . . 0.82 112.112 -167.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -121.17 106.05 39.01 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.554 1.142 . . . . 0.83 113.381 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.1 7.42 1.74 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.727 3.618 . . . . 1.11 114.637 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -75.4 -25.7 57.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.812 1.645 . . . . 6.91 112.735 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -123.99 135.59 53.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.313 -1.736 . . . . 2.47 106.313 168.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -113.05 -2.65 14.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 4.18 113.579 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.4 t -141.11 174.06 10.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.353 0.979 . . . . 2.02 111.752 158.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.43 -24.27 64.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.165 -0.959 . . . . 1.48 111.09 157.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -60.01 -28.62 67.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.352 1.461 . . . . 2.83 114.639 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -78.91 -16.1 57.45 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.199 1.185 . . . . 2.36 114.199 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.1 m -124.42 16.35 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 125.195 1.398 . . . . 1.25 113.291 -172.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -65.44 8.64 0.15 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 128.242 2.617 . . . . 2.5 117.579 -171.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 41.76 0.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.273 1.429 . . . . 3.7 112.171 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -134.49 168.28 19.23 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.937 1.295 . . . . 1.45 113.685 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.7 146.69 26.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.503 1.521 . . . . 0.53 114.259 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.37 145.39 30.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.921 2.489 . . . . 1.6 107.809 167.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 52.3 mtt -140.65 143.4 35.13 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.294 -0.879 . . . . 1.41 112.427 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mt -99.75 123.6 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.772 1.629 . . . . 0.65 108.444 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -109.02 143.29 38.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.293 1.837 . . . . 2.79 111.39 -165.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.12 -37.78 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.865 -1.147 . . . . 1.41 111.914 -169.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.93 153.34 20.06 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.913 0.768 . . . . 0.97 112.125 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.35 -178.9 25.6 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.891 1.71 . . . . 1.31 113.128 163.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -137.01 14.87 3.07 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.027 1.491 . . . . 3.29 115.027 -126.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -105.16 21.82 16.44 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.709 1.374 . . . . 2.54 114.709 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtm -96.55 129.65 43.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.859 -1.151 . . . . 2.7 112.363 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.2 p -126.7 4.93 6.71 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.766 1.395 . . . . 3.34 114.766 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -157.09 124.61 5.33 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.887 -1.133 . . . . 3.53 109.464 -169.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -174.09 142.25 0.85 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 117.926 -1.035 . . . . 3.69 109.558 -167.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.11 -15.12 29.0 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.08 2.52 . . . . 2.72 113.762 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -129.23 133.85 25.62 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.811 1.645 . . . . 4.67 108.955 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.9 124.82 15.7 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.215 2.61 . . . . 3.31 111.783 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp 58.88 5.2 0.48 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.689 1.996 . . . . 3.31 114.007 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.87 9.08 44.8 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.883 -1.136 . . . . 3.82 114.574 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.92 -0.27 33.85 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.411 1.482 . . . . 2.68 114.345 -167.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.87 7.34 5.5 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.342 1.449 . . . . 1.75 115.646 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.24 -6.03 78.63 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.873 1.337 . . . . 2.13 112.921 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 p -70.07 134.06 47.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.356 1.862 . . . . 2.07 110.693 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.43 147.27 45.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.355 1.462 . . . . 5.24 112.02 -172.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -106.3 -17.16 14.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.249 -0.881 . . . . 2.37 112.93 169.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.85 33.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.856 1.428 . . . . 0.54 114.856 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -135.74 149.12 49.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.198 2.199 . . . . 1.32 110.238 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.5 1.71 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.342 1.925 . . . . 0.66 112.474 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.63 141.71 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.569 1.148 . . . . 2.42 112.592 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -77.14 141.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.57 1.148 . . . . 1.02 110.868 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 124.332 1.053 . . . . 4.27 110.977 171.366 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.988 -0.745 . . . . 2.12 108.988 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -128.71 133.53 48.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.899 -1.751 . . . . 1.26 112.504 -137.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -146.69 127.68 14.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 123.226 1.489 . . . . 2.5 112.711 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -109.86 90.94 3.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.251 1.42 . . . . 3.63 110.216 -162.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.5 t -90.04 120.04 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.89 0.476 . . . . 1.0 110.299 -163.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.48 105.4 1.78 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.972 1.272 . . . . 0.79 110.639 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 mmt -85.13 110.49 19.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.999 1.32 . . . . 1.54 110.57 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -98.25 143.78 28.38 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.95 0.9 . . . . 2.8 111.452 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.3 63.01 3.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.895 1.278 . . . . 1.27 111.55 -175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.35 136.79 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.551 0.74 . . . . 1.23 111.205 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -157.96 139.87 14.03 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.597 0.359 . . . . 2.54 111.514 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' H ' ' NH2' ' A' ' 147' ' ' ARG . . . 26.76 -42.99 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.884 1 C-N-CA 134.638 5.175 . . . . 1.21 120.763 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -80.17 -23.26 41.16 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.825 1.25 . . . . 3.08 111.791 166.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.5 -141.08 13.02 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.846 1.212 . . . . 0.96 111.541 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.5 t -54.81 128.79 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.117 1.367 . . . . 1.16 111.78 -174.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.26 -111.0 3.54 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.151 1.834 . . . . 1.22 111.701 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.68 169.35 15.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.515 1.126 . . . . 1.66 110.945 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.9 t -109.44 156.81 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.058 -1.026 . . . . 1.05 111.994 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 pt -147.33 9.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.733 2.013 . . . . 2.74 113.114 -172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.57 162.78 10.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.642 1.115 . . . . 0.69 112.743 -167.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 p -104.45 -177.99 3.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.23 1.012 . . . . 0.79 109.316 168.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.4 t -124.43 130.87 73.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 106.848 -1.538 . . . . 0.42 106.848 151.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG12 ' HB ' ' A' ' 34' ' ' THR . 8.7 p -87.72 123.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.727 -0.471 . . . . 0.89 109.727 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.86 119.98 45.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.04 -1.096 . . . . 1.5 108.04 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -118.47 111.33 18.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.835 0.854 . . . . 1.94 110.848 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 130.47 46.57 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 127.124 2.17 . . . . 3.91 111.165 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 t -161.18 -172.0 3.25 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.705 1.002 . . . . 2.06 113.705 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.32 -31.29 43.49 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.523 1.529 . . . . 6.75 112.721 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.57 17.9 57.56 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 124.962 1.267 . . . . 1.89 115.179 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.29 -140.43 28.4 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.22 1.39 . . . . 0.93 111.372 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.59 107.89 7.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.284 0.634 . . . . 0.66 111.13 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -87.83 107.51 18.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.771 1.228 . . . . 1.87 111.263 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.34 104.61 16.02 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.596 1.958 . . . . 0.58 109.763 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' HG12 ' A' ' 23' ' ' VAL . 4.2 m -113.69 106.66 53.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 107.256 -1.387 . . . . 0.56 107.256 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.1 162.06 17.98 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.371 3.38 . . . . 0.47 109.928 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -153.02 34.7 0.47 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.982 0.896 . . . . 1.22 112.346 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -97.26 142.85 28.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.703 1.201 . . . . 0.63 111.21 -174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.38 23.1 9.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.154 1.909 . . . . 2.25 116.154 -166.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.51 57.51 0.63 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.672 0.789 . . . . 1.33 112.806 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.03 15.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.115 0.966 . . . . 1.42 111.57 172.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 35.3 Cg_endo -62.73 134.36 46.77 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 122.058 1.839 . . . . 0.94 110.973 166.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 18.6 Cg_endo -84.18 27.31 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.706 1 C-N-CA 126.692 4.928 . . . . 1.01 114.825 -152.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.79 -134.79 8.16 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.398 1.475 . . . . 1.25 115.091 -172.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -120.17 136.5 54.6 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.647 1.579 . . . . 2.29 108.588 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -124.87 143.64 50.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.18 0.992 . . . . 1.08 112.631 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.9 153.68 52.32 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.917 -0.873 . . . . 0.54 110.917 169.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -124.07 118.41 26.88 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.277 -1.379 . . . . 2.06 107.277 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -116.5 160.95 19.86 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.068 1.507 . . . . 0.87 115.068 168.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.7 mt -103.13 148.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.521 2.329 . . . . 1.01 108.332 158.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -134.62 145.37 48.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.91 111.001 -174.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.46 87.58 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.784 1.772 . . . . 0.75 115.784 -159.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -116.76 148.63 40.97 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.658 1.183 . . . . 1.08 112.989 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.69 72.57 2.81 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.769 1.176 . . . . 0.87 113.803 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -164.36 96.06 0.76 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.174 0.987 . . . . 1.9 113.422 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -65.39 22.73 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.155 2.182 . . . . 1.31 116.44 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -86.18 129.34 54.13 Favored Pre-proline 0 CA--C 1.55 0.957 0 O-C-N 119.802 -1.811 . . . . 3.09 112.446 -166.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -95.62 173.26 1.11 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.897 3.731 . . . . 1.41 111.99 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.5 154.07 45.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.12 1.368 . . . . 2.2 110.956 165.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -85.05 113.55 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.205 -1.405 . . . . 3.81 107.205 157.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -138.47 121.37 16.59 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.716 1.206 . . . . 4.57 108.547 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 57.69 40.01 26.86 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.755 1.222 . . . . 4.22 112.548 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.37 9.92 86.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.579 1.085 . . . . 3.27 115.34 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.02 154.09 48.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.001 1.401 . . . . 3.38 110.727 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.56 113.13 24.79 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.51 -0.744 . . . . 2.56 111.717 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.35 33.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 116.054 1.872 . . . . 2.69 116.054 -163.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.68 -63.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.365 2.666 . . . . 2.14 114.105 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 172.75 108.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 131.581 3.952 . . . . 1.69 107.6 -176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -110.54 -39.2 4.98 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.141 0.976 . . . . 3.99 111.817 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -19.73 62.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.538 0.94 . . . . 1.29 113.538 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -9.14 53.84 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.299 1.84 . . . . 0.78 113.61 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.55 54.65 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.602 -1.312 . . . . 2.16 112.629 -174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 179.47 51.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.897 0.76 . . . . 1.48 112.993 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.44 31.12 0.06 Allowed 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 114.197 1.184 . . . . 2.83 114.197 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.6 tp 64.92 88.85 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.041 2.137 . . . . 1.77 112.654 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -166.37 121.49 0.91 Allowed Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.136 2.174 . . . . 4.95 110.619 163.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -90.57 -14.16 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.255 2.636 . . . . 2.1 114.118 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -154.33 -37.05 0.1 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.306 1.965 . . . . 5.04 116.306 -159.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -60.33 -32.92 71.7 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.478 1.49 . . . . 4.14 113.669 -163.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 t 171.78 -26.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.792 2.837 . . . . 2.69 111.551 163.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 5.12 82.76 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.048 -1.033 . . . . 2.1 115.287 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -74.44 -25.95 59.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 115.17 1.544 . . . . 6.45 115.17 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.6 t60 99.03 145.79 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 129.35 3.06 . . . . 1.95 111.79 -168.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -119.58 -153.59 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 3.86 112.85 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.81 -138.32 6.71 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 117.659 -1.634 . . . . 2.58 109.37 -155.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.08 -27.2 65.48 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.016 2.477 . . . . 3.04 113.96 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.66 -9.44 58.25 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.976 1.102 . . . . 5.91 113.976 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.01 19.98 70.4 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 116.812 1.485 . . . . 3.02 116.812 167.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.98 100.52 3.95 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.595 1.197 . . . . 4.93 111.0 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.94 -34.92 0.13 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-O 117.193 -1.893 . . . . 3.24 116.128 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -161.83 128.34 3.77 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.756 2.022 . . . . 3.64 110.719 157.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -66.66 -21.42 66.11 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.132 1.16 . . . . 2.69 114.132 178.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.66 23.0 9.41 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.801 1.191 . . . . 0.86 114.91 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.15 134.3 41.4 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.075 1.437 . . . . 1.58 110.444 165.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.28 161.08 62.49 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.385 1.874 . . . . 1.98 110.335 -168.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.89 167.84 25.52 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.572 2.848 . . . . 1.35 112.317 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 132' ' ' ASP . 2.9 m -75.79 147.17 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.845 1.307 . . . . 1.75 113.89 -164.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.94 97.09 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 130.557 3.543 . . . . 2.26 108.397 -175.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 t -83.09 147.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.986 1.315 . . . . 0.83 111.797 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.77 142.41 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.331 2.252 . . . . 1.54 107.93 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.436 ' C ' HD22 ' A' ' 100' ' ' ASN . 0.0 OUTLIER -71.71 160.25 32.95 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.406 0.548 . . . . 2.26 111.688 175.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -57.57 -4.17 0.24 Allowed 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 116.91 2.189 . . . . 2.75 116.91 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -111.8 -11.23 13.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.263 1.425 . . . . 3.0 114.562 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.19 32.61 3.2 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 116.627 1.411 . . . . 0.72 116.627 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.417 ' H ' ' ND2' ' A' ' 100' ' ' ASN . 13.0 mt -121.3 135.89 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.543 1.537 . . . . 1.08 108.62 175.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.24 130.14 55.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.247 1.019 . . . . 0.62 110.14 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -148.98 10.06 0.79 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.811 2.152 . . . . 1.11 116.811 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.58 130.59 40.74 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 120.349 1.431 . . . . 6.04 114.167 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.12 87.33 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.908 3.072 . . . . 2.04 111.742 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.2 t -72.31 160.3 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.295 1.438 . . . . 1.84 108.993 172.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.5 m -142.82 131.88 23.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.653 -1.279 . . . . 1.39 111.505 -171.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.02 91.23 49.71 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.205 1.002 . . . . 0.81 113.4 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.34 2.46 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.227 3.285 . . . . 1.3 115.201 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -72.06 -26.33 62.14 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.025 0.83 . . . . 3.8 111.555 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.86 151.51 26.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.673 2.389 . . . . 2.03 108.822 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -138.21 12.81 2.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.989 1.315 . . . . 4.96 114.044 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.6 t -160.76 152.24 19.36 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.98 -1.075 . . . . 2.22 112.269 161.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.94 -28.55 62.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.204 -0.427 . . . . 1.63 111.635 161.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -54.79 -28.73 51.26 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.105 0.962 . . . . 2.8 112.813 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.17 -12.61 60.63 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.874 0.87 . . . . 1.89 112.766 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.08 12.44 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.417 1.487 . . . . 0.74 113.028 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -63.79 -1.71 1.49 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 117.224 2.305 . . . . 2.26 117.224 -169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -146.15 19.97 1.4 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.249 1.82 . . . . 3.15 111.941 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -104.8 -176.51 3.1 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.026 1.73 . . . . 1.45 112.974 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.21 160.42 22.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.526 1.13 . . . . 0.77 112.368 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 mt -126.63 141.4 51.86 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 129.136 2.974 . . . . 1.77 106.038 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.26 138.8 48.02 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.129 0.877 . . . . 1.3 112.561 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -99.53 116.11 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.46 1.504 . . . . 0.76 107.871 170.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -110.82 145.45 38.16 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.963 1.305 . . . . 1.89 113.266 -162.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.53 -34.7 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.392 1.077 . . . . 1.16 113.436 -154.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.2 151.87 18.3 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.978 -0.849 . . . . 1.18 110.978 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -56.06 148.93 27.47 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.062 0.839 . . . . 1.85 111.006 162.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.438 ' H ' HG12 ' A' ' 96' ' ' VAL . 38.4 t0 -127.05 133.9 50.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.359 1.076 . . . . 3.33 113.232 -159.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -156.48 10.02 0.24 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.794 2.437 . . . . 3.35 111.637 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -83.76 66.71 9.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.007 1.114 . . . . 3.22 114.007 -157.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.5 p -75.23 30.91 0.1 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.075 1.139 . . . . 3.2 114.075 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -165.62 147.15 7.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.745 2.018 . . . . 4.04 111.077 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 155.42 153.35 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 130.489 3.516 . . . . 4.32 111.767 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -86.72 -17.15 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.26 3.307 . . . . 2.35 112.863 163.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -91.33 144.02 29.12 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.878 1.271 . . . . 4.0 110.339 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -73.5 160.01 45.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.178 2.586 . . . . 4.92 113.228 -166.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.31 2.48 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.606 1.963 . . . . 5.4 114.756 170.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.83 3.67 80.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.733 1.159 . . . . 3.45 114.159 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.96 -65.65 4.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.279 1.418 . . . . 1.91 112.958 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.47 64.33 Favored Glycine 0 N--CA 1.476 1.367 0 C-N-CA 124.278 0.942 . . . . 1.66 115.233 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.72 10.72 16.91 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.909 1.718 . . . . 2.02 115.582 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 p -71.39 156.05 39.92 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.581 1.691 . . . . 1.77 109.547 162.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.421 ' NH2' ' H ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.97 143.26 30.39 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.931 1.086 . . . . 6.12 113.931 -173.154 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -99.63 -23.69 14.97 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.239 0.616 . . . . 2.46 111.402 153.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.89 158.31 43.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.251 0.932 . . . . 0.54 113.453 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.46 150.07 51.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.383 1.873 . . . . 1.62 110.05 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -149.32 107.84 0.37 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.049 1.785 . . . . 0.73 112.007 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.04 139.42 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.595 1.158 . . . . 2.5 110.722 165.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.69 117.82 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.788 -0.57 . . . . 1.14 110.202 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 125.629 1.572 . . . . 5.15 110.222 179.386 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 119.276 -0.392 . . . . 1.8 110.627 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -155.47 140.6 17.46 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 119.625 -1.922 . . . . 1.33 111.847 -172.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.33 146.4 21.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.542 1.163 . . . . 3.06 111.881 166.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -109.55 116.94 32.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.571 1.549 . . . . 4.35 113.423 -176.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -103.79 120.97 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.852 -1.155 . . . . 1.17 110.822 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.8 108.63 2.99 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.557 2.027 . . . . 0.69 112.159 178.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 35.0 mtt -90.43 139.17 30.93 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.953 1.834 . . . . 1.32 115.953 -176.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -115.5 146.39 41.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.812 2.045 . . . . 3.08 113.504 -174.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.98 63.08 4.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.555 1.542 . . . . 1.57 113.066 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.8 105.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 120.929 -1.107 . . . . 1.44 113.006 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.3 t -132.3 73.29 1.52 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.017 0.927 . . . . 2.59 112.424 -173.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 71.19 -47.3 0.66 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.839 2.456 . . . . 1.36 114.032 172.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.64 -12.58 61.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.819 1.248 . . . . 2.78 112.085 174.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.67 -165.49 12.65 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.679 1.609 . . . . 1.24 113.542 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.57 134.35 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.856 1.663 . . . . 1.2 110.547 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.34 -83.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.214 1.388 . . . . 1.98 113.732 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -100.49 130.87 46.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.003 1.721 . . . . 2.28 111.941 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -108.14 138.07 45.04 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.109 -0.994 . . . . 1.2 109.857 175.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mm -125.16 -16.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.86 1.43 . . . . 4.03 114.86 -170.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.46 158.35 27.63 Favored Glycine 0 CA--C 1.521 0.467 0 O-C-N 121.518 -0.739 . . . . 1.04 111.907 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 p -88.34 173.98 8.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.062 0.934 . . . . 0.98 109.219 163.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.1 132.91 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.896 -1.52 . . . . 0.59 106.896 148.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.47 128.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 123.551 0.532 . . . . 0.87 110.174 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.48 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 125.283 1.433 . . . . 1.66 108.208 -173.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.61 117.07 34.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 123.067 1.413 . . . . 1.84 110.189 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.259 0.8 OUTLIER -81.95 122.03 27.25 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.205 3.402 . . . . 2.96 109.895 -169.481 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.0 t -144.2 178.44 7.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.17 0.986 . . . . 1.2 111.12 -173.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -28.98 68.06 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.491 1.916 . . . . 4.71 110.357 -176.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.96 13.7 60.59 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.563 1.554 . . . . 1.02 115.289 163.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.62 -151.17 21.15 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 127.627 2.537 . . . . 0.76 116.552 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.54 101.2 4.8 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.869 . . . . 0.76 111.53 -175.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.5 105.2 10.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.622 1.169 . . . . 1.79 110.833 173.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.9 t80 -93.86 116.64 29.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.575 2.35 . . . . 0.64 109.975 -172.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -123.36 112.55 29.65 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 119.824 1.193 . . . . 0.56 108.824 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.53 159.45 10.86 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.169 3.246 . . . . 0.54 111.996 -173.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -150.06 39.61 0.77 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.24 0.543 . . . . 1.36 112.287 171.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.48 142.34 28.68 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.032 -1.668 . . . . 0.88 112.828 -172.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 91.83 3.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.119 1.368 . . . . 2.15 113.436 -171.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' C ' HD22 ' A' ' 40' ' ' LEU . . . 133.1 103.47 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 130.404 3.481 . . . . 2.0 107.227 -171.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.61 ' HA ' ' CE2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -160.84 160.01 25.18 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 131.603 3.961 . . . . 2.63 106.67 167.103 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -63.48 140.27 75.01 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 O-C-N 122.64 0.81 . . . . 1.36 110.094 157.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -86.67 31.48 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.554 2.836 . . . . 1.49 113.513 -152.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.33 -177.44 14.99 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.154 1.359 . . . . 2.15 113.527 -175.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -64.77 129.93 41.62 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 125.336 1.454 . . . . 3.36 112.605 -168.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -125.57 131.34 52.75 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.594 1.158 . . . . 0.94 110.209 -176.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.0 169.52 50.78 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 119.368 0.986 . . . . 0.64 112.753 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 4.1 t80 -137.9 114.71 10.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.969 1.308 . . . . 1.92 108.827 174.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -118.61 163.27 17.06 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.987 1.477 . . . . 0.71 114.987 163.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.17 144.46 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.825 1.65 . . . . 0.69 108.311 155.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -119.02 157.16 28.33 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.276 1.03 . . . . 0.83 111.761 173.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -20.48 66.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 117.197 2.295 . . . . 0.7 117.197 -162.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -132.43 -174.8 3.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.067 1.747 . . . . 1.13 111.8 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 50.93 0.87 Allowed Glycine 0 N--CA 1.471 1.026 0 N-CA-C 116.316 1.286 . . . . 0.89 116.316 -160.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 t -157.89 110.95 2.44 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.513 1.656 . . . . 2.4 112.595 167.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.99 5.19 0.1 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.588 2.355 . . . . 1.37 116.945 -173.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -83.84 140.56 40.6 Favored Pre-proline 0 CA--C 1.546 0.821 0 O-C-N 120.461 -1.399 . . . . 3.79 112.72 -167.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.84 148.84 12.37 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.04 3.16 . . . . 1.22 112.215 173.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.38 21.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.757 0.823 . . . . 1.58 111.204 156.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.1 mm -114.48 103.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.852 1.261 . . . . 2.6 109.428 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HE2' ' OD2' ' A' ' 61' ' ' ASP . 16.5 mtpt -101.63 149.13 24.44 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.393 1.477 . . . . 5.3 110.051 168.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' OD2' ' HE2' ' A' ' 60' ' ' LYS . 12.8 m-20 46.59 39.02 6.25 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.276 1.213 . . . . 4.25 114.276 161.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.6 25.38 75.27 Favored Glycine 0 CA--C 1.537 1.406 0 CA-C-O 118.291 -1.283 . . . . 2.91 115.556 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -156.07 158.25 37.46 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.395 2.098 . . . . 3.04 112.98 -177.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.14 139.73 31.88 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.354 -0.841 . . . . 1.55 113.0 -173.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 m -85.36 13.8 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 114.862 1.43 . . . . 2.85 114.862 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.81 -51.41 0.7 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.849 2.46 . . . . 1.53 113.792 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.81 141.53 4.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.061 1.744 . . . . 2.17 109.419 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.32 -50.99 1.99 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.969 0.508 . . . . 4.87 111.424 173.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.3 1.24 6.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.549 1.314 . . . . 1.59 114.549 -177.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 -18.7 35.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.277 1.431 . . . . 0.91 112.522 166.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 -177.22 53.79 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 122.565 1.092 . . . . 2.23 114.764 176.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.86 179.9 37.35 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.941 1.258 . . . . 1.37 113.669 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -69.51 5.06 1.49 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.042 1.867 . . . . 2.63 116.042 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.3 tp 63.48 89.54 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.9 2.08 . . . . 1.62 109.697 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -159.96 23.1 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 117.473 2.397 . . . . 3.45 117.473 -156.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -61.37 -26.01 80.91 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.336 2.691 . . . . 2.08 116.552 -152.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -131.4 22.75 4.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.197 0.999 . . . . 3.7 111.62 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -89.94 -58.98 2.32 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.815 -1.178 . . . . 3.41 113.294 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 t 159.84 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.294 3.037 . . . . 2.24 111.293 -175.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.07 61.88 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.087 -1.396 . . . . 1.83 115.336 176.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -72.14 -30.33 64.93 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.462 2.131 . . . . 5.33 114.348 -175.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.9 t60 86.67 155.03 0.07 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 129.003 2.921 . . . . 1.65 111.651 -166.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.74 -130.59 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.773 1.229 . . . . 3.86 111.861 -173.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 145.11 -44.82 0.86 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 127.883 2.659 . . . . 2.86 112.601 -174.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -111.39 -11.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.42 2.747 . . . . 3.2 116.317 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -145.61 0.86 0.89 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.883 1.674 . . . . 4.58 115.233 -153.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.99 -12.91 21.88 Favored Glycine 0 N--CA 1.476 1.345 0 O-C-N 120.462 -1.399 . . . . 3.26 114.5 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.48 38.43 0.19 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.679 2.392 . . . . 6.59 114.294 -166.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.94 -87.29 0.06 OUTLIER Glycine 0 C--N 1.342 0.902 0 O-C-N 120.427 -1.421 . . . . 2.5 114.911 -170.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -142.96 143.73 32.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.438 1.895 . . . . 3.59 110.357 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -77.09 -14.43 59.81 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.829 1.195 . . . . 2.87 114.013 170.171 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.63 3.37 79.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.296 -1.28 . . . . 0.85 115.802 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -94.2 129.25 40.88 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 119.424 1.612 . . . . 2.62 112.08 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 1.1 mm? -117.26 168.7 8.54 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.871 2.068 . . . . 1.93 110.221 -177.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 94' ' ' LEU . 67.7 Cg_endo -81.44 167.4 17.3 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.066 2.51 . . . . 1.28 111.859 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.64 137.87 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 115.829 1.788 . . . . 1.6 115.829 -163.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.22 95.19 4.26 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 130.845 3.658 . . . . 1.56 110.059 170.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.34 131.26 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.919 -1.113 . . . . 1.01 111.759 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -118.03 149.5 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 127.328 2.251 . . . . 2.51 109.082 167.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.87 166.36 19.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.723 1.009 . . . . 2.69 113.723 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -13.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 119.389 3.107 . . . . 2.32 119.389 -178.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -119.77 -4.4 10.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.639 1.576 . . . . 4.11 114.355 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.09 38.77 2.25 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 116.785 1.474 . . . . 1.12 116.785 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mm -126.6 130.84 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-N 119.507 1.653 . . . . 2.21 111.903 166.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.46 132.64 37.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.931 1.292 . . . . 0.79 111.17 174.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 t -151.66 -14.2 0.2 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.992 1.849 . . . . 1.12 115.992 -170.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -85.33 133.02 43.31 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 120.398 1.454 . . . . 3.59 112.117 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.73 146.74 24.04 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.862 3.042 . . . . 1.04 112.372 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.25 170.72 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.356 1.863 . . . . 1.14 110.005 172.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 m -135.68 140.76 44.71 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.152 0.887 . . . . 0.84 110.971 -175.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.56 87.3 41.22 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.096 1.358 . . . . 0.82 112.305 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.82 -7.98 14.5 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.408 3.405 . . . . 1.68 114.95 176.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -65.23 -27.27 68.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.426 -0.796 . . . . 4.1 110.921 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.33 142.8 50.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.796 2.039 . . . . 2.36 109.265 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 32.46 0.54 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.074 1.35 . . . . 6.16 113.239 -166.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.6 m -179.81 136.21 0.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.134 2.574 . . . . 1.78 109.867 162.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -32.67 63.34 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 118.946 0.794 . . . . 1.37 111.321 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.8 -27.47 29.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.617 1.567 . . . . 3.3 113.65 174.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.37 -28.98 68.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.184 0.902 . . . . 1.78 112.41 173.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.93 11.96 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.799 1.64 . . . . 0.97 113.063 -161.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.08 -26.39 15.99 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.307 1.843 . . . . 2.1 115.322 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -10.46 55.52 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.809 2.044 . . . . 3.77 114.587 177.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.24 168.84 9.95 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.986 1.476 . . . . 1.45 114.986 -154.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.56 151.5 31.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.337 1.455 . . . . 0.61 112.053 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.22 143.77 39.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.488 1.915 . . . . 1.75 107.854 171.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 53.0 mtt -137.64 139.5 40.32 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.85 0.75 . . . . 1.19 111.946 -178.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.7 mt -100.41 126.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.569 1.548 . . . . 0.79 108.346 171.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -105.85 149.26 26.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.995 1.318 . . . . 3.07 113.43 -162.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.06 -43.0 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.924 0.89 . . . . 1.21 111.827 -167.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.89 171.3 27.15 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.857 -0.897 . . . . 0.97 110.857 158.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.45 -147.88 0.02 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.328 2.871 . . . . 2.2 114.573 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.52 54.03 0.48 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 123.746 1.736 . . . . 3.25 112.114 -150.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -160.94 27.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.511 -1.677 . . . . 3.4 111.655 -162.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 70.5 mtm -132.86 116.25 16.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.529 1.132 . . . . 3.01 111.355 -162.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 t -158.44 176.91 11.83 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.597 1.159 . . . . 3.19 110.738 175.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 68.45 25.59 6.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.634 1.974 . . . . 3.77 114.012 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.94 153.27 78.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.498 1.119 . . . . 4.06 111.774 178.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 -13.85 31.6 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.781 2.987 . . . . 1.92 114.478 -170.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -100.07 87.11 0.68 Allowed Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 117.818 -1.087 . . . . 4.65 108.596 157.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.77 151.95 60.38 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.933 2.422 . . . . 3.16 111.562 -174.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mp 67.38 22.48 9.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 3.62 110.301 -168.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.02 -7.58 4.26 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.569 1.557 . . . . 2.69 114.612 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.81 1.35 87.2 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.096 1.332 . . . . 1.71 114.011 -163.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.7 67.05 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-N 118.982 1.391 . . . . 1.6 114.878 -175.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.59 12.58 7.77 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.564 1.554 . . . . 1.6 116.704 -169.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.4 p -75.18 169.1 18.71 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.341 1.57 . . . . 1.74 110.196 169.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 137.82 51.15 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.5 1.12 . . . . 5.13 111.97 -173.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 3.5 t80 -85.26 -26.21 26.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.686 0.676 . . . . 2.21 111.881 162.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.01 157.78 36.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.236 0.828 . . . . 0.55 113.236 173.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.8 t -136.68 148.56 47.45 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.646 1.978 . . . . 1.5 110.768 175.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -148.69 121.8 1.38 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.042 1.306 . . . . 0.66 113.038 178.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.02 135.43 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.851 1.66 . . . . 1.62 110.911 175.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.6 mt -79.21 155.02 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.068 1.347 . . . . 0.86 111.036 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? . . . . . 0 CA--C 1.544 0.718 0 O-C-N 119.997 -1.689 . . . . 3.45 110.949 169.783 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.609 -0.886 . . . . 1.99 108.609 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -142.54 150.01 39.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.88 1.437 . . . . 1.28 114.88 -133.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.04 141.25 17.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.468 1.128 . . . . 2.95 109.825 167.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -90.67 135.39 33.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.617 -0.72 . . . . 2.87 111.384 176.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.7 t -121.96 125.13 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.276 -0.89 . . . . 1.15 111.108 177.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.13 115.17 4.14 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.836 1.207 . . . . 1.02 110.168 172.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.4 mtp -96.57 107.51 19.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.711 1.204 . . . . 1.71 109.695 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -93.98 146.21 24.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.813 0.671 . . . . 3.21 112.813 -169.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.4 62.75 1.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.378 1.071 . . . . 1.74 113.243 -175.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.6 m -58.54 131.84 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.507 -0.745 . . . . 1.42 111.121 171.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -150.2 48.31 0.91 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.243 1.021 . . . . 2.58 110.943 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.04 -36.7 0.32 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 128.703 2.801 . . . . 1.14 112.004 -178.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.295 0.0 OUTLIER -78.28 41.84 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.248 1.419 . . . . 3.22 114.1 174.205 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.17 -155.97 41.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.855 1.217 . . . . 1.54 112.362 175.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.82 125.28 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.158 -1.053 . . . . 1.17 108.158 163.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.35 -82.06 1.55 Allowed Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.995 0.807 . . . . 2.11 112.113 -166.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -158.37 164.83 35.95 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 122.389 1.09 . . . . 1.64 112.579 167.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 t -103.16 146.76 27.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.758 1.623 . . . . 1.29 112.373 -176.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 pt -148.72 10.39 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.623 1.569 . . . . 2.77 113.516 -164.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.02 177.68 19.12 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.78 1.181 . . . . 0.84 112.364 -165.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 p -129.47 -176.92 4.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.275 1.03 . . . . 1.01 109.984 170.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 54.6 t -126.52 136.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 124.273 1.029 . . . . 0.56 108.367 159.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.56 133.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 123.198 0.312 . . . . 0.84 110.325 171.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mt -108.77 133.78 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.871 -0.789 . . . . 1.69 108.871 168.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -139.04 96.6 3.14 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.343 1.857 . . . . 2.2 110.068 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 141.65 57.36 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 127.301 2.24 . . . . 4.34 111.597 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -156.39 177.52 11.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.745 0.783 . . . . 1.35 111.286 175.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.54 -18.51 62.17 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 3.96 112.012 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 7.26 81.13 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.927 1.251 . . . . 1.04 115.355 166.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.78 -169.66 42.93 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 129.458 3.409 . . . . 0.89 116.145 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.24 105.45 0.34 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.353 1.461 . . . . 0.63 112.03 -175.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -84.75 113.4 21.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 2.1 109.115 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 4.6 t80 -95.01 127.77 41.32 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.735 2.014 . . . . 0.73 108.999 -177.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -137.64 109.77 8.69 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.501 1.501 . . . . 0.63 109.715 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.9 162.99 18.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.775 2.983 . . . . 0.61 111.335 -175.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -150.11 30.7 0.7 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.051 0.76 . . . . 1.47 113.051 174.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.06 140.82 29.47 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.672 -1.267 . . . . 0.77 112.425 -173.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 26.74 9.82 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.082 1.882 . . . . 2.01 116.082 -168.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.65 65.26 0.67 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.131 0.572 . . . . 1.44 112.127 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.2 159.39 69.92 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 121.731 -0.606 . . . . 1.38 111.934 170.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -63.79 129.5 24.99 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 120.933 1.089 . . . . 0.81 111.286 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.46 37.53 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.583 1 C-N-CA 126.752 4.968 . . . . 1.07 113.251 -153.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.21 -135.4 7.31 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 123.52 1.622 . . . . 1.43 112.165 -177.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -116.28 139.27 50.55 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.011 1.325 . . . . 2.53 109.431 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -143.54 144.14 31.83 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.041 0.936 . . . . 1.38 110.568 -168.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.95 160.85 52.21 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 110.262 -1.135 . . . . 0.95 110.262 174.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 128.31 22.79 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 106.801 -1.555 . . . . 1.84 106.801 166.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 93' ' ' ASP . 65.6 m170 -127.99 167.82 16.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.436 2.013 . . . . 1.02 116.436 173.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.7 146.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.716 1.606 . . . . 0.88 109.679 151.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.89 161.27 32.23 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.677 2.791 . . . . 0.95 108.849 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -26.44 67.32 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.118 2.266 . . . . 0.86 117.118 -157.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -140.36 165.65 26.85 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.184 1.394 . . . . 1.68 113.271 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.13 104.11 2.68 Favored Glycine 0 N--CA 1.473 1.161 0 O-C-N 120.806 -1.184 . . . . 0.99 114.801 -172.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m 177.56 -173.56 0.12 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.773 3.229 . . . . 3.45 109.443 171.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 75.8 m -120.03 -23.84 6.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.1 1.36 . . . . 2.41 113.843 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -76.23 142.51 71.89 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.14 1.163 . . . . 3.02 114.14 -158.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.64 160.2 21.97 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.35 3.367 . . . . 1.18 112.41 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.84 154.61 19.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.432 0.693 . . . . 1.77 109.954 158.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.72 123.7 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.206 1.002 . . . . 2.37 108.86 -178.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -169.12 159.76 9.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.498 1.919 . . . . 5.57 109.379 -175.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 t70 58.39 27.82 15.94 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.862 -1.149 . . . . 4.36 113.234 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.03 14.52 82.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.991 1.281 . . . . 2.67 115.032 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -152.65 164.02 38.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.391 1.595 . . . . 2.96 113.683 -168.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.71 113.75 26.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 1.74 111.109 -178.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.76 57.25 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.785 2.034 . . . . 2.19 110.932 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.48 -68.13 0.12 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.964 2.505 . . . . 2.52 116.391 160.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -175.77 47.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.834 2.453 . . . . 2.36 113.024 -167.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -59.48 -21.36 59.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.134 -1.604 . . . . 4.51 113.658 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.38 -19.94 62.21 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 119.669 -1.894 . . . . 1.96 112.874 170.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 -9.27 26.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.199 1.8 . . . . 1.16 113.606 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.63 165.21 32.65 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.018 -1.051 . . . . 2.92 113.355 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.98 -173.09 23.98 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.855 -0.791 . . . . 1.45 112.752 168.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -44.66 138.92 3.14 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.515 0.726 . . . . 2.73 109.275 163.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 66.13 1.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.263 1.825 . . . . 2.91 112.796 -165.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -110.06 83.79 3.2 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 129.002 2.921 . . . . 4.13 108.226 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.36 -21.53 37.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.775 2.984 . . . . 3.24 114.733 -176.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 6.26 0.24 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.293 0.849 . . . . 8.33 113.293 153.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.71 -38.94 67.34 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.365 -1.46 . . . . 4.26 114.828 -144.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t 169.26 -35.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.267 2.227 . . . . 3.84 112.078 -170.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.27 43.84 4.85 Favored Glycine 0 N--CA 1.47 0.931 0 CA-C-O 118.955 -0.914 . . . . 3.15 113.077 176.199 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.316 12.9 ptmt -143.4 -101.08 0.12 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.912 1.449 . . . . 4.1 114.912 -176.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.427 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -163.88 144.2 8.43 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 117.355 2.354 . . . . 2.08 117.355 -157.533 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.64 -130.6 0.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.202 2.201 . . . . 4.08 107.738 160.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.49 -89.59 0.56 Allowed Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.761 1.648 . . . . 2.85 111.868 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -98.33 -21.0 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.297 2.665 . . . . 3.13 114.993 -172.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 157.77 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.684 3.194 . . . . 5.42 110.427 -161.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.76 -151.6 28.1 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.532 1.539 . . . . 3.47 114.592 -172.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.78 13.18 0.27 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.43 2.011 . . . . 7.68 116.43 -160.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.08 -178.55 38.42 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 120.251 1.387 . . . . 2.76 113.071 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 57.32 96.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.246 1.818 . . . . 5.13 115.007 170.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 65.37 6.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.693 -1.254 . . . . 2.95 110.938 169.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.03 7.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.789 -1.562 . . . . 1.26 116.472 -176.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' ' CE1' ' A' ' 82' ' ' HIS . 3.2 m-20 -74.66 147.28 41.67 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.15 1.475 . . . . 1.9 108.85 157.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.48 171.85 6.9 Favored Pre-proline 0 CA--C 1.555 1.151 0 O-C-N 121.314 -0.866 . . . . 1.83 110.521 -142.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.89 133.21 19.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.326 2.018 . . . . 1.78 110.403 -174.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.01 132.39 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 123.362 1.554 . . . . 1.68 112.766 -175.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -68.43 91.93 0.42 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.46 2.304 . . . . 2.46 110.253 168.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.14 131.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.028 -1.045 . . . . 1.04 109.133 166.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.77 133.55 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.407 1.883 . . . . 1.62 106.915 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.41 154.57 22.73 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.808 0.731 . . . . 1.76 112.359 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -24.17 0.4 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 117.924 2.565 . . . . 2.55 117.924 -167.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -93.22 -6.36 47.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.51 1.524 . . . . 2.99 114.103 -176.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.25 20.71 8.48 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 125.072 1.32 . . . . 0.86 115.487 175.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.71 127.81 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 118.161 0.98 . . . . 1.18 109.984 -176.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.68 118.94 31.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 0.9 109.291 169.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.1 t -135.48 4.45 3.13 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.963 1.305 . . . . 1.3 113.695 -178.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.01 119.74 69.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.856 1.662 . . . . 3.35 112.982 -165.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.88 136.38 16.64 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.632 2.888 . . . . 1.21 112.402 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.97 173.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 126.557 1.943 . . . . 1.48 109.848 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 m -145.5 140.26 27.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.537 1.062 . . . . 0.73 110.971 -174.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.34 90.64 5.97 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.609 1.163 . . . . 0.63 111.858 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.82 -2.61 11.21 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.09 3.193 . . . . 1.17 115.293 -176.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.68 -15.95 61.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.379 1.472 . . . . 4.93 112.396 176.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.09 145.31 49.99 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.67 1.988 . . . . 2.57 107.684 175.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -147.44 32.9 0.88 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.603 2.361 . . . . 4.83 111.625 -175.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -163.86 141.8 7.35 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.082 1.353 . . . . 1.65 111.503 156.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.0 tp -65.96 -23.71 66.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.084 -1.01 . . . . 1.82 110.685 175.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.07 -24.99 60.68 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.514 1.126 . . . . 2.66 113.098 169.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -68.19 -15.87 63.75 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.641 1.11 . . . . 2.3 112.392 174.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.93 8.08 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 114.192 1.182 . . . . 0.86 114.192 -172.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -69.93 5.28 1.62 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 116.274 1.953 . . . . 3.16 116.274 -171.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.46 9.09 3.98 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.137 2.175 . . . . 2.69 112.195 177.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -110.45 -178.34 3.47 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.115 1.366 . . . . 1.68 114.311 -168.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -119.51 149.88 41.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.988 1.315 . . . . 0.68 111.8 172.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.07 154.24 17.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.669 1.988 . . . . 1.7 107.828 165.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 56.5 mtt -142.09 141.17 32.71 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.367 -0.833 . . . . 1.3 113.067 170.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.9 mt -88.34 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 108.18 -1.045 . . . . 0.95 108.18 165.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.21 152.64 47.12 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.205 1.557 . . . . 2.02 115.205 -165.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.06 -53.53 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.727 1.611 . . . . 1.41 112.762 -159.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.56 179.39 52.44 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.573 -1.411 . . . . 1.17 109.573 158.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.82 -143.87 0.03 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 127.236 2.351 . . . . 2.29 112.553 168.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -151.53 59.92 0.88 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.185 1.18 . . . . 3.59 114.185 -169.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -149.31 21.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.219 1.008 . . . . 3.0 113.564 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.06 142.71 52.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.017 1.327 . . . . 4.72 112.672 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.4 p -85.04 166.49 16.65 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.88 1.272 . . . . 5.78 112.864 172.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.92 142.43 51.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.814 0.846 . . . . 6.71 112.172 177.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.87 156.76 34.4 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.816 1.246 . . . . 4.59 109.581 -160.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.03 -0.06 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.019 3.146 . . . . 2.6 114.169 174.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -116.79 132.85 23.19 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.169 0.988 . . . . 6.31 108.557 159.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.86 164.68 32.58 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.791 2.327 . . . . 3.57 112.286 -173.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt 69.55 4.84 4.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.814 2.046 . . . . 4.45 113.729 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.57 15.16 77.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.103 0.859 . . . . 2.96 113.359 -175.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.46 -51.52 3.34 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.537 1.541 . . . . 1.86 113.757 -178.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.46 -10.5 73.62 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.333 1.444 . . . . 1.78 115.044 -176.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.49 42.44 1.97 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.653 1.597 . . . . 2.94 113.937 -178.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 57.7 p -119.39 163.64 16.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 128.473 2.709 . . . . 3.69 109.84 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.47 140.17 29.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.667 2.099 . . . . 6.09 116.667 -166.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -98.99 -20.77 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.103 1.361 . . . . 2.82 112.195 155.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.69 153.39 29.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.169 0.895 . . . . 0.74 113.151 173.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 19.0 p -84.66 -149.86 0.12 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.723 1.609 . . . . 2.98 111.88 171.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.17 81.11 0.03 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.28 0.943 . . . . 0.83 113.806 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.69 120.1 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.386 1.075 . . . . 2.16 111.568 176.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 71.2 mt -79.76 138.72 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.147 -0.686 . . . . 0.94 109.147 173.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.549 0.939 0 O-C-N 120.503 -1.373 . . . . 3.89 111.335 -176.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.379 -0.6 . . . . 1.99 109.379 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -138.38 158.46 44.24 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.832 -1.167 . . . . 0.98 114.089 -145.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -160.41 116.65 2.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.518 1.527 . . . . 3.47 108.118 -175.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -90.46 143.14 27.04 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.884 -1.135 . . . . 3.91 110.475 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' C ' HG23 ' A' ' 21' ' ' THR . 58.8 t -134.64 85.59 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 122.424 1.107 . . . . 1.05 111.707 177.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -32.07 114.52 0.08 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 127.252 2.358 . . . . 1.02 113.131 147.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.8 mtt -101.9 148.41 25.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 113.79 -1.205 . . . . 1.37 113.365 171.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.22 148.38 35.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 2.3 110.647 168.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.1 mt -61.18 135.93 57.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.512 -0.922 . . . . 1.16 108.512 166.29 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.5 143.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.423 1.089 . . . . 1.03 108.912 173.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -171.68 91.87 0.13 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.512 -0.921 . . . . 2.44 108.512 -174.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.85 -62.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.943 2.097 . . . . 1.65 113.507 -177.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 0.265 0.1 OUTLIER -80.76 12.62 3.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.91 1.684 . . . . 5.37 114.859 -173.212 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.14 -151.02 32.77 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.221 0.915 . . . . 1.02 112.049 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.98 110.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.452 1.901 . . . . 0.83 111.835 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.58 -72.3 1.11 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.901 1.239 . . . . 1.7 113.636 -175.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.92 153.44 16.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.645 1.178 . . . . 1.9 111.649 -175.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -92.97 145.22 24.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.014 1.726 . . . . 1.39 114.523 -165.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 5.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 115.949 1.833 . . . . 3.58 115.949 -177.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.74 175.54 20.58 Favored Glycine 0 N--CA 1.467 0.704 0 O-C-N 121.197 -0.94 . . . . 0.63 113.86 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 5' ' ' VAL . 64.4 m -115.34 156.51 25.36 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.975 1.31 . . . . 2.65 108.859 172.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.49 133.43 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.889 -1.152 . . . . 0.52 107.889 152.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -91.61 129.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 117.872 0.305 . . . . 0.94 110.911 175.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mt -100.42 129.87 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.406 -0.961 . . . . 1.69 108.406 170.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -133.21 123.55 25.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.272 1.029 . . . . 2.06 109.279 167.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -78.56 157.98 28.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 112.252 0.464 . . . . 3.48 112.252 -177.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 t -156.36 178.49 10.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.906 0.86 . . . . 1.45 109.834 168.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -63.83 -13.42 44.47 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.419 2.288 . . . . 3.86 113.137 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.22 8.73 53.47 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.104 1.812 . . . . 1.28 115.437 165.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.68 -162.85 28.08 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 130.643 3.973 . . . . 0.92 117.638 171.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.55 108.02 2.28 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.357 1.063 . . . . 0.7 111.738 -172.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -85.98 109.75 18.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.41 1.084 . . . . 1.9 110.209 173.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 3.8 t80 -94.29 112.81 24.63 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.375 2.27 . . . . 0.55 108.835 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 m -120.1 112.31 34.84 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 120.003 1.274 . . . . 0.7 108.58 -176.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.58 150.6 7.57 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.011 2.474 . . . . 0.54 113.156 -171.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' NE2' ' HB ' ' A' ' 21' ' ' THR . 7.9 p80 -147.51 41.98 1.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.356 1.074 . . . . 1.51 112.547 171.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.19 156.51 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.707 1.603 . . . . 0.83 113.845 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 167.0 18.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.131 -1.85 . . . . 3.33 109.211 176.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 82.55 19.42 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.14 2.576 . . . . 1.51 113.566 172.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.616 HD12 HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -91.33 164.75 23.56 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 121.678 -0.639 . . . . 1.79 110.231 174.324 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.29 145.3 96.05 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 120.296 0.664 . . . . 0.83 111.578 165.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 10.2 Cg_endo -85.39 25.61 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 125.111 3.874 . . . . 1.06 114.253 -153.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.84 -141.1 6.7 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 125.216 1.389 . . . . 1.28 116.012 -174.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.3 141.92 29.06 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.67 2.388 . . . . 2.4 110.451 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -136.18 137.66 41.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.463 1.105 . . . . 1.63 111.449 -172.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 157.38 52.34 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.899 -1.126 . . . . 0.78 111.631 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 8.4 t80 -130.98 112.92 13.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.155 -1.424 . . . . 1.96 107.155 173.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -118.48 162.21 18.72 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.127 -0.983 . . . . 1.02 113.518 165.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.41 135.08 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.429 1.492 . . . . 0.81 107.281 159.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -115.06 159.08 21.25 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.602 0.761 . . . . 0.95 109.659 170.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.13 79.59 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.827 1.788 . . . . 1.01 115.827 -160.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.97 143.64 48.91 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.398 1.079 . . . . 1.13 113.019 -173.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.55 62.18 2.75 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.512 1.53 . . . . 1.06 114.941 -176.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -162.73 89.88 0.68 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.408 1.604 . . . . 2.07 115.225 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.0 m -74.15 74.25 1.76 Allowed 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.041 -1.662 . . . . 2.74 111.8 166.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -122.27 144.95 43.0 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.239 1.016 . . . . 3.22 110.365 174.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.05 162.43 10.2 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.971 2.447 . . . . 1.14 113.831 -167.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.51 128.78 55.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.387 1.075 . . . . 1.82 108.935 161.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mm -90.71 38.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.456 1.122 . . . . 3.28 110.009 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -66.72 130.34 42.84 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.929 1.291 . . . . 4.17 110.976 -167.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t70 57.65 21.76 7.58 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.148 1.166 . . . . 3.72 114.148 -176.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.05 76.01 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.148 0.88 . . . . 2.57 114.495 177.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.75 134.88 52.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.401 1.601 . . . . 2.88 110.71 172.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.74 95.11 9.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.319 -0.863 . . . . 1.87 112.104 -169.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.73 95.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.596 1.558 . . . . 2.39 108.594 173.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.4 -25.88 0.47 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 119.797 3.258 . . . . 2.87 119.797 -156.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.67 38.06 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 120.128 1.331 . . . . 1.58 114.267 -168.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.26 -34.12 73.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.224 1.01 . . . . 4.77 113.076 -177.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.68 0.55 1.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.036 1.495 . . . . 1.44 115.036 -175.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.57 -10.84 59.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.217 1.407 . . . . 1.0 113.856 175.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.33 32.89 12.58 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 116.796 1.479 . . . . 3.18 116.796 164.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.57 -178.58 31.54 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 119.452 1.626 . . . . 1.09 114.457 174.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -76.2 22.58 0.16 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.197 1.554 . . . . 2.27 115.197 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.254 31.1 tp 64.41 36.16 9.12 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.143 1.377 . . . . 1.7 111.508 172.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -123.17 49.55 2.54 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 116.371 1.989 . . . . 3.61 116.371 -161.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.33 -29.14 46.44 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.51 2.14 . . . . 2.42 113.028 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -127.16 34.88 4.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.649 1.18 . . . . 4.47 111.905 -168.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -119.84 -153.6 0.55 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.834 1.254 . . . . 3.37 110.882 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.6 p -88.99 -25.17 22.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.271 1.428 . . . . 3.08 113.174 175.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.31 88.78 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.392 0.996 . . . . 2.0 114.74 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -98.05 7.94 45.53 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 116.116 1.895 . . . . 4.84 116.116 -169.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.7 t60 68.61 168.04 0.27 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.961 1.704 . . . . 2.05 112.768 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -150.17 155.25 39.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.793 1.405 . . . . 3.6 114.793 -149.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.33 -155.06 6.89 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 126.291 1.9 . . . . 2.6 112.873 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.26 -9.79 24.83 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.861 3.041 . . . . 3.79 113.041 173.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.31 162.56 32.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.48 1.912 . . . . 6.35 109.159 166.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.42 -159.71 23.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.28 0.943 . . . . 4.54 112.84 -172.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.95 137.21 3.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.393 2.277 . . . . 4.69 105.876 168.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.7 -72.87 0.02 OUTLIER Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.195 0.902 . . . . 2.77 114.282 -172.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -150.85 125.75 9.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.596 1.959 . . . . 4.03 110.801 -173.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -62.45 -20.38 64.47 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.223 1.194 . . . . 2.72 114.223 175.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.39 8.22 59.03 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.631 2.062 . . . . 1.18 116.031 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.39 139.75 30.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 118.995 1.397 . . . . 1.65 111.154 167.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.61 163.63 49.75 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 126.784 2.034 . . . . 2.06 110.077 -172.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.77 162.43 26.91 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.141 2.561 . . . . 1.07 112.304 -172.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.12 141.92 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.699 1.37 . . . . 1.52 114.699 -164.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.12 107.09 18.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 130.675 3.59 . . . . 1.76 108.682 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.34 137.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.907 -1.121 . . . . 0.93 110.575 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 40' ' ' LEU . 10.9 m -109.09 161.2 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.356 0.662 . . . . 2.18 109.962 164.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.91 165.07 16.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.864 0.466 . . . . 2.03 110.927 175.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -62.72 4.79 0.14 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 117.568 2.433 . . . . 2.94 117.568 -161.443 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -104.17 -11.08 17.48 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.27 2.628 . . . . 3.45 113.395 176.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.49 24.48 12.26 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 121.365 -0.834 . . . . 0.82 114.675 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.5 mt -126.05 129.84 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.629 1.172 . . . . 1.46 110.92 -176.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -89.22 147.66 24.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.099 2.16 . . . . 1.15 112.075 -172.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.97 -21.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.89 1.276 . . . . 1.22 114.057 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.53 116.95 50.61 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.457 1.103 . . . . 3.06 110.447 176.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -85.07 163.13 11.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.592 2.862 . . . . 1.34 112.349 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.85 161.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.723 1.209 . . . . 1.26 110.577 170.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 m -124.04 139.81 53.58 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.327 1.051 . . . . 0.87 110.041 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.58 97.85 29.71 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.21 1.004 . . . . 0.84 110.79 174.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.88 -0.8 10.36 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.925 3.083 . . . . 1.36 114.333 -176.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -86.94 -2.76 58.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.627 1.571 . . . . 4.06 112.696 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.1 mt -141.53 123.86 15.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.52 2.328 . . . . 2.36 106.242 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -116.18 5.66 13.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.857 1.263 . . . . 4.71 114.158 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.7 t -149.38 150.05 31.83 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.441 0.904 . . . . 1.9 113.441 175.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.78 -28.68 70.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.377 -0.827 . . . . 1.62 112.569 170.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.01 -18.57 65.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.065 1.302 . . . . 3.67 113.58 -177.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.03 -19.49 61.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.338 1.055 . . . . 1.73 112.121 172.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.47 7.26 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.656 1.182 . . . . 0.8 113.941 -170.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -63.68 5.67 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.263 2.32 . . . . 2.46 117.263 -174.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.54 0.43 2.49 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.713 2.005 . . . . 3.0 112.607 -178.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -95.81 171.71 8.48 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.457 1.503 . . . . 1.48 113.577 -168.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.73 150.28 27.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.511 1.124 . . . . 0.51 111.984 165.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 mt -122.4 140.29 52.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.41 2.284 . . . . 1.7 107.803 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.485 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -143.23 146.81 33.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.418 1.008 . . . . 2.55 113.599 177.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.8 119.14 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.274 1.43 . . . . 1.14 108.301 166.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' A' ' 126' ' ' MET . 74.6 m80 -98.57 148.44 23.78 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.672 1.589 . . . . 3.06 112.013 -168.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.8 -46.37 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.173 0.589 . . . . 1.75 112.144 -158.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.35 169.71 13.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.79 1.186 . . . . 1.79 111.14 164.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.28 -174.6 4.68 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.216 1.865 . . . . 1.77 113.433 170.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -159.91 166.22 30.58 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.787 0.835 . . . . 3.53 111.914 -166.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.0 p30 159.04 23.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 132.721 4.408 . . . . 3.07 111.625 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 72.9 mtm -92.37 106.84 18.76 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.897 -1.127 . . . . 3.3 112.504 -165.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 p -93.05 158.86 15.56 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.656 -1.277 . . . . 3.56 113.903 169.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.2 t0 65.58 17.96 11.08 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.417 2.006 . . . . 5.41 116.417 155.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.9 157.08 49.17 Favored Pre-proline 0 CA--C 1.552 1.021 0 O-C-N 120.699 -1.251 . . . . 6.88 113.675 -172.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.36 -21.75 3.52 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.667 2.911 . . . . 3.04 114.134 178.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -102.92 95.74 6.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.088 -1.007 . . . . 7.27 108.382 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.65 143.78 75.99 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.566 2.177 . . . . 3.47 111.504 -164.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 77.06 -10.74 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.472 2.709 . . . . 4.06 113.013 -174.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 62.58 15.41 53.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 2.64 115.66 170.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.1 -21.8 32.45 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.912 1.244 . . . . 2.65 113.631 -170.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.89 -8.18 52.21 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.403 1.478 . . . . 2.49 114.009 176.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.69 -5.14 83.01 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.025 1.298 . . . . 2.07 114.514 170.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.6 p -75.78 132.28 40.33 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.894 1.347 . . . . 1.8 110.174 175.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -97.84 135.08 40.11 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.167 0.987 . . . . 5.97 110.192 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 26.7 t80 -91.0 -40.04 11.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.047 0.385 . . . . 2.24 110.326 164.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.52 29.26 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.909 0.884 . . . . 1.14 111.931 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.2 m -114.73 145.03 42.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.891 2.076 . . . . 2.87 111.233 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.74 167.65 26.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.919 1.723 . . . . 1.37 113.225 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.9 t -135.54 141.91 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.738 1.215 . . . . 1.53 109.734 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.2 mt -89.06 143.47 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.738 1.215 . . . . 0.83 110.774 -176.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 4.62 111.287 -177.27 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.238 0.542 . . . . 1.73 110.659 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -148.43 149.78 32.32 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.856 0.862 . . . . 0.98 110.362 -172.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.04 132.05 16.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.657 1.217 . . . . 2.23 110.053 171.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -88.56 109.79 20.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.179 0.992 . . . . 3.72 111.559 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -87.02 105.51 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.609 -1.307 . . . . 1.47 108.885 -169.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 21' ' ' THR . . . -59.38 108.81 1.8 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.651 1.596 . . . . 1.36 109.953 169.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 33.7 mtt -109.41 154.03 23.16 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.275 1.43 . . . . 1.23 112.508 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -145.9 149.68 34.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.56 1.544 . . . . 3.06 112.003 -169.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.41 66.1 3.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.953 1.301 . . . . 1.6 111.435 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.25 144.83 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.698 0.799 . . . . 0.88 111.599 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.4 t -172.69 72.19 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.451 1.1 . . . . 2.05 111.152 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.11 -19.14 0.15 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.866 2.066 . . . . 1.3 114.834 173.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -28.86 66.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.479 1.912 . . . . 2.91 110.006 164.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.47 -159.23 24.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.182 1.372 . . . . 1.14 111.067 -154.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -46.15 127.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.411 1.884 . . . . 1.14 111.122 165.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.79 -68.02 0.18 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.607 1.575 . . . . 1.66 114.039 -173.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.156 1.382 . . . . 1.85 110.543 171.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -109.25 172.23 6.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.737 -1.227 . . . . 1.34 112.571 178.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.7 pt -151.19 5.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 128.98 2.912 . . . . 3.08 112.479 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.53 159.37 9.08 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 121.137 -0.977 . . . . 0.92 113.751 -161.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 6' ' ' GLY . 72.9 p -125.99 -178.5 4.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.683 1.993 . . . . 1.69 106.74 173.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 33' ' ' PHE . 61.0 t -133.52 125.83 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.359 -0.978 . . . . 0.61 108.359 169.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.0 p -74.77 124.69 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 117.978 0.354 . . . . 0.94 110.599 170.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HD21 ' A' ' 125' ' ' LEU . 8.4 mt -98.41 131.43 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 108.298 -1.001 . . . . 1.56 108.298 163.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -140.05 121.47 15.05 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.132 1.373 . . . . 1.81 108.572 178.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.74 150.26 21.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.801 0.667 . . . . 3.05 112.801 -169.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.6 178.9 9.57 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.108 0.563 . . . . 1.18 110.546 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -60.53 -30.81 69.98 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.676 1.19 . . . . 3.61 110.958 175.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.6 13.96 53.54 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.164 1.364 . . . . 0.89 114.953 168.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.31 -148.49 20.71 Favored Glycine 0 N--CA 1.468 0.782 0 C-N-CA 127.167 2.318 . . . . 0.69 116.268 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.2 mt -79.18 101.54 8.0 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.169 -0.606 . . . . 0.6 110.862 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -75.73 112.37 12.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 2.33 109.587 171.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 22' ' ' VAL . 3.2 t80 -98.79 109.07 21.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 128.02 2.528 . . . . 0.52 108.14 -178.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.422 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 4.5 m -111.13 105.64 57.11 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.335 -1.357 . . . . 0.64 107.335 176.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.31 153.23 24.17 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.316 2.677 . . . . 0.75 110.846 -171.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.97 63.37 0.65 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.177 0.989 . . . . 2.79 111.013 178.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.25 141.78 51.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.057 2.143 . . . . 0.87 111.528 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -129.32 20.82 5.71 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 118.029 2.603 . . . . 2.7 118.029 -158.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.43 19.58 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 115.581 1.697 . . . . 1.9 115.581 -173.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.78 165.35 19.12 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 121.492 -0.755 . . . . 1.75 110.856 -171.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 59.9 Cg_endo -65.95 131.26 26.65 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 N-CA-C 109.806 -0.882 . . . . 1.14 109.806 163.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 41' ' ' PRO . 6.0 Cg_endo -88.88 34.2 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.272 3.315 . . . . 1.13 112.402 -148.175 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.44 -122.54 4.8 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 123.821 1.79 . . . . 1.51 113.616 -178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -134.88 142.41 46.58 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 126.372 1.869 . . . . 3.1 109.747 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -134.59 145.87 49.07 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.572 1.149 . . . . 1.12 111.707 -173.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.82 157.16 26.72 Favored Glycine 0 CA--C 1.542 1.758 0 O-C-N 121.024 -1.048 . . . . 0.63 111.951 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -145.56 120.51 10.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.791 1.237 . . . . 2.05 108.086 168.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.12 165.16 24.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.702 1.742 . . . . 0.86 115.702 164.077 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.0 mt -89.96 144.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.398 1.479 . . . . 0.78 109.143 160.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -127.44 170.19 12.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.885 2.074 . . . . 1.11 111.361 -178.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.98 52.74 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.99 2.218 . . . . 1.02 116.99 -160.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -110.51 -157.41 0.61 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.752 1.221 . . . . 2.31 111.477 -175.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.12 -27.63 8.67 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 117.65 1.82 . . . . 1.94 117.65 -155.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 175.8 140.12 0.06 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.963 2.382 . . . . 3.38 113.877 -173.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.58 67.08 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 117.354 2.353 . . . . 3.58 117.354 -176.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -94.09 152.04 40.09 Favored Pre-proline 0 CA--C 1.55 0.963 0 O-C-N 121.053 -1.029 . . . . 3.32 110.689 160.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -90.22 177.63 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.207 3.272 . . . . 1.49 112.673 -168.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.67 147.21 37.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.995 1.318 . . . . 1.41 110.624 172.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.87 126.94 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.915 0.886 . . . . 2.46 110.989 -174.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.86 156.47 22.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.706 2.402 . . . . 5.79 110.73 173.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 52.09 37.33 21.23 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.078 1.51 . . . . 4.18 115.078 167.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.88 79.38 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.003 -1.061 . . . . 2.52 114.351 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.07 156.04 42.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.857 1.328 . . . . 4.28 113.528 -176.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.77 121.78 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.647 0.779 . . . . 1.67 108.909 164.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.41 132.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.719 1.208 . . . . 3.0 108.567 171.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.3 -37.75 17.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.808 1.243 . . . . 1.9 114.148 -172.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -179.98 123.74 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.465 2.706 . . . . 1.84 110.307 175.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -121.49 -29.07 4.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.905 1.282 . . . . 4.22 112.547 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.96 -0.29 8.98 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.202 -1.561 . . . . 1.86 114.071 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.56 -17.46 33.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.734 1.614 . . . . 1.23 113.273 164.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.59 179.61 52.81 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.642 1.591 . . . . 2.51 114.439 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.5 -172.8 25.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.946 0.784 . . . . 1.17 112.864 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.94 24.07 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.047 1.739 . . . . 2.15 115.627 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.9 tp 52.29 49.04 21.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.211 1.405 . . . . 1.83 110.493 176.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -151.49 110.8 2.98 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.433 -0.803 . . . . 4.29 112.634 -171.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -91.72 -18.96 0.84 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.012 2.475 . . . . 2.92 113.766 174.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -159.25 -22.56 0.07 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.938 1.829 . . . . 3.66 115.938 -163.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -64.76 -35.86 82.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.751 1.614 . . . . 3.58 112.366 -171.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -165.91 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.991 2.517 . . . . 3.93 111.263 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.18 11.14 70.12 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.515 1.531 . . . . 2.39 112.73 -177.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -167.16 -105.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.245 1.818 . . . . 5.68 113.033 -166.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -161.43 141.57 10.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.727 1.751 . . . . 2.47 115.727 -161.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.43 149.83 36.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.092 0.957 . . . . 4.0 113.293 174.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.52 -145.63 17.88 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 110.316 -1.114 . . . . 2.81 110.316 156.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.39 17.56 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.996 3.131 . . . . 3.48 114.253 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.63 -11.08 8.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.691 1.596 . . . . 4.78 114.429 -157.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.14 -7.68 81.58 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 116.955 1.542 . . . . 3.56 116.955 169.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -78.02 83.16 4.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 1.585 . . . . 5.33 109.383 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.8 -177.1 14.89 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 123.936 0.779 . . . . 3.3 114.812 -168.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.617 ' CD2' ' H ' ' A' ' 92' ' ' GLY . 5.4 p-80 -92.04 157.92 16.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.693 0.797 . . . . 5.75 111.274 169.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -63.05 -10.12 12.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.118 1.525 . . . . 3.18 115.118 -179.151 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.617 ' H ' ' CD2' ' A' ' 90' ' ' HIS . . . -115.24 19.9 14.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.798 2.142 . . . . 1.58 113.753 173.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -73.86 135.12 43.36 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.42 1.11 . . . . 2.51 109.491 164.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.01 160.48 31.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.16 1.384 . . . . 1.83 110.294 -147.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.11 168.77 20.07 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.216 3.277 . . . . 1.11 111.633 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 m -82.0 142.89 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 122.894 1.33 . . . . 1.44 113.374 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.76 92.73 3.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 129.061 2.944 . . . . 1.8 109.204 172.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 95.9 t -74.75 137.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.875 0.87 . . . . 1.11 110.366 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.99 143.22 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.427 2.291 . . . . 1.49 106.305 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.8 164.49 12.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.858 0.754 . . . . 2.05 111.701 174.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.64 -23.82 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 129.597 3.159 . . . . 2.85 118.112 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.88 -23.5 52.61 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.935 1.694 . . . . 3.97 112.463 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.46 17.73 32.91 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.948 1.737 . . . . 0.88 112.941 -161.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.1 mt -111.81 119.99 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.962 1.305 . . . . 1.05 110.966 -176.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.84 127.52 39.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.775 1.23 . . . . 0.87 109.732 168.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -156.2 4.49 0.17 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.233 1.568 . . . . 1.36 115.233 -175.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.22 135.9 26.39 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 119.81 1.186 . . . . 3.53 110.638 172.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.0 141.72 49.14 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.017 3.145 . . . . 1.14 112.189 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.09 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.823 2.049 . . . . 1.66 108.151 173.019 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.4 m -145.96 139.64 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.931 1.241 . . . . 0.68 111.707 -178.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.01 94.06 5.05 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.26 1.024 . . . . 0.73 112.462 169.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.79 -5.07 16.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.133 3.222 . . . . 1.35 113.933 172.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -73.11 -7.92 53.45 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.146 1.778 . . . . 4.96 111.863 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.6 mt -124.28 177.16 6.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.735 2.414 . . . . 2.26 109.821 170.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -144.39 -20.69 0.54 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.012 1.856 . . . . 4.08 116.012 -172.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -144.03 163.25 34.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.847 1.203 . . . . 1.48 112.399 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.23 61.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.285 -0.884 . . . . 1.59 110.297 174.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.95 -27.68 69.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.378 1.071 . . . . 3.13 113.503 -166.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 119' ' ' GLU . 9.1 pt-20 -71.48 -20.36 62.09 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.753 1.621 . . . . 1.83 113.869 175.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.33 8.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.374 1.47 . . . . 1.08 112.984 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -62.08 -4.41 1.67 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.107 1.891 . . . . 2.33 116.107 -175.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -137.67 24.26 2.88 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.318 2.247 . . . . 3.01 110.814 -160.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -130.68 158.44 40.06 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.332 1.453 . . . . 1.28 113.931 -168.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.76 150.65 20.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.097 1.759 . . . . 0.93 112.987 168.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 24' ' ' ILE . 7.4 mp -127.36 121.01 29.82 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.043 2.137 . . . . 3.05 109.86 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -103.06 131.65 49.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.786 0.835 . . . . 2.35 111.405 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.6 mt -93.52 123.38 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 107.818 -1.179 . . . . 0.68 107.818 160.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -112.89 140.86 47.33 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.427 1.491 . . . . 1.86 112.262 -159.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -64.03 -41.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.555 -0.716 . . . . 1.24 111.585 -168.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.23 163.57 15.0 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.493 0.568 . . . . 1.23 112.135 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.22 87.72 1.49 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.08 -1.208 . . . . 1.85 110.08 173.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -61.78 122.61 15.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.797 0.839 . . . . 4.3 111.645 178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 171.81 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.239 2.616 . . . . 3.49 109.662 -157.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.9 ptp -74.15 60.42 0.79 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.345 1.458 . . . . 3.33 112.192 171.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 t -74.08 -20.38 60.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.186 1.794 . . . . 3.77 115.111 -165.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -81.87 76.18 8.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 3.36 112.269 -173.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -169.56 156.69 6.42 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.08 1.352 . . . . 3.92 111.78 -179.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.89 -9.65 18.15 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.711 2.941 . . . . 2.89 113.64 176.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -93.2 106.12 18.45 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 119.229 0.922 . . . . 4.38 109.0 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.46 160.22 47.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.104 2.536 . . . . 3.2 113.274 -158.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.58 32.22 21.92 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.834 1.654 . . . . 3.78 111.501 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.34 67.45 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.668 1.128 . . . . 2.68 114.333 -177.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.94 -17.0 18.34 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.156 1.36 . . . . 1.7 113.242 -164.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.92 8.24 60.6 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.006 1.765 . . . . 1.42 114.844 -176.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.49 68.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.302 1.43 . . . . 1.41 115.801 -170.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -58.47 154.46 13.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.181 1.49 . . . . 1.51 110.482 168.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 mmt-85 -96.39 138.47 33.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.388 1.075 . . . . 3.87 109.453 -176.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.86 -18.8 16.22 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.955 0.798 . . . . 3.32 111.774 154.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.31 168.79 25.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.537 1.135 . . . . 0.88 111.409 164.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 51.6 t -152.98 153.26 32.58 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.057 1.343 . . . . 1.87 110.697 172.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -153.17 178.67 30.1 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.181 1.372 . . . . 1.69 114.305 -175.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 139.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.05 1.34 . . . . 2.45 111.302 -171.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 76.2 mt -92.86 143.03 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.44 1.096 . . . . 1.17 109.613 171.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt . . . . . 0 N--CA 1.471 0.62 0 O-C-N 120.67 -1.269 . . . . 3.74 112.508 177.128 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.717 -0.846 . . . . 1.58 108.717 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.22 156.12 47.32 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.167 1.349 . . . . 1.03 114.187 -148.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.68 127.54 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.897 1.679 . . . . 2.32 108.872 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -103.31 98.82 8.68 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.684 1.993 . . . . 3.82 109.708 -174.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -87.77 129.45 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 114.177 1.177 . . . . 2.14 114.177 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.47 103.78 0.73 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.672 1.129 . . . . 1.0 111.057 167.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.31 110.97 13.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.942 1.297 . . . . 1.49 109.971 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -108.66 147.15 32.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 2.44 111.4 -170.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.21 61.18 2.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.981 -1.075 . . . . 1.4 113.192 -171.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -70.87 154.86 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.281 1.432 . . . . 1.41 113.211 -177.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -169.97 -152.97 0.1 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.602 1.561 . . . . 3.33 109.295 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -11.82 2.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 129.03 2.932 . . . . 1.12 116.06 -175.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.82 0.49 32.74 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.953 1.301 . . . . 4.19 112.057 174.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.67 -147.15 21.08 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.695 1.14 . . . . 1.29 110.458 -165.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 10' ' ' VAL . 11.6 t -54.23 134.89 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.732 2.013 . . . . 1.04 112.808 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.28 -112.29 3.66 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.757 1.646 . . . . 1.2 112.803 -175.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.89 166.97 20.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.834 0.817 . . . . 1.94 111.555 168.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.6 t -93.33 148.98 21.57 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.264 1.026 . . . . 1.48 113.192 -174.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 pt -142.1 2.23 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.296 1.438 . . . . 2.82 113.915 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.33 170.25 22.8 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.042 -1.036 . . . . 0.69 112.703 -173.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 p -107.66 178.73 4.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.023 0.929 . . . . 0.9 110.332 171.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 33' ' ' PHE . 46.6 t -128.56 132.54 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.526 -1.287 . . . . 0.41 107.526 152.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.419 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 10.9 p -85.09 119.92 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.72 0.638 . . . . 0.92 109.77 174.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -102.65 130.23 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.227 -1.397 . . . . 1.38 107.227 174.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -136.78 120.5 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.725 0.81 . . . . 2.32 111.232 176.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.41 140.73 48.53 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.247 0.619 . . . . 3.69 111.58 178.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.0 t -143.57 -179.92 6.73 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.387 1.075 . . . . 1.59 108.649 164.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -68.03 -28.29 67.27 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.675 2.39 . . . . 5.21 111.812 -178.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.45 17.87 54.41 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.016 1.769 . . . . 1.5 114.639 162.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.88 -159.01 26.38 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 127.365 2.412 . . . . 0.86 118.411 164.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.97 104.08 8.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.736 0.815 . . . . 0.62 111.371 -168.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -79.94 110.43 15.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.763 1.625 . . . . 1.99 110.217 174.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 22' ' ' VAL . 4.0 t80 -99.06 118.73 36.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.294 2.238 . . . . 0.49 109.475 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.419 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 78.7 m -124.82 111.98 27.24 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-N 119.292 0.951 . . . . 0.61 109.103 176.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.83 165.21 17.8 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.6 2.867 . . . . 0.62 111.008 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -151.0 25.89 0.72 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.495 0.718 . . . . 1.31 112.099 173.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.87 148.23 25.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.498 1.119 . . . . 0.9 113.33 -170.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 144.5 49.47 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.974 1.31 . . . . 2.4 108.56 168.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.93 45.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 128.203 2.601 . . . . 1.36 112.514 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.76 160.98 40.25 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.433 1.093 . . . . 1.69 110.537 169.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.26 125.55 14.22 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 121.124 1.216 . . . . 1.07 110.375 169.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -80.47 74.5 5.51 Favored 'Trans proline' 0 N--CA 1.451 -1.015 1 C-N-CA 125.413 4.075 . . . . 1.76 109.925 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.88 -173.76 13.2 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 116.343 -2.837 . . . . 1.67 111.932 132.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -56.81 140.61 47.37 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.003 1.321 . . . . 2.75 111.668 175.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -136.83 125.47 23.77 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.902 1.281 . . . . 1.13 112.746 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.04 149.91 3.26 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.325 0.964 . . . . 0.67 113.229 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.403 ' CE1' ' CZ ' ' A' ' 33' ' ' PHE . 2.2 t80 -132.4 132.03 42.41 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.598 1.559 . . . . 1.99 106.82 176.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -136.1 168.63 19.02 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 114.867 1.432 . . . . 0.95 114.867 170.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.6 139.51 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.664 1.586 . . . . 0.92 109.545 158.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.55 165.24 13.79 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.962 2.105 . . . . 0.87 111.358 177.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.86 64.43 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.141 1.534 . . . . 0.77 115.141 -159.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -123.73 152.44 42.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.929 0.892 . . . . 1.38 113.074 178.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.95 79.81 1.82 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 125.596 1.57 . . . . 0.98 110.975 174.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -166.53 59.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.46 0.704 . . . . 3.61 112.523 -165.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.8 m -67.2 66.71 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.284 1.834 . . . . 1.86 113.115 173.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -130.53 156.53 79.52 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.219 2.208 . . . . 3.55 108.315 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.16 133.88 15.35 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.005 1.803 . . . . 1.19 110.216 176.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 176.38 6.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.058 -0.974 . . . . 2.84 109.917 161.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -103.2 128.62 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.887 -0.783 . . . . 5.63 108.887 165.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -94.45 -71.31 0.67 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 118.644 -0.694 . . . . 7.67 109.244 161.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.75 106.66 9.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.209 1.403 . . . . 4.13 109.124 169.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.73 -44.9 0.65 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.501 2.0 . . . . 5.16 116.852 174.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.14 158.41 18.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.222 1.409 . . . . 2.89 114.026 -161.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.93 95.98 4.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.961 1.704 . . . . 1.87 111.867 -171.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.92 80.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.93 0.872 . . . . 2.97 112.159 -177.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 46.28 -104.7 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.869 2.467 . . . . 2.02 114.928 163.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.15 25.13 9.74 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.401 1.48 . . . . 1.93 111.979 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -81.67 11.49 4.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.519 1.127 . . . . 8.55 113.501 -174.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.64 -6.61 57.47 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.143 -0.973 . . . . 2.22 112.677 158.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.21 23.8 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.684 1.594 . . . . 1.24 114.311 175.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.15 4.0 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.5 1.524 . . . . 3.65 115.646 167.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.14 -176.85 30.26 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.791 1.186 . . . . 1.35 112.486 -171.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -81.33 62.29 5.17 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 2.16 110.532 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.8 tp 25.21 65.6 0.05 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.627 2.371 . . . . 1.61 112.537 -174.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -127.14 60.65 43.57 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.038 2.135 . . . . 4.83 112.057 -158.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.47 -41.16 9.25 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.387 2.058 . . . . 2.27 109.994 169.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -152.9 165.64 34.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.283 1.833 . . . . 4.5 110.03 167.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 140.88 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 1 C-N-CA 132.706 4.402 . . . . 3.75 113.209 163.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t 150.99 -56.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 130.726 3.61 . . . . 2.61 110.785 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.09 -11.26 69.51 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.342 1.449 . . . . 1.97 115.093 -178.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.48 -25.04 61.86 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.749 1.775 . . . . 4.25 115.243 -176.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.416 ' CE1' ' CG ' ' A' ' 93' ' ' ASP . 24.7 t60 75.44 126.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.393 2.677 . . . . 2.68 113.354 176.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 -57.13 2.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.824 0.849 . . . . 7.45 112.873 165.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.62 -85.13 0.38 Allowed Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.291 -1.283 . . . . 4.91 110.208 -156.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.38 -128.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.857 3.705 . . . . 6.76 111.863 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.73 51.25 1.34 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.498 -1.376 . . . . 10.8 114.693 -159.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.14 -107.55 0.5 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.443 1.021 . . . . 2.6 111.198 167.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -16.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.259 1.024 . . . . 5.01 113.505 171.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.11 92.39 1.15 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.378 0.99 . . . . 3.86 111.897 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 71.42 97.84 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.896 2.078 . . . . 5.22 113.711 162.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -16.61 64.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.506 1.669 . . . . 3.26 115.506 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.84 8.55 79.31 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.81 1.671 . . . . 1.29 113.979 175.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' CG ' ' CE1' ' A' ' 82' ' ' HIS . 72.8 m-20 -80.57 155.05 27.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 3.38 109.93 153.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.54 154.54 21.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 121.029 -1.044 . . . . 1.64 111.609 -133.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.04 143.1 64.29 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.705 2.937 . . . . 1.04 111.89 -171.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.45 133.49 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.724 0.81 . . . . 1.85 111.473 -163.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.84 99.41 2.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.832 2.053 . . . . 1.85 109.044 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.0 t -78.23 121.6 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.496 -0.753 . . . . 0.99 109.811 177.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.81 131.41 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.654 1.982 . . . . 1.73 108.361 175.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -81.05 148.24 29.77 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.643 0.656 . . . . 3.31 112.275 175.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -40.03 -25.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.338 3.055 . . . . 2.58 117.035 -172.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.01 -19.76 62.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.608 1.963 . . . . 4.11 113.444 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.63 31.8 6.24 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.309 1.433 . . . . 0.86 112.852 -172.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.98 145.02 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.954 1.702 . . . . 1.0 108.581 -168.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -124.82 114.85 19.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.059 1.343 . . . . 0.68 110.968 -177.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -125.94 -9.75 6.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.437 1.273 . . . . 1.36 114.437 172.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.8 120.04 79.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 118.833 0.742 . . . . 3.14 110.744 -167.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -85.62 153.8 10.33 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.716 2.944 . . . . 1.12 112.632 -174.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.08 164.39 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.975 1.71 . . . . 1.12 110.146 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.9 m -137.23 136.39 38.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.648 1.113 . . . . 0.83 110.316 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.34 99.79 13.85 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.964 0.906 . . . . 0.79 112.159 175.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.21 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.249 3.299 . . . . 1.09 114.79 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.89 5.74 13.01 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.379 0.991 . . . . 4.87 112.648 174.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.4 mt -140.92 171.94 13.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 129.244 3.018 . . . . 2.19 107.571 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.34 2.35 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.612 1.708 . . . . 6.77 115.612 -174.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -147.38 156.15 42.63 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.092 -1.005 . . . . 2.02 112.203 176.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.42 -26.03 63.48 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.204 -0.935 . . . . 1.5 111.336 161.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.18 -44.31 79.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.508 1.123 . . . . 4.01 113.032 -173.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.68 -8.39 34.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.336 1.454 . . . . 1.85 113.446 177.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.52 20.51 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.897 1.279 . . . . 0.89 113.591 -177.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -68.09 -6.17 21.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.945 2.202 . . . . 2.43 116.945 -172.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.72 39.37 1.67 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.897 1.679 . . . . 3.44 110.668 178.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -117.55 149.1 41.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.453 1.101 . . . . 1.17 112.853 -175.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.72 133.12 33.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.409 1.084 . . . . 0.8 111.23 166.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.14 136.06 46.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.06 -1.089 . . . . 3.07 108.06 165.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.0 mtt -132.1 133.42 44.3 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.217 0.607 . . . . 1.19 111.984 -167.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.31 132.95 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.909 1.283 . . . . 0.64 108.294 168.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 142.41 50.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.738 2.015 . . . . 2.22 110.387 -159.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.73 -46.86 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.209 -0.932 . . . . 1.66 111.732 -168.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.11 138.68 20.98 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 118.467 0.576 . . . . 1.25 111.859 175.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.06 146.94 49.11 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.773 1.654 . . . . 1.45 111.85 167.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -95.4 76.04 3.35 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.379 0.881 . . . . 2.93 113.379 -156.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -163.66 56.23 0.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.182 0.993 . . . . 3.79 112.025 -171.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.28 119.31 5.42 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.91 -1.119 . . . . 2.22 113.27 -171.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 t -146.5 -170.23 3.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.46 1.904 . . . . 3.33 110.538 -178.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 71.35 -41.24 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 129.147 2.979 . . . . 3.67 114.636 169.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -60.57 150.44 74.63 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 4.24 111.707 173.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.01 -21.09 72.98 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.204 2.603 . . . . 2.14 112.739 176.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -101.02 89.4 1.27 Allowed Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.836 0.854 . . . . 4.76 109.923 158.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.9 161.16 43.57 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.484 . . . . 3.67 110.243 172.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp 60.53 9.45 2.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.956 1.302 . . . . 3.28 111.953 -164.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 68.36 3.85 34.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.635 1.112 . . . . 3.12 113.69 -167.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.12 3.27 58.99 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.322 1.439 . . . . 2.07 114.036 -164.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.79 42.37 1.3 Allowed Glycine 0 N--CA 1.476 1.341 0 C-N-CA 127.148 2.309 . . . . 1.74 116.04 -173.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.1 71.36 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.34 0.972 . . . . 2.17 113.437 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 p -61.4 136.81 58.16 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.591 1.956 . . . . 2.05 112.075 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -99.29 162.29 13.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.858 1.663 . . . . 4.68 110.974 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -118.68 -19.36 8.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.153 0.797 . . . . 2.42 113.153 151.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.34 163.05 30.99 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.885 1.221 . . . . 0.55 114.05 173.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.2 t -132.27 144.02 50.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 1.63 110.786 164.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -132.17 101.43 0.46 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.872 2.177 . . . . 1.19 109.571 168.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.25 130.12 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.565 1.146 . . . . 1.78 108.789 172.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 15.2 mt -60.4 127.7 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.404 0.681 . . . . 1.21 111.625 -178.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 10.9 mmpt? . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 113.148 0.795 . . . . 3.37 113.148 178.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.624 0.249 . . . . 3.44 110.616 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -151.82 130.92 12.66 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.67 -1.233 . . . . 2.22 107.67 174.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -126.21 111.13 14.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.173 0.989 . . . . 3.46 110.722 -171.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 23' ' ' VAL 0.284 0.1 OUTLIER -79.41 77.32 5.97 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.122 -0.986 . . . . 3.92 111.214 174.47 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.1 120.62 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.501 -0.75 . . . . 1.0 110.133 -169.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.56 99.32 0.9 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.446 1.498 . . . . 0.81 111.088 -179.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.3 mmm -75.34 97.68 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.719 1.208 . . . . 1.41 110.197 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.57 141.55 41.1 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.653 -0.654 . . . . 2.55 110.717 174.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.95 131.17 44.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.878 0.871 . . . . 1.17 109.208 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 m -143.43 160.71 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 113.498 0.925 . . . . 1.03 113.498 -175.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -172.76 -159.06 0.11 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.369 2.668 . . . . 3.09 107.886 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.84 62.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.539 1.936 . . . . 1.4 113.822 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -72.31 -9.43 58.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 3.82 112.531 171.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.37 -135.27 13.05 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.54 1.064 . . . . 1.12 111.192 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.65 132.33 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.751 1.62 . . . . 1.09 110.702 -174.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.13 -104.51 2.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.747 1.642 . . . . 1.23 112.84 -175.131 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.73 168.69 19.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.569 1.147 . . . . 2.12 110.372 170.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.7 t -98.14 137.91 36.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.832 -1.168 . . . . 1.13 111.576 178.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.92 5.1 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.092 1.357 . . . . 2.84 113.935 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.08 172.44 32.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.777 2.608 . . . . 0.77 112.395 166.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 p -96.91 175.69 6.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.322 0.649 . . . . 0.79 110.084 169.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.75 130.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.795 -1.187 . . . . 0.61 107.795 151.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 4' ' ' LYS 0.258 9.2 p -84.97 113.26 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.352 0.596 . . . . 0.9 111.447 178.004 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 125' ' ' LEU . 50.9 mt -87.26 127.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.542 -1.208 . . . . 1.09 108.012 169.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -132.22 124.89 29.85 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.71 1.204 . . . . 1.88 109.329 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -83.11 142.65 31.1 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.865 0.466 . . . . 4.17 111.624 -174.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -157.82 -179.19 7.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.7 0.8 . . . . 1.43 110.411 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.61 -15.73 63.62 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.136 -0.977 . . . . 3.76 112.543 177.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.81 6.61 79.61 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.57 1.081 . . . . 1.16 115.153 163.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.04 -141.09 18.25 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 127.183 2.325 . . . . 1.16 114.82 174.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.49 96.22 3.44 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.553 1.141 . . . . 0.86 111.659 -175.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -76.38 111.46 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.675 1.19 . . . . 1.86 109.483 172.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.02 116.96 29.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.305 2.242 . . . . 0.54 109.867 -175.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -130.81 114.12 16.52 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 120.257 1.389 . . . . 0.71 110.674 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.95 162.53 7.43 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.089 2.526 . . . . 0.91 113.099 -171.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -151.43 29.88 0.62 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.955 0.902 . . . . 1.39 112.798 171.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mp -92.91 150.46 20.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.963 1.305 . . . . 0.99 112.658 -171.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.18 27.09 4.84 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.008 1.855 . . . . 2.22 116.008 -168.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.52 79.9 0.73 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.868 0.867 . . . . 1.6 112.387 174.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.36 161.44 47.44 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 124.2 1.0 . . . . 1.43 112.479 173.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.6 134.7 45.54 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.267 1.311 . . . . 1.1 111.806 175.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -88.01 23.19 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.921 2.414 . . . . 1.04 115.126 -144.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.78 -153.05 11.48 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.874 1.226 . . . . 1.27 115.974 -172.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -78.47 150.97 32.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.463 2.305 . . . . 2.89 111.157 171.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -149.13 141.23 23.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.923 0.889 . . . . 1.58 112.221 -173.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 153.16 51.67 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 109.561 -1.416 . . . . 0.62 109.561 164.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.14 102.51 3.38 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.101 -1.444 . . . . 2.04 107.101 169.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -106.82 171.07 7.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.076 1.51 . . . . 0.95 115.076 178.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -101.33 131.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.511 1.524 . . . . 0.7 108.689 160.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -108.23 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.802 1.241 . . . . 2.08 110.669 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.09 63.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 115.144 1.535 . . . . 0.81 115.144 -161.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -127.23 151.32 48.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.648 1.179 . . . . 1.6 111.919 173.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.1 81.76 1.69 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.581 1.086 . . . . 0.92 113.193 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 t -170.24 138.59 1.64 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.146 0.978 . . . . 2.21 113.227 173.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.1 m -79.11 -5.15 53.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.038 1.735 . . . . 1.94 114.217 172.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -78.58 132.89 64.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 O-C-N 120.081 -1.637 . . . . 3.5 113.159 -160.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -79.39 170.03 17.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.514 2.809 . . . . 1.41 111.684 172.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 65' ' ' VAL . . . -119.16 165.24 14.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.482 1.513 . . . . 1.7 110.196 167.188 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.66 134.34 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.259 1.023 . . . . 2.58 111.207 -167.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -156.54 134.56 11.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.62 1.568 . . . . 5.79 108.704 173.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.4 t0 55.05 46.72 23.58 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.841 0.856 . . . . 5.1 112.19 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.68 7.27 58.17 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.884 1.113 . . . . 3.72 115.884 173.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.75 162.26 33.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.855 1.327 . . . . 3.55 111.764 -176.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.42 125.93 53.74 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.229 1.012 . . . . 1.91 112.254 -167.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 58' ' ' ALA . 18.1 m -75.01 24.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 116.512 2.041 . . . . 2.92 116.512 -164.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.5 8.23 2.14 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 117.015 2.228 . . . . 2.22 117.015 170.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.579 ' HB3' HH12 ' A' ' 147' ' ' ARG . . . 137.26 115.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 1 C-N-CA 132.278 4.231 . . . . 2.07 110.081 165.784 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.78 -37.76 4.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.564 1.145 . . . . 4.09 110.32 172.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.18 -6.6 6.93 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.252 1.204 . . . . 1.2 114.252 177.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.32 -14.99 62.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.811 1.245 . . . . 1.25 113.292 168.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.8 51.63 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.805 -1.184 . . . . 3.12 115.111 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.09 -172.55 55.26 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.699 1.142 . . . . 1.18 112.25 -169.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -65.31 138.85 58.45 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.277 -1.131 . . . . 2.43 111.387 174.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.69 119.87 13.78 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.28 0.632 . . . . 1.94 112.067 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.97 125.87 5.06 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.02 2.128 . . . . 4.76 110.97 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.04 -19.98 3.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.455 2.77 . . . . 3.7 115.218 178.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 155.6 14.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 128.249 2.62 . . . . 4.07 114.608 -170.134 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.2 -38.78 71.47 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.317 -1.489 . . . . 3.09 112.401 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 81' ' ' LYS . 7.2 t 157.01 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 131.204 3.802 . . . . 2.79 110.621 177.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.45 1.77 66.11 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.416 1.008 . . . . 2.01 114.248 179.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 79' ' ' THR . 18.0 ptmt -73.25 -30.42 63.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.097 1.448 . . . . 3.92 114.72 -174.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.2 t60 117.2 148.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 130.853 3.661 . . . . 1.87 112.806 -171.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -143.56 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.035 1.734 . . . . 3.94 110.052 173.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.91 -132.56 9.93 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.244 -1.309 . . . . 2.47 113.168 167.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.83 -17.45 22.74 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.934 3.09 . . . . 3.74 114.885 -167.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -171.75 149.15 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.439 1.895 . . . . 5.65 109.682 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.01 -145.2 16.92 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.375 0.988 . . . . 3.53 113.242 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.16 145.52 4.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.353 2.661 . . . . 5.81 106.324 -179.278 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.34 -20.81 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 CA-C-O 117.057 -1.968 . . . . 3.14 116.627 173.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -152.22 118.57 5.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.346 1.573 . . . . 3.82 110.199 160.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.25 -12.42 41.04 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.306 1.595 . . . . 2.68 115.306 177.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.56 -4.92 90.15 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.995 1.283 . . . . 1.06 115.067 173.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -74.91 153.98 38.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.756 0.823 . . . . 1.63 110.828 168.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.37 161.6 29.18 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.86 1.264 . . . . 1.83 109.733 -149.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.56 157.78 57.81 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.489 2.792 . . . . 1.17 111.86 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.72 143.13 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.223 1.011 . . . . 1.57 113.22 -173.076 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -88.97 123.07 32.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.998 2.119 . . . . 2.27 110.057 172.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.76 136.34 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.437 0.695 . . . . 1.14 109.833 172.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.2 158.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.459 -1.312 . . . . 2.27 107.459 160.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.74 159.56 17.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.64 0.978 . . . . 2.13 113.64 -174.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -41.94 -17.91 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 129.79 3.236 . . . . 2.29 117.726 177.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -97.24 -13.52 21.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.62 1.568 . . . . 2.51 113.928 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.55 22.95 8.64 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.121 1.343 . . . . 0.75 115.291 177.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.06 135.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.496 1.518 . . . . 1.19 110.228 -178.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.08 120.39 34.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.315 1.446 . . . . 0.81 110.686 -179.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t -150.45 16.04 0.8 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.452 1.101 . . . . 1.72 113.962 -169.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -113.05 130.18 23.81 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.966 0.906 . . . . 3.89 110.998 177.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.13 158.35 52.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.619 2.879 . . . . 1.39 110.885 175.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.46 166.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.38 1.872 . . . . 2.31 107.557 169.587 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.1 m -140.15 136.58 33.65 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.223 0.92 . . . . 0.79 108.982 171.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.94 87.96 9.36 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.388 1.075 . . . . 1.01 111.192 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.48 23.63 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.931 3.754 . . . . 1.06 114.146 -179.01 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 -94.01 -20.68 19.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.95 1.3 . . . . 3.74 112.045 174.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.11 135.47 53.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.838 2.055 . . . . 2.78 107.155 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -92.38 -38.68 11.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.521 0.728 . . . . 5.03 111.775 -177.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.31 154.32 51.57 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.393 1.627 . . . . 2.62 115.393 -172.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.38 -42.73 70.68 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.379 1.071 . . . . 1.72 110.891 170.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.17 -21.89 3.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.266 1.826 . . . . 4.42 113.478 177.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.43 -13.06 38.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.262 1.025 . . . . 2.59 113.061 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 m -120.74 7.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.025 1.73 . . . . 1.05 113.484 -178.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -43.64 -15.08 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.804 3.241 . . . . 3.28 117.643 171.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -128.24 3.37 5.76 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.117 2.567 . . . . 5.12 113.378 -167.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -127.07 174.37 8.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.834 1.254 . . . . 1.82 113.719 -168.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.89 143.07 47.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.227 1.011 . . . . 0.68 112.454 179.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.633 HD21 HD11 ' A' ' 24' ' ' ILE . 16.0 mt -73.46 155.37 39.32 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.451 1.5 . . . . 2.28 108.437 156.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 19.2 ttm -147.05 122.58 10.42 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.75 -0.594 . . . . 2.02 110.677 158.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.3 mt -80.25 122.55 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.513 -1.291 . . . . 0.74 107.513 171.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -100.81 147.47 26.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.134 2.174 . . . . 2.16 111.763 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.25 -54.78 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.302 -0.874 . . . . 1.68 110.129 -171.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.8 164.41 39.2 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.547 -0.621 . . . . 0.97 111.547 166.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.1 -144.05 0.03 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 129.162 3.268 . . . . 2.27 115.036 174.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -162.95 69.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.682 1.993 . . . . 2.97 107.663 -170.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -157.45 14.92 0.25 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.295 -1.32 . . . . 3.81 113.958 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.8 149.58 16.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.924 1.29 . . . . 4.57 112.185 174.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.9 m -128.99 -170.58 2.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.907 1.283 . . . . 4.09 111.834 -168.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.41 -26.48 0.18 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 128.452 2.701 . . . . 4.85 115.955 158.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -70.01 146.41 95.04 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.23 1.812 . . . . 4.38 111.195 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.41 -32.16 50.54 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.352 2.702 . . . . 2.52 113.281 -171.271 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -80.38 115.19 53.2 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.23 0.923 . . . . 4.15 108.906 160.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.75 152.14 82.46 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.23 2.62 . . . . 2.84 112.336 -172.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp 59.52 22.51 11.1 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.852 1.661 . . . . 4.25 111.444 -169.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.83 14.85 66.03 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 120.958 -1.089 . . . . 3.06 113.508 -172.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 108.49 -7.93 34.61 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.722 1.63 . . . . 2.08 114.037 -168.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.83 10.75 1.07 Allowed Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.358 1.579 . . . . 1.73 116.178 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 -12.41 73.56 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.207 1.504 . . . . 1.48 114.426 175.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.8 p -74.88 147.84 40.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.293 1.837 . . . . 2.0 112.555 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.579 HH12 ' HB3' ' A' ' 67' ' ' ALA . 3.2 mmt85 -110.17 150.07 29.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.563 1.545 . . . . 4.34 111.076 -172.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -106.93 -39.16 5.84 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.241 0.46 . . . . 2.66 112.241 160.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.36 144.73 24.03 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.382 1.623 . . . . 0.69 115.382 -175.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.5 t -100.51 137.99 38.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.968 2.507 . . . . 1.5 111.307 173.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -133.46 87.11 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.56 1.553 . . . . 0.88 112.124 175.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.17 130.41 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.808 1.804 . . . . 1.52 110.656 173.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 mt -100.64 154.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 126.468 1.907 . . . . 1.33 110.279 -172.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.52 0 C-N-CA 126.108 1.763 . . . . 4.8 110.408 174.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.381 -0.599 . . . . 3.04 109.381 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.23 152.04 28.83 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.257 -0.902 . . . . 1.65 109.086 -175.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -144.57 116.19 8.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.332 1.539 . . . . 2.48 112.825 176.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -78.8 82.95 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 127.606 2.362 . . . . 2.99 110.569 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -75.79 110.99 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.057 -1.027 . . . . 1.89 112.28 -177.228 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.6 100.48 0.49 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.404 1.954 . . . . 1.19 110.81 177.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 mmt -72.85 125.52 27.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.849 1.66 . . . . 1.54 112.399 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -101.62 153.61 19.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.786 0.803 . . . . 2.43 110.923 157.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.9 mt -58.48 143.57 45.23 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.347 1.459 . . . . 1.36 109.18 163.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 m -141.6 166.1 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.065 0.946 . . . . 1.25 111.535 172.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 t -172.38 -161.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.616 2.366 . . . . 3.22 108.176 -177.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.93 14.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.449 2.7 . . . . 1.88 114.507 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.06 -12.5 10.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.058 1.343 . . . . 3.22 111.349 172.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 -146.25 19.8 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 119.197 0.908 . . . . 1.66 110.893 -167.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 82.0 t -62.28 126.38 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.228 1.811 . . . . 1.05 112.423 -177.07 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.28 -133.19 6.44 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.539 2.019 . . . . 1.41 113.17 177.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.09 145.64 46.34 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 124.52 1.128 . . . . 2.08 110.811 176.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.7 t -75.19 133.58 41.4 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.713 -0.617 . . . . 1.93 109.438 164.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 tt -116.36 -37.05 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 127.908 2.483 . . . . 4.08 111.546 -174.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.29 -178.83 38.08 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.39 -0.909 . . . . 1.46 113.443 -145.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 171.06 12.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 148.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.453 HG11 ' CG ' ' A' ' 33' ' ' PHE . 59.4 t -120.58 132.01 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 106.471 -1.677 . . . . 0.63 106.471 144.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 17.7 m -83.99 129.51 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 C-N-CA 119.744 -0.782 . . . . 3.16 109.803 172.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.45 125.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.623 -0.881 . . . . 1.37 108.623 175.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.68 126.9 30.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.736 1.214 . . . . 2.47 109.96 178.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.78 141.79 29.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.797 0.839 . . . . 3.84 112.946 -172.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -149.63 -176.61 5.47 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.897 0.879 . . . . 1.21 109.684 174.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -75.54 -11.98 60.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.272 -0.892 . . . . 4.16 112.488 174.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.41 7.04 69.78 Favored Glycine 0 N--CA 1.477 1.411 0 O-C-N 120.758 -1.214 . . . . 0.96 114.312 157.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.62 -145.58 26.42 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 127.819 2.628 . . . . 0.78 114.598 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.4 109.46 7.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.187 0.595 . . . . 0.66 110.704 -173.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -82.78 106.68 14.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.348 1.059 . . . . 1.78 110.397 174.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -85.85 110.11 19.16 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.044 1.338 . . . . 0.74 108.345 175.614 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 23' ' ' VAL . 33.4 m -114.6 98.78 50.28 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 119.718 1.144 . . . . 1.29 108.792 178.066 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -85.73 153.51 10.16 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.244 3.296 . . . . 0.74 111.497 -172.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -150.66 41.22 0.77 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.998 0.904 . . . . 1.36 112.725 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mp -93.02 148.95 21.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.273 1.829 . . . . 0.85 112.193 -176.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.86 40.25 2.16 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.24 1.57 . . . . 2.02 115.24 -169.265 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.33 48.53 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 1.39 112.207 -175.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.04 161.0 47.07 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 121.261 -0.9 . . . . 1.34 112.466 176.585 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.26 131.09 36.92 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.595 1.53 . . . . 1.23 110.18 171.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.411 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -90.46 30.64 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.722 1 C-N-CA 126.567 4.845 . . . . 1.29 112.176 -151.976 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.79 166.68 13.01 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 125.582 1.563 . . . . 2.14 109.762 173.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -67.44 143.8 56.06 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.889 0.875 . . . . 2.88 112.814 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -129.69 150.83 50.84 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.076 1.35 . . . . 1.19 111.614 -172.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.84 163.5 24.23 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.519 0.6 . . . . 0.66 113.486 168.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.603 ' CE1' HD12 ' A' ' 125' ' ' LEU . 9.4 t80 -140.76 119.86 12.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.15 1.38 . . . . 2.16 108.398 176.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -134.76 149.12 50.38 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.433 -0.792 . . . . 0.87 112.521 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.3 136.61 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.607 1.963 . . . . 0.96 107.792 165.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -132.8 133.84 43.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.201 1.0 . . . . 1.19 110.652 -163.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.19 65.67 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.628 2.084 . . . . 0.74 116.628 -155.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -118.97 152.3 36.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.988 0.915 . . . . 1.44 112.688 167.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.98 59.75 4.48 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.647 1.118 . . . . 0.96 112.45 170.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 m -148.73 63.9 1.06 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.818 1.044 . . . . 3.21 113.818 -157.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.8 m -65.39 26.66 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 116.452 2.019 . . . . 1.74 116.452 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -78.14 139.13 60.53 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 119.919 -1.738 . . . . 3.89 110.788 175.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.31 143.19 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.753 2.302 . . . . 1.39 111.211 174.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 128.87 35.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.914 0.486 . . . . 2.21 110.461 172.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.44 125.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.215 1.006 . . . . 2.39 110.694 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -166.09 128.17 1.92 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.386 0.674 . . . . 4.88 112.74 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 57.77 52.88 7.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.655 1.582 . . . . 4.81 114.1 169.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.78 77.48 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.082 -1.011 . . . . 3.45 114.544 175.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.94 -164.08 1.35 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.41 1.884 . . . . 4.2 109.178 -177.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.34 144.71 23.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.222 -0.924 . . . . 1.58 112.651 -177.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 t -80.82 98.78 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.97 0.908 . . . . 2.54 109.934 -172.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.97 97.59 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.392 2.277 . . . . 3.43 115.105 -170.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.45 30.73 17.29 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.524 1.93 . . . . 1.99 114.27 174.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.65 -32.36 73.82 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.271 0.841 . . . . 5.38 113.271 -178.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.48 -15.62 50.96 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.898 1.073 . . . . 2.08 113.898 -175.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -3.46 13.9 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.312 1.445 . . . . 1.16 113.585 172.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.22 -171.32 32.34 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 119.943 1.247 . . . . 2.49 113.53 175.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.57 -167.0 39.74 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.74 1.162 . . . . 1.91 112.189 165.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -74.13 40.06 0.12 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.551 1.94 . . . . 3.29 112.833 -178.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp 49.82 61.45 3.16 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.904 1.682 . . . . 1.76 109.854 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -121.65 51.02 2.53 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.299 1.839 . . . . 3.93 114.419 -163.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.2 -18.91 39.42 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.862 3.041 . . . . 1.9 115.865 -166.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.0 31.79 0.06 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.35 0.977 . . . . 4.06 112.46 -171.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.03 -60.41 1.68 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.655 0.983 . . . . 3.73 113.655 -163.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 t 167.99 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.317 2.647 . . . . 3.34 108.54 -162.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.95 -30.93 8.93 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.857 0.741 . . . . 2.39 113.03 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.259 11.7 ptmt -88.74 -177.89 5.64 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 117.88 0.84 . . . . 4.25 112.138 173.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -124.88 164.89 19.07 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.888 1.07 . . . . 2.13 113.888 -155.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -138.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.449 1.1 . . . . 4.57 111.478 -179.072 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.51 -138.09 18.48 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 109.067 -1.613 . . . . 2.73 109.067 -158.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.08 -32.08 64.52 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.344 2.03 . . . . 3.46 113.456 -171.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.03 -1.54 57.17 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 6.01 113.43 -176.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.43 -12.56 0.93 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 118.316 2.086 . . . . 2.87 118.316 167.001 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -84.33 44.85 1.06 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.182 1.491 . . . . 5.3 114.393 -163.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.63 -147.67 6.33 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 117.477 1.751 . . . . 2.83 117.477 -168.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -118.15 154.49 32.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.827 1.651 . . . . 3.82 112.297 -157.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.16 -27.22 65.34 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.475 0.917 . . . . 2.12 113.475 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.4 21.6 16.74 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.58 -1.122 . . . . 0.9 114.581 176.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -97.35 136.07 38.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.874 1.337 . . . . 1.79 111.063 169.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.496 HD22 ' CZ ' ' A' ' 47' ' ' PHE . 3.8 mp -136.6 165.9 31.7 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 125.676 1.59 . . . . 1.78 109.345 -172.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -83.99 161.08 13.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.026 2.484 . . . . 1.09 111.387 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.18 133.82 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.334 1.54 . . . . 1.43 115.044 -164.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 87.01 2.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.096 2.558 . . . . 1.66 109.319 170.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.99 133.01 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.139 0.576 . . . . 0.84 110.809 175.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.7 136.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.956 2.102 . . . . 1.74 106.408 173.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.49 162.99 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.425 -0.321 . . . . 2.37 111.834 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -44.69 -22.52 0.08 Allowed 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 117.899 2.555 . . . . 2.57 117.899 -177.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -7.67 52.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.462 1.905 . . . . 2.65 113.45 -176.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.22 30.39 11.04 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 124.274 0.94 . . . . 0.8 114.197 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.0 mt -124.29 133.57 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.17 1.388 . . . . 1.03 110.165 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.6 139.03 40.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.958 1.703 . . . . 0.74 111.205 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -151.15 -11.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.588 2.44 . . . . 1.98 117.588 -166.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.83 117.97 53.39 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 121.459 1.936 . . . . 4.2 113.619 -172.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.01 78.01 2.63 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.951 3.1 . . . . 2.57 110.216 171.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.57 148.78 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.747 1.619 . . . . 3.53 109.908 175.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.36 139.18 52.53 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.956 -0.757 . . . . 1.46 108.956 160.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -124.87 99.73 34.73 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.646 0.779 . . . . 0.9 111.922 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.31 12.5 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.184 3.256 . . . . 1.22 113.761 178.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -31.47 72.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.909 0.884 . . . . 4.91 111.134 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.17 151.86 37.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.548 2.739 . . . . 2.22 106.868 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -135.35 11.98 3.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.301 1.223 . . . . 4.51 114.301 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -150.25 169.09 22.16 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 119.999 -1.688 . . . . 2.12 111.011 160.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.05 -43.32 11.79 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.104 -0.997 . . . . 1.81 112.104 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -64.85 -19.55 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.897 1.073 . . . . 2.53 113.897 -176.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -16.21 63.98 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.626 0.973 . . . . 2.32 113.626 171.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.2 24.07 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.942 1.697 . . . . 1.2 112.802 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -53.95 -9.14 0.22 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.654 2.465 . . . . 3.34 117.654 178.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.68 50.33 1.37 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.668 1.587 . . . . 2.9 109.875 -169.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -142.62 150.22 40.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.7 1.6 . . . . 2.22 112.347 -169.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.68 137.5 32.27 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.834 -0.541 . . . . 0.9 111.367 167.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.603 HD12 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -97.97 122.09 40.67 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.829 -0.804 . . . . 3.96 108.829 154.855 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 31.1 mtt -122.62 124.26 43.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.386 0.674 . . . . 1.29 111.073 -173.301 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.0 mt -77.17 114.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 107.685 -1.228 . . . . 0.69 107.685 171.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.78 137.8 40.51 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.232 1.413 . . . . 2.58 112.629 -162.028 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.28 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.332 -0.855 . . . . 1.49 111.349 -165.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -87.76 133.42 11.79 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 118.306 0.503 . . . . 1.68 112.258 172.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.53 154.36 21.57 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.517 1.532 . . . . 1.42 112.183 156.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -112.34 36.59 3.33 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.53 0.937 . . . . 3.42 113.53 -128.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.2 5.97 40.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.961 1.304 . . . . 3.61 113.851 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.6 tpp -98.16 132.88 43.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.954 1.464 . . . . 3.03 114.954 -157.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.8 p -176.66 171.19 2.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.554 2.341 . . . . 3.42 111.1 159.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t70 92.44 65.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.176 2.99 . . . . 4.4 111.61 -177.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -151.8 159.68 32.77 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.307 1.843 . . . . 4.08 109.467 -173.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 -9.17 21.44 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.237 3.291 . . . . 3.49 114.417 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -125.13 142.33 41.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.725 1.21 . . . . 4.31 109.241 166.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.33 134.92 54.66 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.314 2.01 . . . . 3.55 111.089 -175.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.5 mt 63.41 17.97 10.69 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.49 1.516 . . . . 3.9 112.527 178.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.39 7.43 60.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.763 1.173 . . . . 4.04 113.941 -174.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.16 -8.28 75.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.17 1.367 . . . . 2.88 113.953 -168.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.36 0.18 42.5 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 119.378 1.589 . . . . 2.03 115.043 -176.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.84 5.71 45.8 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.984 1.754 . . . . 1.71 115.171 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 p -70.38 159.9 33.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.885 1.342 . . . . 2.05 110.864 173.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -112.84 136.1 52.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.489 1.516 . . . . 5.62 109.894 -172.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -90.83 -35.98 14.49 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.157 0.89 . . . . 2.37 112.129 166.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.36 150.14 31.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.519 0.727 . . . . 0.84 112.456 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 t -127.07 131.43 50.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.343 1.857 . . . . 1.77 111.505 -178.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -126.37 97.03 0.48 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.784 2.135 . . . . 1.31 110.465 166.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.76 125.26 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.587 1.155 . . . . 1.67 109.218 172.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.5 mt -58.3 117.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.742 0.782 . . . . 1.27 109.668 176.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 116.059 -0.518 . . . . 4.58 111.602 177.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.658 -0.497 . . . . 1.69 109.658 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.07 152.85 42.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.572 1.323 . . . . 1.15 114.572 -145.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 132.49 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 123.152 1.453 . . . . 2.97 112.057 159.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -94.71 71.46 3.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.154 1.382 . . . . 3.34 111.213 -166.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.17 119.29 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.211 -0.931 . . . . 1.5 110.738 -156.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.02 97.25 1.38 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 126.189 1.852 . . . . 1.01 110.185 -173.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 29.8 mtt -80.22 131.38 35.68 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.574 0.749 . . . . 1.14 112.158 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.0 150.54 22.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.721 0.808 . . . . 2.78 109.878 172.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.1 mt -64.31 140.87 58.91 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.363 -0.977 . . . . 1.37 108.363 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.16 158.11 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 118.511 0.596 . . . . 1.11 112.202 -177.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -171.44 -150.36 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.921 2.089 . . . . 2.6 108.252 173.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.02 -8.35 3.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 128.473 2.709 . . . . 1.68 114.837 -178.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.19 -14.7 32.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.903 0.881 . . . . 4.28 112.065 169.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.451 ' CA ' ' HD3' ' A' ' 57' ' ' PRO . . . 82.85 -142.47 21.65 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.134 0.873 . . . . 1.24 110.968 -162.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.31 120.96 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.555 1.542 . . . . 1.19 111.757 176.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.97 -133.22 7.13 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 125.993 1.759 . . . . 1.93 111.705 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.83 171.48 7.3 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.717 -0.872 . . . . 3.49 110.845 170.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -109.26 137.66 46.8 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.006 1.323 . . . . 1.31 113.502 -176.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.94 4.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.325 1.85 . . . . 2.82 112.887 177.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.33 153.18 7.63 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.489 -0.757 . . . . 0.58 113.903 -168.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.5 p -90.33 175.2 7.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.917 -0.771 . . . . 0.89 108.917 161.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.68 129.45 75.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 106.218 -1.771 . . . . 0.4 106.218 148.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.95 118.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.374 -0.602 . . . . 0.83 109.374 178.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.7 mt -99.0 126.7 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.147 -1.427 . . . . 1.57 107.147 175.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -128.24 122.06 30.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.164 0.983 . . . . 2.59 111.27 169.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 124.58 23.19 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.501 1.92 . . . . 3.28 109.52 171.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.6 p -138.25 174.56 10.43 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.341 0.591 . . . . 2.6 111.416 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.44 -23.86 64.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.267 -0.896 . . . . 3.56 112.496 172.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.38 13.84 66.49 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.794 1.188 . . . . 1.35 114.65 170.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.77 -158.03 31.7 Favored Glycine 0 N--CA 1.469 0.877 0 C-N-CA 126.732 2.11 . . . . 0.97 114.559 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.51 96.72 2.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.958 0.903 . . . . 0.82 111.738 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -72.81 116.59 13.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.72 2.008 . . . . 2.66 109.975 172.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -109.12 111.48 23.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.309 2.244 . . . . 0.57 109.768 -174.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.9 m -119.85 114.29 34.04 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-O 118.275 -0.869 . . . . 0.53 108.986 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.45 160.74 9.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.048 2.498 . . . . 0.42 112.781 -174.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -150.51 26.39 0.76 Allowed 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.546 0.943 . . . . 1.38 113.546 172.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mp -81.91 143.53 31.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.66 112.83 -176.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HE3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -125.18 128.28 48.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 117.575 -1.202 . . . . 2.37 110.673 174.661 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 131.12 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 129.838 3.255 . . . . 1.97 115.971 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -95.92 159.66 31.82 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.115 0.966 . . . . 1.54 112.215 -172.27 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -59.77 133.39 50.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.511 2.141 . . . . 0.8 111.408 171.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.601 ' HA ' HG23 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -92.97 43.08 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.019 2.48 . . . . 0.88 112.589 -150.266 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.25 -158.01 10.05 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 122.895 1.275 . . . . 1.16 115.724 -175.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -81.11 145.0 31.29 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.668 2.387 . . . . 2.82 111.735 173.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -152.39 138.05 17.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.783 1.633 . . . . 1.12 110.018 -174.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.77 165.28 54.81 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 120.398 1.454 . . . . 0.62 114.194 169.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -130.36 121.98 27.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.551 1.541 . . . . 2.1 107.22 177.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -121.74 156.34 33.34 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.179 1.354 . . . . 1.28 112.677 173.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.13 141.05 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.914 1.686 . . . . 0.96 108.839 158.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -119.86 -179.09 3.8 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.767 1.627 . . . . 1.19 110.254 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.69 56.24 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.807 2.151 . . . . 1.09 116.807 -166.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -132.84 159.9 38.47 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.954 1.252 . . . . 1.35 114.015 178.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.63 65.79 4.0 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.972 1.749 . . . . 1.03 113.14 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -146.06 76.15 1.44 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.482 0.919 . . . . 2.27 113.482 -168.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.1 m -60.54 38.49 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 129.303 3.041 . . . . 1.61 117.636 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -120.15 168.9 9.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 119.789 -1.819 . . . . 3.47 112.042 -166.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 92.5 Cg_endo -80.22 145.94 17.46 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.566 2.177 . . . . 1.42 111.085 168.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.06 153.23 18.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.621 -0.718 . . . . 2.77 109.353 159.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.81 116.22 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.083 -1.451 . . . . 4.26 107.083 163.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -79.51 -47.1 16.16 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.706 0.765 . . . . 7.66 110.418 178.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -176.09 118.76 0.15 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.358 3.063 . . . . 5.82 106.511 171.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.44 -4.46 0.95 Allowed Glycine 0 CA--C 1.54 1.65 0 N-CA-C 117.556 1.782 . . . . 3.68 117.556 175.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -159.99 157.39 28.71 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.74 1.77 . . . . 3.3 111.71 -171.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.49 133.98 34.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.4 1.08 . . . . 1.6 112.221 -173.207 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.4 t -115.3 103.57 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.031 1.333 . . . . 3.08 109.001 171.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.98 110.72 4.03 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.342 1.457 . . . . 3.14 112.194 -177.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 122.1 -24.65 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 131.136 3.774 . . . . 2.85 113.876 171.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.85 -11.28 58.29 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.412 1.46 . . . . 6.29 114.246 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 -21.49 64.69 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.782 -1.199 . . . . 2.62 112.785 168.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.65 3.44 16.37 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.355 1.062 . . . . 1.2 113.133 173.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.1 178.75 38.81 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.366 0.984 . . . . 2.21 113.564 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.2 -167.81 10.19 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.374 0.988 . . . . 1.39 112.952 171.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -72.29 52.34 0.26 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.222 1.809 . . . . 2.4 111.501 174.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.6 tp 37.3 58.67 1.23 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.71 2.004 . . . . 1.92 111.465 178.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 85.02 55.57 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.216 1.806 . . . . 4.82 112.273 -150.305 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.81 -63.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.648 2.899 . . . . 1.86 111.672 175.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -143.43 129.38 19.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.473 -1.677 . . . . 5.46 106.473 173.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 p30 174.73 -97.65 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.532 1.933 . . . . 4.57 112.196 179.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t 174.97 -45.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.991 2.516 . . . . 3.12 109.739 -166.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.14 -39.8 3.1 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 126.141 1.829 . . . . 3.94 116.374 149.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -43.26 -51.41 6.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.831 1.653 . . . . 3.96 113.546 -170.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' CE1' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER 162.48 150.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.605 3.162 . . . . 2.43 112.564 168.067 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -82.85 167.26 18.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.267 0.556 . . . . 3.44 112.057 171.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.88 -109.97 0.78 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.595 -1.669 . . . . 5.41 110.95 -167.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.02 -27.03 36.68 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.768 2.979 . . . . 7.58 114.711 -171.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.75 10.55 3.39 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.931 1.293 . . . . 9.63 112.454 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.62 73.23 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.025 -0.875 . . . . 4.13 114.807 171.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -82.94 51.14 1.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.265 1.532 . . . . 6.53 113.839 -166.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.81 -171.66 42.13 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 117.249 1.66 . . . . 2.14 117.249 -167.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -139.74 157.13 46.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.922 1.689 . . . . 5.0 110.848 171.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.413 ' H ' HD23 ' A' ' 91' ' ' LEU . 2.5 pt? -69.36 24.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.582 1.553 . . . . 2.4 115.186 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -153.56 23.46 0.74 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 128.572 2.987 . . . . 0.88 113.042 178.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' CE1' ' A' ' 82' ' ' HIS . 10.5 m-20 -80.53 138.62 36.53 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 106.75 -1.574 . . . . 2.13 106.75 154.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 111' ' ' ALA . 3.7 mp -143.59 147.8 40.81 Favored Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 121.744 2.065 . . . . 2.31 112.577 -171.404 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.94 157.94 54.13 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.124 3.216 . . . . 0.91 113.254 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -70.67 125.97 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 115.429 1.64 . . . . 1.64 115.429 -156.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 67.93 0.8 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.912 2.885 . . . . 1.53 110.313 170.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.8 134.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.508 -0.745 . . . . 1.05 109.429 174.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.601 HG23 ' HA ' ' A' ' 42' ' ' PRO . 6.4 m -115.0 152.14 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.006 0.922 . . . . 2.04 108.9 175.115 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 100' ' ' ASN . 0.1 OUTLIER -70.56 157.07 38.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.531 0.567 . . . . 2.74 112.531 -176.293 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -50.56 -22.55 2.04 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 126.935 2.094 . . . . 2.19 115.527 179.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -88.88 3.56 50.87 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.888 2.475 . . . . 3.76 113.892 -178.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 30.08 21.19 Favored Glycine 0 N--CA 1.475 1.277 0 O-C-N 121.135 -0.978 . . . . 0.67 115.283 173.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.8 131.56 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.252 1.421 . . . . 0.99 109.535 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.83 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.651 1.18 . . . . 0.93 109.969 176.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.9 t -149.4 -33.75 0.2 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.106 1.362 . . . . 1.67 113.183 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -66.13 121.52 76.73 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.848 0.859 . . . . 3.11 111.048 -178.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.65 152.31 22.66 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.149 3.233 . . . . 1.36 112.354 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.27 175.99 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.456 1.503 . . . . 1.26 110.22 170.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.6 m -146.39 143.81 29.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.587 1.155 . . . . 0.99 109.994 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -105.17 101.63 31.66 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.7 1.2 . . . . 1.31 111.766 175.365 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.38 -5.81 10.12 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.981 2.454 . . . . 1.65 116.195 -166.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -77.43 -17.13 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.553 1.524 . . . . 9.67 113.188 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.15 153.55 19.16 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.92 1.688 . . . . 2.91 109.421 -177.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 28.63 1.21 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.878 1.671 . . . . 4.37 111.333 170.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.7 m -163.29 133.54 4.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.344 1.857 . . . . 2.1 110.819 171.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.42 -27.47 67.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.271 1.428 . . . . 2.0 110.488 177.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.42 -26.88 5.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.396 1.878 . . . . 3.6 113.687 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -65.84 -11.67 48.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.461 1.105 . . . . 2.58 113.486 176.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.52 15.49 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.162 1.171 . . . . 0.71 114.162 -172.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -69.06 9.24 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 118.1 2.63 . . . . 2.12 118.1 -169.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -151.72 29.71 0.6 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.765 1.626 . . . . 3.37 111.676 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -116.47 155.22 28.97 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.788 -1.195 . . . . 2.9 112.222 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.97 141.26 28.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.296 0.638 . . . . 0.65 110.46 166.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 141.67 43.82 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.175 -0.676 . . . . 1.6 109.175 160.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.0 mtt -134.24 135.29 42.83 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.375 0.67 . . . . 1.36 112.594 -172.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.5 mt -82.13 105.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.609 1.163 . . . . 0.68 108.65 172.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.11 139.75 30.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.106 1.762 . . . . 2.33 110.979 -176.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.54 -39.08 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.871 -1.143 . . . . 1.69 112.443 -162.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -94.99 144.12 17.0 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.205 0.907 . . . . 1.29 112.043 176.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.39 156.64 25.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 127.014 2.245 . . . . 1.72 115.053 175.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.66 53.26 0.7 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.517 1.151 . . . . 3.2 113.268 -147.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -141.64 2.35 1.6 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.634 1.574 . . . . 2.53 113.423 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 71.2 mtm -92.6 126.47 37.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.121 0.968 . . . . 2.28 111.683 -171.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 -158.3 0.82 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.536 1.134 . . . . 3.27 110.921 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.24 -38.51 0.41 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 129.911 3.284 . . . . 3.65 114.135 -176.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -67.65 146.26 98.46 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.724 2.01 . . . . 3.31 113.42 -166.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.89 -40.44 44.16 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.521 3.481 . . . . 2.35 112.204 -172.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.23 101.42 11.23 Favored Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 105.889 -1.893 . . . . 4.36 105.889 162.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -75.77 179.44 6.25 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.429 2.753 . . . . 3.13 113.338 -162.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.1 mt 66.53 1.08 2.0 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.887 2.075 . . . . 3.83 113.987 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 61.74 27.12 67.83 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.698 1.135 . . . . 2.89 112.388 -175.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.6 -8.88 79.12 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.018 1.294 . . . . 1.95 114.354 -171.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.78 22.09 0.57 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.349 1.928 . . . . 2.19 115.86 -177.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.16 -15.26 65.04 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.936 1.255 . . . . 1.47 113.147 167.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.4 p -74.27 151.58 39.84 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.639 1.22 . . . . 1.71 110.013 172.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.93 142.31 30.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.472 1.109 . . . . 5.55 112.581 -171.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.34 -33.88 12.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.555 0.742 . . . . 2.77 112.235 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.89 155.99 41.66 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.259 1.024 . . . . 0.62 113.038 -176.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.43 151.67 45.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.932 2.093 . . . . 1.43 111.334 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.28 126.76 2.89 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.99 1.281 . . . . 0.66 112.545 173.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.48 123.45 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.955 1.302 . . . . 1.53 109.972 171.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.69 113.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.719 -0.845 . . . . 1.01 108.719 170.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt . . . . . 0 CA--C 1.54 0.585 0 O-C-N 121.745 -0.597 . . . . 3.75 111.121 -174.757 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.528 -0.545 . . . . 1.65 109.528 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -131.78 135.19 46.59 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.65 -1.281 . . . . 1.67 113.788 -137.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -144.7 148.8 34.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.134 1.373 . . . . 2.9 108.587 173.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -126.5 99.95 6.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.778 1.231 . . . . 4.33 110.866 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -90.29 122.24 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 121.861 -0.524 . . . . 1.05 109.985 -173.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.2 104.7 2.06 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.905 1.717 . . . . 0.69 110.752 174.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 mmm -86.93 89.45 7.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.422 1.489 . . . . 1.58 110.655 -175.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -75.39 148.37 39.24 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.231 -0.918 . . . . 2.76 111.04 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.13 140.72 58.24 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.53 -0.732 . . . . 1.33 109.796 174.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.7 138.82 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.892 0.877 . . . . 1.14 110.316 177.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -171.85 69.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.979 0.912 . . . . 2.68 111.909 -170.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 74.37 -42.46 0.5 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.592 2.357 . . . . 1.42 114.285 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.39 -9.22 58.23 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.486 1.039 . . . . 3.07 112.163 174.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.91 -147.82 17.99 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 125.909 1.719 . . . . 1.07 111.455 -173.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.8 t -58.85 127.04 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.795 1.638 . . . . 0.87 110.212 174.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.78 -97.71 2.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.32 0.962 . . . . 1.48 113.694 -168.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.29 127.93 12.41 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.707 1.203 . . . . 2.38 109.864 -170.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 t -90.98 149.95 21.66 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.056 1.132 . . . . 1.15 114.056 -160.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -143.07 -6.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 115.289 1.589 . . . . 2.74 115.289 -173.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.5 153.73 13.31 Favored Glycine 0 N--CA 1.469 0.861 0 O-C-N 120.625 -1.297 . . . . 0.6 114.556 -175.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.0 p -107.19 176.16 5.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.434 -0.95 . . . . 0.84 108.434 163.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.08 134.03 66.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.44 -0.948 . . . . 0.76 108.44 158.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.417 ' CG1' ' HB ' ' A' ' 34' ' ' THR . 14.5 p -88.48 130.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 123.7 0.625 . . . . 1.06 110.296 173.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.26 114.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.064 2.146 . . . . 1.51 108.399 -173.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.08 105.93 11.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.74 0.816 . . . . 2.12 111.348 175.642 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 133.76 55.24 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.107 2.563 . . . . 3.7 111.176 172.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 t -164.02 -172.02 2.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.209 0.604 . . . . 1.93 111.089 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.54 -38.25 66.38 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.674 1.189 . . . . 3.64 111.685 178.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.74 12.36 41.89 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.867 1.222 . . . . 1.28 115.297 173.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 -145.82 32.65 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 127.824 2.63 . . . . 0.98 112.042 -177.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.89 102.21 6.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.997 0.919 . . . . 1.02 111.614 -174.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.59 109.97 12.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.093 0.957 . . . . 2.19 110.556 175.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.95 105.77 17.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.875 2.47 . . . . 0.97 110.191 -169.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.417 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 3.0 m -110.7 108.99 57.99 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 107.84 -1.17 . . . . 1.25 107.84 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.43 157.11 22.27 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.807 2.338 . . . . 0.84 111.211 -177.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -142.78 37.09 1.44 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.911 0.862 . . . . 1.53 111.253 169.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -91.49 158.67 16.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 123.123 1.439 . . . . 0.78 113.841 -174.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' N ' ' HE3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -144.01 159.32 42.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.032 2.133 . . . . 2.96 108.38 174.525 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 85.52 23.66 0.08 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.465 2.706 . . . . 1.44 113.381 171.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.467 HD12 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -92.89 161.75 30.74 Favored Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 121.484 -0.76 . . . . 1.72 110.773 174.158 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.63 135.33 52.2 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 O-C-N 122.655 0.818 . . . . 0.97 110.068 164.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -92.65 24.05 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.968 3.112 . . . . 1.08 112.942 -149.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.7 158.11 15.1 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.003 -1.239 . . . . 2.24 110.003 167.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -51.2 130.9 27.38 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 128.302 2.641 . . . . 3.16 114.915 -175.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -103.83 138.36 40.53 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.832 1.253 . . . . 1.56 112.577 -171.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.63 150.66 50.91 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.926 -0.87 . . . . 0.73 110.926 166.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.92 119.85 28.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.099 -1.445 . . . . 2.02 107.099 175.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -115.25 153.64 30.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.922 0.889 . . . . 0.97 113.27 171.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.483 ' CG2' HD12 ' A' ' 74' ' ' LEU . 71.7 mt -94.75 144.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.396 1.078 . . . . 0.84 109.03 150.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -118.74 156.85 28.62 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.15 1.78 . . . . 0.93 110.214 176.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.1 62.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 117.101 2.26 . . . . 1.11 117.101 -159.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -134.75 -179.2 5.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.8 2.04 . . . . 1.34 110.44 175.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.84 100.55 0.54 Allowed Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.576 -1.327 . . . . 1.25 113.629 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.4 t 175.71 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.079 2.152 . . . . 2.01 110.987 173.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.2 m -71.4 43.43 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 126.902 2.081 . . . . 1.58 115.019 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -106.95 127.95 27.03 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.308 -1.495 . . . . 3.28 111.276 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.84 162.34 29.63 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.824 3.016 . . . . 1.1 112.305 173.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.12 145.76 40.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.125 0.97 . . . . 1.52 109.467 160.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mm -102.07 22.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.669 1.188 . . . . 3.4 111.321 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.14 129.46 27.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.131 1.373 . . . . 4.47 112.2 -175.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 t0 69.83 25.87 4.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.678 1.591 . . . . 3.35 112.737 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.64 28.07 44.55 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.722 1.153 . . . . 2.37 113.541 172.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -158.26 132.54 8.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.009 0.904 . . . . 2.7 110.773 -166.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.8 104.0 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.394 -0.816 . . . . 1.88 111.277 -174.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.61 41.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.674 1.589 . . . . 2.16 112.414 -175.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.46 -63.15 0.26 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.991 2.916 . . . . 1.75 115.563 172.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.77 128.31 2.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.074 2.55 . . . . 1.64 108.315 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -116.48 -46.71 2.76 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.435 1.094 . . . . 4.9 111.72 -177.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.54 -18.73 64.42 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.712 1.004 . . . . 1.41 113.712 -174.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.1 -8.39 56.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.161 1.384 . . . . 1.05 113.45 168.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.64 174.4 49.27 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 120.608 -1.307 . . . . 2.63 112.699 -172.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.37 -160.52 19.5 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 122.156 -0.614 . . . . 1.25 111.768 168.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -48.4 144.0 4.39 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.466 -0.568 . . . . 2.8 109.466 165.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -71.3 61.01 0.3 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.515 1.526 . . . . 2.5 112.152 179.614 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -118.85 -1.21 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 120.724 3.602 . . . . 4.05 120.724 -147.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.66 -56.84 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 123.505 2.288 . . . . 2.94 114.885 -151.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -92.76 54.85 2.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.632 1.173 . . . . 3.31 111.236 -177.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -123.94 -75.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.324 1.05 . . . . 3.39 111.651 174.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t 168.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 130.02 3.328 . . . . 2.57 111.257 -175.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.48 0.19 73.4 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 115.408 0.923 . . . . 1.92 115.408 164.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -84.22 3.87 33.33 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.604 1.705 . . . . 5.08 115.604 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 45.2 t60 62.25 -174.25 0.14 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.911 1.284 . . . . 1.8 111.662 -169.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.27 -155.14 0.47 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.558 -1.339 . . . . 3.98 111.467 -172.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.43 -101.56 0.64 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.041 -1.422 . . . . 2.83 111.007 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.9 -15.38 32.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.501 2.8 . . . . 4.0 113.357 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.59 157.37 12.39 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.77 2.828 . . . . 6.87 108.333 179.215 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.5 179.75 29.55 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.223 0.902 . . . . 4.02 114.857 177.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -156.13 35.64 0.34 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.935 2.094 . . . . 5.81 109.426 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.61 4.56 63.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 116.822 -2.099 . . . . 3.3 116.703 -172.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -177.12 99.5 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.358 1.863 . . . . 4.61 111.561 171.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -14.19 62.78 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.104 1.89 . . . . 3.0 116.104 -176.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 25.37 28.22 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 127.273 2.368 . . . . 1.58 115.537 -170.088 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -93.14 151.73 19.67 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.205 1.402 . . . . 3.05 110.384 167.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.63 157.91 76.23 Favored Pre-proline 0 CA--C 1.556 1.198 0 O-C-N 120.95 -1.094 . . . . 2.21 111.706 -161.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.7 162.38 41.41 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.96 3.106 . . . . 0.93 112.509 -171.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -83.19 128.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 123.431 1.586 . . . . 1.63 112.977 -161.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.03 83.22 6.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.556 2.742 . . . . 2.41 110.033 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.53 143.62 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 125.598 1.559 . . . . 1.0 111.105 176.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.42 157.25 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 127.598 2.359 . . . . 1.73 107.913 170.159 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 163.26 23.0 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 118.743 -0.646 . . . . 2.01 111.852 170.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -19.35 2.2 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.312 1.967 . . . . 3.53 116.312 -174.028 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -94.37 -2.33 52.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.658 1.583 . . . . 3.86 114.578 177.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.12 31.44 8.49 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.149 0.886 . . . . 1.0 115.174 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -116.53 133.78 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.768 1.627 . . . . 1.04 109.449 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.18 108.81 19.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.441 1.496 . . . . 0.69 109.546 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 t -131.43 24.59 4.8 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.079 1.752 . . . . 1.4 111.291 172.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.79 108.54 43.72 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.917 1.687 . . . . 3.04 108.933 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 129.87 14.65 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.791 2.327 . . . . 1.3 110.378 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.29 172.17 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.163 1.385 . . . . 1.5 108.972 175.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.3 m -151.22 145.59 25.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.226 0.921 . . . . 1.21 109.954 -171.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -112.45 89.64 12.99 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 112.992 0.738 . . . . 1.01 112.992 176.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 -4.91 12.86 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.856 3.038 . . . . 1.47 114.307 172.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -73.72 -18.92 60.94 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.751 2.02 . . . . 3.94 112.046 176.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.38 164.02 13.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.379 2.272 . . . . 2.67 108.405 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -154.37 6.11 0.28 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.295 1.591 . . . . 4.43 115.295 -172.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 t -168.95 130.41 1.2 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.338 -1.476 . . . . 1.93 113.099 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.35 -26.94 61.78 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.583 -1.323 . . . . 1.51 111.946 174.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.13 -16.69 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.676 1.361 . . . . 3.09 114.676 175.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.68 -12.89 52.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.385 1.448 . . . . 2.04 113.056 171.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.41 3.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.353 1.461 . . . . 0.9 114.587 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -62.35 -2.56 1.05 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.057 2.243 . . . . 2.36 117.057 -175.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -148.85 29.38 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.036 1.735 . . . . 3.3 110.826 174.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -111.87 -179.53 3.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.83 1.652 . . . . 1.54 111.578 178.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.31 151.74 48.95 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.003 -1.061 . . . . 0.6 111.124 168.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.74 153.48 33.34 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.441 1.097 . . . . 2.37 110.696 164.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.3 mtt -136.97 130.98 32.32 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.329 0.652 . . . . 1.23 110.94 -170.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.0 mt -84.74 109.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.76 107.131 168.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -91.95 147.03 23.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.002 2.121 . . . . 2.12 111.191 -175.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.71 -37.58 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.876 -1.14 . . . . 1.59 113.397 -162.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.16 170.92 15.16 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 124.506 1.05 . . . . 1.58 111.774 170.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.46 169.34 37.19 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 1.45 113.884 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -125.96 11.64 7.73 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.896 1.813 . . . . 2.46 115.896 -141.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.21 9.21 0.46 Allowed 'General case' 0 CA--C 1.553 1.093 0 O-C-N 120.126 -1.609 . . . . 2.87 115.229 -177.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 77.1 mtm -81.19 79.29 7.87 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.527 1.531 . . . . 3.04 112.31 -172.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -81.68 -5.09 57.77 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.957 0.903 . . . . 2.98 113.352 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -149.3 145.05 26.86 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.152 -1.592 . . . . 3.87 111.566 -173.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 151.27 153.88 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.091 1 C-N-CA 132.049 4.139 . . . . 4.1 110.166 173.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.71 -12.1 22.11 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.306 2.671 . . . . 2.15 114.382 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -77.93 116.0 54.99 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 119.76 1.164 . . . . 4.97 108.927 165.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.84 173.33 12.09 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.161 2.574 . . . . 4.35 112.948 -168.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.8 mt 67.04 11.21 8.26 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.355 1.862 . . . . 6.76 113.904 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.28 6.62 59.91 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.437 1.494 . . . . 4.77 114.481 177.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.93 -50.67 2.67 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.127 1.463 . . . . 3.18 114.581 175.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.31 45.14 1.73 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 126.58 2.038 . . . . 2.08 114.602 -175.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.74 -15.12 68.49 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.674 1.13 . . . . 1.84 114.657 -175.014 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.8 p -67.68 125.09 25.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.216 1.406 . . . . 1.94 112.244 -175.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 -91.01 150.41 21.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.011 1.724 . . . . 4.6 110.098 176.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 11.0 t80 -112.49 -42.04 3.74 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.795 0.725 . . . . 2.09 112.265 161.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.99 142.79 32.97 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.316 0.646 . . . . 0.69 112.607 177.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.02 143.44 44.31 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.503 1.521 . . . . 1.32 111.113 176.324 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.57 81.66 0.3 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 128.083 2.754 . . . . 0.77 110.962 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.76 135.66 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 118.091 0.945 . . . . 2.28 110.949 166.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.2 mt -107.54 140.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.045 1.338 . . . . 1.14 110.341 -167.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 3.86 109.822 177.493 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.568 -0.253 . . . . 3.26 110.989 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -155.67 152.45 28.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.095 1.358 . . . . 1.96 110.121 -170.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.84 122.73 5.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.055 0.931 . . . . 2.69 112.669 173.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.76 82.41 5.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.994 -1.066 . . . . 3.25 113.225 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.69 116.05 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.22 -0.925 . . . . 1.52 111.778 -169.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.09 90.38 1.2 Allowed Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.462 1.982 . . . . 1.16 112.319 -177.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mmt -72.81 120.8 18.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.95 . . . . 1.78 113.13 -175.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -104.44 144.37 31.75 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.074 1.75 . . . . 3.52 112.033 -178.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.64 66.53 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.42 1.088 . . . . 1.86 111.105 175.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 m -67.46 138.88 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.552 1.141 . . . . 0.96 110.304 174.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -165.81 61.1 0.11 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.745 0.784 . . . . 2.21 112.317 -171.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 70.61 -26.79 0.17 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.965 2.506 . . . . 1.16 115.265 171.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -17.44 61.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.301 2.24 . . . . 2.58 112.117 173.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.8 -168.04 13.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.545 2.022 . . . . 1.65 109.963 -160.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.2 t -56.64 139.5 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.327 0.651 . . . . 1.04 110.19 155.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.74 -128.2 4.7 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.927 1.727 . . . . 1.38 112.065 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -116.67 162.75 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.755 1.622 . . . . 4.4 111.009 178.224 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -128.45 156.5 43.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.083 0.953 . . . . 1.23 112.745 -164.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.74 7.53 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 125.005 1.322 . . . . 2.98 114.388 -162.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.84 173.82 24.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.063 1.315 . . . . 0.58 112.975 -179.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 p -105.18 174.34 5.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.78 0.832 . . . . 0.95 109.817 168.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 t -123.46 126.67 73.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.962 -1.496 . . . . 0.86 106.962 151.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.55 119.7 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 123.279 0.362 . . . . 0.96 111.408 -177.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.33 126.74 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.847 1.259 . . . . 1.18 108.545 174.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -130.34 127.16 38.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.917 0.887 . . . . 2.33 109.896 170.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 117' ' ' LEU . 12.8 tt0 -77.05 136.67 38.68 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.516 1.927 . . . . 3.37 112.302 -171.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -154.58 -175.53 5.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.254 0.934 . . . . 1.23 111.361 175.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.24 -30.62 70.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.013 0.925 . . . . 4.05 112.037 -179.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.11 11.77 41.07 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.892 0.758 . . . . 1.1 113.762 166.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.36 -141.16 21.92 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 127.441 2.448 . . . . 0.84 114.742 176.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.11 101.9 9.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.057 0.943 . . . . 0.63 111.296 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -78.06 108.24 11.21 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.983 1.313 . . . . 1.85 110.594 175.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -102.69 117.1 33.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.458 2.303 . . . . 0.62 110.269 -171.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 m -127.58 112.36 20.9 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 117.765 -1.112 . . . . 0.69 109.716 -172.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -88.62 159.43 6.42 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.188 2.592 . . . . 0.47 112.224 -173.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.08 25.31 0.72 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.446 0.906 . . . . 1.31 113.446 173.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.31 136.58 33.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.814 0.846 . . . . 0.66 112.822 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.09 156.98 18.99 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.677 -0.692 . . . . 2.6 111.198 161.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 98.15 20.39 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.806 2.442 . . . . 1.79 114.675 156.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.89 154.29 41.13 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 1.42 112.458 176.252 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.07 137.68 45.1 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 O-C-N 122.953 0.975 . . . . 1.6 110.911 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 101' ' ' ASN . 9.7 Cg_endo -85.24 51.74 3.12 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.489 3.459 . . . . 1.73 112.283 -162.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 -162.42 13.99 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 114.868 -1.06 . . . . 1.19 114.047 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.46 140.28 32.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.256 1.822 . . . . 2.69 110.214 171.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.87 136.55 30.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 1.42 109.683 -177.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.72 169.61 29.71 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.629 0.65 . . . . 0.73 112.347 167.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.39 132.68 10.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.209 1.404 . . . . 2.04 108.566 171.112 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HE2' ' CG ' ' A' ' 132' ' ' ASP . 15.6 m170 -129.79 170.49 13.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.231 1.567 . . . . 0.71 115.231 168.633 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 74' ' ' LEU . 44.3 mt -99.01 147.1 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.629 1.572 . . . . 0.61 109.151 153.201 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.59 152.34 40.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.168 1.787 . . . . 0.82 110.503 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.35 -31.44 72.57 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.435 2.013 . . . . 0.92 116.435 -160.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -113.73 169.8 8.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.858 1.663 . . . . 1.2 112.528 177.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.02 67.41 0.22 Allowed Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.948 1.139 . . . . 0.81 115.948 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -166.88 120.5 1.02 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 119.459 1.629 . . . . 2.07 114.572 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 33.4 m -69.93 -6.34 32.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.34 1.856 . . . . 1.43 115.157 176.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -63.96 145.02 98.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 O-C-N 120.993 -1.067 . . . . 3.2 111.825 -168.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.23 150.2 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.978 2.452 . . . . 1.28 111.752 179.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.25 140.96 34.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.517 0.727 . . . . 1.68 109.723 161.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.92 126.75 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.13 -1.063 . . . . 2.7 108.13 169.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -167.32 144.91 4.65 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.731 1.612 . . . . 5.25 109.971 -163.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 59.88 -104.73 0.2 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.072 1.349 . . . . 4.14 108.003 -163.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.68 25.4 3.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.934 1.73 . . . . 2.65 113.501 170.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.88 179.62 9.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.094 1.447 . . . . 4.52 113.318 -167.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.57 108.53 20.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.812 1.245 . . . . 1.66 112.679 -171.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.25 91.43 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.829 1.252 . . . . 2.05 109.937 -179.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.15 114.7 2.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.567 1.547 . . . . 2.98 112.859 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.26 39.18 7.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.54 1.536 . . . . 1.81 113.395 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.84 -43.0 90.64 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.409 0.684 . . . . 4.42 109.896 158.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.78 78.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.664 1.186 . . . . 1.8 113.002 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -16.36 8.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.816 2.046 . . . . 0.87 115.416 179.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.89 176.25 45.35 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 120.072 1.305 . . . . 2.31 112.561 -172.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.24 -175.92 22.72 Favored Glycine 0 N--CA 1.474 1.181 0 N-CA-C 111.732 -0.547 . . . . 1.4 111.732 163.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -70.17 35.88 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.907 1.447 . . . . 3.09 114.907 -176.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.489 HD12 ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER 71.81 89.73 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.2 1.8 . . . . 3.07 109.691 175.317 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.25 102.47 1.24 Allowed Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 127.287 2.235 . . . . 3.87 110.03 -172.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.42 -54.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.259 2.64 . . . . 1.93 111.561 173.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -132.37 15.2 4.55 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.052 1.296 . . . . 4.17 113.651 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.91 -47.17 63.52 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.427 -1.421 . . . . 3.61 111.388 -171.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t 178.16 -65.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.287 2.235 . . . . 2.85 111.855 175.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.29 -21.14 6.13 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.825 1.203 . . . . 1.92 114.502 -170.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -82.62 168.61 17.14 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.117 1.959 . . . . 4.32 113.83 170.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -84.52 146.09 27.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.336 1.054 . . . . 1.58 112.875 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 84' ' ' GLY . 7.1 tt0 -106.87 -156.81 0.59 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.505 1.122 . . . . 3.54 112.56 -178.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' A' ' 83' ' ' GLU . . . -160.47 -128.34 0.95 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 127.23 2.348 . . . . 3.13 110.478 179.081 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.95 -27.22 12.38 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.363 2.709 . . . . 5.55 113.353 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -174.18 164.85 4.07 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.664 2.386 . . . . 8.87 109.979 171.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.22 -135.36 7.72 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 125.796 1.665 . . . . 2.62 109.977 -174.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -142.67 116.13 9.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.289 1.044 . . . . 4.81 112.079 166.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.58 -139.44 3.24 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 127.474 2.464 . . . . 2.14 109.179 166.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -75.49 139.7 42.37 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 117.806 0.803 . . . . 3.7 112.674 176.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.5 -15.84 62.84 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.711 1.375 . . . . 1.98 114.711 177.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.03 9.79 76.15 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 118.496 -1.169 . . . . 0.86 114.892 175.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -82.84 136.09 34.74 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.87 1.335 . . . . 1.65 111.497 171.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 171.2 7.26 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.983 0.913 . . . . 1.91 111.066 -138.24 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.46 159.52 32.45 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.372 2.715 . . . . 1.22 112.45 -169.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -85.26 126.51 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 122.908 1.337 . . . . 1.46 113.423 -173.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.17 68.64 5.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.972 2.909 . . . . 1.64 110.878 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.53 144.76 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.73 0.812 . . . . 1.1 110.749 176.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.91 135.61 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 3.2 109.478 169.548 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.12 154.22 42.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.843 1.257 . . . . 3.21 113.876 178.015 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 42' ' ' PRO . 6.3 p30 -33.34 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 131.188 3.795 . . . . 3.16 118.953 179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -78.72 -21.52 47.94 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.567 1.547 . . . . 3.54 113.319 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.2 34.48 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 124.338 0.971 . . . . 1.31 114.852 178.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mt -124.32 117.13 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.037 1.335 . . . . 1.34 109.413 178.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 125.63 28.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.194 0.998 . . . . 0.61 111.152 -177.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 t -142.7 -7.14 0.86 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.592 1.557 . . . . 1.2 113.502 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.0 117.38 64.66 Favored Pre-proline 0 CA--C 1.55 0.946 0 O-C-N 121.038 -1.038 . . . . 3.27 111.193 -175.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 136.57 14.64 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.446 2.764 . . . . 1.07 111.281 176.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 m -139.97 155.82 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.785 1.234 . . . . 1.17 110.336 176.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.3 m -135.48 138.91 43.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.712 0.687 . . . . 0.78 110.915 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.29 99.77 50.25 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.237 1.015 . . . . 0.71 112.885 -174.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.22 -1.29 11.29 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.58 3.52 . . . . 1.28 115.384 -178.346 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -71.71 -25.32 62.03 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.158 0.89 . . . . 4.06 111.855 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.79 133.04 56.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.003 2.521 . . . . 2.09 106.802 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 12.29 1.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.756 1.021 . . . . 6.74 113.756 -164.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.4 p -132.45 164.09 27.32 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.054 -0.721 . . . . 2.89 109.054 146.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.8 -26.68 22.73 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.649 -0.657 . . . . 2.64 110.547 168.187 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.28 -44.89 44.39 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.391 1.476 . . . . 3.15 113.055 168.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.7 -2.34 14.23 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.877 1.066 . . . . 2.25 113.877 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 18.02 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.304 1.441 . . . . 0.91 113.806 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -64.99 -4.27 4.42 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 118.135 2.642 . . . . 2.17 118.135 -170.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -151.3 58.76 0.9 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.05 1.74 . . . . 4.34 109.9 169.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -114.58 147.93 38.77 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.081 1.352 . . . . 1.45 110.751 173.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.38 140.47 31.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.813 0.845 . . . . 0.8 110.354 164.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.41 149.12 36.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.558 1.943 . . . . 2.86 107.534 170.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 60.6 mtt -132.97 137.73 46.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.813 0.279 . . . . 1.53 111.728 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.53 124.36 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.967 -1.494 . . . . 0.66 106.967 165.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.32 137.97 51.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.289 1.036 . . . . 1.82 112.17 -162.25 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.69 -32.96 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.486 1.291 . . . . 2.7 114.486 -154.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.02 152.61 19.74 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.003 1.287 . . . . 1.32 111.55 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.9 140.35 16.71 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.907 1.717 . . . . 1.76 113.644 175.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.404 ' CG ' ' HE2' ' A' ' 48' ' ' HIS . 15.5 t0 -83.28 -0.02 47.75 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.284 1.587 . . . . 2.42 115.284 -152.394 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -77.2 -16.59 59.02 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.939 1.696 . . . . 3.46 114.977 -168.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.4 ptp -78.59 45.4 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.518 1.527 . . . . 3.11 113.829 -171.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 m -83.2 -33.76 26.08 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 117.902 2.556 . . . . 4.34 117.902 -146.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -92.95 21.77 5.45 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.296 1.039 . . . . 4.44 113.466 -162.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -75.22 146.43 81.69 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.546 1.138 . . . . 3.93 112.454 -172.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.07 -14.54 41.16 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.619 2.879 . . . . 1.92 112.913 173.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -83.58 101.77 1.55 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.695 -0.854 . . . . 4.03 108.695 151.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.24 146.28 93.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.387 2.058 . . . . 3.07 110.422 -177.202 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 mp 71.15 -3.25 2.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.783 2.033 . . . . 3.94 112.927 -173.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.66 5.88 40.02 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.817 1.675 . . . . 2.6 115.839 168.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.5 -38.45 3.01 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.309 1.433 . . . . 2.21 112.678 -167.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.31 -25.74 63.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.961 1.267 . . . . 1.75 114.349 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.43 2.7 14.05 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.88 1.228 . . . . 1.91 115.312 172.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.9 m -66.2 152.27 45.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.761 1.28 . . . . 2.04 108.885 164.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.66 133.24 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.276 1.03 . . . . 4.72 110.513 -169.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -98.09 -16.64 19.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.176 0.59 . . . . 2.36 111.366 156.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.49 160.73 35.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.137 0.88 . . . . 0.7 112.977 164.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.6 t -133.04 150.72 52.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.423 1.889 . . . . 1.54 109.825 167.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -161.21 136.34 4.38 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.393 1.473 . . . . 0.89 111.701 -178.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.96 139.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.119 0.968 . . . . 2.08 111.502 -174.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.03 149.55 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.172 1.389 . . . . 1.25 111.862 174.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 C--O 1.238 0.491 0 C-N-CA 125.311 1.444 . . . . 3.58 111.38 -176.411 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_